PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"32345310","Naloxone should remain the appropriate antidote to treat opioid overdose","Mégarbane B, Chevillard L, Vodovar D.","Crit Care. 2020 Apr 28;24(1):173. doi: 10.1186/s13054-020-2835-5.","Mégarbane B","Crit Care","2020","2020/04/30","PMC7187523","","10.1186/s13054-020-2835-5"
"32314951","Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment","Green TC, Bratberg J, Finnell DS.","Subst Abus. 2020;41(2):147-149. doi: 10.1080/08897077.2020.1752351.","Green TC","Subst Abus","2020","2020/04/22","","","10.1080/08897077.2020.1752351"
"32234712","Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study","Pearce LA, Min JE, Piske M, Zhou H, Homayra F, Slaunwhite A, Irvine M, McGowan G, Nosyk B.","BMJ. 2020 Mar 31;368:m772. doi: 10.1136/bmj.m772.","Pearce LA","BMJ","2020","2020/04/03","PMC7190018","","10.1136/bmj.m772"
"32216889","Postoverdose Initiation of Buprenorphine After Naloxone-Precipitated Withdrawal Is Encouraged as a Standard Practice in the California Bridge Network of Hospitals","Herring AA.","Ann Emerg Med. 2020 Apr;75(4):552-553. doi: 10.1016/j.annemergmed.2019.12.015.","Herring AA","Ann Emerg Med","2020","2020/03/29","","","10.1016/j.annemergmed.2019.12.015"
"32162401","Buprenorphine poisoning in children: a 10-year experience of Marseille Poison Center","Franchitto N.","Fundam Clin Pharmacol. 2020 Apr;34(2):263-264. doi: 10.1111/fcp.12547.","Franchitto N","Fundam Clin Pharmacol","2020","2020/03/13","","","10.1111/fcp.12547"
"32078355","Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017-2018","Weinstein LC, Iqbal Q, Cunningham A, Debates R, Landistratis G, Doggett P, Silverio A.","Am J Public Health. 2020 Apr;110(4):580-586. doi: 10.2105/AJPH.2019.305525. Epub 2020 Feb 20.","Weinstein LC","Am J Public Health","2020","2020/02/21","PMC7067078","","10.2105/AJPH.2019.305525"
"32066158","Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence","Chou R, Ballantyne J, Lembke A.","Ann Intern Med. 2020 Feb 18;172(4):294. doi: 10.7326/L19-0684.","Chou R","Ann Intern Med","2020","2020/02/18","","","10.7326/L19-0684"
"32066157","Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence","Schatman ME, Shapiro H, DiBenedetto DJ.","Ann Intern Med. 2020 Feb 18;172(4):293-294. doi: 10.7326/L19-0683.","Schatman ME","Ann Intern Med","2020","2020/02/18","","","10.7326/L19-0683"
"32033582","Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial","Zamani N, Buckley NA, Hassanian-Moghaddam H.","Crit Care. 2020 Feb 7;24(1):44. doi: 10.1186/s13054-020-2740-y.","Zamani N","Crit Care","2020","2020/02/09","PMC7006192","","10.1186/s13054-020-2740-y"
"32008394","Discontinuing Buprenorphine Treatment of Opioid Use Disorder: What Do We (Not) Know?","Connery HS, Weiss RD.","Am J Psychiatry. 2020 Feb 1;177(2):104-106. doi: 10.1176/appi.ajp.2019.19121245.","Connery HS","Am J Psychiatry","2020","2020/02/04","","","10.1176/appi.ajp.2019.19121245"
"31986185","Affective state determination in a mouse model of colitis-associated colorectal cancer","Chartier LC, Hebart ML, Howarth GS, Whittaker AL, Mashtoub S.","PLoS One. 2020 Jan 27;15(1):e0228413. doi: 10.1371/journal.pone.0228413. eCollection 2020.","Chartier LC","PLoS One","2020","2020/01/28","PMC6984705","","10.1371/journal.pone.0228413"
"31961408","Trends in Buprenorphine Treatment in the United States, 2009-2018","Olfson M, Zhang VS, Schoenbaum M, King M.","JAMA. 2020 Jan 21;323(3):276-277. doi: 10.1001/jama.2019.18913.","Olfson M","JAMA","2020","2020/01/22","PMC6990679","","10.1001/jama.2019.18913"
"31923197","Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data","Alexandridis AA, Dasgupta N, Ringwalt CL, Rosamond WD, Chelminski PR, Marshall SW.","PLoS One. 2020 Jan 10;15(1):e0227350. doi: 10.1371/journal.pone.0227350. eCollection 2020.","Alexandridis AA","PLoS One","2020","2020/01/11","PMC6953786","","10.1371/journal.pone.0227350"
"31914238","Abuses of FDA Regulatory Procedures - The Case of Suboxone","Haffajee RL, Frank RG.","N Engl J Med. 2020 Feb 6;382(6):496-498. doi: 10.1056/NEJMp1906680. Epub 2020 Jan 8.","Haffajee RL","N Engl J Med","2020","2020/01/09","","","10.1056/NEJMp1906680"
"31849027","A double blind randomized clinical trial of buprenorphine augmentation for treatment of psychotic symptoms in opioid addicted bipolar patients","Khalili N, Sabahi A, Vahedian M, Alimardanzadeh M.","J Opioid Manag. 2019 Sep/Oct;15(5):362-366. doi: 10.5055/jom.2019.0525.","Khalili N","J Opioid Manag","2019","2019/12/19","","","10.5055/jom.2019.0525"
"31834635","Interventions for female drug-using offenders","Perry AE, Martyn-St James M, Burns L, Hewitt C, Glanville JM, Aboaja A, Thakkar P, Santosh Kumar KM, Pearson C, Wright K.","Cochrane Database Syst Rev. 2019 Dec 13;12(12):CD010910. doi: 10.1002/14651858.CD010910.pub3.","Perry AE","Cochrane Database Syst Rev","2019","2019/12/14","PMC6910124","","10.1002/14651858.CD010910.pub3"
"31825240","An Ultra-Brief Mindfulness-Based Intervention for Patients in Treatment for Opioid Addiction with Buprenorphine: A Primary Care Feasibility Pilot Study","Bloom-Foster J, Mehl-Madrona L.","J Altern Complement Med. 2020 Jan;26(1):34-43. doi: 10.1089/acm.2019.0242. Epub 2019 Dec 11.","Bloom-Foster J","J Altern Complement Med","2020","2019/12/12","","","10.1089/acm.2019.0242"
"31801008","Opioid Use Disorder in Physicians","Bundy C.","N Engl J Med. 2019 Dec 5;381(23):2280-2281. doi: 10.1056/NEJMc1913323.","Bundy C","N Engl J Med","2019","2019/12/05","","","10.1056/NEJMc1913323"
"31801007","Opioid Use Disorder in Physicians","Lepley J.","N Engl J Med. 2019 Dec 5;381(23):2280. doi: 10.1056/NEJMc1913323.","Lepley J","N Engl J Med","2019","2019/12/05","","","10.1056/NEJMc1913323"
"31801006","Opioid Use Disorder in Physicians","DuPont RL.","N Engl J Med. 2019 Dec 5;381(23):2279-2280. doi: 10.1056/NEJMc1913323.","DuPont RL","N Engl J Med","2019","2019/12/05","","","10.1056/NEJMc1913323"
"31786933","Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder","Williams AR, Samples H, Crystal S, Olfson M.","Am J Psychiatry. 2020 Feb 1;177(2):117-124. doi: 10.1176/appi.ajp.2019.19060612. Epub 2019 Dec 2.","Williams AR","Am J Psychiatry","2020","2019/12/03","PMC7002204","NIHMS1060785","10.1176/appi.ajp.2019.19060612"
"31762128","Commentary on Rhee & Rosenheck (2019): Buprenorphine prescribing for opioid use disorder in medical practice - can office-based out-patient care address the opiate crisis in the United States?","Frank JW, Binswanger IA.","Addiction. 2020 Apr;115(4):786-787. doi: 10.1111/add.14907. Epub 2020 Jan 12.","Frank JW","Addiction","2020","2019/11/26","","","10.1111/add.14907"
"31747388","Abnormal Presentation of Hypoxic Ischemic Encephalopathy Attributed to Polysubstance Exposure","Maddox TR, Haas J, Andrews L, Miller B, Davies TH.","Am J Case Rep. 2019 Nov 20;20:1715-1718. doi: 10.12659/AJCR.918091.","Maddox TR","Am J Case Rep","2019","2019/11/21","PMC6878964","","10.12659/AJCR.918091"
"31732373","Treating Opioid Withdrawal With Buprenorphine in a Community Hospital Emergency Department: An Outreach Program","Edwards FJ, Wicelinski R, Gallagher N, McKinzie A, White R, Domingos A.","Ann Emerg Med. 2020 Jan;75(1):49-56. doi: 10.1016/j.annemergmed.2019.08.420. Epub 2019 Nov 13.","Edwards FJ","Ann Emerg Med","2020","2019/11/17","","","10.1016/j.annemergmed.2019.08.420"
"31724266","Commentary on Stein et al. (2020): Whither detoxification in the face of the opioid epidemic?","Nunes EV, Shulman M.","Addiction. 2020 Jan;115(1):95-96. doi: 10.1111/add.14834. Epub 2019 Nov 13.","Nunes EV","Addiction","2020","2019/11/15","","","10.1111/add.14834"
"31693402","Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation","Stancliff S, Greene D, Zucker HA.","Am J Public Health. 2019 Dec;109(12):1678-1679. doi: 10.2105/AJPH.2019.305370.","Stancliff S","Am J Public Health","2019","2019/11/07","PMC6836767","","10.2105/AJPH.2019.305370"
"31665157","A refinement approach in a mouse model of rehabilitation research. Analgesia strategy, reduction approach and infrared thermography in spinal cord injury","Redaelli V, Papa S, Marsella G, Grignaschi G, Bosi A, Ludwig N, Luzi F, Vismara I, Rimondo S, Veglianese P, Tepteva S, Mazzola S, Zerbi P, Porcu L, Roughan JV, Parati G, Calvillo L.","PLoS One. 2019 Oct 30;14(10):e0224337. doi: 10.1371/journal.pone.0224337. eCollection 2019.","Redaelli V","PLoS One","2019","2019/10/31","PMC6821094","","10.1371/journal.pone.0224337"
"31644840","Unique Pharmacokinetics of Buprenorphine During Pregnancy","Hollabaugh CR, Donovan B, Velazquez S, Sethi R.","Prim Care Companion CNS Disord. 2019 Oct 17;21(5):18l02390. doi: 10.4088/PCC.18l02390.","Hollabaugh CR","Prim Care Companion CNS Disord","2019","2019/10/24","","","10.4088/PCC.18l02390"
"31619286","Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?","Bonny-Noach H.","Isr J Health Policy Res. 2019 Oct 16;8(1):75. doi: 10.1186/s13584-019-0343-3.","Bonny-Noach H","Isr J Health Policy Res","2019","2019/10/18","PMC6796456","","10.1186/s13584-019-0343-3"
"31618091","Hospital Opioid Requirements Following Continuation Versus Discontinuation of Buprenorphine for Addiction - A Retrospective Cohort Study","Houchard G, Kullgren J, Saphire M, Porter K, Abel S.","J Pain Palliat Care Pharmacother. 2019 Sep-Dec;33(3-4):98-106. doi: 10.1080/15360288.2019.1668903. Epub 2019 Oct 16.","Houchard G","J Pain Palliat Care Pharmacother","2019","2019/10/17","","","10.1080/15360288.2019.1668903"
"31599845","Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis","Premkumar A, Grobman WA, Terplan M, Miller ES.","Obstet Gynecol. 2019 Nov;134(5):921-931. doi: 10.1097/AOG.0000000000003503.","Premkumar A","Obstet Gynecol","2019","2019/10/11","PMC6870188","NIHMS1058258","10.1097/AOG.0000000000003503"
"31592735","Pearls for opioid use in seriously ill patients","Kral L, Ku J, Kematick BS, Fudin J.","J Pain Palliat Care Pharmacother. 2019 Mar-Jun;33(1-2):54-58. doi: 10.1080/15360288.2019.1650870. Epub 2019 Oct 8.","Kral L","J Pain Palliat Care Pharmacother","2019","2019/10/09","","","10.1080/15360288.2019.1650870"
"31591014","Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose","Bagley SM, Larochelle MR, Xuan Z, Wang N, Patel A, Bernson D, Silverstein M, Hadland SE, Land T, Samet JH, Walley AY.","Ann Emerg Med. 2020 Jan;75(1):29-38. doi: 10.1016/j.annemergmed.2019.07.030. Epub 2019 Oct 4.","Bagley SM","Ann Emerg Med","2020","2019/10/09","","","10.1016/j.annemergmed.2019.07.030"
"31577058","Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia","Jones NR, Shanahan M, Dobbins T, Degenhardt L, Montebello M, Gisev N, Larney S.","Drug Alcohol Rev. 2019 Sep;38(6):690-698. doi: 10.1111/dar.12976.","Jones NR","Drug Alcohol Rev","2019","2019/10/03","PMC6777861","NIHMS1045296","10.1111/dar.12976"
"31573166","Opioid Use Disorder: Medical Treatment Options","Coffa D, Snyder H.","Am Fam Physician. 2019 Oct 1;100(7):416-425.","Coffa D","Am Fam Physician","2019","2019/10/02","","",""
"31573164","Common Misperceptions About Buprenorphine Prescribing for Opioid Use Disorder","Martin SA, Chiodo LM, Wilson A.","Am Fam Physician. 2019 Oct 1;100(7):396-397.","Martin SA","Am Fam Physician","2019","2019/10/02","","",""
"31556671","Integrating addiction medicine into rural primary care: Strategies and initial outcomes","Logan DE, Lavoie AM, Zwick WR, Kunz K, Bumgardner MA, Molina Y.","J Consult Clin Psychol. 2019 Oct;87(10):952-961. doi: 10.1037/ccp0000410.","Logan DE","J Consult Clin Psychol","2019","2019/09/27","","","10.1037/ccp0000410"
"31543255","Medication-Assisted Treatment for Opioid-Use Disorder","Oesterle TS, Thusius NJ, Rummans TA, Gold MS.","Mayo Clin Proc. 2019 Oct;94(10):2072-2086. doi: 10.1016/j.mayocp.2019.03.029. Epub 2019 Sep 19.","Oesterle TS","Mayo Clin Proc","2019","2019/09/24","","","10.1016/j.mayocp.2019.03.029"
"31533626","Analgesic treatment limits surrogate parameters for early stress and pain response after experimental subarachnoid hemorrhage","Staib-Lasarzik I, Nagel N, Sebastiani A, Griemert EV, Thal SC.","BMC Neurosci. 2019 Sep 18;20(1):49. doi: 10.1186/s12868-019-0531-7.","Staib-Lasarzik I","BMC Neurosci","2019","2019/09/20","PMC6751841","","10.1186/s12868-019-0531-7"
"31532339","Optimising opioid substitution therapy in the prison environment","Alam F, Wright N, Roberts P, Dhadley S, Townley J, Webster R.","Int J Prison Health. 2019 Dec 5;15(4):293-307. doi: 10.1108/IJPH-12-2017-0061.","Alam F","Int J Prison Health","2019","2019/09/19","PMC6761913","","10.1108/IJPH-12-2017-0061"
"31532281","Comparison between methadone and buprenorphine within the QUAD protocol for perioperative analgesia in cats undergoing ovariohysterectomy","Petty MC, Murrell J.","J Feline Med Surg. 2019 Dec;21(12):1206. doi: 10.1177/1098612X19878761. Epub 2019 Sep 18.","Petty MC","J Feline Med Surg","2019","2019/09/19","","","10.1177/1098612X19878761"
"31521065","Clinical applications of buprenorphine depot injection for opioid use disorder","Allikmets S, Vink JP.","Addiction. 2020 Jan;115(1):190. doi: 10.1111/add.14818. Epub 2019 Nov 12.","Allikmets S","Addiction","2020","2019/09/15","","","10.1111/add.14818"
"31513035","Using buprenorphine to treat patients with opioid use disorder","Radi JK, Fogarty KJ, Lagerwey MD.","JAAPA. 2019 Oct;32(10):30-35. doi: 10.1097/01.JAA.0000580544.64346.d7.","Radi JK","JAAPA","2019","2019/09/13","","","10.1097/01.JAA.0000580544.64346.d7"
"31513032","Treating patients with opioid use disorder","Lopes JE Jr.","JAAPA. 2019 Oct;32(10):10-11. doi: 10.1097/01.JAA.0000580564.02464.00.","Lopes JE Jr","JAAPA","2019","2019/09/13","","","10.1097/01.JAA.0000580564.02464.00"
"31495374","Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks","Camenga DR, Colon-Rivera HA, Muvvala SB.","J Stud Alcohol Drugs. 2019 Jul;80(4):393-402.","Camenga DR","J Stud Alcohol Drugs","2019","2019/09/10","","",""
"31473903","The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV","Hileman CO, McComsey GA.","Curr HIV/AIDS Rep. 2019 Oct;16(5):381-388. doi: 10.1007/s11904-019-00463-4.","Hileman CO","Curr HIV/AIDS Rep","2019","2019/09/02","PMC6814576","NIHMS1538784","10.1007/s11904-019-00463-4"
"31463524","Highly selective extraction and voltammetric determination of the opioid drug buprenorphine via a carbon paste electrode impregnated with nano-sized molecularly imprinted polymer","Alizadeh T, Atashi F, Akhoundian M, Ganjali MR.","Mikrochim Acta. 2019 Aug 28;186(9):654. doi: 10.1007/s00604-019-3736-7.","Alizadeh T","Mikrochim Acta","2019","2019/08/30","","","10.1007/s00604-019-3736-7"
"31450173","Increasing heroin, cocaine, and buprenorphine arrests reported to the Maine Diversion Alert Program","Simpson KJ, Moran MT, McCall KL, Herbert J, Foster ML, Simoyan OM, Shah DT, Desrosiers C, Nichols SD, Piper BJ.","Forensic Sci Int. 2019 Oct;303:109924. doi: 10.1016/j.forsciint.2019.109924. Epub 2019 Aug 8.","Simpson KJ","Forensic Sci Int","2019","2019/08/27","","","10.1016/j.forsciint.2019.109924"
"31446894","Commentary on physicians' satisfaction with providing buprenorphine treatment by Knudsen et al","Bart G, Samet J.","Addict Sci Clin Pract. 2019 Aug 26;14(1):33. doi: 10.1186/s13722-019-0164-2.","Bart G","Addict Sci Clin Pract","2019","2019/08/27","PMC6709547","","10.1186/s13722-019-0164-2"
"31436286","Bupenorphine in Wisconsin Drivers: Concerns for Impairment?","Edwards LD.","J Anal Toxicol. 2019 Sep 10;43(8):644-650. doi: 10.1093/jat/bkz068.","Edwards LD","J Anal Toxicol","2019","2019/08/23","","","10.1093/jat/bkz068"
"31428431","Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway","Handal M, Nechanská B, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Mravčík V.","Pharmacol Res Perspect. 2019 Aug 14;7(5):e00501. doi: 10.1002/prp2.501. eCollection 2019 Oct.","Handal M","Pharmacol Res Perspect","2019","2019/08/21","PMC6694203","","10.1002/prp2.501"
"31424700","Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls","Betcher HK, Vande Voort JL, Croarkin PE, Gandhi KD, Shekunov J, Larrabee BR, Limbeck MG, Rummans TA, Romanowicz M.","Prim Care Companion CNS Disord. 2019 Aug 15;21(4):19m02474. doi: 10.4088/PCC.19m02474.","Betcher HK","Prim Care Companion CNS Disord","2019","2019/08/20","","","10.4088/PCC.19m02474"
"31413139","Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment","Withey SL, Spealman RD, Bergman J, Paronis CA.","J Pharmacol Exp Ther. 2019 Nov;371(2):544-554. doi: 10.1124/jpet.119.259010. Epub 2019 Aug 14.","Withey SL","J Pharmacol Exp Ther","2019","2019/08/16","PMC6863455","","10.1124/jpet.119.259010"
"31404013","Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder","Chang HY, Daubresse M, Saloner B, Alexander GC.","Med Care. 2019 Sep;57(9):667-672. doi: 10.1097/MLR.0000000000001165.","Chang HY","Med Care","2019","2019/08/13","","","10.1097/MLR.0000000000001165"
"31399813","[New slow-release buprenorphine formulations for optimization of opioid substitution]","Soyka M, Pogarell O.","Nervenarzt. 2019 Sep;90(9):932-937. doi: 10.1007/s00115-019-0783-6.","Soyka M","Nervenarzt","2019","2019/08/11","","","10.1007/s00115-019-0783-6"
"31394416","Urine is superior to oral fluid for detecting buprenorphine compliance in patients undergoing treatment for opioid addiction","Ransohoff JR, Petrides AK, Piscitello GJ, Flood JG, Melanson SEF.","Drug Alcohol Depend. 2019 Oct 1;203:8-12. doi: 10.1016/j.drugalcdep.2019.06.015. Epub 2019 Aug 1.","Ransohoff JR","Drug Alcohol Depend","2019","2019/08/09","","","10.1016/j.drugalcdep.2019.06.015"
"31376396","Use of naltrexone in treating opioid use disorder in pregnancy","Towers CV, Katz E, Weitz B, Visconti K.","Am J Obstet Gynecol. 2020 Jan;222(1):83.e1-83.e8. doi: 10.1016/j.ajog.2019.07.037. Epub 2019 Jul 31.","Towers CV","Am J Obstet Gynecol","2020","2019/08/04","","","10.1016/j.ajog.2019.07.037"
"31364884","What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine","Vorspan F, Hjelmström P, Simon N, Benyamina A, Dervaux A, Brousse G, Jamain T, Kosim M, Rolland B.","Expert Opin Drug Deliv. 2019 Sep;16(9):907-914. doi: 10.1080/17425247.2019.1649252. Epub 2019 Aug 23.","Vorspan F","Expert Opin Drug Deliv","2019","2019/08/01","","","10.1080/17425247.2019.1649252"
"31362784","A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving","Ahmadi J, Sahraian A, Biuseh M.","Trials. 2019 Jul 30;20(1):468. doi: 10.1186/s13063-019-3554-6.","Ahmadi J","Trials","2019","2019/08/01","PMC6668115","","10.1186/s13063-019-3554-6"
"31361869","Medications for management of opioid use disorder","Koehl JL, Zimmerman DE, Bridgeman PJ.","Am J Health Syst Pharm. 2019 Jul 18;76(15):1097-1103. doi: 10.1093/ajhp/zxz105.","Koehl JL","Am J Health Syst Pharm","2019","2019/07/31","","","10.1093/ajhp/zxz105"
"31361663","Neuropathic Pain due to Neurofibromatosis Treated With Transcutaneous Electrical Nerve Stimulation in a Pregnant Patient: A Case Report","Caño Silva V, Serrano Afonso A.","A A Pract. 2019 Nov 1;13(9):329-331. doi: 10.1213/XAA.0000000000001068.","Caño Silva V","A A Pract","2019","2019/07/31","PMC6818987","","10.1213/XAA.0000000000001068"
"31358559","High Accumulation of Methadone Compared with Buprenorphine in Fetal Rat Brain after Maternal Exposure","Kongstorp M, Bogen IL, Stiris T, Andersen JM.","J Pharmacol Exp Ther. 2019 Oct;371(1):130-137. doi: 10.1124/jpet.119.259531. Epub 2019 Jul 29.","Kongstorp M","J Pharmacol Exp Ther","2019","2019/07/31","","","10.1124/jpet.119.259531"
"31351591","Buprenorphine in acute pain: a partial agonist or not?","Holyoak R, Vlok R, Melhuish T, Thang C, White L.","Br J Anaesth. 2019 Oct;123(4):e484-e485. doi: 10.1016/j.bja.2019.06.016. Epub 2019 Jul 24.","Holyoak R","Br J Anaesth","2019","2019/07/29","","","10.1016/j.bja.2019.06.016"
"31351113","Opioid receptor-mediated changes in the NMDA receptor in developing rat and chicken","Fjelldal MF, Hadera MG, Kongstorp M, Austdal LPE, Šulović A, Andersen JM, Paulsen RE.","Int J Dev Neurosci. 2019 Nov;78:19-27. doi: 10.1016/j.ijdevneu.2019.07.009. Epub 2019 Jul 24.","Fjelldal MF","Int J Dev Neurosci","2019","2019/07/28","","","10.1016/j.ijdevneu.2019.07.009"
"31344599","Epidemiology of severe buprenorphine exposures reported to the U.S. Poison Centers","Rege SV, Ngo DA, Ait-Daoud N, Holstege CP.","Drug Alcohol Depend. 2019 Sep 1;202:115-122. doi: 10.1016/j.drugalcdep.2019.05.015. Epub 2019 Jul 16.","Rege SV","Drug Alcohol Depend","2019","2019/07/26","","","10.1016/j.drugalcdep.2019.05.015"
"31343721","Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization","Kirane H, Drits E, Ahn S, Kapoor S, Morgenstern J, Conigliaro J, Enden J.","J Opioid Manag. 2019 May/Jun;15(3):193-204. doi: 10.5055/jom.2019.0503.","Kirane H","J Opioid Manag","2019","2019/07/26","","","10.5055/jom.2019.0503"
"31343716","Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management","O'Brien T, Ahn JS, Chye R, Le B, Lu H, Olarte G, Palladini M, Salti A, Shao YY, Yaakup H, Buemio KC, Colin CG, Hadjiat Y.","J Opioid Manag. 2019 Mar/Apr;15(2):147-158. doi: 10.5055/jom.2019.0496.","O'Brien T","J Opioid Manag","2019","2019/07/26","","","10.5055/jom.2019.0496"
"31333150","The time for emergency department opioid agonist therapy is now: ""A BC perspective""","Kestler A, Wale J, Allan M.","CJEM. 2019 Jul;21(4):443-445. doi: 10.1017/cem.2019.368.","Kestler A","CJEM","2019","2019/07/24","","","10.1017/cem.2019.368"
"31330267","""They're making it so hard for people to get help:"" Motivations for non-prescribed buprenorphine use in a time of treatment expansion","McLean K, Kavanaugh PR.","Int J Drug Policy. 2019 Sep;71:118-124. doi: 10.1016/j.drugpo.2019.06.019. Epub 2019 Jul 20.","McLean K","Int J Drug Policy","2019","2019/07/23","","","10.1016/j.drugpo.2019.06.019"
"31325758","'Too little dose - too early discontinuation?'-Effect of buprenorphine dose on short term treatment adherence in opioid dependence","Muruganandam P, Shukla L, Sharma P, Kandasamy A, Chand P, Murthy P.","Asian J Psychiatr. 2019 Aug;44:58-60. doi: 10.1016/j.ajp.2019.07.030. Epub 2019 Jul 15.","Muruganandam P","Asian J Psychiatr","2019","2019/07/21","","","10.1016/j.ajp.2019.07.030"
"31307211","Comparison of Single-Agent Versus 3-Additive Regional Anesthesia for Foot and Ankle Surgery","Dang DY, McGarry SM, Melbihess EJ, Haytmanek CT, Stith AT, Griffin MJ, Ackerman KJ, Hirose CB.","Foot Ankle Int. 2019 Oct;40(10):1195-1202. doi: 10.1177/1071100719859020. Epub 2019 Jul 16.","Dang DY","Foot Ankle Int","2019","2019/07/17","","","10.1177/1071100719859020"
"31306648","Strengthening opioid use disorder training among obstetrician-gynecologists: Hollander et al's call to action","Woods GT, Lim SL, Salinaro JR.","Am J Obstet Gynecol. 2019 Nov;221(5):533. doi: 10.1016/j.ajog.2019.07.014. Epub 2019 Jul 12.","Woods GT","Am J Obstet Gynecol","2019","2019/07/16","","","10.1016/j.ajog.2019.07.014"
"31305338","Pharmacokinetics of Single Doses of Methadone and Buprenorphine in Blood and Oral Fluid in Healthy Volunteers and Correlation With Effects on Psychomotor and Cognitive Functions","Strand MC, Ramaekers JG, Gjerde H, Mørland J, Vindenes V.","J Clin Psychopharmacol. 2019 Sep/Oct;39(5):489-493. doi: 10.1097/JCP.0000000000001077.","Strand MC","J Clin Psychopharmacol","2019","2019/07/16","","","10.1097/JCP.0000000000001077"
"31297963","Magnetocardiographic identification of prolonged fetal corrected QT interval in women receiving treatment for opioid use disorder","Bolin EH, Escalona-Vargas D, Daily JA, Siegel ER, Lowery CL, Coker J, Stowe ZN, Eswaran H.","J Obstet Gynaecol Res. 2019 Oct;45(10):1989-1996. doi: 10.1111/jog.14055. Epub 2019 Jul 11.","Bolin EH","J Obstet Gynaecol Res","2019","2019/07/13","","","10.1111/jog.14055"
"31287514","Association Between Medicare and FDA Policies and Prior Authorization Requirements for Buprenorphine Products in Medicare Part D Plans","Mark TL, Parish W, Zarkin GA.","JAMA. 2019 Jul 9;322(2):166-167. doi: 10.1001/jama.2019.6581.","Mark TL","JAMA","2019","2019/07/10","PMC6618771","","10.1001/jama.2019.6581"
"31287271","In Support of Buprenorphine Deregulation","Waters RC.","Fam Pract Manag. 2019 Jul/Aug;26(4):6-8.","Waters RC","Fam Pract Manag","2019","2019/07/10","","",""
"31283903","Reply","Hollander MAG, Jarlenski MP, Krans EE.","Am J Obstet Gynecol. 2019 Oct;221(4):372. doi: 10.1016/j.ajog.2019.07.006. Epub 2019 Jul 5.","Hollander MAG","Am J Obstet Gynecol","2019","2019/07/09","","","10.1016/j.ajog.2019.07.006"
"31279846","Improving treatment of opioid use disorder in pregnancy: first define the workforce","Eden AR, Barreto TW, St Louis J.","Am J Obstet Gynecol. 2019 Oct;221(4):371-372. doi: 10.1016/j.ajog.2019.07.005. Epub 2019 Jul 4.","Eden AR","Am J Obstet Gynecol","2019","2019/07/08","","","10.1016/j.ajog.2019.07.005"
"31279287","Facile design and development of photoluminescent graphene quantum dots grafted dextran/glycol-polymeric hydrogel for thermoresponsive triggered delivery of buprenorphine on pain management in tissue implantation","Yue J, He L, Tang Y, Yang L, Wu B, Ni J.","J Photochem Photobiol B. 2019 Aug;197:111530. doi: 10.1016/j.jphotobiol.2019.111530. Epub 2019 Jun 6.","Yue J","J Photochem Photobiol B","2019","2019/07/07","","","10.1016/j.jphotobiol.2019.111530"
"31274259","Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone","Varghese SP, Kumari P, Wijegunaratne H, Yovankin T, Garlapati V, Koola MM.","Prim Care Companion CNS Disord. 2019 Jul 3;21(4):19l02446. doi: 10.4088/PCC.19l02446.","Varghese SP","Prim Care Companion CNS Disord","2019","2019/07/06","","","10.4088/PCC.19l02446"
"31272821","Get Waivered: A Resident-Driven Campaign to Address the Opioid Overdose Crisis","Martin A, Kunzler N, Nakagawa J, Lee B, Wakeman S, Weiner S, Raja AS.","Ann Emerg Med. 2019 Nov;74(5):691-696. doi: 10.1016/j.annemergmed.2019.04.035. Epub 2019 Jul 2.","Martin A","Ann Emerg Med","2019","2019/07/06","","","10.1016/j.annemergmed.2019.04.035"
"31266495","Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study","Bech AB, Clausen T, Waal H, Šaltytė Benth J, Skeie I.","BMC Health Serv Res. 2019 Jul 2;19(1):440. doi: 10.1186/s12913-019-4282-z.","Bech AB","BMC Health Serv Res","2019","2019/07/04","PMC6604272","","10.1186/s12913-019-4282-z"
"31261299","Care and Treatment Recommendations for Pregnant Women with Opioid Use Disorder","Reising VA, Bergren MD, Bennett A.","MCN Am J Matern Child Nurs. 2019 Jul/Aug;44(4):212-218. doi: 10.1097/NMC.0000000000000538.","Reising VA","MCN Am J Matern Child Nurs","2019","2019/07/02","","","10.1097/NMC.0000000000000538"
"31261194","Prenatal Opioid Maintenance in the United States and Its Effect on Neonatal Abstinence Syndrome: The Case of West Virginia's Opioid Epidemic","Ruley M, Coustasse A.","Health Care Manag (Frederick). 2019 Jul/Sep;38(3):258-266. doi: 10.1097/HCM.0000000000000268.","Ruley M","Health Care Manag (Frederick)","2019","2019/07/02","","","10.1097/HCM.0000000000000268"
"31258036","A Mobile Buprenorphine Treatment Program for Homeless Patients With Opioid Use Disorder","Buzza C, Elser A, Seal J.","Psychiatr Serv. 2019 Jul 1;70(7):635-636. doi: 10.1176/appi.ps.70701.","Buzza C","Psychiatr Serv","2019","2019/07/02","","","10.1176/appi.ps.70701"
"31251931","Interventions for the Treatment of Neonatal Abstinence Syndrome","Cook CE, Fantasia HC.","Nurs Womens Health. 2019 Aug;23(4):357-365. doi: 10.1016/j.nwh.2019.05.006. Epub 2019 Jun 25.","Cook CE","Nurs Womens Health","2019","2019/06/29","","","10.1016/j.nwh.2019.05.006"
"31251426","Brief Report: Low-Barrier Buprenorphine Initiation Predicts Treatment Retention Among Latinx and Non-Latinx Primary Care Patients","Lee CS, Rosales R, Stein MD, Nicholls M, O'Connor BM, Loukas Ryan V, Davis EA.","Am J Addict. 2019 Sep;28(5):409-412. doi: 10.1111/ajad.12925. Epub 2019 Jun 28.","Lee CS","Am J Addict","2019","2019/06/29","PMC6706284","NIHMS1033654","10.1111/ajad.12925"
"31239086","Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder","Herring AA, Schultz CW, Yang E, Greenwald MK.","Am J Emerg Med. 2019 Dec;37(12):2259-2262. doi: 10.1016/j.ajem.2019.05.053. Epub 2019 May 29.","Herring AA","Am J Emerg Med","2019","2019/06/27","","","10.1016/j.ajem.2019.05.053"
"31238952","Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York","Neighbors CJ, Choi S, Healy S, Yerneni R, Sun T, Shapoval L.","Subst Abuse Treat Prev Policy. 2019 Jun 25;14(1):28. doi: 10.1186/s13011-019-0215-4.","Neighbors CJ","Subst Abuse Treat Prev Policy","2019","2019/06/27","PMC6593566","","10.1186/s13011-019-0215-4"
"31232604","Buprenorphine treatment for opioid use disorder: recent progress","Parida S, Carroll KM, Petrakis IL, Sofuoglu M.","Expert Rev Clin Pharmacol. 2019 Aug;12(8):791-803. doi: 10.1080/17512433.2019.1635454. Epub 2019 Jun 30.","Parida S","Expert Rev Clin Pharmacol","2019","2019/06/25","","","10.1080/17512433.2019.1635454"
"31229393","Balancing Benefits and Harms on the Frontier of Buprenorphine Initiation","Strayer RJ, Herring AA, Nelson LS.","Ann Emerg Med. 2019 Sep;74(3):433-435. doi: 10.1016/j.annemergmed.2019.04.024. Epub 2019 Jun 20.","Strayer RJ","Ann Emerg Med","2019","2019/06/24","","","10.1016/j.annemergmed.2019.04.024"
"31209656","Comprehensive Perioperative Management Considerations in Patients Taking Methadone","Cornett EM, Kline RJ, Robichaux SL, Green JB, Anyama BC, Gennuso SA, Okereke EC, Kaye AD.","Curr Pain Headache Rep. 2019 Jun 17;23(7):49. doi: 10.1007/s11916-019-0783-z.","Cornett EM","Curr Pain Headache Rep","2019","2019/06/19","","","10.1007/s11916-019-0783-z"
"31207453","A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients","Chang HY, Krawczyk N, Schneider KE, Ferris L, Eisenberg M, Richards TM, Lyons BC, Jackson K, Weiner JP, Saloner B.","Drug Alcohol Depend. 2019 Aug 1;201:127-133. doi: 10.1016/j.drugalcdep.2019.04.016. Epub 2019 Jun 7.","Chang HY","Drug Alcohol Depend","2019","2019/06/18","PMC6713520","NIHMS1038049","10.1016/j.drugalcdep.2019.04.016"
"31197827","Management and monitoring of opioid use in pregnancy","Rausgaard NLK, Ibsen IO, Jørgensen JS, Lamont RF, Ravn P.","Acta Obstet Gynecol Scand. 2020 Jan;99(1):7-15. doi: 10.1111/aogs.13677. Epub 2019 Jul 5.","Rausgaard NLK","Acta Obstet Gynecol Scand","2020","2019/06/15","","","10.1111/aogs.13677"
"31197606","Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder","Dong R, Wang H, Li D, Lang L, Gray F, Liu Y, Laffont CM, Young M, Jiang J, Liu Z, Learned SM.","Drugs R D. 2019 Sep;19(3):255-265. doi: 10.1007/s40268-019-0277-9.","Dong R","Drugs R D","2019","2019/06/15","PMC6738359","","10.1007/s40268-019-0277-9"
"31176949","Maternal buprenorphine treatment during pregnancy and maternal physiology","Jansson LM, Velez ML, McConnell K, Milio L, Spencer N, Jones H, DiPietro JA.","Drug Alcohol Depend. 2019 Aug 1;201:38-44. doi: 10.1016/j.drugalcdep.2019.03.018. Epub 2019 May 31.","Jansson LM","Drug Alcohol Depend","2019","2019/06/10","","","10.1016/j.drugalcdep.2019.03.018"
"31172852","Comparative study between prison- and community-based treatment satisfaction for opioid use disorder in Lebanon","Khalaf D, Hayek M, Bakhos JJ, Abou-Mrad F.","Int J Prison Health. 2019 Jun 10;15(2):138-152. doi: 10.1108/IJPH-12-2017-0064. Epub 2019 Feb 28.","Khalaf D","Int J Prison Health","2019","2019/06/08","","","10.1108/IJPH-12-2017-0064"
"31167053","Prevention of Opioid Overdose","Babu KM, Brent J, Juurlink DN.","N Engl J Med. 2019 Jun 6;380(23):2246-2255. doi: 10.1056/NEJMra1807054.","Babu KM","N Engl J Med","2019","2019/06/06","","","10.1056/NEJMra1807054"
"31166900","[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review]","Vieira C, Brás M, Fragoso M.","Acta Med Port. 2019 May 31;32(5):388-399. doi: 10.20344/amp.10500. Epub 2019 May 31.","Vieira C","Acta Med Port","2019","2019/06/06","","","10.20344/amp.10500"
"31162216","Pharmacology Update: Probuphine: The Long-Acting Buprenorphine Implant","Lorman WJ.","J Addict Nurs. 2019 Apr/Jun;30(2):123-124. doi: 10.1097/JAN.0000000000000282.","Lorman WJ","J Addict Nurs","2019","2019/06/05","","","10.1097/JAN.0000000000000282"
"31158866","The Next Stage of Buprenorphine Care for Opioid Use Disorder","Martin SA, Chiodo LM, Bosse JD, Wilson A.","Ann Intern Med. 2019 Jun 4;170(11):821-822. doi: 10.7326/L19-0145.","Martin SA","Ann Intern Med","2019","2019/06/04","","","10.7326/L19-0145"
"31158865","The Next Stage of Buprenorphine Care for Opioid Use Disorder","Duncan MH, Ratzliff AD, Powers DM, Banta-Green CJ, Saxon AJ.","Ann Intern Med. 2019 Jun 4;170(11):820-821. doi: 10.7326/L19-0144.","Duncan MH","Ann Intern Med","2019","2019/06/04","","","10.7326/L19-0144"
"31158864","The Next Stage of Buprenorphine Care for Opioid Use Disorder","Sherrick R.","Ann Intern Med. 2019 Jun 4;170(11):820. doi: 10.7326/L19-0143.","Sherrick R","Ann Intern Med","2019","2019/06/04","","","10.7326/L19-0143"
"31158863","The Next Stage of Buprenorphine Care for Opioid Use Disorder","Scolnick B.","Ann Intern Med. 2019 Jun 4;170(11):819-820. doi: 10.7326/L19-0142.","Scolnick B","Ann Intern Med","2019","2019/06/04","","","10.7326/L19-0142"
"31158862","The Next Stage of Buprenorphine Care for Opioid Use Disorder","Malinoff H.","Ann Intern Med. 2019 Jun 4;170(11):819. doi: 10.7326/L19-0141.","Malinoff H","Ann Intern Med","2019","2019/06/04","","","10.7326/L19-0141"
"31158851","Role of an Accurate Treatment Locator and Cash-Only Practices in Access to Buprenorphine for Opioid Use Disorders","Lagisetty PA, Bohnert A.","Ann Intern Med. 2019 Jul 2;171(1):58-59. doi: 10.7326/M19-1429. Epub 2019 Jun 4.","Lagisetty PA","Ann Intern Med","2019","2019/06/04","","","10.7326/M19-1429"
"31158849","Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality: An Audit Study","Beetham T, Saloner B, Wakeman SE, Gaye M, Barnett ML.","Ann Intern Med. 2019 Jul 2;171(1):1-9. doi: 10.7326/M18-3457. Epub 2019 Jun 4.","Beetham T","Ann Intern Med","2019","2019/06/04","PMC7164610","NIHMS1561593","10.7326/M18-3457"
"31153631","Perioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process","Goel A, Azargive S, Weissman JS, Shanthanna H, Hanlon JG, Samman B, Dominicis M, Ladha KS, Lamba W, Duggan S, Di Renna T, Peng P, Wong C, Sinha A, Eipe N, Martell D, Intrater H, MacDougall P, Kwofie K, St-Jean M, Rashiq S, Van Camp K, Flamer D, Satok-Wolman M, Clarke H.","Br J Anaesth. 2019 Aug;123(2):e333-e342. doi: 10.1016/j.bja.2019.03.044. Epub 2019 May 29.","Goel A","Br J Anaesth","2019","2019/06/03","PMC6676043","","10.1016/j.bja.2019.03.044"
"31150408","Comparing the Rat Grimace Scale and a composite behaviour score in rats","Klune CB, Larkin AE, Leung VSY, Pang D.","PLoS One. 2019 May 31;14(5):e0209467. doi: 10.1371/journal.pone.0209467. eCollection 2019.","Klune CB","PLoS One","2019","2019/06/01","PMC6544219","","10.1371/journal.pone.0209467"
"31140750","Enzymatic assay for urine lactose in the assessment of recent intravenous abuse of buprenorphine","Keltanen TN, Heikman PK, Muhonen LH, Gunnar TO, Ojanperä IA.","Drug Test Anal. 2019 Sep;11(9):1412-1418. doi: 10.1002/dta.2654. Epub 2019 Jun 23.","Keltanen TN","Drug Test Anal","2019","2019/05/30","","","10.1002/dta.2654"
"31134864","A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council","Otuonye IS, Banken R, Kumar VM, Pearson SD.","J Manag Care Spec Pharm. 2019 Jun;25(6):630-634. doi: 10.18553/jmcp.2019.25.6.630.","Otuonye IS","J Manag Care Spec Pharm","2019","2019/05/29","","","10.18553/jmcp.2019.25.6.630"
"31134856","The Individualized Treatment of Opioid Use Disorder","Boyett B.","J Manag Care Spec Pharm. 2019 Jun;25(6):634-636. doi: 10.18553/jmcp.2019.25.6.634.","Boyett B","J Manag Care Spec Pharm","2019","2019/05/29","","","10.18553/jmcp.2019.25.6.634"
"31131754","Allergic Contact Dermatitis to Fentanyl TTS with Good Tolerance to Systemic Fentanyl","Rojas-Pérez-Ezquerra P, Micozzi S, Torrado-Español I, Rodríguez-Fernández A, Albéndiz-Gutiérrez V, Noguerado-Mellado B.","Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):66-68. doi: 10.2174/1872213X13666190527105718.","Rojas-Pérez-Ezquerra P","Recent Pat Inflamm Allergy Drug Discov","2019","2019/05/28","PMC6778982","","10.2174/1872213X13666190527105718"
"31131668","Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment","Hallinan R, Elsayed M, Espinoza D, Veillard AS, Morley KC, Lintzeris N, Haber P.","Subst Use Misuse. 2019;54(10):1589-1598. doi: 10.1080/10826084.2018.1552298. Epub 2019 May 26.","Hallinan R","Subst Use Misuse","2019","2019/05/28","","","10.1080/10826084.2018.1552298"
"31131514","Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences","Neale J, Tompkins CNE, Strang J.","Drug Alcohol Rev. 2019 Jul;38(5):510-518. doi: 10.1111/dar.12939. Epub 2019 May 26.","Neale J","Drug Alcohol Rev","2019","2019/05/28","PMC6772117","","10.1111/dar.12939"
"31131505","Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder","Huhn AS, Berry MS, Dunn KE.","Am J Addict. 2019 Jul;28(4):246-261. doi: 10.1111/ajad.12921. Epub 2019 May 26.","Huhn AS","Am J Addict","2019","2019/05/28","PMC6591072","NIHMS1028481","10.1111/ajad.12921"
"31103879","Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program","Payne BE, Klein JW, Simon CB, James JR, Jackson SL, Merrill JO, Zhuang R, Tsui JI.","Drug Alcohol Depend. 2019 Jul 1;200:71-77. doi: 10.1016/j.drugalcdep.2019.03.009. Epub 2019 May 1.","Payne BE","Drug Alcohol Depend","2019","2019/05/20","","","10.1016/j.drugalcdep.2019.03.009"
"31094808","Dezocine Alleviates Morphine-Induced Dependence in Rats","Wu FX, Babazada H, Gao H, Huang XP, Xi CH, Chen CH, Xi J, Yu WF, Liu R.","Anesth Analg. 2019 Jun;128(6):1328-1335. doi: 10.1213/ANE.0000000000003365.","Wu FX","Anesth Analg","2019","2019/05/17","PMC6173660","NIHMS980436","10.1213/ANE.0000000000003365"
"31093953","Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials","Ghazanfarpour M, Najafi MN, Roozbeh N, Mashhadi ME, Keramat-Roudi A, Mégarbane B, Tsatsakis A, Moghaddam MMM, Rezaee R.","Daru. 2019 Jun;27(1):423-431. doi: 10.1007/s40199-019-00266-3. Epub 2019 May 15.","Ghazanfarpour M","Daru","2019","2019/05/17","PMC6593026","","10.1007/s40199-019-00266-3"
"31093318","Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood","Leventelis C, Goutzourelas N, Kortsinidou A, Spanidis Y, Toulia G, Kampitsi A, Tsitsimpikou C, Stagos D, Veskoukis AS, Kouretas D.","Oxid Med Cell Longev. 2019 Apr 9;2019:9417048. doi: 10.1155/2019/9417048. eCollection 2019.","Leventelis C","Oxid Med Cell Longev","2019","2019/05/17","PMC6481042","","10.1155/2019/9417048"
"31085795","An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability","Reindel KL, DeAngelis MJ, Ferrara AS, Conn KM, Phillips EM, Corigliano AT, Zhao F.","Int J Pharm Compd. 2019 May-Jun;23(3):258-263.","Reindel KL","Int J Pharm Compd","2019","2019/05/16","","",""
"31085525","Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States","Lin LA, Knudsen HK.","Ann Fam Med. 2019 May;17(3):212-220. doi: 10.1370/afm.2384.","Lin LA","Ann Fam Med","2019","2019/05/16","PMC6827617","","10.1370/afm.2384"
"31082666","Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP.","Drug Alcohol Depend. 2019 Jul 1;200:34-39. doi: 10.1016/j.drugalcdep.2019.02.031. Epub 2019 May 3.","Morgan JR","Drug Alcohol Depend","2019","2019/05/15","PMC6613830","NIHMS1530317","10.1016/j.drugalcdep.2019.02.031"
"31070927","Simultaneous Transdermal Delivery of Buprenorphine Hydrochloride and Naltrexone Hydrochloride by Iontophoresis","Cordery SF, Husbands SM, Bailey CP, Guy RH, Delgado-Charro MB.","Mol Pharm. 2019 Jun 3;16(6):2808-2816. doi: 10.1021/acs.molpharmaceut.9b00337. Epub 2019 May 22.","Cordery SF","Mol Pharm","2019","2019/05/10","","","10.1021/acs.molpharmaceut.9b00337"
"31067528","Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy","Gastberger S, Baumgartner MR, Soyka M, Quednow BB, Hulka LM, Herdener M, Seifritz E, Mutschler J.","Eur Addict Res. 2019;25(4):207-212. doi: 10.1159/000500542. Epub 2019 May 8.","Gastberger S","Eur Addict Res","2019","2019/05/09","","","10.1159/000500542"
"31066985","Long-Term Retention in an Outpatient Behavioral Health Clinic With Buprenorphine","Montalvo C, Stankiewicz B, Brochier A, Henderson DC, Borba CPC.","Am J Addict. 2019 Sep;28(5):339-346. doi: 10.1111/ajad.12896. Epub 2019 May 8.","Montalvo C","Am J Addict","2019","2019/05/09","","","10.1111/ajad.12896"
"31064390","Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH)","D'Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM, Huntley K, O'Connor PG, Fiellin DA.","Implement Sci. 2019 May 7;14(1):48. doi: 10.1186/s13012-019-0891-5.","D'Onofrio G","Implement Sci","2019","2019/05/09","PMC6505286","","10.1186/s13012-019-0891-5"
"31062848","Ascorbic Acid Improves the Stability of Buprenorphine in Frozen Whole Blood Samples","Sørensen LK, Hasselstrøm JB.","J Anal Toxicol. 2019 Jul 24;43(6):482-488. doi: 10.1093/jat/bkz033.","Sørensen LK","J Anal Toxicol","2019","2019/05/08","","","10.1093/jat/bkz033"
"31047741","Buprenorphine charges to uninsured patients at top-ranked U.S. hospitals","Niforatos JD, Dorner SC, Pescatore RM, Raja AS.","Am J Emerg Med. 2019 Dec;37(12):2253-2254. doi: 10.1016/j.ajem.2019.04.041. Epub 2019 Apr 24.","Niforatos JD","Am J Emerg Med","2019","2019/05/04","","","10.1016/j.ajem.2019.04.041"
"31046072","Medication-Based Treatment to Address Opioid Use Disorder","Leshner AI, Dzau VJ.","JAMA. 2019 Jun 4;321(21):2071-2072. doi: 10.1001/jama.2019.5523.","Leshner AI","JAMA","2019","2019/05/03","","","10.1001/jama.2019.5523"
"31036710","Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine","Simpson KJ, Moran MT, Foster ML, Shah DT, Chung DY, Nichols SD, McCall KL, Piper BJ.","BMJ Open. 2019 Apr 29;9(4):e027117. doi: 10.1136/bmjopen-2018-027117.","Simpson KJ","BMJ Open","2019","2019/05/01","PMC6501962","","10.1136/bmjopen-2018-027117"
"31036608","Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs","Artenie AA, Minoyan N, Jacka B, Høj S, Jutras-Aswad D, Roy É, Gauvin L, Zang G, Bruneau J.","CMAJ. 2019 Apr 29;191(17):E462-E468. doi: 10.1503/cmaj.181506.","Artenie AA","CMAJ","2019","2019/05/01","PMC6488472","","10.1503/cmaj.181506"
"31028107","In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome","Griffin BA, Caperton CO, Russell LN, Cabanlong CV, Wilson CD, Urquhart KR, Martins BS, Zita MD, Patton AL, Alund AW, Owens SM, Fantegrossi WE, Moran JH, Brents LK.","J Pharmacol Exp Ther. 2019 Jul;370(1):9-17. doi: 10.1124/jpet.118.254219. Epub 2019 Apr 26.","Griffin BA","J Pharmacol Exp Ther","2019","2019/04/28","PMC6538887","","10.1124/jpet.118.254219"
"31010564","Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome","Jones HE, Kraft WK.","Clin Perinatol. 2019 Jun;46(2):349-366. doi: 10.1016/j.clp.2019.02.013. Epub 2019 Mar 30.","Jones HE","Clin Perinatol","2019","2019/04/24","","","10.1016/j.clp.2019.02.013"
"31010456","Evaluation of Analgesic Patches in Cynomolgus Macaques (Macaca fascicularis)","Smith AA, Halliday LC, Lindeblad MO, Fortman JD.","J Am Assoc Lab Anim Sci. 2019 May 1;58(3):356-361. doi: 10.30802/AALAS-JAALAS-18-000101. Epub 2019 Apr 22.","Smith AA","J Am Assoc Lab Anim Sci","2019","2019/04/24","PMC6526491","","10.30802/AALAS-JAALAS-18-000101"
"31005380","Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery","Landau R.","Int J Obstet Anesth. 2019 Aug;39:105-116. doi: 10.1016/j.ijoa.2019.01.011. Epub 2019 Feb 10.","Landau R","Int J Obstet Anesth","2019","2019/04/22","","","10.1016/j.ijoa.2019.01.011"
"31003855","Cigarette smoking in subjects maintained with methadone or buprenorphine: The role of psychiatric symptoms and psychological distress","Cosci F, Mansueto G, Zamboni L, Lugoboni F.","J Psychosom Res. 2019 Jul;122:82-87. doi: 10.1016/j.jpsychores.2019.04.009. Epub 2019 Apr 12.","Cosci F","J Psychosom Res","2019","2019/04/21","","","10.1016/j.jpsychores.2019.04.009"
"30993833","Worries About Discontinuing Buprenorphine Treatment: Scale Development and Clinical Correlates","Stein MD, Conti MT, Herman DS, Anderson BJ, Bailey GL, Noppen DV, Abrantes AM.","Am J Addict. 2019 Jul;28(4):270-276. doi: 10.1111/ajad.12884. Epub 2019 Apr 16.","Stein MD","Am J Addict","2019","2019/04/18","PMC6591066","NIHMS1018748","10.1111/ajad.12884"
"30991036","Commonly used fluoroquinolones cross-react with urine drug screens for opiates, buprenorphine, and amphetamines","Colby JM, Patel PC, Fu DY, Rutherford NJ.","Clin Biochem. 2019 Jun;68:50-54. doi: 10.1016/j.clinbiochem.2019.04.009. Epub 2019 Apr 13.","Colby JM","Clin Biochem","2019","2019/04/17","","","10.1016/j.clinbiochem.2019.04.009"
"30990541","Making Amends for the Opioid Epidemic","Sharfstein JM, Olsen Y.","JAMA. 2019 Apr 16;321(15):1446-1447. doi: 10.1001/jama.2019.3505.","Sharfstein JM","JAMA","2019","2019/04/17","","","10.1001/jama.2019.3505"
"30973286","Overdose Risk and Client Characteristics Associated With the Injection of Buprenorphine at a Medically Supervised Injecting Center in Sydney, Australia","Power J, Salmon AM, Latimer J, Jauncey M, Day CA.","Subst Use Misuse. 2019;54(10):1646-1653. doi: 10.1080/10826084.2019.1600147. Epub 2019 Apr 11.","Power J","Subst Use Misuse","2019","2019/04/12","","","10.1080/10826084.2019.1600147"
"30970376","Effects of stimulation of mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys","Flynn SM, Epperly PM, Davenport AT, Cami-Kobeci G, Husbands SM, Ko MC, Czoty PW.","Neuropsychopharmacology. 2019 Jul;44(8):1476-1484. doi: 10.1038/s41386-019-0390-z. Epub 2019 Apr 10.","Flynn SM","Neuropsychopharmacology","2019","2019/04/11","PMC6784996","","10.1038/s41386-019-0390-z"
"30969219","Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder","Krans EE, Kim JY, James AE 3rd, Kelley D, Jarlenski MP.","Obstet Gynecol. 2019 May;133(5):943-951. doi: 10.1097/AOG.0000000000003231.","Krans EE","Obstet Gynecol","2019","2019/04/11","PMC6483844","NIHMS1522435","10.1097/AOG.0000000000003231"
"30964519","Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions","Spetz J, Toretsky C, Chapman S, Phoenix B, Tierney M.","JAMA. 2019 Apr 9;321(14):1407-1408. doi: 10.1001/jama.2019.0834.","Spetz J","JAMA","2019","2019/04/10","PMC6459110","","10.1001/jama.2019.0834"
"30880123","Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats","Moerke MJ, Negus SS.","Neuropharmacology. 2019 Jun;151:180-188. doi: 10.1016/j.neuropharm.2019.03.020. Epub 2019 Mar 14.","Moerke MJ","Neuropharmacology","2019","2019/03/19","PMC6500752","NIHMS1525743","10.1016/j.neuropharm.2019.03.020"
"30875647","Non drug-related and opioid-specific causes of 3262 deaths in Scotland's methadone-prescription clients, 2009-2015","Gao L, Robertson JR, Bird SM.","Drug Alcohol Depend. 2019 Apr 1;197:262-270. doi: 10.1016/j.drugalcdep.2019.01.019. Epub 2019 Feb 19.","Gao L","Drug Alcohol Depend","2019","2019/03/16","PMC6445802","","10.1016/j.drugalcdep.2019.01.019"
"30875177","Common elements in opioid use disorder guidelines for buprenorphine prescribing","Atkinson TJ, Pisansky AJB, Miller KL, Yong RJ.","Am J Manag Care. 2019 Mar 1;25(3):e88-e97.","Atkinson TJ","Am J Manag Care","2019","2019/03/16","","",""
"30867068","Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence","Godersky ME, Saxon AJ, Merrill JO, Samet JH, Simoni JM, Tsui JI.","Addict Sci Clin Pract. 2019 Mar 13;14(1):11. doi: 10.1186/s13722-019-0139-3.","Godersky ME","Addict Sci Clin Pract","2019","2019/03/15","PMC6417248","","10.1186/s13722-019-0139-3"
"30849238","Opioid use disorder deaths and the effects of medication therapy","Mannelli P, Wu LT.","Am J Drug Alcohol Abuse. 2019;45(3):227-229. doi: 10.1080/00952990.2019.1580289. Epub 2019 Mar 8.","Mannelli P","Am J Drug Alcohol Abuse","2019","2019/03/09","PMC6667376","NIHMS1041035","10.1080/00952990.2019.1580289"
"30848965","A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine","Kelty E, Joyce D, Hulse G.","Am J Drug Alcohol Abuse. 2019;45(3):285-291. doi: 10.1080/00952990.2018.1545131. Epub 2019 Mar 8.","Kelty E","Am J Drug Alcohol Abuse","2019","2019/03/09","","","10.1080/00952990.2018.1545131"
"30844221","Prescription Drug and Alcohol Use Disorders: Opioid Use Disorder","Witt L, Butler F.","FP Essent. 2019 Mar;478:19-24.","Witt L","FP Essent","2019","2019/03/08","","",""
"30831429","A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions","Ling S, Mangaoil R, Cleverley K, Sproule B, Puts M.","Drug Alcohol Depend. 2019 Apr 1;197:168-182. doi: 10.1016/j.drugalcdep.2019.02.007. Epub 2019 Feb 15.","Ling S","Drug Alcohol Depend","2019","2019/03/05","","","10.1016/j.drugalcdep.2019.02.007"
"30819839","Perioperative buprenorphine: are we asking the right questions?","Hurley RW.","Reg Anesth Pain Med. 2019 May;44(5):537-539. doi: 10.1136/rapm-2018-100205. Epub 2019 Feb 28.","Hurley RW","Reg Anesth Pain Med","2019","2019/03/02","","","10.1136/rapm-2018-100205"
"30811904","Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment","Binswanger IA.","N Engl J Med. 2019 Mar 28;380(13):1193-1195. doi: 10.1056/NEJMp1900069. Epub 2019 Feb 27.","Binswanger IA","N Engl J Med","2019","2019/02/28","","","10.1056/NEJMp1900069"
"30803850","Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey","Lowenstein M, Kilaru A, Perrone J, Hemmons J, Abdel-Rahman D, Meisel ZF, Delgado MK.","Am J Emerg Med. 2019 Sep;37(9):1787-1790. doi: 10.1016/j.ajem.2019.02.025. Epub 2019 Feb 18.","Lowenstein M","Am J Emerg Med","2019","2019/02/27","","","10.1016/j.ajem.2019.02.025"
"30801681","Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder","Schmith VD, Curd L, Lohmer LRL, Laffont CM, Andorn A, Young MA.","Clin Pharmacol Ther. 2019 Sep;106(3):576-584. doi: 10.1002/cpt.1406. Epub 2019 Apr 8.","Schmith VD","Clin Pharmacol Ther","2019","2019/02/26","PMC6766787","","10.1002/cpt.1406"
"30801358","Suppression of Human Natural Killer Cells by Different Classes of Opioids","Maher DP, Walia D, Heller NM.","Anesth Analg. 2019 May;128(5):1013-1021. doi: 10.1213/ANE.0000000000004058.","Maher DP","Anesth Analg","2019","2019/02/26","PMC6726115","NIHMS1046100","10.1213/ANE.0000000000004058"
"30794024","Definitive urine drug testing in office-based opioid treatment: a literature review","Barthwell AG, Allgaier J, Egli K.","Crit Rev Toxicol. 2018 Nov;48(10):829-852. doi: 10.1080/10408444.2018.1553935. Epub 2019 Feb 22.","Barthwell AG","Crit Rev Toxicol","2018","2019/02/23","","","10.1080/10408444.2018.1553935"
"30792007","Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","Haight BR, Learned SM, Laffont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Ling W, Heidbreder C; RB-US-13-0001 Study Investigators.","Lancet. 2019 Feb 23;393(10173):778-790. doi: 10.1016/S0140-6736(18)32259-1. Epub 2019 Feb 18.","Haight BR","Lancet","2019","2019/02/23","","","10.1016/S0140-6736(18)32259-1"
"30792006","Opioid addiction: long-acting formulations for a long-term disorder","Kunøe N, Lee JD.","Lancet. 2019 Feb 23;393(10173):723-724. doi: 10.1016/S0140-6736(18)32428-0. Epub 2019 Feb 18.","Kunøe N","Lancet","2019","2019/02/23","","","10.1016/S0140-6736(18)32428-0"
"30790376","Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate","Zheng D, Narayan SW, Zoega H, Litchfield M, Buckley NA, Pearson SA, Schaffer AL.","Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):521-527. doi: 10.1002/pds.4755. Epub 2019 Feb 20.","Zheng D","Pharmacoepidemiol Drug Saf","2019","2019/02/22","","","10.1002/pds.4755"
"30786192","Case 6-2019: A 29-Year-Old Woman with Nausea, Vomiting, and Diarrhea","Walley AY, Wakeman SE, Eng G.","N Engl J Med. 2019 Feb 21;380(8):772-779. doi: 10.1056/NEJMcpc1816407.","Walley AY","N Engl J Med","2019","2019/02/21","","","10.1056/NEJMcpc1816407"
"30773411","Elective Naloxone-Induced Opioid Withdrawal for Rapid Initiation of Medication-Assisted Treatment of Opioid Use Disorder","Phillips RH, Salzman M, Haroz R, Rafeq R, Mazzarelli AJ, Pelletier-Bui A.","Ann Emerg Med. 2019 Sep;74(3):430-432. doi: 10.1016/j.annemergmed.2019.01.006. Epub 2019 Feb 14.","Phillips RH","Ann Emerg Med","2019","2019/02/19","","","10.1016/j.annemergmed.2019.01.006"
"30772733","Transdermal buprenorphine patch: Potential for role in management of opioid dependence","Dhawan A, Modak T, Sarkar S.","Asian J Psychiatr. 2019 Feb;40:88-91. doi: 10.1016/j.ajp.2019.02.002. Epub 2019 Feb 10.","Dhawan A","Asian J Psychiatr","2019","2019/02/18","","","10.1016/j.ajp.2019.02.002"
"30769264","Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment","Baldassarri SR, Fiellin DA, Savage ME, Madden LM, Beitel M, Dhingra LK, Fucito L, Camenga D, Bollampally P, Barry DT.","Drug Alcohol Depend. 2019 Apr 1;197:37-41. doi: 10.1016/j.drugalcdep.2018.12.012. Epub 2019 Jan 17.","Baldassarri SR","Drug Alcohol Depend","2019","2019/02/16","PMC6637405","NIHMS1041179","10.1016/j.drugalcdep.2018.12.012"
"30753557","A Novel Enzyme Immunoassay for the Detection of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine","Schubert B, Pitterl F, Saxl B, Pavlic M.","J Anal Toxicol. 2019 Jun 1;43(5):364-368. doi: 10.1093/jat/bkz003.","Schubert B","J Anal Toxicol","2019","2019/02/13","","","10.1093/jat/bkz003"
"30747957","Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018","Hartung DM, Johnston K, Geddes J, Leichtling G, Priest KC, Korthuis PT.","JAMA. 2019 Feb 12;321(6):607-609. doi: 10.1001/jama.2018.20391.","Hartung DM","JAMA","2019","2019/02/13","PMC6439585","","10.1001/jama.2018.20391"
"30745219","Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS)","Mangat AK, Schmölzer GM, Kraft WK.","Semin Fetal Neonatal Med. 2019 Apr;24(2):133-141. doi: 10.1016/j.siny.2019.01.009. Epub 2019 Feb 5.","Mangat AK","Semin Fetal Neonatal Med","2019","2019/02/13","PMC6451887","NIHMS1520752","10.1016/j.siny.2019.01.009"
"30741850","Opioid use disorder during pregnancy: An overview","Carter LC, Read MA, Read L, Nicholas JS, Schmidt E.","JAAPA. 2019 Mar;32(3):20-24. doi: 10.1097/01.JAA.0000553378.44766.1d.","Carter LC","JAAPA","2019","2019/02/12","","","10.1097/01.JAA.0000553378.44766.1d"
"30740990","Buprenorphine Overdose in Young Children: An Underappreciated Risk","Lo Re M, Chaplin M, Aronow B, Modesto-Lowe V.","Clin Pediatr (Phila). 2019 Jun;58(6):613-617. doi: 10.1177/0009922819829038. Epub 2019 Feb 10.","Lo Re M","Clin Pediatr (Phila)","2019","2019/02/12","","","10.1177/0009922819829038"
"30729038","Survey on current treatments for pain after spinal cord damage","Stillman M, Graves D, New PW, Bryce T, Alexander M.","Spinal Cord Ser Cases. 2019 Feb 5;5:14. doi: 10.1038/s41394-019-0160-5. eCollection 2019.","Stillman M","Spinal Cord Ser Cases","2019","2019/02/08","PMC6363782","","10.1038/s41394-019-0160-5"
"30726142","Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis","Van Zee A, Fiellin DA.","Am J Public Health. 2019 Mar;109(3):393-394. doi: 10.2105/AJPH.2018.304899.","Van Zee A","Am J Public Health","2019","2019/02/07","PMC6366517","","10.2105/AJPH.2018.304899"
"30725220","Sex-by-formulation interaction in bioequivalence trials with transdermal patches","González-Rojano E, Marcotegui J, Morales-Alcelay S, Álvarez C, Gordon J, Abad-Santos F, García-Arieta A.","Eur J Clin Pharmacol. 2019 Jun;75(6):801-808. doi: 10.1007/s00228-019-02632-1. Epub 2019 Feb 6.","González-Rojano E","Eur J Clin Pharmacol","2019","2019/02/07","","","10.1007/s00228-019-02632-1"
"30707218","Should Physicians Recommend Replacing Opioids With Cannabis?","Humphreys K, Saitz R.","JAMA. 2019 Feb 19;321(7):639-640. doi: 10.1001/jama.2019.0077.","Humphreys K","JAMA","2019","2019/02/02","","","10.1001/jama.2019.0077"
"30703340","Medical specialty of buprenorphine prescribers for pregnant women with opioid use disorder","Hollander MAG, Jarlenski MP, Donohue JM, Cole ES, Kelley D, Krans EE.","Am J Obstet Gynecol. 2019 May;220(5):502-503. doi: 10.1016/j.ajog.2019.01.226. Epub 2019 Jan 28.","Hollander MAG","Am J Obstet Gynecol","2019","2019/02/01","PMC6518408","NIHMS1027939","10.1016/j.ajog.2019.01.226"
"30685701","Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression","Lin C, Karim HT, Pecina M, Aizenstein HJ, Lenze EJ, Blumberger DM, Mulsant BH, Kharasch ED, Reynolds Iii CF, Karp JF.","Neuroimage Clin. 2019;21:101679. doi: 10.1016/j.nicl.2019.101679. Epub 2019 Jan 22.","Lin C","Neuroimage Clin","2019","2019/01/28","PMC6356006","","10.1016/j.nicl.2019.101679"
"30684117","Medications for Treatment of Opioid Use Disorder among Persons Living with HIV","Fanucchi L, Springer SA, Korthuis PT.","Curr HIV/AIDS Rep. 2019 Feb;16(1):1-6. doi: 10.1007/s11904-019-00436-7.","Fanucchi L","Curr HIV/AIDS Rep","2019","2019/01/27","PMC6420833","NIHMS1010433","10.1007/s11904-019-00436-7"
"30678935","In situ synthesis of rhodium nanoparticles - Mesoporous carbon hybrid via a novel and facile nanocasting method for simultaneous determination of morphine and buprenorphine","Jahanbakhshi M.","Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:479-485. doi: 10.1016/j.msec.2018.12.019. Epub 2018 Dec 14.","Jahanbakhshi M","Mater Sci Eng C Mater Biol Appl","2019","2019/01/26","","","10.1016/j.msec.2018.12.019"
"30676805","Criminal Justice Barriers to Treatment of Opioid Use Disorders in the United States: The Need for Public Health Advocacy","Csete J.","Am J Public Health. 2019 Mar;109(3):419-422. doi: 10.2105/AJPH.2018.304852. Epub 2019 Jan 24.","Csete J","Am J Public Health","2019","2019/01/25","PMC6366485","","10.2105/AJPH.2018.304852"
"30676789","Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs","Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD.","Am J Public Health. 2019 Mar;109(3):434-436. doi: 10.2105/AJPH.2018.304856. Epub 2019 Jan 24.","Andrews CM","Am J Public Health","2019","2019/01/25","PMC6366513","","10.2105/AJPH.2018.304856"
"30676296","No end to the crisis without an end to the waiver","Frank JW, Wakeman SE, Gordon AJ.","Subst Abus. 2018;39(3):263-265. doi: 10.1080/08897077.2018.1543382.","Frank JW","Subst Abus","2018","2019/01/25","","","10.1080/08897077.2018.1543382"
"30667482","Pharmacologic Treatment for Neonatal Abstinence Syndrome: Which Medication Is Best?","Wachman EM, Werler MM.","JAMA Pediatr. 2019 Mar 1;173(3):221-223. doi: 10.1001/jamapediatrics.2018.5029.","Wachman EM","JAMA Pediatr","2019","2019/01/23","","","10.1001/jamapediatrics.2018.5029"
"30667476","Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis","Disher T, Gullickson C, Singh B, Cameron C, Boulos L, Beaubien L, Campbell-Yeo M.","JAMA Pediatr. 2019 Mar 1;173(3):234-243. doi: 10.1001/jamapediatrics.2018.5044.","Disher T","JAMA Pediatr","2019","2019/01/23","PMC6439896","","10.1001/jamapediatrics.2018.5044"
"30666748","Commentary on Jones & McCance-Katze (2019): Buprenorphine and the glass half full-why can't we prescribe more of it, and will nurse practitioners and physician assistants fulfill a chronic unmet need?","Lee JD, McNeely J.","Addiction. 2019 Mar;114(3):483-484. doi: 10.1111/add.14545. Epub 2019 Jan 21.","Lee JD","Addiction","2019","2019/01/23","","","10.1111/add.14545"
"30665272","County-level access to opioid use disorder medications in medicare Part D (2010-2015)","Abraham AJ, Adams GB, Bradford AC, Bradford WD.","Health Serv Res. 2019 Apr;54(2):390-398. doi: 10.1111/1475-6773.13113. Epub 2019 Jan 21.","Abraham AJ","Health Serv Res","2019","2019/01/22","PMC6407357","","10.1111/1475-6773.13113"
"30664299","Buprenorphine for the treatment of posttraumatic stress disorder","Lake EP, Mitchell BG, Shorter DI, Kosten T, Domingo CB, Walder AM.","Am J Addict. 2019 Feb;28(2):86-91. doi: 10.1111/ajad.12860. Epub 2019 Jan 21.","Lake EP","Am J Addict","2019","2019/01/22","","","10.1111/ajad.12860"
"30660808","Rapid, hydrolysis-free, dilute-and-shoot method for the determination of buprenorphine, norbuprenorphine and their glucuronides in urine samples using UHPLC-MS/MS","Agostini M, Renzoni C, Pierini E, Piergiovanni M, Termopoli V, Famiglini G, Palma P, Cappiello A.","J Pharm Biomed Anal. 2019 Mar 20;166:236-243. doi: 10.1016/j.jpba.2019.01.014. Epub 2019 Jan 11.","Agostini M","J Pharm Biomed Anal","2019","2019/01/21","","","10.1016/j.jpba.2019.01.014"
"30660555","High in the sky: Iatrogenic in-flight opioid overdose caused by a dangerous emergency medical kit","Wang JJ, Su MK, Biary R, Hoffman RS.","Travel Med Infect Dis. 2019 Sep-Oct;31:101376. doi: 10.1016/j.tmaid.2019.01.011. Epub 2019 Jan 17.","Wang JJ","Travel Med Infect Dis","2019","2019/01/21","","","10.1016/j.tmaid.2019.01.011"
"30646185","Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees","Wen H, Hockenberry JM, Pollack HA.","JAMA Netw Open. 2018 Sep 7;1(5):e182943. doi: 10.1001/jamanetworkopen.2018.2943.","Wen H","JAMA Netw Open","2018","2019/01/16","PMC6324514","","10.1001/jamanetworkopen.2018.2943"
"30641451","Overdose mortality rates in Croatia and factors associated with self-reported drug overdose among persons who inject drugs in three Croatian cities","Handanagic S, Bozicevic I, Sekerija M, Rutherford GW, Begovac J.","Int J Drug Policy. 2019 Feb;64:95-102. doi: 10.1016/j.drugpo.2018.11.017. Epub 2019 Jan 12.","Handanagic S","Int J Drug Policy","2019","2019/01/15","","","10.1016/j.drugpo.2018.11.017"
"30640372","Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment","Raheemullah A, Lembke A.","JAMA Intern Med. 2019 Mar 1;179(3):427-428. doi: 10.1001/jamainternmed.2018.6749.","Raheemullah A","JAMA Intern Med","2019","2019/01/15","","","10.1001/jamainternmed.2018.6749"
"30629277","A claims analysis of the utilization of tramadol for acute pain in patients prescribed buprenorphine/naloxone for opioid use disorder","Donovan K, Kogut S, Buchanan A, Wen X, Crausman R.","J Opioid Manag. 2018 Nov/Dec;14(6):407-413. doi: 10.5055/jom.2018.0473.","Donovan K","J Opioid Manag","2018","2019/01/11","PMC6476537","NIHMS1012399","10.5055/jom.2018.0473"
"30625491","Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study","Lugoboni F, Zamboni L, Cibin M, Tamburin S; Gruppo InterSERT di Collaborazione Scientifica (GICS).","Eur Addict Res. 2019;25(1):10-19. doi: 10.1159/000496112. Epub 2019 Jan 9.","Lugoboni F","Eur Addict Res","2019","2019/01/10","","","10.1159/000496112"
"30622223","Effect of addition of buprenorphine or dexamethasone to levobupivacaine on postoperative analgesia in ultrasound guided transversus abdominis plane block in patients undergoing unilateral inguinal hernia repair: a prospective randomized double blind controlled trial","Seervi SN, Singariya G, Kamal M, Kumari K, Siddeshwara A, Ujwal S.","Korean J Anesthesiol. 2019 Jun;72(3):245-252. doi: 10.4097/kja.d.18.00182. Epub 2019 Jan 9.","Seervi SN","Korean J Anesthesiol","2019","2019/01/10","PMC6547228","","10.4097/kja.d.18.00182"
"30617273","The importance of buprenorphine research in the opioid crisis","Pendergrass SA, Crist RC, Jones LK, Hoch JR, Berrettini WH.","Mol Psychiatry. 2019 May;24(5):626-632. doi: 10.1038/s41380-018-0329-5. Epub 2019 Jan 7.","Pendergrass SA","Mol Psychiatry","2019","2019/01/09","","","10.1038/s41380-018-0329-5"
"30616926","Managing Opioid Withdrawal in the Emergency Department With Buprenorphine","Herring AA, Perrone J, Nelson LS.","Ann Emerg Med. 2019 May;73(5):481-487. doi: 10.1016/j.annemergmed.2018.11.032. Epub 2019 Jan 5.","Herring AA","Ann Emerg Med","2019","2019/01/09","","","10.1016/j.annemergmed.2018.11.032"
"30616487","Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder","Peeler M, Fiscella K, Terplan M, Sufrin C.","J Correct Health Care. 2019 Jan;25(1):4-14. doi: 10.1177/1078345818819855. Epub 2019 Jan 7.","Peeler M","J Correct Health Care","2019","2019/01/09","PMC6543816","NIHMS1031173","10.1177/1078345818819855"
"30615523","Trends In Buprenorphine Prescribing By Physician Specialty","Wen H, Borders TF, Cummings JR.","Health Aff (Millwood). 2019 Jan;38(1):24-28. doi: 10.1377/hlthaff.2018.05145.","Wen H","Health Aff (Millwood)","2019","2019/01/08","","","10.1377/hlthaff.2018.05145"
"30615514","Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities","Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M.","Health Aff (Millwood). 2019 Jan;38(1):14-23. doi: 10.1377/hlthaff.2018.05162.","Mojtabai R","Health Aff (Millwood)","2019","2019/01/08","PMC6816341","NIHMS1055968","10.1377/hlthaff.2018.05162"
"30614846","Treating Opioid Dependence: Pain Medicine Physiology of Tolerance and Addiction","James DL, Jowza M.","Clin Obstet Gynecol. 2019 Mar;62(1):87-97. doi: 10.1097/GRF.0000000000000422.","James DL","Clin Obstet Gynecol","2019","2019/01/08","","","10.1097/GRF.0000000000000422"
"30606566","In-vitro, ex-vivo, and in-vivo evaluation of buprenorphine HCl release from an in situ forming gel of PLGA-PEG-PLGA using N‑methyl‑2‑pyrrolidone as solvent","Kamali H, Khodaverdi E, Hadizadeh F, Mohajeri SA.","Mater Sci Eng C Mater Biol Appl. 2019 Mar;96:561-575. doi: 10.1016/j.msec.2018.11.058. Epub 2018 Nov 28.","Kamali H","Mater Sci Eng C Mater Biol Appl","2019","2019/01/05","","","10.1016/j.msec.2018.11.058"
"30586522","Emergency Departments - A 24/7/365 Option for Combating the Opioid Crisis","D'Onofrio G, McCormack RP, Hawk K.","N Engl J Med. 2018 Dec 27;379(26):2487-2490. doi: 10.1056/NEJMp1811988.","D'Onofrio G","N Engl J Med","2018","2018/12/27","","","10.1056/NEJMp1811988"
"30586140","Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver","Fiscella K, Wakeman SE, Beletsky L.","JAMA Psychiatry. 2019 Mar 1;76(3):229-230. doi: 10.1001/jamapsychiatry.2018.3685.","Fiscella K","JAMA Psychiatry","2019","2018/12/27","","","10.1001/jamapsychiatry.2018.3685"
"30585906","Medication-assisted treatment for opioid use disorder","Kaplan L.","Nurse Pract. 2019 Mar;44(3):10-12. doi: 10.1097/01.NPR.0000550252.04526.79.","Kaplan L","Nurse Pract","2019","2018/12/27","","","10.1097/01.NPR.0000550252.04526.79"
"30574844","Patterns of buprenorphine use and risk for re-arrest among highly vulnerable opioid-involved women released from jails in rural Appalachia","Surratt HL, Staton M, Leukefeld CG, Oser CB, Webster JM.","J Addict Dis. 2018 Jan-Jun;37(1-2):1-4. doi: 10.1080/10550887.2018.1531738. Epub 2018 Dec 21.","Surratt HL","J Addict Dis","2018","2018/12/22","PMC6551264","NIHMS1520371","10.1080/10550887.2018.1531738"
"30573022","Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs","Finlay AK, Wong JJ, Ellerbe LS, Rubinsky A, Gupta S, Bowe TR, Schmidt EM, Timko C, Burden JL, Harris AHS.","J Stud Alcohol Drugs. 2018 Nov;79(6):909-917. doi: 10.15288/jsad.2018.79.909.","Finlay AK","J Stud Alcohol Drugs","2018","2018/12/22","PMC6308173","NIHMS988731","10.15288/jsad.2018.79.909"
"30569568","Evaluation of an on-site test device for the heroin metabolite 6-acetylmorphine in urine","Picht F, Beck O, Böttcher M.","Drug Test Anal. 2019 Mar;11(3):536-540. doi: 10.1002/dta.2559. Epub 2019 Jan 6.","Picht F","Drug Test Anal","2019","2018/12/21","","","10.1002/dta.2559"
"30569303","Integrated Brief Intervention for PTSD and Substance Use in an Antepartum Unit","Shenai N, Gopalan P, Glance J.","Matern Child Health J. 2019 May;23(5):592-596. doi: 10.1007/s10995-018-2686-8.","Shenai N","Matern Child Health J","2019","2018/12/21","","","10.1007/s10995-018-2686-8"
"30557443","Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse","Murphy SM, McCollister KE, Leff JA, Yang X, Jeng PJ, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR.","Ann Intern Med. 2019 Jan 15;170(2):90-98. doi: 10.7326/M18-0227. Epub 2018 Dec 18.","Murphy SM","Ann Intern Med","2019","2018/12/18","PMC6581635","NIHMS1003362","10.7326/M18-0227"
"30553825","Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats","Burke NN, Ferdousi M, Deaver DR, Finn DP, Roche M, Kelly JP.","Neuropharmacology. 2019 Mar 1;146:327-336. doi: 10.1016/j.neuropharm.2018.12.012. Epub 2018 Dec 13.","Burke NN","Neuropharmacology","2019","2018/12/17","","","10.1016/j.neuropharm.2018.12.012"
"30545409","Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities","Hagedorn H, Kenny M, Gordon AJ, Ackland PE, Noorbaloochi S, Yu W, Harris AHS.","Addict Sci Clin Pract. 2018 Dec 13;13(1):25. doi: 10.1186/s13722-018-0127-z.","Hagedorn H","Addict Sci Clin Pract","2018","2018/12/15","PMC6293521","","10.1186/s13722-018-0127-z"
"30543495","Integration of Buprenorphine Treatment with Primary Care: Comparative Effectiveness on Retention, Utilization, and Cost","Hsu YJ, Marsteller JA, Kachur SG, Fingerhood MI.","Popul Health Manag. 2019 Aug;22(4):292-299. doi: 10.1089/pop.2018.0163. Epub 2018 Dec 13.","Hsu YJ","Popul Health Manag","2019","2018/12/14","","","10.1089/pop.2018.0163"
"30531584","Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations","Coe MA, Lofwall MR, Walsh SL.","J Addict Med. 2019 Mar/Apr;13(2):93-103. doi: 10.1097/ADM.0000000000000457.","Coe MA","J Addict Med","2019","2018/12/12","","","10.1097/ADM.0000000000000457"
"30526648","Single high-dose buprenorphine for opioid craving during withdrawal","Ahmadi J, Jahromi MS, Ghahremani D, London ED.","Trials. 2018 Dec 10;19(1):675. doi: 10.1186/s13063-018-3055-z.","Ahmadi J","Trials","2018","2018/12/12","PMC6288888","","10.1186/s13063-018-3055-z"
"30522370","Pharmacotherapy for opioid addiction in community corrections","Schwartz RP, Mitchell MM, O'Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Gordon MS, Jaffe JH.","Int Rev Psychiatry. 2018 Oct;30(5):117-135. doi: 10.1080/09540261.2018.1524373. Epub 2018 Dec 6.","Schwartz RP","Int Rev Psychiatry","2018","2018/12/08","PMC6551322","NIHMS1514646","10.1080/09540261.2018.1524373"
"30520057","Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailability","Maharao N, Venitz J, Gerk PM.","Biopharm Drug Dispos. 2019 Jan;40(1):18-31. doi: 10.1002/bdd.2166. Epub 2019 Jan 1.","Maharao N","Biopharm Drug Dispos","2019","2018/12/07","","","10.1002/bdd.2166"
"30519581","Pain Management during Rehabilitation after Distal Radius Fracture Stabilized with Volar Locking Plate: A Prospective Cohort Study","Luo P, Lou J, Yang S.","Biomed Res Int. 2018 Nov 5;2018:5786089. doi: 10.1155/2018/5786089. eCollection 2018.","Luo P","Biomed Res Int","2018","2018/12/07","PMC6241235","","10.1155/2018/5786089"
"30515857","A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers","Strand MC, Vindenes V, Gjerde H, Mørland JG, Ramaekers JG.","Br J Clin Pharmacol. 2019 Feb;85(2):442-453. doi: 10.1111/bcp.13818. Epub 2018 Dec 18.","Strand MC","Br J Clin Pharmacol","2019","2018/12/06","PMC6339962","","10.1111/bcp.13818"
"30514306","The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic","Mravčík V, Janíková B, Drbohlavová B, Popov P, Pirona A.","Harm Reduct J. 2018 Dec 4;15(1):60. doi: 10.1186/s12954-018-0268-0.","Mravčík V","Harm Reduct J","2018","2018/12/06","PMC6280526","","10.1186/s12954-018-0268-0"
"30508592","Remission from chronic opioid use-Studying environmental and socio-economic factors on recovery (RECOVER): Study design and participant characteristics","Ling W, Nadipelli VR, Ronquest NA, Albright VA, Aldridge AP, Learned SM, Mehra V, Heidbreder C.","Contemp Clin Trials. 2019 Jan;76:93-103. doi: 10.1016/j.cct.2018.11.015. Epub 2018 Nov 30.","Ling W","Contemp Clin Trials","2019","2018/12/04","","","10.1016/j.cct.2018.11.015"
"30507294","Recommending buprenorphine for pain management","Ehrlich AT, Darcq E.","Pain Manag. 2019 Jan 1;9(1):13-16. doi: 10.2217/pmt-2018-0069. Epub 2018 Dec 3.","Ehrlich AT","Pain Manag","2019","2018/12/04","","","10.2217/pmt-2018-0069"
"30502545","Change in alcohol and other drug use during five years of continuous opioid substitution treatment","Eastwood B, Strang J, Marsden J.","Drug Alcohol Depend. 2019 Jan 1;194:438-446. doi: 10.1016/j.drugalcdep.2018.11.008. Epub 2018 Nov 26.","Eastwood B","Drug Alcohol Depend","2019","2018/12/04","","","10.1016/j.drugalcdep.2018.11.008"
"30484813","What Role Should Psychiatrists Have in Responding to the Opioid Epidemic?","Muvvala SB, Edens EL, Petrakis IL.","JAMA Psychiatry. 2019 Feb 1;76(2):107-108. doi: 10.1001/jamapsychiatry.2018.3123.","Muvvala SB","JAMA Psychiatry","2019","2018/11/29","","","10.1001/jamapsychiatry.2018.3123"
"30484167","The perioperative patient on buprenorphine: a systematic review of perioperative management strategies and patient outcomes","Goel A, Azargive S, Lamba W, Bordman J, Englesakis M, Srikandarajah S, Ladha K, Di Renna T, Shanthanna H, Duggan S, Peng P, Hanlon J, Clarke H.","Can J Anaesth. 2019 Feb;66(2):201-217. doi: 10.1007/s12630-018-1255-3. Epub 2018 Nov 27.","Goel A","Can J Anaesth","2019","2018/11/29","","","10.1007/s12630-018-1255-3"
"30482087","Effect of three opioid-based analgesic protocols on the perioperative autonomic-mediated cardiovascular response in sheep","Bellini L, De Benedictis GM.","Lab Anim. 2019 Oct;53(5):491-499. doi: 10.1177/0023677218815203. Epub 2018 Nov 27.","Bellini L","Lab Anim","2019","2018/11/29","","","10.1177/0023677218815203"
"30480858","Buprenorphine: Therapeutic potential beyond substance abuse","Velasquez S, Rappaport J.","J Leukoc Biol. 2018 Dec;104(6):1047-1048. doi: 10.1002/JLB.3CE0418-172R.","Velasquez S","J Leukoc Biol","2018","2018/11/28","PMC6476568","NIHMS1015124","10.1002/JLB.3CE0418-172R"
"30463712","Buprenorphine-Sustained Release Alters Hemodynamic Parameters in a Rat Burn Model","Guillory AN, Clayton RP, Prasai A, Jay JW, Wetzel M, El Ayadi A, Herndon DN, Finnerty CC.","J Surg Res. 2018 Dec;232:154-159. doi: 10.1016/j.jss.2018.03.016. Epub 2018 Jul 5.","Guillory AN","J Surg Res","2018","2018/11/23","PMC6251494","NIHMS953263","10.1016/j.jss.2018.03.016"
"30457903","Evaluation of the thermal antinociceptive effects and pharmacokinetics after intramuscular administration of buprenorphine hydrochloride to cockatiels (Nymphicus hollandicus)","Guzman DS, Houck EL, Knych HKD, Beaufrère H, Paul-Murphy JR.","Am J Vet Res. 2018 Dec;79(12):1239-1245. doi: 10.2460/ajvr.79.12.1239.","Guzman DS","Am J Vet Res","2018","2018/11/21","","","10.2460/ajvr.79.12.1239"
"30454771","Utilizing Buprenorphine in the Emergency Department after Overdose","Johns SE, Bowman M, Moeller FG.","Trends Pharmacol Sci. 2018 Dec;39(12):998-1000. doi: 10.1016/j.tips.2018.10.002.","Johns SE","Trends Pharmacol Sci","2018","2018/11/21","PMC6953478","NIHMS1022113","10.1016/j.tips.2018.10.002"
"30453290","Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy","Peters L, Soyka M.","Neuropsychobiology. 2019;77(2):73-82. doi: 10.1159/000494697. Epub 2018 Nov 19.","Peters L","Neuropsychobiology","2019","2018/11/20","","","10.1159/000494697"
"30452137","Tackling addiction in primary care","Grahan B.","Minn Med. 2017 May;100(3):32-33.","Grahan B","Minn Med","2017","2018/11/20","","",""
"30452075","Influence of Medication-Induced Preconditioning or Remote Ischemic Preconditioning on the Intrinsic Vascular Extracellular RNA/Ribonuclease System in Cardioprotection","Tolkmitt KJ, Simsekyilmaz S, Schipke J, Mühlfeld C, Preissner KT, Böning A.","Thorac Cardiovasc Surg. 2019 Sep;67(6):494-501. doi: 10.1055/s-0038-1675398. Epub 2018 Nov 16.","Tolkmitt KJ","Thorac Cardiovasc Surg","2019","2018/11/20","","","10.1055/s-0038-1675398"
"30448421","Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat","Smith KL, Cunningham JI, Eyerman DJ, Dean RL 3rd, Deaver DR, Sanchez C.","Neuropharmacology. 2019 Mar 1;146:316-326. doi: 10.1016/j.neuropharm.2018.11.015. Epub 2018 Nov 15.","Smith KL","Neuropharmacology","2019","2018/11/19","","","10.1016/j.neuropharm.2018.11.015"
"30430396","Opioidergic Agents as Antidepressants: Rationale and Promise","Saxena PP, Bodkin JA.","CNS Drugs. 2019 Jan;33(1):9-16. doi: 10.1007/s40263-018-0584-7.","Saxena PP","CNS Drugs","2019","2018/11/16","","","10.1007/s40263-018-0584-7"
"30422610","Preparations for Treating Opioid Use Disorder in the Office","Kowalchuk A, Mejia de Grubb M, Zoorob RJ.","Fam Pract Manag. 2018 Nov/Dec;25(6):21-26.","Kowalchuk A","Fam Pract Manag","2018","2018/11/14","","",""
"30422365","Could prenatal food insecurity influence neonatal abstinence syndrome severity?","Rose-Jacobs R, Trevino-Talbot M, Lloyd-Travaglini C, Cabral HJ, Vibbert M, Saia K, Wachman EM.","Addiction. 2019 Feb;114(2):337-343. doi: 10.1111/add.14458. Epub 2018 Nov 13.","Rose-Jacobs R","Addiction","2019","2018/11/14","","","10.1111/add.14458"
"30418214","Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals","Huhn AS, Strain EC, Bigelow GE, Smith MT, Edwards RR, Tompkins DA.","Anesthesiology. 2019 Jan;130(1):131-141. doi: 10.1097/ALN.0000000000002492.","Huhn AS","Anesthesiology","2019","2018/11/13","PMC6295244","NIHMS1508476","10.1097/ALN.0000000000002492"
"30414072","Requiring Buprenorphine Waivers for Psychiatry Residents","Morris NP, Bentzley BS.","Acad Psychiatry. 2019 Feb;43(1):131-134. doi: 10.1007/s40596-018-1005-4. Epub 2018 Nov 9.","Morris NP","Acad Psychiatry","2019","2018/11/11","","","10.1007/s40596-018-1005-4"
"30403507","How Massachusetts, Vermont, and New York Are Taking Action to Address the Opioid Epidemic","Hernandez Y, Meyers-Ohki S, Farkas S, Ball S, Leonard K, Rotrosen J, Saitz R.","Am J Public Health. 2018 Dec;108(12):1621-1622. doi: 10.2105/AJPH.2018.304741.","Hernandez Y","Am J Public Health","2018","2018/11/08","PMC6236727","","10.2105/AJPH.2018.304741"
"30401353","Medication-Assisted Treatment Considerations for Women with Opiate Addiction Disorders","Jacobs AA, Cangiano M.","Prim Care. 2018 Dec;45(4):731-742. doi: 10.1016/j.pop.2018.08.002. Epub 2018 Oct 5.","Jacobs AA","Prim Care","2018","2018/11/08","","","10.1016/j.pop.2018.08.002"
"30395551","Heroin Addiction in Serbian Patients With Tourette Syndrome","Sarajlija M, Raketic D, Nesic N.","J Psychiatr Pract. 2018 Nov;24(6):424-427. doi: 10.1097/PRA.0000000000000341.","Sarajlija M","J Psychiatr Pract","2018","2018/11/06","","","10.1097/PRA.0000000000000341"
"30391868","Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS","West R, Mikel C, Hofilena D, Guevara M.","Drug Alcohol Depend. 2018 Dec 1;193:183-191. doi: 10.1016/j.drugalcdep.2018.07.023. Epub 2018 Sep 1.","West R","Drug Alcohol Depend","2018","2018/11/05","","","10.1016/j.drugalcdep.2018.07.023"
"30383881","Use of Buprenorphine to Treat Opioid Use Disorder","Bartholow LAM, Pope J.","J Psychosoc Nurs Ment Health Serv. 2018 Nov 1;56(11):9-12. doi: 10.3928/02793695-20181012-02.","Bartholow LAM","J Psychosoc Nurs Ment Health Serv","2018","2018/11/02","","","10.3928/02793695-20181012-02"
"30377951","Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity","Toce MS, Chai PR, Burns MM, Boyer EW.","J Med Toxicol. 2018 Dec;14(4):306-322. doi: 10.1007/s13181-018-0685-1. Epub 2018 Oct 30.","Toce MS","J Med Toxicol","2018","2018/11/01","PMC6242798","","10.1007/s13181-018-0685-1"
"30371839","Quantitative Analysis of Novel Synthetic Opioids, Morphine and Buprenorphine in Oral Fluid by LC-MS-MS","Truver MT, Swortwood MJ.","J Anal Toxicol. 2018 Oct 1;42(8):554-561. doi: 10.1093/jat/bky053.","Truver MT","J Anal Toxicol","2018","2018/10/30","","","10.1093/jat/bky053"
"30359928","Understanding the use of diverted buprenorphine","Cicero TJ, Ellis MS, Chilcoat HD.","Drug Alcohol Depend. 2018 Dec 1;193:117-123. doi: 10.1016/j.drugalcdep.2018.09.007. Epub 2018 Oct 12.","Cicero TJ","Drug Alcohol Depend","2018","2018/10/26","","","10.1016/j.drugalcdep.2018.09.007"
"30359047","Feasibility of an interactive voice response system for daily monitoring of illicit opioid use during buprenorphine treatment","Parker MA, Ochalek TA, Rose GL, Badger GJ, Sigmon SC.","Psychol Addict Behav. 2018 Dec;32(8):956-960. doi: 10.1037/adb0000413. Epub 2018 Oct 25.","Parker MA","Psychol Addict Behav","2018","2018/10/26","PMC6296868","NIHMS988778","10.1037/adb0000413"
"30357262","The Next Stage of Buprenorphine Care for Opioid Use Disorder","Martin SA, Chiodo LM, Bosse JD, Wilson A.","Ann Intern Med. 2018 Nov 6;169(9):628-635. doi: 10.7326/M18-1652. Epub 2018 Oct 23.","Martin SA","Ann Intern Med","2018","2018/10/26","","","10.7326/M18-1652"
"30357257","Time to Change the Way We Approach Opioid Use Disorder: A Challenge to the Status Quo","Hawk K, D'Onofrio G.","Ann Intern Med. 2018 Nov 6;169(9):652-653. doi: 10.7326/M18-2722. Epub 2018 Oct 23.","Hawk K","Ann Intern Med","2018","2018/10/26","","","10.7326/M18-2722"
"30355476","Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting","Cisewski DH, Santos C, Koyfman A, Long B.","Am J Emerg Med. 2019 Jan;37(1):143-150. doi: 10.1016/j.ajem.2018.10.013. Epub 2018 Oct 11.","Cisewski DH","Am J Emerg Med","2019","2018/10/26","","","10.1016/j.ajem.2018.10.013"
"30352671","Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","Samples H, Williams AR, Olfson M, Crystal S.","J Subst Abuse Treat. 2018 Dec;95:9-17. doi: 10.1016/j.jsat.2018.09.001. Epub 2018 Sep 7.","Samples H","J Subst Abuse Treat","2018","2018/10/25","PMC6354252","NIHMS1506442","10.1016/j.jsat.2018.09.001"
"30352669","Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science","Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS.","J Subst Abuse Treat. 2018 Dec;95:43-47. doi: 10.1016/j.jsat.2018.09.006. Epub 2018 Oct 2.","Finlay AK","J Subst Abuse Treat","2018","2018/10/25","PMC6209329","NIHMS990870","10.1016/j.jsat.2018.09.006"
"30352586","Efficacy of buprenorphine for management of surgical castration pain in piglets","Viscardi AV, Turner PV.","BMC Vet Res. 2018 Oct 23;14(1):318. doi: 10.1186/s12917-018-1643-5.","Viscardi AV","BMC Vet Res","2018","2018/10/25","PMC6199726","","10.1186/s12917-018-1643-5"
"30350278","Measurement of Buprenorphine and Norbuprenorphine in Urine","Terrell AR, Adhlakha V, Reddy P.","Methods Mol Biol. 2019;1872:51-59. doi: 10.1007/978-1-4939-8823-5_5.","Terrell AR","Methods Mol Biol","2019","2018/10/24","","","10.1007/978-1-4939-8823-5_5"
"30339720","Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians","Andrilla CHA, Moore TE, Patterson DG.","J Rural Health. 2019 Jan;35(1):113-121. doi: 10.1111/jrh.12328. Epub 2018 Oct 19.","Andrilla CHA","J Rural Health","2019","2018/10/20","","","10.1111/jrh.12328"
"30336099","Letter to the Editor","Davis CS, Carr DH.","J Law Med Ethics. 2018 Sep;46(3):811-812. doi: 10.1177/1073110518804248.","Davis CS","J Law Med Ethics","2018","2018/10/19","","","10.1177/1073110518804248"
"30325727","Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration","Valenstein-Mah H, Hagedorn H, Kay CL, Christopher ML, Gordon AJ.","Subst Abus. 2018;39(3):286-288. doi: 10.1080/08897077.2018.1509251. Epub 2018 Oct 16.","Valenstein-Mah H","Subst Abus","2018","2018/10/17","","","10.1080/08897077.2018.1509251"
"30312275","Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine","Mazhnaya A, Marcus R, Bojko MJ, Zelenev A, Makarenko I, Pykalo I, Filippovych S, Dvoriak S, Altice FL.","J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):288-295. doi: 10.1097/QAI.0000000000001827.","Mazhnaya A","J Acquir Immune Defic Syndr","2018","2018/10/13","","","10.1097/QAI.0000000000001827"
"30297131","Colon constipation in horses after sustained-release buprenorphine administration","Levionnois OL, Graubner C, Spadavecchia C.","Vet Anaesth Analg. 2018 Nov;45(6):876-880. doi: 10.1016/j.vaa.2018.08.004. Epub 2018 Sep 11.","Levionnois OL","Vet Anaesth Analg","2018","2018/10/10","","","10.1016/j.vaa.2018.08.004"
"30291571","Buprenorphine for Chronic Pain: a Systemic Review","Fishman MA, Kim PS.","Curr Pain Headache Rep. 2018 Oct 5;22(12):83. doi: 10.1007/s11916-018-0732-2.","Fishman MA","Curr Pain Headache Rep","2018","2018/10/07","","","10.1007/s11916-018-0732-2"
"30290820","The analgesic effects of buprenorphine (Vetergesic or Simbadol) in combination with carprofen in dogs undergoing ovariohysterectomy: a randomized, blinded, clinical trial","Watanabe R, Monteiro BP, Evangelista MC, Castonguay A, Edge D, Steagall PV.","BMC Vet Res. 2018 Oct 5;14(1):304. doi: 10.1186/s12917-018-1628-4.","Watanabe R","BMC Vet Res","2018","2018/10/07","PMC6173890","","10.1186/s12917-018-1628-4"
"30290291","Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests","Bagley SM, Cheng DM, Winter M, Alford DP, LaBelle C, Walley AY, Samet JH.","Drug Alcohol Depend. 2018 Nov 1;192:245-249. doi: 10.1016/j.drugalcdep.2018.08.010. Epub 2018 Sep 25.","Bagley SM","Drug Alcohol Depend","2018","2018/10/06","PMC6291245","NIHMS1508716","10.1016/j.drugalcdep.2018.08.010"
"30285261","Provision of Buprenorphine to Pregnant Women by For-Profit Clinics in an Appalachian City","Walker JJ, Olsen ME.","South Med J. 2018 Oct;111(10):575-578. doi: 10.14423/SMJ.0000000000000875.","Walker JJ","South Med J","2018","2018/10/05","","","10.14423/SMJ.0000000000000875"
"30265425","Expanding access to buprenorphine treatment in rural areas with the use of telemedicine","Weintraub E, Greenblatt AD, Chang J, Himelhoch S, Welsh C.","Am J Addict. 2018 Dec;27(8):612-617. doi: 10.1111/ajad.12805. Epub 2018 Sep 28.","Weintraub E","Am J Addict","2018","2018/09/29","","","10.1111/ajad.12805"
"30253377","Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence","Coker JL, Catlin D, Ray-Griffith S, Knight B, Stowe ZN.","Drug Alcohol Depend. 2018 Nov 1;192:146-149. doi: 10.1016/j.drugalcdep.2018.07.042. Epub 2018 Sep 15.","Coker JL","Drug Alcohol Depend","2018","2018/09/26","PMC6741779","NIHMS1507871","10.1016/j.drugalcdep.2018.07.042"
"30243418","Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management","Kenney SR, Anderson BJ, Bailey GL, Stein MD.","J Subst Abuse Treat. 2018 Nov;94:55-59. doi: 10.1016/j.jsat.2018.08.011. Epub 2018 Aug 28.","Kenney SR","J Subst Abuse Treat","2018","2018/09/24","PMC6152924","NIHMS1505721","10.1016/j.jsat.2018.08.011"
"30243036","Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder","Meshberg-Cohen S, Black AC, DeViva JC, Petrakis IL, Rosen MI.","Addict Behav. 2019 Feb;89:29-34. doi: 10.1016/j.addbeh.2018.09.010. Epub 2018 Sep 12.","Meshberg-Cohen S","Addict Behav","2019","2018/09/23","","","10.1016/j.addbeh.2018.09.010"
"30242851","Pharmacokinetics and physiologic/behavioral effects of buprenorphine administered sublingually and intravenously to neonatal foals","Grubb TL, Kurkowski D, Sellon DC, Seino KK, Coffey T, Davis JL.","J Vet Pharmacol Ther. 2019 Jan;42(1):26-36. doi: 10.1111/jvp.12715. Epub 2018 Sep 21.","Grubb TL","J Vet Pharmacol Ther","2019","2018/09/23","","","10.1111/jvp.12715"
"30228577","Opioid Use Disorder and Pregnancy","O'Donnell FT, Jackson DL.","Mo Med. 2017 May-Jun;114(3):181-186.","O'Donnell FT","Mo Med","2017","2018/09/20","PMC6140233","",""
"30216393","Buprenorphine to treat opioid use disorder: A practical guide","Nissly T, Levy R.","J Fam Pract. 2018 Jun;67(9):544-548.","Nissly T","J Fam Pract","2018","2018/09/15","","",""
"30213497","Zaprinast diminished pain and enhanced opioid analgesia in a rat neuropathic pain model","Rojewska E, Piotrowska A, Jurga A, Makuch W, Mika J.","Eur J Pharmacol. 2018 Nov 15;839:21-32. doi: 10.1016/j.ejphar.2018.09.001. Epub 2018 Sep 10.","Rojewska E","Eur J Pharmacol","2018","2018/09/15","","","10.1016/j.ejphar.2018.09.001"
"30212383","Sex differences in the effectiveness of buprenorphine to decrease rates of responding in rhesus monkeys","Schwienteck KL, Negus SS, Banks ML.","Behav Pharmacol. 2019 Jun;30(4):358-362. doi: 10.1097/FBP.0000000000000437.","Schwienteck KL","Behav Pharmacol","2019","2018/09/14","PMC6414288","NIHMS1504543","10.1097/FBP.0000000000000437"
"30211703","CE: Acute Pain Management for People with Opioid Use Disorder","Broglio K, Matzo M.","Am J Nurs. 2018 Oct;118(10):30-38. doi: 10.1097/01.NAJ.0000546378.81550.84.","Broglio K","Am J Nurs","2018","2018/09/14","","","10.1097/01.NAJ.0000546378.81550.84"
"30209840","One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years","Nordt C, Vogel M, Dey M, Moldovanyi A, Beck T, Berthel T, Walter M, Seifritz E, Dürsteler KM, Herdener M.","Addiction. 2019 Jan;114(1):103-111. doi: 10.1111/add.14442. Epub 2018 Oct 15.","Nordt C","Addiction","2019","2018/09/14","","","10.1111/add.14442"
"30208470","Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder","Hadland SE, Bagley SM, Rodean J, Silverstein M, Levy S, Larochelle MR, Samet JH, Zima BT.","Version 2. JAMA Pediatr. 2018 Nov 1;172(11):1029-1037. doi: 10.1001/jamapediatrics.2018.2143.","Hadland SE","JAMA Pediatr","2018","2018/09/13","PMC6218311","NIHMS989582","10.1001/jamapediatrics.2018.2143"
"30207769","The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System","Clarke JG, Martin RA, Gresko SA, Rich JD.","Am J Public Health. 2018 Oct;108(10):1323-1325. doi: 10.2105/AJPH.2018.304666.","Clarke JG","Am J Public Health","2018","2018/09/13","PMC6137785","","10.2105/AJPH.2018.304666"
"30205307","Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity","Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FNU, Shaw D, Saia K, Schiff DM.","Drug Alcohol Depend. 2018 Nov 1;192:45-50. doi: 10.1016/j.drugalcdep.2018.07.024. Epub 2018 Sep 1.","Wachman EM","Drug Alcohol Depend","2018","2018/09/12","","","10.1016/j.drugalcdep.2018.07.024"
"30204704","Prenatal Treatment and Outcomes of Women With Opioid Use Disorder","Brogly SB, Saia KE, Werler MM, Regan E, Hernández-Díaz S.","Obstet Gynecol. 2018 Oct;132(4):916-922. doi: 10.1097/AOG.0000000000002881.","Brogly SB","Obstet Gynecol","2018","2018/09/12","PMC6153027","NIHMS1500705","10.1097/AOG.0000000000002881"
"30204694","Trends and Outcomes Associated With Using Long-Acting Opioids During Delivery Hospitalizations","Duffy CR, Wright JD, Landau R, Mourad MJ, Siddiq Z, Kern-Goldberger AR, D'Alton ME, Friedman AM.","Obstet Gynecol. 2018 Oct;132(4):937-947. doi: 10.1097/AOG.0000000000002861.","Duffy CR","Obstet Gynecol","2018","2018/09/12","PMC6153065","NIHMS981031","10.1097/AOG.0000000000002861"
"30204686","Use of Kratom, an Opioid-like Traditional Herb, in Pregnancy","Smid MC, Charles JE, Gordon AJ, Wright TE.","Obstet Gynecol. 2018 Oct;132(4):926-928. doi: 10.1097/AOG.0000000000002871.","Smid MC","Obstet Gynecol","2018","2018/09/12","","","10.1097/AOG.0000000000002871"
"30204554","The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety","Jones JD, Bisaga A, Metz VE, Manubay JM, Mogali S, Ciccocioppo R, Madera G, Doernberg M, Comer SD.","J Psychoactive Drugs. 2018 Nov-Dec;50(5):390-401. doi: 10.1080/02791072.2018.1508789. Epub 2018 Sep 11.","Jones JD","J Psychoactive Drugs","2018","2018/09/12","PMC6487639","NIHMS1022220","10.1080/02791072.2018.1508789"
"30203007","Multimodal Treatment Options, Including Rotating to Buprenorphine, Within a Multidisciplinary Pain Clinic for Patients on Risky Opioid Regimens: A Quality Improvement Study","Oldfield BJ, Edens EL, Agnoli A, Bone CW, Cervone DJ, Edmond SN, Manhapra A, Sellinger JJ, Becker WC.","Pain Med. 2018 Sep 1;19(suppl_1):S38-S45. doi: 10.1093/pm/pny086.","Oldfield BJ","Pain Med","2018","2018/09/12","","","10.1093/pm/pny086"
"30201642","Buprenorphine Provision by Early Career Family Physicians","Tong ST, Hochheimer CJ, Peterson LE, Krist AH.","Ann Fam Med. 2018 Sep;16(5):443-446. doi: 10.1370/afm.2261.","Tong ST","Ann Fam Med","2018","2018/09/12","PMC6130986","","10.1370/afm.2261"
"30199427","Medication Treatment With Methadone or Buprenorphine: Differential Reasons for Premature Discharge","Proctor SL, Birch A, Herschman PL.","J Addict Med. 2019 Mar/Apr;13(2):113-118. doi: 10.1097/ADM.0000000000000456.","Proctor SL","J Addict Med","2019","2018/09/11","","","10.1097/ADM.0000000000000456"
"30194876","Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder","Jones CM, McCance-Katz EF.","Addiction. 2019 Mar;114(3):471-482. doi: 10.1111/add.14436. Epub 2018 Oct 15.","Jones CM","Addiction","2019","2018/09/09","","","10.1111/add.14436"
"30192041","Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States","Lo-Ciganic WH, Donohue JM, Kim JY, Krans EE, Jones BL, Kelley D, James AE, Jarlenski MP.","Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):80-89. doi: 10.1002/pds.4647. Epub 2018 Sep 7.","Lo-Ciganic WH","Pharmacoepidemiol Drug Saf","2019","2018/09/08","PMC6557135","NIHMS1027937","10.1002/pds.4647"
"30180001","Integration of Medication-Assisted Treatment Information for Opioid Use Disorders Into a Graduate Nursing Curriculum","Kameg B, Kaufman R, Lindsay D, Mitchell AM.","J Addict Nurs. 2018 Jul/Sep;29(3):163-166. doi: 10.1097/JAN.0000000000000232.","Kameg B","J Addict Nurs","2018","2018/09/05","","","10.1097/JAN.0000000000000232"
"30170272","High buprenorphine-related mortality is persistent in Finland","Kriikku P, Häkkinen M, Ojanperä I.","Forensic Sci Int. 2018 Oct;291:76-82. doi: 10.1016/j.forsciint.2018.08.010. Epub 2018 Aug 17.","Kriikku P","Forensic Sci Int","2018","2018/09/01","","","10.1016/j.forsciint.2018.08.010"
"30167757","Voriconazole greatly increases the exposure to oral buprenorphine","Fihlman M, Hemmilä T, Hagelberg NM, Backman JT, Laitila J, Laine K, Neuvonen PJ, Olkkola KT, Saari TI.","Eur J Clin Pharmacol. 2018 Dec;74(12):1615-1622. doi: 10.1007/s00228-018-2548-8. Epub 2018 Aug 30.","Fihlman M","Eur J Clin Pharmacol","2018","2018/09/01","","","10.1007/s00228-018-2548-8"
"30157924","The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial","Ahmadi J, Jahromi MS, Ehsaei Z.","Trials. 2018 Aug 29;19(1):462. doi: 10.1186/s13063-018-2843-9.","Ahmadi J","Trials","2018","2018/08/31","PMC6114789","","10.1186/s13063-018-2843-9"
"30152383","Treatment modalities for pregnant women with opioid use disorder","Gressler LE, Titus-Glover D, Shaya FT.","Lancet. 2018 Aug 18;392(10147):551. doi: 10.1016/S0140-6736(18)31471-5. Epub 2018 Aug 16.","Gressler LE","Lancet","2018","2018/08/29","","","10.1016/S0140-6736(18)31471-5"
"30147005","Buprenorphine MAT as an Imperfect Fix","Mund B, Stith K.","J Law Med Ethics. 2018 Jun;46(2):279-291. doi: 10.1177/1073110518782935.","Mund B","J Law Med Ethics","2018","2018/08/28","","","10.1177/1073110518782935"
"30147002","Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward","Breen CT, Fiellin DA.","J Law Med Ethics. 2018 Jun;46(2):272-278. doi: 10.1177/1073110518782934.","Breen CT","J Law Med Ethics","2018","2018/08/28","","","10.1177/1073110518782934"
"30146991","Improving Rural Access to Opioid Treatment Programs","Johnson Q, Mund B, Joudrey PJ.","J Law Med Ethics. 2018 Jun;46(2):437-439. doi: 10.1177/1073110518782951.","Johnson Q","J Law Med Ethics","2018","2018/08/28","","","10.1177/1073110518782951"
"30133422","Expanded table: Some drugs for management of opioid withdrawal symptoms","","Med Lett Drugs Ther. 2018 Aug 27;60(1554):e144-e146.","","Med Lett Drugs Ther","2018","2018/08/23","","",""
"30133420","Management of opioid withdrawal symptoms","","Med Lett Drugs Ther. 2018 Aug 27;60(1554):137-141.","","Med Lett Drugs Ther","2018","2018/08/23","","",""
"30126537","Comparison between buprenorphine provider availability and opioid deaths among US counties","Jones CW, Christman Z, Smith CM, Safferman MR, Salzman M, Baston K, Haroz R.","J Subst Abuse Treat. 2018 Oct;93:19-25. doi: 10.1016/j.jsat.2018.07.008. Epub 2018 Jul 20.","Jones CW","J Subst Abuse Treat","2018","2018/08/22","","","10.1016/j.jsat.2018.07.008"
"30118320","Buprenorphine in the real world: coming to terms with misuse and diversion","Nunes EV.","Am J Drug Alcohol Abuse. 2018;44(6):576-577. doi: 10.1080/00952990.2018.1504952. Epub 2018 Aug 17.","Nunes EV","Am J Drug Alcohol Abuse","2018","2018/08/18","","","10.1080/00952990.2018.1504952"
"30111745","The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review","Serafini G, Adavastro G, Canepa G, De Berardis D, Valchera A, Pompili M, Nasrallah H, Amore M.","Int J Mol Sci. 2018 Aug 15;19(8):2410. doi: 10.3390/ijms19082410.","Serafini G","Int J Mol Sci","2018","2018/08/17","PMC6121503","","10.3390/ijms19082410"
"30108159","In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder","Bidlack JM, Knapp BI, Deaver DR, Plotnikava M, Arnelle D, Wonsey AM, Fern Toh M, Pin SS, Namchuk MN.","J Pharmacol Exp Ther. 2018 Nov;367(2):267-281. doi: 10.1124/jpet.118.249839. Epub 2018 Aug 14.","Bidlack JM","J Pharmacol Exp Ther","2018","2018/08/16","","","10.1124/jpet.118.249839"
"30106494","Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial","Campbell ANC, Barbosa-Leiker C, Hatch-Maillette M, Mennenga SE, Pavlicova M, Scodes J, Saraiya T, Mitchell SG, Rotrosen J, Novo P, Nunes EV, Greenfield SF.","Am J Addict. 2018 Sep;27(6):465-470. doi: 10.1111/ajad.12784. Epub 2018 Aug 14.","Campbell ANC","Am J Addict","2018","2018/08/15","PMC6124662","NIHMS986423","10.1111/ajad.12784"
"30097301","Telemedicine's Role in Addressing the Opioid Epidemic","Yang YT, Weintraub E, Haffajee RL.","Mayo Clin Proc. 2018 Sep;93(9):1177-1180. doi: 10.1016/j.mayocp.2018.07.001. Epub 2018 Aug 7.","Yang YT","Mayo Clin Proc","2018","2018/08/12","PMC6330237","NIHMS1004632","10.1016/j.mayocp.2018.07.001"
"30095564","Commentary on ""The More Things Change: Buprenorphine/Naloxone Diversion Continues While Treatment is Inaccessible""","Mitchell SG, Gryczynski J, Schwartz RP.","J Addict Med. 2018 Nov/Dec;12(6):424-425. doi: 10.1097/ADM.0000000000000437.","Mitchell SG","J Addict Med","2018","2018/08/11","PMC6214742","NIHMS979736","10.1097/ADM.0000000000000437"
"30092933","Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy","Harrison TK, Kornfeld H, Aggarwal AK, Lembke A.","Anesthesiol Clin. 2018 Sep;36(3):345-359. doi: 10.1016/j.anclin.2018.04.002. Epub 2018 Jul 11.","Harrison TK","Anesthesiol Clin","2018","2018/08/11","","","10.1016/j.anclin.2018.04.002"
"30092855","Evaluation of Analgesic Efficacy of Meloxicam and 2 Formulations of Buprenorphine after Laparotomy in Female Sprague-Dawley Rats","Nunamaker EA, Goldman JL, Adams CR, Fortman JD.","J Am Assoc Lab Anim Sci. 2018 Sep 1;57(5):498-507. doi: 10.30802/AALAS-JAALAS-17-000129. Epub 2018 Aug 9.","Nunamaker EA","J Am Assoc Lab Anim Sci","2018","2018/08/11","PMC6159676","","10.30802/AALAS-JAALAS-17-000129"
"30082370","Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study","Larney S, Hickman M, Fiellin DA, Dobbins T, Nielsen S, Jones NR, Mattick RP, Ali R, Degenhardt L.","BMJ Open. 2018 Aug 5;8(8):e025204. doi: 10.1136/bmjopen-2018-025204.","Larney S","BMJ Open","2018","2018/08/08","PMC6078240","","10.1136/bmjopen-2018-025204"
"30080059","The influence of anxiety sensitivity on opioid use disorder treatment outcomes","Baxley C, Weinstock J, Lustman PJ, Garner AA.","Exp Clin Psychopharmacol. 2019 Feb;27(1):64-77. doi: 10.1037/pha0000215. Epub 2018 Aug 6.","Baxley C","Exp Clin Psychopharmacol","2019","2018/08/07","","","10.1037/pha0000215"
"30079432","Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder","Schroeder JR, Phillips KA, Epstein DH, Jobes ML, Furnari MA, Kennedy AP, Heilig M, Preston KL.","Psychopharmacology (Berl). 2018 Oct;235(10):2957-2966. doi: 10.1007/s00213-018-4986-5. Epub 2018 Aug 6.","Schroeder JR","Psychopharmacology (Berl)","2018","2018/08/07","","","10.1007/s00213-018-4986-5"
"30069622","Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment","Knudsen HK, Studts JL.","J Behav Health Serv Res. 2019 Jan;46(1):151-163. doi: 10.1007/s11414-018-9629-4.","Knudsen HK","J Behav Health Serv Res","2019","2018/08/03","PMC6324979","NIHMS1502553","10.1007/s11414-018-9629-4"
"30068260","Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime","Molero Y, Zetterqvist J, Binswanger IA, Hellner C, Larsson H, Fazel S.","Am J Psychiatry. 2018 Oct 1;175(10):970-978. doi: 10.1176/appi.ajp.2018.17101112. Epub 2018 Aug 2.","Molero Y","Am J Psychiatry","2018","2018/08/03","PMC6169735","EMS79141","10.1176/appi.ajp.2018.17101112"
"30064914","Effects of subcutaneous alfaxalone alone and in combination with dexmedetomidine and buprenorphine in guinea pigs (Cavia porcellus)","Doerning CM, Bradley MP, Lester PA, Nowland MH.","Vet Anaesth Analg. 2018 Sep;45(5):658-666. doi: 10.1016/j.vaa.2018.06.004. Epub 2018 Jul 2.","Doerning CM","Vet Anaesth Analg","2018","2018/08/02","","","10.1016/j.vaa.2018.06.004"
"30056321","A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study","Ochalek TA, Heil SH, Higgins ST, Badger GJ, Sigmon SC.","Drug Alcohol Depend. 2018 Sep 1;190:224-228. doi: 10.1016/j.drugalcdep.2018.05.032. Epub 2018 Jul 19.","Ochalek TA","Drug Alcohol Depend","2018","2018/07/30","PMC6446902","NIHMS1012423","10.1016/j.drugalcdep.2018.05.032"
"30056047","Thermal antinociception after buccal administration of a high-concentration formulation of buprenorphine (Simbadol) at 0.24 mg kg(-1) in conscious cats","Doodnaught GM, Monteiro B, Edge D, Steagall PV.","Vet Anaesth Analg. 2018 Sep;45(5):714-716. doi: 10.1016/j.vaa.2018.05.007. Epub 2018 Jun 15.","Doodnaught GM","Vet Anaesth Analg","2018","2018/07/30","","","10.1016/j.vaa.2018.05.007"
"30052562","Buprenorphine Implant Removal 7 Years Postinsertion: A Case Report","Frost M, Bobb R.","J Addict Med. 2019 Jan/Feb;13(1):79-80. doi: 10.1097/ADM.0000000000000447.","Frost M","J Addict Med","2019","2018/07/28","","","10.1097/ADM.0000000000000447"
"30051169","Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option","Davis MP, Pasternak G, Behm B.","Drugs. 2018 Aug;78(12):1211-1228. doi: 10.1007/s40265-018-0953-z.","Davis MP","Drugs","2018","2018/07/28","PMC6822392","NIHMS1501604","10.1007/s40265-018-0953-z"
"30048283","Overview of Drugs Used to Treat Opioid Use Disorder","Aschenbrenner DS.","Am J Nurs. 2018 Aug;118(8):25. doi: 10.1097/01.NAJ.0000544161.29445.db.","Aschenbrenner DS","Am J Nurs","2018","2018/07/27","","","10.1097/01.NAJ.0000544161.29445.db"
"30028385","Treating Chronic Pain: Is Buprenorphine the (or Even an) Answer?","Sun EC, Mao J, Anderson TA.","Anesth Analg. 2018 Aug;127(2):336-337. doi: 10.1213/ANE.0000000000003471.","Sun EC","Anesth Analg","2018","2018/07/21","PMC6579535","NIHMS1035578","10.1213/ANE.0000000000003471"
"30028058","Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone","Mannelli P, Swartz M, Wu LT.","Am J Addict. 2018 Sep;27(6):471-476. doi: 10.1111/ajad.12763. Epub 2018 Jul 20.","Mannelli P","Am J Addict","2018","2018/07/21","","","10.1111/ajad.12763"
"30019812","Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder","Bishop B, Gilmour J, Deering D.","Int J Ment Health Nurs. 2019 Feb;28(1):226-236. doi: 10.1111/inm.12523. Epub 2018 Jul 18.","Bishop B","Int J Ment Health Nurs","2019","2018/07/19","","","10.1111/inm.12523"
"30014887","Factors associated with perceived loss of libido in people who inject opioids: Results from a community-based survey in France","Briand Madrid L, Morel S, Ndiaye K, Mezaache S, Rojas Castro D, Mora M, Olivet F, Laporte V, Protopopescu C, Carrieri P, Roux P.","Drug Alcohol Depend. 2018 Sep 1;190:121-127. doi: 10.1016/j.drugalcdep.2018.05.030. Epub 2018 Jul 11.","Briand Madrid L","Drug Alcohol Depend","2018","2018/07/18","","","10.1016/j.drugalcdep.2018.05.030"
"29995730","Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts","Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, Bharel M, Wilens TE, LaRochelle M, Walley AY, Land T.","Obstet Gynecol. 2018 Aug;132(2):466-474. doi: 10.1097/AOG.0000000000002734.","Schiff DM","Obstet Gynecol","2018","2018/07/12","PMC6060005","NIHMS969171","10.1097/AOG.0000000000002734"
"29981036","Community strengths in addressing opioid use in Northeastern Ontario","Dorman K, Biedermann B, Linklater C, Jaffer Z.","Can J Public Health. 2018 Apr;109(2):219-222. doi: 10.17269/s41997-018-0055-4. Epub 2018 Apr 19.","Dorman K","Can J Public Health","2018","2018/07/08","PMC6964384","","10.17269/s41997-018-0055-4"
"29979890","ERP correlates of cognitive control in children prenatally exposed to methadone or buprenorphine","Konijnenberg C, Jondalen NM, Husby MF, Melinder A.","Dev Neuropsychol. 2018;43(7):642-655. doi: 10.1080/87565641.2018.1493592. Epub 2018 Jul 6.","Konijnenberg C","Dev Neuropsychol","2018","2018/07/07","","","10.1080/87565641.2018.1493592"
"29972748","Primary Care and the Opioid-Overdose Crisis - Buprenorphine Myths and Realities","Wakeman SE, Barnett ML.","N Engl J Med. 2018 Jul 5;379(1):1-4. doi: 10.1056/NEJMp1802741.","Wakeman SE","N Engl J Med","2018","2018/07/05","","","10.1056/NEJMp1802741"
"29972745","Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment","Saloner B, Stoller KB, Alexander GC.","N Engl J Med. 2018 Jul 5;379(1):4-6. doi: 10.1056/NEJMp1804059.","Saloner B","N Engl J Med","2018","2018/07/05","PMC6522243","NIHMS1022585","10.1056/NEJMp1804059"
"29966806","Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study","Roux P, Mezaache S, Briand-Madrid L, Debrus M, Khatmi N, Maradan G, Protopopescu C, Rojas-Castro D, Carrieri P.","Int J Drug Policy. 2018 Sep;59:3-9. doi: 10.1016/j.drugpo.2018.06.013. Epub 2018 Jun 28.","Roux P","Int J Drug Policy","2018","2018/07/04","","","10.1016/j.drugpo.2018.06.013"
"29958128","Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program","Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, Labelle C, Samet JH.","Drug Alcohol Depend. 2018 Aug 1;189:166-171. doi: 10.1016/j.drugalcdep.2018.05.010. Epub 2018 Jun 19.","Weinstein ZM","Drug Alcohol Depend","2018","2018/06/30","PMC6139651","NIHMS1503890","10.1016/j.drugalcdep.2018.05.010"
"29958042","Intent to Refer: Exploring Bias Toward Specific Medication-Assisted Treatments by Community Corrections Employees","Streisel SE.","Subst Use Misuse. 2018 Dec 6;53(14):2421-2430. doi: 10.1080/10826084.2018.1482346. Epub 2018 Jun 29.","Streisel SE","Subst Use Misuse","2018","2018/06/30","","","10.1080/10826084.2018.1482346"
"29956532","[In process]","Krieg B.","Med Monatsschr Pharm. 2016 Nov;39(11):497-8.","Krieg B","Med Monatsschr Pharm","2016","2018/06/30","","",""
"29943638","Evaluation of self-injurious behavior, thermal sensitivity, food intake, fecal output, and pica after injection of three buprenorphine formulations in rats (Rattus norvegicus)","Allen M, Johnson RA.","Am J Vet Res. 2018 Jul;79(7):697-703. doi: 10.2460/ajvr.79.7.697.","Allen M","Am J Vet Res","2018","2018/06/27","","","10.2460/ajvr.79.7.697"
"29941678","Buprenorphine Exposures Among Children and Adolescents Reported to US Poison Control Centers","Post S, Spiller HA, Casavant MJ, Chounthirath T, Smith GA.","Pediatrics. 2018 Jul;142(1):e20173652. doi: 10.1542/peds.2017-3652.","Post S","Pediatrics","2018","2018/06/27","","","10.1542/peds.2017-3652"
"29939049","Interim buprenorphine treatment during delays to comprehensive treatment: Changes in psychiatric symptoms","Streck JM, Ochalek TA, Badger GJ, Sigmon SC.","Exp Clin Psychopharmacol. 2018 Aug;26(4):403-409. doi: 10.1037/pha0000199. Epub 2018 Jun 25.","Streck JM","Exp Clin Psychopharmacol","2018","2018/06/26","PMC6072576","NIHMS947073","10.1037/pha0000199"
"29932847","A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees","Stein BD, Dick AW, Sorbero M, Gordon AJ, Burns RM, Leslie DL, Pacula RL.","Subst Abus. 2018;39(4):419-425. doi: 10.1080/08897077.2018.1449166. Epub 2018 Jun 22.","Stein BD","Subst Abus","2018","2018/06/23","PMC6309581","NIHMS1515174","10.1080/08897077.2018.1449166"
"29929212","Pharmacological therapies for management of opium withdrawal","Rahimi-Movaghar A, Gholami J, Amato L, Hoseinie L, Yousefi-Nooraie R, Amin-Esmaeili M.","Cochrane Database Syst Rev. 2018 Jun 21;6(6):CD007522. doi: 10.1002/14651858.CD007522.pub2.","Rahimi-Movaghar A","Cochrane Database Syst Rev","2018","2018/06/22","PMC6513031","","10.1002/14651858.CD007522.pub2"
"29923637","Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update","Andrilla CHA, Moore TE, Patterson DG, Larson EH.","J Rural Health. 2019 Jan;35(1):108-112. doi: 10.1111/jrh.12307. Epub 2018 Jun 20.","Andrilla CHA","J Rural Health","2019","2018/06/21","","","10.1111/jrh.12307"
"29913516","Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study","Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, Bagley SM, Liebschutz JM, Walley AY.","Ann Intern Med. 2018 Aug 7;169(3):137-145. doi: 10.7326/M17-3107. Epub 2018 Jun 19.","Larochelle MR","Ann Intern Med","2018","2018/06/19","PMC6387681","NIHMS1002372","10.7326/M17-3107"
"29913484","Medicines for Patients After an Opioid Overdose","","Ann Intern Med. 2018 Aug 7;169(3). doi: 10.7326/P18-0009. Epub 2018 Jun 19.","","Ann Intern Med","2018","2018/06/19","","","10.7326/P18-0009"
"29911590","Pain management with buprenorphine patches in elderly patients: Quality of life-As good as it gets?","Westerling D.","Scand J Pain. 2015 Jan 1;6(1):22-23. doi: 10.1016/j.sjpain.2014.09.003.","Westerling D","Scand J Pain","2015","2018/06/19","","","10.1016/j.sjpain.2014.09.003"
"29911578","Evaluation of the cost-effectiveness of buprenorphine in treatment of chronic pain using competing EQ-5D weights","Norrlid H, Dahm P, Tennvall GR.","Scand J Pain. 2015 Jan 1;6(1):24-30. doi: 10.1016/j.sjpain.2014.07.002.","Norrlid H","Scand J Pain","2015","2018/06/19","","","10.1016/j.sjpain.2014.07.002"
"29910015","Developing an opioid use disorder treatment cascade: A review of quality measures","Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M.","J Subst Abuse Treat. 2018 Aug;91:57-68. doi: 10.1016/j.jsat.2018.06.001. Epub 2018 Jun 2.","Williams AR","J Subst Abuse Treat","2018","2018/06/19","PMC6039975","NIHMS975411","10.1016/j.jsat.2018.06.001"
"29908336","Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management","Metrebian N, Weaver T, Pilling S, Hellier J, Byford S, Shearer J, Mitcheson L, Astbury M, Bijral P, Bogdan N, Bowden-Jones O, Day E, Dunn J, Finch E, Forshall S, Glasper A, Morse G, Akhtar S, Bajaria J, Bennett C, Bishop E, Charles V, Davey C, Desai R, Goodfellow C, Haque F, Little N, McKechnie H, Morris J, Mosler F, Mutz J, Pauli R, Poovendran D, Slater E, Strang J.","Contemp Clin Trials. 2018 Aug;71:124-132. doi: 10.1016/j.cct.2018.06.008. Epub 2018 Jun 13.","Metrebian N","Contemp Clin Trials","2018","2018/06/17","","","10.1016/j.cct.2018.06.008"
"29905586","Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?","Wong J, Saver B, Scanlan JM, Gianutsos LP, Bhakta Y, Walsh J, Plawman A, Sapienza D, Rudolf V.","J Addict Med. 2018 Nov/Dec;12(6):435-441. doi: 10.1097/ADM.0000000000000427.","Wong J","J Addict Med","2018","2018/06/16","","","10.1097/ADM.0000000000000427"
"29903459","Single-Injection Adductor Canal Block With Multiple Adjuvants Provides Equivalent Analgesia When Compared With Continuous Adductor Canal Blockade for Primary Total Knee Arthroplasty: A Double-Blinded, Randomized, Controlled, Equivalency Trial","Turner JD, Dobson SW, Henshaw DS, Edwards CJ, Weller RS, Reynolds JW, Russell GB, Jaffe JD.","J Arthroplasty. 2018 Oct;33(10):3160-3166.e1. doi: 10.1016/j.arth.2018.05.026. Epub 2018 May 24.","Turner JD","J Arthroplasty","2018","2018/06/16","","","10.1016/j.arth.2018.05.026"
"29884422","Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users","Schiavon S, Hodgin K, Sellers A, Word M, Galbraith JW, Dantzler J, Cropsey KL.","Addict Behav. 2018 Nov;86:51-55. doi: 10.1016/j.addbeh.2018.05.029. Epub 2018 May 30.","Schiavon S","Addict Behav","2018","2018/06/10","","","10.1016/j.addbeh.2018.05.029"
"29884421","The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder","Krans EE, Bobby S, England M, Gedekoh RH, Chang JC, Maguire B, Genday P, English DH.","Addict Behav. 2018 Nov;86:124-129. doi: 10.1016/j.addbeh.2018.05.016. Epub 2018 May 24.","Krans EE","Addict Behav","2018","2018/06/10","","","10.1016/j.addbeh.2018.05.016"
"29880277","Influence of a single dose of buprenorphine on rabbit (Oryctolagus cuniculus) gastrointestinal motility","Deflers H, Gandar F, Bolen G, Farnir F, Marlier D.","Vet Anaesth Analg. 2018 Jul;45(4):510-519. doi: 10.1016/j.vaa.2018.01.011. Epub 2018 Mar 29.","Deflers H","Vet Anaesth Analg","2018","2018/06/09","","","10.1016/j.vaa.2018.01.011"
"29873094","Gestational changes in buprenorphine exposure: A physiologically-based pharmacokinetic analysis","Zhang H, Kalluri HV, Bastian JR, Chen H, Alshabi A, Caritis SN, Venkataramanan R.","Br J Clin Pharmacol. 2018 Sep;84(9):2075-2087. doi: 10.1111/bcp.13642. Epub 2018 Jun 21.","Zhang H","Br J Clin Pharmacol","2018","2018/06/07","PMC6089832","","10.1111/bcp.13642"
"29864061","Sublocade: The Once-Monthly Buprenorphine Injectable","","J Addict Nurs. 2018 Apr/Jun;29(2):139-140. doi: 10.1097/JAN.0000000000000223.","","J Addict Nurs","2018","2018/06/05","","","10.1097/JAN.0000000000000223"
"29861527","Is tapentadol a potential Trojan horse in the postdextropropoxyphene era in India?","Basu A, Mahadevan J, Ithal D, Selvaraj S, Chand PK, Murthy P.","Indian J Pharmacol. 2018 Jan-Feb;50(1):44-46. doi: 10.4103/ijp.IJP_21_17.","Basu A","Indian J Pharmacol","2018","2018/06/05","PMC5954633","","10.4103/ijp.IJP_21_17"
"29857944","RETRACTED: Sublingual buprenorphine versus intravenous or intramuscular morphine in acute pain: A systematic review and meta-analysis of randomized control trials","Vlok R, An GH, Binks M, Melhuish T, White L.","Am J Emerg Med. 2019 Mar;37(3):381-386. doi: 10.1016/j.ajem.2018.05.052. Epub 2018 May 24.","Vlok R","Am J Emerg Med","2019","2018/06/03","","","10.1016/j.ajem.2018.05.052"
"29847389","Opioid Use Disorders: Perioperative Management of a Special Population","Ward EN, Quaye AN, Wilens TE.","Anesth Analg. 2018 Aug;127(2):539-547. doi: 10.1213/ANE.0000000000003477.","Ward EN","Anesth Analg","2018","2018/05/31","PMC6523021","NIHMS1016752","10.1213/ANE.0000000000003477"
"29845513","Overcoming Barriers to Adopting and Implementing Pharmacotherapy: the Medication Research Partnership","Croff R, Hoffman K, Alanis-Hirsch K, Ford J, McCarty D, Schmidt L.","J Behav Health Serv Res. 2019 Apr;46(2):330-339. doi: 10.1007/s11414-018-9616-9.","Croff R","J Behav Health Serv Res","2019","2018/05/31","PMC6265123","NIHMS971460","10.1007/s11414-018-9616-9"
"29844396","A Judgement Bias Test to Assess Affective State and Potential Therapeutics in a Rat Model of Chemotherapy-Induced Mucositis","George RP, Barker TH, Lymn KA, Bigatton DA, Howarth GS, Whittaker AL.","Sci Rep. 2018 May 29;8(1):8193. doi: 10.1038/s41598-018-26403-7.","George RP","Sci Rep","2018","2018/05/31","PMC5973947","","10.1038/s41598-018-26403-7"
"29805252","Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)","Erdal A, Flo E, Aarsland D, Selbaek G, Ballard C, Slettebo DD, Husebo BS.","Clin Interv Aging. 2018 May 16;13:935-946. doi: 10.2147/CIA.S161052. eCollection 2018.","Erdal A","Clin Interv Aging","2018","2018/05/29","PMC5960239","","10.2147/CIA.S161052"
"29800009","As Overdoses Climb, Emergency Departments Begin Treating Opioid Use Disorder","Rubin R.","JAMA. 2018 Jun 5;319(21):2158-2160. doi: 10.1001/jama.2018.4648.","Rubin R","JAMA","2018","2018/05/26","","","10.1001/jama.2018.4648"
"29799968","Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial","Lofwall MR, Walsh SL, Nunes EV, Bailey GL, Sigmon SC, Kampman KM, Frost M, Tiberg F, Linden M, Sheldon B, Oosman S, Peterson S, Chen M, Kim S.","JAMA Intern Med. 2018 Jun 1;178(6):764-773. doi: 10.1001/jamainternmed.2018.1052.","Lofwall MR","JAMA Intern Med","2018","2018/05/26","PMC6145749","","10.1001/jamainternmed.2018.1052"
"29791013","Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14(+) CD16(+) monocytes","Jaureguiberry-Bravo M, Lopez L, Berman JW.","J Leukoc Biol. 2018 Dec;104(6):1049-1059. doi: 10.1002/JLB.3HI0118-015R. Epub 2018 May 23.","Jaureguiberry-Bravo M","J Leukoc Biol","2018","2018/05/24","PMC6251758","NIHMS964627","10.1002/JLB.3HI0118-015R"
"29787643","A Second Look at ED-initiated Buprenorphine for Opioid Addiction","Hawk K.","ED Manag. 2016 Oct;28(10):113-114.","Hawk K","ED Manag","2016","2018/05/23","","",""
"29783095","Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes","Gordon MS, Blue TR, Couvillion K, Schwartz RP, O'Grady KE, Fitzgerald TT, Vocci FJ.","Drug Alcohol Depend. 2018 Jul 1;188:232-238. doi: 10.1016/j.drugalcdep.2018.04.010. Epub 2018 May 12.","Gordon MS","Drug Alcohol Depend","2018","2018/05/22","PMC5999574","NIHMS967491","10.1016/j.drugalcdep.2018.04.010"
"29781530","A comparison between methadone and buprenorphine for perioperative analgesia in dogs undergoing ovariohysterectomy","Shah MD, Yates D, Hunt J, Murrell JC.","J Small Anim Pract. 2018 Sep;59(9):539-546. doi: 10.1111/jsap.12859. Epub 2018 May 21.","Shah MD","J Small Anim Pract","2018","2018/05/22","","","10.1111/jsap.12859"
"29781244","OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients","Muriel J, Margarit C, Planelles B, Serralta MJ, Puga C, Inda MD, Cutillas E, Morales D, Horga JF, Peiró AM.","Ann N Y Acad Sci. 2018 Aug;1425(1):82-93. doi: 10.1111/nyas.13735. Epub 2018 May 20.","Muriel J","Ann N Y Acad Sci","2018","2018/05/22","","","10.1111/nyas.13735"
"29781091","Fetal assessment in buprenorphine-maintained women using fetal magnetoencephalography: a pilot study","Escalona-Vargas D, Coker JL, Ray-Griffith S, Siegel ER, Lowery CL, Stowe ZN, Eswaran H.","Addiction. 2018 Oct;113(10):1895-1904. doi: 10.1111/add.14266. Epub 2018 Jun 13.","Escalona-Vargas D","Addiction","2018","2018/05/22","","","10.1111/add.14266"
"29779547","Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment","Haffajee RL, Bohnert ASB, Lagisetty PA.","Am J Prev Med. 2018 Jun;54(6 Suppl 3):S230-S242. doi: 10.1016/j.amepre.2017.12.022.","Haffajee RL","Am J Prev Med","2018","2018/05/22","PMC6330240","NIHMS1004715","10.1016/j.amepre.2017.12.022"
"29779544","Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine","Andrilla CHA, Coulthard C, Patterson DG.","Am J Prev Med. 2018 Jun;54(6 Suppl 3):S208-S214. doi: 10.1016/j.amepre.2018.02.006.","Andrilla CHA","Am J Prev Med","2018","2018/05/22","","","10.1016/j.amepre.2018.02.006"
"29778749","Injection Butorphanol dependence: A case report","Shah B, Gupta R, Sarkar S, Balhara YPS.","Asian J Psychiatr. 2018 Jun;35:45-46. doi: 10.1016/j.ajp.2018.05.008. Epub 2018 May 14.","Shah B","Asian J Psychiatr","2018","2018/05/21","","","10.1016/j.ajp.2018.05.008"
"29763278","Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Use Disorder","Goodbar NH, Hanlon KE.","Am Fam Physician. 2018 May 15;97(10):668-670.","Goodbar NH","Am Fam Physician","2018","2018/05/16","","",""
"29735619","Stabilizing the Mother-Infant Dyad for Better Outcomes from OB to FM: Caring for Patients with Perinatal Opioid Use Disorder through the 4th Trimester","Ramage M, Ostrach B, Fagan B, Coulson CC.","N C Med J. 2018 May-Jun;79(3):164-165. doi: 10.18043/ncm.79.3.164.","Ramage M","N C Med J","2018","2018/05/09","","","10.18043/ncm.79.3.164"
"29735615","Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina","Khatiwoda P, Proeschold-Bell RJ, Meade CS, Park LP, Proescholdbell S.","N C Med J. 2018 May-Jun;79(3):149-155. doi: 10.18043/ncm.79.3.149.","Khatiwoda P","N C Med J","2018","2018/05/09","","","10.18043/ncm.79.3.149"
"29734918","Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015","Roberts AW, Saloner B, Dusetzina SB.","Psychiatr Serv. 2018 Jul 1;69(7):832-835. doi: 10.1176/appi.ps.201700315. Epub 2018 May 8.","Roberts AW","Psychiatr Serv","2018","2018/05/09","PMC6028283","NIHMS972690","10.1176/appi.ps.201700315"
"29730987","Stigma associated with medication treatment for young adults with opioid use disorder: a case series","Hadland SE, Park TW, Bagley SM.","Addict Sci Clin Pract. 2018 May 7;13(1):15. doi: 10.1186/s13722-018-0116-2.","Hadland SE","Addict Sci Clin Pract","2018","2018/05/08","PMC5937046","","10.1186/s13722-018-0116-2"
"29728088","Opioid substitution treatment and heroin dependent adolescents: reductions in heroin use and treatment retention over twelve months","Smyth BP, Elmusharaf K, Cullen W.","BMC Pediatr. 2018 May 4;18(1):151. doi: 10.1186/s12887-018-1137-4.","Smyth BP","BMC Pediatr","2018","2018/05/06","PMC5936020","","10.1186/s12887-018-1137-4"
"29727755","Are patients' pejorative representations of buprenorphine associated with their level of addiction and of misuse?","Vanderkam P, Gagey S, Ingrand P, Perault-Pochat MC, Brabant Y, Blanchard C, Tudrej B, Messaadi N, Binder P.","Drug Alcohol Depend. 2018 Jul 1;188:10-15. doi: 10.1016/j.drugalcdep.2018.03.033. Epub 2018 Apr 27.","Vanderkam P","Drug Alcohol Depend","2018","2018/05/05","","","10.1016/j.drugalcdep.2018.03.033"
"29725986","Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)","Erdal A, Flo E, Aarsland D, Ballard C, Slettebo DD, Husebo BS.","Drugs Aging. 2018 Jun;35(6):545-558. doi: 10.1007/s40266-018-0546-2.","Erdal A","Drugs Aging","2018","2018/05/05","PMC5999156","","10.1007/s40266-018-0546-2"
"29716837","Comparison of the postoperative analgesic effects of cimicoxib, buprenorphine and their combination in healthy dogs undergoing ovariohysterectomy","Bustamante R, Daza MA, Canfrán S, García P, Suárez M, Trobo I, Gómez de Segura IA.","Vet Anaesth Analg. 2018 Jul;45(4):545-556. doi: 10.1016/j.vaa.2018.01.003. Epub 2018 Feb 5.","Bustamante R","Vet Anaesth Analg","2018","2018/05/03","","","10.1016/j.vaa.2018.01.003"
"29710138","Opioid Use Disorder After Self-medicating Pain From Traumatic Brain Injury","Kosten TR, Graham DP, Nielsen DA.","JAMA Psychiatry. 2018 Jun 1;75(6):649-650. doi: 10.1001/jamapsychiatry.2018.0098.","Kosten TR","JAMA Psychiatry","2018","2018/05/01","","","10.1001/jamapsychiatry.2018.0098"
"29710079","Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury","Kosten TR, Graham DP, Nielsen DA.","JAMA Psychiatry. 2018 Jun 1;75(6):642-648. doi: 10.1001/jamapsychiatry.2018.0101.","Kosten TR","JAMA Psychiatry","2018","2018/05/01","","","10.1001/jamapsychiatry.2018.0101"
"29706172","Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review","Maglione MA, Raaen L, Chen C, Azhar G, Shahidinia N, Shen M, Maksabedian E, Shanman RM, Newberry S, Hempel S.","J Subst Abuse Treat. 2018 Jun;89:28-51. doi: 10.1016/j.jsat.2018.03.001. Epub 2018 Mar 13.","Maglione MA","J Subst Abuse Treat","2018","2018/05/01","","","10.1016/j.jsat.2018.03.001"
"29698067","Evaluation of the Thermal Antinociceptive Effects of a Sustained-Release Buprenorphine Formulation After Intramuscular Administration to American kestrels ( Falco sparverius)","Guzman DS, Ceulemans SM, Beaufrère H, Olsen GH, Paul-Murphy JR.","J Avian Med Surg. 2018 Mar;32(1):1-7. doi: 10.1647/2016-190.","Guzman DS","J Avian Med Surg","2018","2018/04/27","","","10.1647/2016-190"
"29690955","Analgesic Efficacy and Safety of Buprenorphine in Chinchillas (Chinchilla lanigera)","Fox L, Mans C.","J Am Assoc Lab Anim Sci. 2018 May 1;57(3):286-290. doi: 10.30802/AALAS-JAALAS-17-000108. Epub 2018 Apr 24.","Fox L","J Am Assoc Lab Anim Sci","2018","2018/04/26","PMC5966237","","10.30802/AALAS-JAALAS-17-000108"
"29689538","Opioids and HIV Infection: From Pain Management to Addiction Treatment","Cunningham CO.","Top Antivir Med. 2018 Apr;25(4):143-146.","Cunningham CO","Top Antivir Med","2018","2018/04/25","PMC5935219","",""
"29684941","Opioid Deaths in Milwaukee County, Wisconsin 2013-2017: The Primacy of Heroin and Fentanyl","Peterson BL, Schreiber S, Fumo N, Brooke Lerner E.","J Forensic Sci. 2019 Jan;64(1):144-148. doi: 10.1111/1556-4029.13808. Epub 2018 Apr 23.","Peterson BL","J Forensic Sci","2019","2018/04/24","","","10.1111/1556-4029.13808"
"29680678","Concomitant use of buprenorphine for medication-assisted treatment of opioid use disorder and benzodiazepines: Using the prescription behavior surveillance system","Zhu Y, Coyle DT, Mohamoud M, Zhou E, Eworuke E, Dormitzer C, Staffa J.","Drug Alcohol Depend. 2018 Jun 1;187:221-226. doi: 10.1016/j.drugalcdep.2018.02.019. Epub 2018 Apr 10.","Zhu Y","Drug Alcohol Depend","2018","2018/04/23","","","10.1016/j.drugalcdep.2018.02.019"
"29680426","Willis-Ekbom disease/restless legs syndrome in patients with opioid withdrawal","Gupta R, Ali R, Ray R.","Sleep Med. 2018 May;45:39-43. doi: 10.1016/j.sleep.2017.09.028. Epub 2017 Nov 22.","Gupta R","Sleep Med","2018","2018/04/23","","","10.1016/j.sleep.2017.09.028"
"29677869","Re: Erectile Dysfunction and Quality of Life in Men Receiving Methadone or Buprenorphine Maintenance Treatment. A Cross-Sectional Multicentre Study","Seftel AD.","J Urol. 2018 May;199(5):1095-1097. doi: 10.1016/j.juro.2018.02.055. Epub 2018 Feb 19.","Seftel AD","J Urol","2018","2018/04/22","","","10.1016/j.juro.2018.02.055"
"29674251","Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial","Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA.","Drug Alcohol Depend. 2018 Jun 1;187:171-178. doi: 10.1016/j.drugalcdep.2018.02.023. Epub 2018 Apr 10.","Bisaga A","Drug Alcohol Depend","2018","2018/04/21","","","10.1016/j.drugalcdep.2018.02.023"
"29673369","Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user's perspective","Ghaddar A, Khandaqji S, Abbass Z.","Subst Abuse Treat Prev Policy. 2018 Apr 19;13(1):14. doi: 10.1186/s13011-018-0151-8.","Ghaddar A","Subst Abuse Treat Prev Policy","2018","2018/04/21","PMC5909215","","10.1186/s13011-018-0151-8"
"29672985","The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom","Hickman M, Steer C, Tilling K, Lim AG, Marsden J, Millar T, Strang J, Telfer M, Vickerman P, Macleod J.","Addiction. 2018 Aug;113(8):1461-1476. doi: 10.1111/add.14188. Epub 2018 Apr 19.","Hickman M","Addiction","2018","2018/04/20","PMC6282737","","10.1111/add.14188"
"29672167","Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment","Barbosa-Leiker C, McPherson S, Layton ME, Burduli E, Roll JM, Ling W.","Am J Drug Alcohol Abuse. 2018;44(4):488-496. doi: 10.1080/00952990.2018.1458234. Epub 2018 Apr 19.","Barbosa-Leiker C","Am J Drug Alcohol Abuse","2018","2018/04/20","PMC6186400","NIHMS987269","10.1080/00952990.2018.1458234"
"29671681","Sexual Dysfunctions are Predicted by Childhood Sexual Abuse in Women with Opioid Use Disorder","Ağaçhanlı R, Alnıak İ, Evren C.","Subst Use Misuse. 2018 Nov 10;53(13):2184-2189. doi: 10.1080/10826084.2018.1461228. Epub 2018 Apr 19.","Ağaçhanlı R","Subst Use Misuse","2018","2018/04/20","","","10.1080/10826084.2018.1461228"
"29671504","Buprenorphine Therapy for Opioid Use Disorder","Zoorob R, Kowalchuk A, Mejia de Grubb M.","Am Fam Physician. 2018 Mar 1;97(5):313-320.","Zoorob R","Am Fam Physician","2018","2018/04/20","","",""
"29669393","By One's Own Hand","Miller JB, Baer AN.","Arthritis Rheumatol. 2018 Sep;70(9):1529. doi: 10.1002/art.40525. Epub 2018 Jul 25.","Miller JB","Arthritis Rheumatol","2018","2018/04/19","","","10.1002/art.40525"
"29668514","The role of NPs in medication-assisted treatment for opioid use disorder","Cotton BP, Ferszt GG.","Nurse Pract. 2018 May 17;43(5):8. doi: 10.1097/01.NPR.0000531074.42053.50.","Cotton BP","Nurse Pract","2018","2018/04/19","","","10.1097/01.NPR.0000531074.42053.50"
"29656707","Three-Year Retention in Buprenorphine Treatment for Opioid Use Disorder Among Privately Insured Adults","Manhapra A, Agbese E, Leslie DL, Rosenheck RA.","Psychiatr Serv. 2018 Jul 1;69(7):768-776. doi: 10.1176/appi.ps.201700363. Epub 2018 Apr 16.","Manhapra A","Psychiatr Serv","2018","2018/04/17","","","10.1176/appi.ps.201700363"
"29649890","What Parenteral Opioids to Use in Face of Shortages of Morphine, Hydromorphone, and Fentanyl","Davis MP, McPherson ML, Mehta Z, Behm B, Fernandez C.","Am J Hosp Palliat Care. 2018 Aug;35(8):1118-1122. doi: 10.1177/1049909118771374. Epub 2018 Apr 12.","Davis MP","Am J Hosp Palliat Care","2018","2018/04/14","","","10.1177/1049909118771374"
"29635048","Expression of kappa opioid receptors in developing rat brain - Implications for perinatal buprenorphine exposure","Tan KZ, Cunningham AM, Joshi A, Oei JL, Ward MC.","Reprod Toxicol. 2018 Jun;78:81-89. doi: 10.1016/j.reprotox.2018.04.006. Epub 2018 Apr 7.","Tan KZ","Reprod Toxicol","2018","2018/04/11","","","10.1016/j.reprotox.2018.04.006"
"29634425","Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment","Kowalczyk WJ, Moran LM, Bertz JW, Phillips KA, Ghitza UE, Vahabzadeh M, Lin JL, Epstein DH, Preston KL.","Am J Drug Alcohol Abuse. 2018;44(5):502-511. doi: 10.1080/00952990.2018.1454933. Epub 2018 Apr 10.","Kowalczyk WJ","Am J Drug Alcohol Abuse","2018","2018/04/11","PMC6146282","NIHMS988518","10.1080/00952990.2018.1454933"
"29628389","Effects of buprenorphine, butorphanol or tramadol premedication on anaesthetic induction with alfaxalone in common marmosets (Callithrix jacchus)","Bakker J, Roubos S, Remarque EJ, Arndt SS, Kronen PW, Langermans JA.","Vet Anaesth Analg. 2018 May;45(3):309-319. doi: 10.1016/j.vaa.2017.06.009. Epub 2018 Feb 5.","Bakker J","Vet Anaesth Analg","2018","2018/04/10","","","10.1016/j.vaa.2017.06.009"
"29626742","Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications","Muller AE, Bjørnestad R, Clausen T.","Drug Alcohol Depend. 2018 Jun 1;187:22-28. doi: 10.1016/j.drugalcdep.2018.02.018. Epub 2018 Mar 29.","Muller AE","Drug Alcohol Depend","2018","2018/04/08","","","10.1016/j.drugalcdep.2018.02.018"
"29624528","Lack of Evidence for Ceiling Effect for Buprenorphine Analgesia in Humans","Richardson MG, Raymond BL.","Anesth Analg. 2018 Jul;127(1):310-311. doi: 10.1213/ANE.0000000000003368.","Richardson MG","Anesth Analg","2018","2018/04/07","","","10.1213/ANE.0000000000003368"
"29621905","Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder","Ragguett RM, Rong C, Rosenblat JD, Ho RC, McIntyre RS.","Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):475-482. doi: 10.1080/17425255.2018.1459564. Epub 2018 Apr 6.","Ragguett RM","Expert Opin Drug Metab Toxicol","2018","2018/04/07","","","10.1080/17425255.2018.1459564"
"29614184","Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment","Wachman EM, Schiff DM, Silverstein M.","JAMA. 2018 Apr 3;319(13):1362-1374. doi: 10.1001/jama.2018.2640.","Wachman EM","JAMA","2018","2018/04/04","","","10.1001/jama.2018.2640"
"29596252","New Route for Buprenorphine Administration","Aschenbrenner DS.","Am J Nurs. 2018 Apr;118(4):23. doi: 10.1097/01.NAJ.0000532074.85833.b4.","Aschenbrenner DS","Am J Nurs","2018","2018/03/30","","","10.1097/01.NAJ.0000532074.85833.b4"
"29595410","A novel approach to treating adolescents with opioid use disorder in pediatric primary care","Levy S, Mountain-Ray S, Reynolds J, Mendes SJ, Bromberg J.","Subst Abus. 2018;39(2):173-181. doi: 10.1080/08897077.2018.1455165. Epub 2018 Apr 26.","Levy S","Subst Abus","2018","2018/03/30","","","10.1080/08897077.2018.1455165"
"29579725","Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder","Holt SR, Donroe JH, Cavallo DA, Tetrault JM.","Drug Alcohol Depend. 2018 May 1;186:171-174. doi: 10.1016/j.drugalcdep.2017.12.040. Epub 2018 Mar 2.","Holt SR","Drug Alcohol Depend","2018","2018/03/27","","","10.1016/j.drugalcdep.2017.12.040"
"29578857","Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic","James JR, Gordon LM, Klein JW, Merrill JO, Tsui JI.","Subst Abus. 2019;40(1):11-13. doi: 10.1080/08897077.2018.1449176. Epub 2018 Apr 26.","James JR","Subst Abus","2019","2018/03/27","","","10.1080/08897077.2018.1449176"
"29576108","Efficacy and adverse effects of buprenorphine in acute pain management: systematic review and meta-analysis of randomised controlled trials","White LD, Hodge A, Vlok R, Hurtado G, Eastern K, Melhuish TM.","Br J Anaesth. 2018 Apr;120(4):668-678. doi: 10.1016/j.bja.2017.11.086. Epub 2017 Dec 2.","White LD","Br J Anaesth","2018","2018/03/27","","","10.1016/j.bja.2017.11.086"
"29573649","Perceptions and practices addressing diversion among US buprenorphine prescribers","Lin LA, Lofwall MR, Walsh SL, Gordon AJ, Knudsen HK.","Drug Alcohol Depend. 2018 May 1;186:147-153. doi: 10.1016/j.drugalcdep.2018.01.015. Epub 2018 Mar 10.","Lin LA","Drug Alcohol Depend","2018","2018/03/25","PMC5911230","NIHMS953898","10.1016/j.drugalcdep.2018.01.015"
"29573648","Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial","Schottenfeld RS, Chawarski MC, Sofuoglu M, Chooi WT, Zaharim NM, M Yasin MA, Ahmad I, Syed Jaapar SZ, Vicknasingam BK.","Drug Alcohol Depend. 2018 May 1;186:130-137. doi: 10.1016/j.drugalcdep.2018.01.017. Epub 2018 Mar 10.","Schottenfeld RS","Drug Alcohol Depend","2018","2018/03/25","PMC5911201","NIHMS950577","10.1016/j.drugalcdep.2018.01.017"
"29565661","Impact of Medicaid Expansion on Access to Opioid Analgesic Medications and Medication-Assisted Treatment","Sharp A, Jones A, Sherwood J, Kutsa O, Honermann B, Millett G.","Am J Public Health. 2018 May;108(5):642-648. doi: 10.2105/AJPH.2018.304338. Epub 2018 Mar 22.","Sharp A","Am J Public Health","2018","2018/03/23","PMC5888053","","10.2105/AJPH.2018.304338"
"29563006","Opioid Rotation in Cancer Pain Treatment","Schuster M, Bayer O, Heid F, Laufenberg-Feldmann R.","Dtsch Arztebl Int. 2018 Mar 2;115(9):135-142. doi: 10.3238/arztebl.2018.0135.","Schuster M","Dtsch Arztebl Int","2018","2018/03/23","PMC5876542","","10.3238/arztebl.2018.0135"
"29557855","Risky Sexual Behavior Among Individuals Receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058","Shava E, Lipira LE, Beauchamp GG, Donnell DJ, Lockman S, Ruan Y, Shao Y.","Version 2. J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):300-307. doi: 10.1097/QAI.0000000000001683.","Shava E","J Acquir Immune Defic Syndr","2018","2018/03/21","PMC5997518","NIHMS951940","10.1097/QAI.0000000000001683"
"29543612","Does Cannabis Use Influence Opioid Outcomes and Quality of Life Among Buprenorphine Maintained Patients? A Cross-sectional, Comparative Study","Bagra I, Krishnan V, Rao R, Agrawal A.","J Addict Med. 2018 Jul/Aug;12(4):315-320. doi: 10.1097/ADM.0000000000000406.","Bagra I","J Addict Med","2018","2018/03/16","","","10.1097/ADM.0000000000000406"
"29525482","Expanded buprenorphine prescribing privileges: Sandbagging in the midst of the flood?","Brown JD, Nolte JL.","Res Social Adm Pharm. 2018 Jun;14(6):617-618. doi: 10.1016/j.sapharm.2018.03.001. Epub 2018 Mar 3.","Brown JD","Res Social Adm Pharm","2018","2018/03/12","","","10.1016/j.sapharm.2018.03.001"
"29522780","Response of zebrafish larvae to mild electrical stimuli: A 96-well setup for behavioural screening","Steenbergen PJ.","J Neurosci Methods. 2018 May 1;301:52-61. doi: 10.1016/j.jneumeth.2018.03.002. Epub 2018 Mar 6.","Steenbergen PJ","J Neurosci Methods","2018","2018/03/10","","","10.1016/j.jneumeth.2018.03.002"
"29521421","The pharmacokinetics and analgesic effects of extended-release buprenorphine administered subcutaneously in healthy dogs","Barletta M, Ostenkamp SM, Taylor AC, Quandt J, Lascelles BDX, Messenger KM.","J Vet Pharmacol Ther. 2018 Aug;41(4):502-512. doi: 10.1111/jvp.12497. Epub 2018 Mar 9.","Barletta M","J Vet Pharmacol Ther","2018","2018/03/10","","","10.1111/jvp.12497"
"29516490","The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome","Moore JN, Gastonguay MR, Ng CM, Adeniyi-Jones SC, Moody DE, Fang WB, Ehrlich ME, Kraft WK.","Clin Pharmacol Ther. 2018 Jun;103(6):1029-1037. doi: 10.1002/cpt.1064. Epub 2018 Apr 28.","Moore JN","Clin Pharmacol Ther","2018","2018/03/09","PMC5992055","NIHMS949729","10.1002/cpt.1064"
"29515226","Finding the right treatment for neonatal abstinence syndrome: is this the right time?","Yen E, Davis JM.","J Perinatol. 2018 Jul;38(7):785-787. doi: 10.1038/s41372-018-0090-2. Epub 2018 Mar 7.","Yen E","J Perinatol","2018","2018/03/09","","","10.1038/s41372-018-0090-2"
"29514333","Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose","Athanasos P, Ling W, Bochner F, White JM, Somogyi AA.","Pain Med. 2019 Jan 1;20(1):119-128. doi: 10.1093/pm/pny025.","Athanasos P","Pain Med","2019","2018/03/08","PMC6329438","","10.1093/pm/pny025"
"29513136","Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors","Tesema L, Marshall J, Hathaway R, Pham C, Clarke C, Bergeron G, Yeh J, Soliman M, McCormick D.","Subst Abus. 2018;39(4):434-440. doi: 10.1080/08897077.2018.1449047. Epub 2018 May 14.","Tesema L","Subst Abus","2018","2018/03/08","","","10.1080/08897077.2018.1449047"
"29509558","Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines","Lintzeris N, Monds LA, Rivas C, Leung S, Dunlop A, Newcombe D, Walters C, Galea S, White N, Montebello M, Demirkol A, Swanson N, Ali R.","J Addict Med. 2018 May/Jun;12(3):234-240. doi: 10.1097/ADM.0000000000000396.","Lintzeris N","J Addict Med","2018","2018/03/07","PMC5976217","","10.1097/ADM.0000000000000396"
"29504673","Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants","Moody DE, Fu Y, Fang WB.","Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):327-334. doi: 10.1111/bcpt.12999. Epub 2018 Apr 19.","Moody DE","Basic Clin Pharmacol Toxicol","2018","2018/03/06","","","10.1111/bcpt.12999"
"29486974","Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: an observational study","Hoyt MR, Shah U, Cooley J, Temple M.","Int J Obstet Anesth. 2018 May;34:67-72. doi: 10.1016/j.ijoa.2018.01.001. Epub 2018 Jan 31.","Hoyt MR","Int J Obstet Anesth","2018","2018/03/01","","","10.1016/j.ijoa.2018.01.001"
"29485976","Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder","","Med Lett Drugs Ther. 2018 Feb 26;60(1541):35-37.","","Med Lett Drugs Ther","2018","2018/02/28","","",""
"29474119","Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program","Bachhuber MA, Thompson C, Prybylowski A, Benitez J MSW, Mazzella S MA, Barclay D.","Subst Abus. 2018;39(2):167-172. doi: 10.1080/08897077.2018.1443541. Epub 2018 May 4.","Bachhuber MA","Subst Abus","2018","2018/02/24","","","10.1080/08897077.2018.1443541"
"29471921","Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine","Makarenko I, Mazhnaya A, Marcus R, Pykalo I, Madden L, Filippovich S, Dvoriak S, Altice FL.","J Subst Abuse Treat. 2018 Apr;87:1-8. doi: 10.1016/j.jsat.2018.01.007. Epub 2018 Jan 11.","Makarenko I","J Subst Abuse Treat","2018","2018/02/24","PMC5826566","NIHMS936344","10.1016/j.jsat.2018.01.007"
"29466151","Controlling the Swing of the Opioid Pendulum","Comerci G Jr, Katzman J, Duhigg D.","N Engl J Med. 2018 Feb 22;378(8):691-693. doi: 10.1056/NEJMp1713159.","Comerci G Jr","N Engl J Med","2018","2018/02/22","","","10.1056/NEJMp1713159"
"29466036","Pharmacokinetics of buprenorphine after intravenous and oral transmucosal administration in guinea pigs (Cavia porcellus)","Sadar MJ, Knych HK, Drazenovich TL, Paul-Murphy JR.","Am J Vet Res. 2018 Mar;79(3):260-266. doi: 10.2460/ajvr.79.3.260.","Sadar MJ","Am J Vet Res","2018","2018/02/22","","","10.2460/ajvr.79.3.260"
"29453925","Impact of opioid therapy on gonadal hormones: focus on buprenorphine","Varma A, Sapra M, Iranmanesh A.","Horm Mol Biol Clin Investig. 2018 Feb 17;36(2):/j/hmbci.2018.36.issue-2/hmbci-2017-0080/hmbci-2017-0080.xml. doi: 10.1515/hmbci-2017-0080.","Varma A","Horm Mol Biol Clin Investig","2018","2018/02/18","","","10.1515/hmbci-2017-0080"
"29452378","Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period","Lembke A, Ottestad E, Schmiesing C.","Pain Med. 2019 Mar 1;20(3):425-428. doi: 10.1093/pm/pny019.","Lembke A","Pain Med","2019","2018/02/17","PMC6387981","","10.1093/pm/pny019"
"29450443","Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System","Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BDL, Alexander-Scott N, Boss R, Rich JD.","JAMA Psychiatry. 2018 Apr 1;75(4):405-407. doi: 10.1001/jamapsychiatry.2017.4614.","Green TC","JAMA Psychiatry","2018","2018/02/17","PMC5875331","","10.1001/jamapsychiatry.2017.4614"
"29447177","Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey","Kouyoumdjian FG, Patel A, To MJ, Kiefer L, Regenstreif L.","PLoS One. 2018 Feb 15;13(2):e0192431. doi: 10.1371/journal.pone.0192431. eCollection 2018.","Kouyoumdjian FG","PLoS One","2018","2018/02/16","PMC5813939","","10.1371/journal.pone.0192431"
"29443676","Caring for Ms. L. - Overcoming My Fear of Treating Opioid Use Disorder","Provenzano AM.","N Engl J Med. 2018 Feb 15;378(7):600-601. doi: 10.1056/NEJMp1715093.","Provenzano AM","N Engl J Med","2018","2018/02/15","","","10.1056/NEJMp1715093"
"29443414","Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway","Nechanská B, Mravčík V, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Handal M.","Addiction. 2018 Jul;113(7):1286-1294. doi: 10.1111/add.14192. Epub 2018 Mar 24.","Nechanská B","Addiction","2018","2018/02/15","PMC6221017","","10.1111/add.14192"
"29440012","Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study","Mordecai L, Reynolds C, Donaldson LJ, de C Williams AC.","Br J Gen Pract. 2018 Mar;68(668):e225-e233. doi: 10.3399/bjgp18X695057. Epub 2018 Feb 12.","Mordecai L","Br J Gen Pract","2018","2018/02/15","PMC5819988","","10.3399/bjgp18X695057"
"29433361","Takotsubo cardiomyopathy associated with buprenorphine precipitated withdrawal","Surmaitis RM, Khalid MM, Vearrier D, Greenberg MI.","Clin Toxicol (Phila). 2018 Sep;56(9):863-864. doi: 10.1080/15563650.2018.1437921. Epub 2018 Feb 12.","Surmaitis RM","Clin Toxicol (Phila)","2018","2018/02/14","","","10.1080/15563650.2018.1437921"
"29433352","Buprenorphine alone or with naloxone: Which is safer?","Kelty E, Cumming C, Troeung L, Hulse G.","J Psychopharmacol. 2018 Mar;32(3):344-352. doi: 10.1177/0269881118756015. Epub 2018 Feb 13.","Kelty E","J Psychopharmacol","2018","2018/02/14","","","10.1177/0269881118756015"
"29432333","Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review","Borodovsky JT, Levy S, Fishman M, Marsch LA.","J Addict Med. 2018 May/Jun;12(3):170-183. doi: 10.1097/ADM.0000000000000388.","Borodovsky JT","J Addict Med","2018","2018/02/13","PMC5970018","NIHMS933394","10.1097/ADM.0000000000000388"
"29432086","Overcoming medication stigma in peer recovery: A new paradigm","Krawczyk N, Negron T, Nieto M, Agus D, Fingerhood MI.","Subst Abus. 2018;39(4):404-409. doi: 10.1080/08897077.2018.1439798. Epub 2018 Apr 4.","Krawczyk N","Subst Abus","2018","2018/02/13","PMC6087684","NIHMS970849","10.1080/08897077.2018.1439798"
"29426304","Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy","Akiyama MJ, Agyemang L, Arnsten JH, Heo M, Norton BL, Schackman BR, Linas BP, Litwin AH.","BMC Infect Dis. 2018 Feb 9;18(1):74. doi: 10.1186/s12879-018-2964-5.","Akiyama MJ","BMC Infect Dis","2018","2018/02/11","PMC5807730","","10.1186/s12879-018-2964-5"
"29420414","The Comprehensive Addiction and Recovery Act: Opioid Use Disorder and Midwifery Practice","Murphy J, Goodman D, Johnson MC, Terplan M.","Obstet Gynecol. 2018 Mar;131(3):542-544. doi: 10.1097/AOG.0000000000002493.","Murphy J","Obstet Gynecol","2018","2018/02/09","","","10.1097/AOG.0000000000002493"
"29415847","Predictors of treatment retention in postpartum women prescribed buprenorphine during pregnancy","O'Connor AB, Uhler B, O'Brien LM, Knuppel K.","J Subst Abuse Treat. 2018 Mar;86:26-29. doi: 10.1016/j.jsat.2017.12.001. Epub 2017 Dec 8.","O'Connor AB","J Subst Abuse Treat","2018","2018/02/09","","","10.1016/j.jsat.2017.12.001"
"29413437","Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes","Kaltenbach K, O'Grady KE, Heil SH, Salisbury AL, Coyle MG, Fischer G, Martin PR, Stine S, Jones HE.","Drug Alcohol Depend. 2018 Apr 1;185:40-49. doi: 10.1016/j.drugalcdep.2017.11.030. Epub 2018 Feb 1.","Kaltenbach K","Drug Alcohol Depend","2018","2018/02/08","PMC5906792","NIHMS939455","10.1016/j.drugalcdep.2017.11.030"
"29394163","Buprenorphine Depresses Respiratory Variability in Obese Mice with Altered Leptin Signaling","Angel C, Glovak ZT, Alami W, Mihalko S, Price J, Jiang Y, Baghdoyan HA, Lydic R.","Anesthesiology. 2018 May;128(5):984-991. doi: 10.1097/ALN.0000000000002073.","Angel C","Anesthesiology","2018","2018/02/03","PMC5903969","NIHMS926493","10.1097/ALN.0000000000002073"
"29389213","Tobacco withdrawal among opioid-dependent smokers","Streck JM, Heil SH, Higgins ST, Bunn JY, Sigmon SC.","Exp Clin Psychopharmacol. 2018 Apr;26(2):119-124. doi: 10.1037/pha0000185. Epub 2018 Feb 1.","Streck JM","Exp Clin Psychopharmacol","2018","2018/02/02","PMC5897167","NIHMS929941","10.1037/pha0000185"
"29378623","Patient perspectives of transitioning from prescription opioids to heroin and the role of route of administration","Monico LB, Mitchell SG.","Subst Abuse Treat Prev Policy. 2018 Jan 29;13(1):4. doi: 10.1186/s13011-017-0137-y.","Monico LB","Subst Abuse Treat Prev Policy","2018","2018/01/31","PMC5789586","","10.1186/s13011-017-0137-y"
"29372750","The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome","Lemon LS, Naimi A, Caritis SN, Platt RW, Venkataramanan R, Bodnar LM.","Paediatr Perinat Epidemiol. 2018 Mar;32(2):213-222. doi: 10.1111/ppe.12443. Epub 2018 Jan 26.","Lemon LS","Paediatr Perinat Epidemiol","2018","2018/01/27","PMC5902412","NIHMS931174","10.1111/ppe.12443"
"29369763","Underused Weapon In the War on Addiction","Kelley T.","Manag Care. 2018 Jan;27(1):15-17.","Kelley T","Manag Care","2018","2018/01/26","","",""
"29367086","Sedation of sheep following the administration of acepromazine with buprenorphine or morphine is similar","Musk GC, Wilkes GJ.","Res Vet Sci. 2018 Jun;118:41-42. doi: 10.1016/j.rvsc.2018.01.013. Epub 2018 Jan 31.","Musk GC","Res Vet Sci","2018","2018/01/26","","","10.1016/j.rvsc.2018.01.013"
"29359974","Evaluation of self-injurious behavior, food intake, fecal output, and thermal withdrawal latencies after injection of a high-concentration buprenorphine formulation in rats (Rattus norvegicus)","Allen M, Nietlisbach N, Johnson RA.","Am J Vet Res. 2018 Feb;79(2):154-162. doi: 10.2460/ajvr.79.2.154.","Allen M","Am J Vet Res","2018","2018/01/24","","","10.2460/ajvr.79.2.154"
"29357661","[Pain management for cancer patients in drug-assisted rehabilitation]","Fredheim OMS.","Tidsskr Nor Laegeforen. 2018 Jan 22;138(2). doi: 10.4045/tidsskr.17.0171. Print 2018 Jan 23.","Fredheim OMS","Tidsskr Nor Laegeforen","2018","2018/01/24","","","10.4045/tidsskr.17.0171"
"29357325","Buprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures","Jonan AB, Kaye AD, Urman RD.","Pain Physician. 2018 Jan;21(1):E1-E12.","Jonan AB","Pain Physician","2018","2018/01/23","","",""
"29356208","Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study","Neale J, Tompkins CNE, McDonald R, Strang J.","Addiction. 2018 Jun;113(6):1066-1076. doi: 10.1111/add.14163. Epub 2018 Feb 21.","Neale J","Addiction","2018","2018/01/23","PMC5969063","","10.1111/add.14163"
"29324253","A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices","Andraka-Christou B, Capone MJ.","Int J Drug Policy. 2018 Apr;54:9-17. doi: 10.1016/j.drugpo.2017.11.021. Epub 2018 Jan 8.","Andraka-Christou B","Int J Drug Policy","2018","2018/01/12","","","10.1016/j.drugpo.2017.11.021"
"29320915","Healthcare utilization and costs associated with treatment for opioid dependence","Shah A, Duncan M, Atreja N, Tai KS, Gore M.","J Med Econ. 2018 Apr;21(4):406-415. doi: 10.1080/13696998.2018.1427101. Epub 2018 Feb 1.","Shah A","J Med Econ","2018","2018/01/12","","","10.1080/13696998.2018.1427101"
"29309700","The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine","Lim SCB, Schug S, Krishnarajah J.","Pain Med. 2019 Jan 1;20(1):143-152. doi: 10.1093/pm/pnx321.","Lim SCB","Pain Med","2019","2018/01/09","","","10.1093/pm/pnx321"
"29302989","Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder","Shcherbakova N, Tereso G, Spain J, Roose RJ.","Ann Pharmacother. 2018 May;52(5):405-414. doi: 10.1177/1060028017751913. Epub 2018 Jan 5.","Shcherbakova N","Ann Pharmacother","2018","2018/01/06","","","10.1177/1060028017751913"
"29302767","Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow Residents","Majer JM, Beasley C, Stecker E, Bobak TJ, Norris J, Nguyen HM, Ogata M, Siegel J, Wiedbusch E, Dovale I, Gelfman N, Callahan S, Jason LA.","Community Ment Health J. 2018 Jul;54(5):571-577. doi: 10.1007/s10597-017-0218-4. Epub 2018 Jan 4.","Majer JM","Community Ment Health J","2018","2018/01/06","","","10.1007/s10597-017-0218-4"
"29302227","Treatment of opioid dependence with buprenorphine: current update","Soyka M.","Dialogues Clin Neurosci. 2017 Sep;19(3):299-308.","Soyka M","Dialogues Clin Neurosci","2017","2018/01/06","PMC5741113","",""
"29302220","A brief review of the genetics and pharmacogenetics of opioid use disorders","Berrettini W.","Dialogues Clin Neurosci. 2017 Sep;19(3):229-236.","Berrettini W","Dialogues Clin Neurosci","2017","2018/01/06","PMC5741106","",""
"29296014","Do recordkeeping errors alone justify a noncompliance citation?","Silverman J.","Lab Anim (NY). 2017 Aug 31;46(9):337. doi: 10.1038/laban.1331.","Silverman J","Lab Anim (NY)","2017","2018/01/04","","","10.1038/laban.1331"
"29292291","Medication Treatment of Adolescent Opioid Use Disorder in Primary Care","Carney BL, Hadland SE, Bagley SM.","Pediatr Rev. 2018 Jan;39(1):43-45. doi: 10.1542/pir.2017-0153.","Carney BL","Pediatr Rev","2018","2018/01/03","PMC6163000","NIHMS989722","10.1542/pir.2017-0153"
"29287158","Pharmacokinetics of a concentrated buprenorphine formulation in red-tailed hawks (Buteo jamaicensis)","Gleeson MD, Guzman DS, Knych HK, Kass PH, Drazenovich TL, Hawkins MG.","Am J Vet Res. 2018 Jan;79(1):13-20. doi: 10.2460/ajvr.79.1.13.","Gleeson MD","Am J Vet Res","2018","2017/12/30","","","10.2460/ajvr.79.1.13"
"29285767","Opioid Neonatal Abstinence Syndrome: An Overview","Wexelblatt SL, McAllister JM, Nathan AT, Hall ES.","Clin Pharmacol Ther. 2018 Jun;103(6):979-981. doi: 10.1002/cpt.958. Epub 2017 Dec 29.","Wexelblatt SL","Clin Pharmacol Ther","2018","2017/12/30","","","10.1002/cpt.958"
"29282768","Effects of pain treatment on sleep in nursing home patients with dementia and depression: A multicenter placebo-controlled randomized clinical trial","Blytt KM, Bjorvatn B, Husebo B, Flo E.","Int J Geriatr Psychiatry. 2018 Apr;33(4):663-670. doi: 10.1002/gps.4839. Epub 2017 Dec 28.","Blytt KM","Int J Geriatr Psychiatry","2018","2017/12/29","PMC5873424","","10.1002/gps.4839"
"29282239","Prescribing Opioid Replacement Therapy in U.S. Correctional Settings","Farahmand P, Modesto-Lowe V, Chaplin MM.","J Am Acad Psychiatry Law. 2017 Dec;45(4):472-477.","Farahmand P","J Am Acad Psychiatry Law","2017","2017/12/29","","",""
"29275046","Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment","Yee A, Loh HS, Danaee M, Riahi S, Ng CG, Sulaiman AH.","J Sex Med. 2018 Feb;15(2):159-166. doi: 10.1016/j.jsxm.2017.12.004. Epub 2017 Dec 21.","Yee A","J Sex Med","2018","2017/12/25","","","10.1016/j.jsxm.2017.12.004"
"29268879","Decision Science Can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant Women","Thao V, Enns EA, Patrick SW, Levy R, Kozhimannil KB.","Womens Health Issues. 2018 Jan-Feb;28(1):2-5. doi: 10.1016/j.whi.2017.10.008.","Thao V","Womens Health Issues","2018","2017/12/23","","","10.1016/j.whi.2017.10.008"
"29268702","Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study","Ober AJ, Watkins KE, Hunter SB, Ewing B, Lamp K, Lind M, Becker K, Heinzerling K, Osilla KC, Diamant AL, Setodji CM.","BMC Fam Pract. 2017 Dec 21;18(1):107. doi: 10.1186/s12875-017-0673-6.","Ober AJ","BMC Fam Pract","2017","2017/12/23","PMC5740845","","10.1186/s12875-017-0673-6"
"29266577","Emergency Department Treatment of Opioid Addiction: An Opportunity to Lead","Martin A, Mitchell A, Wakeman S, White B, Raja A.","Acad Emerg Med. 2018 May;25(5):601-604. doi: 10.1111/acem.13367. Epub 2018 Feb 13.","Martin A","Acad Emerg Med","2018","2017/12/22","","","10.1111/acem.13367"
"29260692","[Faecal impaction in elderly patients is a potential severe condition]","Nissen SK, Stenberg MR, Ryg J.","Ugeskr Laeger. 2017 Dec 18;179(51):V05170390.","Nissen SK","Ugeskr Laeger","2017","2017/12/21","","",""
"29256372","Pharmacokinetics and Adverse Effects of 3 Sustained-release Buprenorphine Dosages in Healthy Guinea Pigs (Cavia porcellus)","Zanetti AS, Putta SK, Casebolt DB, Louie SG.","J Am Assoc Lab Anim Sci. 2017 Nov 1;56(6):768-778.","Zanetti AS","J Am Assoc Lab Anim Sci","2017","2017/12/20","PMC5710156","",""
"29245103","Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration","Kelly MM, Reilly E, Quiñones T, Desai N, Rosenheck R.","Drug Alcohol Depend. 2018 Feb 1;183:111-117. doi: 10.1016/j.drugalcdep.2017.10.017. Epub 2017 Dec 2.","Kelly MM","Drug Alcohol Depend","2018","2017/12/16","","","10.1016/j.drugalcdep.2017.10.017"
"29241428","State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder","Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedmann PD.","Psychiatr Serv. 2018 Apr 1;69(4):448-455. doi: 10.1176/appi.ps.201700196. Epub 2017 Dec 15.","Abraham AJ","Psychiatr Serv","2018","2017/12/16","PMC6703818","NIHMS1532327","10.1176/appi.ps.201700196"
"29239947","Treatment of Chronic Pain With Various Buprenorphine Formulations: A Systematic Review of Clinical Studies","Aiyer R, Gulati A, Gungor S, Bhatia A, Mehta N.","Anesth Analg. 2018 Aug;127(2):529-538. doi: 10.1213/ANE.0000000000002718.","Aiyer R","Anesth Analg","2018","2017/12/15","","","10.1213/ANE.0000000000002718"
"29234968","A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013","Marotta PL, McCullagh CA.","Eur J Epidemiol. 2018 Jul;33(7):679-688. doi: 10.1007/s10654-017-0342-z. Epub 2017 Dec 12.","Marotta PL","Eur J Epidemiol","2018","2017/12/14","PMC5997507","NIHMS947445","10.1007/s10654-017-0342-z"
"29231163","Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine ","Strang J, Knight A, Baillie S, Reed K, Bogdanowicz K, Bell J.","Int J Clin Pharmacol Ther. 2018 Feb;56(2):81-85. doi: 10.5414/CP203118.","Strang J","Int J Clin Pharmacol Ther","2018","2017/12/13","","","10.5414/CP203118"
"29223912","Prenatal buprenorphine exposure and neonatal neurobehavioral functioning","Velez ML, McConnell K, Spencer N, Montoya L, Tuten M, Jansson LM.","Early Hum Dev. 2018 Feb;117:7-14. doi: 10.1016/j.earlhumdev.2017.11.009. Epub 2017 Dec 7.","Velez ML","Early Hum Dev","2018","2017/12/11","","","10.1016/j.earlhumdev.2017.11.009"
"29220615","Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue","McElrath K, Joseph H.","Subst Use Misuse. 2018 Jan 28;53(2):177-180. doi: 10.1080/10826084.2017.1404106. Epub 2017 Dec 8.","McElrath K","Subst Use Misuse","2018","2017/12/09","","","10.1080/10826084.2017.1404106"
"29207902","Analgesics promote welfare and sustain tumour growth in orthotopic 4T1 and B16 mouse cancer models","Lofgren J, Miller AL, Lee CCS, Bradshaw C, Flecknell P, Roughan J.","Lab Anim. 2018 Aug;52(4):351-364. doi: 10.1177/0023677217739934. Epub 2017 Dec 5.","Lofgren J","Lab Anim","2018","2017/12/07","PMC6068963","","10.1177/0023677217739934"
"29200340","Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine","Krawczyk N, Picher CE, Feder KA, Saloner B.","Health Aff (Millwood). 2017 Dec;36(12):2046-2053. doi: 10.1377/hlthaff.2017.0890.","Krawczyk N","Health Aff (Millwood)","2017","2017/12/05","PMC6035729","NIHMS977694","10.1377/hlthaff.2017.0890"
"29200333","The Promises And Pitfalls Of Treating Addiction","Gregg JL.","Health Aff (Millwood). 2017 Dec;36(12):2204-2206. doi: 10.1377/hlthaff.2017.0632.","Gregg JL","Health Aff (Millwood)","2017","2017/12/05","","","10.1377/hlthaff.2017.0632"
"29200050","A Call for Compassionate Care","Alexander K.","J Addict Nurs. 2017 Oct/Dec;28(4):220-223. doi: 10.1097/JAN.0000000000000198.","Alexander K","J Addict Nurs","2017","2017/12/05","","","10.1097/JAN.0000000000000198"
"29197801","In contrast to morphine, buprenorphine enhances macrophage-induced humoral immunity and, as oxycodone, slightly suppresses the effector phase of cell-mediated immune response in mice","Filipczak-Bryniarska I, Nazimek K, Nowak B, Kozlowski M, Wąsik M, Bryniarski K.","Int Immunopharmacol. 2018 Jan;54:344-353. doi: 10.1016/j.intimp.2017.11.039. Epub 2017 Dec 1.","Filipczak-Bryniarska I","Int Immunopharmacol","2018","2017/12/04","","","10.1016/j.intimp.2017.11.039"
"29195596","Group-based treatment of opioid use disorder with buprenorphine: A systematic review","Sokol R, LaVertu AE, Morrill D, Albanese C, Schuman-Olivier Z.","J Subst Abuse Treat. 2018 Jan;84:78-87. doi: 10.1016/j.jsat.2017.11.003. Epub 2017 Nov 9.","Sokol R","J Subst Abuse Treat","2018","2017/12/03","","","10.1016/j.jsat.2017.11.003"
"29195592","Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison Centers","Butler SF, Black RA, Severtson SG, Dart RC, Green JL.","J Subst Abuse Treat. 2018 Jan;84:42-49. doi: 10.1016/j.jsat.2017.10.010. Epub 2017 Oct 27.","Butler SF","J Subst Abuse Treat","2018","2017/12/03","","","10.1016/j.jsat.2017.10.010"
"29191755","Pharmacological validation of voluntary gait and mechanical sensitivity assays associated with inflammatory and neuropathic pain in mice","Shepherd AJ, Mohapatra DP.","Neuropharmacology. 2018 Mar 1;130:18-29. doi: 10.1016/j.neuropharm.2017.11.036. Epub 2017 Nov 27.","Shepherd AJ","Neuropharmacology","2018","2017/12/02","PMC5743638","NIHMS925512","10.1016/j.neuropharm.2017.11.036"
"29190831","Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study","Lugoboni F, Zamboni L, Federico A, Tamburin S; Gruppo InterSERT di Collaborazione Scientifica (GICS).","PLoS One. 2017 Nov 30;12(11):e0188994. doi: 10.1371/journal.pone.0188994. eCollection 2017.","Lugoboni F","PLoS One","2017","2017/12/01","PMC5708835","","10.1371/journal.pone.0188994"
"29190156","Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions","Chang DC, Klimas J, Wood E, Fairbairn N.","Am J Drug Alcohol Abuse. 2018;44(2):143-146. doi: 10.1080/00952990.2017.1399403. Epub 2017 Nov 30.","Chang DC","Am J Drug Alcohol Abuse","2018","2017/12/01","PMC5815926","NIHMS934678","10.1080/00952990.2017.1399403"
"29183228","Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus","Dematteis M, Auriacombe M, D'Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP, Leonardi C, Maremmani I, Torrens M, Walcher S, Soyka M.","Expert Opin Pharmacother. 2017 Dec;18(18):1987-1999. doi: 10.1080/14656566.2017.1409722. Epub 2017 Dec 3.","Dematteis M","Expert Opin Pharmacother","2017","2017/11/30","","","10.1080/14656566.2017.1409722"
"29182394","Effects of intravenous administration of lidocaine and buprenorphine on gastrointestinal tract motility and signs of pain in New Zealand White rabbits after ovariohysterectomy","Schnellbacher RW, Divers SJ, Comolli JR, Beaufrère H, Maglaras CH, Andrade N, Barbur LA, Rosselli DD, Stejskal M, Barletta M, Mayer J, Rodriguez P, Quandt JE.","Am J Vet Res. 2017 Dec;78(12):1359-1371. doi: 10.2460/ajvr.78.12.1359.","Schnellbacher RW","Am J Vet Res","2017","2017/11/29","","","10.2460/ajvr.78.12.1359"
"29179255","Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy","Bogdanowicz KM, Stewart R, Chang CK, Shetty H, Khondoker M, Day E, Hayes RD, Strang J.","Addiction. 2018 May;113(5):946-951. doi: 10.1111/add.14114. Epub 2018 Jan 10.","Bogdanowicz KM","Addiction","2018","2017/11/28","","","10.1111/add.14114"
"29176511","Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio","Molfenter T, Sherbeck C, Starr S, Kim JS, Zehner M, Quanbeck A, Jacobson N, McCarty D.","Version 2. J Addict Med. 2018 Mar/Apr;12(2):85-91. doi: 10.1097/ADM.0000000000000369.","Molfenter T","J Addict Med","2018","2017/11/28","PMC5847436","NIHMS915971","10.1097/ADM.0000000000000369"
"29161171","At the Expense of a Life: Race, Class, and the Meaning of Buprenorphine in Pharmaceuticalized ""Care""","Hatcher AE, Mendoza S, Hansen H.","Subst Use Misuse. 2018 Jan 28;53(2):301-310. doi: 10.1080/10826084.2017.1385633. Epub 2017 Nov 21.","Hatcher AE","Subst Use Misuse","2018","2017/11/22","PMC5901978","NIHMS953821","10.1080/10826084.2017.1385633"
"29158248","Pregnancy Increases Norbuprenorphine Clearance in Mice by Induction of Hepatic Glucuronidation","Liao MZ, Gao C, Phillips BR, Neradugomma NK, Han LW, Bhatt DK, Prasad B, Shen DD, Mao Q.","Drug Metab Dispos. 2018 Feb;46(2):100-108. doi: 10.1124/dmd.117.076745. Epub 2017 Nov 20.","Liao MZ","Drug Metab Dispos","2018","2017/11/22","PMC5765905","","10.1124/dmd.117.076745"
"29155919","Neonatal Outcomes in a Medicaid Population With Opioid Dependence","Brogly SB, Hernández-Diaz S, Regan E, Fadli E, Hahn KA, Werler MM.","Am J Epidemiol. 2018 Jun 1;187(6):1153-1161. doi: 10.1093/aje/kwx341.","Brogly SB","Am J Epidemiol","2018","2017/11/21","PMC5982783","","10.1093/aje/kwx341"
"29155916","Invited Commentary: A Novel Strategy for Addressing Unmeasured Confounding When Comparing Opioid Agonist Therapies in Pregnancy","Lemon LS.","Am J Epidemiol. 2018 Jun 1;187(6):1162-1164. doi: 10.1093/aje/kwx342.","Lemon LS","Am J Epidemiol","2018","2017/11/21","","","10.1093/aje/kwx342"
"29148881","Ultrarapid Influence of Buprenorphine on Major Depression in Opioid-Dependent Patients: A Double Blind, Randomized Clinical Trial","Ahmadi J, Sefidfard Jahromi M.","Subst Use Misuse. 2018 Jan 28;53(2):286-289. doi: 10.1080/10826084.2017.1400063. Epub 2017 Nov 17.","Ahmadi J","Subst Use Misuse","2018","2017/11/18","","","10.1080/10826084.2017.1400063"
"29143483","The impact of mental health comorbidities on adherence to buprenorphine: A claims based analysis","Litz M, Leslie D.","Am J Addict. 2017 Dec;26(8):859-863. doi: 10.1111/ajad.12644. Epub 2017 Nov 16.","Litz M","Am J Addict","2017","2017/11/17","","","10.1111/ajad.12644"
"29143398","A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control children","Kelty E, Hulse G.","Am J Addict. 2017 Dec;26(8):845-851. doi: 10.1111/ajad.12642. Epub 2017 Nov 16.","Kelty E","Am J Addict","2017","2017/11/17","","","10.1111/ajad.12642"
"29141653","Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial","Molfenter T, Knudsen HK, Brown R, Jacobson N, Horst J, Van Etten M, Kim JS, Haram E, Collier E, Starr S, Toy A, Madden L.","Implement Sci. 2017 Nov 15;12(1):135. doi: 10.1186/s13012-017-0665-x.","Molfenter T","Implement Sci","2017","2017/11/17","PMC5688699","","10.1186/s13012-017-0665-x"
"29140822","Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study","Cochran GT, Hruschak V, Abdullah W, Krans E, Douaihy AB, Bobby S, Fusco R, Tarter R.","J Addict Med. 2018 Jan/Feb;12(1):72-79. doi: 10.1097/ADM.0000000000000370.","Cochran GT","J Addict Med","2018","2017/11/16","PMC5786468","NIHMS915973","10.1097/ADM.0000000000000370"
"29129197","High prevalence of urine tampering in an office-based opioid treatment practice detected by evaluating the norbuprenorphine to buprenorphine ratio","Accurso AJ, Lee JD, McNeely J.","J Subst Abuse Treat. 2017 Dec;83:62-67. doi: 10.1016/j.jsat.2017.10.002. Epub 2017 Oct 12.","Accurso AJ","J Subst Abuse Treat","2017","2017/11/14","","","10.1016/j.jsat.2017.10.002"
"29121294","Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion: a double-blind, randomized, active-controlled trial","Mercieri M, Palmisani S, De Blasi RA, D'Andrilli A, Naccarato A, Silvestri B, Tigano S, Massullo D, Rocco M, Arcioni R.","Br J Anaesth. 2017 Oct 1;119(4):792-802. doi: 10.1093/bja/aex174.","Mercieri M","Br J Anaesth","2017","2017/11/10","","","10.1093/bja/aex174"
"29112997","Comparison of Neonatal Abstinence Syndrome Treatment with Sublingual Buprenorphine versus Conventional Opioids","Hall ES, Rice WR, Folger AT, Wexelblatt SL.","Am J Perinatol. 2018 Mar;35(4):405-412. doi: 10.1055/s-0037-1608634. Epub 2017 Nov 7.","Hall ES","Am J Perinatol","2018","2017/11/08","","","10.1055/s-0037-1608634"
"29112519","Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome","Lemon LS, Caritis SN, Venkataramanan R, Platt RW, Bodnar LM.","Epidemiology. 2018 Mar;29(2):261-268. doi: 10.1097/EDE.0000000000000780.","Lemon LS","Epidemiology","2018","2017/11/08","PMC5792296","NIHMS917791","10.1097/EDE.0000000000000780"
"29105752","Buprenorphine in Neonatal Abstinence Syndrome","Kraft WK.","Clin Pharmacol Ther. 2018 Jan;103(1):112-119. doi: 10.1002/cpt.930. Epub 2017 Nov 28.","Kraft WK","Clin Pharmacol Ther","2018","2017/11/07","PMC5739935","NIHMS918799","10.1002/cpt.930"
"29102550","A Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions of Buprenorphine After Subcutaneous Administration of CAM2038 With Perpetrators of CYP3A4","Liu T, Gobburu JVS.","J Pharm Sci. 2018 Mar;107(3):942-948. doi: 10.1016/j.xphs.2017.10.035. Epub 2017 Nov 2.","Liu T","J Pharm Sci","2018","2017/11/06","","","10.1016/j.xphs.2017.10.035"
"29096661","Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France","Roux P, Rojas Castro D, Ndiaye K, Briand Madrid L, Laporte V, Mora M, Maradan G, Morel S, Spire B, Carrieri P.","Subst Abuse Treat Prev Policy. 2017 Nov 2;12(1):46. doi: 10.1186/s13011-017-0131-4.","Roux P","Subst Abuse Treat Prev Policy","2017","2017/11/04","PMC5667450","","10.1186/s13011-017-0131-4"
"29096292","Prescribing patterns of buprenorphine waivered physicians","Thomas CP, Doyle E, Kreiner PW, Jones CM, Dubenitz J, Horan A, Stein BD.","Drug Alcohol Depend. 2017 Dec 1;181:213-218. doi: 10.1016/j.drugalcdep.2017.10.002. Epub 2017 Oct 18.","Thomas CP","Drug Alcohol Depend","2017","2017/11/03","","","10.1016/j.drugalcdep.2017.10.002"
"29073311","Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders","Winetsky D, Weinrieb RM, Perrone J.","J Hosp Med. 2018 Jan;13(1):62-64. doi: 10.12788/jhm.2861. Epub 2017 Oct 18.","Winetsky D","J Hosp Med","2018","2017/10/27","","","10.12788/jhm.2861"
"29068826","Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care?","Hensley L, Sulo S, Kozmic S, Parilla BV.","J Addict Med. 2018 Jan/Feb;12(1):61-64. doi: 10.1097/ADM.0000000000000364.","Hensley L","J Addict Med","2018","2017/10/26","","","10.1097/ADM.0000000000000364"
"29065377","Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack","Heidebrecht F, MacLeod MB, Dawkins L.","Addict Behav. 2018 Feb;77:210-216. doi: 10.1016/j.addbeh.2017.10.013. Epub 2017 Oct 18.","Heidebrecht F","Addict Behav","2018","2017/10/25","","","10.1016/j.addbeh.2017.10.013"
"29064208","[ACUTE PAIN MANAGEMENT IN PATIENT ON OPIOID SUBSTITUTION THERAPY WITH METHADONE OR BUPRENORPHINE]","Adam VN, Matolić M, Stojčić EG, Mršić V, Rašić Ž.","Acta Med Croatica. 2016 Sep;70(3):173-8.","Adam VN","Acta Med Croatica","2016","2017/10/25","","",""
"29059715","Suicide by Medication Overdose in Prison: A Study of Three Cases","Bartoli C, Berland-Benhaim C, Tuchtan-Torrents L, Kintz P, Leonetti G, Pelissier-Alicot AL.","J Forensic Sci. 2018 Jul;63(4):1316-1320. doi: 10.1111/1556-4029.13671. Epub 2017 Oct 23.","Bartoli C","J Forensic Sci","2018","2017/10/24","","","10.1111/1556-4029.13671"
"29056859","Efficacy and Safety of Transdermal Buprenorphine versus Oral Tramadol/Acetaminophen in Patients with Persistent Postoperative Pain after Spinal Surgery","Lee JH, Kim JH, Kim JH, Kim HS, Min WK, Park YS, Lee KY, Lee JH.","Pain Res Manag. 2017;2017:2071494. doi: 10.1155/2017/2071494. Epub 2017 Sep 13.","Lee JH","Pain Res Manag","2017","2017/10/24","PMC5615987","","10.1155/2017/2071494"
"29054032","Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment","Haber PS, Elsayed M, Espinoza D, Lintzeris N, Veillard AS, Hallinan R.","Drug Alcohol Depend. 2017 Dec 1;181:132-139. doi: 10.1016/j.drugalcdep.2017.09.024. Epub 2017 Oct 13.","Haber PS","Drug Alcohol Depend","2017","2017/10/21","","","10.1016/j.drugalcdep.2017.09.024"
"29049062","Opioid Use in Pregnancy","Killion MM.","MCN Am J Matern Child Nurs. 2017 Nov/Dec;42(6):360. doi: 10.1097/NMC.0000000000000387.","Killion MM","MCN Am J Matern Child Nurs","2017","2017/10/20","","","10.1097/NMC.0000000000000387"
"29048415","Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome","Tolia VN, Murthy K, Bennett MM, Miller ES, Benjamin DK, Smith PB, Clark RH.","J Perinatol. 2018 Jan;38(1):75-79. doi: 10.1038/jp.2017.157. Epub 2017 Oct 19.","Tolia VN","J Perinatol","2018","2017/10/20","","","10.1038/jp.2017.157"
"29040331","Primary care models for treating opioid use disorders: What actually works? A systematic review","Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A.","PLoS One. 2017 Oct 17;12(10):e0186315. doi: 10.1371/journal.pone.0186315. eCollection 2017.","Lagisetty P","PLoS One","2017","2017/10/18","PMC5645096","","10.1371/journal.pone.0186315"
"29036723","Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers","Priestley T, Chappa AK, Mould DR, Upton RN, Shusterman N, Passik S, Tormo VJ, Camper S.","Pain Med. 2018 Oct 1;19(10):1988-1996. doi: 10.1093/pm/pnx235.","Priestley T","Pain Med","2018","2017/10/17","","","10.1093/pm/pnx235"
"29035705","Linking patients with buprenorphine treatment in primary care: Predictors of engagement","Simon CB, Tsui JI, Merrill JO, Adwell A, Tamru E, Klein JW.","Drug Alcohol Depend. 2017 Dec 1;181:58-62. doi: 10.1016/j.drugalcdep.2017.09.017. Epub 2017 Oct 10.","Simon CB","Drug Alcohol Depend","2017","2017/10/17","","","10.1016/j.drugalcdep.2017.09.017"
"29025085","Effects of Buprenorphine on Responses to Emotional Stimuli in Individuals with a Range of Mood Symptomatology","Bershad AK, Ruiz NA, de Wit H.","Int J Neuropsychopharmacol. 2018 Feb 1;21(2):120-127. doi: 10.1093/ijnp/pyx077.","Bershad AK","Int J Neuropsychopharmacol","2018","2017/10/13","PMC5793829","","10.1093/ijnp/pyx077"
"29020387","Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine","Browne CA, Falcon E, Robinson SA, Berton O, Lucki I.","Int J Neuropsychopharmacol. 2018 Feb 1;21(2):164-174. doi: 10.1093/ijnp/pyx079.","Browne CA","Int J Neuropsychopharmacol","2018","2017/10/12","PMC5793841","","10.1093/ijnp/pyx079"
"29016376","Possible Psychosis Associated With Buprenorphine Withdrawal","Navkhare P, Kalra G, Saddichha S.","J Clin Psychopharmacol. 2017 Dec;37(6):748-749. doi: 10.1097/JCP.0000000000000803.","Navkhare P","J Clin Psychopharmacol","2017","2017/10/11","","","10.1097/JCP.0000000000000803"
"28972704","Successful Treatment of Major Depressive Disorder With Add-On Buprenorphine in a Patient With Previous Nonresponse to Standard Antidepressants","Elsayed M, Gahr M, Connemann BJ, Schönfeldt-Lecuona C.","Prim Care Companion CNS Disord. 2017 Sep 28;19(5):16l02091. doi: 10.4088/PCC.16l02091.","Elsayed M","Prim Care Companion CNS Disord","2017","2017/10/04","","","10.4088/PCC.16l02091"
"28968623","Responsible Opioid Prescribing for Chronic Pain: Interpreting the CDC Guideline, Understanding New Rhode Island Regulations","Gordon AL, Snyder AF.","R I Med J (2013). 2017 Oct 2;100(10):45-47.","Gordon AL","R I Med J (2013)","2017","2017/10/03","","",""
"28967123","Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice","Almatroudi A, Ostovar M, Bailey CP, Husbands SM, Bailey SJ.","Br J Pharmacol. 2018 Jul;175(14):2869-2880. doi: 10.1111/bph.14060. Epub 2017 Nov 6.","Almatroudi A","Br J Pharmacol","2018","2017/10/03","PMC6016679","","10.1111/bph.14060"
"28966276","C-Homomorphinan Derivatives as Lead Compounds to Obtain Safer and More Clinically Useful Analgesics","Ishikawa K, Karaki F, Tayama K, Higashi E, Hirayama S, Itoh K, Fujii H.","Chem Pharm Bull (Tokyo). 2017;65(10):920-929. doi: 10.1248/cpb.c17-00385.","Ishikawa K","Chem Pharm Bull (Tokyo)","2017","2017/10/03","","","10.1248/cpb.c17-00385"
"28962922","Treadmill exercise alleviated prenatal buprenorphine exposure-induced depression in rats","Wu CC, Hung CJ, Lin SY, Wang YY, Chang CY, Chen WY, Liao SL, Raung SL, Yang CP, Chen CJ.","Neurochem Int. 2017 Nov;110:91-100. doi: 10.1016/j.neuint.2017.09.012. Epub 2017 Sep 27.","Wu CC","Neurochem Int","2017","2017/10/01","","","10.1016/j.neuint.2017.09.012"
"28961489","Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model","Zychowska M, Rojewska E, Piotrowska A, Kreiner G, Nalepa I, Mika J.","Int Immunopharmacol. 2017 Nov;52:261-271. doi: 10.1016/j.intimp.2017.09.021. Epub 2017 Oct 12.","Zychowska M","Int Immunopharmacol","2017","2017/09/30","","","10.1016/j.intimp.2017.09.021"
"28957756","Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine","Madden L, Bojko MJ, Farnum S, Mazhnaya A, Fomenko T, Marcus R, Barry D, Ivanchuk I, Kolomiets V, Filippovych S, Dvoryak S, Altice FL.","Int J Drug Policy. 2017 Nov;49:48-53. doi: 10.1016/j.drugpo.2017.07.025. Epub 2017 Sep 26.","Madden L","Int J Drug Policy","2017","2017/09/29","","","10.1016/j.drugpo.2017.07.025"
"28951506","Digital ischaemia after intra-arterial drug injection","Neuss MJ, Holland TL.","BMJ Case Rep. 2017 Sep 25;2017:bcr2017222141. doi: 10.1136/bcr-2017-222141.","Neuss MJ","BMJ Case Rep","2017","2017/09/28","PMC5747780","","10.1136/bcr-2017-222141"
"28948894","Minimally invasive technique for intrathecal administration of morphine in rats: practicality and antinociceptive properties","Thomas AA, Detilleux J, Sandersen CF, Flecknell PA.","Lab Anim. 2017 Oct;51(5):479-489. doi: 10.1177/0023677216682771. Epub 2016 Dec 21.","Thomas AA","Lab Anim","2017","2017/09/27","","","10.1177/0023677216682771"
"28920534","Analgesic effects of gabapentin and buprenorphine in cats undergoing ovariohysterectomy using two pain-scoring systems: a randomized clinical trial","Steagall PV, Benito J, Monteiro BP, Doodnaught GM, Beauchamp G, Evangelista MC.","J Feline Med Surg. 2018 Aug;20(8):741-748. doi: 10.1177/1098612X17730173. Epub 2017 Sep 18.","Steagall PV","J Feline Med Surg","2018","2017/09/19","","","10.1177/1098612X17730173"
"28917206","Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine","O'Connor AB, Kelly BK, O'Brien LM.","Drug Alcohol Depend. 2017 Nov 1;180:200-203. doi: 10.1016/j.drugalcdep.2017.08.012. Epub 2017 Sep 7.","O'Connor AB","Drug Alcohol Depend","2017","2017/09/17","","","10.1016/j.drugalcdep.2017.08.012"
"28914663","Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers","Knudsen HK, Lofwall MR, Walsh SL, Havens JR, Studts JL.","J Addict Med. 2018 Jan/Feb;12(1):31-39. doi: 10.1097/ADM.0000000000000360.","Knudsen HK","J Addict Med","2018","2017/09/16","PMC5786469","NIHMS903356","10.1097/ADM.0000000000000360"
"28905733","Why It's Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy","Wakeman SE.","AMA J Ethics. 2017 Sep 1;19(9):922-930. doi: 10.1001/journalofethics.2017.19.9.stas1-1709.","Wakeman SE","AMA J Ethics","2017","2017/09/15","","","10.1001/journalofethics.2017.19.9.stas1-1709"
"28905717","Use of Liposomal Bupivacaine for Postoperative Analgesia in an Incisional Pain Model in Rats (Rattus norvegicus)","Kang SC, Jampachaisri K, Seymour TL, Felt SA, Pacharinsak C.","J Am Assoc Lab Anim Sci. 2017 Jan 1;56(1):63-68.","Kang SC","J Am Assoc Lab Anim Sci","2017","2017/09/15","PMC5250497","",""
"28901836","The overlap of sleep disturbance and depression in primary care patients treated with buprenorphine","Garnaat SL, Weisberg RB, Uebelacker LA, Herman DS, Bailey GL, Anderson BJ, Sharkey KM, Stein MD.","Subst Abus. 2017 Oct-Dec;38(4):450-454. doi: 10.1080/08897077.2017.1361498. Epub 2017 Sep 13.","Garnaat SL","Subst Abus","2017","2017/09/14","","","10.1080/08897077.2017.1361498"
"28895776","Evaluation of analgesic effect and absorption of buprenorphine after buccal administration in cats with oral disease","Stathopoulou TR, Kouki M, Pypendop BH, Johnston A, Papadimitriou S, Pelligand L.","J Feline Med Surg. 2018 Aug;20(8):704-710. doi: 10.1177/1098612X17727234. Epub 2017 Sep 12.","Stathopoulou TR","J Feline Med Surg","2018","2017/09/13","","","10.1177/1098612X17727234"
"28894357","Advances in the delivery of buprenorphine for opioid dependence","Rosenthal RN, Goradia VV.","Drug Des Devel Ther. 2017 Aug 28;11:2493-2505. doi: 10.2147/DDDT.S72543. eCollection 2017.","Rosenthal RN","Drug Des Devel Ther","2017","2017/09/13","PMC5584886","","10.2147/DDDT.S72543"
"28893589","Leptin status alters buprenorphine-induced antinociception in obese mice with dysfunctional leptin receptors","Glovak Z, Mihalko S, Baghdoyan HA, Lydic R.","Neurosci Lett. 2017 Nov 1;660:29-33. doi: 10.1016/j.neulet.2017.09.012. Epub 2017 Sep 8.","Glovak Z","Neurosci Lett","2017","2017/09/13","PMC5651198","NIHMS905876","10.1016/j.neulet.2017.09.012"
"28885516","Treating Acute Pain in the Opiate-Dependent Patient","Dever C.","J Trauma Nurs. 2017 Sep/Oct;24(5):292-299. doi: 10.1097/JTN.0000000000000309.","Dever C","J Trauma Nurs","2017","2017/09/09","","","10.1097/JTN.0000000000000309"
"28885300","Use of Smoking Cessation Methods Among Patients Receiving Office-based Buprenorphine Maintenance Treatment","Shah PA, Cunningham CO, Brisbane MT, DeLuca JP, Nahvi S.","J Addict Med. 2017 Nov/Dec;11(6):494-497. doi: 10.1097/ADM.0000000000000356.","Shah PA","J Addict Med","2017","2017/09/09","PMC5659878","NIHMS901633","10.1097/ADM.0000000000000356"
"28880503","Buprenorphine for the Neonatal Abstinence Syndrome","Grossman MR, Berkwitt AK, Osborn RR.","N Engl J Med. 2017 Sep 7;377(10):996-7. doi: 10.1056/NEJMc1709121.","Grossman MR","N Engl J Med","2017","2017/09/08","","","10.1056/NEJMc1709121"
"28880502","Buprenorphine for the Neonatal Abstinence Syndrome","Whalen B, MacMillan K, Edwards W.","N Engl J Med. 2017 Sep 7;377(10):996. doi: 10.1056/NEJMc1709121.","Whalen B","N Engl J Med","2017","2017/09/08","","","10.1056/NEJMc1709121"
"28877016","Buprenorphine for the Neonatal Abstinence Syndrome","Kraft WK, Adeniyi-Jones SC, Ehrlich ME.","N Engl J Med. 2017 Sep 7;377(10):997-998. doi: 10.1056/NEJMc1709121.","Kraft WK","N Engl J Med","2017","2017/09/07","PMC6424493","NIHMS1007559","10.1056/NEJMc1709121"
"28877015","Buprenorphine for the Neonatal Abstinence Syndrome","Christiansen S.","N Engl J Med. 2017 Sep 7;377(10):996. doi: 10.1056/NEJMc1709121.","Christiansen S","N Engl J Med","2017","2017/09/07","","","10.1056/NEJMc1709121"
"28869859","Maternal buprenorphine treatment and infant outcome","Jansson LM, Velez ML, McConnell K, Spencer N, Tuten M, Jones H, Rios R, King VL, Gandotra N, Millio L, DiPietro JA.","Drug Alcohol Depend. 2017 Nov 1;180:56-61. doi: 10.1016/j.drugalcdep.2017.08.001. Epub 2017 Aug 31.","Jansson LM","Drug Alcohol Depend","2017","2017/09/05","PMC5788458","NIHMS905192","10.1016/j.drugalcdep.2017.08.001"
"28866369","Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice","Donroe JH, Holt SR, O'Connor PG, Sukumar N, Tetrault JM.","Drug Alcohol Depend. 2017 Nov 1;180:46-51. doi: 10.1016/j.drugalcdep.2017.07.040. Epub 2017 Aug 24.","Donroe JH","Drug Alcohol Depend","2017","2017/09/04","","","10.1016/j.drugalcdep.2017.07.040"
"28863059","Recovery Beyond Buprenorphine: Nurse-Led Group Therapy","Fogger SA, Lehmann K.","J Addict Nurs. 2017 Jul/Sep;28(3):152-156. doi: 10.1097/JAN.0000000000000180.","Fogger SA","J Addict Nurs","2017","2017/09/02","","","10.1097/JAN.0000000000000180"
"28862903","Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary","McElrath K.","Subst Use Misuse. 2018 Jan 28;53(2):334-343. doi: 10.1080/10826084.2017.1342662. Epub 2017 Sep 1.","McElrath K","Subst Use Misuse","2018","2017/09/02","","","10.1080/10826084.2017.1342662"
"28860712","A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients","Nosek K, Leppert W, Nosek H, Wordliczek J, Onichimowski D.","Drug Des Devel Ther. 2017 Aug 22;11:2409-2419. doi: 10.2147/DDDT.S141007. eCollection 2017.","Nosek K","Drug Des Devel Ther","2017","2017/09/02","PMC5574595","","10.2147/DDDT.S141007"
"28844013","Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount","Jones JD, Manubay JM, Mogali S, Metz VE, Madera G, Martinez S, Mumtaz M, Comer SD.","Drug Alcohol Depend. 2017 Oct 1;179:362-369. doi: 10.1016/j.drugalcdep.2017.06.033. Epub 2017 Jul 26.","Jones JD","Drug Alcohol Depend","2017","2017/08/28","","","10.1016/j.drugalcdep.2017.06.033"
"28840839","Buprenorphine differentially affects M1- and M2-polarized macrophages from human umbilical cord blood","Sun J, Guo W, Du X.","Eur Cytokine Netw. 2017 Jun 1;28(2):85-92. doi: 10.1684/ecn.2017.0392.","Sun J","Eur Cytokine Netw","2017","2017/08/26","","","10.1684/ecn.2017.0392"
"28838259","A study on the safety evaluation of buphrenorphine administered through an autoinjector compared with manual injection using haematological and biochemical variables in rats","Sheela D, Vijayaraghavan R, Senthilkumar S.","Hum Exp Toxicol. 2017 Sep;36(9):901-909. doi: 10.1177/0960327116674528. Epub 2016 Oct 20.","Sheela D","Hum Exp Toxicol","2017","2017/08/26","","","10.1177/0960327116674528"
"28834479","Stretching the Scope - Becoming Frontline Addiction-Medicine Providers","Rapoport AB, Rowley CF.","N Engl J Med. 2017 Aug 24;377(8):705-707. doi: 10.1056/NEJMp1706492.","Rapoport AB","N Engl J Med","2017","2017/08/24","","","10.1056/NEJMp1706492"
"28829626","Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy","Johnson S, Martin PR.","Am J Drug Alcohol Abuse. 2018;44(3):310-316. doi: 10.1080/00952990.2017.1363218. Epub 2017 Aug 22.","Johnson S","Am J Drug Alcohol Abuse","2018","2017/08/23","","","10.1080/00952990.2017.1363218"
"28828950","Evaluation of interobserver agreement for postoperative pain and sedation assessment in cats","Benito J, Monteiro BP, Beauchamp G, Lascelles BDX, Steagall PV.","J Am Vet Med Assoc. 2017 Sep 1;251(5):544-551. doi: 10.2460/javma.251.5.544.","Benito J","J Am Vet Med Assoc","2017","2017/08/23","","","10.2460/javma.251.5.544"
"28821312","Opioid misuse epidemic: Addressing opioid prescribing and organization initiatives for holistic, safe and compassionate care","Naegle M; Expert Panel Psychiatric, Mental Health & Substance Abuse, Mitchell AM; Expert Panel Psychiatric, Mental Health & Substance Abuse, Flinter M; Expert Panel Primary Care, Dunphy L; Expert Panel Primary Care, Vanhook P; Expert Panel Primary Care, Delaney KR; Expert Panel Psychiatric, Mental Health & Substance Abuse.","Nurs Outlook. 2017 Jul-Aug;65(4):477-479. doi: 10.1016/j.outlook.2017.07.001.","Naegle M","Nurs Outlook","2017","2017/08/20","","","10.1016/j.outlook.2017.07.001"
"28817294","Heterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomes","Ruetsch C, Tkacz J, Nadipelli VR, Brady BL, Ronquest N, Un H, Volpicelli J.","Am J Manag Care. 2017 Jun 1;23(6):e172-e179.","Ruetsch C","Am J Manag Care","2017","2017/08/18","","",""
"28816216","The promise and challenges of buprenorphine implant for treatment of opioid dependence","Basu D, Sahoo S, Ghosh A.","Natl Med J India. 2017 Mar-Apr;30(2):80-81.","Basu D","Natl Med J India","2017","2017/08/18","","",""
"28815789","Cost-effectiveness of emergency department-initiated treatment for opioid dependence","Busch SH, Fiellin DA, Chawarski MC, Owens PH, Pantalon MV, Hawk K, Bernstein SL, O'Connor PG, D'Onofrio G.","Addiction. 2017 Nov;112(11):2002-2010. doi: 10.1111/add.13900. Epub 2017 Aug 16.","Busch SH","Addiction","2017","2017/08/18","PMC5657503","NIHMS883890","10.1111/add.13900"
"28814313","A mixed methods study of HIV-related services in buprenorphine treatment","Knudsen HK, Cook J, Lofwall MR, Walsh SL, Studts JL, Havens JR.","Subst Abuse Treat Prev Policy. 2017 Aug 16;12(1):37. doi: 10.1186/s13011-017-0122-5.","Knudsen HK","Subst Abuse Treat Prev Policy","2017","2017/08/18","PMC5559779","","10.1186/s13011-017-0122-5"
"28807904","No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir","Kosloski MP, Zhao W, Asatryan A, Kort J, Geoffroy P, Liu W.","Antimicrob Agents Chemother. 2017 Sep 22;61(10):e00958-17. doi: 10.1128/AAC.00958-17. Print 2017 Oct.","Kosloski MP","Antimicrob Agents Chemother","2017","2017/08/16","PMC5610490","","10.1128/AAC.00958-17"
"28806388","Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine","Lescut C, Gaboriau L, Carton L, Rolland B.","J Clin Psychopharmacol. 2017 Oct;37(5):631-633. doi: 10.1097/JCP.0000000000000763.","Lescut C","J Clin Psychopharmacol","2017","2017/08/15","","","10.1097/JCP.0000000000000763"
"28800420","Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic","Dumchev K, Dvoryak S, Chernova O, Morozova O, Altice FL.","Int J Drug Policy. 2017 Oct;48:44-53. doi: 10.1016/j.drugpo.2017.05.014. Epub 2017 Aug 8.","Dumchev K","Int J Drug Policy","2017","2017/08/12","PMC5603251","NIHMS876373","10.1016/j.drugpo.2017.05.014"
"28800186","Ameliorative response to detoxification, psychotherapy, and medical management in patients maintained on opioids for pain","Belkin M, Reinheimer HS, Levy J, Johnson B.","Am J Addict. 2017 Oct;26(7):738-743. doi: 10.1111/ajad.12605. Epub 2017 Aug 11.","Belkin M","Am J Addict","2017","2017/08/12","","","10.1111/ajad.12605"
"28799677","Text message reminders for improving patient appointment adherence in an office-based buprenorphine program: A feasibility study","Tofighi B, Grazioli F, Bereket S, Grossman E, Aphinyanaphongs Y, Lee JD.","Am J Addict. 2017 Sep;26(6):581-586. doi: 10.1111/ajad.12557. Epub 2017 Aug 11.","Tofighi B","Am J Addict","2017","2017/08/12","","","10.1111/ajad.12557"
"28796591","Utilization of buprenorphine and methadone among opioid users who inject drugs","Tsui JI, Burt R, Thiede H, Glick SN.","Subst Abus. 2018 Jan 2;39(1):83-88. doi: 10.1080/08897077.2017.1363844. Epub 2017 Sep 18.","Tsui JI","Subst Abus","2018","2017/08/11","PMC6467071","NIHMS1022158","10.1080/08897077.2017.1363844"
"28795846","A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment","Rudolf G, Walsh J, Plawman A, Gianutsos P, Alto W, Mancl L, Rudolf V.","Am J Drug Alcohol Abuse. 2018;44(3):302-309. doi: 10.1080/00952990.2017.1334209. Epub 2017 Aug 10.","Rudolf G","Am J Drug Alcohol Abuse","2018","2017/08/11","","","10.1080/00952990.2017.1334209"
"28780906","Screening, treatment initiation, and referral for substance use disorders","Bernstein SL, D'Onofrio G.","Addict Sci Clin Pract. 2017 Aug 7;12(1):18. doi: 10.1186/s13722-017-0083-z.","Bernstein SL","Addict Sci Clin Pract","2017","2017/08/08","PMC5545867","","10.1186/s13722-017-0083-z"
"28778219","Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain","Yoon DH, Bin SI, Chan SK, Chung CK, In Y, Kim H, Lichauco JJ, Mok CC, Moon YW, Ng TK, Penserga EG, Shin DA, You D, Moon H.","BMC Musculoskelet Disord. 2017 Aug 4;18(1):337. doi: 10.1186/s12891-017-1664-4.","Yoon DH","BMC Musculoskelet Disord","2017","2017/08/06","PMC5545039","","10.1186/s12891-017-1664-4"
"28763315","Efficacy and safety of buprenorphine in peripheral nerve blocks: A meta-analysis of randomised controlled trials","Schnabel A, Reichl SU, Zahn PK, Pogatzki-Zahn EM, Meyer-Frießem CH.","Eur J Anaesthesiol. 2017 Sep;34(9):576-586. doi: 10.1097/EJA.0000000000000628.","Schnabel A","Eur J Anaesthesiol","2017","2017/08/02","","","10.1097/EJA.0000000000000628"
"28759482","Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients","Kowalczyk WJ, Bertz JW, Moran LM, Phillips KA, Ghitza UE, Epstein DH, Preston KL.","J Addict Med. 2017 Nov/Dec;11(6):454-460. doi: 10.1097/ADM.0000000000000345.","Kowalczyk WJ","J Addict Med","2017","2017/08/01","PMC5659962","NIHMS893445","10.1097/ADM.0000000000000345"
"28755768","A naturalistic study of predictors of retention in treatment among emerging adults entering first buprenorphine maintenance treatment for opioid use disorders","Dayal P, Balhara YPS.","J Subst Abuse Treat. 2017 Sep;80:1-5. doi: 10.1016/j.jsat.2017.06.004. Epub 2017 Jun 15.","Dayal P","J Subst Abuse Treat","2017","2017/07/31","","","10.1016/j.jsat.2017.06.004"
"28735039","Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients","Dunn KE, Finan PH, Andrew Tompkins D, Strain EC.","Addict Behav. 2018 Jan;76:8-14. doi: 10.1016/j.addbeh.2017.07.016. Epub 2017 Jul 14.","Dunn KE","Addict Behav","2018","2017/07/24","PMC5614840","NIHMS894761","10.1016/j.addbeh.2017.07.016"
"28733101","Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014","Guan Q, Khuu W, Spithoff S, Kiran T, Kahan M, Tadrous M, Martins D, Leece P, Gomes T.","Drug Alcohol Depend. 2017 Aug 1;177:315-321. doi: 10.1016/j.drugalcdep.2017.05.002. Epub 2017 Jul 19.","Guan Q","Drug Alcohol Depend","2017","2017/07/23","","","10.1016/j.drugalcdep.2017.05.002"
"28733097","Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY.","J Subst Abuse Treat. 2018 Feb;85:90-96. doi: 10.1016/j.jsat.2017.07.001. Epub 2017 Jul 3.","Morgan JR","J Subst Abuse Treat","2018","2017/07/23","PMC5750108","NIHMS894082","10.1016/j.jsat.2017.07.001"
"28730328","Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: a prospective, randomized controlled non-inferiority trial","Kim HJ, Ahn HS, Nam Y, Chang BS, Lee CK, Yeom JS.","Eur Spine J. 2017 Nov;26(11):2961-2968. doi: 10.1007/s00586-017-5213-5. Epub 2017 Jul 20.","Kim HJ","Eur Spine J","2017","2017/07/22","","","10.1007/s00586-017-5213-5"
"28727661","Comparison of Post-Cesarean Section Opioid Analgesic Requirements in Women With Opioid Use Disorder Treated With Methadone or Buprenorphine","Vilkins AL, Bagley SM, Hahn KA, Rojas-Miguez F, Wachman EM, Saia K, Alford DP.","J Addict Med. 2017 Sep/Oct;11(5):397-401. doi: 10.1097/ADM.0000000000000339.","Vilkins AL","J Addict Med","2017","2017/07/21","","","10.1097/ADM.0000000000000339"
"28724496","Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection","DenHerder JM, Reed RL, Sargent JL, Bobe G, Stevens JF, Diggs HE.","J Am Assoc Lab Anim Sci. 2017 Jul 1;56(4):457-461.","DenHerder JM","J Am Assoc Lab Anim Sci","2017","2017/07/21","PMC5517336","",""
"28724492","Evaluation of Pain Assessment Techniques and Analgesia Efficacy in a Female Guinea Pig (Cavia porcellus) Model of Surgical Pain","Oliver VL, Athavale S, Simon KE, Kendall LV, Nemzek JA, Lofgren JL.","J Am Assoc Lab Anim Sci. 2017 Jul 1;56(4):425-435.","Oliver VL","J Am Assoc Lab Anim Sci","2017","2017/07/21","PMC5517332","",""
"28723256","Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment","Suzuki J, Zinser J, Issa M, Rodriguez C.","Subst Abus. 2017 Oct-Dec;38(4):504-507. doi: 10.1080/08897077.2017.1356796. Epub 2017 Jul 19.","Suzuki J","Subst Abus","2017","2017/07/21","","","10.1080/08897077.2017.1356796"
"28718693","Effects of sedation with dexmedetomidine and buprenorphine on echocardiographic variables, blood pressure and heart rate in healthy cats","Johard E, Tidholm A, Ljungvall I, Häggström J, Höglund K.","J Feline Med Surg. 2018 Jun;20(6):554-562. doi: 10.1177/1098612X17720327. Epub 2017 Jul 18.","Johard E","J Feline Med Surg","2018","2017/07/19","","","10.1177/1098612X17720327"
"28701435","Opioid agonist therapy","Broad K, Colon-Rivera HA, Haque L.","Can Fam Physician. 2017 Jul;63(7):509-510.","Broad K","Can Fam Physician","2017","2017/07/14","PMC5507220","",""
"28700791","Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial","Dunn KE, Tompkins DA, Bigelow GE, Strain EC.","JAMA Psychiatry. 2017 Sep 1;74(9):885-893. doi: 10.1001/jamapsychiatry.2017.1838.","Dunn KE","JAMA Psychiatry","2017","2017/07/13","PMC5710234","","10.1001/jamapsychiatry.2017.1838"
"28698151","The effects of methamphetamine and buprenorphine, and their interaction on anxiety-like behavior and locomotion in male rats","Etaee F, Asadbegi M, Taslimi Z, Shahidi S, Sarihi A, Soleimani Asl S, Komaki A.","Neurosci Lett. 2017 Aug 10;655:172-178. doi: 10.1016/j.neulet.2017.04.043. Epub 2017 Jul 8.","Etaee F","Neurosci Lett","2017","2017/07/13","","","10.1016/j.neulet.2017.04.043"
"28694273","Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder","Andrilla CHA, Coulthard C, Larson EH.","Ann Fam Med. 2017 Jul;15(4):359-362. doi: 10.1370/afm.2099.","Andrilla CHA","Ann Fam Med","2017","2017/07/12","PMC5505456","","10.1370/afm.2099"
"28694272","Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study","Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M.","Ann Fam Med. 2017 Jul;15(4):355-358. doi: 10.1370/afm.2098.","Dupouy J","Ann Fam Med","2017","2017/07/12","PMC5505455","","10.1370/afm.2098"
"28688108","A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration","Kalluri HV, Zhang H, Caritis SN, Venkataramanan R.","Br J Clin Pharmacol. 2017 Nov;83(11):2458-2473. doi: 10.1111/bcp.13368. Epub 2017 Aug 22.","Kalluri HV","Br J Clin Pharmacol","2017","2017/07/09","PMC5651326","","10.1111/bcp.13368"
"28683783","Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine","Heikman PK, Muhonen LH, Ojanperä IA.","BMC Psychiatry. 2017 Jul 6;17(1):245. doi: 10.1186/s12888-017-1415-y.","Heikman PK","BMC Psychiatry","2017","2017/07/08","PMC5501578","","10.1186/s12888-017-1415-y"
"28683421","Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency","Gubner NR, Guydish J, Humfleet GL, Benowitz NL, Hall SM.","Drug Alcohol Depend. 2017 Sep 1;178:267-270. doi: 10.1016/j.drugalcdep.2017.05.020. Epub 2017 Jun 23.","Gubner NR","Drug Alcohol Depend","2017","2017/07/07","PMC5553616","NIHMS887633","10.1016/j.drugalcdep.2017.05.020"
"28683172","Opioids for cancer pain - an overview of Cochrane reviews","Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA.","Cochrane Database Syst Rev. 2017 Jul 6;7(7):CD012592. doi: 10.1002/14651858.CD012592.pub2.","Wiffen PJ","Cochrane Database Syst Rev","2017","2017/07/07","PMC6483487","","10.1002/14651858.CD012592.pub2"
"28682892","In patients undergoing fast track total knee arthroplasty, addition of buprenorphine to a femoral nerve block has no clinical advantage: A prospective, double-blinded, randomized, placebo controlled trial","van Beek R, Zonneveldt HJ, van der Ploeg T, Steens J, Lirk P, Hollmann MW.","Medicine (Baltimore). 2017 Jul;96(27):e7393. doi: 10.1097/MD.0000000000007393.","van Beek R","Medicine (Baltimore)","2017","2017/07/07","PMC5502165","","10.1097/MD.0000000000007393"
"28673522","Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine","Hui D, Weinstein ZM, Cheng DM, Quinn E, Kim H, Labelle C, Samet JH.","J Subst Abuse Treat. 2017 Aug;79:12-19. doi: 10.1016/j.jsat.2017.05.010. Epub 2017 May 16.","Hui D","J Subst Abuse Treat","2017","2017/07/05","PMC5522736","NIHMS878505","10.1016/j.jsat.2017.05.010"
"28669739","An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","Caritis SN, Bastian JR, Zhang H, Kalluri H, English D, England M, Bobby S, Venkataramanan R.","Am J Obstet Gynecol. 2017 Oct;217(4):459.e1-459.e6. doi: 10.1016/j.ajog.2017.06.029. Epub 2017 Jun 29.","Caritis SN","Am J Obstet Gynecol","2017","2017/07/04","PMC5614874","NIHMS897736","10.1016/j.ajog.2017.06.029"
"28655025","Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial","Walsh SL, Comer SD, Lofwall MR, Vince B, Levy-Cooperman N, Kelsh D, Coe MA, Jones JD, Nuzzo PA, Tiberg F, Sheldon B, Kim S.","JAMA Psychiatry. 2017 Sep 1;74(9):894-902. doi: 10.1001/jamapsychiatry.2017.1874.","Walsh SL","JAMA Psychiatry","2017","2017/06/28","PMC5710238","","10.1001/jamapsychiatry.2017.1874"
"28648162","[Treatment of acute pain in opioid addicts]","Rindom H, Højsted J, Brünés N.","Ugeskr Laeger. 2017 Jun 26;179(26):V02170153.","Rindom H","Ugeskr Laeger","2017","2017/06/27","","",""
"28647677","Buprenorphine augmentation improved symptoms of OCD, compared to placebo - Results from a randomized, double-blind and placebo-controlled clinical trial","Ahmadpanah M, Reihani A, Ghaleiha A, Soltanian A, Haghighi M, Jahangard L, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S.","J Psychiatr Res. 2017 Nov;94:23-28. doi: 10.1016/j.jpsychires.2017.06.004. Epub 2017 Jun 13.","Ahmadpanah M","J Psychiatr Res","2017","2017/06/26","","","10.1016/j.jpsychires.2017.06.004"
"28644085","Pharmacokinetics of a Sustained Release Formulation of Buprenorphine After Intramuscular and Subcutaneous Administration to American Kestrels ( Falco sparverius )","Guzman DS, Knych HK, Olsen GH, Paul-Murphy JR.","J Avian Med Surg. 2017 Jun;31(2):102-107. doi: 10.1647/2015-155.","Guzman DS","J Avian Med Surg","2017","2017/06/24","","","10.1647/2015-155"
"28641929","Initiation and Engagement with Methadone Treatment among Pregnant and Postpartum Women","Mattocks KM, Clark R, Weinreb L.","Womens Health Issues. 2017 Nov-Dec;27(6):646-651. doi: 10.1016/j.whi.2017.05.002. Epub 2017 Jun 19.","Mattocks KM","Womens Health Issues","2017","2017/06/24","","","10.1016/j.whi.2017.05.002"
"28635181","Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption","Kallupi M, Shen Q, de Guglielmo G, Yasuda D, Journigan VB, Zaveri NT, Ciccocioppo R.","Addict Biol. 2018 Mar;23(2):585-595. doi: 10.1111/adb.12513. Epub 2017 Jun 21.","Kallupi M","Addict Biol","2018","2017/06/22","PMC5740020","NIHMS888760","10.1111/adb.12513"
"28628701","Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014","Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR.","Version 2. JAMA Pediatr. 2017 Aug 1;171(8):747-755. doi: 10.1001/jamapediatrics.2017.0745.","Hadland SE","JAMA Pediatr","2017","2017/06/20","PMC5649381","NIHMS911093","10.1001/jamapediatrics.2017.0745"
"28628699","Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder","Saloner B, Feder KA, Krawczyk N.","JAMA Pediatr. 2017 Aug 1;171(8):729-731. doi: 10.1001/jamapediatrics.2017.1269.","Saloner B","JAMA Pediatr","2017","2017/06/20","PMC6007012","NIHMS970846","10.1001/jamapediatrics.2017.1269"
"28627790","Regional cerebral blood flow in opiate dependence relates to substance use and neuropsychological performance","Murray DE, Durazzo TC, Schmidt TP, Murray TA, Abé C, Guydish J, Meyerhoff DJ.","Addict Biol. 2018 Mar;23(2):781-795. doi: 10.1111/adb.12523. Epub 2017 Jun 19.","Murray DE","Addict Biol","2018","2017/06/20","PMC5736471","NIHMS873212","10.1111/adb.12523"
"28611509","Hepatitis C in injection drug users: It is time to treat","Grassi A, Ballardini G.","World J Gastroenterol. 2017 May 28;23(20):3569-3571. doi: 10.3748/wjg.v23.i20.3569.","Grassi A","World J Gastroenterol","2017","2017/06/15","PMC5449413","","10.3748/wjg.v23.i20.3569"
"28609749","Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone","Kelty E, Hulse G.","Int J Drug Policy. 2017 Aug;46:54-60. doi: 10.1016/j.drugpo.2017.05.039. Epub 2017 Jun 10.","Kelty E","Int J Drug Policy","2017","2017/06/14","","","10.1016/j.drugpo.2017.05.039"
"28604141","Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder","Carter JA, Dammerman R, Frost M.","J Med Econ. 2017 Aug;20(8):893-901. doi: 10.1080/13696998.2017.1341416. Epub 2017 Jun 22.","Carter JA","J Med Econ","2017","2017/06/13","","","10.1080/13696998.2017.1341416"
"28603825","The profile of drug users in Tunisia: Implications for prevention","Sellami R, Feki I, Zahaf A, Masmoudi J.","Tunis Med. 2016 Aug-Sep;94(8-9):531-534.","Sellami R","Tunis Med","2016","2017/06/13","","",""
"28593441","Context and craving during stressful events in the daily lives of drug-dependent patients","Preston KL, Kowalczyk WJ, Phillips KA, Jobes ML, Vahabzadeh M, Lin JL, Mezghanni M, Epstein DH.","Psychopharmacology (Berl). 2017 Sep;234(17):2631-2642. doi: 10.1007/s00213-017-4663-0. Epub 2017 Jun 8.","Preston KL","Psychopharmacology (Berl)","2017","2017/06/09","PMC5709189","NIHMS883197","10.1007/s00213-017-4663-0"
"28590045","Computer-aided design and synthesis of a highly selective molecularly imprinted polymer for the extraction and determination of buprenorphine in biological fluids","Ganjavi F, Ansari M, Kazemipour M, Zeidabadinejad L.","J Sep Sci. 2017 Aug;40(15):3175-3182. doi: 10.1002/jssc.201700213. Epub 2017 Jul 14.","Ganjavi F","J Sep Sci","2017","2017/06/08","","","10.1002/jssc.201700213"
"28587620","Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial","Ahmadi J, Razeghian Jahromi L.","Trials. 2017 Jun 6;18(1):259. doi: 10.1186/s13063-017-2007-3.","Ahmadi J","Trials","2017","2017/06/08","PMC5461765","","10.1186/s13063-017-2007-3"
"28586812","Patient and Public Safety Maximized by Rapid Opioid Taper-Reply","Guillod P, Edens EL, Becker WC.","JAMA Intern Med. 2017 Jun 1;177(6):896. doi: 10.1001/jamainternmed.2017.1454.","Guillod P","JAMA Intern Med","2017","2017/06/07","","","10.1001/jamainternmed.2017.1454"
"28586806","Patient and Public Safety Maximized by Rapid Opioid Taper","Geller AS.","JAMA Intern Med. 2017 Jun 1;177(6):895-896. doi: 10.1001/jamainternmed.2017.1451.","Geller AS","JAMA Intern Med","2017","2017/06/07","","","10.1001/jamainternmed.2017.1451"
"28586444","Technical Communication: Admixture of Bupivacaine-Clonidine-Buprenorphine-Dexamethasone at the Bedside in a Tertiary Care Hospital Block Room Is Not Associated with Any Apparent Burdens of Endotoxin or Microbial Growth","Williams BA, Podnar SM, Bonant SA, Schanck AM.","Pain Med. 2017 Apr 1;18(4):781-785. doi: 10.1093/pm/pnw282.","Williams BA","Pain Med","2017","2017/06/07","","","10.1093/pm/pnw282"
"28572711","Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in Arthritis","Hemshekhar M, Anaparti V, Hitchon C, Mookherjee N.","Mediators Inflamm. 2017;2017:2515408. doi: 10.1155/2017/2515408. Epub 2017 May 9.","Hemshekhar M","Mediators Inflamm","2017","2017/06/03","PMC5441125","","10.1155/2017/2515408"
"28571505","Buprenorphine implants in medical treatment of opioid addiction","Chavoustie S, Frost M, Snyder O, Owen J, Darwish M, Dammerman R, Sanjurjo V.","Expert Rev Clin Pharmacol. 2017 Aug;10(8):799-807. doi: 10.1080/17512433.2017.1336434. Epub 2017 Jun 21.","Chavoustie S","Expert Rev Clin Pharmacol","2017","2017/06/03","","","10.1080/17512433.2017.1336434"
"28569590","Pharmacokinetic comparison of two buprenorphine formulations after buccal administration in healthy male cats","Gulledge BM, Messenger KM, Cornell KK, Lindell H, Schmiedt CW.","J Feline Med Surg. 2018 Apr;20(4):312-318. doi: 10.1177/1098612X17710843. Epub 2017 Jun 1.","Gulledge BM","J Feline Med Surg","2018","2017/06/02","","","10.1177/1098612X17710843"
"28561914","Opioid Use Disorder in Pregnancy","Roper V, Cox KJ.","J Midwifery Womens Health. 2017 May;62(3):329-340. doi: 10.1111/jmwh.12619. Epub 2017 May 31.","Roper V","J Midwifery Womens Health","2017","2017/06/01","","","10.1111/jmwh.12619"
"28554602","The relationship between diversion-related attitudes and sharing and selling buprenorphine","Kenney SR, Anderson BJ, Bailey GL, Stein MD.","J Subst Abuse Treat. 2017 Jul;78:43-47. doi: 10.1016/j.jsat.2017.04.017. Epub 2017 Apr 27.","Kenney SR","J Subst Abuse Treat","2017","2017/05/31","PMC7189524","NIHMS1579876","10.1016/j.jsat.2017.04.017"
"28554599","Pharmacokinetics and pharmacodynamics of a buprenorphine subcutaneous depot formulation (CAM2038) for once-weekly dosing in patients with opioid use disorder","Haasen C, Linden M, Tiberg F.","J Subst Abuse Treat. 2017 Jul;78:22-29. doi: 10.1016/j.jsat.2017.04.008. Epub 2017 Apr 14.","Haasen C","J Subst Abuse Treat","2017","2017/05/31","","","10.1016/j.jsat.2017.04.008"
"28554597","Why aren't physicians prescribing more buprenorphine?","Huhn AS, Dunn KE.","J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12.","Huhn AS","J Subst Abuse Treat","2017","2017/05/31","PMC5524453","NIHMS870270","10.1016/j.jsat.2017.04.005"
"28549161","Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients","Hall SM, Humfleet GL, Gasper JJ, Delucchi KL, Hersh DF, Guydish JR.","Nicotine Tob Res. 2018 Apr 2;20(5):628-635. doi: 10.1093/ntr/ntx113.","Hall SM","Nicotine Tob Res","2018","2017/05/27","PMC7207071","","10.1093/ntr/ntx113"
"28548551","Comparison of intramuscular butorphanol and buprenorphine combined with dexmedetomidine for sedation in cats","Bhalla RJ, Trimble TA, Leece EA, Vettorato E.","J Feline Med Surg. 2018 Apr;20(4):325-331. doi: 10.1177/1098612X17709612. Epub 2017 May 26.","Bhalla RJ","J Feline Med Surg","2018","2017/05/27","","","10.1177/1098612X17709612"
"28546740","New developments in managing opioid addiction: impact of a subdermal buprenorphine implant","Itzoe M, Guarnieri M.","Drug Des Devel Ther. 2017 May 10;11:1429-1437. doi: 10.2147/DDDT.S109331. eCollection 2017.","Itzoe M","Drug Des Devel Ther","2017","2017/05/27","PMC5436774","","10.2147/DDDT.S109331"
"28543191","Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women","Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ.","Pharmacotherapy. 2017 Jul;37(7):824-839. doi: 10.1002/phar.1958. Epub 2017 Jul 2.","Tran TH","Pharmacotherapy","2017","2017/05/26","","","10.1002/phar.1958"
"28536981","A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates","Kelty E, Hulse G.","Drugs. 2017 Jul;77(11):1211-1219. doi: 10.1007/s40265-017-0763-8.","Kelty E","Drugs","2017","2017/05/25","","","10.1007/s40265-017-0763-8"
"28536980","A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls","Kelty E, Hulse G.","Drugs. 2017 Jul;77(11):1199-1210. doi: 10.1007/s40265-017-0762-9.","Kelty E","Drugs","2017","2017/05/25","","","10.1007/s40265-017-0762-9"
"28530896","Use and misuse of opioid agonists in opioid addiction","Modesto-Lowe V, Swiezbin K, Chaplin M, Hoefer G.","Cleve Clin J Med. 2017 May;84(5):377-384. doi: 10.3949/ccjm.84a.16091.","Modesto-Lowe V","Cleve Clin J Med","2017","2017/05/23","","","10.3949/ccjm.84a.16091"
"28530682","Association of nausea with buprenorphine analgesia for rats","Sarabia-Estrada R, Cowan A, Tyler BM, Guarnieri M.","Lab Anim (NY). 2017 May 22;46(6):242-244. doi: 10.1038/laban.1277.","Sarabia-Estrada R","Lab Anim (NY)","2017","2017/05/23","PMC7091644","","10.1038/laban.1277"
"28526967","Update on Barriers to Pharmacotherapy for Opioid Use Disorders","Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O'Grady KE, Schwartz RP.","Curr Psychiatry Rep. 2017 Jun;19(6):35. doi: 10.1007/s11920-017-0783-9.","Sharma A","Curr Psychiatry Rep","2017","2017/05/21","PMC7075636","NIHMS1552800","10.1007/s11920-017-0783-9"
"28526486","Plasma concentrations of transdermal fentanyl and buprenorphine in pigs (Sus scrofa domesticus)","Osorio Lujan S, Habre W, Daali Y, Pan Z, Kronen PW.","Vet Anaesth Analg. 2017 May;44(3):665-675. doi: 10.1016/j.vaa.2016.09.002. Epub 2017 Jan 11.","Osorio Lujan S","Vet Anaesth Analg","2017","2017/05/21","","","10.1016/j.vaa.2016.09.002"
"28519244","Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies","Raffaeli G, Cavallaro G, Allegaert K, Wildschut ED, Fumagalli M, Agosti M, Tibboel D, Mosca F.","Pharmacotherapy. 2017 Jul;37(7):814-823. doi: 10.1002/phar.1954. Epub 2017 Jul 2.","Raffaeli G","Pharmacotherapy","2017","2017/05/19","","","10.1002/phar.1954"
"28514299","Application of a buprenorphine transdermal patch for the perioperative analgesia in patients who underwent simple lumbar discectomy","Tang J, Fan J, Yao Y, Cai W, Yin G, Zhou W.","Medicine (Baltimore). 2017 May;96(20):e6844. doi: 10.1097/MD.0000000000006844.","Tang J","Medicine (Baltimore)","2017","2017/05/18","PMC5440136","","10.1097/MD.0000000000006844"
"28511196","To Stop or Not, That Is the Question: Acute Pain Management for the Patient on Chronic Buprenorphine","Anderson TA, Quaye ANA, Ward EN, Wilens TE, Hilliard PE, Brummett CM.","Anesthesiology. 2017 Jun;126(6):1180-1186. doi: 10.1097/ALN.0000000000001633.","Anderson TA","Anesthesiology","2017","2017/05/17","PMC7041233","NIHMS1014047","10.1097/ALN.0000000000001633"
"28505488","Predictors of buprenorphine treatment success of opioid dependence in two Baltimore City grassroots recovery programs","Damian AJ, Mendelson T, Agus D.","Addict Behav. 2017 Oct;73:129-132. doi: 10.1016/j.addbeh.2017.05.010. Epub 2017 May 10.","Damian AJ","Addict Behav","2017","2017/05/16","PMC5789789","NIHMS935865","10.1016/j.addbeh.2017.05.010"
"28502792","Drug Binding Poses Relate Structure with Efficacy in the μ Opioid Receptor","Sutcliffe KJ, Henderson G, Kelly E, Sessions RB.","J Mol Biol. 2017 Jun 16;429(12):1840-1851. doi: 10.1016/j.jmb.2017.05.009. Epub 2017 May 11.","Sutcliffe KJ","J Mol Biol","2017","2017/05/16","PMC5472181","","10.1016/j.jmb.2017.05.009"
"28499432","Development and evaluation of a community-based buprenorphine treatment intervention","Fox AD, Sohler NL, Frost T, Lopez C, Cunningham CO.","Harm Reduct J. 2017 May 12;14(1):23. doi: 10.1186/s12954-017-0149-y.","Fox AD","Harm Reduct J","2017","2017/05/14","PMC5427587","","10.1186/s12954-017-0149-y"
"28492461","Overcoming Barriers to Initiating Medication-assisted Treatment for Heroin Use Disorder in a General Medical Hospital: A Case Report and Narrative Literature Review","Hassamal S, Goldenberg M, Ishak W, Haglund M, Miotto K, Danovitch I.","J Psychiatr Pract. 2017 May;23(3):221-229. doi: 10.1097/PRA.0000000000000231.","Hassamal S","J Psychiatr Pract","2017","2017/05/12","","","10.1097/PRA.0000000000000231"
"28489467","Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study","Kenworthy J, Yi Y, Wright A, Brown J, Maria Madrigal A, Dunlop WCN.","J Med Econ. 2017 Jul;20(7):740-748. doi: 10.1080/13696998.2017.1325744. Epub 2017 May 25.","Kenworthy J","J Med Econ","2017","2017/05/11","","","10.1080/13696998.2017.1325744"
"28488266","QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings","Isbister GK, Brown AL, Gill A, Scott AJ, Calver L, Dunlop AJ.","Br J Clin Pharmacol. 2017 Oct;83(10):2274-2282. doi: 10.1111/bcp.13326. Epub 2017 Jun 14.","Isbister GK","Br J Clin Pharmacol","2017","2017/05/11","PMC5595951","","10.1111/bcp.13326"
"28488155","Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data","Rieckmann TR, Gideonse N, Risser A, DeVoe JE, Abraham AJ.","J Behav Health Serv Res. 2017 Jul;44(3):351-363. doi: 10.1007/s11414-017-9553-z.","Rieckmann TR","J Behav Health Serv Res","2017","2017/05/11","","","10.1007/s11414-017-9553-z"
"28483102","Use of Buprenorphine in treatment of refractory depression-A review of current literature","Stanciu CN, Glass OM, Penders TM.","Asian J Psychiatr. 2017 Apr;26:94-98. doi: 10.1016/j.ajp.2017.01.015. Epub 2017 Jan 27.","Stanciu CN","Asian J Psychiatr","2017","2017/05/10","","","10.1016/j.ajp.2017.01.015"
"28481727","Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder","Shiner B, Leonard Westgate C, Bernardy NC, Schnurr PP, Watts BV.","J Dual Diagn. 2017 Jul-Sep;13(3):201-212. doi: 10.1080/15504263.2017.1325033. Epub 2017 May 8.","Shiner B","J Dual Diagn","2017","2017/05/09","PMC6190703","NIHMS988226","10.1080/15504263.2017.1325033"
"28479900","Opiate withdrawal syndrome in buprenorphine abusers admitted to a rehabilitation center in Tunisia","Derbel I, Ghorbel A, Akrout FM, Zahaf A.","Afr Health Sci. 2016 Dec;16(4):1067-1077. doi: 10.4314/ahs.v16i4.24.","Derbel I","Afr Health Sci","2016","2017/05/09","PMC5398454","","10.4314/ahs.v16i4.24"
"28473157","Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs","Lugoboni F, Levin FR, Pieri MC, Manfredini M, Zamboni L, Somaini L, Gerra G, Gruppo InterSert Collaborazione Scientifica Gics.","Psychiatry Res. 2017 Apr;250:210-216. doi: 10.1016/j.psychres.2017.01.052. Epub 2017 Jan 21.","Lugoboni F","Psychiatry Res","2017","2017/05/06","PMC5518312","NIHMS877591","10.1016/j.psychres.2017.01.052"
"28472543","Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration","Manhapra A, Petrakis I, Rosenheck R.","Am J Addict. 2017 Sep;26(6):572-580. doi: 10.1111/ajad.12553. Epub 2017 May 4.","Manhapra A","Am J Addict","2017","2017/05/05","","","10.1111/ajad.12553"
"28468518","Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome","Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, Ehrlich ME.","N Engl J Med. 2017 Jun 15;376(24):2341-2348. doi: 10.1056/NEJMoa1614835. Epub 2017 May 4.","Kraft WK","N Engl J Med","2017","2017/05/05","PMC5662132","NIHMS889790","10.1056/NEJMoa1614835"
"28468077","[Changes and the impact on immune function of opioid-dependent subjects by Jitai tabelets during the withdrawal stage]","Li XX, Fan HY, Sun L, Liang JC, Deng YP.","Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Apr 10;38(4):531-536. doi: 10.3760/cma.j.issn.0254-6450.2017.04.024.","Li XX","Zhonghua Liu Xing Bing Xue Za Zhi","2017","2017/05/04","","","10.3760/cma.j.issn.0254-6450.2017.04.024"
"28466581","Analgesia and mouse strain influence neuromuscular plasticity in inflamed intestine","Blennerhassett MG, Lourenssen SR, Parlow LRG, Ghasemlou N, Winterborn AN.","Neurogastroenterol Motil. 2017 Oct;29(10):1-12. doi: 10.1111/nmo.13097. Epub 2017 May 3.","Blennerhassett MG","Neurogastroenterol Motil","2017","2017/05/04","","","10.1111/nmo.13097"
"28459984","Treatment of Opioid Use Disorder During Pregnancy May Increase Cases of Neonatal Abstinence Syndrome-Reply","Brown JD, Talbert JC.","JAMA Pediatr. 2017 Jul 1;171(7):707-708. doi: 10.1001/jamapediatrics.2017.0863.","Brown JD","JAMA Pediatr","2017","2017/05/02","","","10.1001/jamapediatrics.2017.0863"
"28457152","Current Progress in Opioid Treatment","Woody GE.","Am J Psychiatry. 2017 May 1;174(5):414-416. doi: 10.1176/appi.ajp.2016.16121398.","Woody GE","Am J Psychiatry","2017","2017/05/02","","","10.1176/appi.ajp.2016.16121398"
"28447431","Commentary on Daubresse et al. (2017): An epidemic of outdated data","Gellad WF.","Addiction. 2017 Jun;112(6):1054-1055. doi: 10.1111/add.13817.","Gellad WF","Addiction","2017","2017/04/28","","","10.1111/add.13817"
"28446428","Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R.","BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550.","Sordo L","BMJ","2017","2017/04/28","PMC5421454","","10.1136/bmj.j1550"
"28445495","Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats","Doodnaught GM, Monteiro BP, Benito J, Edge D, Beaudry F, Pelligand L, Steagall P.","PLoS One. 2017 Apr 26;12(4):e0176443. doi: 10.1371/journal.pone.0176443. eCollection 2017.","Doodnaught GM","PLoS One","2017","2017/04/27","PMC5405979","","10.1371/journal.pone.0176443"
"28441131","The occasional treatment of opioid use disorder","Robinson A, Carlson RF, Kelly L.","Can J Rural Med. 2017 Spring;22(2):69-75.","Robinson A","Can J Rural Med","2017","2017/04/26","","",""
"28426507","Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient","Pan A, Zakowski M.","Clin Obstet Gynecol. 2017 Jun;60(2):447-458. doi: 10.1097/GRF.0000000000000288.","Pan A","Clin Obstet Gynecol","2017","2017/04/21","","","10.1097/GRF.0000000000000288"
"28426332","Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System","Campbell CI, Parthasarathy S, Young-Wolff KC, Satre DD.","J Psychoactive Drugs. 2017 Apr-Jun;49(2):160-168. doi: 10.1080/02791072.2017.1305519. Epub 2017 Apr 20.","Campbell CI","J Psychoactive Drugs","2017","2017/04/21","PMC5555852","NIHMS878975","10.1080/02791072.2017.1305519"
"28418123","Image Gallery: Nicolau syndrome after misuse of buprenorphine","Espitia O, Vigneau-Victorri C, Pistorius MA.","Br J Dermatol. 2017 Apr;176(4):e35. doi: 10.1111/bjd.15322.","Espitia O","Br J Dermatol","2017","2017/04/19","","","10.1111/bjd.15322"
"28416162","Pharmacokinetics of buprenorphine following constant rate infusion for postoperative analgesia in dogs undergoing ovariectomy","Barbarossa A, Rambaldi J, Giunti M, Zaghini A, Cunto M, Zambelli D, Valgimigli S, Santoro F, Romagnoli N.","Vet Anaesth Analg. 2017 May;44(3):435-443. doi: 10.1016/j.vaa.2016.05.010. Epub 2017 Jan 11.","Barbarossa A","Vet Anaesth Analg","2017","2017/04/19","","","10.1016/j.vaa.2016.05.010"
"28411002","P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine-Response to 'Letter to the Editor'","Liao MZ, Shen DD, Mao Q.","Pharmacol Res. 2017 Jul;121:253. doi: 10.1016/j.phrs.2017.04.007. Epub 2017 Apr 12.","Liao MZ","Pharmacol Res","2017","2017/04/16","","","10.1016/j.phrs.2017.04.007"
"28406856","Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance","Klaman SL, Isaacs K, Leopold A, Perpich J, Hayashi S, Vender J, Campopiano M, Jones HE.","J Addict Med. 2017 May/Jun;11(3):178-190. doi: 10.1097/ADM.0000000000000308.","Klaman SL","J Addict Med","2017","2017/04/14","PMC5457836","","10.1097/ADM.0000000000000308"
"28401523","Injection of Pharmaceuticals Designed for Oral Use: Harms Experienced and Effective Harm Reduction Through Filtration","McLean S, Patel R, Bruno R.","Curr Top Behav Neurosci. 2017;34:77-98. doi: 10.1007/7854_2016_470.","McLean S","Curr Top Behav Neurosci","2017","2017/04/13","","","10.1007/7854_2016_470"
"28400151","P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine-Significance of zeitgeber time on pharmacokinetics","Dash RP, Rais R.","Pharmacol Res. 2017 Jul;121:251-252. doi: 10.1016/j.phrs.2017.04.004. Epub 2017 Apr 8.","Dash RP","Pharmacol Res","2017","2017/04/13","","","10.1016/j.phrs.2017.04.004"
"28399084","[The peculiarities of the comprehensive study of buprenorphine]","Lobacheva GK, Simonov EA, Kuzovlev VY, Kairgaliev DV, Gavrilin YV, Atroshchenko YM.","Sud Med Ekspert. 2017;60(2):30-35. doi: 10.17116/sudmed201760230-35.","Lobacheva GK","Sud Med Ekspert","2017","2017/04/12","","","10.17116/sudmed201760230-35"
"28394849","Inhibition of Voltage-Gated Na+ Channels by Bupivacaine Is Enhanced by the Adjuvants Buprenorphine, Ketamine, and Clonidine","Stoetzer C, Martell C, de la Roche J, Leffler A.","Reg Anesth Pain Med. 2017 Jul/Aug;42(4):462-468. doi: 10.1097/AAP.0000000000000596.","Stoetzer C","Reg Anesth Pain Med","2017","2017/04/11","","","10.1097/AAP.0000000000000596"
"28394437","Access to treatment for opioid use disorders: Medical student preparation","McCance-Katz EF, George P, Scott NA, Dollase R, Tunkel AR, McDonald J.","Am J Addict. 2017 Jun;26(4):316-318. doi: 10.1111/ajad.12550. Epub 2017 Apr 10.","McCance-Katz EF","Am J Addict","2017","2017/04/11","","","10.1111/ajad.12550"
"28393895","Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement","Santoro GC, Carrion J, Patel K, Vilchez C, Veith J, Brodie JD, Dewey SL.","Neuropsychopharmacology. 2017 Aug;42(9):1841-1849. doi: 10.1038/npp.2017.69. Epub 2017 Apr 10.","Santoro GC","Neuropsychopharmacology","2017","2017/04/11","PMC5520789","","10.1038/npp.2017.69"
"28376505","Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample","Soyka M, Strehle J, Rehm J, Bühringer G, Wittchen HU.","Eur Addict Res. 2017;23(2):97-105. doi: 10.1159/000468518. Epub 2017 Apr 5.","Soyka M","Eur Addict Res","2017","2017/04/05","","","10.1159/000468518"
"28363321","Buprenorphine physician supply: Relationship with state-level prescription opioid mortality","Knudsen HK, Havens JR, Lofwall MR, Studts JL, Walsh SL.","Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1(Suppl 1):S55-S64. doi: 10.1016/j.drugalcdep.2016.08.642.","Knudsen HK","Drug Alcohol Depend","2017","2017/04/02","PMC5584581","NIHMS899864","10.1016/j.drugalcdep.2016.08.642"
"28350229","Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014","Reif S, Creedon TB, Horgan CM, Stewart MT, Garnick DW.","J Psychoactive Drugs. 2017 Apr-Jun;49(2):102-110. doi: 10.1080/02791072.2017.1300360. Epub 2017 Mar 28.","Reif S","J Psychoactive Drugs","2017","2017/03/29","PMC5861719","NIHMS944949","10.1080/02791072.2017.1300360"
"28347772","Bifunctional opioid/nociceptin hybrid KGNOP1 effectively attenuates pain-related behaviour in a rat model of neuropathy","Starnowska J, Guillemyn K, Makuch W, Mika J, Ballet S, Przewlocka B.","Eur J Pharm Sci. 2017 Jun 15;104:221-229. doi: 10.1016/j.ejps.2017.03.029. Epub 2017 Mar 24.","Starnowska J","Eur J Pharm Sci","2017","2017/03/29","","","10.1016/j.ejps.2017.03.029"
"28343557","Infants Born to Opioid-Dependent Women in Ontario, 2002-2014","Brogly SB, Turner S, Lajkosz K, Davies G, Newman A, Johnson A, Dow K.","J Obstet Gynaecol Can. 2017 Mar;39(3):157-165. doi: 10.1016/j.jogc.2016.11.009.","Brogly SB","J Obstet Gynaecol Can","2017","2017/03/28","","","10.1016/j.jogc.2016.11.009"
"28341722","Sciatic and femoral nerve blockade using bupivacaine alone, or in combination with dexmedetomidine or buprenorphine in cats","Evangelista MC, Doodnaught GM, Fantoni DT, Steagall PVM.","Vet Rec. 2017 Jun 17;180(24):592. doi: 10.1136/vr.104152. Epub 2017 Mar 24.","Evangelista MC","Vet Rec","2017","2017/03/26","","","10.1136/vr.104152"
"28327378","Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services","Leone B, Di Nicola M, Moccia L, Pettorruso M, De Risio L, Nucara G, Zamboni L, Callea A, Janiri L, Cibin M, Lugoboni F; GICS.","Addict Behav. 2017 Aug;71:107-110. doi: 10.1016/j.addbeh.2017.03.010. Epub 2017 Mar 10.","Leone B","Addict Behav","2017","2017/03/23","","","10.1016/j.addbeh.2017.03.010"
"28326977","Effects of Buprenorphine Added to Bupivacaine Infraorbital Nerve Blocks on Isoflurane Minimum Alveolar Concentration Using a Model for Acute Dental/Oral Surgical Pain in Dogs","Snyder LB, Snyder CJ, Hetzel S.","J Vet Dent. 2016 Jun;33(2):90-96. doi: 10.1177/0898756416657232. Epub 2016 Aug 6.","Snyder LB","J Vet Dent","2016","2017/03/23","","","10.1177/0898756416657232"
"28324627","Hospitalized opioid-dependent patients: Exploring predictors of buprenorphine treatment entry and retention after discharge","Lee CS, Liebschutz JM, Anderson BJ, Stein MD.","Am J Addict. 2017 Oct;26(7):667-672. doi: 10.1111/ajad.12533. Epub 2017 Mar 21.","Lee CS","Am J Addict","2017","2017/03/22","PMC5608622","NIHMS861004","10.1111/ajad.12533"
"28315808","Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study","Abrahamsson T, Berge J, Öjehagen A, Håkansson A.","Drug Alcohol Depend. 2017 May 1;174:58-64. doi: 10.1016/j.drugalcdep.2017.01.013. Epub 2017 Feb 28.","Abrahamsson T","Drug Alcohol Depend","2017","2017/03/20","","","10.1016/j.drugalcdep.2017.01.013"
"28315645","Pharmacokinetic Profiles of Meloxicam and Sustained-release Buprenorphine in Prairie Dogs (Cynomys ludovicianus)","Cary CD, Lukovsky-Akhsanov NL, Gallardo-Romero NF, Tansey CM, Ostergaard SD, Taylor WD Jr, Morgan CN, Powell N, Lathrop GW, Hutson CL.","J Am Assoc Lab Anim Sci. 2017 Mar 1;56(2):160-165.","Cary CD","J Am Assoc Lab Anim Sci","2017","2017/03/20","PMC5361041","",""
"28315644","Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits","Martin-Flores M, Singh B, Walsh CA, Brooks EP, Taylor L, Mitchell LM.","J Am Assoc Lab Anim Sci. 2017 Mar 1;56(2):155-159.","Martin-Flores M","J Am Assoc Lab Anim Sci","2017","2017/03/20","PMC5361040","",""
"28304248","Sustained-Release Buprenorphine Improves Postsurgical Clinical Condition but Does Not Alter Survival or Cytokine Levels in a Murine Model of Polymicrobial Sepsis","Herndon NL, Bandyopadhyay S, Hod EA, Prestia KA.","Comp Med. 2016 Dec 1;66(6):455-462.","Herndon NL","Comp Med","2016","2017/03/18","PMC5157960","",""
"28296674","Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment","Wen H, Hockenberry JM, Borders TF, Druss BG.","Med Care. 2017 Apr;55(4):336-341. doi: 10.1097/MLR.0000000000000703.","Wen H","Med Care","2017","2017/03/16","","","10.1097/MLR.0000000000000703"
"28296603","Another Senseless Death - The Case for Supervised Injection Facilities","Wakeman SE.","N Engl J Med. 2017 Mar 16;376(11):1011-1013. doi: 10.1056/NEJMp1613651.","Wakeman SE","N Engl J Med","2017","2017/03/16","","","10.1056/NEJMp1613651"
"28296579","Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers","Knudsen HK, Studts JL.","J Psychoactive Drugs. 2017 Apr-Jun;49(2):111-121. doi: 10.1080/02791072.2017.1295335. Epub 2017 Mar 15.","Knudsen HK","J Psychoactive Drugs","2017","2017/03/16","PMC5572769","NIHMS898776","10.1080/02791072.2017.1295335"
"28292505","Unintentional methadone and buprenorphine exposures in children: Developing prevention messages","Schwartz L, Mercurio-Zappala M, Howland MA, Hoffman RS, Su MK.","J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S83-S86. doi: 10.1016/j.japh.2017.01.015.","Schwartz L","J Am Pharm Assoc (2003)","2017","2017/03/16","","","10.1016/j.japh.2017.01.015"
"28290640","Buprenorphine Maintenance vs. Placebo for Opioid Dependence","Raleigh MF.","Am Fam Physician. 2017 Mar 1;95(5):Online.","Raleigh MF","Am Fam Physician","2017","2017/03/15","","",""
"28276662","Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence","Yan K.","N Engl J Med. 2017 Mar 9;376(10):1000. doi: 10.1056/NEJMc1700539.","Yan K","N Engl J Med","2017","2017/03/10","","","10.1056/NEJMc1700539"
"28273017","Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence","Sigmon SC, Schwartz RP, Higgins ST.","N Engl J Med. 2017 Mar 9;376(10):1000-1001. doi: 10.1056/NEJMc1700539.","Sigmon SC","N Engl J Med","2017","2017/03/09","PMC5514413","NIHMS873053","10.1056/NEJMc1700539"
"28268215","Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study","Strang J, Reed K, Bogdanowicz K, Bell J, van der Waal R, Keen J, Beavan P, Baillie S, Knight A.","Eur Addict Res. 2017;23(2):61-70. doi: 10.1159/000456612. Epub 2017 Mar 8.","Strang J","Eur Addict Res","2017","2017/03/08","","","10.1159/000456612"
"28267949","Buprenorphine-related complications in elderly hospitalised patients: a case series","Richards S, Torre L, Lawther B.","Anaesth Intensive Care. 2017 Mar;45(2):256-261. doi: 10.1177/0310057X1704500217.","Richards S","Anaesth Intensive Care","2017","2017/03/08","","","10.1177/0310057X1704500217"
"28267934","Buprenorphine for the management of acute pain","Macintyre PE, Huxtable CA.","Anaesth Intensive Care. 2017 Mar;45(2):143-146. doi: 10.1177/0310057X1704500202.","Macintyre PE","Anaesth Intensive Care","2017","2017/03/08","","","10.1177/0310057X1704500202"
"28267837","Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids","Nielsen S, Larance B, Lintzeris N.","JAMA. 2017 Mar 7;317(9):967-968. doi: 10.1001/jama.2017.0001.","Nielsen S","JAMA","2017","2017/03/08","","","10.1001/jama.2017.0001"
"28261981","Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome","Mactier H.","Addiction. 2017 Apr;112(4):717-718. doi: 10.1111/add.13735.","Mactier H","Addiction","2017","2017/03/07","","","10.1111/add.13735"
"28258833","Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis","Herdener M, Dürsteler KM, Seifritz E, Nordt C.","Lancet Psychiatry. 2017 Apr;4(4):302-309. doi: 10.1016/S2215-0366(17)30080-9. Epub 2017 Mar 1.","Herdener M","Lancet Psychiatry","2017","2017/03/05","","","10.1016/S2215-0366(17)30080-9"
"28258807","Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder","Feder KA, Krawczyk N, Saloner B.","J Adolesc Health. 2017 Jun;60(6):747-750. doi: 10.1016/j.jadohealth.2016.12.023. Epub 2017 Mar 1.","Feder KA","J Adolesc Health","2017","2017/03/05","PMC6003902","NIHMS970845","10.1016/j.jadohealth.2016.12.023"
"28252511","Nurse Practitioner Prescriptive Authority for Buprenorphine: From DATA 2000 to CARA 2016","Fornili KS, Fogger SA.","J Addict Nurs. 2017 Jan/Mar;28(1):43-48. doi: 10.1097/JAN.0000000000000160.","Fornili KS","J Addict Nurs","2017","2017/03/03","","","10.1097/JAN.0000000000000160"
"28245872","Public sector low threshold office-based buprenorphine treatment: outcomes at year 7","Bhatraju EP, Grossman E, Tofighi B, McNeely J, DiRocco D, Flannery M, Garment A, Goldfeld K, Gourevitch MN, Lee JD.","Addict Sci Clin Pract. 2017 Feb 28;12(1):7. doi: 10.1186/s13722-017-0072-2.","Bhatraju EP","Addict Sci Clin Pract","2017","2017/03/02","PMC5331716","","10.1186/s13722-017-0072-2"
"28243878","Capsule Commentary on D'Onofrio et al., Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention","Murimi IB.","J Gen Intern Med. 2017 Jun;32(6):683. doi: 10.1007/s11606-017-4015-0.","Murimi IB","J Gen Intern Med","2017","2017/03/01","PMC5442021","","10.1007/s11606-017-4015-0"
"28242537","Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine","Morozova O, Dvoriak S, Pykalo I, Altice FL.","Drug Alcohol Depend. 2017 Apr 1;173:132-138. doi: 10.1016/j.drugalcdep.2016.12.025. Epub 2017 Feb 21.","Morozova O","Drug Alcohol Depend","2017","2017/03/01","PMC5545131","NIHMS888229","10.1016/j.drugalcdep.2016.12.025"
"28242230","Thermal antinociception following oral administration of tapentadol in conscious cats","Doodnaught GM, Evangelista MC, Steagall PVM.","Vet Anaesth Analg. 2017 Mar;44(2):364-369. doi: 10.1016/j.vaa.2016.05.001. Epub 2017 Jan 7.","Doodnaught GM","Vet Anaesth Analg","2017","2017/03/01","","","10.1016/j.vaa.2016.05.001"
"28240955","Pharmacokinetics and pharmacodynamics of buprenorphine and sustained-release buprenorphine after administration to adult alpacas","Dooley SB, Aarnes TK, Lakritz J, Lerche P, Bednarski RM, Hubbell JA.","Am J Vet Res. 2017 Mar;78(3):321-329. doi: 10.2460/ajvr.78.3.321.","Dooley SB","Am J Vet Res","2017","2017/02/28","","","10.2460/ajvr.78.3.321"
"28237362","Intravenous Buprenorphine: A Substitute for Naloxone in Methadone-Overdosed Patients?","Zamani N, Hassanian-Moghaddam H.","Ann Emerg Med. 2017 Jun;69(6):737-739. doi: 10.1016/j.annemergmed.2016.12.024. Epub 2017 Feb 23.","Zamani N","Ann Emerg Med","2017","2017/02/27","","","10.1016/j.annemergmed.2016.12.024"
"28237052","Retention in buprenorphine treatment is associated with improved HCV care outcomes","Norton BL, Beitin A, Glenn M, DeLuca J, Litwin AH, Cunningham CO.","J Subst Abuse Treat. 2017 Apr;75:38-42. doi: 10.1016/j.jsat.2017.01.015. Epub 2017 Jan 27.","Norton BL","J Subst Abuse Treat","2017","2017/02/27","PMC5856469","NIHMS849900","10.1016/j.jsat.2017.01.015"
"28235462","Opioid detoxification during pregnancy needs to be grounded in addiction science","Terplan M.","Am J Obstet Gynecol. 2017 Jun;216(6):623. doi: 10.1016/j.ajog.2017.02.030. Epub 2017 Feb 22.","Terplan M","Am J Obstet Gynecol","2017","2017/02/26","","","10.1016/j.ajog.2017.02.030"
"28235415","A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence","Chetty M, Kenworthy JJ, Langham S, Walker A, Dunlop WC.","Addict Sci Clin Pract. 2017 Feb 24;12(1):6. doi: 10.1186/s13722-017-0071-3.","Chetty M","Addict Sci Clin Pract","2017","2017/02/26","PMC5324212","","10.1186/s13722-017-0071-3"
"28220474","Buprenorphine for managing opioid withdrawal","Gowing L, Ali R, White JM, Mbewe D.","Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD002025. doi: 10.1002/14651858.CD002025.pub5.","Gowing L","Cochrane Database Syst Rev","2017","2017/02/22","PMC6464315","","10.1002/14651858.CD002025.pub5"
"28209683","Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study","Mamakwa S, Kahan M, Kanate D, Kirlew M, Folk D, Cirone S, Rea S, Parsons P, Edwards C, Gordon J, Main F, Kelly L.","Can Fam Physician. 2017 Feb;63(2):137-145.","Mamakwa S","Can Fam Physician","2017","2017/02/18","PMC5395389","",""
"28207646","Translational Interpretations of Combined Bupivacaine-Clonidine-Buprenorphine-Dexamethasone","Williams BA, Ibinson JW, Ezaru CS, Rakesh H, Mangione MP.","Reg Anesth Pain Med. 2017 Mar/Apr;42(2):271-272. doi: 10.1097/AAP.0000000000000547.","Williams BA","Reg Anesth Pain Med","2017","2017/02/17","","","10.1097/AAP.0000000000000547"
"28201761","Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine","Kim SY, Kim H, Park Y, Lim J, Kim J, Koo SH, Kwon GC.","J Anal Toxicol. 2017 Jun 1;41(5):412-420. doi: 10.1093/jat/bkx014.","Kim SY","J Anal Toxicol","2017","2017/02/16","","","10.1093/jat/bkx014"
"28194688","Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention","D'Onofrio G, Chawarski MC, O'Connor PG, Pantalon MV, Busch SH, Owens PH, Hawk K, Bernstein SL, Fiellin DA.","J Gen Intern Med. 2017 Jun;32(6):660-666. doi: 10.1007/s11606-017-3993-2. Epub 2017 Feb 13.","D'Onofrio G","J Gen Intern Med","2017","2017/02/15","PMC5442013","","10.1007/s11606-017-3993-2"
"28191917","Newborn birth-weight of pregnant women on methadone or buprenorphine maintenance treatment: A national contingency management approach trial","Peles E, Sason A, Schreiber S, Adelson M.","Am J Addict. 2017 Mar;26(2):167-175. doi: 10.1111/ajad.12508. Epub 2017 Feb 13.","Peles E","Am J Addict","2017","2017/02/14","","","10.1111/ajad.12508"
"28188773","Maternal buprenorphine treatment and fetal neurobehavioral development","Jansson LM, Velez M, McConnell K, Spencer N, Tuten M, Jones HE, King VL, Gandotra N, Milio LA, Voegtline K, DiPietro JA.","Am J Obstet Gynecol. 2017 May;216(5):529.e1-529.e8. doi: 10.1016/j.ajog.2017.01.040. Epub 2017 Feb 7.","Jansson LM","Am J Obstet Gynecol","2017","2017/02/12","PMC5420468","NIHMS850342","10.1016/j.ajog.2017.01.040"
"28188737","Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism","Browne CA, Erickson RL, Blendy JA, Lucki I.","Neuropharmacology. 2017 May 1;117:401-407. doi: 10.1016/j.neuropharm.2017.02.005. Epub 2017 Feb 7.","Browne CA","Neuropharmacology","2017","2017/02/12","PMC5479141","NIHMS858696","10.1016/j.neuropharm.2017.02.005"
"28188310","Staring down the opioid epidemic","Unger JR.","J Fam Pract. 2017 Jan;66(1):8.","Unger JR","J Fam Pract","2017","2017/02/12","","",""
"28187838","Pharmacologic Treatment of Opioid Addiction During Pregnancy","Keough L, Fantasia HC.","Nurs Womens Health. 2017 Feb-Mar;21(1):34-44. doi: 10.1016/j.nwh.2016.12.010.","Keough L","Nurs Womens Health","2017","2017/02/12","","","10.1016/j.nwh.2016.12.010"
"28171798","Distribution of bupivacaine hydrochloride after sciatic and femoral nerve blocks in cats: A magnetic resonance imaging study","Evangelista MC, de Lassalle J, Chevrier C, Carmel EN, Fantoni DT, Steagall PVM.","Res Vet Sci. 2017 Dec;115:61-65. doi: 10.1016/j.rvsc.2017.01.023. Epub 2017 Jan 27.","Evangelista MC","Res Vet Sci","2017","2017/02/08","","","10.1016/j.rvsc.2017.01.023"
"28168791","Commentary on Nikoo et al. (2017): The role of research","Bell J.","Addiction. 2017 Mar;112(3):430-431. doi: 10.1111/add.13704.","Bell J","Addiction","2017","2017/02/08","","","10.1111/add.13704"
"28164407","Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction","Worley MJ, Heinzerling KG, Shoptaw S, Ling W.","Addiction. 2017 Jul;112(7):1202-1209. doi: 10.1111/add.13782. Epub 2017 Feb 28.","Worley MJ","Addiction","2017","2017/02/07","PMC5461207","NIHMS849638","10.1111/add.13782"
"28163027","Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia","Thornton JD, Lyvers E, Scott VGG, Dwibedi N.","J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S12-S18.e4. doi: 10.1016/j.japh.2016.12.070. Epub 2017 Feb 2.","Thornton JD","J Am Pharm Assoc (2003)","2017","2017/02/07","PMC5352525","NIHMS839098","10.1016/j.japh.2016.12.070"
"28162850","Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment","Brown JL, Gause NK, Lewis D, Winhusen T.","J Subst Abuse Treat. 2017 May;76:77-80. doi: 10.1016/j.jsat.2017.01.017. Epub 2017 Feb 2.","Brown JL","J Subst Abuse Treat","2017","2017/02/07","","","10.1016/j.jsat.2017.01.017"
"28155249","Are UK opioid substitution treatment agencies fit for purpose?","Raistrick D.","Addiction. 2017 Aug;112(8):1340-1342. doi: 10.1111/add.13737. Epub 2017 Feb 2.","Raistrick D","Addiction","2017","2017/02/04","","","10.1111/add.13737"
"28132703","Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians","Gahr M, Eller J, Cabanis M, Hiemke C, Freudenmann RW, Connemann BJ, Lang D, Schönfeldt-Lecuona C.","J Subst Abuse Treat. 2017 Mar;74:7-15. doi: 10.1016/j.jsat.2016.12.002. Epub 2016 Dec 14.","Gahr M","J Subst Abuse Treat","2017","2017/01/31","","","10.1016/j.jsat.2016.12.002"
"28132702","Long-term retention in Office Based Opioid Treatment with buprenorphine","Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, Drainoni ML, Bachman SS, Samet JH.","J Subst Abuse Treat. 2017 Mar;74:65-70. doi: 10.1016/j.jsat.2016.12.010. Epub 2016 Dec 30.","Weinstein ZM","J Subst Abuse Treat","2017","2017/01/31","PMC5312773","NIHMS841918","10.1016/j.jsat.2016.12.010"
"28132694","Buprenorphine prescribing practice trends and attitudes among New York providers","Kermack A, Flannery M, Tofighi B, McNeely J, Lee JD.","J Subst Abuse Treat. 2017 Mar;74:1-6. doi: 10.1016/j.jsat.2016.10.005. Epub 2016 Oct 29.","Kermack A","J Subst Abuse Treat","2017","2017/01/31","","","10.1016/j.jsat.2016.10.005"
"28130543","Monitoring Intravenous Abuse of Methadone or Buprenorphine in Opiate Maintenance Treatment (OMT): A Simple and Fast LC-MS-MS Method for the Detection of Disaccharides in Urine Samples","Jungen H, Andresen-Streichert H, Müller A, Iwersen-Bergmann S.","J Anal Toxicol. 2017 Jan;41(1):22-31. doi: 10.1093/jat/bkw099. Epub 2016 Oct 6.","Jungen H","J Anal Toxicol","2017","2017/01/29","","","10.1093/jat/bkw099"
"28124391","Patient-centred care and patient engagement to inform the use of psychosocial interventions with opioid substitution treatment: another path for Day & Mitcheson to follow","Strike CJ, Guta A.","Addiction. 2017 Aug;112(8):1338-1339. doi: 10.1111/add.13708. Epub 2017 Jan 25.","Strike CJ","Addiction","2017","2017/01/27","","","10.1111/add.13708"
"28121168","Do all screening immunoassay positive buprenorphine samples need to be confirmed?","Saleem M, Martin H, Tolya A, Coates P.","Ann Clin Biochem. 2017 Nov;54(6):707-711. doi: 10.1177/0004563216688489. Epub 2017 May 15.","Saleem M","Ann Clin Biochem","2017","2017/01/26","","","10.1177/0004563216688489"
"28118835","Pilot evaluation of a novel unilateral onychectomy model and efficacy of an extended release buprenorphine product","Enomoto M, Kigin PD, Bledsoe D, Slone R, Hash J, Smith CE, Lascelles BD.","BMC Vet Res. 2017 Jan 24;13(1):32. doi: 10.1186/s12917-017-0943-5.","Enomoto M","BMC Vet Res","2017","2017/01/26","PMC5259973","","10.1186/s12917-017-0943-5"
"28111265","P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine","Liao MZ, Gao C, Shireman LM, Phillips B, Risler LJ, Neradugomma NK, Choudhari P, Prasad B, Shen DD, Mao Q.","Pharmacol Res. 2017 May;119:61-71. doi: 10.1016/j.phrs.2017.01.018. Epub 2017 Jan 19.","Liao MZ","Pharmacol Res","2017","2017/01/24","PMC5392442","NIHMS849788","10.1016/j.phrs.2017.01.018"
"28107680","A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release","Gordon MS, Kinlock TW, Schwartz RP, O'Grady KE, Fitzgerald TT, Vocci FJ.","Drug Alcohol Depend. 2017 Mar 1;172:34-42. doi: 10.1016/j.drugalcdep.2016.11.037. Epub 2017 Jan 11.","Gordon MS","Drug Alcohol Depend","2017","2017/01/21","PMC5309171","NIHMS842779","10.1016/j.drugalcdep.2016.11.037"
"28107580","Non-buprenorphine opioid utilization among patients using buprenorphine","Daubresse M, Saloner B, Pollack HA, Alexander GC.","Addiction. 2017 Jun;112(6):1045-1053. doi: 10.1111/add.13762. Epub 2017 Feb 23.","Daubresse M","Addiction","2017","2017/01/21","","","10.1111/add.13762"
"28107210","Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis","Zheng W, Nickasch M, Lander L, Wen S, Xiao M, Marshalek P, Dix E, Sullivan C.","J Addict Med. 2017 Mar/Apr;11(2):138-144. doi: 10.1097/ADM.0000000000000287.","Zheng W","J Addict Med","2017","2017/01/21","PMC5354971","NIHMS833240","10.1097/ADM.0000000000000287"
"28097659","Substance Use Disorders and Addiction is on the rise: What can we do?","Parrish E.","Perspect Psychiatr Care. 2017 Jan;53(1):3-4. doi: 10.1111/ppc.12210.","Parrish E","Perspect Psychiatr Care","2017","2017/01/19","","","10.1111/ppc.12210"
"28086837","Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study","Hewell VM, Vasquez AR, Rivkin ID.","Subst Abuse Treat Prev Policy. 2017 Jan 11;12(1):3. doi: 10.1186/s13011-016-0085-y.","Hewell VM","Subst Abuse Treat Prev Policy","2017","2017/01/15","PMC5237159","","10.1186/s13011-016-0085-y"
"28086177","Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses","Bi-Mohammed Z, Wright NM, Hearty P, King N, Gavin H.","Drug Alcohol Depend. 2017 Feb 1;171:122-131. doi: 10.1016/j.drugalcdep.2016.11.032. Epub 2016 Dec 14.","Bi-Mohammed Z","Drug Alcohol Depend","2017","2017/01/14","","","10.1016/j.drugalcdep.2016.11.032"
"28075537","The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding?","Brogly SB, Saia K, Hernández-Diaz S, Werler M, Sebastiani P.","Addiction. 2016 Dec;111(12):2130-2131. doi: 10.1111/add.13551.","Brogly SB","Addiction","2016","2017/01/12","PMC5571444","NIHMS809381","10.1111/add.13551"
"28075535","Response to Smith and Brogly et al. commentaries on Zedler et al","Joyce AR, Zedler BK, Amick HR, Murrelle EL, Jones HE.","Addiction. 2016 Dec;111(12):2131-2133. doi: 10.1111/add.13608.","Joyce AR","Addiction","2016","2017/01/12","","","10.1111/add.13608"
"28070862","Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 Study","Albayaty M, Linden M, Olsson H, Johnsson M, Strandgården K, Tiberg F.","Adv Ther. 2017 Feb;34(2):560-575. doi: 10.1007/s12325-016-0472-9. Epub 2017 Jan 9.","Albayaty M","Adv Ther","2017","2017/01/11","","","10.1007/s12325-016-0472-9"
"28069861","The Fine Line Between Doctoring And Dealing","Lagisetty P.","Health Aff (Millwood). 2017 Jan 1;36(1):186-189. doi: 10.1377/hlthaff.2016.0394.","Lagisetty P","Health Aff (Millwood)","2017","2017/01/11","","","10.1377/hlthaff.2016.0394"
"28068780","Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine","Sullivan M, Bisaga A, Pavlicova M, Choi CJ, Mishlen K, Carpenter KM, Levin FR, Dakwar E, Mariani JJ, Nunes EV.","Am J Psychiatry. 2017 May 1;174(5):459-467. doi: 10.1176/appi.ajp.2016.16050548. Epub 2017 Jan 10.","Sullivan M","Am J Psychiatry","2017","2017/01/11","PMC5411308","NIHMS835206","10.1176/appi.ajp.2016.16050548"
"28063060","Pain Relief in Nonhuman Primate Models of Arthritis","Vierboom MPM, Breedveld E, Keehnen M, Klomp R, Bakker J.","Methods Mol Biol. 2017;1559:411-417. doi: 10.1007/978-1-4939-6786-5_28.","Vierboom MPM","Methods Mol Biol","2017","2017/01/08","","","10.1007/978-1-4939-6786-5_28"
"28059434","Assessment of abuse liability of Tramadol among experienced drug users: Double-blind crossover randomized controlled trial","Das M, Jain R, Dhawan A, Kaur A.","J Opioid Manag. 2016 Nov/Dec;12(6):421-430. doi: 10.5055/jom.2016.0361.","Das M","J Opioid Manag","2016","2017/01/07","","","10.5055/jom.2016.0361"
"28024988","Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study","Serra AE, Lemon LS, Mokhtari NB, Parks WT, Catov JM, Venkataramanan R, Caritis SN.","Am J Obstet Gynecol. 2017 Apr;216(4):418.e1-418.e5. doi: 10.1016/j.ajog.2016.12.016. Epub 2016 Dec 23.","Serra AE","Am J Obstet Gynecol","2017","2016/12/28","","","10.1016/j.ajog.2016.12.016"
"28017182","Prevalence of restless legs syndrome during detoxification from alcohol and opioids","Mackie SE, McHugh RK, McDermott K, Griffin ML, Winkelman JW, Weiss RD.","J Subst Abuse Treat. 2017 Feb;73:35-39. doi: 10.1016/j.jsat.2016.10.001. Epub 2016 Oct 6.","Mackie SE","J Subst Abuse Treat","2017","2016/12/27","PMC5193169","NIHMS830877","10.1016/j.jsat.2016.10.001"
"28002704","Interim Buprenorphine vs. Waiting List for Opioid Dependence","Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST.","N Engl J Med. 2016 Dec 22;375(25):2504-2505. doi: 10.1056/NEJMc1610047.","Sigmon SC","N Engl J Med","2016","2016/12/22","PMC5373028","NIHMS850761","10.1056/NEJMc1610047"
"27984521","Buprenorphine Analgesia Leads to Coagulopathy and Increased Plasma Fibrinogen in Healthy Rats: Implications For Small Animal Research","Griffin MJ, Letson HL, Dobson GP.","Shock. 2017 Jul;48(1):78-84. doi: 10.1097/SHK.0000000000000821.","Griffin MJ","Shock","2017","2016/12/17","","","10.1097/SHK.0000000000000821"
"27978771","The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review","Carroll KM, Weiss RD.","Am J Psychiatry. 2017 Aug 1;174(8):738-747. doi: 10.1176/appi.ajp.2016.16070792. Epub 2016 Dec 16.","Carroll KM","Am J Psychiatry","2017","2016/12/17","PMC5474206","NIHMS835209","10.1176/appi.ajp.2016.16070792"
"27977317","Disproportionality analysis of buprenorphine transdermal system and cardiac arrhythmia using FDA and WHO postmarketing reporting system data","Sessler NE, Walker E, Chickballapur H, Kacholakalayil J, Coplan PM.","Postgrad Med. 2017 Jan;129(1):62-68. doi: 10.1080/00325481.2016.1271698.","Sessler NE","Postgrad Med","2017","2016/12/16","","","10.1080/00325481.2016.1271698"
"27974484","Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts","Neradugomma NK, Liao MZ, Mao Q.","Mol Pharmacol. 2017 Mar;91(3):237-249. doi: 10.1124/mol.116.107367. Epub 2016 Dec 14.","Neradugomma NK","Mol Pharmacol","2017","2016/12/16","PMC5325079","","10.1124/mol.116.107367"
"27958381","A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence","Crist RC, Doyle GA, Nelson EC, Degenhardt L, Martin NG, Montgomery GW, Saxon AJ, Ling W, Berrettini WH.","Pharmacogenomics J. 2018 Jan;18(1):173-179. doi: 10.1038/tpj.2016.89. Epub 2016 Dec 13.","Crist RC","Pharmacogenomics J","2018","2016/12/14","PMC5468510","NIHMS830045","10.1038/tpj.2016.89"
"27955689","The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial","Gustafson DH Sr, Landucci G, McTavish F, Kornfield R, Johnson RA, Mares ML, Westergaard RP, Quanbeck A, Alagoz E, Pe-Romashko K, Thomas C, Shah D.","Trials. 2016 Dec 12;17(1):592. doi: 10.1186/s13063-016-1726-1.","Gustafson DH Sr","Trials","2016","2016/12/14","PMC5153683","","10.1186/s13063-016-1726-1"
"27940188","Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial","Marsden J, Stillwell G, Hellier J, Brown AM, Byford S, Kelleher M, Kelly J, Murphy C, Shearer J, Mitcheson L.","Contemp Clin Trials. 2017 Feb;53:36-43. doi: 10.1016/j.cct.2016.12.003. Epub 2016 Dec 8.","Marsden J","Contemp Clin Trials","2017","2016/12/13","","","10.1016/j.cct.2016.12.003"
"27931318","Pharmacokinetics and Paw Withdrawal Pressure in Female Guinea Pigs (Cavia porcellus) Treated with Sustained-Release Buprenorphine and Buprenorphine Hydrochloride","Smith BJ, Wegenast DJ, Hansen RJ, Hess AM, Kendall LV.","J Am Assoc Lab Anim Sci. 2016 Nov;55(6):789-793.","Smith BJ","J Am Assoc Lab Anim Sci","2016","2016/12/10","PMC5113881","",""
"27929709","Safety of buprenorphine transdermal system in the management of pain in older adults","Pergolizzi JV, Raffa RB, Marcum Z, Colucci S, Ripa SR.","Postgrad Med. 2017 Jan;129(1):92-101. doi: 10.1080/00325481.2017.1270699. Epub 2016 Dec 26.","Pergolizzi JV","Postgrad Med","2017","2016/12/09","","","10.1080/00325481.2017.1270699"
"27929214","Rural Opioid Use Disorder Treatment Depends on Family Physicians","Wingrove P, Park B, Bazemore A.","Am Fam Physician. 2016 Oct 1;94(7):546.","Wingrove P","Am Fam Physician","2016","2016/12/09","","",""
"27927048","Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials","Harris SC, Morganroth J, Ripa SR, Thorn MD, Colucci S.","Postgrad Med. 2017 Jan;129(1):69-80. doi: 10.1080/00325481.2017.1270156.","Harris SC","Postgrad Med","2017","2016/12/09","","","10.1080/00325481.2017.1270156"
"27926949","Efficacy and Tolerability of Co-Administering Full µ-Opioid Receptor Agonists with Buprenorphine and Mixed Opioid Agonists","Ruan X, Luo J, Kaye AD.","Drug Res (Stuttg). 2017 Mar;67(3):189-190. doi: 10.1055/s-0042-119946. Epub 2016 Dec 7.","Ruan X","Drug Res (Stuttg)","2017","2016/12/08","","","10.1055/s-0042-119946"
"27925868","Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D","Gellad WF, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Mor M, Hale JA, Radomski T, Hausmann LR, Fine MJ, Good CB.","Subst Abus. 2017 Jan-Mar;38(1):22-25. doi: 10.1080/08897077.2016.1267071. Epub 2016 Dec 7.","Gellad WF","Subst Abus","2017","2016/12/08","PMC5315586","NIHMS823301","10.1080/08897077.2016.1267071"
"27925249","Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of concept","Maharao NV, Joshi AA, Gerk PM.","Biopharm Drug Dispos. 2017 Mar;38(2):139-154. doi: 10.1002/bdd.2050. Epub 2017 Jan 24.","Maharao NV","Biopharm Drug Dispos","2017","2016/12/08","","","10.1002/bdd.2050"
"27922764","Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System","Coplan PM, Sessler NE, Harikrishnan V, Singh R, Perkel C.","Postgrad Med. 2017 Jan;129(1):55-61. doi: 10.1080/00325481.2017.1269596. Epub 2016 Dec 21.","Coplan PM","Postgrad Med","2017","2016/12/07","","","10.1080/00325481.2017.1269596"
"27919103","Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review","Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, Chou R.","Ann Intern Med. 2017 Feb 21;166(4):268-278. doi: 10.7326/M16-2149. Epub 2016 Dec 6.","Korthuis PT","Ann Intern Med","2017","2016/12/06","PMC5504692","NIHMS870055","10.7326/M16-2149"
"27901359","Buprenorphine transdermal system utilization","Wallace L, Kadakia A.","Postgrad Med. 2017 Jan;129(1):81-86. doi: 10.1080/00325481.2017.1267537. Epub 2016 Dec 15.","Wallace L","Postgrad Med","2017","2016/12/01","","","10.1080/00325481.2017.1267537"
"27897918","Buprenorphine shared medical appointments for the treatment of opioid dependence in a homeless clinic","Doorley SL, Ho CJ, Echeverria E, Preston C, Ngo H, Kamal A, Cunningham CO.","Subst Abus. 2017 Jan-Mar;38(1):26-30. doi: 10.1080/08897077.2016.1264535. Epub 2016 Nov 29.","Doorley SL","Subst Abus","2017","2016/11/30","PMC5592108","NIHMS901229","10.1080/08897077.2016.1264535"
"27896372","Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis","Janas A, Folwarczna J.","Naunyn Schmiedebergs Arch Pharmacol. 2017 Feb;390(2):175-185. doi: 10.1007/s00210-016-1295-6. Epub 2016 Nov 28.","Janas A","Naunyn Schmiedebergs Arch Pharmacol","2017","2016/11/30","PMC5233738","","10.1007/s00210-016-1295-6"
"27894615","Opioid dependence and pregnancy: minimizing stress on the fetal brain","Ruan X, Luo JJ, Kaye AD.","Am J Obstet Gynecol. 2017 Apr;216(4):430. doi: 10.1016/j.ajog.2016.11.1040. Epub 2016 Nov 25.","Ruan X","Am J Obstet Gynecol","2017","2016/11/30","","","10.1016/j.ajog.2016.11.1040"
"27876117","Neonatal abstinence syndrome and the gastrointestinal tract","Maguire D, Gröer M.","Med Hypotheses. 2016 Dec;97:11-15. doi: 10.1016/j.mehy.2016.10.006. Epub 2016 Oct 19.","Maguire D","Med Hypotheses","2016","2016/11/24","","","10.1016/j.mehy.2016.10.006"
"27865152","Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine","Weinstein ZM, Cheng DM, Quinn E, Hui D, Kim H, Gryczynski G, Samet JH.","Drug Alcohol Depend. 2017 Jan 1;170:9-16. doi: 10.1016/j.drugalcdep.2016.10.039. Epub 2016 Nov 5.","Weinstein ZM","Drug Alcohol Depend","2017","2016/11/20","PMC5183557","NIHMS828275","10.1016/j.drugalcdep.2016.10.039"
"27823911","[Trend in buprenorphine and methadone shopping behavior in France from 2004 to 2014]","Kernisant M, Delorme J, Kabore JL, Brousse G, Laporte C, Zenut M, Chenaf C, Authier N.","Presse Med. 2016 Dec;45(12 Pt 1):e369-e375. doi: 10.1016/j.lpm.2016.10.011. Epub 2016 Nov 4.","Kernisant M","Presse Med","2016","2016/11/09","","","10.1016/j.lpm.2016.10.011"
"27818236","A role for the mu opioid receptor in the antidepressant effects of buprenorphine","Robinson SA, Erickson RL, Browne CA, Lucki I.","Behav Brain Res. 2017 Feb 15;319:96-103. doi: 10.1016/j.bbr.2016.10.050. Epub 2016 Nov 3.","Robinson SA","Behav Brain Res","2017","2016/11/08","PMC5587126","NIHMS901612","10.1016/j.bbr.2016.10.050"
"27806420","[Unexpected Complications in the Withdrawal Treatment of the Research Chemical AH-7921]","Bernius A, Blaas V, Rentsch D, Büttner A, Thome J.","Fortschr Neurol Psychiatr. 2016 Oct;84(S 02):S80-S83. doi: 10.1055/s-0042-113960. Epub 2016 Nov 2.","Bernius A","Fortschr Neurol Psychiatr","2016","2016/11/03","","","10.1055/s-0042-113960"
"27806350","Enteral Docosahexaenoic Acid Reduces Analgesic Administration in Neonates Undergoing Cardiovascular Surgery","Bernabe-Garcia M, López-Alarcon M, Salgado-Sosa A, Villegas-Silva R, Maldonado-Hernandez J, Rodríguez-Cruz M, Rivas-Ruiz R, Chavez-Sanchez L, Blanco-Favela FA, Mancilla-Ramirez J, Gordillo-Alvarez V, Madrigal-Muñiz O.","Ann Nutr Metab. 2016;69(2):150-160. doi: 10.1159/000452227. Epub 2016 Nov 2.","Bernabe-Garcia M","Ann Nutr Metab","2016","2016/11/03","","","10.1159/000452227"
"27803387","Editor's Highlight: Neurorespiratory Effects of Buprenorphine and Ethanol in Combination: A Mechanistic Study of Drug-Drug Interactions in the Rat","Cohier C, Chevillard L, Salle S, Risède P, Roussel O, Mégarbane B.","Toxicol Sci. 2017 Feb;155(2):389-399. doi: 10.1093/toxsci/kfw221. Epub 2016 Nov 1.","Cohier C","Toxicol Sci","2017","2016/11/03","","","10.1093/toxsci/kfw221"
"27799240","Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population","Jumah NA, Edwards C, Balfour-Boehm J, Loewen K, Dooley J, Gerber Finn L, Kelly L.","BMJ Open. 2016 Oct 31;6(10):e011774. doi: 10.1136/bmjopen-2016-011774.","Jumah NA","BMJ Open","2016","2016/11/02","PMC5093362","","10.1136/bmjopen-2016-011774"
"27788815","Treatment of Opioid Dependence With Buprenorphine/Naloxone After Liver Transplantation: Report of Two Cases","Aldemir E, Coskunol H, Kilic M, Sert I.","Transplant Proc. 2016 Oct;48(8):2769-2772. doi: 10.1016/j.transproceed.2016.08.005.","Aldemir E","Transplant Proc","2016","2016/10/30","","","10.1016/j.transproceed.2016.08.005"
"27781278","Improving the oral bioavailability of buprenorphine: an in-vivo proof of concept","Joshi A, Halquist M, Konsoula Z, Liu Y, Jones JP 3rd, Heidbreder C, Gerk PM.","J Pharm Pharmacol. 2017 Jan;69(1):23-31. doi: 10.1111/jphp.12652. Epub 2016 Oct 26.","Joshi A","J Pharm Pharmacol","2017","2016/10/27","","","10.1111/jphp.12652"
"27776678","Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment","Moore BA, Fiellin DA, Cutter CJ, Buono FD, Barry DT, Fiellin LE, O'Connor PG, Schottenfeld RS.","J Subst Abuse Treat. 2016 Dec;71:54-57. doi: 10.1016/j.jsat.2016.08.016. Epub 2016 Sep 2.","Moore BA","J Subst Abuse Treat","2016","2016/10/26","PMC5119533","NIHMS814533","10.1016/j.jsat.2016.08.016"
"27770695","Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial)","Carrieri P, Vilotitch A, Nordmann S, Lions C, Michel L, Mora M, Morel A, Maradan G, Spire B, Roux P; Methaville Study Group.","Int J Drug Policy. 2017 Jan;39:86-91. doi: 10.1016/j.drugpo.2016.08.005. Epub 2016 Oct 19.","Carrieri P","Int J Drug Policy","2017","2016/10/23","","","10.1016/j.drugpo.2016.08.005"
"27764078","Notes from the Field: Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion - United States, 2008-2015","Budnitz DS, Lovegrove MC, Sapiano MR, Mathew J, Kegler SR, Geller AI, Hampp C.","MMWR Morb Mortal Wkly Rep. 2016 Oct 21;65(41):1148-1149. doi: 10.15585/mmwr.mm6541a5.","Budnitz DS","MMWR Morb Mortal Wkly Rep","2016","2016/10/21","","","10.15585/mmwr.mm6541a5"
"27756148","Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center","Toce MS, Burns MM, O'Donnell KA.","Clin Toxicol (Phila). 2017 Jan;55(1):12-17. doi: 10.1080/15563650.2016.1244337. Epub 2016 Oct 19.","Toce MS","Clin Toxicol (Phila)","2017","2016/10/21","","","10.1080/15563650.2016.1244337"
"27746208","Analysis of inflammation-induced depression of home cage wheel running in rats reveals the difference between opioid antinociception and restoration of function","Kandasamy R, Calsbeek JJ, Morgan MM.","Behav Brain Res. 2017 Jan 15;317:502-507. doi: 10.1016/j.bbr.2016.10.024. Epub 2016 Oct 13.","Kandasamy R","Behav Brain Res","2017","2016/10/18","PMC5107346","NIHMS823836","10.1016/j.bbr.2016.10.024"
"27745534","Integrating Buprenorphine Into an Opioid Treatment Program: Tailoring Care for Patients With Opioid Use Disorders","Polydorou S, Ross S, Coleman P, Duncan L, Roxas N, Thomas A, Mendoza S, Hansen H.","Psychiatr Serv. 2017 Mar 1;68(3):295-298. doi: 10.1176/appi.ps.201500501. Epub 2016 Oct 17.","Polydorou S","Psychiatr Serv","2017","2016/10/18","PMC5540137","NIHMS839280","10.1176/appi.ps.201500501"
"27736284","Continuous Perioperative Sublingual Buprenorphine","Silva MJ, Rubinstein A.","J Pain Palliat Care Pharmacother. 2016 Dec;30(4):289-293. doi: 10.1080/15360288.2016.1231734. Epub 2016 Oct 13.","Silva MJ","J Pain Palliat Care Pharmacother","2016","2016/10/14","","","10.1080/15360288.2016.1231734"
"27734745","Update on pharmacotherapy for treatment of opioid use disorder","Ayanga D, Shorter D, Kosten TR.","Expert Opin Pharmacother. 2016 Dec;17(17):2307-2318. doi: 10.1080/14656566.2016.1244529. Epub 2016 Oct 20.","Ayanga D","Expert Opin Pharmacother","2016","2016/10/14","","","10.1080/14656566.2016.1244529"
"27729254","Opioid dependence and pregnancy: minimizing stress on the fetal brain","McCarthy JJ, Leamon MH, Finnegan LP, Fassbender C.","Am J Obstet Gynecol. 2017 Mar;216(3):226-231. doi: 10.1016/j.ajog.2016.10.003. Epub 2016 Oct 8.","McCarthy JJ","Am J Obstet Gynecol","2017","2016/10/13","","","10.1016/j.ajog.2016.10.003"
"27726319","Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements. Final rule","Substance Abuse and Mental Health Services Administration (SAMHSA), HHS.","Fed Regist. 2016 Sep 27;81(187):66191-6.","Substance Abuse and Mental Health Services Administration (SAMHSA), HHS","Fed Regist","2016","2016/10/12","","",""
"27723910","Neonatal Abstinence Syndrome: Twelve Years of Experience at a Regional Referral Center","Mücke S, Nagel M, Siedentopf J, Bührer C, Hüseman D.","Klin Padiatr. 2017 Jan;229(1):32-39. doi: 10.1055/s-0042-115300. Epub 2016 Oct 10.","Mücke S","Klin Padiatr","2017","2016/10/11","","","10.1055/s-0042-115300"
"27715904","Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus-positive patients","Riggins DP, Cunningham CO, Ning Y, Fox AD.","Subst Abus. 2017 Jul-Sep;38(3):297-302. doi: 10.1080/08897077.2016.1220443. Epub 2016 Aug 11.","Riggins DP","Subst Abus","2017","2016/10/08","PMC5303565","NIHMS842103","10.1080/08897077.2016.1220443"
"27692193","Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma","Allen B, Harocopos A.","J Subst Abuse Treat. 2016 Nov;70:81-86. doi: 10.1016/j.jsat.2016.08.002. Epub 2016 Aug 12.","Allen B","J Subst Abuse Treat","2016","2016/10/04","","","10.1016/j.jsat.2016.08.002"
"27690553","Ultra-Low-Dose Buprenorphine for Mental Pain: Response to Ruan et al","Yovell Y, Bar G.","Am J Psychiatry. 2016 Oct 1;173(10):1043-1044. doi: 10.1176/appi.ajp.2016.16050512r.","Yovell Y","Am J Psychiatry","2016","2016/10/04","","","10.1176/appi.ajp.2016.16050512r"
"27690549","Effects of Ultra-Low-Dose Buprenorphine on Suicidal Ideation Confounded by Physical Pain Relief?","Ruan X, Mancuso KF, Kaye AD.","Am J Psychiatry. 2016 Oct 1;173(10):1043. doi: 10.1176/appi.ajp.2016.16050512.","Ruan X","Am J Psychiatry","2016","2016/10/04","","","10.1176/appi.ajp.2016.16050512"
"27687214","Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy","Bastian JR, Chen H, Zhang H, Rothenberger S, Tarter R, English D, Venkataramanan R, Caritis SN.","Am J Obstet Gynecol. 2017 Jan;216(1):64.e1-64.e7. doi: 10.1016/j.ajog.2016.09.095. Epub 2016 Sep 26.","Bastian JR","Am J Obstet Gynecol","2017","2016/10/01","PMC5245872","NIHMS819186","10.1016/j.ajog.2016.09.095"
"27681372","Antinociceptive effects of voluntarily ingested buprenorphine in the hot-plate test in laboratory rats","Hestehave S, Munro G, Pedersen TB, Abelson KSP.","Lab Anim. 2017 Jun;51(3):264-272. doi: 10.1177/0023677216668553. Epub 2016 Sep 27.","Hestehave S","Lab Anim","2017","2016/09/30","","","10.1177/0023677216668553"
"27654688","Evaluation of buprenorphine hydrochloride Pluronic(®) gel formulation in male C57BL/6NCrl mice","Blankenship-Paris TL, Dutton JW, Goulding DR, McGee CA, Kissling GE, Myers PH.","Lab Anim (NY). 2016 Sep 21;45(10):370-9. doi: 10.1038/laban.1106.","Blankenship-Paris TL","Lab Anim (NY)","2016","2016/09/23","PMC5116768","NIHMS829297","10.1038/laban.1106"
"27651026","No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery","Okkerse P, Alvarez-Jimenez R, Hay JL, Tehim A, Kumar R, de Kam ML, Groeneveld GJ.","Eur J Pain. 2017 Mar;21(3):494-506. doi: 10.1002/ejp.943. Epub 2016 Sep 21.","Okkerse P","Eur J Pain","2017","2016/09/22","","","10.1002/ejp.943"
"27647616","Caring for patients with opioid use disorder in the hospital","Donroe JH, Holt SR, Tetrault JM.","CMAJ. 2016 Dec 6;188(17-18):1232-1239. doi: 10.1503/cmaj.160290. Epub 2016 Sep 19.","Donroe JH","CMAJ","2016","2016/09/21","PMC5135493","","10.1503/cmaj.160290"
"27647259","Pharmacokinetics of liposomal encapsulated buprenorphine suspension following subcutaneous administration to cats","Johnson RJ, Kerr CL, Enouri SS, Modi P, Lascelles BDX, Del Castillo JRE.","J Vet Pharmacol Ther. 2017 Jun;40(3):256-269. doi: 10.1111/jvp.12357. Epub 2016 Sep 20.","Johnson RJ","J Vet Pharmacol Ther","2017","2016/09/21","","","10.1111/jvp.12357"
"27646674","Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the 'other epidemic'","Eibl JK, Morin-Taus KA, Marsh DC.","Subst Abuse Treat Prev Policy. 2016 Sep 20;11(1):33. doi: 10.1186/s13011-016-0076-z.","Eibl JK","Subst Abuse Treat Prev Policy","2016","2016/09/21","PMC5029095","","10.1186/s13011-016-0076-z"
"27636696","Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All","McPherson C.","Neonatal Netw. 2016;35(5):314-20. doi: 10.1891/0730-0832.35.5.314.","McPherson C","Neonatal Netw","2016","2016/09/17","","","10.1891/0730-0832.35.5.314"
"27629823","Impact of early childhood trauma on retention and phase advancement in an outpatient buprenorphine treatment program","Kumar N, Stowe ZN, Han X, Mancino MJ.","Am J Addict. 2016 Oct;25(7):542-8. doi: 10.1111/ajad.12437. Epub 2016 Sep 15.","Kumar N","Am J Addict","2016","2016/09/16","","","10.1111/ajad.12437"
"27619355","Curious Crosses: Injection-Induced Lesions","Bhatt AS, Perkins S, McKinnon E, Perfect JR.","Am J Med. 2017 Jan;130(1):31-33. doi: 10.1016/j.amjmed.2016.08.023. Epub 2016 Sep 9.","Bhatt AS","Am J Med","2017","2016/09/14","","","10.1016/j.amjmed.2016.08.023"
"27617799","Three Complementary Approaches to Characterize Buprenorphine Misuse","Eiden C, Nogue E, Diot C, Frauger E, Jouanjus E, Léglise Y, Picot MC, Peyriere H.","Subst Use Misuse. 2016 Dec 5;51(14):1912-9. doi: 10.1080/10826084.2016.1201509. Epub 2016 Sep 12.","Eiden C","Subst Use Misuse","2016","2016/09/13","","","10.1080/10826084.2016.1201509"
"27614330","Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine","Konijnenberg C, Sarfi M, Melinder A.","Early Hum Dev. 2016 Oct;101:91-7. doi: 10.1016/j.earlhumdev.2016.08.013. Epub 2016 Sep 8.","Konijnenberg C","Early Hum Dev","2016","2016/09/11","","","10.1016/j.earlhumdev.2016.08.013"
"27603712","High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments","Lugoboni F, Mirijello A, Zamboni L, Faccini M, Casari R, Cossari A, Gasbarrini A, Addolorato G, On Behalf Of Gics.","Expert Opin Pharmacother. 2016 Nov;17(16):2135-2141. doi: 10.1080/14656566.2016.1232391. Epub 2016 Sep 21.","Lugoboni F","Expert Opin Pharmacother","2016","2016/09/08","","","10.1080/14656566.2016.1232391"
"27576596","Efficacy of buprenorphine added to 2% lignocaine plus adrenaline 1:80,000 in providing postoperative analgesia after lower third molar surgery","Chhabra N, Sharma P, Chhabra S, Gupta N.","Int J Oral Maxillofac Surg. 2016 Dec;45(12):1644-1651. doi: 10.1016/j.ijom.2016.08.003. Epub 2016 Aug 28.","Chhabra N","Int J Oral Maxillofac Surg","2016","2016/09/01","","","10.1016/j.ijom.2016.08.003"
"27575825","What's in a number? Recommending practicality in the DATA 2000 patient limits","Barthwell AG, Young JM, Barnes MC, Kulkarni SR.","J Opioid Manag. 2016 Jul-Aug;12(4):243-50. doi: 10.5055/jom.2016.0339.","Barthwell AG","J Opioid Manag","2016","2016/08/31","","","10.5055/jom.2016.0339"
"27574837","Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder","Barry DT, Cutter CJ, Beitel M, Kerns RD, Liong C, Schottenfeld RS.","J Clin Psychiatry. 2016 Oct;77(10):1413-1419. doi: 10.4088/JCP.15m09963.","Barry DT","J Clin Psychiatry","2016","2016/08/31","PMC6296217","NIHMS1000281","10.4088/JCP.15m09963"
"27573851","Buprenorphine analogue BU08028 is one step closer to the Holy Grail of opioid research","Li JX.","Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10225-7. doi: 10.1073/pnas.1612752113. Epub 2016 Aug 29.","Li JX","Proc Natl Acad Sci U S A","2016","2016/08/31","PMC5027450","","10.1073/pnas.1612752113"
"27573832","A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates","Ding H, Czoty PW, Kiguchi N, Cami-Kobeci G, Sukhtankar DD, Nader MA, Husbands SM, Ko MC.","Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5511-8. doi: 10.1073/pnas.1605295113. Epub 2016 Aug 29.","Ding H","Proc Natl Acad Sci U S A","2016","2016/08/31","PMC5027459","","10.1073/pnas.1605295113"
"27569459","Effects of opioids on proximal renal tubular cells undergoing ATP depletion","Bellini L, Vadori M, De Benedictis GM, Busetto R.","J Pharmacol Sci. 2016 Aug;131(4):288-91. doi: 10.1016/j.jphs.2016.08.002. Epub 2016 Aug 12.","Bellini L","J Pharmacol Sci","2016","2016/08/30","","","10.1016/j.jphs.2016.08.002"
"27563013","Maternal Buprenorphine Maintenance and Lactation","Jansson LM, Spencer N, McConnell K, Velez M, Tuten M, Harrow CA, Jones HE, Swortwood MJ, Barnes AJ, Scheidweiler KB, Huestis MA.","J Hum Lact. 2016 Nov;32(4):675-681. doi: 10.1177/0890334416663198. Epub 2016 Sep 26.","Jansson LM","J Hum Lact","2016","2016/08/27","","","10.1177/0890334416663198"
"27562968","Definitive Drug and Metabolite Screening in Urine by UPLC-MS-MS Using a Novel Calibration Technique","Rosano TG, Ohouo PY, LeQue JJ, Freeto SM, Wood M.","J Anal Toxicol. 2016 Oct;40(8):628-638. doi: 10.1093/jat/bkw050. Epub 2016 Aug 25.","Rosano TG","J Anal Toxicol","2016","2016/08/27","","","10.1093/jat/bkw050"
"27561982","Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential","Sigmon SC, Bigelow GE.","Addiction. 2017 Mar;112(3):386-387. doi: 10.1111/add.13539. Epub 2016 Aug 26.","Sigmon SC","Addiction","2017","2016/08/27","","","10.1111/add.13539"
"27555206","Addition of buprenorphine to local anesthetic in adductor canal blocks after total knee arthroplasty improves postoperative pain relief: a randomized controlled trial","Krishnan SH, Gilbert LA, Ghoddoussi F, Applefield DJ, Kassab SS, Ellis TA 2nd.","J Clin Anesth. 2016 Sep;33:432-7. doi: 10.1016/j.jclinane.2016.04.021. Epub 2016 Jun 5.","Krishnan SH","J Clin Anesth","2016","2016/08/25","","","10.1016/j.jclinane.2016.04.021"
"27550978","Medication-Assisted Treatment of Adolescents With Opioid Use Disorders","COMMITTEE ON SUBSTANCE USE AND PREVENTION.","Pediatrics. 2016 Sep;138(3):e20161893. doi: 10.1542/peds.2016-1893. Epub 2016 Aug 22.","COMMITTEE ON SUBSTANCE USE AND PREVENTION","Pediatrics","2016","2016/08/24","","","10.1542/peds.2016-1893"
"27550143","Re-purposing anticoagulation clinics: expanding access to opioid agonist therapy in primary care settings","Lagisetty P, Heisler M, Bohnert A.","Addiction. 2017 Mar;112(3):384-385. doi: 10.1111/add.13531. Epub 2016 Aug 23.","Lagisetty P","Addiction","2017","2016/08/24","","","10.1111/add.13531"
"27537841","Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial","Dore GJ, Altice F, Litwin AH, Dalgard O, Gane EJ, Shibolet O, Luetkemeyer A, Nahass R, Peng CY, Conway B, Grebely J, Howe AY, Gendrano IN, Chen E, Huang HC, Dutko FJ, Nickle DC, Nguyen BY, Wahl J, Barr E, Robertson MN, Platt HL; C-EDGE CO-STAR Study Group.","Ann Intern Med. 2016 Nov 1;165(9):625-634. doi: 10.7326/M16-0816. Epub 2016 Aug 9.","Dore GJ","Ann Intern Med","2016","2016/08/19","","","10.7326/M16-0816"
"27530823","Real-time application of the Rat Grimace Scale as a welfare refinement in laboratory rats","Leung V, Zhang E, Pang DS.","Sci Rep. 2016 Aug 17;6:31667. doi: 10.1038/srep31667.","Leung V","Sci Rep","2016","2016/08/18","PMC4987703","","10.1038/srep31667"
"27524395","Puffy hand syndrome","Vivaldelli E, Sansone S, Maier A, Wiedermann CJ.","Lancet. 2017 Jan 21;389(10066):298. doi: 10.1016/S0140-6736(16)31011-X. Epub 2016 Aug 11.","Vivaldelli E","Lancet","2017","2016/08/16","","","10.1016/S0140-6736(16)31011-X"
"27510521","Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction","Fihlman M, Hemmilä T, Hagelberg NM, Kuusniemi K, Backman JT, Laitila J, Laine K, Neuvonen PJ, Olkkola KT, Saari TI.","Eur J Clin Pharmacol. 2016 Nov;72(11):1363-1371. doi: 10.1007/s00228-016-2109-y. Epub 2016 Aug 10.","Fihlman M","Eur J Clin Pharmacol","2016","2016/08/12","","","10.1007/s00228-016-2109-y"
"27504930","Enzymatic assays for detecting lactose and sucrose in urine to reveal intravenous drug abuse with emphasis on buprenorphine","Keltanen T, Mariottini C, Walta AM, Rahikainen AL, Ojanperä I.","Drug Test Anal. 2017 Jun;9(6):949-952. doi: 10.1002/dta.2050. Epub 2016 Sep 2.","Keltanen T","Drug Test Anal","2017","2016/08/10","","","10.1002/dta.2050"
"27504926","The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine","Barry DT, Fazzino T, Necrason E, Ginn J, Fiellin LE, Fiellin DA, Moore BA.","J Addict Med. 2016 Sep-Oct;10(5):352-6. doi: 10.1097/ADM.0000000000000247.","Barry DT","J Addict Med","2016","2016/08/10","PMC5042831","NIHMS800504","10.1097/ADM.0000000000000247"
"27504867","Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence","van Niel JC, Schneider J, Tzschentke TM.","Drug Res (Stuttg). 2016 Nov;66(11):562-570. doi: 10.1055/s-0042-109393. Epub 2016 Aug 9.","van Niel JC","Drug Res (Stuttg)","2016","2016/08/10","","","10.1055/s-0042-109393"
"27495167","Evaluation of the vaginal flora in pregnant women receiving opioid maintenance therapy: a matched case-control study","Farr A, Kiss H, Hagmann M, Holzer I, Kueronya V, Husslein PW, Petricevic L.","BMC Pregnancy Childbirth. 2016 Aug 5;16(1):206. doi: 10.1186/s12884-016-1003-z.","Farr A","BMC Pregnancy Childbirth","2016","2016/08/07","PMC4974689","","10.1186/s12884-016-1003-z"
"27488225","Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America","Mendoza S, Rivera-Cabrero AS, Hansen H.","Transcult Psychiatry. 2016 Aug;53(4):465-87. doi: 10.1177/1363461516660884. Epub 2016 Aug 3.","Mendoza S","Transcult Psychiatry","2016","2016/08/05","PMC5540139","NIHMS839281","10.1177/1363461516660884"
"27487158","New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents","Pimentel CB, Gurwitz JH, Tjia J, Hume AL, Lapane KL.","J Am Geriatr Soc. 2016 Sep;64(9):1772-8. doi: 10.1111/jgs.14306. Epub 2016 Aug 3.","Pimentel CB","J Am Geriatr Soc","2016","2016/08/04","PMC5040602","NIHMS781831","10.1111/jgs.14306"
"27483415","Relative Contribution of Adjuvants to Local Anesthetic for Prolonging the Duration of Peripheral Nerve Blocks in Rats","Buvanendran A, Kroin JS, Li J, Moric M, Tuman KJ.","Reg Anesth Pain Med. 2016 Sep-Oct;41(5):589-92. doi: 10.1097/AAP.0000000000000453.","Buvanendran A","Reg Anesth Pain Med","2016","2016/08/03","","","10.1097/AAP.0000000000000453"
"27473985","Carprofen neither reduces postoperative facial expression scores in rabbits treated with buprenorphine nor alters long term bone formation after maxillary sinus grafting","Hedenqvist P, Trbakovic A, Thor A, Ley C, Ekman S, Jensen-Waern M.","Res Vet Sci. 2016 Aug;107:123-131. doi: 10.1016/j.rvsc.2016.05.010. Epub 2016 May 25.","Hedenqvist P","Res Vet Sci","2016","2016/07/31","","","10.1016/j.rvsc.2016.05.010"
"27464203","Treatment of Opioid-Use Disorders","Schuckit MA.","N Engl J Med. 2016 Jul 28;375(4):357-68. doi: 10.1056/NEJMra1604339.","Schuckit MA","N Engl J Med","2016","2016/07/28","","","10.1056/NEJMra1604339"
"27462930","Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?","Blum K, Gold M, Clark HW, Dushaj K, Badgaiyan RD.","Subst Use Misuse. 2016 Oct 14;51(12):1674-1679. doi: 10.1080/10826084.2016.1200097. Epub 2016 Jul 27.","Blum K","Subst Use Misuse","2016","2016/07/28","PMC5055459","NIHMS814867","10.1080/10826084.2016.1200097"
"27445237","Effects of thienorphine on the contraction of isolated ureter and bladder of guinea pigs","Zhou P, Li Y, Yong Z, Yan H, Su R, Gong Z.","Eur J Pharmacol. 2016 Oct 15;789:144-151. doi: 10.1016/j.ejphar.2016.07.029. Epub 2016 Jul 18.","Zhou P","Eur J Pharmacol","2016","2016/07/23","","","10.1016/j.ejphar.2016.07.029"
"27434505","Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study","Gimbel J, Spierings EL, Katz N, Xiang Q, Tzanis E, Finn A.","Pain. 2016 Nov;157(11):2517-2526. doi: 10.1097/j.pain.0000000000000670.","Gimbel J","Pain","2016","2016/07/20","PMC5065057","","10.1097/j.pain.0000000000000670"
"27434441","Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial","Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, Vocci FJ; PRO-814 Study Group.","JAMA. 2016 Jul 19;316(3):282-90. doi: 10.1001/jama.2016.9382.","Rosenthal RN","JAMA","2016","2016/07/20","","","10.1001/jama.2016.9382"
"27434440","Improving Outcomes for Persons With Opioid Use Disorders: Buprenorphine Implants to Improve Adherence and Access to Care","Compton WM, Volkow ND.","JAMA. 2016 Jul 19;316(3):277-9. doi: 10.1001/jama.2016.8897.","Compton WM","JAMA","2016","2016/07/20","","","10.1001/jama.2016.8897"
"27431049","Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization","Cushman PA, Liebschutz JM, Anderson BJ, Moreau MR, Stein MD.","J Subst Abuse Treat. 2016 Sep;68:68-73. doi: 10.1016/j.jsat.2016.06.003. Epub 2016 Jun 11.","Cushman PA","J Subst Abuse Treat","2016","2016/07/20","PMC5018431","NIHMS801205","10.1016/j.jsat.2016.06.003"
"27431048","Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection","Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Lo Re V 3rd, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA.","J Subst Abuse Treat. 2016 Sep;68:62-7. doi: 10.1016/j.jsat.2016.06.002. Epub 2016 Jun 6.","Tetrault JM","J Subst Abuse Treat","2016","2016/07/20","PMC4976086","NIHMS800847","10.1016/j.jsat.2016.06.002"
"27422763","Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy","Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Edwards RR, Samet JH.","Drug Alcohol Depend. 2016 Sep 1;166:26-31. doi: 10.1016/j.drugalcdep.2016.06.024. Epub 2016 Jun 27.","Tsui JI","Drug Alcohol Depend","2016","2016/07/17","PMC4983520","NIHMS802816","10.1016/j.drugalcdep.2016.06.024"
"27408341","Plasma concentrations of buprenorphine following a single subcutaneous administration of a sustained release formulation of buprenorphine in sheep","Zullian C, Lema P, Lavoie M, Dodelet-Devillers A, Beaudry F, Vachon P.","Can J Vet Res. 2016 Jul;80(3):250-3.","Zullian C","Can J Vet Res","2016","2016/07/14","PMC4924562","",""
"27403784","Buprenorphine implants (Probuphine) for opioid dependence","","Med Lett Drugs Ther. 2016 Jul 18;58(1499):94-5.","","Med Lett Drugs Ther","2016","2016/07/13","","",""
"27400463","Medication Assisted Treatment for Opioid Use Disorders. Final rule","Substance Abuse and Mental Health Services Administration, HHS.","Fed Regist. 2016 Jul 8;81(131):44711-39.","Substance Abuse and Mental Health Services Administration, HHS","Fed Regist","2016","2016/07/13","","",""
"27393486","Barriers to Post-Acute Care for Patients on Opioid Agonist Therapy; An Example of Systematic Stigmatization of Addiction","Wakeman SE, Rich JD.","J Gen Intern Med. 2017 Jan;32(1):17-19. doi: 10.1007/s11606-016-3799-7. Epub 2016 Jul 8.","Wakeman SE","J Gen Intern Med","2017","2016/07/10","PMC5215148","","10.1007/s11606-016-3799-7"
"27390058","Quantitative determination of buprenorphine, naloxone and their metabolites in rat plasma using hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry","Joshi A, Parris B, Liu Y, Heidbreder C, Gerk PM, Halquist M.","Biomed Chromatogr. 2017 Feb;31(2). doi: 10.1002/bmc.3785. Epub 2016 Aug 22.","Joshi A","Biomed Chromatogr","2017","2016/07/09","","","10.1002/bmc.3785"
"27376622","Buprenorphine dosing choices in specific populations: review of expert opinion","Maremmani I, Rolland B, Somaini L, Roncero C, Reimer J, Wright N, Littlewood R, Krajci P, Alho H, D'Agnone O, Simon N.","Expert Opin Pharmacother. 2016 Sep;17(13):1727-31. doi: 10.1080/14656566.2016.1209486. Epub 2016 Aug 2.","Maremmani I","Expert Opin Pharmacother","2016","2016/07/05","","","10.1080/14656566.2016.1209486"
"27374385","Clinical evaluation of intranasal medetomidine-ketamine and medetomidine-S(+)-ketamine for induction of anaesthesia in rabbits in two centres with two different administration techniques","Weiland LC, Kluge K, Kutter APN, Kronen PW.","Vet Anaesth Analg. 2017 Jan;44(1):98-105. doi: 10.1111/vaa.12408. Epub 2017 Feb 23.","Weiland LC","Vet Anaesth Analg","2017","2016/07/05","","","10.1111/vaa.12408"
"27370527","Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine","Makarenko I, Mazhnaya A, Polonsky M, Marcus R, Bojko MJ, Filippovych S, Springer S, Dvoriak S, Altice FL.","Drug Alcohol Depend. 2016 Aug 1;165:213-20. doi: 10.1016/j.drugalcdep.2016.06.011. Epub 2016 Jun 17.","Makarenko I","Drug Alcohol Depend","2016","2016/07/03","PMC5094181","NIHMS800700","10.1016/j.drugalcdep.2016.06.011"
"27356522","The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research","Walsh SL, Babalonis S.","Curr Top Behav Neurosci. 2017;34:33-58. doi: 10.1007/7854_2016_448.","Walsh SL","Curr Top Behav Neurosci","2017","2016/07/01","","","10.1007/7854_2016_448"
"27343545","Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis","Low AJ, Mburu G, Welton NJ, May MT, Davies CF, French C, Turner KM, Looker KJ, Christensen H, McLean S, Rhodes T, Platt L, Hickman M, Guise A, Vickerman P.","Clin Infect Dis. 2016 Oct 15;63(8):1094-1104. doi: 10.1093/cid/ciw416. Epub 2016 Jun 25.","Low AJ","Clin Infect Dis","2016","2016/06/26","PMC5036913","","10.1093/cid/ciw416"
"27338968","Opioid Use Disorders","Sharma B, Bruner A, Barnett G, Fishman M.","Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):473-87. doi: 10.1016/j.chc.2016.03.002. Epub 2016 Apr 9.","Sharma B","Child Adolesc Psychiatr Clin N Am","2016","2016/06/25","PMC4920977","NIHMS776910","10.1016/j.chc.2016.03.002"
"27314487","Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis Pain","Conaghan PG, Serpell M, McSkimming P, Junor R, Dickerson S.","Patient. 2016 Aug;9(4):359-71. doi: 10.1007/s40271-016-0181-0.","Conaghan PG","Patient","2016","2016/06/18","PMC4925685","","10.1007/s40271-016-0181-0"
"27311495","Transdermal Buprenorphine Relieves Neuropathic Pain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial in Diabetic Peripheral Neuropathic Pain","Simpson RW, Wlodarczyk JH.","Diabetes Care. 2016 Sep;39(9):1493-500. doi: 10.2337/dc16-0123. Epub 2016 Jun 16.","Simpson RW","Diabetes Care","2016","2016/06/18","","","10.2337/dc16-0123"
"27304767","Weighing the Risks and Benefits of Chronic Opioid Therapy","Lembke A, Humphreys K, Newmark J.","Am Fam Physician. 2016 Jun 15;93(12):982-90.","Lembke A","Am Fam Physician","2016","2016/06/16","","",""
"27287965","Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale","Jones HE, Seashore C, Johnson E, Horton E, O'Grady KE, Andringa K, Grossman MR, Whalen B, Holmes AV.","Am J Addict. 2016 Aug;25(5):370-3. doi: 10.1111/ajad.12388. Epub 2016 Jun 11.","Jones HE","Am J Addict","2016","2016/06/12","","","10.1111/ajad.12388"
"27287352","Development, Implementation, and Evaluation of a Pilot Parenting Educational Intervention in a Pregnancy Buprenorphine Clinic","Giles AC, Ren D, Founds S.","Nurs Womens Health. 2016 Jun-Jul;20(3):258-67. doi: 10.1016/j.nwh.2016.04.024.","Giles AC","Nurs Womens Health","2016","2016/06/12","","","10.1016/j.nwh.2016.04.024"
"27273759","Reply to Cataldo (2016): Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration","Kao D, Haigney MC, Mehler PS, Krantz M.","Addiction. 2016 Sep;111(9):1686-7. doi: 10.1111/add.13425. Epub 2016 Jun 8.","Kao D","Addiction","2016","2016/06/09","","","10.1111/add.13425"
"27273625","Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration","Cataldo M.","Addiction. 2016 Sep;111(9):1685-6. doi: 10.1111/add.13411. Epub 2016 Jun 8.","Cataldo M","Addiction","2016","2016/06/09","","","10.1111/add.13411"
"27273511","Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series","Nielsen S, Bruno R, Degenhardt L, Demirkol A, Lintzeris N.","Drug Alcohol Rev. 2017 May;36(3):311-316. doi: 10.1111/dar.12418. Epub 2016 Jun 7.","Nielsen S","Drug Alcohol Rev","2017","2016/06/09","","","10.1111/dar.12418"
"27267785","Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial","Webster L, Hjelmström P, Sumner M, Gunderson EW.","J Addict Dis. 2016 Oct-Dec;35(4):325-338. doi: 10.1080/10550887.2016.1195608. Epub 2016 Jun 7.","Webster L","J Addict Dis","2016","2016/06/09","","","10.1080/10550887.2016.1195608"
"27244045","Neonatal Abstinence Syndrome: Presentation and Treatment Considerations","Jones HE, Kaltenbach K, Johnson E, Seashore C, Freeman E, Malloy E.","J Addict Med. 2016 Jul-Aug;10(4):224-8. doi: 10.1097/ADM.0000000000000222.","Jones HE","J Addict Med","2016","2016/06/01","","","10.1097/ADM.0000000000000222"
"27235660","[Occurrence of peripheral edema in a switch from buprenorphine alone to the buprenorphine-naloxone combination: About one case]","Javelot H, Royer T, Javelot T, Muller C, Tebacher M.","Therapie. 2016 Jun;71(3):341-3. doi: 10.1016/j.therap.2016.02.022. Epub 2016 Feb 11.","Javelot H","Therapie","2016","2016/05/29","","","10.1016/j.therap.2016.02.022"
"27235654","[Characteristics of subjects under opiate maintenance treatment in primary care using the OPEMA data 2013]","Gentile G, Frauger E, Giocanti A, Pauly V, Orleans V, Amaslidou D, Thirion X, Micallef J; Réseau national des centres d’addictovigilance.","Therapie. 2016 Jun;71(3):307-13. doi: 10.1016/j.therap.2016.02.001. Epub 2016 Feb 5.","Gentile G","Therapie","2016","2016/05/29","","","10.1016/j.therap.2016.02.001"
"27235620","Pharmacotherapy for Substance Use Disorders","Klein JW.","Med Clin North Am. 2016 Jul;100(4):891-910. doi: 10.1016/j.mcna.2016.03.011. Epub 2016 Apr 20.","Klein JW","Med Clin North Am","2016","2016/05/29","","","10.1016/j.mcna.2016.03.011"
"27227503","Pharmacokinetics of bupivacaine after intraperitoneal administration to cats undergoing ovariohysterectomy","Benito J, Monteiro BP, Beaudry F, Lavoie AM, Lascelles BD, Steagall PV.","Am J Vet Res. 2016 Jun;77(6):641-5. doi: 10.2460/ajvr.77.6.641.","Benito J","Am J Vet Res","2016","2016/05/27","","","10.2460/ajvr.77.6.641"
"27223837","Treatment Quality for Buprenorphine Care: The Pot at the End of the Rainbow","Gordon A, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Donohue JM.","J Addict Med. 2016 May-Jun;10(3):210-1. doi: 10.1097/ADM.0000000000000210.","Gordon A","J Addict Med","2016","2016/05/26","","","10.1097/ADM.0000000000000210"
"27223836","Measuring Quality of Buprenorphine Care","Sherrick RC.","J Addict Med. 2016 May-Jun;10(3):209-10. doi: 10.1097/ADM.0000000000000209.","Sherrick RC","J Addict Med","2016","2016/05/26","","","10.1097/ADM.0000000000000209"
"27223691","Mediation of buprenorphine analgesia by a combination of traditional and truncated mu opioid receptor splice variants","Grinnell SG, Ansonoff M, Marrone GF, Lu Z, Narayan A, Xu J, Rossi G, Majumdar S, Pan YX, Bassoni DL, Pintar J, Pasternak GW.","Synapse. 2016 Oct;70(10):395-407. doi: 10.1002/syn.21914. Epub 2016 Jul 12.","Grinnell SG","Synapse","2016","2016/05/26","PMC4980214","NIHMS790429","10.1002/syn.21914"
"27223595","Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, Jones HE.","Addiction. 2016 Dec;111(12):2115-2128. doi: 10.1111/add.13462. Epub 2016 Jun 30.","Zedler BK","Addiction","2016","2016/05/26","PMC5129590","","10.1111/add.13462"
"27211996","Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification","Uebelacker LA, Bailey G, Herman D, Anderson B, Stein M.","J Subst Abuse Treat. 2016 Jul;66:48-53. doi: 10.1016/j.jsat.2016.02.009. Epub 2016 Mar 9.","Uebelacker LA","J Subst Abuse Treat","2016","2016/05/24","PMC4892369","NIHMS786788","10.1016/j.jsat.2016.02.009"
"27211993","Access to Addiction Pharmacotherapy in Private Health Plans","Reif S, Horgan CM, Hodgkin D, Matteucci AM, Creedon TB, Stewart MT.","J Subst Abuse Treat. 2016 Jul;66:23-9. doi: 10.1016/j.jsat.2016.03.001. Epub 2016 Mar 14.","Reif S","J Subst Abuse Treat","2016","2016/05/24","PMC4879589","NIHMS768330","10.1016/j.jsat.2016.03.001"
"27203162","[Investigation of the medical and social situation of patients managed by opiate replacement regimens for over 10 years by their GP]","Messaadi N, Favre J, Rolland B, Cottencin O, Calafiore M, Stalnikiewicz B, Berkhout C.","Therapie. 2016 Oct;71(5):439-446. doi: 10.1016/j.therap.2016.01.011. Epub 2016 Apr 11.","Messaadi N","Therapie","2016","2016/05/21","","","10.1016/j.therap.2016.01.011"
"27199497","Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy","Noormohammadi A, Forinash A, Yancey A, Crannage E, Campbell K, Shyken J.","Ann Pharmacother. 2016 Aug;50(8):666-72. doi: 10.1177/1060028016648367. Epub 2016 May 19.","Noormohammadi A","Ann Pharmacother","2016","2016/05/21","","","10.1177/1060028016648367"
"27179822","Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","Hansen H, Siegel C, Wanderling J, DiRocco D.","Drug Alcohol Depend. 2016 Jul 1;164:14-21. doi: 10.1016/j.drugalcdep.2016.03.028. Epub 2016 May 4.","Hansen H","Drug Alcohol Depend","2016","2016/05/16","PMC5539992","NIHMS839284","10.1016/j.drugalcdep.2016.03.028"
"27177564","Voluntary Running-Wheel Activity, Arterial Blood Gases, and Thermal Antinociception in Rats after 3 Buprenorphine Formulations","Johnson RA.","J Am Assoc Lab Anim Sci. 2016;55(3):306-11.","Johnson RA","J Am Assoc Lab Anim Sci","2016","2016/05/15","PMC4865692","",""
"27177563","Postoperative Analgesia Due to Sustained-Release Buprenorphine, Sustained-Release Meloxicam, and Carprofen Gel in a Model of Incisional Pain in Rats (Rattus norvegicus)","Seymour TL, Adams SC, Felt SA, Jampachaisri K, Yeomans DC, Pacharinsak C.","J Am Assoc Lab Anim Sci. 2016;55(3):300-5.","Seymour TL","J Am Assoc Lab Anim Sci","2016","2016/05/15","PMC4865691","",""
"27172230","The Use of Transdermal Buprenorphine in Complex Regional Pain Syndrome: A Report of Two Cases","Onofrio S, Vartan CM, Nazario M, DiScala S, Cuevas-Trisan R, Melendez-Benabe J.","J Pain Palliat Care Pharmacother. 2016 Jun;30(2):124-7. doi: 10.3109/15360288.2016.1173756. Epub 2016 May 12.","Onofrio S","J Pain Palliat Care Pharmacother","2016","2016/05/13","","","10.3109/15360288.2016.1173756"
"27163782","Monitoring neonatal abstinence syndrome in buprenorphine-exposed in vitro fertilization twins: A case study","Brandt L, Swoboda P, Fischer G, Unger A.","Subst Abus. 2016 Oct-Dec;37(4):501-506. doi: 10.1080/08897077.2016.1184738.","Brandt L","Subst Abus","2016","2016/05/11","","","10.1080/08897077.2016.1184738"
"27157143","Opioid agonist treatment for pharmaceutical opioid dependent people","Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N.","Cochrane Database Syst Rev. 2016 May 9;(5):CD011117. doi: 10.1002/14651858.CD011117.pub2.","Nielsen S","Cochrane Database Syst Rev","2016","2016/05/10","","","10.1002/14651858.CD011117.pub2"
"27140427","Drug interactions between buprenorphine, methadone and hepatitis C therapeutics","Ogbuagu O, Friedland G, Bruce RD.","Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):721-31. doi: 10.1080/17425255.2016.1183644. Epub 2016 May 30.","Ogbuagu O","Expert Opin Drug Metab Toxicol","2016","2016/05/04","","","10.1080/17425255.2016.1183644"
"27138058","Buprenorphine for the treatment of depression?","Balon R.","Acta Psychiatr Scand. 2016 Jul;134(1):85-6. doi: 10.1111/acps.12585. Epub 2016 May 2.","Balon R","Acta Psychiatr Scand","2016","2016/05/04","","","10.1111/acps.12585"
"27132312","Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults","Cottrill CB, Matson SC.","Adolesc Med State Art Rev. 2014 Aug;25(2):251-65.","Cottrill CB","Adolesc Med State Art Rev","2014","2016/05/03","","",""
"27131800","Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults","Arias F, Arnsten JH, Cunningham CO, Coulehan K, Batchelder A, Brisbane M, Segal K, Rivera-Mindt M.","Addict Behav. 2016 Sep;60:137-43. doi: 10.1016/j.addbeh.2016.03.018. Epub 2016 Mar 31.","Arias F","Addict Behav","2016","2016/05/02","PMC6508857","NIHMS1021739","10.1016/j.addbeh.2016.03.018"
"27123798","Buprenorphine Prescribing: To Expand or Not to Expand","Li X, Shorter D, Kosten TR.","J Psychiatr Pract. 2016 May;22(3):183-92. doi: 10.1097/PRA.0000000000000154.","Li X","J Psychiatr Pract","2016","2016/04/29","PMC4852384","NIHMS772734","10.1097/PRA.0000000000000154"
"27114000","Implementing opioid substitution in Lebanon: Inception and challenges","El-Khoury J, Abbas Z, Nakhle PE, Matar MT.","Int J Drug Policy. 2016 May;31:178-83. doi: 10.1016/j.drugpo.2016.02.015. Epub 2016 Feb 23.","El-Khoury J","Int J Drug Policy","2016","2016/04/27","","","10.1016/j.drugpo.2016.02.015"
"27100203","Perceptions Related to Pharmacological Treatment of Opioid Dependence Among Individuals Seeking Treatment at a Tertiary Care Center in Northern India: A Descriptive Study","Prakash S, Balhara Y.","Subst Use Misuse. 2016 Jun 6;51(7):861-9. doi: 10.3109/10826084.2016.1155615. Epub 2016 Apr 21.","Prakash S","Subst Use Misuse","2016","2016/04/22","","","10.3109/10826084.2016.1155615"
"27097276","Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine","Rastegar DA, Sharfstein Kawasaki S, King VL, Harris EE, Brooner RK.","Subst Use Misuse. 2016 Jun 6;51(7):803-11. doi: 10.3109/10826084.2016.1155608. Epub 2016 Apr 20.","Rastegar DA","Subst Use Misuse","2016","2016/04/21","","","10.3109/10826084.2016.1155608"
"27093305","Use of psychotropic drug urine test strips in opiate maintenance therapy: A clinical assessment of its advantages","Victorri-Vigneau C, Rousselet M, Grall-Bronnec M, Bouquié R, Belliot E, Guerlais M, Guillet JY, Jolliet P.","Subst Abus. 2016 Oct-Dec;37(4):584-590. doi: 10.1080/08897077.2016.1176979. Epub 2016 Apr 19.","Victorri-Vigneau C","Subst Abus","2016","2016/04/20","","","10.1080/08897077.2016.1176979"
"27086392","An early evangelist for treating opioid addiction","Muchmore S.","Mod Healthc. 2016 Jan 18;46(3):14, 18.","Muchmore S","Mod Healthc","2016","2016/04/19","","",""
"27086374","Opioid addiction treatment argued as 'essential' insurance benefit","Herman B.","Mod Healthc. 2016 Jan 4;46(1):10.","Herman B","Mod Healthc","2016","2016/04/19","","",""
"27083254","Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry","Swortwood MJ, Scheidweiler KB, Barnes AJ, Jansson LM, Huestis MA.","J Chromatogr A. 2016 May 13;1446:70-7. doi: 10.1016/j.chroma.2016.03.076. Epub 2016 Mar 31.","Swortwood MJ","J Chromatogr A","2016","2016/04/17","","","10.1016/j.chroma.2016.03.076"
"27053175","Breastfeeding among Mothers on Opioid Maintenance Treatment: A Literature Review","Tsai LC, Doan TJ.","J Hum Lact. 2016 Aug;32(3):521-9. doi: 10.1177/0890334416641909. Epub 2016 Apr 6.","Tsai LC","J Hum Lact","2016","2016/04/08","","","10.1177/0890334416641909"
"27049548","President's message. The perfect storm: Substance Abuse and Mental Health Services Administration (SAMHSA) Buprenorphine notice of proposed rule-making (NPRM)","Morrone WR.","J Addict Dis. 2016;35(2):157-8. doi: 10.1080/10550887.2016.1148999.","Morrone WR","J Addict Dis","2016","2016/04/07","","","10.1080/10550887.2016.1148999"
"27049508","Buprenorphine buccal film (Belbuca) for chronic pain","","Med Lett Drugs Ther. 2016 Apr 11;58(1492):47-8.","","Med Lett Drugs Ther","2016","2016/04/07","","",""
"27046310","Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men","Sheynin J, Moustafa AA, Beck KD, Servatius RJ, Casbolt PA, Haber P, Elsayed M, Hogarth L, Myers CE.","J Clin Psychiatry. 2016 Mar;77(3):386-94. doi: 10.4088/JCP.14m09284.","Sheynin J","J Clin Psychiatry","2016","2016/04/06","PMC4822714","NIHMS721725","10.4088/JCP.14m09284"
"27042734","Pregnancy: morphine, or sometimes buprenorphine, when paracetamol is ineffective","","Prescrire Int. 2016 Feb;25(168):49.","","Prescrire Int","2016","2016/04/05","","",""
"27035058","Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder","Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC.","J Clin Psychiatry. 2016 Sep;77(9):1182-1188. doi: 10.4088/JCP.15m09893.","Seal KH","J Clin Psychiatry","2016","2016/04/02","","","10.4088/JCP.15m09893"
"27012435","Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers","Walsh SL, Nuzzo PA, Babalonis S, Casselton V, Lofwall MR.","Drug Alcohol Depend. 2016 May 1;162:190-8. doi: 10.1016/j.drugalcdep.2016.03.005. Epub 2016 Mar 14.","Walsh SL","Drug Alcohol Depend","2016","2016/03/26","PMC4833536","NIHMS771735","10.1016/j.drugalcdep.2016.03.005"
"27009622","Buprenorphine and the treatment of depression, anxiety, non-suicidal self-injury, and suicidality","Sher L.","Acta Psychiatr Scand. 2016 Jul;134(1):84-5. doi: 10.1111/acps.12577. Epub 2016 Mar 24.","Sher L","Acta Psychiatr Scand","2016","2016/03/25","","","10.1111/acps.12577"
"27009099","Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis","Jaureguiberry-Bravo M, Wilson R, Carvallo L, Berman JW.","Curr HIV Res. 2016;14(5):417-430. doi: 10.2174/1570162x14666160324124132.","Jaureguiberry-Bravo M","Curr HIV Res","2016","2016/03/25","PMC5487025","NIHMS866731","10.2174/1570162x14666160324124132"
"27008037","A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here","Ling W.","J Neuroimmune Pharmacol. 2016 Sep;11(3):394-400. doi: 10.1007/s11481-016-9663-z. Epub 2016 Mar 23.","Ling W","J Neuroimmune Pharmacol","2016","2016/03/24","","","10.1007/s11481-016-9663-z"
"27007583","Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis","King JB, Sainski-Nguyen AM, Bellows BK.","J Pain Palliat Care Pharmacother. 2016;30(1):55-65. doi: 10.3109/15360288.2015.1135847.","King JB","J Pain Palliat Care Pharmacother","2016","2016/03/24","","","10.3109/15360288.2015.1135847"
"27006272","Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France","Delorme J, Chenaf C, Kabore JL, Pereira B, Mulliez A, Tremey A, Brousse G, Zenut M, Laporte C, Authier N.","Drug Alcohol Depend. 2016 May 1;162:99-106. doi: 10.1016/j.drugalcdep.2016.02.035. Epub 2016 Mar 3.","Delorme J","Drug Alcohol Depend","2016","2016/03/24","","","10.1016/j.drugalcdep.2016.02.035"
"27003021","Safety and clinical effectiveness of a compounded sustained-release formulation of buprenorphine for postoperative analgesia in New Zealand White rabbits","DiVincenti L Jr, Meirelles LA, Westcott RA.","J Am Vet Med Assoc. 2016 Apr 1;248(7):795-801. doi: 10.2460/javma.248.7.795.","DiVincenti L Jr","J Am Vet Med Assoc","2016","2016/03/23","","","10.2460/javma.248.7.795"
"26996987","Detoxification from opiate drugs during pregnancy","Bell J, Towers CV, Hennessy MD, Heitzman C, Smith B, Chattin K.","Am J Obstet Gynecol. 2016 Sep;215(3):374.e1-6. doi: 10.1016/j.ajog.2016.03.015. Epub 2016 Mar 17.","Bell J","Am J Obstet Gynecol","2016","2016/03/22","","","10.1016/j.ajog.2016.03.015"
"26996928","Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System","Wiegand TJ, Le Lait MC, Bartelson BB, Dart RC, Green JL.","J Pain. 2016 Jun;17(6):745-52. doi: 10.1016/j.jpain.2016.02.015. Epub 2016 Mar 18.","Wiegand TJ","J Pain","2016","2016/03/22","","","10.1016/j.jpain.2016.02.015"
"26991660","Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis","Suzuki J.","Am J Addict. 2016 Apr;25(3):191-4. doi: 10.1111/ajad.12349. Epub 2016 Mar 15.","Suzuki J","Am J Addict","2016","2016/03/19","","","10.1111/ajad.12349"
"26988423","Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders","Carey KJ, Huang W, Linas BP, Tsui JI.","J Subst Abuse Treat. 2016 Jul;66:54-9. doi: 10.1016/j.jsat.2016.01.009. Epub 2016 Feb 13.","Carey KJ","J Subst Abuse Treat","2016","2016/03/19","PMC5097249","NIHMS818644","10.1016/j.jsat.2016.01.009"
"26985649","Methadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study: Re: Meyer et al","McCarthy JJ.","J Addict Med. 2016 Mar-Apr;10(2):133-4. doi: 10.1097/ADM.0000000000000183.","McCarthy JJ","J Addict Med","2016","2016/03/18","","","10.1097/ADM.0000000000000183"
"26979295","Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors","Falcon E, Browne CA, Leon RM, Fleites VC, Sweeney R, Kirby LG, Lucki I.","Neuropsychopharmacology. 2016 Aug;41(9):2344-51. doi: 10.1038/npp.2016.38. Epub 2016 Mar 16.","Falcon E","Neuropsychopharmacology","2016","2016/03/17","PMC4946065","","10.1038/npp.2016.38"
"26962463","Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model","Jurga AM, Rojewska E, Piotrowska A, Makuch W, Pilat D, Przewlocka B, Mika J.","Neural Plast. 2016;2016:5238730. doi: 10.1155/2016/5238730. Epub 2015 Dec 29.","Jurga AM","Neural Plast","2016","2016/03/11","PMC4709736","","10.1155/2016/5238730"
"26960851","[Opiate substitution records success stories]","Heinlein H.","MMW Fortschr Med. 2015 Dec 14;157(21-22):29. doi: 10.1007/s15006-015-7595-9.","Heinlein H","MMW Fortschr Med","2015","2016/03/11","","","10.1007/s15006-015-7595-9"
"26944440","Opioid-induced functional esophagogastric junction obstruction","Sáez-González E, Díaz-Jaime FC, García-Morales N, Herreras-López J, Ortiz V, Ortuño J, Garrigues V.","Gastroenterol Hepatol. 2017 Apr;40(4):296-298. doi: 10.1016/j.gastrohep.2015.12.014. Epub 2016 Mar 2.","Sáez-González E","Gastroenterol Hepatol","2017","2016/03/06","","","10.1016/j.gastrohep.2015.12.014"
"26940870","Two Models of Integrating Buprenorphine Treatment and Medical Staff within Formerly ""Drug-Free"" Outpatient Programs","Monico L, Schwartz RP, Gryczynski J, O'Grady KE, Mitchell SG.","J Psychoactive Drugs. 2016 Apr-Jun;48(2):101-8. doi: 10.1080/02791072.2015.1130884. Epub 2016 Mar 3.","Monico L","J Psychoactive Drugs","2016","2016/03/05","PMC4956482","NIHMS801710","10.1080/02791072.2015.1130884"
"26933874","Mobile Phone Messaging During Unobserved ""Home"" Induction to Buprenorphine","Tofighi B, Grossman E, Sherman S, Nunes EV, Lee JD.","J Addict Med. 2016 Sep-Oct;10(5):309-13. doi: 10.1097/ADM.0000000000000198.","Tofighi B","J Addict Med","2016","2016/03/03","","","10.1097/ADM.0000000000000198"
"26931763","Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients","ESUB-MG Study Group.","BMC Fam Pract. 2016 Mar 1;17:24. doi: 10.1186/s12875-016-0413-3.","ESUB-MG Study Group","BMC Fam Pract","2016","2016/03/03","PMC4774159","","10.1186/s12875-016-0413-3"
"26919594","Antinociceptive effects of intravenous administration of hydromorphone hydrochloride alone or followed by buprenorphine hydrochloride or butorphanol tartrate to healthy conscious cats","Simon BT, Steagall PV, Monteiro BP, Troncy E, Lizarraga I.","Am J Vet Res. 2016 Mar;77(3):245-51. doi: 10.2460/ajvr.77.3.245.","Simon BT","Am J Vet Res","2016","2016/02/27","","","10.2460/ajvr.77.3.245"
"26918564","A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults","Marsch LA, Moore SK, Borodovsky JT, Solhkhah R, Badger GJ, Semino S, Jarrett K, Condon KD, Rossettie K, Vincent P, Hajizadeh N, Ducat E.","Addiction. 2016 Aug;111(8):1406-15. doi: 10.1111/add.13363. Epub 2016 Apr 21.","Marsch LA","Addiction","2016","2016/02/27","PMC4940230","NIHMS762296","10.1111/add.13363"
"26914546","Factors associated with buprenorphine versus methadone use in pregnancy","Krans EE, Bogen D, Richardson G, Park SY, Dunn SL, Day N.","Subst Abus. 2016 Oct-Dec;37(4):550-557. doi: 10.1080/08897077.2016.1146649. Epub 2016 Feb 25.","Krans EE","Subst Abus","2016","2016/02/26","PMC5596875","NIHMS890536","10.1080/08897077.2016.1146649"
"26900669","Using a Learning Collaborative Strategy With Office-based Practices to Increase Access and Improve Quality of Care for Patients With Opioid Use Disorders","Nordstrom BR, Saunders EC, McLeman B, Meier A, Xie H, Lambert-Harris C, Tanzman B, Brooklyn J, King G, Kloster N, Lord CF, Roberts W, McGovern MP.","J Addict Med. 2016 Mar-Apr;10(2):117-23. doi: 10.1097/ADM.0000000000000200.","Nordstrom BR","J Addict Med","2016","2016/02/23","PMC4865252","NIHMS782884","10.1097/ADM.0000000000000200"
"26899477","Total Joint Arthroplasty in Patients Taking Methadone or Buprenorphine/Naloxone Preoperatively for Prior Heroin Addiction: A Prospective Matched Cohort Study","Hansen LE, Stone GL, Matson CA, Tybor DJ, Pevear ME, Smith EL.","J Arthroplasty. 2016 Aug;31(8):1698-701. doi: 10.1016/j.arth.2016.01.032. Epub 2016 Jan 29.","Hansen LE","J Arthroplasty","2016","2016/02/23","","","10.1016/j.arth.2016.01.032"
"26898023","[Vigilance of veterinary medicinal products: Reports of adverse reactions in the year 2014]","Müntener CR, Kupper J, Naegeli H, Schäublin M.","Schweiz Arch Tierheilkd. 2015 Nov;157(11):601-5. doi: 10.17236/sat00039.","Müntener CR","Schweiz Arch Tierheilkd","2015","2016/02/23","","","10.17236/sat00039"
"26896319","The Incidence of Peripheral Nerve Injury After Multimodal Perineural Anesthesia/Analgesia Does Not Appear to Differ from That Following Single-Drug Nerve Blocks (2011-2014)","Williams BA, Ibinson JW, Gould AJ, Mangione MP.","Pain Med. 2017 Apr 1;18(4):628-636. doi: 10.1093/pm/pnv107.","Williams BA","Pain Med","2017","2016/02/21","","","10.1093/pm/pnv107"
"26879874","New Pain Management Options for the Surgical Patient on Methadone and Buprenorphine","Sen S, Arulkumar S, Cornett EM, Gayle JA, Flower RR, Fox CJ, Kaye AD.","Curr Pain Headache Rep. 2016 Mar;20(3):16. doi: 10.1007/s11916-016-0549-9.","Sen S","Curr Pain Headache Rep","2016","2016/02/17","","","10.1007/s11916-016-0549-9"
"26869247","Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial","Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E.","Am J Psychiatry. 2016 May 1;173(5):499-508. doi: 10.1176/appi.ajp.2015.15070921. Epub 2016 Feb 12.","Fava M","Am J Psychiatry","2016","2016/02/13","","","10.1176/appi.ajp.2015.15070921"
"26865472","Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects","Wang Y, Cipriano A, Munera C, Harris SC.","J Clin Pharmacol. 2016 Oct;56(10):1263-71. doi: 10.1002/jcph.718. Epub 2016 Mar 21.","Wang Y","J Clin Pharmacol","2016","2016/02/12","","","10.1002/jcph.718"
"26861654","Relationship Between Buprenorphine Dosing and Triglyceride Lowering and creatine kinase [corrected] Elevation in Felines: Possible Human Implications","Srinivas NR.","J Pain Palliat Care Pharmacother. 2016;30(1):49-52. doi: 10.3109/15360288.2015.1134751. Epub 2016 Feb 9.","Srinivas NR","J Pain Palliat Care Pharmacother","2016","2016/02/11","","","10.3109/15360288.2015.1134751"
"26861165","Changes in the medical management of patients on opioid analgesics following a diagnosis of substance abuse","Paulozzi LJ, Zhou C, Jones CM, Xu L, Florence CS.","Pharmacoepidemiol Drug Saf. 2016 May;25(5):545-52. doi: 10.1002/pds.3980. Epub 2016 Feb 10.","Paulozzi LJ","Pharmacoepidemiol Drug Saf","2016","2016/02/11","","","10.1002/pds.3980"
"26857811","Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies","Betts KS, Chan G, McIlwraith F, Dietze P, Whittaker E, Burns L, Alati R.","Addiction. 2016 Jul;111(7):1214-23. doi: 10.1111/add.13339. Epub 2016 Apr 3.","Betts KS","Addiction","2016","2016/02/10","","","10.1111/add.13339"
"26849034","Evaluation of the influence of atipamezole on the postoperative analgesic effect of buprenorphine in cats undergoing a surgical ovariohysterectomy","Warne LN, Beths T, Carter JE, Whittem T, Bauquier SH.","Vet Anaesth Analg. 2016 Jul;43(4):424-8. doi: 10.1111/vaa.12340. Epub 2016 Feb 5.","Warne LN","Vet Anaesth Analg","2016","2016/02/06","","","10.1111/vaa.12340"
"26848803","Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders","Komaromy M, Duhigg D, Metcalf A, Carlson C, Kalishman S, Hayes L, Burke T, Thornton K, Arora S.","Subst Abus. 2016;37(1):20-4. doi: 10.1080/08897077.2015.1129388.","Komaromy M","Subst Abus","2016","2016/02/06","PMC4873719","","10.1080/08897077.2015.1129388"
"26832998","Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients","Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I.","Drug Alcohol Depend. 2016 Mar 1;160:222-6. doi: 10.1016/j.drugalcdep.2016.01.013. Epub 2016 Jan 24.","Finlay AK","Drug Alcohol Depend","2016","2016/02/03","PMC4767599","NIHMS752771","10.1016/j.drugalcdep.2016.01.013"
"26832931","Opioid substitution therapy: Lowering the treatment thresholds","Kourounis G, Richards BD, Kyprianou E, Symeonidou E, Malliori MM, Samartzis L.","Drug Alcohol Depend. 2016 Apr 1;161:1-8. doi: 10.1016/j.drugalcdep.2015.12.021. Epub 2015 Dec 30.","Kourounis G","Drug Alcohol Depend","2016","2016/02/03","","","10.1016/j.drugalcdep.2015.12.021"
"26831174","Addition of magnesium sulphate to ropivacaine for spinal analgesia in dogs undergoing tibial plateau levelling osteotomy","Adami C, Casoni D, Noussitou F, Rytz U, Spadavecchia C.","Vet J. 2016 Mar;209:163-8. doi: 10.1016/j.tvjl.2015.11.017. Epub 2015 Dec 3.","Adami C","Vet J","2016","2016/02/03","","","10.1016/j.tvjl.2015.11.017"
"26820154","Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment","Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG.","PLoS One. 2016 Jan 28;11(1):e0147852. doi: 10.1371/journal.pone.0147852. eCollection 2016.","Yee A","PLoS One","2016","2016/01/29","PMC4731474","","10.1371/journal.pone.0147852"
"26820059","Relapse prevention medications in community treatment for young adults with opioid addiction","Vo HT, Robbins E, Westwood M, Lezama D, Fishman M.","Subst Abus. 2016 Jul-Sep;37(3):392-397. doi: 10.1080/08897077.2016.1143435. Epub 2016 Jan 28.","Vo HT","Subst Abus","2016","2016/01/29","","","10.1080/08897077.2016.1143435"
"26818083","Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany","Schulte B, Schmidt CS, Strada L, Götzke C, Hiller P, Fischer B, Reimer J.","Int J Drug Policy. 2016 Mar;29:57-65. doi: 10.1016/j.drugpo.2015.12.024. Epub 2015 Dec 31.","Schulte B","Int J Drug Policy","2016","2016/01/29","","","10.1016/j.drugpo.2015.12.024"
"26817983","Analgesic Activity of Tramadol and Buprenorphine after Voluntary Ingestion by Rats (Rattus norvegicus)","Taylor BF, Ramirez HE, Battles AH, Andrutis KA, Neubert JK.","J Am Assoc Lab Anim Sci. 2016 Jan;55(1):74-82.","Taylor BF","J Am Assoc Lab Anim Sci","2016","2016/01/29","PMC4747014","",""
"26817982","Efficacy of Sustained-Release Buprenorphine in an Experimental Laparotomy Model in Female Mice","Kendall LV, Wegenast DJ, Smith BJ, Dorsey KM, Kang S, Lee NY, Hess AM.","J Am Assoc Lab Anim Sci. 2016 Jan;55(1):66-73.","Kendall LV","J Am Assoc Lab Anim Sci","2016","2016/01/29","PMC4747013","",""
"26814246","Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study","YaDeau JT, Gordon MA, Goytizolo EA, Lin Y, Fields KG, Goon AK, Holck G, Miu TW, Gulotta LV, Dines DM, Craig EV.","Pain Med. 2016 May;17(5):940-60. doi: 10.1093/pm/pnv010. Epub 2015 Dec 14.","YaDeau JT","Pain Med","2016","2016/01/28","PMC6280991","","10.1093/pm/pnv010"
"26811236","Use of an Acetyl Derivative to Improve GC-MS Determination of Norbuprenorphine in the Presence of High Concentrations of Buprenorphine in Urine","Gervais JR, Hobbs GA.","J Anal Toxicol. 2016 Apr;40(3):208-12. doi: 10.1093/jat/bkw001. Epub 2016 Jan 25.","Gervais JR","J Anal Toxicol","2016","2016/01/27","PMC4885923","","10.1093/jat/bkw001"
"26811185","Response to Letter From Ruan and Bumgarner: Breakthrough Pain Associated With a Reduction in Serum Buprenorphine Concentration During Dialysis","Salili AR, Müller D, Skendaj R, Jehle AW, Taegtmeyer AB.","Clin Ther. 2016 Mar;38(3):679-80. doi: 10.1016/j.clinthera.2015.12.013. Epub 2016 Jan 22.","Salili AR","Clin Ther","2016","2016/01/27","","","10.1016/j.clinthera.2015.12.013"
"26810130","Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs","Frimpong JA, D'Aunno T, Helleringer S, Metsch LR.","J Subst Abuse Treat. 2016 Apr;63:46-53. doi: 10.1016/j.jsat.2015.12.001. Epub 2015 Dec 28.","Frimpong JA","J Subst Abuse Treat","2016","2016/01/27","PMC4775419","NIHMS754360","10.1016/j.jsat.2015.12.001"
"26808307","A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction","Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D.","Version 2. J Addict Med. 2016 Mar-Apr;10(2):93-103. doi: 10.1097/ADM.0000000000000193.","Dugosh K","J Addict Med","2016","2016/01/26","PMC4795974","NIHMS743456","10.1097/ADM.0000000000000193"
"26804898","Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration","Manhapra A, Quinones L, Rosenheck R.","Drug Alcohol Depend. 2016 Mar 1;160:82-9. doi: 10.1016/j.drugalcdep.2015.12.035. Epub 2016 Jan 13.","Manhapra A","Drug Alcohol Depend","2016","2016/01/26","PMC4767635","NIHMS751510","10.1016/j.drugalcdep.2015.12.035"
"26804639","Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers","Bai SA, Xiang Q, Finn A.","Clin Ther. 2016 Feb;38(2):358-69. doi: 10.1016/j.clinthera.2015.12.016. Epub 2016 Jan 21.","Bai SA","Clin Ther","2016","2016/01/26","","","10.1016/j.clinthera.2015.12.016"
"26803331","Breakthrough Pain Associated With a Reduction in Serum Buprenorphine Concentration During Dialysis","Ruan X, Bumgarner GW.","Clin Ther. 2016 Mar;38(3):678-9. doi: 10.1016/j.clinthera.2015.12.012. Epub 2016 Jan 20.","Ruan X","Clin Ther","2016","2016/01/25","","","10.1016/j.clinthera.2015.12.012"
"26800851","Changes in psychological well-being among heroin-dependent adolescents during psychologically supported opiate substitution treatment","Smyth BP, Ducray K, Cullen W.","Early Interv Psychiatry. 2018 Jun;12(3):417-425. doi: 10.1111/eip.12318. Epub 2016 Jan 23.","Smyth BP","Early Interv Psychiatry","2018","2016/01/24","","","10.1111/eip.12318"
"26796596","Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","Yarborough BJ, Stumbo SP, McCarty D, Mertens J, Weisner C, Green CA.","Drug Alcohol Depend. 2016 Mar 1;160:112-8. doi: 10.1016/j.drugalcdep.2015.12.031. Epub 2016 Jan 6.","Yarborough BJ","Drug Alcohol Depend","2016","2016/01/23","PMC4767611","NIHMS749929","10.1016/j.drugalcdep.2015.12.031"
"26777900","Amygdalar activation of group I metabotropic glutamate receptors produces anti- and pro-conflict effects depending upon animal sex in a sexually dimorphic conditioned conflict-based anxiety model","De Jesús-Burgos MI, González-García S, Cruz-Santa Y, Pérez-Acevedo NL.","Behav Brain Res. 2016 Apr 1;302:200-12. doi: 10.1016/j.bbr.2016.01.009. Epub 2016 Jan 8.","De Jesús-Burgos MI","Behav Brain Res","2016","2016/01/19","PMC4839301","NIHMS754602","10.1016/j.bbr.2016.01.009"
"26771870","Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices","MacDonald K, Lamb K, Thomas ML, Khentigan W.","Subst Use Misuse. 2016 Jan 2;51(1):85-90. doi: 10.3109/10826084.2015.1089905. Epub 2016 Jan 15.","MacDonald K","Subst Use Misuse","2016","2016/01/16","","","10.3109/10826084.2015.1089905"
"26767339","Commentary on Pierce et al. (2016): Raising the bar of addiction treatment--first do no harm","Banta-Green CJ, Coffin PO.","Addiction. 2016 Feb;111(2):309-10. doi: 10.1111/add.13228.","Banta-Green CJ","Addiction","2016","2016/01/16","","","10.1111/add.13228"
"26763728","Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine","Pilat D, Piotrowska A, Rojewska E, Jurga A, Ślusarczyk J, Makuch W, Basta-Kaim A, Przewlocka B, Mika J.","Mol Cell Neurosci. 2016 Mar;71:114-24. doi: 10.1016/j.mcn.2015.12.013. Epub 2016 Jan 5.","Pilat D","Mol Cell Neurosci","2016","2016/01/15","","","10.1016/j.mcn.2015.12.013"
"26758991","Buprenorphine--the unique opioid adjuvant in regional anesthesia","Kosel J, Bobik P, Tomczyk M.","Expert Rev Clin Pharmacol. 2016;9(3):375-83. doi: 10.1586/17512433.2016.1141047. Epub 2016 Jan 28.","Kosel J","Expert Rev Clin Pharmacol","2016","2016/01/14","","","10.1586/17512433.2016.1141047"
"26757093","Drug test results as a predictor of retention among patients using buprenorphine in a comprehensive outpatient treatment program","Campbell MD, Kolodner G, Spencer RA, DuPont RL.","J Addict Dis. 2016 Oct-Dec;35(4):315-324. doi: 10.1080/10550887.2016.1139427. Epub 2016 Jan 12.","Campbell MD","J Addict Dis","2016","2016/01/13","","","10.1080/10550887.2016.1139427"
"26749217","Differentiating the Effect of an Opioid Agonist on Cardiac Repolarization From µ-Receptor-mediated, Indirect Effects on the QT Interval: A Randomized, 3-way Crossover Study in Healthy Subjects","Darpo B, Zhou M, Bai SA, Ferber G, Xiang Q, Finn A.","Clin Ther. 2016 Feb;38(2):315-26. doi: 10.1016/j.clinthera.2015.12.004. Epub 2015 Dec 31.","Darpo B","Clin Ther","2016","2016/01/11","","","10.1016/j.clinthera.2015.12.004"
"26745033","Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment","Binder P, Messaadi N, Perault-Pochat MC, Gagey S, Brabant Y, Ingrand P.","J Addict Dis. 2016;35(2):101-8. doi: 10.1080/10550887.2015.1136494. Epub 2016 Jan 8.","Binder P","J Addict Dis","2016","2016/01/09","","","10.1080/10550887.2015.1136494"
"26741809","Sublingual Buprenorphine-Induced Psychomimetic Effects","Saddichha S, Subodh BN, Chand PK.","Am J Ther. 2016 Jan-Feb;23(1):e242-3. doi: 10.1097/MJT.0b013e3181e9b645.","Saddichha S","Am J Ther","2016","2016/01/08","","","10.1097/MJT.0b013e3181e9b645"
"26730511","Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by liquid chromatography/tandem mass spectrometry","Liu Y, Li X, Xu A, Nasser AF, Heidbreder C.","J Pharm Biomed Anal. 2016 Feb 20;120:142-52. doi: 10.1016/j.jpba.2015.12.008. Epub 2015 Dec 17.","Liu Y","J Pharm Biomed Anal","2016","2016/01/06","","","10.1016/j.jpba.2015.12.008"
"26723885","Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development","Matheson C, Thiruvothiyur M, Robertson H, Bond C.","Int J Drug Policy. 2016 Jan;27:105-12. doi: 10.1016/j.drugpo.2015.11.006. Epub 2015 Nov 27.","Matheson C","Int J Drug Policy","2016","2016/01/03","","","10.1016/j.drugpo.2015.11.006"
"26720742","Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study","Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF.","Ann Intern Med. 2016 Jan 5;164(1):1-9. doi: 10.7326/M15-0038. Epub 2015 Dec 29.","Larochelle MR","Ann Intern Med","2016","2016/01/01","","","10.7326/M15-0038"
"26719075","Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations","Walter C, Knothe C, Lötsch J.","Clin Pharmacokinet. 2016 Jul;55(7):751-767. doi: 10.1007/s40262-015-0362-3.","Walter C","Clin Pharmacokinet","2016","2016/01/01","","","10.1007/s40262-015-0362-3"
"26703873","A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome","Hall ES, Isemann BT, Wexelblatt SL, Meinzen-Derr J, Wiles JR, Harvey S, Akinbi HT.","J Pediatr. 2016 Mar;170:39-44.e1. doi: 10.1016/j.jpeds.2015.11.039. Epub 2015 Dec 15.","Hall ES","J Pediatr","2016","2015/12/26","","","10.1016/j.jpeds.2015.11.039"
"26689067","[Understanding Oral and Nasal Mucosal Absorption of Fentanyl, and Rectal Absorption of Buprenorphine]","Shimoyama N, Shimoyama M, Kubota Y, Kato Y.","Masui. 2015 Nov;64(11):1160-5.","Shimoyama N","Masui","2015","2015/12/23","","",""
"26689065","[Transdermal System-Buprenorphine and Fentanyl]","Sakurai H.","Masui. 2015 Nov;64(11):1145-50.","Sakurai H","Masui","2015","2015/12/23","","",""
"26684956","Lack of adverse effects during a target animal safety trial of extended-release buprenorphine in Fischer 344 rats","Cowan A, Sarabia-Estrada R, Wilkerson G, McKnight P, Guarnieri M.","Lab Anim (NY). 2016 Jan;45(1):28-34. doi: 10.1038/laban.745.","Cowan A","Lab Anim (NY)","2016","2015/12/20","PMC7092016","","10.1038/laban.745"
"26684923","Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial","Yovell Y, Bar G, Mashiah M, Baruch Y, Briskman I, Asherov J, Lotan A, Rigbi A, Panksepp J.","Am J Psychiatry. 2016 May 1;173(5):491-8. doi: 10.1176/appi.ajp.2015.15040535. Epub 2015 Dec 18.","Yovell Y","Am J Psychiatry","2016","2015/12/20","","","10.1176/appi.ajp.2015.15040535"
"26682722","Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment","Suzuki J, Dodds T.","Subst Abus. 2016;37(1):31-4. doi: 10.1080/08897077.2015.1132292.","Suzuki J","Subst Abus","2016","2015/12/20","","","10.1080/08897077.2015.1132292"
"26672650","Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy","Mittal L, Suzuki J.","Subst Abus. 2017 Jul-Sep;38(3):261-264. doi: 10.1080/08897077.2015.1129525. Epub 2015 Dec 16.","Mittal L","Subst Abus","2017","2015/12/18","","","10.1080/08897077.2015.1129525"
"26670868","Text message content preferences to improve buprenorphine maintenance treatment in primary care","Tofighi B, Grossman E, Bereket S, D Lee J.","J Addict Dis. 2016;35(2):92-100. doi: 10.1080/10550887.2015.1127716. Epub 2015 Dec 15.","Tofighi B","J Addict Dis","2016","2015/12/17","","","10.1080/10550887.2015.1127716"
"26669528","Commentary on Cousins et al. (2016): Accumulating evidence on risk of mortality on and off opioid substitution treatment","Hickman M, Macleod J, Degenhardt L.","Addiction. 2016 Jan;111(1):83-4. doi: 10.1111/add.13185.","Hickman M","Addiction","2016","2015/12/17","","","10.1111/add.13185"
"26669324","The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review","Schmidt-Hansen M, Taubert M, Bromham N, Hilgart JS, Arnold S.","BMJ Support Palliat Care. 2016 Sep;6(3):292-306. doi: 10.1136/bmjspcare-2015-000939. Epub 2015 Dec 15.","Schmidt-Hansen M","BMJ Support Palliat Care","2016","2015/12/17","","","10.1136/bmjspcare-2015-000939"
"26662858","Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization","Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, Kelley D, Donohue JM.","Addiction. 2016 May;111(5):892-902. doi: 10.1111/add.13270. Epub 2016 Jan 30.","Lo-Ciganic WH","Addiction","2016","2015/12/15","","","10.1111/add.13270"
"26660175","Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS","Marin SJ, McMillin GA.","Methods Mol Biol. 2016;1383:69-78. doi: 10.1007/978-1-4939-3252-8_8.","Marin SJ","Methods Mol Biol","2016","2015/12/15","","","10.1007/978-1-4939-3252-8_8"
"26660174","Quantitation of Total Buprenorphine and Norbuprenorphine in Meconium by LC-MS/MS","Marin SJ, McMillin GA.","Methods Mol Biol. 2016;1383:59-68. doi: 10.1007/978-1-4939-3252-8_7.","Marin SJ","Methods Mol Biol","2016","2015/12/15","","","10.1007/978-1-4939-3252-8_7"
"26658085","Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting","Pélissier F, Rougé Bugat ME, Nubukpo P, Franchitto N.","J Clin Psychopharmacol. 2016 Feb;36(1):100-3. doi: 10.1097/JCP.0000000000000448.","Pélissier F","J Clin Psychopharmacol","2016","2015/12/15","","","10.1097/JCP.0000000000000448"
"26650971","Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder","Nasser AF, Greenwald MK, Vince B, Fudala PJ, Twumasi-Ankrah P, Liu Y, Jones JP 3rd, Heidbreder C.","J Clin Psychopharmacol. 2016 Feb;36(1):18-26. doi: 10.1097/JCP.0000000000000434.","Nasser AF","J Clin Psychopharmacol","2016","2015/12/10","PMC5549150","NIHMS884533","10.1097/JCP.0000000000000434"
"26639639","The Effect of a Payer-Mandated Decrease in Buprenorphine Dose on Aberrant Drug Tests and Treatment Retention Among Patients with Opioid Dependence","Accurso AJ, Rastegar DA.","J Subst Abuse Treat. 2016 Feb;61:74-9. doi: 10.1016/j.jsat.2015.09.004. Epub 2015 Oct 1.","Accurso AJ","J Subst Abuse Treat","2016","2015/12/08","","","10.1016/j.jsat.2015.09.004"
"26634956","Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain","Rauck RL, Potts J, Xiang Q, Tzanis E, Finn A.","Postgrad Med. 2016 Jan;128(1):1-11. doi: 10.1080/00325481.2016.1128307. Epub 2015 Dec 22.","Rauck RL","Postgrad Med","2016","2015/12/05","","","10.1080/00325481.2016.1128307"
"26632862","Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting the μ-Opioid Receptor","Schembri LS, Stoddart LA, Briddon SJ, Kellam B, Canals M, Graham B, Scammells PJ.","J Med Chem. 2015 Dec 24;58(24):9754-67. doi: 10.1021/acs.jmedchem.5b01664. Epub 2015 Dec 16.","Schembri LS","J Med Chem","2015","2015/12/04","","","10.1021/acs.jmedchem.5b01664"
"26632786","Pharmacokinetics and Antinociceptive Activity of Sustained-Release Buprenorphine in Sheep","Walkowiak KJ, Graham ML.","J Am Assoc Lab Anim Sci. 2015 Nov;54(6):763-8.","Walkowiak KJ","J Am Assoc Lab Anim Sci","2015","2015/12/04","PMC4671792","",""
"26623697","Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy","Tofighi B, Grossman E, Goldfeld KS, Williams AR, Rotrosen J, Lee JD.","Subst Use Misuse. 2015;50(12):1571-8. doi: 10.3109/10826084.2015.1023455. Epub 2015 Nov 19.","Tofighi B","Subst Use Misuse","2015","2015/12/02","","","10.3109/10826084.2015.1023455"
"26613636","Malmö Treatment Referral and Intervention Study (MATRIS)—effective referral from syringe exchange to treatment for heroin dependence: a pilot randomized controlled trial","Bråbäck M, Nilsson S, Isendahl P, Troberg K, Brådvik L, Håkansson A.","Addiction. 2016 May;111(5):866-73. doi: 10.1111/add.13249.","Bråbäck M","Addiction","2016","2015/11/29","","","10.1111/add.13249"
"26589431","Robustness of arterial blood gas analysis for assessment of respiratory safety pharmacology in rats","Whiteside GT, Hummel M, Boulet J, Beyenhof JD, Strenkowski B, John JD, Knappenberger T, Maselli H, Koetzner L.","J Pharmacol Toxicol Methods. 2016 Mar-Apr;78:32-41. doi: 10.1016/j.vascn.2015.11.001. Epub 2015 Nov 14.","Whiteside GT","J Pharmacol Toxicol Methods","2016","2015/11/22","","","10.1016/j.vascn.2015.11.001"
"26587696","Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers","Tierney M, Finnell DS, Naegle MA, LaBelle C, Gordon AJ.","Subst Abus. 2015;36(4):389-92. doi: 10.1080/08897077.2015.1101733.","Tierney M","Subst Abus","2015","2015/11/21","","","10.1080/08897077.2015.1101733"
"26583450","Correlates of Skin and Soft Tissue Infections in Injection Drug Users in a Syringe-Exchange Program in Malmö, Sweden","Dahlman D, Håkansson A, Björkman P, Blomé MA, Kral AH.","Subst Use Misuse. 2015;50(12):1529-35. doi: 10.3109/10826084.2015.1023450. Epub 2015 Nov 19.","Dahlman D","Subst Use Misuse","2015","2015/11/20","","","10.3109/10826084.2015.1023450"
"26581470","Intraoperative end-tidal concentration of isoflurane in cats undergoing ovariectomy that received tramadol, buprenorphine or a combination of both","Bellini L, Mollo A, Contiero B, Busetto R.","J Feline Med Surg. 2017 Feb;19(2):110-116. doi: 10.1177/1098612X15615655. Epub 2016 Jul 11.","Bellini L","J Feline Med Surg","2017","2015/11/20","","","10.1177/1098612X15615655"
"26574020","The New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice","Wiegand TJ.","J Med Toxicol. 2016 Mar;12(1):64-70. doi: 10.1007/s13181-015-0518-4.","Wiegand TJ","J Med Toxicol","2016","2015/11/18","PMC4781797","","10.1007/s13181-015-0518-4"
"26572942","Breakthrough Pain Associated with a Reduction in Serum Buprenorphine Concentration during Dialysis","Salili AR, Müller D, Skendaj R, Jehle AW, Taegtmeyer AB.","Clin Ther. 2016 Jan 1;38(1):212-5. doi: 10.1016/j.clinthera.2015.10.009. Epub 2015 Nov 10.","Salili AR","Clin Ther","2016","2015/11/18","","","10.1016/j.clinthera.2015.10.009"
"26566771","Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain","Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD.","J Addict Dis. 2016;35(1):42-51. doi: 10.1080/10550887.2016.1107264.","Wilder CM","J Addict Dis","2016","2015/11/15","PMC4751580","NIHMS753497","10.1080/10550887.2016.1107264"
"26566761","Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013","Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, Stein BD.","Subst Abus. 2016;37(1):63-9. doi: 10.1080/08897077.2015.1080208. Epub 2015 Nov 13.","Burns RM","Subst Abus","2016","2015/11/15","PMC4801690","NIHMS703077","10.1080/08897077.2015.1080208"
"26566712","Optimizing psychosocial support during office-based buprenorphine treatment in primary care: Patients' experiences and preferences","Fox AD, Masyukova M, Cunningham CO.","Subst Abus. 2016;37(1):70-5. doi: 10.1080/08897077.2015.1088496. Epub 2015 Nov 13.","Fox AD","Subst Abus","2016","2015/11/15","PMC4801741","NIHMS747268","10.1080/08897077.2015.1088496"
"26554176","UNUSUAL OVERDOSE","Faber B, Barr J.","JEMS. 2015 Sep;40(9):22-3.","Faber B","JEMS","2015","2015/11/12","","",""
"26547914","Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study","Serpell M, Tripathi S, Scherzinger S, Rojas-Farreras S, Oksche A, Wilson M.","Patient. 2016 Feb;9(1):35-46. doi: 10.1007/s40271-015-0151-y.","Serpell M","Patient","2016","2015/11/09","PMC4720699","","10.1007/s40271-015-0151-y"
"26529670","Comparison of bupivacaine and dexmedetomidine femoral and sciatic nerve blocks with bupivacaine and buprenorphine epidural injection for stifle arthroplasty in dogs","Bartel AK, Campoy L, Martin-Flores M, Gleed RD, Walker KJ, Scanapico CE, Reichard AB.","Vet Anaesth Analg. 2016 Jul;43(4):435-43. doi: 10.1111/vaa.12318. Epub 2015 Nov 3.","Bartel AK","Vet Anaesth Analg","2016","2015/11/04","","","10.1111/vaa.12318"
"26521014","Clinical effects of buprenorphine on open field behaviour and gait symmetry in healthy and lame weaned piglets","Meijer E, van Nes A, Back W, van der Staay FJ.","Vet J. 2015 Dec;206(3):298-303. doi: 10.1016/j.tvjl.2015.10.016. Epub 2015 Oct 22.","Meijer E","Vet J","2015","2015/11/02","","","10.1016/j.tvjl.2015.10.016"
"26518253","Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients","Dunn KE, Finan PH, Tompkins DA, Fingerhood M, Strain EC.","Drug Alcohol Depend. 2015 Dec 1;157:143-9. doi: 10.1016/j.drugalcdep.2015.10.018. Epub 2015 Oct 19.","Dunn KE","Drug Alcohol Depend","2015","2015/11/01","PMC4663104","NIHMS731403","10.1016/j.drugalcdep.2015.10.018"
"26517324","Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program","Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM.","J Addict Med. 2015 Nov-Dec;9(6):470-7. doi: 10.1097/ADM.0000000000000164.","Gordon AJ","J Addict Med","2015","2015/10/31","","","10.1097/ADM.0000000000000164"
"26514156","Revision of Breastfeeding Guidelines in the Setting of Maternal Opioid Use Disorder: One Institution's Experience","Wachman EM, Saia K, Humphreys R, Minear S, Combs G, Philipp BL.","J Hum Lact. 2016 May;32(2):382-7. doi: 10.1177/0890334415613823. Epub 2015 Oct 29.","Wachman EM","J Hum Lact","2016","2015/10/31","","","10.1177/0890334415613823"
"26491960","Maternal Buprenorphine Dose at Delivery and Its Relationship to Neonatal Outcomes","O'Connor AB, O'Brien L, Alto WA.","Eur Addict Res. 2016;22(3):127-30. doi: 10.1159/000441220. Epub 2015 Oct 23.","O'Connor AB","Eur Addict Res","2016","2015/10/23","","","10.1159/000441220"
"26483356","States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence","Knudsen HK, Lofwall MR, Havens JR, Walsh SL.","Drug Alcohol Depend. 2015 Dec 1;157:36-43. doi: 10.1016/j.drugalcdep.2015.09.032. Epub 2015 Oct 9.","Knudsen HK","Drug Alcohol Depend","2015","2015/10/21","PMC4663127","NIHMS729346","10.1016/j.drugalcdep.2015.09.032"
"26479717","Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder","Laffont CM, Gomeni R, Heidbreder C, Jones JP 3rd, Nasser AF.","J Clin Pharmacol. 2016 Jul;56(7):806-15. doi: 10.1002/jcph.665. Epub 2016 Mar 11.","Laffont CM","J Clin Pharmacol","2016","2015/10/20","","","10.1002/jcph.665"
"26479400","French Experience with Buprenorphine : Do Physicians Follow the Guidelines?","Guillou Landreat M, Rozaire C, Guillet JY, Victorri Vigneau C, Le Reste JY, Grall Bronnec M.","PLoS One. 2015 Oct 19;10(10):e0137708. doi: 10.1371/journal.pone.0137708. eCollection 2015.","Guillou Landreat M","PLoS One","2015","2015/10/20","PMC4610705","","10.1371/journal.pone.0137708"
"26479277","Preliminary investigation comparing a detomidine continuous rate infusion combined with either morphine or buprenorphine for standing sedation in horses","Potter JJ, MacFarlane PD, Love EJ, Tremaine H, Taylor PM, Murrell JC.","Vet Anaesth Analg. 2016 Mar;43(2):189-94. doi: 10.1111/vaa.12316. Epub 2015 Oct 19.","Potter JJ","Vet Anaesth Analg","2016","2015/10/20","","","10.1111/vaa.12316"
"26468683","The Effect of Buprenorphine on Methamphetamine Cravings","Salehi M, Emadossadat A, Kheirabadi GR, Maracy MR, Sharbafchi MR.","J Clin Psychopharmacol. 2015 Dec;35(6):724-7. doi: 10.1097/JCP.0000000000000408.","Salehi M","J Clin Psychopharmacol","2015","2015/10/16","","","10.1097/JCP.0000000000000408"
"26467975","Retention in medication-assisted treatment for opiate dependence: A systematic review","Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C.","J Addict Dis. 2016;35(1):22-35. doi: 10.1080/10550887.2016.1100960. Epub 2015 Oct 14.","Timko C","J Addict Dis","2016","2015/10/16","PMC6542472","NIHMS1013457","10.1080/10550887.2016.1100960"
"26467541","Analgesic efficacy of intraperitoneal administration of bupivacaine in cats","Benito J, Monteiro B, Lavoie AM, Beauchamp G, Lascelles BDX, Steagall PV.","J Feline Med Surg. 2016 Nov;18(11):906-912. doi: 10.1177/1098612X15610162. Epub 2016 Jul 11.","Benito J","J Feline Med Surg","2016","2015/10/16","","","10.1177/1098612X15610162"
"26464200","Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission","Bachireddy C, Weisberg DF, Altice FL.","Addiction. 2015 Dec;110(12):1869-71. doi: 10.1111/add.13055. Epub 2015 Oct 13.","Bachireddy C","Addiction","2015","2015/10/15","","","10.1111/add.13055"
"26457976","A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report","Goodman DJ, Milliken CU, Theiler RN, Nordstrom BR, Akerman SC.","J Dual Diagn. 2015;11(3-4):248-57. doi: 10.1080/15504263.2015.1104484.","Goodman DJ","J Dual Diagn","2015","2015/10/13","PMC4762276","NIHMS752210","10.1080/15504263.2015.1104484"
"26452239","Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England","Pierce M, Bird SM, Hickman M, Marsden J, Dunn G, Jones A, Millar T.","Addiction. 2016 Feb;111(2):298-308. doi: 10.1111/add.13193. Epub 2015 Nov 25.","Pierce M","Addiction","2016","2015/10/10","PMC4950033","","10.1111/add.13193"
"26437312","Management of opioid-dependent patients: comparison of the cost associated with use of buprenorphine/naloxone or methadone, and their interactions with concomitant treatments for infectious or psychiatric comorbidities","Roncero C, Domínguez-Hernández R, Díaz T, Fernández JM, Forcada R, Martínez JM, Seijo P, Terán A, Oyagüez I.","Adicciones. 2015 Sep 15;27(3):179-89.","Roncero C","Adicciones","2015","2015/10/06","","",""
"26432025","Visual evoked potential latencies of three-year-old children prenatally exposed to buprenorphine or methadone compared with non-opioid exposed children: The results of a longitudinal study","Whitham JN, Spurrier NJ, Baghurst PA, Weston P, Sawyer MG.","Neurotoxicol Teratol. 2015 Nov-Dec;52(Pt A):17-24. doi: 10.1016/j.ntt.2015.09.008. Epub 2015 Sep 30.","Whitham JN","Neurotoxicol Teratol","2015","2015/10/04","","","10.1016/j.ntt.2015.09.008"
"26421677","Buprenorphine for neuropathic pain in adults","Wiffen PJ, Derry S, Moore RA, Stannard C, Aldington D, Cole P, Knaggs R.","Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD011603. doi: 10.1002/14651858.CD011603.pub2.","Wiffen PJ","Cochrane Database Syst Rev","2015","2015/10/01","PMC6481375","","10.1002/14651858.CD011603.pub2"
"26414784","Therapies in early development for the treatment of opiate addiction","Rodríguez-Arias M, Aguilar MA, Miñarro J.","Expert Opin Investig Drugs. 2015;24(11):1459-72. doi: 10.1517/13543784.2015.1086746. Epub 2015 Sep 28.","Rodríguez-Arias M","Expert Opin Investig Drugs","2015","2015/09/29","","","10.1517/13543784.2015.1086746"
"26412406","Reply to 'Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial'","Brown MS.","J Perinatol. 2015 Oct;35(10):892. doi: 10.1038/jp.2015.47.","Brown MS","J Perinatol","2015","2015/09/29","","","10.1038/jp.2015.47"
"26412405","Neonatal abstinence syndrome: use of clonazepam?","Henderson C, Karnack C.","J Perinatol. 2015 Oct;35(10):891. doi: 10.1038/jp.2015.49.","Henderson C","J Perinatol","2015","2015/09/29","","","10.1038/jp.2015.49"
"26409030","Effects of buprenorphine on responses to social stimuli in healthy adults","Bershad AK, Seiden JA, de Wit H.","Psychoneuroendocrinology. 2016 Jan;63:43-9. doi: 10.1016/j.psyneuen.2015.09.011. Epub 2015 Sep 12.","Bershad AK","Psychoneuroendocrinology","2016","2015/09/27","PMC4695221","NIHMS723578","10.1016/j.psyneuen.2015.09.011"
"26407542","Influence of UGT2B7, CYP3A4, and OPRM1 Gene Polymorphisms on Transdermal Buprenorphine Pain Control in Patients with Critical Lower Limb Ischemia Awaiting Revascularization","Blanco F, Muriel C, Labrador J, Gonzalez-Porras JR, Gonzalez-Sarmiento R, Lozano FS.","Pain Pract. 2016 Sep;16(7):842-9. doi: 10.1111/papr.12343. Epub 2015 Sep 26.","Blanco F","Pain Pract","2016","2015/09/27","","","10.1111/papr.12343"
"26406300","American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","Kampman K, Jarvis M.","J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166.","Kampman K","J Addict Med","2015","2015/09/26","PMC4605275","","10.1097/ADM.0000000000000166"
"26404500","Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice","Zielińska M, Ben Haddou T, Cami-Kobeci G, Sałaga M, Jarmuż A, Padysz M, Kordek R, Spetea M, Husbands SM, Fichna J.","Eur J Pharmacol. 2015 Oct 15;765:582-90. doi: 10.1016/j.ejphar.2015.09.021. Epub 2015 Sep 25.","Zielińska M","Eur J Pharmacol","2015","2015/09/26","PMC5064847","NIHMS821205","10.1016/j.ejphar.2015.09.021"
"26398978","['High dose' Buprenorphine and heroin addicts management, a French abscess]","Nau JY.","Rev Med Suisse. 2015 Jul 15;11(481):1460-1.","Nau JY","Rev Med Suisse","2015","2015/09/25","","",""
"26390769","Opioid Addiction Treatment Using Buprenorphine-Naloxone In A Community-Based Internal Medicine Practice","Van Doren BA, Foulks-Rodriguez KA, Yarborough W.","J Okla State Med Assoc. 2015 Jul;108(7):303-9.","Van Doren BA","J Okla State Med Assoc","2015","2015/09/23","","",""
"26384620","Comparative safety of methadone and buprenorphine","Saxon AJ.","Lancet Psychiatry. 2015 Oct;2(10):855-6. doi: 10.1016/S2215-0366(15)00413-7. Epub 2015 Sep 15.","Saxon AJ","Lancet Psychiatry","2015","2015/09/20","","","10.1016/S2215-0366(15)00413-7"
"26384619","Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study","Kimber J, Larney S, Hickman M, Randall D, Degenhardt L.","Lancet Psychiatry. 2015 Oct;2(10):901-8. doi: 10.1016/S2215-0366(15)00366-1. Epub 2015 Sep 15.","Kimber J","Lancet Psychiatry","2015","2015/09/20","","","10.1016/S2215-0366(15)00366-1"
"26383747","What Is Your Diagnosis? Diskospondylitis","Hill MF, Warren-Smith C, Granger N.","J Am Vet Med Assoc. 2015 Oct 1;247(7):743-5. doi: 10.2460/javma.247.7.743.","Hill MF","J Am Vet Med Assoc","2015","2015/09/19","","","10.2460/javma.247.7.743"
"26374128","Opioid dependency rehabilitation with the opioid maintenance treatment programme - a qualitative study from the clients' perspective","Granerud A, Toft H.","Subst Abuse Treat Prev Policy. 2015 Sep 15;10:35. doi: 10.1186/s13011-015-0031-4.","Granerud A","Subst Abuse Treat Prev Policy","2015","2015/09/17","PMC4571127","","10.1186/s13011-015-0031-4"
"26372412","Stochastic Pharmacokinetic-Pharmacodynamic Analysis of the Effect of Transdermal Buprenorphine on Electroencephalogram and Analgesia","Olesen AE, Olofsen E, Andresen T, Graversen C, Drewes AM, Dahan A.","Anesth Analg. 2015 Nov;121(5):1165-75. doi: 10.1213/ANE.0000000000000939.","Olesen AE","Anesth Analg","2015","2015/09/16","","","10.1213/ANE.0000000000000939"
"26355141","Using Shared Medical Appointments to Increase Access to Buprenorphine Treatment","Roll D, Spottswood M, Huang H.","J Am Board Fam Med. 2015 Sep-Oct;28(5):676-7. doi: 10.3122/jabfm.2015.05.150017.","Roll D","J Am Board Fam Med","2015","2015/09/11","","","10.3122/jabfm.2015.05.150017"
"26350930","Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties","Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW.","Milbank Q. 2015 Sep;93(3):561-83. doi: 10.1111/1468-0009.12137.","Stein BD","Milbank Q","2015","2015/09/10","PMC4567853","","10.1111/1468-0009.12137"
"26315948","Pharmacological Management of Opioid Use Disorder in Pregnant Women","Wilder CM, Winhusen T.","CNS Drugs. 2015 Aug;29(8):625-36. doi: 10.1007/s40263-015-0273-8.","Wilder CM","CNS Drugs","2015","2015/08/29","","","10.1007/s40263-015-0273-8"
"26312963","Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series","DeVido J, Connery H, Hill KP.","J Opioid Manag. 2015 Jul-Aug;11(4):363-6. doi: 10.5055/jom.2015.0285.","DeVido J","J Opioid Manag","2015","2015/08/28","PMC4754775","NIHMS749056","10.5055/jom.2015.0285"
"26312959","Triple dosing with high doses of buprenorphine: Withdrawal and plasma concentrations","Hvittfeldt E, Charlotte G, Fridolf I, Håkansson A.","J Opioid Manag. 2015 Jul-Aug;11(4):319-24. doi: 10.5055/jom.2015.0281.","Hvittfeldt E","J Opioid Manag","2015","2015/08/28","","","10.5055/jom.2015.0281"
"26309105","Effects of premedication with sustained-release buprenorphine hydrochloride and anesthetic induction with ketamine hydrochloride or propofol in combination with diazepam on intraocular pressure in healthy sheep","Gatson BJ, Pablo L, Plummer CE, Granone TD.","Am J Vet Res. 2015 Sep;76(9):771-9. doi: 10.2460/ajvr.76.9.771.","Gatson BJ","Am J Vet Res","2015","2015/08/27","","","10.2460/ajvr.76.9.771"
"26305657","Opioid Dependence Treatment in the Emergency Department--Reply","Fiellin DA, O'Connor PG, D'Onofrio G.","JAMA. 2015 Aug 25;314(8):835. doi: 10.1001/jama.2015.8527.","Fiellin DA","JAMA","2015","2015/08/26","","","10.1001/jama.2015.8527"
"26305656","Opioid Dependence Treatment in the Emergency Department","Swartz AW.","JAMA. 2015 Aug 25;314(8):834-5. doi: 10.1001/jama.2015.8519.","Swartz AW","JAMA","2015","2015/08/26","","","10.1001/jama.2015.8519"
"26305073","Buprenorphine infrequently found in fatal overdose in New York City","Paone D, Tuazon E, Stajic M, Sampson B, Allen B, Mantha S, Kunins H.","Drug Alcohol Depend. 2015 Oct 1;155:298-301. doi: 10.1016/j.drugalcdep.2015.08.007. Epub 2015 Aug 15.","Paone D","Drug Alcohol Depend","2015","2015/08/26","","","10.1016/j.drugalcdep.2015.08.007"
"26298399","Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection","Walley AY, Palmisano J, Sorensen-Alawad A, Chaisson C, Raj A, Samet JH, Drainoni ML.","J Subst Abuse Treat. 2015 Dec;59:59-66. doi: 10.1016/j.jsat.2015.07.007. Epub 2015 Jul 21.","Walley AY","J Subst Abuse Treat","2015","2015/08/24","","","10.1016/j.jsat.2015.07.007"
"26258203","Patients more likely to engage in treatment at 30 days when given buprenorphine in the ED, referred for follow-up","","ED Manag. 2015 Aug;27(8):92-5.","","ED Manag","2015","2015/08/11","","",""
"26256469","Bridging waitlist delays with interim buprenorphine treatment: initial feasibility","Sigmon SC, C Meyer A, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP.","Addict Behav. 2015 Dec;51:136-42. doi: 10.1016/j.addbeh.2015.07.030. Epub 2015 Jul 29.","Sigmon SC","Addict Behav","2015","2015/08/11","PMC4558243","NIHMS711912","10.1016/j.addbeh.2015.07.030"
"26247080","Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs","Sugarman J, Stalter R, Bokoch K, Liu TY, Donnell D.","IRB. 2015 Jan-Feb;37(1):17-9.","Sugarman J","IRB","2015","2015/08/07","PMC4591048","NIHMS725751",""
"26240258","Buprenorphine waivers for physicians","Weeks WB, O'Connell MJ.","Health Aff (Millwood). 2015 Aug;34(8):1428. doi: 10.1377/hlthaff.2015.0762.","Weeks WB","Health Aff (Millwood)","2015","2015/08/05","","","10.1377/hlthaff.2015.0762"
"26234590","A New Role for Clonidine in Addictions: Catching Relapses Before They Happen","deWit H.","Am J Psychiatry. 2015 Aug 1;172(8):700-1. doi: 10.1176/appi.ajp.2015.15040426.","deWit H","Am J Psychiatry","2015","2015/08/04","","","10.1176/appi.ajp.2015.15040426"
"26233698","Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers","LaBelle CT, Han SC, Bergeron A, Samet JH.","J Subst Abuse Treat. 2016 Jan;60:6-13. doi: 10.1016/j.jsat.2015.06.010. Epub 2015 Jun 26.","LaBelle CT","J Subst Abuse Treat","2016","2015/08/03","PMC4682362","NIHMS740758","10.1016/j.jsat.2015.06.010"
"26224444","Assessment of an Orofacial Operant Pain Assay as a Preclinical Tool for Evaluating Analgesic Efficacy in Rodents","Ramirez HE, Queeney TJ, Dunbar ML, Eichner MC, Del Castillo DI, Battles AH, Neubert JK.","J Am Assoc Lab Anim Sci. 2015 Jul;54(4):426-32.","Ramirez HE","J Am Assoc Lab Anim Sci","2015","2015/07/31","PMC4521578","",""
"26224441","Analgesic Efficacy of Firocoxib, a Selective Inhibitor of Cyclooxygenase 2, in a Mouse Model of Incisional Pain","Reddyjarugu B, Pavek T, Southard T, Barry J, Singh B.","J Am Assoc Lab Anim Sci. 2015 Jul;54(4):405-10.","Reddyjarugu B","J Am Assoc Lab Anim Sci","2015","2015/07/31","PMC4521575","",""
"26212632","Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas","Meyer M, Phillips J.","Prev Med. 2015 Nov;80:18-22. doi: 10.1016/j.ypmed.2015.07.015. Epub 2015 Jul 26.","Meyer M","Prev Med","2015","2015/07/28","PMC4592470","NIHMS714428","10.1016/j.ypmed.2015.07.015"
"26212260","A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence","Gisev N, Shanahan M, Weatherburn DJ, Mattick RP, Larney S, Burns L, Degenhardt L.","Addiction. 2015 Dec;110(12):1975-84. doi: 10.1111/add.13073. Epub 2015 Sep 23.","Gisev N","Addiction","2015","2015/07/28","","","10.1111/add.13073"
"26205326","The unique role of transdermal buprenorphine in the global chronic pain epidemic","Pergolizzi JV Jr, Scholten W, Smith KJ, Leighton-Scott J, Willis JC, Henningfield JE.","Acta Anaesthesiol Taiwan. 2015 Jun;53(2):71-6. doi: 10.1016/j.aat.2015.06.001. Epub 2015 Jul 21.","Pergolizzi JV Jr","Acta Anaesthesiol Taiwan","2015","2015/07/25","","","10.1016/j.aat.2015.06.001"
"26190414","Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats","Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Jurga A, Slusarczyk J, Trojan E, Basta-Kaim A, Mika J.","Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:68-78. doi: 10.1016/j.pnpbp.2015.07.005. Epub 2015 Jul 16.","Kwiatkowski K","Prog Neuropsychopharmacol Biol Psychiatry","2016","2015/07/21","","","10.1016/j.pnpbp.2015.07.005"
"26186388","Opioid use disorder during pregnancy in Tennessee: expediency vs. science","Martin PR, Finlayson AJ.","Am J Drug Alcohol Abuse. 2015;41(5):367-70. doi: 10.3109/00952990.2015.1047502.","Martin PR","Am J Drug Alcohol Abuse","2015","2015/07/18","","","10.3109/00952990.2015.1047502"
"26179573","Effect of pretreatment with hydromorphone or buprenorphine on thermal antinociception induced by fentanyl in awake cats","Ambros B.","J Feline Med Surg. 2016 Oct;18(10):818-25. doi: 10.1177/1098612X15595835. Epub 2015 Jul 15.","Ambros B","J Feline Med Surg","2016","2015/07/17","","","10.1177/1098612X15595835"
"26172282","Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome","Ng CM, Dombrowsky E, Lin H, Erlich ME, Moody DE, Barrett JS, Kraft WK.","Pharmacotherapy. 2015 Jul;35(7):670-80. doi: 10.1002/phar.1610. Epub 2015 Jul 14.","Ng CM","Pharmacotherapy","2015","2015/07/15","PMC5119858","NIHMS830474","10.1002/phar.1610"
"26171718","Ethanol Reversal of Tolerance to the Respiratory Depressant Effects of Morphine","Hill R, Lyndon A, Withey S, Roberts J, Kershaw Y, MacLachlan J, Lingford-Hughes A, Kelly E, Bailey C, Hickman M, Henderson G.","Version 2. Neuropsychopharmacology. 2016 Feb;41(3):762-73. doi: 10.1038/npp.2015.201. Epub 2015 Jul 14.","Hill R","Neuropsychopharmacology","2016","2015/07/15","PMC4610039","EMS64064","10.1038/npp.2015.201"
"26168816","Counselor training and attitudes toward pharmacotherapies for opioid use disorder","Aletraris L, Edmond MB, Paino M, Fields D, Roman PM.","Subst Abus. 2016;37(1):47-53. doi: 10.1080/08897077.2015.1062457. Epub 2015 Jul 13.","Aletraris L","Subst Abus","2016","2015/07/15","PMC4879956","NIHMS771313","10.1080/08897077.2015.1062457"
"26167561","Is periconceptional opioid use safe?","Chan F, Koren G.","Can Fam Physician. 2015 May;61(5):431-3.","Chan F","Can Fam Physician","2015","2015/07/14","PMC4430058","",""
"26154531","Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma","Holbrook AM.","Am J Drug Alcohol Abuse. 2015;41(5):371-3. doi: 10.3109/00952990.2015.1059625.","Holbrook AM","Am J Drug Alcohol Abuse","2015","2015/07/09","","","10.3109/00952990.2015.1059625"
"26153065","Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors","Wang PC, Ho IK, Lee CW.","J Cell Mol Med. 2015 Nov;19(11):2587-96. doi: 10.1111/jcmm.12644. Epub 2015 Jul 8.","Wang PC","J Cell Mol Med","2015","2015/07/09","PMC4627564","","10.1111/jcmm.12644"
"26134641","Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude","Gerhold KJ, Drdla-Schutting R, Honsek SD, Forsthuber L, Sandkühler J.","J Neurosci. 2015 Jul 1;35(26):9580-94. doi: 10.1523/JNEUROSCI.0731-14.2015.","Gerhold KJ","J Neurosci","2015","2015/07/03","PMC4571500","","10.1523/JNEUROSCI.0731-14.2015"
"26124175","Assessment of drug-drug interactions between daclatasvir and methadone or buprenorphine-naloxone","Garimella T, Wang R, Luo WL, Wastall P, Kandoussi H, DeMicco M, Bruce RD, Hwang C, Bertz R, Bifano M.","Antimicrob Agents Chemother. 2015 Sep;59(9):5503-10. doi: 10.1128/AAC.00478-15. Epub 2015 Jun 29.","Garimella T","Antimicrob Agents Chemother","2015","2015/07/01","PMC4538464","","10.1128/AAC.00478-15"
"26110357","Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World","Parrino MW, Maremmani AG, Samuels PN, Maremmani I.","J Addict Dis. 2015;34(2-3):255-62. doi: 10.1080/10550887.2015.1059113.","Parrino MW","J Addict Dis","2015","2015/06/26","","","10.1080/10550887.2015.1059113"
"26107096","Pharmacotherapy: Quest for the quitting pill","Willyard C.","Nature. 2015 Jun 25;522(7557):S53-5. doi: 10.1038/522S53a.","Willyard C","Nature","2015","2015/06/25","","","10.1038/522S53a"
"26102240","To Be Free and Normal: Addiction, Governance, and the Therapeutics of Buprenorphine","Harris S.","Med Anthropol Q. 2015 Dec;29(4):512-30. doi: 10.1111/maq.12232. Epub 2015 Aug 18.","Harris S","Med Anthropol Q","2015","2015/06/24","PMC4689659","NIHMS662653","10.1111/maq.12232"
"26098042","The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis","Knudsen HK.","J Stud Alcohol Drugs. 2015 Jul;76(4):644-54. doi: 10.15288/jsad.2015.76.644.","Knudsen HK","J Stud Alcohol Drugs","2015","2015/06/23","PMC4495082","","10.15288/jsad.2015.76.644"
"26080038","Harm Reduction: Front Line Public Health","Stancliff S, Phillips BW, Maghsoudi N, Joseph H.","J Addict Dis. 2015;34(2-3):206-19. doi: 10.1080/10550887.2015.1059651.","Stancliff S","J Addict Dis","2015","2015/06/17","","","10.1080/10550887.2015.1059651"
"26079104","Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research","Schwartz RP, Kelly SM, Gryczynski J, Mitchell SG, O'Grady KE, Jaffe JH.","J Addict Dis. 2015;34(2-3):151-61. doi: 10.1080/10550887.2015.1059222.","Schwartz RP","J Addict Dis","2015","2015/06/17","PMC4550504","NIHMS703038","10.1080/10550887.2015.1059222"
"26076211","Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care","Wakeman SE, Rich JD.","J Addict Dis. 2015;34(2-3):220-5. doi: 10.1080/10550887.2015.1059217.","Wakeman SE","J Addict Dis","2015","2015/06/16","","","10.1080/10550887.2015.1059217"
"26076048","Stigma from the Viewpoint of the Patient","Woods JS, Joseph H.","J Addict Dis. 2015;34(2-3):238-47. doi: 10.1080/10550887.2015.1059714.","Woods JS","J Addict Dis","2015","2015/06/16","","","10.1080/10550887.2015.1059714"
"26075588","Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration","Kao DP, Haigney MC, Mehler PS, Krantz MJ.","Addiction. 2015 Sep;110(9):1468-75. doi: 10.1111/add.13013.","Kao DP","Addiction","2015","2015/06/16","PMC4521976","NIHMS700016","10.1111/add.13013"
"26071501","Maternal-Fetal Rights and Substance Abuse: Gestation Without Representation","Boudreaux JM, Thompson JW Jr.","J Am Acad Psychiatry Law. 2015 Jun;43(2):137-40.","Boudreaux JM","J Am Acad Psychiatry Law","2015","2015/06/14","","",""
"26068437","Concluding statement - neuropharmacological basis and clinical rationale for control of transdermal buprenorphine as a step II analgesic","Henningfield JE, Sun WZ.","Acta Anaesthesiol Taiwan. 2015 Jun;53(2):77-9. doi: 10.1016/j.aat.2015.05.002. Epub 2015 Jun 9.","Henningfield JE","Acta Anaesthesiol Taiwan","2015","2015/06/13","","","10.1016/j.aat.2015.05.002"
"26066931","National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment","Jones CM, Campopiano M, Baldwin G, McCance-Katz E.","Am J Public Health. 2015 Aug;105(8):e55-63. doi: 10.2105/AJPH.2015.302664. Epub 2015 Jun 11.","Jones CM","Am J Public Health","2015","2015/06/13","PMC4504312","","10.2105/AJPH.2015.302664"
"26056209","Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11","Dick AW, Pacula RL, Gordon AJ, Sorbero M, Burns RM, Leslie D, Stein BD.","Health Aff (Millwood). 2015 Jun;34(6):1028-34. doi: 10.1377/hlthaff.2014.1205.","Dick AW","Health Aff (Millwood)","2015","2015/06/10","PMC4743254","NIHMS720004","10.1377/hlthaff.2014.1205"
"26048638","Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders","Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Mao J, Edwards RR, Samet JH.","Drug Alcohol Depend. 2015 Aug 1;153:286-92. doi: 10.1016/j.drugalcdep.2015.05.011. Epub 2015 May 22.","Tsui JI","Drug Alcohol Depend","2015","2015/06/07","PMC4509826","NIHMS700423","10.1016/j.drugalcdep.2015.05.011"
"26048187","A Retrospective Evaluation of Inpatient Transfer from High-Dose Methadone to Buprenorphine Substitution Therapy","Oretti R.","J Subst Abuse Treat. 2015 Oct;57:102-5. doi: 10.1016/j.jsat.2015.05.004. Epub 2015 May 13.","Oretti R","J Subst Abuse Treat","2015","2015/06/07","","","10.1016/j.jsat.2015.05.004"
"26045511","Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice","Almatroudi A, Husbands SM, Bailey CP, Bailey SJ.","J Psychopharmacol. 2015 Jul;29(7):812-21. doi: 10.1177/0269881115586937. Epub 2015 Jun 4.","Almatroudi A","J Psychopharmacol","2015","2015/06/06","PMC5075030","NIHMS821198","10.1177/0269881115586937"
"26045456","Effects of Dexmedetomidine and Ketamine-Dexmedetomidine with and without Buprenorphine on Corticoadrenal Function in Rabbits","González-Gil A, Villa A, Millán P, Martínez-Fernández L, Illera JC.","J Am Assoc Lab Anim Sci. 2015 May;54(3):299-303.","González-Gil A","J Am Assoc Lab Anim Sci","2015","2015/06/06","PMC4460943","",""
"26043968","IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model","Pilat D, Rojewska E, Jurga AM, Piotrowska A, Makuch W, Przewlocka B, Mika J.","Eur J Pharmacol. 2015 Oct 5;764:240-8. doi: 10.1016/j.ejphar.2015.05.058. Epub 2015 Jun 1.","Pilat D","Eur J Pharmacol","2015","2015/06/06","","","10.1016/j.ejphar.2015.05.058"
"26035085","Interventions for female drug-using offenders","Perry AE, Neilson M, Martyn-St James M, Glanville JM, Woodhouse R, Hewitt C.","Cochrane Database Syst Rev. 2015 Jun 2;(6):CD010910. doi: 10.1002/14651858.CD010910.pub2.","Perry AE","Cochrane Database Syst Rev","2015","2015/06/03","","","10.1002/14651858.CD010910.pub2"
"26035084","Pharmacological interventions for drug-using offenders","Perry AE, Neilson M, Martyn-St James M, Glanville JM, Woodhouse R, Godfrey C, Hewitt C.","Cochrane Database Syst Rev. 2015 Jun 2;(6):CD010862. doi: 10.1002/14651858.CD010862.pub2.","Perry AE","Cochrane Database Syst Rev","2015","2015/06/03","","","10.1002/14651858.CD010862.pub2"
"26028686","Chronic progressive polyarthritis in a domestic shorthair cat","Inkpen H.","Can Vet J. 2015 Jun;56(6):621-3.","Inkpen H","Can Vet J","2015","2015/06/02","PMC4431162","",""
"26025481","The paradox of control: An ethnographic analysis of opiate maintenance treatment in a Norwegian prison","Mjåland K.","Int J Drug Policy. 2015 Aug;26(8):781-9. doi: 10.1016/j.drugpo.2015.04.020. Epub 2015 May 4.","Mjåland K","Int J Drug Policy","2015","2015/05/31","","","10.1016/j.drugpo.2015.04.020"
"26024998","The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales","Marteau D, McDonald R, Patel K.","BMJ Open. 2015 May 29;5(5):e007629. doi: 10.1136/bmjopen-2015-007629.","Marteau D","BMJ Open","2015","2015/05/31","PMC4452747","","10.1136/bmjopen-2015-007629"
"26020158","Author's Reply","Meyer M.","J Addict Med. 2015 May-Jun;9(3):253. doi: 10.1097/ADM.0000000000000136.","Meyer M","J Addict Med","2015","2015/05/29","","","10.1097/ADM.0000000000000136"
"26020157","Methadone and buprenorphine during pregnancy","Newman RG, Gevertz SG.","J Addict Med. 2015 May-Jun;9(3):252. doi: 10.1097/ADM.0000000000000135.","Newman RG","J Addict Med","2015","2015/05/29","","","10.1097/ADM.0000000000000135"
"26020156","Author's Reply","Fareed A.","J Addict Med. 2015 May-Jun;9(3):251-2. doi: 10.1097/ADM.0000000000000116.","Fareed A","J Addict Med","2015","2015/05/29","","","10.1097/ADM.0000000000000116"
"26020155","Cocaine use and buprenorphine compliance","DeMaria PA Jr.","J Addict Med. 2015 May-Jun;9(3):251. doi: 10.1097/ADM.0000000000000113.","DeMaria PA Jr","J Addict Med","2015","2015/05/29","","","10.1097/ADM.0000000000000113"
"26017618","Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs","Suzuki J, Ellison TV, Connery HS, Surber C, Renner JA.","Acad Psychiatry. 2016 Jun;40(3):498-502. doi: 10.1007/s40596-015-0313-1. Epub 2015 May 28.","Suzuki J","Acad Psychiatry","2016","2015/05/29","","","10.1007/s40596-015-0313-1"
"26013471","[New drugs for horses and production animals in 2014]","Emmerich IU.","Tierarztl Prax Ausg G Grosstiere Nutztiere. 2015;43(3):154-8. doi: 10.15653/TPG-150250. Epub 2015 May 27.","Emmerich IU","Tierarztl Prax Ausg G Grosstiere Nutztiere","2015","2015/05/28","","","10.15653/TPG-150250"
"26003659","Prenatally buprenorphine-exposed children: health to 3 years of age","Kivistö K, Tupola S, Kivitie-Kallio S.","Eur J Pediatr. 2015 Nov;174(11):1525-33. doi: 10.1007/s00431-015-2562-0. Epub 2015 May 24.","Kivistö K","Eur J Pediatr","2015","2015/05/25","","","10.1007/s00431-015-2562-0"
"26001919","Responding to illicit drug use in family practice","Robertson JR, Robertson AR.","Curr Opin Psychiatry. 2015 Jul;28(4):286-91. doi: 10.1097/YCO.0000000000000174.","Robertson JR","Curr Opin Psychiatry","2015","2015/05/24","","","10.1097/YCO.0000000000000174"
"25997674","Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History","Clark RE, Baxter JD, Aweh G, O'Connell E, Fisher WH, Barton BA.","J Subst Abuse Treat. 2015 Oct;57:75-80. doi: 10.1016/j.jsat.2015.05.001. Epub 2015 May 7.","Clark RE","J Subst Abuse Treat","2015","2015/05/23","PMC4560989","NIHMS689049","10.1016/j.jsat.2015.05.001"
"25996041","Buprenorphine: revisiting the efficacy of transdermal delivery system","Kitzmiller JP, Barnett CJ, Steiner NS, Stoicea N, Kamar N, Luzum JA, Mikulik E, Bergese SD.","Ther Deliv. 2015;6(4):419-22. doi: 10.4155/tde.15.3.","Kitzmiller JP","Ther Deliv","2015","2015/05/22","","","10.4155/tde.15.3"
"25986647","Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes","Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O'Grady KE, Jaffe JH.","J Subst Abuse Treat. 2015 Oct;57:89-95. doi: 10.1016/j.jsat.2015.05.005. Epub 2015 May 12.","Monico LB","J Subst Abuse Treat","2015","2015/05/20","PMC4560966","NIHMS691990","10.1016/j.jsat.2015.05.005"
"25980599","Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention","Monico LB, Mitchell SG, Gryczynski J, Schwartz RP, O'Grady KE, Olsen YK, Jaffe JH.","J Subst Abuse Treat. 2015 Oct;57:57-62. doi: 10.1016/j.jsat.2015.04.010. Epub 2015 May 7.","Monico LB","J Subst Abuse Treat","2015","2015/05/19","PMC4561018","NIHMS688993","10.1016/j.jsat.2015.04.010"
"25974277","Addition of Dexamethasone and Buprenorphine to Bupivacaine Sciatic Nerve Block: A Randomized Controlled Trial","YaDeau JT, Paroli L, Fields KG, Kahn RL, LaSala VR, Jules-Elysee KM, Kim DH, Haskins SC, Hedden J, Goon A, Roberts MM, Levine DS.","Reg Anesth Pain Med. 2015 Jul-Aug;40(4):321-9. doi: 10.1097/AAP.0000000000000254.","YaDeau JT","Reg Anesth Pain Med","2015","2015/05/15","PMC4470755","NIHMS669792","10.1097/AAP.0000000000000254"
"25967268","Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009","Welle-Strand GK, Skurtveit S, Tanum L, Waal H, Bakstad B, Bjarkø L, Ravndal E.","Eur Addict Res. 2015;21(5):253-61. doi: 10.1159/000381670. Epub 2015 May 5.","Welle-Strand GK","Eur Addict Res","2015","2015/05/14","","","10.1159/000381670"
"25962609","Validated Method for the Quantification of Buprenorphine in Postmortem Blood Using Solid-Phase Extraction and Two-Dimensional Gas Chromatography-Mass Spectrometry","Nahar LK, Andrews R, Paterson S.","J Anal Toxicol. 2015 Sep;39(7):519-25. doi: 10.1093/jat/bkv051. Epub 2015 May 10.","Nahar LK","J Anal Toxicol","2015","2015/05/13","","","10.1093/jat/bkv051"
"25950595","Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use","Mitchell SG, Gryczynski J, Schwartz RP, Myers CP, O'Grady KE, Olsen YK, Jaffe JH.","J Psychoactive Drugs. 2015 Apr-Jun;47(2):149-57. doi: 10.1080/02791072.2015.1014948.","Mitchell SG","J Psychoactive Drugs","2015","2015/05/08","PMC4425232","NIHMS675424","10.1080/02791072.2015.1014948"
"25950232","The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations","Larance B, Dietze P, Ali R, Lintzeris N, White N, Jenkinson R, Degenhardt L.","Drug Alcohol Rev. 2015 Nov;34(6):603-10. doi: 10.1111/dar.12277. Epub 2015 May 6.","Larance B","Drug Alcohol Rev","2015","2015/05/08","","","10.1111/dar.12277"
"25944578","Pharmacokinetic and pharmacodynamic evaluation of high doses of buprenorphine delivered via high-concentration formulations in cats","Taylor PM, Luangdilok CH, Sear JW.","J Feline Med Surg. 2016 Apr;18(4):290-302. doi: 10.1177/1098612X15581206. Epub 2015 May 5.","Taylor PM","J Feline Med Surg","2016","2015/05/07","","","10.1177/1098612X15581206"
"25937593","Interim treatment: Bridging delays to opioid treatment access","Sigmon SC.","Prev Med. 2015 Nov;80:32-6. doi: 10.1016/j.ypmed.2015.04.017. Epub 2015 Apr 30.","Sigmon SC","Prev Med","2015","2015/05/05","PMC4592374","NIHMS686307","10.1016/j.ypmed.2015.04.017"
"25919527","Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial","D'Onofrio G, O'Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA.","JAMA. 2015 Apr 28;313(16):1636-44. doi: 10.1001/jama.2015.3474.","D'Onofrio G","JAMA","2015","2015/04/29","PMC4527523","NIHMS711412","10.1001/jama.2015.3474"
"25918966","Mobile phone use patterns and preferences in safety net office-based buprenorphine patients","Tofighi B, Grossman E, Buirkle E, McNeely J, Gourevitch M, Lee JD.","J Addict Med. 2015 May-Jun;9(3):217-21. doi: 10.1097/ADM.0000000000000121.","Tofighi B","J Addict Med","2015","2015/04/29","PMC4693598","NIHMS663293","10.1097/ADM.0000000000000121"
"25914912","Effectiveness of opioid analgesics in chronic noncancer pain","Ferrari R, Zanolin ME, Duse G, Visentin M.","Pain Pract. 2015 Mar;15(3):272-8. doi: 10.1111/papr.12176.","Ferrari R","Pain Pract","2015","2015/04/28","","","10.1111/papr.12176"
"25910516","Initial evaluation of a canine stifle arthrotomy post-operative pain model","Tomas A, Bledsoe D, Wall S, Davidson G, Lascelles BD.","Vet J. 2015 Jun;204(3):293-8. doi: 10.1016/j.tvjl.2015.03.010. Epub 2015 Mar 14.","Tomas A","Vet J","2015","2015/04/26","","","10.1016/j.tvjl.2015.03.010"
"25907815","Baseline characteristics of patients predicting suitability for rapid naltrexone induction","Mogali S, Khan NA, Drill ES, Pavlicova M, Sullivan MA, Nunes E, Bisaga A.","Am J Addict. 2015 Apr;24(3):258-64. doi: 10.1111/ajad.12180.","Mogali S","Am J Addict","2015","2015/04/25","PMC4496800","NIHMS701450","10.1111/ajad.12180"
"25899872","Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy","Bentzley BS, Barth KS, Back SE, Aronson G, Book SW.","J Subst Abuse Treat. 2015 Sep;56:48-53. doi: 10.1016/j.jsat.2015.04.002. Epub 2015 Apr 7.","Bentzley BS","J Subst Abuse Treat","2015","2015/04/23","PMC4519420","NIHMS678860","10.1016/j.jsat.2015.04.002"
"25898137","C7β-methyl analogues of the orvinols: the discovery of kappa opioid antagonists with nociceptin/orphanin FQ peptide (NOP) receptor partial agonism and low, or zero, efficacy at mu opioid receptors","Cueva JP, Roche C, Ostovar M, Kumar V, Clark MJ, Hillhouse TM, Lewis JW, Traynor JR, Husbands SM.","J Med Chem. 2015 May 28;58(10):4242-9. doi: 10.1021/acs.jmedchem.5b00130. Epub 2015 May 6.","Cueva JP","J Med Chem","2015","2015/04/22","PMC4450370","","10.1021/acs.jmedchem.5b00130"
"25889208","Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden","Richert T, Johnson B.","Harm Reduct J. 2015 Feb 18;12:1. doi: 10.1186/s12954-015-0037-2.","Richert T","Harm Reduct J","2015","2015/04/19","PMC4337060","","10.1186/s12954-015-0037-2"
"25884206","Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio","Molfenter T, Sherbeck C, Zehner M, Quanbeck A, McCarty D, Kim JS, Starr S.","Subst Abuse Treat Prev Policy. 2015 Mar 28;10:13. doi: 10.1186/s13011-015-0009-2.","Molfenter T","Subst Abuse Treat Prev Policy","2015","2015/04/18","PMC4395880","","10.1186/s13011-015-0009-2"
"25881164","Buprenorphine maintenance program with contracted work/education and low tolerance for non-prescribed drug use: a cohort study of outcome for women and men after seven years","Öhlin L, Fridell M, Nyhlén A.","BMC Psychiatry. 2015 Mar 24;15:56. doi: 10.1186/s12888-015-0415-z.","Öhlin L","BMC Psychiatry","2015","2015/04/17","PMC4410480","","10.1186/s12888-015-0415-z"
"25869219","Vermont responds to its opioid crisis","Simpatico TA.","Prev Med. 2015 Nov;80:10-1. doi: 10.1016/j.ypmed.2015.04.002. Epub 2015 Apr 11.","Simpatico TA","Prev Med","2015","2015/04/15","","","10.1016/j.ypmed.2015.04.002"
"25868557","Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism","Moody DE, Liu F, Fang WB.","J Anal Toxicol. 2015 Jun;39(5):374-86. doi: 10.1093/jat/bkv030. Epub 2015 Apr 12.","Moody DE","J Anal Toxicol","2015","2015/04/15","","","10.1093/jat/bkv030"
"25865734","A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression","Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Dain B, Pergolizzi JV Jr, Raffa R, Ripa SR.","Pain Pract. 2016 Apr;16(4):473-85. doi: 10.1111/papr.12298. Epub 2015 Apr 11.","Yarlas A","Pain Pract","2016","2015/04/14","","","10.1111/papr.12298"
"25861916","Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine","Hirst A, Knight C, Hirst M, Dunlop W, Akehurst R.","Eur J Health Econ. 2016 Mar;17(2):217-27. doi: 10.1007/s10198-015-0673-1. Epub 2015 Apr 11.","Hirst A","Eur J Health Econ","2016","2015/04/12","PMC4757608","","10.1007/s10198-015-0673-1"
"25851990","Embolic stroke associated with intra-carotid injection of buprenorphine","Moisset X, Sia MA, Perie M, Ferrier A, Bourgois N.","Rev Neurol (Paris). 2015 May;171(5):450-1. doi: 10.1016/j.neurol.2015.02.008. Epub 2015 Apr 4.","Moisset X","Rev Neurol (Paris)","2015","2015/04/09","","","10.1016/j.neurol.2015.02.008"
"25844527","Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process","Farmer CM, Lindsay D, Williams J, Ayers A, Schuster J, Cilia A, Flaherty MT, Mandell T, Gordon AJ, Stein BD.","Subst Abus. 2015;36(2):209-16. doi: 10.1080/08897077.2015.1012613. Epub 2015 Apr 6.","Farmer CM","Subst Abus","2015","2015/04/07","PMC4470850","NIHMS682402","10.1080/08897077.2015.1012613"
"25842589","Importance of research and services among people who inject drugs in Pakistan","Altaf A, Shah SA, Vermund S.","J Pak Med Assoc. 2014 Dec;64(12):1413-4.","Altaf A","J Pak Med Assoc","2014","2015/04/07","","",""
"25841703","Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia","Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL.","J Subst Abuse Treat. 2015 Jul;54:29-36. doi: 10.1016/j.jsat.2015.01.014. Epub 2015 Feb 18.","Vijay A","J Subst Abuse Treat","2015","2015/04/06","PMC4758679","NIHMS755235","10.1016/j.jsat.2015.01.014"
"25841225","Buprenorphine for opiate dependence: clinic based therapy in Israel","Goren L, Carmel Z, Marchevsky S.","Isr J Psychiatry Relat Sci. 2014;51(4):281-4.","Goren L","Isr J Psychiatry Relat Sci","2014","2015/04/05","","",""
"25839406","Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine","Lalezari J, Sullivan JG, Varunok P, Galen E, Kowdley KV, Rustgi V, Aguilar H, Felizarta F, McGovern B, King M, Polepally AR, Cohen DE.","J Hepatol. 2015 Aug;63(2):364-9. doi: 10.1016/j.jhep.2015.03.029. Epub 2015 Apr 1.","Lalezari J","J Hepatol","2015","2015/04/04","","","10.1016/j.jhep.2015.03.029"
"25838001","Attentional bias and treatment adherence in substitute-prescribed opiate users","Charles M, Wellington CE, Mokrysz C, Freeman TP, O'Ryan D, Curran HV.","Addict Behav. 2015 Jul;46:100-5. doi: 10.1016/j.addbeh.2015.03.017. Epub 2015 Mar 24.","Charles M","Addict Behav","2015","2015/04/04","","","10.1016/j.addbeh.2015.03.017"
"25837290","Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment","Fox AD, Chamberlain A, Frost T, Cunningham CO.","Subst Abus. 2015;36(2):155-60. doi: 10.1080/08897077.2015.1011820.","Fox AD","Subst Abus","2015","2015/04/04","PMC4706457","NIHMS747195","10.1080/08897077.2015.1011820"
"25836317","Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine","Bier JB, Finger AS, Bier BA, Johnson TA, Coyle MG.","J Perinatol. 2015 Aug;35(8):656-9. doi: 10.1038/jp.2015.22. Epub 2015 Apr 2.","Bier JB","J Perinatol","2015","2015/04/04","","","10.1038/jp.2015.22"
"25831576","Pharmacokinetics of a single subcutaneous dose of sustained release buprenorphine in northern elephant seals (Mirounga angustirostris)","Molter CM, Barbosa L, Johnson S, Knych HK, Chinnadurai SK, Wack RF.","J Zoo Wildl Med. 2015 Mar;46(1):52-61. doi: 10.1638/2014-0115R.1.","Molter CM","J Zoo Wildl Med","2015","2015/04/03","","","10.1638/2014-0115R.1"
"25826743","Buprenorphine for treating cancer pain","Schmidt-Hansen M, Bromham N, Taubert M, Arnold S, Hilgart JS.","Cochrane Database Syst Rev. 2015 Mar 31;2015(3):CD009596. doi: 10.1002/14651858.CD009596.pub4.","Schmidt-Hansen M","Cochrane Database Syst Rev","2015","2015/04/01","PMC6513197","","10.1002/14651858.CD009596.pub4"
"25826044","The Time Is Now: The Role of Pharmacotherapies in Expanding Treatment for Opioid Use Disorder","Gordon AJ, Jenkins JA.","Subst Abus. 2015;36(2):127-8. doi: 10.1080/08897077.2015.1033884.","Gordon AJ","Subst Abus","2015","2015/04/01","","","10.1080/08897077.2015.1033884"
"25823907","Characterizing opioid withdrawal during double-blind buprenorphine detoxification","Dunn KE, Saulsgiver KA, Miller ME, Nuzzo PA, Sigmon SC.","Drug Alcohol Depend. 2015 Jun 1;151:47-55. doi: 10.1016/j.drugalcdep.2015.02.033. Epub 2015 Mar 12.","Dunn KE","Drug Alcohol Depend","2015","2015/04/01","PMC4447545","NIHMS671472","10.1016/j.drugalcdep.2015.02.033"
"25823632","Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013","Turner L, Kruszewski SP, Alexander GC.","Am J Addict. 2015 Jan;24(1):24-9. doi: 10.1111/ajad.12174.","Turner L","Am J Addict","2015","2015/04/01","","","10.1111/ajad.12174"
"25823630","Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series","Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD.","Am J Addict. 2015 Jan;24(1):10-4. doi: 10.1111/ajad.12161.","Suzuki J","Am J Addict","2015","2015/04/01","","","10.1111/ajad.12161"
"25822268","Buprenorphine Maintenance vs. Methadone Maintenance or Placebo for Opioid Use Disorder","Salisbury-Afshar E.","Am Fam Physician. 2015 Feb 1;91(3):165-6.","Salisbury-Afshar E","Am Fam Physician","2015","2015/03/31","","",""
"25821874","Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program","Kanate D, Folk D, Cirone S, Gordon J, Kirlew M, Veale T, Bocking N, Rea S, Kelly L.","Can Fam Physician. 2015 Feb;61(2):160-5.","Kanate D","Can Fam Physician","2015","2015/03/31","PMC4325865","",""
"25819700","Naltrexone-facilitated buprenorphine discontinuation: a feasibility trial","Dakwar E, Kleber HD.","J Subst Abuse Treat. 2015 Jun;53:60-3. doi: 10.1016/j.jsat.2015.01.004. Epub 2015 Jan 15.","Dakwar E","J Subst Abuse Treat","2015","2015/03/31","","","10.1016/j.jsat.2015.01.004"
"25811238","Recognizing Potential Buprenorphine Medication Misuse: Product Packaging Does Not Degrade With Laundering","Gunderson EW.","Subst Abus. 2015;36(2):161-5. doi: 10.1080/08897077.2015.1007201.","Gunderson EW","Subst Abus","2015","2015/03/27","","","10.1080/08897077.2015.1007201"
"25808363","UHPLC-MS/MS quantification of buprenorphine, norbuprenorphine, methadone, and glucuronide conjugates in umbilical cord plasma","Kyle AR, Carmical J, Shah D, Pryor J, Brown S.","Biomed Chromatogr. 2015 Oct;29(10):1567-74. doi: 10.1002/bmc.3460. Epub 2015 Mar 22.","Kyle AR","Biomed Chromatogr","2015","2015/03/27","","","10.1002/bmc.3460"
"25807454","The stepped treatment engagement protocol for homeless, needle exchange heroin-dependent patients","Tringale R, Subica AM, Danielian A, Kaplan C.","J Addict Med. 2015 Mar-Apr;9(2):163-4. doi: 10.1097/ADM.0000000000000096.","Tringale R","J Addict Med","2015","2015/03/26","","","10.1097/ADM.0000000000000096"
"25801127","Quantification of morphine, morphine 6-glucuronide, buprenorphine, and the enantiomers of methadone by enantioselective mass spectrometric chromatography in whole blood","Christoffersen DJ, Brasch-Andersen C, Thomsen JL, Worm-Leonhard M, Damkier P, Brøsen K.","Forensic Sci Med Pathol. 2015 Jun;11(2):193-201. doi: 10.1007/s12024-015-9673-9. Epub 2015 Mar 24.","Christoffersen DJ","Forensic Sci Med Pathol","2015","2015/03/25","","","10.1007/s12024-015-9673-9"
"25800409","Interpretation of urine drug testing results in patients using transdermal buprenorphine preparations for the treatment of chronic noncancer pain","Markman JD, Barbosa WA, Gewandter JS, Frazer M, Rast S, Dugan M, Nandigam K, Villareal A, Kwong TC.","Pain Med. 2015 Jun;16(6):1132-6. doi: 10.1111/pme.12740. Epub 2015 Mar 20.","Markman JD","Pain Med","2015","2015/03/25","","","10.1111/pme.12740"
"25794231","Effect of buprenorphine on total intravenous anesthetic requirements during spine surgery","Khelemsky Y, Schauer J, Loo N.","Pain Physician. 2015 Mar-Apr;18(2):E261-4.","Khelemsky Y","Pain Physician","2015","2015/03/21","","",""
"25783757","Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment","Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA, Schmittner JP, Epstein DH, Preston KL.","Am J Psychiatry. 2015 Aug 1;172(8):760-7. doi: 10.1176/appi.ajp.2014.14081014. Epub 2015 Mar 17.","Kowalczyk WJ","Am J Psychiatry","2015","2015/03/19","PMC6233893","NIHMS988515","10.1176/appi.ajp.2014.14081014"
"25775099","Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence","Jackson H, Mandell K, Johnson K, Chatterjee D, Vanness DJ.","Subst Abus. 2015;36(2):226-31. doi: 10.1080/08897077.2015.1010031. Epub 2015 Mar 16.","Jackson H","Subst Abus","2015","2015/03/17","PMC4470733","NIHMS694046","10.1080/08897077.2015.1010031"
"25774404","Buprenorphine use remains hit or miss","Miller J.","Behav Healthc. 2014 Nov-Dec;34(6):24.","Miller J","Behav Healthc","2014","2015/03/17","","",""
"25772950","A multicentre, prospective, randomised, blinded clinical trial to compare some perioperative effects of buprenorphine or butorphanol premedication before equine elective general anaesthesia and surgery","Taylor PM, Hoare HR, de Vries A, Love EJ, Coumbe KM, White KL, Murrell JC.","Equine Vet J. 2016 Jul;48(4):442-50. doi: 10.1111/evj.12442. Epub 2015 Jun 10.","Taylor PM","Equine Vet J","2016","2015/03/17","PMC5033022","","10.1111/evj.12442"
"25771691","Commentary on Burns et al. (2015): retention in buprenorphine treatment","Saxon AJ.","Addiction. 2015 Apr;110(4):656-7. doi: 10.1111/add.12865.","Saxon AJ","Addiction","2015","2015/03/17","PMC4367122","NIHMS661159","10.1111/add.12865"
"25769319","[A randomized, double-blind, controlled study: Ji-Tai tablet for the treatment of acute withdrawl syndrome of mild heroin dependence]","Wang Y, Tang C, Cheng S, Cui G, Zhang R, Zhang Z, Xie L, Lin Y, Hao W.","Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Feb;40(2):117-22. doi: 10.11817/j.issn.1672-7347.2015.02.001.","Wang Y","Zhong Nan Da Xue Xue Bao Yi Xue Ban","2015","2015/03/15","","","10.11817/j.issn.1672-7347.2015.02.001"
"25765484","HIV-gp120 and physical dependence to buprenorphine","Palma J, Abood ME, Benamar K.","Drug Alcohol Depend. 2015 May 1;150:175-8. doi: 10.1016/j.drugalcdep.2015.02.021. Epub 2015 Feb 26.","Palma J","Drug Alcohol Depend","2015","2015/03/14","PMC4573588","NIHMS721377","10.1016/j.drugalcdep.2015.02.021"
"25760046","Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity","Fitting S, Zou S, El-Hage N, Suzuki M, Paris JJ, Schier CJ, Rodríguez JW, Rodriguez M, Knapp PE, Hauser KF.","Curr HIV Res. 2014;12(6):424-34. doi: 10.2174/1570162x1206150311161147.","Fitting S","Curr HIV Res","2014","2015/03/12","PMC4475822","","10.2174/1570162x1206150311161147"
"25759139","Exploring prison buprenorphine misuse in the United Kingdom: a qualitative study of former prisoners","Tompkins CN, Wright NM, Waterman MG, Sheard L.","Int J Prison Health. 2009;5(2):71-87. doi: 10.1080/17449200902880482.","Tompkins CN","Int J Prison Health","2009","2015/03/12","","","10.1080/17449200902880482"
"25757712","Subjective effects of prisoners using buprenorphine for detoxification","Johnstone A, Duffy T, Martin C.","Int J Prison Health. 2011;7(4):52-65. doi: 10.1108/17449201111256907.","Johnstone A","Int J Prison Health","2011","2015/03/12","","","10.1108/17449201111256907"
"25757520","First Dutch national guidelines--pharmacological care for detained opioid addicts","Arends MT, De Haan HA, Van 't Hoff GI.","Int J Prison Health. 2009;5(4):192-200. doi: 10.1080/17449200903343167.","Arends MT","Int J Prison Health","2009","2015/03/12","","","10.1080/17449200903343167"
"25749509","Pharmacological options for the management of refractory cancer pain-what is the evidence?","Afsharimani B, Kindl K, Good P, Hardy J.","Support Care Cancer. 2015 May;23(5):1473-81. doi: 10.1007/s00520-015-2678-9. Epub 2015 Mar 7.","Afsharimani B","Support Care Cancer","2015","2015/03/10","","","10.1007/s00520-015-2678-9"
"25749264","Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients","DiPaula BA, Menachery E.","J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):187-92. doi: 10.1331/JAPhA.2015.14177.","DiPaula BA","J Am Pharm Assoc (2003)","2015","2015/03/10","","","10.1331/JAPhA.2015.14177"
"25749118","[Analgesic management of acute pain in patients receiving methadone or buprenorphine]","Zinck L, Sonne NM, Madsen SL, Nikolajsen L.","Ugeskr Laeger. 2015 Mar 2;177(10):V10140557.","Zinck L","Ugeskr Laeger","2015","2015/03/10","","",""
"25747921","Long-term course of opioid addiction","Hser YI, Evans E, Grella C, Ling W, Anglin D.","Harv Rev Psychiatry. 2015 Mar-Apr;23(2):76-89. doi: 10.1097/HRP.0000000000000052.","Hser YI","Harv Rev Psychiatry","2015","2015/03/10","","","10.1097/HRP.0000000000000052"
"25747920","Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","Connery HS.","Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75. doi: 10.1097/HRP.0000000000000075.","Connery HS","Harv Rev Psychiatry","2015","2015/03/10","","","10.1097/HRP.0000000000000075"
"25744650","Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms","Johnson B, Richert T.","J Subst Abuse Treat. 2015 Jul;54:50-5. doi: 10.1016/j.jsat.2015.01.013. Epub 2015 Feb 18.","Johnson B","J Subst Abuse Treat","2015","2015/03/07","","","10.1016/j.jsat.2015.01.013"
"25743750","Effect of buprenorphine on genotoxicity evaluation of chemicals by the rat liver micronucleus test with partial hepatectomy","Itoh S, Nagata M, Hattori C, Takasaki W.","J Toxicol Sci. 2015 Feb;40(1):109-14. doi: 10.2131/jts.40.109.","Itoh S","J Toxicol Sci","2015","2015/03/07","","","10.2131/jts.40.109"
"25742206","Buprenorphine-naloxone treatment of prescription opioid abuse: does past performance predict future results?","Langleben DD.","J Clin Psychiatry. 2015 Feb;76(2):195-7. doi: 10.4088/JCP.14com09617.","Langleben DD","J Clin Psychiatry","2015","2015/03/06","","","10.4088/JCP.14com09617"
"25738320","Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study","Suzuki J, Zinser J, Klaiber B, Hannon M, Grassi H, Spinosa M, Ramirez A, Issa M, Chin Feman SP.","Subst Abus. 2015;36(2):166-9. doi: 10.1080/08897077.2014.998400.","Suzuki J","Subst Abus","2015","2015/03/05","","","10.1080/08897077.2014.998400"
"25735465","Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder","Wilder C, Lewis D, Winhusen T.","Drug Alcohol Depend. 2015 Apr 1;149:225-31. doi: 10.1016/j.drugalcdep.2015.02.012. Epub 2015 Feb 19.","Wilder C","Drug Alcohol Depend","2015","2015/03/05","","","10.1016/j.drugalcdep.2015.02.012"
"25732991","Buprenorphine ingestion in a 23-month-old boy","Swartzentruber GS, Richardson WH, Mack EH.","Hosp Pediatr. 2015 Mar;5(3):164-6. doi: 10.1542/hpeds.2014-0070.","Swartzentruber GS","Hosp Pediatr","2015","2015/03/04","","","10.1542/hpeds.2014-0070"
"25716997","Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes","Carvallo L, Lopez L, Che FY, Lim J, Eugenin EA, Williams DW, Nieves E, Calderon TM, Madrid-Aliste C, Fiser A, Weiss L, Angeletti RH, Berman JW.","J Immunol. 2015 Apr 1;194(7):3246-58. doi: 10.4049/jimmunol.1302647. Epub 2015 Feb 25.","Carvallo L","J Immunol","2015","2015/02/27","PMC4369415","NIHMS658567","10.4049/jimmunol.1302647"
"25715074","Alcohol Screening among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program","Klimas J, Muench J, Wiest K, Croff R, Rieckman T, McCarty D.","J Psychoactive Drugs. 2015 Jan-Mar;47(1):65-70. doi: 10.1080/02791072.2014.991859.","Klimas J","J Psychoactive Drugs","2015","2015/02/26","PMC4741092","NIHMS754812","10.1080/02791072.2014.991859"
"25706332","Adherence to Buprenorphine Treatment Guidelines in a Medicaid Program","Baxter JD, Clark RE, Samnaliev M, Aweh G, O'Connell E.","Subst Abus. 2015;36(2):174-82. doi: 10.1080/08897077.2014.991469.","Baxter JD","Subst Abus","2015","2015/02/24","","","10.1080/08897077.2014.991469"
"25683352","Assessment of a carbon dioxide laser for the measurement of thermal nociceptive thresholds following intramuscular administration of analgesic drugs in pain-free female cats","Farnworth MJ, Barrett LA, Adams NJ, Beausoleil NJ, Weidgraaf K, Hekman M, Chambers JP, Thomas DG, Waran NK, Stafford KJ.","Vet Anaesth Analg. 2015 Nov;42(6):638-47. doi: 10.1111/vaa.12245. Epub 2015 Feb 14.","Farnworth MJ","Vet Anaesth Analg","2015","2015/02/17","","","10.1111/vaa.12245"
"25683329","Effects of buprenorphine on balance of oxidant/antioxidant system in the different ages of male rat liver","Samarghandian S, Azimi-Nezhad M, Afshari R, Farkhondeh T, Karimnezhad F.","J Biochem Mol Toxicol. 2015 Jun;29(6):249-53. doi: 10.1002/jbt.21691. Epub 2015 Feb 12.","Samarghandian S","J Biochem Mol Toxicol","2015","2015/02/17","","","10.1002/jbt.21691"
"25680734","Beyond-use date determination of buprenorphine buccal solution using a stability-indicating high-performance liquid chromatographic assay","Kirk LM, Brown SD.","J Feline Med Surg. 2015 Dec;17(12):1035-40. doi: 10.1177/1098612X15569329. Epub 2015 Feb 13.","Kirk LM","J Feline Med Surg","2015","2015/02/15","","","10.1177/1098612X15569329"
"25678375","Chronic pain and depression among primary care patients treated with buprenorphine","Stein MD, Herman DS, Bailey GL, Straus J, Anderson BJ, Uebelacker LA, Weisberg RB.","J Gen Intern Med. 2015 Jul;30(7):935-41. doi: 10.1007/s11606-015-3212-y. Epub 2015 Feb 13.","Stein MD","J Gen Intern Med","2015","2015/02/14","PMC4471032","","10.1007/s11606-015-3212-y"
"25675861","An observational study of buprenorphine treatment of the prescription opioid dependent pain patient","Streltzer J, Davidson R, Goebert D.","Am J Addict. 2015 Jun;24(4):357-61. doi: 10.1111/ajad.12198. Epub 2015 Feb 12.","Streltzer J","Am J Addict","2015","2015/02/14","","","10.1111/ajad.12198"
"25671806","The untapped potential of office-based buprenorphine treatment","Sigmon SC.","JAMA Psychiatry. 2015 Apr;72(4):395-6. doi: 10.1001/jamapsychiatry.2014.2421.","Sigmon SC","JAMA Psychiatry","2015","2015/02/12","","","10.1001/jamapsychiatry.2014.2421"
"25666027","Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy","Hulskotte EG, Bruce RD, Feng HP, Webster LR, Xuan F, Lin WH, O'Mara E, Wagner JA, Butterton JR.","Eur J Clin Pharmacol. 2015 Mar;71(3):303-11. doi: 10.1007/s00228-014-1789-4. Epub 2015 Feb 11.","Hulskotte EG","Eur J Clin Pharmacol","2015","2015/02/11","","","10.1007/s00228-014-1789-4"
"25665273","Buprenorphine: a new player in neonatal withdrawal syndrome","Nanda S, Brant R, Regier M, Yossuck P.","W V Med J. 2015 Jan-Feb;111(1):16-21.","Nanda S","W V Med J","2015","2015/02/11","","",""
"25663675","Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy","Tzatzarakis MN, Vakonaki E, Kovatsi L, Belivanis S, Mantsi M, Alegakis A, Liesivuori J, Tsatsakis AM.","J Anal Toxicol. 2015 May;39(4):313-20. doi: 10.1093/jat/bkv003. Epub 2015 Feb 7.","Tzatzarakis MN","J Anal Toxicol","2015","2015/02/10","","","10.1093/jat/bkv003"
"25661018","Sources of prescription opioids among diagnosed opioid abusers","Shei A, Rice JB, Kirson NY, Bodnar K, Birnbaum HG, Holly P, Ben-Joseph R.","Curr Med Res Opin. 2015 Apr;31(4):779-84. doi: 10.1185/03007995.2015.1016607. Epub 2015 Feb 24.","Shei A","Curr Med Res Opin","2015","2015/02/10","","","10.1185/03007995.2015.1016607"
"25660046","Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs","Monibi FA, Dodam JR, Axiak-Bechtel SM, Amorim J, Zhang Y, Tsuruta K, Mann FA, DeClue AE.","Res Vet Sci. 2015 Apr;99:70-6. doi: 10.1016/j.rvsc.2015.01.010. Epub 2015 Jan 21.","Monibi FA","Res Vet Sci","2015","2015/02/10","","","10.1016/j.rvsc.2015.01.010"
"25651434","Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","DeFlavio JR, Rolin SA, Nordstrom BR, Kazal LA Jr.","Rural Remote Health. 2015;15:3019. Epub 2015 Feb 4.","DeFlavio JR","Rural Remote Health","2015","2015/02/05","","",""
"25650977","Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica)","Thiede AJ, Garcia KD, Stolarik DF, Ma J, Jenkins GJ, Nunamaker EA.","J Am Assoc Lab Anim Sci. 2014 Nov;53(6):692-9.","Thiede AJ","J Am Assoc Lab Anim Sci","2014","2015/02/05","PMC4253584","",""
"25650975","Atipamezole reverses ketamine-dexmedetomidine anesthesia without altering the antinociceptive effects of butorphanol and buprenorphine in female C57BL/6J mice","Izer JM, Whitcomb TL, Wilson RP.","J Am Assoc Lab Anim Sci. 2014 Nov;53(6):675-83.","Izer JM","J Am Assoc Lab Anim Sci","2014","2015/02/05","PMC4253582","",""
"25650386","Primary tumour growth in an orthotopic osteosarcoma mouse model is not influenced by analgesic treatment with buprenorphine and meloxicam","Husmann K, Arlt MJ, Jirkof P, Arras M, Born W, Fuchs B.","Lab Anim. 2015 Oct;49(4):284-93. doi: 10.1177/0023677215570989. Epub 2015 Feb 3.","Husmann K","Lab Anim","2015","2015/02/05","","","10.1177/0023677215570989"
"25649847","The choice of general anesthetics may not affect neuroinflammation and impairment of learning and memory after surgery in elderly rats","Zhang J, Tan H, Jiang W, Zuo Z.","J Neuroimmune Pharmacol. 2015 Mar;10(1):179-89. doi: 10.1007/s11481-014-9580-y. Epub 2015 Feb 4.","Zhang J","J Neuroimmune Pharmacol","2015","2015/02/05","","","10.1007/s11481-014-9580-y"
"25649778","Noninvasive metrics for identification of brain injury deficits in piglets","Jaber SM, Sullivan S, Margulies SS.","Dev Neuropsychol. 2015 Jan;40(1):34-9. doi: 10.1080/87565641.2014.969733.","Jaber SM","Dev Neuropsychol","2015","2015/02/05","PMC4318352","NIHMS644003","10.1080/87565641.2014.969733"
"25626451","Past-year gambling behaviour among patients receiving opioid substitution treatment","Castrén S, Salonen AH, Alho H, Lahti T, Simojoki K.","Subst Abuse Treat Prev Policy. 2015 Jan 27;10:4. doi: 10.1186/1747-597X-10-4.","Castrén S","Subst Abuse Treat Prev Policy","2015","2015/01/29","PMC4417343","","10.1186/1747-597X-10-4"
"25624097","Factors associated with work and taking prescribed methadone or buprenorphine among Swedish opiate addicts","Blom Nilsson M, Chassler D, Lundgren LM.","Eval Program Plann. 2015 Apr;49:172-7. doi: 10.1016/j.evalprogplan.2014.12.015. Epub 2014 Dec 18.","Blom Nilsson M","Eval Program Plann","2015","2015/01/28","","","10.1016/j.evalprogplan.2014.12.015"
"25623082","The safety of high-dose buprenorphine administered subcutaneously in cats","Sramek MK, Haas MC, Coleman GD, Atterson PR, Hamlin RL.","J Vet Pharmacol Ther. 2015 Oct;38(5):434-42. doi: 10.1111/jvp.12203. Epub 2015 Jan 27.","Sramek MK","J Vet Pharmacol Ther","2015","2015/01/28","","","10.1111/jvp.12203"
"25622776","Using behavioral economics to predict opioid use during prescription opioid dependence treatment","Worley MJ, Shoptaw SJ, Bickel WK, Ling W.","Drug Alcohol Depend. 2015 Mar 1;148:62-8. doi: 10.1016/j.drugalcdep.2014.12.018. Epub 2014 Dec 30.","Worley MJ","Drug Alcohol Depend","2015","2015/01/28","PMC4666717","NIHMS658427","10.1016/j.drugalcdep.2014.12.018"
"25622120","Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study","Meyer MC, Johnston AM, Crocker AM, Heil SH.","J Addict Med. 2015 Mar-Apr;9(2):81-6. doi: 10.1097/ADM.0000000000000092.","Meyer MC","J Addict Med","2015","2015/01/27","PMC4375023","NIHMS635993","10.1097/ADM.0000000000000092"
"25601365","Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes","Bentzley BS, Barth KS, Back SE, Book SW.","J Subst Abuse Treat. 2015 May;52:48-57. doi: 10.1016/j.jsat.2014.12.011. Epub 2014 Dec 30.","Bentzley BS","J Subst Abuse Treat","2015","2015/01/21","PMC4382404","NIHMS652223","10.1016/j.jsat.2014.12.011"
"25599968","Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials","Yarlas A, Miller K, Wen W, Lynch SY, Ripa SR, Pergolizzi JV, Raffa RB.","Pain Pract. 2016 Mar;16(3):345-58. doi: 10.1111/papr.12281. Epub 2015 Jan 20.","Yarlas A","Pain Pract","2016","2015/01/21","","","10.1111/papr.12281"
"25592332","Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review","Akerman SC, Brunette MF, Green AI, Goodman DJ, Blunt HB, Heil SH.","J Subst Abuse Treat. 2015 May;52:40-7. doi: 10.1016/j.jsat.2014.12.002. Epub 2014 Dec 22.","Akerman SC","J Subst Abuse Treat","2015","2015/01/17","PMC4382443","NIHMS652817","10.1016/j.jsat.2014.12.002"
"25592182","Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder","Fox AD, Maradiaga J, Weiss L, Sanchez J, Starrels JL, Cunningham CO.","Addict Sci Clin Pract. 2015 Jan 16;10(1):2. doi: 10.1186/s13722-014-0023-0.","Fox AD","Addict Sci Clin Pract","2015","2015/01/17","PMC4410477","","10.1186/s13722-014-0023-0"
"25583888","Geographic and specialty distribution of US physicians trained to treat opioid use disorder","Rosenblatt RA, Andrilla CH, Catlin M, Larson EH.","Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.","Rosenblatt RA","Ann Fam Med","2015","2015/01/14","PMC4291261","","10.1370/afm.1735"
"25572305","Preliminary investigation of the thermal antinociceptive effects of codeine in cats","Steagall PV, Monteiro BP, Lavoie AM, Troncy E.","J Feline Med Surg. 2015 Dec;17(12):1061-4. doi: 10.1177/1098612X14564710. Epub 2015 Jan 8.","Steagall PV","J Feline Med Surg","2015","2015/01/10","","","10.1177/1098612X14564710"
"25569708","Improved memory for reward cues following acute buprenorphine administration in humans","Syal S, Ipser J, Terburg D, Solms M, Panksepp J, Malcolm-Smith S, Bos PA, Montoya ER, Stein DJ, van Honk J.","Psychoneuroendocrinology. 2015 Mar;53:10-5. doi: 10.1016/j.psyneuen.2014.11.009. Epub 2014 Nov 16.","Syal S","Psychoneuroendocrinology","2015","2015/01/09","","","10.1016/j.psyneuen.2014.11.009"
"25569005","Buprenorphine and naloxone compared with methadone treatment in pregnancy","Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J.","Obstet Gynecol. 2015 Feb;125(2):363-8. doi: 10.1097/AOG.0000000000000640.","Wiegand SL","Obstet Gynecol","2015","2015/01/09","","","10.1097/AOG.0000000000000640"
"25564105","Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058","Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN; HPTN 058 Protocol Team.","J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):554-61. doi: 10.1097/QAI.0000000000000510.","Metzger DS","J Acquir Immune Defic Syndr","2015","2015/01/08","PMC4382671","NIHMS651868","10.1097/QAI.0000000000000510"
"25562730","Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment","Carlsson S, Olsson R, Lindkvist I, Beck O.","Scand J Clin Lab Invest. 2015 Apr;75(2):156-61. doi: 10.3109/00365513.2014.993336. Epub 2015 Jan 6.","Carlsson S","Scand J Clin Lab Invest","2015","2015/01/07","","","10.3109/00365513.2014.993336"
"25562462","Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population","McDermott KA, Griffin ML, Connery HS, Hilario EY, Fiellin DA, Fitzmaurice GM, Weiss RD.","J Clin Psychiatry. 2015 Feb;76(2):189-94. doi: 10.4088/JCP.14m09096.","McDermott KA","J Clin Psychiatry","2015","2015/01/07","PMC4352119","NIHMS655273","10.4088/JCP.14m09096"
"25556392","Exogenous lipoid pneumonia as a contributory factor in a drug-related death","Moreau E, Rérolle C, Deveaux M, Paraf F, Saint-Martin P.","J Forensic Sci. 2015 Mar;60(2):514-7. doi: 10.1111/1556-4029.12677. Epub 2014 Dec 30.","Moreau E","J Forensic Sci","2015","2015/01/06","","","10.1111/1556-4029.12677"
"25555887","Predictors of long term opioid withdrawal outcome after short-term stabilization with buprenorphine","Saleh MI.","Eur Rev Med Pharmacol Sci. 2014;18(24):3935-42.","Saleh MI","Eur Rev Med Pharmacol Sci","2014","2015/01/04","","",""
"25550126","Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers","Haddad MS, Zelenev A, Altice FL.","J Urban Health. 2015 Feb;92(1):193-213. doi: 10.1007/s11524-014-9924-1.","Haddad MS","J Urban Health","2015","2015/01/01","PMC4338126","","10.1007/s11524-014-9924-1"
"25544740","Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans","Bershad AK, Jaffe JH, Childs E, de Wit H.","Psychoneuroendocrinology. 2015 Feb;52:281-8. doi: 10.1016/j.psyneuen.2014.12.004. Epub 2014 Dec 9.","Bershad AK","Psychoneuroendocrinology","2015","2014/12/30","PMC4297554","NIHMS648154","10.1016/j.psyneuen.2014.12.004"
"25543167","Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses","Bretteville-Jensen AL, Lillehagen M, Gjersing L, Andreas JB.","Drug Alcohol Depend. 2015 Feb 1;147:89-96. doi: 10.1016/j.drugalcdep.2014.12.002. Epub 2014 Dec 13.","Bretteville-Jensen AL","Drug Alcohol Depend","2015","2014/12/29","","","10.1016/j.drugalcdep.2014.12.002"
"25540212","A woman's experience of tapering from buprenorphine during pregnancy","Welle-Strand GK, Kvamme O, Andreassen A, Ravndal E.","BMJ Case Rep. 2014 Dec 24;2014:bcr2014207207. doi: 10.1136/bcr-2014-207207.","Welle-Strand GK","BMJ Case Rep","2014","2014/12/26","PMC4281552","","10.1136/bcr-2014-207207"
"25526395","Spontaneous pain-like behaviors are more sensitive to morphine and buprenorphine than mechanically evoked behaviors in a rat model of acute postoperative pain","Kabadi R, Kouya F, Cohen HW, Banik RK.","Anesth Analg. 2015 Feb;120(2):472-8. doi: 10.1213/ANE.0000000000000571.","Kabadi R","Anesth Analg","2015","2014/12/20","","","10.1213/ANE.0000000000000571"
"25526229","Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain","Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Pergolizzi JV Jr, Raffa R, Ripa SR.","Postgrad Med. 2015 Jan;127(1):38-45. doi: 10.1080/00325481.2014.992715. Epub 2014 Dec 15.","Yarlas A","Postgrad Med","2015","2014/12/20","","","10.1080/00325481.2014.992715"
"25523998","Opioids for field procedures in equine practice","Schauvliege S.","Vet Rec. 2014 Dec 20-27;175(24):621-2. doi: 10.1136/vr.g7571.","Schauvliege S","Vet Rec","2014","2014/12/20","","","10.1136/vr.g7571"
"25522892","Urine Spiking in a Pain Medicine Clinic: An Attempt to Simulate Adherence","Lee D, Bazydlo LA, Reisfield GM, Goldberger BA.","Pain Med. 2015 Jul;16(7):1449-51. doi: 10.1111/pme.12663. Epub 2014 Dec 18.","Lee D","Pain Med","2015","2014/12/20","","","10.1111/pme.12663"
"25521224","A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro","Knapman A, Santiago M, Connor M.","Br J Pharmacol. 2015 May;172(9):2258-72. doi: 10.1111/bph.13047. Epub 2015 Mar 17.","Knapman A","Br J Pharmacol","2015","2014/12/19","PMC4403092","","10.1111/bph.13047"
"25519865","Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use-buprenorphine/naloxone treatment and recovery in a surgical patient","Conroy S, Hill D.","BMJ Case Rep. 2014 Dec 17;2014:bcr2014207458. doi: 10.1136/bcr-2014-207458.","Conroy S","BMJ Case Rep","2014","2014/12/19","PMC4275746","","10.1136/bcr-2014-207458"
"25518754","Evaluation of opioid modulation in major depressive disorder","Ehrich E, Turncliff R, Du Y, Leigh-Pemberton R, Fernandez E, Jones R, Fava M.","Neuropsychopharmacology. 2015 May;40(6):1448-55. doi: 10.1038/npp.2014.330. Epub 2014 Dec 18.","Ehrich E","Neuropsychopharmacology","2015","2014/12/19","PMC4397403","","10.1038/npp.2014.330"
"25516077","A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia","Burns L, Gisev N, Larney S, Dobbins T, Gibson A, Kimber J, Larance B, Mattick RP, Butler T, Degenhardt L.","Addiction. 2015 Apr;110(4):646-55. doi: 10.1111/add.12834.","Burns L","Addiction","2015","2014/12/18","","","10.1111/add.12834"
"25512031","Buprenorphine added to bupivacaine prolongs femoral nerve block duration and improves analgesia in patients undergoing primary total knee arthroplasty-a randomised prospective double-blind study","Kosel J, Bobik P, Siemiątkowski A.","J Arthroplasty. 2015 Feb;30(2):320-4. doi: 10.1016/j.arth.2014.07.016. Epub 2014 Jul 24.","Kosel J","J Arthroplasty","2015","2014/12/17","","","10.1016/j.arth.2014.07.016"
"25510513","Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine","Zamani N, Hassanian-Moghaddam H, Bayat AH, Haghparast A, Shadnia S, Rahimi M, Hashemi Demaneh B, Assar N.","Toxicol Lett. 2015 Feb 3;232(3):590-4. doi: 10.1016/j.toxlet.2014.12.007. Epub 2014 Dec 12.","Zamani N","Toxicol Lett","2015","2014/12/17","","","10.1016/j.toxlet.2014.12.007"
"25510307","A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine","Stein MD, Herman DS, Moitra E, Hecht J, Lopez R, Anderson BJ, Brown RA.","Drug Alcohol Depend. 2015 Feb 1;147:243-50. doi: 10.1016/j.drugalcdep.2014.11.007. Epub 2014 Nov 26.","Stein MD","Drug Alcohol Depend","2015","2014/12/17","PMC4297723","NIHMS649368","10.1016/j.drugalcdep.2014.11.007"
"25503691","[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks]","Häuser W, Bernardy K, Maier C.","Schmerz. 2015 Feb;29(1):96-108. doi: 10.1007/s00482-014-1452-0.","Häuser W","Schmerz","2015","2014/12/16","","","10.1007/s00482-014-1452-0"
"25503600","Effectiveness and Safety of Transdermal Buprenorphine Versus Sustained-release Tramadol in Patients With Moderate to Severe Musculoskeletal Pain: An 8-Week, Randomized, Double-Blind, Double-Dummy, Multicenter, Active-controlled, Noninferiority Study","Leng X, Li Z, Lv H, Zheng Y, Liu Y, Dai K, Yao C, Yan X, Zeng X.","Clin J Pain. 2015 Jul;31(7):612-20. doi: 10.1097/AJP.0000000000000144.","Leng X","Clin J Pain","2015","2014/12/16","","","10.1097/AJP.0000000000000144"
"25496247","Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication","Johnson B, Richert T.","J Addict Dis. 2015;34(1):1-17. doi: 10.1080/10550887.2014.975617.","Johnson B","J Addict Dis","2015","2014/12/16","","","10.1080/10550887.2014.975617"
"25490611","Liver enzyme levels in adolescent patients treated with buprenorphine and additional psychotropic agents","Ciftci Demirci A, Gunes H, Adaletli H, Bulanik E, Erdogan A.","Am J Drug Alcohol Abuse. 2015 Jan;41(1):107-13. doi: 10.3109/00952990.2014.983272.","Ciftci Demirci A","Am J Drug Alcohol Abuse","2015","2014/12/10","","","10.3109/00952990.2014.983272"
"25490610","Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings","Murphy SM, Dweik D, McPherson S, Roll JM.","Am J Drug Alcohol Abuse. 2015 Jan;41(1):88-92. doi: 10.3109/00952990.2014.983274.","Murphy SM","Am J Drug Alcohol Abuse","2015","2014/12/10","PMC4638227","NIHMS727629","10.3109/00952990.2014.983274"
"25488320","Buprenorphine for pain relief in mice: repeated injections vs sustained-release depot formulation","Jirkof P, Tourvieille A, Cinelli P, Arras M.","Lab Anim. 2015 Jul;49(3):177-87. doi: 10.1177/0023677214562849. Epub 2014 Dec 8.","Jirkof P","Lab Anim","2015","2014/12/10","","","10.1177/0023677214562849"
"25485881","Hyperalgesia and increased sevoflurane minimum alveolar concentration induced by opioids in the rat: a randomised experimental study","Abreu M, Aguado D, Benito J, García-Fernández J, Segura IA.","Eur J Anaesthesiol. 2015 Apr;32(4):232-41. doi: 10.1097/EJA.0000000000000188.","Abreu M","Eur J Anaesthesiol","2015","2014/12/09","","","10.1097/EJA.0000000000000188"
"25481453","Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers","Meyer AC, Miller ME, Sigmon SC.","Addict Behav. 2015 Mar;42:189-93. doi: 10.1016/j.addbeh.2014.11.006. Epub 2014 Nov 18.","Meyer AC","Addict Behav","2015","2014/12/08","PMC4272898","NIHMS648510","10.1016/j.addbeh.2014.11.006"
"25480096","The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection","Tetrault JM, McCance-Katz EF, Moody DE, Fiellin DA, Lruie BS, DInh AT, Fiellin LE.","J Subst Abuse Treat. 2015 Apr;51:70-4. doi: 10.1016/j.jsat.2014.10.010. Epub 2014 Nov 5.","Tetrault JM","J Subst Abuse Treat","2015","2014/12/07","","","10.1016/j.jsat.2014.10.010"
"25479914","Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers","Woodcock EA, Lundahl LH, Greenwald MK.","Drug Alcohol Depend. 2015 Jan 1;146:89-96. doi: 10.1016/j.drugalcdep.2014.11.016. Epub 2014 Nov 26.","Woodcock EA","Drug Alcohol Depend","2015","2014/12/07","PMC4272885","NIHMS645547","10.1016/j.drugalcdep.2014.11.016"
"25474108","Crushed and injected buprenorphine tablets: characteristics of princeps and generic solutions","Bouquié R, Wainstein L, Pilet P, Mussini JM, Deslandes G, Clouet J, Dailly E, Jolliet P, Victorri-Vigneau C.","PLoS One. 2014 Dec 4;9(12):e113991. doi: 10.1371/journal.pone.0113991. eCollection 2014.","Bouquié R","PLoS One","2014","2014/12/05","PMC4256378","","10.1371/journal.pone.0113991"
"25465344","Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors","Johnson B, Richert T.","Int J Drug Policy. 2015 Feb;26(2):183-90. doi: 10.1016/j.drugpo.2014.10.003. Epub 2014 Oct 30.","Johnson B","Int J Drug Policy","2015","2014/12/04","","","10.1016/j.drugpo.2014.10.003"
"25459926","Generic on-line solid phase extraction sample preparation strategies for the analysis of drugs in biological matrices by LC-MS/MS","Bourgogne E, Grivet C, Varesio E, Hopfgartner G.","J Pharm Biomed Anal. 2015 Jan;102:290-8. doi: 10.1016/j.jpba.2014.09.030. Epub 2014 Sep 30.","Bourgogne E","J Pharm Biomed Anal","2015","2014/12/03","","","10.1016/j.jpba.2014.09.030"
"25456326","Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain","Wachholtz A, Gonzalez G.","Drug Alcohol Depend. 2014 Dec 1;145:143-9. doi: 10.1016/j.drugalcdep.2014.10.010. Epub 2014 Oct 28.","Wachholtz A","Drug Alcohol Depend","2014","2014/12/03","PMC4254606","NIHMS638557","10.1016/j.drugalcdep.2014.10.010"
"25456093","Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia","Piralishvili G, Otiashvili D, Sikharulidze Z, Kamkamidze G, Poole S, Woody GE.","J Subst Abuse Treat. 2015 Mar;50:32-7. doi: 10.1016/j.jsat.2014.10.003. Epub 2014 Oct 22.","Piralishvili G","J Subst Abuse Treat","2015","2014/12/03","","","10.1016/j.jsat.2014.10.003"
"25453747","Antidepressant-like effects of buprenorphine in rats are strain dependent","Browne CA, van Nest DS, Lucki I.","Behav Brain Res. 2015 Feb 1;278:385-92. doi: 10.1016/j.bbr.2014.10.014. Epub 2014 Oct 18.","Browne CA","Behav Brain Res","2015","2014/12/03","PMC4382376","NIHMS636646","10.1016/j.bbr.2014.10.014"
"25432908","Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone","Hard B.","BMJ Case Rep. 2014 Nov 28;2014:bcr2014207308. doi: 10.1136/bcr-2014-207308.","Hard B","BMJ Case Rep","2014","2014/11/30","PMC4248123","","10.1136/bcr-2014-207308"
"25413371","Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment","Soyka M.","Eur Addict Res. 2015;21(2):78-87. doi: 10.1159/000363232. Epub 2014 Nov 19.","Soyka M","Eur Addict Res","2015","2014/11/22","","","10.1159/000363232"
"25407020","Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study","Ayres R, Ingram J, Rees A, Neale J, Beattie A, Telfer M.","Subst Abuse Treat Prev Policy. 2014 Nov 18;9:44. doi: 10.1186/1747-597X-9-44.","Ayres R","Subst Abuse Treat Prev Policy","2014","2014/11/20","PMC4240819","","10.1186/1747-597X-9-44"
"25402596","Visual selective attention is impaired in children prenatally exposed to opioid agonist medication","Konijnenberg C, Melinder A.","Eur Addict Res. 2015;21(2):63-70. doi: 10.1159/000366018. Epub 2014 Nov 14.","Konijnenberg C","Eur Addict Res","2015","2014/11/18","","","10.1159/000366018"
"25394611","Does concurrent in utero exposure to buprenorphine and antidepressant medications influence the course of neonatal abstinence syndrome?","O'Connor AB, O'Brien L, Alto WA, Wong J.","J Matern Fetal Neonatal Med. 2016;29(1):112-4. doi: 10.3109/14767058.2014.987750. Epub 2014 Dec 10.","O'Connor AB","J Matern Fetal Neonatal Med","2016","2014/11/15","","","10.3109/14767058.2014.987750"
"25392437","Response","Koren G.","Can Fam Physician. 2014 Nov;60(11):986.","Koren G","Can Fam Physician","2014","2014/11/14","PMC4229156","",""
"25392436","Not antagonist treatment","Newman R, Gevertz S.","Can Fam Physician. 2014 Nov;60(11):986.","Newman R","Can Fam Physician","2014","2014/11/14","PMC4229155","",""
"25389219","Considerations on the role of buprenorphine in recovery from heroin addiction from a UK perspective","Nutt DJ.","J Psychopharmacol. 2015 Jan;29(1):43-9. doi: 10.1177/0269881114555248. Epub 2014 Nov 11.","Nutt DJ","J Psychopharmacol","2015","2014/11/13","","","10.1177/0269881114555248"
"25385094","Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy","Joseph D, Schobelock MJ, Riesenberg RR, Vince BD, Webster LR, Adeniji A, Elgadi M, Huang F.","Antimicrob Agents Chemother. 2015 Jan;59(1):498-504. doi: 10.1128/AAC.04046-14. Epub 2014 Nov 10.","Joseph D","Antimicrob Agents Chemother","2015","2014/11/12","PMC4291392","","10.1128/AAC.04046-14"
"25384936","Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?","Vickerman P, Page K, Maher L, Hickman M.","Addiction. 2014 Dec;109(12):2060-1. doi: 10.1111/add.12750.","Vickerman P","Addiction","2014","2014/11/12","PMC4520398","NIHMS709060","10.1111/add.12750"
"25377071","Research priorities regarding multimodal peripheral nerve blocks for postoperative analgesia and anesthesia based on hospital quality data extracted from over 1,300 cases (2011-2014)","Williams BA, Ibinson JW, Mangione MP, Modrak RT, Tonarelli EJ, Rakesh H, Kmatz AM, Cohen PZ.","Pain Med. 2015 Jan;16(1):7-12. doi: 10.1111/pme.12609. Epub 2014 Nov 6.","Williams BA","Pain Med","2015","2014/11/08","","","10.1111/pme.12609"
"25364995","Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective","Johnson B, Richert T.","J Psychoactive Drugs. 2014 Nov-Dec;46(5):427-35. doi: 10.1080/02791072.2014.960109.","Johnson B","J Psychoactive Drugs","2014","2014/11/04","","","10.1080/02791072.2014.960109"
"25364994","Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study","Teruya C, Schwartz RP, Mitchell SG, Hasson AL, Thomas C, Buoncristiani SH, Hser YI, Wiest K, Cohen AJ, Glick N, Jacobs P, McLaughlin P, Ling W.","J Psychoactive Drugs. 2014 Nov-Dec;46(5):412-26. doi: 10.1080/02791072.2014.921743.","Teruya C","J Psychoactive Drugs","2014","2014/11/04","PMC4220245","NIHMS615520","10.1080/02791072.2014.921743"
"25358852","Striatal dopamine D1 and D2 receptors are differentially regulated following buprenorphine or methadone treatment","Allouche S, Le Marec T, Coquerel A, Noble F, Marie N.","Psychopharmacology (Berl). 2015 May;232(9):1527-33. doi: 10.1007/s00213-014-3785-x. Epub 2014 Oct 31.","Allouche S","Psychopharmacology (Berl)","2015","2014/11/01","","","10.1007/s00213-014-3785-x"
"25357093","Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial","Brown MS, Hayes MJ, Thornton LM.","J Perinatol. 2015 Apr;35(4):278-83. doi: 10.1038/jp.2014.194. Epub 2014 Oct 30.","Brown MS","J Perinatol","2015","2014/10/31","","","10.1038/jp.2014.194"
"25354916","Executive function in preschool children prenatally exposed to methadone or buprenorphine","Konijnenberg C, Melinder A.","Child Neuropsychol. 2015;21(5):570-85. doi: 10.1080/09297049.2014.967201. Epub 2014 Oct 30.","Konijnenberg C","Child Neuropsychol","2015","2014/10/31","","","10.1080/09297049.2014.967201"
"25354289","Somatosensory and auditory processing in opioid-exposed newborns with neonatal abstinence syndrome: a magnetoencephalographic approach","Kivistö K, Nevalainen P, Lauronen L, Tupola S, Pihko E, Kivitie-Kallio S.","J Matern Fetal Neonatal Med. 2015;28(17):2015-9. doi: 10.3109/14767058.2014.978755. Epub 2014 Nov 11.","Kivistö K","J Matern Fetal Neonatal Med","2015","2014/10/30","","","10.3109/14767058.2014.978755"
"25353069","Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French survey","Wainstein L, Bernier C, Gérardin M, Bouquié R, Espitia O, Mussini JM, Jolliet P, Victorri-Vigneau C.","Br J Dermatol. 2015;172(5):1412-4. doi: 10.1111/bjd.13503. Epub 2015 Mar 9.","Wainstein L","Br J Dermatol","2015","2014/10/30","","","10.1111/bjd.13503"
"25351887","Clinical benchmarks regarding multimodal peripheral nerve blocks for postoperative analgesia: observations regarding combined perineural midazolam-clonidine-buprenorphine-dexamethasone","Williams BA, Ibinson JW, Mangione MP, Scanlan RL, Cohen PZ.","Pain Med. 2015 Jan;16(1):1-6. doi: 10.1111/pme.12599. Epub 2014 Oct 28.","Williams BA","Pain Med","2015","2014/10/30","","","10.1111/pme.12599"
"25348227","Clarification on transdermal buprenorphine","Dankiewicz EH, Haddox JD.","J Pain Palliat Care Pharmacother. 2014 Dec;28(4):415-6. doi: 10.3109/15360288.2014.972489. Epub 2014 Oct 28.","Dankiewicz EH","J Pain Palliat Care Pharmacother","2014","2014/10/29","","","10.3109/15360288.2014.972489"
"25348172","An unusual case of death probably triggered by the association of buprenorphine at therapeutic dose with ethanol and benzodiazepines and with very low norbuprenorphine level","Bardy G, Cathala P, Eiden C, Baccino E, Petit P, Mathieu O.","J Forensic Sci. 2015 Jan;60 Suppl 1:S269-71. doi: 10.1111/1556-4029.12621. Epub 2014 Oct 27.","Bardy G","J Forensic Sci","2015","2014/10/29","","","10.1111/1556-4029.12621"
"25347412","Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K.","JAMA Intern Med. 2014 Dec;174(12):1974-81. doi: 10.1001/jamainternmed.2014.5416.","Tsui JI","JAMA Intern Med","2014","2014/10/28","PMC4506774","NIHMS707090","10.1001/jamainternmed.2014.5416"
"25347242","[Therapy in heroin addiction]","Hosztafi S, Fürst Z.","Neuropsychopharmacol Hung. 2014 Sep;16(3):127-40.","Hosztafi S","Neuropsychopharmacol Hung","2014","2014/10/28","","",""
"25341411","Preclinical modeling of primal emotional affects (Seeking, Panic and Play): gateways to the development of new treatments for depression","Panksepp J, Yovell Y.","Psychopathology. 2014;47(6):383-93. doi: 10.1159/000366208. Epub 2014 Oct 22.","Panksepp J","Psychopathology","2014","2014/10/25","","","10.1159/000366208"
"25339320","Multimodal perineural analgesia with combined bupivacaine-clonidine-buprenorphine-dexamethasone: safe in vivo and chemically compatible in solution","Williams BA, Butt MT, Zeller JR, Coffee S, Pippi MA.","Pain Med. 2015 Jan;16(1):186-98. doi: 10.1111/pme.12592. Epub 2014 Oct 23.","Williams BA","Pain Med","2015","2014/10/24","","","10.1111/pme.12592"
"25337714","Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge study","Seah S, Asad AB, Baumgartner R, Feng D, Williams DS, Manigbas E, Beaver JD, Reese T, Henry B, Evelhoch JL, Chin CL.","PLoS One. 2014 Oct 22;9(10):e110432. doi: 10.1371/journal.pone.0110432. eCollection 2014.","Seah S","PLoS One","2014","2014/10/23","PMC4206294","","10.1371/journal.pone.0110432"
"25330017","Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial","Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O'Connor PG.","JAMA Intern Med. 2014 Dec;174(12):1947-54. doi: 10.1001/jamainternmed.2014.5302.","Fiellin DA","JAMA Intern Med","2014","2014/10/21","PMC6167926","NIHMS988351","10.1001/jamainternmed.2014.5302"
"25321188","Modeling longitudinal changes in buprenorphine treatment outcome for opioid dependence","Saleh MI.","Pharmacopsychiatry. 2014 Nov;47(7):251-8. doi: 10.1055/s-0034-1390467. Epub 2014 Oct 16.","Saleh MI","Pharmacopsychiatry","2014","2014/10/17","","","10.1055/s-0034-1390467"
"25314340","Combined abuse of clonidine and amitriptyline in a patient on buprenorphine maintenance treatment","Seale JP, Dittmer T, Sigman EJ, Clemons H, Johnson JA.","J Addict Med. 2014 Nov-Dec;8(6):476-8. doi: 10.1097/ADM.0000000000000081.","Seale JP","J Addict Med","2014","2014/10/15","PMC4227908","","10.1097/ADM.0000000000000081"
"25312475","Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder","Becker WC, Ganoczy D, Fiellin DA, Bohnert AS.","J Subst Abuse Treat. 2015 Jan;48(1):128-31. doi: 10.1016/j.jsat.2014.09.007. Epub 2014 Sep 26.","Becker WC","J Subst Abuse Treat","2015","2014/10/15","","","10.1016/j.jsat.2014.09.007"
"25307441","[Treatment of chronic hepatitis C in drug users: ethic, successful and useful]","Remy AJ, Wenger H, Bouchkira H.","Presse Med. 2014 Dec;43(12 Pt 1):1314-6. doi: 10.1016/j.lpm.2014.08.007. Epub 2014 Oct 11.","Remy AJ","Presse Med","2014","2014/10/14","","","10.1016/j.lpm.2014.08.007"
"25305714","Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: a cross-sectional survey of drug using prisoners","Wright NM, Mohammed Z, Hughes GJ.","Drug Alcohol Depend. 2014 Nov 1;144:254-8. doi: 10.1016/j.drugalcdep.2014.09.775. Epub 2014 Sep 30.","Wright NM","Drug Alcohol Depend","2014","2014/10/13","","","10.1016/j.drugalcdep.2014.09.775"
"25305141","Safety studies of post-surgical buprenorphine therapy for mice","Traul KA, Romero JB, Brayton C, DeTolla L, Forbes-McBean N, Halquist MS, Karnes HT, Sarabia-Estrada R, Tomlinson MJ, Tyler BM, Ye X, Zadnik P, Guarnieri M.","Lab Anim. 2015 Apr;49(2):100-10. doi: 10.1177/0023677214554216. Epub 2014 Oct 10.","Traul KA","Lab Anim","2015","2014/10/12","","","10.1177/0023677214554216"
"25304049","Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care","Zaller N, Mazhnaya A, Larney S, Islam Z, Shost A, Prokhorova T, Rybak N, Flanigan T.","Int J Drug Policy. 2015 Jan;26(1):37-42. doi: 10.1016/j.drugpo.2014.09.004. Epub 2014 Sep 16.","Zaller N","Int J Drug Policy","2015","2014/10/12","PMC4465255","NIHMS668771","10.1016/j.drugpo.2014.09.004"
"25303611","A high-quality RCT documents that elderly with dementia, the most neglected pain patients, have effective and safe pain relief from paracetamol alone or with buprenorphine patch","Breivik H.","Eur J Pain. 2014 Nov;18(10):1363-4. doi: 10.1002/ejp.558.","Breivik H","Eur J Pain","2014","2014/10/11","","","10.1002/ejp.558"
"25296014","Effects of buprenorphine and estrous cycle in a murine model of cecal ligation and puncture","Kennedy LH, Hwang H, Wolfe AM, Hauptman J, Nemzek-Hamlin JA.","Comp Med. 2014 Aug;64(4):270-82.","Kennedy LH","Comp Med","2014","2014/10/09","PMC4170092","",""
"25295868","Injection of crushed tablets--a prospective observational study","Jonsson B, Backman E, Salmonson H, Höjer J.","Clin Toxicol (Phila). 2014 Nov;52(9):982-3. doi: 10.3109/15563650.2014.967400. Epub 2014 Oct 8.","Jonsson B","Clin Toxicol (Phila)","2014","2014/10/09","","","10.3109/15563650.2014.967400"
"25295655","Analysis of buprenorphine/naloxone dosing impact on treatment duration, resource use and costs in the treatment of opioid-dependent adults: a retrospective study of US public and private health care claims","Khemiri A, Kharitonova E, Zah V, Ruby J, Toumi M.","Postgrad Med. 2014 Sep;126(5):113-20. doi: 10.3810/pgm.2014.09.2805.","Khemiri A","Postgrad Med","2014","2014/10/09","","","10.3810/pgm.2014.09.2805"
"25282598","Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model","Northrup TF, Stotts AL, Green C, Potter JS, Marino EN, Walker R, Weiss RD, Trivedi M.","Addict Behav. 2015 Feb;41:20-8. doi: 10.1016/j.addbeh.2014.09.021. Epub 2014 Sep 28.","Northrup TF","Addict Behav","2015","2014/10/06","PMC4252696","NIHMS630754","10.1016/j.addbeh.2014.09.021"
"25275875","Group medication management for buprenorphine/naloxone in opioid-dependent veterans","Berger R, Pulido C, Lacro J, Groban S, Robinson S.","J Addict Med. 2014 Nov-Dec;8(6):415-20. doi: 10.1097/ADM.0000000000000071.","Berger R","J Addict Med","2014","2014/10/03","","","10.1097/ADM.0000000000000071"
"25272148","Challenges and opportunities in using wastewater analysis to measure drug use in a small prison facility","van Dyken E, Lai FY, Thai PK, Ort C, Bruno R, Hall W, Kirkbride KP, Mueller JF, Prichard J.","Drug Alcohol Rev. 2016 Mar;35(2):138-47. doi: 10.1111/dar.12156. Epub 2014 Oct 1.","van Dyken E","Drug Alcohol Rev","2016","2014/10/02","","","10.1111/dar.12156"
"25271655","Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders","Park TW, Friedmann PD.","R I Med J (2013). 2014 Oct 1;97(10):20-4.","Park TW","R I Med J (2013)","2014","2014/10/02","PMC4406629","NIHMS677839",""
"25269566","Pharmacokinetics of oral transmucosal and intramuscular dexmedetomidine combined with buprenorphine in cats","Porters N, de Rooster H, Bosmans T, Baert K, Cherlet M, Croubels S, De Backer P, Polis I.","J Vet Pharmacol Ther. 2015 Apr;38(2):203-8. doi: 10.1111/jvp.12172. Epub 2014 Oct 1.","Porters N","J Vet Pharmacol Ther","2015","2014/10/02","","","10.1111/jvp.12172"
"25267606","Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder","Schuman-Olivier Z, Claire Greene M, Bergman BG, Kelly JF.","Drug Alcohol Depend. 2014 Nov 1;144:178-85. doi: 10.1016/j.drugalcdep.2014.09.009. Epub 2014 Sep 18.","Schuman-Olivier Z","Drug Alcohol Depend","2014","2014/10/01","PMC4253677","NIHMS634086","10.1016/j.drugalcdep.2014.09.009"
"25262056","Buprenorphine provides better anaesthetic conditions than butorphanol for field castration in ponies: results of a randomised clinical trial","Rigotti C, De Vries A, Taylor PM.","Vet Rec. 2014 Dec 20-27;175(24):623. doi: 10.1136/vr.102729. Epub 2014 Sep 26.","Rigotti C","Vet Rec","2014","2014/09/29","","","10.1136/vr.102729"
"25255072","Clinical efficacy of sustained-release buprenorphine with meloxicam for postoperative analgesia in beagle dogs undergoing ovariohysterectomy","Nunamaker EA, Stolarik DF, Ma J, Wilsey AS, Jenkins GJ, Medina CL.","J Am Assoc Lab Anim Sci. 2014 Sep;53(5):494-501.","Nunamaker EA","J Am Assoc Lab Anim Sci","2014","2014/09/26","PMC4181691","",""
"25255071","Effects of analgesic use on inflammation and hematology in a murine model of venous thrombosis","Hish GA Jr, Diaz JA, Hawley AE, Myers DD Jr, Lester PA.","J Am Assoc Lab Anim Sci. 2014 Sep;53(5):485-93.","Hish GA Jr","J Am Assoc Lab Anim Sci","2014","2014/09/26","PMC4181690","",""
"25255070","Pharmacokinetics of sustained-release analgesics in mice","Kendall LV, Hansen RJ, Dorsey K, Kang S, Lunghofer PJ, Gustafson DL.","J Am Assoc Lab Anim Sci. 2014 Sep;53(5):478-84.","Kendall LV","J Am Assoc Lab Anim Sci","2014","2014/09/26","PMC4181689","",""
"25254670","Addiction prescribing limits","Haynes B.","J Addict Med. 2014 Sep-Oct;8(5):387. doi: 10.1097/ADM.0000000000000088.","Haynes B","J Addict Med","2014","2014/09/26","","","10.1097/ADM.0000000000000088"
"25254668","Clinical case conference: unobserved ""home"" induction onto buprenorphine","Lee JD, McNeely J, Grossman E, Vocci F, Fiellin DA.","J Addict Med. 2014 Sep-Oct;8(5):309-14. doi: 10.1097/ADM.0000000000000060.","Lee JD","J Addict Med","2014","2014/09/26","","","10.1097/ADM.0000000000000060"
"25254667","Unobserved ""home"" induction onto buprenorphine","Lee JD, Vocci F, Fiellin DA.","J Addict Med. 2014 Sep-Oct;8(5):299-308. doi: 10.1097/ADM.0000000000000059.","Lee JD","J Addict Med","2014","2014/09/26","","","10.1097/ADM.0000000000000059"
"25251308","Prescription drug monitoring programs and buprenorphine maintenance: clinical considerations","Hoefer M, Petrakis I.","Am J Addict. 2014 Nov-Dec;23(6):616-7. doi: 10.1111/j.1521-0391.2014.12149.x. Epub 2014 Sep 22.","Hoefer M","Am J Addict","2014","2014/09/25","","","10.1111/j.1521-0391.2014.12149.x"
"25251050","Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: results from a 12-month observational study","Soyka M, Backmund M, Schmidt P, Apelt S.","Am J Addict. 2014 Nov-Dec;23(6):563-9. doi: 10.1111/j.1521-0391.2014.12131.x. Epub 2014 Sep 22.","Soyka M","Am J Addict","2014","2014/09/25","","","10.1111/j.1521-0391.2014.12131.x"
"25243431","Authors' reply: ""Risk reduction with buprenorphine-naloxone and methadone: patient's choice""","Woody G, Bruce D, Korthuis PT, Chhatre S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Poole S, Metzger D, Ling W.","J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):e142-3. doi: 10.1097/QAI.0000000000000344.","Woody G","J Acquir Immune Defic Syndr","2014","2014/09/23","PMC4229390","NIHMS625619","10.1097/QAI.0000000000000344"
"25239738","Frequent use of opioids in patients with dementia and nursing home residents: A study of the entire elderly population of Denmark","Jensen-Dahm C, Gasse C, Astrup A, Mortensen PB, Waldemar G.","Alzheimers Dement. 2015 Jun;11(6):691-9. doi: 10.1016/j.jalz.2014.06.013. Epub 2014 Sep 16.","Jensen-Dahm C","Alzheimers Dement","2015","2014/09/21","","","10.1016/j.jalz.2014.06.013"
"25239213","The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol","Dennis BB, Naji L, Bawor M, Bonner A, Varenbut M, Daiter J, Plater C, Pare G, Marsh DC, Worster A, Desai D, Samaan Z, Thabane L.","Syst Rev. 2014 Sep 19;3:105. doi: 10.1186/2046-4053-3-105.","Dennis BB","Syst Rev","2014","2014/09/21","PMC4171401","","10.1186/2046-4053-3-105"
"25226480","Treating prescription opioid dependence","Ruetsch C.","JAMA. 2014 Sep 17;312(11):1145-6. doi: 10.1001/jama.2014.4318.","Ruetsch C","JAMA","2014","2014/09/17","","","10.1001/jama.2014.4318"
"25221985","Buprenorphine diversion and misuse in outpatient practice","Lofwall MR, Martin J, Tierney M, Fatséas M, Auriacombe M, Lintzeris N.","J Addict Med. 2014 Sep-Oct;8(5):327-32. doi: 10.1097/ADM.0000000000000029.","Lofwall MR","J Addict Med","2014","2014/09/16","","","10.1097/ADM.0000000000000029"
"25221984","A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world","Lofwall MR, Walsh SL.","J Addict Med. 2014 Sep-Oct;8(5):315-26. doi: 10.1097/ADM.0000000000000045.","Lofwall MR","J Addict Med","2014","2014/09/16","PMC4177012","NIHMS581580","10.1097/ADM.0000000000000045"
"25220043","Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients","Daitch D, Daitch J, Novinson D, Frey M, Mitnick C, Pergolizzi J Jr.","Pain Med. 2014 Dec;15(12):2087-94. doi: 10.1111/pme.12520. Epub 2014 Sep 12.","Daitch D","Pain Med","2014","2014/09/16","","","10.1111/pme.12520"
"25218919","Supply of buprenorphine waivered physicians: the influence of state policies","Stein BD, Gordon AJ, Dick AW, Burns RM, Pacula RL, Farmer CM, Leslie DL, Sorbero M.","J Subst Abuse Treat. 2015 Jan;48(1):104-11. doi: 10.1016/j.jsat.2014.07.010. Epub 2014 Aug 2.","Stein BD","J Subst Abuse Treat","2015","2014/09/15","PMC4420477","NIHMS618802","10.1016/j.jsat.2014.07.010"
"25212472","[Psychopathology of the misuse of Subutex®: The Popeye syndrome]","Békaert J, Podevin G.","Encephale. 2015 Jun;41(3):229-37. doi: 10.1016/j.encep.2014.08.009. Epub 2014 Sep 16.","Békaert J","Encephale","2015","2014/09/13","","","10.1016/j.encep.2014.08.009"
"25205666","Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants","Fox AD, Chamberlain A, Sohler NL, Frost T, Cunningham CO.","J Subst Abuse Treat. 2015 Jan;48(1):112-6. doi: 10.1016/j.jsat.2014.07.015. Epub 2014 Aug 7.","Fox AD","J Subst Abuse Treat","2015","2014/09/11","PMC4250323","NIHMS626865","10.1016/j.jsat.2014.07.015"
"25199822","Review of the assessment and management of neonatal abstinence syndrome","Bagley SM, Wachman EM, Holland E, Brogly SB.","Addict Sci Clin Pract. 2014 Sep 9;9(1):19. doi: 10.1186/1940-0640-9-19.","Bagley SM","Addict Sci Clin Pract","2014","2014/09/10","PMC4166410","","10.1186/1940-0640-9-19"
"25199095","Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice","Clark TS, Clark DD, Hoyt RF Jr.","J Am Assoc Lab Anim Sci. 2014 Jul;53(4):387-91.","Clark TS","J Am Assoc Lab Anim Sci","2014","2014/09/09","PMC4113239","",""
"25198209","23-year-old woman being treated for opioid dependence, unexpected weight gain","Chudgar NP, Greenblatt L.","J Fam Pract. 2014 Jul;63(7):366-7.","Chudgar NP","J Fam Pract","2014","2014/09/09","","",""
"25197828","Risk reduction with buprenorphine-naloxone and methadone: patient's choice","Newman RG.","J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):e142. doi: 10.1097/QAI.0000000000000332.","Newman RG","J Acquir Immune Defic Syndr","2014","2014/09/09","","","10.1097/QAI.0000000000000332"
"25195682","Increasing use of opioids for pain","Fredheim OM.","Eur J Pain. 2014 Oct;18(9):1219-20. doi: 10.1002/ejp.505.","Fredheim OM","Eur J Pain","2014","2014/09/09","","","10.1002/ejp.505"
"25193176","The applicability of a gel delivery system for self-administration of buprenorphine to laboratory mice","Hovard A, Teilmann A, Hau J, Abelson K.","Lab Anim. 2015 Jan;49(1):40-5. doi: 10.1177/0023677214551108. Epub 2014 Sep 5.","Hovard A","Lab Anim","2015","2014/09/07","","","10.1177/0023677214551108"
"25191915","Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","Karp JF, Butters MA, Begley AE, Miller MD, Lenze EJ, Blumberger DM, Mulsant BH, Reynolds CF 3rd.","J Clin Psychiatry. 2014 Aug;75(8):e785-93. doi: 10.4088/JCP.13m08725.","Karp JF","J Clin Psychiatry","2014","2014/09/06","PMC4157317","NIHMS609147","10.4088/JCP.13m08725"
"25189089","The multi-site prescription opioid addiction treatment study: 18-month outcomes","Potter JS, Dreifuss JA, Marino EN, Provost SE, Dodd DR, Rice LS, Fitzmaurice GM, Griffin ML, Weiss RD.","J Subst Abuse Treat. 2015 Jan;48(1):62-9. doi: 10.1016/j.jsat.2014.07.009. Epub 2014 Aug 2.","Potter JS","J Subst Abuse Treat","2015","2014/09/06","PMC4250351","NIHMS618619","10.1016/j.jsat.2014.07.009"
"25183042","Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome","Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, Van Hook J, Marcotte M.","Contemp Clin Trials. 2014 Sep;39(1):158-65. doi: 10.1016/j.cct.2014.08.009. Epub 2014 Aug 23.","Winhusen T","Contemp Clin Trials","2014","2014/09/04","","","10.1016/j.cct.2014.08.009"
"25179217","Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","Greenwald MK, Comer SD, Fiellin DA.","Drug Alcohol Depend. 2014 Nov 1;144:1-11. doi: 10.1016/j.drugalcdep.2014.07.035. Epub 2014 Aug 19.","Greenwald MK","Drug Alcohol Depend","2014","2014/09/03","PMC4252738","NIHMS625207","10.1016/j.drugalcdep.2014.07.035"
"25178815","Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice","Falcon E, Maier K, Robinson SA, Hill-Smith TE, Lucki I.","Psychopharmacology (Berl). 2015 Mar;232(5):907-15. doi: 10.1007/s00213-014-3723-y. Epub 2014 Sep 3.","Falcon E","Psychopharmacology (Berl)","2015","2014/09/03","PMC4326609","NIHMS625278","10.1007/s00213-014-3723-y"
"25171726","Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies","Li X, Shorter D, Kosten TR.","Expert Opin Pharmacother. 2014 Oct;15(15):2263-75. doi: 10.1517/14656566.2014.955469. Epub 2014 Aug 29.","Li X","Expert Opin Pharmacother","2014","2014/08/30","","","10.1517/14656566.2014.955469"
"25170033","Prepubertal gonadectomy in cats: different injectable anaesthetic combinations and comparison with gonadectomy at traditional age","Porters N, de Rooster H, Moons CP, Duchateau L, Goethals K, Bosmans T, Polis I.","J Feline Med Surg. 2015 Jun;17(6):458-67. doi: 10.1177/1098612X14546919. Epub 2014 Aug 28.","Porters N","J Feline Med Surg","2015","2014/08/30","","","10.1177/1098612X14546919"
"25163749","Pharmacodynamic modelling of placebo and buprenorphine effects on event-related potentials in experimental pain","Juul RV, Foster DJ, Upton RN, Andresen T, Graversen C, Drewes AM, Christrup LL, Kreilgaard M.","Basic Clin Pharmacol Toxicol. 2014 Oct;115(4):343-51. doi: 10.1111/bcpt.12217. Epub 2014 Mar 17.","Juul RV","Basic Clin Pharmacol Toxicol","2014","2014/08/29","","","10.1111/bcpt.12217"
"25163678","Buprenorphine for cancer pain: is it ready for prime time?","Prommer E.","Am J Hosp Palliat Care. 2015 Dec;32(8):881-9. doi: 10.1177/1049909114547227. Epub 2014 Aug 27.","Prommer E","Am J Hosp Palliat Care","2015","2014/08/29","","","10.1177/1049909114547227"
"25162607","Buprenorphine in the workers' compensation setting","Colameco S, Pohl M.","J Opioid Manag. 2014 Jul-Aug;10(4):277-83. doi: 10.5055/jom.2014.0215.","Colameco S","J Opioid Manag","2014","2014/08/28","","","10.5055/jom.2014.0215"
"25156759","Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update","Soyka M.","Expert Opin Drug Deliv. 2015 Feb;12(2):339-47. doi: 10.1517/17425247.2014.953479. Epub 2014 Aug 25.","Soyka M","Expert Opin Drug Deliv","2015","2014/08/27","","","10.1517/17425247.2014.953479"
"25153315","Meloxicam and buprenorphine treatment after ovarian transplantation does not affect estrous cyclicity and follicular integrity in aged CBA/J mice","Le AH, Bonachea LA, Cargill SL.","PLoS One. 2014 Aug 25;9(8):e106013. doi: 10.1371/journal.pone.0106013. eCollection 2014.","Le AH","PLoS One","2014","2014/08/26","PMC4143324","","10.1371/journal.pone.0106013"
"25150272","Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis","Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P.","Am J Epidemiol. 2014 Oct 1;180(7):673-86. doi: 10.1093/aje/kwu190. Epub 2014 Aug 22.","Brogly SB","Am J Epidemiol","2014","2014/08/24","","","10.1093/aje/kwu190"
"25137081","Parenting and concerns of pregnant women in buprenorphine treatment","Rizzo RA, Neumann AM, King SO, Hoey RF, Finnell DS, Blondell RD.","MCN Am J Matern Child Nurs. 2014 Sep-Oct;39(5):319-24. doi: 10.1097/NMC.0000000000000066.","Rizzo RA","MCN Am J Matern Child Nurs","2014","2014/08/20","PMC4139710","NIHMS592149","10.1097/NMC.0000000000000066"
"25134875","Addiction disorders","Merrill JO, Duncan MH.","Med Clin North Am. 2014 Sep;98(5):1097-122. doi: 10.1016/j.mcna.2014.06.008.","Merrill JO","Med Clin North Am","2014","2014/08/20","","","10.1016/j.mcna.2014.06.008"
"25127184","Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients","Notley C, Blyth A, Maskrey V, Pinto H, Holland R.","Subst Abus. 2015;36(2):232-9. doi: 10.1080/08897077.2014.941085. Epub 2014 Aug 15.","Notley C","Subst Abus","2015","2014/08/16","","","10.1080/08897077.2014.941085"
"25123823","Costs of care for persons with opioid dependence in commercial integrated health systems","Lynch FL, McCarty D, Mertens J, Perrin NA, Green CA, Parthasarathy S, Dickerson JF, Anderson BM, Pating D.","Addict Sci Clin Pract. 2014 Aug 14;9(1):16. doi: 10.1186/1940-0640-9-16.","Lynch FL","Addict Sci Clin Pract","2014","2014/08/16","PMC4142137","","10.1186/1940-0640-9-16"
"25115236","Diffusion and diversion of suboxone: an exploration of illicit street opioid selling","Furst RT.","J Addict Dis. 2014;33(3):177-86. doi: 10.1080/10550887.2014.950030.","Furst RT","J Addict Dis","2014","2014/08/14","","","10.1080/10550887.2014.950030"
"25106089","Opioid selective antinociception following microinjection into the periaqueductal gray of the rat","Morgan MM, Reid RA, Stormann TM, Lautermilch NJ.","J Pain. 2014 Nov;15(11):1102-1109. doi: 10.1016/j.jpain.2014.07.008. Epub 2014 Aug 5.","Morgan MM","J Pain","2014","2014/08/10","","","10.1016/j.jpain.2014.07.008"
"25090173","Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, Dossabhoy S, Stein M.","JAMA Intern Med. 2014 Aug;174(8):1369-76. doi: 10.1001/jamainternmed.2014.2556.","Liebschutz JM","JAMA Intern Med","2014","2014/08/05","PMC4811188","NIHMS771366","10.1001/jamainternmed.2014.2556"
"25090043","Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence","Christensen DR, Landes RD, Jackson L, Marsch LA, Mancino MJ, Chopra MP, Bickel WK.","J Consult Clin Psychol. 2014 Dec;82(6):964-72. doi: 10.1037/a0037496. Epub 2014 Aug 4.","Christensen DR","J Consult Clin Psychol","2014","2014/08/05","PMC4244262","NIHMS617076","10.1037/a0037496"
"25084802","The anti-suicidal potential of buprenorphine: a case report","Striebel JM, Kalapatapu RK.","Int J Psychiatry Med. 2014;47(2):169-74. doi: 10.2190/PM.47.2.g.","Striebel JM","Int J Psychiatry Med","2014","2014/08/03","PMC4120471","NIHMS581289","10.2190/PM.47.2.g"
"25072677","Factors affecting noncompliance with buprenorphine maintenance treatment","Fareed A, Eilender P, Ketchen B, Buchanan-Cummings AM, Scheinberg K, Crampton K, Nash A, Shongo-Hiango H, Drexler K.","J Addict Med. 2014 Sep-Oct;8(5):345-50. doi: 10.1097/ADM.0000000000000057.","Fareed A","J Addict Med","2014","2014/07/30","","","10.1097/ADM.0000000000000057"
"25070601","The clinical analgesic efficacy of buprenorphine","Raffa RB, Haidery M, Huang HM, Kalladeen K, Lockstein DE, Ono H, Shope MJ, Sowunmi OA, Tran JK, Pergolizzi JV Jr.","J Clin Pharm Ther. 2014 Dec;39(6):577-83. doi: 10.1111/jcpt.12196. Epub 2014 Jul 29.","Raffa RB","J Clin Pharm Ther","2014","2014/07/30","","","10.1111/jcpt.12196"
"25069011","A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite study","Proctor SL, Copeland AL, Kopak AM, Herschman PL, Polukhina N.","Exp Clin Psychopharmacol. 2014 Oct;22(5):424-33. doi: 10.1037/a0037550. Epub 2014 Jul 28.","Proctor SL","Exp Clin Psychopharmacol","2014","2014/07/29","","","10.1037/a0037550"
"25065489","Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users","Nielsen S, Hillhouse M, Mooney L, Ang A, Ling W.","J Subst Abuse Treat. 2015 Jan;48(1):70-6. doi: 10.1016/j.jsat.2014.06.006. Epub 2014 Jun 28.","Nielsen S","J Subst Abuse Treat","2015","2014/07/29","PMC4250309","NIHMS616474","10.1016/j.jsat.2014.06.006"
"25065457","Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency","Suzuki J, Connery HS, Ellison TV, Renner JA.","Am J Addict. 2014 Nov-Dec;23(6):618-22. doi: 10.1111/j.1521-0391.2014.12143.x. Epub 2014 Jul 25.","Suzuki J","Am J Addict","2014","2014/07/29","PMC4391742","NIHMS674220","10.1111/j.1521-0391.2014.12143.x"
"25063147","Determination of buprenorphine by differential pulse voltammetry on carbon paste electrode using SDS as an enhancement factor","Behpour M, Valipour A, Keshavarz M.","Mater Sci Eng C Mater Biol Appl. 2014 Sep;42:500-5. doi: 10.1016/j.msec.2014.05.067. Epub 2014 Jun 6.","Behpour M","Mater Sci Eng C Mater Biol Appl","2014","2014/07/27","","","10.1016/j.msec.2014.05.067"
"25062522","Care of the infant with neonatal abstinence syndrome: strength of the evidence","Maguire D.","J Perinat Neonatal Nurs. 2014 Jul-Sep;28(3):204-11; quiz E3-4. doi: 10.1097/JPN.0000000000000042.","Maguire D","J Perinat Neonatal Nurs","2014","2014/07/26","","","10.1097/JPN.0000000000000042"
"25062519","Buprenorphine for the treatment of opioid dependence in pregnancy","Mittal L.","J Perinat Neonatal Nurs. 2014 Jul-Sep;28(3):178-84. doi: 10.1097/JPN.0000000000000044.","Mittal L","J Perinat Neonatal Nurs","2014","2014/07/26","","","10.1097/JPN.0000000000000044"
"25061701","Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius)","Gustavsen KA, Guzman DS, Knych HK, Petritz OA, Olsen GH, Paul-Murphy JR.","Am J Vet Res. 2014 Aug;75(8):711-5. doi: 10.2460/ajvr.75.8.711.","Gustavsen KA","Am J Vet Res","2014","2014/07/26","","","10.2460/ajvr.75.8.711"
"25061700","Evaluation of thermal antinociceptive effects after intramuscular administration of buprenorphine hydrochloride to American kestrels (Falco sparverius)","Ceulemans SM, Guzman DS, Olsen GH, Beaufrère H, Paul-Murphy JR.","Am J Vet Res. 2014 Aug;75(8):705-10. doi: 10.2460/ajvr.75.8.705.","Ceulemans SM","Am J Vet Res","2014","2014/07/26","","","10.2460/ajvr.75.8.705"
"25060839","Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users","Jones JD, Sullivan MA, Vosburg SK, Manubay JM, Mogali S, Metz V, Comer SD.","Addict Biol. 2015 Jul;20(4):784-98. doi: 10.1111/adb.12163. Epub 2014 Jul 25.","Jones JD","Addict Biol","2015","2014/07/26","PMC4305506","NIHMS604375","10.1111/adb.12163"
"25060491","Compulsive-like responding for opioid analgesics in rats with extended access","Wade CL, Vendruscolo LF, Schlosburg JE, Hernandez DO, Koob GF.","Neuropsychopharmacology. 2015 Jan;40(2):421-8. doi: 10.1038/npp.2014.188. Epub 2014 Jul 25.","Wade CL","Neuropsychopharmacology","2015","2014/07/26","PMC4443956","","10.1038/npp.2014.188"
"25052793","Buprenorphine prescription compliance: an original observational and longitudinal study","Guillou Landreat M, Sebille-Rivain V, Victorri Vigneau C, Foucher Y, Venisse JL, Jolliet P.","J Psychoactive Drugs. 2014 Apr-Jun;46(2):162-7. doi: 10.1080/02791072.2014.904061.","Guillou Landreat M","J Psychoactive Drugs","2014","2014/07/24","","","10.1080/02791072.2014.904061"
"25046332","Laboratory and clinical evaluation of on-site urine drug testing","Beck O, Carlsson S, Tusic M, Olsson R, Franzen L, Hulten P.","Scand J Clin Lab Invest. 2014 Nov;74(8):681-6. doi: 10.3109/00365513.2014.939995. Epub 2014 Jul 21.","Beck O","Scand J Clin Lab Invest","2014","2014/07/22","","","10.3109/00365513.2014.939995"
"25041444","Antinociceptive effect of buprenorphine and evaluation of the nociceptive withdrawal reflex in foals","Risberg ÅI, Spadavecchia C, Ranheim B, Hendrickson EH, Lervik A, Haga HA.","Vet Anaesth Analg. 2015 May;42(3):329-38. doi: 10.1111/vaa.12205. Epub 2014 Jul 21.","Risberg ÅI","Vet Anaesth Analg","2015","2014/07/22","","","10.1111/vaa.12205"
"25040021","The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence","Clark RE, Baxter JD, Barton BA, Aweh G, O'Connell E, Fisher WH.","Version 2. Health Serv Res. 2014 Dec;49(6):1964-79. doi: 10.1111/1475-6773.12201. Epub 2014 Jul 9.","Clark RE","Health Serv Res","2014","2014/07/22","PMC4237648","NIHMS596575","10.1111/1475-6773.12201"
"25023716","Characteristics and quality of life of opioid-dependent pregnant women in Austria","Metz VE, Comer SD, Wuerzl J, Pribasnig A, Fischer G.","Arch Womens Ment Health. 2014 Dec;17(6):529-39. doi: 10.1007/s00737-014-0443-6. Epub 2014 Jul 15.","Metz VE","Arch Womens Ment Health","2014","2014/07/16","PMC4239179","NIHMS613651","10.1007/s00737-014-0443-6"
"25022635","Safety of the newer class of opioid antagonists in pregnancy","Poon S, Pupco A, Koren G, Bozzo P.","Can Fam Physician. 2014 Jul;60(7):631-2, e348-9.","Poon S","Can Fam Physician","2014","2014/07/16","PMC4096261","",""
"25015687","A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?","Larance B, Carragher N, Mattick RP, Lintzeris N, Ali R, Degenhardt L.","Drug Alcohol Depend. 2014 Sep 1;142:46-55. doi: 10.1016/j.drugalcdep.2014.05.018. Epub 2014 Jun 2.","Larance B","Drug Alcohol Depend","2014","2014/07/13","","","10.1016/j.drugalcdep.2014.05.018"
"25015174","A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependence","Nasser AF, Heidbreder C, Gomeni R, Fudala PJ, Zheng B, Greenwald MK.","Clin Pharmacokinet. 2014 Sep;53(9):813-24. doi: 10.1007/s40262-014-0155-0.","Nasser AF","Clin Pharmacokinet","2014","2014/07/13","","","10.1007/s40262-014-0155-0"
"24999060","Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand","Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celentano DD, Metzger D, Jackson JB, Burns D; HPTN 058 study group.","Drug Alcohol Depend. 2014 Sep 1;142:139-45. doi: 10.1016/j.drugalcdep.2014.06.013. Epub 2014 Jun 19.","Lucas GM","Drug Alcohol Depend","2014","2014/07/08","PMC4127183","NIHMS611372","10.1016/j.drugalcdep.2014.06.013"
"24995716","Sublingual buprenorphine as an analgesic in chronic pain: a systematic review","Cote J, Montgomery L.","Pain Med. 2014 Jul;15(7):1171-8. doi: 10.1111/pme.12386. Epub 2014 Jul 4.","Cote J","Pain Med","2014","2014/07/05","","","10.1111/pme.12386"
"24990199","Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study","Yee A, Loh HS, Hisham Hashim HM, Ng CG.","Int J Impot Res. 2014 Sep-Oct;26(5):161-6. doi: 10.1038/ijir.2014.18. Epub 2014 Jul 3.","Yee A","Int J Impot Res","2014","2014/07/04","","","10.1038/ijir.2014.18"
"24985936","Perioperative management of a patient undergoing Clagett window closure stabilized on Suboxone® for chronic pain: a case report","Huang A, Katznelson R, de Perrot M, Clarke H.","Can J Anaesth. 2014 Sep;61(9):826-31. doi: 10.1007/s12630-014-0193-y. Epub 2014 Jul 2.","Huang A","Can J Anaesth","2014","2014/07/03","","","10.1007/s12630-014-0193-y"
"24984689","Factors contributing to the rise of buprenorphine misuse: 2008-2013","Cicero TJ, Ellis MS, Surratt HL, Kurtz SP.","Drug Alcohol Depend. 2014 Sep 1;142:98-104. doi: 10.1016/j.drugalcdep.2014.06.005. Epub 2014 Jun 18.","Cicero TJ","Drug Alcohol Depend","2014","2014/07/03","","","10.1016/j.drugalcdep.2014.06.005"
"24984130","Evaluation of the perioperative analgesic efficacy of buprenorphine, compared with butorphanol, in cats","Warne LN, Beths T, Holm M, Carter JE, Bauquier SH.","J Am Vet Med Assoc. 2014 Jul 15;245(2):195-202. doi: 10.2460/javma.245.2.195.","Warne LN","J Am Vet Med Assoc","2014","2014/07/02","","","10.2460/javma.245.2.195"
"24978013","Improving care for hospitalized, opioid-dependent patients: a promising start","Kushel M.","JAMA Intern Med. 2014 Aug;174(8):1377-8. doi: 10.1001/jamainternmed.2014.728.","Kushel M","JAMA Intern Med","2014","2014/07/01","","","10.1001/jamainternmed.2014.728"
"24973401","A pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomes","Brown RA, Bloom EL, Hecht J, Moitra E, Herman DS, Stein MD.","Behav Modif. 2014 Sep;38(5):730-59. doi: 10.1177/0145445514538279. Epub 2014 Jun 27.","Brown RA","Behav Modif","2014","2014/06/29","PMC4876823","NIHMS782956","10.1177/0145445514538279"
"24962326","A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry","Gordon MS, Kinlock TW, Schwartz RP, Fitzgerald TT, O'Grady KE, Vocci FJ.","Drug Alcohol Depend. 2014 Sep 1;142:33-40. doi: 10.1016/j.drugalcdep.2014.05.011. Epub 2014 Jun 2.","Gordon MS","Drug Alcohol Depend","2014","2014/06/26","PMC4129444","NIHMS601089","10.1016/j.drugalcdep.2014.05.011"
"24959727","Evaluation of an improved sustained-release buprenorphine formulation for use in mice","Healy JR, Tonkin JL, Kamarec SR, Saludes MA, Ibrahim SY, Matsumoto RR, Wimsatt JH.","Am J Vet Res. 2014 Jul;75(7):619-25. doi: 10.2460/ajvr.75.7.619.","Healy JR","Am J Vet Res","2014","2014/06/25","","","10.2460/ajvr.75.7.619"
"24957634","Maintenance treatments for opiate -dependent adolescents","Minozzi S, Amato L, Bellisario C, Davoli M.","Cochrane Database Syst Rev. 2014 Jun 24;(6):CD007210. doi: 10.1002/14651858.CD007210.pub3.","Minozzi S","Cochrane Database Syst Rev","2014","2014/06/25","","","10.1002/14651858.CD007210.pub3"
"24953563","Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine","Sundström M, Pelander A, Ojanperä I.","Drug Test Anal. 2015 May;7(5):420-7. doi: 10.1002/dta.1683. Epub 2014 Jun 20.","Sundström M","Drug Test Anal","2015","2014/06/24","","","10.1002/dta.1683"
"24953168","Emerging adult age status predicts poor buprenorphine treatment retention","Schuman-Olivier Z, Weiss RD, Hoeppner BB, Borodovsky J, Albanese MJ.","J Subst Abuse Treat. 2014 Sep;47(3):202-12. doi: 10.1016/j.jsat.2014.04.006. Epub 2014 May 20.","Schuman-Olivier Z","J Subst Abuse Treat","2014","2014/06/24","PMC4180514","NIHMS599267","10.1016/j.jsat.2014.04.006"
"24944070","A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center","Balhara YP.","J Opioid Manag. 2014 May-Jun;10(3):200-6. doi: 10.5055/jom.2014.0208.","Balhara YP","J Opioid Manag","2014","2014/06/20","","","10.5055/jom.2014.0208"
"24944066","Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically","Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD.","J Opioid Manag. 2014 May-Jun;10(3):159-68. doi: 10.5055/jom.2014.0204.","Suzuki J","J Opioid Manag","2014","2014/06/20","PMC4085743","NIHMS597679","10.5055/jom.2014.0204"
"24942534","Opioid use in Albuquerque, New Mexico: a needs assessment of recent changes and treatment availability","Greenfield BL, Owens MD, Ley D.","Addict Sci Clin Pract. 2014 Jun 18;9(1):10. doi: 10.1186/1940-0640-9-10.","Greenfield BL","Addict Sci Clin Pract","2014","2014/06/20","PMC4070335","","10.1186/1940-0640-9-10"
"24933507","Synthesis and evaluation of three structurally related ¹⁸F-labeled orvinols of different intrinsic activities: 6-O-[¹⁸F]fluoroethyl-diprenorphine ([¹⁸F]FDPN), 6-O-[¹⁸F]fluoroethyl-buprenorphine ([¹⁸F]FBPN), and 6-O-[¹⁸F]fluoroethyl-phenethyl-orvinol ([¹⁸F]FPEO)","Schoultz BW, Hjørnevik T, Reed BJ, Marton J, Coello CS, Willoch F, Henriksen G.","J Med Chem. 2014 Jun 26;57(12):5464-9. doi: 10.1021/jm500503k. Epub 2014 Jun 16.","Schoultz BW","J Med Chem","2014","2014/06/17","","","10.1021/jm500503k"
"24930319","[Long-term treatment of chronic pain with low-dose 7-day buprenorphine transdermal patch. Observational data from elderly patients of pain relief and quality of life]","Uberall MA, Müller-Schwefe GH.","MMW Fortschr Med. 2013 Oct 10;155 Suppl 3:87-96. doi: 10.1007/s15006-013-2188-y.","Uberall MA","MMW Fortschr Med","2013","2014/06/17","","","10.1007/s15006-013-2188-y"
"24927504","[Use of generic high dose buprenorphine (HDB): about a qualitative survey]","El-Haïk Y, Frauger E, Tanti-Hardouin N, Micallef J, Thirion X.","Therapie. 2014 May-Jun;69(3):239-41. doi: 10.2515/therapie/2014032. Epub 2014 Jun 16.","El-Haïk Y","Therapie","2014","2014/06/14","","","10.2515/therapie/2014032"
"24925983","Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis)","Belsey SL, Couchman L, Flanagan RJ.","J Anal Toxicol. 2014 Sep;38(7):438-43. doi: 10.1093/jat/bku060. Epub 2014 Jun 12.","Belsey SL","J Anal Toxicol","2014","2014/06/14","","","10.1093/jat/bku060"
"24912863","Smoking cessation treatment among office-based buprenorphine treatment patients","Nahvi S, Blackstock O, Sohler NL, Thompson D, Cunningham CO.","J Subst Abuse Treat. 2014 Aug;47(2):175-9. doi: 10.1016/j.jsat.2014.04.001. Epub 2014 Apr 27.","Nahvi S","J Subst Abuse Treat","2014","2014/06/11","PMC4104355","NIHMS590249","10.1016/j.jsat.2014.04.001"
"24912424","Medication errors related to transdermal opioid patches: lessons from a regional incident reporting system","Lövborg H, Holmlund M, Hägg S.","BMC Pharmacol Toxicol. 2014 Jun 9;15:31. doi: 10.1186/2050-6511-15-31.","Lövborg H","BMC Pharmacol Toxicol","2014","2014/06/11","PMC4062292","","10.1186/2050-6511-15-31"
"24905761","Pharmacology corner. Buprenorphine","","J Addict Nurs. 2014 Apr-Jun;25(2):103-4. doi: 10.1097/JAN.0000000000000031.","","J Addict Nurs","2014","2014/06/07","","","10.1097/JAN.0000000000000031"
"24903063","BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice","Khroyan TV, Wu J, Polgar WE, Cami-Kobeci G, Fotaki N, Husbands SM, Toll L.","Br J Pharmacol. 2015 Jan;172(2):668-80. doi: 10.1111/bph.12796. Epub 2014 Nov 5.","Khroyan TV","Br J Pharmacol","2015","2014/06/07","PMC4292977","","10.1111/bph.12796"
"24885218","Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment","Casati A, Piontek D, Pfeiffer-Gerschel T.","Subst Abuse Treat Prev Policy. 2014 May 21;9:19. doi: 10.1186/1747-597X-9-19.","Casati A","Subst Abuse Treat Prev Policy","2014","2014/06/03","PMC4035758","","10.1186/1747-597X-9-19"
"24880512","Potentiation of the effect of buprenorphine/naloxone with gabapentin or quetiapine","Reeves RR, Ladner ME.","Am J Psychiatry. 2014 Jun;171(6):691. doi: 10.1176/appi.ajp.2014.13111526.","Reeves RR","Am J Psychiatry","2014","2014/06/02","","","10.1176/appi.ajp.2014.13111526"
"24874817","Addendum: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice","Mitchell C, Willenbring H.","Nat Protoc. 2014;9(6). doi: 10.1038/nprot.2014.122.","Mitchell C","Nat Protoc","2014","2014/05/31","","","10.1038/nprot.2014.122"
"24873999","Advertising representation, treatment menu and economic circulation of substance misuse treatment centers in Iran: a rapid survey based on newspaper advertisements","Rezaee S, Ekhtiari H.","Int J Drug Policy. 2014 May;25(3):465-70. doi: 10.1016/j.drugpo.2014.04.018. Epub 2014 May 9.","Rezaee S","Int J Drug Policy","2014","2014/05/31","","","10.1016/j.drugpo.2014.04.018"
"24870204","Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles","Yang Y, Xie XY, Mei XG.","Drug Deliv. 2016;23(3):787-93. doi: 10.3109/10717544.2014.916765. Epub 2014 May 28.","Yang Y","Drug Deliv","2016","2014/05/30","","","10.3109/10717544.2014.916765"
"24862514","Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold","Hedges AR, Pypendop BH, Shilo-Benjamini Y, Stanley SD, Ilkiw JE.","J Vet Pharmacol Ther. 2014 Jun;37(3):252-9. doi: 10.1111/jvp.12084. Epub 2013 Oct 30.","Hedges AR","J Vet Pharmacol Ther","2014","2014/05/28","","","10.1111/jvp.12084"
"24861887","Effects of thienorphine on synaptic structure and synaptophysin expression in the rat nucleus accumbens","Yong Z, Yan L, Gao X, Gong Z, Su R.","Neuroscience. 2014 Aug 22;274:53-8. doi: 10.1016/j.neuroscience.2014.05.026. Epub 2014 May 23.","Yong Z","Neuroscience","2014","2014/05/28","","","10.1016/j.neuroscience.2014.05.026"
"24859230","Intravenous methadone application as a serious risk factor for an overdose death: methadone-related fatalities in Hamburg from 2007 to 2012","Iwersen-Bergmann S, Jungen H, Andresen-Streichert H, Müller A, Elakkary S, Püschel K, Heinemann A.","Int J Legal Med. 2014 Sep;128(5):751-64. doi: 10.1007/s00414-014-1017-x. Epub 2014 May 25.","Iwersen-Bergmann S","Int J Legal Med","2014","2014/05/27","","","10.1007/s00414-014-1017-x"
"24858136","Prevalence of heroin markers in urine for pain management patients","Knight J, Puet BL, DePriest A, Heltsley R, Hild C, Black DL, Robert T, Caplan YH, Cone EJ.","Forensic Sci Int. 2014 Oct;243:79-83. doi: 10.1016/j.forsciint.2014.04.037. Epub 2014 May 9.","Knight J","Forensic Sci Int","2014","2014/05/27","","","10.1016/j.forsciint.2014.04.037"
"24855751","[It is both permitted and forbidden to drive after taking drugs]","Sjöberg C.","Lakartidningen. 2014 Apr 29-May 13;111(18-19):810-1.","Sjöberg C","Lakartidningen","2014","2014/05/27","","",""
"24851376","[Opioid substitution treatment and risk reduction]","Karila L, Zarmdini R, Cottencin O, Lejoyeux M.","Rev Prat. 2014 Mar;64(3):395-6.","Karila L","Rev Prat","2014","2014/05/24","","",""
"24850608","Evaluation of state opioid substitution treatment program in Georgia","Piralishvili G, Chavchanidze M, Gamkrelidze I, Nikolaishvili N.","Georgian Med News. 2014 Apr;(229):62-6.","Piralishvili G","Georgian Med News","2014","2014/05/23","","",""
"24846673","Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro","Knapman A, Santiago M, Connor M.","Br J Pharmacol. 2014 Sep;171(18):4273-88. doi: 10.1111/bph.12785.","Knapman A","Br J Pharmacol","2014","2014/05/22","PMC4241093","","10.1111/bph.12785"
"24845493","Neonatal opioid withdrawal syndrome","Sutter MB, Leeman L, Hsi A.","Obstet Gynecol Clin North Am. 2014 Jun;41(2):317-34. doi: 10.1016/j.ogc.2014.02.010.","Sutter MB","Obstet Gynecol Clin North Am","2014","2014/05/22","","","10.1016/j.ogc.2014.02.010"
"24845488","Buprenorphine and methadone for opioid addiction during pregnancy","Mozurkewich EL, Rayburn WF.","Obstet Gynecol Clin North Am. 2014 Jun;41(2):241-53. doi: 10.1016/j.ogc.2014.02.005. Epub 2014 Apr 3.","Mozurkewich EL","Obstet Gynecol Clin North Am","2014","2014/05/22","","","10.1016/j.ogc.2014.02.005"
"24845165","Spontaneous reductions in smoking during double-blind buprenorphine detoxification","Patrick ME, Dunn KE, Badger GJ, Heil SH, Higgins ST, Sigmon SC.","Addict Behav. 2014 Sep;39(9):1353-6. doi: 10.1016/j.addbeh.2014.04.023. Epub 2014 May 5.","Patrick ME","Addict Behav","2014","2014/05/22","PMC4083850","NIHMS592391","10.1016/j.addbeh.2014.04.023"
"24841329","Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence","Clay E, Khemiri A, Zah V, Aballéa S, Ruby J, Asche CV.","J Med Econ. 2014 Sep;17(9):626-36. doi: 10.3111/13696998.2014.925463. Epub 2014 Jun 6.","Clay E","J Med Econ","2014","2014/05/21","","","10.3111/13696998.2014.925463"
"24835268","Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec) in post-traumatic pain","Correa-Illanes G, Roa RG, B Piñeros JL, Ferrer FT, Adriasola VR.","Pain Manag. 2014 May;4(3):181-90. doi: 10.2217/pmt.14.9. Epub 2014 May 16.","Correa-Illanes G","Pain Manag","2014","2014/05/20","","","10.2217/pmt.14.9"
"24831754","Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?","Weiss RD, Griffin ML, Potter JS, Dodd DR, Dreifuss JA, Connery HS, Carroll KM.","Drug Alcohol Depend. 2014 Jul 1;140:118-22. doi: 10.1016/j.drugalcdep.2014.04.005. Epub 2014 Apr 24.","Weiss RD","Drug Alcohol Depend","2014","2014/05/17","PMC4053488","NIHMS588824","10.1016/j.drugalcdep.2014.04.005"
"24830319","Effects of thienorphine on contraction of the guinea pig sphincter of Oddi, choledochus and gall bladder","Zhou P, Li T, Su R, Gong Z.","Eur J Pharmacol. 2014 Aug 15;737:22-8. doi: 10.1016/j.ejphar.2014.04.044. Epub 2014 May 14.","Zhou P","Eur J Pharmacol","2014","2014/05/17","","","10.1016/j.ejphar.2014.04.044"
"24821346","A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment","Fingerhood MI, King VL, Brooner RK, Rastegar DA.","Subst Abus. 2014;35(2):122-6. doi: 10.1080/08897077.2013.819828.","Fingerhood MI","Subst Abus","2014","2014/05/14","","","10.1080/08897077.2013.819828"
"24820999","Analgesic effects of maxillary and inferior alveolar nerve blocks in cats undergoing dental extractions","Aguiar J, Chebroux A, Martinez-Taboada F, Leece EA.","J Feline Med Surg. 2015 Feb;17(2):110-6. doi: 10.1177/1098612X14533551. Epub 2014 May 12.","Aguiar J","J Feline Med Surg","2015","2014/05/14","","","10.1177/1098612X14533551"
"24819710","Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial","Sandvik RK, Selbaek G, Seifert R, Aarsland D, Ballard C, Corbett A, Husebo BS.","Eur J Pain. 2014 Nov;18(10):1490-500. doi: 10.1002/ejp.523. Epub 2014 May 13.","Sandvik RK","Eur J Pain","2014","2014/05/14","PMC4232010","","10.1002/ejp.523"
"24817054","Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment","Belivanis S, Tzatzarakis MN, Vakonaki E, Kovatsi L, Mantsi M, Alegakis A, Kavvalakis MP, Vynias D, Tsatsakis AM.","Drug Test Anal. 2014 Jun;6 Suppl 1:93-100. doi: 10.1002/dta.1611.","Belivanis S","Drug Test Anal","2014","2014/05/13","","","10.1002/dta.1611"
"24815321","Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms","Sobczak M, Cami-Kobeci G, Sałaga M, Husbands SM, Fichna J.","Eur J Pharmacol. 2014 Aug 5;736:63-9. doi: 10.1016/j.ejphar.2014.04.038. Epub 2014 May 6.","Sobczak M","Eur J Pharmacol","2014","2014/05/13","PMC4341819","NIHMS664270","10.1016/j.ejphar.2014.04.038"
"24802159","Improved buprenorphine immunoassay performance after urine treatment with β-glucuronidase","Snyder ML, Darragh A, Flood JG, Jones J, Ropar K, Jarolim P, Melanson SE.","J Anal Toxicol. 2014 Jul-Aug;38(6):375-9. doi: 10.1093/jat/bku045. Epub 2014 May 6.","Snyder ML","J Anal Toxicol","2014","2014/05/08","","","10.1093/jat/bku045"
"24793093","The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users","Jones JD, Madera G, Comer SD.","Pharmacol Biochem Behav. 2014 Jul;122:299-306. doi: 10.1016/j.pbb.2014.04.012. Epub 2014 May 2.","Jones JD","Pharmacol Biochem Behav","2014","2014/05/06","PMC4094364","NIHMS591989","10.1016/j.pbb.2014.04.012"
"24788959","Promise and deceit: pharmakos, drug replacement therapy, and the perils of experience","Meyers T.","Cult Med Psychiatry. 2014 Jun;38(2):182-96. doi: 10.1007/s11013-014-9376-9.","Meyers T","Cult Med Psychiatry","2014","2014/05/03","","","10.1007/s11013-014-9376-9"
"24779501","Self-management of buprenorphine/naloxone among online discussion board users","Brown SE, Altice FL.","Subst Use Misuse. 2014 Jun;49(8):1017-24. doi: 10.3109/10826084.2014.888449.","Brown SE","Subst Use Misuse","2014","2014/05/01","PMC5592159","NIHMS898518","10.3109/10826084.2014.888449"
"24777492","Detoxification treatments for opiate dependent adolescents","Minozzi S, Amato L, Bellisario C, Davoli M.","Cochrane Database Syst Rev. 2014 Apr 29;(4):CD006749. doi: 10.1002/14651858.CD006749.pub3.","Minozzi S","Cochrane Database Syst Rev","2014","2014/04/30","","","10.1002/14651858.CD006749.pub3"
"24769261","Respiratory effects of buprenorphine/naloxone alone and in combination with diazepam in naive and tolerant rats","Cohier C, Chevillard L, Risède P, Roussel O, Mégarbane B.","Toxicol Lett. 2014 Jul 15;228(2):75-84. doi: 10.1016/j.toxlet.2014.04.009. Epub 2014 Apr 21.","Cohier C","Toxicol Lett","2014","2014/04/29","","","10.1016/j.toxlet.2014.04.009"
"24767442","Fabrication of an ultrasensitive impedimetric buprenorphine hydrochloride biosensor from computational and experimental angles","Gholivand MB, Jalalvand AR, Goicoechea HC, Skov T.","Talanta. 2014 Jun;124:27-35. doi: 10.1016/j.talanta.2014.02.017. Epub 2014 Feb 18.","Gholivand MB","Talanta","2014","2014/04/29","","","10.1016/j.talanta.2014.02.017"
"24761755","Selectively promiscuous opioid ligands: discovery of high affinity/low efficacy opioid ligands with substantial nociceptin opioid peptide receptor affinity","Kumar V, Ridzwan IE, Grivas K, Lewis JW, Clark MJ, Meurice C, Jimenez-Gomez C, Pogozheva I, Mosberg H, Traynor JR, Husbands SM.","J Med Chem. 2014 May 22;57(10):4049-57. doi: 10.1021/jm401964y. Epub 2014 May 9.","Kumar V","J Med Chem","2014","2014/04/26","PMC4033651","","10.1021/jm401964y"
"24756859","Changes in trends and pattern of strong opioid prescribing in primary care","Zin CS, Chen LC, Knaggs RD.","Eur J Pain. 2014 Oct;18(9):1343-51. doi: 10.1002/j.1532-2149.2014.496.x. Epub 2014 Apr 22.","Zin CS","Eur J Pain","2014","2014/04/24","PMC4238849","","10.1002/j.1532-2149.2014.496.x"
"24751432","HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial","Woody GE, Bruce D, Korthuis PT, Chhatre S, Poole S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Metzger D, Ling W.","J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):288-93. doi: 10.1097/QAI.0000000000000165.","Woody GE","J Acquir Immune Defic Syndr","2014","2014/04/23","PMC4146664","NIHMS584131","10.1097/QAI.0000000000000165"
"24745064","Impact of the blood sampling site on time-concentration drug profiles following intravenous or buccal drug administration","Hedges AR, Pypendop BH, Shilo Y, Stanley SD, Ilkiw JE.","J Vet Pharmacol Ther. 2014 Apr;37(2):145-50. doi: 10.1111/jvp.12075.","Hedges AR","J Vet Pharmacol Ther","2014","2014/04/19","","","10.1111/jvp.12075"
"24736526","Post-surgical analgesia in rainbow trout: is reduced cardioventilatory activity a sign of improved animal welfare or the adverse effects of an opioid drug?","Gräns A, Sandblom E, Kiessling A, Axelsson M.","PLoS One. 2014 Apr 15;9(4):e95283. doi: 10.1371/journal.pone.0095283. eCollection 2014.","Gräns A","PLoS One","2014","2014/04/17","PMC3988158","","10.1371/journal.pone.0095283"
"24735085","Opioid-related mortality and filled prescriptions for buprenorphine and methadone","Wikner BN, Öhman I, Seldén T, Druid H, Brandt L, Kieler H.","Drug Alcohol Rev. 2014 Sep;33(5):491-8. doi: 10.1111/dar.12143. Epub 2014 Apr 16.","Wikner BN","Drug Alcohol Rev","2014","2014/04/17","","","10.1111/dar.12143"
"24735059","Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses","Love EJ, Pelligand L, Taylor PM, Murrell JC, Sear JW.","Vet Anaesth Analg. 2015 Jan;42(1):17-29. doi: 10.1111/vaa.12165. Epub 2014 Apr 16.","Love EJ","Vet Anaesth Analg","2015","2014/04/17","","","10.1111/vaa.12165"
"24733007","Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers","Zhu AZ, Zhou Q, Cox LS, David SP, Ahluwalia JS, Benowitz NL, Tyndale RF.","Clin Pharmacol Ther. 2014 Aug;96(2):256-65. doi: 10.1038/clpt.2014.88. Epub 2014 Apr 14.","Zhu AZ","Clin Pharmacol Ther","2014","2014/04/16","PMC4111775","NIHMS582801","10.1038/clpt.2014.88"
"24726429","The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients","Edelman EJ, Chantarat T, Caffrey S, Chaudhry A, O'Connor PG, Weiss L, Fiellin DA, Fiellin LE.","Drug Alcohol Depend. 2014 Jun 1;139:79-85. doi: 10.1016/j.drugalcdep.2014.03.006. Epub 2014 Mar 15.","Edelman EJ","Drug Alcohol Depend","2014","2014/04/15","PMC4029496","NIHMS578255","10.1016/j.drugalcdep.2014.03.006"
"24724891","Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphine","Sethi R, Petrakis I.","Am J Addict. 2014 May-Jun;23(3):318-9. doi: 10.1111/j.1521-0391.2014.12087.x.","Sethi R","Am J Addict","2014","2014/04/15","","","10.1111/j.1521-0391.2014.12087.x"
"24715666","Observation of improved adherence with frequent urine drug testing in patients with pain","Yee DA, Hughes MM, Guo AY, Barakat NH, Tse SA, Ma JD, Best BM, Atayee RS.","J Opioid Manag. 2014 Mar-Apr;10(2):111-8. doi: 10.5055/jom.2014.0200.","Yee DA","J Opioid Manag","2014","2014/04/10","","","10.5055/jom.2014.0200"
"24715663","Transdermal opioids for cancer pain control in patients with renal impairment","Melilli G, Samolsky Dekel BG, Frenquelli C, Mellone R, Pannuti F.","J Opioid Manag. 2014 Mar-Apr;10(2):85-93. doi: 10.5055/jom.2014.0197.","Melilli G","J Opioid Manag","2014","2014/04/10","","","10.5055/jom.2014.0197"
"24713865","Hair analysis for long-term monitoring of buprenorphine intake in opiate withdrawal","Pirro V, Fusari I, Di Corcia D, Gerace E, De Vivo E, Salomone A, Vincenti M.","Ther Drug Monit. 2014 Dec;36(6):796-807. doi: 10.1097/FTD.0000000000000078.","Pirro V","Ther Drug Monit","2014","2014/04/10","","","10.1097/FTD.0000000000000078"
"24706398","Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study","Besson J, Beck T, Wiesbeck G, Hämmig R, Kuntz A, Abid S, Stohler R.","Swiss Med Wkly. 2014 Mar 31;144:w13933. doi: 10.4414/smw.2014.13933. eCollection 2014.","Besson J","Swiss Med Wkly","2014","2014/04/08","","","10.4414/smw.2014.13933"
"24701967","Buprenorphine Treatment for Probationers and Parolees","Gordon MS, Kinlock TW, Schwartz RP, Couvillion KA, Sudec LJ, O'Grady KE, Vocci FJ, Shabazz H.","Subst Abus. 2015;36(2):217-25. doi: 10.1080/08897077.2014.902787. Epub 2014 Apr 4.","Gordon MS","Subst Abus","2015","2014/04/08","PMC4185269","NIHMS586844","10.1080/08897077.2014.902787"
"24695742","Naltrexone implant treatment for buprenorphine dependence--Mauritian case series","Jhugroo A, Ellayah D, Norman A, Hulse G.","J Psychopharmacol. 2014 Aug;28(8):800-3. doi: 10.1177/0269881114528592. Epub 2014 Apr 2.","Jhugroo A","J Psychopharmacol","2014","2014/04/04","","","10.1177/0269881114528592"
"24695018","A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic","Matson SC, Hobson G, Abdel-Rasoul M, Bonny AE.","J Addict Med. 2014 May-Jun;8(3):176-82. doi: 10.1097/ADM.0000000000000035.","Matson SC","J Addict Med","2014","2014/04/04","","","10.1097/ADM.0000000000000035"
"24689806","US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system","Pergolizzi JV Jr, Ben-Joseph R, Chang CL, Hess G.","Curr Med Res Opin. 2014 Aug;30(8):1579-87. doi: 10.1185/03007995.2014.901941. Epub 2014 Apr 4.","Pergolizzi JV Jr","Curr Med Res Opin","2014","2014/04/03","","","10.1185/03007995.2014.901941"
"24684621","Comparative pharmacokinetics of intravenous fentanyl and buprenorphine in healthy greyhound dogs","KuKanich B, Allen P.","J Vet Pharmacol Ther. 2014 Dec;37(6):595-7. doi: 10.1111/jvp.12129. Epub 2014 Mar 29.","KuKanich B","J Vet Pharmacol Ther","2014","2014/04/02","PMC4219927","NIHMS573593","10.1111/jvp.12129"
"24680219","Abuse and diversion of buprenorphine sublingual tablets and film","Lavonas EJ, Severtson SG, Martinez EM, Bucher-Bartelson B, Le Lait MC, Green JL, Murrelle LE, Cicero TJ, Kurtz SP, Rosenblum A, Surratt HL, Dart RC.","J Subst Abuse Treat. 2014 Jul;47(1):27-34. doi: 10.1016/j.jsat.2014.02.003. Epub 2014 Mar 3.","Lavonas EJ","J Subst Abuse Treat","2014","2014/04/01","","","10.1016/j.jsat.2014.02.003"
"24679456","Effects of opioids on phagocytic function, oxidative burst capacity, cytokine production and apoptosis in canine leukocytes","Declue AE, Yu DH, Prochnow S, Axiak-Bechtel S, Amorim J, Tsuruta K, Donaldson R, Lino G, Monibi F, Honaker A, Dodam J.","Vet J. 2014 May;200(2):270-5. doi: 10.1016/j.tvjl.2014.02.019. Epub 2014 Feb 25.","Declue AE","Vet J","2014","2014/04/01","","","10.1016/j.tvjl.2014.02.019"
"24666428","Pharmacokinetics of buprenorphine following intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta)","Kelly KR, Pypendop BH, Christe KL.","J Vet Pharmacol Ther. 2014 Oct;37(5):480-5. doi: 10.1111/jvp.12113. Epub 2014 Mar 25.","Kelly KR","J Vet Pharmacol Ther","2014","2014/03/27","PMC4163085","NIHMS561285","10.1111/jvp.12113"
"24666315","Use of the low-dose buprenorphine patch: author commentary","Childers JW, Arnold RM.","J Palliat Med. 2014 Apr;17(4):381-2. doi: 10.1089/jpm.2014.9437. Epub 2014 Mar 25.","Childers JW","J Palliat Med","2014","2014/03/27","","","10.1089/jpm.2014.9437"
"24656054","A randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification","Brigham GS, Slesnick N, Winhusen TM, Lewis DF, Guo X, Somoza E.","Drug Alcohol Depend. 2014 May 1;138:240-3. doi: 10.1016/j.drugalcdep.2014.02.013. Epub 2014 Feb 23.","Brigham GS","Drug Alcohol Depend","2014","2014/03/25","PMC4022345","NIHMS570791","10.1016/j.drugalcdep.2014.02.013"
"24655078","A review of the studies using buprenorphine in cats","Steagall PV, Monteiro-Steagall BP, Taylor PM.","J Vet Intern Med. 2014 May-Jun;28(3):762-70. doi: 10.1111/jvim.12346. Epub 2014 Mar 21.","Steagall PV","J Vet Intern Med","2014","2014/03/25","PMC4895465","","10.1111/jvim.12346"
"24649783","Marked variability in peri-partum anesthetic management of patients on buprenorphine maintenance therapy (BMT): can there be an underlying acute opioid induced hyperalgesia precipitated by neuraxial opioids in BMT patients?","Gupta D, Christensen C, Soskin V.","Middle East J Anaesthesiol. 2013 Oct;22(3):273-81.","Gupta D","Middle East J Anaesthesiol","2013","2014/03/22","","",""
"24644198","A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function","Boland JW, Foulds GA, Ahmedzai SH, Pockley AG.","BMJ Support Palliat Care. 2014 Dec;4(4):357-67. doi: 10.1136/bmjspcare-2013-000573. Epub 2013 Dec 27.","Boland JW","BMJ Support Palliat Care","2014","2014/03/20","","","10.1136/bmjspcare-2013-000573"
"24641546","In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile","Kuo A, Wyse BD, Meutermans W, Smith MT.","Br J Pharmacol. 2015 Jan;172(2):532-48. doi: 10.1111/bph.12696. Epub 2014 Jul 1.","Kuo A","Br J Pharmacol","2015","2014/03/20","PMC4292966","","10.1111/bph.12696"
"24630268","[Iatrogenic dependence to meperidine in the elderly]","Rolland B, Bera-Louville A, Deheul S, Roche J, Blond S, Cottencin O.","Presse Med. 2014 Jun;43(6 Pt 1):727-9. doi: 10.1016/j.lpm.2013.09.014. Epub 2014 Mar 11.","Rolland B","Presse Med","2014","2014/03/18","","","10.1016/j.lpm.2013.09.014"
"24629782","Comparison of toxicity associated with nonmedical use of benzodiazepines with buprenorphine or methadone","Lee SC, Klein-Schwartz W, Doyon S, Welsh C.","Drug Alcohol Depend. 2014 May 1;138:118-23. doi: 10.1016/j.drugalcdep.2014.02.014. Epub 2014 Feb 23.","Lee SC","Drug Alcohol Depend","2014","2014/03/18","","","10.1016/j.drugalcdep.2014.02.014"
"24628996","A successful treatment of buprenorphine withdrawal with the dopamine receptor agonist pramipexole","Makhinson M, Gomez-Makhinson J.","Am J Addict. 2014 Sep-Oct;23(5):475-7. doi: 10.1111/j.1521-0391.2014.12133.x. Epub 2014 Mar 15.","Makhinson M","Am J Addict","2014","2014/03/18","","","10.1111/j.1521-0391.2014.12133.x"
"24628132","Use of the low-dose buprenorphine patch: a response","Dankiewicz EH.","J Palliat Med. 2014 Apr;17(4):379-80. doi: 10.1089/jpm.2014.9438. Epub 2014 Mar 14.","Dankiewicz EH","J Palliat Med","2014","2014/03/18","PMC3991960","","10.1089/jpm.2014.9438"
"24624763","[Better efficacy of buprenorphine and methadone in opioid dependence. Requirements for abstinence from non-opioids before starting treatment paid off]","Hoffmann O, Frisell F, Ljungberg T.","Lakartidningen. 2014 Jan 29-Feb 4;111(5):147-9.","Hoffmann O","Lakartidningen","2014","2014/03/15","","",""
"24619775","Psychiatric comorbidity, red flag behaviors, and associated outcomes among office-based buprenorphine patients following Hurricane Sandy","Williams AR, Tofighi B, Rotrosen J, Lee JD, Grossman E.","J Urban Health. 2014 Apr;91(2):366-75. doi: 10.1007/s11524-014-9866-7.","Williams AR","J Urban Health","2014","2014/03/13","PMC3978155","","10.1007/s11524-014-9866-7"
"24617653","Benzodiazepines increase the reward effects of buprenorphine in a conditioned place preference test in the mouse","Ma LL, Freret T, Lange M, Bourgine J, Coquerel A, Lelong-Boulouard V.","Fundam Clin Pharmacol. 2014 Dec;28(6):681-9. doi: 10.1111/fcp.12072. Epub 2014 Apr 17.","Ma LL","Fundam Clin Pharmacol","2014","2014/03/13","","","10.1111/fcp.12072"
"24615308","Barriers to primary care physicians prescribing buprenorphine","Hutchinson E, Catlin M, Andrilla CH, Baldwin LM, Rosenblatt RA.","Ann Fam Med. 2014 Mar-Apr;12(2):128-33. doi: 10.1370/afm.1595.","Hutchinson E","Ann Fam Med","2014","2014/03/12","PMC3948759","","10.1370/afm.1595"
"24613946","The Baltimore Buprenorphine Initiative: understanding the role of buprenorphine in addressing heroin addiction in an urban-based community","Murphy LS, Oros MT, Dorsey SG.","J Addict Nurs. 2014 Jan-Mar;25(1):16-25; quiz 26-7. doi: 10.1097/JAN.0000000000000014.","Murphy LS","J Addict Nurs","2014","2014/03/12","","","10.1097/JAN.0000000000000014"
"24606726","Rewarding or aversive effects of buprenorphine/naloxone combination (Suboxone) depend on conditioning trial duration","Canestrelli C, Marie N, Noble F.","Int J Neuropsychopharmacol. 2014 Sep;17(9):1367-73. doi: 10.1017/S146114571400025X. Epub 2014 Mar 10.","Canestrelli C","Int J Neuropsychopharmacol","2014","2014/03/11","","","10.1017/S146114571400025X"
"24605959","Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?","Koller G.","Addiction. 2014 Apr;109(4):608-9. doi: 10.1111/add.12488.","Koller G","Addiction","2014","2014/03/11","","","10.1111/add.12488"
"24602547","Antinociceptive effects of sustained-release buprenorphine in a model of incisional pain in rats (Rattus norvegicus)","Chum HH, Jampachairsri K, McKeon GP, Yeomans DC, Pacharinsak C, Felt SA.","J Am Assoc Lab Anim Sci. 2014 Mar;53(2):193-7.","Chum HH","J Am Assoc Lab Anim Sci","2014","2014/03/08","PMC3966277","",""
"24602363","Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial","Mannelli P, Wu LT, Peindl KS, Swartz MS, Woody GE.","Drug Alcohol Depend. 2014 May 1;138:83-8. doi: 10.1016/j.drugalcdep.2014.02.002. Epub 2014 Feb 15.","Mannelli P","Drug Alcohol Depend","2014","2014/03/08","PMC4017322","NIHMS574040","10.1016/j.drugalcdep.2014.02.002"
"24599244","Prescription opioid dependence: the clinical challenge","Newman RG.","JAMA Psychiatry. 2014 Mar;71(3):338. doi: 10.1001/jamapsychiatry.2013.4530.","Newman RG","JAMA Psychiatry","2014","2014/03/07","","","10.1001/jamapsychiatry.2013.4530"
"24594902","Impact of research network participation on the adoption of buprenorphine for substance abuse treatment","Rieckmann TR, Abraham AJ, Kovas AE, McFarland BH, Roman PM.","Addict Behav. 2014 May;39(5):889-96. doi: 10.1016/j.addbeh.2014.01.016. Epub 2014 Feb 7.","Rieckmann TR","Addict Behav","2014","2014/03/06","PMC4063285","NIHMS572385","10.1016/j.addbeh.2014.01.016"
"24594221","Execution of control among 'non-compliant', imprisoned individuals in opioid maintenance treatment","Havnes IA, Clausen T, Middelthon AL.","Int J Drug Policy. 2014 May;25(3):480-5. doi: 10.1016/j.drugpo.2014.01.018. Epub 2014 Feb 7.","Havnes IA","Int J Drug Policy","2014","2014/03/06","","","10.1016/j.drugpo.2014.01.018"
"24591547","Behavioural treatment combined with buprenorphine does not reduce opioid use compared with buprenorphine alone","Weiss RD.","Evid Based Ment Health. 2014 May;17(2):e2. doi: 10.1136/eb-2013-101639. Epub 2014 Mar 3.","Weiss RD","Evid Based Ment Health","2014","2014/03/05","","","10.1136/eb-2013-101639"
"24588297","I heard about it from a friend: assessing interest in buprenorphine treatment","Fox AD, Shah PA, Sohler NL, Lopez CM, Starrels JL, Cunningham CO.","Subst Abus. 2014;35(1):74-9. doi: 10.1080/08897077.2013.804484.","Fox AD","Subst Abus","2014","2014/03/05","PMC3942801","NIHMS481256","10.1080/08897077.2013.804484"
"24577059","Confronting the stigma of opioid use disorder--and its treatment","Olsen Y, Sharfstein JM.","JAMA. 2014 Apr 9;311(14):1393-4. doi: 10.1001/jama.2014.2147.","Olsen Y","JAMA","2014","2014/03/01","","","10.1001/jama.2014.2147"
"24569357","Buprenorphine versus tramadol as perineural adjuvants for postoperative analgesia in patients undergoing arthroscopic rotator cuff repair under middle interscalene block: a retrospective study","Alemanno F, Westermann B, Bettoni A, Candiani A, Cesana BM.","Minerva Anestesiol. 2014 Nov;80(11):1198-204. Epub 2014 Feb 25.","Alemanno F","Minerva Anestesiol","2014","2014/02/27","","",""
"24566267","Hollow fiber liquid-phase microextraction combined with ultra-high performance liquid chromatography-tandem mass spectrometry for the simultaneous determination of naloxone, buprenorphine and norbuprenorphine in human plasma","Sun W, Qu S, Du Z.","J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Mar 1;951-952:157-63. doi: 10.1016/j.jchromb.2014.01.029. Epub 2014 Jan 29.","Sun W","J Chromatogr B Analyt Technol Biomed Life Sci","2014","2014/02/26","","","10.1016/j.jchromb.2014.01.029"
"24560129","Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland","Uosukainen H, Ilomäki J, Kauhanen J, Tacke U, Föhr J, Tiihonen J, Bell JS.","J Subst Abuse Treat. 2014 May-Jun;46(5):561-6. doi: 10.1016/j.jsat.2014.01.004. Epub 2014 Jan 10.","Uosukainen H","J Subst Abuse Treat","2014","2014/02/25","","","10.1016/j.jsat.2014.01.004"
"24550443","Opioid analgesics stop the development of clostridial gas gangrene","Chakravorty A, Awad MM, Hiscox TJ, Cheung JK, Choo JM, Lyras D, Rood JI.","J Infect Dis. 2014 Aug 1;210(3):483-92. doi: 10.1093/infdis/jiu101. Epub 2014 Feb 18.","Chakravorty A","J Infect Dis","2014","2014/02/20","","","10.1093/infdis/jiu101"
"24534592","Additives to local anesthetics for peripheral nerve blocks: Evidence, limitations, and recommendations","Bailard NS, Ortiz J, Flores RA.","Am J Health Syst Pharm. 2014 Mar 1;71(5):373-85. doi: 10.2146/ajhp130336.","Bailard NS","Am J Health Syst Pharm","2014","2014/02/19","","","10.2146/ajhp130336"
"24521036","Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: a longitudinal study","Tsui JI, Anderson BJ, Strong DR, Stein MD.","Am J Drug Alcohol Abuse. 2014 Mar;40(2):163-9. doi: 10.3109/00952990.2013.848875. Epub 2014 Feb 12.","Tsui JI","Am J Drug Alcohol Abuse","2014","2014/02/14","PMC4868341","NIHMS777323","10.3109/00952990.2013.848875"
"24509068","Buprenorphine-naloxone therapy in pain management","Chen KY, Chen L, Mao J.","Anesthesiology. 2014 May;120(5):1262-74. doi: 10.1097/ALN.0000000000000170.","Chen KY","Anesthesiology","2014","2014/02/11","PMC3999180","NIHMS559403","10.1097/ALN.0000000000000170"
"24501913","[Treatment for opioid dependence: buprenorphine/naloxone should always be the first choice]","Grönbladh L, Heine L.","Lakartidningen. 2013 Dec 13-2014 Jan 7;110(51-52):2314.","Grönbladh L","Lakartidningen","2013","2014/02/08","","",""
"24500948","Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","Mattick RP, Breen C, Kimber J, Davoli M.","Cochrane Database Syst Rev. 2014 Feb 6;(2):CD002207. doi: 10.1002/14651858.CD002207.pub4.","Mattick RP","Cochrane Database Syst Rev","2014","2014/02/07","","","10.1002/14651858.CD002207.pub4"
"24500040","Access to treatment for opioid dependence in rural America: challenges and future directions","Sigmon SC.","JAMA Psychiatry. 2014 Apr;71(4):359-60. doi: 10.1001/jamapsychiatry.2013.4450.","Sigmon SC","JAMA Psychiatry","2014","2014/02/07","","","10.1001/jamapsychiatry.2013.4450"
"24499640","2013 Update in addiction medicine for the generalist","Gordon AJ, Bertholet N, McNeely J, Starrels JL, Tetrault JM, Walley AY.","Addict Sci Clin Pract. 2013 Nov 4;8(1):18. doi: 10.1186/1940-0640-8-18.","Gordon AJ","Addict Sci Clin Pract","2013","2014/02/07","PMC3819258","","10.1186/1940-0640-8-18"
"24484983","Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence","Bidlack JM.","Adv Pharmacol. 2014;69:387-418. doi: 10.1016/B978-0-12-420118-7.00010-X.","Bidlack JM","Adv Pharmacol","2014","2014/02/04","","","10.1016/B978-0-12-420118-7.00010-X"
"24481929","Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program","Shah PA, Sohler NL, López C, Fox AD, Cunningham CO.","J Opioid Manag. 2013 Nov-Dec;9(6):407-13. doi: 10.5055/jom.2013.0183.","Shah PA","J Opioid Manag","2013","2014/02/01","PMC4012750","NIHMS576214","10.5055/jom.2013.0183"
"24468235","Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","Hall G, Neighbors CJ, Iheoma J, Dauber S, Adams M, Culleton R, Muench F, Borys S, McDonald R, Morgenstern J.","J Subst Abuse Treat. 2014 Apr;46(4):511-5. doi: 10.1016/j.jsat.2013.11.002. Epub 2013 Dec 2.","Hall G","J Subst Abuse Treat","2014","2014/01/29","","","10.1016/j.jsat.2013.11.002"
"24467734","Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy","Tofighi B, Grossman E, Williams AR, Biary R, Rotrosen J, Lee JD.","Addict Sci Clin Pract. 2014 Jan 27;9(1):3. doi: 10.1186/1940-0640-9-3.","Tofighi B","Addict Sci Clin Pract","2014","2014/01/29","PMC3940298","","10.1186/1940-0640-9-3"
"24462581","Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment","Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR.","Drug Alcohol Depend. 2014 Mar 1;136:36-42. doi: 10.1016/j.drugalcdep.2013.12.007. Epub 2013 Dec 25.","Schottenfeld RS","Drug Alcohol Depend","2014","2014/01/28","","","10.1016/j.drugalcdep.2013.12.007"
"24461476","The diversion and injection of a buprenorphine-naloxone soluble film formulation","Larance B, Lintzeris N, Ali R, Dietze P, Mattick R, Jenkinson R, White N, Degenhardt L.","Drug Alcohol Depend. 2014 Mar 1;136:21-7. doi: 10.1016/j.drugalcdep.2013.12.005. Epub 2014 Jan 8.","Larance B","Drug Alcohol Depend","2014","2014/01/28","","","10.1016/j.drugalcdep.2013.12.005"
"24458222","A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions","Lapeyre-Mestre M, Gony M, Carvajal A, Macias D, Conforti A, D'Incau P, Heerdink R, Van der Stichele R, Bergman U.","Eur Addict Res. 2014;20(4):174-82. doi: 10.1159/000356812. Epub 2014 Jan 16.","Lapeyre-Mestre M","Eur Addict Res","2014","2014/01/25","","","10.1159/000356812"
"24444055","Predicting medication persistence to buprenorphine transdermal system","Pergolizzi JV, Ben-Joseph R, Chang CL, Hess G.","Pain Pract. 2015 Feb;15(2):140-9. doi: 10.1111/papr.12155. Epub 2014 Jan 20.","Pergolizzi JV","Pain Pract","2015","2014/01/22","","","10.1111/papr.12155"
"24438113","Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy","Soyka M, Hillemacher T.","Addiction. 2014 Jan;109(1):88-9. doi: 10.1111/add.12376.","Soyka M","Addiction","2014","2014/01/21","","","10.1111/add.12376"
"24438111","Commentary on Freelemyer et al. (2014): medication-assisted treatment in Africa-need is growing but response remains tepid","Obot IS.","Addiction. 2014 Jan;109(1):33-4. doi: 10.1111/add.12364.","Obot IS","Addiction","2014","2014/01/21","","","10.1111/add.12364"
"24428768","Patient perspectives of an integrated program of medical care and substance use treatment","Drainoni ML, Farrell C, Sorensen-Alawad A, Palmisano JN, Chaisson C, Walley AY.","AIDS Patient Care STDS. 2014 Feb;28(2):71-81. doi: 10.1089/apc.2013.0179. Epub 2014 Jan 15.","Drainoni ML","AIDS Patient Care STDS","2014","2014/01/17","PMC3926137","","10.1089/apc.2013.0179"
"24428135","Outcome evaluation of the opioid agonist maintenance treatment in Iran","Esmaeili HR, Ziaddinni H, Nikravesh MR, Baneshi MR, Nakhaee N.","Drug Alcohol Rev. 2014 Mar;33(2):186-93. doi: 10.1111/dar.12112. Epub 2014 Jan 16.","Esmaeili HR","Drug Alcohol Rev","2014","2014/01/17","","","10.1111/dar.12112"
"24401792","Inferior alveolar nerve transection enhanced formalin-induced nocifensive responses in the upper lip: systemic buprenorphine had more antinociceptive efficacy over morphine","Kuki F, Sugiyo S, Abe T, Niwa H, Takemura M.","Pharmacology. 2014;93(1-2):10-7. doi: 10.1159/000356713. Epub 2014 Jan 8.","Kuki F","Pharmacology","2014","2014/01/10","","","10.1159/000356713"
"24399765","Interventions for female drug-using offenders","Perry AE, Neilson M, Martyn-St James M, Glanville JM, McCool R, Duffy S, Godfrey C, Hewitt C.","Cochrane Database Syst Rev. 2014 Jan 8;(1):CD010910. doi: 10.1002/14651858.CD010910.","Perry AE","Cochrane Database Syst Rev","2014","2014/01/09","","","10.1002/14651858.CD010910"
"24399105","The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age","Gower S, Bartu A, Ilett KF, Doherty D, McLaurin R, Hamilton D.","J Hum Lact. 2014 May;30(2):217-23. doi: 10.1177/0890334413517748. Epub 2014 Jan 7.","Gower S","J Hum Lact","2014","2014/01/09","","","10.1177/0890334413517748"
"24394747","The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and health","Miller K, Yarlas A, Wen W, Dain B, Lynch SY, Ripa SR, Pergolizzi JV Jr, Raffa R.","Clin J Pain. 2014 Dec;30(12):1015-22. doi: 10.1097/AJP.0000000000000068.","Miller K","Clin J Pain","2014","2014/01/08","","","10.1097/AJP.0000000000000068"
"24394496","A novel community-based buprenorphine program: client description and initial outcomes","Daniels AM, Salisbury-Afshar E, Hoffberg A, Agus D, Fingerhood MI.","J Addict Med. 2014 Jan-Feb;8(1):40-6. doi: 10.1097/ADM.0000000000000004.","Daniels AM","J Addict Med","2014","2014/01/08","","","10.1097/ADM.0000000000000004"
"24382761","Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy","Park TW, Bohnert AS, Austin KL, Saitz R, Pizer SD.","Psychiatr Serv. 2014 Jan 1;65(1):4. doi: 10.1176/appi.ps.650308.","Park TW","Psychiatr Serv","2014","2014/01/03","PMC5697151","NIHMS915712","10.1176/appi.ps.650308"
"24380101","Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines","Balhara YP.","J Opioid Manag. 2013 Jul-Aug;9(4):237.","Balhara YP","J Opioid Manag","2013","2014/01/02","","",""
"24367510","Depression-like effect of prenatal buprenorphine exposure in rats","Hung CJ, Wu CC, Chen WY, Chang CY, Kuan YH, Pan HC, Liao SL, Chen CJ.","PLoS One. 2013 Dec 18;8(12):e82262. doi: 10.1371/journal.pone.0082262. eCollection 2013.","Hung CJ","PLoS One","2013","2013/12/25","PMC3867331","","10.1371/journal.pone.0082262"
"24366859","Maintenance agonist treatments for opiate-dependent pregnant women","Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M.","Cochrane Database Syst Rev. 2013 Dec 23;(12):CD006318. doi: 10.1002/14651858.CD006318.pub3.","Minozzi S","Cochrane Database Syst Rev","2013","2013/12/25","","","10.1002/14651858.CD006318.pub3"
"24365462","Pyrrolidine dithiocarbamate attenuates surgery-induced neuroinflammation and cognitive dysfunction possibly via inhibition of nuclear factor κB","Zhang J, Jiang W, Zuo Z.","Neuroscience. 2014 Mar 7;261:1-10. doi: 10.1016/j.neuroscience.2013.12.034. Epub 2013 Dec 21.","Zhang J","Neuroscience","2014","2013/12/25","PMC3950371","NIHMS557566","10.1016/j.neuroscience.2013.12.034"
"24359719","Multicenter clinical evaluation of a multi-dose formulation of propofol in the dog","Mama KR, Gaynor JS, Harvey RC, Robertson SA, Koenig RL, Cozzi EM.","BMC Vet Res. 2013 Dec 23;9:261. doi: 10.1186/1746-6148-9-261.","Mama KR","BMC Vet Res","2013","2013/12/24","PMC3901023","","10.1186/1746-6148-9-261"
"24353217","Pharmacological interventions for drug-using offenders","Perry AE, Neilson M, Martyn-St James M, Glanville JM, McCool R, Duffy S, Godfrey C, Hewitt C.","Cochrane Database Syst Rev. 2013 Dec 19;(12):CD010862. doi: 10.1002/14651858.CD010862.","Perry AE","Cochrane Database Syst Rev","2013","2013/12/20","","","10.1002/14651858.CD010862"
"24353018","Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study","Lundorff L, Sjøgren P, Hansen OB, Jonsson T, Nielsen PR, Christrup L.","J Opioid Manag. 2013 Jul-Aug;9(4):255-62. doi: 10.5055/jom.2013.0166.","Lundorff L","J Opioid Manag","2013","2013/12/20","","","10.5055/jom.2013.0166"
"24344738","The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study","Yee A, Loh HS, Hisham Hashim HM, Ng CG.","J Sex Med. 2014 Jan;11(1):22-32. doi: 10.1111/jsm.12352. Epub 2013 Oct 28.","Yee A","J Sex Med","2014","2013/12/19","","","10.1111/jsm.12352"
"24340431","[Opioid dependence: New national guidelines must allow maintenance treatment]","Heilig M.","Lakartidningen. 2013 Oct 23-29;110(43-44):1908-9.","Heilig M","Lakartidningen","2013","2013/12/18","","",""
"24332511","Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients","Tkacz J, Volpicelli J, Un H, Ruetsch C.","J Subst Abuse Treat. 2014 Apr;46(4):456-62. doi: 10.1016/j.jsat.2013.10.014. Epub 2013 Nov 12.","Tkacz J","J Subst Abuse Treat","2014","2013/12/17","","","10.1016/j.jsat.2013.10.014"
"24330593","Multiple mechanisms underlying the long duration of action of thienorphine, a novel partial opioid agonist for the treatment of addiction","Yu G, Li SH, Cui MX, Yan LD, Yong Z, Zhou PL, Su RB, Gong ZH.","CNS Neurosci Ther. 2014 Mar;20(3):282-8. doi: 10.1111/cns.12210. Epub 2013 Dec 16.","Yu G","CNS Neurosci Ther","2014","2013/12/17","PMC6492997","","10.1111/cns.12210"
"24322311","[Neuroleptic malignant syndrome after cardiac surgery]","Uehara M, Inaoka M, Miyaki Y, Nakashima S, Fuzii A, Higami T.","Kyobu Geka. 2013 Nov;66(12):1052-5.","Uehara M","Kyobu Geka","2013","2013/12/11","","",""
"24321744","Prenatal buprenorphine exposure decreases neurogenesis in rats","Wu CC, Hung CJ, Shen CH, Chen WY, Chang CY, Pan HC, Liao SL, Chen CJ.","Toxicol Lett. 2014 Feb 10;225(1):92-101. doi: 10.1016/j.toxlet.2013.12.001. Epub 2013 Dec 7.","Wu CC","Toxicol Lett","2014","2013/12/11","","","10.1016/j.toxlet.2013.12.001"
"24320787","Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study","Karlsson J, Söderström A, Augustini BG, Berggren AC.","Curr Med Res Opin. 2014 Apr;30(4):575-87. doi: 10.1185/03007995.2013.873714. Epub 2013 Dec 23.","Karlsson J","Curr Med Res Opin","2014","2013/12/11","","","10.1185/03007995.2013.873714"
"24313243","Predictive factors for relapse in patients on buprenorphine maintenance","Ferri M, Finlayson AJ, Wang L, Martin PR.","Am J Addict. 2014 Jan-Feb;23(1):62-7. doi: 10.1111/j.1521-0391.2013.12074.x. Epub 2013 Jun 10.","Ferri M","Am J Addict","2014","2013/12/10","PMC3922612","NIHMS468858","10.1111/j.1521-0391.2013.12074.x"
"24313239","Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individuals","Masson CL, Rainey PM, Moody DE, McCance-Katz EF.","Am J Addict. 2014 Jan-Feb;23(1):34-40. doi: 10.1111/j.1521-0391.2013.12052.x. Epub 2013 Jun 10.","Masson CL","Am J Addict","2014","2013/12/10","PMC3998818","NIHMS508331","10.1111/j.1521-0391.2013.12052.x"
"24304349","Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial","Holland R, Maskrey V, Swift L, Notley C, Robinson A, Nagar J, Gale T, Kouimtsidis C.","Addiction. 2014 Apr;109(4):596-607. doi: 10.1111/add.12439. Epub 2014 Jan 19.","Holland R","Addiction","2014","2013/12/06","","","10.1111/add.12439"
"24290979","Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy","Jones HE, Dengler E, Garrison A, O'Grady KE, Seashore C, Horton E, Andringa K, Jansson LM, Thorp J.","Drug Alcohol Depend. 2014 Jan 1;134:414-417. doi: 10.1016/j.drugalcdep.2013.11.006. Epub 2013 Nov 16.","Jones HE","Drug Alcohol Depend","2014","2013/12/03","PMC4117648","NIHMS547006","10.1016/j.drugalcdep.2013.11.006"
"24284855","Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment","Bounes V, Palmaro A, Lapeyre-Mestre M, Roussin A.","Pain Physician. 2013 Nov-Dec;16(6):E739-47.","Bounes V","Pain Physician","2013","2013/11/29","","",""
"24280659","Allergic contact dermatitis from buprenorphine and oral tolerance to other opioid derivatives in three patients","Huilaja L, Riekki R, Immonen A, Tasanen K.","Dermatology. 2014;228(2):130-1. doi: 10.1159/000356248. Epub 2013 Nov 23.","Huilaja L","Dermatology","2014","2013/11/28","","","10.1159/000356248"
"24274990","Association between gene variants and response to buprenorphine maintenance treatment","Gerra G, Somaini L, Leonardi C, Cortese E, Maremmani I, Manfredini M, Donnini C.","Psychiatry Res. 2014 Jan 30;215(1):202-7. doi: 10.1016/j.psychres.2013.11.001. Epub 2013 Nov 11.","Gerra G","Psychiatry Res","2014","2013/11/27","","","10.1016/j.psychres.2013.11.001"
"24270319","[Is the availability of buprenorphine/naloxone therapy for opioid-dependent inmates a necessity? ]","Marco A, López-Burgos A, García-Marcos L, Gallego C, Antón JJ, Errasti A.","Rev Esp Sanid Penit. 2013 Feb;15(3):105-13. doi: 10.4321/S1575-06202013000300004.","Marco A","Rev Esp Sanid Penit","2013","2013/11/26","","","10.4321/S1575-06202013000300004"
"24268947","A qualitative study of the adoption of buprenorphine for opioid addiction treatment","Green CA, McCarty D, Mertens J, Lynch FL, Hilde A, Firemark A, Weisner CM, Pating D, Anderson BM.","J Subst Abuse Treat. 2014 Mar;46(3):390-401. doi: 10.1016/j.jsat.2013.09.002. Epub 2013 Oct 23.","Green CA","J Subst Abuse Treat","2014","2013/11/26","PMC3897203","NIHMS527852","10.1016/j.jsat.2013.09.002"
"24259614","Acute hepatitis and renal failure related to intranasal buprenorphine misuse: case report and analysis of cases reported to the French network for drug monitoring","Eiden C, Ripault MP, Larrey D, Faillie JL, Pinzani V, Pageaux GP, Peyrière H.","Ann Pharmacother. 2013 Dec;47(12):1721-6. doi: 10.1177/1060028013507429. Epub 2013 Oct 15.","Eiden C","Ann Pharmacother","2013","2013/11/22","","","10.1177/1060028013507429"
"24256307","Influence of uridine diphosphate-glucuronyltransferase 2B7 (UGT2B7) variants on postoperative buprenorphine analgesia","Sastre JA, Varela G, López M, Muriel C, González-Sarmiento R.","Pain Pract. 2015 Jan;15(1):22-30. doi: 10.1111/papr.12152. Epub 2013 Nov 20.","Sastre JA","Pain Pract","2015","2013/11/22","","","10.1111/papr.12152"
"24256157","Regaining control: the patient experience of supervised compared with unsupervised consumption in opiate substitution treatment","Notley C, Holland R, Maskrey V, Nagar J, Kouimtsidis C.","Drug Alcohol Rev. 2014 Jan;33(1):64-70. doi: 10.1111/dar.12079. Epub 2013 Nov 20.","Notley C","Drug Alcohol Rev","2014","2013/11/22","","","10.1111/dar.12079"
"24247147","Medication-assisted treatment with buprenorphine: assessing the evidence","Thomas CP, Fullerton CA, Kim M, Montejano L, Lyman DR, Dougherty RH, Daniels AS, Ghose SS, Delphin-Rittmon ME.","Psychiatr Serv. 2014 Feb 1;65(2):158-70. doi: 10.1176/appi.ps.201300256.","Thomas CP","Psychiatr Serv","2014","2013/11/20","","","10.1176/appi.ps.201300256"
"24246120","Pharmacists' role in the continued care of patients under opiate substitution treatment","Messaadi N, Pansu A, Cohen O, Cottencin O.","Therapie. 2013 Nov-Dec;68(6):393-400. doi: 10.2515/therapie/2013059. Epub 2013 Nov 11.","Messaadi N","Therapie","2013","2013/11/20","","","10.2515/therapie/2013059"
"24245573","Buprenorphine for chronic pain","Calderon R, Copenhaver D.","J Pain Palliat Care Pharmacother. 2013 Dec;27(4):402-5. doi: 10.3109/15360288.2013.847522. Epub 2013 Nov 18.","Calderon R","J Pain Palliat Care Pharmacother","2013","2013/11/20","","","10.3109/15360288.2013.847522"
"24238714","Leaving buprenorphine treatment: patients' reasons for cessation of care","Gryczynski J, Mitchell SG, Jaffe JH, O'Grady KE, Olsen YK, Schwartz RP.","J Subst Abuse Treat. 2014 Mar;46(3):356-61. doi: 10.1016/j.jsat.2013.10.004. Epub 2013 Oct 14.","Gryczynski J","J Subst Abuse Treat","2014","2013/11/19","PMC3947058","NIHMS532159","10.1016/j.jsat.2013.10.004"
"24237901","Commentary on Rosenthal et al. (2013): Buprenorphine implant-new hopes, old questions","Basu D.","Addiction. 2013 Dec;108(12):2150-1. doi: 10.1111/add.12374.","Basu D","Addiction","2013","2013/11/19","","","10.1111/add.12374"
"24227768","A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine","Tompkins DA, Smith MT, Mintzer MZ, Campbell CM, Strain EC.","J Pharmacol Exp Ther. 2014 Feb;348(2):217-26. doi: 10.1124/jpet.113.209478. Epub 2013 Nov 13.","Tompkins DA","J Pharmacol Exp Ther","2014","2013/11/15","PMC3912547","","10.1124/jpet.113.209478"
"24222013","Opioids and traffic safety--focus on buprenorphine","Soyka M.","Pharmacopsychiatry. 2014 Jan;47(1):7-17. doi: 10.1055/s-0033-1358707. Epub 2013 Nov 12.","Soyka M","Pharmacopsychiatry","2014","2013/11/14","","","10.1055/s-0033-1358707"
"24219166","Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder","Griffin ML, Dodd DR, Potter JS, Rice LS, Dickinson W, Sparenborg S, Weiss RD.","Am J Drug Alcohol Abuse. 2014 Mar;40(2):157-62. doi: 10.3109/00952990.2013.842241. Epub 2013 Nov 12.","Griffin ML","Am J Drug Alcohol Abuse","2014","2013/11/14","PMC3947491","NIHMS542167","10.3109/00952990.2013.842241"
"24210532","From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme","Riksheim M, Gossop M, Clausen T.","J Subst Abuse Treat. 2014 Mar;46(3):291-4. doi: 10.1016/j.jsat.2013.10.006. Epub 2013 Oct 14.","Riksheim M","J Subst Abuse Treat","2014","2013/11/12","","","10.1016/j.jsat.2013.10.006"
"24209382","Determinants of buprenorphine treatment for opioid dependence","Murphy SM, Fishman PA, McPherson S, Dyck DG, Roll JR.","J Subst Abuse Treat. 2014 Mar;46(3):315-9. doi: 10.1016/j.jsat.2013.09.003. Epub 2013 Oct 25.","Murphy SM","J Subst Abuse Treat","2014","2013/11/12","","","10.1016/j.jsat.2013.09.003"
"24189173","HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment","Edelman EJ, Moore BA, Caffrey S, Sikkema KJ, Jones ES, Schottenfeld RS, Fiellin DA, Fiellin LE.","J Addict Med. 2013 Nov-Dec;7(6):410-6. doi: 10.1097/ADM.0b013e3182a3b603.","Edelman EJ","J Addict Med","2013","2013/11/06","","","10.1097/ADM.0b013e3182a3b603"
"24186493","Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland","Favrod-Coune T, Baroudi M, Casillas A, Rieder JP, Gétaz L, Barro J, Gaspoz JM, Broers B, Wolff H.","Swiss Med Wkly. 2013 Nov 1;143:w13898. doi: 10.4414/smw.2013.13898. eCollection 2013.","Favrod-Coune T","Swiss Med Wkly","2013","2013/11/05","","","10.4414/smw.2013.13898"
"24182727","Patients with chronic pain","Salama-Hanna J, Chen G.","Med Clin North Am. 2013 Nov;97(6):1201-15. doi: 10.1016/j.mcna.2013.07.005. Epub 2013 Sep 14.","Salama-Hanna J","Med Clin North Am","2013","2013/11/05","","","10.1016/j.mcna.2013.07.005"
"24159913","Necrosis of the intranasal structures and soft palate as a result of heroin snorting: a case series","Peyrière H, Léglise Y, Rousseau A, Cartier C, Gibaja V, Galland P.","Subst Abus. 2013;34(4):409-14. doi: 10.1080/08897077.2013.781565.","Peyrière H","Subst Abus","2013","2013/10/29","","","10.1080/08897077.2013.781565"
"24153411","A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers","Sigmon SC, Dunn KE, Saulsgiver K, Patrick ME, Badger GJ, Heil SH, Brooklyn JR, Higgins ST.","JAMA Psychiatry. 2013 Dec;70(12):1347-54. doi: 10.1001/jamapsychiatry.2013.2216.","Sigmon SC","JAMA Psychiatry","2013","2013/10/25","PMC4131728","NIHMS599500","10.1001/jamapsychiatry.2013.2216"
"24152140","Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake","Eastwood EC, Phillips TJ.","Genes Brain Behav. 2014 Feb;13(2):226-35. doi: 10.1111/gbb.12100. Epub 2013 Nov 18.","Eastwood EC","Genes Brain Behav","2014","2013/10/25","PMC3976242","NIHMS536605","10.1111/gbb.12100"
"24148523","A combined liquid three-phase micro-extraction and differential pulse voltammetric method for preconcentration and detection of ultra-trace amounts of buprenorphine using a modified pencil electrode","Ensafi AA, Khoddami E, Rezaei B.","Talanta. 2013 Nov 15;116:1113-20. doi: 10.1016/j.talanta.2013.08.016. Epub 2013 Aug 19.","Ensafi AA","Talanta","2013","2013/10/24","","","10.1016/j.talanta.2013.08.016"
"24139199","Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden","Richert T, Johnson B.","Harm Reduct J. 2013 Oct 18;10:27. doi: 10.1186/1477-7517-10-27.","Richert T","Harm Reduct J","2013","2013/10/22","PMC3853648","","10.1186/1477-7517-10-27"
"24132830","Dental health of young children prenatally exposed to buprenorphine. A concern of child neglect?","Kivistö K, Alapulli H, Tupola S, Alaluusua S, Kivitie-Kallio S.","Eur Arch Paediatr Dent. 2014 Jun;15(3):197-202. doi: 10.1007/s40368-013-0095-7. Epub 2013 Oct 17.","Kivistö K","Eur Arch Paediatr Dent","2014","2013/10/18","","","10.1007/s40368-013-0095-7"
"24131626","'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'","Havnes IA, Clausen T, Middelthon AL.","Harm Reduct J. 2013 Oct 16;10:24. doi: 10.1186/1477-7517-10-24.","Havnes IA","Harm Reduct J","2013","2013/10/18","PMC3854011","","10.1186/1477-7517-10-24"
"24131165","Clinician beliefs and attitudes about buprenorphine/naloxone diversion","Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA Jr, Weiss RD.","Am J Addict. 2013 Nov-Dec;22(6):574-80. doi: 10.1111/j.1521-0391.2013.12024.x. Epub 2013 Apr 11.","Schuman-Olivier Z","Am J Addict","2013","2013/10/18","PMC3801272","NIHMS450669","10.1111/j.1521-0391.2013.12024.x"
"24130973","Managing opioid dependence in pregnancy -- a general practice perspective","Arunogiri S, Foo L, Frei M, Lubman DI.","Aust Fam Physician. 2013 Oct;42(10):713-6.","Arunogiri S","Aust Fam Physician","2013","2013/10/17","","",""
"24129113","In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence","","Med Lett Drugs Ther. 2013 Oct 14;55(1427):83.","","Med Lett Drugs Ther","2013","2013/10/17","","",""
"24126707","Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females","Clarke TK, Crist RC, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.","Pharmacogenomics J. 2014 Jun;14(3):303-8. doi: 10.1038/tpj.2013.30. Epub 2013 Oct 15.","Clarke TK","Pharmacogenomics J","2014","2013/10/16","PMC3988270","NIHMS508747","10.1038/tpj.2013.30"
"24126024","Acute urinary retention secondary to buprenorphine administration","Edwards RT, McCormick-Deaton C, Hosanagar A.","Am J Emerg Med. 2014 Jan;32(1):109.e1-2. doi: 10.1016/j.ajem.2013.08.022. Epub 2013 Oct 11.","Edwards RT","Am J Emerg Med","2014","2013/10/16","","","10.1016/j.ajem.2013.08.022"
"24120973","Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers","Jones HE, Deppen K, Hudak ML, Leffert L, McClelland C, Sahin L, Starer J, Terplan M, Thorp JM Jr, Walsh J, Creanga AA.","Am J Obstet Gynecol. 2014 Apr;210(4):302-310. doi: 10.1016/j.ajog.2013.10.010. Epub 2013 Oct 10.","Jones HE","Am J Obstet Gynecol","2014","2013/10/15","PMC7213596","NIHMS727143","10.1016/j.ajog.2013.10.010"
"24113212","Neonatal and longer term management following substance misuse in pregnancy","Mactier H.","Early Hum Dev. 2013 Nov;89(11):887-92. doi: 10.1016/j.earlhumdev.2013.08.024. Epub 2013 Oct 7.","Mactier H","Early Hum Dev","2013","2013/10/12","","","10.1016/j.earlhumdev.2013.08.024"
"24112096","The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample","Nielsen S, Hillhouse M, Weiss RD, Mooney L, Sharpe Potter J, Lee J, Gourevitch MN, Ling W.","Am J Addict. 2014 Jul-Aug;23(4):343-8. doi: 10.1111/j.1521-0391.2013.12105.x. Epub 2013 Sep 24.","Nielsen S","Am J Addict","2014","2013/10/12","PMC4151625","NIHMS617788","10.1111/j.1521-0391.2013.12105.x"
"24099717","Disaccharides in urine samples as markers of intravenous abuse of methadone and buprenorphine","Jungen H, Andresen-Streichert H, Müller A, Iwersen-Bergmann S.","J Anal Toxicol. 2013 Nov-Dec;37(9):652-8. doi: 10.1093/jat/bkt086. Epub 2013 Oct 6.","Jungen H","J Anal Toxicol","2013","2013/10/09","","","10.1093/jat/bkt086"
"24099551","Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers","Fischer A, Jönsson M, Hjelmström P.","Drug Dev Ind Pharm. 2015 Jan;41(1):79-84. doi: 10.3109/03639045.2013.846365. Epub 2013 Oct 7.","Fischer A","Drug Dev Ind Pharm","2015","2013/10/09","PMC4364559","","10.3109/03639045.2013.846365"
"24098748","Comparative effects of vasectomy surgery and buprenorphine treatment on faecal corticosterone concentrations and behaviour assessed by manual and automated analysis methods in C57 and C3H mice","Wright-Williams S, Flecknell PA, Roughan JV.","PLoS One. 2013 Sep 30;8(9):e75948. doi: 10.1371/journal.pone.0075948. eCollection 2013.","Wright-Williams S","PLoS One","2013","2013/10/08","PMC3786965","","10.1371/journal.pone.0075948"
"24095872","High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry","Regina KJ, Kharasch ED.","J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Nov 15;939:23-31. doi: 10.1016/j.jchromb.2013.09.004. Epub 2013 Sep 8.","Regina KJ","J Chromatogr B Analyt Technol Biomed Life Sci","2013","2013/10/08","PMC3936475","NIHMS530154","10.1016/j.jchromb.2013.09.004"
"24080973","Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphine","Guo AY, Ma JD, Best BM, Atayee RS.","J Anal Toxicol. 2013 Nov-Dec;37(9):636-41. doi: 10.1093/jat/bkt082. Epub 2013 Sep 29.","Guo AY","J Anal Toxicol","2013","2013/10/02","","","10.1093/jat/bkt082"
"24080771","Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway","Karlstad Ø, Furu K, Skurtveit S, Selmer R.","Eur Addict Res. 2014;20(2):59-65. doi: 10.1159/000353969. Epub 2013 Sep 27.","Karlstad Ø","Eur Addict Res","2014","2013/10/02","","","10.1159/000353969"
"24074852","Psychometric properties of the adjective rating scale for withdrawal across treatment groups, gender, and over time","Barbosa-Leiker C, McPherson S, Mamey MR, Burns GL, Roll J.","J Subst Abuse Treat. 2014 Feb;46(2):251-6. doi: 10.1016/j.jsat.2013.08.020. Epub 2013 Sep 24.","Barbosa-Leiker C","J Subst Abuse Treat","2014","2013/10/01","PMC3870009","NIHMS520415","10.1016/j.jsat.2013.08.020"
"24074190","Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up","Fareed A, Patil D, Scheinberg K, Blackinton Gale R, Vayalapalli S, Casarella J, Drexler K.","J Addict Dis. 2013;32(3):244-51. doi: 10.1080/10550887.2013.824333.","Fareed A","J Addict Dis","2013","2013/10/01","","","10.1080/10550887.2013.824333"
"24053859","Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning","Häkkinen M, Heikman P, Ojanperä I.","Forensic Sci Int. 2013 Oct 10;232(1-3):11-5. doi: 10.1016/j.forsciint.2013.06.017. Epub 2013 Jul 19.","Häkkinen M","Forensic Sci Int","2013","2013/09/24","","","10.1016/j.forsciint.2013.06.017"
"24051897","Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs","Andrews CM, D'Aunno TA, Pollack HA, Friedmann PD.","Med Care Res Rev. 2014 Feb;71(1):43-60. doi: 10.1177/1077558713503188. Epub 2013 Sep 18.","Andrews CM","Med Care Res Rev","2014","2013/09/21","PMC4399853","NIHMS677808","10.1177/1077558713503188"
"24051063","Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers","Dunn KE, Saulsgiver KA, Patrick ME, Heil SH, Higgins ST, Sigmon SC.","Drug Alcohol Depend. 2013 Dec 1;133(2):625-32. doi: 10.1016/j.drugalcdep.2013.08.007. Epub 2013 Aug 30.","Dunn KE","Drug Alcohol Depend","2013","2013/09/21","PMC3824383","NIHMS521012","10.1016/j.drugalcdep.2013.08.007"
"24045030","Days of heroin use predict poor self-reported health in hospitalized heroin users","Meshesha LZ, Tsui JI, Liebschutz JM, Crooks D, Anderson BJ, Herman DS, Stein MD.","Addict Behav. 2013 Dec;38(12):2884-7. doi: 10.1016/j.addbeh.2013.08.002. Epub 2013 Aug 14.","Meshesha LZ","Addict Behav","2013","2013/09/19","PMC3882159","NIHMS524915","10.1016/j.addbeh.2013.08.002"
"24041213","Effects of multimodal analgesia with LowDose buprenorphine and meloxicam on fecal glucocorticoid metabolites after surgery in New Zealand white rabbits (Oryctolagus cuniculus)","Goldschlager GB, Gillespie VL, Palme R, Baxter MG.","J Am Assoc Lab Anim Sci. 2013 Sep;52(5):571-6.","Goldschlager GB","J Am Assoc Lab Anim Sci","2013","2013/09/18","PMC3784663","",""
"24041211","Hemodynamic and behavioral differences after administration of meloxicam, buprenorphine, or tramadol as analgesics for telemeter implantation in mice","Rätsep MT, Barrette VF, Winterborn A, Adams MA, Croy BA.","J Am Assoc Lab Anim Sci. 2013 Sep;52(5):560-6.","Rätsep MT","J Am Assoc Lab Anim Sci","2013","2013/09/18","PMC3784661","",""
"24041131","""This is not who I want to be:"" experiences of opioid-dependent youth before, and during, combined buprenorphine and behavioral treatment","Moore SK, Guarino H, Marsch LA.","Subst Use Misuse. 2014 Feb;49(3):303-14. doi: 10.3109/10826084.2013.832328. Epub 2013 Sep 16.","Moore SK","Subst Use Misuse","2014","2013/09/18","PMC5839470","NIHMS939042","10.3109/10826084.2013.832328"
"24033782","Commentary on Ling et al. (2013): is there a role for psychotherapy in the treatment of opioid dependence?","Petry NM.","Addiction. 2013 Oct;108(10):1799-800. doi: 10.1111/add.12307.","Petry NM","Addiction","2013","2013/09/17","","","10.1111/add.12307"
"24020477","Breastfeeding promotion for management of neonatal abstinence syndrome","Pritham UA.","J Obstet Gynecol Neonatal Nurs. 2013 Sep-Oct;42(5):517-26. doi: 10.1111/1552-6909.12242. Epub 2013 Sep 4.","Pritham UA","J Obstet Gynecol Neonatal Nurs","2013","2013/09/12","","","10.1111/1552-6909.12242"
"24018232","Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland","Genberg BL, Gillespie M, Schuster CR, Johanson CE, Astemborski J, Kirk GD, Vlahov D, Mehta SH.","Addict Behav. 2013 Dec;38(12):2868-73. doi: 10.1016/j.addbeh.2013.08.008. Epub 2013 Aug 17.","Genberg BL","Addict Behav","2013","2013/09/11","PMC3805723","NIHMS516720","10.1016/j.addbeh.2013.08.008"
"24014144","Longitudinal missing data strategies for substance use clinical trials using generalized estimating equations: an example with a buprenorphine trial","McPherson S, Barbosa-Leiker C, McDonell M, Howell D, Roll J.","Hum Psychopharmacol. 2013 Sep;28(5):506-15. doi: 10.1002/hup.2339.","McPherson S","Hum Psychopharmacol","2013","2013/09/10","PMC3830126","NIHMS524605","10.1002/hup.2339"
"23999378","Maternal stress and behavioral adaptation in methadone- or buprenorphine-exposed toddlers","Sarfi M, Sundet JM, Waal H.","Infant Behav Dev. 2013 Dec;36(4):707-16. doi: 10.1016/j.infbeh.2013.08.006. Epub 2013 Aug 31.","Sarfi M","Infant Behav Dev","2013","2013/09/04","","","10.1016/j.infbeh.2013.08.006"
"23995832","Buprenorphine in the treatment of non-suicidal self-injury: a case series and discussion of the literature","Norelli LJ, Smith HS, Sher L, Blackwood TA.","Int J Adolesc Med Health. 2013;25(3):323-30. doi: 10.1515/ijamh-2013-0069.","Norelli LJ","Int J Adolesc Med Health","2013","2013/09/03","","","10.1515/ijamh-2013-0069"
"23993129","Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children","Lavonas EJ, Banner W, Bradt P, Bucher-Bartelson B, Brown KR, Rajan P, Murrelle L, Dart RC, Green JL.","J Pediatr. 2013 Nov;163(5):1377-83.e1-3. doi: 10.1016/j.jpeds.2013.06.058. Epub 2013 Aug 29.","Lavonas EJ","J Pediatr","2013","2013/09/03","","","10.1016/j.jpeds.2013.06.058"
"23983012","Analysis of buprenorphine in whole blood using liquid chromatography-tandem mass spectrometry","Stephenson JB.","J Anal Toxicol. 2013 Oct;37(8):495-9. doi: 10.1093/jat/bkt074. Epub 2013 Aug 27.","Stephenson JB","J Anal Toxicol","2013","2013/08/29","","","10.1093/jat/bkt074"
"23972754","Management of neonatal abstinence syndrome from opioids","Grim K, Harrison TE, Wilder RT.","Clin Perinatol. 2013 Sep;40(3):509-24. doi: 10.1016/j.clp.2013.05.004. Epub 2013 Jul 17.","Grim K","Clin Perinatol","2013","2013/08/27","","","10.1016/j.clp.2013.05.004"
"23972743","Chronic opioid use during pregnancy: maternal and fetal implications","Stanhope TJ, Gill LA, Rose C.","Clin Perinatol. 2013 Sep;40(3):337-50. doi: 10.1016/j.clp.2013.05.015. Epub 2013 Jul 4.","Stanhope TJ","Clin Perinatol","2013","2013/08/27","","","10.1016/j.clp.2013.05.015"
"23971710","Low-dose buprenorphine patch for pain #268","Childers JW, Arnold RM.","J Palliat Med. 2013 Oct;16(10):1299-300. doi: 10.1089/jpm.2013.9473. Epub 2013 Aug 24.","Childers JW","J Palliat Med","2013","2013/08/27","","","10.1089/jpm.2013.9473"
"23967714","Pain management in palliative cancer patients: a prospective observational study on the use of high dosages of transdermal buprenorphine","Clement PM, Beuselinck B, Mertens PG, Cornelissen P, Menten J.","Acta Clin Belg. 2013 Mar-Apr;68(2):87-91. doi: 10.2143/ACB.3141.","Clement PM","Acta Clin Belg","2013","2013/08/24","","","10.2143/ACB.3141"
"23962419","Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment","Maas J, Barton G, Maskrey V, Pinto H, Holland R.","Drug Alcohol Depend. 2013 Dec 1;133(2):494-501. doi: 10.1016/j.drugalcdep.2013.07.018. Epub 2013 Aug 17.","Maas J","Drug Alcohol Depend","2013","2013/08/22","","","10.1016/j.drugalcdep.2013.07.018"
"23961726","Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial","Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, Jacobs P, Teruya C, McLaughlin P, Wiest K, Cohen A, Ling W.","Addiction. 2014 Jan;109(1):79-87. doi: 10.1111/add.12333. Epub 2013 Oct 9.","Hser YI","Addiction","2014","2013/08/22","PMC3947022","NIHMS519619","10.1111/add.12333"
"23955407","Evaluation of tribromoethanol, tribromoethanol-buprenorphine and ketamine-xylazine combinations for anaesthesia in Sprague-Dawley rats undergoing ovariectomy","Ajadi RA, Gazal NA, Teketay DH, Gazal SO.","Niger J Physiol Sci. 2013 Jun 30;28(1):51-6.","Ajadi RA","Niger J Physiol Sci","2013","2013/08/20","","",""
"23951853","[Maintaining opioid abstinence long after inpatient treatment with opioid substitution in an addictology hospital unit]","Bouab O, Lahmek P, Meunier N, Aubin HJ, Michel L.","Rev Med Brux. 2013 May-Jun;34(3):132-40.","Bouab O","Rev Med Brux","2013","2013/08/20","","",""
"23949903","Drug laws and the 'derivative' problem","King LA, Ujváry I, Brandt SD.","Drug Test Anal. 2014 Jul-Aug;6(7-8):879-83. doi: 10.1002/dta.1523. Epub 2013 Aug 15.","King LA","Drug Test Anal","2014","2013/08/17","","","10.1002/dta.1523"
"23937228","Successful medical treatment of glans ischemia after voluntary buprenorphine injection","Brecheteau F, Grison P, Abraham P, Lebdai S, Kemgang S, Souday V, Nedelcu C, Culty T, Larré S, Azzouzi AR, Bigot P.","J Sex Med. 2013 Nov;10(11):2866-70. doi: 10.1111/jsm.12282. Epub 2013 Aug 12.","Brecheteau F","J Sex Med","2013","2013/08/14","","","10.1111/jsm.12282"
"23934003","Primary care patient characteristics associated with completion of 6-month buprenorphine treatment","Neumann AM, Blondell RD, Azadfard M, Nathan G, Homish GG.","Addict Behav. 2013 Nov;38(11):2724-8. doi: 10.1016/j.addbeh.2013.07.007. Epub 2013 Jul 25.","Neumann AM","Addict Behav","2013","2013/08/13","","","10.1016/j.addbeh.2013.07.007"
"23932842","Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice","Barwatt JW, Hofford RS, Emery MA, Bates ML, Wellman PJ, Eitan S.","Drug Alcohol Depend. 2013 Oct 1;132(3):420-6. doi: 10.1016/j.drugalcdep.2013.07.016. Epub 2013 Aug 9.","Barwatt JW","Drug Alcohol Depend","2013","2013/08/13","","","10.1016/j.drugalcdep.2013.07.016"
"23931660","Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy","O'Connor AB, Collett A, Alto WA, O'Brien LM.","J Midwifery Womens Health. 2013 Jul-Aug;58(4):383-8. doi: 10.1111/jmwh.12009.","O'Connor AB","J Midwifery Womens Health","2013","2013/08/13","","","10.1111/jmwh.12009"
"23930470","A comprehensive response to the opioid epidemic: Hazelden's approach","Seppala MD.","Minn Med. 2013 Mar;96(3):45-7.","Seppala MD","Minn Med","2013","2013/08/13","","",""
"23923476","Methadone as an additional opioid for a cancer patient with severe neuropathic and bone pain not responsive to other opioids and adjuvant analgesics","Leppert W, Kowalski G.","J Palliat Care. 2013 Summer;29(2):119-21.","Leppert W","J Palliat Care","2013","2013/08/08","","",""
"23922192","Safety and efficacy of transdermal buprenorphine for the relief of cancer pain","Naing C, Aung K, Racloz V, Yeoh PN.","J Cancer Res Clin Oncol. 2013 Dec;139(12):1963-70. doi: 10.1007/s00432-013-1487-0. Epub 2013 Aug 7.","Naing C","J Cancer Res Clin Oncol","2013","2013/08/08","","","10.1007/s00432-013-1487-0"
"23919595","Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone","Rosenthal RN, Ling W, Casadonte P, Vocci F, Bailey GL, Kampman K, Patkar A, Chavoustie S, Blasey C, Sigmon S, Beebe KL.","Addiction. 2013 Dec;108(12):2141-9. doi: 10.1111/add.12315. Epub 2013 Sep 18.","Rosenthal RN","Addiction","2013","2013/08/08","PMC4669043","NIHMS513893","10.1111/add.12315"
"23916321","Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial","Otiashvili D, Piralishvili G, Sikharulidze Z, Kamkamidze G, Poole S, Woody GE.","Drug Alcohol Depend. 2013 Dec 1;133(2):376-82. doi: 10.1016/j.drugalcdep.2013.06.024. Epub 2013 Jul 31.","Otiashvili D","Drug Alcohol Depend","2013","2013/08/07","PMC3818507","NIHMS502114","10.1016/j.drugalcdep.2013.06.024"
"23910721","Sedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular administration in cats","Porters N, Bosmans T, Debille M, de Rooster H, Duchateau L, Polis I.","Vet Anaesth Analg. 2014 Jan;41(1):90-6. doi: 10.1111/vaa.12076. Epub 2013 Aug 2.","Porters N","Vet Anaesth Analg","2014","2013/08/06","","","10.1111/vaa.12076"
"23909970","A case of topical opioid-induced delirium mistaken as behavioural and psychological symptoms of dementia in demented state","Ito G, Kanemoto K.","Psychogeriatrics. 2013 Jun;13(2):118-23. doi: 10.1111/psyg.12007.","Ito G","Psychogeriatrics","2013","2013/08/06","","","10.1111/psyg.12007"
"23909865","Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants","Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarkø L, Ravndal E.","Acta Paediatr. 2013 Nov;102(11):1060-6. doi: 10.1111/apa.12378. Epub 2013 Sep 2.","Welle-Strand GK","Acta Paediatr","2013","2013/08/06","","","10.1111/apa.12378"
"23905402","[Buprenorphine transdermal patch (Norspan tape)]","Hamaguchi S, Ikeda T.","Masui. 2013 Jul;62(7):799-807.","Hamaguchi S","Masui","2013","2013/08/03","","",""
"23904546","Lord, deliver us from pain","Veyckemans F, Rodenstein D.","Eur Respir J. 2013 Aug;42(2):297-8. doi: 10.1183/09031936.00005213.","Veyckemans F","Eur Respir J","2013","2013/08/02","","","10.1183/09031936.00005213"
"23896305","Mortality among clients seeking treatment for buprenorphine abuse in Finland","Uosukainen H, Kauhanen J, Bell JS, Ronkainen K, Tiihonen J, Föhr J, Onyeka IN, Korhonen MJ.","Drug Alcohol Depend. 2013 Dec 1;133(2):391-7. doi: 10.1016/j.drugalcdep.2013.06.022. Epub 2013 Jul 26.","Uosukainen H","Drug Alcohol Depend","2013","2013/07/31","","","10.1016/j.drugalcdep.2013.06.022"
"23891461","Change in symptoms of erectile dysfunction in depressed men initiating buprenorphine therapy","Cioe PA, Anderson BJ, Stein MD.","J Subst Abuse Treat. 2013 Nov-Dec;45(5):451-6. doi: 10.1016/j.jsat.2013.06.004. Epub 2013 Jul 23.","Cioe PA","J Subst Abuse Treat","2013","2013/07/30","PMC4020627","NIHMS577144","10.1016/j.jsat.2013.06.004"
"23888429","Opioids for acute pancreatitis pain","Basurto Ona X, Rigau Comas D, Urrútia G.","Cochrane Database Syst Rev. 2013 Jul 26;(7):CD009179. doi: 10.1002/14651858.CD009179.pub2.","Basurto Ona X","Cochrane Database Syst Rev","2013","2013/07/27","","","10.1002/14651858.CD009179.pub2"
"23886460","[Opiate substitution treatment's cycles in a five-year followed-up cohort in ambulatory practice]","Dupouy J, Bez J, Barsony J, Oustric S, Lapeyre-Mestre M.","Therapie. 2013 May-Jun;68(3):155-61. doi: 10.2515/therapie/2013022. Epub 2013 Jul 26.","Dupouy J","Therapie","2013","2013/07/27","","","10.2515/therapie/2013022"
"23877740","Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?","Clark RE, Baxter JD.","JAMA Intern Med. 2013 Sep 23;173(17):1571-2. doi: 10.1001/jamainternmed.2013.9059.","Clark RE","JAMA Intern Med","2013","2013/07/24","","","10.1001/jamainternmed.2013.9059"
"23874860","Long term Suboxone™ emotional reactivity as measured by automatic detection in speech","Hill E, Han D, Dumouchel P, Dehak N, Quatieri T, Moehs C, Oscar-Berman M, Giordano J, Simpatico T, Barh D, Blum K.","PLoS One. 2013 Jul 9;8(7):e69043. doi: 10.1371/journal.pone.0069043. Print 2013.","Hill E","PLoS One","2013","2013/07/23","PMC3706486","","10.1371/journal.pone.0069043"
"23872995","Acute pain management for patients under opioid maintenance treatment: what physicians do in emergency departments?","Bounes V, Jouanjus E, Roussin A, Lapeyre-Mestre M.","Eur J Emerg Med. 2014 Feb;21(1):73-6. doi: 10.1097/MEJ.0b013e328363c9e0.","Bounes V","Eur J Emerg Med","2014","2013/07/23","","","10.1097/MEJ.0b013e328363c9e0"
"23866883","Buprenorphine-induced linear IgA bullous dermatosis ""down the rail""","Pol H, Devaux S, Tournier E, Fortenfant F, Paul C.","J Am Acad Dermatol. 2013 Aug;69(2):e106-7. doi: 10.1016/j.jaad.2013.02.006.","Pol H","J Am Acad Dermatol","2013","2013/07/23","","","10.1016/j.jaad.2013.02.006"
"23859702","Comparison of premedication with buprenorphine or methadone with meloxicam for postoperative analgesia in dogs undergoing orthopaedic surgery","Hunt JR, Attenburrow PM, Slingsby LS, Murrell JC.","J Small Anim Pract. 2013 Aug;54(8):418-24. doi: 10.1111/jsap.12103. Epub 2013 Jul 13.","Hunt JR","J Small Anim Pract","2013","2013/07/18","","","10.1111/jsap.12103"
"23859638","Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review","Feelemyer J, Des Jarlais D, Arasteh K, Abdul-Quader AS, Hagan H.","Addiction. 2014 Jan;109(1):20-32. doi: 10.1111/add.12303. Epub 2013 Aug 15.","Feelemyer J","Addiction","2014","2013/07/18","PMC5312702","NIHMS850022","10.1111/add.12303"
"23855724","HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations","D'Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD.","Version 2. Health Serv Res. 2014 Feb;49(1):230-48. doi: 10.1111/1475-6773.12094. Epub 2013 Jul 16.","D'Aunno T","Health Serv Res","2014","2013/07/17","PMC3839251","NIHMS496454","10.1111/1475-6773.12094"
"23855719","Adoption and diffusion of evidence-based addiction medications in substance abuse treatment","Heinrich CJ, Cummings GR.","Health Serv Res. 2014 Feb;49(1):127-52. doi: 10.1111/1475-6773.12093. Epub 2013 Jul 16.","Heinrich CJ","Health Serv Res","2014","2013/07/17","PMC3922470","","10.1111/1475-6773.12093"
"23855333","Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure","Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, Oliveto AH.","Exp Clin Psychopharmacol. 2013 Aug;21(4):294-302. doi: 10.1037/a0033724. Epub 2013 Jul 15.","Sanders NC","Exp Clin Psychopharmacol","2013","2013/07/17","PMC3972066","NIHMS555669","10.1037/a0033724"
"23849409","Assessment of postoperative analgesia after application of ultrasound-guided regional anesthesia for surgery in a swine femoral fracture model","Royal JM, Settle TL, Bodo M, Lombardini E, Kent ML, Upp J, Rothwell SW.","J Am Assoc Lab Anim Sci. 2013;52(3):265-76.","Royal JM","J Am Assoc Lab Anim Sci","2013","2013/07/16","PMC3690448","",""
"23849373","Buprenorphine therapy: an increasing challenge in oral and maxillofacial surgery","Wasson M, Beirne OR.","Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Aug;116(2):142-6. doi: 10.1016/j.oooo.2013.04.018.","Wasson M","Oral Surg Oral Med Oral Pathol Oral Radiol","2013","2013/07/16","","","10.1016/j.oooo.2013.04.018"
"23847869","[Substitution treatment with drug-free contract care--outcome]","Ohlin L, Tätting P, Fridell M.","Lakartidningen. 2013 Jun 5-18;110(23-24):1158-60.","Ohlin L","Lakartidningen","2013","2013/07/16","","",""
"23846520","Transdermal buprenorphine, opioid rotation to sublingual buprenorphine, and the avoidance of precipitated withdrawal: a review of the literature and demonstration in three chronic pain patients treated with butrans","Kornfeld H, Reetz H.","Am J Ther. 2015 May-Jun;22(3):199-205. doi: 10.1097/MJT.0b013e31828bfb6e.","Kornfeld H","Am J Ther","2015","2013/07/13","","","10.1097/MJT.0b013e31828bfb6e"
"23845658","Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone","Gaalema DE, Heil SH, Badger GJ, Metayer JS, Johnston AM.","Drug Alcohol Depend. 2013 Nov 1;133(1):266-9. doi: 10.1016/j.drugalcdep.2013.06.004. Epub 2013 Jul 8.","Gaalema DE","Drug Alcohol Depend","2013","2013/07/13","PMC3786061","NIHMS504044","10.1016/j.drugalcdep.2013.06.004"
"23844954","A buprenorphine education and training program for primary care residents: implementation and evaluation","Kunins HV, Sohler NL, Giovanniello A, Thompson D, Cunningham CO.","Subst Abus. 2013;34(3):242-7. doi: 10.1080/08897077.2012.752777.","Kunins HV","Subst Abus","2013","2013/07/13","PMC3799907","NIHMS509769","10.1080/08897077.2012.752777"
"23839029","Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts","Comer SD, Metz VE, Cooper ZD, Kowalczyk WJ, Jones JD, Sullivan MA, Manubay JM, Vosburg SK, Smith ME, Peyser D, Saccone PA.","Behav Pharmacol. 2013 Sep;24(5-6):504-16. doi: 10.1097/FBP.0b013e328363d1c4.","Comer SD","Behav Pharmacol","2013","2013/07/11","PMC4056333","NIHMS587656","10.1097/FBP.0b013e328363d1c4"
"23838758","Babies breaking bad: neonatal and iatrogenic withdrawal syndromes","Cramton RE, Gruchala NE.","Curr Opin Pediatr. 2013 Aug;25(4):532-42. doi: 10.1097/MOP.0b013e328362cd0d.","Cramton RE","Curr Opin Pediatr","2013","2013/07/11","","","10.1097/MOP.0b013e328362cd0d"
"23837730","Nociceptive thermal threshold testing in horses - effect of neuroleptic sedation and neuroleptanalgesia at different stimulation sites","Poller C, Hopster K, Rohn K, Kästner SB.","BMC Vet Res. 2013 Jul 9;9:135. doi: 10.1186/1746-6148-9-135.","Poller C","BMC Vet Res","2013","2013/07/11","PMC3708779","","10.1186/1746-6148-9-135"
"23829344","Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET","Watson BJ, Taylor LG, Reid AG, Wilson SJ, Stokes PR, Brooks DJ, Myers JF, Turkheimer FE, Nutt DJ, Lingford-Hughes AR.","Addict Biol. 2014 Nov;19(6):1032-40. doi: 10.1111/adb.12073. Epub 2013 Jul 5.","Watson BJ","Addict Biol","2014","2013/07/09","PMC4282066","","10.1111/adb.12073"
"23820366","Buprenorphine/naloxone therapy for opioid refractory neuropathic pain following traumatic amputation: a case series","Licina L, Hamsher C, Lautenschager K, Dhanjal S, Williams N, Spevak C.","Mil Med. 2013 Jul;178(7):e858-61. doi: 10.7205/MILMED-D-12-00310.","Licina L","Mil Med","2013","2013/07/04","","","10.7205/MILMED-D-12-00310"
"23811060","Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants","Wilcox CE, Bogenschutz MP, Nakazawa M, Woody G.","Addict Behav. 2013 Oct;38(10):2568-74. doi: 10.1016/j.addbeh.2013.05.015. Epub 2013 Jun 13.","Wilcox CE","Addict Behav","2013","2013/07/02","PMC3733244","NIHMS493676","10.1016/j.addbeh.2013.05.015"
"23795882","Predictors of diabetes mellitus and abnormal blood glucose in patients receiving opioid maintenance treatment","Fareed A, Byrd-Sellers J, Vayalapalli S, Drexler K, Phillips L.","Am J Addict. 2013 Jul-Aug;22(4):411-6. doi: 10.1111/j.1521-0391.2013.12043.x.","Fareed A","Am J Addict","2013","2013/06/26","","","10.1111/j.1521-0391.2013.12043.x"
"23795874","Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users","Cunningham CO, Giovanniello A, Kunins HV, Roose RJ, Fox AD, Sohler NL.","Am J Addict. 2013 Jul-Aug;22(4):352-7. doi: 10.1111/j.1521-0391.2013.12032.x.","Cunningham CO","Am J Addict","2013","2013/06/26","PMC3694744","NIHMS450674","10.1111/j.1521-0391.2013.12032.x"
"23786504","Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurement","Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR.","Am J Addict. 2012 Nov;21 Suppl 1:S1-4. doi: 10.1111/j.1521-0391.2012.00289.x.","Jones HE","Am J Addict","2012","2013/06/22","","","10.1111/j.1521-0391.2012.00289.x"
"23782362","Allergic contact dermatitis caused by transdermal buprenorphine","Kyrklund C, Hyry H, Alanko K.","Contact Dermatitis. 2013 Jul;69(1):60-1. doi: 10.1111/cod.12051.","Kyrklund C","Contact Dermatitis","2013","2013/06/21","","","10.1111/cod.12051"
"23781656","Post marketing surveillance of sublingual buprenorphine naloxone combination tablets","Ray R, Vaswani M, Deb KS, Sethi H, Chopra A, Kishore N, Goyal R.","Indian J Physiol Pharmacol. 2012 Oct-Dec;56(4):359-66.","Ray R","Indian J Physiol Pharmacol","2012","2013/06/21","","",""
"23775478","Buprenorphine use in pregnant opioid users: a critical review","Soyka M.","CNS Drugs. 2013 Aug;27(8):653-62. doi: 10.1007/s40263-013-0072-z.","Soyka M","CNS Drugs","2013","2013/06/19","","","10.1007/s40263-013-0072-z"
"23773400","Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study","Bukten A, Herskedal A, Skurtveit S, Bramness JG, Clausen T.","Addiction. 2013 Nov;108(11):1954-61. doi: 10.1111/add.12275. Epub 2013 Jul 19.","Bukten A","Addiction","2013","2013/06/19","","","10.1111/add.12275"
"23763429","Efforts to reduce overdose deaths","Sherman SG, Han J, Welsh C, Chaulk P, Serio-Chapman C.","Am J Public Health. 2013 Aug;103(8):e1-2. doi: 10.2105/AJPH.2013.301410. Epub 2013 Jun 13.","Sherman SG","Am J Public Health","2013","2013/06/15","PMC4007886","","10.2105/AJPH.2013.301410"
"23763406","Schwartz et al. respond","Schwartz RP, Gryczynski J, O'Grady KE, Sharfstein JM, Warren G, Olsen YK, Mitchell SG, Jaffe JH.","Am J Public Health. 2013 Aug;103(8):e2-3. doi: 10.2105/AJPH.2013.301428. Epub 2013 Jun 13.","Schwartz RP","Am J Public Health","2013","2013/06/15","PMC4007877","","10.2105/AJPH.2013.301428"
"23758187","The use of transdermal buprenorphine to relieve radiotherapy-related pain in head and neck cancer patients","Menten J, Carpentier I, Deschutter H, Nuyts S, Van Beek K.","Cancer Invest. 2013 Jul;31(6):412-20. doi: 10.3109/07357907.2013.800094. Epub 2013 Jun 11.","Menten J","Cancer Invest","2013","2013/06/14","","","10.3109/07357907.2013.800094"
"23750774","Engagement, retention, and abstinence for three types of opioid users in Florida","McCabe BE, Santisteban DA, Mena MP, Duchene DM, McLean C, Monroe M.","Subst Use Misuse. 2013 Jun;48(8):623-34. doi: 10.3109/10826084.2013.800112. Epub 2013 Jun 10.","McCabe BE","Subst Use Misuse","2013","2013/06/12","PMC3901156","NIHMS526107","10.3109/10826084.2013.800112"
"23748879","Colon anastomotic leakage: improving the mouse model","Pommergaard HC, Achiam MP, Rosenberg J.","Surg Today. 2014 May;44(5):933-9. doi: 10.1007/s00595-013-0632-3. Epub 2013 Jun 9.","Pommergaard HC","Surg Today","2014","2013/06/11","","","10.1007/s00595-013-0632-3"
"23745982","Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants","Patel P, Abdel-Latif ME, Hazelton B, Wodak A, Chen J, Emsley F, Feller JM, Lui K, Oei JL.","J Paediatr Child Health. 2013 Sep;49(9):746-53. doi: 10.1111/jpc.12264. Epub 2013 Jun 9.","Patel P","J Paediatr Child Health","2013","2013/06/11","","","10.1111/jpc.12264"
"23744347","Opioid antagonists for smoking cessation","David SP, Lancaster T, Stead LF, Evins AE, Prochaska JJ.","Cochrane Database Syst Rev. 2013 Jun 6;6(6):CD003086. doi: 10.1002/14651858.CD003086.pub3.","David SP","Cochrane Database Syst Rev","2013","2013/06/08","PMC4038652","NIHMS579848","10.1002/14651858.CD003086.pub3"
"23742694","Evaluation of sedation for standing clinical procedures in horses using detomidine combined with buprenorphine","Taylor P, Coumbe K, Henson F, Scott D, Taylor A.","Vet Anaesth Analg. 2014 Jan;41(1):14-24. doi: 10.1111/vaa.12055. Epub 2013 Jun 7.","Taylor P","Vet Anaesth Analg","2014","2013/06/08","","","10.1111/vaa.12055"
"23739025","Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START)","Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W.","J Stud Alcohol Drugs. 2013 Jul;74(4):605-13. doi: 10.15288/jsad.2013.74.605.","Potter JS","J Stud Alcohol Drugs","2013","2013/06/07","PMC3711351","","10.15288/jsad.2013.74.605"
"23736517","Postcastration analgesia in ponies using buprenorphine hydrochloride","Love EJ, Taylor PM, Whay HR, Murrell J.","Vet Rec. 2013 Jun 15;172(24):635. doi: 10.1136/vr.101440. Epub 2013 Jun 4.","Love EJ","Vet Rec","2013","2013/06/06","","","10.1136/vr.101440"
"23734878","Deviant smooth pursuit in preschool children exposed prenatally to methadone or buprenorphine and tobacco affects integrative visuomotor capabilities","Melinder A, Konijnenberg C, Sarfi M.","Addiction. 2013 Dec;108(12):2175-82. doi: 10.1111/add.12267. Epub 2013 Jul 17.","Melinder A","Addiction","2013","2013/06/06","PMC4226328","","10.1111/add.12267"
"23734858","Comparison of behavioral treatment conditions in buprenorphine maintenance","Ling W, Hillhouse M, Ang A, Jenkins J, Fahey J.","Addiction. 2013 Oct;108(10):1788-98. doi: 10.1111/add.12266. Epub 2013 Jul 12.","Ling W","Addiction","2013","2013/06/06","PMC3866908","NIHMS516868","10.1111/add.12266"
"23731419","Medications for substance use disorders","Douaihy AB, Kelly TM, Sullivan C.","Soc Work Public Health. 2013;28(3-4):264-78. doi: 10.1080/19371918.2013.759031.","Douaihy AB","Soc Work Public Health","2013","2013/06/05","PMC3767185","NIHMS496118","10.1080/19371918.2013.759031"
"23727654","Sublingual buprenorphine for chronic pain: a survey of clinician prescribing practices","Rosen K, Gutierrez A, Haller D, Potter JS.","Clin J Pain. 2014 Apr;30(4):295-300. doi: 10.1097/AJP.0b013e318298ddad.","Rosen K","Clin J Pain","2014","2013/06/04","PMC3806898","NIHMS485700","10.1097/AJP.0b013e318298ddad"
"23723052","The effect of chronic thienorphine administration on long-term potentiation and synaptic structure in rat hippocampus","Yong Z, Yan L, Dong Z, Wang X, Su R, Gong Z.","Synapse. 2013 Nov;67(11):779-85. doi: 10.1002/syn.21682. Epub 2013 Jul 4.","Yong Z","Synapse","2013","2013/06/01","","","10.1002/syn.21682"
"23722632","Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes","Cunningham CO, Roose RJ, Starrels JL, Giovanniello A, Sohler NL.","J Addict Med. 2013 Jul-Aug;7(4):287-93. doi: 10.1097/ADM.0b013e31829727b2.","Cunningham CO","J Addict Med","2013","2013/06/01","PMC3737355","NIHMS482088","10.1097/ADM.0b013e31829727b2"
"23719588","Parenteral analgesics for pain relief in acute pancreatitis: a systematic review","Meng W, Yuan J, Zhang C, Bai Z, Zhou W, Yan J, Li X.","Pancreatology. 2013 May-Jun;13(3):201-6. doi: 10.1016/j.pan.2013.02.003. Epub 2013 Feb 26.","Meng W","Pancreatology","2013","2013/05/31","","","10.1016/j.pan.2013.02.003"
"23709320","Consumer attitudes about opioid addiction treatment: a focus group study in New York City","Sohler NL, Weiss L, Egan JE, López CM, Favaro J, Cordero R, Cunningham CO.","J Opioid Manag. 2013 Mar-Apr;9(2):111-9. doi: 10.5055/jom.2013.0152.","Sohler NL","J Opioid Manag","2013","2013/05/28","PMC4012752","NIHMS576213","10.5055/jom.2013.0152"
"23709302","Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects","Chawla JM, Pal H, Lal R, Jain R, Schooler N, Balhara YP.","J Opioid Manag. 2013 Jan-Feb;9(1):35-41. doi: 10.5055/jom.2013.0145.","Chawla JM","J Opioid Manag","2013","2013/05/28","","","10.5055/jom.2013.0145"
"23707283","Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone","Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg SK, Cooper ZD, Manubay JM, Mogali S, Comer SD.","Pain. 2013 Aug;154(8):1442-8. doi: 10.1016/j.pain.2013.05.004. Epub 2013 May 7.","Roux P","Pain","2013","2013/05/28","PMC3770461","NIHMS477686","10.1016/j.pain.2013.05.004"
"23702611","Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","Hansen HB, Siegel CE, Case BG, Bertollo DN, DiRocco D, Galanter M.","J Behav Health Serv Res. 2013 Jul;40(3):367-77. doi: 10.1007/s11414-013-9341-3.","Hansen HB","J Behav Health Serv Res","2013","2013/05/25","PMC3818282","NIHMS484739","10.1007/s11414-013-9341-3"
"23697094","Basic epidemiology of opiate misuse substitution treatment in Belgium","Ledoux Y.","J Pharm Belg. 2012 Sep;(3):30-9.","Ledoux Y","J Pharm Belg","2012","2013/05/24","","",""
"23692014","Dose patterns among patients using low-dose buprenorphine patches","Lesén E, Ericson L, Simonsberg C, Varelius R, Björholt I, Söderpalm B.","Pain Med. 2013 Sep;14(9):1374-80. doi: 10.1111/pme.12142. Epub 2013 May 21.","Lesén E","Pain Med","2013","2013/05/23","","","10.1111/pme.12142"
"23690105","Efficacy of core decompression of femoral head to treat avascular necrosis in intravenous drug users","Abrisham SM, Hajiesmaeili MR, Soleimani H, Pahlavanhosseini H.","Acta Med Iran. 2013 May 7;51(4):250-3.","Abrisham SM","Acta Med Iran","2013","2013/05/22","","",""
"23688843","Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes","Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ.","Drug Alcohol Depend. 2013 Oct 1;132(3):580-6. doi: 10.1016/j.drugalcdep.2013.04.006. Epub 2013 May 18.","Schuman-Olivier Z","Drug Alcohol Depend","2013","2013/05/22","PMC3916951","NIHMS472006","10.1016/j.drugalcdep.2013.04.006"
"23678668","[Pain therapy in the elderly:7-day transdermal buprenorphine patch in clinical practice. Results of a non-interventional study]","Wahle K, Krings D, Schwenke K.","MMW Fortschr Med. 2013 Mar 21;155 Suppl 1:25-31. doi: 10.1007/s15006-013-0733-3.","Wahle K","MMW Fortschr Med","2013","2013/05/18","","","10.1007/s15006-013-0733-3"
"23669129","Medical outcomes associated with nonmedical use of methadone and buprenorphine","Lee S, Klein-Schwartz W, Welsh C, Doyon S.","J Emerg Med. 2013 Aug;45(2):199-205. doi: 10.1016/j.jemermed.2012.11.104. Epub 2013 May 11.","Lee S","J Emerg Med","2013","2013/05/15","","","10.1016/j.jemermed.2012.11.104"
"23665497","Up-regulation of monoamine oxidase activity in the striatum of rats following chronic treatment of thienorphine","Yong Z, Yan L, Wang X, Su R, Gong Z.","Eur J Pharmacol. 2013 Aug 5;713(1-3):44-6. doi: 10.1016/j.ejphar.2013.04.041. Epub 2013 May 9.","Yong Z","Eur J Pharmacol","2013","2013/05/14","","","10.1016/j.ejphar.2013.04.041"
"23665439","Development of test strips for rapid buprenorphine detection in vitro","Li SJ, Wang D, Zhang J, Zheng J, Chen WX.","Clin Biochem. 2013 Aug;46(12):1093-1098. doi: 10.1016/j.clinbiochem.2013.05.001. Epub 2013 May 9.","Li SJ","Clin Biochem","2013","2013/05/14","","","10.1016/j.clinbiochem.2013.05.001"
"23663749","Testing use of payers to facilitate evidence-based practice adoption: protocol for a cluster-randomized trial","Molfenter T, Kim JS, Quanbeck A, Patel-Porter T, Starr S, McCarty D.","Implement Sci. 2013 May 10;8:50. doi: 10.1186/1748-5908-8-50.","Molfenter T","Implement Sci","2013","2013/05/14","PMC3666944","","10.1186/1748-5908-8-50"
"23656339","A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice","Bruce RD, Moody DE, Altice FL, Gourevitch MN, Friedland GH.","Expert Rev Clin Pharmacol. 2013 May;6(3):249-69. doi: 10.1586/ecp.13.18.","Bruce RD","Expert Rev Clin Pharmacol","2013","2013/05/10","PMC4198941","NIHMS544174","10.1586/ecp.13.18"
"23652222","Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain","Sukhtankar DD, Zaveri NT, Husbands SM, Ko MC.","J Pharmacol Exp Ther. 2013 Jul;346(1):11-22. doi: 10.1124/jpet.113.203984. Epub 2013 May 7.","Sukhtankar DD","J Pharmacol Exp Ther","2013","2013/05/09","PMC3684842","","10.1124/jpet.113.203984"
"23652177","Current developments in the treatment of neuropathic pain in AIDS patients","Eroglu A.","Minerva Anestesiol. 2013 Aug;79(8):835-7. Epub 2013 May 6.","Eroglu A","Minerva Anestesiol","2013","2013/05/09","","",""
"23651992","Abstinence versus agonist maintenance treatment: an outdated debate?","Uchtenhagen A.","Eur Addict Res. 2013;19(6):283-6. doi: 10.1159/000350373. Epub 2013 May 7.","Uchtenhagen A","Eur Addict Res","2013","2013/05/09","","","10.1159/000350373"
"23648060","Buprenorphine","Foster B, Twycross R, Mihalyo M, Wilcock A.","J Pain Symptom Manage. 2013 May;45(5):939-49. doi: 10.1016/j.jpainsymman.2013.03.001.","Foster B","J Pain Symptom Manage","2013","2013/05/08","","","10.1016/j.jpainsymman.2013.03.001"
"23647815","Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review","McCormick Z, Chu SK, Chang-Chien GC, Joseph P.","Pain Med. 2013 Aug;14(8):1187-91. doi: 10.1111/pme.12135. Epub 2013 May 3.","McCormick Z","Pain Med","2013","2013/05/08","","","10.1111/pme.12135"
"23641443","Suboxone pharma foibles/FDA does its job well","Gordon A, Kretzschmar A, Gilbert E.","R I Med J (2013). 2013 Apr 1;96(4):13.","Gordon A","R I Med J (2013)","2013","2013/05/04","","",""
"23630985","Indigenous Canadians confront prescription opioid misuse","Webster PC.","Lancet. 2013 Apr 27;381(9876):1447-8. doi: 10.1016/s0140-6736(13)60913-7.","Webster PC","Lancet","2013","2013/05/01","","","10.1016/s0140-6736(13)60913-7"
"23624329","Comparison of the transcriptional responses induced by acute morphine, methadone and buprenorphine","Belkaï E, Crété D, Courtin C, Noble F, Marie-Claire C.","Eur J Pharmacol. 2013 Jul 5;711(1-3):10-8. doi: 10.1016/j.ejphar.2013.04.015. Epub 2013 Apr 24.","Belkaï E","Eur J Pharmacol","2013","2013/04/30","","","10.1016/j.ejphar.2013.04.015"
"23617873","Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","Gryczynski J, Jaffe JH, Schwartz RP, Dušek KA, Gugsa N, Monroe CL, O'Grady KE, Olsen YK, Mitchell SG.","Am J Addict. 2013 May-Jun;22(3):285-91. doi: 10.1111/j.1521-0391.2012.12004.x.","Gryczynski J","Am J Addict","2013","2013/04/27","PMC4215541","NIHMS637993","10.1111/j.1521-0391.2012.12004.x"
"23617867","Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data","Debelak K, Morrone WR, O'Grady KE, Jones HE.","Am J Addict. 2013 May-Jun;22(3):252-4. doi: 10.1111/j.1521-0391.2012.12005.x.","Debelak K","Am J Addict","2013","2013/04/27","","","10.1111/j.1521-0391.2012.12005.x"
"23617861","Pain and associated substance use among opioid dependent individuals seeking office-based treatment with buprenorphine-naloxone: a needs assessment study","Barry DT, Savant JD, Beitel M, Cutter CJ, Moore BA, Schottenfeld RS, Fiellin DA.","Am J Addict. 2013 May-Jun;22(3):212-7. doi: 10.1111/j.1521-0391.2012.00327.x.","Barry DT","Am J Addict","2013","2013/04/27","PMC3641684","NIHMS418052","10.1111/j.1521-0391.2012.00327.x"
"23617857","Steps physicians report taking to reduce diversion of buprenorphine","Yang A, Arfken CL, Johanson CE.","Am J Addict. 2013 May-Jun;22(3):184-7. doi: 10.1111/j.1521-0391.2012.00335.x.","Yang A","Am J Addict","2013","2013/04/27","","","10.1111/j.1521-0391.2012.00335.x"
"23616210","Primary care management of opioid dependence: the addition of CBT gives no extra benefit compared to standard physician management alone","Miotto K.","Evid Based Ment Health. 2013 Aug;16(3):76. doi: 10.1136/eb-2013-101253. Epub 2013 Apr 24.","Miotto K","Evid Based Ment Health","2013","2013/04/26","","","10.1136/eb-2013-101253"
"23612625","Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?","O'Connor AB, O'Brien L, Alto WA.","J Perinat Med. 2013 Sep 1;41(5):621-3. doi: 10.1515/jpm-2012-0288.","O'Connor AB","J Perinat Med","2013","2013/04/25","","","10.1515/jpm-2012-0288"
"23612435","An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans","Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.","Neuropsychopharmacology. 2013 Sep;38(10):2003-10. doi: 10.1038/npp.2013.99. Epub 2013 Apr 23.","Crist RC","Neuropsychopharmacology","2013","2013/04/25","PMC3746708","","10.1038/npp.2013.99"
"23611363","The response of agitated behavior to pain management in persons with dementia","Husebo BS, Ballard C, Cohen-Mansfield J, Seifert R, Aarsland D.","Am J Geriatr Psychiatry. 2014 Jul;22(7):708-17. doi: 10.1016/j.jagp.2012.12.006. Epub 2013 Apr 20.","Husebo BS","Am J Geriatr Psychiatry","2014","2013/04/25","","","10.1016/j.jagp.2012.12.006"
"23609213","Buprenorphine and medication management in a community corrections population: a pilot study","Cropsey KL, Lane PS, Perkins AC, Clark CB, Hardy S, McCullumsmith C, Stitzer ML.","J Addict Med. 2013 May-Jun;7(3):210-5. doi: 10.1097/ADM.0b013e31828e6b21.","Cropsey KL","J Addict Med","2013","2013/04/24","","","10.1097/ADM.0b013e31828e6b21"
"23605225","Neurofeedback training for opiate addiction: improvement of mental health and craving","Dehghani-Arani F, Rostami R, Nadali H.","Appl Psychophysiol Biofeedback. 2013 Jun;38(2):133-41. doi: 10.1007/s10484-013-9218-5.","Dehghani-Arani F","Appl Psychophysiol Biofeedback","2013","2013/04/23","PMC3650238","","10.1007/s10484-013-9218-5"
"23603932","Antihyperalgesic effect of buprenorphine involves nociceptin/orphanin FQ peptide-receptor activation in rats with spinal nerve injury-induced neuropathy","Takahashi T, Okubo K, Kojima S, Nishikawa H, Takemura M, Tsubota-Matsunami M, Sekiguchi F, Kawabata A.","J Pharmacol Sci. 2013;122(1):51-4. doi: 10.1254/jphs.13029sc. Epub 2013 Apr 20.","Takahashi T","J Pharmacol Sci","2013","2013/04/23","","","10.1254/jphs.13029sc"
"23599011","The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone treatment","Bruce RD, Winkle P, Custodio JM, Wei LX, Rhee MS, Kearney BP, Ramanathan S, Friedland GH.","J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):480-4. doi: 10.1097/QAI.0b013e3182961d31.","Bruce RD","J Acquir Immune Defic Syndr","2013","2013/04/20","","","10.1097/QAI.0b013e3182961d31"
"23588567","Response to the letter to the editor by Dr. Srinivas on the recent publication of Al-Tawil et al. on the pharmacokinetics of transdermal buprenorphine patch in the elderly","Johnson H, Berggren AC.","Eur J Clin Pharmacol. 2013 Aug;69(8):1609-10. doi: 10.1007/s00228-013-1509-5. Epub 2013 Apr 16.","Johnson H","Eur J Clin Pharmacol","2013","2013/04/17","PMC3710568","","10.1007/s00228-013-1509-5"
"23588566","Transdermal buprenorphine-interesting observations on the metabolite norbuprenorphine levels in elderly subjects","Srinivas NR.","Eur J Clin Pharmacol. 2013 Aug;69(8):1607-8. doi: 10.1007/s00228-013-1508-6. Epub 2013 Apr 16.","Srinivas NR","Eur J Clin Pharmacol","2013","2013/04/17","","","10.1007/s00228-013-1508-6"
"23585610","Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse","Uddin F.","Can Fam Physician. 2013 Apr;59(4):391-3.","Uddin F","Can Fam Physician","2013","2013/04/16","PMC3625089","",""
"23584313","When opioids fail in chronic pain management: the role for buprenorphine and hospitalization","Berland DW, Malinoff HL, Weiner MA, Przybylski R.","Am J Ther. 2013 Jul-Aug;20(4):316-21. doi: 10.1097/MJT.0b013e31827ab599.","Berland DW","Am J Ther","2013","2013/04/16","","","10.1097/MJT.0b013e31827ab599"
"23582417","Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice","Jacobsen KR, Fauerby N, Raida Z, Kalliokoski O, Hau J, Johansen FF, Abelson KS.","Comp Med. 2013 Apr;63(2):105-13.","Jacobsen KR","Comp Med","2013","2013/04/16","PMC3625051","",""
"23577902","Reimbursement and practice policies among providers of buprenorphine-naloxone treatment","Wisniewski AM, Dlugosz MR, Blondell RD.","Subst Abus. 2013;34(2):105-7. doi: 10.1080/08897077.2012.677753.","Wisniewski AM","Subst Abus","2013","2013/04/13","","","10.1080/08897077.2012.677753"
"23577898","Treating opioid use disorders during pregnancy: historical, current, and future directions","Jones HE.","Subst Abus. 2013;34(2):89-91. doi: 10.1080/08897077.2012.752779.","Jones HE","Subst Abus","2013","2013/04/13","","","10.1080/08897077.2012.752779"
"23567099","First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland","Uosukainen H, Bell JS, Laitinen K, Tacke U, Ilomäki J, Turunen JH.","Int J Drug Policy. 2013 Sep;24(5):492-7. doi: 10.1016/j.drugpo.2013.02.004. Epub 2013 Apr 6.","Uosukainen H","Int J Drug Policy","2013","2013/04/10","","","10.1016/j.drugpo.2013.02.004"
"23566446","Retention in methadone and buprenorphine treatment among African Americans","Gryczynski J, Mitchell SG, Jaffe JH, Kelly SM, Myers CP, O'Grady KE, Olsen YK, Schwartz RP.","J Subst Abuse Treat. 2013 Sep;45(3):287-92. doi: 10.1016/j.jsat.2013.02.008. Epub 2013 Apr 5.","Gryczynski J","J Subst Abuse Treat","2013","2013/04/10","PMC3714350","NIHMS454407","10.1016/j.jsat.2013.02.008"
"23563044","Can P-glycoprotein expression on malignant tumor tissues predict opioid transport at the blood-brain barrier in cancer patients?","Mégarbane B, Alhaddad H.","Pharmacol Rep. 2013;65(1):235-6. doi: 10.1016/s1734-1140(13)70984-8.","Mégarbane B","Pharmacol Rep","2013","2013/04/09","","","10.1016/s1734-1140(13)70984-8"
"23562407","Postoperative analgesic effects of dexketoprofen, buprenorphine and tramadol in dogs undergoing ovariohysterectomy","Morgaz J, Navarrete R, Muñoz-Rascón P, Domínguez JM, Fernández-Sarmiento JA, Gómez-Villamandos RJ, Granados MM.","Res Vet Sci. 2013 Aug;95(1):278-82. doi: 10.1016/j.rvsc.2013.03.003. Epub 2013 Apr 3.","Morgaz J","Res Vet Sci","2013","2013/04/09","","","10.1016/j.rvsc.2013.03.003"
"23562033","Pharmacokinetics of 2 formulations of buprenorphine in macaques (Macaca mulatta and Macaca fascicularis)","Nunamaker EA, Halliday LC, Moody DE, Fang WB, Lindeblad M, Fortman JD.","J Am Assoc Lab Anim Sci. 2013 Jan;52(1):48-56.","Nunamaker EA","J Am Assoc Lab Anim Sci","2013","2013/04/09","PMC3548201","",""
"23558760","Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients","Canneti A, Luzi M, Di Marco P, Cannata F, Pasqualitto F, Spinoglio A, Reale C.","Minerva Anestesiol. 2013 Aug;79(8):871-83. Epub 2013 Apr 5.","Canneti A","Minerva Anestesiol","2013","2013/04/06","","",""
"23554530","Mitigating the risk of HIV infection with opioid substitution treatment","Gowing LR, Hickman M, Degenhardt L.","Bull World Health Organ. 2013 Feb 1;91(2):148-9. doi: 10.2471/BLT.12.109553.","Gowing LR","Bull World Health Organ","2013","2013/04/05","PMC3605008","","10.2471/BLT.12.109553"
"23554519","Opioid treatment in Ukraine risks losing momentum","","Bull World Health Organ. 2013 Feb 1;91(2):87-8. doi: 10.2471/BLT.13.020213.","","Bull World Health Organ","2013","2013/04/05","PMC3605015","","10.2471/BLT.13.020213"
"23551991","Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine","Chiang YC, Hung TW, Ho IK.","Addict Biol. 2014 Jul;19(4):676-86. doi: 10.1111/adb.12055. Epub 2013 Apr 3.","Chiang YC","Addict Biol","2014","2013/04/05","","","10.1111/adb.12055"
"23550514","Anaphylaxis after the injection of buprenorphine","Boggs CL, Ripple MG, Ali Z, Brassell M, Levine B, Jufer-Phipps R, Doyon S, Fowler DR.","J Forensic Sci. 2013 Sep;58(5):1381-3. doi: 10.1111/1556-4029.12161. Epub 2013 Mar 29.","Boggs CL","J Forensic Sci","2013","2013/04/05","","","10.1111/1556-4029.12161"
"23545276","Significant cost savings achieved by in-sourcing urine drug testing for monitoring medication compliance in pain management","Melanson SE, Tanasijevic MJ, Snyder ML, Darragh A, Quade C, Jarolim P.","Clin Chim Acta. 2013 Jun 25;422:10-4. doi: 10.1016/j.cca.2013.03.010. Epub 2013 Mar 29.","Melanson SE","Clin Chim Acta","2013","2013/04/03","","","10.1016/j.cca.2013.03.010"
"23542298","The clinical conundrum of perioperative pain management in patients with opioid dependence: lessons from two cases","Israel JS, Poore SO.","Plast Reconstr Surg. 2013 Apr;131(4):657e-8e. doi: 10.1097/PRS.0b013e31828277bd.","Israel JS","Plast Reconstr Surg","2013","2013/04/02","","","10.1097/PRS.0b013e31828277bd"
"23541303","Initiation of buprenorphine during incarceration and retention in treatment upon release","Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD.","J Subst Abuse Treat. 2013 Aug;45(2):222-6. doi: 10.1016/j.jsat.2013.02.005. Epub 2013 Mar 27.","Zaller N","J Subst Abuse Treat","2013","2013/04/02","PMC3690138","NIHMS461773","10.1016/j.jsat.2013.02.005"
"23539497","Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction","Zhou PL, Li YL, Yan LD, Yong Z, Yu G, Dong HJ, Yan H, Su RB, Gong ZH.","World J Gastroenterol. 2013 Mar 7;19(9):1444-50. doi: 10.3748/wjg.v19.i9.1444.","Zhou PL","World J Gastroenterol","2013","2013/03/30","PMC3602504","","10.3748/wjg.v19.i9.1444"
"23537174","Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine","Moody DE.","Expert Opin Drug Metab Toxicol. 2013 Jun;9(6):675-97. doi: 10.1517/17425255.2013.783567. Epub 2013 Mar 29.","Moody DE","Expert Opin Drug Metab Toxicol","2013","2013/03/30","","","10.1517/17425255.2013.783567"
"23530789","Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy","Macintyre PE, Russell RA, Usher KA, Gaughwin M, Huxtable CA.","Anaesth Intensive Care. 2013 Mar;41(2):222-30. doi: 10.1177/0310057X1304100212.","Macintyre PE","Anaesth Intensive Care","2013","2013/03/28","","","10.1177/0310057X1304100212"
"23528523","Association of cannabis use with opioid outcomes among opioid-dependent youth","Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, Woody GE, Weiss RD.","Drug Alcohol Depend. 2013 Sep 1;132(1-2):342-5. doi: 10.1016/j.drugalcdep.2013.02.030. Epub 2013 Mar 22.","Hill KP","Drug Alcohol Depend","2013","2013/03/27","PMC3724203","NIHMS462232","10.1016/j.drugalcdep.2013.02.030"
"23523131","Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention","Holbrook AM, Jones HE, Heil SH, Martin PR, Stine SM, Fischer G, Coyle MG, Kaltenbach K.","Drug Alcohol Depend. 2013 Sep 1;132(1-2):329-34. doi: 10.1016/j.drugalcdep.2013.02.031. Epub 2013 Mar 21.","Holbrook AM","Drug Alcohol Depend","2013","2013/03/26","PMC3732530","NIHMS461275","10.1016/j.drugalcdep.2013.02.031"
"23521205","A novel approach to pharmaco-EEG for investigating analgesics: assessment of spectral indices in single-sweep evoked brain potentials","Gram M, Graversen C, Nielsen AK, Arendt-Nielsen T, Mørch CD, Andresen T, Drewes AM.","Br J Clin Pharmacol. 2013 Dec;76(6):951-63. doi: 10.1111/bcp.12120.","Gram M","Br J Clin Pharmacol","2013","2013/03/26","PMC3845319","","10.1111/bcp.12120"
"23518339","[Management of opioid maintenance treatments when analgesic treatments are required]","Laprevote V, Geoffroy PA, Rolland B, Leheup BF, Di Patrizio P, Cottencin O, Schwan R.","Presse Med. 2013 Jul-Aug;42(7-8):1085-90. doi: 10.1016/j.lpm.2012.09.036. Epub 2013 Mar 19.","Laprevote V","Presse Med","2013","2013/03/23","","","10.1016/j.lpm.2012.09.036"
"23518287","Italy's electronic health record system for opioid agonist treatment","Serpelloni G, Gomma M, Genetti B, Zermiani M, Rimondo C, Mollica R, Gryczynski J, O'Grady KE, Schwartz RP.","J Subst Abuse Treat. 2013 Aug;45(2):190-5. doi: 10.1016/j.jsat.2013.02.001. Epub 2013 Mar 19.","Serpelloni G","J Subst Abuse Treat","2013","2013/03/23","PMC3690466","NIHMS459641","10.1016/j.jsat.2013.02.001"
"23518130","[Comment on this case report]","Chiron LM, Pihet M, Rouleau F, de Gentile L, Bouchara JP, Chabasse D.","J Mycol Med. 2012 Sep;22(3):294-7. doi: 10.1016/j.mycmed.2012.07.048.","Chiron LM","J Mycol Med","2012","2013/03/23","","","10.1016/j.mycmed.2012.07.048"
"23512803","Urine naloxone concentration at different phases of buprenorphine maintenance treatment","Heikman P, Häkkinen M, Gergov M, Ojanperä I.","Drug Test Anal. 2014 Mar;6(3):220-5. doi: 10.1002/dta.1464. Epub 2013 Mar 19.","Heikman P","Drug Test Anal","2014","2013/03/21","","","10.1002/dta.1464"
"23507562","[About the opioid substitution treatment]","Collin C, Tricotel A, Courné MA.","Rev Epidemiol Sante Publique. 2013 Apr;61(2):93-4. doi: 10.1016/j.respe.2013.02.006. Epub 2013 Mar 16.","Collin C","Rev Epidemiol Sante Publique","2013","2013/03/20","","","10.1016/j.respe.2013.02.006"
"23507455","Simultaneous determination of opiates, methadone, buprenorphine and metabolites in human urine by superficially porous liquid chromatography tandem mass spectrometry","Lin HR, Chen CL, Huang CL, Chen ST, Lua AC.","J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Apr 15;925:10-5. doi: 10.1016/j.jchromb.2013.02.020. Epub 2013 Feb 27.","Lin HR","J Chromatogr B Analyt Technol Biomed Life Sci","2013","2013/03/20","","","10.1016/j.jchromb.2013.02.020"
"23506252","Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis","Wen W, Lynch SY, Munera C, Swanton R, Ripa SR, Maibach H.","Expert Opin Drug Saf. 2013 May;12(3):309-19. doi: 10.1517/14740338.2013.780025. Epub 2013 Mar 19.","Wen W","Expert Opin Drug Saf","2013","2013/03/20","","","10.1517/14740338.2013.780025"
"23489947","[Should high-dose buprenorphine be withdrawn from the French market?]","Rolland B, Muyssen A, Danel T, Cottencin O.","Rev Epidemiol Sante Publique. 2013 Apr;61(2):91-2. doi: 10.1016/j.respe.2013.02.001. Epub 2013 Mar 11.","Rolland B","Rev Epidemiol Sante Publique","2013","2013/03/16","","","10.1016/j.respe.2013.02.001"
"23489089","Buprenorphine and buprenorphine/naloxone intoxication in children - how strong is the risk?","Soyka M.","Curr Drug Abuse Rev. 2013 Mar;6(1):63-70. doi: 10.2174/18744737112059990010.","Soyka M","Curr Drug Abuse Rev","2013","2013/03/16","","","10.2174/18744737112059990010"
"23488511","Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009","Schwartz RP, Gryczynski J, O'Grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH.","Am J Public Health. 2013 May;103(5):917-22. doi: 10.2105/AJPH.2012.301049. Epub 2013 Mar 14.","Schwartz RP","Am J Public Health","2013","2013/03/16","PMC3670653","","10.2105/AJPH.2012.301049"
"23481062","Does buprenorphine maintenance improve the quality of life of opioid users?","Dhawan A, Chopra A.","Indian J Med Res. 2013 Jan;137(1):130-5.","Dhawan A","Indian J Med Res","2013","2013/03/14","PMC3657876","",""
"23480249","A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction","Neumann AM, Blondell RD, Jaanimägi U, Giambrone AK, Homish GG, Lozano JR, Kowalik U, Azadfard M.","J Addict Dis. 2013;32(1):68-78. doi: 10.1080/10550887.2012.759872.","Neumann AM","J Addict Dis","2013","2013/03/14","PMC3604999","NIHMS433680","10.1080/10550887.2012.759872"
"23480248","Suboxone misuse along the opiate maintenance treatment pathway","Furst RT.","J Addict Dis. 2013;32(1):53-67. doi: 10.1080/10550887.2012.759860.","Furst RT","J Addict Dis","2013","2013/03/14","","","10.1080/10550887.2012.759860"
"23475406","Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study","Gálvez R, Schäfer M, Hans G, Falke D, Steigerwald I.","Adv Ther. 2013 Mar;30(3):229-59. doi: 10.1007/s12325-013-0015-6. Epub 2013 Mar 7.","Gálvez R","Adv Ther","2013","2013/03/12","","","10.1007/s12325-013-0015-6"
"23471956","False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride","Birch MA, Couchman L, Pietromartire S, Karna T, Paton C, McAllister R, Marsh A, Flanagan RJ.","J Anal Toxicol. 2013 May;37(4):233-6. doi: 10.1093/jat/bkt016. Epub 2013 Mar 6.","Birch MA","J Anal Toxicol","2013","2013/03/09","","","10.1093/jat/bkt016"
"23456431","Impact of opioid pharmacotherapy on arterial stiffness and vascular ageing: cross-sectional and longitudinal studies","Reece AS, Hulse GK.","Cardiovasc Toxicol. 2013 Sep;13(3):254-66. doi: 10.1007/s12012-013-9204-4.","Reece AS","Cardiovasc Toxicol","2013","2013/03/05","","","10.1007/s12012-013-9204-4"
"23452789","Development and application of carbon nanotubes assisted electromembrane extraction (CNTs/EME) for the determination of buprenorphine as a model of basic drugs from urine samples","Hasheminasab KS, Fakhari AR.","Anal Chim Acta. 2013 Mar 12;767:75-80. doi: 10.1016/j.aca.2012.12.046. Epub 2013 Jan 5.","Hasheminasab KS","Anal Chim Acta","2013","2013/03/05","","","10.1016/j.aca.2012.12.046"
"23440817","Pharmacological therapies for maintenance treatments of opium dependence","Rahimi-Movaghar A, Amin-Esmaeili M, Hefazi M, Yousefi-Nooraie R.","Cochrane Database Syst Rev. 2013 Jan 31;(1):CD007775. doi: 10.1002/14651858.CD007775.pub2.","Rahimi-Movaghar A","Cochrane Database Syst Rev","2013","2013/02/27","","","10.1002/14651858.CD007775.pub2"
"23434263","Comparison of the analgesic effects of robenacoxib, buprenorphine and their combination in cats after ovariohysterectomy","Staffieri F, Centonze P, Gigante G, De Pietro L, Crovace A.","Vet J. 2013 Aug;197(2):363-7. doi: 10.1016/j.tvjl.2013.01.018. Epub 2013 Feb 21.","Staffieri F","Vet J","2013","2013/02/26","","","10.1016/j.tvjl.2013.01.018"
"23433750","The effect of an electronic medicine dispenser on diversion of buprenorphine-naloxone-experience from a medium-sized Finnish city","Uosukainen H, Pentikäinen H, Tacke U.","J Subst Abuse Treat. 2013 Jul;45(1):143-7. doi: 10.1016/j.jsat.2013.01.003. Epub 2013 Feb 21.","Uosukainen H","J Subst Abuse Treat","2013","2013/02/26","","","10.1016/j.jsat.2013.01.003"
"23432078","Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy","Sundelin Wahlsten V, Sarman I.","Acta Paediatr. 2013 May;102(5):544-9. doi: 10.1111/apa.12210. Epub 2013 Mar 20.","Sundelin Wahlsten V","Acta Paediatr","2013","2013/02/26","","","10.1111/apa.12210"
"23423312","Determination of buprenorphine, fentanyl and LSD in whole blood by UPLC-MS-MS","Berg T, Jørgenrud B, Strand DH.","J Anal Toxicol. 2013 Apr;37(3):159-65. doi: 10.1093/jat/bkt005. Epub 2013 Feb 18.","Berg T","J Anal Toxicol","2013","2013/02/21","","","10.1093/jat/bkt005"
"23421567","Pharmacokinetic interactions between buprenorphine/naloxone and raltegravir in subjects receiving chronic buprenorphine/naloxone treatment","Douglas Bruce R, Moody DE, Chodkowski D, Andrews L, Fang WB, Morrison J, Parsons TL, Friedland GH.","Am J Drug Alcohol Abuse. 2013 Mar;39(2):80-5. doi: 10.3109/00952990.2013.764885.","Douglas Bruce R","Am J Drug Alcohol Abuse","2013","2013/02/21","","","10.3109/00952990.2013.764885"
"23420918","Severe DRESS syndrome managed with therapeutic plasma exchange","Alexander T, Iglesia E, Park Y, Duncan D, Peden D, Sheikh S, Ferris M.","Pediatrics. 2013 Mar;131(3):e945-9. doi: 10.1542/peds.2012-2117. Epub 2013 Feb 18.","Alexander T","Pediatrics","2013","2013/02/20","","","10.1542/peds.2012-2117"
"23419814","The transdermal delivery of fentanyl","Lane ME.","Eur J Pharm Biopharm. 2013 Aug;84(3):449-55. doi: 10.1016/j.ejpb.2013.01.018. Epub 2013 Feb 16.","Lane ME","Eur J Pharm Biopharm","2013","2013/02/20","","","10.1016/j.ejpb.2013.01.018"
"23416790","Thermal sensitivity as a measure of spontaneous morphine withdrawal in mice","Balter RE, Dykstra LA.","J Pharmacol Toxicol Methods. 2013 May-Jun;67(3):162-8. doi: 10.1016/j.vascn.2013.02.003. Epub 2013 Feb 14.","Balter RE","J Pharmacol Toxicol Methods","2013","2013/02/19","PMC3631460","NIHMS446504","10.1016/j.vascn.2013.02.003"
"23416213","Effect of thienorphine on the isolated uterine strips from pregnant rats","Zhou P, Yan L, Yong Z, Yu G, Dong H, Yan H, Su R, Gong Z.","Eur J Pharmacol. 2013 Mar 5;703(1-3):83-90. doi: 10.1016/j.ejphar.2013.01.063. Epub 2013 Feb 15.","Zhou P","Eur J Pharmacol","2013","2013/02/19","","","10.1016/j.ejphar.2013.01.063"
"23408251","Evaluation of buprenorphine LUCIO immunoassay versus GC-MS using urines from a workplace drug testing program","Alves MN, Piccinotti A, Tameni S, Polettini A.","J Anal Toxicol. 2013 Apr;37(3):175-8. doi: 10.1093/jat/bkt006. Epub 2013 Feb 13.","Alves MN","J Anal Toxicol","2013","2013/02/15","","","10.1093/jat/bkt006"
"23398458","Femoral fracture repair and sciatic and femoral nerve blocks in a guinea pig","Aguiar J, Mogridge G, Hall J.","J Small Anim Pract. 2014 Dec;55(12):635-9. doi: 10.1111/jsap.12033. Epub 2013 Feb 9.","Aguiar J","J Small Anim Pract","2014","2013/02/13","","","10.1111/jsap.12033"
"23391965","Social network support for individuals receiving opiate substitution treatment and its association with treatment progress","Day E, Copello A, Karia M, Roche J, Grewal P, George S, Haque S, Chohan G.","Eur Addict Res. 2013;19(4):211-21. doi: 10.1159/000343827. Epub 2013 Feb 7.","Day E","Eur Addict Res","2013","2013/02/09","","","10.1159/000343827"
"23388678","Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment","Tetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA.","J Addict Med. 2013 Mar-Apr;7(2):102-7. doi: 10.1097/ADM.0b013e31827f9bdf.","Tetrault JM","J Addict Med","2013","2013/02/08","PMC3618545","NIHMS431360","10.1097/ADM.0b013e31827f9bdf"
"23388531","Needs assessment and treatment compliance at state opioid substitution treatment programes in Georgia","Piralishvili G, Gamkrelidze I, Nikolaishvili N, Chavchanidze M.","Georgian Med News. 2013 Jan;(214):28-32.","Piralishvili G","Georgian Med News","2013","2013/02/08","","",""
"23378096","True ion pick (TIPick): a denoising and peak picking algorithm to extract ion signals from liquid chromatography/mass spectrometry data","Ho TJ, Kuo CH, Wang SY, Chen GY, Tseng YJ.","J Mass Spectrom. 2013 Feb;48(2):234-42. doi: 10.1002/jms.3154.","Ho TJ","J Mass Spectrom","2013","2013/02/05","","","10.1002/jms.3154"
"23376546","Gender and strain contributions to the variability of buprenorphine-related respiratory toxicity in mice","Alhaddad H, Cisternino S, Saubamea B, Schlatter J, Chiadmi F, Risède P, Smirnova M, Cochois-Guégan V, Tournier N, Baud FJ, Mégarbane B.","Toxicology. 2013 Mar 8;305:99-108. doi: 10.1016/j.tox.2013.01.013. Epub 2013 Jan 29.","Alhaddad H","Toxicology","2013","2013/02/05","","","10.1016/j.tox.2013.01.013"
"23374027","Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain","Miller K, Yarlas A, Wen W, Dain B, Lynch SY, Brennan MJ, Ripa SR.","Expert Opin Pharmacother. 2013 Feb;14(3):269-77. doi: 10.1517/14656566.2013.767331.","Miller K","Expert Opin Pharmacother","2013","2013/02/05","","","10.1517/14656566.2013.767331"
"23370795","Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects","Becerra L, Upadhyay J, Chang PC, Bishop J, Anderson J, Baumgartner R, Schwarz AJ, Coimbra A, Wallin D, Nutile L, George E, Maier G, Sunkaraneni S, Iyengar S, Evelhoch JL, Bleakman D, Hargreaves R, Borsook D.","J Pharmacol Exp Ther. 2013 Apr;345(1):41-51. doi: 10.1124/jpet.112.201145. Epub 2013 Jan 31.","Becerra L","J Pharmacol Exp Ther","2013","2013/02/02","","","10.1124/jpet.112.201145"
"23364815","Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects","Green A, Kaul A, O'Shea J, Sharma E, Bennett L, Mullings EL, Munafò MR, Nutt DJ, Melichar JK, Donaldson LF.","J Psychopharmacol. 2013 Mar;27(3):265-75. doi: 10.1177/0269881112472567. Epub 2013 Jan 29.","Green A","J Psychopharmacol","2013","2013/02/01","","","10.1177/0269881112472567"
"23357637","Buprenorphine and norbuprenorphine quantification in human plasma by simple protein precipitation and ultra-high performance liquid chromatography tandem mass spectrometry","Lüthi G, Blangy V, Eap CB, Ansermot N.","J Pharm Biomed Anal. 2013 Apr 15;77:1-8. doi: 10.1016/j.jpba.2012.12.023. Epub 2012 Dec 28.","Lüthi G","J Pharm Biomed Anal","2013","2013/01/30","","","10.1016/j.jpba.2012.12.023"
"23349342","A successful switch from transdermal fentanyl to transdermal buprenorphine in a patient with neuropathic pain: a case report","Leppert W.","Am J Hosp Palliat Care. 2014 Feb;31(1):101-4. doi: 10.1177/1049909112472722. Epub 2013 Jan 23.","Leppert W","Am J Hosp Palliat Care","2014","2013/01/26","","","10.1177/1049909112472722"
"23344700","Emergency department visits and hospitalizations for buprenorphine ingestion by children--United States, 2010-2011","Centers for Disease Control and Prevention (CDC).","MMWR Morb Mortal Wkly Rep. 2013 Jan 25;62(3):56.","Centers for Disease Control and Prevention (CDC)","MMWR Morb Mortal Wkly Rep","2013","2013/01/25","PMC4604875","",""
"23337847","Breastfeeding and substance abuse","D'Apolito K.","Clin Obstet Gynecol. 2013 Mar;56(1):202-11. doi: 10.1097/GRF.0b013e31827e6b71.","D'Apolito K","Clin Obstet Gynecol","2013","2013/01/23","","","10.1097/GRF.0b013e31827e6b71"
"23333292","Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study","Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD.","Drug Alcohol Depend. 2013 Jul 1;131(1-2):112-8. doi: 10.1016/j.drugalcdep.2012.12.010. Epub 2013 Jan 18.","Dreifuss JA","Drug Alcohol Depend","2013","2013/01/22","PMC3638044","NIHMS429945","10.1016/j.drugalcdep.2012.12.010"
"23332439","Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes","Haddad MS, Zelenev A, Altice FL.","Drug Alcohol Depend. 2013 Jul 1;131(1-2):127-35. doi: 10.1016/j.drugalcdep.2012.12.008. Epub 2013 Jan 17.","Haddad MS","Drug Alcohol Depend","2013","2013/01/22","PMC3674170","NIHMS429944","10.1016/j.drugalcdep.2012.12.008"
"23331881","Naltrexone in the treatment of opioid-dependent pregnant women: common ground","Jones HE, Chisolm MS, Jansson LM, Terplan M.","Addiction. 2013 Feb;108(2):255-6. doi: 10.1111/add.12071.","Jones HE","Addiction","2013","2013/01/22","","","10.1111/add.12071"
"23331880","Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research","Clark N, Verster A.","Addiction. 2013 Feb;108(2):253-5. doi: 10.1111/j.1360-0443.2012.04096.x.","Clark N","Addiction","2013","2013/01/22","","","10.1111/j.1360-0443.2012.04096.x"
"23331878","Blocking endogenous opioids during development--do we understand the consequences?","White J.","Addiction. 2013 Feb;108(2):251-2. doi: 10.1111/j.1360-0443.2012.03914.x.","White J","Addiction","2013","2013/01/22","","","10.1111/j.1360-0443.2012.03914.x"
"23331877","Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?","Stitzer ML.","Addiction. 2013 Feb;108(2):249-50. doi: 10.1111/j.1360-0443.2012.03883.x.","Stitzer ML","Addiction","2013","2013/01/22","","","10.1111/j.1360-0443.2012.03883.x"
"23327175","Influence of ketamine on the cardiopulmonary effects of intramuscular administration of dexmedetomidine-buprenorphine with subsequent reversal with atipamezole in dogs","Ko JC, Barletta M, Sen I, Weil AB, Krimins RA, Payton ME, Constable P.","J Am Vet Med Assoc. 2013 Feb 1;242(3):339-45. doi: 10.2460/javma.242.3.339.","Ko JC","J Am Vet Med Assoc","2013","2013/01/19","","","10.2460/javma.242.3.339"
"23320402","A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain","Mitra F, Chowdhury S, Shelley M, Williams G.","Pain Med. 2013 Jan;14(1):75-83. doi: 10.1111/pme.12011.","Mitra F","Pain Med","2013","2013/01/17","","","10.1111/pme.12011"
"23317685","A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence","Lintzeris N, Leung SY, Dunlop AJ, Larance B, White N, Rivas GR, Holland RM, Degenhardt L, Muhleisen P, Hurley M, Ali R.","Drug Alcohol Depend. 2013 Jul 1;131(1-2):119-26. doi: 10.1016/j.drugalcdep.2012.12.009. Epub 2013 Jan 12.","Lintzeris N","Drug Alcohol Depend","2013","2013/01/16","","","10.1016/j.drugalcdep.2012.12.009"
"23294889","Duration of action of sustained-release buprenorphine in 2 strains of mice","Carbone ET, Lindstrom KE, Diep S, Carbone L.","J Am Assoc Lab Anim Sci. 2012 Nov;51(6):815-9.","Carbone ET","J Am Assoc Lab Anim Sci","2012","2013/01/09","PMC3508187","",""
"23294888","Evaluation of common anesthetic and analgesic techniques for tail biopsy in mice","Jones CP, Carver S, Kendall LV.","J Am Assoc Lab Anim Sci. 2012 Nov;51(6):808-14.","Jones CP","J Am Assoc Lab Anim Sci","2012","2013/01/09","PMC3508186","",""
"23293233","Evaluation of the quality of life (Whoqol-Bref) among methadone and suboxone substitution state program patients and healthy volunteers in Georgia","Piralishvili G, Gamkrelidze I, Nikolaishvili N, Chavchanidze M.","Georgian Med News. 2012 Dec;(213):44-7.","Piralishvili G","Georgian Med News","2012","2013/01/08","","",""
"23293011","Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: results from a nationwide non-interventional study in routine care","Apelt SM, Scherbaum N, Gölz J, Backmund M, Soyka M.","Pharmacopsychiatry. 2013 May;46(3):94-107. doi: 10.1055/s-0032-1330033. Epub 2013 Jan 4.","Apelt SM","Pharmacopsychiatry","2013","2013/01/08","","","10.1055/s-0032-1330033"
"23288871","A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine","Chisolm MS, Fitzsimons H, Leoutsakos JM, Acquavita SP, Heil SH, Wilson-Murphy M, Tuten M, Kaltenbach K, Martin PR, Winklbaur B, Jansson LM, Jones HE.","Nicotine Tob Res. 2013 Jul;15(7):1297-304. doi: 10.1093/ntr/nts274. Epub 2013 Jan 3.","Chisolm MS","Nicotine Tob Res","2013","2013/01/05","PMC3682847","","10.1093/ntr/nts274"
"23279623","Sedative and analgesic effects of buprenorphine, combined with either acepromazine or dexmedetomidine, for premedication prior to elective surgery in cats and dogs","Hunt JR, Grint NJ, Taylor PM, Murrell JC.","Vet Anaesth Analg. 2013 May;40(3):297-307. doi: 10.1111/vaa.12003. Epub 2012 Dec 24.","Hunt JR","Vet Anaesth Analg","2013","2013/01/03","","","10.1111/vaa.12003"
"23265445","Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine","Mark TL, Dilonardo J, Vandivort R, Miller K.","J Subst Abuse Treat. 2013 May-Jun;44(5):481-7. doi: 10.1016/j.jsat.2012.11.004. Epub 2012 Dec 21.","Mark TL","J Subst Abuse Treat","2013","2012/12/26","","","10.1016/j.jsat.2012.11.004"
"23264319","Transdermal buprenorphine controls central neuropathic pain","Weiner M, Sarantopoulos C, Gordon E.","J Opioid Manag. 2012 Nov-Dec;8(6):414-5. doi: 10.5055/jom.2012.0141.","Weiner M","J Opioid Manag","2012","2012/12/25","","","10.5055/jom.2012.0141"
"23264315","Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol","Rosenblum A, Cruciani RA, Strain EC, Cleland CM, Joseph H, Magura S, Marsch LA, McNicholas LF, Savage SR, Sundaram A, Portenoy RK.","J Opioid Manag. 2012 Nov-Dec;8(6):369-82. doi: 10.5055/jom.2012.0137.","Rosenblum A","J Opioid Manag","2012","2012/12/25","PMC3630795","NIHMS436596","10.5055/jom.2012.0137"
"23260506","A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine","Fiellin DA, Barry DT, Sullivan LE, Cutter CJ, Moore BA, O'Connor PG, Schottenfeld RS.","Am J Med. 2013 Jan;126(1):74.e11-7. doi: 10.1016/j.amjmed.2012.07.005.","Fiellin DA","Am J Med","2013","2012/12/25","PMC3621718","NIHMS424726","10.1016/j.amjmed.2012.07.005"
"23259516","Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration","Strand MC, Fjeld B, Arnestad M, Mørland J.","Traffic Inj Prev. 2013;14(1):26-38. doi: 10.1080/15389588.2012.689451.","Strand MC","Traffic Inj Prev","2013","2012/12/25","","","10.1080/15389588.2012.689451"
"23257574","Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study","Skeie I, Brekke M, Clausen T, Gossop M, Lindbaek M, Reinertsen E, Thoresen M, Waal H.","Eur Addict Res. 2013;19(4):194-201. doi: 10.1159/000345229. Epub 2012 Dec 21.","Skeie I","Eur Addict Res","2013","2012/12/22","","","10.1159/000345229"
"23253768","Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine","Edelman EJ, Fiellin DA.","Am J Prev Med. 2013 Jan;44(1 Suppl 2):S86-90. doi: 10.1016/j.amepre.2012.09.035.","Edelman EJ","Am J Prev Med","2013","2012/12/21","PMC3645931","NIHMS459494","10.1016/j.amepre.2012.09.035"
"23246635","Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans","Huestis MA, Cone EJ, Pirnay SO, Umbricht A, Preston KL.","Drug Alcohol Depend. 2013 Aug 1;131(3):258-62. doi: 10.1016/j.drugalcdep.2012.11.014. Epub 2012 Dec 14.","Huestis MA","Drug Alcohol Depend","2013","2012/12/19","PMC3663890","NIHMS430592","10.1016/j.drugalcdep.2012.11.014"
"23244551","False-positive buprenorphine EIA urine toxicology results due to high dose morphine: a case report","Tenore PL.","J Addict Dis. 2012;31(4):329-31. doi: 10.1080/10550887.2012.735598.","Tenore PL","J Addict Dis","2012","2012/12/19","","","10.1080/10550887.2012.735598"
"23244549","Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy","Jones HE, Heil SH, Kaltenbach K, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR.","J Addict Dis. 2012;31(4):321-6; discussion 327-8. doi: 10.1080/10550887.2012.736289.","Jones HE","J Addict Dis","2012","2012/12/19","","","10.1080/10550887.2012.736289"
"23240906","A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm","Cordery SF, Taverner A, Ridzwan IE, Guy RH, Delgado-Charro MB, Husbands SM, Bailey CP.","Addict Biol. 2014 Jul;19(4):575-86. doi: 10.1111/adb.12020. Epub 2012 Dec 14.","Cordery SF","Addict Biol","2014","2012/12/18","","","10.1111/adb.12020"
"23235296","Buprenorphine prescribing practices and exposures reported to a poison center--Utah, 2002-2011","Centers for Disease Control and Prevention (CDC).","MMWR Morb Mortal Wkly Rep. 2012 Dec 14;61(49):997-1001.","Centers for Disease Control and Prevention (CDC)","MMWR Morb Mortal Wkly Rep","2012","2012/12/14","","",""
"23233054","Opioid addiction in pregnancy","Shainker SA, Saia K, Lee-Parritz A.","Obstet Gynecol Surv. 2012 Dec;67(12):817-25. doi: 10.1097/OGX.0b013e3182788e8c.","Shainker SA","Obstet Gynecol Surv","2012","2012/12/13","","","10.1097/OGX.0b013e3182788e8c"
"23227572","Opioid drugs in maintenance and detoxification treatment of opiate addiction; proposed modification of dispensing restrictions for buprenorphine and buprenorphine combination as used in approved opioid treatment medications. Final rule","Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS).","Fed Regist. 2012 Dec 6;77(235):72752-61.","Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS)","Fed Regist","2012","2012/12/12","","",""
"23226534","Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia","Ruger JP, Chawarski M, Mazlan M, Ng N, Schottenfeld R.","PLoS One. 2012;7(12):e50673. doi: 10.1371/journal.pone.0050673. Epub 2012 Dec 4.","Ruger JP","PLoS One","2012","2012/12/11","PMC3514172","","10.1371/journal.pone.0050673"
"23222095","A comparison of buprenorphine taper outcomes between prescription opioid and heroin users","Nielsen S, Hillhouse M, Thomas C, Hasson A, Ling W.","J Addict Med. 2013 Jan-Feb;7(1):33-8. doi: 10.1097/ADM.0b013e318277e92e.","Nielsen S","J Addict Med","2013","2012/12/11","PMC3567310","NIHMS420134","10.1097/ADM.0b013e318277e92e"
"23216174","Rifampin reduces oral morphine absorption: a case of transdermal buprenorphine selection based on morphine pharmacokinetics","Fudin J, Fontenelle DV, Payne A.","J Pain Palliat Care Pharmacother. 2012 Dec;26(4):362-7. doi: 10.3109/15360288.2012.734903.","Fudin J","J Pain Palliat Care Pharmacother","2012","2012/12/11","","","10.3109/15360288.2012.734903"
"23210630","Pharmacological maintenance treatments of opiate addiction","Bell J.","Br J Clin Pharmacol. 2014 Feb;77(2):253-63. doi: 10.1111/bcp.12051.","Bell J","Br J Clin Pharmacol","2014","2012/12/06","PMC4014029","","10.1111/bcp.12051"
"23207629","Formulation and evaluation of thienorphine hydrochloride sublingual delivery system","Liu F, Zhao Y, Sun J, Gao Y, Zhang Z.","Chem Pharm Bull (Tokyo). 2012;60(12):1479-86. doi: 10.1248/cpb.c12-00508.","Liu F","Chem Pharm Bull (Tokyo)","2012","2012/12/05","","","10.1248/cpb.c12-00508"
"23201172","Availability of buprenorphine on the Internet for purchase without a prescription","Bachhuber MA, Cunningham CO.","Drug Alcohol Depend. 2013 Jun 1;130(1-3):238-40. doi: 10.1016/j.drugalcdep.2012.11.004. Epub 2012 Nov 30.","Bachhuber MA","Drug Alcohol Depend","2013","2012/12/04","PMC3600391","NIHMS422064","10.1016/j.drugalcdep.2012.11.004"
"23200931","A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back pain","Yarlas A, Miller K, Wen W, Dain B, Lynch SY, Pergolizzi JV, Raffa RB, Ripa SR.","J Pain. 2013 Jan;14(1):14-23. doi: 10.1016/j.jpain.2012.09.016. Epub 2012 Nov 29.","Yarlas A","J Pain","2013","2012/12/04","","","10.1016/j.jpain.2012.09.016"
"23186149","Just call it ""treatment""","Friedmann PD, Schwartz RP.","Addict Sci Clin Pract. 2012 Jun 9;7(1):10. doi: 10.1186/1940-0640-7-10.","Friedmann PD","Addict Sci Clin Pract","2012","2012/11/29","PMC3507631","","10.1186/1940-0640-7-10"
"23186008","Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems","Rowe TA, Jacapraro JS, Rastegar DA.","Addict Sci Clin Pract. 2012 Oct 29;7(1):22. doi: 10.1186/1940-0640-7-22.","Rowe TA","Addict Sci Clin Pract","2012","2012/11/29","PMC3509402","","10.1186/1940-0640-7-22"
"23164063","Deficits in social perception in opioid maintenance patients, abstinent opioid users and non-opioid users","McDonald S, Darke S, Kaye S, Torok M.","Addiction. 2013 Mar;108(3):566-74. doi: 10.1111/add.12040. Epub 2012 Dec 5.","McDonald S","Addiction","2013","2012/11/21","","","10.1111/add.12040"
"23161599","Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women","Winklbaur-Hausknost B, Jagsch R, Graf-Rohrmeister K, Unger A, Baewert A, Langer M, Thau K, Fischer G.","Hum Psychopharmacol. 2013 Jan;28(1):15-24. doi: 10.1002/hup.2275. Epub 2012 Nov 13.","Winklbaur-Hausknost B","Hum Psychopharmacol","2013","2012/11/20","","","10.1002/hup.2275"
"23161001","Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals","Greenwald MK, Lundahl LH, Steinmiller CL.","Psychopharmacology (Berl). 2013 Feb;225(4):811-24. doi: 10.1007/s00213-012-2868-9. Epub 2012 Nov 17.","Greenwald MK","Psychopharmacology (Berl)","2013","2012/11/20","PMC3558534","NIHMS423438","10.1007/s00213-012-2868-9"
"23159524","Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology","Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W.","Contemp Clin Trials. 2013 Mar;34(2):196-204. doi: 10.1016/j.cct.2012.11.002. Epub 2012 Nov 16.","Mooney LJ","Contemp Clin Trials","2013","2012/11/20","PMC3760415","NIHMS430218","10.1016/j.cct.2012.11.002"
"23153637","Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry","Saleh A, Stephanson NN, Granelli I, Villén T, Beck O.","J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Nov 15;909:6-13. doi: 10.1016/j.jchromb.2012.10.006. Epub 2012 Oct 9.","Saleh A","J Chromatogr B Analyt Technol Biomed Life Sci","2012","2012/11/17","","","10.1016/j.jchromb.2012.10.006"
"23145768","Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?","Garcia-Portilla MP, Bobes-Bascaran MT, Bascaran MT, Saiz PA, Bobes J.","Br J Clin Pharmacol. 2014 Feb;77(2):272-84. doi: 10.1111/bcp.12031.","Garcia-Portilla MP","Br J Clin Pharmacol","2014","2012/11/14","PMC4014027","","10.1111/bcp.12031"
"23137766","Clinical management of drug-drug interactions in HCV therapy: challenges and solutions","Burger D, Back D, Buggisch P, Buti M, Craxí A, Foster G, Klinker H, Larrey D, Nikitin I, Pol S, Puoti M, Romero-Gómez M, Wedemeyer H, Zeuzem S.","J Hepatol. 2013 Apr;58(4):792-800. doi: 10.1016/j.jhep.2012.10.027. Epub 2012 Nov 5.","Burger D","J Hepatol","2013","2012/11/10","","","10.1016/j.jhep.2012.10.027"
"23135165","Patterns of symptom reporting during pregnancy comparing opioid maintained and control women","Gordon AL, Lopatko OV, Stacey H, Pearson V, Woods A, Fisk A, White JM.","J Addict Med. 2012 Dec;6(4):258-64. doi: 10.1097/ADM.0b013e31826b299d.","Gordon AL","J Addict Med","2012","2012/11/09","","","10.1097/ADM.0b013e31826b299d"
"23129079","Buprenorphine may not be as safe as you think: a pediatric fatality from unintentional exposure","Kim HK, Smiddy M, Hoffman RS, Nelson LS.","Pediatrics. 2012 Dec;130(6):e1700-3. doi: 10.1542/peds.2012-1342. Epub 2012 Nov 5.","Kim HK","Pediatrics","2012","2012/11/07","","","10.1542/peds.2012-1342"
"23125072","Medications development for opioid abuse","Negus SS, Banks ML.","Cold Spring Harb Perspect Med. 2013 Jan 1;3(1):a012104. doi: 10.1101/cshperspect.a012104.","Negus SS","Cold Spring Harb Perspect Med","2013","2012/11/06","PMC3530034","","10.1101/cshperspect.a012104"
"23121989","Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study","Rapeli P, Fabritius C, Kalska H, Alho H.","Subst Abuse Treat Prev Policy. 2012 Nov 2;7:45. doi: 10.1186/1747-597X-7-45.","Rapeli P","Subst Abuse Treat Prev Policy","2012","2012/11/06","PMC3551729","","10.1186/1747-597X-7-45"
"23114824","Medically assisted treatment for opiate addiction--suboxone method as prevention of social exclusion of youth--Tuzla model","Hasanović M, Pajević I, Kuldija A, Delić A.","Psychiatr Danub. 2012 Oct;24 Suppl 3:S398-404.","Hasanović M","Psychiatr Danub","2012","2012/11/02","","",""
"23114823","Treatment of addicts in Bosnia and Herzegovina--constraints and opportunities","Mehić-Basara N, Cerić I.","Psychiatr Danub. 2012 Oct;24 Suppl 3:S392-7.","Mehić-Basara N","Psychiatr Danub","2012","2012/11/02","","",""
"23110274","Validation of a novel rat-holding device for studying heat- and mechanical-evoked trigeminal nocifensive behavioral responses","Garrett FG, Hawkins JL, Overmyer AE, Hayden JB, Durham PL.","J Orofac Pain. 2012 Fall;26(4):337-44.","Garrett FG","J Orofac Pain","2012","2012/10/31","PMC5894827","NIHMS954893",""
"23106931","Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication","McNicholas LF, Holbrook AM, O'Grady KE, Jones HE, Coyle MG, Martin PR, Heil SH, Stine SM, Kaltenbach K.","Addiction. 2012 Nov;107 Suppl 1(0 1):91-7. doi: 10.1111/j.1360-0443.2012.04043.x.","McNicholas LF","Addiction","2012","2012/10/31","PMC4268861","NIHMS647334","10.1111/j.1360-0443.2012.04043.x"
"23106930","Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine","Holbrook AM, Baxter JK, Jones HE, Heil SH, Coyle MG, Martin PR, Stine SM, Kaltenbach K.","Addiction. 2012 Nov;107 Suppl 1(Suppl 1):83-90. doi: 10.1111/j.1360-0443.2012.04042.x.","Holbrook AM","Addiction","2012","2012/10/31","PMC4368056","NIHMS647333","10.1111/j.1360-0443.2012.04042.x"
"23106929","Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes","Benningfield MM, Dietrich MS, Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Fischer G, Martin PR.","Addiction. 2012 Nov;107 Suppl 1(0 1):74-82. doi: 10.1111/j.1360-0443.2012.04041.x.","Benningfield MM","Addiction","2012","2012/10/31","PMC4315620","NIHMS647332","10.1111/j.1360-0443.2012.04041.x"
"23106928","Neonatal neurobehavior effects following buprenorphine versus methadone exposure","Coyle MG, Salisbury AL, Lester BM, Jones HE, Lin H, Graf-Rohrmeister K, Fischer G.","Addiction. 2012 Nov;107 Suppl 1(0 1):63-73. doi: 10.1111/j.1360-0443.2012.04040.x.","Coyle MG","Addiction","2012","2012/10/31","PMC4337995","NIHMS647331","10.1111/j.1360-0443.2012.04040.x"
"23106927","Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates","Gaalema DE, Scott TL, Heil SH, Coyle MG, Kaltenbach K, Badger GJ, Arria AM, Stine SM, Martin PR, Jones HE.","Addiction. 2012 Nov;107 Suppl 1(0 1):53-62. doi: 10.1111/j.1360-0443.2012.04039.x.","Gaalema DE","Addiction","2012","2012/10/31","PMC4165073","NIHMS623090","10.1111/j.1360-0443.2012.04039.x"
"23106926","Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication","Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, Martin PR, Jones HE.","Addiction. 2012 Nov;107 Suppl 1(0 1):45-52. doi: 10.1111/j.1360-0443.2012.04038.x.","Kaltenbach K","Addiction","2012","2012/10/31","PMC4268864","NIHMS647330","10.1111/j.1360-0443.2012.04038.x"
"23106925","Fetal assessment before and after dosing with buprenorphine or methadone","Salisbury AL, Coyle MG, O'Grady KE, Heil SH, Martin PR, Stine SM, Kaltenbach K, Weninger M, Jones HE.","Addiction. 2012 Nov;107 Suppl 1(0 1):36-44. doi: 10.1111/j.1360-0443.2012.04037.x.","Salisbury AL","Addiction","2012","2012/10/31","PMC4277183","NIHMS647103","10.1111/j.1360-0443.2012.04037.x"
"23106924","Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learned","Jones HE, Fischer G, Heil SH, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, O'Grady KE, Arria AM.","Addiction. 2012 Nov;107 Suppl 1(0 1):28-35. doi: 10.1111/j.1360-0443.2012.04036.x.","Jones HE","Addiction","2012","2012/10/31","PMC4497510","NIHMS647102","10.1111/j.1360-0443.2012.04036.x"
"23106923","Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, Fischer G.","Addiction. 2012 Nov;107 Suppl 1(0 1):5-27. doi: 10.1111/j.1360-0443.2012.04035.x.","Jones HE","Addiction","2012","2012/10/31","PMC4506646","NIHMS647092","10.1111/j.1360-0443.2012.04035.x"
"23106922","Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses","Bandstra ES.","Addiction. 2012 Nov;107 Suppl 1:1-4. doi: 10.1111/j.1360-0443.2012.04059.x.","Bandstra ES","Addiction","2012","2012/10/31","","","10.1111/j.1360-0443.2012.04059.x"
"23103550","Different patterns of administration modulate propensity of methadone and buprenorphine to promote locomotor sensitization in mice","Allouche S, Le Marec T, Noble F, Marie N.","Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:286-91. doi: 10.1016/j.pnpbp.2012.10.013. Epub 2012 Oct 26.","Allouche S","Prog Neuropsychopharmacol Biol Psychiatry","2013","2012/10/30","","","10.1016/j.pnpbp.2012.10.013"
"23100497","Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone","Farney RJ, McDonald AM, Boyle KM, Snow GL, Nuttall RT, Coudreaut MF, Wander TJ, Walker JM.","Eur Respir J. 2013 Aug;42(2):394-403. doi: 10.1183/09031936.00120012. Epub 2012 Oct 25.","Farney RJ","Eur Respir J","2013","2012/10/27","","","10.1183/09031936.00120012"
"23097561","Optimizing the dosing interval of buprenorphine in a multimodal postoperative analgesic strategy in the rat: minimizing side-effects without affecting weight gain and food intake","Schaap MW, Uilenreef JJ, Mitsogiannis MD, van 't Klooster JG, Arndt SS, Hellebrekers LJ.","Lab Anim. 2012 Oct;46(4):287-92. doi: 10.1258/la.2012.012058.","Schaap MW","Lab Anim","2012","2012/10/26","","","10.1258/la.2012.012058"
"23092049","Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options","Bonhomme J, Shim RS, Gooden R, Tyus D, Rust G.","J Natl Med Assoc. 2012 Jul-Aug;104(7-8):342-50. doi: 10.1016/s0027-9684(15)30175-9.","Bonhomme J","J Natl Med Assoc","2012","2012/10/25","PMC4039205","NIHMS564666","10.1016/s0027-9684(15)30175-9"
"23087138","Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein(+) cancers","Wang J, Cai B, Huang DX, Yang SD, Guo L.","Pharmacol Rep. 2012;64(4):870-7. doi: 10.1016/s1734-1140(12)70881-2.","Wang J","Pharmacol Rep","2012","2012/10/23","","","10.1016/s1734-1140(12)70881-2"
"23086347","Local anesthetics in diabetic rats (and patients): shifting from a known slippery slope toward a potentially better multimodal perineural paradigm?","Ibinson JW, Mangione MP, Williams BA.","Reg Anesth Pain Med. 2012 Nov-Dec;37(6):574-6. doi: 10.1097/AAP.0b013e31826e5218.","Ibinson JW","Reg Anesth Pain Med","2012","2012/10/23","","","10.1097/AAP.0b013e31826e5218"
"23084592","Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations","Stallvik M, Nordstrand B, Kristensen Ø, Bathen J, Skogvoll E, Spigset O.","Drug Alcohol Depend. 2013 Apr 1;129(1-2):88-93. doi: 10.1016/j.drugalcdep.2012.09.016. Epub 2012 Oct 16.","Stallvik M","Drug Alcohol Depend","2013","2012/10/23","","","10.1016/j.drugalcdep.2012.09.016"
"23082538","Antinociceptive efficacy of buprenorphine and hydromorphone in red-eared slider turtles (Trachemys scripta elegans)","Mans C, Lahner LL, Baker BB, Johnson SM, Sladky KK.","J Zoo Wildl Med. 2012 Sep;43(3):662-5. doi: 10.1638/2011-0260R.1.","Mans C","J Zoo Wildl Med","2012","2012/10/23","","","10.1638/2011-0260R.1"
"23079917","Safety and efficacy of buprenorphine for analgesia in laboratory mice and rats","Guarnieri M, Brayton C, DeTolla L, Forbes-McBean N, Sarabia-Estrada R, Zadnik P.","Lab Anim (NY). 2012 Nov;41(11):337-43. doi: 10.1038/laban.152.","Guarnieri M","Lab Anim (NY)","2012","2012/10/20","","","10.1038/laban.152"
"23074230","Reduced pupil diameter in volunteers on stable buprenorphine maintenance therapy with telaprevir: a drug-drug interaction involving p-glycoprotein at the blood-brain barrier?","Mégarbane B, Alhaddad H, Declèves X.","Antimicrob Agents Chemother. 2012 Nov;56(11):6070. doi: 10.1128/AAC.01295-12.","Mégarbane B","Antimicrob Agents Chemother","2012","2012/10/18","PMC3486590","","10.1128/AAC.01295-12"
"23073726","Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics","Schaeffer T.","J Med Toxicol. 2012 Dec;8(4):400-7. doi: 10.1007/s13181-012-0270-y.","Schaeffer T","J Med Toxicol","2012","2012/10/18","PMC3550267","","10.1007/s13181-012-0270-y"
"23062049","Opioid dependence","Praveen KT, Law F, O'Shea J, Melichar J.","Am Fam Physician. 2012 Sep 15;86(6):565-6.","Praveen KT","Am Fam Physician","2012","2012/10/16","","",""
"23060530","Cingulate biochemistry in heroin users on substitution pharmacotherapy","Verdejo-García A, Lubman DI, Roffel K, Vilar-López R, Bora E, MacKenzie T, Yücel M.","Aust N Z J Psychiatry. 2013 Mar;47(3):244-9. doi: 10.1177/0004867412463088. Epub 2012 Oct 11.","Verdejo-García A","Aust N Z J Psychiatry","2013","2012/10/13","","","10.1177/0004867412463088"
"23059064","Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome","McLemore GL, Lewis T, Jones CH, Gauda EB.","Semin Fetal Neonatal Med. 2013 Feb;18(1):35-41. doi: 10.1016/j.siny.2012.09.002. Epub 2012 Oct 9.","McLemore GL","Semin Fetal Neonatal Med","2013","2012/10/13","PMC4142759","NIHMS602030","10.1016/j.siny.2012.09.002"
"23045289","Detection of drugs of abuse in exhaled breath from users following recovery from intoxication","Beck O, Stephanson N, Sandqvist S, Franck J.","J Anal Toxicol. 2012 Nov-Dec;36(9):638-46. doi: 10.1093/jat/bks079. Epub 2012 Oct 7.","Beck O","J Anal Toxicol","2012","2012/10/10","","","10.1093/jat/bks079"
"23043810","Effect of pain management on immunization efficacy in mice","Kolstad AM, Rodriguiz RM, Kim CJ, Hale LP.","J Am Assoc Lab Anim Sci. 2012 Jul;51(4):448-57.","Kolstad AM","J Am Assoc Lab Anim Sci","2012","2012/10/10","PMC3400693","",""
"23041680","Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone","Barry DT, Savant JD, Beitel M, Cutter CJ, Moore BA, Schottenfeld RS, Fiellin DA.","J Addict Med. 2012 Dec;6(4):274-9. doi: 10.1097/ADM.0b013e31826d1df3.","Barry DT","J Addict Med","2012","2012/10/09","PMC3492534","NIHMS405046","10.1097/ADM.0b013e31826d1df3"
"23034996","Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain","Ruggiero A, Coccia P, Arena R, Maurizi P, Battista A, Ridola V, Attinà G, Riccardi R.","Pediatr Blood Cancer. 2013 Mar;60(3):433-7. doi: 10.1002/pbc.24332. Epub 2012 Oct 3.","Ruggiero A","Pediatr Blood Cancer","2013","2012/10/05","","","10.1002/pbc.24332"
"23026548","Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levels","Kapil RP, Cipriano A, Friedman K, Michels G, Shet MS, Colucci SV, Apseloff G, Kitzmiller J, Harris SC.","J Pain Symptom Manage. 2013 Jul;46(1):65-75. doi: 10.1016/j.jpainsymman.2012.06.014. Epub 2012 Sep 29.","Kapil RP","J Pain Symptom Manage","2013","2012/10/03","","","10.1016/j.jpainsymman.2012.06.014"
"23021099","Predictors of outcome after short-term stabilization with buprenorphine","Hillhouse M, Canamar CP, Ling W.","J Subst Abuse Treat. 2013 Mar;44(3):336-42. doi: 10.1016/j.jsat.2012.08.016. Epub 2012 Sep 26.","Hillhouse M","J Subst Abuse Treat","2013","2012/10/02","PMC3545105","NIHMS403181","10.1016/j.jsat.2012.08.016"
"23013781","Heroin dependence duration influences the metabolic parameters: mechanisms and consequences of impaired insulin sensitivity in hepatitis C virus seronegative heroin dependents","Pereska Z, Bozinovska C, Dimitrovski C, Cakalarovski K, Chibishev A, Zdravkovska M, Babulovska A, Janicevic D.","J Addict Med. 2012 Dec;6(4):304-10. doi: 10.1097/ADM.0b013e31826bd76c.","Pereska Z","J Addict Med","2012","2012/09/28","","","10.1097/ADM.0b013e31826bd76c"
"23013384","Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence","Soyka M.","Expert Opin Drug Deliv. 2012 Nov;9(11):1409-17. doi: 10.1517/17425247.2012.729574. Epub 2012 Sep 26.","Soyka M","Expert Opin Drug Deliv","2012","2012/09/28","","","10.1517/17425247.2012.729574"
"23007109","Buprenorphine from detox and beyond: preliminary evaluation of a pilot program to increase heroin dependent individuals' engagement in a full continuum of care","Donovan DM, Knox PC, Skytta JA, Blayney JA, DiCenzo J.","J Subst Abuse Treat. 2013 Apr;44(4):426-32. doi: 10.1016/j.jsat.2012.08.019. Epub 2012 Sep 21.","Donovan DM","J Subst Abuse Treat","2013","2012/09/26","","","10.1016/j.jsat.2012.08.019"
"22999817","A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans","Mitchell SG, Gryczynski J, Schwartz RP, O'Grady KE, Olsen YK, Jaffe JH.","Drug Alcohol Depend. 2013 Mar 1;128(3):222-9. doi: 10.1016/j.drugalcdep.2012.08.027. Epub 2012 Sep 20.","Mitchell SG","Drug Alcohol Depend","2013","2012/09/25","PMC3561484","NIHMS409331","10.1016/j.drugalcdep.2012.08.027"
"22998333","Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats","Steagall PV, Pelligand L, Giordano T, Auberger C, Sear JW, Luna SP, Taylor PM.","Vet Anaesth Analg. 2013 Jan;40(1):83-95. doi: 10.1111/j.1467-2995.2012.00779.x. Epub 2012 Sep 24.","Steagall PV","Vet Anaesth Analg","2013","2012/09/25","","","10.1111/j.1467-2995.2012.00779.x"
"22989279","Pain is not associated with worse office-based buprenorphine treatment outcomes","Fox AD, Sohler NL, Starrels JL, Ning Y, Giovanniello A, Cunningham CO.","Subst Abus. 2012;33(4):361-5. doi: 10.1080/08897077.2011.638734.","Fox AD","Subst Abus","2012","2012/09/20","PMC3447624","NIHMS390655","10.1080/08897077.2011.638734"
"22980471","[Reimbursement of opiate substitution drugs to militaries in 2007]","d'Argouges F, Desjeux G, Marsan P, Thevenin-Garron V.","Encephale. 2012 Sep;38(4):304-9. doi: 10.1016/j.encep.2011.11.010. Epub 2012 Jan 5.","d'Argouges F","Encephale","2012","2012/09/18","","","10.1016/j.encep.2011.11.010"
"22980449","Prescription opioid abuse, chronic pain, and primary care: a Co-occurring Disorders Clinic in the chronic disease model","Pade PA, Cardon KE, Hoffman RM, Geppert CM.","J Subst Abuse Treat. 2012 Dec;43(4):446-50. doi: 10.1016/j.jsat.2012.08.010. Epub 2012 Sep 11.","Pade PA","J Subst Abuse Treat","2012","2012/09/18","","","10.1016/j.jsat.2012.08.010"
"22978772","Low-dose 7-day transdermal buprenorphine in daily clinical practice - perceptions of elderly patients with moderate non-malignant chronic pain","Uberall MA, Müller-Schwefe GH.","Curr Med Res Opin. 2012 Oct;28(10):1585-95. doi: 10.1185/03007995.2012.731387. Epub 2012 Oct 2.","Uberall MA","Curr Med Res Opin","2012","2012/09/18","","","10.1185/03007995.2012.731387"
"22975888","Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice","Alhaddad H, Cisternino S, Declèves X, Tournier N, Schlatter J, Chiadmi F, Risède P, Smirnova M, Besengez C, Scherrmann JM, Baud FJ, Mégarbane B.","Crit Care Med. 2012 Dec;40(12):3215-23. doi: 10.1097/CCM.0b013e318265680a.","Alhaddad H","Crit Care Med","2012","2012/09/15","","","10.1097/CCM.0b013e318265680a"
"22969145","Voluntary ingestion of nut paste for administration of buprenorphine in rats and mice","Abelson KS, Jacobsen KR, Sundbom R, Kalliokoski O, Hau J.","Lab Anim. 2012 Oct;46(4):349-51. doi: 10.1258/la.2012.012028. Epub 2012 Sep 11.","Abelson KS","Lab Anim","2012","2012/09/13","","","10.1258/la.2012.012028"
"22946908","Sulfation of buprenorphine, pentazocine, and naloxone by human cytosolic sulfotransferases","Kurogi K, Chen M, Lee Y, Shi B, Yan T, Liu MY, Sakakibara Y, Suiko M, Liu MC.","Drug Metab Lett. 2012 Jun 1;6(2):109-15.","Kurogi K","Drug Metab Lett","2012","2012/09/06","","",""
"22941853","High dose of buprenorphine in terminally ill patient with liver failure: efficacy and tolerability","Ciccozzi A, Angeletti C, Baldascino G, Petrucci E, Bonetti C, De Santis S, Paladini A, Varrassi G, Marinangeli F.","J Opioid Manag. 2012 Jul-Aug;8(4):253-9. doi: 10.5055/jom.2012.0123.","Ciccozzi A","J Opioid Manag","2012","2012/09/04","","","10.5055/jom.2012.0123"
"22939650","Who prescribes buprenorphine for rural patients? The impact of specialty, location and practice type in Washington State","Kvamme E, Catlin M, Banta-Green C, Roll J, Rosenblatt R.","J Subst Abuse Treat. 2013 Mar;44(3):355-60. doi: 10.1016/j.jsat.2012.07.006. Epub 2012 Aug 30.","Kvamme E","J Subst Abuse Treat","2013","2012/09/04","PMC3886338","NIHMS532938","10.1016/j.jsat.2012.07.006"
"22938914","Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients","Tetrault JM, Moore BA, Barry DT, O'Connor PG, Schottenfeld R, Fiellin DA, Fiellin LE.","J Subst Abuse Treat. 2012 Dec;43(4):433-9. doi: 10.1016/j.jsat.2012.07.011. Epub 2012 Aug 29.","Tetrault JM","J Subst Abuse Treat","2012","2012/09/04","","","10.1016/j.jsat.2012.07.011"
"22933386","Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency","Bas DB, Su J, Sandor K, Agalave NM, Lundberg J, Codeluppi S, Baharpoor A, Nandakumar KS, Holmdahl R, Svensson CI.","Arthritis Rheum. 2012 Dec;64(12):3886-96. doi: 10.1002/art.37686.","Bas DB","Arthritis Rheum","2012","2012/08/31","","","10.1002/art.37686"
"22921476","Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial","Saxon AJ, Ling W, Hillhouse M, Thomas C, Hasson A, Ang A, Doraimani G, Tasissa G, Lokhnygina Y, Leimberger J, Bruce RD, McCarthy J, Wiest K, McLaughlin P, Bilangi R, Cohen A, Woody G, Jacobs P.","Drug Alcohol Depend. 2013 Feb 1;128(1-2):71-6. doi: 10.1016/j.drugalcdep.2012.08.002. Epub 2012 Aug 22.","Saxon AJ","Drug Alcohol Depend","2013","2012/08/28","PMC3543467","NIHMS405369","10.1016/j.drugalcdep.2012.08.002"
"22915104","Role of orbitofrontal cortex neuronal ensembles in the expression of incubation of heroin craving","Fanous S, Goldart EM, Theberge FR, Bossert JM, Shaham Y, Hope BT.","Version 2. J Neurosci. 2012 Aug 22;32(34):11600-9. doi: 10.1523/JNEUROSCI.1914-12.2012.","Fanous S","J Neurosci","2012","2012/08/24","PMC3435881","NIHMS403449","10.1523/JNEUROSCI.1914-12.2012"
"22902085","Evaluation and management of opioid dependence in pregnancy","Park EM, Meltzer-Brody S, Suzuki J.","Psychosomatics. 2012 Sep-Oct;53(5):424-32. doi: 10.1016/j.psym.2012.04.003. Epub 2012 Aug 14.","Park EM","Psychosomatics","2012","2012/08/21","PMC5298932","NIHMS848621","10.1016/j.psym.2012.04.003"
"22890187","Limb Idleness Index (LII): a novel measurement of pain in a rat model of osteoarthritis","Fu SC, Cheuk YC, Hung LK, Chan KM.","Osteoarthritis Cartilage. 2012 Nov;20(11):1409-16. doi: 10.1016/j.joca.2012.08.006. Epub 2012 Aug 10.","Fu SC","Osteoarthritis Cartilage","2012","2012/08/15","","","10.1016/j.joca.2012.08.006"
"22884575","Comparison of fatal poisonings by prescription opioids","Häkkinen M, Launiainen T, Vuori E, Ojanperä I.","Forensic Sci Int. 2012 Oct 10;222(1-3):327-31. doi: 10.1016/j.forsciint.2012.07.011. Epub 2012 Aug 10.","Häkkinen M","Forensic Sci Int","2012","2012/08/14","","","10.1016/j.forsciint.2012.07.011"
"22882403","Buprenorphine/naloxone and dental caries: a case report","Suzuki J, Park EM.","Am J Addict. 2012 Sep-Oct;21(5):494-5. doi: 10.1111/j.1521-0391.2012.00254.x.","Suzuki J","Am J Addict","2012","2012/08/14","","","10.1111/j.1521-0391.2012.00254.x"
"22882402","Treatment of buprenorphine precipitated withdrawal: a case report","Jutras-Aswad D, Widlitz M, Scimeca MM.","Am J Addict. 2012 Sep-Oct;21(5):492-3. doi: 10.1111/j.1521-0391.2012.00262.x.","Jutras-Aswad D","Am J Addict","2012","2012/08/14","","","10.1111/j.1521-0391.2012.00262.x"
"22882401","Buprenorphine compliance","Demaria PA Jr, Risler RB.","Am J Addict. 2012 Sep-Oct;21(5):491. doi: 10.1111/j.1521-0391.2012.00265.x.","Demaria PA Jr","Am J Addict","2012","2012/08/14","","","10.1111/j.1521-0391.2012.00265.x"
"22882389","Course and treatment of buprenorphine/naloxone withdrawal: an analysis of case reports","Westermeyer J, McCance-Katz EF.","Am J Addict. 2012 Sep-Oct;21(5):401-3. doi: 10.1111/j.1521-0391.2012.00259.x. Epub 2012 Jul 24.","Westermeyer J","Am J Addict","2012","2012/08/14","PMC3723396","NIHMS471313","10.1111/j.1521-0391.2012.00259.x"
"22882166","Prescription drug use among pregnant women in opioid Maintenance Treatment","Lund IO, Skurtveit S, Engeland A, Furu K, Ravndal E, Handal M.","Addiction. 2013 Feb;108(2):367-76. doi: 10.1111/j.1360-0443.2012.04049.x. Epub 2012 Oct 18.","Lund IO","Addiction","2013","2012/08/14","","","10.1111/j.1360-0443.2012.04049.x"
"22876835","Transdermal buprenorphine for postoperative pain control in gynecological surgery: a prospective randomized study","Setti T, Sanfilippo F, Leykin Y.","Curr Med Res Opin. 2012 Oct;28(10):1597-608. doi: 10.1185/03007995.2012.719864. Epub 2012 Sep 10.","Setti T","Curr Med Res Opin","2012","2012/08/11","","","10.1185/03007995.2012.719864"
"22875830","A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence","Wee S, Vendruscolo LF, Misra KK, Schlosburg JE, Koob GF.","Sci Transl Med. 2012 Aug 8;4(146):146ra110. doi: 10.1126/scitranslmed.3003948.","Wee S","Sci Transl Med","2012","2012/08/10","PMC3448552","NIHMS403879","10.1126/scitranslmed.3003948"
"22873189","Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations","Stancliff S, Joseph H, Fong C, Furst T, Comer SD, Roux P.","J Addict Dis. 2012;31(3):278-87. doi: 10.1080/10550887.2012.694603.","Stancliff S","J Addict Dis","2012","2012/08/10","PMC3620719","NIHMS451338","10.1080/10550887.2012.694603"
"22873184","Reducing stigma through education to enhance Medication-Assisted Recovery","Woods JS, Joseph H.","J Addict Dis. 2012;31(3):226-35. doi: 10.1080/10550887.2012.694599.","Woods JS","J Addict Dis","2012","2012/08/10","","","10.1080/10550887.2012.694599"
"22873183","Maintenance medication for opiate addiction: the foundation of recovery","Bart G.","J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598.","Bart G","J Addict Dis","2012","2012/08/10","PMC3411273","NIHMS390074","10.1080/10550887.2012.694598"
"22864399","Persistence on a stress-challenge task before initiating buprenorphine treatment was associated with successful transition from opioid use to early abstinence","Strong DR, Brown RA, Sims M, Herman DS, Anderson BJ, Stein MD.","J Addict Med. 2012 Sep;6(3):219-25. doi: 10.1097/ADM.0b013e31825d927f.","Strong DR","J Addict Med","2012","2012/08/07","PMC3980199","NIHMS386107","10.1097/ADM.0b013e31825d927f"
"22862872","Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice","Fiscella K.","Mayo Clin Proc. 2012 Aug;87(8):806; author reply 806-8. doi: 10.1016/j.mayocp.2012.04.008.","Fiscella K","Mayo Clin Proc","2012","2012/08/07","PMC3498069","","10.1016/j.mayocp.2012.04.008"
"22862870","Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy","Selzer J, Stancliff S.","Mayo Clin Proc. 2012 Aug;87(8):805-6; author repply 806-8. doi: 10.1016/j.mayocp.2012.06.010.","Selzer J","Mayo Clin Proc","2012","2012/08/07","PMC3498220","","10.1016/j.mayocp.2012.06.010"
"22862869","Buprenorphine maintenance therapy in opioid-addicted health care professionals","Newman RG.","Mayo Clin Proc. 2012 Aug;87(8):804-5; author reply 806-8. doi: 10.1016/j.mayocp.2012.06.008.","Newman RG","Mayo Clin Proc","2012","2012/08/07","PMC3498186","","10.1016/j.mayocp.2012.06.008"
"22862867","Opioid substitution therapy for dependent health care practitioners: approach with caution","Earley PH.","Mayo Clin Proc. 2012 Aug;87(8):803-4; author reply 806-8. doi: 10.1016/j.mayocp.2012.06.007.","Earley PH","Mayo Clin Proc","2012","2012/08/07","PMC3498089","","10.1016/j.mayocp.2012.06.007"
"22850099","[National and regional market penetration rates of generic's high dosage buprenorphine: its evolution from 2006 to 2008, using reimbursed drug database]","Boczek C, Frauger E, Micallef J, Allaria-Lapierre V, Reggio P, Sciortino V.","Therapie. 2012 Mar-Apr;67(2):129-36. doi: 10.2515/therapie/2012011. Epub 2012 Aug 2.","Boczek C","Therapie","2012","2012/08/02","","","10.2515/therapie/2012011"
"22845057","Criminal behavior in opioid-dependent patients before and during maintenance therapy: 6-year follow-up of a nationally representative cohort sample","Soyka M, Träder A, Klotsche J, Haberthür A, Bühringer G, Rehm J, Wittchen HU.","J Forensic Sci. 2012 Nov;57(6):1524-30. doi: 10.1111/j.1556-4029.2012.02234.x. Epub 2012 Jul 30.","Soyka M","J Forensic Sci","2012","2012/08/01","","","10.1111/j.1556-4029.2012.02234.x"
"22845044","Effect of ketoconazole on the pharmacokinetic profile of buprenorphine following administration of a once-weekly buprenorphine transdermal system","Kapil RP, Cipriano A, Michels GH, Perrino P, O'Keefe SA, Shet MS, Colucci SV, Noveck RJ, Harris SC.","Clin Drug Investig. 2012 Sep 1;32(9):583-92. doi: 10.1007/BF03261913.","Kapil RP","Clin Drug Investig","2012","2012/08/01","","","10.1007/BF03261913"
"22841461","[Lactic acidosis due to thiamine deficiency]","Alvarado MX, Rodriguez Morera J, Martin Fernandez X, Juanós Iborra M.","Med Clin (Barc). 2012 Dec 1;139(13):604. doi: 10.1016/j.medcli.2012.05.019. Epub 2012 Jul 28.","Alvarado MX","Med Clin (Barc)","2012","2012/07/31","","","10.1016/j.medcli.2012.05.019"
"22841456","Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009","Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjarkø L, Ravndal E.","Drug Alcohol Depend. 2013 Jan 1;127(1-3):200-6. doi: 10.1016/j.drugalcdep.2012.07.001. Epub 2012 Jul 25.","Welle-Strand GK","Drug Alcohol Depend","2013","2012/07/31","","","10.1016/j.drugalcdep.2012.07.001"
"22838110","[The risk behavior of drug addicts requires holistic approach from the society. Syringe exchange and methadone-/buprenorphine treatment are important elements]","Håkansson AC.","Lakartidningen. 2012 Jun 19-26;109(25):1216-7.","Håkansson AC","Lakartidningen","2012","2012/07/31","","",""
"22835751","A comparison of suboxone and clonidine treatment outcomes in opiate detoxification","Steele A, Cunningham P.","Arch Psychiatr Nurs. 2012 Aug;26(4):316-23. doi: 10.1016/j.apnu.2011.10.006. Epub 2012 Jan 12.","Steele A","Arch Psychiatr Nurs","2012","2012/07/28","","","10.1016/j.apnu.2011.10.006"
"22835477","Twelve-year trend in treatment seeking for buprenorphine abuse in Finland","Uosukainen H, Kauhanen J, Voutilainen S, Föhr J, Paasolainen M, Tiihonen J, Laitinen K, Onyeka IN, Bell JS.","Drug Alcohol Depend. 2013 Jan 1;127(1-3):207-14. doi: 10.1016/j.drugalcdep.2012.07.002. Epub 2012 Jul 25.","Uosukainen H","Drug Alcohol Depend","2013","2012/07/28","","","10.1016/j.drugalcdep.2012.07.002"
"22813654","Agonist treatment in opioid use: advances and controversy","Viswanath B, Chand P, Benegal V, Murthy P.","Asian J Psychiatr. 2012 Jun;5(2):125-31. doi: 10.1016/j.ajp.2012.01.004. Epub 2012 May 4.","Viswanath B","Asian J Psychiatr","2012","2012/07/21","","","10.1016/j.ajp.2012.01.004"
"22813462","Deep understanding of the interaction between thienorphine and UDP-glucuronosyltransferase (UGT) isoforms","Dong RH, Fang ZZ, Zhu LL, Ge GB, Li XB, Hu CM, Cao YF, Xia YL, Yang L, Liu ZY.","Xenobiotica. 2013 Feb;43(2):133-9. doi: 10.3109/00498254.2012.706723. Epub 2012 Jul 20.","Dong RH","Xenobiotica","2013","2012/07/21","","","10.3109/00498254.2012.706723"
"22810057","Financial factors and the implementation of medications for treating opioid use disorders","Knudsen HK, Roman PM.","J Addict Med. 2012 Dec;6(4):280-6. doi: 10.1097/ADM.0b013e318262a97a.","Knudsen HK","J Addict Med","2012","2012/07/20","PMC3492536","NIHMS391261","10.1097/ADM.0b013e318262a97a"
"22809653","Buprenorphine for chronic pain management","Sloan P.","J Support Oncol. 2012 Nov-Dec;10(6):220-1. doi: 10.1016/j.suponc.2012.06.002. Epub 2012 Jul 17.","Sloan P","J Support Oncol","2012","2012/07/20","","","10.1016/j.suponc.2012.06.002"
"22809652","Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain","Davis MP.","J Support Oncol. 2012 Nov-Dec;10(6):209-19. doi: 10.1016/j.suponc.2012.05.002. Epub 2012 Jul 17.","Davis MP","J Support Oncol","2012","2012/07/20","","","10.1016/j.suponc.2012.05.002"
"22805228","Diminished brain functional magnetic resonance imaging activation in patients on opiate maintenance despite normal spatial working memory task performance","Bach P, Vollstädt-Klein S, Frischknecht U, Hoerst M, Kiefer F, Mann K, Ende G, Hermann D.","Clin Neuropharmacol. 2012 Jul-Aug;35(4):153-60. doi: 10.1097/WNF.0b013e31825c38f5.","Bach P","Clin Neuropharmacol","2012","2012/07/19","","","10.1097/WNF.0b013e31825c38f5"
"22797321","A non-invasive model for measuring nociception after tooth pulp exposure","Kramer PR, He J, Puri J, Bellinger LL.","J Dent Res. 2012 Sep;91(9):883-7. doi: 10.1177/0022034512454297. Epub 2012 Jul 12.","Kramer PR","J Dent Res","2012","2012/07/17","PMC3420391","","10.1177/0022034512454297"
"22795215","A case of acute psychosis after buprenorphine withdrawal: abrupt versus progressive discontinuation could make a difference","Weibel S, Mallaret M, Bennouna-Greene M, Bertschy G.","J Clin Psychiatry. 2012 Jun;73(6):e756. doi: 10.4088/JCP.11cr07608.","Weibel S","J Clin Psychiatry","2012","2012/07/17","","","10.4088/JCP.11cr07608"
"22786462","Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine","Daitch J, Frey ME, Silver D, Mitnick C, Daitch D, Pergolizzi J Jr.","Pain Physician. 2012 Jul;15(3 Suppl):ES59-66.","Daitch J","Pain Physician","2012","2012/07/13","","",""
"22776195","Effects of buprenorphine on a cecal ligation and puncture model in C57BL/6 mice","Cotroneo TM, Hugunin KM, Shuster KA, Hwang HJ, Kakaraparthi BN, Nemzek-Hamlin JA.","J Am Assoc Lab Anim Sci. 2012 May;51(3):357-65.","Cotroneo TM","J Am Assoc Lab Anim Sci","2012","2012/07/11","PMC3358986","",""
"22775351","Neurodevelopmental investigation of the mirror neurone system in children of women receiving opioid maintenance therapy during pregnancy","Konijnenberg C, Melinder A.","Addiction. 2013 Jan;108(1):154-60. doi: 10.1111/j.1360-0443.2012.04006.x. Epub 2012 Oct 5.","Konijnenberg C","Addiction","2013","2012/07/11","","","10.1111/j.1360-0443.2012.04006.x"
"22771144","Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment","Savant JD, Barry DT, Cutter CJ, Joy MT, Dinh A, Schottenfeld RS, Fiellin DA.","Drug Alcohol Depend. 2013 Jan 1;127(1-3):243-7. doi: 10.1016/j.drugalcdep.2012.06.020. Epub 2012 Jul 6.","Savant JD","Drug Alcohol Depend","2013","2012/07/10","PMC3525769","NIHMS393093","10.1016/j.drugalcdep.2012.06.020"
"22743574","Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates","Cremeans CM, Gruley E, Kyle DJ, Ko MC.","J Pharmacol Exp Ther. 2012 Oct;343(1):72-81. doi: 10.1124/jpet.112.194308. Epub 2012 Jun 28.","Cremeans CM","J Pharmacol Exp Ther","2012","2012/06/30","PMC3464037","","10.1124/jpet.112.194308"
"22739506","P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception","Brown SM, Campbell SD, Crafford A, Regina KJ, Holtzman MJ, Kharasch ED.","J Pharmacol Exp Ther. 2012 Oct;343(1):53-61. doi: 10.1124/jpet.112.193433. Epub 2012 Jun 27.","Brown SM","J Pharmacol Exp Ther","2012","2012/06/29","PMC3464040","","10.1124/jpet.112.193433"
"22731882","Methadone in combination with acepromazine as premedication prior to neutering in the cat","Bortolami E, Murrell JC, Slingsby LS.","Vet Anaesth Analg. 2013 Mar;40(2):181-93. doi: 10.1111/j.1467-2995.2012.00736.x. Epub 2012 Jun 26.","Bortolami E","Vet Anaesth Analg","2013","2012/06/27","","","10.1111/j.1467-2995.2012.00736.x"
"22731776","The effectiveness of a long-acting transdermal fentanyl solution compared to buprenorphine for the control of postoperative pain in dogs in a randomized, multicentered clinical study","Linton DD, Wilson MG, Newbound GC, Freise KJ, Clark TP.","J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:53-64. doi: 10.1111/j.1365-2885.2012.01408.x.","Linton DD","J Vet Pharmacol Ther","2012","2012/06/27","","","10.1111/j.1365-2885.2012.01408.x"
"22726911","Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users","Darke S, McDonald S, Kaye S, Torok M.","Drug Alcohol Depend. 2012 Dec 1;126(3):309-15. doi: 10.1016/j.drugalcdep.2012.05.032. Epub 2012 Jun 20.","Darke S","Drug Alcohol Depend","2012","2012/06/26","","","10.1016/j.drugalcdep.2012.05.032"
"22719814","Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners","Springer SA, Qiu J, Saber-Tehrani AS, Altice FL.","PLoS One. 2012;7(5):e38335. doi: 10.1371/journal.pone.0038335. Epub 2012 May 31.","Springer SA","PLoS One","2012","2012/06/22","PMC3365007","","10.1371/journal.pone.0038335"
"22718901","Neonatal abstinence syndrome can be a problem","Mactier H, McGlone L, Hamilton R, MacKinnon JR.","BMJ. 2012 Jun 19;344:e4200. doi: 10.1136/bmj.e4200.","Mactier H","BMJ","2012","2012/06/22","","","10.1136/bmj.e4200"
"22708140","The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment","Ferrara MM.","Seton Hall Law Rev. 2012;42(2):741-67.","Ferrara MM","Seton Hall Law Rev","2012","2012/06/20","","",""
"22706617","Pharmacokinetics of transdermal buprenorphine patch in the elderly","Al-Tawil N, Odar-Cederlöf I, Berggren AC, Johnson HE, Persson J.","Eur J Clin Pharmacol. 2013 Feb;69(2):143-9. doi: 10.1007/s00228-012-1320-8. Epub 2012 Jun 17.","Al-Tawil N","Eur J Clin Pharmacol","2013","2012/06/19","PMC3548110","","10.1007/s00228-012-1320-8"
"22704124","Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine","Lofwall MR, Havens JR.","Drug Alcohol Depend. 2012 Dec 1;126(3):379-83. doi: 10.1016/j.drugalcdep.2012.05.025. Epub 2012 Jun 15.","Lofwall MR","Drug Alcohol Depend","2012","2012/06/19","PMC3449053","NIHMS380860","10.1016/j.drugalcdep.2012.05.025"
"22703715","Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared","McKeganey N, Russell C, Cockayne L.","J Subst Abuse Treat. 2013 Jan;44(1):97-102. doi: 10.1016/j.jsat.2012.04.003. Epub 2012 Jun 15.","McKeganey N","J Subst Abuse Treat","2013","2012/06/19","","","10.1016/j.jsat.2012.04.003"
"22691393","[Naltrexone and opiate substitutive treatment]","Dupouy J, Poutrain JC, Lapeyre-Mestre M.","Therapie. 2011 Nov-Dec;66(6):549-52. doi: 10.2515/therapie/2011072. Epub 2011 Dec 21.","Dupouy J","Therapie","2011","2012/06/14","","","10.2515/therapie/2011072"
"22690174","Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy","Pajusco B, Chiamulera C, Quaglio G, Moro L, Casari R, Amen G, Faccini M, Lugoboni F.","Int J Environ Res Public Health. 2012 Mar;9(3):932-42. doi: 10.3390/ijerph9030932. Epub 2012 Mar 16.","Pajusco B","Int J Environ Res Public Health","2012","2012/06/13","PMC3367288","","10.3390/ijerph9030932"
"22688601","Use of buprenorphine in children with chronic pseudoobstruction syndrome: case series and review of literature","Prapaitrakool S, Hollmann MW, Wartenberg HC, Preckel B, Brugger S.","Clin J Pain. 2012 Oct;28(8):722-5. doi: 10.1097/AJP.0b013e318243f609.","Prapaitrakool S","Clin J Pain","2012","2012/06/13","","","10.1097/AJP.0b013e318243f609"
"22676570","The science and practice of medication-assisted treatments for opioid dependence","Pecoraro A, Ma M, Woody GE.","Subst Use Misuse. 2012 Jun-Jul;47(8-9):1026-40. doi: 10.3109/10826084.2012.663292.","Pecoraro A","Subst Use Misuse","2012","2012/06/09","","","10.3109/10826084.2012.663292"
"22676569","HIV/AIDS and drug use in China--interactions, impacts, and issues","Zhao M, Ling W.","Subst Use Misuse. 2012 Jun-Jul;47(8-9):1015-25. doi: 10.3109/10826084.2012.663284.","Zhao M","Subst Use Misuse","2012","2012/06/09","PMC4151620","NIHMS615702","10.3109/10826084.2012.663284"
"22662401","Attitudes toward psychotropic medications","Fife SA, Ketzenberger KE, Olson JN.","Psychol Rep. 2012 Apr;110(2):475-6. doi: 10.2466/07.13.17.PR0.110.2.475-476.","Fife SA","Psychol Rep","2012","2012/06/06","","","10.2466/07.13.17.PR0.110.2.475-476"
"22651957","Reduced fear-recognition sensitivity following acute buprenorphine administration in healthy volunteers","Ipser JC, Terburg D, Syal S, Phillips N, Solms M, Panksepp J, Malcolm-Smith S, Thomas K, Stein DJ, van Honk J.","Psychoneuroendocrinology. 2013 Jan;38(1):166-70. doi: 10.1016/j.psyneuen.2012.05.002. Epub 2012 May 30.","Ipser JC","Psychoneuroendocrinology","2013","2012/06/02","","","10.1016/j.psyneuen.2012.05.002"
"22644357","Buprenorphine added to levobupivacaine enhances postoperative analgesia of middle interscalene brachial plexus block","Behr A, Freo U, Ori C, Westermann B, Alemanno F.","J Anesth. 2012 Oct;26(5):746-51. doi: 10.1007/s00540-012-1416-4. Epub 2012 May 29.","Behr A","J Anesth","2012","2012/05/31","","","10.1007/s00540-012-1416-4"
"22642013","[Agitation and aggressive behavior in demented patients: pain therapy improves behavioral problems]","","MMW Fortschr Med. 2012 Jan 19;154(1):76-7.","","MMW Fortschr Med","2012","2012/05/31","","",""
"22640765","Treatment of opioid dependence in the setting of pregnancy","Young JL, Martin PR.","Psychiatr Clin North Am. 2012 Jun;35(2):441-60. doi: 10.1016/j.psc.2012.03.008. Epub 2012 Apr 11.","Young JL","Psychiatr Clin North Am","2012","2012/05/30","","","10.1016/j.psc.2012.03.008"
"22626890","Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth","Warden D, Subramaniam GA, Carmody T, Woody GE, Minhajuddin A, Poole SA, Potter J, Fishman M, Bogenschutz M, Patkar A, Trivedi MH.","Addict Behav. 2012 Sep;37(9):1046-53. doi: 10.1016/j.addbeh.2012.04.011. Epub 2012 May 8.","Warden D","Addict Behav","2012","2012/05/26","PMC3691698","NIHMS375593","10.1016/j.addbeh.2012.04.011"
"22626615","Tramadol induces conditioned place preference in rats: interactions with morphine and buprenorphine","Zhang M, Jing L, Liu Q, Wen RT, Li JX, Li YL, Gong Q, Liang JH.","Neurosci Lett. 2012 Jun 27;520(1):87-91. doi: 10.1016/j.neulet.2012.05.037. Epub 2012 May 22.","Zhang M","Neurosci Lett","2012","2012/05/26","","","10.1016/j.neulet.2012.05.037"
"22614936","Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study","Moore BA, Barry DT, Sullivan LE, Oʼconnor PG, Cutter CJ, Schottenfeld RS, Fiellin DA.","J Addict Med. 2012 Sep;6(3):205-11. doi: 10.1097/ADM.0b013e3182596492.","Moore BA","J Addict Med","2012","2012/05/23","PMC3419276","NIHMS385435","10.1097/ADM.0b013e3182596492"
"22614935","Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?","Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL.","J Addict Med. 2012 Sep;6(3):179-85. doi: 10.1097/ADM.0b013e318257377f.","Taylor LE","J Addict Med","2012","2012/05/23","PMC4209296","NIHMS636568","10.1097/ADM.0b013e318257377f"
"22613171","Opioid maintenance therapy restores CD4+ T cell function by normalizing CD4+CD25(high) regulatory T cell frequencies in heroin user","Riss GL, Chang DI, Wevers C, Westendorf AM, Buer J, Scherbaum N, Hansen W.","Brain Behav Immun. 2012 Aug;26(6):972-8. doi: 10.1016/j.bbi.2012.05.008. Epub 2012 May 18.","Riss GL","Brain Behav Immun","2012","2012/05/23","","","10.1016/j.bbi.2012.05.008"
"22589497","Maintenance drugs to treat opioid dependence","Farrell M, Wodak A, Gowing L.","BMJ. 2012 May 15;344:e2823. doi: 10.1136/bmj.e2823.","Farrell M","BMJ","2012","2012/05/17","","","10.1136/bmj.e2823"
"22587811","Messages about methadone and buprenorphine in reality television: a content analysis of celebrity rehab with Dr. Drew","Roose R, Fuentes L, Cheema M.","Subst Use Misuse. 2012 Aug;47(10):1117-24. doi: 10.3109/10826084.2012.680172. Epub 2012 May 15.","Roose R","Subst Use Misuse","2012","2012/05/17","","","10.3109/10826084.2012.680172"
"22577788","Treatment of pain in patients taking buprenorphine for opioid addiction #221","Childers JW, Arnold RM.","J Palliat Med. 2012 May;15(5):613-4. doi: 10.1089/jpm.2012.9591.","Childers JW","J Palliat Med","2012","2012/05/15","","","10.1089/jpm.2012.9591"
"22577050","Effects of a standardized anesthetic protocol on hematologic variables in healthy cats","Dhumeaux MP, Snead EC, Epp TY, Taylor SM, Carr AP, Dickinson RM, Leis ML.","J Feline Med Surg. 2012 Oct;14(10):701-5. doi: 10.1177/1098612X12448588. Epub 2012 May 10.","Dhumeaux MP","J Feline Med Surg","2012","2012/05/12","","","10.1177/1098612X12448588"
"22565115","Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome","Seldén T, Ahlner J, Druid H, Kronstrand R.","Forensic Sci Int. 2012 Jul 10;220(1-3):284-90. doi: 10.1016/j.forsciint.2012.03.016. Epub 2012 May 6.","Seldén T","Forensic Sci Int","2012","2012/05/09","","","10.1016/j.forsciint.2012.03.016"
"22564847","Effect of telaprevir on the pharmacokinetics of buprenorphine in volunteers on stable buprenorphine/naloxone maintenance therapy","Luo X, Trevejo J, van Heeswijk RP, Smith F, Garg V.","Antimicrob Agents Chemother. 2012 Jul;56(7):3641-7. doi: 10.1128/AAC.00077-12. Epub 2012 May 7.","Luo X","Antimicrob Agents Chemother","2012","2012/05/09","PMC3393419","","10.1128/AAC.00077-12"
"22564314","Buprenorphine: a newer drug for treating neonatal abstinence syndrome","Bell SG.","Neonatal Netw. 2012 May-Jun;31(3):178-83. doi: 10.1891/0730-0832.31.3.178.","Bell SG","Neonatal Netw","2012","2012/05/09","","","10.1891/0730-0832.31.3.178"
"22561499","[Study on the distribution of buprenorphione in the bodies of the rabbits]","Liu D, He J.","Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Mar;37(3):296-9. doi: 10.3969/j.issn.1672-7347.2012.03.015.","Liu D","Zhong Nan Da Xue Xue Bao Yi Xue Ban","2012","2012/05/08","","","10.3969/j.issn.1672-7347.2012.03.015"
"22559256","Evaluation of buprenorphine dosage adequacy in opioid receptor agonist substitution therapy for heroin dependence: first use of the BUprenorphine-naloxone Dosage Adequacy eVAluation (BUDAVA) questionnaire","D'Amore A, Romano F, Biancolillo V, Lauro G, Armenante C, Pizzirusso A, Del Tufo S, Ruoppolo C, Auriemma F, Cassese F, Oliva P, Amato P.","Clin Drug Investig. 2012 Jul 1;32(7):427-32. doi: 10.2165/11633230-000000000-00000.","D'Amore A","Clin Drug Investig","2012","2012/05/08","","","10.2165/11633230-000000000-00000"
"22540432","Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatment","Tkacz J, Severt J, Kassed C, Ruetsch C.","J Addict Dis. 2012;31(2):100-11. doi: 10.1080/10550887.2012.665729.","Tkacz J","J Addict Dis","2012","2012/05/01","","","10.1080/10550887.2012.665729"
"22534003","Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence","Schwarz R, Zelenev A, Bruce RD, Altice FL.","J Subst Abuse Treat. 2012 Dec;43(4):451-7. doi: 10.1016/j.jsat.2012.03.008. Epub 2012 Apr 24.","Schwarz R","J Subst Abuse Treat","2012","2012/04/27","PMC3419304","NIHMS366899","10.1016/j.jsat.2012.03.008"
"22532618","Perioperative pain relief by a COX-2 inhibitor affects ileal repair and provides a model for anastomotic leakage in the intestine","van der Vijver RJ, van Laarhoven CJ, de Man BM, Lomme RM, Hendriks T.","Surg Innov. 2013 Apr;20(2):113-8. doi: 10.1177/1553350612442793. Epub 2012 Apr 24.","van der Vijver RJ","Surg Innov","2013","2012/04/26","","","10.1177/1553350612442793"
"22530273","[Buprenorphin and benzodiazepines, an association with high risk. Reality of co-prescriptions by the general practitioners]","Di Patrizio P, Houille S, Schwan R, Boivin JM.","Rev Prat. 2010 Dec 20;60(10 Suppl):29-34.","Di Patrizio P","Rev Prat","2010","2012/04/26","","",""
"22526067","Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain","Ravera E, Di Santo S, Bosco R, Arboscello C, Chiarlone R.","Aging Clin Exp Res. 2011 Oct-Dec;23(5-6):328-32. doi: 10.1007/BF03325231.","Ravera E","Aging Clin Exp Res","2011","2012/04/25","","","10.1007/BF03325231"
"22525931","ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy","ACOG Committee on Health Care for Underserved Women; American Society of Addiction Medicine.","Obstet Gynecol. 2012 May;119(5):1070-6. doi: 10.1097/AOG.0b013e318256496e.","ACOG Committee on Health Care for Underserved Women","Obstet Gynecol","2012","2012/04/25","","","10.1097/AOG.0b013e318256496e"
"22520768","Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?","Bhupal HK.","Br J Gen Pract. 2012 Feb;62(595):68-9. doi: 10.3399/bjgp12X625058.","Bhupal HK","Br J Gen Pract","2012","2012/04/24","PMC3268471","","10.3399/bjgp12X625058"
"22517450","Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome","Meyer M, Benvenuto A, Howard D, Johnston A, Plante D, Metayer J, Mandell T.","J Addict Med. 2012 Jun;6(2):124-30. doi: 10.1097/ADM.0b013e3182541933.","Meyer M","J Addict Med","2012","2012/04/21","","","10.1097/ADM.0b013e3182541933"
"22512363","Methadone and buprenorphine for the management of opioid dependence in pregnancy","Jones HE, Finnegan LP, Kaltenbach K.","Drugs. 2012 Apr 16;72(6):747-57. doi: 10.2165/11632820-000000000-00000.","Jones HE","Drugs","2012","2012/04/20","","","10.2165/11632820-000000000-00000"
"22505603","Analgesia after feline ovariohysterectomy under midazolam-medetomidine-ketamine anaesthesia with buprenorphine or butorphanol, and carprofen or meloxicam: a prospective, randomised clinical trial","Polson S, Taylor PM, Yates D.","J Feline Med Surg. 2012 Aug;14(8):553-9. doi: 10.1177/1098612X12444743. Epub 2012 Apr 13.","Polson S","J Feline Med Surg","2012","2012/04/17","","","10.1177/1098612X12444743"
"22504149","Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial μ-opioid receptor agonist buprenorphine","Leffler A, Frank G, Kistner K, Niedermirtl F, Koppert W, Reeh PW, Nau C.","Anesthesiology. 2012 Jun;116(6):1335-46. doi: 10.1097/ALN.0b013e3182557917.","Leffler A","Anesthesiology","2012","2012/04/17","","","10.1097/ALN.0b013e3182557917"
"22494234","Treatment of opioid dependence and cancer pain with sublingual buprenorphine: a case report","Park EM, Suzuki J.","Am J Addict. 2012 May-Jun;21(3):283-4. doi: 10.1111/j.1521-0391.2012.00219.x. Epub 2012 Mar 27.","Park EM","Am J Addict","2012","2012/04/13","","","10.1111/j.1521-0391.2012.00219.x"
"22482491","[Systemic reactivation of contact eczema following tramadol administration in a patient with buprenorphine-induced eczema]","Schmutz JL, Trechot P.","Ann Dermatol Venereol. 2012 Apr;139(4):335-6. doi: 10.1016/j.annder.2012.02.010. Epub 2012 Mar 23.","Schmutz JL","Ann Dermatol Venereol","2012","2012/04/10","","","10.1016/j.annder.2012.02.010"
"22479887","Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose","Yokell MA, Zaller ND, Green TC, McKenzie M, Rich JD.","J Opioid Manag. 2012 Jan-Feb;8(1):63-6. doi: 10.5055/jom.2012.0098.","Yokell MA","J Opioid Manag","2012","2012/04/07","PMC3343634","NIHMS371729","10.5055/jom.2012.0098"
"22479884","Urinalysis-based comparative evaluation of pattern of use of dextropropoxyphene and buprenorphine among opioid-dependent subjects","Balhara YP, Jain R.","J Opioid Manag. 2012 Jan-Feb;8(1):45-9.","Balhara YP","J Opioid Manag","2012","2012/04/07","","",""
"22479882","Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters","Quest TL, Merrill JO, Roll J, Saxon AJ, Rosenblatt RA.","J Opioid Manag. 2012 Jan-Feb;8(1):29-38. doi: 10.5055/jom.2012.0093.","Quest TL","J Opioid Manag","2012","2012/04/07","PMC4367201","NIHMS553272","10.5055/jom.2012.0093"
"22475985","Comparisons of analgesic potency and side effects of buprenorphine and buprenorphine with ultra-low-dose naloxone","Ling W, Hillhouse M, Jenkins J, Miotto K, Torrington M, Chapleo C.","J Addict Med. 2012 Jun;6(2):118-23. doi: 10.1097/ADM.0b013e31824fceca.","Ling W","J Addict Med","2012","2012/04/06","","","10.1097/ADM.0b013e31824fceca"
"22471713","Isoflurane causes neocortical but not hippocampal-dependent memory impairment in mice","Fidalgo AR, Cibelli M, White JP, Nagy I, Wan Y, Ma D.","Acta Anaesthesiol Scand. 2012 Sep;56(8):1052-7. doi: 10.1111/j.1399-6576.2012.02691.x. Epub 2012 Apr 4.","Fidalgo AR","Acta Anaesthesiol Scand","2012","2012/04/05","","","10.1111/j.1399-6576.2012.02691.x"
"22471668","Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research","Jones HE, Chisolm MS, Jansson LM, Terplan M.","Addiction. 2013 Feb;108(2):233-47. doi: 10.1111/j.1360-0443.2012.03811.x. Epub 2012 Apr 4.","Jones HE","Addiction","2013","2012/04/05","","","10.1111/j.1360-0443.2012.03811.x"
"22469638","Interaction of fentanyl and buprenorphine in an experimental model of pain and central sensitization in human volunteers","Tröster A, Ihmsen H, Singler B, Filitz J, Koppert W.","Clin J Pain. 2012 Oct;28(8):705-11. doi: 10.1097/AJP.0b013e318241d948.","Tröster A","Clin J Pain","2012","2012/04/04","","","10.1097/AJP.0b013e318241d948"
"22468667","The prescribing of buprenorphine by advanced practice addictions nurses","Strobbe S, Hobbins D.","J Addict Nurs. 2012 Feb;23(1):82-3. doi: 10.3109/10884602.2011.649026.","Strobbe S","J Addict Nurs","2012","2012/04/04","","","10.3109/10884602.2011.649026"
"22468666","Buprenorphine prescribing by APRNs","Rundio A.","J Addict Nurs. 2012 Feb;23(1):80-1. doi: 10.3109/10884602.2011.648735.","Rundio A","J Addict Nurs","2012","2012/04/04","","","10.3109/10884602.2011.648735"
"22462186","[Postoperative pain management under epidural analgesia]","Matsunaga M, Wakasaki R, Higa K, Sakurai S, Shono S, Nitahara K.","Masui. 2008 Nov;57 Suppl:S256-63.","Matsunaga M","Masui","2008","2012/04/03","","",""
"22456493","Double successful buprenorphine/naloxone induction to facilitate cardiac transplantation in an iatrogenically opiate-dependent patient","Rodgman C, Pletsch G.","J Addict Med. 2012 Jun;6(2):177-8. doi: 10.1097/ADM.0b013e3182486e44.","Rodgman C","J Addict Med","2012","2012/03/30","","","10.1097/ADM.0b013e3182486e44"
"22452493","Comparison of the analgesic efficacy of oral ABT-116 administration with that of transmucosal buprenorphine administration in dogs","Niyom S, Mama KR, De Rezende ML.","Am J Vet Res. 2012 Apr;73(4):476-81. doi: 10.2460/ajvr.73.4.476.","Niyom S","Am J Vet Res","2012","2012/03/29","","","10.2460/ajvr.73.4.476"
"22448769","Functional imaging of emotion reactivity in opiate-dependent borderline personality disorder","Smoski MJ, Salsman N, Wang L, Smith V, Lynch TR, Dager SR, LaBar KS, Linehan MM.","Personal Disord. 2011 Jul;2(3):230-41. doi: 10.1037/a0022228.","Smoski MJ","Personal Disord","2011","2012/03/28","PMC3555434","NIHMS311275","10.1037/a0022228"
"22443154","Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain","Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R, Kleijnen J.","Curr Med Res Opin. 2012 May;28(5):833-45. doi: 10.1185/03007995.2012.678938. Epub 2012 Apr 25.","Wolff RF","Curr Med Res Opin","2012","2012/03/27","","","10.1185/03007995.2012.678938"
"22432983","Management of opioid substitution therapy during medical intervention","Murnion B.","Intern Med J. 2012 Mar;42(3):242-6. doi: 10.1111/j.1445-5994.2012.02714.x.","Murnion B","Intern Med J","2012","2012/03/22","","","10.1111/j.1445-5994.2012.02714.x"
"22430023","Effect of adjuvant drugs on the action of local anesthetics in isolated rat sciatic nerves","Yilmaz-Rastoder E, Gold MS, Hough KA, Gebhart GF, Williams BA.","Reg Anesth Pain Med. 2012 Jul-Aug;37(4):403-9. doi: 10.1097/AAP.0b013e3182485965.","Yilmaz-Rastoder E","Reg Anesth Pain Med","2012","2012/03/21","PMC3616512","NIHMS453580","10.1097/AAP.0b013e3182485965"
"22429821","Criminal charges prior to and after initiation of office-based buprenorphine treatment","Harris EE, Jacapraro JS, Rastegar DA.","Subst Abuse Treat Prev Policy. 2012 Mar 19;7:10. doi: 10.1186/1747-597X-7-10.","Harris EE","Subst Abuse Treat Prev Policy","2012","2012/03/21","PMC3359252","","10.1186/1747-597X-7-10"
"22428819","In control?: Ukrainian opiate substitution treatment patients strive for a voice in their treatment","Golovanevskaya M, Vlasenko L, Saucier R.","Subst Use Misuse. 2012 Apr;47(5):511-21. doi: 10.3109/10826084.2012.644117.","Golovanevskaya M","Subst Use Misuse","2012","2012/03/21","","","10.3109/10826084.2012.644117"
"22428721","Buprenorphine exposure in infants of opioid-dependent mothers at birth","Bartu AE, Ilett KF, Hackett LP, Doherty DA, Hamilton D.","Aust N Z J Obstet Gynaecol. 2012 Aug;52(4):342-7. doi: 10.1111/j.1479-828X.2012.01424.x. Epub 2012 Mar 19.","Bartu AE","Aust N Z J Obstet Gynaecol","2012","2012/03/21","","","10.1111/j.1479-828X.2012.01424.x"
"22427466","[Changes in psychosocial symptoms of opiate users over six months with buprenorphine/naloxone substitution therapy]","Petke Z, Csorba J, Meszaros J, Vingender I, Farkas J, Demetrovics Z, Kovacs Z, Menczel Z, Pataki Z, Simor P, Havasi A, Melles K, Marvanykovi F, Racz J.","Neuropsychopharmacol Hung. 2012 Mar;14(1):7-17.","Petke Z","Neuropsychopharmacol Hung","2012","2012/03/20","","",""
"22417836","A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse","Melanson SE, Snyder ML, Jarolim P, Flood JG.","J Anal Toxicol. 2012 Apr;36(3):201-6. doi: 10.1093/jat/bks003.","Melanson SE","J Anal Toxicol","2012","2012/03/16","","","10.1093/jat/bks003"
"22409388","A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain","Ripa SR, McCarberg BH, Munera C, Wen W, Landau CJ.","Expert Opin Pharmacother. 2012 Jun;13(9):1229-41. doi: 10.1517/14656566.2012.667073. Epub 2012 Mar 12.","Ripa SR","Expert Opin Pharmacother","2012","2012/03/14","","","10.1517/14656566.2012.667073"
"22404717","Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice","Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G.","Am J Drug Alcohol Abuse. 2012 May;38(3):187-99. doi: 10.3109/00952990.2011.653426. Epub 2012 Mar 12.","Sigmon SC","Am J Drug Alcohol Abuse","2012","2012/03/13","PMC4331107","NIHMS661048","10.3109/00952990.2011.653426"
"22403414","Comparison of two formulations of buprenorphine in cats administered by the oral transmucosal route","Bortolami E, Slingsby L, Love EJ.","J Feline Med Surg. 2012 Aug;14(8):534-9. doi: 10.1177/1098612X12442038. Epub 2012 Mar 8.","Bortolami E","J Feline Med Surg","2012","2012/03/10","","","10.1177/1098612X12442038"
"22396085","Peripartum pain management in opioid dependent women","Höflich AS, Langer M, Jagsch R, Bäwert A, Winklbaur B, Fischer G, Unger A.","Eur J Pain. 2012 Apr;16(4):574-84. doi: 10.1016/j.ejpain.2011.08.008.","Höflich AS","Eur J Pain","2012","2012/03/08","PMC3290684","NIHMS326629","10.1016/j.ejpain.2011.08.008"
"22386182","Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy","Hamza H, Bryson EO.","Mayo Clin Proc. 2012 Mar;87(3):260-7. doi: 10.1016/j.mayocp.2011.09.007.","Hamza H","Mayo Clin Proc","2012","2012/03/06","PMC3538407","","10.1016/j.mayocp.2011.09.007"
"22386175","Opioid-abusing health care professionals: options for treatment and returning to work after treatment","Seppala MD, Oreskovich MR.","Mayo Clin Proc. 2012 Mar;87(3):213-5. doi: 10.1016/j.mayocp.2012.02.002.","Seppala MD","Mayo Clin Proc","2012","2012/03/06","PMC3498284","","10.1016/j.mayocp.2012.02.002"
"22375882","Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome","Pritham UA, Paul JA, Hayes MJ.","J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):180-190. doi: 10.1111/j.1552-6909.2011.01330.x. Epub 2012 Feb 29.","Pritham UA","J Obstet Gynecol Neonatal Nurs","2012","2012/03/02","PMC3407283","NIHMS373433","10.1111/j.1552-6909.2011.01330.x"
"22370011","""Subutex is safe"": perceptions of risk in using illicit drugs during pregnancy","Leppo A.","Int J Drug Policy. 2012 Sep;23(5):365-73. doi: 10.1016/j.drugpo.2012.01.004. Epub 2012 Feb 26.","Leppo A","Int J Drug Policy","2012","2012/02/29","","","10.1016/j.drugpo.2012.01.004"
"22369187","Buprenorphine 5, 10 and 20 μg/h transdermal patch: a guide to its use in chronic non-malignant pain","Plosker GL, Lyseng-Williamson KA.","CNS Drugs. 2012 Apr 1;26(4):367-73. doi: 10.2165/11208360-000000000-00000.","Plosker GL","CNS Drugs","2012","2012/02/29","","","10.2165/11208360-000000000-00000"
"22369095","Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients","Coller JK, Michalakas JR, James HM, Farquharson AL, Colvill J, White JM, Somogyi AA.","Br J Clin Pharmacol. 2012 Nov;74(5):835-41. doi: 10.1111/j.1365-2125.2012.04256.x.","Coller JK","Br J Clin Pharmacol","2012","2012/02/29","PMC3495148","","10.1111/j.1365-2125.2012.04256.x"
"22367499","Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians","Edelman EJ, Dinh AT, Moore BA, Schottenfeld RS, Fiellin DA, Sullivan LE.","J Addict Med. 2012 Jun;6(2):159-65. doi: 10.1097/ADM.0b013e31824339fc.","Edelman EJ","J Addict Med","2012","2012/02/28","PMC3447983","NIHMS399281","10.1097/ADM.0b013e31824339fc"
"22361364","Effects of thienorphine on release of dopamine and noradrenalin: an in vivo microdialysis study in rats","Yong Z, Yan L, Zhou P, Yu G, Dong H, Gong Z.","Neurosci Lett. 2012 Apr 4;513(2):132-6. doi: 10.1016/j.neulet.2012.02.013. Epub 2012 Feb 14.","Yong Z","Neurosci Lett","2012","2012/02/25","","","10.1016/j.neulet.2012.02.013"
"22356665","Effect of buprenorphine dose on treatment outcome","Fareed A, Vayalapalli S, Casarella J, Drexler K.","J Addict Dis. 2012;31(1):8-18. doi: 10.1080/10550887.2011.642758.","Fareed A","J Addict Dis","2012","2012/02/24","","","10.1080/10550887.2011.642758"
"22356664","The emerging buprenorphine epidemic in the United States","Wish ED, Artigiani E, Billing A, Hauser W, Hemberg J, Shiplet M, DuPont RL.","J Addict Dis. 2012;31(1):3-7. doi: 10.1080/10550887.2011.642757.","Wish ED","J Addict Dis","2012","2012/02/24","","","10.1080/10550887.2011.642757"
"22356663","Buprenorphine in the treatment of heroin addiction: déjà vu all over again","Stimmel B.","J Addict Dis. 2012;31(1):1-2. doi: 10.1080/10550887.2011.643179.","Stimmel B","J Addict Dis","2012","2012/02/24","","","10.1080/10550887.2011.643179"
"22354163","Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics","Baewert A, Jagsch R, Winklbaur B, Kaiser G, Thau K, Unger A, Aschauer C, Weninger M, Metz V.","Eur Addict Res. 2012;18(3):130-9. doi: 10.1159/000335082. Epub 2012 Feb 21.","Baewert A","Eur Addict Res","2012","2012/02/23","PMC3696360","","10.1159/000335082"
"22348921","The effect of telephonic patient support on treatment for opioid dependence: outcomes at one year follow-up","Ruetsch C, Tkacz J, McPherson TL, Cacciola J.","Addict Behav. 2012 May;37(5):686-9. doi: 10.1016/j.addbeh.2012.01.013. Epub 2012 Jan 25.","Ruetsch C","Addict Behav","2012","2012/02/22","","","10.1016/j.addbeh.2012.01.013"
"22337776","Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry","McMillin GA, Davis R, Carlisle H, Clark C, Marin SJ, Moody DE.","J Anal Toxicol. 2012 Mar;36(2):81-7. doi: 10.1093/jat/bkr020.","McMillin GA","J Anal Toxicol","2012","2012/02/17","","","10.1093/jat/bkr020"
"22335489","Unplanned pregnancy and contraceptive use in women attending drug treatment services","Black KI, Stephens C, Haber PS, Lintzeris N.","Aust N Z J Obstet Gynaecol. 2012 Apr;52(2):146-50. doi: 10.1111/j.1479-828X.2012.01413.x. Epub 2012 Feb 15.","Black KI","Aust N Z J Obstet Gynaecol","2012","2012/02/17","","","10.1111/j.1479-828X.2012.01413.x"
"22331325","[Clinical usability and practicability of Alfaxalone for short-term anaesthesia in the cat after premedication with Buprenorphine]","Bösing B, Tünsmeyer J, Mischke R, Beyerbach M, Kästner SB.","Tierarztl Prax Ausg K Kleintiere Heimtiere. 2012;40(1):17-25.","Bösing B","Tierarztl Prax Ausg K Kleintiere Heimtiere","2012","2012/02/15","","",""
"22330867","Using the Mouse Grimace Scale to reevaluate the efficacy of postoperative analgesics in laboratory mice","Matsumiya LC, Sorge RE, Sotocinal SG, Tabaka JM, Wieskopf JS, Zaloum A, King OD, Mogil JS.","J Am Assoc Lab Anim Sci. 2012 Jan;51(1):42-9.","Matsumiya LC","J Am Assoc Lab Anim Sci","2012","2012/02/15","PMC3276965","",""
"22301084","Comparing buprenorphine induction experience with heroin and prescription opioid users","Nielsen S, Hillhouse M, Mooney L, Fahey J, Ling W.","J Subst Abuse Treat. 2012 Oct;43(3):285-90. doi: 10.1016/j.jsat.2011.12.009. Epub 2012 Feb 1.","Nielsen S","J Subst Abuse Treat","2012","2012/02/04","PMC3350757","NIHMS346485","10.1016/j.jsat.2011.12.009"
"22285736","Comments on the article by Conaghan et al","Endenburg S, Konings S, Verkleij SP.","Osteoarthritis Cartilage. 2012 Apr;20(4):336; author reply 337-8. doi: 10.1016/j.joca.2011.11.018. Epub 2012 Jan 12.","Endenburg S","Osteoarthritis Cartilage","2012","2012/01/31","","","10.1016/j.joca.2011.11.018"
"22284835","Premorbid and current neuropsychological function in opiate abusers receiving treatment","Pluck G, Lee KH, Rele R, Spence SA, Sarkar S, Lagundoye O, Parks RW.","Drug Alcohol Depend. 2012 Jul 1;124(1-2):181-4. doi: 10.1016/j.drugalcdep.2012.01.001. Epub 2012 Jan 28.","Pluck G","Drug Alcohol Depend","2012","2012/01/31","","","10.1016/j.drugalcdep.2012.01.001"
"22281215","Simultaneous analysis of some club drugs in whole blood using solid phase extraction and gas chromatography-mass spectrometry","Castro AL, Tarelho S, Silvestre A, Teixeira HM.","J Forensic Leg Med. 2012 Feb;19(2):77-82. doi: 10.1016/j.jflm.2011.12.006. Epub 2012 Jan 4.","Castro AL","J Forensic Leg Med","2012","2012/01/28","","","10.1016/j.jflm.2011.12.006"
"22280332","Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives","Mannelli P, Peindl KS, Lee T, Bhatia KS, Wu LT.","Curr Drug Abuse Rev. 2012 Mar;5(1):52-63. doi: 10.2174/1874473711205010052.","Mannelli P","Curr Drug Abuse Rev","2012","2012/01/28","PMC3496559","NIHMS412595","10.2174/1874473711205010052"
"22267618","Update on the clinical use of buprenorphine: in opioid-related disorders","Ducharme S, Fraser R, Gill K.","Can Fam Physician. 2012 Jan;58(1):37-41.","Ducharme S","Can Fam Physician","2012","2012/01/24","PMC3264008","",""
"22263716","Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access","Trigg BG, Dickman SL.","Subst Abus. 2012;33(1):76-84. doi: 10.1080/08897077.2011.611455.","Trigg BG","Subst Abus","2012","2012/01/24","","","10.1080/08897077.2011.611455"
"22263715","Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort","Harris A, Selling D, Luther C, Hershberger J, Brittain J, Dickman S, Glick A, Lee JD.","Subst Abus. 2012;33(1):70-5. doi: 10.1080/08897077.2011.620479.","Harris A","Subst Abus","2012","2012/01/24","","","10.1080/08897077.2011.620479"
"22263714","Assessing need for medication-assisted treatment for opiate-dependent prison inmates","Albizu-García CE, Caraballo JN, Caraballo-Correa G, Hernández-Viver A, Román-Badenas L.","Subst Abus. 2012;33(1):60-9. doi: 10.1080/08897077.2011.620462.","Albizu-García CE","Subst Abus","2012","2012/01/24","PMC3372322","NIHMS359081","10.1080/08897077.2011.620462"
"22263712","Buprenorphine-naloxone maintenance following release from jail","Lee JD, Grossman E, Truncali A, Rotrosen J, Rosenblum A, Magura S, Gourevitch MN.","Subst Abus. 2012;33(1):40-7. doi: 10.1080/08897077.2011.620475.","Lee JD","Subst Abus","2012","2012/01/24","PMC3310898","NIHMS359083","10.1080/08897077.2011.620475"
"22263709","Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions","Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O'Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK; Mat Working Group Of CJ-Dats.","Subst Abus. 2012;33(1):9-18. doi: 10.1080/08897077.2011.611460.","Friedmann PD","Subst Abus","2012","2012/01/24","PMC3295578","NIHMS359080","10.1080/08897077.2011.611460"
"22261004","Effects of lidocaine constant rate infusion on sevoflurane requirement, autonomic responses, and postoperative analgesia in dogs undergoing ovariectomy under opioid-based balanced anesthesia","Columbano N, Secci F, Careddu GM, Sotgiu G, Rossi G, Driessen B.","Vet J. 2012 Aug;193(2):448-55. doi: 10.1016/j.tvjl.2011.12.005. Epub 2012 Jan 17.","Columbano N","Vet J","2012","2012/01/21","","","10.1016/j.tvjl.2011.12.005"
"22256949","The history of the development of buprenorphine as an addiction therapeutic","Campbell ND, Lovell AM.","Ann N Y Acad Sci. 2012 Feb;1248:124-39. doi: 10.1111/j.1749-6632.2011.06352.x. Epub 2012 Jan 18.","Campbell ND","Ann N Y Acad Sci","2012","2012/01/20","","","10.1111/j.1749-6632.2011.06352.x"
"22242643","A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients","Kelly SM, Brown BS, Katz EC, O'Grady KE, Mitchell SG, King S, Schwartz RP.","Am J Drug Alcohol Abuse. 2012 May;38(3):233-8. doi: 10.3109/00952990.2011.643983. Epub 2012 Jan 13.","Kelly SM","Am J Drug Alcohol Abuse","2012","2012/01/17","PMC4230528","NIHMS640002","10.3109/00952990.2011.643983"
"22242248","[Methadone and buprenorphine--attractive on the street and outside treatment programs]","Johnson B.","Lakartidningen. 2011 Oct 9-15;108(45):2309-11.","Johnson B","Lakartidningen","2011","2012/01/17","","",""
"22238292","Premedication with meloxicam exacerbates intracranial haemorrhage in an immature swine model of non-impact inertial head injury","Friess SH, Naim MY, Kilbaugh TJ, Ralston J, Margulies SS.","Lab Anim. 2012 Apr;46(2):164-6. doi: 10.1258/la.2011.011084. Epub 2012 Jan 11.","Friess SH","Lab Anim","2012","2012/01/13","PMC3971837","NIHMS565309","10.1258/la.2011.011084"
"22233471","Systemic contact dermatitis following oral exposure to tramadol in a patient with allergic contact dermatitis caused by buprenorphine","Kaae J, Menné T, Thyssen JP.","Contact Dermatitis. 2012 Feb;66(2):106-7. doi: 10.1111/j.1600-0536.2011.01981.x.","Kaae J","Contact Dermatitis","2012","2012/01/12","","","10.1111/j.1600-0536.2011.01981.x"
"22227786","Neonatal abstinence syndrome","Jansson LM, Velez M.","Curr Opin Pediatr. 2012 Apr;24(2):252-8. doi: 10.1097/MOP.0b013e32834fdc3a.","Jansson LM","Curr Opin Pediatr","2012","2012/01/10","","","10.1097/MOP.0b013e32834fdc3a"
"22220585","Personality differences between drug injectors and non-injectors among substance-dependent patients in substitution treatment","Saint-Lèbes J, Rodgers R, Birmes P, Schmitt L.","Am J Drug Alcohol Abuse. 2012 Mar;38(2):135-9. doi: 10.3109/00952990.2011.643982. Epub 2012 Jan 5.","Saint-Lèbes J","Am J Drug Alcohol Abuse","2012","2012/01/07","","","10.3109/00952990.2011.643982"
"22216993","Use and misuse of opioid replacement therapies: a Queensland study","Smirnov A, Kemp R.","Subst Use Misuse. 2012 Jan;47(1):78-85. doi: 10.3109/10826084.2011.629017.","Smirnov A","Subst Use Misuse","2012","2012/01/06","","","10.3109/10826084.2011.629017"
"22215271","Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care","Schackman BR, Leff JA, Polsky D, Moore BA, Fiellin DA.","J Gen Intern Med. 2012 Jun;27(6):669-76. doi: 10.1007/s11606-011-1962-8. Epub 2012 Jan 4.","Schackman BR","J Gen Intern Med","2012","2012/01/05","PMC3358393","","10.1007/s11606-011-1962-8"
"22211347","Compliance with buprenorphine medication-assisted treatment and relapse to opioid use","Tkacz J, Severt J, Cacciola J, Ruetsch C.","Am J Addict. 2012 Jan-Feb;21(1):55-62. doi: 10.1111/j.1521-0391.2011.00186.x. Epub 2011 Nov 18.","Tkacz J","Am J Addict","2012","2012/01/04","","","10.1111/j.1521-0391.2011.00186.x"
"22207722","Assessment of locomotion in chlorine exposed mice by computer vision and neural networks","Filippidis AS, Zarogiannis SG, Randich A, Ness TJ, Matalon S.","J Appl Physiol (1985). 2012 Mar;112(6):1064-72. doi: 10.1152/japplphysiol.01023.2011. Epub 2011 Dec 29.","Filippidis AS","J Appl Physiol (1985)","2012","2011/12/31","PMC3311652","","10.1152/japplphysiol.01023.2011"
"22198453","Actigraphic measurements in opioid detoxification with methadone or buprenorphine","Pjrek E, Frey R, Naderi-Heiden A, Strnad A, Kowarik A, Kasper S, Winkler D.","J Clin Psychopharmacol. 2012 Feb;32(1):75-82. doi: 10.1097/JCP.0b013e31823f91d1.","Pjrek E","J Clin Psychopharmacol","2012","2011/12/27","","","10.1097/JCP.0b013e31823f91d1"
"22196236","Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neurons","Brailoiu GC, Deliu E, Hooper R, Dun NJ, Undieh AS, Adler MW, Benamar K, Brailoiu E.","Drug Alcohol Depend. 2012 Jun 1;123(1-3):277-81. doi: 10.1016/j.drugalcdep.2011.11.021. Epub 2011 Dec 21.","Brailoiu GC","Drug Alcohol Depend","2012","2011/12/27","PMC3321394","NIHMS346300","10.1016/j.drugalcdep.2011.11.021"
"22186079","[Severe distal ischemic syndrome after buprenorphine volunteer intra-arterial injection]","Glaizal M, Lucciardi J, Tichadou L, Spadari M, Hayek-Lanthois M, Micallef J, de Haro L.","Therapie. 2011 Nov-Dec;66(6):545-7. doi: 10.2515/therapie/2011069. Epub 2011 Dec 21.","Glaizal M","Therapie","2011","2011/12/22","","","10.2515/therapie/2011069"
"22175698","Treatment outcome for flexible dosing buprenorphine maintenance treatment","Fareed A, Vayalapalli S, Casarella J, Drexler K.","Am J Drug Alcohol Abuse. 2012 Mar;38(2):155-60. doi: 10.3109/00952990.2011.643988. Epub 2011 Dec 19.","Fareed A","Am J Drug Alcohol Abuse","2012","2011/12/20","","","10.3109/00952990.2011.643988"
"22156892","A double-blind, placebo-controlled study on the effect of buprenorphine and fentanyl on descending pain modulation: a human experimental study","Arendt-Nielsen L, Andresen T, Malver LP, Oksche A, Mansikka H, Drewes AM.","Clin J Pain. 2012 Sep;28(7):623-7. doi: 10.1097/AJP.0b013e31823e15cb.","Arendt-Nielsen L","Clin J Pain","2012","2011/12/14","","","10.1097/AJP.0b013e31823e15cb"
"22148986","Is maternal opioid use hazardous to breast-fed infants?","Hendrickson RG, McKeown NJ.","Clin Toxicol (Phila). 2012 Jan;50(1):1-14. doi: 10.3109/15563650.2011.635147. Epub 2011 Dec 13.","Hendrickson RG","Clin Toxicol (Phila)","2012","2011/12/14","","","10.3109/15563650.2011.635147"
"22141389","Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain","Plosker GL.","Drugs. 2011 Dec 24;71(18):2491-509. doi: 10.2165/11208250-000000000-00000.","Plosker GL","Drugs","2011","2011/12/07","","","10.2165/11208250-000000000-00000"
"22137646","Motivational assessment of non-treatment buprenorphine research participation in heroin dependent individuals","Papke G, Greenwald MK.","Drug Alcohol Depend. 2012 Jun 1;123(1-3):173-9. doi: 10.1016/j.drugalcdep.2011.11.005. Epub 2011 Dec 2.","Papke G","Drug Alcohol Depend","2012","2011/12/06","PMC3306501","NIHMS343113","10.1016/j.drugalcdep.2011.11.005"
"22137413","Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial","Wright NM, Sheard L, Adams CE, Rushforth BJ, Harrison W, Bound N, Hart R, Tompkins CN.","Br J Gen Pract. 2011 Dec;61(593):e772-80. doi: 10.3399/bjgp11X613106.","Wright NM","Br J Gen Pract","2011","2011/12/06","PMC3223774","","10.3399/bjgp11X613106"
"22137383","New approaches to dealing with opioid drug dependence","Rushforth BJ, Wright NM.","Br J Gen Pract. 2011 Dec;61(593):710-1. doi: 10.3399/bjgp11X612927.","Rushforth BJ","Br J Gen Pract","2011","2011/12/06","PMC3223744","","10.3399/bjgp11X612927"
"22135922","Determination of an optimal dose of medetomidine-ketamine-buprenorphine for anaesthesia in the Cape ground squirrel (Xerus inauris)","Jouber KE, Serfontein T, Scantlebury M, Manjerovice MB, Bateman PW, Bennett NC, Waterman JM.","J S Afr Vet Assoc. 2011 Jun;82(2):94-6. doi: 10.4102/jsava.v82i2.41.","Jouber KE","J S Afr Vet Assoc","2011","2011/12/06","","","10.4102/jsava.v82i2.41"
"22119647","Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine","Upadhyay J, Anderson J, Baumgartner R, Coimbra A, Schwarz AJ, Pendse G, Wallin D, Nutile L, Bishop J, George E, Elman I, Sunkaraneni S, Maier G, Iyengar S, Evelhoch JL, Bleakman D, Hargreaves R, Becerra L, Borsook D.","Neuroimage. 2012 Feb 15;59(4):3762-73. doi: 10.1016/j.neuroimage.2011.11.034. Epub 2011 Nov 18.","Upadhyay J","Neuroimage","2012","2011/11/29","","","10.1016/j.neuroimage.2011.11.034"
"22115887","Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors","Oliva EM, Harris AH, Trafton JA, Gordon AJ.","Drug Alcohol Depend. 2012 May 1;122(3):241-6. doi: 10.1016/j.drugalcdep.2011.10.004. Epub 2011 Nov 23.","Oliva EM","Drug Alcohol Depend","2012","2011/11/26","","","10.1016/j.drugalcdep.2011.10.004"
"22115823","Sublingual buprenorphine in acute pain management: a double-blind randomized clinical trial","Jalili M, Fathi M, Moradi-Lakeh M, Zehtabchi S.","Ann Emerg Med. 2012 Apr;59(4):276-80. doi: 10.1016/j.annemergmed.2011.10.021. Epub 2011 Nov 23.","Jalili M","Ann Emerg Med","2012","2011/11/26","","","10.1016/j.annemergmed.2011.10.021"
"22109894","Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey","Nordmann S, Frauger E, Pauly V, Orléans V, Pradel V, Mallaret M, Thirion X, Micallef J.","Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):184-90. doi: 10.1002/pds.2263. Epub 2011 Nov 23.","Nordmann S","Pharmacoepidemiol Drug Saf","2012","2011/11/24","","","10.1002/pds.2263"
"22107875","Improvement in psychopathology among opioid-dependent adolescents during behavioral-pharmacological treatment","Moore SK, Marsch LA, Badger GJ, Solhkhah R, Hofstein Y.","J Addict Med. 2011 Dec;5(4):264-71. doi: 10.1097/ADM.0b013e3182191099.","Moore SK","J Addict Med","2011","2011/11/24","PMC3223378","NIHMS287656","10.1097/ADM.0b013e3182191099"
"22105061","Comparison of buprenorphine treatment for opioid dependence in 3 settings","Miotto K, Hillhouse M, Donovick R, Cunningham-Rathner J, Charuvastra C, Torrington M, Esagoff AE, Ling W.","J Addict Med. 2012 Mar;6(1):68-76. doi: 10.1097/ADM.0b013e318233d621.","Miotto K","J Addict Med","2012","2011/11/23","PMC3276753","NIHMS326900","10.1097/ADM.0b013e318233d621"
"22104480","Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study","Corsenac P, Lagarde E, Gadegbeku B, Delorme B, Tricotel A, Castot A, Moore N, Philip P, Laumon B, Orriols L.","Drug Alcohol Depend. 2012 Jun 1;123(1-3):91-7. doi: 10.1016/j.drugalcdep.2011.10.022. Epub 2011 Nov 21.","Corsenac P","Drug Alcohol Depend","2012","2011/11/23","","","10.1016/j.drugalcdep.2011.10.022"
"22100576","Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir","Gruber VA, Rainey PM, Moody DE, Morse GD, Ma Q, Prathikanti S, Pade PA, Alvanzo AA, McCance-Katz EF.","Clin Infect Dis. 2012 Feb 1;54(3):414-23. doi: 10.1093/cid/cir799. Epub 2011 Nov 18.","Gruber VA","Clin Infect Dis","2012","2011/11/22","PMC3258270","","10.1093/cid/cir799"
"22093488","The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone","Stein BD, Gordon AJ, Sorbero M, Dick AW, Schuster J, Farmer C.","Drug Alcohol Depend. 2012 Jun 1;123(1-3):72-8. doi: 10.1016/j.drugalcdep.2011.10.016. Epub 2011 Nov 16.","Stein BD","Drug Alcohol Depend","2012","2011/11/19","","","10.1016/j.drugalcdep.2011.10.016"
"22092357","Low-dose transdermal buprenorphine - long-term use and co-medication with other potentially addictive drugs","Nordbø A, Skurtveit S, Borchgrevink PC, Kaasa S, Fredheim OM.","Acta Anaesthesiol Scand. 2012 Jan;56(1):88-94. doi: 10.1111/j.1399-6576.2011.02537.x. Epub 2011 Oct 14.","Nordbø A","Acta Anaesthesiol Scand","2012","2011/11/19","","","10.1111/j.1399-6576.2011.02537.x"
"22092298","Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects","Gelston EA, Coller JK, Lopatko OV, James HM, Schmidt H, White JM, Somogyi AA.","Br J Clin Pharmacol. 2012 May;73(5):786-94. doi: 10.1111/j.1365-2125.2011.04145.x.","Gelston EA","Br J Clin Pharmacol","2012","2011/11/19","PMC3403206","","10.1111/j.1365-2125.2011.04145.x"
"22091732","Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide","Ruger JP, Chawarski M, Mazlan M, Luekens C, Ng N, Schottenfeld R.","Health Serv Res. 2012 Apr;47(2):865-87. doi: 10.1111/j.1475-6773.2011.01335.x. Epub 2011 Oct 18.","Ruger JP","Health Serv Res","2012","2011/11/19","PMC3419893","","10.1111/j.1475-6773.2011.01335.x"
"22088886","Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?","Unger A, Jagsch R, Bäwert A, Winklbaur B, Rohrmeister K, Martin PR, Coyle M, Fischer G.","Gend Med. 2011 Dec;8(6):355-64. doi: 10.1016/j.genm.2011.10.001. Epub 2011 Nov 15.","Unger A","Gend Med","2011","2011/11/18","PMC3241965","NIHMS339316","10.1016/j.genm.2011.10.001"
"22087721","Evaluation of dexmedetomidine and ketamine in combination with various opioids as injectable anesthetic combinations for castration in cats","Ko JC, Austin BR, Barletta M, Weil AB, Krimins RA, Payton ME.","J Am Vet Med Assoc. 2011 Dec 1;239(11):1453-62. doi: 10.2460/javma.239.11.1453.","Ko JC","J Am Vet Med Assoc","2011","2011/11/18","","","10.2460/javma.239.11.1453"
"22086665","Medication-assisted treatment research with criminal justice populations: challenges of implementation","Gordon MS, Kinlock TW, Miller PM.","Behav Sci Law. 2011 Nov-Dec;29(6):829-45. doi: 10.1002/bsl.1015.","Gordon MS","Behav Sci Law","2011","2011/11/17","PMC3243915","NIHMS341354","10.1002/bsl.1015"
"22079577","The opiate analgesic buprenorphine decreases proliferation of adult hippocampal neuroblasts and increases survival of their progeny","Pettit AS, Desroches R, Bennett SA.","Neuroscience. 2012 Jan 3;200:211-22. doi: 10.1016/j.neuroscience.2011.10.039. Epub 2011 Oct 30.","Pettit AS","Neuroscience","2012","2011/11/15","","","10.1016/j.neuroscience.2011.10.039"
"22065255","Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W.","Arch Gen Psychiatry. 2011 Dec;68(12):1238-46. doi: 10.1001/archgenpsychiatry.2011.121. Epub 2011 Nov 7.","Weiss RD","Arch Gen Psychiatry","2011","2011/11/09","PMC3470422","NIHMS307513","10.1001/archgenpsychiatry.2011.121"
"22060728","Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy","Trautmann S, Wittchen HU.","Subst Use Misuse. 2012 Jan;47(1):22-30. doi: 10.3109/10826084.2011.620052. Epub 2011 Nov 7.","Trautmann S","Subst Use Misuse","2012","2011/11/09","","","10.3109/10826084.2011.620052"
"22056203","Interactions among benzodiazepine and buprenorphine/naloxone","Yuan W, Williams BN.","J Emerg Nurs. 2012 Jan;38(1):5-6. doi: 10.1016/j.jen.2011.08.010. Epub 2011 Nov 4.","Yuan W","J Emerg Nurs","2012","2011/11/08","","","10.1016/j.jen.2011.08.010"
"22047817","Effects of sedation with acepromazine maleate and buprenorphine hydrochloride on femoral artery blood flow in healthy dogs","Nogueira RB, Fernández del Palacio MJ, López JT, Resende RM.","Res Vet Sci. 2012 Oct;93(2):989-92. doi: 10.1016/j.rvsc.2011.10.004. Epub 2011 Nov 1.","Nogueira RB","Res Vet Sci","2012","2011/11/04","","","10.1016/j.rvsc.2011.10.004"
"22042215","Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction","Kraus ML, Alford DP, Kotz MM, Levounis P, Mandell TW, Meyer M, Salsitz EA, Wetterau N, Wyatt SA; American Society Of Addiction Medicine.","J Addict Med. 2011 Dec;5(4):254-63. doi: 10.1097/ADM.0b013e3182312983.","Kraus ML","J Addict Med","2011","2011/11/02","","","10.1097/ADM.0b013e3182312983"
"22037640","Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active","Brown SM, Holtzman M, Kim T, Kharasch ED.","Anesthesiology. 2011 Dec;115(6):1251-60. doi: 10.1097/ALN.0b013e318238fea0.","Brown SM","Anesthesiology","2011","2011/11/01","PMC3560935","NIHMS333891","10.1097/ALN.0b013e318238fea0"
"22036303","Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids","Daniulaityte R, Falck R, Carlson RG.","Drug Alcohol Depend. 2012 May 1;122(3):201-7. doi: 10.1016/j.drugalcdep.2011.09.029. Epub 2011 Oct 28.","Daniulaityte R","Drug Alcohol Depend","2012","2011/11/01","PMC3293107","NIHMS336546","10.1016/j.drugalcdep.2011.09.029"
"22033233","Additional explanation for lack of pharmacodynamic interaction between atazanavir and buprenorphine reported by Vergara-Rodriquez et al","Bruce RD.","J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):e112; author reply e112-3. doi: 10.1097/QAI.0b013e31822c1d28.","Bruce RD","J Acquir Immune Defic Syndr","2011","2011/10/29","","","10.1097/QAI.0b013e31822c1d28"
"22030474","Buprenorphine in combination with naloxone at a ratio of 15:1 does not enhance antinociception from buprenorphine in healthy cats","Slingsby LS, Murrell JC, Taylor PM.","Vet J. 2012 Jun;192(3):523-4. doi: 10.1016/j.tvjl.2011.09.008. Epub 2011 Oct 24.","Slingsby LS","Vet J","2012","2011/10/28","","","10.1016/j.tvjl.2011.09.008"
"22030204","Buprenorphine/naloxone inhibition of remifentanil procedural sedation","Gilmore T, Saccheti A, Cortese T.","Am J Emerg Med. 2012 Oct;30(8):1655.e3-4. doi: 10.1016/j.ajem.2011.07.024. Epub 2011 Oct 24.","Gilmore T","Am J Emerg Med","2012","2011/10/28","","","10.1016/j.ajem.2011.07.024"
"22026524","Attitudes toward evidence-based pharmacological treatments among community-based addiction treatment programs targeting vulnerable patient groups","Krull I, Lundgren L, Zerden Lde S.","J Addict Dis. 2011 Oct;30(4):323-33. doi: 10.1080/10550887.2011.609808.","Krull I","J Addict Dis","2011","2011/10/27","","","10.1080/10550887.2011.609808"
"22026523","Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy","Newman RG, Gevertz SG.","J Addict Dis. 2011 Oct;30(4):318-22. doi: 10.1080/10550887.2011.609806.","Newman RG","J Addict Dis","2011","2011/10/27","","","10.1080/10550887.2011.609806"
"22026126","Effects of gamma-irradiation on PLGA microspheres loaded with thienorphine","Yang Y, Gao Y, Mei X.","Pharmazie. 2011 Sep;66(9):694-7.","Yang Y","Pharmazie","2011","2011/10/27","","",""
"22024000","Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth","Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff B, Trivedi M, Weiss R, Potter J, Poole SA, Woody GE.","J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1120-8. doi: 10.1016/j.jaac.2011.07.010.","Subramaniam GA","J Am Acad Child Adolesc Psychiatry","2011","2011/10/26","PMC3786351","NIHMS501645","10.1016/j.jaac.2011.07.010"
"22014257","A case series of buprenorphine/naloxone treatment in a primary care practice","Doolittle B, Becker W.","Subst Abus. 2011 Oct;32(4):262-5. doi: 10.1080/08897077.2011.599256.","Doolittle B","Subst Abus","2011","2011/10/22","","","10.1080/08897077.2011.599256"
"22011128","Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment","Ilett KF, Hackett LP, Gower S, Doherty DA, Hamilton D, Bartu AE.","Breastfeed Med. 2012 Aug;7:269-74. doi: 10.1089/bfm.2011.0096. Epub 2011 Oct 19.","Ilett KF","Breastfeed Med","2012","2011/10/21","","","10.1089/bfm.2011.0096"
"22002899","Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy","Eschenroeder AC, Vestal-Laborde AA, Sanchez ES, Robinson SE, Sato-Bigbee C.","Glia. 2012 Jan;60(1):125-36. doi: 10.1002/glia.21253. Epub 2011 Oct 14.","Eschenroeder AC","Glia","2012","2011/10/18","PMC3217102","NIHMS326977","10.1002/glia.21253"
"22001981","Transdermal buprenorphine in the treatment of cancer and non-cancer pain - the results of multicenter studies in Poland","Przeklasa-Muszyńska A, Dobrogowski J.","Pharmacol Rep. 2011;63(4):935-48. doi: 10.1016/s1734-1140(11)70609-0.","Przeklasa-Muszyńska A","Pharmacol Rep","2011","2011/10/18","","","10.1016/s1734-1140(11)70609-0"
"22000601","Studying up harm reduction policy: the office as an assemblage","Chen JS.","Int J Drug Policy. 2011 Nov;22(6):471-7. doi: 10.1016/j.drugpo.2011.08.008. Epub 2011 Oct 13.","Chen JS","Int J Drug Policy","2011","2011/10/18","PMC7126114","","10.1016/j.drugpo.2011.08.008"
"21988814","A study to evaluate buprenorphine at 40 μg kg(-1) compared to 20 μg kg(-1) as a post-operative analgesic in the dog","Slingsby LS, Taylor PM, Murrell JC.","Vet Anaesth Analg. 2011 Nov;38(6):584-93. doi: 10.1111/j.1467-2995.2011.00656.x.","Slingsby LS","Vet Anaesth Analg","2011","2011/10/13","","","10.1111/j.1467-2995.2011.00656.x"
"21987030","Health-related quality of life changes associated with buprenorphine treatment for opioid dependence","Raisch DW, Campbell HM, Garnand DA, Jones MA, Sather MR, Naik R, Ling W.","Qual Life Res. 2012 Sep;21(7):1177-83. doi: 10.1007/s11136-011-0027-0. Epub 2011 Oct 11.","Raisch DW","Qual Life Res","2012","2011/10/12","PMC4153754","NIHMS619954","10.1007/s11136-011-0027-0"
"21970125","Acute pain management in opioid-tolerant patients: a growing challenge","Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE.","Anaesth Intensive Care. 2011 Sep;39(5):804-23. doi: 10.1177/0310057X1103900505.","Huxtable CA","Anaesth Intensive Care","2011","2011/10/06","","","10.1177/0310057X1103900505"
"21969026","[Breast feeding during methadon- and buprenorphin therapy]","Müller MJ, Lange M, Paul T, Seeliger S.","Klin Padiatr. 2011 Dec;223(7):408-13. doi: 10.1055/s-0031-1283193. Epub 2011 Sep 26.","Müller MJ","Klin Padiatr","2011","2011/10/05","","","10.1055/s-0031-1283193"
"21967467","Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres","Yang Y, Gao Y, Mei X.","Pharm Dev Technol. 2013 Sep-Oct;18(5):1169-74. doi: 10.3109/10837450.2011.618948. Epub 2011 Oct 4.","Yang Y","Pharm Dev Technol","2013","2011/10/05","","","10.3109/10837450.2011.618948"
"21962726","African American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patients","Mitchell SG, Kelly SM, Gryczynski J, Myers CP, Jaffe JH, O'Grady KE, Olsen YK, Schwartz RP.","Drug Alcohol Depend. 2012 Apr 1;122(1-2):55-60. doi: 10.1016/j.drugalcdep.2011.09.009. Epub 2011 Sep 29.","Mitchell SG","Drug Alcohol Depend","2012","2011/10/04","PMC3251709","NIHMS325416","10.1016/j.drugalcdep.2011.09.009"
"21956617","Commercial factors override science in combination addiction drug trial","Byrne A.","Clin Pharmacol Ther. 2011 Nov;90(5):649; author reply 650. doi: 10.1038/clpt.2011.166. Epub 2011 Sep 28.","Byrne A","Clin Pharmacol Ther","2011","2011/09/30","","","10.1038/clpt.2011.166"
"21956081","Additives to local anesthetics for peripheral nerve blockade","Brummett CM, Williams BA.","Int Anesthesiol Clin. 2011 Fall;49(4):104-16. doi: 10.1097/AIA.0b013e31820e4a49.","Brummett CM","Int Anesthesiol Clin","2011","2011/09/30","PMC3427651","NIHMS398160","10.1097/AIA.0b013e31820e4a49"
"21955033","The effectiveness of opioid maintenance treatment in prison settings: a systematic review","Hedrich D, Alves P, Farrell M, Stöver H, Møller L, Mayet S.","Addiction. 2012 Mar;107(3):501-17. doi: 10.1111/j.1360-0443.2011.03676.x.","Hedrich D","Addiction","2012","2011/09/30","","","10.1111/j.1360-0443.2011.03676.x"
"21948099","Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?","Blum K, Chen TJ, Bailey J, Bowirrat A, Femino J, Chen AL, Simpatico T, Morse S, Giordano J, Damle U, Kerner M, Braverman ER, Fornari F, Downs BW, Rector C, Barh D, Oscar-Berman M.","Mol Neurobiol. 2011 Dec;44(3):250-68. doi: 10.1007/s12035-011-8206-0. Epub 2011 Sep 24.","Blum K","Mol Neurobiol","2011","2011/09/28","PMC3682495","NIHMS470220","10.1007/s12035-011-8206-0"
"21945130","Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study","Steiner DJ, Sitar S, Wen W, Sawyerr G, Munera C, Ripa SR, Landau C.","J Pain Symptom Manage. 2011 Dec;42(6):903-17. doi: 10.1016/j.jpainsymman.2011.04.006. Epub 2011 Sep 25.","Steiner DJ","J Pain Symptom Manage","2011","2011/09/28","","","10.1016/j.jpainsymman.2011.04.006"
"21940134","Outcome of heroin-dependent adolescents presenting for opiate substitution treatment","Smyth BP, Fagan J, Kernan K.","J Subst Abuse Treat. 2012 Jan;42(1):35-44. doi: 10.1016/j.jsat.2011.07.007. Epub 2011 Sep 21.","Smyth BP","J Subst Abuse Treat","2012","2011/09/24","","","10.1016/j.jsat.2011.07.007"
"21937837","Endocrine and behavioural effects of transdermal buprenorphine in pain-suffering women of different reproductive ages","Aurilio C, Ceccarelli I, Pota V, Sansone P, Massafra C, Barbarisi M, Pace MC, Passavanti MB, Bravi F, Aloisi AM.","Endocr J. 2011;58(12):1071-8. doi: 10.1507/endocrj.ej11-0095. Epub 2011 Sep 22.","Aurilio C","Endocr J","2011","2011/09/23","","","10.1507/endocrj.ej11-0095"
"21936751","Compensation effects on clinical trial data collection in opioid-dependent young adults","Wilcox CE, Bogenschutz MP, Nakazawa M, Woody GE.","Am J Drug Alcohol Abuse. 2012 Jan;38(1):81-6. doi: 10.3109/00952990.2011.600393. Epub 2011 Sep 22.","Wilcox CE","Am J Drug Alcohol Abuse","2012","2011/09/23","PMC3745824","NIHMS498046","10.3109/00952990.2011.600393"
"21932759","Opiate addiction and prescription drug abuse: a pragmatic approach","Hasan KM, Hasan OK.","W V Med J. 2010;106(4 Spec No):84-5.","Hasan KM","W V Med J","2010","2011/09/22","","",""
"21932755","Buprenorphine clinics: an integrated and multidisciplinary approach to treating opioid dependence","Marshalek PJ, Sullivan CR.","W V Med J. 2010;106(4 Spec No):60-3.","Marshalek PJ","W V Med J","2010","2011/09/22","","",""
"21929827","Opioid dependence","Praveen KT, Law F, O'Shea J, Melichar J.","BMJ Clin Evid. 2011 Sep 20;2011:1015.","Praveen KT","BMJ Clin Evid","2011","2011/09/21","PMC3275107","",""
"21927835","Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning","Häkkinen M, Launiainen T, Vuori E, Ojanperä I.","Eur J Clin Pharmacol. 2012 Mar;68(3):301-9. doi: 10.1007/s00228-011-1122-4. Epub 2011 Sep 17.","Häkkinen M","Eur J Clin Pharmacol","2012","2011/09/20","","","10.1007/s00228-011-1122-4"
"21919976","Individual versus team-based case-management for clients of opioid treatment services: an initial evaluation of what clients prefer","Day CA, Demirkol A, Tynan M, Curry K, Hines S, Lintzeris N, Haber PS.","Drug Alcohol Rev. 2012 Jun;31(4):499-506. doi: 10.1111/j.1465-3362.2011.00347.x. Epub 2011 Sep 15.","Day CA","Drug Alcohol Rev","2012","2011/09/17","","","10.1111/j.1465-3362.2011.00347.x"
"21901695","Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","Amato L, Minozzi S, Davoli M, Vecchi S.","Cochrane Database Syst Rev. 2011 Sep 7;(9):CD005031. doi: 10.1002/14651858.CD005031.pub4.","Amato L","Cochrane Database Syst Rev","2011","2011/09/09","","","10.1002/14651858.CD005031.pub4"
"21888441","The worldwide opioid epidemic: implications for treatment and research in pregnancy and the newborn","Knoppert D.","Paediatr Drugs. 2011 Oct 1;13(5):277-9. doi: 10.2165/11592700-000000000-00000.","Knoppert D","Paediatr Drugs","2011","2011/09/06","","","10.2165/11592700-000000000-00000"
"21885310","Evaluation of medetomidine, ketamine and buprenorphine for neutering feral cats","Harrison KA, Robertson SA, Levy JK, Isaza NM.","J Feline Med Surg. 2011 Dec;13(12):896-902. doi: 10.1016/j.jfms.2011.06.010. Epub 2011 Aug 31.","Harrison KA","J Feline Med Surg","2011","2011/09/03","","","10.1016/j.jfms.2011.06.010"
"21883606","Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study","Bukten A, Skurtveit S, Gossop M, Waal H, Stangeland P, Havnes I, Clausen T.","Addiction. 2012 Feb;107(2):393-9. doi: 10.1111/j.1360-0443.2011.03637.x. Epub 2011 Oct 26.","Bukten A","Addiction","2012","2011/09/03","","","10.1111/j.1360-0443.2011.03637.x"
"21881461","Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study","Soyka M, Träder A, Klotsche J, Backmund M, Bühringer G, Rehm J, Wittchen HU.","J Clin Psychopharmacol. 2011 Oct;31(5):678-80. doi: 10.1097/JCP.0b013e31822cd446.","Soyka M","J Clin Psychopharmacol","2011","2011/09/02","","","10.1097/JCP.0b013e31822cd446"
"21869765","Update on the pharmacologic management of neonatal abstinence syndrome","Bio LL, Siu A, Poon CY.","J Perinatol. 2011 Nov;31(11):692-701. doi: 10.1038/jp.2011.116. Epub 2011 Aug 25.","Bio LL","J Perinatol","2011","2011/08/27","","","10.1038/jp.2011.116"
"21867403","Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?","McCarthy JJ.","J Matern Fetal Neonatal Med. 2012 Feb;25(2):109-12. doi: 10.3109/14767058.2011.600371. Epub 2011 Aug 25.","McCarthy JJ","J Matern Fetal Neonatal Med","2012","2011/08/27","","","10.3109/14767058.2011.600371"
"21866885","Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphine","Cami-Kobeci G, Polgar WE, Khroyan TV, Toll L, Husbands SM.","J Med Chem. 2011 Oct 13;54(19):6531-7. doi: 10.1021/jm2003238. Epub 2011 Sep 7.","Cami-Kobeci G","J Med Chem","2011","2011/08/27","PMC3188691","NIHMS322306","10.1021/jm2003238"
"21863064","Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418","Wen Q, Yu G, Li YL, Yan LD, Gong ZH.","Acta Pharmacol Sin. 2011 Oct;32(10):1215-24. doi: 10.1038/aps.2011.83. Epub 2011 Aug 22.","Wen Q","Acta Pharmacol Sin","2011","2011/08/25","PMC4010084","","10.1038/aps.2011.83"
"21862241","Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians","Johanson CE, Arfken CL, di Menza S, Schuster CR.","Drug Alcohol Depend. 2012 Jan 1;120(1-3):190-5. doi: 10.1016/j.drugalcdep.2011.07.019. Epub 2011 Aug 21.","Johanson CE","Drug Alcohol Depend","2012","2011/08/25","","","10.1016/j.drugalcdep.2011.07.019"
"21861411","[Comparison of intrathecal morphine and buprenorphine for postoperative analgesia in cesarean delivery]","Kawamoto S, Tatsumi K, Kataoka T, Kamikawa T, Yanagida T, Mandai R.","Masui. 2011 Aug;60(8):892-6.","Kawamoto S","Masui","2011","2011/08/25","","",""
"21860340","Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women","Concheiro M, Jones HE, Johnson RE, Choo R, Huestis MA.","Ther Drug Monit. 2011 Oct;33(5):619-26. doi: 10.1097/FTD.0b013e318228bb2a.","Concheiro M","Ther Drug Monit","2011","2011/08/24","PMC3178674","NIHMS311108","10.1097/FTD.0b013e318228bb2a"
"21858959","Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health's office-based Buprenorphine Pilot Program","Hersh D, Little SL, Gleghorn A.","J Psychoactive Drugs. 2011 Apr-Jun;43(2):136-45. doi: 10.1080/02791072.2011.587704.","Hersh D","J Psychoactive Drugs","2011","2011/08/24","","","10.1080/02791072.2011.587704"
"21857500","Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat","Gauthier EA, Guzick SE, Brummett CM, Baghdoyan HA, Lydic R.","Anesthesiology. 2011 Oct;115(4):743-53. doi: 10.1097/ALN.0b013e31822e9f85.","Gauthier EA","Anesthesiology","2011","2011/08/23","PMC3197808","NIHMS319694","10.1097/ALN.0b013e31822e9f85"
"21857233","The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome","Wachman EM, Newby PK, Vreeland J, Byun J, Bonzagni A, Bauchner H, Philipp BL.","J Addict Med. 2011 Dec;5(4):293-9. doi: 10.1097/ADM.0b013e3182266a3a.","Wachman EM","J Addict Med","2011","2011/08/23","","","10.1097/ADM.0b013e3182266a3a"
"21856474","Promise of extended-release naltrexone is a red herring","Bart G.","Lancet. 2011 Aug 20;378(9792):663; author reply 663-4. doi: 10.1016/S0140-6736(11)61328-7.","Bart G","Lancet","2011","2011/08/23","","","10.1016/S0140-6736(11)61328-7"
"21854644","Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates","Rapeli P, Fabritius C, Kalska H, Alho H.","BMC Clin Pharmacol. 2011 Aug 21;11:13. doi: 10.1186/1472-6904-11-13.","Rapeli P","BMC Clin Pharmacol","2011","2011/08/23","PMC3176473","","10.1186/1472-6904-11-13"
"21854290","Participant characteristics and buprenorphine dose","Hillhouse M, Canamar CP, Doraimani G, Thomas C, Hasson A, Ling W.","Am J Drug Alcohol Abuse. 2011 Sep;37(5):453-9. doi: 10.3109/00952990.2011.596974.","Hillhouse M","Am J Drug Alcohol Abuse","2011","2011/08/23","PMC3272773","NIHMS349052","10.3109/00952990.2011.596974"
"21854273","Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial","Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, Ling W.","Am J Drug Alcohol Abuse. 2011 Sep;37(5):313-23. doi: 10.3109/00952990.2011.596982.","Back SE","Am J Drug Alcohol Abuse","2011","2011/08/23","PMC3164783","NIHMS298753","10.3109/00952990.2011.596982"
"21853690","Transfer from high dose methadone to buprenorphine/naloxone","Wallace M.","Aust Nurs J. 2011 Jul;19(1):42-3.","Wallace M","Aust Nurs J","2011","2011/08/23","","",""
"21852093","Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058","Lucas GM, Beauchamp G, Aramrattana A, Shao Y, Liu W, Fu L, Jackson JB, Celentano DD, Richardson P, Metzger D; HPTN 058 study group.","Int J Drug Policy. 2012 Mar;23(2):162-5. doi: 10.1016/j.drugpo.2011.06.005. Epub 2011 Aug 17.","Lucas GM","Int J Drug Policy","2012","2011/08/20","PMC3236277","NIHMS319133","10.1016/j.drugpo.2011.06.005"
"21851203","A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study","Soyka M, Limmer C, Lehnert R, Koller G, Martin G, Küfner H, Kagerer S, Haberthür A.","Am J Drug Alcohol Abuse. 2011 Nov;37(6):497-508. doi: 10.3109/00952990.2011.600381. Epub 2011 Aug 18.","Soyka M","Am J Drug Alcohol Abuse","2011","2011/08/20","","","10.3109/00952990.2011.600381"
"21849979","Imaging drugs with and without clinical analgesic efficacy","Upadhyay J, Anderson J, Schwarz AJ, Coimbra A, Baumgartner R, Pendse G, George E, Nutile L, Wallin D, Bishop J, Neni S, Maier G, Iyengar S, Evelhoch JL, Bleakman D, Hargreaves R, Becerra L, Borsook D.","Neuropsychopharmacology. 2011 Dec;36(13):2659-73. doi: 10.1038/npp.2011.156. Epub 2011 Aug 17.","Upadhyay J","Neuropsychopharmacology","2011","2011/08/19","PMC3230490","","10.1038/npp.2011.156"
"21845796","Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey","Curcio F, Franco T, Topa M, Baldassarre C; Gruppo Responsabili UO Sert T.","Eur Rev Med Pharmacol Sci. 2011 Aug;15(8):871-4.","Curcio F","Eur Rev Med Pharmacol Sci","2011","2011/08/18","","",""
"21844838","Bethanechol for buprenorphine-related urinary hesitancy: a case series","Varma A, Smigiel J, Eck N, Brooks S.","J Addict Med. 2011 Sep;5(3):227-8. doi: 10.1097/ADM.0b013e3181ed2f50.","Varma A","J Addict Med","2011","2011/08/17","","","10.1097/ADM.0b013e3181ed2f50"
"21844833","Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users","Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND.","J Addict Med. 2011 Sep;5(3):175-80. doi: 10.1097/ADM.0b013e3182034e31.","Bazazi AR","J Addict Med","2011","2011/08/17","PMC3157053","NIHMS314964","10.1097/ADM.0b013e3182034e31"
"21839210","Combined liquid chromatography-coulometric detection and microextraction by packed sorbent for the plasma analysis of long acting opioids in heroin addicted patients","Somaini L, Saracino MA, Marcheselli C, Zanchini S, Gerra G, Raggi MA.","Anal Chim Acta. 2011 Sep 30;702(2):280-7. doi: 10.1016/j.aca.2011.06.032. Epub 2011 Jul 20.","Somaini L","Anal Chim Acta","2011","2011/08/16","","","10.1016/j.aca.2011.06.032"
"21838973","Effects of multimodal analgesia on the success of mouse embryo transfer surgery","Parker JM, Austin J, Wilkerson J, Carbone L.","J Am Assoc Lab Anim Sci. 2011 Jul;50(4):466-70.","Parker JM","J Am Assoc Lab Anim Sci","2011","2011/08/16","PMC3148641","",""
"21838850","Transdermal buprenorphine to switch patients from higher dose methadone to buprenorphine without severe withdrawal symptoms","Hess M, Boesch L, Leisinger R, Stohler R.","Am J Addict. 2011 Sep-Oct;20(5):480-1. doi: 10.1111/j.1521-0391.2011.00159.x. Epub 2011 Jul 18.","Hess M","Am J Addict","2011","2011/08/16","","","10.1111/j.1521-0391.2011.00159.x"
"21838837","Improving temporal efficiency of outpatient buprenorphine induction","Gunderson EW, Levin FR, Rombone MM, Vosburg SK, Kleber HD.","Am J Addict. 2011 Sep-Oct;20(5):397-404. doi: 10.1111/j.1521-0391.2011.00153.x. Epub 2011 Jul 18.","Gunderson EW","Am J Addict","2011","2011/08/16","PMC3156625","NIHMS309216","10.1111/j.1521-0391.2011.00153.x"
"21833948","Oral substitution treatment of injecting opioid users for prevention of HIV infection","Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R.","Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004145. doi: 10.1002/14651858.CD004145.pub4.","Gowing L","Cochrane Database Syst Rev","2011","2011/08/12","","","10.1002/14651858.CD004145.pub4"
"21831565","Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages","Savage SA, Abraham AJ, Knudsen HK, Rothrauff TC, Roman PM.","J Subst Abuse Treat. 2012 Jan;42(1):16-24. doi: 10.1016/j.jsat.2011.06.009. Epub 2011 Aug 9.","Savage SA","J Subst Abuse Treat","2012","2011/08/12","PMC3225636","NIHMS317945","10.1016/j.jsat.2011.06.009"
"21831060","Gabapentin as part of multi-modal analgesia in two cats suffering multiple injuries","Vettorato E, Corletto F.","Vet Anaesth Analg. 2011 Sep;38(5):518-20. doi: 10.1111/j.1467-2995.2011.00638.x.","Vettorato E","Vet Anaesth Analg","2011","2011/08/12","","","10.1111/j.1467-2995.2011.00638.x"
"21824659","Risks and realities: dyadic interaction between 6-month-old infants and their mothers in opioid maintenance treatment","Sarfi M, Smith L, Waal H, Sundet JM.","Infant Behav Dev. 2011 Dec;34(4):578-89. doi: 10.1016/j.infbeh.2011.06.006. Epub 2011 Aug 7.","Sarfi M","Infant Behav Dev","2011","2011/08/10","","","10.1016/j.infbeh.2011.06.006"
"21823171","Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women","Metz V, Jagsch R, Ebner N, Würzl J, Pribasnig A, Aschauer C, Fischer G.","Hum Psychopharmacol. 2011 Aug;26(6):412-21. doi: 10.1002/hup.1224. Epub 2011 Aug 8.","Metz V","Hum Psychopharmacol","2011","2011/08/09","PMC5494260","NIHMS710906","10.1002/hup.1224"
"21821560","The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine","Clark RE, Samnaliev M, Baxter JD, Leung GY.","Health Aff (Millwood). 2011 Aug;30(8):1425-33. doi: 10.1377/hlthaff.2010.0532.","Clark RE","Health Aff (Millwood)","2011","2011/08/09","","","10.1377/hlthaff.2010.0532"
"21821379","A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment","Rieckmann TR, Kovas AE, McFarland BH, Abraham AJ.","J Subst Abuse Treat. 2011 Dec;41(4):374-85. doi: 10.1016/j.jsat.2011.05.005. Epub 2011 Aug 6.","Rieckmann TR","J Subst Abuse Treat","2011","2011/08/09","PMC3486698","NIHMS300798","10.1016/j.jsat.2011.05.005"
"21819795","Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes","Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA.","J Anal Toxicol. 2010 Oct;34(8):498-505. doi: 10.1093/jat/34.8.498.","Concheiro M","J Anal Toxicol","2010","2011/08/09","","","10.1093/jat/34.8.498"
"21817918","A coincidence of addiction to ""Kratom"" and severe primary hypothyroidism","Sheleg SV, Collins GB.","J Addict Med. 2011 Dec;5(4):300-1. doi: 10.1097/ADM.0b013e318221fbfa.","Sheleg SV","J Addict Med","2011","2011/08/06","","","10.1097/ADM.0b013e318221fbfa"
"21807566","Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study","Steiner D, Munera C, Hale M, Ripa S, Landau C.","J Pain. 2011 Nov;12(11):1163-73. doi: 10.1016/j.jpain.2011.06.003. Epub 2011 Jul 31.","Steiner D","J Pain","2011","2011/08/03","","","10.1016/j.jpain.2011.06.003"
"21800442","Prescribing opioid substitution therapy","Pawar P.","Aust Fam Physician. 2011 Jun;40(6):362-3.","Pawar P","Aust Fam Physician","2011","2011/07/30","","",""
"21786326","Unusual false-positive case of urinary screening for buprenorphine","Lippi G, Romero A, Cervellin G, Mercadanti M.","J Clin Lab Anal. 2011;25(4):244-5. doi: 10.1002/jcla.20466.","Lippi G","J Clin Lab Anal","2011","2011/07/26","PMC6647635","","10.1002/jcla.20466"
"21782352","Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system","Cropsey KL, Lane PS, Hale GJ, Jackson DO, Clark CB, Ingersoll KS, Islam MA, Stitzer ML.","Drug Alcohol Depend. 2011 Dec 15;119(3):172-8. doi: 10.1016/j.drugalcdep.2011.06.021. Epub 2011 Jul 23.","Cropsey KL","Drug Alcohol Depend","2011","2011/07/26","PMC3214606","NIHMS313429","10.1016/j.drugalcdep.2011.06.021"
"21781635","Cutaneous reactions to transdermal therapeutic systems","Bershow A, Warshaw E.","Dermatitis. 2011 Jul-Aug;22(4):193-203.","Bershow A","Dermatitis","2011","2011/07/26","","",""
"21749526","A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals","Amass L, Pukeleviciene V, Subata E, Almeida AR, Pieri MC, D'Egidio P, Stankova Z, Costa A, Smyth BP, Sakoman S, Wei Y, Strang J.","Addiction. 2012 Jan;107(1):142-51. doi: 10.1111/j.1360-0443.2011.03577.x. Epub 2011 Oct 12.","Amass L","Addiction","2012","2011/07/14","","","10.1111/j.1360-0443.2011.03577.x"
"21744558","[Norspan depot patch more and more common but its role in the treatment is difficult to assess]","Schwan S, Hallbert P.","Lakartidningen. 2011 Mar 9-15;108(10):548-9.","Schwan S","Lakartidningen","2011","2011/07/13","","",""
"21743375","Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes","de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA.","Ther Drug Monit. 2011 Aug;33(4):443-52. doi: 10.1097/FTD.0b013e31822724f0.","de Castro A","Ther Drug Monit","2011","2011/07/12","PMC3138889","NIHMS308982","10.1097/FTD.0b013e31822724f0"
"21741781","The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review","Dunn KE, Sigmon SC, Strain EC, Heil SH, Higgins ST.","Drug Alcohol Depend. 2011 Dec 1;119(1-2):1-9. doi: 10.1016/j.drugalcdep.2011.05.033. Epub 2011 Jul 8.","Dunn KE","Drug Alcohol Depend","2011","2011/07/12","PMC3205338","NIHMS310180","10.1016/j.drugalcdep.2011.05.033"
"21741031","Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals","Fatseas M, Denis C, Massida Z, Verger M, Franques-Rénéric P, Auriacombe M.","Biol Psychiatry. 2011 Oct 15;70(8):720-7. doi: 10.1016/j.biopsych.2011.05.015. Epub 2011 Jul 8.","Fatseas M","Biol Psychiatry","2011","2011/07/12","","","10.1016/j.biopsych.2011.05.015"
"21731186","Epidural analgesia with morphine or buprenorphine in ponies with lipopolysaccharide (LPS)-induced carpal synovitis","Freitas GC, Carregaro AB, Gehrcke MI, De La Côrte FD, Lara VM, Pozzobon R, Brass KE.","Can J Vet Res. 2011 Apr;75(2):141-6.","Freitas GC","Can J Vet Res","2011","2011/07/07","PMC3062925","",""
"21724673","Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence","Fishman MJ, Wu LT, Woody GE.","Am J Psychiatry. 2011 Jul;168(7):675-9. doi: 10.1176/appi.ajp.2010.10060879.","Fishman MJ","Am J Psychiatry","2011","2011/07/05","PMC3178807","NIHMS322901","10.1176/appi.ajp.2010.10060879"
"21721023","Development and validation of a method for the determination of buprenorphine and norbuprenorphine in breast milk by gas chromatography-mass spectrometry","Nikolaou P, Papoutsis I, Athanaselis S, Pistos C, Dona A, Spiliopoulou C.","Biomed Chromatogr. 2012 Mar;26(3):358-62. doi: 10.1002/bmc.1666. Epub 2011 Jul 1.","Nikolaou P","Biomed Chromatogr","2012","2011/07/02","","","10.1002/bmc.1666"
"21718192","Questions conclusions in study of postoperative analgesia with buprenorphine","Pascoe P, Pypendop B.","J Am Vet Med Assoc. 2011 Jul 1;239(1):43; author reply 43-4. doi: 10.2460/javma.239.1.43.","Pascoe P","J Am Vet Med Assoc","2011","2011/07/02","","","10.2460/javma.239.1.43"
"21710759","[Effectiveness of low dose PCEA for postoperative pain after laparoscopic gynecological surgeries--a comparison of laparoscopic ovarian cystectomy and myomectomy]","Shimohata K, Shimohata T, Ikeda N, Sato Y, Ono T, Motegi R, Ishikura H, Sato M, Miyashita K.","Masui. 2011 Jun;60(6):666-70.","Shimohata K","Masui","2011","2011/06/30","","",""
"21710757","[Effect of buprenorphine on postoperative analgesia following remifentanil-based anesthesia]","Kimoto M.","Masui. 2011 Jun;60(6):656-60.","Kimoto M","Masui","2011","2011/06/30","","",""
"21702102","[Some adjuvants added to local anesthetics improve the duration and quality of epidural anesthesia]","Kasaba T.","Masui. 2010 Nov;59 Suppl:S157-65.","Kasaba T","Masui","2010","2011/06/28","","",""
"21696648","Opioid dependence","O'Shea J, Law F, Melichar J.","BMJ Clin Evid. 2009 Jul 24;2009:1015.","O'Shea J","BMJ Clin Evid","2009","2011/06/24","PMC2907824","",""
"21696438","Effects of acepromazine, butorphanol and buprenorphine on thermal and mechanical nociceptive thresholds in horses","Love EJ, Taylor PM, Murrell J, Whay HR.","Equine Vet J. 2012 Mar;44(2):221-5. doi: 10.1111/j.2042-3306.2011.00412.x. Epub 2011 Jun 23.","Love EJ","Equine Vet J","2012","2011/06/24","","","10.1111/j.2042-3306.2011.00412.x"
"21671107","Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors","Lee CW, Yan JY, Chiang YC, Hung TW, Wang HL, Chiou LC, Ho IK.","Neurochem Res. 2011 Nov;36(11):2008-21. doi: 10.1007/s11064-011-0525-z. Epub 2011 Jun 14.","Lee CW","Neurochem Res","2011","2011/06/15","PMC3183316","","10.1007/s11064-011-0525-z"
"21664789","Efficacy of continuing medical education to reduce the risk of buprenorphine diversion","Lofwall MR, Wunsch MJ, Nuzzo PA, Walsh SL.","J Subst Abuse Treat. 2011 Oct;41(3):321-9. doi: 10.1016/j.jsat.2011.04.008. Epub 2011 Jun 12.","Lofwall MR","J Subst Abuse Treat","2011","2011/06/14","","","10.1016/j.jsat.2011.04.008"
"21645198","A randomized, blinded, controlled trial of the antiemetic effect of ondansetron on dexmedetomidine-induced emesis in cats","Santos LC, Ludders JW, Erb HN, Martin-Flores M, Basher KL, Kirch P.","Vet Anaesth Analg. 2011 Jul;38(4):320-7. doi: 10.1111/j.1467-2995.2011.00619.x. Epub 2011 Jun 6.","Santos LC","Vet Anaesth Analg","2011","2011/06/08","","","10.1111/j.1467-2995.2011.00619.x"
"21640969","Management of women treated with buprenorphine during pregnancy","Alto WA, O'Connor AB.","Am J Obstet Gynecol. 2011 Oct;205(4):302-8. doi: 10.1016/j.ajog.2011.04.001. Epub 2011 Apr 13.","Alto WA","Am J Obstet Gynecol","2011","2011/06/07","","","10.1016/j.ajog.2011.04.001"
"21619723","Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry","Oiestad EL, Johansen U, Oiestad AM, Christophersen AS.","J Anal Toxicol. 2011 Jun;35(5):280-93. doi: 10.1093/anatox/35.5.280.","Oiestad EL","J Anal Toxicol","2011","2011/05/31","","","10.1093/anatox/35.5.280"
"21614796","[Synergistic combination therapy in osteoporosis. Strategies against painful bone loss]","Aumiller J.","MMW Fortschr Med. 2011 May 12;153(19):14-5. doi: 10.1007/BF03368321.","Aumiller J","MMW Fortschr Med","2011","2011/05/27","","","10.1007/BF03368321"
"21600706","Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120","Palma J, Cowan A, Geller EB, Adler MW, Benamar K.","Drug Alcohol Depend. 2011 Nov 1;118(2-3):497-9. doi: 10.1016/j.drugalcdep.2011.04.010. Epub 2011 May 19.","Palma J","Drug Alcohol Depend","2011","2011/05/24","PMC3925649","NIHMS292221","10.1016/j.drugalcdep.2011.04.010"
"21599628","Promising medications for cocaine dependence treatment","Somaini L, Donnini C, Raggi MA, Amore M, Ciccocioppo R, Saracino MA, Kalluppi M, Malagoli M, Gerra ML, Gerra G.","Recent Pat CNS Drug Discov. 2011 May 1;6(2):146-60. doi: 10.2174/157488911795933893.","Somaini L","Recent Pat CNS Drug Discov","2011","2011/05/24","","","10.2174/157488911795933893"
"21598463","[Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac]","Böhme K, Heckes B, Thomitzek K.","MMW Fortschr Med. 2011 Jan 13;152 Suppl 4:125-32.","Böhme K","MMW Fortschr Med","2011","2011/05/24","","",""
"21597537","Opioid substitution therapy--a study of GP participation in prescribing","Scarborough J, Eliott J, Braunack-Mayer A.","Aust Fam Physician. 2011 Apr;40(4):241-5.","Scarborough J","Aust Fam Physician","2011","2011/05/21","","",""
"21596492","Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients","McCance-Katz EF, Moody DE, Prathikanti S, Friedland G, Rainey PM.","Drug Alcohol Depend. 2011 Nov 1;118(2-3):326-34. doi: 10.1016/j.drugalcdep.2011.04.013. Epub 2011 May 19.","McCance-Katz EF","Drug Alcohol Depend","2011","2011/05/21","PMC3272858","NIHMS297924","10.1016/j.drugalcdep.2011.04.013"
"21591321","[The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study]","Schutter U, Ritzdorf I, Heckes B.","MMW Fortschr Med. 2010 Jul 1;152 Suppl 2:62-9.","Schutter U","MMW Fortschr Med","2010","2011/05/20","","",""
"21576406","Post-operative corticosterone levels in plasma and feces of mice subjected to permanent catheterization and automated blood sampling","Sundbom R, Jacobsen KR, Kalliokoski O, Hau J, Abelson KS.","In Vivo. 2011 May-Jun;25(3):335-42.","Sundbom R","In Vivo","2011","2011/05/18","","",""
"21569440","Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile","Öhlin L, Hesse M, Fridell M, Tätting P.","BMC Psychiatry. 2011 May 12;11:81. doi: 10.1186/1471-244X-11-81.","Öhlin L","BMC Psychiatry","2011","2011/05/17","PMC3112080","","10.1186/1471-244X-11-81"
"21565452","Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing","Larance B, Degenhardt L, Lintzeris N, Bell J, Winstock A, Dietze P, Mattick R, Ali R, Horyniak D.","Drug Alcohol Depend. 2011 Nov 1;118(2-3):265-73. doi: 10.1016/j.drugalcdep.2011.04.002. Epub 2011 May 12.","Larance B","Drug Alcohol Depend","2011","2011/05/14","","","10.1016/j.drugalcdep.2011.04.002"
"21545559","Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users","Roux P, Carrieri MP, Keijzer L, Dasgupta N.","Drug Alcohol Rev. 2011 May;30(3):287-90. doi: 10.1111/j.1465-3362.2011.00285.x.","Roux P","Drug Alcohol Rev","2011","2011/05/07","","","10.1111/j.1465-3362.2011.00285.x"
"21538146","Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study","Lacroix I, Berrebi A, Garipuy D, Schmitt L, Hammou Y, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C.","Eur J Clin Pharmacol. 2011 Oct;67(10):1053-9. doi: 10.1007/s00228-011-1049-9. Epub 2011 May 3.","Lacroix I","Eur J Clin Pharmacol","2011","2011/05/04","","","10.1007/s00228-011-1049-9"
"21536702","Prescription pain medication dependence","Dodrill CL, Helmer DA, Kosten TR.","Am J Psychiatry. 2011 May;168(5):466-71. doi: 10.1176/appi.ajp.2010.10020260.","Dodrill CL","Am J Psychiatry","2011","2011/05/04","","","10.1176/appi.ajp.2010.10020260"
"21535372","Buprenorphine for the treatment of perinatal opioid dependence: pharmacology and implications for antepartum, intrapartum, and postpartum care","Goodman D.","J Midwifery Womens Health. 2011 May-Jun;56(3):240-7. doi: 10.1111/j.1542-2011.2011.00049.x.","Goodman D","J Midwifery Womens Health","2011","2011/05/04","","","10.1111/j.1542-2011.2011.00049.x"
"21528924","Synthesis of PAMAM dendrimer derivatives with enhanced buffering capacity and remarkable gene transfection efficiency","Yu GS, Bae YM, Choi H, Kong B, Choi IS, Choi JS.","Bioconjug Chem. 2011 Jun 15;22(6):1046-55. doi: 10.1021/bc100479t. Epub 2011 May 12.","Yu GS","Bioconjug Chem","2011","2011/05/03","","","10.1021/bc100479t"
"21515090","Conditioned place preference reveals tonic pain in an animal model of central pain","Davoody L, Quiton RL, Lucas JM, Ji Y, Keller A, Masri R.","J Pain. 2011 Aug;12(8):868-74. doi: 10.1016/j.jpain.2011.01.010. Epub 2011 Apr 23.","Davoody L","J Pain","2011","2011/04/26","PMC3145044","NIHMS275284","10.1016/j.jpain.2011.01.010"
"21515002","Gender differences in pharmacokinetics of maintenance dosed buprenorphine","Moody DE, Fang WB, Morrison J, McCance-Katz E.","Drug Alcohol Depend. 2011 Nov 1;118(2-3):479-83. doi: 10.1016/j.drugalcdep.2011.03.024. Epub 2011 Apr 23.","Moody DE","Drug Alcohol Depend","2011","2011/04/26","PMC3162987","NIHMS294014","10.1016/j.drugalcdep.2011.03.024"
"21502936","Transdermal buprenorphine (Butrans) for chronic pain","","Med Lett Drugs Ther. 2011 Apr 18;53(1362):31-2.","","Med Lett Drugs Ther","2011","2011/04/20","","",""
"21501371","Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site","Messenger KM, Davis JL, LaFevers DH, Barlow BM, Posner LP.","Vet Anaesth Analg. 2011 Jul;38(4):374-84. doi: 10.1111/j.1467-2995.2011.00613.x. Epub 2011 Apr 19.","Messenger KM","Vet Anaesth Analg","2011","2011/04/20","","","10.1111/j.1467-2995.2011.00613.x"
"21498267","Assessment of the sedative effects of buprenorphine administered with 10 μg/kg detomidine in horses","Love EJ, Taylor PM, Murrell J, Whay HR, Waterman-Pearson AE.","Vet Rec. 2011 Apr 9;168(14):379. doi: 10.1136/vr.c7288. Epub 2011 Mar 31.","Love EJ","Vet Rec","2011","2011/04/19","","","10.1136/vr.c7288"
"21495679","Synthesis of buprenorphine from oripavine via N-demethylation of oripavine quaternary salts","Werner L, Machara A, Adams DR, Cox DP, Hudlicky T.","J Org Chem. 2011 Jun 3;76(11):4628-34. doi: 10.1021/jo200567n. Epub 2011 May 2.","Werner L","J Org Chem","2011","2011/04/19","","","10.1021/jo200567n"
"21493447","Assessment of the sedative effects of buprenorphine administered with 20 microg/kg detomidine in horses","Love EJ, Taylor PM, Murrell J, Whay HR, Waterman-Pearson AE.","Vet Rec. 2011 Apr 16;168(15):409. doi: 10.1136/vr.c7315. Epub 2011 Apr 11.","Love EJ","Vet Rec","2011","2011/04/16","","","10.1136/vr.c7315"
"21491383","Oral naltrexone maintenance treatment for opioid dependence","Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.","Cochrane Database Syst Rev. 2011 Apr 13;2011(4):CD001333. doi: 10.1002/14651858.CD001333.pub4.","Minozzi S","Cochrane Database Syst Rev","2011","2011/04/15","PMC7045778","","10.1002/14651858.CD001333.pub4"
"21486104","The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence","Soyka M, Kranzler HR, van den Brink W, Krystal J, Möller HJ, Kasper S; WFSBP Task Force on Treatment, Guidelines for Substance Use Disorders.","World J Biol Psychiatry. 2011 Apr;12(3):160-87. doi: 10.3109/15622975.2011.561872.","Soyka M","World J Biol Psychiatry","2011","2011/04/14","","","10.3109/15622975.2011.561872"
"21480679","Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration","Gordon AJ, Kavanagh G, Krumm M, Ramgopal R, Paidisetty S, Aghevli M, Goodman F, Trafton J, Liberto J.","Psychol Addict Behav. 2011 Jun;25(2):215-24. doi: 10.1037/a0022776.","Gordon AJ","Psychol Addict Behav","2011","2011/04/13","","","10.1037/a0022776"
"21480011","Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development","Konijnenberg C, Melinder A.","Child Neuropsychol. 2011;17(5):495-519. doi: 10.1080/09297049.2011.553591. Epub 2011 Jun 24.","Konijnenberg C","Child Neuropsychol","2011","2011/04/12","","","10.1080/09297049.2011.553591"
"21477658","Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial","Conaghan PG, O'Brien CM, Wilson M, Schofield JP.","Osteoarthritis Cartilage. 2011 Aug;19(8):930-8. doi: 10.1016/j.joca.2011.03.011. Epub 2011 Apr 6.","Conaghan PG","Osteoarthritis Cartilage","2011","2011/04/12","","","10.1016/j.joca.2011.03.011"
"21477061","Buprenorphine plasma concentration in the management of opioid dependence","Jutras-Aswad D, Scimeca MM.","Am J Addict. 2011 May-Jun;20(3):304-5. doi: 10.1111/j.1521-0391.2011.00133.x. Epub 2011 Mar 31.","Jutras-Aswad D","Am J Addict","2011","2011/04/12","","","10.1111/j.1521-0391.2011.00133.x"
"21466501","Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review","Yokell MA, Zaller ND, Green TC, Rich JD.","Curr Drug Abuse Rev. 2011 Mar;4(1):28-41. doi: 10.2174/1874473711104010028.","Yokell MA","Curr Drug Abuse Rev","2011","2011/04/07","PMC3154701","NIHMS314965","10.2174/1874473711104010028"
"21463165","Why does depression hurt? Ancestral primary-process separation-distress (PANIC/GRIEF) and diminished brain reward (SEEKING) processes in the genesis of depressive affect","Panksepp J, Watt D.","Psychiatry. 2011 Spring;74(1):5-13. doi: 10.1521/psyc.2011.74.1.5.","Panksepp J","Psychiatry","2011","2011/04/06","","","10.1521/psyc.2011.74.1.5"
"21461193","Sedative and cardiopulmonary effects of buprenorphine and xylazine in horses","Cruz FS, Carregaro AB, Machado M, Antonow RR.","Can J Vet Res. 2011 Jan;75(1):35-41.","Cruz FS","Can J Vet Res","2011","2011/04/05","PMC3003560","",""
"21459544","Factors associated with Medicaid patients' access to buprenorphine treatment","Baxter JD, Clark RE, Samnaliev M, Leung GY, Hashemi L.","J Subst Abuse Treat. 2011 Jul;41(1):88-96. doi: 10.1016/j.jsat.2011.02.002. Epub 2011 Apr 2.","Baxter JD","J Subst Abuse Treat","2011","2011/04/05","","","10.1016/j.jsat.2011.02.002"
"21456888","Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland","Przeklasa-Muszynska A, Dobrogowski J.","Curr Med Res Opin. 2011 Jun;27(6):1109-17. doi: 10.1185/03007995.2011.569017. Epub 2011 Apr 1.","Przeklasa-Muszynska A","Curr Med Res Opin","2011","2011/04/05","","","10.1185/03007995.2011.569017"
"21453146","Comparison of the efficacy and adverse effects of sustained-release buprenorphine hydrochloride following subcutaneous administration and buprenorphine hydrochloride following oral transmucosal administration in cats undergoing ovariohysterectomy","Catbagan DL, Quimby JM, Mama KR, Rychel JK, Mich PM.","Am J Vet Res. 2011 Apr;72(4):461-6. doi: 10.2460/ajvr.72.4.461.","Catbagan DL","Am J Vet Res","2011","2011/04/02","","","10.2460/ajvr.72.4.461"
"21450498","Acute leukoencephalopathy after buprenorphine intoxication in a 2-year-old child","Bellot B, Michel F, Thomachot L, Chaumoitre K, Battaglia F, Lagier P.","Eur J Paediatr Neurol. 2011 Jul;15(4):368-71. doi: 10.1016/j.ejpn.2011.03.002. Epub 2011 Mar 29.","Bellot B","Eur J Paediatr Neurol","2011","2011/04/01","","","10.1016/j.ejpn.2011.03.002"
"21444858","Buprenorphine as a safety net for opioid treatment of nonmalignant pain","Kornfeld H.","Arch Intern Med. 2011 Mar 28;171(6):596-7. doi: 10.1001/archinternmed.2011.83.","Kornfeld H","Arch Intern Med","2011","2011/03/30","","","10.1001/archinternmed.2011.83"
"21439217","Differences in postsurgical recovery of CF1 mice after intraperitoneal implantation of radiotelemetry devices through a midline or flank surgical approach","Chappell MG, Koeller CA, Hall SI.","J Am Assoc Lab Anim Sci. 2011 Mar;50(2):227-37.","Chappell MG","J Am Assoc Lab Anim Sci","2011","2011/03/29","PMC3061424","",""
"21439214","Respiratory rates and arterial blood-gas tensions in healthy rabbits given buprenorphine, butorphanol, midazolam, or their combinations","Schroeder CA, Smith LJ.","J Am Assoc Lab Anim Sci. 2011 Mar;50(2):205-11.","Schroeder CA","J Am Assoc Lab Anim Sci","2011","2011/03/29","PMC3061421","",""
"21439213","Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats","Foley PL, Liang H, Crichlow AR.","J Am Assoc Lab Anim Sci. 2011 Mar;50(2):198-204.","Foley PL","J Am Assoc Lab Anim Sci","2011","2011/03/29","PMC3061420","",""
"21439212","Analgesic effects of tramadol, tramadol-gabapentin, and buprenorphine in an incisional model of pain in rats (Rattus norvegicus)","McKeon GP, Pacharinsak C, Long CT, Howard AM, Jampachaisri K, Yeomans DC, Felt SA.","J Am Assoc Lab Anim Sci. 2011 Mar;50(2):192-7.","McKeon GP","J Am Assoc Lab Anim Sci","2011","2011/03/29","PMC3061419","",""
"21439211","Effects of buprenorphine, meloxicam, and flunixin meglumine as postoperative analgesia in mice","Tubbs JT, Kissling GE, Travlos GS, Goulding DR, Clark JA, King-Herbert AP, Blankenship-Paris TL.","J Am Assoc Lab Anim Sci. 2011 Mar;50(2):185-91.","Tubbs JT","J Am Assoc Lab Anim Sci","2011","2011/03/29","PMC3061418","",""
"21438938","Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison","Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G.","Addiction. 2011 Jul;106(7):1355-62. doi: 10.1111/j.1360-0443.2011.03440.x. Epub 2011 May 12.","Unger A","Addiction","2011","2011/03/29","PMC3107876","NIHMS282888","10.1111/j.1360-0443.2011.03440.x"
"21438849","Tipranavir/ritonavir induction of buprenorphine glucuronide metabolism in HIV-negative subjects chronically receiving buprenorphine/naloxone","Bruce RD, Moody DE, Fang WB, Chodkowski D, Andrews L, Friedland GH.","Am J Drug Alcohol Abuse. 2011 Jul;37(4):224-8. doi: 10.3109/00952990.2011.568081. Epub 2011 Mar 28.","Bruce RD","Am J Drug Alcohol Abuse","2011","2011/03/29","","","10.3109/00952990.2011.568081"
"21434652","Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D-glucuronide","Fan J, Brown SM, Tu Z, Kharasch ED.","Bioconjug Chem. 2011 Apr 20;22(4):752-8. doi: 10.1021/bc100550u. Epub 2011 Mar 24.","Fan J","Bioconjug Chem","2011","2011/03/26","PMC3091394","NIHMS283574","10.1021/bc100550u"
"21434580","A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts","Jain K, Jain R, Dhawan A.","J Opioid Manag. 2011 Jan-Feb;7(1):11-20. doi: 10.5055/jom.2011.0044.","Jain K","J Opioid Manag","2011","2011/03/26","","","10.5055/jom.2011.0044"
"21434494","PA prescribing of buprenorphine; swapping out aminoglycosides","DeDea L.","JAAPA. 2011 Mar;24(3):17. doi: 10.1097/01720610-201103000-00001.","DeDea L","JAAPA","2011","2011/03/26","","","10.1097/01720610-201103000-00001"
"21419010","[The analgesic effect of plexus anesthesia with buprenorphine in patients]","Li B, Chen XL, Sun CC, Lü GY.","Zhonghua Yi Xue Za Zhi. 2011 Feb 1;91(5):334-6.","Li B","Zhonghua Yi Xue Za Zhi","2011","2011/03/23","","",""
"21403039","Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience","Alford DP, LaBelle CT, Kretsch N, Bergeron A, Winter M, Botticelli M, Samet JH.","Arch Intern Med. 2011 Mar 14;171(5):425-31. doi: 10.1001/archinternmed.2010.541.","Alford DP","Arch Intern Med","2011","2011/03/16","PMC3059544","NIHMS240250","10.1001/archinternmed.2010.541"
"21402963","Buprenorphine: new treatment of opioid addiction in primary care","Kahan M, Srivastava A, Ordean A, Cirone S.","Can Fam Physician. 2011 Mar;57(3):281-9.","Kahan M","Can Fam Physician","2011","2011/03/16","PMC3056674","",""
"21397143","The possible consequences of combining Lorazepam and buprenorphine/naloxone: a case review","Martin HA.","J Emerg Nurs. 2011 Mar;37(2):200-2. doi: 10.1016/j.jen.2010.11.013.","Martin HA","J Emerg Nurs","2011","2011/03/15","","","10.1016/j.jen.2010.11.013"
"21395892","The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers","Middleton LS, Nuzzo PA, Lofwall MR, Moody DE, Walsh SL.","Addiction. 2011 Aug;106(8):1460-73. doi: 10.1111/j.1360-0443.2011.03424.x. Epub 2011 May 3.","Middleton LS","Addiction","2011","2011/03/15","PMC3776483","NIHMS325837","10.1111/j.1360-0443.2011.03424.x"
"21392040","Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse","Davis JL, Messenger KM, LaFevers DH, Barlow BM, Posner LP.","J Vet Pharmacol Ther. 2012 Feb;35(1):52-8. doi: 10.1111/j.1365-2885.2011.01284.x. Epub 2011 Mar 11.","Davis JL","J Vet Pharmacol Ther","2012","2011/03/12","","","10.1111/j.1365-2885.2011.01284.x"
"21383220","Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes","O'Connor A, Alto W, Musgrave K, Gibbons D, Llanto L, Holden S, Karnes J.","J Am Board Fam Med. 2011 Mar-Apr;24(2):194-201. doi: 10.3122/jabfm.2011.02.100155.","O'Connor A","J Am Board Fam Med","2011","2011/03/09","","","10.3122/jabfm.2011.02.100155"
"21377275","Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation","Roman PM, Abraham AJ, Knudsen HK.","Addict Behav. 2011 Jun;36(6):584-589. doi: 10.1016/j.addbeh.2011.01.032. Epub 2011 Jan 27.","Roman PM","Addict Behav","2011","2011/03/08","PMC3087632","NIHMS282288","10.1016/j.addbeh.2011.01.032"
"21366875","Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence","Ramdurg S, Ambekar A, Lal R.","J Sex Med. 2012 Dec;9(12):3198-204. doi: 10.1111/j.1743-6109.2011.02219.x. Epub 2011 Mar 2.","Ramdurg S","J Sex Med","2012","2011/03/04","","","10.1111/j.1743-6109.2011.02219.x"
"21356580","Development and validation of a sensitive UPLC-MS/MS method for the analysis of narcotic analgesics in urine and whole blood in forensic context","Verplaetse R, Tytgat J.","Forensic Sci Int. 2012 Feb 10;215(1-3):136-45. doi: 10.1016/j.forsciint.2011.01.047. Epub 2011 Feb 26.","Verplaetse R","Forensic Sci Int","2012","2011/03/02","","","10.1016/j.forsciint.2011.01.047"
"21356421","Opioid dependence","Benich JJ 3rd.","Prim Care. 2011 Mar;38(1):59-70. doi: 10.1016/j.pop.2010.11.005. Epub 2010 Dec 24.","Benich JJ 3rd","Prim Care","2011","2011/03/02","","","10.1016/j.pop.2010.11.005"
"21355939","Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients","Larance B, Degenhardt L, O'Brien S, Lintzeris N, Winstock A, Mattick RP, Bell J, Ali R.","Drug Alcohol Rev. 2011 Nov;30(6):613-20. doi: 10.1111/j.1465-3362.2010.00274.x. Epub 2011 Jan 5.","Larance B","Drug Alcohol Rev","2011","2011/03/02","","","10.1111/j.1465-3362.2010.00274.x"
"21355929","Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation","Longman C, Lintzeris N, Temple-Smith M, Gilchrist G.","Drug Alcohol Rev. 2011 Jul;30(4):355-9. doi: 10.1111/j.1465-3362.2010.00212.x. Epub 2010 Jun 22.","Longman C","Drug Alcohol Rev","2011","2011/03/02","","","10.1111/j.1465-3362.2010.00212.x"
"21354729","Segmental hair analysis can demonstrate external contamination in postmortem cases","Kintz P.","Forensic Sci Int. 2012 Feb 10;215(1-3):73-6. doi: 10.1016/j.forsciint.2011.01.041. Epub 2011 Feb 26.","Kintz P","Forensic Sci Int","2012","2011/03/01","","","10.1016/j.forsciint.2011.01.041"
"21353749","The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function","Shmygalev S, Damm M, Weckbecker K, Berghaus G, Petzke F, Sabatowski R.","Drug Alcohol Depend. 2011 Sep 1;117(2-3):190-7. doi: 10.1016/j.drugalcdep.2011.01.017. Epub 2011 Feb 25.","Shmygalev S","Drug Alcohol Depend","2011","2011/03/01","","","10.1016/j.drugalcdep.2011.01.017"
"21351457","[In vitro comparison of thienorphine metabolism in liver microsomes of human, Beagle dog and rat]","Deng JT, Zhuang XM, Li H.","Yao Xue Xue Bao. 2010 Jan;45(1):98-103.","Deng JT","Yao Xue Xue Bao","2010","2011/03/01","","",""
"21350889","Perioperative considerations for ""new"" kids on the opioid block","Moyo J, Rashiq S.","Can J Anaesth. 2011 May;58(5):417-9, 419-22. doi: 10.1007/s12630-011-9476-8. Epub 2011 Feb 25.","Moyo J","Can J Anaesth","2011","2011/02/26","","","10.1007/s12630-011-9476-8"
"21338514","Reported analgesic administration to rabbits undergoing experimental surgical procedures","Coulter CA, Flecknell PA, Leach MC, Richardson CA.","BMC Vet Res. 2011 Feb 21;7:12. doi: 10.1186/1746-6148-7-12.","Coulter CA","BMC Vet Res","2011","2011/02/23","PMC3058034","","10.1186/1746-6148-7-12"
"21328090","Clinical correlates of health-related quality of life among opioid-dependent patients","Heslin KC, Stein JA, Heinzerling KG, Pan D, Magladry C, Hays RD.","Qual Life Res. 2011 Oct;20(8):1205-13. doi: 10.1007/s11136-011-9858-y. Epub 2011 Feb 17.","Heslin KC","Qual Life Res","2011","2011/02/18","PMC3178032","","10.1007/s11136-011-9858-y"
"21325999","Transdermal opioids for cancer pain","Cachia E, Ahmedzai SH.","Curr Opin Support Palliat Care. 2011 Mar;5(1):15-9. doi: 10.1097/SPC.0b013e3283437a39.","Cachia E","Curr Opin Support Palliat Care","2011","2011/02/18","","","10.1097/SPC.0b013e3283437a39"
"21322902","Painkillers fuel growth in drug addiction. Opioid overdoses now kill more people than cocaine or heroin","","Harv Ment Health Lett. 2011 Jan;27(7):4-5.","","Harv Ment Health Lett","2011","2011/02/18","","",""
"21320007","Questions conclusion in study on managing urethral obstructions in cats","McGrath M.","J Am Vet Med Assoc. 2011 Feb 15;238(4):424-5; author reply 424-5. doi: 10.2460/javma.238.4.424.","McGrath M","J Am Vet Med Assoc","2011","2011/02/16","","","10.2460/javma.238.4.424"
"21317602","Policy implications of integrating buprenorphine/naloxone treatment and HIV care","Finkelstein R, Netherland J, Sylla L, Gourevitch MN, Cajina A, Cheever L; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S98-S104. doi: 10.1097/QAI.0b013e31820a9a97.","Finkelstein R","J Acquir Immune Defic Syndr","2011","2011/02/15","","","10.1097/QAI.0b013e31820a9a97"
"21317600","Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine","Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S83-90. doi: 10.1097/QAI.0b013e31820bc9a5.","Korthuis PT","J Acquir Immune Defic Syndr","2011","2011/02/15","PMC3066190","NIHMS271330","10.1097/QAI.0b013e31820bc9a5"
"21317599","The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation","Schackman BR, Leff JA, Botsko M, Fiellin DA, Altice FL, Korthuis PT, Sohler N, Weiss L, Egan JE, Netherland J, Gass J, Finkelstein R; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S76-82. doi: 10.1097/QAI.0b013e31820a9a66.","Schackman BR","J Acquir Immune Defic Syndr","2011","2011/02/15","PMC3270565","NIHMS295715","10.1097/QAI.0b013e31820a9a66"
"21317598","The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment","Weiss L, Egan JE, Botsko M, Netherland J, Fiellin DA, Finkelstein R.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S7-13. doi: 10.1097/QAI.0b013e3182097426.","Weiss L","J Acquir Immune Defic Syndr","2011","2011/02/15","","","10.1097/QAI.0b013e3182097426"
"21317597","Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative","Weiss L, Netherland J, Egan JE, Flanigan TP, Fiellin DA, Finkelstein R, Altice FL; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S68-75. doi: 10.1097/QAI.0b013e31820a8226.","Weiss L","J Acquir Immune Defic Syndr","2011","2011/02/15","","","10.1097/QAI.0b013e31820a8226"
"21317596","Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients","Vergara-Rodriguez P, Tozzi MJ, Botsko M, Nandi V, Altice F, Egan JE, O'Connor PG, Sullivan LE, Fiellin DA; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S62-7. doi: 10.1097/QAI.0b013e31820a820f.","Vergara-Rodriguez P","J Acquir Immune Defic Syndr","2011","2011/02/15","","","10.1097/QAI.0b013e31820a820f"
"21317595","The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone","Sullivan LE, Botsko M, Cunningham CO, O'Connor PG, Hersh D, Mitty J, Lum PJ, Schottenfeld RS, Fiellin DA; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S54-61. doi: 10.1097/QAI.0b013e3182097576.","Sullivan LE","J Acquir Immune Defic Syndr","2011","2011/02/15","PMC3065971","NIHMS265853","10.1097/QAI.0b013e3182097576"
"21317594","Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care","Egan JE, Netherland J, Gass J, Finkelstein R, Weiss L; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S46-53. doi: 10.1097/QAI.0b013e3182097561.","Egan JE","J Acquir Immune Defic Syndr","2011","2011/02/15","","","10.1097/QAI.0b013e3182097561"
"21317593","Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics","Korthuis PT, Tozzi MJ, Nandi V, Fiellin DA, Weiss L, Egan JE, Botsko M, Acosta A, Gourevitch MN, Hersh D, Hsu J, Boverman J, Altice FL; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S39-45. doi: 10.1097/QAI.0b013e318209754c.","Korthuis PT","J Acquir Immune Defic Syndr","2011","2011/02/15","PMC3073082","NIHMS265852","10.1097/QAI.0b013e318209754c"
"21317592","Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone","Fiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman LB, Chaudhry A, Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, O'Connor PG; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(0 1):S33-8. doi: 10.1097/QAI.0b013e3182097537.","Fiellin DA","J Acquir Immune Defic Syndr","2011","2011/02/15","PMC3863630","NIHMS525377","10.1097/QAI.0b013e3182097537"
"21317591","A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care","Cheever LW, Kresina TF, Cajina A, Lubran R.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S3-6. doi: 10.1097/QAI.0b013e318209740f.","Cheever LW","J Acquir Immune Defic Syndr","2011","2011/02/15","","","10.1097/QAI.0b013e318209740f"
"21317590","HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study","Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S22-32. doi: 10.1097/QAI.0b013e318209751e.","Altice FL","J Acquir Immune Defic Syndr","2011","2011/02/15","PMC3263431","NIHMS295694","10.1097/QAI.0b013e318209751e"
"21317589","Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care","Chaudhry AA, Botsko M, Weiss L, Egan JE, Mitty J, Estrada B, Lucas GM, Woodson T, Flanigan TP, Fiellin DA; BHIVES Collaborative.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S14-21. doi: 10.1097/QAI.0b013e318209d3b9.","Chaudhry AA","J Acquir Immune Defic Syndr","2011","2011/02/15","","","10.1097/QAI.0b013e318209d3b9"
"21317588","Integration of buprenorphine for substance-abuse treatment by HIV care providers","Friedland G, Vlahov D.","J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S1-2. doi: 10.1097/QAI.0b013e31820bc9ba.","Friedland G","J Acquir Immune Defic Syndr","2011","2011/02/15","","","10.1097/QAI.0b013e31820bc9ba"
"21310583","A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions","Cunningham CO, Giovanniello A, Li X, Kunins HV, Roose RJ, Sohler NL.","J Subst Abuse Treat. 2011 Jun;40(4):349-56. doi: 10.1016/j.jsat.2010.12.002. Epub 2011 Feb 18.","Cunningham CO","J Subst Abuse Treat","2011","2011/02/12","PMC3081891","NIHMS264255","10.1016/j.jsat.2010.12.002"
"21309952","MR spectroscopy in opiate maintenance therapy: association of glutamate with the number of previous withdrawals in the anterior cingulate cortex","Hermann D, Frischknecht U, Heinrich M, Hoerst M, Vollmert C, Vollstädt-Klein S, Tunc-Skarka N, Kiefer F, Mann K, Ende G.","Addict Biol. 2012 May;17(3):659-67. doi: 10.1111/j.1369-1600.2010.00290.x. Epub 2011 Feb 11.","Hermann D","Addict Biol","2012","2011/02/12","","","10.1111/j.1369-1600.2010.00290.x"
"21306845","LC-MS-MS analysis of buprenorphine and norbuprenorphine in whole blood from suspected drug users","Seldén T, Roman M, Druid H, Kronstrand R.","Forensic Sci Int. 2011 Jun 15;209(1-3):113-9. doi: 10.1016/j.forsciint.2011.01.011. Epub 2011 Feb 8.","Seldén T","Forensic Sci Int","2011","2011/02/11","","","10.1016/j.forsciint.2011.01.011"
"21301858","Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage","Skopp G, Kniest A, Haisser J, Mann K, Hermann D.","Int J Legal Med. 2011 Mar;125(2):277-81. doi: 10.1007/s00414-011-0555-8. Epub 2011 Feb 8.","Skopp G","Int J Legal Med","2011","2011/02/09","","","10.1007/s00414-011-0555-8"
"21299671","Commentary on Kraft et al. (2011): Treatment of neonatal abstinence syndrome - morphine, buprenorphine and beyond","Jones HE.","Addiction. 2011 Mar;106(3):581-2. doi: 10.1111/j.1360-0443.2010.03236.x.","Jones HE","Addiction","2011","2011/02/09","","","10.1111/j.1360-0443.2010.03236.x"
"21281215","Efficacy of oral transmucosal and intravenous administration of buprenorphine before surgery for postoperative analgesia in dogs undergoing ovariohysterectomy","Ko JC, Freeman LJ, Barletta M, Weil AB, Payton ME, Johnson BM, Inoue T.","J Am Vet Med Assoc. 2011 Feb 1;238(3):318-28. doi: 10.2460/javma.238.3.318.","Ko JC","J Am Vet Med Assoc","2011","2011/02/02","","","10.2460/javma.238.3.318"
"21277704","Transitioning opioid-dependent patients from detoxification to long-term treatment: efficacy of intensive role induction","Katz EC, Brown BS, Schwartz RP, O'Grady KE, King SD, Gandhi D.","Drug Alcohol Depend. 2011 Aug 1;117(1):24-30. doi: 10.1016/j.drugalcdep.2010.12.024. Epub 2011 Feb 1.","Katz EC","Drug Alcohol Depend","2011","2011/02/01","PMC3090541","NIHMS265381","10.1016/j.drugalcdep.2010.12.024"
"21270789","Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films","Strain EC, Harrison JA, Bigelow GE.","Clin Pharmacol Ther. 2011 Mar;89(3):443-9. doi: 10.1038/clpt.2010.352. Epub 2011 Jan 26.","Strain EC","Clin Pharmacol Ther","2011","2011/01/29","PMC3225026","NIHMS337074","10.1038/clpt.2010.352"
"21269813","[Neonatal seizures, buprenorphine abstinence syndrome, and substitutive treatment with morphine]","Dahan S, Elefant E, Girard I, Azcona B, Champion V, Mitanchez D.","Arch Pediatr. 2011 Mar;18(3):287-90. doi: 10.1016/j.arcped.2010.12.003. Epub 2011 Jan 26.","Dahan S","Arch Pediatr","2011","2011/01/29","","","10.1016/j.arcped.2010.12.003"
"21245178","Buprenorphine implants and opioid dependence","Rastegar DA.","JAMA. 2011 Jan 19;305(3):253; author reply 254-5. doi: 10.1001/jama.2010.1988.","Rastegar DA","JAMA","2011","2011/01/20","","","10.1001/jama.2010.1988"
"21245177","Buprenorphine implants and opioid dependence","Basu D, Kumar V.","JAMA. 2011 Jan 19;305(3):253-4; author reply 254. doi: 10.1001/jama.2010.1989.","Basu D","JAMA","2011","2011/01/20","","","10.1001/jama.2010.1989"
"21239911","Perioperative implications of buprenorphine maintenance treatment for opioid addiction","Gevirtz C, Frost EA, Bryson EO.","Int Anesthesiol Clin. 2011 Winter;49(1):147-55. doi: 10.1097/AIA.0b013e31820aecd4.","Gevirtz C","Int Anesthesiol Clin","2011","2011/01/18","","","10.1097/AIA.0b013e31820aecd4"
"21219701","Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine","Vindenes V, Yttredal B, Oiestad EL, Waal H, Bernard JP, Mørland JG, Christophersen AS.","J Anal Toxicol. 2011 Jan;35(1):32-9. doi: 10.1093/anatox/35.1.32.","Vindenes V","J Anal Toxicol","2011","2011/01/12","","","10.1093/anatox/35.1.32"
"21214706","Two doses of dexmedetomidine in combination with buprenorphine for premedication in dogs; a comparison with acepromazine and buprenorphine","Bell AM, Auckburally A, Pawson P, Scott EM, Flaherty D.","Vet Anaesth Analg. 2011 Jan;38(1):15-23. doi: 10.1111/j.1467-2995.2010.00576.x.","Bell AM","Vet Anaesth Analg","2011","2011/01/11","","","10.1111/j.1467-2995.2010.00576.x"
"21205451","A model for clinical evaluation of perioperative analgesia in rabbits (Oryctolagus cuniculus)","Weaver LA, Blaze CA, Linder DE, Andrutis KA, Karas AZ.","J Am Assoc Lab Anim Sci. 2010 Nov;49(6):845-51.","Weaver LA","J Am Assoc Lab Anim Sci","2010","2011/01/06","PMC2994053","",""
"21199314","Transdermal buprenorphine for central neuropathic pain: clinical reports","Guetti C, Angeletti C, Marinangeli F, Ciccozzi A, Baldascino G, Paladini A, Varrassi G.","Pain Pract. 2011 Sep-Oct;11(5):446-52. doi: 10.1111/j.1533-2500.2010.00434.x. Epub 2010 Dec 29.","Guetti C","Pain Pract","2011","2011/01/05","","","10.1111/j.1533-2500.2010.00434.x"
"21186976","Buprenorphine-induced elevated liver enzymes in an adolescent patient","Upadhyay A, Xueming Y.","J Child Adolesc Psychopharmacol. 2010 Dec;20(6):545-6. doi: 10.1089/cap.2009.0093.","Upadhyay A","J Child Adolesc Psychopharmacol","2010","2010/12/29","","","10.1089/cap.2009.0093"
"21186929","Hypothetical intertemporal choice and real economic behavior: delay discounting predicts voucher redemptions during contingency-management procedures","Bickel WK, Jones BA, Landes RD, Christensen DR, Jackson L, Mancino M.","Exp Clin Psychopharmacol. 2010 Dec;18(6):546-52. doi: 10.1037/a0021739.","Bickel WK","Exp Clin Psychopharmacol","2010","2010/12/29","PMC4034533","NIHMS577657","10.1037/a0021739"
"21182491","Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain","Andresen T, Staahl C, Oksche A, Mansikka H, Arendt-Nielsen L, Drewes AM.","Br J Pharmacol. 2011 Oct;164(3):934-45. doi: 10.1111/j.1476-5381.2010.01180.x.","Andresen T","Br J Pharmacol","2011","2010/12/25","PMC3195916","","10.1111/j.1476-5381.2010.01180.x"
"21181418","[Glossopharyngeal neuralgia after resection of a glossopharyngeal schwannoma]","Lassen CL, Kleinjung T, Strutz J, Graf BM, Wiese CH.","Schmerz. 2011 Feb;25(1):89-92. doi: 10.1007/s00482-010-1007-y.","Lassen CL","Schmerz","2011","2010/12/25","","","10.1007/s00482-010-1007-y"
"21177476","The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward","Khroyan TV, Polgar WE, Cami-Kobeci G, Husbands SM, Zaveri NT, Toll L.","J Pharmacol Exp Ther. 2011 Mar;336(3):952-61. doi: 10.1124/jpet.110.175620. Epub 2010 Dec 21.","Khroyan TV","J Pharmacol Exp Ther","2011","2010/12/24","PMC3061529","","10.1124/jpet.110.175620"
"21175445","(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy","Gordon AL, Lopatko OV, Somogyi AA, Foster DJ, White JM.","Br J Clin Pharmacol. 2010 Dec;70(6):895-902. doi: 10.1111/j.1365-2125.2010.03759.x.","Gordon AL","Br J Clin Pharmacol","2010","2010/12/24","PMC3014073","","10.1111/j.1365-2125.2010.03759.x"
"21169793","p38 Mitogen-activated protein kinase activation by nerve growth factor in primary sensory neurons upregulates μ-opioid receptors to enhance opioid responsiveness toward better pain control","Yamdeu RS, Shaqura M, Mousa SA, Schäfer M, Droese J.","Anesthesiology. 2011 Jan;114(1):150-61. doi: 10.1097/ALN.0b013e318201c88c.","Yamdeu RS","Anesthesiology","2011","2010/12/21","","","10.1097/ALN.0b013e318201c88c"
"21163592","Cigarette smoking and short-term addiction treatment outcome","Harrell PT, Montoya ID, Preston KL, Juliano LM, Gorelick DA.","Drug Alcohol Depend. 2011 Jun 1;115(3):161-6. doi: 10.1016/j.drugalcdep.2010.08.017. Epub 2010 Dec 15.","Harrell PT","Drug Alcohol Depend","2011","2010/12/18","PMC3080462","NIHMS260250","10.1016/j.drugalcdep.2010.08.017"
"21155682","A comparison of acepromazine-buprenorphine and medetomidine-buprenorphine for preanesthetic medication of dogs","Grint NJ, Alderson B, Dugdale AH.","J Am Vet Med Assoc. 2010 Dec 15;237(12):1431-7. doi: 10.2460/javma.237.12.1431.","Grint NJ","J Am Vet Med Assoc","2010","2010/12/16","","","10.2460/javma.237.12.1431"
"21154653","Energy-dependent collision-induced dissociation study of buprenorphine and its synthetic precursors","Biri B, Kalmár J, Nagy L, Sipos A, Zsuga M, Kéki S.","Rapid Commun Mass Spectrom. 2011 Jan 15;25(1):41-9. doi: 10.1002/rcm.4821.","Biri B","Rapid Commun Mass Spectrom","2011","2010/12/15","","","10.1002/rcm.4821"
"21153585","Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine","Strano-Rossi S, Bermejo AM, de la Torre X, Botrè F.","Anal Bioanal Chem. 2011 Feb;399(4):1623-30. doi: 10.1007/s00216-010-4471-4. Epub 2010 Dec 12.","Strano-Rossi S","Anal Bioanal Chem","2011","2010/12/15","","","10.1007/s00216-010-4471-4"
"21145700","Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old","Gianni W, Madaio AR, Ceci M, Benincasa E, Conati G, Franchi F, Galetti G, Nieddu A, Salani B, Zuccaro SM.","J Pain Symptom Manage. 2011 Apr;41(4):707-14. doi: 10.1016/j.jpainsymman.2010.06.015. Epub 2010 Dec 10.","Gianni W","J Pain Symptom Manage","2011","2010/12/15","","","10.1016/j.jpainsymman.2010.06.015"
"21142534","Neonatal abstinence syndrome after methadone or buprenorphine exposure","Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G.","N Engl J Med. 2010 Dec 9;363(24):2320-31. doi: 10.1056/NEJMoa1005359.","Jones HE","N Engl J Med","2010","2010/12/15","PMC3073631","NIHMS258739","10.1056/NEJMoa1005359"
"21138531","Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models","Andresen T, Upton RN, Foster DJ, Christrup LL, Arendt-Nielsen L, Drewes AM.","Basic Clin Pharmacol Toxicol. 2011 Apr;108(4):274-84. doi: 10.1111/j.1742-7843.2010.00649.x. Epub 2010 Dec 8.","Andresen T","Basic Clin Pharmacol Toxicol","2011","2010/12/09","","","10.1111/j.1742-7843.2010.00649.x"
"21135593","Cardiovascular-associated disease in an addicted population: an observation study","Demarie D, Marletta G, Imazio M, Cappa C, Ferro S, Compostino R, De Vivo E, Trinchero R, Bignamini E.","J Cardiovasc Med (Hagerstown). 2011 Jan;12(1):51-4. doi: 10.2459/JCM.0b013e32834033f2.","Demarie D","J Cardiovasc Med (Hagerstown)","2011","2010/12/08","","","10.2459/JCM.0b013e32834033f2"
"21126674","Sublingual buprenorphine","Golembiewski J, Rakic AM.","J Perianesth Nurs. 2010 Dec;25(6):413-5. doi: 10.1016/j.jopan.2010.09.007.","Golembiewski J","J Perianesth Nurs","2010","2010/12/04","","","10.1016/j.jopan.2010.09.007"
"21125263","Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry","Concheiro M, Shakleya DM, Huestis MA.","Anal Bioanal Chem. 2011 Apr;400(1):69-78. doi: 10.1007/s00216-010-4392-2. Epub 2010 Dec 2.","Concheiro M","Anal Bioanal Chem","2011","2010/12/03","PMC3717346","NIHMS486899","10.1007/s00216-010-4392-2"
"21118011","A protocol for managing urethral obstruction in male cats without urethral catheterization","Cooper ES, Owens TJ, Chew DJ, Buffington CA.","J Am Vet Med Assoc. 2010 Dec 1;237(11):1261-6. doi: 10.2460/javma.237.11.1261.","Cooper ES","J Am Vet Med Assoc","2010","2010/12/02","PMC4511701","NIHMS707928","10.2460/javma.237.11.1261"
"21114985","Buprenorphine-induced hyperalgesia in the rat","Wala EP, Holtman JR Jr.","Eur J Pharmacol. 2011 Jan 25;651(1-3):89-95. doi: 10.1016/j.ejphar.2010.10.083. Epub 2010 Nov 30.","Wala EP","Eur J Pharmacol","2011","2010/12/01","","","10.1016/j.ejphar.2010.10.083"
"21112758","The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia","Horyniak D, Dietze P, Larance B, Winstock A, Degenhardt L.","Int J Drug Policy. 2011 Mar;22(2):167-71. doi: 10.1016/j.drugpo.2010.10.004. Epub 2010 Nov 27.","Horyniak D","Int J Drug Policy","2011","2010/11/30","","","10.1016/j.drugpo.2010.10.004"
"21112161","Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain","Benamar K, Palma J, Cowan A, Geller EB, Adler MW.","Drug Alcohol Depend. 2011 Apr 1;114(2-3):246-8. doi: 10.1016/j.drugalcdep.2010.08.015. Epub 2010 Nov 26.","Benamar K","Drug Alcohol Depend","2011","2010/11/30","PMC3985345","NIHMS567130","10.1016/j.drugalcdep.2010.08.015"
"21105573","Preparation and in vivo evaluation of thienorphine-loaded PLGA microspheres","Yang Y, Gao Y.","Pharmazie. 2010 Oct;65(10):729-32.","Yang Y","Pharmazie","2010","2010/11/26","","",""
"21091589","Buprenorphine TTS for children--a review of the drug's clinical pharmacology","Michel E, Anderson BJ, Zernikow B.","Paediatr Anaesth. 2011 Mar;21(3):280-90. doi: 10.1111/j.1460-9592.2010.03437.x. Epub 2010 Nov 21.","Michel E","Paediatr Anaesth","2011","2010/11/25","","","10.1111/j.1460-9592.2010.03437.x"
"21074741","Anesthesia for patients on buprenorphine","Bryson EO, Lipson S, Gevirtz C.","Anesthesiol Clin. 2010 Dec;28(4):611-7. doi: 10.1016/j.anclin.2010.08.005.","Bryson EO","Anesthesiol Clin","2010","2010/11/16","","","10.1016/j.anclin.2010.08.005"
"21074740","Buprenorphine in postoperative pain management","Vadivelu N, Anwar M.","Anesthesiol Clin. 2010 Dec;28(4):601-9. doi: 10.1016/j.anclin.2010.08.015.","Vadivelu N","Anesthesiol Clin","2010","2010/11/16","","","10.1016/j.anclin.2010.08.015"
"21073831","[The licit opioid consumption in Denmark]","Jarlbaek L, Kehlet H, Sjøgren P.","Ugeskr Laeger. 2010 Nov 15;172(46):3173-8.","Jarlbaek L","Ugeskr Laeger","2010","2010/11/16","","",""
"21064010","[Procaine infusion for pain treatment of acute pancreatitis: a randomized, placebo-controlled double-blind trial]","Wilms B, Meffert KS, Schultes B.","Dtsch Med Wochenschr. 2010 Nov;135(46):2290-5. doi: 10.1055/s-0030-1267512. Epub 2010 Nov 9.","Wilms B","Dtsch Med Wochenschr","2010","2010/11/11","","","10.1055/s-0030-1267512"
"21053756","Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance","Awgu E, Magura S, Rosenblum A.","J Psychoactive Drugs. 2010 Sep;42(3):339-46. doi: 10.1080/02791072.2010.10400696.","Awgu E","J Psychoactive Drugs","2010","2010/11/09","PMC3527632","NIHMS426213","10.1080/02791072.2010.10400696"
"21051498","Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal","Paronis CA, Bergman J.","J Pharmacol Exp Ther. 2011 Feb;336(2):488-95. doi: 10.1124/jpet.110.173823. Epub 2010 Nov 4.","Paronis CA","J Pharmacol Exp Ther","2011","2010/11/06","PMC3033719","","10.1124/jpet.110.173823"
"21050175","The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications","Zaveri NT.","Curr Top Med Chem. 2011;11(9):1151-6. doi: 10.2174/156802611795371341.","Zaveri NT","Curr Top Med Chem","2011","2010/11/06","PMC3899399","NIHMS546055","10.2174/156802611795371341"
"21047302","Accidental and non-accidental ingestion of methadone and buprenorphine in childhood: a single center experience, 1999-2009","Martin TC, Rocque MA.","Curr Drug Saf. 2011 Feb 1;6(1):12-6. doi: 10.2174/157488611794480034.","Martin TC","Curr Drug Saf","2011","2010/11/05","","","10.2174/157488611794480034"
"21047194","Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients","Aalto M, Visapää JP, Halme JT, Fabritius C, Salaspuro M.","Nord J Psychiatry. 2011 Sep;65(4):238-43. doi: 10.3109/08039488.2010.531762. Epub 2010 Nov 3.","Aalto M","Nord J Psychiatry","2011","2010/11/05","","","10.3109/08039488.2010.531762"
"21045597","Drug treatment as HIV prevention: a research update","Metzger DS, Woody GE, O'Brien CP.","J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(Suppl 1):S32-6. doi: 10.1097/QAI.0b013e3181f9c10b.","Metzger DS","J Acquir Immune Defic Syndr","2010","2010/11/04","PMC3155766","NIHMS312263","10.1097/QAI.0b013e3181f9c10b"
"21042200","Buprenorphine enhances and prolongs the postoperative analgesic effect of bupivacaine in patients receiving infragluteal sciatic nerve block","Candido KD, Hennes J, Gonzalez S, Mikat-Stevens M, Pinzur M, Vasic V, Knezevic NN.","Anesthesiology. 2010 Dec;113(6):1419-26. doi: 10.1097/ALN.0b013e3181f90ce8.","Candido KD","Anesthesiology","2010","2010/11/03","","","10.1097/ALN.0b013e3181f90ce8"
"20980992","The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone","Jones JD, Sullivan MA, Manubay J, Vosburg SK, Comer SD.","Neuropsychopharmacology. 2011 Jan;36(2):411-22. doi: 10.1038/npp.2010.172. Epub 2010 Oct 27.","Jones JD","Neuropsychopharmacology","2011","2010/10/29","PMC3055661","","10.1038/npp.2010.172"
"20978062","Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","Cornish R, Macleod J, Strang J, Vickerman P, Hickman M.","Version 2. BMJ. 2010 Oct 26;341:c5475. doi: 10.1136/bmj.c5475.","Cornish R","BMJ","2010","2010/10/28","PMC2965139","","10.1136/bmj.c5475"
"20975316","Practical guidelines for acute pancreatitis","Pezzilli R, Zerbi A, Di Carlo V, Bassi C, Delle Fave GF; Working Group of the Italian Association for the Study of the Pancreas on Acute Pancreatitis.","Pancreatology. 2010;10(5):523-35. doi: 10.1159/000314602. Epub 2010 Oct 23.","Pezzilli R","Pancreatology","2010","2010/10/27","","","10.1159/000314602"
"20970267","Fatalities in relation to buprenorphine snorting and ethanol co-ingestion: mechanisms of toxicity","Mégarbane B, Vodovar D, Baud FJ.","Forensic Sci Int. 2011 Apr 15;207(1-3):e59-60. doi: 10.1016/j.forsciint.2010.09.014. Epub 2010 Oct 20.","Mégarbane B","Forensic Sci Int","2011","2010/10/26","","","10.1016/j.forsciint.2010.09.014"
"20965297","Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women","McCance-Katz EF.","Life Sci. 2011 May 23;88(21-22):953-8. doi: 10.1016/j.lfs.2010.09.016. Epub 2010 Oct 19.","McCance-Katz EF","Life Sci","2011","2010/10/23","PMC3272849","NIHMS249435","10.1016/j.lfs.2010.09.016"
"20960411","Pharmacokinetics of buprenorphine in a sodium carboxymethylcellulose gel after buccal transmucosal administration in dogs","Krotscheck U, Boothe DM, Little AA, Erb HN.","Vet Ther. 2010 Fall;11(3):E1-8.","Krotscheck U","Vet Ther","2010","2010/10/21","","",""
"20958853","Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment","Maremmani I, Gerra G.","Am J Addict. 2010 Nov-Dec;19(6):557-68. doi: 10.1111/j.1521-0391.2010.00086.x. Epub 2010 Sep 21.","Maremmani I","Am J Addict","2010","2010/10/21","","","10.1111/j.1521-0391.2010.00086.x"
"20956077","""Should I stay or should I go?"" Coming off methadone and buprenorphine treatment","Winstock AR, Lintzeris N, Lea T.","Int J Drug Policy. 2011 Jan;22(1):77-81. doi: 10.1016/j.drugpo.2010.08.001. Epub 2010 Oct 16.","Winstock AR","Int J Drug Policy","2011","2010/10/20","","","10.1016/j.drugpo.2010.08.001"
"20955107","Heroin anticraving medications: a systematic review","Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K.","Am J Drug Alcohol Abuse. 2010 Nov;36(6):332-41. doi: 10.3109/00952990.2010.505991. Epub 2010 Oct 19.","Fareed A","Am J Drug Alcohol Abuse","2010","2010/10/20","","","10.3109/00952990.2010.505991"
"20952727","The effect of voluntarily ingested buprenorphine on rats subjected to surgically induced global cerebral ischaemia","Kalliokoski O, Abelson KS, Koch J, Boschian A, Thormose SF, Fauerby N, Rasmussen RS, Johansen FF, Hau J.","In Vivo. 2010 Sep-Oct;24(5):641-6.","Kalliokoski O","In Vivo","2010","2010/10/19","","",""
"20940391","Advances in the treatment of opioid dependence: continued progress and ongoing challenges","O'Connor PG.","JAMA. 2010 Oct 13;304(14):1612-4. doi: 10.1001/jama.2010.1496.","O'Connor PG","JAMA","2010","2010/10/14","","","10.1001/jama.2010.1496"
"20940383","Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial","Ling W, Casadonte P, Bigelow G, Kampman KM, Patkar A, Bailey GL, Rosenthal RN, Beebe KL.","JAMA. 2010 Oct 13;304(14):1576-83. doi: 10.1001/jama.2010.1427.","Ling W","JAMA","2010","2010/10/14","","","10.1001/jama.2010.1427"
"20940093","Development and validation of a highly sensitive GC/MS method for the determination of buprenorphine and nor-buprenorphine in blood","Papoutsis II, Nikolaou PD, Athanaselis SA, Pistos CM, Spiliopoulou CA, Maravelias CP.","J Pharm Biomed Anal. 2011 Feb 20;54(3):588-91. doi: 10.1016/j.jpba.2010.09.023.","Papoutsis II","J Pharm Biomed Anal","2011","2010/10/14","","","10.1016/j.jpba.2010.09.023"
"20925688","Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome","Kraft WK, Dysart K, Greenspan JS, Gibson E, Kaltenbach K, Ehrlich ME.","Addiction. 2011 Mar;106(3):574-80. doi: 10.1111/j.1360-0443.2010.03170.x. Epub 2010 Oct 6.","Kraft WK","Addiction","2011","2010/10/08","PMC3022999","NIHMS231900","10.1111/j.1360-0443.2010.03170.x"
"20924888","The use and abuse of opioids. President's message","Lande RG.","J Addict Dis. 2010 Oct;29(4):502-3. doi: 10.1080/10550887.2010.510410.","Lande RG","J Addict Dis","2010","2010/10/07","","","10.1080/10550887.2010.510410"
"20921918","Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone","Pedapati EV, Bateman ST.","Pediatr Crit Care Med. 2011 Mar;12(2):e102-7. doi: 10.1097/PCC.0b013e3181f3a118.","Pedapati EV","Pediatr Crit Care Med","2011","2010/10/06","","","10.1097/PCC.0b013e3181f3a118"
"20919996","Is neonatal abstinence syndrome related to the amount of opiate used?","Thajam D, Atkinson DE, Sibley CP, Lavender T.","J Obstet Gynecol Neonatal Nurs. 2010 Sep-Oct;39(5):503-9. doi: 10.1111/j.1552-6909.2010.01174.x.","Thajam D","J Obstet Gynecol Neonatal Nurs","2010","2010/10/06","","","10.1111/j.1552-6909.2010.01174.x"
"20888988","Addiction treatment in Russia","Krupitsky E, Woody GE, Zvartau E, O'Brien CP.","Lancet. 2010 Oct 2;376(9747):1145. doi: 10.1016/S0140-6736(10)61537-1.","Krupitsky E","Lancet","2010","2010/10/05","","","10.1016/S0140-6736(10)61537-1"
"20881947","Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers","Greenwald MK, Lundahl LH, Steinmiller CL.","Version 2. Neuropsychopharmacology. 2010 Dec;35(13):2624-37. doi: 10.1038/npp.2010.175. Epub 2010 Sep 29.","Greenwald MK","Neuropsychopharmacology","2010","2010/10/01","PMC2978797","NIHMS232470","10.1038/npp.2010.175"
"20877747","Opioid dependence - management in general practice","Frei M.","Aust Fam Physician. 2010 Aug;39(8):548-52.","Frei M","Aust Fam Physician","2010","2010/09/30","","",""
"20868741","Fetal neurobehavioral effects of exposure to methadone or buprenorphine","Jansson LM, Dipietro JA, Velez M, Elko A, Williams E, Milio L, O'Grady K, Jones HE.","Neurotoxicol Teratol. 2011 Mar-Apr;33(2):240-3. doi: 10.1016/j.ntt.2010.09.003. Epub 2010 Sep 22.","Jansson LM","Neurotoxicol Teratol","2011","2010/09/28","PMC3040781","NIHMS240778","10.1016/j.ntt.2010.09.003"
"20864426","Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit","Blandthorn J, Forster DA, Love V.","Women Birth. 2011 Mar;24(1):32-9. doi: 10.1016/j.wombi.2010.07.001. Epub 2010 Oct 14.","Blandthorn J","Women Birth","2011","2010/09/25","","","10.1016/j.wombi.2010.07.001"
"20858364","Comparison of buprenorphine and meloxicam for postsurgical analgesia in rats: effects on body weight, locomotor activity, and hemodynamic parameters","Bourque SL, Adams MA, Nakatsu K, Winterborn A.","J Am Assoc Lab Anim Sci. 2010 Sep;49(5):617-22.","Bourque SL","J Am Assoc Lab Anim Sci","2010","2010/09/23","PMC2949432","",""
"20858363","Assessment of carprofen and buprenorphine on recovery of mice after surgical removal of the mammary fat pad","Adamson TW, Kendall LV, Goss S, Grayson K, Touma C, Palme R, Chen JQ, Borowsky AD.","J Am Assoc Lab Anim Sci. 2010 Sep;49(5):610-6.","Adamson TW","J Am Assoc Lab Anim Sci","2010","2010/09/23","PMC2949431","",""
"20845653","Buprenorphine: a more accessible treatment for opioid dependence","Flassing J.","JAAPA. 2010 Sep;23(9):40-3. doi: 10.1097/01720610-201009000-00008.","Flassing J","JAAPA","2010","2010/09/18","","","10.1097/01720610-201009000-00008"
"20840169","Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study","Carrieri MP, Roux P, Cohen J, Ravaux I, Dellamonica P, Protopopescu C, Spire B, Rosenblum A.","Addiction. 2010 Dec;105(12):2160-8. doi: 10.1111/j.1360-0443.2010.03108.x. Epub 2010 Sep 15.","Carrieri MP","Addiction","2010","2010/09/16","","","10.1111/j.1360-0443.2010.03108.x"
"20837556","Plasma concentrations of corticosterone and buprenorphine in rats subjected to jugular vein catheterization","Goldkuhl R, Jacobsen KR, Kalliokoski O, Hau J, Abelson KS.","Lab Anim. 2010 Oct;44(4):337-43. doi: 10.1258/la.2010.009115. Epub 2010 Sep 13.","Goldkuhl R","Lab Anim","2010","2010/09/15","","","10.1258/la.2010.009115"
"20829393","Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells","Li L, Hassan HE, Tolson AH, Ferguson SS, Eddington ND, Wang H.","J Pharmacol Exp Ther. 2010 Dec;335(3):562-71. doi: 10.1124/jpet.110.173187. Epub 2010 Sep 9.","Li L","J Pharmacol Exp Ther","2010","2010/09/11","PMC2993555","","10.1124/jpet.110.173187"
"20828070","[The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study]","Schutter U, Ritzdorf I, Heckes B.","MMW Fortschr Med. 2010 Aug 12;152(31-33):49.","Schutter U","MMW Fortschr Med","2010","2010/09/11","","",""
"20819387","The effects of perioperative analgesia on litter size in Crl:CD1(ICR) mice undergoing embryo transfer","Goulding DR, Myers PH, Goulding EH, Blankenship TL, Grant MF, Forsythe DB.","J Am Assoc Lab Anim Sci. 2010 Jul;49(4):423-6.","Goulding DR","J Am Assoc Lab Anim Sci","2010","2010/09/08","PMC2919181","",""
"20817384","The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment","Pinto H, Maskrey V, Swift L, Rumball D, Wagle A, Holland R.","J Subst Abuse Treat. 2010 Dec;39(4):340-52. doi: 10.1016/j.jsat.2010.07.009.","Pinto H","J Subst Abuse Treat","2010","2010/09/07","","","10.1016/j.jsat.2010.07.009"
"20803788","Impact of anesthesia, analgesia, and euthanasia technique on the inflammatory cytokine profile in a rodent model of severe burn injury","Al-Mousawi AM, Kulp GA, Branski LK, Kraft R, Mecott GA, Williams FN, Herndon DN, Jeschke MG.","Shock. 2010 Sep;34(3):261-8. doi: 10.1097/shk.0b013e3181d8e2a6.","Al-Mousawi AM","Shock","2010","2010/08/31","PMC3827633","NIHMS319901","10.1097/shk.0b013e3181d8e2a6"
"20803785","Effects of tramadol and buprenorphine on select immunologic factors in a cecal ligation and puncture model","Hugunin KM, Fry C, Shuster K, Nemzek JA.","Shock. 2010 Sep;34(3):250-60. doi: 10.1097/shk.0b013e3181cdc412.","Hugunin KM","Shock","2010","2010/08/31","","","10.1097/shk.0b013e3181cdc412"
"20803321","Drug treatment as HIV prevention: expanding treatment options","Metzger DS, Zhang Y.","Curr HIV/AIDS Rep. 2010 Nov;7(4):220-5. doi: 10.1007/s11904-010-0059-z.","Metzger DS","Curr HIV/AIDS Rep","2010","2010/08/31","PMC3155767","NIHMS312447","10.1007/s11904-010-0059-z"
"20728384","Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects","Hay JL, La Vincente SF, Somogyi AA, Chapleo CB, White JM.","Eur J Pain. 2011 Mar;15(3):293-8. doi: 10.1016/j.ejpain.2010.07.009. Epub 2010 Aug 21.","Hay JL","Eur J Pain","2011","2010/08/24","","","10.1016/j.ejpain.2010.07.009"
"20728299","A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: study feasibility and sample description","Ruetsch C, Cacciola J, Tkacz J.","J Subst Abuse Treat. 2010 Dec;39(4):307-17. doi: 10.1016/j.jsat.2010.07.003. Epub 2010 Aug 21.","Ruetsch C","J Subst Abuse Treat","2010","2010/08/24","","","10.1016/j.jsat.2010.07.003"
"20727704","Physician introduction to opioids for pain among patients with opioid dependence and depressive symptoms","Tsui JI, Herman DS, Kettavong M, Alford D, Anderson BJ, Stein MD.","J Subst Abuse Treat. 2010 Dec;39(4):378-83. doi: 10.1016/j.jsat.2010.06.012. Epub 2010 Aug 19.","Tsui JI","J Subst Abuse Treat","2010","2010/08/24","PMC3129653","NIHMS290891","10.1016/j.jsat.2010.06.012"
"20712608","Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes","Santos LC, Ludders JW, Erb HN, Basher KL, Kirch P, Gleed RD.","Vet Anaesth Analg. 2010 Sep;37(5):417-24. doi: 10.1111/j.1467-2995.2010.00555.x.","Santos LC","Vet Anaesth Analg","2010","2010/08/18","","","10.1111/j.1467-2995.2010.00555.x"
"20709341","Plasma concentrations of buprenorphine after epidural administration in conscious cats","Duke-Novakovski T, Clark CR, Ambros B, Gilbert P, Steagall PV.","Res Vet Sci. 2011 Jun;90(3):480-3. doi: 10.1016/j.rvsc.2010.07.010. Epub 2010 Aug 14.","Duke-Novakovski T","Res Vet Sci","2011","2010/08/17","","","10.1016/j.rvsc.2010.07.010"
"20702049","Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor","Anchersen K, Hansteen V, Gossop M, Clausen T, Waal H.","Drug Alcohol Depend. 2010 Dec 1;112(3):216-9. doi: 10.1016/j.drugalcdep.2010.06.015. Epub 2010 Aug 10.","Anchersen K","Drug Alcohol Depend","2010","2010/08/13","","","10.1016/j.drugalcdep.2010.06.015"
"20699077","[Buprenorphine for the treatment of opioid dependence: a study on generic substitution conducted in community pharmacies]","Julians-Minou G, Bruch S, Peyre N, Sudérie G, Lapeyre-Mestre M, Roussin A.","Therapie. 2010 May-Jun;65(3):241-7. doi: 10.2515/therapie/2010012. Epub 2010 Aug 11.","Julians-Minou G","Therapie","2010","2010/08/12","","","10.2515/therapie/2010012"
"20692778","Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse","Pauly V, Frauger E, Pradel V, Rouby F, Berbis J, Natali F, Reggio P, Coudert H, Micallef J, Thirion X.","Drug Alcohol Depend. 2011 Jan 1;113(1):29-36. doi: 10.1016/j.drugalcdep.2010.06.016. Epub 2010 Aug 8.","Pauly V","Drug Alcohol Depend","2011","2010/08/10","","","10.1016/j.drugalcdep.2010.06.016"
"20689114","Buprenorphine transdermal system has REMS","Thompson CA.","Am J Health Syst Pharm. 2010 Aug 15;67(16):1306. doi: 10.2146/news100055.","Thompson CA","Am J Health Syst Pharm","2010","2010/08/07","","","10.2146/news100055"
"20685494","Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase","Gordon A, Callaghan D, Spink D, Cloutier C, Dzongowski P, O'Mahony W, Sinclair D, Rashiq S, Buckley N, Cohen G, Kim J, Boulanger A, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC, Michalko KJ.","Clin Ther. 2010 May;32(5):844-60. doi: 10.1016/j.clinthera.2010.04.018.","Gordon A","Clin Ther","2010","2010/08/06","","","10.1016/j.clinthera.2010.04.018"
"20682186","Factors associated with complicated buprenorphine inductions","Whitley SD, Sohler NL, Kunins HV, Giovanniello A, Li X, Sacajiu G, Cunningham CO.","J Subst Abuse Treat. 2010 Jul;39(1):51-7. doi: 10.1016/j.jsat.2010.04.001.","Whitley SD","J Subst Abuse Treat","2010","2010/08/05","PMC4755478","NIHMS758106","10.1016/j.jsat.2010.04.001"
"20678551","Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: an uncontrolled trial","Mei W, Zhang JX, Xiao Z.","Neuroscience. 2010 Oct 27;170(3):808-15. doi: 10.1016/j.neuroscience.2010.07.033. Epub 2010 Aug 4.","Mei W","Neuroscience","2010","2010/08/04","","","10.1016/j.neuroscience.2010.07.033"
"20672450","Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir","Bruce RD, Altice FL, Moody DE, Morse GD, Andrews L, Lin SN, Fang WB, Ma Q, Friedland GH.","J Acquir Immune Defic Syndr. 2010 Aug;54(5):511-4. doi: 10.1097/qai.0b013e3181d3cad3.","Bruce RD","J Acquir Immune Defic Syndr","2010","2010/07/31","PMC4841260","NIHMS198833","10.1097/qai.0b013e3181d3cad3"
"20670047","Transdermal buprenorphine in non-oncological moderate-to-severe chronic pain","Gatti A, Dauri M, Leonardis F, Longo G, Marinangeli F, Mammucari M, Sabato AF.","Clin Drug Investig. 2010;30 Suppl 2:31-8. doi: 10.2165/1158409-S0-000000000-00000.","Gatti A","Clin Drug Investig","2010","2010/07/31","","","10.2165/1158409-S0-000000000-00000"
"20666206","Outpatient opioid addiction treatment using buprenorphine","Roberson CM.","Ala Nurse. 2010 Jun-Aug;37(2):13-6; quiz 17.","Roberson CM","Ala Nurse","2010","2010/07/30","","",""
"20658895","Breastfeeding rates among mothers of infants with neonatal abstinence syndrome","Wachman EM, Byun J, Philipp BL.","Breastfeed Med. 2010 Aug;5(4):159-64. doi: 10.1089/bfm.2009.0079.","Wachman EM","Breastfeed Med","2010","2010/07/28","","","10.1089/bfm.2009.0079"
"20652688","High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry","Concheiro M, Gray TR, Shakleya DM, Huestis MA.","Anal Bioanal Chem. 2010 Sep;398(2):915-24. doi: 10.1007/s00216-010-3903-5. Epub 2010 Jul 23.","Concheiro M","Anal Bioanal Chem","2010","2010/07/24","PMC3163083","NIHMS316998","10.1007/s00216-010-3903-5"
"20650513","Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward","Wolfe D, Carrieri MP, Shepard D.","Lancet. 2010 Jul 31;376(9738):355-66. doi: 10.1016/S0140-6736(10)60832-X.","Wolfe D","Lancet","2010","2010/07/24","","","10.1016/S0140-6736(10)60832-X"
"20648912","Buprenorphine in the treatment of opiate dependence","Wesson DR, Smith DE.","J Psychoactive Drugs. 2010 Jun;42(2):161-75. doi: 10.1080/02791072.2010.10400689.","Wesson DR","J Psychoactive Drugs","2010","2010/07/23","","","10.1080/02791072.2010.10400689"
"20642248","A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis","Munera C, Drehobl M, Sessler NE, Landau C.","J Opioid Manag. 2010 May-Jun;6(3):193-202. doi: 10.5055/jom.2010.0017.","Munera C","J Opioid Manag","2010","2010/07/21","","","10.5055/jom.2010.0017"
"20639555","Buprenorphine may boost HIV treatment","Kuehn BM.","JAMA. 2010 Jul 21;304(3):261-3. doi: 10.1001/jama.2010.963.","Kuehn BM","JAMA","2010","2010/07/20","","","10.1001/jama.2010.963"
"20636568","Postoperative analgesic effects of intravenous, intramuscular, subcutaneous or oral transmucosal buprenorphine administered to cats undergoing ovariohysterectomy","Giordano T, Steagall PV, Ferreira TH, Minto BW, de Sá Lorena SE, Brondani J, Luna SP.","Vet Anaesth Analg. 2010 Jul;37(4):357-66. doi: 10.1111/j.1467-2995.2010.00541.x.","Giordano T","Vet Anaesth Analg","2010","2010/07/20","","","10.1111/j.1467-2995.2010.00541.x"
"20632700","Medical treatment of opioid dependence within the South African context","Weich L.","SADJ. 2010 May;65(4):168-71.","Weich L","SADJ","2010","2010/07/17","","",""
"20626723","Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility","Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G.","Addiction. 2010 Sep;105(9):1669-76. doi: 10.1111/j.1360-0443.2010.03015.x. Epub 2010 Jul 9.","Fishman MJ","Addiction","2010","2010/07/15","","","10.1111/j.1360-0443.2010.03015.x"
"20626379","Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial","Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE.","Addiction. 2010 Sep;105(9):1616-24. doi: 10.1111/j.1360-0443.2010.03001.x. Epub 2010 Jul 12.","Polsky D","Addiction","2010","2010/07/15","PMC2967450","NIHMS245693","10.1111/j.1360-0443.2010.03001.x"
"20626377","Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity?","Romelsjö A, Engdahl B, Stenbacka M, Fugelstad A, Davstad I, Leifman A, Thiblin I.","Addiction. 2010 Sep;105(9):1625-32. doi: 10.1111/j.1360-0443.2010.02999.x. Epub 2010 Jul 12.","Romelsjö A","Addiction","2010","2010/07/15","","","10.1111/j.1360-0443.2010.02999.x"
"20616266","Law enforcement and drug treatment: a culture clash","Cohen J.","Science. 2010 Jul 9;329(5988):169. doi: 10.1126/science.329.5988.169.","Cohen J","Science","2010","2010/07/10","","","10.1126/science.329.5988.169"
"20607647","Transplacental transfer and metabolism of buprenorphine in preterm human placenta","Fokina VM, Patrikeeva SL, Zharikova OL, Nanovskaya TN, Hankins GV, Ahmed MS.","Am J Perinatol. 2011 Jan;28(1):25-32. doi: 10.1055/s-0030-1262508. Epub 2010 Jul 6.","Fokina VM","Am J Perinatol","2011","2010/07/08","","","10.1055/s-0030-1262508"
"20598836","Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons","Stein MD, Herman DS, Kettavong M, Cioe PA, Friedmann PD, Tellioglu T, Anderson BJ.","J Subst Abuse Treat. 2010 Sep;39(2):157-66. doi: 10.1016/j.jsat.2010.05.014. Epub 2010 Jul 3.","Stein MD","J Subst Abuse Treat","2010","2010/07/06","PMC2910850","NIHMS219512","10.1016/j.jsat.2010.05.014"
"20598829","Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians","Arfken CL, Johanson CE, di Menza S, Schuster CR.","J Subst Abuse Treat. 2010 Sep;39(2):96-104. doi: 10.1016/j.jsat.2010.05.004. Epub 2010 Jul 3.","Arfken CL","J Subst Abuse Treat","2010","2010/07/06","","","10.1016/j.jsat.2010.05.004"
"20590378","Pregnancy under subutex (buprenorphine): opinions expressed on French internet forums","Simmat-Durand L.","Subst Use Misuse. 2010 Aug;45(10):1652-67. doi: 10.3109/10826081003682164.","Simmat-Durand L","Subst Use Misuse","2010","2010/07/02","","","10.3109/10826081003682164"
"20584850","Pain management in the paediatric population: the regulatory situation in Europe","Fortinguerra F, Maschi S, Clavenna A, Bonati M.","Arch Dis Child. 2010 Sep;95(9):749-53. doi: 10.1136/adc.2009.179549. Epub 2010 Jun 28.","Fortinguerra F","Arch Dis Child","2010","2010/06/30","","","10.1136/adc.2009.179549"
"20584799","The management of heroin misuse in pregnancy: time for a rethink?","Mactier H.","Arch Dis Child Fetal Neonatal Ed. 2011 Nov;96(6):F457-60. doi: 10.1136/adc.2009.181057. Epub 2010 Jun 28.","Mactier H","Arch Dis Child Fetal Neonatal Ed","2011","2010/06/30","","","10.1136/adc.2009.181057"
"20577717","Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers","Duke AN, Correia CJ, Walsh SL, Bigelow GE, Strain EC.","Psychopharmacology (Berl). 2010 Aug;211(3):303-12. doi: 10.1007/s00213-010-1898-4. Epub 2010 Jun 25.","Duke AN","Psychopharmacology (Berl)","2010","2010/06/26","PMC2941639","NIHMS233016","10.1007/s00213-010-1898-4"
"20577660","Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain","Gordon A, Rashiq S, Moulin DE, Clark AJ, Beaulieu AD, Eisenhoffer J, Piraino PS, Quigley P, Harsanyi Z, Darke AC.","Pain Res Manag. 2010 May-Jun;15(3):169-78. doi: 10.1155/2010/216725.","Gordon A","Pain Res Manag","2010","2010/06/26","PMC2912613","","10.1155/2010/216725"
"20554411","Fatal poisoning due to snorting buprenorphine and alcohol consumption","Ferrant O, Papin F, Clin B, Lacroix C, Saussereau E, Remoué JE, Goullé JP.","Forensic Sci Int. 2011 Jan 30;204(1-3):e8-11. doi: 10.1016/j.forsciint.2010.05.015. Epub 2010 Jun 15.","Ferrant O","Forensic Sci Int","2011","2010/06/18","","","10.1016/j.forsciint.2010.05.015"
"20551400","Medication helps make therapy work for teens addicted to prescription opioids","Kuehn BM.","JAMA. 2010 Jun 16;303(23):2343-5. doi: 10.1001/jama.2010.789.","Kuehn BM","JAMA","2010","2010/06/17","","","10.1001/jama.2010.789"
"20545875","Post-marketing surveillance of methadone and buprenorphine in the United States","Dasgupta N, Bailey EJ, Cicero T, Inciardi J, Parrino M, Rosenblum A, Dart RC.","Pain Med. 2010 Jul;11(7):1078-91. doi: 10.1111/j.1526-4637.2010.00877.x. Epub 2010 Jun 8.","Dasgupta N","Pain Med","2010","2010/06/16","","","10.1111/j.1526-4637.2010.00877.x"
"20541900","A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain","James IG, O'Brien CM, McDonald CJ.","J Pain Symptom Manage. 2010 Aug;40(2):266-78. doi: 10.1016/j.jpainsymman.2010.01.013. Epub 2010 Jun 11.","James IG","J Pain Symptom Manage","2010","2010/06/15","","","10.1016/j.jpainsymman.2010.01.013"
"20538178","Oropharyngeal mucositis pain treatment with transdermal buprenorphine in patients after allogeneic stem cell transplantation","Vokurka S, Skardova J, Karas M, Kostkova J, Steinerova K, Koza V, Bystricka E.","J Pain Symptom Manage. 2010 Jun;39(6):e4-6. doi: 10.1016/j.jpainsymman.2010.02.003.","Vokurka S","J Pain Symptom Manage","2010","2010/06/12","","","10.1016/j.jpainsymman.2010.02.003"
"20537815","Effects of experimental Unemployment, Employment and Punishment analogs on opioid seeking and consumption in heroin-dependent volunteers","Greenwald MK.","Drug Alcohol Depend. 2010 Sep 1;111(1-2):64-73. doi: 10.1016/j.drugalcdep.2010.03.020. Epub 2010 May 26.","Greenwald MK","Drug Alcohol Depend","2010","2010/06/12","PMC2930063","NIHMS204282","10.1016/j.drugalcdep.2010.03.020"
"20536336","Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: influence of surgery and postoperative single housing on visceromotor responses","Larauche M, Gourcerol G, Million M, Adelson DW, Taché Y.","Stress. 2010 Jul;13(4):343-54. doi: 10.3109/10253891003664166.","Larauche M","Stress","2010","2010/06/12","PMC3295848","NIHMS356154","10.3109/10253891003664166"
"20532839","Methadone, buprenorphine, and street drug interactions with antiretroviral medications","Gruber VA, McCance-Katz EF.","Curr HIV/AIDS Rep. 2010 Aug;7(3):152-60. doi: 10.1007/s11904-010-0048-2.","Gruber VA","Curr HIV/AIDS Rep","2010","2010/06/10","PMC2892618","","10.1007/s11904-010-0048-2"
"20529288","Enhancement of tolerance development to morphine in rats prenatally exposed to morphine, methadone, and buprenorphine","Chiang YC, Hung TW, Lee CW, Yan JY, Ho IK.","J Biomed Sci. 2010 Jun 7;17(1):46. doi: 10.1186/1423-0127-17-46.","Chiang YC","J Biomed Sci","2010","2010/06/10","PMC2890660","","10.1186/1423-0127-17-46"
"20525028","Buprenorphine in maintenance treatment: experience among Italian physicians in drug addiction centers","Quaglio G, Pattaro C, Gerra G, Mezzelani P, Montanari L, Jarlais DC, Lugoboni F.","Am J Addict. 2010 May-Jun;19(3):222-30. doi: 10.1111/j.1521-0391.2010.00040.x.","Quaglio G","Am J Addict","2010","2010/06/08","","","10.1111/j.1521-0391.2010.00040.x"
"20521592","[All methadone therapy must be safer]","Nilsson LH.","Lakartidningen. 2010 May 5-11;107(18):1213-4.","Nilsson LH","Lakartidningen","2010","2010/06/05","","",""
"20513828","Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial","Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, Cook K, Moore RD.","Ann Intern Med. 2010 Jun 1;152(11):704-11. doi: 10.7326/0003-4819-152-11-201006010-00003.","Lucas GM","Ann Intern Med","2010","2010/06/02","PMC2886293","NIHMS201816","10.7326/0003-4819-152-11-201006010-00003"
"20512898","Robust, unbiased general linear model estimation of phMRI signal amplitude in the presence of variation in the temporal response profile","Pendse GV, Schwarz AJ, Baumgartner R, Coimbra A, Upadhyay J, Borsook D, Becerra L.","J Magn Reson Imaging. 2010 Jun;31(6):1445-57. doi: 10.1002/jmri.22180.","Pendse GV","J Magn Reson Imaging","2010","2010/06/01","","","10.1002/jmri.22180"
"20509084","Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy","Brown ES, Tirado C, Minhajuddin A, Hillhouse M, Adinoff B, Ling W, Doraimani G, Thomas C.","J Ethn Subst Abuse. 2010;9(2):106-14. doi: 10.1080/15332641003772587.","Brown ES","J Ethn Subst Abuse","2010","2010/05/29","PMC3176716","NIHMS318176","10.1080/15332641003772587"
"20492579","Current knowledge of buprenorphine and its unique pharmacological profile","Pergolizzi J, Aloisi AM, Dahan A, Filitz J, Langford R, Likar R, Mercadante S, Morlion B, Raffa RB, Sabatowski R, Sacerdote P, Torres LM, Weinbroum AA.","Pain Pract. 2010 Sep-Oct;10(5):428-50. doi: 10.1111/j.1533-2500.2010.00378.x.","Pergolizzi J","Pain Pract","2010","2010/05/25","","","10.1111/j.1533-2500.2010.00378.x"
"20483578","Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran","Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, Sedaghat A, Ono-Kihara M, Kihara M.","Int J Drug Policy. 2010 Nov;21(6):493-500. doi: 10.1016/j.drugpo.2010.04.006. Epub 2010 May 18.","Zamani S","Int J Drug Policy","2010","2010/05/21","","","10.1016/j.drugpo.2010.04.006"
"20482340","Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale","Jones HE, O'Grady KE, Johnson RE, Velez M, Jansson LM.","Subst Use Misuse. 2010 Nov;45(13):2244-57. doi: 10.3109/10826084.2010.484474. Epub 2010 May 19.","Jones HE","Subst Use Misuse","2010","2010/05/21","","","10.3109/10826084.2010.484474"
"20478668","Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia","Vicknasingam B, Mazlan M, Schottenfeld RS, Chawarski MC.","Drug Alcohol Depend. 2010 Sep 1;111(1-2):44-9. doi: 10.1016/j.drugalcdep.2010.03.014. Epub 2010 May 15.","Vicknasingam B","Drug Alcohol Depend","2010","2010/05/19","","","10.1016/j.drugalcdep.2010.03.014"
"20476679","[Post-operative analgesia in case of ano-rectal diseases]","Rossitto M, Pantè S, Manfrè A, Ciccolo A.","Ann Ital Chir. 2009 Nov-Dec;80(6):459-61; discussion 461.","Rossitto M","Ann Ital Chir","2009","2010/05/19","","",""
"20458550","The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment","Egan JE, Casadonte P, Gartenmann T, Martin J, McCance-Katz EF, Netherland J, Renner JA, Weiss L, Saxon AJ, Fiellin DA.","J Gen Intern Med. 2010 Sep;25(9):936-41. doi: 10.1007/s11606-010-1377-y. Epub 2010 May 11.","Egan JE","J Gen Intern Med","2010","2010/05/12","PMC2917666","","10.1007/s11606-010-1377-y"
"20450244","Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting","Amato P.","Clin Drug Investig. 2010;30 Suppl 1:33-9. doi: 10.2165/11536060-000000000-00000.","Amato P","Clin Drug Investig","2010","2010/05/11","","","10.2165/11536060-000000000-00000"
"20450243","Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre","Stimolo C, Favero VD, Zecchinato G, Buson R, Cusin D, Pellachin P, Simonetto P.","Clin Drug Investig. 2010;30 Suppl 1:27-31. doi: 10.2165/11536030-000000000-00000.","Stimolo C","Clin Drug Investig","2010","2010/05/11","","","10.2165/11536030-000000000-00000"
"20450242","Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study","Magnelli F, Biondi L, Calabria R, Fiore A, Peluso E, Vonella D, Rota AG.","Clin Drug Investig. 2010;30 Suppl 1:21-6. doi: 10.2165/11536010-000000000-00000.","Magnelli F","Clin Drug Investig","2010","2010/05/11","","","10.2165/11536010-000000000-00000"
"20450241","Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre","Montesano F, Zaccone D, Battaglia E, Genco F, Mellace V.","Clin Drug Investig. 2010;30 Suppl 1:13-9. doi: 10.2165/11536040-000000000-00000.","Montesano F","Clin Drug Investig","2010","2010/05/11","","","10.2165/11536040-000000000-00000"
"20450240","Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy","Moratti E, Kashanpour H, Lombardelli T, Maisto M.","Clin Drug Investig. 2010;30 Suppl 1:3-11. doi: 10.2165/11536020-000000000-00000.","Moratti E","Clin Drug Investig","2010","2010/05/11","","","10.2165/11536020-000000000-00000"
"20447786","Estimation of illicit drugs consumption by wastewater analysis in Paris area (France)","Karolak S, Nefau T, Bailly E, Solgadi A, Levi Y.","Forensic Sci Int. 2010 Jul 15;200(1-3):153-60. doi: 10.1016/j.forsciint.2010.04.007. Epub 2010 May 5.","Karolak S","Forensic Sci Int","2010","2010/05/08","","","10.1016/j.forsciint.2010.04.007"
"20447231","A case of poppy tea dependence in an octogenarian lady","Nanjayya SB, Murthy P, Chand PK, Kandaswamy A, Nikketha BS, Benegal V, Shivappa M.","Drug Alcohol Rev. 2010 Mar;29(2):216-8. doi: 10.1111/j.1465-3362.2009.00134.x.","Nanjayya SB","Drug Alcohol Rev","2010","2010/05/08","","","10.1111/j.1465-3362.2009.00134.x"
"20444630","Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","Meyer M, Paranya G, Keefer Norris A, Howard D.","Eur J Pain. 2010 Oct;14(9):939-43. doi: 10.1016/j.ejpain.2010.03.002. Epub 2010 May 4.","Meyer M","Eur J Pain","2010","2010/05/07","","","10.1016/j.ejpain.2010.03.002"
"20434868","Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers","Schuman-Olivier Z, Albanese M, Nelson SE, Roland L, Puopolo F, Klinker L, Shaffer HJ.","J Subst Abuse Treat. 2010 Jul;39(1):41-50. doi: 10.1016/j.jsat.2010.03.014.","Schuman-Olivier Z","J Subst Abuse Treat","2010","2010/05/04","","","10.1016/j.jsat.2010.03.014"
"20421512","Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone","Sekar V, Tomaka F, Lefebvre E, De Pauw M, Vangeneugden T, van den Brink W, Hoetelmans R.","J Clin Pharmacol. 2011 Feb;51(2):271-8. doi: 10.1177/0091270010365558. Epub 2010 Apr 26.","Sekar V","J Clin Pharmacol","2011","2010/04/28","","","10.1177/0091270010365558"
"20420250","Buprenorphine maintenance therapy hinders acute pain management in trauma","Harrington CJ, Zaydfudim V.","Am Surg. 2010 Apr;76(4):397-9.","Harrington CJ","Am Surg","2010","2010/04/28","","",""
"20415289","The diverse clinical uses of opioid receptor drugs","Howland RH.","J Psychosoc Nurs Ment Health Serv. 2010 May;48(5):11-4. doi: 10.3928/02793695-20100408-01.","Howland RH","J Psychosoc Nurs Ment Health Serv","2010","2010/04/27","","","10.3928/02793695-20100408-01"
"20407980","Prenatal drug exposure: infant and toddler outcomes","Bandstra ES, Morrow CE, Mansoor E, Accornero VH.","J Addict Dis. 2010 Apr;29(2):245-58. doi: 10.1080/10550881003684871.","Bandstra ES","J Addict Dis","2010","2010/04/22","","","10.1080/10550881003684871"
"20407978","Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine","Unger A, Jung E, Winklbaur B, Fischer G.","J Addict Dis. 2010 Apr;29(2):217-30. doi: 10.1080/10550881003684814.","Unger A","J Addict Dis","2010","2010/04/22","PMC2858865","NIHMS179775","10.1080/10550881003684814"
"20403021","Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers","Comer SD, Sullivan MA, Vosburg SK, Manubay J, Amass L, Cooper ZD, Saccone P, Kleber HD.","Addiction. 2010 Apr;105(4):709-18. doi: 10.1111/j.1360-0443.2009.02843.x.","Comer SD","Addiction","2010","2010/04/21","PMC3489277","NIHMS367012","10.1111/j.1360-0443.2009.02843.x"
"20393347","HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study","Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE.","J Acquir Immune Defic Syndr. 2010 Sep;55(1):65-72. doi: 10.1097/QAI.0b013e3181d916db.","Meade CS","J Acquir Immune Defic Syndr","2010","2010/04/16","PMC3148945","NIHMS312786","10.1097/QAI.0b013e3181d916db"
"20391820","Treatment of acute pain in opioid tolerant patients","Bean HK, Gannon R.","Conn Med. 2010 Mar;74(3):143-8.","Bean HK","Conn Med","2010","2010/04/16","","",""
"20390697","Favorable mortality profile of naltrexone implants for opiate addiction","Reece AS.","J Addict Dis. 2010 Jan;29(1):30-50. doi: 10.1080/10550880903435988.","Reece AS","J Addict Dis","2010","2010/04/15","","","10.1080/10550880903435988"
"20390696","Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes","Hillhouse M, Domier CP, Chim D, Ling W.","J Addict Dis. 2010 Jan;29(1):23-9. doi: 10.1080/10550880903438925.","Hillhouse M","J Addict Dis","2010","2010/04/15","PMC2856108","NIHMS160339","10.1080/10550880903438925"
"20379336","[Treatment of acute pain during drug-assisted rehabilitation]","Fredheim OM, Nøstdahl T, Nordstrand B, Høivik T, Rygnestad T, Borchgrevink PC.","Tidsskr Nor Laegeforen. 2010 Apr 8;130(7):738-40. doi: 10.4045/tidsskr.09.1110.","Fredheim OM","Tidsskr Nor Laegeforen","2010","2010/04/10","","","10.4045/tidsskr.09.1110"
"20369247","Buprenorphine-related deaths: unusual forensic situations","Pelissier-Alicot AL, Sastre C, Baillif-Couniou V, Gaulier JM, Kintz P, Kuhlmann E, Perich P, Bartoli C, Piercecchi-Marti MD, Leonetti G.","Int J Legal Med. 2010 Nov;124(6):647-51. doi: 10.1007/s00414-010-0449-1. Epub 2010 Apr 6.","Pelissier-Alicot AL","Int J Legal Med","2010","2010/04/07","","","10.1007/s00414-010-0449-1"
"20363983","Effects of voluntarily-ingested buprenorphine on plasma corticosterone levels, body weight, water intake, and behaviour in permanently catheterised rats","Goldkuhl R, Hau J, Abelson KS.","In Vivo. 2010 Mar-Apr;24(2):131-5.","Goldkuhl R","In Vivo","2010","2010/04/06","","",""
"20362408","High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin","Waizmann M, Ackermann G.","J Subst Abuse Treat. 2010 Jun;38(4):338-45. doi: 10.1016/j.jsat.2010.02.002. Epub 2010 Apr 1.","Waizmann M","J Subst Abuse Treat","2010","2010/04/06","","","10.1016/j.jsat.2010.02.002"
"20346350","Distribution of vestibulospinal contacts on the dendrites of ipsilateral splenius motoneurons: an anatomical substrate for push-pull interactions during vestibulocollic reflexes","Grande G, Bui TV, Rose PK.","Brain Res. 2010 May 28;1333:9-27. doi: 10.1016/j.brainres.2010.03.065. Epub 2010 Mar 24.","Grande G","Brain Res","2010","2010/03/30","","","10.1016/j.brainres.2010.03.065"
"20307799","Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network","Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W.","J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S80-6. doi: 10.1016/j.jsat.2009.12.007.","Potter JS","J Subst Abuse Treat","2010","2010/03/24","PMC3150507","NIHMS183956","10.1016/j.jsat.2009.12.007"
"20307796","From research to the real world: buprenorphine in the decade of the Clinical Trials Network","Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B.","J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S53-60. doi: 10.1016/j.jsat.2010.01.009.","Ling W","J Subst Abuse Treat","2010","2010/03/24","PMC2853172","NIHMS175768","10.1016/j.jsat.2010.01.009"
"20307795","A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network","Roman PM, Abraham AJ, Rothrauff TC, Knudsen HK.","J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S44-52. doi: 10.1016/j.jsat.2009.12.008.","Roman PM","J Subst Abuse Treat","2010","2010/03/24","PMC2844868","NIHMS175766","10.1016/j.jsat.2009.12.008"
"20307793","Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network","Martino S, Brigham GS, Higgins C, Gallon S, Freese TE, Albright LM, Hulsey EG, Krom L, Storti SA, Perl H, Nugent CD, Pintello D, Condon TP.","J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S31-43. doi: 10.1016/j.jsat.2009.12.013.","Martino S","J Subst Abuse Treat","2010","2010/03/24","PMC2855549","NIHMS183960","10.1016/j.jsat.2009.12.013"
"20304726","A statistical framework for optimal design matrix generation with application to fMRI","Pendse GV, Baumgartner R, Schwarz AJ, Coimbra A, Borsook D, Becerra L.","IEEE Trans Med Imaging. 2010 Sep;29(9):1573-611. doi: 10.1109/TMI.2010.2044512. Epub 2010 Mar 18.","Pendse GV","IEEE Trans Med Imaging","2010","2010/03/23","","","10.1109/TMI.2010.2044512"
"20303699","Penile and scrotal skin necrosis after injection of crushed buprenorphine tablets","Kluger N, Girard C, Guillot B, Bessis D.","Presse Med. 2010 May;39(5):610-1. doi: 10.1016/j.lpm.2009.12.007. Epub 2010 Mar 19.","Kluger N","Presse Med","2010","2010/03/23","","","10.1016/j.lpm.2009.12.007"
"20303678","Pituitary gland volume among heroin users stabilised on substitution pharmacotherapy","Lorenzetti V, Lubman DI, Velakoulis D, Yücel M.","Drug Alcohol Depend. 2010 Jul 1;110(1-2):164-6. doi: 10.1016/j.drugalcdep.2010.02.012. Epub 2010 Mar 19.","Lorenzetti V","Drug Alcohol Depend","2010","2010/03/23","","","10.1016/j.drugalcdep.2010.02.012"
"20302238","The addicted physician. A rational response to an irrational disease","Seppala MD, Berge KH.","Minn Med. 2010 Feb;93(2):46-9.","Seppala MD","Minn Med","2010","2010/03/23","","",""
"20237808","Postoperative analgesia","Inoue S.","J Anesth. 2010 Apr;24(2):333-6. doi: 10.1007/s00540-010-0920-7. Epub 2010 Mar 18.","Inoue S","J Anesth","2010","2010/03/19","","","10.1007/s00540-010-0920-7"
"20233020","Transdermal buprenorphine for oropharyngeal mucositis-associated pain in patients treated with radiotherapy for head and neck cancer","Huscher A, De Stefani A, Smussi I, Borghetti P, Pasinetti N, Bonetti B, Magrini SM.","J Palliat Med. 2010 Apr;13(4):357-8. doi: 10.1089/jpm.2009.0356.","Huscher A","J Palliat Med","2010","2010/03/18","","","10.1089/jpm.2009.0356"
"20232057","Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse","Jackson KJ, Carroll FI, Negus SS, Damaj MI.","Psychopharmacology (Berl). 2010 Jun;210(2):285-94. doi: 10.1007/s00213-010-1803-1. Epub 2010 Mar 16.","Jackson KJ","Psychopharmacology (Berl)","2010","2010/03/17","PMC2866121","NIHMS195811","10.1007/s00213-010-1803-1"
"20230567","Combination of dexmedetomidine with buprenorphine enhances the antinociceptive effect to a thermal stimulus in the cat compared with either agent alone","Slingsby LS, Murrell JC, Taylor PM.","Vet Anaesth Analg. 2010 Mar;37(2):162-70. doi: 10.1111/j.1467-2995.2009.00519.x.","Slingsby LS","Vet Anaesth Analg","2010","2010/03/17","","","10.1111/j.1467-2995.2009.00519.x"
"20230555","Anaesthesia with a combination of ketamine and medetomidine in the rabbit: effect of premedication with buprenorphine","Murphy KL, Roughan JV, Baxter MG, Flecknell PA.","Vet Anaesth Analg. 2010 May;37(3):222-9. doi: 10.1111/j.1467-2995.2009.00525.x. Epub 2010 Mar 10.","Murphy KL","Vet Anaesth Analg","2010","2010/03/17","","","10.1111/j.1467-2995.2009.00525.x"
"20226512","Sublingual desensitization for buprenorphine hypersensitivity","Stutius LM, Pessach I, Lee J, Lo MS, Levy S, Schram P, Schizer M, Wong J, Phipatanakul W, Umetsu DT.","J Allergy Clin Immunol. 2010 Apr;125(4):938-9. doi: 10.1016/j.jaci.2009.12.982. Epub 2010 Mar 11.","Stutius LM","J Allergy Clin Immunol","2010","2010/03/16","PMC2850949","NIHMS167986","10.1016/j.jaci.2009.12.982"
"20225509","Uzbekistan: government discontinues pilot opiate substitution therapy program","Khachatrian A.","HIV AIDS Policy Law Rev. 2009 Dec;14(2):26-7.","Khachatrian A","HIV AIDS Policy Law Rev","2009","2010/03/16","","",""
"20216119","Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes","Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA.","Ther Drug Monit. 2010 Apr;32(2):206-15. doi: 10.1097/FTD.0b013e3181d0bd68.","Concheiro M","Ther Drug Monit","2010","2010/03/11","PMC2921577","NIHMS198653","10.1097/FTD.0b013e3181d0bd68"
"20213205","Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone","Wang EA, Moore BA, Sullivan LE, Fiellin DA.","J Gen Intern Med. 2010 Jul;25(7):670-4. doi: 10.1007/s11606-010-1306-0. Epub 2010 Mar 6.","Wang EA","J Gen Intern Med","2010","2010/03/10","PMC2881960","","10.1007/s11606-010-1306-0"
"20211913","Embolic stroke associated with injection of buprenorphine tablets","Kramer ED, Dasgupta N, Lim CC, Lee SH, Wong YC, Hui F.","Neurology. 2010 Mar 9;74(10):863; author reply 863-4. doi: 10.1212/WNL.0b013e3181d2b5f6.","Kramer ED","Neurology","2010","2010/03/10","","","10.1212/WNL.0b013e3181d2b5f6"
"20206560","Antinociceptive efficacy and plasma concentrations of transdermal buprenorphine in dogs","Pieper K, Schuster T, Levionnois O, Matis U, Bergadano A.","Vet J. 2011 Mar;187(3):335-41. doi: 10.1016/j.tvjl.2010.01.013. Epub 2010 Mar 4.","Pieper K","Vet J","2011","2010/03/09","","","10.1016/j.tvjl.2010.01.013"
"20189638","HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use.","Lancet. 2010 Mar 20;375(9719):1014-28. doi: 10.1016/S0140-6736(10)60232-2. Epub 2010 Feb 26.","Mathers BM","Lancet","2010","2010/03/02","","","10.1016/S0140-6736(10)60232-2"
"20189341","Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment","Mégarbane B, Buisine A, Jacobs F, Résière D, Chevillard L, Vicaut E, Baud FJ.","J Subst Abuse Treat. 2010 Jun;38(4):403-7. doi: 10.1016/j.jsat.2010.01.006. Epub 2010 Feb 26.","Mégarbane B","J Subst Abuse Treat","2010","2010/03/02","","","10.1016/j.jsat.2010.01.006"
"20180662","Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials","Castells X, Kosten TR, Capellà D, Vidal X, Colom J, Casas M.","Am J Drug Alcohol Abuse. 2009;35(5):339-49. doi: 10.1080/00952990903108215.","Castells X","Am J Drug Alcohol Abuse","2009","2010/02/26","","","10.1080/00952990903108215"
"20177974","Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment","Springer SA, Chen S, Altice FL.","J Urban Health. 2010 Jul;87(4):592-602. doi: 10.1007/s11524-010-9438-4.","Springer SA","J Urban Health","2010","2010/02/24","PMC2900572","","10.1007/s11524-010-9438-4"
"20169438","The pharmacological treatment of opioid addiction--a clinical perspective","Lobmaier P, Gossop M, Waal H, Bramness J.","Eur J Clin Pharmacol. 2010 Jun;66(6):537-45. doi: 10.1007/s00228-010-0793-6. Epub 2010 Feb 19.","Lobmaier P","Eur J Clin Pharmacol","2010","2010/02/20","","","10.1007/s00228-010-0793-6"
"20164504","Maximising the treatment outcomes of opioid substitution treatment","Day E.","Evid Based Ment Health. 2010 Feb;13(1):5-7. doi: 10.1136/ebmh.13.1.5.","Day E","Evid Based Ment Health","2010","2010/02/19","","","10.1136/ebmh.13.1.5"
"20163395","Pharmacy willingness to partner with office-based opioid dependence treatment providers in conducting random buprenorphine pill counts","Lofwall MR, Wunsch MJ, Walsh SL.","Am J Addict. 2010 Mar-Apr;19(2):195-6. doi: 10.1111/j.1521-0391.2009.00026.x.","Lofwall MR","Am J Addict","2010","2010/02/19","","","10.1111/j.1521-0391.2009.00026.x"
"20157043","Livedoid and necrotic skin lesions due to intra-arterial buprenorphine injections evidenced by maltese cross-shaped histologic bodies","Schneider P, Duong TA, Ortonne N, Bagot M, Bouaziz JD.","Arch Dermatol. 2010 Feb;146(2):208-9. doi: 10.1001/archdermatol.2009.372.","Schneider P","Arch Dermatol","2010","2010/02/17","","","10.1001/archdermatol.2009.372"
"20155596","What is diversion of supervised buprenorphine and how common is it?","Winstock AR, Lea T, Sheridan J.","J Addict Dis. 2009 Jul;28(3):269-78. doi: 10.1080/10550880903028841.","Winstock AR","J Addict Dis","2009","2010/02/16","","","10.1080/10550880903028841"
"20155591","Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence","Monte AA, Mandell T, Wilford BB, Tennyson J, Boyer EW.","J Addict Dis. 2009 Jul;28(3):226-31. doi: 10.1080/10550880903014767.","Monte AA","J Addict Dis","2009","2010/02/16","","","10.1080/10550880903014767"
"20150662","Early experience with Suboxone maintenance therapy in Hungary","Demetrovics Z, Farkas J, Csorba J, Németh A, Mervó B, Szemelyácz J, Fleischmann E, Kassai-Farkas A, Petke Z, Oroján T, Rózsa S, Rigó P, Funk S, Kapitány M, Kollár A, Rácz J.","Neuropsychopharmacol Hung. 2009 Dec;11(4):249-57.","Demetrovics Z","Neuropsychopharmacol Hung","2009","2010/02/13","","",""
"20145406","Impact of surgical severity and analgesic treatment on plasma corticosterone in rats during surgery","Goldkuhl R, Klockars A, Carlsson HE, Hau J, Abelson KS.","Eur Surg Res. 2010;44(2):117-23. doi: 10.1159/000264962. Epub 2010 Feb 9.","Goldkuhl R","Eur Surg Res","2010","2010/02/11","","","10.1159/000264962"
"20142307","Utility of saccadic eye movement analysis as an objective biomarker to detect the sedative interaction between opioids and sleep deprivation in opioid-naive and opioid-tolerant populations","Grace PM, Stanford T, Gentgall M, Rolan PE.","J Psychopharmacol. 2010 Nov;24(11):1631-40. doi: 10.1177/0269881109352704. Epub 2010 Feb 8.","Grace PM","J Psychopharmacol","2010","2010/02/10","","","10.1177/0269881109352704"
"20140302","Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits","Sakuraba S, Tsujita M, Arisaka H, Takeda J, Yoshida K, Kuwana S.","Biol Res. 2009;42(4):469-75. Epub 2010 Jan 29.","Sakuraba S","Biol Res","2009","2010/02/09","","",""
"20132125","Methadone and buprenorphine toxicity in children","Boyer EW, McCance-Katz EF, Marcus S.","Am J Addict. 2010 Jan-Feb;19(1):89-95. doi: 10.1111/j.1521-0391.2009.00002.x.","Boyer EW","Am J Addict","2010","2010/02/06","","","10.1111/j.1521-0391.2009.00002.x"
"20132124","Indicators of buprenorphine and methadone use and abuse: what do we know?","Maxwell JC, McCance-Katz EF.","Am J Addict. 2010 Jan-Feb;19(1):73-88. doi: 10.1111/j.1521-0391.2009.00008.x.","Maxwell JC","Am J Addict","2010","2010/02/06","PMC3723402","NIHMS471262","10.1111/j.1521-0391.2009.00008.x"
"20132123","Benzodiazepines, methadone and buprenorphine: interactions and clinical management","Lintzeris N, Nielsen S.","Am J Addict. 2010 Jan-Feb;19(1):59-72. doi: 10.1111/j.1521-0391.2009.00007.x.","Lintzeris N","Am J Addict","2010","2010/02/06","","","10.1111/j.1521-0391.2009.00007.x"
"20132122","The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence","Sullivan LE, Moore BA, O'Connor PG, Barry DT, Chawarski MC, Schottenfeld RS, Fiellin DA.","Am J Addict. 2010 Jan-Feb;19(1):53-8. doi: 10.1111/j.1521-0391.2009.00003.x.","Sullivan LE","Am J Addict","2010","2010/02/06","PMC3107713","NIHMS186414","10.1111/j.1521-0391.2009.00003.x"
"20132120","Effect of cocaine use on buprenorphine pharmacokinetics in humans","McCance-Katz EF, Rainey PM, Moody DE.","Am J Addict. 2010 Jan-Feb;19(1):38-46. doi: 10.1111/j.1521-0391.2009.00001.x.","McCance-Katz EF","Am J Addict","2010","2010/02/06","","","10.1111/j.1521-0391.2009.00001.x"
"20132119","Lack of clinically significant drug interactions between nevirapine and buprenorphine","McCance-Katz EF, Moody DE, Morse GD, Ma Q, Rainey PM.","Am J Addict. 2010 Jan-Feb;19(1):30-7. doi: 10.1111/j.1521-0391.2009.00006.x.","McCance-Katz EF","Am J Addict","2010","2010/02/06","PMC3723410","NIHMS471260","10.1111/j.1521-0391.2009.00006.x"
"20132118","Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir","Baker J, Rainey PM, Moody DE, Morse GD, Ma Q, McCance-Katz EF.","Am J Addict. 2010 Jan-Feb;19(1):17-29. doi: 10.1111/j.1521-0391.2009.00004.x.","Baker J","Am J Addict","2010","2010/02/06","PMC3723405","NIHMS471248","10.1111/j.1521-0391.2009.00004.x"
"20132117","Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","McCance-Katz EF, Sullivan LE, Nallani S.","Am J Addict. 2010 Jan-Feb;19(1):4-16. doi: 10.1111/j.1521-0391.2009.00005.x.","McCance-Katz EF","Am J Addict","2010","2010/02/06","PMC3334287","NIHMS186415","10.1111/j.1521-0391.2009.00005.x"
"20132116","Drug interactions of clinical importance with methadone and buprenorphine","McCance-Katz EF, Mandell TW.","Am J Addict. 2010 Jan-Feb;19(1):2-3. doi: 10.1111/j.1521-0391.2009.00011.x.","McCance-Katz EF","Am J Addict","2010","2010/02/06","PMC3723408","NIHMS471317","10.1111/j.1521-0391.2009.00011.x"
"20130408","Bioavailability of buprenorphine from crushed and whole buprenorphine (subutex) tablets","Simojoki K, Lillsunde P, Lintzeris N, Alho H.","Eur Addict Res. 2010;16(2):85-90. doi: 10.1159/000279766. Epub 2010 Feb 3.","Simojoki K","Eur Addict Res","2010","2010/02/05","","","10.1159/000279766"
"20122691","Issues pertaining to the analysis of buprenorphine and its metabolites by gas chromatography-mass spectrometry","Wang YS, Lin DL, Yang SC, Wu MY, Liu RH, Su LW, Cheng PS, Liu C, Fuh MR.","J Chromatogr A. 2010 Mar 5;1217(10):1688-94. doi: 10.1016/j.chroma.2010.01.038. Epub 2010 Jan 18.","Wang YS","J Chromatogr A","2010","2010/02/04","","","10.1016/j.chroma.2010.01.038"
"20116457","A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology","Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W.","Contemp Clin Trials. 2010 Mar;31(2):189-99. doi: 10.1016/j.cct.2010.01.003. Epub 2010 Jan 29.","Weiss RD","Contemp Clin Trials","2010","2010/02/02","PMC2831115","NIHMS174593","10.1016/j.cct.2010.01.003"
"20111869","An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation","Oechsler S, Skopp G.","Int J Legal Med. 2010 May;124(3):187-94. doi: 10.1007/s00414-010-0418-8. Epub 2010 Jan 29.","Oechsler S","Int J Legal Med","2010","2010/01/30","","","10.1007/s00414-010-0418-8"
"20106601","Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial","Gunderson EW, Wang XQ, Fiellin DA, Bryan B, Levin FR.","Addict Behav. 2010 May;35(5):537-40. doi: 10.1016/j.addbeh.2010.01.001. Epub 2010 Jan 18.","Gunderson EW","Addict Behav","2010","2010/01/29","PMC2830372","NIHMS173830","10.1016/j.addbeh.2010.01.001"
"20094116","[Family practitioner and the heroin addict]","Haraldsen M.","Tidsskr Nor Laegeforen. 2010 Jan 14;130(1):16. doi: 10.4045/tidsskr.09.0400.","Haraldsen M","Tidsskr Nor Laegeforen","2010","2010/01/23","","","10.4045/tidsskr.09.0400"
"20081245","Magnesium ions and opioid agonists in vincristine-induced neuropathy","Bujalska M, Makulska-Nowak H, Gumułka SW.","Pharmacol Rep. 2009 Nov-Dec;61(6):1096-104. doi: 10.1016/s1734-1140(09)70172-0.","Bujalska M","Pharmacol Rep","2009","2010/01/19","","","10.1016/s1734-1140(09)70172-0"
"20080369","Buprenorphine detection in hair samples by immunometric screening test: preliminary experience","Svaizer F, Lotti A, Gottardi M, Miozzo MP.","Forensic Sci Int. 2010 Mar 20;196(1-3):118-20. doi: 10.1016/j.forsciint.2009.12.047. Epub 2010 Jan 18.","Svaizer F","Forensic Sci Int","2010","2010/01/19","","","10.1016/j.forsciint.2009.12.047"
"20078490","Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia","Winstock AR, Lea T, Sheridan J.","Addiction. 2010 Feb;105(2):335-42. doi: 10.1111/j.1360-0443.2009.02774.x.","Winstock AR","Addiction","2010","2010/01/19","","","10.1111/j.1360-0443.2009.02774.x"
"20078480","Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review","Larney S.","Addiction. 2010 Feb;105(2):216-23. doi: 10.1111/j.1360-0443.2009.02826.x.","Larney S","Addiction","2010","2010/01/19","","","10.1111/j.1360-0443.2009.02826.x"
"20074867","A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis","Meader N.","Drug Alcohol Depend. 2010 Apr 1;108(1-2):110-4. doi: 10.1016/j.drugalcdep.2009.12.008. Epub 2010 Jan 13.","Meader N","Drug Alcohol Depend","2010","2010/01/16","","","10.1016/j.drugalcdep.2009.12.008"
"20073406","A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine-naloxone combination","Tacke U, Uosukainen H, Kananen M, Kontra K, Pentikänen H.","J Opioid Manag. 2009 Nov-Dec;5(6):321-9. doi: 10.5055/jom.2009.0032.","Tacke U","J Opioid Manag","2009","2010/01/16","","","10.5055/jom.2009.0032"
"20061095","On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data","Tallarida RJ, Cowan A, Raffa RB.","Drug Alcohol Depend. 2010 Jun 1;109(1-3):126-9. doi: 10.1016/j.drugalcdep.2009.12.014. Epub 2010 Jan 12.","Tallarida RJ","Drug Alcohol Depend","2010","2010/01/12","PMC3996554","NIHMS573675","10.1016/j.drugalcdep.2009.12.014"
"20056555","Comparison of subcutaneous and transdermal administration of buprenorphine for pre-emptive analgesia in dogs undergoing elective ovariohysterectomy","Moll X, Fresno L, García F, Prandi D, Andaluz A.","Vet J. 2011 Jan;187(1):124-8. doi: 10.1016/j.tvjl.2009.11.011. Epub 2009 Dec 28.","Moll X","Vet J","2011","2010/01/09","","","10.1016/j.tvjl.2009.11.011"
"20053487","[Infectious adverse events related to misuse of high-dose buprenorphine: a retrospective study of 42 cases]","Grau D, Vidal N, Faucherre V, Léglise Y, Pinzani V, Blayac JP, Reynes J, Peyrière H.","Rev Med Interne. 2010 Mar;31(3):188-93. doi: 10.1016/j.revmed.2009.10.433. Epub 2010 Jan 6.","Grau D","Rev Med Interne","2010","2010/01/08","","","10.1016/j.revmed.2009.10.433"
"20051159","[Guideline 'Medicinal care for drug addicts in penal institutions']","Westra M, de Haan HA, Arends MT, van Everdingen JJ, Klazinga NS; Centraal BegeleidingsOrgaan.","Ned Tijdschr Geneeskd. 2009;153:A726.","Westra M","Ned Tijdschr Geneeskd","2009","2010/01/07","","",""
"20045358","Serum concentrations of buprenorphine after oral and parenteral administration in male mice","Kalliokoski O, Jacobsen KR, Hau J, Abelson KS.","Vet J. 2011 Feb;187(2):251-4. doi: 10.1016/j.tvjl.2009.11.013. Epub 2009 Dec 31.","Kalliokoski O","Vet J","2011","2010/01/05","","","10.1016/j.tvjl.2009.11.013"
"20043989","Chronic in utero buprenorphine exposure causes prolonged respiratory effects in the guinea pig neonate","Wallisch M, Subban CV, Nettleton RT, Olsen GD.","Neurotoxicol Teratol. 2010 May-Jun;32(3):398-405. doi: 10.1016/j.ntt.2009.12.007. Epub 2009 Dec 31.","Wallisch M","Neurotoxicol Teratol","2010","2010/01/02","PMC2854243","NIHMS169688","10.1016/j.ntt.2009.12.007"
"20034328","[Therapeutic response in outpatient opioid substitution treatment]","Barisić V, Barisić Z.","Acta Med Croatica. 2009 Oct;63(4):279-83.","Barisić V","Acta Med Croatica","2009","2009/12/26","","",""
"20033362","Buprenorphine modulates methamphetamine-induced dopamine dynamics in the rat caudate nucleus","Pereira FC, Gough B, Macedo TR, Ribeiro CF, Ali SF, Binienda ZK.","Neurotox Res. 2011 Jan;19(1):94-101. doi: 10.1007/s12640-009-9143-9. Epub 2009 Dec 22.","Pereira FC","Neurotox Res","2011","2009/12/25","","","10.1007/s12640-009-9143-9"
"20025454","Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance","Ponizovsky AM, Margolis A, Heled L, Rosca P, Radomislensky I, Grinshpoon A.","Subst Use Misuse. 2010;45(1-2):288-313. doi: 10.3109/10826080902873010.","Ponizovsky AM","Subst Use Misuse","2010","2009/12/23","","","10.3109/10826080902873010"
"20025451","Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia","Winstock AR, Lea T.","Subst Use Misuse. 2010;45(1-2):240-52. doi: 10.3109/10826080903080664.","Winstock AR","Subst Use Misuse","2010","2009/12/23","","","10.3109/10826080903080664"
"20017817","Effects of opioids and anesthetic drugs on body temperature in cats","Posner LP, Pavuk AA, Rokshar JL, Carter JE, Levine JF.","Vet Anaesth Analg. 2010 Jan;37(1):35-43. doi: 10.1111/j.1467-2995.2009.00508.x.","Posner LP","Vet Anaesth Analg","2010","2009/12/19","","","10.1111/j.1467-2995.2009.00508.x"
"20014914","Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening","Schwarz RK, Bruce RD, Ball SA, Herme M, Altice FL.","Am J Drug Alcohol Abuse. 2009;35(6):439-44. doi: 10.3109/00952990903447741.","Schwarz RK","Am J Drug Alcohol Abuse","2009","2009/12/18","","","10.3109/00952990903447741"
"20010421","Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression","Dahan A, Aarts L, Smith TW.","Anesthesiology. 2010 Jan;112(1):226-38. doi: 10.1097/ALN.0b013e3181c38c25.","Dahan A","Anesthesiology","2010","2009/12/17","","","10.1097/ALN.0b013e3181c38c25"
"20006453","Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes","Oechsler S, Skopp G.","Forensic Sci Int. 2010 Feb 25;195(1-3):73-7. doi: 10.1016/j.forsciint.2009.11.015. Epub 2009 Dec 16.","Oechsler S","Forensic Sci Int","2010","2009/12/17","","","10.1016/j.forsciint.2009.11.015"
"20004317","[Blasch-kolinear psoriasis revealed by infliximab therapy]","Sfia M, Roth-Mall B, Tortel MC, Guillaume JC, Cribier B.","Ann Dermatol Venereol. 2009 Dec;136(12):898-903. doi: 10.1016/j.annder.2009.09.011.","Sfia M","Ann Dermatol Venereol","2009","2009/12/17","","","10.1016/j.annder.2009.09.011"
"19948382","Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study","Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD.","Drug Alcohol Depend. 2010 Mar 1;107(2-3):253-6. doi: 10.1016/j.drugalcdep.2009.10.014. Epub 2009 Nov 30.","Chakrabarti A","Drug Alcohol Depend","2010","2009/12/02","PMC2821971","NIHMS162050","10.1016/j.drugalcdep.2009.10.014"
"19945361","Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women","Concheiro M, Jones H, Johnson RE, Shakleya DM, Huestis MA.","J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jan 1;878(1):13-20. doi: 10.1016/j.jchromb.2009.11.005.","Concheiro M","J Chromatogr B Analyt Technol Biomed Life Sci","2010","2009/12/01","PMC3844292","NIHMS161879","10.1016/j.jchromb.2009.11.005"
"19935937","[Interactions with methadone and buprenorphine]","Bakke E, Bachs L.","Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2364-6. doi: 10.4045/tidsskr.09.0471.","Bakke E","Tidsskr Nor Laegeforen","2009","2009/11/26","","","10.4045/tidsskr.09.0471"
"19931991","Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine","Sarfi M, Martinsen H, Bakstad B, Røislien J, Waal H.","Early Hum Dev. 2009 Dec;85(12):773-8. doi: 10.1016/j.earlhumdev.2009.10.006. Epub 2009 Nov 20.","Sarfi M","Early Hum Dev","2009","2009/11/26","","","10.1016/j.earlhumdev.2009.10.006"
"19930026","Why do patients report transferring between methadone and buprenorphine?","Winstock AR, Lintzeris N, Lea T.","Drug Alcohol Rev. 2009 Nov;28(6):686-7. doi: 10.1111/j.1465-3362.2009.00127.x.","Winstock AR","Drug Alcohol Rev","2009","2009/11/26","","","10.1111/j.1465-3362.2009.00127.x"
"19926271","Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine","Schaub M, Chtenguelov V, Subata E, Weiler G, Uchtenhagen A.","Int J Drug Policy. 2010 May;21(3):229-33. doi: 10.1016/j.drugpo.2009.10.005. Epub 2009 Nov 18.","Schaub M","Int J Drug Policy","2010","2009/11/21","","","10.1016/j.drugpo.2009.10.005"
"19925973","Buprenorphine with bupivacaine for intraoral nerve blocks to provide postoperative analgesia in outpatients after minor oral surgery","Modi M, Rastogi S, Kumar A.","J Oral Maxillofac Surg. 2009 Dec;67(12):2571-6. doi: 10.1016/j.joms.2009.07.014.","Modi M","J Oral Maxillofac Surg","2009","2009/11/21","","","10.1016/j.joms.2009.07.014"
"19923837","Suboxone (buprenorphine/naloxone) as an agonist opioid treatment in Spain: a budgetary impact analysis","Martínez-Raga J, González Saiz F, Pascual C, Casado MA, Sabater Torres FJ.","Eur Addict Res. 2010;16(1):31-42. doi: 10.1159/000259614. Epub 2009 Nov 19.","Martínez-Raga J","Eur Addict Res","2010","2009/11/20","","","10.1159/000259614"
"19922884","Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study","Mercadante S, Porzio G, Ferrera P, Aielli F, Verna L, Tirelli W, Villari P, Casuccio A.","Clin Ther. 2009 Oct;31(10):2134-8. doi: 10.1016/j.clinthera.2009.10.013.","Mercadante S","Clin Ther","2009","2009/11/20","","","10.1016/j.clinthera.2009.10.013"
"19922570","Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting","Senn O, Seidenberg A, Rosemann T.","Addiction. 2009 Dec;104(12):2033-8. doi: 10.1111/j.1360-0443.2009.02766.x.","Senn O","Addiction","2009","2009/11/20","","","10.1111/j.1360-0443.2009.02766.x"
"19921357","Postoperative analgesic effect of preoperative intravenous flurbiprofen in arthroscopic rotator cuff repair","Takada M, Fukusaki M, Terao Y, Yamashita K, Takada M, Ando Y, Sumikawa K.","J Anesth. 2009;23(4):500-3. doi: 10.1007/s00540-009-0799-3. Epub 2009 Nov 18.","Takada M","J Anesth","2009","2009/11/19","","","10.1007/s00540-009-0799-3"
"19920716","Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group","Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT; Cancer Pain Outcome Research Study Group (CPOR SG) Investigators, Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F.","Clin J Pain. 2009 Oct;25(8):671-82. doi: 10.1097/AJP.0b013e3181a38f9d.","Apolone G","Clin J Pain","2009","2009/11/19","","","10.1097/AJP.0b013e3181a38f9d"
"19918165","Effectiveness of full agonist opioids in patients stabilized on buprenorphine undergoing major surgery: a case series","Kornfeld H, Manfredi L.","Am J Ther. 2010 Sep-Oct;17(5):523-8. doi: 10.1097/MJT.0b013e3181be0804.","Kornfeld H","Am J Ther","2010","2009/11/18","","","10.1097/MJT.0b013e3181be0804"
"19898579","[A political order]","Eide-Olsen B.","Tidsskr Nor Laegeforen. 2009 Nov 5;129(21):2260-1. doi: 10.4045/tidsskr.09.0916.","Eide-Olsen B","Tidsskr Nor Laegeforen","2009","2009/11/10","","","10.4045/tidsskr.09.0916"
"19888882","Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles","Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY.","J Microencapsul. 2009 Dec;26(8):734-47. doi: 10.3109/02652040902746679.","Wang JJ","J Microencapsul","2009","2009/11/06","","","10.3109/02652040902746679"
"19887803","Why do the clients of Georgian needle exchange programmes inject buprenorphine?","Otiashvili D, Zabransky T, Kirtadze I, Piralishvili G, Chavchanidze M, Miovsky M.","Eur Addict Res. 2010;16(1):1-8. doi: 10.1159/000253858. Epub 2009 Nov 2.","Otiashvili D","Eur Addict Res","2010","2009/11/06","","","10.1159/000253858"
"19887017","Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)","Tournier N, Chevillard L, Megarbane B, Pirnay S, Scherrmann JM, Declèves X.","Int J Neuropsychopharmacol. 2010 Aug;13(7):905-15. doi: 10.1017/S1461145709990848. Epub 2009 Nov 4.","Tournier N","Int J Neuropsychopharmacol","2010","2009/11/06","","","10.1017/S1461145709990848"
"19882460","Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation?","Burris S, Davis C.","Am J Bioeth. 2009 Nov;9(11):48-54. doi: 10.1080/15265160903197507.","Burris S","Am J Bioeth","2009","2009/11/03","","","10.1080/15265160903197507"
"19882396","HIV provider endorsement of primary care buprenorphine treatment: a vignette study","Kunins HV, Sohler NL, Roose RJ, Cunningham CO.","Fam Med. 2009 Nov-Dec;41(10):722-8.","Kunins HV","Fam Med","2009","2009/11/03","PMC2827924","NIHMS161102",""
"19874646","Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry","Fang WB, Chang Y, McCance-Katz EF, Moody DE.","J Anal Toxicol. 2009 Oct;33(8):409-17. doi: 10.1093/jat/33.8.409.","Fang WB","J Anal Toxicol","2009","2009/10/31","","","10.1093/jat/33.8.409"
"19874152","Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","Gwin Mitchell S, Kelly SM, Brown BS, Schacht Reisinger H, Peterson JA, Ruhf A, Agar MH, O'Grady KE, Schwartz RP.","Am J Addict. 2009 Sep-Oct;18(5):346-55. doi: 10.3109/10550490903077820.","Gwin Mitchell S","Am J Addict","2009","2009/10/31","PMC2771323","NIHMS137072","10.3109/10550490903077820"
"19858164","Influence of preferred foodstuffs on the antinociceptive effects of orally administered buprenorphine in laboratory rats","Leach MC, Forrester AR, Flecknell PA.","Lab Anim. 2010 Jan;44(1):54-8. doi: 10.1258/la.2009.009029. Epub 2009 Oct 26.","Leach MC","Lab Anim","2010","2009/10/28","","","10.1258/la.2009.009029"
"19843785","The effects of sevoflurane and propofol on glucose metabolism under aerobic conditions in fed rats","Kitamura T, Ogawa M, Kawamura G, Sato K, Yamada Y.","Anesth Analg. 2009 Nov;109(5):1479-85. doi: 10.1213/ANE.0b013e3181b8554a.","Kitamura T","Anesth Analg","2009","2009/10/22","","","10.1213/ANE.0b013e3181b8554a"
"19841060","Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes","Rouguieg K, Picard N, Sauvage FL, Gaulier JM, Marquet P.","Drug Metab Dispos. 2010 Jan;38(1):40-5. doi: 10.1124/dmd.109.029546.","Rouguieg K","Drug Metab Dispos","2010","2009/10/21","","","10.1124/dmd.109.029546"
"19836984","A prospective multi-centre clinical trial to compare buprenorphine and butorphanol for postoperative analgesia in cats","Taylor PM, Kirby JJ, Robinson C, Watkins EA, Clarke DD, Ford MA, Church KE.","J Feline Med Surg. 2010 Apr;12(4):247-55. doi: 10.1016/j.jfms.2009.09.004. Epub 2009 Oct 17.","Taylor PM","J Feline Med Surg","2010","2009/10/20","","","10.1016/j.jfms.2009.09.004"
"19820227","Multifocal bone infarcts and buprenorphine: association or coincidence?","Laroche M, Brouchet A, Mazières B.","J Rheumatol. 2009 Oct;36(10):2369-70. doi: 10.3899/jrheum.090100.","Laroche M","J Rheumatol","2009","2009/10/13","","","10.3899/jrheum.090100"
"19819313","Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats","Chevillard L, Mégarbane B, Risède P, Baud FJ.","Toxicol Lett. 2009 Dec 15;191(2-3):327-40. doi: 10.1016/j.toxlet.2009.09.017. Epub 2009 Oct 9.","Chevillard L","Toxicol Lett","2009","2009/10/13","","","10.1016/j.toxlet.2009.09.017"
"19808129","Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study","Gallagher AM, Leighton-Scott J, van Staa TP.","Clin Ther. 2009 Aug;31(8):1707-15. doi: 10.1016/j.clinthera.2009.08.022.","Gallagher AM","Clin Ther","2009","2009/10/08","","","10.1016/j.clinthera.2009.08.022"
"19807275","Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment","Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, Spire B.","Clin Infect Dis. 2009 Nov 1;49(9):1433-40. doi: 10.1086/630209.","Roux P","Clin Infect Dis","2009","2009/10/08","","","10.1086/630209"
"19806910","[Structure-activity relationships analysis of thienorphine and its derivatives]","Yu G, Liu YS, Yan LD, Wen Q, Gong ZH.","Yao Xue Xue Bao. 2009 Jul;44(7):726-30.","Yu G","Yao Xue Xue Bao","2009","2009/10/08","","",""
"19801566","Analgesic patches and defibrillators: a cautionary tale","Brown MR, Denman R, Platts D.","Europace. 2009 Nov;11(11):1552-3. doi: 10.1093/europace/eup261. Epub 2009 Oct 3.","Brown MR","Europace","2009","2009/10/06","","","10.1093/europace/eup261"
"19801178","Home- versus office-based buprenorphine inductions for opioid-dependent patients","Sohler NL, Li X, Kunins HV, Sacajiu G, Giovanniello A, Whitley S, Cunningham CO.","J Subst Abuse Treat. 2010 Mar;38(2):153-9. doi: 10.1016/j.jsat.2009.08.001. Epub 2009 Oct 3.","Sohler NL","J Subst Abuse Treat","2010","2009/10/06","PMC2849656","NIHMS182406","10.1016/j.jsat.2009.08.001"
"19800758","Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter study","Daulouède JP, Caer Y, Galland P, Villeger P, Brunelle E, Bachellier J, Piquet JM, Harbonnier J, Leglise Y, Courty P.","J Subst Abuse Treat. 2010 Jan;38(1):83-9. doi: 10.1016/j.jsat.2009.07.002. Epub 2009 Oct 2.","Daulouède JP","J Subst Abuse Treat","2010","2009/10/06","","","10.1016/j.jsat.2009.07.002"
"19800681","Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study","Marsden J, Eastwood B, Bradbury C, Dale-Perera A, Farrell M, Hammond P, Knight J, Randhawa K, Wright C; National Drug Treatment Monitoring System Outcomes Study Group.","Lancet. 2009 Oct 10;374(9697):1262-70. doi: 10.1016/S0140-6736(09)61420-3. Epub 2009 Oct 1.","Marsden J","Lancet","2009","2009/10/06","","","10.1016/S0140-6736(09)61420-3"
"19785976","Treatment of opioid-dependent adolescents and young adults with buprenorphine","Subramaniam GA, Fishman MJ, Woody G.","Curr Psychiatry Rep. 2009 Oct;11(5):360-3. doi: 10.1007/s11920-009-0054-5.","Subramaniam GA","Curr Psychiatry Rep","2009","2009/09/30","","","10.1007/s11920-009-0054-5"
"19773542","Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes","Moody DE, Fang WB, Lin SN, Weyant DM, Strom SC, Omiecinski CJ.","Drug Metab Dispos. 2009 Dec;37(12):2323-9. doi: 10.1124/dmd.109.028605. Epub 2009 Sep 22.","Moody DE","Drug Metab Dispos","2009","2009/09/24","PMC2784702","","10.1124/dmd.109.028605"
"19769668","Subcutaneous pre-anaesthetic medication with acepromazine-buprenorphine is effective as and less painful than the intramuscular route","Gurney M, Cripps P, Mosing M.","J Small Anim Pract. 2009 Sep;50(9):474-7. doi: 10.1111/j.1748-5827.2009.00786.x.","Gurney M","J Small Anim Pract","2009","2009/09/23","","","10.1111/j.1748-5827.2009.00786.x"
"19767156","Case histories in pharmaceutical risk management","McCormick CG, Henningfield JE, Haddox JD, Varughese S, Lindholm A, Rosen S, Wissel J, Waxman D, Carter LP, Seeger V, Johnson RE.","Drug Alcohol Depend. 2009 Dec 1;105 Suppl 1:S42-55. doi: 10.1016/j.drugalcdep.2009.08.003. Epub 2009 Sep 19.","McCormick CG","Drug Alcohol Depend","2009","2009/09/22","","","10.1016/j.drugalcdep.2009.08.003"
"19757617","Rodent pain study lacked appropriate literature review","Cassutto BH.","Contemp Top Lab Anim Sci. 2003 Mar;42(2):7; author reply 7-8.","Cassutto BH","Contemp Top Lab Anim Sci","2003","2009/09/18","","",""
"19754919","Plasma buprenorphine concentrations after the application of a 70 microg/h transdermal patch in dogs. Preliminary report","Andaluz A, Moll X, Ventura R, Abellán R, Fresno L, García F.","J Vet Pharmacol Ther. 2009 Oct;32(5):503-5. doi: 10.1111/j.1365-2885.2009.01058.x.","Andaluz A","J Vet Pharmacol Ther","2009","2009/09/17","","","10.1111/j.1365-2885.2009.01058.x"
"19754915","Antinociceptive effects of epidural buprenorphine or medetomidine, or the combination, in conscious cats","Steagall PV, Millette V, Mantovani FB, Gilbert P, Luna SP, Duke-Novakovski T.","J Vet Pharmacol Ther. 2009 Oct;32(5):477-84. doi: 10.1111/j.1365-2885.2009.01069.x.","Steagall PV","J Vet Pharmacol Ther","2009","2009/09/17","","","10.1111/j.1365-2885.2009.01069.x"
"19752455","Embolic stroke associated with injection of buprenorphine tablets","Lim CC, Lee SH, Wong YC, Hui F.","Neurology. 2009 Sep 15;73(11):876-9. doi: 10.1212/WNL.0b013e3181b784c0.","Lim CC","Neurology","2009","2009/09/16","","","10.1212/WNL.0b013e3181b784c0"
"19751825","The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials","Whitham JN, Spurrier NJ, Sawyer MG, Baghurst PA, Taplin JE, White JM, Gordon AL.","Neurotoxicol Teratol. 2010 Mar-Apr;32(2):280-8. doi: 10.1016/j.ntt.2009.09.001. Epub 2009 Sep 12.","Whitham JN","Neurotoxicol Teratol","2010","2009/09/16","","","10.1016/j.ntt.2009.09.001"
"19739698","Spotlight on buprenorphine/naloxone in the treatment of opioid dependence","Orman JS, Keating GM.","CNS Drugs. 2009 Oct;23(10):899-902. doi: 10.2165/11203740-000000000-00000.","Orman JS","CNS Drugs","2009","2009/09/11","","","10.2165/11203740-000000000-00000"
"19726139","Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone","Bruce RD, Altice FL, Moody DE, Lin SN, Fang WB, Sabo JP, Wruck JM, Piliero PJ, Conner C, Andrews L, Friedland GH.","Drug Alcohol Depend. 2009 Dec 1;105(3):234-9. doi: 10.1016/j.drugalcdep.2009.07.007. Epub 2009 Sep 1.","Bruce RD","Drug Alcohol Depend","2009","2009/09/04","PMC2779257","NIHMS138087","10.1016/j.drugalcdep.2009.07.007"
"19717249","Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy","Parran TV, Adelman CA, Merkin B, Pagano ME, Defranco R, Ionescu RA, Mace AG.","Drug Alcohol Depend. 2010 Jan 1;106(1):56-60. doi: 10.1016/j.drugalcdep.2009.07.013. Epub 2009 Aug 29.","Parran TV","Drug Alcohol Depend","2010","2009/09/01","PMC3263699","NIHMS349863","10.1016/j.drugalcdep.2009.07.013"
"19713488","Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists","Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L.","J Pharmacol Exp Ther. 2009 Dec;331(3):946-53. doi: 10.1124/jpet.109.156711. Epub 2009 Aug 27.","Khroyan TV","J Pharmacol Exp Ther","2009","2009/08/29","PMC2784721","","10.1124/jpet.109.156711"
"19709054","A comparison of subarachnoid buprenorphine or xylazine as an adjunct to lidocaine for analgesia in goats","Staffieri F, Driessen B, Lacitignola L, Crovace A.","Vet Anaesth Analg. 2009 Sep;36(5):502-11. doi: 10.1111/j.1467-2995.2009.00478.x.","Staffieri F","Vet Anaesth Analg","2009","2009/08/28","","","10.1111/j.1467-2995.2009.00478.x"
"19708849","The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence","Mammen K, Bell J.","Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405.","Mammen K","Expert Opin Pharmacother","2009","2009/08/28","","","10.1517/14656560903213405"
"19699606","Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus","Marinangeli F, Guetti C, Angeletti C, Bonetti C, Paladini A, Piroli A, Varrassi G.","J Pain Symptom Manage. 2009 Oct;38(4):e5-8. doi: 10.1016/j.jpainsymman.2009.05.008. Epub 2009 Aug 21.","Marinangeli F","J Pain Symptom Manage","2009","2009/08/25","","","10.1016/j.jpainsymman.2009.05.008"
"19697569","The risk of tramadol abuse and dependence: findings in two patients","Stoehr JD, Essary AC, Ou C, Ashby R, Sucher M.","JAAPA. 2009 Jul;22(7):31-2, 34-5. doi: 10.1097/01720610-200907000-00008.","Stoehr JD","JAAPA","2009","2009/08/25","","","10.1097/01720610-200907000-00008"
"19695424","Buprenorphine withdrawal in a toddler","Levine M, Ruha AM.","Ann Emerg Med. 2009 Sep;54(3):477-8. doi: 10.1016/j.annemergmed.2009.03.032.","Levine M","Ann Emerg Med","2009","2009/08/22","","","10.1016/j.annemergmed.2009.03.032"
"19695374","[Opioid substitution therapy in France: a physician's overview]","Michel L.","Ann Pharm Fr. 2009 Sep;67(5):369-73. doi: 10.1016/j.pharma.2009.05.006. Epub 2009 Jul 29.","Michel L","Ann Pharm Fr","2009","2009/08/22","","","10.1016/j.pharma.2009.05.006"
"19695373","[Opiate substitution: the users' point of view]","Chappard P.","Ann Pharm Fr. 2009 Sep;67(5):365-8. doi: 10.1016/j.pharma.2009.06.001. Epub 2009 Jul 31.","Chappard P","Ann Pharm Fr","2009","2009/08/22","","","10.1016/j.pharma.2009.06.001"
"19695371","[Mechanisms of opioid-induced overdose: experimental approach to clinical concerns]","Baud FJ.","Ann Pharm Fr. 2009 Sep;67(5):353-9. doi: 10.1016/j.pharma.2009.06.005. Epub 2009 Aug 3.","Baud FJ","Ann Pharm Fr","2009","2009/08/22","","","10.1016/j.pharma.2009.06.005"
"19695365","[Opiate replacement therapy in France: assessment of the public policies]","Chast F.","Ann Pharm Fr. 2009 Sep;67(5):299-303. doi: 10.1016/j.pharma.2009.06.006. Epub 2009 Jul 30.","Chast F","Ann Pharm Fr","2009","2009/08/22","","","10.1016/j.pharma.2009.06.006"
"19684909","An empirical study on the selection of analytes and corresponding cutoffs for immunoassay and GC-MS in a two-step test strategy--buprenorphine example","Wu MY, Wang YS, Lin CC, Lin DL, Su LW, Huang MH, Liu RH.","Analyst. 2009 Sep;134(9):1848-56. doi: 10.1039/b902137j. Epub 2009 Jul 3.","Wu MY","Analyst","2009","2009/08/18","","","10.1039/b902137j"
"19666890","Buprenorphine for neuropathic pain--targeting hyperalgesia","Induru RR, Davis MP.","Am J Hosp Palliat Care. 2009 Dec-2010 Jan;26(6):470-3. doi: 10.1177/1049909109341868. Epub 2009 Aug 7.","Induru RR","Am J Hosp Palliat Care","2009","2009/08/12","","","10.1177/1049909109341868"
"19662927","Dexmedetomidine as a novel therapeutic for postoperative pain in a patient treated with buprenorphine","Brummett CM, Trivedi KA, Dubovoy AV, Berland DW.","J Opioid Manag. 2009 May-Jun;5(3):175-9. doi: 10.5055/jom.2009.0018.","Brummett CM","J Opioid Manag","2009","2009/08/11","","","10.5055/jom.2009.0018"
"19662922","Buprenorphine: a safe agent for opioid dependent patients who are under the increased risk of stroke?","Yulug B, Ozan E.","J Opioid Manag. 2009 May-Jun;5(3):134.","Yulug B","J Opioid Manag","2009","2009/08/11","","",""
"19653810","Molecular, anatomical, physiological, and behavioral studies of rats treated with buprenorphine after spinal cord injury","Santiago JM, Rosas O, Torrado AI, González MM, Kalyan-Masih PO, Miranda JD.","J Neurotrauma. 2009 Oct;26(10):1783-93. doi: 10.1089/neu.2007.0502.","Santiago JM","J Neurotrauma","2009","2009/08/06","PMC2864459","","10.1089/neu.2007.0502"
"19653788","Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine","Chopra MP, Landes RD, Gatchalian KM, Jackson LC, Buchhalter AR, Stitzer ML, Marsch LA, Bickel WK.","Exp Clin Psychopharmacol. 2009 Aug;17(4):226-36. doi: 10.1037/a0016597.","Chopra MP","Exp Clin Psychopharmacol","2009","2009/08/06","PMC2852314","NIHMS187135","10.1037/a0016597"
"19650155","Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy","Messinis L, Lyros E, Andrian V, Katsakiori P, Panagis G, Georgiou V, Papathanasopoulos P.","Hum Psychopharmacol. 2009 Oct;24(7):524-31. doi: 10.1002/hup.1050.","Messinis L","Hum Psychopharmacol","2009","2009/08/04","","","10.1002/hup.1050"
"19646283","Optimized surgical techniques and postoperative care improve survival rates and permit accurate telemetric recording in exercising mice","Schuler B, Rettich A, Vogel J, Gassmann M, Arras M.","BMC Vet Res. 2009 Aug 2;5:28. doi: 10.1186/1746-6148-5-28.","Schuler B","BMC Vet Res","2009","2009/08/04","PMC2727500","","10.1186/1746-6148-5-28"
"19645647","Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation","Degenhardt L, Larance BK, Bell JR, Winstock AR, Lintzeris N, Ali RL, Scheuer N, Mattick RP.","Med J Aust. 2009 Aug 3;191(3):161-5.","Degenhardt L","Med J Aust","2009","2009/08/04","","",""
"19625142","Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey","Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD.","Drug Alcohol Depend. 2009 Nov 1;105(1-2):83-8. doi: 10.1016/j.drugalcdep.2009.06.015. Epub 2009 Jul 21.","Nunn A","Drug Alcohol Depend","2009","2009/07/24","PMC2743749","NIHMS128878","10.1016/j.drugalcdep.2009.06.015"
"19624330","Comparing buprenorphine 'tapers'--to what end?","Newman RG.","Addiction. 2009 Aug;104(8):1428-9; author reply 1429-30. doi: 10.1111/j.1360-0443.2009.02612.x.","Newman RG","Addiction","2009","2009/07/24","","","10.1111/j.1360-0443.2009.02612.x"
"19618840","[Experience of using injectable formulation of buprenorphine for the detoxification treatment of heroin dependence patients]","Aso K.","Nihon Arukoru Yakubutsu Igakkai Zasshi. 2009 Jun;44(3):156-66.","Aso K","Nihon Arukoru Yakubutsu Igakkai Zasshi","2009","2009/07/22","","",""
"19608355","Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L.","Drug Alcohol Depend. 2009 Nov 1;105(1-2):9-15. doi: 10.1016/j.drugalcdep.2009.05.021. Epub 2009 Jul 15.","Degenhardt L","Drug Alcohol Depend","2009","2009/07/18","","","10.1016/j.drugalcdep.2009.05.021"
"19602218","The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification","Sheard L, Wright NM, Adams CE, Bound N, Rushforth B, Hart R, Tompkins CN.","Trials. 2009 Jul 14;10:53. doi: 10.1186/1745-6215-10-53.","Sheard L","Trials","2009","2009/07/16","PMC2715402","","10.1186/1745-6215-10-53"
"19601871","Glucuronidation of buprenorphine and norbuprenorphine by human liver microsomes and UDP-glucuronosyltransferases","Chang Y, Moody DE.","Drug Metab Lett. 2009 Apr;3(2):101-7. doi: 10.2174/187231209788654117.","Chang Y","Drug Metab Lett","2009","2009/07/16","","","10.2174/187231209788654117"
"19597874","Surgical management of infected pseudoaneurysms in intravenous drug abusers: single institution experience and a proposed algorithm","Tan KK, Chen K, Chia KH, Lee CW, Nalachandran S.","World J Surg. 2009 Sep;33(9):1830-5. doi: 10.1007/s00268-009-0123-2.","Tan KK","World J Surg","2009","2009/07/15","","","10.1007/s00268-009-0123-2"
"19595641","Continuous buprenorphine delivery effect in streptozotocine-induced painful diabetic neuropathy in rats","Canta A, Chiorazzi A, Meregalli C, Carozzi V, Oggioni N, Lauria G, Lombardi R, Bianchi R, Porretta-Serapiglia C, Cavaletti G.","J Pain. 2009 Sep;10(9):961-8. doi: 10.1016/j.jpain.2009.04.003.","Canta A","J Pain","2009","2009/07/15","","","10.1016/j.jpain.2009.04.003"
"19591929","Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection","Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY.","Eur J Pharm Sci. 2009 Sep 10;38(2):138-46. doi: 10.1016/j.ejps.2009.06.008. Epub 2009 Jul 8.","Wang JJ","Eur J Pharm Sci","2009","2009/07/14","","","10.1016/j.ejps.2009.06.008"
"19591064","Inquiries about and initiation of buprenorphine treatment in an inner-city clinic","Cunningham CO, Giovanniello A, Sacajiu G, Li X, Brisbane M, Sohler NL.","Subst Abus. 2009 Jul-Sep;30(3):261-2. doi: 10.1080/08897070903041301.","Cunningham CO","Subst Abus","2009","2009/07/11","PMC2746741","NIHMS120277","10.1080/08897070903041301"
"19588330","Buprenorphine for the management of opioid withdrawal","Gowing L, Ali R, White JM.","Cochrane Database Syst Rev. 2009 Jul 8;(3):CD002025. doi: 10.1002/14651858.CD002025.pub4.","Gowing L","Cochrane Database Syst Rev","2009","2009/07/10","","","10.1002/14651858.CD002025.pub4"
"19577406","Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network","Knudsen HK, Abraham AJ, Johnson JA, Roman PM.","J Subst Abuse Treat. 2009 Oct;37(3):307-12. doi: 10.1016/j.jsat.2008.12.004. Epub 2009 Jul 3.","Knudsen HK","J Subst Abuse Treat","2009","2009/07/07","PMC2746383","NIHMS130302","10.1016/j.jsat.2008.12.004"
"19575703","Incorrect comments regarding the use of butorphanol-medetomidine as a premedicant in cats","Davies M.","J Small Anim Pract. 2009 Jul;50(7):378; author reply 378-9. doi: 10.1111/j.1748-5827.2009.00793.x.","Davies M","J Small Anim Pract","2009","2009/07/07","","","10.1111/j.1748-5827.2009.00793.x"
"19574017","A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification","Meade CS, Lukas SE, McDonald LJ, Fitzmaurice GM, Eldridge JA, Merrill N, Weiss RD.","J Subst Abuse Treat. 2010 Jan;38(1):12-21. doi: 10.1016/j.jsat.2009.05.010. Epub 2009 Jul 1.","Meade CS","J Subst Abuse Treat","2010","2009/07/04","PMC2789908","NIHMS120239","10.1016/j.jsat.2009.05.010"
"19563562","Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment","Bell J, Trinh L, Butler B, Randall D, Rubin G.","Addiction. 2009 Jul;104(7):1193-200. doi: 10.1111/j.1360-0443.2009.02627.x.","Bell J","Addiction","2009","2009/07/01","","","10.1111/j.1360-0443.2009.02627.x"
"19553061","Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year","Soeffing JM, Martin LD, Fingerhood MI, Jasinski DR, Rastegar DA.","J Subst Abuse Treat. 2009 Dec;37(4):426-30. doi: 10.1016/j.jsat.2009.05.003. Epub 2009 Jun 23.","Soeffing JM","J Subst Abuse Treat","2009","2009/06/26","","","10.1016/j.jsat.2009.05.003"
"19549053","Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention","Burns L, Randall D, Hall WD, Law M, Butler T, Bell J, Degenhardt L.","Addiction. 2009 Aug;104(8):1363-72. doi: 10.1111/j.1360-0443.2009.02633.x. Epub 2009 Jun 22.","Burns L","Addiction","2009","2009/06/25","","","10.1111/j.1360-0443.2009.02633.x"
"19544152","Effect of plasma proteins on buprenorphine transfer across dually perfused placental lobule","Nanovskaya TN, Bowen RS, Patrikeeva SL, Hankins GD, Ahmed MS.","J Matern Fetal Neonatal Med. 2009 Aug;22(8):646-53. doi: 10.1080/14767050802610328.","Nanovskaya TN","J Matern Fetal Neonatal Med","2009","2009/06/23","PMC4435547","NIHMS688427","10.1080/14767050802610328"
"19540407","[Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature]","Laqueille X, Launay C, Dervaux A, Kanit M.","Encephale. 2009 Jun;35(3):220-5. doi: 10.1016/j.encep.2008.05.005. Epub 2008 Oct 1.","Laqueille X","Encephale","2009","2009/06/23","","","10.1016/j.encep.2008.05.005"
"19540049","Endocrine consequences of opioid therapy","Aloisi AM, Aurilio C, Bachiocco V, Biasi G, Fiorenzani P, Pace MC, Paci V, Pari G, Passavanti G, Ravaioli L, Sindaco G, Vellucci R, Ceccarelli I.","Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S162-8. doi: 10.1016/j.psyneuen.2009.05.013.","Aloisi AM","Psychoneuroendocrinology","2009","2009/06/23","","","10.1016/j.psyneuen.2009.05.013"
"19538000","Opioid dependence treatment: options in pharmacotherapy","Stotts AL, Dodrill CL, Kosten TR.","Expert Opin Pharmacother. 2009 Aug;10(11):1727-40. doi: 10.1517/14656560903037168.","Stotts AL","Expert Opin Pharmacother","2009","2009/06/23","PMC2874458","NIHMS198468","10.1517/14656560903037168"
"19522261","[Prospective study on anesthesia for lumbar spine surgery--the effectiveness of the perioperative epidural anesthesia with buprenorphine]","Hashimoto K, Monma F, Amagasa M, Seo N.","Masui. 2009 Jun;58(6):708-12.","Hashimoto K","Masui","2009","2009/06/16","","",""
"19514947","A new illicit opioid dependence outbreak, evidence for a combination of opioids and steroids","Koushesh HR, Afshari R, Afshari R.","Drug Chem Toxicol. 2009;32(2):114-9. doi: 10.1080/01480540802588485.","Koushesh HR","Drug Chem Toxicol","2009","2009/06/12","","","10.1080/01480540802588485"
"19500085","The in vivo response of novel buprenorphine metabolites, M1 and M3, to antiretroviral inducers and inhibitors of buprenorphine metabolism","Moody DE, Chang Y, Huang W, McCance-Katz EF.","Basic Clin Pharmacol Toxicol. 2009 Sep;105(3):211-5. doi: 10.1111/j.1742-7843.2009.00432.x. Epub 2009 Jun 4.","Moody DE","Basic Clin Pharmacol Toxicol","2009","2009/06/09","PMC3723409","NIHMS471253","10.1111/j.1742-7843.2009.00432.x"
"19494155","Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization","Virk MS, Arttamangkul S, Birdsong WT, Williams JT.","Version 2. J Neurosci. 2009 Jun 3;29(22):7341-8. doi: 10.1523/JNEUROSCI.3723-08.2009.","Virk MS","J Neurosci","2009","2009/06/05","PMC2752300","NIHMS122764","10.1523/JNEUROSCI.3723-08.2009"
"19492216","Buprenorphine for opioid dependence","Milne M, Crouch BI, Caravati EM.","J Pain Palliat Care Pharmacother. 2009;23(2):153-5. doi: 10.1080/15360280902900869.","Milne M","J Pain Palliat Care Pharmacother","2009","2009/06/04","","","10.1080/15360280902900869"
"19476717","Comparison of side effects between buprenorphine and meloxicam used postoperatively in Dutch belted rabbits (Oryctolagus cuniculus)","Cooper CS, Metcalf-Pate KA, Barat CE, Cook JA, Scorpio DG.","J Am Assoc Lab Anim Sci. 2009 May;48(3):279-85.","Cooper CS","J Am Assoc Lab Anim Sci","2009","2009/05/30","PMC2696831","",""
"19469753","The use of buprenorphine to reverse opioid overdose deserves further evaluation","Welsh C.","Addiction. 2008 Dec;103(12):2066-7. doi: 10.1111/j.1360-0443.2008.02410.x.","Welsh C","Addiction","2008","2009/05/28","","","10.1111/j.1360-0443.2008.02410.x"
"19469751","The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended","Nielsen S, Lintzeris N.","Addiction. 2008 Dec;103(12):2065-6. doi: 10.1111/j.1360-0443.2008.02385.x.","Nielsen S","Addiction","2008","2009/05/28","","","10.1111/j.1360-0443.2008.02385.x"
"19466922","Comparison of costs and utilization among buprenorphine and methadone patients","Barnett PG.","Addiction. 2009 Jun;104(6):982-92. doi: 10.1111/j.1360-0443.2009.02539.x.","Barnett PG","Addiction","2009","2009/05/27","","","10.1111/j.1360-0443.2009.02539.x"
"19462305","Pulmonary hypertension in first episode infective endocarditis among intravenous buprenorphine users: case report","Ho RC, Ho EC, Tan CH, Mak A.","Am J Drug Alcohol Abuse. 2009;35(3):199-202. doi: 10.1080/00952990902939719.","Ho RC","Am J Drug Alcohol Abuse","2009","2009/05/23","","","10.1080/00952990902939719"
"19462298","Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy","Jones HE, O'Grady K, Dahne J, Johnson R, Lemoine L, Milio L, Ordean A, Selby P.","Am J Drug Alcohol Abuse. 2009;35(3):151-6. doi: 10.1080/00952990902825413.","Jones HE","Am J Drug Alcohol Abuse","2009","2009/05/23","PMC2925397","NIHMS222525","10.1080/00952990902825413"
"19461836","Opioid induced hyperalgesia: clinical implications for the pain practitioner","Silverman SM.","Pain Physician. 2009 May-Jun;12(3):679-84.","Silverman SM","Pain Physician","2009","2009/05/23","","",""
"19453959","Gabapentin and opioid craving","Tay KH.","Pain Med. 2009 May-Jun;10(4):774. doi: 10.1111/j.1526-4637.2009.00617.x. Epub 2009 Apr 22.","Tay KH","Pain Med","2009","2009/05/21","","","10.1111/j.1526-4637.2009.00617.x"
"19448245","A new pattern of buprenorphine misuse may complicate perioperative pain control","Marcucci C, Fudin J, Thomas P, Sandson NB, Welsh C.","Anesth Analg. 2009 Jun;108(6):1996-7. doi: 10.1213/ane.0b013e3181a193f5.","Marcucci C","Anesth Analg","2009","2009/05/19","","","10.1213/ane.0b013e3181a193f5"
"19444740","Comment on ""Outcomes of DATA certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration""","Small MD.","Am J Addict. 2009 Jul-Aug;18(4):336; author reply 337-8. doi: 10.1080/10550490902931381.","Small MD","Am J Addict","2009","2009/05/16","","","10.1080/10550490902931381"
"19443999","Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulation","Poisnel G, Dhilly M, Le Boisselier R, Barre L, Debruyne D.","J Pharmacol Sci. 2009 May;110(1):36-46. doi: 10.1254/jphs.08249fp.","Poisnel G","J Pharmacol Sci","2009","2009/05/16","","","10.1254/jphs.08249fp"
"19443138","Comparing overdose mortality associated with methadone and buprenorphine treatment","Bell JR, Butler B, Lawrance A, Batey R, Salmelainen P.","Drug Alcohol Depend. 2009 Sep 1;104(1-2):73-7. doi: 10.1016/j.drugalcdep.2009.03.020. Epub 2009 May 13.","Bell JR","Drug Alcohol Depend","2009","2009/05/16","","","10.1016/j.drugalcdep.2009.03.020"
"19435402","The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus","Pergolizzi JV Jr, Mercadante S, Echaburu AV, Van den Eynden B, Fragoso RM, Mordarski S, Lybaert W, Beniak J, Orońska A, Slama O; Euromed Communications meeting.","Curr Med Res Opin. 2009 Jun;25(6):1517-28. doi: 10.1185/03007990902920731.","Pergolizzi JV Jr","Curr Med Res Opin","2009","2009/05/14","","","10.1185/03007990902920731"
"19428542","The use of motion analysis to measure pain-related behaviour in a rat model of degenerative tendon injuries","Fu SC, Chan KM, Chan LS, Fong DT, Lui PY.","J Neurosci Methods. 2009 May 15;179(2):309-18. doi: 10.1016/j.jneumeth.2009.02.011. Epub 2009 Mar 4.","Fu SC","J Neurosci Methods","2009","2009/05/12","","","10.1016/j.jneumeth.2009.02.011"
"19426291","Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06)","Marzo JN, Rotily M, Meroueh F, Varastet M, Hunault C, Obradovic I, Zin A.","Addiction. 2009 Jul;104(7):1233-40. doi: 10.1111/j.1360-0443.2009.02558.x. Epub 2009 Apr 29.","Marzo JN","Addiction","2009","2009/05/12","","","10.1111/j.1360-0443.2009.02558.x"
"19422676","Opioids switching with transdermal systems in chronic cancer pain","Aurilio C, Pace MC, Pota V, Sansone P, Barbarisi M, Grella E, Passavanti MB.","J Exp Clin Cancer Res. 2009 May 7;28(1):61. doi: 10.1186/1756-9966-28-61.","Aurilio C","J Exp Clin Cancer Res","2009","2009/05/09","PMC2684533","","10.1186/1756-9966-28-61"
"19422392","Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine","Ding Z, Raffa RB.","Br J Pharmacol. 2009 Jul;157(5):831-43. doi: 10.1111/j.1476-5381.2009.00209.x. Epub 2009 Apr 30.","Ding Z","Br J Pharmacol","2009","2009/05/09","PMC2721267","","10.1111/j.1476-5381.2009.00209.x"
"19421664","Protein-losing enteropathy post-valvular surgery with severe tricuspid regurgitation in Subutex-related endocarditis","Lee LC, Wong R, Raju GC, Khor C, Yip J.","Singapore Med J. 2009 Apr;50(4):e124-6.","Lee LC","Singapore Med J","2009","2009/05/08","","",""
"19420948","Feasibility of buprenorphine maintenance therapy programs in the Ukraine: first promising treatment outcomes","Schaub M, Subata E, Chtenguelov V, Weiler G, Uchtenhagen A.","Eur Addict Res. 2009;15(3):157-62. doi: 10.1159/000217586. Epub 2009 May 7.","Schaub M","Eur Addict Res","2009","2009/05/08","","","10.1159/000217586"
"19413789","What more do we need to know about medication-assisted treatment for prescription opioid abusers?","Magura S.","Addiction. 2009 May;104(5):784-5. doi: 10.1111/j.1360-0443.2009.02581.x.","Magura S","Addiction","2009","2009/05/06","","","10.1111/j.1360-0443.2009.02581.x"
"19413461","PecSys: in situ gelling system for optimised nasal drug delivery","Watts P, Smith A.","Expert Opin Drug Deliv. 2009 May;6(5):543-52. doi: 10.1517/17425240902939135.","Watts P","Expert Opin Drug Deliv","2009","2009/05/06","","","10.1517/17425240902939135"
"19409968","Inflammation-induced increase in hyperpolarization-activated, cyclic nucleotide-gated channel protein in trigeminal ganglion neurons and the effect of buprenorphine","Cho HJ, Staikopoulos V, Furness JB, Jennings EA.","Neuroscience. 2009 Aug 18;162(2):453-61. doi: 10.1016/j.neuroscience.2009.04.063. Epub 2009 May 3.","Cho HJ","Neuroscience","2009","2009/05/05","","","10.1016/j.neuroscience.2009.04.063"
"19406914","Cross-reactivity of naloxone with oxycodone immunoassays: implications for individuals taking Suboxone","Jenkins AJ, Poirier JG 3rd, Juhascik MP.","Clin Chem. 2009 Jul;55(7):1434-6. doi: 10.1373/clinchem.2009.125096. Epub 2009 Apr 30.","Jenkins AJ","Clin Chem","2009","2009/05/02","","","10.1373/clinchem.2009.125096"
"19406593","Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry","Concheiro M, Shakleya DM, Huestis MA.","Forensic Sci Int. 2009 Jul 1;188(1-3):144-51. doi: 10.1016/j.forsciint.2009.04.005. Epub 2009 Apr 29.","Concheiro M","Forensic Sci Int","2009","2009/05/02","PMC2700060","NIHMS109094","10.1016/j.forsciint.2009.04.005"
"19403243","Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence","White J, Bell J, Saunders JB, Williamson P, Makowska M, Farquharson A, Beebe KL.","Drug Alcohol Depend. 2009 Jul 1;103(1-2):37-43. doi: 10.1016/j.drugalcdep.2009.03.008. Epub 2009 Apr 28.","White J","Drug Alcohol Depend","2009","2009/05/01","","","10.1016/j.drugalcdep.2009.03.008"
"19402772","Buprenorphine for opioid dependence","Ling W.","Expert Rev Neurother. 2009 May;9(5):609-16. doi: 10.1586/ern.09.26.","Ling W","Expert Rev Neurother","2009","2009/05/01","PMC4151622","NIHMS619406","10.1586/ern.09.26"
"19396968","[Accompanying patients in substitution treatment for opiates: consulting and coaching in the office]]","De Wulf I, Duquet N, Saevels J, Puttemans MK, Allard L, Bogaert J, Brohée JP, Karadag EN, Lagrain J, Ledoux MY, Remy C, Verrando R; CDSP; CWOA.","J Pharm Belg. 2009 Mar;(1):Suppl 1-20.","De Wulf I","J Pharm Belg","2009","2009/04/28","","",""
"19395770","Allometric scaling of chemical restraint associated with inhalant anesthesia in giant anteaters","Carregaro AB, Gerardi PM, Honsho DK.","J Wildl Dis. 2009 Apr;45(2):547-51. doi: 10.7589/0090-3558-45.2.547.","Carregaro AB","J Wildl Dis","2009","2009/04/28","","","10.7589/0090-3558-45.2.547"
"19394789","Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine","Reece AS.","J Subst Abuse Treat. 2009 Oct;37(3):256-65. doi: 10.1016/j.jsat.2009.03.008. Epub 2009 Apr 25.","Reece AS","J Subst Abuse Treat","2009","2009/04/28","","","10.1016/j.jsat.2009.03.008"
"19393843","Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery","Oifa S, Sydoruk T, White I, Ekstein MP, Marouani N, Chazan S, Skornick Y, Weinbroum AA.","Clin Ther. 2009 Mar;31(3):527-41. doi: 10.1016/j.clinthera.2009.03.018.","Oifa S","Clin Ther","2009","2009/04/28","","","10.1016/j.clinthera.2009.03.018"
"19393841","Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study","Karlsson M, Berggren AC.","Clin Ther. 2009 Mar;31(3):503-13. doi: 10.1016/j.clinthera.2009.03.001.","Karlsson M","Clin Ther","2009","2009/04/28","","","10.1016/j.clinthera.2009.03.001"
"19392907","Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study","Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H.","Addiction. 2009 Jun;104(6):993-9. doi: 10.1111/j.1360-0443.2009.02549.x. Epub 2009 Apr 9.","Anchersen K","Addiction","2009","2009/04/28","","","10.1111/j.1360-0443.2009.02549.x"
"19391289","Buprenorphine and pregnancy","","Prescrire Int. 2009 Feb;18(99):22.","","Prescrire Int","2009","2009/04/28","","",""
"19383935","Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis","Peyrière H, Tatem L, Bories C, Pageaux GP, Blayac JP, Larrey D.","Ann Pharmacother. 2009 May;43(5):973-7. doi: 10.1345/aph.1L628. Epub 2009 Apr 21.","Peyrière H","Ann Pharmacother","2009","2009/04/23","","","10.1345/aph.1L628"
"19383214","Comparison of buprenorphine and butorphanol analgesia in the eastern red-spotted newt (Notophthalmus viridescens)","Koeller CA.","J Am Assoc Lab Anim Sci. 2009 Mar;48(2):171-5.","Koeller CA","J Am Assoc Lab Anim Sci","2009","2009/04/23","PMC2679657","",""
"19383210","Magnetic resonance imaging of acute injury in rats and the effects of buprenorphine on limb volume","McBrier NM, Neuberger T, Denegar CR, Sharkey NA, Webb AG.","J Am Assoc Lab Anim Sci. 2009 Mar;48(2):147-51.","McBrier NM","J Am Assoc Lab Anim Sci","2009","2009/04/23","PMC2679659","",""
"19378450","Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment","Madden A, Lea T, Bath N, Winstock AR.","Drug Alcohol Rev. 2008 Nov;27(6):671-8. doi: 10.1080/09595230801935706.","Madden A","Drug Alcohol Rev","2008","2009/04/21","","","10.1080/09595230801935706"
"19374740","Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals","Rapeli P, Fabritius C, Kalska H, Alho H.","Subst Abuse Treat Prev Policy. 2009 Apr 17;4:6. doi: 10.1186/1747-597X-4-6.","Rapeli P","Subst Abuse Treat Prev Policy","2009","2009/04/21","PMC2676265","","10.1186/1747-597X-4-6"
"19370679","Maintenance treatments for opiate dependent adolescent","Minozzi S, Amato L, Davoli M.","Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007210. doi: 10.1002/14651858.CD007210.pub2.","Minozzi S","Cochrane Database Syst Rev","2009","2009/04/17","","","10.1002/14651858.CD007210.pub2"
"19370651","Detoxification treatments for opiate dependent adolescents","Minozzi S, Amato L, Davoli M.","Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006749. doi: 10.1002/14651858.CD006749.pub2.","Minozzi S","Cochrane Database Syst Rev","2009","2009/04/17","","","10.1002/14651858.CD006749.pub2"
"19370547","Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation","Hassan HE, Myers AL, Coop A, Eddington ND.","J Pharm Sci. 2009 Dec;98(12):4928-40. doi: 10.1002/jps.21770.","Hassan HE","J Pharm Sci","2009","2009/04/17","PMC3401593","NIHMS389754","10.1002/jps.21770"
"19368419","Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence","Orman JS, Keating GM.","Drugs. 2009;69(5):577-607. doi: 10.2165/00003495-200969050-00006.","Orman JS","Drugs","2009","2009/04/17","","","10.2165/00003495-200969050-00006"
"19360539","Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them ""substitution""?","Gerra G, Maremmani I, Capovani B, Somaini L, Berterame S, Tomas-Rossello J, Saenz E, Busse A, Kleber H.","Subst Use Misuse. 2009;44(5):663-71. doi: 10.1080/10826080902810251.","Gerra G","Subst Use Misuse","2009","2009/04/11","","","10.1080/10826080902810251"
"19346946","The implications of medication development in the treatment of substance use disorders in developing countries","Thirthalli J, Chand PK.","Curr Opin Psychiatry. 2009 May;22(3):274-80. doi: 10.1097/YCO.0b013e32832a1dc0.","Thirthalli J","Curr Opin Psychiatry","2009","2009/04/07","","","10.1097/YCO.0b013e32832a1dc0"
"19345298","Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit","Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S.","J Pain Symptom Manage. 2009 Apr;37(4):632-41. doi: 10.1016/j.jpainsymman.2007.12.024.","Mercadante S","J Pain Symptom Manage","2009","2009/04/07","","","10.1016/j.jpainsymman.2007.12.024"
"19344049","Buprenorphine: a review","Wakhlu S.","J Opioid Manag. 2009 Jan-Feb;5(1):59-64. doi: 10.5055/jom.2009.0007.","Wakhlu S","J Opioid Manag","2009","2009/04/07","","","10.5055/jom.2009.0007"
"19335661","Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy","Schäfer A, Wittchen HU, Backmund M, Soyka M, Gölz J, Siegert J, Schäfer M, Tretter F, Kraus MR.","Addiction. 2009 Apr;104(4):630-40. doi: 10.1111/j.1360-0443.2009.02509.x.","Schäfer A","Addiction","2009","2009/04/02","","","10.1111/j.1360-0443.2009.02509.x"
"19332991","Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study","Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E.","Eur Addict Res. 2009;15(3):128-34. doi: 10.1159/000210042. Epub 2009 Mar 31.","Bakstad B","Eur Addict Res","2009","2009/04/01","","","10.1159/000210042"
"19328024","Outcome after injections of crushed tablets in intravenous drug abusers in the Helsinki University Central Hospital","Partanen TA, Vikatmaa P, Tukiainen E, Lepäntalo M, Vuola J.","Eur J Vasc Endovasc Surg. 2009 Jun;37(6):704-11. doi: 10.1016/j.ejvs.2009.01.016. Epub 2009 Mar 26.","Partanen TA","Eur J Vasc Endovasc Surg","2009","2009/03/31","","","10.1016/j.ejvs.2009.01.016"
"19325013","Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment","Kacinko SL, Jones HE, Johnson RE, Choo RE, Concheiro-Guisan M, Huestis MA.","Clin Chem. 2009 Jun;55(6):1177-87. doi: 10.1373/clinchem.2008.113712. Epub 2009 Mar 26.","Kacinko SL","Clin Chem","2009","2009/03/28","PMC3166514","NIHMS317044","10.1373/clinchem.2008.113712"
"19322003","Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones","Wang CJ, Huang SW, Chang CH.","Urol Int. 2009;82(2):166-9. doi: 10.1159/000200793. Epub 2009 Mar 19.","Wang CJ","Urol Int","2009","2009/03/27","","","10.1159/000200793"
"19305006","Analgesia for cats after ovariohysterectomy with either buprenorphine or carprofen alone or in combination","Steagall PV, Taylor PM, Rodrigues LC, Ferreira TH, Minto BW, Aguiar AJ.","Vet Rec. 2009 Mar 21;164(12):359-63. doi: 10.1136/vr.164.12.359.","Steagall PV","Vet Rec","2009","2009/03/24","","","10.1136/vr.164.12.359"
"19301934","Pediatric palliative care: use of opioids for the management of pain","Zernikow B, Michel E, Craig F, Anderson BJ.","Paediatr Drugs. 2009;11(2):129-51. doi: 10.2165/00148581-200911020-00004.","Zernikow B","Paediatr Drugs","2009","2009/03/24","","","10.2165/00148581-200911020-00004"
"19296223","Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs","Friedmann PD, Jiang L, Alexander JA.","J Behav Health Serv Res. 2010 Jul;37(3):322-37. doi: 10.1007/s11414-009-9169-z. Epub 2009 Mar 19.","Friedmann PD","J Behav Health Serv Res","2010","2009/03/20","PMC3682405","NIHMS469109","10.1007/s11414-009-9169-z"
"19295055","Evaluation of buprenorphine in a postoperative pain model in rats","Curtin LI, Grakowsky JA, Suarez M, Thompson AC, DiPirro JM, Martin LB, Kristal MB.","Comp Med. 2009 Feb;59(1):60-71.","Curtin LI","Comp Med","2009","2009/03/20","PMC2703135","",""
"19285495","Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both mu-opioid and nociceptin/orphanin peptide receptors","Capuano A, De Corato A, Tringali G, Currò D, Dello Russo C, Navarra P.","Eur J Pharmacol. 2009 May 1;609(1-3):45-50. doi: 10.1016/j.ejphar.2009.03.013. Epub 2009 Mar 12.","Capuano A","Eur J Pharmacol","2009","2009/03/17","","","10.1016/j.ejphar.2009.03.013"
"19283574","Acceptability of technology-based methods substance abuse counseling in office based buprenorphine maintenance for opioid dependence","Gandhi D, Welsh C, Bennett M, Carreño J, Himelhoch S.","Am J Addict. 2009 Mar-Apr;18(2):182-3. doi: 10.1080/10550490902772553.","Gandhi D","Am J Addict","2009","2009/03/14","PMC3774144","NIHMS492990","10.1080/10550490902772553"
"19283573","Is there a better way to match patients to opioid maintenance treatment: a case report","Fareed A, Casarella J, Amar R, Drexler K.","Am J Addict. 2009 Mar-Apr;18(2):180-1. doi: 10.1080/10550490802544102.","Fareed A","Am J Addict","2009","2009/03/14","","","10.1080/10550490802544102"
"19282469","Prescription of opioids in Italy: everything, but the morphine","Bandieri E, Chiarolanza A, Luppi M, Magrini N, Marata AM, Ripamonti C.","Ann Oncol. 2009 May;20(5):961-2. doi: 10.1093/annonc/mdp041. Epub 2009 Mar 12.","Bandieri E","Ann Oncol","2009","2009/03/14","","","10.1093/annonc/mdp041"
"19281102","The changing face of opioid addiction: prescription pain pill dependence and treatment","Byrne MH, Lander L, Ferris M.","Health Soc Work. 2009 Feb;34(1):53-6. doi: 10.1093/hsw/34.1.53.","Byrne MH","Health Soc Work","2009","2009/03/14","","","10.1093/hsw/34.1.53"
"19269730","[Necrosis of the glans penis: a complication of an injection of buprenorphin in a opioid abuser]","Hornez E, Laroche J, Monchal T, Bourgouin S, Riviere P, Fournier R, Dantzer E.","Ann Chir Plast Esthet. 2010 Apr;55(2):159-61. doi: 10.1016/j.anplas.2008.12.004. Epub 2009 Mar 9.","Hornez E","Ann Chir Plast Esthet","2010","2009/03/10","","","10.1016/j.anplas.2008.12.004"
"19254157","Comparison of the analgesic properties of transdermally administered fentanyl and intramuscularly administered buprenorphine during and following experimental orthopedic surgery in sheep","Ahern BJ, Soma LR, Boston RC, Schaer TP.","Am J Vet Res. 2009 Mar;70(3):418-22. doi: 10.2460/ajvr.70.3.418.","Ahern BJ","Am J Vet Res","2009","2009/03/04","","","10.2460/ajvr.70.3.418"
"19247639","Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry","Concheiro-Guisan M, Shakleya DM, Huestis MA.","Anal Bioanal Chem. 2009 May;394(2):513-22. doi: 10.1007/s00216-009-2706-z. Epub 2009 Feb 27.","Concheiro-Guisan M","Anal Bioanal Chem","2009","2009/02/28","PMC3159561","NIHMS317011","10.1007/s00216-009-2706-z"
"19238786","[Infants of drug-addicted mothers: pitfalls of replacement therapy]","Vert P, Hamon I, Hubert C, Legagneur M, Hascoet JM.","Bull Acad Natl Med. 2008 May;192(5):961-9; discussion 969.","Vert P","Bull Acad Natl Med","2008","2009/02/26","","",""
"19236356","Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria","Bammer G, Ritter A, Kutin JJ, Lintzeris N.","Aust N Z J Public Health. 2009 Feb;33(1):34-9. doi: 10.1111/j.1753-6405.2009.00335.x.","Bammer G","Aust N Z J Public Health","2009","2009/02/25","","","10.1111/j.1753-6405.2009.00335.x"
"19233749","Treating chronic hepatitis C in recovering opiate addicts: yes, we can","Kreek MJ, Talal AH, Piccolo P.","Dig Liver Dis. 2009 Apr;41(4):308-10. doi: 10.1016/j.dld.2009.01.003. Epub 2009 Feb 23.","Kreek MJ","Dig Liver Dis","2009","2009/02/24","PMC2778039","NIHMS107059","10.1016/j.dld.2009.01.003"
"19229225","Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine","Brennan MP, Sinusas AJ, Horvath TL, Collins JG, Harding MJ.","Lab Anim (NY). 2009 Mar;38(3):87-93. doi: 10.1038/laban0309-87.","Brennan MP","Lab Anim (NY)","2009","2009/02/21","PMC2805902","NIHMS143176","10.1038/laban0309-87"
"19224082","Infective endocarditis secondary to intravenous Subutex abuse","Chong E, Poh KK, Shen L, Yeh IB, Chai P.","Singapore Med J. 2009 Jan;50(1):34-42.","Chong E","Singapore Med J","2009","2009/02/19","","",""
"19219093","[Substitution treatment of drug addicts during pregnancy: consequences for the children?]","Sandtorv L, Reigstad H, Bruarøy S, Elgen I, Laegreid LM.","Tidsskr Nor Laegeforen. 2009 Feb 12;129(4):287-90. doi: 10.4045/tidsskr.09.33335.","Sandtorv L","Tidsskr Nor Laegeforen","2009","2009/02/17","","","10.4045/tidsskr.09.33335"
"19215987","Patterns of major depression and drug-related problems amongst heroin users across 36 months","Darke S, Mills K, Teesson M, Ross J, Williamson A, Havard A.","Psychiatry Res. 2009 Mar 31;166(1):7-14. doi: 10.1016/j.psychres.2007.12.007. Epub 2009 Feb 11.","Darke S","Psychiatry Res","2009","2009/02/14","","","10.1016/j.psychres.2007.12.007"
"19212931","Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market","Bruce RD, Govindasamy S, Sylla L, Kamarulzaman A, Altice FL.","Am J Drug Alcohol Abuse. 2009;35(2):68-72. doi: 10.1080/00952990802585406.","Bruce RD","Am J Drug Alcohol Abuse","2009","2009/02/13","PMC2791788","NIHMS153748","10.1080/00952990802585406"
"19209537","[Effects of transdermal buprenorphine in cancer patients. Results from the Cancer Pain Outcome Research (CPOR) Study Group]","Greco MT, Deandrea S, Corli O, Montanari M, Caraceni A, Apolone G; Cancer Pain Outcome Research Study Group.","Recenti Prog Med. 2008 Nov;99(11):538-51.","Greco MT","Recenti Prog Med","2008","2009/02/13","","",""
"19209431","Buprenorphine: a new tool in the arsenal","","HRSA Careaction. 2004 Mar:1-8.","","HRSA Careaction","2004","2009/02/12","","",""
"19207433","Cutaneous complications among i.v. buprenorphine users","Ho RC, Ho EC, Mak A.","J Dermatol. 2009 Jan;36(1):22-9. doi: 10.1111/j.1346-8138.2008.00581.x.","Ho RC","J Dermatol","2009","2009/02/12","","","10.1111/j.1346-8138.2008.00581.x"
"19200263","The effects of nitrous oxide on recovery from isoflurane anaesthesia in dogs","Laing S, Paul V, Murison PJ.","J Small Anim Pract. 2009 Feb;50(2):82-6. doi: 10.1111/j.1748-5827.2008.00689.x.","Laing S","J Small Anim Pract","2009","2009/02/10","","","10.1111/j.1748-5827.2008.00689.x"
"19200262","Investigating medetomidine-buprenorphine as preanaesthetic medication in cats","Grint NJ, Burford J, Dugdale AH.","J Small Anim Pract. 2009 Feb;50(2):73-81. doi: 10.1111/j.1748-5827.2008.00688.x.","Grint NJ","J Small Anim Pract","2009","2009/02/10","","","10.1111/j.1748-5827.2008.00688.x"
"19199166","Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes","Katz EC, Schwartz RP, King S, Highfield DA, O'Grady KE, Billings T, Gandhi D, Weintraub E, Glovinsky D, Barksdale W, Brown BS.","Am J Drug Alcohol Abuse. 2009;35(2):63-7. doi: 10.1080/00952990802585380.","Katz EC","Am J Drug Alcohol Abuse","2009","2009/02/10","PMC3140220","NIHMS308003","10.1080/00952990802585380"
"19197597","The prevalence of childhood trauma among those seeking buprenorphine treatment","Sansone RA, Whitecar P, Wiederman MW.","J Addict Dis. 2009;28(1):64-7. doi: 10.1080/10550880802545101.","Sansone RA","J Addict Dis","2009","2009/02/07","","","10.1080/10550880802545101"
"19197596","Methods and motivations for buprenorphine diversion from public opioid substitution treatment clinics","Winstock AR, Lea T, Jackson AP.","J Addict Dis. 2009;28(1):57-63. doi: 10.1080/10550880802545036.","Winstock AR","J Addict Dis","2009","2009/02/07","","","10.1080/10550880802545036"
"19197589","Swiss recommendations for substitution treatment: a report that ""got it right""","Newman RG.","J Addict Dis. 2009;28(1):1-7. doi: 10.1080/10550880802544492.","Newman RG","J Addict Dis","2009","2009/02/07","","","10.1080/10550880802544492"
"19196468","The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) prisons project: a randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification","Sheard L, Wright NM, El-Sayeh HG, Adams CE, Li R, Tompkins CN.","Subst Abuse Treat Prev Policy. 2009 Feb 5;4:1. doi: 10.1186/1747-597X-4-1.","Sheard L","Subst Abuse Treat Prev Policy","2009","2009/02/07","PMC2649065","","10.1186/1747-597X-4-1"
"19192863","Opioid abstinence reinforcement delays heroin lapse during buprenorphine dose tapering","Greenwald MK.","J Appl Behav Anal. 2008 Winter;41(4):603-7. doi: 10.1901/jaba.2008.41-603.","Greenwald MK","J Appl Behav Anal","2008","2009/02/06","PMC2606597","","10.1901/jaba.2008.41-603"
"19192068","Short- and intermediate-term efficacy of buprenorphine TDS in chronic painful neuropathies","Penza P, Campanella A, Martini A, Melli G, Lombardi R, Camozzi F, Devigili G, Lauria G.","J Peripher Nerv Syst. 2008 Dec;13(4):283-8. doi: 10.1111/j.1529-8027.2008.00194.x.","Penza P","J Peripher Nerv Syst","2008","2009/02/05","","","10.1111/j.1529-8027.2008.00194.x"
"19182485","A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?","Larney S, Dolan K.","Eur Addict Res. 2009;15(2):107-12. doi: 10.1159/000199046. Epub 2009 Feb 2.","Larney S","Eur Addict Res","2009","2009/02/03","","","10.1159/000199046"
"19172850","Effect of selol on the opioids activity in streptozotocin induced hyperalgesia","Bujalska M, Winecka R, Gumułka SW.","Acta Pol Pharm. 2008 Nov-Dec;65(6):691-6.","Bujalska M","Acta Pol Pharm","2008","2009/01/29","","",""
"19168053","Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study","Capuano A, De Corato A, Treglia M, Tringali G, Dello Russo C, Navarra P.","Eur J Pharmacol. 2009 Mar 1;605(1-3):57-62. doi: 10.1016/j.ejphar.2008.12.029. Epub 2009 Jan 10.","Capuano A","Eur J Pharmacol","2009","2009/01/27","","","10.1016/j.ejphar.2008.12.029"
"19156956","[Low-dose strong opioid (LDSO)--treatment of pain in osteoarthritis]","Bolten WW, Böhme K, Grifka J, Schutter U, Schwarz H, Sittl R, Sturm D, Wahle K.","MMW Fortschr Med. 2008 Dec 11;150(51-52):41.","Bolten WW","MMW Fortschr Med","2008","2009/01/22","","",""
"19151804","[Treatment of opioid withdrawal]","Shaygani S, Waal H.","Tidsskr Nor Laegeforen. 2009 Jan 15;129(2):114-5. doi: 10.4045/tidsskr.09.32466.","Shaygani S","Tidsskr Nor Laegeforen","2009","2009/01/20","","","10.4045/tidsskr.09.32466"
"19151800","[General practitioner views on drug-assisted rehabilitation and the Norwegian substance abuse reform]","Aasland OG, Spilhaug G, Johannesen A.","Tidsskr Nor Laegeforen. 2009 Jan 15;129(2):97-100. doi: 10.4045/tidsskr.09.27007.","Aasland OG","Tidsskr Nor Laegeforen","2009","2009/01/20","","","10.4045/tidsskr.09.27007"
"19149822","Buprenorphine tapering schedule and illicit opioid use","Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, Hasson A, Annon J, Saxon A, Selzer J, Boverman J, Bilangi R.","Addiction. 2009 Feb;104(2):256-65. doi: 10.1111/j.1360-0443.2008.02455.x.","Ling W","Addiction","2009","2009/01/20","PMC3150159","NIHMS308375","10.1111/j.1360-0443.2008.02455.x"
"19136395","Transfer of buprenorphine into breast milk and calculation of infant drug dose","Lindemalm S, Nydert P, Svensson JO, Stahle L, Sarman I.","J Hum Lact. 2009 May;25(2):199-205. doi: 10.1177/0890334408328295. Epub 2009 Jan 8.","Lindemalm S","J Hum Lact","2009","2009/01/13","","","10.1177/0890334408328295"
"19122930","Unusual complication of intravenous Subutex abuse: two cases of septic sacroiliitis","Yang SS, Lee K.","Singapore Med J. 2008 Dec;49(12):e343-6.","Yang SS","Singapore Med J","2008","2009/01/06","","",""
"19121161","A comparison of epidural buprenorphine plus detomidine with morphine plus detomidine in horses undergoing bilateral stifle arthroscopy","Fischer BL, Ludders JW, Asakawa M, Fortier LA, Fubini SL, Nixon AJ, Radcliffe RM, Erb HN.","Vet Anaesth Analg. 2009 Jan;36(1):67-76. doi: 10.1111/j.1467-2995.2008.00422.x.","Fischer BL","Vet Anaesth Analg","2009","2009/01/06","","","10.1111/j.1467-2995.2008.00422.x"
"19116954","Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice","Coles LD, Lee IJ, Hassan HE, Eddington ND.","J Pharm Sci. 2009 Aug;98(8):2832-46. doi: 10.1002/jps.21644.","Coles LD","J Pharm Sci","2009","2009/01/01","","","10.1002/jps.21644"
"19112993","[Transdermal buprenorphine: a current overview of pharmacological and clinical data]","Faymonville ME, Libbrecht D.","Rev Med Liege. 2008 Nov;63(11):671-6.","Faymonville ME","Rev Med Liege","2008","2008/12/31","","",""
"19110701","Pharmacokinetics of buprenorphine after single-dose subcutaneous administration in red-eared sliders (Trachemys scripta elegans)","Kummrow MS, Tseng F, Hesse L, Court M.","J Zoo Wildl Med. 2008 Dec;39(4):590-5. doi: 10.1638/2008-0033.1.","Kummrow MS","J Zoo Wildl Med","2008","2008/12/30","","","10.1638/2008-0033.1"
"19104845","Equipotent doses to switch from high doses of opioids to transdermal buprenorphine","Mercadante S, Casuccio A, Tirelli W, Giarratano A.","Support Care Cancer. 2009 Jun;17(6):715-8. doi: 10.1007/s00520-008-0546-6. Epub 2008 Dec 23.","Mercadante S","Support Care Cancer","2009","2008/12/24","","","10.1007/s00520-008-0546-6"
"19101743","Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach","Hass B, Lungershausen J, Hertel N, Poulsen Nautrup B, Kotowa W, Liedgens H.","Eur J Health Econ. 2009 Jul;10(3):309-21. doi: 10.1007/s10198-008-0134-1. Epub 2008 Dec 21.","Hass B","Eur J Health Econ","2009","2008/12/23","","","10.1007/s10198-008-0134-1"
"19095476","Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?","Skurtveit S, Furu K, Kaasa S, Borchgrevink PC.","Eur J Pain. 2009 Oct;13(9):949-53. doi: 10.1016/j.ejpain.2008.11.005. Epub 2008 Dec 17.","Skurtveit S","Eur J Pain","2009","2008/12/20","","","10.1016/j.ejpain.2008.11.005"
"19089508","Home buprenorphine/naloxone induction in primary care","Lee JD, Grossman E, DiRocco D, Gourevitch MN.","J Gen Intern Med. 2009 Feb;24(2):226-32. doi: 10.1007/s11606-008-0866-8. Epub 2008 Dec 17.","Lee JD","J Gen Intern Med","2009","2008/12/18","PMC2628995","","10.1007/s11606-008-0866-8"
"19089500","Integrating buprenorphine treatment into office-based practice: a qualitative study","Barry DT, Irwin KS, Jones ES, Becker WC, Tetrault JM, Sullivan LE, Hansen H, O'Connor PG, Schottenfeld RS, Fiellin DA.","J Gen Intern Med. 2009 Feb;24(2):218-25. doi: 10.1007/s11606-008-0881-9. Epub 2008 Dec 17.","Barry DT","J Gen Intern Med","2009","2008/12/18","PMC2628993","","10.1007/s11606-008-0881-9"
"19084658","Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation","Mostafavi A, Abedi G, Jamshidi A, Afzali D, Talebi M.","Talanta. 2009 Feb 15;77(4):1415-9. doi: 10.1016/j.talanta.2008.09.024. Epub 2008 Sep 24.","Mostafavi A","Talanta","2009","2008/12/17","","","10.1016/j.talanta.2008.09.024"
"19081679","Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study","Sigmon SC, Dunn KE, Badger GJ, Heil SH, Higgins ST.","Addict Behav. 2009 Mar;34(3):304-11. doi: 10.1016/j.addbeh.2008.11.017. Epub 2008 Nov 24.","Sigmon SC","Addict Behav","2009","2008/12/17","PMC2643343","NIHMS91618","10.1016/j.addbeh.2008.11.017"
"19076888","Allergic contact dermatitis from transdermal buprenorphine","Vander Hulst K, Parera Amer E, Jacobs C, Dewulf V, Baeck M, Pujol Vallverdú RM, Giménez-Arnau A, Tennstedt D, Goossens A.","Contact Dermatitis. 2008 Dec;59(6):366-9. doi: 10.1111/j.1600-0536.2008.01472.x.","Vander Hulst K","Contact Dermatitis","2008","2008/12/17","","","10.1111/j.1600-0536.2008.01472.x"
"19069302","Effects of indomethacin and buprenorphine analgesia on the postoperative recovery of mice","Farris HE.","J Am Assoc Lab Anim Sci. 2008 Nov;47(6):8; author reply 8-9.","Farris HE","J Am Assoc Lab Anim Sci","2008","2008/12/17","PMC2687138","",""
"19066981","[High-dose buprenorphine for outpatient palliative pain therapy]","Gastmeier K, Freye E.","Schmerz. 2009 Apr;23(2):180-6. doi: 10.1007/s00482-008-0742-9.","Gastmeier K","Schmerz","2009","2008/12/11","","","10.1007/s00482-008-0742-9"
"19059045","Opiate agonist treatment for addiction","Newman RG.","Lancet. 2008 Dec 6;372(9654):1951-2; author reply 1952. doi: 10.1016/S0140-6736(08)61838-3.","Newman RG","Lancet","2008","2008/12/09","","","10.1016/S0140-6736(08)61838-3"
"19058904","Pregnancy under high-dose buprenorphine","Simmat-Durand L, Lejeune C, Gourarier L; Groupe d' Etudes Grossesse et Addictions (GEGA).","Eur J Obstet Gynecol Reprod Biol. 2009 Feb;142(2):119-23. doi: 10.1016/j.ejogrb.2008.10.012. Epub 2008 Dec 5.","Simmat-Durand L","Eur J Obstet Gynecol Reprod Biol","2009","2008/12/09","","","10.1016/j.ejogrb.2008.10.012"
"19040199","Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine","Pradel V, Frauger E, Thirion X, Ronfle E, Lapierre V, Masut A, Coudert C, Blin O, Micallef J.","Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):36-43. doi: 10.1002/pds.1681.","Pradel V","Pharmacoepidemiol Drug Saf","2009","2008/12/02","","","10.1002/pds.1681"
"19035061","Treating opioid dependency and coexistent chronic nonmalignant pain","Blondell RD, Ashrafioun L.","Am Fam Physician. 2008 Nov 15;78(10):1132-3.","Blondell RD","Am Fam Physician","2008","2008/11/28","","",""
"19034736","Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration","Gordon AJ, Liberto J, Granda S, Salmon-Cox S, Andree T, McNicholas L.","Am J Addict. 2008 Nov-Dec;17(6):459-62. doi: 10.1080/10550490802408613.","Gordon AJ","Am J Addict","2008","2008/11/27","","","10.1080/10550490802408613"
"19031975","[New guidelines against unfair treatment of narcotic addicts necessary]","Heilig M, Gunne L.","Lakartidningen. 2008 Oct 29-Nov 4;105(44):3093-4.","Heilig M","Lakartidningen","2008","2008/11/27","","",""
"19028746","Haemodynamic changes in acute opiate withdrawal","Stuart Reece A.","QJM. 2009 May;102(5):357. doi: 10.1093/qjmed/hcn151. Epub 2008 Nov 21.","Stuart Reece A","QJM","2009","2008/11/26","","","10.1093/qjmed/hcn151"
"19025217","[Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain]","Tschirner M, Ritzdorf I, Brünjes R.","MMW Fortschr Med. 2008 Sep 18;150 Suppl 3:142-8.","Tschirner M","MMW Fortschr Med","2008","2008/11/26","","",""
"19021929","Comparison of nonhydrolysis and hydrolysis methods for the determination of buprenorphine metabolites in urine by liquid chromatography-tandem mass spectrometry","Al-Asmari AI, Anderson RA.","J Anal Toxicol. 2008 Nov-Dec;32(9):744-53. doi: 10.1093/jat/32.9.744.","Al-Asmari AI","J Anal Toxicol","2008","2008/11/22","","","10.1093/jat/32.9.744"
"19019049","Treatment of ischemic pain in patients suffering from peripheral vasculopathy with transdermal buprenorphine plus epidural morphine with ropivacaine vs. epidural morphine with ropivacaine","Aurilio C, Pace MC, Passavanti MB, Paladini A, Maisto M, Iannotti M, Pota V, D'amora E, Sansone P, Barbarisi M.","Pain Pract. 2009 Mar-Apr;9(2):105-14. doi: 10.1111/j.1533-2500.2008.00237.x. Epub 2008 Sep 17.","Aurilio C","Pain Pract","2009","2008/11/21","","","10.1111/j.1533-2500.2008.00237.x"
"19011441","Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial","Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P, Limmer C, Kuefner H, Hennig-Fast K.","J Clin Psychopharmacol. 2008 Dec;28(6):699-703. doi: 10.1097/JCP.0b013e31818a6d38.","Soyka M","J Clin Psychopharmacol","2008","2008/11/18","","","10.1097/JCP.0b013e31818a6d38"
"19007513","A simple gas chromatography-mass spectrometry procedure for the simultaneous determination of buprenorphine and norbuprenorphine in human urine","Fuller DC.","J Anal Toxicol. 2008 Oct;32(8):626-30. doi: 10.1093/jat/32.8.626.","Fuller DC","J Anal Toxicol","2008","2008/11/15","","","10.1093/jat/32.8.626"
"19007507","Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine","Kronstrand R, Nyström I, Andersson M, Gunnarsson L, Hägg S, Josefsson M, Ahlner J.","J Anal Toxicol. 2008 Oct;32(8):586-93. doi: 10.1093/jat/32.8.586.","Kronstrand R","J Anal Toxicol","2008","2008/11/15","","","10.1093/jat/32.8.586"
"19004598","Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence","Ridge G, Gossop M, Lintzeris N, Witton J, Strang J.","J Subst Abuse Treat. 2009 Jul;37(1):95-100. doi: 10.1016/j.jsat.2008.09.007. Epub 2008 Nov 11.","Ridge G","J Subst Abuse Treat","2009","2008/11/14","","","10.1016/j.jsat.2008.09.007"
"19004597","Opioid treatment programs in the Clinical Trials Network: representativeness and buprenorphine adoption","Ducharme LJ, Roman PM.","J Subst Abuse Treat. 2009 Jul;37(1):90-4. doi: 10.1016/j.jsat.2008.09.003. Epub 2008 Nov 11.","Ducharme LJ","J Subst Abuse Treat","2009","2008/11/14","PMC2746491","NIHMS123776","10.1016/j.jsat.2008.09.003"
"18999012","Developing an Internet-based practice tool to assist physicians associated with buprenorphine treatment of opioid addiction","Tanner TB, Coulehan MB, Rossie KM, Ross AJ, Metcalf MP.","AMIA Annu Symp Proc. 2008 Nov 6:1056.","Tanner TB","AMIA Annu Symp Proc","2008","2008/11/13","","",""
"18987062","Influence of early neonatal experience on nociceptive responses and analgesic effects in rats","Dickinson AL, Leach MC, Flecknell PA.","Lab Anim. 2009 Jan;43(1):11-6. doi: 10.1258/la.2007.007078. Epub 2008 Nov 5.","Dickinson AL","Lab Anim","2009","2008/11/07","","","10.1258/la.2007.007078"
"18984896","Treatment of adolescent opioid dependence: no quick fix","Fiellin DA.","JAMA. 2008 Nov 5;300(17):2057-9. doi: 10.1001/jama.2008.567.","Fiellin DA","JAMA","2008","2008/11/06","","","10.1001/jama.2008.567"
"18984887","Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS, Forman R, Vetter V, McNicholas L, Blaine J, Lynch KG, Fudala P.","JAMA. 2008 Nov 5;300(17):2003-11. doi: 10.1001/jama.2008.574.","Woody GE","JAMA","2008","2008/11/06","PMC2610690","NIHMS78835","10.1001/jama.2008.574"
"18982913","Management of chronic pain in the elderly: focus on transdermal buprenorphine","Vadivelu N, Hines RL.","Clin Interv Aging. 2008;3(3):421-30. doi: 10.2147/cia.s1880.","Vadivelu N","Clin Interv Aging","2008","2008/11/06","PMC2682375","","10.2147/cia.s1880"
"18977159","Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine","Wirz S, Wittmann M, Schenk M, Schroeck A, Schaefer N, Mueller M, Standop J, Kloecker N, Nadstawek J.","Eur J Pain. 2009 Aug;13(7):737-43. doi: 10.1016/j.ejpain.2008.09.005. Epub 2008 Oct 31.","Wirz S","Eur J Pain","2009","2008/11/04","","","10.1016/j.ejpain.2008.09.005"
"18956529","Psychotherapeutic benefits of opioid agonist therapy","Tenore PL.","J Addict Dis. 2008;27(3):49-65. doi: 10.1080/10550880802122646.","Tenore PL","J Addict Dis","2008","2008/10/30","","","10.1080/10550880802122646"
"18956527","Electrocardiogram characteristics of methadone and buprenorphine maintained subjects","Athanasos P, Farquharson AL, Compton P, Psaltis P, Hay J.","J Addict Dis. 2008;27(3):31-5. doi: 10.1080/10550880802122596.","Athanasos P","J Addict Dis","2008","2008/10/30","","","10.1080/10550880802122596"
"18951215","Prenatal buprenorphine exposure: effects on biochemical markers of hypoxia and early neonatal outcome","Kahila H, Stefanovic V, Loukovaara M, Alfthan H, Hämäläinen E, Halmesmäki E.","Acta Obstet Gynecol Scand. 2008;87(11):1213-9. doi: 10.1080/00016340802460297.","Kahila H","Acta Obstet Gynecol Scand","2008","2008/10/28","","","10.1080/00016340802460297"
"18938116","Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy","Belfiori B, Ciliegi P, Chiodera A, Bacosi D, Tosti A, Baldelli F, Francisci D.","Dig Liver Dis. 2009 Apr;41(4):303-7. doi: 10.1016/j.dld.2008.08.009. Epub 2008 Oct 19.","Belfiori B","Dig Liver Dis","2009","2008/10/22","","","10.1016/j.dld.2008.08.009"
"18930603","Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","Magura S, Lee JD, Hershberger J, Joseph H, Marsch L, Shropshire C, Rosenblum A.","Drug Alcohol Depend. 2009 Jan 1;99(1-3):222-30. doi: 10.1016/j.drugalcdep.2008.08.006. Epub 2008 Oct 18.","Magura S","Drug Alcohol Depend","2009","2008/10/22","PMC2658719","NIHMS90814","10.1016/j.drugalcdep.2008.08.006"
"18928077","Buprenorphine treatment in an urban community health center: what to expect","Cunningham C, Giovanniello A, Sacajiu G, Whitley S, Mund P, Beil R, Sohler N.","Fam Med. 2008 Jul-Aug;40(7):500-6.","Cunningham C","Fam Med","2008","2008/10/22","PMC2840630","NIHMS182411",""
"18926274","Substitution treatment in Malaysia","Noordin NM, Merican MI, Rahman HA, Lee SS, Ramly R.","Lancet. 2008 Sep 27;372(9644):1149-50. doi: 10.1016/S0140-6736(08)61479-8.","Noordin NM","Lancet","2008","2008/10/18","","","10.1016/S0140-6736(08)61479-8"
"18922673","[<< Puffy hands >> syndrome]","Delage M, Samimi M, Lebidre E, Baulieu F, Lorette G, Maruani A.","Presse Med. 2009 Jan;38(1):153-5. doi: 10.1016/j.lpm.2008.04.009. Epub 2008 Oct 14.","Delage M","Presse Med","2009","2008/10/17","","","10.1016/j.lpm.2008.04.009"
"18840620","Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats","Gades NM, Danneman PJ, Wixson SK, Tolley EA.","Lab Anim. 2008 Oct;42(4):516. doi: 10.1258/la.2008.008999.","Gades NM","Lab Anim","2008","2008/10/09","","","10.1258/la.2008.008999"
"18837640","Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine","Mendelson J, Flower K, Pletcher MJ, Galloway GP.","Exp Clin Psychopharmacol. 2008 Oct;16(5):435-41. doi: 10.1037/a0013637.","Mendelson J","Exp Clin Psychopharmacol","2008","2008/10/08","PMC4687728","NIHMS692562","10.1037/a0013637"
"18837637","Opioids and the treatment of chronic pain: controversies, current status, and future directions","Rosenblum A, Marsch LA, Joseph H, Portenoy RK.","Exp Clin Psychopharmacol. 2008 Oct;16(5):405-16. doi: 10.1037/a0013628.","Rosenblum A","Exp Clin Psychopharmacol","2008","2008/10/08","PMC2711509","NIHMS97365","10.1037/a0013628"
"18831352","Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects","De S, Jain R, Ray R, Dhawan A, Varghese ST.","Indian J Physiol Pharmacol. 2008 Jan-Mar;52(1):53-63.","De S","Indian J Physiol Pharmacol","2008","2008/10/04","","",""
"18824311","Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence","Lavie E, Fatséas M, Denis C, Auriacombe M.","Drug Alcohol Depend. 2009 Jan 1;99(1-3):338-44. doi: 10.1016/j.drugalcdep.2008.07.017. Epub 2008 Sep 27.","Lavie E","Drug Alcohol Depend","2009","2008/10/01","","","10.1016/j.drugalcdep.2008.07.017"
"18819759","Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty","Mark TL, Kassed CA, Vandivort-Warren R, Levit KR, Kranzler HR.","Drug Alcohol Depend. 2009 Jan 1;99(1-3):345-9. doi: 10.1016/j.drugalcdep.2008.07.018. Epub 2008 Sep 25.","Mark TL","Drug Alcohol Depend","2009","2008/09/30","PMC3166770","NIHMS320798","10.1016/j.drugalcdep.2008.07.018"
"18807743","DOTS in drug addicts with TB : Delhi experience","Dhingra VK, Lall D, Aggarwal N, Vashist RP.","Indian J Tuberc. 2008 Jul;55(3):122-6.","Dhingra VK","Indian J Tuberc","2008","2008/09/24","","",""
"18805656","Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence","Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS Jr, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W.","Drug Alcohol Depend. 2009 Jan 1;99(1-3):28-36. doi: 10.1016/j.drugalcdep.2008.06.016. Epub 2008 Sep 20.","Ziedonis DM","Drug Alcohol Depend","2009","2008/09/23","PMC2770269","NIHMS146193","10.1016/j.drugalcdep.2008.06.016"
"18804923","Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients","Jones ES, Moore BA, Sindelar JL, O'Connor PG, Schottenfeld RS, Fiellin DA.","Drug Alcohol Depend. 2009 Jan 1;99(1-3):132-40. doi: 10.1016/j.drugalcdep.2008.07.013. Epub 2008 Sep 19.","Jones ES","Drug Alcohol Depend","2009","2008/09/23","PMC2646001","NIHMS90557","10.1016/j.drugalcdep.2008.07.013"
"18802942","Transdermal buprenorphine in children with cancer-related pain","Attinà G, Ruggiero A, Maurizi P, Arlotta A, Chiaretti A, Riccardi R.","Pediatr Blood Cancer. 2009 Jan;52(1):125-7. doi: 10.1002/pbc.21736.","Attinà G","Pediatr Blood Cancer","2009","2008/09/20","","","10.1002/pbc.21736"
"18801404","Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study","Nava F, Manzato E, Leonardi C, Lucchini A.","Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1867-72. doi: 10.1016/j.pnpbp.2008.08.019. Epub 2008 Sep 4.","Nava F","Prog Neuropsychopharmacol Biol Psychiatry","2008","2008/09/20","","","10.1016/j.pnpbp.2008.08.019"
"18794671","Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy","Nyhuis PW, Gastpar M, Scherbaum N.","J Clin Psychopharmacol. 2008 Oct;28(5):593-5. doi: 10.1097/JCP.0b013e31818638a4.","Nyhuis PW","J Clin Psychopharmacol","2008","2008/09/17","","","10.1097/JCP.0b013e31818638a4"
"18783498","Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates","Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G.","Addiction. 2008 Sep;103(9):1429-40. doi: 10.1111/j.1360-0443.2008.02283.x.","Winklbaur B","Addiction","2008","2008/09/12","","","10.1111/j.1360-0443.2008.02283.x"
"18778390","The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study","Roux P, Carrieri MP, Villes V, Dellamonica P, Poizot-Martin I, Ravaux I, Spire B; MANIF2000 cohort study group.","Addiction. 2008 Nov;103(11):1828-36. doi: 10.1111/j.1360-0443.2008.02323.x. Epub 2008 Sep 4.","Roux P","Addiction","2008","2008/09/10","","","10.1111/j.1360-0443.2008.02323.x"
"18775604","Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France","Roux P, Villes V, Bry D, Spire B, Feroni I, Marcellin F, Carrieri MP.","Addict Behav. 2008 Dec;33(12):1625-9. doi: 10.1016/j.addbeh.2008.07.018. Epub 2008 Aug 3.","Roux P","Addict Behav","2008","2008/09/09","","","10.1016/j.addbeh.2008.07.018"
"18774623","The underrecognized toll of prescription opioid abuse on young children","Bailey JE, Campagna E, Dart RC; RADARS System Poison Center Investigators.","Ann Emerg Med. 2009 Apr;53(4):419-24. doi: 10.1016/j.annemergmed.2008.07.015. Epub 2008 Sep 6.","Bailey JE","Ann Emerg Med","2009","2008/09/09","","","10.1016/j.annemergmed.2008.07.015"
"18774063","Serotonin syndrome triggered by a single dose of suboxone","Isenberg D, Wong SC, Curtis JA.","Am J Emerg Med. 2008 Sep;26(7):840.e3-5. doi: 10.1016/j.ajem.2008.01.039.","Isenberg D","Am J Emerg Med","2008","2008/09/09","","","10.1016/j.ajem.2008.01.039"
"18770082","Attitudes toward buprenorphine and methadone among opioid-dependent individuals","Schwartz RP, Kelly SM, O'Grady KE, Mitchell SG, Peterson JA, Reisinger HS, Agar MH, Brown BS.","Am J Addict. 2008 Sep-Oct;17(5):396-401. doi: 10.1080/10550490802268835.","Schwartz RP","Am J Addict","2008","2008/09/05","PMC2814176","NIHMS162603","10.1080/10550490802268835"
"18758763","Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine","Kacinko SL, Concheiro-Guisan M, Shakleya DM, Huestis MA.","Anal Bioanal Chem. 2008 Nov;392(5):903-11. doi: 10.1007/s00216-008-2326-z. Epub 2008 Aug 30.","Kacinko SL","Anal Bioanal Chem","2008","2008/09/02","PMC2670341","NIHMS105202","10.1007/s00216-008-2326-z"
"18724572","The prevalence of borderline personality among buprenorphine patients","Sansone RA, Whitecar P, Wiederman MW.","Int J Psychiatry Med. 2008;38(2):217-26. doi: 10.2190/PM.38.2.h.","Sansone RA","Int J Psychiatry Med","2008","2008/08/30","","","10.2190/PM.38.2.h"
"18720267","Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment","Loeber S, Kniest A, Diehl A, Mann K, Croissant B.","Am J Drug Alcohol Abuse. 2008;34(5):584-93. doi: 10.1080/00952990802308239.","Loeber S","Am J Drug Alcohol Abuse","2008","2008/08/23","","","10.1080/00952990802308239"
"18715741","Factors affecting willingness to provide buprenorphine treatment","Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA; BHIVES Collaborative.","J Subst Abuse Treat. 2009 Apr;36(3):244-51. doi: 10.1016/j.jsat.2008.06.006. Epub 2008 Aug 20.","Netherland J","J Subst Abuse Treat","2009","2008/08/22","PMC2866292","NIHMS182403","10.1016/j.jsat.2008.06.006"
"18713521","Urinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay","Hull MJ, Bierer MF, Griggs DA, Long WH, Nixon AL, Flood JG.","J Anal Toxicol. 2008 Sep;32(7):516-21. doi: 10.1093/jat/32.7.516.","Hull MJ","J Anal Toxicol","2008","2008/08/21","","","10.1093/jat/32.7.516"
"18712130","[Treatment of chronic osteoarthritis pain: effectivity and safety of a 7 day matrix patch with a low dose buprenorphine]","Schutter U, Ritzdorf I, Heckes B.","MMW Fortschr Med. 2008 Jun 26;150 Suppl 2:96-103.","Schutter U","MMW Fortschr Med","2008","2008/08/21","","",""
"18708654","Maintenance of anaesthesia in sheep with isoflurane, desflurane or sevoflurane","Mohamadnia AR, Hughes G, Clarke KW.","Vet Rec. 2008 Aug 16;163(7):210-5. doi: 10.1136/vr.163.7.210.","Mohamadnia AR","Vet Rec","2008","2008/08/19","","","10.1136/vr.163.7.210"
"18703559","Buprenorphine alters desmethylflunitrazepam disposition and flunitrazepam toxicity in rats","Pirnay S, Megarbane B, Declèves X, Risède P, Borron SW, Bouchonnet S, Perrin B, Debray M, Milan N, Duarte T, Ricordel I, Baud FJ.","Toxicol Sci. 2008 Nov;106(1):64-73. doi: 10.1093/toxsci/kfn163. Epub 2008 Aug 14.","Pirnay S","Toxicol Sci","2008","2008/08/16","","","10.1093/toxsci/kfn163"
"18702446","Effects of indomethacin and buprenorphine analgesia on the postoperative recovery of mice","Blaha MD, Leon LR.","J Am Assoc Lab Anim Sci. 2008 Jul;47(4):8-19.","Blaha MD","J Am Assoc Lab Anim Sci","2008","2008/08/16","PMC2694718","",""
"18701886","Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes","Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA.","Clin Pharmacol Ther. 2008 Nov;84(5):604-12. doi: 10.1038/clpt.2008.156. Epub 2008 Aug 13.","Kacinko SL","Clin Pharmacol Ther","2008","2008/08/15","PMC2714885","NIHMS106416","10.1038/clpt.2008.156"
"18701828","Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia","Bujalska M, Malinowska E, Makulska-Nowak H, Gumułka SW.","Pharmacology. 2008;82(3):180-6. doi: 10.1159/000151346. Epub 2008 Aug 14.","Bujalska M","Pharmacology","2008","2008/08/15","","","10.1159/000151346"
"18694901","Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial","Kraft WK, Gibson E, Dysart K, Damle VS, Larusso JL, Greenspan JS, Moody DE, Kaltenbach K, Ehrlich ME.","Pediatrics. 2008 Sep;122(3):e601-7. doi: 10.1542/peds.2008-0571. Epub 2008 Aug 11.","Kraft WK","Pediatrics","2008","2008/08/13","PMC2574639","NIHMS66569","10.1542/peds.2008-0571"
"18691917","Dose-related antinociceptive effects of intravenous buprenorphine in cats","Steagall PV, Mantovani FB, Taylor PM, Dixon MJ, Luna SP.","Vet J. 2009 Nov;182(2):203-9. doi: 10.1016/j.tvjl.2008.06.017. Epub 2008 Aug 8.","Steagall PV","Vet J","2009","2008/08/12","","","10.1016/j.tvjl.2008.06.017"
"18688120","Epidural analgesia during brachytherapy for cervical cancer patients","Janaki MG, Nirmala S, Kadam AR, Ramesh BS, Sunitha KS.","J Cancer Res Ther. 2008 Apr-Jun;4(2):60-3. doi: 10.4103/0973-1482.40825.","Janaki MG","J Cancer Res Ther","2008","2008/08/09","","","10.4103/0973-1482.40825"
"18686025","Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes","Esses JL, Rosman J, Do LT, Schweitzer P, Hanon S.","J Interv Card Electrophysiol. 2008 Nov;23(2):117-9. doi: 10.1007/s10840-008-9280-8. Epub 2008 Aug 7.","Esses JL","J Interv Card Electrophysiol","2008","2008/08/08","","","10.1007/s10840-008-9280-8"
"18684226","Effects of various combinations of benzodiazepines with buprenorphine on arterial blood gases in rats","Pirnay SO, Mégarbane B, Borron SW, Risède P, Monier C, Ricordel I, Baud FJ.","Basic Clin Pharmacol Toxicol. 2008 Sep;103(3):228-39. doi: 10.1111/j.1742-7843.2008.00273.x. Epub 2008 Jul 18.","Pirnay SO","Basic Clin Pharmacol Toxicol","2008","2008/08/08","","","10.1111/j.1742-7843.2008.00273.x"
"18678689","Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists","Thomas CP, Reif S, Haq S, Wallack SS, Hoyt A, Ritter GA.","Psychiatr Serv. 2008 Aug;59(8):909-16. doi: 10.1176/ps.2008.59.8.909.","Thomas CP","Psychiatr Serv","2008","2008/08/06","","","10.1176/ps.2008.59.8.909"
"18672960","Effects of epidurally administered morphine or buprenorphine on the thermal threshold in cats","Pypendop BH, Siao KT, Pascoe PJ, Ilkiw JE.","Am J Vet Res. 2008 Aug;69(8):983-7. doi: 10.2460/ajvr.69.8.983.","Pypendop BH","Am J Vet Res","2008","2008/08/05","","","10.2460/ajvr.69.8.983"
"18668369","Substance abuse treatment organizations as mediators of social policy: slowing the adoption of a congressionally approved medication","Wallack SS, Thomas CP, Martin TC, Chilingerian J, Reif S.","J Behav Health Serv Res. 2010 Jan;37(1):64-78. doi: 10.1007/s11414-008-9132-4. Epub 2008 Jul 31.","Wallack SS","J Behav Health Serv Res","2010","2008/08/01","","","10.1007/s11414-008-9132-4"
"18662364","High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study","Barutell C, Camba A, González-Escalada JR, Rodríguez M; Opioid Group of the Spanish Society for the Study of Pain.","Pain Pract. 2008 Sep-Oct;8(5):355-61. doi: 10.1111/j.1533-2500.2008.00205.x. Epub 2008 Jul 25.","Barutell C","Pain Pract","2008","2008/07/30","","","10.1111/j.1533-2500.2008.00205.x"
"18636999","Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS","Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, Jie S, Mardiati R, Mokri A, Moskalewicz J, Newcombe D, Poznyak V, Subata E, Uchtenhagen A, Utami DS, Vial R, Zhao C.","Addiction. 2008 Sep;103(9):1484-92. doi: 10.1111/j.1360-0443.2008.02249.x. Epub 2008 Jul 10.","Lawrinson P","Addiction","2008","2008/07/19","","","10.1111/j.1360-0443.2008.02249.x"
"18634857","The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine","Marquez P, Borse J, Nguyen AT, Hamid A, Lutfy K.","Neuroscience. 2008 Aug 26;155(3):597-602. doi: 10.1016/j.neuroscience.2008.06.027. Epub 2008 Jun 19.","Marquez P","Neuroscience","2008","2008/07/19","PMC2631239","NIHMS68811","10.1016/j.neuroscience.2008.06.027"
"18612883","Preliminary study of buprenorphine and bupropion for opioid-dependent smokers","Mooney ME, Poling J, Gonzalez G, Gonsai K, Kosten T, Sofuoglu M.","Am J Addict. 2008 Jul-Aug;17(4):287-92. doi: 10.1080/10550490802138814.","Mooney ME","Am J Addict","2008","2008/07/10","PMC2588345","NIHMS78562","10.1080/10550490802138814"
"18608275","Transdermal buprenorphine intoxication","Magdalan J, Merwid-Lad A.","Clin Toxicol (Phila). 2008 Nov;46(9):915-6. doi: 10.1080/15563650701834672.","Magdalan J","Clin Toxicol (Phila)","2008","2008/07/09","","","10.1080/15563650701834672"
"18604522","Effects of chronic buprenorphine treatment on levels of nucleus accumbens glutamate and on the expression of cocaine-induced behavioral sensitization in rats","Placenza FM, Rajabi H, Stewart J.","Psychopharmacology (Berl). 2008 Oct;200(3):347-55. doi: 10.1007/s00213-008-1210-z. Epub 2008 Jul 5.","Placenza FM","Psychopharmacology (Berl)","2008","2008/07/08","","","10.1007/s00213-008-1210-z"
"18598301","Pharmacokinetic-pharmacodynamic relationships of cognitive and psychomotor effects of intravenous buprenorphine infusion in human volunteers","Jensen ML, Sjøgren P, Upton RN, Foster DJ, Bonde P, Graae C, Skram U, Stevner L, Christrup LL.","Basic Clin Pharmacol Toxicol. 2008 Jul;103(1):94-101. doi: 10.1111/j.1742-7843.2008.00250.x.","Jensen ML","Basic Clin Pharmacol Toxicol","2008","2008/07/05","","","10.1111/j.1742-7843.2008.00250.x"
"18597246","Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs","Abbo LA, Ko JC, Maxwell LK, Galinsky RE, Moody DE, Johnson BM, Fang WB.","Vet Ther. 2008 Summer;9(2):83-93.","Abbo LA","Vet Ther","2008","2008/07/04","","",""
"18596376","Effect of subcutaneous injection and oral voluntary ingestion of buprenorphine on post-operative serum corticosterone levels in male rats","Goldkuhl R, Carlsson HE, Hau J, Abelson KS.","Eur Surg Res. 2008;41(3):272-8. doi: 10.1159/000142372. Epub 2008 Jul 3.","Goldkuhl R","Eur Surg Res","2008","2008/07/04","","","10.1159/000142372"
"18594026","A 50-year-old woman addicted to heroin: review of treatment of heroin addiction","O'Brien CP.","JAMA. 2008 Jul 16;300(3):314-21. doi: 10.1001/jama.300.1.jrr80005. Epub 2008 Jul 1.","O'Brien CP","JAMA","2008","2008/07/03","PMC3812920","NIHMS314996","10.1001/jama.300.1.jrr80005"
"18592319","Office-based management of opioid dependence with buprenorphine: clinical practices and barriers","Walley AY, Alperen JK, Cheng DM, Botticelli M, Castro-Donlan C, Samet JH, Alford DP.","J Gen Intern Med. 2008 Sep;23(9):1393-8. doi: 10.1007/s11606-008-0686-x.","Walley AY","J Gen Intern Med","2008","2008/07/02","PMC2518016","","10.1007/s11606-008-0686-x"
"18589179","Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning","Pan H, Wang L, Zhang X, Zhang G, Mai H, Han Y, Guo S.","Transplant Proc. 2008 Jun;40(5):1714-21. doi: 10.1016/j.transproceed.2008.03.152.","Pan H","Transplant Proc","2008","2008/07/01","","","10.1016/j.transproceed.2008.03.152"
"18586174","Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial","Schottenfeld RS, Chawarski MC, Mazlan M.","Lancet. 2008 Jun 28;371(9631):2192-200. doi: 10.1016/S0140-6736(08)60954-X.","Schottenfeld RS","Lancet","2008","2008/07/01","PMC4041792","NIHMS57282","10.1016/S0140-6736(08)60954-X"
"18586157","Oral substitution treatments for opioid dependence","Hall WD, Mattick RP.","Lancet. 2008 Jun 28;371(9631):2150-1. doi: 10.1016/S0140-6736(08)60930-7.","Hall WD","Lancet","2008","2008/07/01","","","10.1016/S0140-6736(08)60930-7"
"18584580","Case series of buprenorphine injectors in Kuala Lumpur, Malaysia","Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altice FL.","Am J Drug Alcohol Abuse. 2008;34(4):511-7. doi: 10.1080/00952990802122259.","Bruce RD","Am J Drug Alcohol Abuse","2008","2008/06/28","","","10.1080/00952990802122259"
"18584576","Comparison of characteristics of opioid-using pregnant women in rural and urban settings","Heil SH, Sigmon SC, Jones HE, Wagner M.","Am J Drug Alcohol Abuse. 2008;34(4):463-71. doi: 10.1080/00952990802122358.","Heil SH","Am J Drug Alcohol Abuse","2008","2008/06/28","PMC2662476","NIHMS96832","10.1080/00952990802122358"
"18584566","Pharmacogenetic treatments for drug addiction: alcohol and opiates","Haile CN, Kosten TA, Kosten TR.","Am J Drug Alcohol Abuse. 2008;34(4):355-81. doi: 10.1080/00952990802122564.","Haile CN","Am J Drug Alcohol Abuse","2008","2008/06/28","","","10.1080/00952990802122564"
"18584401","Addiction: a chronic medical condition","Newman RG.","Drug Alcohol Rev. 2008 Jul;27(4):450. doi: 10.1080/09595230802089727.","Newman RG","Drug Alcohol Rev","2008","2008/06/28","","","10.1080/09595230802089727"
"18584400","Buprenorphine use by the smoking route in gaols in NSW","Winstock AR.","Drug Alcohol Rev. 2008 Jul;27(4):449-50. doi: 10.1080/09595230802043807.","Winstock AR","Drug Alcohol Rev","2008","2008/06/28","","","10.1080/09595230802043807"
"18584389","Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment","Winstock AR, Lea T, Sheridan J.","Drug Alcohol Rev. 2008 Jul;27(4):393-7. doi: 10.1080/09595230802093745.","Winstock AR","Drug Alcohol Rev","2008","2008/06/28","","","10.1080/09595230802093745"
"18583914","Post-treatment outcomes of buprenorphine detoxification in community settings: a systematic review","Horspool MJ, Seivewright N, Armitage CJ, Mathers N.","Eur Addict Res. 2008;14(4):179-85. doi: 10.1159/000141641. Epub 2008 Jun 27.","Horspool MJ","Eur Addict Res","2008","2008/06/28","","","10.1159/000141641"
"18574363","Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age","Likar R, Vadlau EM, Breschan C, Kager I, Korak-Leiter M, Ziervogel G.","Clin J Pain. 2008 Jul-Aug;24(6):536-43. doi: 10.1097/AJP.0b013e3181673b65.","Likar R","Clin J Pain","2008","2008/06/25","","","10.1097/AJP.0b013e3181673b65"
"18570665","State policy influence on the early diffusion of buprenorphine in community treatment programs","Ducharme LJ, Abraham AJ.","Subst Abuse Treat Prev Policy. 2008 Jun 20;3:17. doi: 10.1186/1747-597X-3-17.","Ducharme LJ","Subst Abuse Treat Prev Policy","2008","2008/06/24","PMC2464589","","10.1186/1747-597X-3-17"
"18567516","Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine","Kress HG.","Eur J Pain. 2009 Mar;13(3):219-30. doi: 10.1016/j.ejpain.2008.04.011. Epub 2008 Jun 24.","Kress HG","Eur J Pain","2009","2008/06/24","","","10.1016/j.ejpain.2008.04.011"
"18563859","Formation of the N-methylpyridinium derivative to improve the detection of buprenorphine by liquid chromatography-mass spectrometry","Thieme D, Sachs H, Thevis M.","J Mass Spectrom. 2008 Jul;43(7):974-9. doi: 10.1002/jms.1433.","Thieme D","J Mass Spectrom","2008","2008/06/20","","","10.1002/jms.1433"
"18559110","A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone)","Simojoki K, Vorma H, Alho H.","Subst Abuse Treat Prev Policy. 2008 Jun 17;3:16. doi: 10.1186/1747-597X-3-16.","Simojoki K","Subst Abuse Treat Prev Policy","2008","2008/06/19","PMC2453114","","10.1186/1747-597X-3-16"
"18557164","A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners","Springer SA, Bruce RD.","J Opioid Manag. 2008 Mar-Apr;4(2):81-6. doi: 10.5055/jom.2008.0012.","Springer SA","J Opioid Manag","2008","2008/06/18","PMC2476214","NIHMS56896","10.5055/jom.2008.0012"
"18554353","A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone)","Welsh C, Sherman SG, Tobin KE.","Addiction. 2008 Jul;103(7):1226-8. doi: 10.1111/j.1360-0443.2008.02244.x.","Welsh C","Addiction","2008","2008/06/17","","","10.1111/j.1360-0443.2008.02244.x"
"18552730","Response: integrating buprenorphine therapy into clinical practice","Doot MC, Payte JT, Van Zee A.","Sci Pract Perspect. 2004 Aug;2(2):20-3. doi: 10.1151/spp042220.","Doot MC","Sci Pract Perspect","2004","2008/06/17","PMC2851025","","10.1151/spp042220"
"18552729","Community treatment programs take up buprenorphine","Casadonte PP, Kolodner GF, Horton T, McMurphy SM.","Sci Pract Perspect. 2004 Aug;2(2):24-9. doi: 10.1151/spp042224.","Casadonte PP","Sci Pract Perspect","2004","2008/06/17","PMC2851018","","10.1151/spp042224"
"18552728","Practical considerations for the clinical use of buprenorphine","Jones HE.","Sci Pract Perspect. 2004 Aug;2(2):4-20. doi: 10.1151/spp04224.","Jones HE","Sci Pract Perspect","2004","2008/06/17","PMC2851017","","10.1151/spp04224"
"18552727","Stepping into the wide world","Anderson D.","Sci Pract Perspect. 2004 Aug;2(2):3.","Anderson D","Sci Pract Perspect","2004","2008/06/17","PMC2851026","",""
"18548365","[Driving ability under opioids: current assessment of published studies]","Sabatowski R.","Dtsch Med Wochenschr. 2008 Jun;133 Suppl 2:S25-8. doi: 10.1055/s-2008-1081067.","Sabatowski R","Dtsch Med Wochenschr","2008","2008/07/02","","","10.1055/s-2008-1081067"
"18544218","Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine","Shaikh S, Hull MJ, Bishop KA, Griggs DA, Long WH, Nixon AL, Flood JG.","J Anal Toxicol. 2008 Jun;32(5):339-43. doi: 10.1093/jat/32.5.339.","Shaikh S","J Anal Toxicol","2008","2008/06/12","","","10.1093/jat/32.5.339"
"18518651","Pharmacokinetics of buprenorphine following intravenous administration in dogs","Krotscheck U, Boothe DM, Little AA.","Am J Vet Res. 2008 Jun;69(6):722-7. doi: 10.2460/ajvr.69.6.722.","Krotscheck U","Am J Vet Res","2008","2008/06/04","","","10.2460/ajvr.69.6.722"
"18503626","Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone)","Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.","Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.","Pergolizzi J","Pain Pract","2008","2008/05/28","","","10.1111/j.1533-2500.2008.00204.x"
"18489017","Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial","Bickel WK, Marsch LA, Buchhalter AR, Badger GJ.","Exp Clin Psychopharmacol. 2008 Apr;16(2):132-43. doi: 10.1037/1064-1297.16.2.132.","Bickel WK","Exp Clin Psychopharmacol","2008","2008/05/21","PMC2746734","NIHMS129062","10.1037/1064-1297.16.2.132"
"18482930","Measurement of buprenorphine in urine: immunoassay versus LC-MS/MS","Twigger S, Fox E, Allen K.","Ann Clin Biochem. 2008 May;45(Pt 3):339. doi: 10.1258/acb.2008.007250.","Twigger S","Ann Clin Biochem","2008","2008/05/17","","","10.1258/acb.2008.007250"
"18479840","Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management","Roux P, Villes V, Blanche J, Bry D, Spire B, Feroni I, Carrieri MP.","Drug Alcohol Depend. 2008 Sep 1;97(1-2):105-13. doi: 10.1016/j.drugalcdep.2008.03.025. Epub 2008 May 13.","Roux P","Drug Alcohol Depend","2008","2008/05/16","","","10.1016/j.drugalcdep.2008.03.025"
"18474065","Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero","Hytinantti T, Kahila H, Renlund M, Järvenpää AL, Halmesmäki E, Kivitie-Kallio S.","Acta Paediatr. 2008 Aug;97(8):1040-4. doi: 10.1111/j.1651-2227.2008.00838.x. Epub 2008 May 16.","Hytinantti T","Acta Paediatr","2008","2008/05/14","","","10.1111/j.1651-2227.2008.00838.x"
"18467137","Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs","Andaluz A, Moll X, Abellán R, Ventura R, Carbó M, Fresno L, García F.","Vet J. 2009 Sep;181(3):299-304. doi: 10.1016/j.tvjl.2008.03.001. Epub 2008 May 7.","Andaluz A","Vet J","2009","2008/05/10","","","10.1016/j.tvjl.2008.03.001"
"18463995","Suicidality in opioid-dependent subjects","Trémeau F, Darreye A, Staner L, Corrêa H, Weibel H, Khidichian F, Macher JP.","Am J Addict. 2008 May-Jun;17(3):187-94. doi: 10.1080/10550490802020160.","Trémeau F","Am J Addict","2008","2008/05/09","","","10.1080/10550490802020160"
"18462262","Outbreak of exogenous Cushing's syndrome due to unlicensed medications","Azizi F, Jahed A, Hedayati M, Lankarani M, Bejestani HS, Esfahanian F, Beyraghi N, Noroozi A, Kobarfard F.","Clin Endocrinol (Oxf). 2008 Dec;69(6):921-5. doi: 10.1111/j.1365-2265.2008.03290.x. Epub 2008 May 6.","Azizi F","Clin Endocrinol (Oxf)","2008","2008/05/09","","","10.1111/j.1365-2265.2008.03290.x"
"18458279","Narrative review: buprenorphine for opioid-dependent patients in office practice","Sullivan LE, Fiellin DA.","Ann Intern Med. 2008 May 6;148(9):662-70. doi: 10.7326/0003-4819-148-9-200805060-00006.","Sullivan LE","Ann Intern Med","2008","2008/05/07","PMC3694223","NIHMS476171","10.7326/0003-4819-148-9-200805060-00006"
"18451197","Multiple embolic phenomenon in the brain associated with parenteral buprenorphine abuse","Lee TS, Ng BY.","J Neuropsychiatry Clin Neurosci. 2008 Spring;20(2):235-7. doi: 10.1176/jnp.2008.20.2.235a.","Lee TS","J Neuropsychiatry Clin Neurosci","2008","2008/05/03","","","10.1176/jnp.2008.20.2.235a"
"18444447","Effect of buprenorphine on psychomotor functions in patients on buprenorphine maintenance","Singhal A, Tripathi BM, Pal HR, Jena R, Jain R.","J Opioid Manag. 2008 Jan-Feb;4(1):41-7. doi: 10.5055/jom.2008.0007.","Singhal A","J Opioid Manag","2008","2008/05/01","","","10.5055/jom.2008.0007"
"18443666","[Drug therapy of opioid withdrawal]","Cortese S, Risso M.","Vertex. 2008 Jan-Feb;19(77):522-6.","Cortese S","Vertex","2008","2008/04/30","","",""
"18438689","[Topical application of morphine and buprenorphine gel has no effect in the sunburn model]","Draxler J, Schuch M, Paul A, Sycha T, Valenta C, Likar R, Gustorff B.","Schmerz. 2008 Oct;22(5):571-4. doi: 10.1007/s00482-008-0660-x.","Draxler J","Schmerz","2008","2008/04/29","","","10.1007/s00482-008-0660-x"
"18435875","The effects of buprenorphine on behaviour in the ACI and BN rat inbred strains","Avsaroglu H, Sommer R, Hellebrekers LJ, van Zutphen LF, van Lith HA.","Lab Anim. 2008 Apr;42(2):171-84. doi: 10.1258/la.2007.007017.","Avsaroglu H","Lab Anim","2008","2008/04/26","","","10.1258/la.2007.007017"
"18435873","Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats","Ilbäck NG, Siller M, Stålhandske T.","Lab Anim. 2008 Apr;42(2):149-60. doi: 10.1258/la.2007.06002e.","Ilbäck NG","Lab Anim","2008","2008/04/26","","","10.1258/la.2007.06002e"
"18425946","Maintenance agonist treatments for opiate dependent pregnant women","Minozzi S, Amato L, Vecchi S, Davoli M.","Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006318. doi: 10.1002/14651858.CD006318.pub2.","Minozzi S","Cochrane Database Syst Rev","2008","2008/04/22","","","10.1002/14651858.CD006318.pub2"
"18425880","Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","Mattick RP, Kimber J, Breen C, Davoli M.","Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002207. doi: 10.1002/14651858.CD002207.pub3.","Mattick RP","Cochrane Database Syst Rev","2008","2008/04/22","","","10.1002/14651858.CD002207.pub3"
"18423901","Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: follow-up of a randomised trial","Bell JR, Ryan A, Mutch C, Batey R, Rea F.","Drug Alcohol Depend. 2008 Jul 1;96(1-2):183-6. doi: 10.1016/j.drugalcdep.2008.02.012. Epub 2008 Apr 18.","Bell JR","Drug Alcohol Depend","2008","2008/04/22","","","10.1016/j.drugalcdep.2008.02.012"
"18416765","Allergic contact dermatitis due to transdermal buprenorphine","Pérez-Pérez L, Cabanillas M, Loureiro M, Fernández-Redondo V, Labandeira J, Toribio J.","Contact Dermatitis. 2008 May;58(5):310-2. doi: 10.1111/j.1600-0536.2007.01206.x.","Pérez-Pérez L","Contact Dermatitis","2008","2008/04/18","","","10.1111/j.1600-0536.2007.01206.x"
"18411010","Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain","Poulain P, Denier W, Douma J, Hoerauf K, Samija M, Sopata M, Wolfram G.","J Pain Symptom Manage. 2008 Aug;36(2):117-25. doi: 10.1016/j.jpainsymman.2007.09.011. Epub 2008 Apr 14.","Poulain P","J Pain Symptom Manage","2008","2008/04/16","","","10.1016/j.jpainsymman.2007.09.011"
"18409661","Management of pain in the older person with cancer. Part 2: treatment options","Delgado-Guay MO, Bruera E.","Oncology (Williston Park). 2008 Feb;22(2):148-52; discussion 152, 155, 160 passim.","Delgado-Guay MO","Oncology (Williston Park)","2008","2008/04/16","","",""
"18401319","[Endogenous Candida endophthalmitis in drug misusers injecting intravenous buprenorphine]","Hirsbein D, Attal P, Gueudry J, Guet I, Brasseur G, Vasseneix C.","J Fr Ophtalmol. 2008 Feb;31(2):180-3. doi: 10.1016/s0181-5512(08)70351-6.","Hirsbein D","J Fr Ophtalmol","2008","2008/04/11","","","10.1016/s0181-5512(08)70351-6"
"18395841","Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver","Furrer K, Tian Y, Pfammatter T, Jochum W, El-Badry AM, Graf R, Clavien PA.","Hepatology. 2008 May;47(5):1615-23. doi: 10.1002/hep.22164.","Furrer K","Hepatology","2008","2008/04/09","","","10.1002/hep.22164"
"18393054","Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years","Fiellin DA, Moore BA, Sullivan LE, Becker WC, Pantalon MV, Chawarski MC, Barry DT, O'Connor PG, Schottenfeld RS.","Am J Addict. 2008 Mar-Apr;17(2):116-20. doi: 10.1080/10550490701860971.","Fiellin DA","Am J Addict","2008","2008/04/09","","","10.1080/10550490701860971"
"18392754","Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959)","Fischer BD, Miller LL, Henry FE, Picker MJ, Dykstra LA.","Psychopharmacology (Berl). 2008 Jun;198(2):271-8. doi: 10.1007/s00213-008-1130-y. Epub 2008 Apr 8.","Fischer BD","Psychopharmacology (Berl)","2008","2008/04/09","","","10.1007/s00213-008-1130-y"
"18382224","Opioid dependence and pregnancy","Winklbaur B, Jung E, Fischer G.","Curr Opin Psychiatry. 2008 May;21(3):255-9. doi: 10.1097/YCO.0b013e3282fb25e5.","Winklbaur B","Curr Opin Psychiatry","2008","2008/04/03","","","10.1097/YCO.0b013e3282fb25e5"
"18381654","Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain","Sanchez ES, Bigbee JW, Fobbs W, Robinson SE, Sato-Bigbee C.","Glia. 2008 Jul;56(9):1017-27. doi: 10.1002/glia.20675.","Sanchez ES","Glia","2008","2008/04/03","PMC2577583","NIHMS74119","10.1002/glia.20675"
"18381506","Toxicity of buprenorphine overdoses in children","Hayes BD, Klein-Schwartz W, Doyon S.","Pediatrics. 2008 Apr;121(4):e782-6. doi: 10.1542/peds.2007-1774.","Hayes BD","Pediatrics","2008","2008/04/03","","","10.1542/peds.2007-1774"
"18371868","Online solid-phase extraction liquid chromatography-electrospray-tandem mass spectrometry analysis of buprenorphine and three metabolites in human urine","Liu AC, Lin TY, Su LW, Fuh MR.","Talanta. 2008 Mar 15;75(1):198-204. doi: 10.1016/j.talanta.2007.10.050. Epub 2007 Nov 9.","Liu AC","Talanta","2008","2008/03/29","","","10.1016/j.talanta.2007.10.050"
"18363493","Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature","Tassinari D, Sartori S, Tamburini E, Scarpi E, Raffaeli W, Tombesi P, Maltoni M.","J Palliat Med. 2008 Apr;11(3):492-501. doi: 10.1089/jpm.2007.0200.","Tassinari D","J Palliat Med","2008","2008/03/28","","","10.1089/jpm.2007.0200"
"18363014","Another complication of subutex abuse","Joethy J, Yong FC, Puhaindran M.","Singapore Med J. 2008 Mar;49(3):267-8.","Joethy J","Singapore Med J","2008","2008/03/26","","",""
"18359216","Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","Winstock AR, Lea T, Sheridan J.","Int J Drug Policy. 2008 Dec;19(6):450-8. doi: 10.1016/j.drugpo.2007.03.002. Epub 2008 Mar 21.","Winstock AR","Int J Drug Policy","2008","2008/03/25","","","10.1016/j.drugpo.2007.03.002"
"18355989","Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series","Kakko J, Heilig M, Sarman I.","Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19.","Kakko J","Drug Alcohol Depend","2008","2008/03/22","","","10.1016/j.drugalcdep.2008.01.025"
"18355923","New technique for drug application to the spinal cord of walking mice","Akay T, Fouad K, Pearson KG.","J Neurosci Methods. 2008 Jun 15;171(1):39-47. doi: 10.1016/j.jneumeth.2008.02.001. Epub 2008 Feb 12.","Akay T","J Neurosci Methods","2008","2008/03/22","","","10.1016/j.jneumeth.2008.02.001"
"18349865","Drug addiction: a critical problem calling for novel solutions","Tyndale R.","Clin Pharmacol Ther. 2008 Apr;83(4):503-6. doi: 10.1038/clpt.2008.11.","Tyndale R","Clin Pharmacol Ther","2008","2008/03/20","","","10.1038/clpt.2008.11"
"18348767","Changes in minimal alveolar concentration of isoflurane following treatment with medetomidine and tiletamine/zolazepam, epidural morphine or systemic buprenorphine in pigs","Malavasi LM, Jensen-Waern M, Augustsson H, Nyman G.","Lab Anim. 2008 Jan;42(1):62-70. doi: 10.1258/la.2007.006048.","Malavasi LM","Lab Anim","2008","2008/03/20","","","10.1258/la.2007.006048"
"18337025","Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients","Wittchen HU, Apelt SM, Soyka M, Gastpar M, Backmund M, Gölz J, Kraus MR, Tretter F, Schäfer M, Siegert J, Scherbaum N, Rehm J, Bühringer G.","Drug Alcohol Depend. 2008 Jun 1;95(3):245-57. doi: 10.1016/j.drugalcdep.2008.01.015. Epub 2008 Mar 11.","Wittchen HU","Drug Alcohol Depend","2008","2008/03/14","","","10.1016/j.drugalcdep.2008.01.015"
"18332624","Brain haemorrhage and cerebral vasospasm associated with chronic use of cannabis and buprenorphine","Renard D, Gaillard N.","Cerebrovasc Dis. 2008;25(3):282-3. doi: 10.1159/000119638. Epub 2008 Mar 7.","Renard D","Cerebrovasc Dis","2008","2008/03/12","","","10.1159/000119638"
"18331121","Is buprenorphine-naloxone ready for prime time in the treatment of opioid addiction in managed care?","Curtiss FR.","J Manag Care Pharm. 2008 Mar;14(2):195-7. doi: 10.18553/jmcp.2008.14.2.195.","Curtiss FR","J Manag Care Pharm","2008","2008/03/12","","","10.18553/jmcp.2008.14.2.195"
"18331120","Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use","Kaur AD, McQueen A, Jan S.","J Manag Care Pharm. 2008 Mar;14(2):186-94. doi: 10.18553/jmcp.2008.14.2.186.","Kaur AD","J Manag Care Pharm","2008","2008/03/12","","","10.18553/jmcp.2008.14.2.186"
"18327673","Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation","Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE.","Psychopharmacology (Berl). 2008 Jun;198(2):149-58. doi: 10.1007/s00213-008-1105-z. Epub 2008 Mar 9.","Lanier RK","Psychopharmacology (Berl)","2008","2008/03/11","","","10.1007/s00213-008-1105-z"
"18324390","Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone","Glover EM, Davis M.","Psychopharmacology (Berl). 2008 Jun;198(2):167-80. doi: 10.1007/s00213-008-1112-0. Epub 2008 Mar 7.","Glover EM","Psychopharmacology (Berl)","2008","2008/03/08","","","10.1007/s00213-008-1112-0"
"18316438","Psychotic symptoms following buprenorphine withdrawal","Karila L, Berlin I, Benyamina A, Reynaud M.","Am J Psychiatry. 2008 Mar;165(3):400-1. doi: 10.1176/appi.ajp.2007.07071103.","Karila L","Am J Psychiatry","2008","2008/03/05","","","10.1176/appi.ajp.2007.07071103"
"18316282","The implementation of buprenorphine/naloxone in college health practice","DeMaria PA, Patkar AA.","J Am Coll Health. 2008 Jan-Feb;56(4):391-3. doi: 10.3200/JACH.56.44.391-394.","DeMaria PA","J Am Coll Health","2008","2008/03/05","","","10.3200/JACH.56.44.391-394"
"18305456","Contingency management: utility in the treatment of drug abuse disorders","Stitzer ML, Vandrey R.","Clin Pharmacol Ther. 2008 Apr;83(4):644-7. doi: 10.1038/sj.clpt.6100508. Epub 2008 Feb 27.","Stitzer ML","Clin Pharmacol Ther","2008","2008/02/29","","","10.1038/sj.clpt.6100508"
"18299778","[Emergent dimensions for the construction of an opiate substitute treatment perception scale]","Lozano Rojas OM, Acedos Bilbao I, González Saiz F, Ballesta Gómez R.","Adicciones. 2008;20(1):19-26.","Lozano Rojas OM","Adicciones","2008","2008/02/27","","",""
"18295435","Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events","Nielsen S, Dietze P, Cantwell K, Lee N, Taylor D.","J Subst Abuse Treat. 2008 Dec;35(4):457-61. doi: 10.1016/j.jsat.2007.12.007. Epub 2008 Mar 4.","Nielsen S","J Subst Abuse Treat","2008","2008/02/26","","","10.1016/j.jsat.2007.12.007"
"18294936","Acute liver and renal failure during treatment with buprenorphine at therapeutic dose","Zuin M, Giorgini A, Selmi C, Battezzati PM, Cocchi CA, Crosignani A, Benetti A, Invernizzi P, Podda M.","Dig Liver Dis. 2009 Jul;41(7):e8-e10. doi: 10.1016/j.dld.2007.12.014. Epub 2008 Feb 21.","Zuin M","Dig Liver Dis","2009","2008/02/26","","","10.1016/j.dld.2007.12.014"
"18294814","Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","Sacerdote P, Franchi S, Gerra G, Leccese V, Panerai AE, Somaini L.","Brain Behav Immun. 2008 May;22(4):606-13. doi: 10.1016/j.bbi.2007.12.013. Epub 2008 Feb 21.","Sacerdote P","Brain Behav Immun","2008","2008/02/26","","","10.1016/j.bbi.2007.12.013"
"18293793","Improving access to buprenorphine. A managed care company overcomes several obstacles to make this treatment more available","Nemecek D.","Behav Healthc. 2007 Nov;27(11):40-2.","Nemecek D","Behav Healthc","2007","2008/02/26","","",""
"18290581","Use and misuse of buprenorphine in the management of opioid addiction","Cicero TJ, Surratt HL, Inciardi J.","J Opioid Manag. 2007 Nov-Dec;3(6):302-8. doi: 10.5055/jom.2007.0018.","Cicero TJ","J Opioid Manag","2007","2008/02/23","","","10.5055/jom.2007.0018"
"18288906","Buprenorphine diversion: a possible reason for increased incidence of infective endocarditis among injection drug users? The Singapore experience","Chai LY, Khare CB, Chua A, Fisher DA, Tambyah PA.","Clin Infect Dis. 2008 Mar 15;46(6):953-5; author reply 955-6. doi: 10.1086/528869.","Chai LY","Clin Infect Dis","2008","2008/02/22","","","10.1086/528869"
"18286804","Pharmacologic treatments for opioid dependence: detoxification and maintenance options","Kleber HD.","Dialogues Clin Neurosci. 2007;9(4):455-70.","Kleber HD","Dialogues Clin Neurosci","2007","2008/02/22","PMC3202507","",""
"18283247","Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department","Binder T, Vavrinková B.","Neuro Endocrinol Lett. 2008 Feb;29(1):80-6.","Binder T","Neuro Endocrinol Lett","2008","2008/02/20","","",""
"18282250","Respiratory and cardiovascular effects of buprenorphine in conscious rabbits","Shafford HL, Schadt JC.","Vet Anaesth Analg. 2008 Jul;35(4):326-32. doi: 10.1111/j.1467-2995.2007.00383.x. Epub 2008 Feb 18.","Shafford HL","Vet Anaesth Analg","2008","2008/02/20","","","10.1111/j.1467-2995.2007.00383.x"
"18282249","Effect of buprenorphine on the cardiovascular and respiratory response to visceral pain in conscious rabbits","Shafford HL, Schadt JC.","Vet Anaesth Analg. 2008 Jul;35(4):333-40. doi: 10.1111/j.1467-2995.2007.00384.x. Epub 2008 Feb 18.","Shafford HL","Vet Anaesth Analg","2008","2008/02/20","","","10.1111/j.1467-2995.2007.00384.x"
"18264882","Buprenorphine injection in Melbourne, Australia--an update","Aitken CK, Higgs PG, Hellard ME.","Drug Alcohol Rev. 2008 Mar;27(2):197-9. doi: 10.1080/09595230701829553.","Aitken CK","Drug Alcohol Rev","2008","2008/02/12","","","10.1080/09595230701829553"
"18248941","Treatment of opioid-dependent pregnant women: clinical and research issues","Jones HE, Martin PR, Heil SH, Kaltenbach K, Selby P, Coyle MG, Stine SM, O'Grady KE, Arria AM, Fischer G.","J Subst Abuse Treat. 2008 Oct;35(3):245-59. doi: 10.1016/j.jsat.2007.10.007. Epub 2008 Jan 14.","Jones HE","J Subst Abuse Treat","2008","2008/02/06","PMC2633026","NIHMS71150","10.1016/j.jsat.2007.10.007"
"18239755","Caring for patients with opioid dependence","Bunker J, Winstock A, Zwar NA.","Aust Fam Physician. 2008 Jan-Feb;37(1-2):57-60.","Bunker J","Aust Fam Physician","2008","2008/02/02","","",""
"18236140","Buprederm, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies","Park I, Kim D, Song J, In CH, Jeong SW, Lee SH, Min B, Lee D, Kim SO.","Pharm Res. 2008 May;25(5):1052-62. doi: 10.1007/s11095-007-9470-6. Epub 2008 Feb 1.","Park I","Pharm Res","2008","2008/02/01","","","10.1007/s11095-007-9470-6"
"18226517","Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention","Bruce RD, Schleifer RA.","Int J Drug Policy. 2008 Feb;19(1):17-23. doi: 10.1016/j.drugpo.2007.11.019. Epub 2008 Jan 15.","Bruce RD","Int J Drug Policy","2008","2008/01/30","PMC2366202","NIHMS43472","10.1016/j.drugpo.2007.11.019"
"18221622","Toward a rational selection of treatment for addiction","O'Brien CP.","Curr Psychiatry Rep. 2007 Dec;9(6):441-2. doi: 10.1007/s11920-007-0058-y.","O'Brien CP","Curr Psychiatry Rep","2007","2008/01/29","","","10.1007/s11920-007-0058-y"
"18216800","The use of buprenorphine as an analgesic after rodent embryo transfer","Krueger KL, Fujiwara Y.","Lab Anim (NY). 2008 Feb;37(2):87-90. doi: 10.1038/laban0208-87.","Krueger KL","Lab Anim (NY)","2008","2008/01/25","","","10.1038/laban0208-87"
"18215395","Evaluation of various derivatization approaches for gas chromatography-mass spectrometry analysis of buprenorphine and norbuprenorphine","Wu CH, Yang SC, Wang YS, Chen BG, Lin CC, Liu RH.","J Chromatogr A. 2008 Feb 22;1182(1):93-112. doi: 10.1016/j.chroma.2007.11.063. Epub 2007 Nov 28.","Wu CH","J Chromatogr A","2008","2008/01/25","","","10.1016/j.chroma.2007.11.063"
"18212797","Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders","McCann DJ.","Clin Pharmacol Ther. 2008 Apr;83(4):627-30. doi: 10.1038/sj.clpt.6100503. Epub 2008 Jan 23.","McCann DJ","Clin Pharmacol Ther","2008","2008/01/24","","","10.1038/sj.clpt.6100503"
"18210992","Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice","Buitrago S, Martin TE, Tetens-Woodring J, Belicha-Villanueva A, Wilding GE.","J Am Assoc Lab Anim Sci. 2008 Jan;47(1):11-7.","Buitrago S","J Am Assoc Lab Anim Sci","2008","2008/01/24","PMC2652618","",""
"18209513","Buprenorphine: new tricks with an old molecule for pain management","Heit HA, Gourlay DL.","Clin J Pain. 2008 Feb;24(2):93-7. doi: 10.1097/AJP.0b013e31815ca2b4.","Heit HA","Clin J Pain","2008","2008/01/23","","","10.1097/AJP.0b013e31815ca2b4"
"18205978","Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study","Soyka M, Zingg C, Koller G, Kuefner H.","Int J Neuropsychopharmacol. 2008 Aug;11(5):641-53. doi: 10.1017/S146114570700836X. Epub 2008 Jan 21.","Soyka M","Int J Neuropsychopharmacol","2008","2008/01/22","","","10.1017/S146114570700836X"
"18202730","[Determination of buprenorphine in urine]","Hegstad S, Christophersen AS, Khiabani HZ.","Tidsskr Nor Laegeforen. 2008 Jan 17;128(2):184-5.","Hegstad S","Tidsskr Nor Laegeforen","2008","2008/01/19","","",""
"18193922","Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?","Gunderson EW, Fiellin DA.","CNS Drugs. 2008;22(2):99-111. doi: 10.2165/00023210-200822020-00002.","Gunderson EW","CNS Drugs","2008","2008/01/16","","","10.2165/00023210-200822020-00002"
"18190664","Exposure to opioid maintenance treatment reduces long-term mortality","Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S.","Addiction. 2008 Mar;103(3):462-8. doi: 10.1111/j.1360-0443.2007.02090.x. Epub 2008 Jan 8.","Gibson A","Addiction","2008","2008/01/15","","","10.1111/j.1360-0443.2007.02090.x"
"18185883","Tetanus in an injecting buprenorphine abuser","Teo FS, Hsu LY, Lam KN, Johan A.","Ann Acad Med Singapore. 2007 Dec;36(12):1021-3.","Teo FS","Ann Acad Med Singapore","2007","2008/01/11","","",""
"18173815","Challenging the equipotency calculation for transdermal buprenorphine: four case studies","Likar R, Krainer B, Sittl R.","Int J Clin Pract. 2008 Jan;62(1):152-6. doi: 10.1111/j.1742-1241.2007.01531.x.","Likar R","Int J Clin Pract","2008","2008/01/05","","","10.1111/j.1742-1241.2007.01531.x"
"18164193","Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined","Winstock AR, Nittis M, Whitton G, Lea T.","Int J Drug Policy. 2009 Jan;20(1):85-9. doi: 10.1016/j.drugpo.2007.11.002. Epub 2007 Dec 27.","Winstock AR","Int J Drug Policy","2009","2008/01/01","","","10.1016/j.drugpo.2007.11.002"
"18164145","Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial","Chawarski MC, Mazlan M, Schottenfeld RS.","Drug Alcohol Depend. 2008 Apr 1;94(1-3):281-4. doi: 10.1016/j.drugalcdep.2007.11.008. Epub 2007 Dec 27.","Chawarski MC","Drug Alcohol Depend","2008","2008/01/01","","","10.1016/j.drugalcdep.2007.11.008"
"18162330","Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres","Leonardi C, Hanna N, Laurenzi P, Fagetti R; I.D.A.C. Group.","Drug Alcohol Depend. 2008 Apr 1;94(1-3):125-32. doi: 10.1016/j.drugalcdep.2007.10.017. Epub 2007 Dec 26.","Leonardi C","Drug Alcohol Depend","2008","2007/12/29","","","10.1016/j.drugalcdep.2007.10.017"
"18155364","Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study","Clausen T, Anchersen K, Waal H.","Drug Alcohol Depend. 2008 Apr 1;94(1-3):151-7. doi: 10.1016/j.drugalcdep.2007.11.003. Epub 2007 Dec 21.","Clausen T","Drug Alcohol Depend","2008","2007/12/25","","","10.1016/j.drugalcdep.2007.11.003"
"18093096","Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment","Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J.","J Sex Med. 2008 Mar;5(3):684-92. doi: 10.1111/j.1743-6109.2007.00702.x. Epub 2007 Dec 18.","Hallinan R","J Sex Med","2008","2007/12/21","","","10.1111/j.1743-6109.2007.00702.x"
"18088293","Methadone and buprenorphine treatment during pregnancy: what are the effects on infants?","Pritham UA, Troese M, Stetson A.","Nurs Womens Health. 2007 Dec;11(6):558-67. doi: 10.1111/j.1751-486X.2007.00243.x.","Pritham UA","Nurs Womens Health","2007","2007/12/20","","","10.1111/j.1751-486X.2007.00243.x"
"18087846","Buprenorphine in the treatment of opioid dependence","George S, Day E.","Br J Hosp Med (Lond). 2007 Nov;68(11):594-7. doi: 10.12968/hmed.2007.68.11.27681.","George S","Br J Hosp Med (Lond)","2007","2007/12/20","","","10.12968/hmed.2007.68.11.27681"
"18087797","Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection","","Prescrire Int. 2007 Dec;16(92):232-5.","","Prescrire Int","2007","2007/12/20","","",""
"18085322","Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist/antagonist buprenorphine","Sarton E, Teppema L, Dahan A.","Adv Exp Med Biol. 2008;605:486-91. doi: 10.1007/978-0-387-73693-8_85.","Sarton E","Adv Exp Med Biol","2008","2007/12/19","","","10.1007/978-0-387-73693-8_85"
"18084371","[End of opioid addicts' dancing around?]","Haraldsen M.","Tidsskr Nor Laegeforen. 2007 Dec 13;127(24):3238.","Haraldsen M","Tidsskr Nor Laegeforen","2007","2007/12/18","","",""
"18083312","Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment","Quaglio G, Lugoboni F, Pattaro C, Melara B; G.I.C.S, Mezzelani P, Des Jarlais DC; G.I.C.S.","Drug Alcohol Depend. 2008 Apr 1;94(1-3):12-8. doi: 10.1016/j.drugalcdep.2007.09.025.","Quaglio G","Drug Alcohol Depend","2008","2007/12/18","","","10.1016/j.drugalcdep.2007.09.025"
"18071169","QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC.","Arch Intern Med. 2007 Dec 10;167(22):2469-75. doi: 10.1001/archinte.167.22.2469.","Wedam EF","Arch Intern Med","2007","2007/12/12","","","10.1001/archinte.167.22.2469"
"18059322","Activities of mixed NOP and mu-opioid receptor ligands","Spagnolo B, Calo G, Polgar WE, Jiang F, Olsen CM, Berzetei-Gurske I, Khroyan TV, Husbands SM, Lewis JW, Toll L, Zaveri NT.","Br J Pharmacol. 2008 Feb;153(3):609-19. doi: 10.1038/sj.bjp.0707598. Epub 2007 Dec 3.","Spagnolo B","Br J Pharmacol","2008","2007/12/07","PMC2241792","","10.1038/sj.bjp.0707598"
"18044957","Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium","Kacinko SL, Shakleya DM, Huestis MA.","Anal Chem. 2008 Jan 1;80(1):246-52. doi: 10.1021/ac701627q. Epub 2007 Nov 29.","Kacinko SL","Anal Chem","2008","2007/11/30","PMC2689547","NIHMS118562","10.1021/ac701627q"
"18042474","Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study","Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.","Clin Ther. 2007 Oct;29(10):2179-93. doi: 10.1016/j.clinthera.2007.10.010.","Landau CJ","Clin Ther","2007","2007/11/29","","","10.1016/j.clinthera.2007.10.010"
"18034381","Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists","Lawrinson P, Roche A, Terao H, Le PP.","Drug Alcohol Rev. 2008 Jan;27(1):47-53. doi: 10.1080/09595230701710852.","Lawrinson P","Drug Alcohol Rev","2008","2007/11/24","","","10.1080/09595230701710852"
"18032012","Earlier warning: a multi-indicator approach to monitoring trends in the illicit use of medicines","Mounteney J, Haugland S.","Int J Drug Policy. 2009 Mar;20(2):161-9. doi: 10.1016/j.drugpo.2007.09.006. Epub 2007 Nov 26.","Mounteney J","Int J Drug Policy","2009","2007/11/23","","","10.1016/j.drugpo.2007.09.006"
"18031426","Why we do what we do-delivery of buprenorphine and the treatment of opioid addiction","Ling W.","Addiction. 2007 Dec;102(12):1908-9. doi: 10.1111/j.1360-0443.2007.02047.x.","Ling W","Addiction","2007","2007/11/23","","","10.1111/j.1360-0443.2007.02047.x"
"18018814","Abuse of buprenorphine in the United States: 2003-2005","Smith MY, Bailey JE, Woody GE, Kleber HD.","J Addict Dis. 2007;26(3):107-11. doi: 10.1300/J069v26n03_12.","Smith MY","J Addict Dis","2007","2007/11/21","","","10.1300/J069v26n03_12"
"18018812","Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting","Torrington M, Domier CP, Hillhouse M, Ling W.","J Addict Dis. 2007;26(3):93-9. doi: 10.1300/J069v26n03_10.","Torrington M","J Addict Dis","2007","2007/11/21","","","10.1300/J069v26n03_10"
"18018803","Buprenorphine misuse, abuse, and diversion: when will we ever learn?","Stimmel B.","J Addict Dis. 2007;26(3):1-3. doi: 10.1300/J069v26n03_01.","Stimmel B","J Addict Dis","2007","2007/11/21","","","10.1300/J069v26n03_01"
"18008179","Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone","Colombini N, Elias R, Busuttil M, Dubuc M, Einaudi MA, Bues-Charbit M.","Pharm World Sci. 2008 Jun;30(3):227-34. doi: 10.1007/s11096-007-9176-1. Epub 2007 Nov 16.","Colombini N","Pharm World Sci","2008","2007/11/17","","","10.1007/s11096-007-9176-1"
"17994482","Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases","Bruce RD, Altice FL.","Am J Drug Alcohol Abuse. 2007;33(6):869-74. doi: 10.1080/00952990701653875.","Bruce RD","Am J Drug Alcohol Abuse","2007","2007/11/13","","","10.1080/00952990701653875"
"17994223","NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats","Mendez IA, Trujillo KA.","Psychopharmacology (Berl). 2008 Feb;196(3):497-509. doi: 10.1007/s00213-007-0984-8. Epub 2007 Nov 10.","Mendez IA","Psychopharmacology (Berl)","2008","2007/11/13","","","10.1007/s00213-007-0984-8"
"17988455","Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid","Cone EJ, Clarke J, Tsanaclis L.","J Anal Toxicol. 2007 Oct;31(8):424-33. doi: 10.1093/jat/31.8.424.","Cone EJ","J Anal Toxicol","2007","2007/11/09","","","10.1093/jat/31.8.424"
"17986490","Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland","Matheson C, Bond CM, Tinelli M.","J Public Health (Oxf). 2007 Dec;29(4):350-7. doi: 10.1093/pubmed/fdm064. Epub 2007 Nov 6.","Matheson C","J Public Health (Oxf)","2007","2007/11/08","","","10.1093/pubmed/fdm064"
"17983559","[Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network]","Modelon H, Frauger E, Laurenceau D, Thirion X, Mallaret M, Micallef J; ŕeseau des CEIP.","Therapie. 2007 Jul-Aug;62(4):337-46. doi: 10.2515/therapie:2007061. Epub 2007 Nov 6.","Modelon H","Therapie","2007","2007/11/07","","","10.2515/therapie:2007061"
"17974942","Data do not support buprenorphine as a first-line treatment for addiction","Byrne A, Wodak A.","Am J Psychiatry. 2007 Nov;164(11):1757; author reply 1757-8. doi: 10.1176/appi.ajp.2007.07071058.","Byrne A","Am J Psychiatry","2007","2007/11/03","","","10.1176/appi.ajp.2007.07071058"
"17971165","Hypogonadism in men receiving methadone and buprenorphine maintenance treatment","Hallinan R, Byrne A, Agho K, McMahon CG, Tynan P, Attia J.","Int J Androl. 2009 Apr;32(2):131-9. doi: 10.1111/j.1365-2605.2007.00824.x. Epub 2007 Oct 30.","Hallinan R","Int J Androl","2009","2007/11/01","","","10.1111/j.1365-2605.2007.00824.x"
"17966605","[The effect of substitution therapy on the birth weight of the newborn, its postpartum adaptation, trophic and course of the neonatal abstinence syndrome]","Vavrinková B, Binder T.","Ceska Gynekol. 2007 Aug;72(4):247-53.","Vavrinková B","Ceska Gynekol","2007","2007/10/31","","",""
"17965635","[Management of drug addiction in France (a short history)]","Chossegros P.","Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 3):4S44-50.","Chossegros P","Gastroenterol Clin Biol","2007","2007/10/30","","",""
"17961313","Comparison of three commercial tests for buprenorphine screening in urine","Leino A, Loo BM.","Ann Clin Biochem. 2007 Nov;44(Pt 6):563-5. doi: 10.1258/000456307782268129.","Leino A","Ann Clin Biochem","2007","2007/10/27","","","10.1258/000456307782268129"
"17959980","Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients","Dagtekin O, Gerbershagen HJ, Wagner W, Petzke F, Radbruch L, Sabatowski R.","Anesth Analg. 2007 Nov;105(5):1442-8, table of contents. doi: 10.1213/01.ane.0000281078.65585.1e.","Dagtekin O","Anesth Analg","2007","2007/10/26","","","10.1213/01.ane.0000281078.65585.1e"
"17957979","Buprenorphine--a review of its role in neuropathic pain","Hans G.","J Opioid Manag. 2007 Jul-Aug;3(4):195-206. doi: 10.5055/jom.2007.0005.","Hans G","J Opioid Manag","2007","2007/10/26","","","10.5055/jom.2007.0005"
"17952158","[Treatment of opiate addicts in general practice]","Haraldsen M.","Tidsskr Nor Laegeforen. 2007 Oct 18;127(20):2706-7; author reply 2707.","Haraldsen M","Tidsskr Nor Laegeforen","2007","2007/10/24","","",""
"17935587","Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005","Sheridan J, Manning V, Ridge G, Mayet S, Strang J.","Addiction. 2007 Nov;102(11):1824-30. doi: 10.1111/j.1360-0443.2007.02016.x.","Sheridan J","Addiction","2007","2007/10/16","","","10.1111/j.1360-0443.2007.02016.x"
"17933594","Simultaneous determination of thienorphine and its active metabolite thienorphine glucuronide in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies","Kong Q, Qiao J, Wang X, Yuan S, Zhang Z, Gong Z, Ruan J.","J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 1;859(1):52-61. doi: 10.1016/j.jchromb.2007.09.028. Epub 2007 Sep 29.","Kong Q","J Chromatogr B Analyt Technol Biomed Life Sci","2007","2007/10/16","","","10.1016/j.jchromb.2007.09.028"
"17933486","Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors","Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O'Connor PG, Schottenfeld RS, Fiellin DA.","J Subst Abuse Treat. 2008 Jul;35(1):87-92. doi: 10.1016/j.jsat.2007.08.004. Epub 2007 Oct 15.","Sullivan LE","J Subst Abuse Treat","2008","2007/10/16","PMC2587397","NIHMS54540","10.1016/j.jsat.2007.08.004"
"17925988","Concomitant use of midazolam and buprenorphine and its implications among drug users in Singapore","Ng WL, Mythily S, Song G, Chan YH, Winslow M.","Ann Acad Med Singapore. 2007 Sep;36(9):774-7.","Ng WL","Ann Acad Med Singapore","2007","2007/10/11","","",""
"17922561","Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers","Yassen A, Olofsen E, van Dorp E, Sarton E, Teppema L, Danhof M, Dahan A.","Clin Pharmacokinet. 2007;46(11):965-80. doi: 10.2165/00003088-200746110-00004.","Yassen A","Clin Pharmacokinet","2007","2007/10/10","","","10.2165/00003088-200746110-00004"
"17921260","Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration","Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder JR, Jasinski DR, Johnson RE, Jones HE, Huestis MA.","Clin Chem. 2007 Dec;53(12):2136-43. doi: 10.1373/clinchem.2007.091413. Epub 2007 Oct 5.","Goodwin RS","Clin Chem","2007","2007/10/09","","","10.1373/clinchem.2007.091413"
"17919544","Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study","Escher M, Daali Y, Chabert J, Hopfgartner G, Dayer P, Desmeules J.","Clin Ther. 2007 Aug;29(8):1620-31. doi: 10.1016/j.clinthera.2007.08.007.","Escher M","Clin Ther","2007","2007/10/09","","","10.1016/j.clinthera.2007.08.007"
"17919542","Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison","Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.","Clin Ther. 2007 Aug;29(8):1591-606. doi: 10.1016/j.clinthera.2007.08.001.","Likar R","Clin Ther","2007","2007/10/09","","","10.1016/j.clinthera.2007.08.001"
"17915812","In vitro dissolution method for evaluation of buprenorphine in situ gel formulation: a technical note","Graves RA, Freeman T, Mandal TK.","AAPS PharmSciTech. 2007 Aug 3;8(3):E62. doi: 10.1208/pt0803062.","Graves RA","AAPS PharmSciTech","2007","2007/10/06","","","10.1208/pt0803062"
"17915074","Why buprenorphine is so successful in treating opiate addiction in France","Fatseas M, Auriacombe M.","Curr Psychiatry Rep. 2007 Oct;9(5):358-64. doi: 10.1007/s11920-007-0046-2.","Fatseas M","Curr Psychiatry Rep","2007","2007/10/05","","","10.1007/s11920-007-0046-2"
"17914664","Pharmacokinetic-pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats","Yassen A, Olofsen E, Kan J, Dahan A, Danhof M.","Pharm Res. 2008 Jan;25(1):183-93. doi: 10.1007/s11095-007-9440-z. Epub 2007 Oct 4.","Yassen A","Pharm Res","2008","2007/10/05","PMC2190336","","10.1007/s11095-007-9440-z"
"17913395","Prescription opioid use, misuse, and diversion among street drug users in New York City","Davis WR, Johnson BD.","Drug Alcohol Depend. 2008 Jan 1;92(1-3):267-76. doi: 10.1016/j.drugalcdep.2007.08.008. Epub 2007 Oct 29.","Davis WR","Drug Alcohol Depend","2008","2007/10/05","PMC2317747","NIHMS37381","10.1016/j.drugalcdep.2007.08.008"
"17908825","Using buprenorphine for outpatient opioid detoxification","Manlandro JJ Jr.","J Am Osteopath Assoc. 2007 Sep;107(9 Suppl 5):ES11-6.","Manlandro JJ Jr","J Am Osteopath Assoc","2007","2007/10/19","","",""
"17900853","Transdermal buprenorphine may be effective in the treatment of pruritus in primary biliary cirrhosis","Reddy L, Krajnik M, Zylicz Z.","J Pain Symptom Manage. 2007 Nov;34(5):455-6. doi: 10.1016/j.jpainsymman.2007.08.001. Epub 2007 Sep 27.","Reddy L","J Pain Symptom Manage","2007","2007/09/29","","","10.1016/j.jpainsymman.2007.08.001"
"17896524","[A study in extraction method of buprenorphine in urine]","Liu DX, He JN.","Fa Yi Xue Za Zhi. 2007 Aug;23(4):292-4.","Liu DX","Fa Yi Xue Za Zhi","2007","2007/09/28","","",""
"17891657","Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence","Copenhaver MM, Bruce RD, Altice FL.","Am J Drug Alcohol Abuse. 2007;33(5):643-54. doi: 10.1080/00952990701522674.","Copenhaver MM","Am J Drug Alcohol Abuse","2007","2007/09/25","PMC2274830","NIHMS33246","10.1080/00952990701522674"
"17891656","Quality of life among heroin users on buprenorphine versus methadone maintenance","Ponizovsky AM, Grinshpoon A.","Am J Drug Alcohol Abuse. 2007;33(5):631-42. doi: 10.1080/00952990701523698.","Ponizovsky AM","Am J Drug Alcohol Abuse","2007","2007/09/25","","","10.1080/00952990701523698"
"17891655","Pharmacotherapeutic environments for substance use disorders","Gardner TJ, Kosten TR.","Am J Drug Alcohol Abuse. 2007;33(5):627-9. doi: 10.1080/00952990701578676.","Gardner TJ","Am J Drug Alcohol Abuse","2007","2007/09/25","","","10.1080/00952990701578676"
"17882607","Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine","Knudsen HK, Ducharme LJ, Roman PM.","Am J Addict. 2007 Sep-Oct;16(5):365-71. doi: 10.1080/10550490701525418.","Knudsen HK","Am J Addict","2007","2007/09/21","","","10.1080/10550490701525418"
"17876257","Suboxone (buprenorphine/naloxone) toxicity in pediatric patients: a case report","Schwarz KA, Cantrell FL, Vohra RB, Clark RF.","Pediatr Emerg Care. 2007 Sep;23(9):651-2. doi: 10.1097/PEC.0b013e31814a6aac.","Schwarz KA","Pediatr Emerg Care","2007","2007/09/19","","","10.1097/PEC.0b013e31814a6aac"
"17874319","Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteers","Jensen ML, Foster DJ, Upton RN, Kristensen K, Hansen SH, Jensen NH, Nielsen BN, Skram U, Villesen HH, Christrup L.","Eur J Clin Pharmacol. 2007 Dec;63(12):1153-9. doi: 10.1007/s00228-007-0377-2. Epub 2007 Sep 16.","Jensen ML","Eur J Clin Pharmacol","2007","2007/09/18","","","10.1007/s00228-007-0377-2"
"17854341","Evaluation of a transdermal buprenorphine formulation in opioid detoxification","Lanier RK, Umbricht A, Harrison JA, Nuwayser ES, Bigelow GE.","Addiction. 2007 Oct;102(10):1648-56. doi: 10.1111/j.1360-0443.2007.01944.x.","Lanier RK","Addiction","2007","2007/09/15","","","10.1111/j.1360-0443.2007.01944.x"
"17851243","Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study","Krook AL, Stokka D, Heger B, Nygaard E.","Eur Addict Res. 2007;13(4):216-21. doi: 10.1159/000104884.","Krook AL","Eur Addict Res","2007","2007/09/14","","","10.1159/000104884"
"17851242","Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration","Hakansson A, Medvedeo A, Andersson M, Berglund M.","Eur Addict Res. 2007;13(4):207-15. doi: 10.1159/000104883.","Hakansson A","Eur Addict Res","2007","2007/09/14","","","10.1159/000104883"
"17850768","Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence","Kakko J, von Wachenfeldt J, Svanborg KD, Lidström J, Barr CS, Heilig M.","Biol Psychiatry. 2008 Jan 15;63(2):172-7. doi: 10.1016/j.biopsych.2007.05.001. Epub 2007 Sep 11.","Kakko J","Biol Psychiatry","2008","2007/09/14","","","10.1016/j.biopsych.2007.05.001"
"17850228","Comparison between analgesic effects of buprenorphine, carprofen, and buprenorphine with carprofen for canine ovariohysterectomy","Shih AC, Robertson S, Isaza N, Pablo L, Davies W.","Vet Anaesth Analg. 2008 Jan;35(1):69-79. doi: 10.1111/j.1467-2995.2007.00352.x. Epub 2007 Sep 7.","Shih AC","Vet Anaesth Analg","2008","2007/09/14","","","10.1111/j.1467-2995.2007.00352.x"
"17827420","Buprenorphine does not aggravate ischemic neuronal injury in experimental focal cerebral ischemia","Yulug B, Cam E, Yildiz A, Kilic E.","J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):331-4. doi: 10.1176/jnp.2007.19.3.331.","Yulug B","J Neuropsychiatry Clin Neurosci","2007","2007/09/11","","","10.1176/jnp.2007.19.3.331"
"17823672","Effect of intra-articular administration of buprenorphine after arthrocentesis of the temporomandibular joint: a pilot study","Präger TM, Mischkowski RA, Zöller JE.","Quintessence Int. 2007 Sep;38(8):e484-9.","Präger TM","Quintessence Int","2007","2007/09/08","","",""
"17805212","Opioids: from physical pain to the pain of social isolation","Stein DJ, van Honk J, Ipser J, Solms M, Panksepp J.","CNS Spectr. 2007 Sep;12(9):669-70, 672-4. doi: 10.1017/s1092852900021490.","Stein DJ","CNS Spectr","2007","2007/09/07","","","10.1017/s1092852900021490"
"17784896","A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence","Bell J, Shanahan M, Mutch C, Rea F, Ryan A, Batey R, Dunlop A, Winstock A.","Addiction. 2007 Dec;102(12):1899-907. doi: 10.1111/j.1360-0443.2007.01979.x. Epub 2007 Sep 3.","Bell J","Addiction","2007","2007/09/06","","","10.1111/j.1360-0443.2007.01979.x"
"17763831","Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy","McInnes F, Clear N, James G, Stevens HN, Vivanco U, Humphrey M.","Pharm Res. 2008 Apr;25(4):869-74. doi: 10.1007/s11095-007-9423-0. Epub 2007 Sep 1.","McInnes F","Pharm Res","2008","2007/09/04","","","10.1007/s11095-007-9423-0"
"17725885","Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogeneous immunoassay for the detection of buprenorphine and norbuprenorphine in urine","Wang G, Vincent M, Rodrigues W, Agrawal A, Moore C, Barhate R, Abolencia E, Coulter C, Soares J, Zheng YF, Taylor C, Morjana N.","J Anal Toxicol. 2007 Sep;31(7):377-82. doi: 10.1093/jat/31.7.377.","Wang G","J Anal Toxicol","2007","2007/08/30","","","10.1093/jat/31.7.377"
"17718810","A comparison of tepoxalin-buprenorphine combination and buprenorphine for postoperative analgesia in dogs: a clinical study","Bosmans T, Gasthuys F, Duchateau L, de Bruin T, Verhoeven G, Polis I.","J Vet Med A Physiol Pathol Clin Med. 2007 Sep;54(7):364-9. doi: 10.1111/j.1439-0442.2007.00967.x.","Bosmans T","J Vet Med A Physiol Pathol Clin Med","2007","2007/08/28","","","10.1111/j.1439-0442.2007.00967.x"
"17707737","Clinical update: codeine maintenance in opioid dependence","Hall WD, Mattick RP.","Lancet. 2007 Aug 18;370(9587):550-2. doi: 10.1016/S0140-6736(07)61273-2.","Hall WD","Lancet","2007","2007/08/21","","","10.1016/S0140-6736(07)61273-2"
"17695670","Addiction: a nurse's story. Opioids became an obsession--until he was caught","Hastings J, Burn J.","Am J Nurs. 2007 Aug;107(8):75-7, 79. doi: 10.1097/01.naj.0000282301.11065.8e.","Hastings J","Am J Nurs","2007","2007/08/19","","","10.1097/01.naj.0000282301.11065.8e"
"17689382","HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications","Bruce RD, Dvoryak S, Sylla L, Altice FL.","Int J Drug Policy. 2007 Aug;18(4):326-8. doi: 10.1016/j.drugpo.2006.12.011. Epub 2007 Feb 5.","Bruce RD","Int J Drug Policy","2007","2007/08/11","PMC2084072","NIHMS28995","10.1016/j.drugpo.2006.12.011"
"17689374","Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)","Spire B, Lucas GM, Carrieri MP.","Int J Drug Policy. 2007 Aug;18(4):262-70. doi: 10.1016/j.drugpo.2006.12.014. Epub 2007 Jan 26.","Spire B","Int J Drug Policy","2007","2007/08/11","","","10.1016/j.drugpo.2006.12.014"
"17682629","Buprenorphine maintenance: a new treatment for opioid dependence","Collins GB, McAllister MS.","Cleve Clin J Med. 2007 Jul;74(7):514-20. doi: 10.3949/ccjm.74.7.514.","Collins GB","Cleve Clin J Med","2007","2007/08/09","","","10.3949/ccjm.74.7.514"
"17680182","Epidural ropivacaine infusion for the treatment of pain following axillary muscle-sparing thoracotomy: a dose-evaluation study","Sakai T, Tomiyasu S, Sumikawa K.","J Anesth. 2007;21(3):320-4. doi: 10.1007/s00540-007-0527-9. Epub 2007 Aug 1.","Sakai T","J Anesth","2007","2007/08/08","","","10.1007/s00540-007-0527-9"
"17664052","Nurse practitioner and physician assistant interest in prescribing buprenorphine","Roose RJ, Kunins HV, Sohler NL, Elam RT, Cunningham CO.","J Subst Abuse Treat. 2008 Jun;34(4):456-9. doi: 10.1016/j.jsat.2007.05.009. Epub 2007 Jul 30.","Roose RJ","J Subst Abuse Treat","2008","2007/08/01","PMC2486415","NIHMS51078","10.1016/j.jsat.2007.05.009"
"17651725","Effect of sodium ozagrel on the activity of rat CYP2D6","Wu H, Yu W, Huang L, Wang J, Tang X, Yang W, Liu Y, Yu H, Zhu D.","Eur J Pharmacol. 2007 Nov 14;573(1-3):55-9. doi: 10.1016/j.ejphar.2007.06.055. Epub 2007 Jul 4.","Wu H","Eur J Pharmacol","2007","2007/07/27","","","10.1016/j.ejphar.2007.06.055"
"17646070","Chemical profile of counterfeit buprenorphine vials seized in Tehran, Iran","Soltaninejad K, Faryadi M, Akhgari M, Bahmanabadi L.","Forensic Sci Int. 2007 Oct 25;172(2-3):e4-5. doi: 10.1016/j.forsciint.2007.06.016. Epub 2007 Jul 23.","Soltaninejad K","Forensic Sci Int","2007","2007/07/25","","","10.1016/j.forsciint.2007.06.016"
"17643869","Interaction between buprenorphine and atazanavir or atazanavir/ritonavir","McCance-Katz EF, Moody DE, Morse GD, Ma Q, DiFrancesco R, Friedland G, Pade P, Rainey PM.","Drug Alcohol Depend. 2007 Dec 1;91(2-3):269-78. doi: 10.1016/j.drugalcdep.2007.06.007. Epub 2007 Jul 23.","McCance-Katz EF","Drug Alcohol Depend","2007","2007/07/24","PMC3272856","NIHMS33190","10.1016/j.drugalcdep.2007.06.007"
"17640461","Differences in response to anaesthetics and analgesics between inbred rat strains","Avsaroglu H, van der Sar AS, van Lith HA, van Zutphen LF, Hellebrekers LJ.","Lab Anim. 2007 Jul;41(3):337-44. doi: 10.1258/002367707781282811.","Avsaroglu H","Lab Anim","2007","2007/07/21","","","10.1258/002367707781282811"
"17638583","Buprenorphine injection to the stellate ganglion in the treatment of upper body chronic pain syndromes","Goebel A, Lawson A, Allen S, Glynn C.","Eur J Pain. 2008 Apr;12(3):266-74. doi: 10.1016/j.ejpain.2007.05.009. Epub 2007 Jul 16.","Goebel A","Eur J Pain","2008","2007/07/20","","","10.1016/j.ejpain.2007.05.009"
"17636553","Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States","Cicero TJ, Surratt H, Inciardi JA, Munoz A.","Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):827-40. doi: 10.1002/pds.1452.","Cicero TJ","Pharmacoepidemiol Drug Saf","2007","2007/07/20","","","10.1002/pds.1452"
"17629666","Switching from transdermal drugs: an observational ""N of 1"" study of fentanyl and buprenorphine","Mercadante S, Porzio G, Fulfaro F, Aielli F, Verna L, Ficorella C, Casuccio A, Riina S, Intravaia G, Mangione S.","J Pain Symptom Manage. 2007 Nov;34(5):532-8. doi: 10.1016/j.jpainsymman.2007.01.006. Epub 2007 Jul 16.","Mercadante S","J Pain Symptom Manage","2007","2007/07/17","","","10.1016/j.jpainsymman.2007.01.006"
"17625665","Continuous infusion in adult females dogs submitted to ovariohysterectomy with midazolam-xylazine and/or medetomidine pre-treated with methotrimeprazine and buprenorphine","Silva Fdo C, Hatschbach E, Lima AF, Carvalho YK, Massone F.","Acta Cir Bras. 2007 Jul-Aug;22(4):272-8. doi: 10.1590/s0102-86502007000400008.","Silva Fdo C","Acta Cir Bras","2007","2007/07/13","","","10.1590/s0102-86502007000400008"
"17625449","Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study","Belfiori B, Chiodera A, Ciliegi P, Tosti A, Baldelli F, Stagni G, Francisci D.","Eur J Gastroenterol Hepatol. 2007 Aug;19(8):731-2. doi: 10.1097/01.meg.0000280175.79379.04.","Belfiori B","Eur J Gastroenterol Hepatol","2007","2007/07/13","","","10.1097/01.meg.0000280175.79379.04"
"17624687","Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients","Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J.","Drug Alcohol Depend. 2007 Dec 1;91(2-3):187-94. doi: 10.1016/j.drugalcdep.2007.05.019. Epub 2007 Jul 12.","Lintzeris N","Drug Alcohol Depend","2007","2007/07/13","","","10.1016/j.drugalcdep.2007.05.019"
"17619934","Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians","Cunningham CO, Kunins HV, Roose RJ, Elam RT, Sohler NL.","J Gen Intern Med. 2007 Sep;22(9):1325-9. doi: 10.1007/s11606-007-0264-7. Epub 2007 Jul 10.","Cunningham CO","J Gen Intern Med","2007","2007/07/11","PMC2219773","","10.1007/s11606-007-0264-7"
"17615060","Deficit of circulating stem--progenitor cells in opiate addiction: a pilot study","Reece AS, Davidson P.","Subst Abuse Treat Prev Policy. 2007 Jul 5;2:19. doi: 10.1186/1747-597X-2-19.","Reece AS","Subst Abuse Treat Prev Policy","2007","2007/07/07","PMC1949819","","10.1186/1747-597X-2-19"
"17613961","Buprenorphine misuse in Finland","Aalto M, Halme J, Visapää JP, Salaspuro M.","Subst Use Misuse. 2007;42(6):1027-8. doi: 10.1080/10826080701434857.","Aalto M","Subst Use Misuse","2007","2007/07/07","","","10.1080/10826080701434857"
"17605603","Antinociceptive effects of butorphanol, buprenorphine, or both, administered intramuscularly in cats","Johnson JA, Robertson SA, Pypendop BH.","Am J Vet Res. 2007 Jul;68(7):699-703. doi: 10.2460/ajvr.68.7.699.","Johnson JA","Am J Vet Res","2007","2007/07/04","","","10.2460/ajvr.68.7.699"
"17601735","Functionalization of the 6,14-bridge of the orvinols. Part 3: preparation and pharmacological evaluation of 18- and 19-hydroxyl substituted orvinols","Wu H, Smith TA, Huang H, Wang JB, Deschamps JR, Coop A.","Bioorg Med Chem Lett. 2007 Sep 1;17(17):4829-31. doi: 10.1016/j.bmcl.2007.06.050. Epub 2007 Jun 20.","Wu H","Bioorg Med Chem Lett","2007","2007/07/03","PMC2084076","NIHMS28975","10.1016/j.bmcl.2007.06.050"
"17596905","A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatment","Branstetter SA, Bower EH, Kamien J, Amass L.","J Subst Abuse Treat. 2008 Mar;34(2):208-14. doi: 10.1016/j.jsat.2007.03.009. Epub 2007 Jun 27.","Branstetter SA","J Subst Abuse Treat","2008","2007/06/29","","","10.1016/j.jsat.2007.03.009"
"17594994","Outcomes of buprenorphine maintenance in office-based practice","Magura S, Lee SJ, Salsitz EA, Kolodny A, Whitley SD, Taubes T, Seewald R, Joseph H, Kayman DJ, Fong C, Marsch LA, Rosenblum A.","J Addict Dis. 2007;26(2):13-23. doi: 10.1300/J069v26n02_03.","Magura S","J Addict Dis","2007","2007/06/28","","","10.1300/J069v26n02_03"
"17594993","Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification","Blondell RD, Smith SJ, Servoss TJ, DeVaul SK, Simons RL.","J Addict Dis. 2007;26(2):3-11. doi: 10.1300/J069v26n02_02.","Blondell RD","J Addict Dis","2007","2007/06/28","","","10.1300/J069v26n02_02"
"17594992","Optimizing opioid detoxification: rearranging deck chairs on the Titanic","Stein MD, Friedmann PD.","J Addict Dis. 2007;26(2):1-2. doi: 10.1300/J069v26n02_01.","Stein MD","J Addict Dis","2007","2007/06/28","","","10.1300/J069v26n02_01"
"17588494","Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients","Maremmani I, Pani PP, Pacini M, Perugi G.","J Subst Abuse Treat. 2007 Jul;33(1):91-8. doi: 10.1016/j.jsat.2006.11.009. Epub 2007 Jan 16.","Maremmani I","J Subst Abuse Treat","2007","2007/06/26","","","10.1016/j.jsat.2006.11.009"
"17588493","Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services","Whitley SD, Kunins HV, Arnsten JH, Gourevitch MN.","J Subst Abuse Treat. 2007 Jul;33(1):85-90. doi: 10.1016/j.jsat.2006.11.003. Epub 2007 Jan 9.","Whitley SD","J Subst Abuse Treat","2007","2007/06/26","","","10.1016/j.jsat.2006.11.003"
"17581533","Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers","Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ.","Neuropsychopharmacology. 2008 Apr;33(5):1179-91. doi: 10.1038/sj.npp.1301479. Epub 2007 Jun 20.","Comer SD","Neuropsychopharmacology","2008","2007/06/22","PMC3787689","NIHMS516235","10.1038/sj.npp.1301479"
"17570908","Influence of peak and trough levels of opioid maintenance therapy on driving aptitude","Baewert A, Gombas W, Schindler SD, Peternell-Moelzer A, Eder H, Jagsch R, Fischer G.","Eur Addict Res. 2007;13(3):127-35. doi: 10.1159/000101548.","Baewert A","Eur Addict Res","2007","2007/06/16","","","10.1159/000101548"
"17568402","Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects","La Vincente SF, White JM, Somogyi AA, Bochner F, Chapleo CB.","Clin Pharmacol Ther. 2008 Jan;83(1):144-52. doi: 10.1038/sj.clpt.6100262. Epub 2007 Jun 13.","La Vincente SF","Clin Pharmacol Ther","2008","2007/06/15","","","10.1038/sj.clpt.6100262"
"17565668","Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls","Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H.","BMC Clin Pharmacol. 2007 Jun 12;7:5. doi: 10.1186/1472-6904-7-5.","Rapeli P","BMC Clin Pharmacol","2007","2007/06/15","PMC1914339","","10.1186/1472-6904-7-5"
"17564877","The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia","Winstock AR, Lea T, Ritter A.","Drug Alcohol Rev. 2007 Jul;26(4):411-6. doi: 10.1080/09595230701373891.","Winstock AR","Drug Alcohol Rev","2007","2007/06/15","","","10.1080/09595230701373891"
"17564876","Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records","Gibson AE, Degenhardt LJ.","Drug Alcohol Rev. 2007 Jul;26(4):405-10. doi: 10.1080/09595230701373834.","Gibson AE","Drug Alcohol Rev","2007","2007/06/15","","","10.1080/09595230701373834"
"17559481","Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients","Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy JV.","Pain Pract. 2007 Jun;7(2):123-9. doi: 10.1111/j.1533-2500.2007.00119.x.","Freye E","Pain Pract","2007","2007/06/15","","","10.1111/j.1533-2500.2007.00119.x"
"17558032","Sublingual administration of buprenorphine for long-term analgesia in the horse","Walker AF.","Vet Rec. 2007 Jun 9;160(23):808-9. doi: 10.1136/vr.160.23.808.","Walker AF","Vet Rec","2007","2007/06/15","","","10.1136/vr.160.23.808"
"17557657","An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island","Mitty J, Macleod C, Loewenthal H, Thompson L, Bazerman L.","Med Health R I. 2007 May;90(5):145-7.","Mitty J","Med Health R I","2007","2007/06/15","","",""
"17555645","Rapid quantification of buprenorphine-glucuronide and norbuprenorphine-glucuronide in human urine by LC-MS-MS","Hegstad S, Khiabani HZ, Øiestad EL, Berg T, Christophersen AS.","J Anal Toxicol. 2007 May;31(4):214-9. doi: 10.1093/jat/31.4.214.","Hegstad S","J Anal Toxicol","2007","2007/06/09","","","10.1093/jat/31.4.214"
"17545747","Combination of olanzapine with opioid-agonists in the treatment of heroin-addicted patients affected by comorbid schizophrenia spectrum disorders","Gerra G, Di Petta G, D'Amore A, Iannotta P, Bardicchia F, Falorni F, Coacci A, Strepparola G, Campione G, Lucchini A, Vedda G, Serio G, Manzato E, Antonioni M, Bertacca S, Moi G, Zaimovic A.","Clin Neuropharmacol. 2007 May-Jun;30(3):127-35. doi: 10.1097/wnf.0b013e31803354f6.","Gerra G","Clin Neuropharmacol","2007","2007/06/05","","","10.1097/wnf.0b013e31803354f6"
"17543828","Local opioid analgesia at cervical sympathetic ganglia: what is the contribution of placebo effect?","Michalek P, Gabrhelík T.","Reg Anesth Pain Med. 2007 May-Jun;32(3):269-70. doi: 10.1016/j.rapm.2007.01.003.","Michalek P","Reg Anesth Pain Med","2007","2007/06/05","","","10.1016/j.rapm.2007.01.003"
"17542385","Re: Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users","Oyemade A.","Can J Psychiatry. 2007 May;52(5):335; author reply 335-6. doi: 10.1177/070674370705200512.","Oyemade A","Can J Psychiatry","2007","2007/06/05","","","10.1177/070674370705200512"
"17541066","Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient","Book SW, Myrick H, Malcolm R, Strain EC.","Am J Psychiatry. 2007 Jun;164(6):979. doi: 10.1176/ajp.2007.164.6.979.","Book SW","Am J Psychiatry","2007","2007/06/02","","","10.1176/ajp.2007.164.6.979"
"17538746","Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore","Winslow M, Subramaniam M, Ng WL, Lee A, Song G, Chan YH.","Singapore Med J. 2007 Jun;48(6):504-8.","Winslow M","Singapore Med J","2007","2007/06/01","","",""
"17536617","The effects of analgesic supplements on neural activity in the main olfactory bulb of the mouse","Mast TG, Griff ER.","Comp Med. 2007 Apr;57(2):167-74.","Mast TG","Comp Med","2007","2007/06/01","","",""
"17531960","Regarding ""Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system""","Gorelick DA.","Biol Psychiatry. 2007 Sep 15;62(6):702; author reply 702. doi: 10.1016/j.biopsych.2007.01.019. Epub 2007 May 25.","Gorelick DA","Biol Psychiatry","2007","2007/05/29","PMC1994814","NIHMS30096","10.1016/j.biopsych.2007.01.019"
"17517480","Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone","Rosado J, Walsh SL, Bigelow GE, Strain EC.","Drug Alcohol Depend. 2007 Oct 8;90(2-3):261-9. doi: 10.1016/j.drugalcdep.2007.04.006. Epub 2007 May 22.","Rosado J","Drug Alcohol Depend","2007","2007/05/23","PMC2094723","NIHMS30198","10.1016/j.drugalcdep.2007.04.006"
"17512157","Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence","Chawarski MC, Fiellin DA, O'Connor PG, Bernard M, Schottenfeld RS.","J Subst Abuse Treat. 2007 Dec;33(4):411-5. doi: 10.1016/j.jsat.2007.03.004. Epub 2007 May 23.","Chawarski MC","J Subst Abuse Treat","2007","2007/05/22","PMC3632440","NIHMS34590","10.1016/j.jsat.2007.03.004"
"17506153","Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005","Strang J, Manning V, Mayet S, Ridge G, Best D, Sheridan J.","Addiction. 2007 May;102(5):761-70. doi: 10.1111/j.1360-0443.2007.01762.x.","Strang J","Addiction","2007","2007/05/17","","","10.1111/j.1360-0443.2007.01762.x"
"17499959","Availability of addiction medications in private health plans","Horgan CM, Reif S, Hodgkin D, Garnick DW, Merrick EL.","J Subst Abuse Treat. 2008 Mar;34(2):147-56. doi: 10.1016/j.jsat.2007.02.004. Epub 2007 May 17.","Horgan CM","J Subst Abuse Treat","2008","2007/05/15","PMC2347353","NIHMS40530","10.1016/j.jsat.2007.02.004"
"17493771","Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years","Gordon AJ, Trafton JA, Saxon AJ, Gifford AL, Goodman F, Calabrese VS, McNicholas L, Liberto J; Buprenorphine Work Group of the Substance Use Disorders Quality Enhancement Research Initiative.","Drug Alcohol Depend. 2007 Oct 8;90(2-3):292-6. doi: 10.1016/j.drugalcdep.2007.03.010. Epub 2007 May 10.","Gordon AJ","Drug Alcohol Depend","2007","2007/05/12","","","10.1016/j.drugalcdep.2007.03.010"
"17490635","Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice","Swenson J, Olgun S, Radjavi A, Kaur T, Reilly CM.","Eur J Pharmacol. 2007 Jul 12;567(1-2):67-76. doi: 10.1016/j.ejphar.2007.03.048. Epub 2007 Apr 6.","Swenson J","Eur J Pharmacol","2007","2007/05/11","PMC2570058","NIHMS25231","10.1016/j.ejphar.2007.03.048"
"17490466","Effects of buprenorphine, carprofen and saline on thermal and mechanical nociceptive thresholds in cats","Steagall PV, Taylor PM, Brondani JT, Luna SP, Dixon MJ, Ferreira TH.","Vet Anaesth Analg. 2007 Sep;34(5):344-50. doi: 10.1111/j.1467-2995.2006.00331.x. Epub 2007 May 8.","Steagall PV","Vet Anaesth Analg","2007","2007/05/11","","","10.1111/j.1467-2995.2006.00331.x"
"17488881","Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates","Hume SP, Lingford-Hughes AR, Nataf V, Hirani E, Ahmad R, Davies AN, Nutt DJ.","J Pharmacol Exp Ther. 2007 Aug;322(2):661-7. doi: 10.1124/jpet.107.121749. Epub 2007 May 8.","Hume SP","J Pharmacol Exp Ther","2007","2007/05/10","","","10.1124/jpet.107.121749"
"17487949","Assessment of buprenorphine, carprofen, and their combination for postoperative analgesia in olive baboons (Papio anubis)","Allison SO, Halliday LC, French JA, Novikov DD, Fortman JD.","J Am Assoc Lab Anim Sci. 2007 May;46(3):24-31.","Allison SO","J Am Assoc Lab Anim Sci","2007","2007/05/10","PMC2987732","NIHMS250271",""
"17487946","Effects of buprenorphine on intracerebral collagenase-induced hematoma in Sprague-Dawley rats","Ferland C, Veilleux-Lemieux D, Vachon P.","J Am Assoc Lab Anim Sci. 2007 May;46(3):13-6.","Ferland C","J Am Assoc Lab Anim Sci","2007","2007/05/10","","",""
"17481458","Using buprenorphine short-term taper to facilitate early treatment engagement","Brigham GS, Amass L, Winhusen T, Harrer JM, Pelt A.","J Subst Abuse Treat. 2007 Jun;32(4):349-56. doi: 10.1016/j.jsat.2006.09.006. Epub 2006 Dec 8.","Brigham GS","J Subst Abuse Treat","2007","2007/05/08","","","10.1016/j.jsat.2006.09.006"
"17481455","Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network","Ducharme LJ, Knudsen HK, Roman PM, Johnson JA.","J Subst Abuse Treat. 2007 Jun;32(4):321-9. doi: 10.1016/j.jsat.2006.05.021. Epub 2007 Feb 22.","Ducharme LJ","J Subst Abuse Treat","2007","2007/05/08","PMC2365704","NIHMS46657","10.1016/j.jsat.2006.05.021"
"17478058","Benzodiazepine prescription for patients in opioid maintenance treatment in Norway","Bramness JG, Kornør H.","Drug Alcohol Depend. 2007 Oct 8;90(2-3):203-9. doi: 10.1016/j.drugalcdep.2007.03.008. Epub 2007 May 2.","Bramness JG","Drug Alcohol Depend","2007","2007/05/05","","","10.1016/j.drugalcdep.2007.03.008"
"17475739","A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial","Kakko J, Grönbladh L, Svanborg KD, von Wachenfeldt J, Rück C, Rawlings B, Nilsson LH, Heilig M.","Am J Psychiatry. 2007 May;164(5):797-803. doi: 10.1176/ajp.2007.164.5.797.","Kakko J","Am J Psychiatry","2007","2007/05/04","","","10.1176/ajp.2007.164.5.797"
"17475725","Medical treatment of opiate dependence: expanding treatment options","Brady KT.","Am J Psychiatry. 2007 May;164(5):702-4. doi: 10.1176/ajp.2007.164.5.702.","Brady KT","Am J Psychiatry","2007","2007/05/04","","","10.1176/ajp.2007.164.5.702"
"17472657","Clinical pharmacology of buprenorphine in healthy, lactating goats","Ingvast-Larsson C, Svartberg K, Hydbring-Sandberg E, Bondesson U, Olsson K.","J Vet Pharmacol Ther. 2007 Jun;30(3):249-56. doi: 10.1111/j.1365-2885.2007.00858.x.","Ingvast-Larsson C","J Vet Pharmacol Ther","2007","2007/05/03","","","10.1111/j.1365-2885.2007.00858.x"
"17468320","Use of a transdermal matrix patch of buprenorphine in cats: preliminary pharmacokinetic and pharmacodynamic data","Murrell JC, Robertson SA, Taylor PM, McCown JL, Bloomfield M, Sear JW.","Vet Rec. 2007 Apr 28;160(17):578-83. doi: 10.1136/vr.160.17.578.","Murrell JC","Vet Rec","2007","2007/05/01","","","10.1136/vr.160.17.578"
"17465641","Animal-to-human extrapolation of the pharmacokinetic and pharmacodynamic properties of buprenorphine","Yassen A, Olofsen E, Kan J, Dahan A, Danhof M.","Clin Pharmacokinet. 2007;46(5):433-47. doi: 10.2165/00003088-200746050-00005.","Yassen A","Clin Pharmacokinet","2007","2007/05/01","","","10.2165/00003088-200746050-00005"
"17456611","Complications arising from intravenous buprenorphine abuse","Seet RC, Oh VM, Lim EC.","QJM. 2007 May;100(5):312-3. doi: 10.1093/qjmed/hcm027.","Seet RC","QJM","2007","2007/04/26","","","10.1093/qjmed/hcm027"
"17455115","Comparison of cerebral pharmacokinetics of buprenorphine and norbuprenorphine in an in vivo sheep model","Jensen ML, Foster D, Upton R, Grant C, Martinez A, Somogyi A.","Xenobiotica. 2007 Apr;37(4):441-57. doi: 10.1080/00498250701251126.","Jensen ML","Xenobiotica","2007","2007/04/25","","","10.1080/00498250701251126"
"17454012","Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment","Watson B, Conigrave KM, Wallace C, Whitfield JB, Wurst F, Haber PS.","Drug Alcohol Rev. 2007 May;26(3):231-9. doi: 10.1080/09595230701247681.","Watson B","Drug Alcohol Rev","2007","2007/04/25","","","10.1080/09595230701247681"
"17448411","Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children's hospital-based outpatient treatment program","Levy S, Vaughan BL, Angulo M, Knight JR.","J Adolesc Health. 2007 May;40(5):477-82. doi: 10.1016/j.jadohealth.2006.11.142. Epub 2007 Mar 9.","Levy S","J Adolesc Health","2007","2007/04/24","","","10.1016/j.jadohealth.2006.11.142"
"17446599","Georgian drug misusers switch to Western heroin substitute","Cleaver H.","BMJ. 2007 Apr 21;334(7598):821. doi: 10.1136/bmj.39185.649201.DB.","Cleaver H","BMJ","2007","2007/04/21","PMC1853181","","10.1136/bmj.39185.649201.DB"
"17442473","Buprenorphine substitution treatment in France: drug users' views of the doctor-user relationship","Guichard A, Lert F, Brodeur JM, Richard L.","Soc Sci Med. 2007 Jun;64(12):2578-93. doi: 10.1016/j.socscimed.2007.02.049. Epub 2007 Apr 17.","Guichard A","Soc Sci Med","2007","2007/04/20","PMC1950347","HALMS142914","10.1016/j.socscimed.2007.02.049"
"17439863","Buprenorphine treatment: factors and first-hand experiences for providers to consider","Meier BR, Patkar AA.","J Addict Dis. 2007;26(1):3-14. doi: 10.1300/J069v26n01_02.","Meier BR","J Addict Dis","2007","2007/04/19","","","10.1300/J069v26n01_02"
"17436107","Psychiatrists as administrators: the perspective of a mental health department psychiatrist","Kolodny A.","Psychiatr Q. 2007 Sep;78(3):193-8. doi: 10.1007/s11126-007-9040-4.","Kolodny A","Psychiatr Q","2007","2007/04/17","","","10.1007/s11126-007-9040-4"
"17430618","The antinociceptive efficacy of buprenorphine administered through the drinking water of rats","Jessen L, Christensen S, Bjerrum OJ.","Lab Anim. 2007 Apr;41(2):185-96. doi: 10.1258/002367707780378131.","Jessen L","Lab Anim","2007","2007/04/14","","","10.1258/002367707780378131"
"17418990","Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France)","Labat L, Fontaine B, Delzenne C, Doublet A, Marek MC, Tellier D, Tonneau M, Lhermitte M, Frimat P.","Forensic Sci Int. 2008 Jan 30;174(2-3):90-4. doi: 10.1016/j.forsciint.2007.03.004. Epub 2007 Apr 6.","Labat L","Forensic Sci Int","2008","2007/04/10","","","10.1016/j.forsciint.2007.03.004"
"17414244","Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?","Reed LJ, Glasper A, de Wet CJ, Bearn J, Gossop M.","J Clin Psychopharmacol. 2007 Apr;27(2):188-92. doi: 10.1097/JCP.0b013e318032ec2a.","Reed LJ","J Clin Psychopharmacol","2007","2007/04/07","","","10.1097/JCP.0b013e318032ec2a"
"17405584","Buprenorphine for opioid dependence","","Drug Ther Bull. 2007 Mar;45(3):20-4. doi: 10.1136/dtb.2007.45320.","","Drug Ther Bull","2007","2007/04/05","","","10.1136/dtb.2007.45320"
"17400414","Treatment completion on an inpatient detoxification unit: impact of a change to sublingual buprenorphine-naloxone","Soeffing JM, Rastegar DA.","J Subst Abuse Treat. 2007 Dec;33(4):401-4. doi: 10.1016/j.jsat.2007.01.004. Epub 2007 Apr 2.","Soeffing JM","J Subst Abuse Treat","2007","2007/04/03","","","10.1016/j.jsat.2007.01.004"
"17391891","Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users","DiFrancesco R, Fischl MA, Donnelly J, Zingman BS, McCance-Katz EF, Moody DE, Reichman RC, Gripshover B, Morse GD.","J Pharm Biomed Anal. 2007 May 9;44(1):188-95. doi: 10.1016/j.jpba.2007.02.014. Epub 2007 Feb 16.","DiFrancesco R","J Pharm Biomed Anal","2007","2007/03/30","","","10.1016/j.jpba.2007.02.014"
"17389539","Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings","Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S.","Ann Fam Med. 2007 Mar-Apr;5(2):146-50. doi: 10.1370/afm.665.","Mintzer IL","Ann Fam Med","2007","2007/03/29","PMC1838690","","10.1370/afm.665"
"17379119","Preadministration of flurbiprofen suppresses prostaglandin production and postoperative pain in orthopedic patients undergoing tourniquet inflation","Takada M, Fukusaki M, Terao Y, Yamashita K, Inadomi C, Takada M, Sumikawa K.","J Clin Anesth. 2007 Mar;19(2):97-100. doi: 10.1016/j.jclinane.2006.05.028.","Takada M","J Clin Anesth","2007","2007/03/24","","","10.1016/j.jclinane.2006.05.028"
"17375011","[Necrotic livedo after injection of buprenorphine (Subutex)]","Potier A, Leclech C, Croue A, Chappard D, Verret JL.","Ann Dermatol Venereol. 2007 Feb;134(2):148-50. doi: 10.1016/s0151-9638(07)91607-5.","Potier A","Ann Dermatol Venereol","2007","2007/03/22","","","10.1016/s0151-9638(07)91607-5"
"17373571","WHO Expert Committee on Drug Dependence","WHO Expert Committee on Drug Dependence.","World Health Organ Tech Rep Ser. 2006;(942):i, 1-21, 23-4 passim.","WHO Expert Committee on Drug Dependence","World Health Organ Tech Rep Ser","2006","2007/03/22","","",""
"17373566","Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients","Ang-Lee K, Oreskovich MR, Saxon AJ, Jaffe C, Meredith C, Ellis ML, Malte CA, Knox PC.","J Psychoactive Drugs. 2006 Dec;38(4):505-12. doi: 10.1080/02791072.2006.10400589.","Ang-Lee K","J Psychoactive Drugs","2006","2007/03/22","","","10.1080/02791072.2006.10400589"
"17373044","[Guidelines for acute detoxication and substitution treatment in persons unknown or only superficially known to the physician]","Dejgaard B.","Ugeskr Laeger. 2007 Mar 5;169(10):936.","Dejgaard B","Ugeskr Laeger","2007","2007/03/21","","",""
"17372805","Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O'Connor PG, Schottenfeld RS.","Version 2. J Gen Intern Med. 2007 Apr;22(4):527-30. doi: 10.1007/s11606-007-0129-0.","Moore BA","J Gen Intern Med","2007","2007/03/21","PMC1829433","","10.1007/s11606-007-0129-0"
"17367825","The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference","Marquez P, Baliram R, Kieffer BL, Lutfy K.","Neuropharmacology. 2007 May;52(6):1336-41. doi: 10.1016/j.neuropharm.2007.01.005. Epub 2007 Jan 20.","Marquez P","Neuropharmacology","2007","2007/03/21","PMC2267901","NIHMS42093","10.1016/j.neuropharm.2007.01.005"
"17367094","Buprenorphine: a unique opioid with broad clinical applications","Vadivelu N, Hines RL.","J Opioid Manag. 2007 Jan-Feb;3(1):49-58. doi: 10.5055/jom.2007.0038.","Vadivelu N","J Opioid Manag","2007","2007/03/21","","","10.5055/jom.2007.0038"
"17365275","P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier","Suzuki T, Zaima C, Moriki Y, Fukami T, Tomono K.","J Drug Target. 2007 Jan;15(1):67-74. doi: 10.1080/10611860601141606.","Suzuki T","J Drug Target","2007","2007/03/17","","","10.1080/10611860601141606"
"17364849","Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified","Nielsen S, Dietze P, Dunlop A, Muhleisen P, Lee N, Taylor D.","Drug Alcohol Rev. 2007 Mar;26(2):143-51. doi: 10.1080/09595230601146645.","Nielsen S","Drug Alcohol Rev","2007","2007/03/17","","","10.1080/09595230601146645"
"17364848","Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status","Kornør H, Waal H, Sandvik L.","Drug Alcohol Rev. 2007 Mar;26(2):135-41. doi: 10.1080/09595230601146603.","Kornør H","Drug Alcohol Rev","2007","2007/03/17","","","10.1080/09595230601146603"
"17364836","The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?","Darke S, Ross J, Teesson M.","Drug Alcohol Rev. 2007 Jan;26(1):49-54. doi: 10.1080/09595230601036986.","Darke S","Drug Alcohol Rev","2007","2007/03/17","","","10.1080/09595230601036986"
"17364425","Tramadol dependence: treatment with buprenorphine/naloxone","Ritvo JI, Koonce R, Thurstone CC, Causey HL 3rd.","Am J Addict. 2007 Jan-Feb;16(1):67-8. doi: 10.1080/10550490601080118.","Ritvo JI","Am J Addict","2007","2007/03/17","","","10.1080/10550490601080118"
"17364281","A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome","Kahila H, Saisto T, Kivitie-Kallio S, Haukkamaa M, Halmesmäki E.","Acta Obstet Gynecol Scand. 2007;86(2):185-90. doi: 10.1080/00016340601110770.","Kahila H","Acta Obstet Gynecol Scand","2007","2007/03/17","","","10.1080/00016340601110770"
"17363018","Carprofen and buprenorphine prevent hyperalgesia in a model of inflammatory pain in cats","Taylor PM, Steagall PV, Dixon MJ, Ferreira TH, Luna SP.","Res Vet Sci. 2007 Dec;83(3):369-75. doi: 10.1016/j.rvsc.2007.01.007. Epub 2007 Mar 23.","Taylor PM","Res Vet Sci","2007","2007/03/17","","","10.1016/j.rvsc.2007.01.007"
"17356993","Patient satisfaction with primary care office-based buprenorphine/naloxone treatment","Barry DT, Moore BA, Pantalon MV, Chawarski MC, Sullivan LE, O'Connor PG, Schottenfeld RS, Fiellin DA.","Version 2. J Gen Intern Med. 2007 Feb;22(2):242-5. doi: 10.1007/s11606-006-0050-y.","Barry DT","J Gen Intern Med","2007","2007/03/16","PMC1824745","","10.1007/s11606-006-0050-y"
"17356982","Treating homeless opioid dependent patients with buprenorphine in an office-based setting","Alford DP, LaBelle CT, Richardson JM, O'Connell JJ, Hohl CA, Cheng DM, Samet JH.","Version 2. J Gen Intern Med. 2007 Feb;22(2):171-6. doi: 10.1007/s11606-006-0023-1.","Alford DP","J Gen Intern Med","2007","2007/03/16","PMC1824722","","10.1007/s11606-006-0023-1"
"17354146","Brain magnetic resonance imaging of infants exposed prenatally to buprenorphine","Kahila H, Kivitie-Kallio S, Halmesmäki E, Valanne L, Autti T.","Acta Radiol. 2007 Mar;48(2):228-31. doi: 10.1080/02841850601100875.","Kahila H","Acta Radiol","2007","2007/03/14","","","10.1080/02841850601100875"
"17351659","Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments","Cordonnier L, Sanchez M, Roques BP, Noble F.","Br J Pharmacol. 2007 May;151(1):94-102. doi: 10.1038/sj.bjp.0707195. Epub 2007 Mar 12.","Cordonnier L","Br J Pharmacol","2007","2007/03/14","PMC2012985","","10.1038/sj.bjp.0707195"
"17346785","Chronic buprenorphine reduces the response to sucrose-associated cues in non food-deprived rats","Hood S, Sorge RE, Stewart J.","Pharmacol Biochem Behav. 2007 Mar;86(3):566-75. doi: 10.1016/j.pbb.2007.01.020. Epub 2007 Feb 6.","Hood S","Pharmacol Biochem Behav","2007","2007/03/10","","","10.1016/j.pbb.2007.01.020"
"17344330","Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen","Fanoe S, Hvidt C, Ege P, Jensen GB.","Heart. 2007 Sep;93(9):1051-5. doi: 10.1136/hrt.2006.100180. Epub 2007 Mar 7.","Fanoe S","Heart","2007","2007/03/09","PMC1955005","","10.1136/hrt.2006.100180"
"17335723","[Effectiveness and safety of transdermal buprenorphine for chronic pain treatment in the elderly: a prospective observational study]","Muriel Villoria C, Pérez-Castejón Garrote JM, Sánchez Magro I, Neira Alvarez M.","Med Clin (Barc). 2007 Feb 17;128(6):204-10. doi: 10.1157/13098717.","Muriel Villoria C","Med Clin (Barc)","2007","2007/03/06","","","10.1157/13098717"
"17334674","Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics","Lee WR, Shen SC, Fang CL, Liu CR, Fang JY.","Lasers Med Sci. 2007 Nov;22(4):271-8. doi: 10.1007/s10103-007-0452-z. Epub 2007 Mar 3.","Lee WR","Lasers Med Sci","2007","2007/03/06","","","10.1007/s10103-007-0452-z"
"17331012","Effects of buprenorphine on nociception and spontaneous locomotor activity in horses","Carregaro AB, Luna SP, Mataqueiro MI, de Queiroz-Neto A.","Am J Vet Res. 2007 Mar;68(3):246-50. doi: 10.2460/ajvr.68.3.246.","Carregaro AB","Am J Vet Res","2007","2007/03/03","","","10.2460/ajvr.68.3.246"
"17315420","No potentiation of fentanyl by use of transdermal buprenorphine in patients undergoing fast-track anesthesia for open-heart surgery","Freye E, Hartung E, Levy JV.","J Opioid Manag. 2005 Jul-Aug;1(3):162-7. doi: 10.5055/jom.2005.0036.","Freye E","J Opioid Manag","2005","2007/02/24","","","10.5055/jom.2005.0036"
"17315409","A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence","Hopper JA, Wu J, Martus W, Pierre JD.","J Opioid Manag. 2005 Mar-Apr;1(1):31-5. doi: 10.5055/jom.2005.0009.","Hopper JA","J Opioid Manag","2005","2007/02/24","","","10.5055/jom.2005.0009"
"17313907","Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS.","Health Technol Assess. 2007 Mar;11(9):1-171, iii-iv. doi: 10.3310/hta11090.","Connock M","Health Technol Assess","2007","2007/02/23","","","10.3310/hta11090"
"17306730","Regarding naltrexone for probationers and parolees","Stancliff S.","J Subst Abuse Treat. 2007 Mar;32(2):217-8; author reply 218-9. doi: 10.1016/j.jsat.2006.11.011. Epub 2007 Feb 1.","Stancliff S","J Subst Abuse Treat","2007","2007/02/20","","","10.1016/j.jsat.2006.11.011"
"17306729","Client and counselor attitudes toward the use of medications for treatment of opioid dependence","Rieckmann T, Daley M, Fuller BE, Thomas CP, McCarty D.","J Subst Abuse Treat. 2007 Mar;32(2):207-15. doi: 10.1016/j.jsat.2006.09.002. Epub 2006 Dec 8.","Rieckmann T","J Subst Abuse Treat","2007","2007/02/20","PMC2847884","NIHMS19035","10.1016/j.jsat.2006.09.002"
"17306728","Buprenorphine for acute heroin detoxification: diffusion of research into practice","Kovas AE, McFarland BH, McCarty DJ, Boverman JF, Thayer JA.","J Subst Abuse Treat. 2007 Mar;32(2):199-206. doi: 10.1016/j.jsat.2006.08.003. Epub 2006 Nov 21.","Kovas AE","J Subst Abuse Treat","2007","2007/02/20","","","10.1016/j.jsat.2006.08.003"
"17306725","Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation","Collins ED, Horton T, Reinke K, Amass L, Nunes EV.","J Subst Abuse Treat. 2007 Mar;32(2):167-75. doi: 10.1016/j.jsat.2006.03.018. Epub 2006 Nov 21.","Collins ED","J Subst Abuse Treat","2007","2007/02/20","","","10.1016/j.jsat.2006.03.018"
"17298658","Buprenorphine-associated gastroparesis during in-patient heroin detoxification","Jakobovits SL, McDonough M, Chen RY.","Addiction. 2007 Mar;102(3):490-1. doi: 10.1111/j.1360-0443.2006.01684.x.","Jakobovits SL","Addiction","2007","2007/02/15","","","10.1111/j.1360-0443.2006.01684.x"
"17291715","Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment","Franchi S, Panerai AE, Sacerdote P.","Brain Behav Immun. 2007 Aug;21(6):767-74. doi: 10.1016/j.bbi.2007.01.001. Epub 2007 Feb 8.","Franchi S","Brain Behav Immun","2007","2007/02/13","","","10.1016/j.bbi.2007.01.001"
"17287036","Altered states: the impact of immediate craving on the valuation of current and future opioids","Badger GJ, Bickel WK, Giordano LA, Jacobs EA, Loewenstein G, Marsch L.","J Health Econ. 2007 Sep 1;26(5):865-76. doi: 10.1016/j.jhealeco.2007.01.002. Epub 2007 Jan 16.","Badger GJ","J Health Econ","2007","2007/02/09","","","10.1016/j.jhealeco.2007.01.002"
"17286641","Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment","Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D.","Addiction. 2007 Apr;102(4):616-22. doi: 10.1111/j.1360-0443.2006.01731.x. Epub 2007 Feb 6.","Nielsen S","Addiction","2007","2007/02/09","","","10.1111/j.1360-0443.2006.01731.x"
"17285405","A comparison of intravenous-based and epidural-based techniques for anesthesia and postoperative analgesia in elderly patients undergoing laparoscopic cholecystectomy","Nishikawa K, Kimura S, Shimodate Y, Igarashi M, Namiki A.","J Anesth. 2007;21(1):1-6. doi: 10.1007/s00540-006-0459-9. Epub 2007 Jan 30.","Nishikawa K","J Anesth","2007","2007/02/08","","","10.1007/s00540-006-0459-9"
"17284966","An unusual case of livedoid and necrotic lesions in a drug addict","Pierre-Alexandre J, François le P, Abdellah S, Karim T, Christian de G, Frédérique C.","Am J Dermatopathol. 2007 Feb;29(1):72-4. doi: 10.1097/01.dad.0000211508.67736.d4.","Pierre-Alexandre J","Am J Dermatopathol","2007","2007/02/08","","","10.1097/01.dad.0000211508.67736.d4"
"17283225","Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats","Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M.","J Pharmacol Exp Ther. 2007 May;321(2):598-607. doi: 10.1124/jpet.106.115972. Epub 2007 Feb 5.","Yassen A","J Pharmacol Exp Ther","2007","2007/02/07","","","10.1124/jpet.106.115972"
"17276008","Comment on Koltzenburg et al.: Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine. Pain 2006;126:165-74","Angst MS, Clark JD.","Pain. 2007 Apr;128(3):292-4. doi: 10.1016/j.pain.2006.12.024. Epub 2007 Feb 2.","Angst MS","Pain","2007","2007/02/06","","","10.1016/j.pain.2006.12.024"
"17265131","Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study","Darke S, Williamson A, Ross J, Mills KL, Havard A, Teesson M.","J Urban Health. 2007 Mar;84(2):283-91. doi: 10.1007/s11524-006-9156-0.","Darke S","J Urban Health","2007","2007/02/01","PMC2231629","","10.1007/s11524-006-9156-0"
"17244875","Buprenorphine for the treatment of opioid dependence","Boothby LA, Doering PL.","Am J Health Syst Pharm. 2007 Feb 1;64(3):266-72. doi: 10.2146/ajhp060403.","Boothby LA","Am J Health Syst Pharm","2007","2007/01/25","","","10.2146/ajhp060403"
"17240086","Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers--a competing risk approach","Ødegård E, Amundsen EJ, Kielland KB.","Drug Alcohol Depend. 2007 Jul 10;89(2-3):176-82. doi: 10.1016/j.drugalcdep.2006.12.016. Epub 2007 Jan 19.","Ødegård E","Drug Alcohol Depend","2007","2007/01/24","","","10.1016/j.drugalcdep.2006.12.016"
"17228335","Effects of d-amphetamine and buprenorphine combinations on speedball (cocaine+heroin) self-administration by rhesus monkeys","Mello NK, Negus SS.","Neuropsychopharmacology. 2007 Sep;32(9):1985-94. doi: 10.1038/sj.npp.1301319. Epub 2007 Jan 17.","Mello NK","Neuropsychopharmacology","2007","2007/01/18","","","10.1038/sj.npp.1301319"
"17220427","Thienorphine: receptor binding and behavioral effects in rhesus monkeys","Li JX, Becker GL, Traynor JR, Gong ZH, France CP.","J Pharmacol Exp Ther. 2007 Apr;321(1):227-36. doi: 10.1124/jpet.106.113290. Epub 2007 Jan 12.","Li JX","J Pharmacol Exp Ther","2007","2007/01/16","","","10.1124/jpet.106.113290"
"17211652","The effects of buprenorphine on fentanyl withdrawal in rats","Bruijnzeel AW, Marcinkiewcz C, Isaac S, Booth MM, Dennis DM, Gold MS.","Psychopharmacology (Berl). 2007 May;191(4):931-41. doi: 10.1007/s00213-006-0670-2. Epub 2007 Jan 9.","Bruijnzeel AW","Psychopharmacology (Berl)","2007","2007/01/11","","","10.1007/s00213-006-0670-2"
"17210079","Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial","Wright NM, Sheard L, Tompkins CN, Adams CE, Allgar VL, Oldham NS.","BMC Fam Pract. 2007 Jan 8;8:3. doi: 10.1186/1471-2296-8-3.","Wright NM","BMC Fam Pract","2007","2007/01/11","PMC1774569","","10.1186/1471-2296-8-3"
"17185999","Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers","Yassen A, Olofsen E, Romberg R, Sarton E, Teppema L, Danhof M, Dahan A.","Clin Pharmacol Ther. 2007 Jan;81(1):50-8. doi: 10.1038/sj.clpt.6100025.","Yassen A","Clin Pharmacol Ther","2007","2006/12/23","","","10.1038/sj.clpt.6100025"
"17184061","[Use of a Transtec transdermal therapeutic system of buprenorphine for analgesia in the early periods after cardiosurgical operations]","Eremenko AA, Urbanov AV, Avetisian MI.","Anesteziol Reanimatol. 2006 Sep-Oct;(5):40-4.","Eremenko AA","Anesteziol Reanimatol","2006","2006/12/23","","",""
"17179191","Pharmacist influence in buprenorphine treatment outcomes for opioid dependence","Tomko JR, Giannetti VJ.","Ann Pharmacother. 2007 Jan;41(1):161. doi: 10.1345/aph.1H108. Epub 2006 Dec 19.","Tomko JR","Ann Pharmacother","2007","2006/12/21","","","10.1345/aph.1H108"
"17160765","[Treatment of chronic hepatitis C within a heroine-assisted treatment program]","Deibler P, Haasen C, Reimer J.","Dtsch Med Wochenschr. 2006 Dec 15;131(50):2835-7. doi: 10.1055/s-2006-957209.","Deibler P","Dtsch Med Wochenschr","2006","2006/12/13","","","10.1055/s-2006-957209"
"17147106","The Beck Depression Inventory in patients undergoing opiate agonist maintenance treatment","Hesse M.","Br J Clin Psychol. 2006 Sep;45(Pt 3):417-25. doi: 10.1348/014466505x68069.","Hesse M","Br J Clin Psychol","2006","2006/12/07","","","10.1348/014466505x68069"
"17145457","Substance use and recovery: charting a course toward optimism. Interview by Kathleen R Delaney","Snow D.","Arch Psychiatr Nurs. 2006 Dec;20(6):288-90. doi: 10.1016/j.apnu.2006.08.001.","Snow D","Arch Psychiatr Nurs","2006","2006/12/06","","","10.1016/j.apnu.2006.08.001"
"17141582","Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry","Rodriguez-Rosas ME, Lofwall MR, Strain EC, Siluk D, Wainer IW.","J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 1;850(1-2):538-43. doi: 10.1016/j.jchromb.2006.11.025. Epub 2006 Dec 1.","Rodriguez-Rosas ME","J Chromatogr B Analyt Technol Biomed Life Sci","2007","2006/12/05","","","10.1016/j.jchromb.2006.11.025"
"17139391","Myofasciitis and polyneuritis related to Buprenorphine abuse","Sharma V, Vasoo S, Ong B.","Neurol Clin Neurophysiol. 2005 Nov 2;2005:2.","Sharma V","Neurol Clin Neurophysiol","2005","2006/12/02","","",""
"17135179","Evaluation of a combined online and in person training in the use of buprenorphine","Gunderson EW, Fiellin DA, Levin FR, Sullivan LE, Kleber HD.","Subst Abus. 2006 Sep;27(3):39-45. doi: 10.1300/J465v27n03_06.","Gunderson EW","Subst Abus","2006","2006/12/01","PMC3864017","NIHMS171409","10.1300/J465v27n03_06"
"17135176","Training HIV physicians to prescribe buprenorphine for opioid dependence","Sullivan LE, Tetrault J, Bangalore D, Fiellin DA.","Subst Abus. 2006 Sep;27(3):13-8. doi: 10.1300/J465v27n03_03.","Sullivan LE","Subst Abus","2006","2006/12/01","","","10.1300/J465v27n03_03"
"17131133","What is new in neuropathic pain?","Davis MP.","Support Care Cancer. 2007 Apr;15(4):363-72. doi: 10.1007/s00520-006-0156-0. Epub 2006 Nov 28.","Davis MP","Support Care Cancer","2007","2006/11/30","","","10.1007/s00520-006-0156-0"
"17129610","Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects","Gerra G, Zaimovic A, Raggi MA, Moi G, Branchi B, Moroni M, Brambilla F.","Psychiatry Res. 2007 Jan 15;149(1-3):201-13. doi: 10.1016/j.psychres.2006.02.013. Epub 2006 Nov 28.","Gerra G","Psychiatry Res","2007","2006/11/30","","","10.1016/j.psychres.2006.02.013"
"17127381","Buprenorphine in long-term control of chronic pain in cancer patients","Pace MC, Passavanti MB, Grella E, Mazzariello L, Maisto M, Barbarisi M, Baccari E, Sansone P, Aurilio C.","Front Biosci. 2007 Jan 1;12:1291-9. doi: 10.2741/2147.","Pace MC","Front Biosci","2007","2006/11/28","","","10.2741/2147"
"17114381","Effects of two doses of buprenorphine four or six hours apart on nociceptive thresholds, pain and sedation in dogs after castration","Slingsby LS, Taylor PM, Waterman-Pearson AE.","Vet Rec. 2006 Nov 18;159(21):705-11. doi: 10.1136/vr.159.21.705.","Slingsby LS","Vet Rec","2006","2006/11/23","","","10.1136/vr.159.21.705"
"17112927","Images in emergency medicine. Extensive groin abscess and myositis after intravenous cubital buprenorphine injection","Gautschi OP, Zellweger R.","Ann Emerg Med. 2006 Dec;48(6):656, 659. doi: 10.1016/j.annemergmed.2006.02.022.","Gautschi OP","Ann Emerg Med","2006","2006/11/23","","","10.1016/j.annemergmed.2006.02.022"
"17111839","[Molecular simulations of the loading of methadone and buprenorphine into carbon nanotubes]","Shen HJ.","Yao Xue Xue Bao. 2006 Sep;41(9):888-92.","Shen HJ","Yao Xue Xue Bao","2006","2006/11/23","","",""
"17110826","One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients","Soyka M, Apelt SM, Lieb M, Wittchen HU.","J Clin Psychopharmacol. 2006 Dec;26(6):657-60. doi: 10.1097/01.jcp.0000245561.99036.49.","Soyka M","J Clin Psychopharmacol","2006","2006/11/18","","","10.1097/01.jcp.0000245561.99036.49"
"17109312","Buprenorphine and HIV primary care: report of a forum for collaborative HIV research workshop","Miller V; Forum for Collaborative HIV Research Workshop Participants and Steering Committee Members.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S254-7. doi: 10.1086/508192.","Miller V","Clin Infect Dis","2006","2006/11/17","","","10.1086/508192"
"17109311","Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care","Schackman BR, Merrill JO, McCarty D, Levi J, Lubinski C.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S247-53. doi: 10.1086/508190.","Schackman BR","Clin Infect Dis","2006","2006/11/17","","","10.1086/508190"
"17109310","Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir","McCance-Katz EF, Moody DE, Smith PF, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Jatlow P, Rainey PM.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S235-46. doi: 10.1086/508188.","McCance-Katz EF","Clin Infect Dis","2006","2006/11/17","","","10.1086/508188"
"17109309","Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine","McCance-Katz EF, Moody DE, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Smith P, Ogundele A, Jatlow P, Rainey PM.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S224-34. doi: 10.1086/508187.","McCance-Katz EF","Clin Infect Dis","2006","2006/11/17","","","10.1086/508187"
"17109308","Pharmacokinetic interactions between buprenorphine and antiretroviral medications","Bruce RD, McCance-Katz E, Kharasch ED, Moody DE, Morse GD.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S216-23. doi: 10.1086/508186.","Bruce RD","Clin Infect Dis","2006","2006/11/17","","","10.1086/508186"
"17109307","Buprenorphine use: the international experience","Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S197-215. doi: 10.1086/508184.","Carrieri MP","Clin Infect Dis","2006","2006/11/17","","","10.1086/508184"
"17109306","Initial strategies for integrating buprenorphine into HIV care settings in the United States","Sullivan LE, Bruce RD, Haltiwanger D, Lucas GM, Eldred L, Finkelstein R, Fiellin DA.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S191-6. doi: 10.1086/508183.","Sullivan LE","Clin Infect Dis","2006","2006/11/17","","","10.1086/508183"
"17109305","A trial of integrated buprenorphine/naloxone and HIV clinical care","Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S184-90. doi: 10.1086/508182.","Sullivan LE","Clin Infect Dis","2006","2006/11/17","","","10.1086/508182"
"17109304","The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention","Altice FL, Sullivan LE, Smith-Rohrberg D, Basu S, Stancliff S, Eldred L.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S178-83. doi: 10.1086/508181.","Altice FL","Clin Infect Dis","2006","2006/11/17","","","10.1086/508181"
"17109303","Opioid dependence: rationale for and efficacy of existing and new treatments","Fiellin DA, Friedland GH, Gourevitch MN.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S173-7. doi: 10.1086/508180.","Fiellin DA","Clin Infect Dis","2006","2006/11/17","","","10.1086/508180"
"17109302","Buprenorphine and HIV primary care: new opportunities for integrated treatment","Khalsa J, Vocci F, Altice F, Fiellin D, Miller V.","Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S169-72. doi: 10.1086/508179.","Khalsa J","Clin Infect Dis","2006","2006/11/17","","","10.1086/508179"
"17107609","Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment","Kristensen Ø, Lølandsmo T, Isaksen A, Vederhus JK, Clausen T.","BMC Psychiatry. 2006 Nov 15;6:54. doi: 10.1186/1471-244X-6-54.","Kristensen Ø","BMC Psychiatry","2006","2006/11/17","PMC1660570","","10.1186/1471-244X-6-54"
"17106658","Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients","Mercadante S, Ferrera P, Villari P.","Support Care Cancer. 2007 Apr;15(4):441-4. doi: 10.1007/s00520-006-0169-8. Epub 2006 Nov 15.","Mercadante S","Support Care Cancer","2007","2006/11/16","","","10.1007/s00520-006-0169-8"
"17089985","Lack of analgesic efficacy in female rats of the commonly recommended oral dose of buprenorphine","Thompson AC, DiPirro JM, Sylvester AR, Martin LB, Kristal MB.","J Am Assoc Lab Anim Sci. 2006 Nov;45(6):13-6.","Thompson AC","J Am Assoc Lab Anim Sci","2006","2006/11/09","","",""
"17089480","The medical management of opioid dependence in HIV primary care settings","Lum PJ, Tulsky JP.","Curr HIV/AIDS Rep. 2006 Nov;3(4):195-204. doi: 10.1007/s11904-006-0016-z.","Lum PJ","Curr HIV/AIDS Rep","2006","2006/11/09","","","10.1007/s11904-006-0016-z"
"17088229","Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence","Kissin W, McLeod C, Sonnefeld J, Stanton A.","J Addict Dis. 2006;25(4):91-103. doi: 10.1300/J069v25n04_09.","Kissin W","J Addict Dis","2006","2006/11/08","","","10.1300/J069v25n04_09"
"17084876","Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression","Hreiche R, Mégarbane B, Pirnay S, Borron SW, Monier C, Risède P, Milan N, Descatoire V, Pessayre D, Baud FJ.","Toxicol Appl Pharmacol. 2006 Dec 15;217(3):352-62. doi: 10.1016/j.taap.2006.09.011. Epub 2006 Sep 30.","Hreiche R","Toxicol Appl Pharmacol","2006","2006/11/07","","","10.1016/j.taap.2006.09.011"
"17084756","Intravenous drug use and HIV","Newman RG.","Lancet. 2006 Nov 4;368(9547):1574. doi: 10.1016/S0140-6736(06)69661-X.","Newman RG","Lancet","2006","2006/11/07","","","10.1016/S0140-6736(06)69661-X"
"17083612","Investigation of the interaction between buprenorphine and sufentanil during anaesthesia for ovariectomy in dogs","Goyenechea Jaramillo LA, Murrell JC, Hellebrekers LJ.","Vet Anaesth Analg. 2006 Nov;33(6):399-407. doi: 10.1111/j.1467-2995.2006.00285.x.","Goyenechea Jaramillo LA","Vet Anaesth Analg","2006","2006/11/07","","","10.1111/j.1467-2995.2006.00285.x"
"17083610","Postanesthetic hyperthermia in cats: a retrospective comparison between hydromorphone and buprenorphine","Niedfeldt RL, Robertson SA.","Vet Anaesth Analg. 2006 Nov;33(6):381-9. doi: 10.1111/j.1467-2995.2005.00275.x.","Niedfeldt RL","Vet Anaesth Analg","2006","2006/11/07","","","10.1111/j.1467-2995.2005.00275.x"
"17083457","Effects of subcutaneous methadone, morphine, buprenorphine or saline on thermal and pressure thresholds in cats","Steagall PV, Carnicelli P, Taylor PM, Luna SP, Dixon M, Ferreira TH.","J Vet Pharmacol Ther. 2006 Dec;29(6):531-7. doi: 10.1111/j.1365-2885.2006.00800.x.","Steagall PV","J Vet Pharmacol Ther","2006","2006/11/07","","","10.1111/j.1365-2885.2006.00800.x"
"17078595","[What are the cardiovascular complications of the analgesics and glucocorticoids?]","Bertin P.","Presse Med. 2006 Sep;35(9 Spec No 1):1S47-51.","Bertin P","Presse Med","2006","2006/11/03","","",""
"17076790","Clinical efficacy and safety of dexmedetomidine and buprenorphine, butorphanol or diazepam for canine hip radiography","Leppänen MK, McKusick BC, Granholm MM, Westerholm FC, Tulamo R, Short CE.","J Small Anim Pract. 2006 Nov;47(11):663-9. doi: 10.1111/j.1748-5827.2006.00030.x.","Leppänen MK","J Small Anim Pract","2006","2006/11/02","","","10.1111/j.1748-5827.2006.00030.x"
"17075657","Surgical complications in parenteral Subutex abusers","Lo HY, Leong CS.","Singapore Med J. 2006 Nov;47(11):924-7.","Lo HY","Singapore Med J","2006","2006/11/01","","",""
"17075655","Tackling Subutex abuse in Singapore","Lee CE.","Singapore Med J. 2006 Nov;47(11):919-21.","Lee CE","Singapore Med J","2006","2006/11/01","","",""
"17073131","[Can we stop the hepatitis C virus transmission in drug users?]","Lert F.","Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S61-1S67.","Lert F","Rev Epidemiol Sante Publique","2006","2006/11/01","","",""
"17073128","[Health related quality of life among HIV-HCV co-infected patients]","Préau M, Protopopescu C, Spire B, Dellamonica P, Poizot-Martin I, Villes V, Carrieri MP; Groupe d'etude MANIF-2000.","Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S33-1S43.","Préau M","Rev Epidemiol Sante Publique","2006","2006/11/01","","",""
"17062541","On blending practice and research: the search for commonalities in substance abuse treatment","Kellogg S, Kreek MJ.","Subst Abus. 2006 Jun;27(1-2):9-24. doi: 10.1300/J465v27n01_03.","Kellogg S","Subst Abus","2006","2006/10/26","","","10.1300/J465v27n01_03"
"17062539","Buprenorphine for heroin addicts: the issue of illicit opioid abuse during maintenance","Cho E, Dermatis H, Galanter M.","Subst Abus. 2006 Jun;27(1-2):1-3. doi: 10.1300/J465v27n01_01.","Cho E","Subst Abus","2006","2006/10/26","","","10.1300/J465v27n01_01"
"17055191","Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users","Alho H, Sinclair D, Vuori E, Holopainen A.","Drug Alcohol Depend. 2007 Apr 17;88(1):75-8. doi: 10.1016/j.drugalcdep.2006.09.012. Epub 2006 Oct 19.","Alho H","Drug Alcohol Depend","2007","2006/10/24","","","10.1016/j.drugalcdep.2006.09.012"
"17054160","Opioid antagonists for smoking cessation","David S, Lancaster T, Stead LF, Evins AE.","Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003086. doi: 10.1002/14651858.CD003086.pub2.","David S","Cochrane Database Syst Rev","2006","2006/10/21","","","10.1002/14651858.CD003086.pub2"
"17050900","Counseling plus buprenorphine-naloxone for opioid dependence","Gorelick DA.","N Engl J Med. 2006 Oct 19;355(16):1736; author reply 1736-7. doi: 10.1056/NEJMc062301.","Gorelick DA","N Engl J Med","2006","2006/10/20","","","10.1056/NEJMc062301"
"17046338","Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes","Mercolini L, Mandrioli R, Conti M, Leonardi C, Gerra G, Raggi MA.","J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 1;847(2):95-102. doi: 10.1016/j.jchromb.2006.09.035. Epub 2006 Oct 13.","Mercolini L","J Chromatogr B Analyt Technol Biomed Life Sci","2007","2006/10/19","","","10.1016/j.jchromb.2006.09.035"
"17037004","The depot of buprenorphine decanoate produced a dose-related long-lasting antinociceptive effect in guinea pigs","Wu SZ, Liu KS, Chu KS, Cheng KI, Kuei CH, Wang JJ, Tzeng JI.","Acta Anaesthesiol Taiwan. 2006 Sep;44(3):161-8.","Wu SZ","Acta Anaesthesiol Taiwan","2006","2006/10/14","","",""
"17037003","Comparison of intravenous patient-controlled analgesia with buprenorphine versus morphine after lumbar spinal fusion--a prospective randomized clinical trial","Chang KY, Chang WK, Chang WL, Lin SM, Chan KH, Sung CS, Tsou MY.","Acta Anaesthesiol Taiwan. 2006 Sep;44(3):153-9.","Chang KY","Acta Anaesthesiol Taiwan","2006","2006/10/14","","",""
"17036999","Translational medicine in ultra-long injectable opioid drug discovery--when abuse liability and toxicity meet analgesic efficacy","Sun WZ.","Acta Anaesthesiol Taiwan. 2006 Sep;44(3):133-4.","Sun WZ","Acta Anaesthesiol Taiwan","2006","2006/10/14","","",""
"17017836","Buprenorphine: reflections of an addictions psychiatrist","Selzer J.","J Clin Psychiatry. 2006 Sep;67(9):1466-7. doi: 10.4088/jcp.v67n0920.","Selzer J","J Clin Psychiatry","2006","2006/10/05","","","10.4088/jcp.v67n0920"
"17015570","Adverse effects in children after unintentional buprenorphine exposure","Geib AJ, Babu K, Ewald MB, Boyer EW.","Pediatrics. 2006 Oct;118(4):1746-51. doi: 10.1542/peds.2006-0948.","Geib AJ","Pediatrics","2006","2006/10/04","","","10.1542/peds.2006-0948"
"17014315","Cardiopulmonary effects of buprenorphine in horses","Carregaro AB, Neto FJ, Beier SL, Luna SP.","Am J Vet Res. 2006 Oct;67(10):1675-80. doi: 10.2460/ajvr.67.10.1675.","Carregaro AB","Am J Vet Res","2006","2006/10/04","","","10.2460/ajvr.67.10.1675"
"17013637","Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period","Correia CJ, Walsh SL, Bigelow GE, Strain EC.","Psychopharmacology (Berl). 2006 Dec;189(3):297-306. doi: 10.1007/s00213-006-0571-4. Epub 2006 Sep 30.","Correia CJ","Psychopharmacology (Berl)","2006","2006/10/03","","","10.1007/s00213-006-0571-4"
"17012944","Innovations in agonist maintenance treatment of opioid-dependent patients","Haasen C, van den Brink W.","Curr Opin Psychiatry. 2006 Nov;19(6):631-6. doi: 10.1097/01.yco.0000245759.13997.9d.","Haasen C","Curr Opin Psychiatry","2006","2006/10/03","","","10.1097/01.yco.0000245759.13997.9d"
"17001553","Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel","Nekhayeva IA, Nanovskaya TN, Hankins GD, Ahmed MS.","Am J Perinatol. 2006 Oct;23(7):423-30. doi: 10.1055/s-2006-951301. Epub 2006 Sep 25.","Nekhayeva IA","Am J Perinatol","2006","2006/09/27","","","10.1055/s-2006-951301"
"16983521","Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany","Greiner W, Lehmann K, Earnshaw S, Bug C, Sabatowski R.","Eur J Health Econ. 2006 Dec;7(4):290-6. doi: 10.1007/s10198-006-0376-8.","Greiner W","Eur J Health Econ","2006","2006/09/20","","","10.1007/s10198-006-0376-8"
"16982291","Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany","Sittl R, Nuijten M, Poulsen Nautrup B.","Clin Ther. 2006 Aug;28(8):1144-1154. doi: 10.1016/j.clinthera.2006.08.002.","Sittl R","Clin Ther","2006","2006/09/20","","","10.1016/j.clinthera.2006.08.002"
"16981980","Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies","Louis F.","Int J Clin Pract. 2006 Oct;60(10):1330-4. doi: 10.1111/j.1742-1241.2006.01109.x.","Louis F","Int J Clin Pract","2006","2006/09/20","","","10.1111/j.1742-1241.2006.01109.x"
"16966198","Response to ""transferring methadone-stabilized pregnant patients to buprenorphine""","Newman RG.","Am J Addict. 2006 Sep-Oct;15(5):400; author reply 401-2. doi: 10.1080/10550490600860452.","Newman RG","Am J Addict","2006","2006/09/13","","","10.1080/10550490600860452"
"16964809","Substance abuse in pregnancy: opioid substitution in a northern Ireland maternity unit","Mawhinney S, Ashe RG, Lowry J.","Ulster Med J. 2006 Sep;75(3):187-91.","Mawhinney S","Ulster Med J","2006","2006/09/13","PMC1891783","",""
"16958555","Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences","Mégarbane B, Hreiche R, Pirnay S, Marie N, Baud FJ.","Toxicol Rev. 2006;25(2):79-85. doi: 10.2165/00139709-200625020-00002.","Mégarbane B","Toxicol Rev","2006","2006/09/09","","","10.2165/00139709-200625020-00002"
"16956874","Less pain, more gain: buprenorphine-naloxone and patient retention in treatment","Renzelli CM, Capretto NA.","J Addict Dis. 2006;25(3):97-104. doi: 10.1300/J069v25n03_12.","Renzelli CM","J Addict Dis","2006","2006/09/08","","","10.1300/J069v25n03_12"
"16953647","Buprenorphine-containing treatments: place in the management of opioid addiction","Robinson SE.","CNS Drugs. 2006;20(9):697-712. doi: 10.2165/00023210-200620090-00001.","Robinson SE","CNS Drugs","2006","2006/09/07","","","10.2165/00023210-200620090-00001"
"16952820","Ganglionic local opioid application (GLOA) for treatment of chronic headache and facial pain","Harris CL, Hamid B, Rosenquist RW, Schultz-Stubner SH.","Reg Anesth Pain Med. 2006 Sep-Oct;31(5):460-2. doi: 10.1016/j.rapm.2006.03.011.","Harris CL","Reg Anesth Pain Med","2006","2006/09/06","","","10.1016/j.rapm.2006.03.011"
"16950210","Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices","Greenwald M, Johanson CE, Bueller J, Chang Y, Moody DE, Kilbourn M, Koeppe R, Zubieta JK.","Biol Psychiatry. 2007 Jan 1;61(1):101-10. doi: 10.1016/j.biopsych.2006.04.043. Epub 2006 Sep 1.","Greenwald M","Biol Psychiatry","2007","2006/09/05","","","10.1016/j.biopsych.2006.04.043"
"16948588","Effects of epidural administration of morphine and buprenorphine on the minimum alveolar concentration of isoflurane in cats","Pypendop BH, Pascoe PJ, Ilkiw JE.","Am J Vet Res. 2006 Sep;67(9):1471-5. doi: 10.2460/ajvr.67.9.1471.","Pypendop BH","Am J Vet Res","2006","2006/09/05","","","10.2460/ajvr.67.9.1471"
"16945367","Mu and kappa opioid receptor agonists antagonize icilin-induced wet-dog shaking in rats","Werkheiser JL, Rawls SM, Cowan A.","Eur J Pharmacol. 2006 Oct 10;547(1-3):101-5. doi: 10.1016/j.ejphar.2006.07.026. Epub 2006 Jul 25.","Werkheiser JL","Eur J Pharmacol","2006","2006/09/02","","","10.1016/j.ejphar.2006.07.026"
"16939945","New challenges and opportunities in managing substance abuse in Malaysia","Mazlan M, Schottenfeld RS, Chawarski MC.","Drug Alcohol Rev. 2006 Sep;25(5):473-8. doi: 10.1080/09595230600883354.","Mazlan M","Drug Alcohol Rev","2006","2006/08/31","","","10.1080/09595230600883354"
"16930865","Evaluation of the use of buprenorphine for opioid withdrawal in an emergency department","Berg ML, Idrees U, Ding R, Nesbit SA, Liang HK, McCarthy ML.","Drug Alcohol Depend. 2007 Jan 12;86(2-3):239-44. doi: 10.1016/j.drugalcdep.2006.06.014. Epub 2006 Aug 22.","Berg ML","Drug Alcohol Depend","2007","2006/08/26","","","10.1016/j.drugalcdep.2006.06.014"
"16930862","The relationship between temporal discounting and the prisoner's dilemma game in intranasal abusers of prescription opioids","Yi R, Buchhalter AR, Gatchalian KM, Bickel WK.","Drug Alcohol Depend. 2007 Feb 23;87(1):94-7. doi: 10.1016/j.drugalcdep.2006.07.007. Epub 2006 Aug 22.","Yi R","Drug Alcohol Depend","2007","2006/08/26","","","10.1016/j.drugalcdep.2006.07.007"
"16923675","Post-cesarean pain management of patients maintained on methadone or buprenorphine","Jones HE, Johnson RE, Milio L.","Am J Addict. 2006 May-Jun;15(3):258-9. doi: 10.1080/10550490600626721.","Jones HE","Am J Addict","2006","2006/08/23","","","10.1080/10550490600626721"
"16923672","Buprenorphine treatment: a three-year prospective study in opioid-addicted patients of a public out-patient addiction center in Milan","Cozzolino E, Guglielmino L, Vigezzi P, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L.","Am J Addict. 2006 May-Jun;15(3):246-51. doi: 10.1080/10550490600626606.","Cozzolino E","Am J Addict","2006","2006/08/23","","","10.1080/10550490600626606"
"16919747","HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone","Lott DC, Strain EC, Brooner RK, Bigelow GE, Johnson RE.","J Subst Abuse Treat. 2006 Sep;31(2):187-94. doi: 10.1016/j.jsat.2006.04.005. Epub 2006 Jul 18.","Lott DC","J Subst Abuse Treat","2006","2006/08/22","","","10.1016/j.jsat.2006.04.005"
"16911735","Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis","Andresz V, Marcantoni N, Binder F, Velten M, Alt M, Weber JC, Stephan D.","Addiction. 2006 Sep;101(9):1347-51. doi: 10.1111/j.1360-0443.2006.01521.x.","Andresz V","Addiction","2006","2006/08/17","","","10.1111/j.1360-0443.2006.01521.x"
"16902770","The effects of chronic buprenorphine on intake of heroin and cocaine in rats and its effects on nucleus accumbens dopamine levels during self-administration","Sorge RE, Stewart J.","Psychopharmacology (Berl). 2006 Sep;188(1):28-41. doi: 10.1007/s00213-006-0485-1. Epub 2006 Aug 11.","Sorge RE","Psychopharmacology (Berl)","2006","2006/08/12","","","10.1007/s00213-006-0485-1"
"16902730","Buprenorphine-associated deaths in Singapore","Lai SH, Teo CE.","Ann Acad Med Singapore. 2006 Jul;35(7):508-11.","Lai SH","Ann Acad Med Singapore","2006","2006/08/12","","",""
"16902726","Abuse of prescription buprenorphine, regulatory controls and the role of the primary physician","Chua SM, Lee TS.","Ann Acad Med Singapore. 2006 Jul;35(7):492-5.","Chua SM","Ann Acad Med Singapore","2006","2006/08/12","","",""
"16902725","Complications relating to intravenous buprenorphine abuse: a single institution case series","Yeo AK, Chan CY, Chia KH.","Ann Acad Med Singapore. 2006 Jul;35(7):487-91.","Yeo AK","Ann Acad Med Singapore","2006","2006/08/12","","",""
"16902719","Socio-demographic profile and help-seeking behaviour of buprenorphine abusers in Singapore","Winslow M, Ng WL, Mythily S, Song G, Yiong HC.","Ann Acad Med Singapore. 2006 Jul;35(7):451-6.","Winslow M","Ann Acad Med Singapore","2006","2006/08/12","","",""
"16902718","Medicalising the treatment of opioid dependence","Peh LH, Ng BY.","Ann Acad Med Singapore. 2006 Jul;35(7):447-9.","Peh LH","Ann Acad Med Singapore","2006","2006/08/12","","",""
"16901645","Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine","Koltzenburg M, Pokorny R, Gasser UE, Richarz U.","Pain. 2006 Dec 15;126(1-3):165-74. doi: 10.1016/j.pain.2006.06.028. Epub 2006 Aug 9.","Koltzenburg M","Pain","2006","2006/08/12","","","10.1016/j.pain.2006.06.028"
"16893317","Clinic-based treatment for opioid dependence: a qualitative inquiry","McMurphy S, Shea J, Switzer J, Turner BJ.","Am J Health Behav. 2006 Sep-Oct;30(5):544-54. doi: 10.5555/ajhb.2006.30.5.544.","McMurphy S","Am J Health Behav","2006","2006/08/09","","","10.5555/ajhb.2006.30.5.544"
"16890339","Reorganization of the composition of brain oscillations and their temporal characteristics in opioid dependent patients","Fingelkurts AA, Fingelkurts AA, Kivisaari R, Autti T, Borisov S, Puuskari V, Jokela O, Kähkönen S.","Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1453-65. doi: 10.1016/j.pnpbp.2006.06.005. Epub 2006 Aug 4.","Fingelkurts AA","Prog Neuropsychopharmacol Biol Psychiatry","2006","2006/08/08","","","10.1016/j.pnpbp.2006.06.005"
"16884182","Refractometry for quality control of anesthetic drug mixtures","Stabenow JM, Maske ML, Vogler GA.","J Am Assoc Lab Anim Sci. 2006 Jul;45(4):60-3.","Stabenow JM","J Am Assoc Lab Anim Sci","2006","2006/08/04","","",""
"16879940","A survey of buprenorphine related deaths in Singapore","Lai SH, Yao YJ, Lo DS.","Forensic Sci Int. 2006 Oct 16;162(1-3):80-6. doi: 10.1016/j.forsciint.2006.03.037. Epub 2006 Aug 1.","Lai SH","Forensic Sci Int","2006","2006/08/02","","","10.1016/j.forsciint.2006.03.037"
"16877185","Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine","Mercadante S, Villari P, Ferrera P, Porzio G, Aielli F, Verna L, Casuccio A.","J Pain Symptom Manage. 2006 Aug;32(2):175-9. doi: 10.1016/j.jpainsymman.2006.01.013.","Mercadante S","J Pain Symptom Manage","2006","2006/08/01","","","10.1016/j.jpainsymman.2006.01.013"
"16870915","Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence","Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, Schottenfeld RS.","N Engl J Med. 2006 Jul 27;355(4):365-74. doi: 10.1056/NEJMoa055255.","Fiellin DA","N Engl J Med","2006","2006/07/28","","","10.1056/NEJMoa055255"
"16869033","Designer drug Subutex takes its toll in Tbilisi","Parfitt T.","Lancet. 2006 Jul 22;368(9532):273-4. doi: 10.1016/S0140-6736(06)69056-9.","Parfitt T","Lancet","2006","2006/07/27","","","10.1016/S0140-6736(06)69056-9"
"16860176","Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials","Likar R, Kayser H, Sittl R.","Clin Ther. 2006 Jun;28(6):943-52. doi: 10.1016/j.clinthera.2006.06.012.","Likar R","Clin Ther","2006","2006/07/25","","","10.1016/j.clinthera.2006.06.012"
"16859402","Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence","Maas B, Kerr T, Fairbairn N, Montaner J, Wood E.","Expert Opin Drug Metab Toxicol. 2006 Aug;2(4):533-43. doi: 10.1517/17425255.2.4.533.","Maas B","Expert Opin Drug Metab Toxicol","2006","2006/07/25","","","10.1517/17425255.2.4.533"
"16856549","[Main causes of the emergence delay from balanced anesthesia]","Onaka M, Yamamoto H.","Masui. 2006 Jul;55(7):880-5.","Onaka M","Masui","2006","2006/07/22","","",""
"16855177","Mechanism-based pharmacokinetic-pharmacodynamic modeling of the respiratory-depressant effect of buprenorphine and fentanyl in rats","Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M.","J Pharmacol Exp Ther. 2006 Nov;319(2):682-92. doi: 10.1124/jpet.106.107953. Epub 2006 Jul 19.","Yassen A","J Pharmacol Exp Ther","2006","2006/07/21","","","10.1124/jpet.106.107953"
"16854666","Unusual presentations for pharmacotherapy-poppy seed dependence","Lloyd-Jones DM, Bonomo Y.","Drug Alcohol Rev. 2006 Jul;25(4):375-6. doi: 10.1080/09595230600741370.","Lloyd-Jones DM","Drug Alcohol Rev","2006","2006/07/21","","","10.1080/09595230600741370"
"16850600","[Study on colloidal gold labeled anti-buprenorphine monoclonal antibody for rapid test kit to detect buprenorphine]","Zeng LB, Chen LK, Hu XL, Chen L, Wang XS, Zhang YR.","Fa Yi Xue Za Zhi. 2006 Apr;22(2):130-2.","Zeng LB","Fa Yi Xue Za Zhi","2006","2006/07/21","","",""
"16849346","Ingested foreign body, to remove or not to remove","Shariff MK, Oppong K, Thompson N.","Gut. 2006 Aug;55(8):1103, 1155. doi: 10.1136/gut.2005.083543.","Shariff MK","Gut","2006","2006/07/20","PMC1856294","","10.1136/gut.2005.083543"
"16842385","Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian region","Chinellato A, Terrazzani G, Debetto P, Zambon P, Guzzinati S, Walley T, Giusti P.","Br J Clin Pharmacol. 2006 Jul;62(1):130-3. doi: 10.1111/j.1365-2125.2006.02600.x.","Chinellato A","Br J Clin Pharmacol","2006","2006/07/18","PMC1885071","","10.1111/j.1365-2125.2006.02600.x"
"16827252","Comparison of intrathecal fentanyl and buprenorphine in urological surgery","Khan FA, Hamdani GA.","J Pak Med Assoc. 2006 Jun;56(6):277-81.","Khan FA","J Pak Med Assoc","2006","2006/07/11","","",""
"16816046","Non-commercial clinical trials of a medicinal product: can they survive the current process of research approvals in the UK?","Sheard L, Tompkins CN, Wright NM, Adams CE.","J Med Ethics. 2006 Jul;32(7):430-4. doi: 10.1136/jme.2005.015180.","Sheard L","J Med Ethics","2006","2006/07/04","PMC2564494","","10.1136/jme.2005.015180"
"16814937","Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance","Singhal A, Tripathi BM, Pal HR, Jena R, Jain R.","Addict Behav. 2007 Feb;32(2):320-31. doi: 10.1016/j.addbeh.2006.05.003. Epub 2006 Jul 11.","Singhal A","Addict Behav","2007","2006/07/04","","","10.1016/j.addbeh.2006.05.003"
"16814005","Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients","Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.","J Subst Abuse Treat. 2006 Jul;31(1):3-7. doi: 10.1016/j.jsat.2006.03.007.","Vigezzi P","J Subst Abuse Treat","2006","2006/07/04","","","10.1016/j.jsat.2006.03.007"
"16809994","Naloxone reversal of buprenorphine-induced respiratory depression","van Dorp E, Yassen A, Sarton E, Romberg R, Olofsen E, Teppema L, Danhof M, Dahan A.","Anesthesiology. 2006 Jul;105(1):51-7. doi: 10.1097/00000542-200607000-00012.","van Dorp E","Anesthesiology","2006","2006/07/01","","","10.1097/00000542-200607000-00012"
"16806444","The effects of long-term chronic buprenorphine treatment on the locomotor and nucleus accumbens dopamine response to acute heroin and cocaine in rats","Sorge RE, Stewart J.","Pharmacol Biochem Behav. 2006 Jun;84(2):300-5. doi: 10.1016/j.pbb.2006.05.013. Epub 2006 Jun 27.","Sorge RE","Pharmacol Biochem Behav","2006","2006/06/30","","","10.1016/j.pbb.2006.05.013"
"16803661","Quantitative analysis of buprenorphine and norbuprenorphine in urine using liquid chromatography tandem mass spectrometry","Fox EJ, Tetlow VA, Allen KR.","J Anal Toxicol. 2006 May;30(4):238-44. doi: 10.1093/jat/30.4.238.","Fox EJ","J Anal Toxicol","2006","2006/06/29","","","10.1093/jat/30.4.238"
"16802166","Effect of psychotropic medication on the in vitro metabolism of buprenorphine in human cDNA-expressed cytochrome P450 enzymes","Bomsien S, Aderjan R, Mattern R, Skopp G.","Eur J Clin Pharmacol. 2006 Aug;62(8):639-43. doi: 10.1007/s00228-006-0147-6. Epub 2006 Jun 27.","Bomsien S","Eur J Clin Pharmacol","2006","2006/06/28","","","10.1007/s00228-006-0147-6"
"16785455","Buprenorphine: a potential new treatment option for opioid dependence","Srivastava A, Kahan M.","CMAJ. 2006 Jun 20;174(13):1835. doi: 10.1503/cmaj.050658.","Srivastava A","CMAJ","2006","2006/06/21","PMC1475897","","10.1503/cmaj.050658"
"16785214","Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts","Nava F, Caldiroli E, Premi S, Lucchini A.","J Addict Dis. 2006;25(2):9-16. doi: 10.1300/J069v25n02_02.","Nava F","J Addict Dis","2006","2006/06/21","","","10.1300/J069v25n02_02"
"16783071","[Comparative evaluation of clinical symptoms and status of bone metabolism in patients with heroin and buprenorphine addiction in the period of withdrawal]","Sikharulidze ZD, Kopaliani MG, Kilasoniia LO.","Georgian Med News. 2006 May;(134):72-6.","Sikharulidze ZD","Georgian Med News","2006","2006/06/20","","",""
"16781931","Exploratory buprenorphine ingestion in an infant","Cho CS, Calello DP, Osterhoudt KC.","Ann Emerg Med. 2006 Jul;48(1):109. doi: 10.1016/j.annemergmed.2006.02.031.","Cho CS","Ann Emerg Med","2006","2006/06/20","","","10.1016/j.annemergmed.2006.02.031"
"16772537","Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception","Fischer BD, Dykstra LA.","J Pharmacol Exp Ther. 2006 Sep;318(3):1300-6. doi: 10.1124/jpet.106.101683. Epub 2006 Jun 13.","Fischer BD","J Pharmacol Exp Ther","2006","2006/06/15","","","10.1124/jpet.106.101683"
"16769444","Heroin dependence and HIV infection in Malaysia","Chawarski MC, Mazlan M, Schottenfeld RS.","Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S39-42. doi: 10.1016/s0376-8716(06)80007-4.","Chawarski MC","Drug Alcohol Depend","2006","2006/06/14","","","10.1016/s0376-8716(06)80007-4"
"16764218","Transdermal buprenorphine in cancer pain and palliative care","Sittl R.","Palliat Med. 2006;20 Suppl 1:s25-30.","Sittl R","Palliat Med","2006","2006/06/13","","",""
"16764217","Renal impairment: a challenge for opioid treatment? The role of buprenorphine","Böger RH.","Palliat Med. 2006;20 Suppl 1:s17-23.","Böger RH","Palliat Med","2006","2006/06/13","","",""
"16764215","Opioid-induced respiratory effects: new data on buprenorphine","Dahan A.","Palliat Med. 2006;20 Suppl 1:s3-8.","Dahan A","Palliat Med","2006","2006/06/13","","",""
"16756418","A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine","Gross A, Marsch LA, Badger GJ, Bickel WK.","Exp Clin Psychopharmacol. 2006 May;14(2):148-56. doi: 10.1037/1064-1297.14.2.148.","Gross A","Exp Clin Psychopharmacol","2006","2006/06/08","","","10.1037/1064-1297.14.2.148"
"16753646","Providing opioid substitution treatment to Indigenous heroin users within a community health service setting in Adelaide","Williams N, Nasir R, Smither G, Troon S.","Drug Alcohol Rev. 2006 May;25(3):227-32. doi: 10.1080/09595230600644699.","Williams N","Drug Alcohol Rev","2006","2006/06/07","","","10.1080/09595230600644699"
"16740084","Analgesic effects of subarachnoidally administered hyperbaric opioids in horses","Natalini CC, Polydoro Ada S, Linardi RL.","Am J Vet Res. 2006 Jun;67(6):941-6. doi: 10.2460/ajvr.67.6.941.","Natalini CC","Am J Vet Res","2006","2006/06/03","","","10.2460/ajvr.67.6.941"
"16732095","Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers","Yassen A, Olofsen E, Romberg R, Sarton E, Danhof M, Dahan A.","Anesthesiology. 2006 Jun;104(6):1232-42. doi: 10.1097/00000542-200606000-00019.","Yassen A","Anesthesiology","2006","2006/05/30","","","10.1097/00000542-200606000-00019"
"16721696","Fatal poisoning in methadone and buprenorphine treated patients -- are there differences?","Soyka M, Penning R, Wittchen U.","Pharmacopsychiatry. 2006 May;39(3):85-7. doi: 10.1055/s-2006-941482.","Soyka M","Pharmacopsychiatry","2006","2006/05/25","","","10.1055/s-2006-941482"
"16720083","Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse","Lelong-Boulouard V, Quentin T, Moreaux F, Debruyne D, Boulouard M, Coquerel A.","Drug Alcohol Depend. 2006 Nov 8;85(2):103-13. doi: 10.1016/j.drugalcdep.2006.03.017. Epub 2006 May 23.","Lelong-Boulouard V","Drug Alcohol Depend","2006","2006/05/25","","","10.1016/j.drugalcdep.2006.03.017"
"16719249","Managing opioid addiction with buprenorphine","Donaher PA, Welsh C.","Am Fam Physician. 2006 May 1;73(9):1573-8.","Donaher PA","Am Fam Physician","2006","2006/05/25","","",""
"16719242","Buprenorphine: effective treatment of opioid addiction starts in the office","Fiellin DA.","Am Fam Physician. 2006 May 1;73(9):1513-4.","Fiellin DA","Am Fam Physician","2006","2006/05/25","","",""
"16716852","Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors","Knudsen HK, Ducharme LJ, Roman PM.","J Subst Abuse Treat. 2006 Jun;30(4):363-73. doi: 10.1016/j.jsat.2006.03.013.","Knudsen HK","J Subst Abuse Treat","2006","2006/05/24","","","10.1016/j.jsat.2006.03.013"
"16702892","Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients","Lintzeris N, Mitchell TB, Bond A, Nestor L, Strang J.","J Clin Psychopharmacol. 2006 Jun;26(3):274-83. doi: 10.1097/01.jcp.0000219050.33008.61.","Lintzeris N","J Clin Psychopharmacol","2006","2006/05/17","","","10.1097/01.jcp.0000219050.33008.61"
"16700149","[Accidental ingestion of methadone and buprenorphine by children. A case review of the Lille Poison Centre between 1995 and 2005]","Nisse P, Cezard C, Peucelle D, Mathieu-Nolf M.","Acta Clin Belg. 2006;61 Suppl 1:37-40. doi: 10.1179/acb.2006.067.","Nisse P","Acta Clin Belg","2006","2006/05/17","","","10.1179/acb.2006.067"
"16700146","[Heroin substitution treatments. Analysis of current solutions, trends, and perspectives]","Guffens JM.","Acta Clin Belg. 2006;61 Suppl 1:18-24. doi: 10.1179/acb.2006.064.","Guffens JM","Acta Clin Belg","2006","2006/05/17","","","10.1179/acb.2006.064"
"16673195","Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital","Cunningham CO, Sohler NL, McCoy K, Kunins HV.","Fam Med. 2006 May;38(5):336-40.","Cunningham CO","Fam Med","2006","2006/05/05","","",""
"16669899","Opiate addiction in China: current situation and treatments","Tang YL, Zhao D, Zhao C, Cubells JF.","Addiction. 2006 May;101(5):657-65. doi: 10.1111/j.1360-0443.2006.01367.x.","Tang YL","Addiction","2006","2006/05/04","","","10.1111/j.1360-0443.2006.01367.x"
"16652030","Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice","Bruce RD, Altice FL, Gourevitch MN, Friedland GH.","J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):563-72. doi: 10.1097/01.qai.0000219769.89679.ec.","Bruce RD","J Acquir Immune Defic Syndr","2006","2006/05/03","","","10.1097/01.qai.0000219769.89679.ec"
"16650985","A highly selective kappa-opioid receptor agonist with low addictive potential and dependence liability","Park HS, Lee HY, Kim YH, Park JK, Zvartau EE, Lee H.","Bioorg Med Chem Lett. 2006 Jul 1;16(13):3609-13. doi: 10.1016/j.bmcl.2006.02.017. Epub 2006 May 2.","Park HS","Bioorg Med Chem Lett","2006","2006/05/03","","","10.1016/j.bmcl.2006.02.017"
"16643251","The effects of pentazocine, buprenorphine and butorphanol on human neutrophil functions","Mikawa K, Akamatsu H, Nishina K, Uesugi T, Niwa Y.","Acta Anaesthesiol Scand. 2006 May;50(5):643-4. doi: 10.1111/j.1399-6576.2006.00952.x.","Mikawa K","Acta Anaesthesiol Scand","2006","2006/04/29","","","10.1111/j.1399-6576.2006.00952.x"
"16642964","Pharmacokinetics of buprenorphine after intravenous administration in the mouse","Yu S, Zhang X, Sun Y, Peng Y, Johnson J, Mandrell T, Shukla AJ, Laizure SC.","J Am Assoc Lab Anim Sci. 2006 May;45(3):12-6.","Yu S","J Am Assoc Lab Anim Sci","2006","2006/04/29","","",""
"16641169","Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapy","Moro C, Taino R, Mandalà M, Labianca R.","Ann Oncol. 2006 Sep;17(9):1466-7. doi: 10.1093/annonc/mdl059. Epub 2006 Apr 26.","Moro C","Ann Oncol","2006","2006/04/28","","","10.1093/annonc/mdl059"
"16639978","Are repeated doses of buprenorphine detrimental to postoperative recovery after laparotomy in rats?","Bomzon A.","Comp Med. 2006 Apr;56(2):114-8.","Bomzon A","Comp Med","2006","2006/04/28","","",""
"16632824","Novel depots of buprenorphine prodrugs have a long-acting antinociceptive effect","Liu KS, Tzeng JI, Chen YW, Huang KL, Kuei CH, Wang JJ.","Anesth Analg. 2006 May;102(5):1445-51. doi: 10.1213/01.ane.0000205747.05693.30.","Liu KS","Anesth Analg","2006","2006/04/25","","","10.1213/01.ane.0000205747.05693.30"
"16628138","The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry","Huang W, Moody DE, McCance-Katz EF.","Ther Drug Monit. 2006 Apr;28(2):245-51. doi: 10.1097/01.ftd.0000197094.92559.b4.","Huang W","Ther Drug Monit","2006","2006/04/22","","","10.1097/01.ftd.0000197094.92559.b4"
"16627307","Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review","Bell J, Mutch C.","Drug Alcohol Rev. 2006 Mar;25(2):167-71. doi: 10.1080/09595230500537670.","Bell J","Drug Alcohol Rev","2006","2006/04/22","","","10.1080/09595230500537670"
"16627306","Retention and attendance with supervised buprenorphine treatment: a case-note review","Bell J, Burrell T.","Drug Alcohol Rev. 2006 Mar;25(2):161-5. doi: 10.1080/09595230500537647.","Bell J","Drug Alcohol Rev","2006","2006/04/22","","","10.1080/09595230500537647"
"16627305","A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance","Caplehorn J, Deeks JJ.","Drug Alcohol Rev. 2006 Mar;25(2):157-60. doi: 10.1080/09595230600681527.","Caplehorn J","Drug Alcohol Rev","2006","2006/04/22","","","10.1080/09595230600681527"
"16627301","Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling","Kornør H, Waal H, Ali RL.","Drug Alcohol Rev. 2006 Mar;25(2):123-30. doi: 10.1080/09595230500537209.","Kornør H","Drug Alcohol Rev","2006","2006/04/22","","","10.1080/09595230500537209"
"16625553","Buprenorphine for the management of opioid withdrawal","Gowing L, Ali R, White J.","Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002025. doi: 10.1002/14651858.CD002025.pub3.","Gowing L","Cochrane Database Syst Rev","2006","2006/04/21","","","10.1002/14651858.CD002025.pub3"
"16620543","Validation of the Immunalysis microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine","Miller EI, Torrance HJ, Oliver JS.","J Anal Toxicol. 2006 Mar;30(2):115-9. doi: 10.1093/jat/30.2.115.","Miller EI","J Anal Toxicol","2006","2006/04/20","","","10.1093/jat/30.2.115"
"16616994","Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply","Greenwald MK, Hursh SR.","Drug Alcohol Depend. 2006 Oct 15;85(1):35-48. doi: 10.1016/j.drugalcdep.2006.03.007. Epub 2006 Apr 17.","Greenwald MK","Drug Alcohol Depend","2006","2006/04/18","","","10.1016/j.drugalcdep.2006.03.007"
"16616162","Effect of opioid substitution therapy on alcohol metabolism","Clark NC, Dietze P, Lenné MG, Redman JR.","J Subst Abuse Treat. 2006 Apr;30(3):191-6. doi: 10.1016/j.jsat.2005.11.010.","Clark NC","J Subst Abuse Treat","2006","2006/04/18","","","10.1016/j.jsat.2005.11.010"
"16612846","[Buprenorphine matrix patch well tolerated. The challenge of tumor pain]","","MMW Fortschr Med. 2006 Jan 12;148(1-2):42-3.","","MMW Fortschr Med","2006","2006/04/14","","",""
"16612211","The place of detoxification in treatment of opioid dependence","Gowing LR, Ali RL.","Curr Opin Psychiatry. 2006 May;19(3):266-70. doi: 10.1097/01.yco.0000218596.54054.a1.","Gowing LR","Curr Opin Psychiatry","2006","2006/04/14","","","10.1097/01.yco.0000218596.54054.a1"
"16610415","[Is anti-hyperalgesia clinically relevant? Dosage increase is hardly necessary]","","MMW Fortschr Med. 2006 Jan 12;148(1-2):43.","","MMW Fortschr Med","2006","2006/04/14","","",""
"16610414","[Erroneous opinions refuted. New knowledge about an old effective substance]","","MMW Fortschr Med. 2006 Jan 12;148(1-2):42.","","MMW Fortschr Med","2006","2006/04/14","","",""
"16604748","Buprenorphine replacement therapy: a confirmed benefit","","Prescrire Int. 2006 Apr;15(82):64-70.","","Prescrire Int","2006","2006/04/12","","",""
"16597570","Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives","Wallen MC, Lorman WJ, Gosciniak JL.","J Addict Dis. 2006;25(1):23-31. doi: 10.1300/J069v25n01_05.","Wallen MC","J Addict Dis","2006","2006/04/07","","","10.1300/J069v25n01_05"
"16595358","Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study","Threlkeld M, Parran TV, Adelman CA, Grey SF, Yu J.","Am J Addict. 2006 Mar-Apr;15(2):186-91. doi: 10.1080/10550490500528712.","Threlkeld M","Am J Addict","2006","2006/04/06","","","10.1080/10550490500528712"
"16583408","Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments","Barratt DT, Coller JK, Somogyi AA.","Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):323-31. doi: 10.1002/ajmg.b.30319.","Barratt DT","Am J Med Genet B Neuropsychiatr Genet","2006","2006/04/04","","","10.1002/ajmg.b.30319"
"16580783","Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats","Ceccarelli I, De Padova AM, Fiorenzani P, Massafra C, Aloisi AM.","Neuroscience. 2006 Jul 7;140(3):929-37. doi: 10.1016/j.neuroscience.2006.02.044. Epub 2006 Apr 3.","Ceccarelli I","Neuroscience","2006","2006/04/04","","","10.1016/j.neuroscience.2006.02.044"
"16574034","A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers","Schmid-Grendelmeier P, Pokorny R, Gasser UE, Richarz U.","Curr Med Res Opin. 2006 Mar;22(3):501-9. doi: 10.1185/030079906X89829.","Schmid-Grendelmeier P","Curr Med Res Opin","2006","2006/04/01","","","10.1185/030079906X89829"
"16573839","Transdermal opioids for cancer pain","Skaer TL.","Health Qual Life Outcomes. 2006 Mar 31;4:24. doi: 10.1186/1477-7525-4-24.","Skaer TL","Health Qual Life Outcomes","2006","2006/04/01","PMC1526423","","10.1186/1477-7525-4-24"
"16572262","Development of tolerance and sensitization to different opioid agonists in rats","Grecksch G, Bartzsch K, Widera A, Becker A, Höllt V, Koch T.","Psychopharmacology (Berl). 2006 Jun;186(2):177-84. doi: 10.1007/s00213-006-0365-8. Epub 2006 Mar 30.","Grecksch G","Psychopharmacology (Berl)","2006","2006/03/31","","","10.1007/s00213-006-0365-8"
"16569757","Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine","Yu G, Yue YJ, Cui MX, Gong ZH.","J Pharmacol Exp Ther. 2006 Jul;318(1):282-7. doi: 10.1124/jpet.105.099937. Epub 2006 Mar 28.","Yu G","J Pharmacol Exp Ther","2006","2006/03/30","","","10.1124/jpet.105.099937"
"16569721","Helping 'them': our role in recovery from opioid dependence","Loxterkamp D.","Ann Fam Med. 2006 Mar-Apr;4(2):168-71. doi: 10.1370/afm.518.","Loxterkamp D","Ann Fam Med","2006","2006/03/30","PMC1467002","","10.1370/afm.518"
"16565573","Suspected takotsubo cardiomyopathy caused by withdrawal of bupirenorphine in a child","Maruyama S, Nomura Y, Fukushige T, Eguchi T, Nishi J, Yoshinaga M, Kawano Y.","Circ J. 2006 Apr;70(4):509-11. doi: 10.1253/circj.70.509.","Maruyama S","Circ J","2006","2006/03/28","","","10.1253/circj.70.509"
"16565164","Buprenorphine activates mu and opioid receptor like-1 receptors simultaneously, but the analgesic effect is mainly mediated by mu receptor activation in the rat formalin test","Yamamoto T, Shono K, Tanabe S.","J Pharmacol Exp Ther. 2006 Jul;318(1):206-13. doi: 10.1124/jpet.105.100859. Epub 2006 Mar 24.","Yamamoto T","J Pharmacol Exp Ther","2006","2006/03/28","","","10.1124/jpet.105.100859"
"16564141","Development of opioid formulations with limited diversion and abuse potential","Fudala PJ, Johnson RE.","Drug Alcohol Depend. 2006 Jun;83 Suppl 1:S40-7. doi: 10.1016/j.drugalcdep.2006.01.016. Epub 2006 Mar 24.","Fudala PJ","Drug Alcohol Depend","2006","2006/03/28","","","10.1016/j.drugalcdep.2006.01.016"
"16554136","Liquid chromatographic-electrospray ionization mass spectrometric quantitative analysis of buprenorphine, norbuprenorphine, nordiazepam and oxazepam in rat plasma","Pirnay S, Hervé F, Bouchonnet S, Perrin B, Baud FJ, Ricordel I.","J Pharm Biomed Anal. 2006 Jun 16;41(4):1135-45. doi: 10.1016/j.jpba.2006.02.020. Epub 2006 Mar 22.","Pirnay S","J Pharm Biomed Anal","2006","2006/03/24","","","10.1016/j.jpba.2006.02.020"
"16550495","Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples","Favretto D, Frison G, Vogliardi S, Ferrara SD.","Rapid Commun Mass Spectrom. 2006;20(8):1257-65. doi: 10.1002/rcm.2444.","Favretto D","Rapid Commun Mass Spectrom","2006","2006/03/22","","","10.1002/rcm.2444"
"16548940","Buprenorphine in pregnancy: the advantages","Nocon JJ.","Addiction. 2006 Apr;101(4):608. doi: 10.1111/j.1360-0443.2006.01360.x.","Nocon JJ","Addiction","2006","2006/03/22","","","10.1111/j.1360-0443.2006.01360.x"
"16547090","Buprenorphine induces ceiling in respiratory depression but not in analgesia","Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M.","Br J Anaesth. 2006 May;96(5):627-32. doi: 10.1093/bja/ael051. Epub 2006 Mar 17.","Dahan A","Br J Anaesth","2006","2006/03/21","","","10.1093/bja/ael051"
"16546629","Intravenous use of buprenorphine tablets associated with rhabdomyolysis and compressive sciatic neuropathy","Seet RC, Lim EC.","Ann Emerg Med. 2006 Apr;47(4):396-7. doi: 10.1016/j.annemergmed.2005.11.044.","Seet RC","Ann Emerg Med","2006","2006/03/21","","","10.1016/j.annemergmed.2005.11.044"
"16544426","Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice","Lindsay DS, Kaur T, Mitchell SM, Goodwin DG, Strobl J, Dubey JP.","J Parasitol. 2005 Dec;91(6):1488-90. doi: 10.1645/GE-732R.1.","Lindsay DS","J Parasitol","2005","2006/03/21","","","10.1645/GE-732R.1"
"16544403","Methadone and buprenorphine added to the WHO list of essential medicines","Herget G.","HIV AIDS Policy Law Rev. 2005 Dec;10(3):23-4.","Herget G","HIV AIDS Policy Law Rev","2005","2006/03/21","","",""
"16536900","Novel depots of buprenorphine have a long-acting effect for the management of physical dependence to morphine","Liu KS, Kao CH, Liu SY, Sung KC, Kuei CH, Wang JJ.","J Pharm Pharmacol. 2006 Mar;58(3):337-44. doi: 10.1211/jpp.58.3.0007.","Liu KS","J Pharm Pharmacol","2006","2006/03/16","","","10.1211/jpp.58.3.0007"
"16536895","In-vitro and in-vivo characterization of a buprenorphine delivery system","Kleppner SR, Patel R, McDonough J, Costantini LC.","J Pharm Pharmacol. 2006 Mar;58(3):295-302. doi: 10.1211/jpp.58.3.0002.","Kleppner SR","J Pharm Pharmacol","2006","2006/03/16","","","10.1211/jpp.58.3.0002"
"16533497","Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system","Ciccocioppo R, Economidou D, Rimondini R, Sommer W, Massi M, Heilig M.","Biol Psychiatry. 2007 Jan 1;61(1):4-12. doi: 10.1016/j.biopsych.2006.01.006. Epub 2006 Mar 14.","Ciccocioppo R","Biol Psychiatry","2007","2006/03/15","PMC3035814","NIHMS266996","10.1016/j.biopsych.2006.01.006"
"16524668","Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine","Ponizovsky AM, Grinshpoon A, Margolis A, Cohen R, Rosca P.","Addict Behav. 2006 Nov;31(11):2002-13. doi: 10.1016/j.addbeh.2006.01.014. Epub 2006 Mar 9.","Ponizovsky AM","Addict Behav","2006","2006/03/10","","","10.1016/j.addbeh.2006.01.014"
"16524662","Anti-hyperalgesia properties of buprenorphine","Russo MA.","Pain. 2006 May;122(1-2):216; author reply 216. doi: 10.1016/j.pain.2006.01.024. Epub 2006 Mar 9.","Russo MA","Pain","2006","2006/03/10","","","10.1016/j.pain.2006.01.024"
"16515317","[Quality assurance in patient addiction treated with drug substitution]","","Krankenpfl J. 2005;43(7-10):248.","","Krankenpfl J","2005","2006/03/07","","",""
"16514314","Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir","Bruce RD, Altice FL.","AIDS. 2006 Mar 21;20(5):783-4. doi: 10.1097/01.aids.0000216384.22432.9a.","Bruce RD","AIDS","2006","2006/03/04","","","10.1097/01.aids.0000216384.22432.9a"
"16507617","Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients","Baker JR, Best AM, Pade PA, McCance-Katz EF.","Ann Pharmacother. 2006 Mar;40(3):392-6. doi: 10.1345/aph.1G524. Epub 2006 Feb 28.","Baker JR","Ann Pharmacother","2006","2006/03/02","","","10.1345/aph.1G524"
"16502886","AOD expertise","Emerton T.","Aust Nurs J. 2005 May;12(10):3.","Emerton T","Aust Nurs J","2005","2006/03/01","","",""
"16499515","An injection depot formulation of buprenorphine: extended bio-delivery and effects","Sigmon SC, Moody DE, Nuwayser ES, Bigelow GE.","Addiction. 2006 Mar;101(3):420-32. doi: 10.1111/j.1360-0443.2006.01348.x.","Sigmon SC","Addiction","2006","2006/02/28","","","10.1111/j.1360-0443.2006.01348.x"
"16493560","[No potentiation of fentanyl by use of transdermal buprenorphine in patients undergoing fast-track anesthesia for open-heart surgery]","Freye E, Hartung E, Levy JV.","Anasthesiol Intensivmed Notfallmed Schmerzther. 2006 Feb;41(2):86-92. doi: 10.1055/s-2005-870501.","Freye E","Anasthesiol Intensivmed Notfallmed Schmerzther","2006","2006/02/24","","","10.1055/s-2005-870501"
"16493349","[Addictive behavior after starting buprenorphine maintenance treatment]","Fanello S, Daoud S, Panici JY, Parot E, Hitoto H, Garnier F.","Presse Med. 2006 Feb;35(2 Pt 1):212-8. doi: 10.1016/s0755-4982(06)74556-0.","Fanello S","Presse Med","2006","2006/02/24","","","10.1016/s0755-4982(06)74556-0"
"16493098","Detoxification and treating opioid dependence","de Jong CJ.","JAMA. 2006 Feb 22;295(8):887; author reply 887-8. doi: 10.1001/jama.295.8.887-a.","de Jong CJ","JAMA","2006","2006/02/24","","","10.1001/jama.295.8.887-a"
"16493097","Detoxification and treating opioid dependence","Contreras JA.","JAMA. 2006 Feb 22;295(8):886-7; author reply 887-8. doi: 10.1001/jama.295.8.886-b.","Contreras JA","JAMA","2006","2006/02/24","","","10.1001/jama.295.8.886-b"
"16493096","Heroin detoxification","Favrat B, Besson J.","JAMA. 2006 Feb 22;295(8):885; author reply 886. doi: 10.1001/jama.295.8.885-a.","Favrat B","JAMA","2006","2006/02/24","","","10.1001/jama.295.8.885-a"
"16493095","Heroin detoxification","Miller MM.","JAMA. 2006 Feb 22;295(8):885-6; author reply 886. doi: 10.1001/jama.295.8.885-b.","Miller MM","JAMA","2006","2006/02/24","","","10.1001/jama.295.8.885-b"
"16492659","Provider satisfaction with office-based treatment of opioid dependence: a systematic review","Becker WC, Fiellin DA.","Subst Abus. 2005 Mar;26(1):15-22. doi: 10.1300/j465v26n01_02.","Becker WC","Subst Abus","2005","2006/02/24","","","10.1300/j465v26n01_02"
"16491894","[Effects of continuous infusion of landiolol on the hemodynamic response to tracheal intubation]","Onaka M, Yamamoto H.","Masui. 2006 Feb;55(2):174-8.","Onaka M","Masui","2006","2006/02/24","","",""
"16490679","Slow tapering from methadone maintenance in a program encouraging indefinite maintenance","Calsyn DA, Malcy JA, Saxon AJ.","J Subst Abuse Treat. 2006 Mar;30(2):159-63. doi: 10.1016/j.jsat.2005.11.007.","Calsyn DA","J Subst Abuse Treat","2006","2006/02/24","","","10.1016/j.jsat.2005.11.007"
"16490191","Reversibility of opioid receptor occupancy of buprenorphine in vivo","Englberger W, Kögel B, Friderichs E, Strassburger W, Germann T.","Eur J Pharmacol. 2006 Mar 18;534(1-3):95-102. doi: 10.1016/j.ejphar.2006.01.022. Epub 2006 Feb 21.","Englberger W","Eur J Pharmacol","2006","2006/02/24","","","10.1016/j.ejphar.2006.01.022"
"16475644","[Transdermal buprenorphine and silent acute coronary syndrome]","Vidal MA, Calderón E, Pernia A, Calderón-Pla E, Torres LM.","Rev Esp Anestesiol Reanim. 2006 Jan;53(1):58-9.","Vidal MA","Rev Esp Anestesiol Reanim","2006","2006/02/16","","",""
"16468244","[Abuse of buprenorphine becomes a problem of the Czech Republic]","Nespor K, Csémy L.","Cas Lek Cesk. 2006;145(1):59-60.","Nespor K","Cas Lek Cesk","2006","2006/02/14","","",""
"16464448","Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice","Mori T, Ito S, Kita T, Narita M, Suzuki T, Sawaguchi T.","Eur J Pharmacol. 2006 Feb 17;532(1-2):81-7. doi: 10.1016/j.ejphar.2005.12.035. Epub 2006 Feb 7.","Mori T","Eur J Pharmacol","2006","2006/02/09","","","10.1016/j.ejphar.2005.12.035"
"16456085","Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone","Negus SS.","J Pharmacol Exp Ther. 2006 May;317(2):711-23. doi: 10.1124/jpet.105.095380. Epub 2006 Feb 2.","Negus SS","J Pharmacol Exp Ther","2006","2006/02/04","","","10.1124/jpet.105.095380"
"16455059","The effect of methadone and buprenorphine on human placental aromatase","Zharikova OL, Deshmukh SV, Nanovskaya TN, Hankins GD, Ahmed MS.","Biochem Pharmacol. 2006 Apr 14;71(8):1255-64. doi: 10.1016/j.bcp.2005.12.035. Epub 2006 Feb 7.","Zharikova OL","Biochem Pharmacol","2006","2006/02/04","","","10.1016/j.bcp.2005.12.035"
"16452993","Unlimited access to heroin self-administration: independent motivational markers of opiate dependence","Chen SA, O'Dell LE, Hoefer ME, Greenwell TN, Zorrilla EP, Koob GF.","Neuropsychopharmacology. 2006 Dec;31(12):2692-707. doi: 10.1038/sj.npp.1301008. Epub 2006 Jan 25.","Chen SA","Neuropsychopharmacology","2006","2006/02/03","","","10.1038/sj.npp.1301008"
"16450639","Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians","Coffin PO, Blaney S, Fuller C, Vadnai L, Miller S, Vlahov D.","Am J Drug Alcohol Abuse. 2006;32(1):1-6. doi: 10.1080/00952990500328455.","Coffin PO","Am J Drug Alcohol Abuse","2006","2006/02/03","","","10.1080/00952990500328455"
"16450597","An esterification method for synthesizing prodrugs of buprenorphine","Chin LS, Huang KL, Liu KS, Chu CC, Tzeng JI, Ho ST, Wang JJ.","Acta Anaesthesiol Taiwan. 2005 Dec;43(4):223-9.","Chin LS","Acta Anaesthesiol Taiwan","2005","2006/02/03","","",""
"16449094","Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study","Jones HE, Suess P, Jasinski DR, Johnson RE.","Am J Addict. 2006 Jan-Feb;15(1):61-70. doi: 10.1080/10550490500419094.","Jones HE","Am J Addict","2006","2006/02/02","","","10.1080/10550490500419094"
"16449087","Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?","Caldiero RM, Parran TV Jr, Adelman CL, Piche B.","Am J Addict. 2006 Jan-Feb;15(1):1-7. doi: 10.1080/10550490500418989.","Caldiero RM","Am J Addict","2006","2006/02/02","","","10.1080/10550490500418989"
"16447120","Models for integrating buprenorphine therapy into the primary HIV care setting","Basu S, Smith-Rohrberg D, Bruce RD, Altice FL.","Clin Infect Dis. 2006 Mar 1;42(5):716-21. doi: 10.1086/500200. Epub 2006 Jan 24.","Basu S","Clin Infect Dis","2006","2006/02/01","","","10.1086/500200"
"16445556","Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study","Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H.","Addiction. 2006 Feb;101(2):275-81. doi: 10.1111/j.1360-0443.2006.01321.x.","Fischer G","Addiction","2006","2006/02/01","","","10.1111/j.1360-0443.2006.01321.x"
"16434562","Role of buprenorphine in the management of heroin addiction","Sung S, Conry JM.","Ann Pharmacother. 2006 Mar;40(3):501-5. doi: 10.1345/aph.1G276. Epub 2006 Jan 24.","Sung S","Ann Pharmacother","2006","2006/01/26","","","10.1345/aph.1G276"
"16432270","Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials","Ciraulo DA, Hitzemann RJ, Somoza E, Knapp CM, Rotrosen J, Sarid-Segal O, Ciraulo AM, Greenblatt DJ, Chiang CN.","J Clin Pharmacol. 2006 Feb;46(2):179-92. doi: 10.1177/0091270005284192.","Ciraulo DA","J Clin Pharmacol","2006","2006/01/25","","","10.1177/0091270005284192"
"16426877","Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine","Filitz J, Griessinger N, Sittl R, Likar R, Schüttler J, Koppert W.","Eur J Pain. 2006 Nov;10(8):743-8. doi: 10.1016/j.ejpain.2005.12.001. Epub 2006 Jan 19.","Filitz J","Eur J Pain","2006","2006/01/24","","","10.1016/j.ejpain.2005.12.001"
"16426168","Evaluation of signs of postoperative pain and complications after forelimb onychectomy in cats receiving buprenorphine alone or with bupivacaine administered as a four-point regional nerve block","Curcio K, Bidwell LA, Bohart GV, Hauptman JG.","J Am Vet Med Assoc. 2006 Jan 1;228(1):65-8. doi: 10.2460/javma.228.1.65.","Curcio K","J Am Vet Med Assoc","2006","2006/01/24","","","10.2460/javma.228.1.65"
"16418412","Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","Alford DP, Compton P, Samet JH.","Ann Intern Med. 2006 Jan 17;144(2):127-34. doi: 10.7326/0003-4819-144-2-200601170-00010.","Alford DP","Ann Intern Med","2006","2006/01/19","PMC1892816","NIHMS17732","10.7326/0003-4819-144-2-200601170-00010"
"16413702","Pharmaco-economics of community maintenance for opiate dependence: a review of evidence and methodology","Simoens S, Ludbrook A, Matheson C, Bond C.","Drug Alcohol Depend. 2006 Sep 1;84(1):28-39. doi: 10.1016/j.drugalcdep.2005.12.009. Epub 2006 Jan 18.","Simoens S","Drug Alcohol Depend","2006","2006/01/18","","","10.1016/j.drugalcdep.2005.12.009"
"16413146","Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability","Koch AL, Arfken CL, Schuster CR.","Drug Alcohol Depend. 2006 Jul 27;83(3):274-8. doi: 10.1016/j.drugalcdep.2005.12.005. Epub 2006 Jan 18.","Koch AL","Drug Alcohol Depend","2006","2006/01/18","","","10.1016/j.drugalcdep.2005.12.005"
"16401652","Naltrexone and buprenorphine combination in the treatment of opioid dependence","Gerra G, Fantoma A, Zaimovic A.","J Psychopharmacol. 2006 Nov;20(6):806-14. doi: 10.1177/0269881106060835. Epub 2006 Jan 9.","Gerra G","J Psychopharmacol","2006","2006/01/13","","","10.1177/0269881106060835"
"16393744","Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants","Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.","Subst Use Misuse. 2006;41(2):223-44. doi: 10.1080/10826080500391845.","Giacomuzzi S","Subst Use Misuse","2006","2006/01/06","","","10.1080/10826080500391845"
"16391920","[Buprenorphine in children. A clinical and pharmacological review]","Michel E, Zernikow B.","Schmerz. 2006 Feb;20(1):40-50. doi: 10.1007/s00482-005-0456-1.","Michel E","Schmerz","2006","2006/01/05","","","10.1007/s00482-005-0456-1"
"16381669","Novel metabolites of buprenorphine detected in human liver microsomes and human urine","Chang Y, Moody DE, McCance-Katz EF.","Drug Metab Dispos. 2006 Mar;34(3):440-8. doi: 10.1124/dmd.105.006148. Epub 2005 Dec 28.","Chang Y","Drug Metab Dispos","2006","2005/12/31","","","10.1124/dmd.105.006148"
"16379630","Comparison of oral and subcutaneous administration of buprenorphine and meloxicam for preemptive analgesia in cats undergoing ovariohysterectomy","Gassel AD, Tobias KM, Egger CM, Rohrbach BW.","J Am Vet Med Assoc. 2005 Dec 15;227(12):1937-44. doi: 10.2460/javma.2005.227.1937.","Gassel AD","J Am Vet Med Assoc","2005","2005/12/29","","","10.2460/javma.2005.227.1937"
"16367987","A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial","Raistrick D, West D, Finnegan O, Thistlethwaite G, Brearley R, Banbery J.","Addiction. 2005 Dec;100(12):1860-7. doi: 10.1111/j.1360-0443.2005.01273.x.","Raistrick D","Addiction","2005","2005/12/22","","","10.1111/j.1360-0443.2005.01273.x"
"16366759","Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence","Marsch LA, Stephens MA, Mudric T, Strain EC, Bigelow GE, Johnson RE.","Exp Clin Psychopharmacol. 2005 Nov;13(4):293-302. doi: 10.1037/1064-1297.13.4.293.","Marsch LA","Exp Clin Psychopharmacol","2005","2005/12/22","","","10.1037/1064-1297.13.4.293"
"16365961","Canadian developments. Buprenorphine now approved for the treatment of opiate addiction","Garmaise D.","HIV AIDS Policy Law Rev. 2005 Aug;10(2):20, 22.","Garmaise D","HIV AIDS Policy Law Rev","2005","2005/12/22","","",""
"16356333","Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment","Böttcher M, Beck O.","J Anal Toxicol. 2005 Nov-Dec;29(8):769-76. doi: 10.1093/jat/29.8.769.","Böttcher M","J Anal Toxicol","2005","2005/12/17","","","10.1093/jat/29.8.769"
"16343811","Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies","Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, Diana M.","Drug Alcohol Depend. 2006 Jun 28;83(2):163-8. doi: 10.1016/j.drugalcdep.2005.11.008. Epub 2005 Dec 15.","Pirastu R","Drug Alcohol Depend","2006","2005/12/14","","","10.1016/j.drugalcdep.2005.11.008"
"16343809","One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)","Teesson M, Ross J, Darke S, Lynskey M, Ali R, Ritter A, Cooke R.","Drug Alcohol Depend. 2006 Jun 28;83(2):174-80. doi: 10.1016/j.drugalcdep.2005.11.009. Epub 2005 Dec 15.","Teesson M","Drug Alcohol Depend","2006","2005/12/14","","","10.1016/j.drugalcdep.2005.11.009"
"16339224","Is methadone too dangerous for opiate addiction?","Luty J, O'Gara C, Sessay M.","BMJ. 2005 Dec 10;331(7529):1352-3. doi: 10.1136/bmj.331.7529.1352.","Luty J","BMJ","2005","2005/12/13","PMC1309631","","10.1136/bmj.331.7529.1352"
"16324802","Simulated opioid withdrawal engenders risk-prone choice: a comparison of intravenous and intranasal-using populations","Kirshenbaum AP, Bickel WK, Boynton DM.","Drug Alcohol Depend. 2006 Jun 28;83(2):130-6. doi: 10.1016/j.drugalcdep.2005.11.002. Epub 2005 Dec 1.","Kirshenbaum AP","Drug Alcohol Depend","2006","2005/12/06","","","10.1016/j.drugalcdep.2005.11.002"
"16318959","Opioid plasma concentrations in methadone-and buprenorphine-maintained patients","Jagsch R, Gombas W, Schindler SD, Eder H, Moody DE, Fischer G.","Addict Biol. 2005 Dec;10(4):365-71. doi: 10.1080/13556210500358441.","Jagsch R","Addict Biol","2005","2005/12/02","","","10.1080/13556210500358441"
"16316789","Enriched analgesic efficacy studies: an assessment by clinical trial simulation","Lemmens HJ, Wada DR, Munera C, Eltahtawy A, Stanski DR.","Contemp Clin Trials. 2006 Apr;27(2):165-73. doi: 10.1016/j.cct.2005.10.005. Epub 2005 Nov 28.","Lemmens HJ","Contemp Clin Trials","2006","2005/12/01","","","10.1016/j.cct.2005.10.005"
"16311183","Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms","Chawarski MC, Moody DE, Pakes J, O'Connor PG, Schottenfeld RS.","J Subst Abuse Treat. 2005 Dec;29(4):307-12. doi: 10.1016/j.jsat.2005.08.011.","Chawarski MC","J Subst Abuse Treat","2005","2005/11/29","","","10.1016/j.jsat.2005.08.011"
"16309810","Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study","Gerra G, Leonardi C, D'Amore A, Strepparola G, Fagetti R, Assi C, Zaimovic A, Lucchini A.","Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):265-72. doi: 10.1016/j.pnpbp.2005.10.007. Epub 2005 Nov 23.","Gerra G","Prog Neuropsychopharmacol Biol Psychiatry","2006","2005/11/29","","","10.1016/j.pnpbp.2005.10.007"
"16309376","Buprenorphine detection in biological samples","De Giovanni N, Fucci N, Scarlata S, Donzelli G.","Clin Chem Lab Med. 2005;43(12):1377-9. doi: 10.1515/CCLM.2005.235.","De Giovanni N","Clin Chem Lab Med","2005","2005/11/29","","","10.1515/CCLM.2005.235"
"16307630","Buprenorphine retention in primary care","Stein MD, Cioe P, Friedmann PD.","J Gen Intern Med. 2005 Nov;20(11):1038-41. doi: 10.1111/j.1525-1497.2005.0228.x.","Stein MD","J Gen Intern Med","2005","2005/11/26","PMC1490248","","10.1111/j.1525-1497.2005.0228.x"
"16298835","The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS)","Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R.","Drug Alcohol Rev. 2005 Sep;24(5):411-8. doi: 10.1080/09595230500286039.","Ross J","Drug Alcohol Rev","2005","2005/11/22","","","10.1080/09595230500286039"
"16294560","Allowing physicians to treat those in need a significant step forward","Soper RG.","Tenn Med. 2005 Oct;98(10):464.","Soper RG","Tenn Med","2005","2005/11/22","","",""
"16288738","Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol","Cichewicz DL, Welch SP, Smith FL.","Eur J Pharmacol. 2005 Nov 21;525(1-3):74-82. doi: 10.1016/j.ejphar.2005.09.039. Epub 2005 Nov 8.","Cichewicz DL","Eur J Pharmacol","2005","2005/11/18","","","10.1016/j.ejphar.2005.09.039"
"16284682","Severe upper limb complications from parenteral abuse of Subutex","Loo HW, Yam AK, Tan TC, Peng YP, Teoh LC.","Ann Acad Med Singapore. 2005 Oct;34(9):575-8.","Loo HW","Ann Acad Med Singapore","2005","2005/11/15","","",""
"16283207","[Transdermal buprenorphine during pregnancy]","Ebner E, Wiedmann M.","Schmerz. 2006 Aug;20(4):334-7. doi: 10.1007/s00482-005-0445-4.","Ebner E","Schmerz","2006","2005/11/12","","","10.1007/s00482-005-0445-4"
"16269137","Clorazepate affects cell surface regulation of delta and kappa opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain","Quentin T, Debruyne D, Lelong-Boulouard V, Poisnel G, Barre L, Coquerel A.","Brain Res. 2005 Nov 23;1063(1):84-95. doi: 10.1016/j.brainres.2005.09.013. Epub 2005 Nov 2.","Quentin T","Brain Res","2005","2005/11/05","","","10.1016/j.brainres.2005.09.013"
"16265622","Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents","McCance-Katz EF.","Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S89-95. doi: 10.1086/429503.","McCance-Katz EF","Clin Infect Dis","2005","2005/11/03","","","10.1086/429503"
"16257138","Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution","Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S; Groupe d'Etudes Grossesse et Addictions (GEGA).","Drug Alcohol Depend. 2006 May 20;82(3):250-7. doi: 10.1016/j.drugalcdep.2005.10.001. Epub 2005 Oct 27.","Lejeune C","Drug Alcohol Depend","2006","2005/11/01","","","10.1016/j.drugalcdep.2005.10.001"
"16251822","Integration of pharmacotherapy for opioid addiction into HIV primary care for HIV/hepatitis C virus-co-infected patients","Kresina TF, Eldred L, Bruce RD, Francis H.","AIDS. 2005 Oct;19 Suppl 3:S221-6. doi: 10.1097/01.aids.0000192093.46506.e5.","Kresina TF","AIDS","2005","2005/10/28","","","10.1097/01.aids.0000192093.46506.e5"
"16251550","Potential for abuse of buprenorphine in office-based treatment of opioid dependence","Cicero TJ, Inciardi JA.","N Engl J Med. 2005 Oct 27;353(17):1863-5. doi: 10.1056/NEJM200510273531724.","Cicero TJ","N Engl J Med","2005","2005/10/28","","","10.1056/NEJM200510273531724"
"16230961","[Collaboration between general practitioners and pharmacists in the management of patients on high-dosage buprenorphine treatment. Prescribers' practices]","Feroni I, Aubisson S, Bouhnik AD, Paraponaris A, Masut A, Coudert C, Obadia Y.","Presse Med. 2005 Oct 8;34(17):1213-9. doi: 10.1016/s0755-4982(05)84159-4.","Feroni I","Presse Med","2005","2005/10/19","","","10.1016/s0755-4982(05)84159-4"
"16225076","Cytogenetic aspects of buprenorphine maintenance treatment program--preliminary report","Piatek P, Pach D, Kamenczak A, Schmager J.","Przegl Lek. 2005;62(6):391-3.","Piatek P","Przegl Lek","2005","2005/10/18","","",""
"16224834","Opiate maintenance alternatives: new studies","","Harv Ment Health Lett. 2005 Sep;22(3):6.","","Harv Ment Health Lett","2005","2005/10/18","","",""
"16207308","PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration","Robertson SA, Lascelles BD, Taylor PM, Sear JW.","J Vet Pharmacol Ther. 2005 Oct;28(5):453-60. doi: 10.1111/j.1365-2885.2005.00677.x.","Robertson SA","J Vet Pharmacol Ther","2005","2005/10/07","","","10.1111/j.1365-2885.2005.00677.x"
"16203962","Adolescent opioid abuse","O'Brien CP.","Arch Gen Psychiatry. 2005 Oct;62(10):1165. doi: 10.1001/archpsyc.62.10.1165.","O'Brien CP","Arch Gen Psychiatry","2005","2005/10/06","","","10.1001/archpsyc.62.10.1165"
"16203961","Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial","Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.","Arch Gen Psychiatry. 2005 Oct;62(10):1157-64. doi: 10.1001/archpsyc.62.10.1157.","Marsch LA","Arch Gen Psychiatry","2005","2005/10/06","","","10.1001/archpsyc.62.10.1157"
"16202525","Opioids: from analgesia to anti-hyperalgesia?","Simonnet G.","Pain. 2005 Nov;118(1-2):8-9. doi: 10.1016/j.pain.2005.07.021. Epub 2005 Oct 3.","Simonnet G","Pain","2005","2005/10/06","","","10.1016/j.pain.2005.07.021"
"16191669","Low efficacy of non-opioid drugs in opioid withdrawal symptoms","Hermann D, Klages E, Welzel H, Mann K, Croissant B.","Addict Biol. 2005 Jun;10(2):165-9. doi: 10.1080/13556210500123514.","Hermann D","Addict Biol","2005","2005/09/30","","","10.1080/13556210500123514"
"16191668","Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone","Seifert J, Metzner C, Paetzold W, Borsutzky M, Ohlmeier M, Passie T, Hauser U, Becker H, Wiese B, Emrich H, Schneider U.","Addict Biol. 2005 Jun;10(2):157-64. doi: 10.1080/13556210500123191.","Seifert J","Addict Biol","2005","2005/09/30","","","10.1080/13556210500123191"
"16191667","Induction of patients with moderately severe methadone dependence onto buprenorphine","Glasper A, Reed LJ, de Wet CJ, Gossop M, Bearn J.","Addict Biol. 2005 Jun;10(2):149-55. doi: 10.1080/13556210500123126.","Glasper A","Addict Biol","2005","2005/09/30","","","10.1080/13556210500123126"
"16186090","Public policy statement on Office-Based Opioid Agonist Treatment (OBOT)","","J Addict Dis. 2005;24(3):153-61. doi: 10.1300/J069v24n03_12.","","J Addict Dis","2005","2005/09/28","","","10.1300/J069v24n03_12"
"16186080","French general practitioners' attitudes and prescription patterns toward buprenorphine maintenance treatment: does doctor shopping reflect buprenorphine misuse?","Feroni I, Peretti-Watel P, Paraponaris A, Masut A, Ronfle E, Mabriez JC, Obadia Y.","J Addict Dis. 2005;24(3):7-22. doi: 10.1300/J069v24n03_02.","Feroni I","J Addict Dis","2005","2005/09/28","","","10.1300/J069v24n03_02"
"16186079","Maintenance for opioid addiction with buprenorphine and methadone: ""The only thing new in the world is the history you don't know""","Stimmel B.","J Addict Dis. 2005;24(3):1-6. doi: 10.1300/J069v24n03_01.","Stimmel B","J Addict Dis","2005","2005/09/28","","","10.1300/J069v24n03_01"
"16172091","Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence","Wong JG, Holmboe ES, Jara GB, Martin J, Becker WC, Fiellin DA.","Subst Abus. 2004 Dec;25(4):35-40. doi: 10.1300/j465v25n04_05.","Wong JG","Subst Abus","2004","2005/09/21","","","10.1300/j465v25n04_05"
"16169027","Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation","Mégarbane B, Marie N, Pirnay S, Borron SW, Gueye PN, Risède P, Monier C, Noble F, Baud FJ.","Toxicol Appl Pharmacol. 2006 May 1;212(3):256-67. doi: 10.1016/j.taap.2005.08.002. Epub 2005 Sep 16.","Mégarbane B","Toxicol Appl Pharmacol","2006","2005/09/20","","","10.1016/j.taap.2005.08.002"
"16168181","Hydrolysis of conjugated metabolites of buprenorphine II. The quantitative enzymatic hydrolysis of norbuprenorphine-3-beta-D-glucuronide in human urine","Elsohly MA, Gul W, Feng S, Murphy TP.","J Anal Toxicol. 2005 Sep;29(6):570-3. doi: 10.1093/jat/29.6.570.","Elsohly MA","J Anal Toxicol","2005","2005/09/20","","","10.1093/jat/29.6.570"
"16165125","[(3)H]Alvimopan binding to the micro opioid receptor: comparative binding kinetics of opioid antagonists","Cassel JA, Daubert JD, DeHaven RN.","Eur J Pharmacol. 2005 Sep 27;520(1-3):29-36. doi: 10.1016/j.ejphar.2005.08.008.","Cassel JA","Eur J Pharmacol","2005","2005/09/17","","","10.1016/j.ejphar.2005.08.008"
"16160628","Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial","Soyka M, Hock B, Kagerer S, Lehnert R, Limmer C, Kuefner H.","J Clin Psychopharmacol. 2005 Oct;25(5):490-3. doi: 10.1097/01.jcp.0000178417.60426.60.","Soyka M","J Clin Psychopharmacol","2005","2005/09/15","","","10.1097/01.jcp.0000178417.60426.60"
"16159743","Cutaneous complications of direct intra-arterial injections in drug addicts","Del Giudice P, Vandenbos F, Boissy C, Cua E, Marion B, Bernard E, Dellamonica P, Counillon E.","Acta Derm Venereol. 2005;85(5):451-2. doi: 10.1080/00015550510033192.","Del Giudice P","Acta Derm Venereol","2005","2005/09/15","","","10.1080/00015550510033192"
"16158910","Duration of effects on clinical parameters and referred hyperalgesia in rats after abdominal surgery and multiple doses of analgesic","Cooper DM, Hoffman W, Wheat N, Lee HY.","Comp Med. 2005 Aug;55(4):344-53.","Cooper DM","Comp Med","2005","2005/09/15","","",""
"16154698","Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model","Koppert W, Ihmsen H, Körber N, Wehrfritz A, Sittl R, Schmelz M, Schüttler J.","Pain. 2005 Nov;118(1-2):15-22. doi: 10.1016/j.pain.2005.06.030. Epub 2005 Sep 9.","Koppert W","Pain","2005","2005/09/13","","","10.1016/j.pain.2005.06.030"
"16154481","Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study","Sittl R, Nuijten M, Nautrup BP.","Clin Ther. 2005 Jul;27(7):1022-31. doi: 10.1016/j.clinthera.2005.06.024.","Sittl R","Clin Ther","2005","2005/09/13","","","10.1016/j.clinthera.2005.06.024"
"16148422","Sublingual buprenorphine is effective in the treatment of chronic pain syndrome","Malinoff HL, Barkin RL, Wilson G.","Am J Ther. 2005 Sep-Oct;12(5):379-84. doi: 10.1097/01.mjt.0000160935.62883.ff.","Malinoff HL","Am J Ther","2005","2005/09/09","","","10.1097/01.mjt.0000160935.62883.ff"
"16144974","Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals","Comer SD, Sullivan MA, Walker EA.","J Pharmacol Exp Ther. 2005 Dec;315(3):1320-30. doi: 10.1124/jpet.105.090423. Epub 2005 Sep 6.","Comer SD","J Pharmacol Exp Ther","2005","2005/09/08","PMC4079467","NIHMS516232","10.1124/jpet.105.090423"
"16144748","Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine","Compton P, Ling W, Moody D, Chiang N.","Drug Alcohol Depend. 2006 Mar 15;82(1):25-31. doi: 10.1016/j.drugalcdep.2005.08.005. Epub 2005 Sep 6.","Compton P","Drug Alcohol Depend","2006","2005/09/08","","","10.1016/j.drugalcdep.2005.08.005"
"16139189","Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice","Kögel B, Christoph T, Strassburger W, Friderichs E.","Eur J Pain. 2005 Oct;9(5):599-611. doi: 10.1016/j.ejpain.2005.02.002.","Kögel B","Eur J Pain","2005","2005/09/06","","","10.1016/j.ejpain.2005.02.002"
"16139186","Opioid switch in palliative care, opioid choice by clinical need and opioid availability","Müller-Busch HC, Lindena G, Tietze K, Woskanjan S.","Eur J Pain. 2005 Oct;9(5):571-9. doi: 10.1016/j.ejpain.2004.12.003. Epub 2005 Jan 20.","Müller-Busch HC","Eur J Pain","2005","2005/09/06","","","10.1016/j.ejpain.2004.12.003"
"16135338","Buprenorphine diffusion: the attitudes of substance abuse treatment counselors","Knudsen HK, Ducharme LJ, Roman PM, Link T.","J Subst Abuse Treat. 2005 Sep;29(2):95-106. doi: 10.1016/j.jsat.2005.05.002.","Knudsen HK","J Subst Abuse Treat","2005","2005/09/02","","","10.1016/j.jsat.2005.05.002"
"16135206","Effects of pre- versus post-anaesthetic buprenorphine on propofol-anaesthetized rats","Penderis J, Franklin RJ.","Vet Anaesth Analg. 2005 Sep;32(5):256-60. doi: 10.1111/j.1467-2995.2005.00183.x.","Penderis J","Vet Anaesth Analg","2005","2005/09/02","","","10.1111/j.1467-2995.2005.00183.x"
"16128730","Trends in prescribing of buprenorphine","Bearn J, de Wet C, Reed L.","Addiction. 2005 Sep;100(9):1374-5. doi: 10.1111/j.1360-0443.2005.01240.x.","Bearn J","Addiction","2005","2005/09/01","","","10.1111/j.1360-0443.2005.01240.x"
"16128729","Buprenorphine prescription and the increased relative cost","Alvarez FJ, Gonzalez-Saiz F.","Addiction. 2005 Sep;100(9):1373-4. doi: 10.1111/j.1360-0443.2005.01211.x.","Alvarez FJ","Addiction","2005","2005/09/01","","","10.1111/j.1360-0443.2005.01211.x"
"16118388","Methods of detoxification and their role in treating patients with opioid dependence","O'Connor PG.","JAMA. 2005 Aug 24;294(8):961-3. doi: 10.1001/jama.294.8.961.","O'Connor PG","JAMA","2005","2005/08/25","","","10.1001/jama.294.8.961"
"16118380","Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial","Collins ED, Kleber HD, Whittington RA, Heitler NE.","JAMA. 2005 Aug 24;294(8):903-13. doi: 10.1001/jama.294.8.903.","Collins ED","JAMA","2005","2005/08/25","","","10.1001/jama.294.8.903"
"16118361","Buprenorphine for office-based treatment of patients with opioid addiction","Manlandro JJ Jr.","J Am Osteopath Assoc. 2005 Jun;105(6 Suppl 3):S8-13.","Manlandro JJ Jr","J Am Osteopath Assoc","2005","2005/08/25","","",""
"16107991","Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence","Sullivan LE, Fiellin DA.","Clin Infect Dis. 2005 Sep 15;41(6):891-6. doi: 10.1086/432888. Epub 2005 Aug 10.","Sullivan LE","Clin Infect Dis","2005","2005/08/19","","","10.1086/432888"
"16105995","Office-based treatment for opioid addiction achieving goals","Kuehn BM.","JAMA. 2005 Aug 17;294(7):784-6. doi: 10.1001/jama.294.7.784.","Kuehn BM","JAMA","2005","2005/08/18","","","10.1001/jama.294.7.784"
"16102374","Examining the influence of drop-outs in a follow-up of maintained opiate users","Encrenaz G, Rondeau V, Messiah A, Auriacombe M.","Drug Alcohol Depend. 2005 Sep 1;79(3):303-10. doi: 10.1016/j.drugalcdep.2005.01.021. Epub 2005 Mar 31.","Encrenaz G","Drug Alcohol Depend","2005","2005/08/17","","","10.1016/j.drugalcdep.2005.01.021"
"16097397","Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study","Wittchen HU, Apelt SM, Bühringer G, Gastpar M, Backmund M, Gölz J, Kraus MR, Tretter F, Klotsche J, Siegert J, Pittrow D, Soyka M.","Int J Methods Psychiatr Res. 2005;14(1):14-28. doi: 10.1002/mpr.14.","Wittchen HU","Int J Methods Psychiatr Res","2005","2005/08/16","PMC6878433","","10.1002/mpr.14"
"16096130","From opioid maintenance to abstinence: a literature review","Kornør H, Waal H.","Drug Alcohol Rev. 2005 May;24(3):267-74. doi: 10.1080/09595230500170241.","Kornør H","Drug Alcohol Rev","2005","2005/08/13","","","10.1080/09595230500170241"
"16087826","Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence","Turner BJ, Laine C, Lin YT, Lynch K.","Arch Intern Med. 2005 Aug 8-22;165(15):1769-76. doi: 10.1001/archinte.165.15.1769.","Turner BJ","Arch Intern Med","2005","2005/08/10","","","10.1001/archinte.165.15.1769"
"16083522","Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients","Griessinger N, Sittl R, Likar R.","Curr Med Res Opin. 2005 Aug;21(8):1147-56. doi: 10.1185/030079905X53315.","Griessinger N","Curr Med Res Opin","2005","2005/08/09","","","10.1185/030079905X53315"
"16076316","Allergic contact dermatitis from buprenorphine","Callejo Melgosa AM, Martínez JC, Fuentes MJ, Martín C.","Allergy. 2005 Sep;60(9):1217-8. doi: 10.1111/j.1398-9995.2005.00883.x.","Callejo Melgosa AM","Allergy","2005","2005/08/04","","","10.1111/j.1398-9995.2005.00883.x"
"16055764","Medication development for addictive disorders: the state of the science","Vocci FJ, Acri J, Elkashef A.","Am J Psychiatry. 2005 Aug;162(8):1432-40. doi: 10.1176/appi.ajp.162.8.1432.","Vocci FJ","Am J Psychiatry","2005","2005/08/02","","","10.1176/appi.ajp.162.8.1432"
"16044413","In vitro release of clomipramine HCl and buprenorphine HCl from poly adipic anhydride (PAA) and poly trimethylene carbonate (PTMC) blends","Dinarvand R, Alimorad MM, Amanlou M, Akbari H.","J Biomed Mater Res A. 2005 Oct 1;75(1):185-91. doi: 10.1002/jbm.a.30398.","Dinarvand R","J Biomed Mater Res A","2005","2005/07/27","","","10.1002/jbm.a.30398"
"16044112","Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry","Grimm D, Pauly E, Pöschl J, Linderkamp O, Skopp G.","Ther Drug Monit. 2005 Aug;27(4):526-30. doi: 10.1097/01.ftd.0000164612.83932.be.","Grimm D","Ther Drug Monit","2005","2005/07/27","","","10.1097/01.ftd.0000164612.83932.be"
"16042639","A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network","Ling W, Amass L, Shoptaw S, Annon JJ, Hillhouse M, Babcock D, Brigham G, Harrer J, Reid M, Muir J, Buchan B, Orr D, Woody G, Krejci J, Ziedonis D; Buprenorphine Study Protocol Group.","Addiction. 2005 Aug;100(8):1090-100. doi: 10.1111/j.1360-0443.2005.01154.x.","Ling W","Addiction","2005","2005/07/27","PMC1480367","NIHMS4540","10.1111/j.1360-0443.2005.01154.x"
"16042623","Opiate detoxification: what are the goals?","O'Brien CP.","Addiction. 2005 Aug;100(8):1035. doi: 10.1111/j.1360-0443.2005.01213.x.","O'Brien CP","Addiction","2005","2005/07/27","","","10.1111/j.1360-0443.2005.01213.x"
"16036196","Use of sublingual buprenorphine for pain relief in office hysteroscopy","Lin YH, Hwang JL, Huang LW, Chen HJ.","J Minim Invasive Gynecol. 2005 Jul-Aug;12(4):347-50. doi: 10.1016/j.jmig.2005.05.013.","Lin YH","J Minim Invasive Gynecol","2005","2005/07/23","","","10.1016/j.jmig.2005.05.013"
"16032446","Pain management after lumbar spinal fusion surgery using continuous subcutaneous infusion of buprenorphine","Kawamata T, Sato Y, Niiyama Y, Omote K, Namiki A.","J Anesth. 2005;19(3):199-203. doi: 10.1007/s00540-005-0309-1.","Kawamata T","J Anesth","2005","2005/07/21","","","10.1007/s00540-005-0309-1"
"16026126","[Enterobacter cloacae spondylodiscitis through misuse of high-dose intravenous buprenorphine]","Etchepare F, Coutaux A, Edel Y, Bourgeois P.","Presse Med. 2005 Jun 4;34(10):725-7. doi: 10.1016/s0755-4982(05)84026-6.","Etchepare F","Presse Med","2005","2005/07/20","","","10.1016/s0755-4982(05)84026-6"
"16026125","[Infectious complications and misuse of high-dose buprenorphine]","Cazorla C, Grenier de Cardenal D, Schuhmacher H, Thomas L, Wack A, May T, Rabaud C.","Presse Med. 2005 Jun 4;34(10):719-24. doi: 10.1016/s0755-4982(05)84025-4.","Cazorla C","Presse Med","2005","2005/07/20","","","10.1016/s0755-4982(05)84025-4"
"16026124","[Absence of correlation between mental disorders and high-dose buprenorphine. A case-control study]","Phan O, Sanchez M, Bouthillon-Heitzmann P.","Presse Med. 2005 Jun 4;34(10):711-8. doi: 10.1016/s0755-4982(05)84024-2.","Phan O","Presse Med","2005","2005/07/20","","","10.1016/s0755-4982(05)84024-2"
"16026122","[The real border for the treatment of drug addicts]","Sanchez M.","Presse Med. 2005 Jun 4;34(10):701-2. doi: 10.1016/s0755-4982(05)84022-9.","Sanchez M","Presse Med","2005","2005/07/20","","","10.1016/s0755-4982(05)84022-9"
"16025322","Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers","Comer SD, Walker EA, Collins ED.","Psychopharmacology (Berl). 2005 Oct;181(4):664-75. doi: 10.1007/s00213-005-0023-6. Epub 2005 Sep 29.","Comer SD","Psychopharmacology (Berl)","2005","2005/07/19","PMC4079466","NIHMS516227","10.1007/s00213-005-0023-6"
"16023087","Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brain","Debruyne D, Quentin T, Poisnel G, Lelong-Boulouard V, Barré L, Coquerel A.","Brain Res. 2005 Aug 9;1052(2):222-31. doi: 10.1016/j.brainres.2005.06.027.","Debruyne D","Brain Res","2005","2005/07/19","","","10.1016/j.brainres.2005.06.027"
"16019973","Males and females differ in response to opioid agonist medications","Jones HE, Fitzgerald H, Johnson RE.","Am J Addict. 2005 May-Jun;14(3):223-33. doi: 10.1080/10550490590949569.","Jones HE","Am J Addict","2005","2005/07/16","","","10.1080/10550490590949569"
"16012418","Transdermal buprenorphine combined with spinal morphine and naropine for pain relief in chronic peripheral vasculopathy","Aurilio B, Pace MC, Passavanti MB.","Minerva Anestesiol. 2005 Jul-Aug;71(7-8):445-9.","Aurilio B","Minerva Anestesiol","2005","2005/07/14","","",""
"16010532","Buprenorphine in cancer pain","Davis MP.","Support Care Cancer. 2005 Nov;13(11):878-87. doi: 10.1007/s00520-005-0849-9. Epub 2005 Jul 12.","Davis MP","Support Care Cancer","2005","2005/07/13","","","10.1007/s00520-005-0849-9"
"16004754","Methadone vs buprenorphine","Byrne A, Hallinan R, Watson R, Wodak A.","Br J Gen Pract. 2005 Jul;55(516):558-9; author reply 559.","Byrne A","Br J Gen Pract","2005","2005/07/12","PMC1472782","",""
"15977920","Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes","Krantz MJ, Garcia JA, Mehler PS.","Pharmacotherapy. 2005 Apr;25(4):611-4. doi: 10.1592/phco.25.4.611.61020.","Krantz MJ","Pharmacotherapy","2005","2005/06/28","","","10.1592/phco.25.4.611.61020"
"15975529","In vivo preparation and identification of mitral cells in the main olfactory bulb of the mouse","Mast TG, Griff ER.","Brain Res Brain Res Protoc. 2005 Jul;15(2):105-13. doi: 10.1016/j.brainresprot.2005.05.001.","Mast TG","Brain Res Brain Res Protoc","2005","2005/06/25","","","10.1016/j.brainresprot.2005.05.001"
"15975254","Simultaneous determination of buprenorphine and norbuprenorphine in serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry","Scislowski M, Piekoszewski W, Kamenczak A, Florek E.","J Anal Toxicol. 2005 May-Jun;29(4):249-53. doi: 10.1093/jat/29.4.249.","Scislowski M","J Anal Toxicol","2005","2005/06/25","","","10.1093/jat/29.4.249"
"15972245","A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)","Shanahan MD, Doran CM, Digiusto E, Bell J, Lintzeris N, White J, Ali R, Saunders JB, Mattick RP, Gilmour S.","Addict Behav. 2006 Mar;31(3):371-87. doi: 10.1016/j.addbeh.2005.05.016. Epub 2005 Jun 21.","Shanahan MD","Addict Behav","2006","2005/06/24","","","10.1016/j.addbeh.2005.05.016"
"15970068","The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales","Strang J, Sheridan J, Hunt C, Kerr B, Gerada C, Pringle M.","Br J Gen Pract. 2005 Jun;55(515):444-51.","Strang J","Br J Gen Pract","2005","2005/06/23","PMC1472740","",""
"15966752","Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","Elkader A, Sproule B.","Clin Pharmacokinet. 2005;44(7):661-80. doi: 10.2165/00003088-200544070-00001.","Elkader A","Clin Pharmacokinet","2005","2005/06/22","","","10.2165/00003088-200544070-00001"
"15957687","High-dose buprenorphine: perioperative precautions and management strategies","Roberts DM, Meyer-Witting M.","Anaesth Intensive Care. 2005 Feb;33(1):17-25. doi: 10.1177/0310057X0503300104.","Roberts DM","Anaesth Intensive Care","2005","2005/06/17","","","10.1177/0310057X0503300104"
"15957155","Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002","Schifano F, Corkery J, Gilvarry E, Deluca P, Oyefeso A, Ghodse AH.","Hum Psychopharmacol. 2005 Jul;20(5):343-8. doi: 10.1002/hup.698.","Schifano F","Hum Psychopharmacol","2005","2005/06/16","","","10.1002/hup.698"
"15946731","Cross-tolerance and mu agonist efficacy in pigeons treated with LAAM or buprenorphine","Galici R, McMahon LR, France CP.","Pharmacol Biochem Behav. 2005 Jul;81(3):626-34. doi: 10.1016/j.pbb.2005.05.003.","Galici R","Pharmacol Biochem Behav","2005","2005/06/11","","","10.1016/j.pbb.2005.05.003"
"15943959","Influence of estrous cycle and gonadal hormone depletion on nociception and opioid antinociception in female rats of four strains","Terner JM, Lomas LM, Picker MJ.","J Pain. 2005 Jun;6(6):372-83. doi: 10.1016/j.jpain.2005.01.354.","Terner JM","J Pain","2005","2005/06/10","","","10.1016/j.jpain.2005.01.354"
"15943950","The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?","Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA.","Drug Alcohol Depend. 2005 Jul;79(1):113-6. doi: 10.1016/j.drugalcdep.2004.12.008.","Sullivan LE","Drug Alcohol Depend","2005","2005/06/10","","","10.1016/j.drugalcdep.2004.12.008"
"15943948","The effect of buprenorphine and benzodiazepines on respiration in the rat","Nielsen S, Taylor DA.","Drug Alcohol Depend. 2005 Jul;79(1):95-101. doi: 10.1016/j.drugalcdep.2005.01.004. Epub 2005 Feb 17.","Nielsen S","Drug Alcohol Depend","2005","2005/06/10","","","10.1016/j.drugalcdep.2005.01.004"
"15943939","Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome","Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L.","Drug Alcohol Depend. 2005 Jul;79(1):1-10. doi: 10.1016/j.drugalcdep.2004.11.013.","Jones HE","Drug Alcohol Depend","2005","2005/06/10","","","10.1016/j.drugalcdep.2004.11.013"
"15938664","Transdermal buprenorphine in the treatment of chronic pain","Sittl R.","Expert Rev Neurother. 2005 May;5(3):315-23. doi: 10.1586/14737175.5.3.315.","Sittl R","Expert Rev Neurother","2005","2005/06/09","","","10.1586/14737175.5.3.315"
"15935707","Liquid chromatography-mass spectrometric analysis of buprenorphine and its N-dealkylated metabolite norbuprenorphine in rat brain tissue and plasma","Yue H, Borenstein MR, Jansen SA, Raffa RB.","J Pharmacol Toxicol Methods. 2005 Nov-Dec;52(3):314-22. doi: 10.1016/j.vascn.2005.04.012. Epub 2005 Jun 1.","Yue H","J Pharmacol Toxicol Methods","2005","2005/06/07","","","10.1016/j.vascn.2005.04.012"
"15925962","Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment","Giacomuzzi SM, Ertl M, Kemmler G, Riemer Y, Vigl A.","ScientificWorldJournal. 2005 May 24;5:452-68. doi: 10.1100/tsw.2005.52.","Giacomuzzi SM","ScientificWorldJournal","2005","2005/06/01","PMC5936538","","10.1100/tsw.2005.52"
"15925266","An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research","Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP.","J Subst Abuse Treat. 2005 Jun;28(4):321-9. doi: 10.1016/j.jsat.2005.02.007.","Amato L","J Subst Abuse Treat","2005","2005/06/01","","","10.1016/j.jsat.2005.02.007"
"15922818","Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study","Muriel C, Failde I, Micó JA, Neira M, Sánchez-Magro I.","Clin Ther. 2005 Apr;27(4):451-62. doi: 10.1016/j.clinthera.2005.04.007.","Muriel C","Clin Ther","2005","2005/06/01","","","10.1016/j.clinthera.2005.04.007"
"15921868","Driving impairment on buprenorphine and slow-release oral morphine in drug-dependent patients","Giacomuzzi S, Haaser W, Pilsz L, Riemer Y.","Forensic Sci Int. 2005 Sep 10;152(2-3):323-4. doi: 10.1016/j.forsciint.2005.04.011.","Giacomuzzi S","Forensic Sci Int","2005","2005/06/01","","","10.1016/j.forsciint.2005.04.011"
"15917146","Flunitrazepam does not alter cerebral distribution of buprenorphine in the rat","Megarbane B, Pirnay S, Borron SW, Trout H, Monier C, Risède P, Boschi G, Baud FJ.","Toxicol Lett. 2005 Jul 4;157(3):211-9. doi: 10.1016/j.toxlet.2005.02.002. Epub 2005 Apr 1.","Megarbane B","Toxicol Lett","2005","2005/05/27","","","10.1016/j.toxlet.2005.02.002"
"15912848","[Transdermal systems]","Lipp HP.","Krankenpfl J. 2005;43(1-3):61.","Lipp HP","Krankenpfl J","2005","2005/05/26","","",""
"15910654","Justification for routine screening of pharmaceutical products in immune function tests: a review of the recommendations of Putman et al. (2003)","Ryle PR.","Fundam Clin Pharmacol. 2005 Jun;19(3):317-22; discussion 329-30. doi: 10.1111/j.1472-8206.2005.00337.x.","Ryle PR","Fundam Clin Pharmacol","2005","2005/05/25","","","10.1111/j.1472-8206.2005.00337.x"
"15902999","[High-dose buprenorphine substitution during incarceration. Management of opiate addicts]","Revnaud-Maurupt C, Caer Y, Escaffre N, Gagneau M, Galinier A, Marzo JN, Meroueh F.","Presse Med. 2005 Apr 9;34(7):487-90.","Revnaud-Maurupt C","Presse Med","2005","2005/05/21","","",""
"15897523","Diffuse cystic leucoencephalopathy after buprenorphine injection","Seet RC, Rathakrishnan R, Chan BP, Lim EC.","J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):890-1. doi: 10.1136/jnnp.2004.052878.","Seet RC","J Neurol Neurosurg Psychiatry","2005","2005/05/18","PMC1739678","","10.1136/jnnp.2004.052878"
"15896581","Addition of 0.1% bupivacaine to buprenorphine and droperidol in patient-controlled epidural analgesia improved postoperative pain scores on coughing after gynecological surgery","Inoue S, Mitsuhata H, Kawakami T, Shimohata K, Hirabayashi Y, Seo N.","J Clin Anesth. 2005 May;17(3):167-71. doi: 10.1016/j.jclinane.2004.06.015.","Inoue S","J Clin Anesth","2005","2005/05/18","","","10.1016/j.jclinane.2004.06.015"
"15882404","Anti-nociceptive efficacy of carprofen, levomethadone and buprenorphine for pain relief in cats following major orthopaedic surgery","Möllenhoff A, Nolte I, Kramer S.","J Vet Med A Physiol Pathol Clin Med. 2005 May;52(4):186-98. doi: 10.1111/j.1439-0442.2005.00710.x.","Möllenhoff A","J Vet Med A Physiol Pathol Clin Med","2005","2005/05/11","","","10.1111/j.1439-0442.2005.00710.x"
"15868999","A novel long-acting analgesic: buprenorphine palmitate in rats","Que J, Lin LC, Liu SY, Chu CC, Liu KS, Ho ST, Wang JJ.","Acta Anaesthesiol Taiwan. 2005 Mar;43(1):11-6.","Que J","Acta Anaesthesiol Taiwan","2005","2005/05/05","","",""
"15857725","Influence of psychotherapy attendance on buprenorphine treatment outcome","Montoya ID, Schroeder JR, Preston KL, Covi L, Umbricht A, Contoreggi C, Fudala PJ, Johnson RE, Gorelick DA.","J Subst Abuse Treat. 2005 Apr;28(3):247-54. doi: 10.1016/j.jsat.2005.01.004.","Montoya ID","J Subst Abuse Treat","2005","2005/04/29","PMC2633651","NIHMS81318","10.1016/j.jsat.2005.01.004"
"15850443","Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species","Aboltins CA, Allen P, Daffy JR.","Med J Aust. 2005 Apr 18;182(8):427.","Aboltins CA","Med J Aust","2005","2005/04/27","","",""
"15843500","Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization","White DA, Holtzman SG.","J Pharmacol Exp Ther. 2005 Jul;314(1):374-82. doi: 10.1124/jpet.104.078584. Epub 2005 Apr 20.","White DA","J Pharmacol Exp Ther","2005","2005/04/22","","","10.1124/jpet.104.078584"
"15834736","Cross-reactivity of the CEDIA buprenorphine assay with opiates: an Austrian phenomenon?","Pavlic M, Libiseller K, Grubwieser P, Rabl W.","Int J Legal Med. 2005 Nov;119(6):378-81. doi: 10.1007/s00414-005-0544-x. Epub 2005 Apr 16.","Pavlic M","Int J Legal Med","2005","2005/04/19","","","10.1007/s00414-005-0544-x"
"15833777","Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats","Dahan A, Yassen A, Bijl H, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M.","Br J Anaesth. 2005 Jun;94(6):825-34. doi: 10.1093/bja/aei145. Epub 2005 Apr 15.","Dahan A","Br J Anaesth","2005","2005/04/19","","","10.1093/bja/aei145"
"15832591","Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use","Verrando R, Robaeys G, Matheï C, Buntinx F.","Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):81-5.","Verrando R","Acta Gastroenterol Belg","2005","2005/04/19","","",""
"15813021","[Effects of intragastric administration of thenorphine on morphine-induced behavioral sensitization in mice]","Zhao WL, Liang JH, Gong ZH.","Yao Xue Xue Bao. 2004 Dec;39(12):961-5.","Zhao WL","Yao Xue Xue Bao","2004","2005/04/09","","",""
"15811486","Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study","Sittl R, Likar R, Nautrup BP.","Clin Ther. 2005 Feb;27(2):225-37. doi: 10.1016/j.clinthera.2005.02.012.","Sittl R","Clin Ther","2005","2005/04/07","","","10.1016/j.clinthera.2005.02.012"
"15810464","[The algimetry evaluation by thermic and pressoric nociceptive stimulus in dogs pre treated with methotrimeprazine, midazolam and ketamine with or without butorphanol or buprenorphine]","Rosa AL, Massone F.","Acta Cir Bras. 2005 Jan-Feb;20(1):39-45. doi: 10.1590/s0102-86502005000100007.","Rosa AL","Acta Cir Bras","2005","2005/04/07","","","10.1590/s0102-86502005000100007"
"15810140","[Questionnaire study of general practitioners regarding experience and attitude to opioid substitution therapy]","Mravcík V, Coufalová M, Popov P, Zábranský T, Procházka R.","Epidemiol Mikrobiol Imunol. 2005 Feb;54(1):27-33.","Mravcík V","Epidemiol Mikrobiol Imunol","2005","2005/04/07","","",""
"15808047","Buprenorphine versus methadone--safety first?","Davies D.","Br J Gen Pract. 2005 Mar;55(512):232-3.","Davies D","Br J Gen Pract","2005","2005/04/06","PMC1463104","",""
"15806416","Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers","Neri S, Bruno CM, Pulvirenti D, Malaguarnera M, Italiano C, Mauceri B, Abate G, Cilio D, Calvagno S, Tsami A, Ignaccolo L, Interlandi D, Prestianni L, Ricchena M, Noto R.","Psychopharmacology (Berl). 2005 May;179(3):700-4. doi: 10.1007/s00213-005-2239-x. Epub 2005 Apr 2.","Neri S","Psychopharmacology (Berl)","2005","2005/04/05","","","10.1007/s00213-005-2239-x"
"15804873","Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response","Kosten T, Sofuoglu M, Poling J, Gonsai K, Oliveto A.","Am J Addict. 2005 Jan-Feb;14(1):8-17. doi: 10.1080/10550490590899817.","Kosten T","Am J Addict","2005","2005/04/05","","","10.1080/10550490590899817"
"15799254","[Buprenorphine treatment during pregnancy--risk factors and advantages need to be considered carefully]","Strengell P, Vahtola M, Tammela O, Seppä K.","Duodecim. 2005;121(4):392-9.","Strengell P","Duodecim","2005","2005/04/01","","",""
"15798781","Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement","Sorge RE, Rajabi H, Stewart J.","Neuropsychopharmacology. 2005 Sep;30(9):1681-92. doi: 10.1038/sj.npp.1300712.","Sorge RE","Neuropsychopharmacology","2005","2005/03/31","","","10.1038/sj.npp.1300712"
"15789818","[Use of the health insurance database by the centres for evaluation and information on pharmacodependance: examples, interests and future prospects]","Micallef J, Pradel V, Thirion X, Jolliet P, Lapeyre-Mestre M.","Therapie. 2004 Nov-Dec;59(6):581-8. doi: 10.2515/therapie:2004100.","Micallef J","Therapie","2004","2005/03/26","","","10.2515/therapie:2004100"
"15784521","Opiate dependence treatment with buprenorphine: one year's experience in a family practice residency setting","Colameco S, Armando J, Trotz C.","J Addict Dis. 2005;24(2):25-32. doi: 10.1300/J069v24n02_03.","Colameco S","J Addict Dis","2005","2005/03/24","","","10.1300/J069v24n02_03"
"15784064","The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-03","de Wet CJ, Reed LJ, Bearn J.","Addiction. 2005 Apr;100(4):495-9. doi: 10.1111/j.1360-0443.2005.01039.x.","de Wet CJ","Addiction","2005","2005/03/24","","","10.1111/j.1360-0443.2005.01039.x"
"15781180","Buprenorphine: considerations for pain management","Johnson RE, Fudala PJ, Payne R.","J Pain Symptom Manage. 2005 Mar;29(3):297-326. doi: 10.1016/j.jpainsymman.2004.07.005.","Johnson RE","J Pain Symptom Manage","2005","2005/03/23","","","10.1016/j.jpainsymman.2004.07.005"
"15778888","Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor","Smith MA, Chisholm KA, Bryant PA, Greene JL, McClean JM, Stoops WW, Yancey DL.","Psychopharmacology (Berl). 2005 Aug;181(1):27-37. doi: 10.1007/s00213-005-2218-2. Epub 2005 Oct 15.","Smith MA","Psychopharmacology (Berl)","2005","2005/03/22","","","10.1007/s00213-005-2218-2"
"15769555","Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone","Jones HE, Johnson RE, Jasinski DR, Milio L.","Drug Alcohol Depend. 2005 Apr 4;78(1):33-8. doi: 10.1016/j.drugalcdep.2004.08.027.","Jones HE","Drug Alcohol Depend","2005","2005/03/17","","","10.1016/j.drugalcdep.2004.08.027"
"15766208","Evaluating postoperative analgesics in mice using telemetry","Goecke JC, Awad H, Lawson JC, Boivin GP.","Comp Med. 2005 Feb;55(1):37-44.","Goecke JC","Comp Med","2005","2005/03/16","","",""
"15764468","Office-based buprenorphine treatment for opioid-dependent patients","McCance-Katz EF.","Harv Rev Psychiatry. 2004 Nov-Dec;12(6):321-38. doi: 10.1080/10673220490905688.","McCance-Katz EF","Harv Rev Psychiatry","2004","2005/03/15","","","10.1080/10673220490905688"
"15745203","Drug misuse: a review of treatments","Gerada C.","Clin Med (Lond). 2005 Jan-Feb;5(1):69-73. doi: 10.7861/clinmedicine.5-1-69.","Gerada C","Clin Med (Lond)","2005","2005/03/05","PMC4954073","","10.7861/clinmedicine.5-1-69"
"15743975","In vitro metabolism study of buprenorphine: evidence for new metabolic pathways","Picard N, Cresteil T, Djebli N, Marquet P.","Drug Metab Dispos. 2005 May;33(5):689-95. doi: 10.1124/dmd.105.003681. Epub 2005 Mar 2.","Picard N","Drug Metab Dispos","2005","2005/03/04","","","10.1124/dmd.105.003681"
"15741914","[Prescription of high dose buprenorphine by general practitioners]","Feroni I, Paraponaris A, Aubisson S, Bouhnik A, Masut A, Ronfle E, Coudert C, Mabriez JC; et le groupe Bupré MG 13.","Rev Epidemiol Sante Publique. 2004 Dec;52(6):511-22. doi: 10.1016/s0398-7620(04)99091-8.","Feroni I","Rev Epidemiol Sante Publique","2004","2005/03/03","","","10.1016/s0398-7620(04)99091-8"
"15738616","[Distinct mechanisms underlying pleasure and analgesia]","Ide S, Minami M, Satoh M, Sora I, Ikeda K.","Nihon Yakurigaku Zasshi. 2005 Jan;125(1):11-5. doi: 10.1254/fpj.125.11.","Ide S","Nihon Yakurigaku Zasshi","2005","2005/03/02","","","10.1254/fpj.125.11"
"15734164","Simultaneous determination of buprenorphine and its prodrug, buprenorphine propionate, by high-performance liquid chromatography with fluorescence detection: application to pharmacokinetic studies in rabbits","Liu SY, Liu KS, Kuei CH, Tzeng JI, Ho ST, Wang JJ.","J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Apr 25;818(2):233-9. doi: 10.1016/j.jchromb.2005.01.002.","Liu SY","J Chromatogr B Analyt Technol Biomed Life Sci","2005","2005/03/01","","","10.1016/j.jchromb.2005.01.002"
"15730815","[Xuan-xia-qu-du capsule combined with small dose of buprenorphine in the treatment of heroine dependence drug withdrawal syndrome ]","Sheng XQ, Hao W.","Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1994-6.","Sheng XQ","Zhonghua Yi Xue Za Zhi","2004","2005/02/26","","",""
"15730114","Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence","Raisch DW, Fudala PJ, Saxon AJ, Walsh R, Casadonte P, Ling W, Johnson BA, Malkerneker U, Ordorica P, Williford WO, Sather MR.","J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):23-32. doi: 10.1331/1544345052843200.","Raisch DW","J Am Pharm Assoc (2003)","2005","2005/02/26","","","10.1331/1544345052843200"
"15728068","Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies","Likar R, Sittl R.","Anesth Analg. 2005 Mar;100(3):781-5, table of contents. doi: 10.1213/01.ANE.0000145066.06538.20.","Likar R","Anesth Analg","2005","2005/02/25","","","10.1213/01.ANE.0000145066.06538.20"
"15720937","The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence","Simoens S, Matheson C, Bond C, Inkster K, Ludbrook A.","Br J Gen Pract. 2005 Feb;55(511):139-46.","Simoens S","Br J Gen Pract","2005","2005/02/22","PMC1463190","",""
"15718062","Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project","Digiusto E, Lintzeris N, Breen C, Kimber J, Mattick RP, Bell J, Ali R, Saunders JB; NEPOD Research Group.","Addict Behav. 2005 Mar;30(3):443-56. doi: 10.1016/j.addbeh.2004.06.002.","Digiusto E","Addict Behav","2005","2005/02/19","","","10.1016/j.addbeh.2004.06.002"
"15717347","Treating opiate addiction, Part I. Detoxification and maintenance","","Harv Ment Health Lett. 2004 Dec;21(6):4-6.","","Harv Ment Health Lett","2004","2005/02/19","","",""
"15707209","Hepatitis C virus incidence among injecting drug users on opioid replacement therapy","Hallinan R, Byrne A, Amin J, Dore GJ.","Aust N Z J Public Health. 2004 Dec;28(6):576-8. doi: 10.1111/j.1467-842x.2004.tb00050.x.","Hallinan R","Aust N Z J Public Health","2004","2005/02/15","","","10.1111/j.1467-842x.2004.tb00050.x"
"15701707","Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics","Yassen A, Olofsen E, Dahan A, Danhof M.","J Pharmacol Exp Ther. 2005 Jun;313(3):1136-49. doi: 10.1124/jpet.104.082560. Epub 2005 Feb 8.","Yassen A","J Pharmacol Exp Ther","2005","2005/02/11","","","10.1124/jpet.104.082560"
"15693730","A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting","Harris AH, Gospodarevskaya E, Ritter AJ.","Pharmacoeconomics. 2005;23(1):77-91. doi: 10.2165/00019053-200523010-00007.","Harris AH","Pharmacoeconomics","2005","2005/02/08","","","10.2165/00019053-200523010-00007"
"15684471","Effect of nonspecific binding to microsomes and metabolic elimination of buprenorphine on the inhibition of cytochrome P4502D6","Umeda S, Harakawa N, Yamamoto M, Ueno K.","Biol Pharm Bull. 2005 Feb;28(2):212-6. doi: 10.1248/bpb.28.212.","Umeda S","Biol Pharm Bull","2005","2005/02/03","","","10.1248/bpb.28.212"
"15683771","Effects of epidural anaesthesia-analgesia on intravenous anaesthesia with propofol","Tusell JM, Andaluz A, Prandi D, Costa C, García F.","Vet J. 2005 Jan;169(1):108-12. doi: 10.1016/j.tvjl.2004.01.030.","Tusell JM","Vet J","2005","2005/02/03","","","10.1016/j.tvjl.2004.01.030"
"15679755","Cocaine-induced trichotillomania","George S, Moselhy H.","Addiction. 2005 Feb;100(2):255-6. doi: 10.1111/j.1360-0443.2004.00955.x.","George S","Addiction","2005","2005/02/01","","","10.1111/j.1360-0443.2004.00955.x"
"15679749","Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?","Jenkinson RA, Clark NC, Fry CL, Dobbin M.","Addiction. 2005 Feb;100(2):197-205. doi: 10.1111/j.1360-0443.2004.00958.x.","Jenkinson RA","Addiction","2005","2005/02/01","","","10.1111/j.1360-0443.2004.00958.x"
"15679744","Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users","Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA.","Addiction. 2005 Feb;100(2):150-8. doi: 10.1111/j.1360-0443.2004.00963.x.","Sullivan LE","Addiction","2005","2005/02/01","","","10.1111/j.1360-0443.2004.00963.x"
"15677600","Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence","Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR.","Am J Psychiatry. 2005 Feb;162(2):340-9. doi: 10.1176/appi.ajp.162.2.340.","Schottenfeld RS","Am J Psychiatry","2005","2005/01/29","","","10.1176/appi.ajp.162.2.340"
"15668743","The role of tramadol in cancer pain treatment--a review","Leppert W, Łuczak J.","Support Care Cancer. 2005 Jan;13(1):5-17. doi: 10.1007/s00520-004-0720-4. Epub 2004 Nov 18.","Leppert W","Support Care Cancer","2005","2005/01/26","","","10.1007/s00520-004-0720-4"
"15665884","[Buprenorphine and methadone to opiate addicts--a randomized trial]","Kristensen Ø, Espegren O, Asland R, Jakobsen E, Lie Ø, Seiler S.","Tidsskr Nor Laegeforen. 2005 Jan 20;125(2):148-51.","Kristensen Ø","Tidsskr Nor Laegeforen","2005","2005/01/25","","",""
"15664721","Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing","Marsch LA, Bickel WK, Badger GJ, Jacobs EA.","Drug Alcohol Depend. 2005 Feb 14;77(2):195-204. doi: 10.1016/j.drugalcdep.2004.08.011.","Marsch LA","Drug Alcohol Depend","2005","2005/01/25","","","10.1016/j.drugalcdep.2004.08.011"
"15659298","Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain","Christoph T, Kögel B, Schiene K, Méen M, De Vry J, Friderichs E.","Eur J Pharmacol. 2005 Jan 10;507(1-3):87-98. doi: 10.1016/j.ejphar.2004.11.052. Epub 2004 Dec 30.","Christoph T","Eur J Pharmacol","2005","2005/01/22","","","10.1016/j.ejphar.2004.11.052"
"15657781","Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes","Chang Y, Moody DE.","Eur J Clin Pharmacol. 2005 Feb;60(12):875-81. doi: 10.1007/s00228-004-0856-7. Epub 2005 Jan 19.","Chang Y","Eur J Clin Pharmacol","2005","2005/01/20","","","10.1007/s00228-004-0856-7"
"15652443","Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report","Zylicz Z, Stork N, Krajnik M.","J Pain Symptom Manage. 2005 Jan;29(1):100-3. doi: 10.1016/j.jpainsymman.2004.04.009.","Zylicz Z","J Pain Symptom Manage","2005","2005/01/18","","","10.1016/j.jpainsymman.2004.04.009"
"15641647","Ingestion of high-dose buprenorphine by a 4 year-old child","Gaulier JM, Charvier F, Monceaux F, Marquet P, Lachatre G.","J Toxicol Clin Toxicol. 2004;42(7):993-5. doi: 10.1081/clt-200042470.","Gaulier JM","J Toxicol Clin Toxicol","2004","2005/01/12","","","10.1081/clt-200042470"
"15639693","Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study","Sorge J, Sittl R.","Clin Ther. 2004 Nov;26(11):1808-20. doi: 10.1016/j.clinthera.2004.11.008.","Sorge J","Clin Ther","2004","2005/01/11","","","10.1016/j.clinthera.2004.11.008"
"15637731","Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma","Murphy CM, Huestis MA.","J Mass Spectrom. 2005 Jan;40(1):70-4. doi: 10.1002/jms.776.","Murphy CM","J Mass Spectrom","2005","2005/01/08","","","10.1002/jms.776"
"15620210","Expression of the polyubiquitin gene early in the buprenorphine hydrochloride-induced apoptosis of NG108-15 cells","Kugawa F, Aoki M.","DNA Seq. 2004 Aug;15(4):237-45. doi: 10.1080/10425170400006372.","Kugawa F","DNA Seq","2004","2004/12/29","","","10.1080/10425170400006372"
"15617175","[Therapeutic strategies for opioid addiction: the role of substitution therapy]","Act UP-Paris; Agence française de Sécurité sanitaire des produits de santé; AIDES; Auto-support des usagers de drogues; Association de services publics de soins aux toxicomanes et en alcoologie; Association des équipes de liasison et de soins en addictologie; Association française pour la réduction des risques; Association nationale des intervenants en toxicomanie; Association nationale médecine générale et conduites addictives; Caisse nationale de l'assurance maladie des travailleurs salariés; Centre de documentation et de recherche en médecine générale; Collège national des enseignants universitaires d'addictologie; Collège national des généralistes enseignants; Fédération française de psychiatrie; Mission interministérielle de lutte contre la drogue et la toxicomanie; Observatoire français des drogues et des toxicomanies; Ordre national des médecins; Ordre national des pharmaciens; Réseau Toxibase; Société d'addictologie francophone; Société de formation thérapeutique du généraliste; Société française d'alcoologie; Société française de médecine générale; Société française de pharmacie clinique; SOS Addictions.","Presse Med. 2004 Oct 23;33(18 Suppl):41-7.","Act UP-Paris","Presse Med","2004","2004/12/24","","",""
"15617170","[The profile of drug addicts attending the Sainte Marguerite University Hospital in Marseille analysis of the active file from 1996 to 2001]","Lançon C, Jaquet I, Labrune N, Bartolo K, De Stopeleire C, Auquier P.","Presse Med. 2004 Oct 23;33(18 Suppl):11-7. doi: 10.1016/s0755-4982(04)72376-3.","Lançon C","Presse Med","2004","2004/12/24","","","10.1016/s0755-4982(04)72376-3"
"15617169","[Risk factors of early drop-out during induction of high-dose buprenorphine substitution therapy. A study of 1085 opiate addicts]","Batel P, Reynaud-Maurupt C, Lavignasse P, Constant MV, Kopp P, Jourdain JJ, Videau B, Mucchielli A, Riff B, Lowenstein W.","Presse Med. 2004 Oct 23;33(18 Suppl):5-9. doi: 10.1016/s0755-4982(04)72375-1.","Batel P","Presse Med","2004","2004/12/24","","","10.1016/s0755-4982(04)72375-1"
"15617168","[A new route]","Sanchez M.","Presse Med. 2004 Oct 23;33(18 Suppl):3-4. doi: 10.1016/s0755-4982(04)72374-x.","Sanchez M","Presse Med","2004","2004/12/24","","","10.1016/s0755-4982(04)72374-x"
"15607843","A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin","Oreskovich MR, Saxon AJ, Ellis ML, Malte CA, Reoux JP, Knox PC.","Drug Alcohol Depend. 2005 Jan 7;77(1):71-9. doi: 10.1016/j.drugalcdep.2004.07.008.","Oreskovich MR","Drug Alcohol Depend","2005","2004/12/21","","","10.1016/j.drugalcdep.2004.07.008"
"15589713","Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence","Dean AJ, Bell J, Christie MJ, Mattick RP.","Eur Psychiatry. 2004 Dec;19(8):510-3. doi: 10.1016/j.eurpsy.2004.09.002.","Dean AJ","Eur Psychiatry","2004","2004/12/14","","","10.1016/j.eurpsy.2004.09.002"
"15586207","Opiate overdose and health treatment options for opiate users in New South Wales, 1999-2002","Cook S, Indig D, Gray J, McGrath D.","N S W Public Health Bull. 2004 Jul-Aug;15(7-8):125-31. doi: 10.1071/nb04030.","Cook S","N S W Public Health Bull","2004","2004/12/09","","","10.1071/nb04030"
"15575370","Evaluation of liposome-encapsulated oxymorphone hydrochloride in mice after splenectomy","Clark MD, Krugner-Higby L, Smith LJ, Heath TD, Clark KL, Olson D.","Comp Med. 2004 Oct;54(5):558-63.","Clark MD","Comp Med","2004","2004/12/04","","",""
"15570521","[Buprenorphine or methadone for detoxification of young opioid addicts?]","Ebner R, Schreiber W, Zierer C.","Psychiatr Prax. 2004 Nov;31 Suppl 1:S108-10. doi: 10.1055/s-2004-828448.","Ebner R","Psychiatr Prax","2004","2004/12/01","","","10.1055/s-2004-828448"
"15570492","[Outcome of a substitution therapy program in an outpatient treatment setting of a psychiatric hospital]","Unglaub W, Loncarek E, Wismath M, Johann M, Wodarz N, Klein H.","Psychiatr Prax. 2004 Nov;31 Suppl 1:S26-8. doi: 10.1055/s-2004-828423.","Unglaub W","Psychiatr Prax","2004","2004/12/01","","","10.1055/s-2004-828423"
"15566992","Opioid substitution and HIV/AIDS treatment and prevention","Kerr T, Wodak A, Elliott R, Montaner JS, Wood E.","Lancet. 2004 Nov 27-Dec 3;364(9449):1918-9. doi: 10.1016/S0140-6736(04)17490-4.","Kerr T","Lancet","2004","2004/11/30","","","10.1016/S0140-6736(04)17490-4"
"15561460","French general practitioners' prescribing high-dosage buprenorphine maintenance treatment: is the existing training (good) enough?","Feroni I, Peretti-Watel P, Masut A, Coudert C, Paraponaris A, Obadia Y.","Addict Behav. 2005 Jan;30(1):187-91. doi: 10.1016/j.addbeh.2004.04.019.","Feroni I","Addict Behav","2005","2004/11/25","","","10.1016/j.addbeh.2004.04.019"
"15552931","[Effect of bcl-2 over-expression on the membrane structure of NG108-15 nerve cells: effectiveness of membrane-structure analysis using FACS for the first screening of apoptosis-inducing drugs]","Kugawa F, Ueno A, Aoki M.","Rinsho Byori. 2004 Sep;52(9):725-31.","Kugawa F","Rinsho Byori","2004","2004/11/24","","",""
"15552888","[Essential therapeutic strategies for acute pancreatitis--guidelines for initial treatment and their significance]","Hirata K.","Nihon Rinsho. 2004 Nov;62(11):2049-56.","Hirata K","Nihon Rinsho","2004","2004/11/24","","",""
"15551890","The antinociceptive effect of buprenorphine and its long-acting ester buprenorphine benzoate in rats","Yang C, Lan KM, Liu KS, Chen YW, Tzeng JI, Ho ST, Wang JJ.","Acta Anaesthesiol Taiwan. 2004 Sep;42(3):135-9.","Yang C","Acta Anaesthesiol Taiwan","2004","2004/11/24","","",""
"15542542","Burn injury induces a change in T cell homeostasis affecting preferentially CD4+ T cells","Patenaude J, D'Elia M, Hamelin C, Garrel D, Bernier J.","J Leukoc Biol. 2005 Feb;77(2):141-50. doi: 10.1189/jlb.0703314. Epub 2004 Nov 12.","Patenaude J","J Leukoc Biol","2005","2004/11/16","","","10.1189/jlb.0703314"
"15534969","Public policy statement on buprenorphine for opiate dependence and withdrawal","","J Addict Dis. 2004;23(4):116-7.","","J Addict Dis","2004","2004/11/13","","",""
"15525461","A new buprenorphine analogy, thenorphine, inhibits morphine-induced behavioral sensitization in mice","Zhao WL, Gong ZH, Liang JH.","Acta Pharmacol Sin. 2004 Nov;25(11):1413-8.","Zhao WL","Acta Pharmacol Sin","2004","2004/11/05","","",""
"15516297","A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry(HILIC-MS)","Giroud C, Michaud K, Sporkert F, Eap C, Augsburger M, Cardinal P, Mangin P.","J Anal Toxicol. 2004 Sep;28(6):464-74. doi: 10.1093/jat/28.6.464.","Giroud C","J Anal Toxicol","2004","2004/11/02","","","10.1093/jat/28.6.464"
"15502059","Intrathecal morphine, but not buprenorphine or pentazocine, can induce spastic paraparesis after a noninjurious interval of spinal cord ischemia in the rat","Nakamura S, Kakinohana M, Sugahara K, Kinjo S, Miyata Y.","Anesth Analg. 2004 Nov;99(5):1528-31; table of contents. doi: 10.1213/01.ANE.0000133915.56613.D9.","Nakamura S","Anesth Analg","2004","2004/10/27","","","10.1213/01.ANE.0000133915.56613.D9"
"15500602","Treatment of drug dependence enters a new high technological era","Kleber HD.","Addiction. 2004 Nov;99(11):1476-7. doi: 10.1111/j.1360-0443.2004.00901.x.","Kleber HD","Addiction","2004","2004/10/27","","","10.1111/j.1360-0443.2004.00901.x"
"15500597","Evaluation of an injection depot formulation of buprenorphine: placebo comparison","Sigmon SC, Wong CJ, Chausmer AL, Liebson IA, Bigelow GE.","Addiction. 2004 Nov;99(11):1439-49. doi: 10.1111/j.1360-0443.2004.00834.x.","Sigmon SC","Addiction","2004","2004/10/27","","","10.1111/j.1360-0443.2004.00834.x"
"15500559","Spontaneous clearance of hepatitis C virus after long-term opiate dependence therapy with buprenorphine","Brunelle E, Ledru S, Rotily M, Becker C, Davion T, Vosgien V, Martinot M, Halfon P.","J Viral Hepat. 2004 Nov;11(6):571-3. doi: 10.1111/j.1365-2893.2004.00527.x.","Brunelle E","J Viral Hepat","2004","2004/10/27","","","10.1111/j.1365-2893.2004.00527.x"
"15495026","Buprenorphine for the management of opioid withdrawal","Gowing L, Ali R, White J.","Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002025. doi: 10.1002/14651858.CD002025.pub2.","Gowing L","Cochrane Database Syst Rev","2004","2004/10/21","","","10.1002/14651858.CD002025.pub2"
"15483091","Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence","Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmüller D.","J Clin Endocrinol Metab. 2005 Jan;90(1):203-6. doi: 10.1210/jc.2004-0929. Epub 2004 Oct 13.","Bliesener N","J Clin Endocrinol Metab","2005","2004/10/16","","","10.1210/jc.2004-0929"
"15480815","Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases","Schriek P.","Support Care Cancer. 2004 Dec;12(12):882-4. doi: 10.1007/s00520-004-0695-1. Epub 2004 Oct 9.","Schriek P","Support Care Cancer","2004","2004/10/14","","","10.1007/s00520-004-0695-1"
"15472568","Behaviour-based assessment of the duration of laparotomy-induced abdominal pain and the analgesic effects of carprofen and buprenorphine in rats","Roughan JV, Flecknell PA.","Behav Pharmacol. 2004 Nov;15(7):461-72. doi: 10.1097/00008877-200411000-00002.","Roughan JV","Behav Pharmacol","2004","2004/10/09","","","10.1097/00008877-200411000-00002"
"15450648","Consensus statement on office-based treatment of opioid dependence using buprenorphine","Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR.","J Subst Abuse Treat. 2004 Sep;27(2):153-9. doi: 10.1016/j.jsat.2004.06.005.","Fiellin DA","J Subst Abuse Treat","2004","2004/09/29","","","10.1016/j.jsat.2004.06.005"
"15386835","Buprenorphine in primary HIV care clinics: a big pill to swallow","Lucas GM.","Hopkins HIV Rep. 2004 Jul;16(4):5-7.","Lucas GM","Hopkins HIV Rep","2004","2004/09/25","","",""
"15385230","Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets","Feeney GF, Fairweather P.","Drug Alcohol Rev. 2003 Sep;22(3):359-61. doi: 10.1080/0959523031000154508.","Feeney GF","Drug Alcohol Rev","2003","2004/09/24","","","10.1080/0959523031000154508"
"15371928","Acute hepatitis due to buprenorphine administration","Hervé S, Riachi G, Noblet C, Guillement N, Tanasescu S, Goria O, Thuillez C, Tranvouez JL, Ducrotte P, Lerebours E.","Eur J Gastroenterol Hepatol. 2004 Oct;16(10):1033-7. doi: 10.1097/00042737-200410000-00013.","Hervé S","Eur J Gastroenterol Hepatol","2004","2004/09/17","","","10.1097/00042737-200410000-00013"
"15370952","Buprenorphine: a safe method for detoxifying pregnant heroin addicts and their unborn","Comer VG, Annitto WJ.","Am J Addict. 2004 May-Jun;13(3):317-8. doi: 10.1080/10550490490460256.","Comer VG","Am J Addict","2004","2004/09/17","","","10.1080/10550490490460256"
"15370024","Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence","Darke S, Hetherington K, Ross J, Lynskey M, Teesson M.","Drug Alcohol Rev. 2004 Jun;23(2):177-83. doi: 10.1080/095952304100017044163.","Darke S","Drug Alcohol Rev","2004","2004/09/17","","","10.1080/095952304100017044163"
"15370023","A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal","Doran CM, Shanahan M, Bell J, Gibson A.","Drug Alcohol Rev. 2004 Jun;23(2):171-5. doi: 10.1080/095952304100017044154.","Doran CM","Drug Alcohol Rev","2004","2004/09/17","","","10.1080/095952304100017044154"
"15370011","A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence","Bell J, Byron G, Gibson A, Morris A.","Drug Alcohol Rev. 2004 Sep;23(3):311-7. doi: 10.1080/09595230412331289473.","Bell J","Drug Alcohol Rev","2004","2004/09/17","","","10.1080/09595230412331289473"
"15369577","Opiate agonist maintenance treatment for injecting drug user peer educators","Des Jarlais DC, Hammett TM, Wei L, Van LK, Donghua M, Ngu D.","Addiction. 2004 Oct;99(10):1355-6. doi: 10.1111/j.1360-0443.2004.00883.x.","Des Jarlais DC","Addiction","2004","2004/09/17","","","10.1111/j.1360-0443.2004.00883.x"
"15369209","Effects of a high-dose fast tapering buprenorphine detoxification program on symptom relief and treatment retention","Palmstierna T.","J Psychoactive Drugs. 2004 Jun;36(2):273-7. doi: 10.1080/02791072.2004.10399738.","Palmstierna T","J Psychoactive Drugs","2004","2004/09/17","","","10.1080/02791072.2004.10399738"
"15366107","New pharmacological tool approved for opioid addiction","Sansovich D.","HIV Clin. 2004 Summer;16(3):9-11.","Sansovich D","HIV Clin","2004","2004/09/16","","",""
"15364630","Bupreorphine:a new pharmacotherapy for opioid addictions treatment","Stock C, Shum JH.","J Pain Palliat Care Pharmacother. 2004;18(3):35-54.","Stock C","J Pain Palliat Care Pharmacother","2004","2004/09/15","","",""
"15363957","Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist","Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, Woods JH, Traynor JR.","Eur J Pharmacol. 2004 Sep 19;499(1-2):107-16. doi: 10.1016/j.ejphar.2004.07.097.","Neilan CL","Eur J Pharmacol","2004","2004/09/15","","","10.1016/j.ejphar.2004.07.097"
"15362084","Post-marketing surveillance of buprenorphine","Ray R, Pal H, Kumar R, Maulick P, Mangla R.","Pharmacoepidemiol Drug Saf. 2004 Sep;13(9):615-9. doi: 10.1002/pds.975.","Ray R","Pharmacoepidemiol Drug Saf","2004","2004/09/14","","","10.1002/pds.975"
"15355756","Recent advances in the treatment of opiate addiction","Fudala PJ, Woody GW.","Curr Psychiatry Rep. 2004 Oct;6(5):339-46. doi: 10.1007/s11920-004-0020-1.","Fudala PJ","Curr Psychiatry Rep","2004","2004/09/10","","","10.1007/s11920-004-0020-1"
"15354595","Pharmacological treatments for substance use disorders","Bailey KP.","J Psychosoc Nurs Ment Health Serv. 2004 Aug;42(8):14-20.","Bailey KP","J Psychosoc Nurs Ment Health Serv","2004","2004/09/10","","",""
"15349002","Effects of high-dose intravenous buprenorphine in experienced opioid abusers","Umbricht A, Huestis MA, Cone EJ, Preston KL.","J Clin Psychopharmacol. 2004 Oct;24(5):479-87. doi: 10.1097/01.jcp.0000138766.15858.c6.","Umbricht A","J Clin Psychopharmacol","2004","2004/09/07","","","10.1097/01.jcp.0000138766.15858.c6"
"15340216","Over-expressed Bcl-2 cannot suppress apoptosis via the mitochondria in buprenorphine hydrochloride-treated NG108-15 cells","Kugawa F, Nakamura M, Ueno A, Aoki M.","Biol Pharm Bull. 2004 Sep;27(9):1340-7. doi: 10.1248/bpb.27.1340.","Kugawa F","Biol Pharm Bull","2004","2004/09/02","","","10.1248/bpb.27.1340"
"15334848","Relationships between a proprietary index, bispectral index, and hemodynamic variables as a means for evaluating depth of anesthesia in dogs anesthetized with sevoflurane","Carrasco-Jiménez MS, Martín Cancho MF, Lima JR, Crisóstomo V, Usón-Gargallo J, Ezquerra LJ.","Am J Vet Res. 2004 Aug;65(8):1128-35. doi: 10.2460/ajvr.2004.65.1128.","Carrasco-Jiménez MS","Am J Vet Res","2004","2004/09/01","","","10.2460/ajvr.2004.65.1128"
"15319805","Pupillometry in the detection of concomitant drug use in opioid-maintained patients","Murillo R, Crucilla C, Schmittner J, Hotchkiss E, Pickworth WB.","Methods Find Exp Clin Pharmacol. 2004 May;26(4):271-5.","Murillo R","Methods Find Exp Clin Pharmacol","2004","2004/08/21","","",""
"15283822","Buprenorphine blocks withdrawal in morphine-dependent rat pups","Stoller DC, Smith FL.","Paediatr Anaesth. 2004 Aug;14(8):642-9. doi: 10.1111/j.1460-9592.2004.01264.x.","Stoller DC","Paediatr Anaesth","2004","2004/07/31","","","10.1111/j.1460-9592.2004.01264.x"
"15279126","Counseling buprenorphine patients: information and treatment approaches for counselors","McCann MJ.","J Psychoactive Drugs. 2004 May;Suppl 2:139-46. doi: 10.1080/02791072.2004.10400049.","McCann MJ","J Psychoactive Drugs","2004","2004/07/29","","","10.1080/02791072.2004.10400049"
"15279125","Evolving use of buprenorphine in the treatment of addiction","Martin J.","J Psychoactive Drugs. 2004 May;Suppl 2:129-37. doi: 10.1080/02791072.2004.10400048.","Martin J","J Psychoactive Drugs","2004","2004/07/29","","","10.1080/02791072.2004.10400048"
"15279124","Buprenorphine in the treatment of opiate dependence: its pharmacology and social context of use in the U.S","Wesson DR.","J Psychoactive Drugs. 2004 May;Suppl 2:119-28. doi: 10.1080/02791072.2004.10400047.","Wesson DR","J Psychoactive Drugs","2004","2004/07/29","","","10.1080/02791072.2004.10400047"
"15279123","Diffusion of substance abuse treatment: will buprenorphine be a success?","Ling W, Cunningham-Rathner J, Rawson R.","J Psychoactive Drugs. 2004 May;Suppl 2:115-7. doi: 10.1080/02791072.2004.10400046.","Ling W","J Psychoactive Drugs","2004","2004/07/29","","","10.1080/02791072.2004.10400046"
"15275790","Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses","Martucci C, Panerai AE, Sacerdote P.","Pain. 2004 Jul;110(1-2):385-92. doi: 10.1016/j.pain.2004.04.020.","Martucci C","Pain","2004","2004/07/28","","","10.1016/j.pain.2004.04.020"
"15270376","Self-reported drug use and urinalysis results","Jain R.","Indian J Physiol Pharmacol. 2004 Jan;48(1):101-5.","Jain R","Indian J Physiol Pharmacol","2004","2004/07/24","","",""
"15269931","Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database","Pradel V, Thirion X, Ronfle E, Masut A, Micallef J, Bégaud B.","Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):473-81. doi: 10.1002/pds.892.","Pradel V","Pharmacoepidemiol Drug Saf","2004","2004/07/23","","","10.1002/pds.892"
"15266465","Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","Mattick RP, Kimber J, Breen C, Davoli M.","Cochrane Database Syst Rev. 2004;(3):CD002207. doi: 10.1002/14651858.CD002207.pub2.","Mattick RP","Cochrane Database Syst Rev","2004","2004/07/22","","","10.1002/14651858.CD002207.pub2"
"15265095","A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths","Pirnay S, Borron SW, Giudicelli CP, Tourneau J, Baud FJ, Ricordel I.","Addiction. 2004 Aug;99(8):978-88. doi: 10.1111/j.1360-0443.2004.00790.x.","Pirnay S","Addiction","2004","2004/07/22","","","10.1111/j.1360-0443.2004.00790.x"
"15258440","Buprenorphine maintenance: office-based treatment with addiction clinic support","Ortner R, Jagsch R, Schindler SD, Primorac A, Fischer G; General Practitioner Addiction Team.","Eur Addict Res. 2004;10(3):105-11. doi: 10.1159/000077698.","Ortner R","Eur Addict Res","2004","2004/07/20","","","10.1159/000077698"
"15255831","Possible manic potential of buprenorphine","Jagadheesan K, Muirhead D.","Aust N Z J Psychiatry. 2004 Jul;38(7):560-1. doi: 10.1111/j.1440-1614.2004.01411.x.","Jagadheesan K","Aust N Z J Psychiatry","2004","2004/07/17","","","10.1111/j.1440-1614.2004.01411.x"
"15253276","Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations","Thompson AC, Kristal MB, Sallaj A, Acheson A, Martin LB, Martin T.","Comp Med. 2004 Jun;54(3):293-300.","Thompson AC","Comp Med","2004","2004/07/16","","",""
"15246701","Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling","Hou Y, Tan Y, Belcheva MM, Clark AL, Zahm DS, Coscia CJ.","Brain Res Dev Brain Res. 2004 Jul 19;151(1-2):149-57. doi: 10.1016/j.devbrainres.2004.05.002.","Hou Y","Brain Res Dev Brain Res","2004","2004/07/13","","","10.1016/j.devbrainres.2004.05.002"
"15240036","Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens","Cirimele V, Etienne S, Villain M, Ludes B, Kintz P.","Forensic Sci Int. 2004 Jul 16;143(2-3):153-6. doi: 10.1016/j.forsciint.2004.02.035.","Cirimele V","Forensic Sci Int","2004","2004/07/09","","","10.1016/j.forsciint.2004.02.035"
"15240031","The development and application of a rapid gas chromatography-mass spectrometry method to monitor buprenorphine withdrawal protocols","George S, George C, Chauhan M.","Forensic Sci Int. 2004 Jul 16;143(2-3):121-5. doi: 10.1016/j.forsciint.2004.03.024.","George S","Forensic Sci Int","2004","2004/07/09","","","10.1016/j.forsciint.2004.03.024"
"15235624","What's your diagnosis? Respiratory distress in rats","Bosgraaf CA, Suchy H, Harrison C, Toth LA.","Lab Anim (NY). 2004 Mar;33(3):21-2. doi: 10.1038/laban0304-21.","Bosgraaf CA","Lab Anim (NY)","2004","2004/07/06","","","10.1038/laban0304-21"
"15234740","[Acute pancreatitis after intravenous buprenorphine misuse in a heroin addict]","Sepulveda S, Dermine H, Mulot A, Villard M, Haberer JP.","Ann Fr Anesth Reanim. 2004 Jun;23(6):658-9. doi: 10.1016/j.annfar.2004.03.006.","Sepulveda S","Ann Fr Anesth Reanim","2004","2004/07/06","","","10.1016/j.annfar.2004.03.006"
"15232010","Office-based buprenorphine offers a second chance","Sederer LI, Kolodny A.","Psychiatr Serv. 2004 Jul;55(7):743. doi: 10.1176/appi.ps.55.7.743.","Sederer LI","Psychiatr Serv","2004","2004/07/03","","","10.1176/appi.ps.55.7.743"
"15225887","Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome","Gerra G, Borella F, Zaimovic A, Moi G, Bussandri M, Bubici C, Bertacca S.","Drug Alcohol Depend. 2004 Jul 15;75(1):37-45. doi: 10.1016/j.drugalcdep.2003.11.017.","Gerra G","Drug Alcohol Depend","2004","2004/07/01","","","10.1016/j.drugalcdep.2003.11.017"
"15223097","Opioid detoxification using high doses of buprenorphine in 24 hours: a randomized, double blind, controlled clinical trial","Assadi SM, Hafezi M, Mokri A, Razzaghi EM, Ghaeli P.","J Subst Abuse Treat. 2004 Jul;27(1):75-82. doi: 10.1016/j.jsat.2004.05.002.","Assadi SM","J Subst Abuse Treat","2004","2004/06/30","","","10.1016/j.jsat.2004.05.002"
"15217203","Relationship between Tridimensional Personality Questionnaire scores and clinic attendance among cocaine abusing, buprenorphine maintained outpatients","Roll JM, Saules KK, Chudzynski JE, Sodano R.","Subst Use Misuse. 2004 May;39(6):1025-40. doi: 10.1081/ja-120030898.","Roll JM","Subst Use Misuse","2004","2004/06/26","","","10.1081/ja-120030898"
"15204675","Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience","Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.","Am J Addict. 2004;13 Suppl 1(Suppl 1):S42-66. doi: 10.1080/10550490490440807.","Amass L","Am J Addict","2004","2004/06/19","PMC1255908","NIHMS5111","10.1080/10550490490440807"
"15204674","Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial","Lintzeris N, Ritter A, Panjari M, Clark N, Kutin J, Bammer G.","Am J Addict. 2004;13 Suppl 1:S29-41. doi: 10.1080/10550490490440799.","Lintzeris N","Am J Addict","2004","2004/06/19","","","10.1080/10550490490440799"
"15204673","French field experience with buprenorphine","Auriacombe M, Fatséas M, Dubernet J, Daulouède JP, Tignol J.","Am J Addict. 2004;13 Suppl 1:S17-28. doi: 10.1080/10550490490440780.","Auriacombe M","Am J Addict","2004","2004/06/19","","","10.1080/10550490490440780"
"15204672","Challenges in increasing access to buprenorphine treatment for opiate addiction","West JC, Kosten TR, Wilk J, Svikis D, Triffleman E, Rae DS, Narrow WE, Duffy FF, Regier DA.","Am J Addict. 2004;13 Suppl 1:S8-16. doi: 10.1080/10550490490440753.","West JC","Am J Addict","2004","2004/06/19","","","10.1080/10550490490440753"
"15204671","Buprenorphine for office-based practice: consensus conference overview","Kosten TR, Fiellin DA; U.S. National Buprenorphine Implementation Program.","Am J Addict. 2004;13 Suppl 1:S1-7. doi: 10.1080/10550490490440744.","Kosten TR","Am J Addict","2004","2004/06/19","","","10.1080/10550490490440744"
"15204669","Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone","Kosten T, Falcioni J, Oliveto A, Feingold A.","Am J Addict. 2004 Mar-Apr;13(2):191-201. doi: 10.1080/10550490490435966.","Kosten T","Am J Addict","2004","2004/06/19","","","10.1080/10550490490435966"
"15203048","Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study","Pirnay S, Bouchonnet S, Hervé F, Libong D, Milan N, D'Athis P, Baud F, Ricordel I.","J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Aug 5;807(2):335-42. doi: 10.1016/j.jchromb.2004.04.029.","Pirnay S","J Chromatogr B Analyt Technol Biomed Life Sci","2004","2004/06/19","","","10.1016/j.jchromb.2004.04.029"
"15200007","Development of mucoadhesive dosage forms of buprenorphine for sublingual drug delivery","Das NG, Das SK.","Drug Deliv. 2004 Mar-Apr;11(2):89-95. doi: 10.1080/10717540490280688.","Das NG","Drug Deliv","2004","2004/06/18","","","10.1080/10717540490280688"
"15182896","Network therapy: decreased secondary opioid use during buprenorphine maintenance","Galanter M, Dermatis H, Glickman L, Maslansky R, Sellers MB, Neumann E, Rahman-Dujarric C.","J Subst Abuse Treat. 2004 Jun;26(4):313-8. doi: 10.1016/j.jsat.2004.03.002.","Galanter M","J Subst Abuse Treat","2004","2004/06/09","","","10.1016/j.jsat.2004.03.002"
"15181649","Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?","Costa E Silva JA.","Hum Psychopharmacol. 2004 Jun;19(4):215-24. doi: 10.1002/hup.588.","Costa E Silva JA","Hum Psychopharmacol","2004","2004/06/08","","","10.1002/hup.588"
"15155266","Effects of anesthetics on systemic hemodynamics in mice","Janssen BJ, De Celle T, Debets JJ, Brouns AE, Callahan MF, Smith TL.","Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1618-24. doi: 10.1152/ajpheart.01192.2003. Epub 2004 May 20.","Janssen BJ","Am J Physiol Heart Circ Physiol","2004","2004/05/25","","","10.1152/ajpheart.01192.2003"
"15152448","Treatment options for opiate addiction","","J Ky Med Assoc. 2004 May;102(5):221-4.","","J Ky Med Assoc","2004","2004/05/22","","",""
"15148524","Effect of insulin hypoglycemic stress on nociceptive responses to mu- and kappa-opioid receptor agonists at LH-surge in female rats","Srivastava RK, Verma S, Tandon M.","Methods Find Exp Clin Pharmacol. 2004 Apr;26(3):189-94. doi: 10.1358/mf.2004.26.3.809725.","Srivastava RK","Methods Find Exp Clin Pharmacol","2004","2004/05/19","","","10.1358/mf.2004.26.3.809725"
"15145702","Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats","Bulka A, Kouya PF, Böttiger Y, Svensson JO, Xu XJ, Wiesenfeld-Hallin Z.","Eur J Pharmacol. 2004 May 10;492(1):27-34. doi: 10.1016/j.ejphar.2004.03.041.","Bulka A","Eur J Pharmacol","2004","2004/05/18","","","10.1016/j.ejphar.2004.03.041"
"15143980","Opioid consumption in hospitals of the Friuli-Venezia Giulia region: a four-year retrospective study","Bortolussi R, Spazzapan S, Lombardi D, Colussi AM, Veronesi A, Matovic M, De Cicco M.","Tumori. 2004 Jan-Feb;90(1):96-102.","Bortolussi R","Tumori","2004","2004/05/18","","",""
"15138444","Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats","Stinus L, Cador M, Zorrilla EP, Koob GF.","Neuropsychopharmacology. 2005 Jan;30(1):90-8. doi: 10.1038/sj.npp.1300487.","Stinus L","Neuropsychopharmacology","2005","2004/05/13","","","10.1038/sj.npp.1300487"
"15135650","Apoptosis-like cell death of human breast cancer cell line MCF-7 induced by buprenorphine hydrochloride","Kugawa F, Matsumoto K, Aoki M.","Life Sci. 2004 Jun 4;75(3):287-99. doi: 10.1016/j.lfs.2003.11.032.","Kugawa F","Life Sci","2004","2004/05/12","","","10.1016/j.lfs.2003.11.032"
"15117415","The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728]","Oldham NS, Wright NM, Adams CE, Sheard L, Tompkins CN.","BMC Fam Pract. 2004 Apr 29;5:9. doi: 10.1186/1471-2296-5-9.","Oldham NS","BMC Fam Pract","2004","2004/05/01","PMC450295","","10.1186/1471-2296-5-9"
"15111917","Buprenorphine: a primer for emergency physicians","Sporer KA.","Ann Emerg Med. 2004 May;43(5):580-4. doi: 10.1016/S0196064403012058.","Sporer KA","Ann Emerg Med","2004","2004/04/28","","","10.1016/S0196064403012058"
"15100784","Poly(dimethylsiloxane) electrospray devices fabricated with diamond-like carbon-poly(dimethylsiloxane) coated SU-8 masters","Huikko K, Ostman P, Grigoras K, Tuomikoski S, Tiainen VM, Soininen A, Puolanne K, Manz A, Franssila S, Kostiainen R, Kotiaho T.","Lab Chip. 2003 May;3(2):67-72. doi: 10.1039/b300345k. Epub 2003 Mar 6.","Huikko K","Lab Chip","2003","2004/04/22","","","10.1039/b300345k"
"15100703","Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice","Ide S, Minami M, Satoh M, Uhl GR, Sora I, Ikeda K.","Neuropsychopharmacology. 2004 Sep;29(9):1656-63. doi: 10.1038/sj.npp.1300463.","Ide S","Neuropsychopharmacology","2004","2004/04/22","","","10.1038/sj.npp.1300463"
"15099664","A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers","Mintzer MZ, Correia CJ, Strain EC.","Drug Alcohol Depend. 2004 May 10;74(2):205-9. doi: 10.1016/j.drugalcdep.2003.12.008.","Mintzer MZ","Drug Alcohol Depend","2004","2004/04/22","","","10.1016/j.drugalcdep.2003.12.008"
"15089877","High dose buprenorphine in pregnancy","Ross D.","Aust N Z J Obstet Gynaecol. 2004 Feb;44(1):80. doi: 10.1111/j.1479-828X.2004.00167.x.","Ross D","Aust N Z J Obstet Gynaecol","2004","2004/04/20","","","10.1111/j.1479-828X.2004.00167.x"
"15080765","Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality","Harris DS, Mendelson JE, Lin ET, Upton RA, Jones RT.","Clin Pharmacokinet. 2004;43(5):329-40. doi: 10.2165/00003088-200443050-00005.","Harris DS","Clin Pharmacokinet","2004","2004/04/15","","","10.2165/00003088-200443050-00005"
"15072805","Relative bioavailability of different buprenorphine formulations under chronic dosing conditions","Strain EC, Moody DE, Stoller KB, Walsh SL, Bigelow GE.","Drug Alcohol Depend. 2004 Apr 9;74(1):37-43. doi: 10.1016/j.drugalcdep.2003.11.008.","Strain EC","Drug Alcohol Depend","2004","2004/04/10","","","10.1016/j.drugalcdep.2003.11.008"
"15063914","Training rural practitioners to use buprenorphine; using The Change Book to facilitate technology transfer","McCarty D, Rieckmann T, Green C, Gallon S, Knudsen J.","J Subst Abuse Treat. 2004 Apr;26(3):203-8. doi: 10.1016/S0740-5472(03)00247-2.","McCarty D","J Subst Abuse Treat","2004","2004/04/06","","","10.1016/S0740-5472(03)00247-2"
"15056480","Buprenorphine in the treatment of opioid dependence","Davids E, Gastpar M.","Eur Neuropsychopharmacol. 2004 May;14(3):209-16. doi: 10.1016/S0924-977X(03)00146-9.","Davids E","Eur Neuropsychopharmacol","2004","2004/04/02","","","10.1016/S0924-977X(03)00146-9"
"15050727","Buprenorphine reduces central sensitization after repetitive C-fiber stimulation in rats","Kouya PF, Xu XJ.","Neurosci Lett. 2004 Apr 8;359(1-2):127-9. doi: 10.1016/j.neulet.2004.02.007.","Kouya PF","Neurosci Lett","2004","2004/03/31","","","10.1016/j.neulet.2004.02.007"
"15049745","Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)","Digiusto E, Shakeshaft A, Ritter A, O'Brien S, Mattick RP; NEPOD Research Group.","Addiction. 2004 Apr;99(4):450-60. doi: 10.1111/j.1360-0443.2004.00654.x.","Digiusto E","Addiction","2004","2004/03/31","","","10.1111/j.1360-0443.2004.00654.x"
"15047123","Activation of nociceptive neurons in T9 and T10 in cerulein pancreatitis","Kim EH, Hoge SG, Lightner AM, Grady EF, Coelho AM, Kirkwood KS.","J Surg Res. 2004 Apr;117(2):195-201. doi: 10.1016/S0022-4804(03)00123-9.","Kim EH","J Surg Res","2004","2004/03/30","","","10.1016/S0022-4804(03)00123-9"
"15037219","Buprenorphine produces naltrexone reversible alterations of immune status","Carrigan KA, Saurer TB, Ijames SG, Lysle DT.","Int Immunopharmacol. 2004 Mar;4(3):419-28. doi: 10.1016/j.intimp.2004.01.011.","Carrigan KA","Int Immunopharmacol","2004","2004/03/24","","","10.1016/j.intimp.2004.01.011"
"15036544","Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews","Amato L, Davoli M, Ferri M, Gowing L, Perucci CA.","Drug Alcohol Depend. 2004 Mar 8;73(3):219-26. doi: 10.1016/j.drugalcdep.2003.11.002.","Amato L","Drug Alcohol Depend","2004","2004/03/24","","","10.1016/j.drugalcdep.2003.11.002"
"15029983","Controlled trial of maintenance treatment of intravenous buprenorphine dependence","Ahmadi J, Ahmadi K.","Ir J Med Sci. 2003 Oct-Dec;172(4):171-3. doi: 10.1007/BF02915283.","Ahmadi J","Ir J Med Sci","2003","2004/03/20","","","10.1007/BF02915283"
"15021279","Buprenorphine-soaked absorbable gelatin sponge: an alternative method for postlaminectomy pain relief","Mishra LD, Nath SS, Gairola RL, Verma RK, Mohanty S.","J Neurosurg Anesthesiol. 2004 Apr;16(2):115-21. doi: 10.1097/00008506-200404000-00002.","Mishra LD","J Neurosurg Anesthesiol","2004","2004/03/17","","","10.1097/00008506-200404000-00002"
"15011424","[Comparison of analgesics used during balanced anesthesia on the incidence of PONV]","Onaka M, Yamamoto H.","Masui. 2004 Feb;53(2):161-6.","Onaka M","Masui","2004","2004/03/12","","",""
"15004452","Maintenance therapy with synthetic opioids and driving aptitude","Schindler SD, Ortner R, Peternell A, Eder H, Opgenoorth E, Fischer G.","Eur Addict Res. 2004;10(2):80-7. doi: 10.1159/000076118.","Schindler SD","Eur Addict Res","2004","2004/03/09","","","10.1159/000076118"
"14991469","Oral etodolac, a COX-2 inhibitor, reduces postoperative pain immediately after fast-track cardiac surgery","Koizuka S, Saito S, Obata H, Sasaki M, Nishikawa K, Takahashi K, Saito Y, Goto F.","J Anesth. 2004;18(1):9-13. doi: 10.1007/s00540-003-0215-3.","Koizuka S","J Anesth","2004","2004/03/03","","","10.1007/s00540-003-0215-3"
"14769623","Treating opioid dependence. Growing implications for primary care","Krantz MJ, Mehler PS.","Arch Intern Med. 2004 Feb 9;164(3):277-88. doi: 10.1001/archinte.164.3.277.","Krantz MJ","Arch Intern Med","2004","2004/02/11","","","10.1001/archinte.164.3.277"
"14756713","Buprenorphine in pregnant opioid-dependent women: first results of a prospective study","Lacroix I, Berrebi A, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C.","Addiction. 2004 Feb;99(2):209-14. doi: 10.1046/j.1360-0443.2003.00600.x.","Lacroix I","Addiction","2004","2004/02/06","","","10.1046/j.1360-0443.2003.00600.x"
"14751421","Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients","Poirier MF, Laqueille X, Jalfre V, Willard D, Bourdel MC, Fermanian J, Olié JP.","Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):267-72. doi: 10.1016/j.pnpbp.2003.10.003.","Poirier MF","Prog Neuropsychopharmacol Biol Psychiatry","2004","2004/01/31","","","10.1016/j.pnpbp.2003.10.003"
"14749690","Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence","Montoya ID, Gorelick DA, Preston KL, Schroeder JR, Umbricht A, Cheskin LJ, Lange WR, Contoreggi C, Johnson RE, Fudala PJ.","Clin Pharmacol Ther. 2004 Jan;75(1):34-48. doi: 10.1016/j.clpt.2003.09.004.","Montoya ID","Clin Pharmacol Ther","2004","2004/01/30","PMC2633656","NIHMS81307","10.1016/j.clpt.2003.09.004"
"14745842","Microarray profile analysis of toxic cocaine-induced alterations in the expression of mouse brain gene sequences: a possible 'protective' effect of buprenorphine","Hayase T, Yamamoto Y, Yamamoto K, Muso E, Shiota K.","J Appl Toxicol. 2004 Jan-Feb;24(1):15-20. doi: 10.1002/jat.939.","Hayase T","J Appl Toxicol","2004","2004/01/28","","","10.1002/jat.939"
"14740599","Kinking of epidural catheter--a case report","Bajaj P, Raiger LK, Raman V.","Middle East J Anaesthesiol. 2003 Oct;17(3):463-6.","Bajaj P","Middle East J Anaesthesiol","2003","2004/01/27","","",""
"14723474","Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study","Tamaskar R, Parran TV Jr, Heggi A, Brateanu A, Rabb M, Yu J.","J Addict Dis. 2003;22(4):5-12. doi: 10.1300/j069v22n04_02.","Tamaskar R","J Addict Dis","2003","2004/01/16","","","10.1300/j069v22n04_02"
"14723473","The emperor' s new clothes","Schnoll SH.","J Addict Dis. 2003;22(4):1-4. doi: 10.1300/j069v22n04_01.","Schnoll SH","J Addict Dis","2003","2004/01/16","","","10.1300/j069v22n04_01"
"14713135","Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence","Sofuoglu M, Gonzalez G, Poling J, Kosten TR.","Am J Drug Alcohol Abuse. 2003;29(4):713-27. doi: 10.1081/ada-120026256.","Sofuoglu M","Am J Drug Alcohol Abuse","2003","2004/01/10","","","10.1081/ada-120026256"
"14708606","Sex differences in opioid-induced enhancement of contact hypersensitivity","Elliott JC, Picker MJ, Nelson CJ, Carrigan KA, Lysle DT.","J Invest Dermatol. 2003 Nov;121(5):1053-9. doi: 10.1046/j.1523-1747.2003.12569.x.","Elliott JC","J Invest Dermatol","2003","2004/01/08","","","10.1046/j.1523-1747.2003.12569.x"
"14698800","Twelve-month maintenance treatment of opium-dependent patients","Ahmadi J, Babaee-Beigi M, Alishahi M, Maany I, Hidari T.","J Subst Abuse Treat. 2004 Jan;26(1):363-6. doi: 10.1016/s0740-5472(03)00141-7.","Ahmadi J","J Subst Abuse Treat","2004","2003/12/31","","","10.1016/s0740-5472(03)00141-7"
"14695422","Office-based treatment of opiate addiction","Heit HA, Gourlay DL.","N Engl J Med. 2003 Dec 25;349(26):2567-8; author reply 2567-8. doi: 10.1056/NEJM200312253492619.","Heit HA","N Engl J Med","2003","2003/12/26","","","10.1056/NEJM200312253492619"
"14687955","Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification","Sobel BF, Sigmon SC, Walsh SL, Johnson RE, Liebson IA, Nuwayser ES, Kerrigan JH, Bigelow GE.","Drug Alcohol Depend. 2004 Jan 7;73(1):11-22. doi: 10.1016/j.drugalcdep.2003.08.006.","Sobel BF","Drug Alcohol Depend","2004","2003/12/23","","","10.1016/j.drugalcdep.2003.08.006"
"14687954","Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors","Darke S, Ross J, Lynskey M, Teesson M.","Drug Alcohol Depend. 2004 Jan 7;73(1):1-10. doi: 10.1016/j.drugalcdep.2003.08.008.","Darke S","Drug Alcohol Depend","2004","2003/12/23","","","10.1016/j.drugalcdep.2003.08.008"
"14682200","[Peritonitis after high-dose buprenorphine (Subutex) use: apropos of a case]","Nguyen N, Spadari M, Ruiz JM, Camprasse MA, Galinier A, Jean-Pastor MJ, Valli M.","Therapie. 2003 Sep-Oct;58(5):469-71. doi: 10.2515/therapie:2003078.","Nguyen N","Therapie","2003","2003/12/20","","","10.2515/therapie:2003078"
"14661566","[Comparison of requirement for postoperative analgesics after inhalation and total intravenous anesthesia]","Kamata K, Nagata O, Iwakiri H, Ozaki M.","Masui. 2003 Nov;52(11):1200-3.","Kamata K","Masui","2003","2003/12/10","","",""
"14660137","Crushing buprenorphine tablets","Muhleisen P, Spence J, Nielsen S.","Drug Alcohol Rev. 2003 Dec;22(4):471-2. doi: 10.1080/09595230310001613994.","Muhleisen P","Drug Alcohol Rev","2003","2003/12/09","","","10.1080/09595230310001613994"
"14660133","Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users","Lubman D, Koutsogiannis Z, Kronborg I.","Drug Alcohol Rev. 2003 Dec;22(4):433-6. doi: 10.1080/09595230310001613958.","Lubman D","Drug Alcohol Rev","2003","2003/12/09","","","10.1080/09595230310001613958"
"14649343","Improvement in postoperative pain relief by the addition of midazolam to an intrathecal injection of buprenorphine and bupivacaine","Shah FR, Halbe AR, Panchal ID, Goodchild CS.","Eur J Anaesthesiol. 2003 Nov;20(11):904-10. doi: 10.1017/s0265021503001455.","Shah FR","Eur J Anaesthesiol","2003","2003/12/03","","","10.1017/s0265021503001455"
"14643947","Opiate maintenance with buprenorphine in ambulatory care: a 24-week follow-up study of new users","Lapeyre-Mestre M, Llau ME, Gony M, Navel AM, Bez J, Grau M, Montastruc JL.","Drug Alcohol Depend. 2003 Dec 11;72(3):297-303. doi: 10.1016/j.drugalcdep.2003.08.005.","Lapeyre-Mestre M","Drug Alcohol Depend","2003","2003/12/04","","","10.1016/j.drugalcdep.2003.08.005"
"14643944","The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving","Lenné MG, Dietze P, Rumbold GR, Redman JR, Triggs TJ.","Drug Alcohol Depend. 2003 Dec 11;72(3):271-8. doi: 10.1016/j.drugalcdep.2003.08.002.","Lenné MG","Drug Alcohol Depend","2003","2003/12/04","","","10.1016/j.drugalcdep.2003.08.002"
"14626165","[Opioid-related disorders]","Funada M.","Ryoikibetsu Shokogun Shirizu. 2003;(40):480-3.","Funada M","Ryoikibetsu Shokogun Shirizu","2003","2003/11/25","","",""
"14621350","Public policy statement on buprenorphine for opiate dependence and withdrawal","","J Addict Dis. 2003;22(3):113-4.","","J Addict Dis","2003","2003/11/19","","",""
"14621343","Short-term buprenorphine maintenance: treatment outcome","Galanter M, Dermatis H, Resnick R, Maslansky R, Neumann E.","J Addict Dis. 2003;22(3):39-49. doi: 10.1300/J069v22n03_04.","Galanter M","J Addict Dis","2003","2003/11/19","","","10.1300/J069v22n03_04"
"14616190","Comments on Mattick et al.: the need for independent data re-analyses","Caplehorn J.","Addiction. 2003 Nov;98(11):1633-4. doi: 10.1046/j.1360-0443.2003.00547.x.","Caplehorn J","Addiction","2003","2003/11/18","","","10.1046/j.1360-0443.2003.00547.x"
"14616186","Buprenorphine withdrawal syndrome in newborns: a report of 13 cases","Kayemba-Kay's S, Laclyde JP.","Addiction. 2003 Nov;98(11):1599-604. doi: 10.1046/j.1360-0443.2003.00551.x.","Kayemba-Kay's S","Addiction","2003","2003/11/18","","","10.1046/j.1360-0443.2003.00551.x"
"14616185","Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France","Guichard A, Lert F, Calderon C, Gaigi H, Maguet O, Soletti J, Brodeur JM, Richard L, Benigeri M, Zunzunegui MV.","Addiction. 2003 Nov;98(11):1585-97. doi: 10.1046/j.1360-0443.2003.00500.x.","Guichard A","Addiction","2003","2003/11/18","","","10.1046/j.1360-0443.2003.00500.x"
"14615956","Recovery of male rats from major abdominal surgery after treatment with various analgesics","Sharp J, Zammit T, Azar T, Lawson D.","Contemp Top Lab Anim Sci. 2003 Nov;42(6):22-7.","Sharp J","Contemp Top Lab Anim Sci","2003","2003/11/18","","",""
"14615874","Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations","Tzschentke TM.","Psychopharmacology (Berl). 2004 Feb;172(1):58-67. doi: 10.1007/s00213-003-1626-4. Epub 2003 Nov 13.","Tzschentke TM","Psychopharmacology (Berl)","2004","2003/11/15","","","10.1007/s00213-003-1626-4"
"14614092","Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors","Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ.","J Neurosci. 2003 Nov 12;23(32):10331-7. doi: 10.1523/JNEUROSCI.23-32-10331.2003.","Lutfy K","J Neurosci","2003","2003/11/14","PMC6741014","","10.1523/JNEUROSCI.23-32-10331.2003"
"14609426","A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial","Caplehorn JR.","Med J Aust. 2003 Nov 17;179(10):557-8; author reply 558.","Caplehorn JR","Med J Aust","2003","2003/11/12","","",""
"14607012","Buprenorphine in drug-facilitated sexual abuse: a fatal case involving a 14-year-old boy","Kintz P, Villain M, Tracqui A, Cirimele V, Ludes B.","J Anal Toxicol. 2003 Oct;27(7):527-9. doi: 10.1093/jat/27.7.527.","Kintz P","J Anal Toxicol","2003","2003/11/11","","","10.1093/jat/27.7.527"
"14607001","Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry","Kronstrand R, Seldén TG, Josefsson M.","J Anal Toxicol. 2003 Oct;27(7):464-70. doi: 10.1093/jat/27.7.464.","Kronstrand R","J Anal Toxicol","2003","2003/11/11","","","10.1093/jat/27.7.464"
"14604460","Opioid system in depression","Matussek N.","Int J Neuropsychopharmacol. 2003 Dec;6(4):443. doi: 10.1017/S1461145703003808.","Matussek N","Int J Neuropsychopharmacol","2003","2003/11/08","","","10.1017/S1461145703003808"
"14597216","No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters","D'Elia M, Patenaude J, Hamelin C, Garrel DR, Bernier J.","Clin Immunol. 2003 Nov;109(2):179-87. doi: 10.1016/s1521-6616(03)00177-3.","D'Elia M","Clin Immunol","2003","2003/11/05","","","10.1016/s1521-6616(03)00177-3"
"14587179","[Substitution study. Is it allowed to give placebos to junkies?]","Ullmann R.","MMW Fortschr Med. 2003 Jul 10;145(27-28):13.","Ullmann R","MMW Fortschr Med","2003","2003/11/01","","",""
"14584576","Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine","Robertson SA, Taylor PM, Lascelles BD, Dixon MJ.","Vet Rec. 2003 Oct 11;153(15):462-5. doi: 10.1136/vr.153.15.462.","Robertson SA","Vet Rec","2003","2003/10/31","","","10.1136/vr.153.15.462"
"14582802","Substitution management in opioid dependence","Uchtenhagen A.","J Neural Transm Suppl. 2003;(66):33-60. doi: 10.1007/978-3-7091-0541-2_3.","Uchtenhagen A","J Neural Transm Suppl","2003","2003/10/30","","","10.1007/978-3-7091-0541-2_3"
"14578583","Pyrogens enhance beta-endorphin release in hypothalamus and trigger fever that can be attenuated by buprenorphine","Tsai SM, Lin MT, Wang JJ, Huang WT.","J Pharmacol Sci. 2003 Oct;93(2):155-62. doi: 10.1254/jphs.93.155.","Tsai SM","J Pharmacol Sci","2003","2003/10/28","","","10.1254/jphs.93.155"
"14563545","Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naïve healthy male volunteers under a naltrexone block","McAleer SD, Mills RJ, Polack T, Hussain T, Rolan PE, Gibbs AD, Mullins FG, Hussein Z.","Drug Alcohol Depend. 2003 Oct 24;72(1):75-83. doi: 10.1016/s0376-8716(03)00188-1.","McAleer SD","Drug Alcohol Depend","2003","2003/10/18","","","10.1016/s0376-8716(03)00188-1"
"14563539","Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users","Carrieri MP, Rey D, Loundou A, Lepeu G, Sobel A, Obadia Y; MANIF-2000 Study Group.","Drug Alcohol Depend. 2003 Oct 24;72(1):13-21. doi: 10.1016/s0376-8716(03)00189-3.","Carrieri MP","Drug Alcohol Depend","2003","2003/10/18","","","10.1016/s0376-8716(03)00189-3"
"14556394","[Substitutions therapy of opiate addiction in Denmark]","Ishøy T, Iversen C.","Ugeskr Laeger. 2003 Sep 15;165(38):3620-3.","Ishøy T","Ugeskr Laeger","2003","2003/10/15","","",""
"14556390","[Buprenorphine as opioid substitution to pregnant addicts]","Rasmussen ET, Nielsen LB.","Ugeskr Laeger. 2003 Sep 15;165(38):3607-8.","Rasmussen ET","Ugeskr Laeger","2003","2003/10/15","","",""
"14556389","[Substitution therapy with buprenorphine to pregnant women with opioid dependency]","Olofsson MJ, Ege PP.","Ugeskr Laeger. 2003 Sep 15;165(38):3605.","Olofsson MJ","Ugeskr Laeger","2003","2003/10/15","","",""
"14510037","Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management","Gonzalez G, Feingold A, Oliveto A, Gonsai K, Kosten TR.","Am J Drug Alcohol Abuse. 2003 Aug;29(3):497-514. doi: 10.1081/ada-120023455.","Gonzalez G","Am J Drug Alcohol Abuse","2003","2003/09/27","","","10.1081/ada-120023455"
"14504028","Transferring methadone-maintained outpatients to the buprenorphine sublingual tablet: a preliminary study","Greenwald MK, Schuh KJ, Stine SM.","Am J Addict. 2003 Jul-Sep;12(4):365-74.","Greenwald MK","Am J Addict","2003","2003/09/25","","",""
"14498854","Hormonal, metabolic and physiological effects of laparoscopic surgery using a detomidine-buprenorphine combination in standing horses","van Dijk P, Lankveld DP, Rijkenhuizen AB, Jonker FH.","Vet Anaesth Analg. 2003 Apr;30(2):72-80.","van Dijk P","Vet Anaesth Analg","2003","2003/09/23","","",""
"12962515","Transdermal buprenorphine","Evans HC, Easthope SE.","Drugs. 2003;63(19):1999-2010; discussion 2011-2. doi: 10.2165/00003495-200363190-00003.","Evans HC","Drugs","2003","2003/09/10","","","10.2165/00003495-200363190-00003"
"12959012","[Reduced drug craving and better social function with buprenorphine therapy. Combination therapy as an alternative to methadone therapy in heroin addiction]","Heilig M, Kakko J.","Lakartidningen. 2003 Aug 7;100(32-33):2526-7.","Heilig M","Lakartidningen","2003","2003/09/10","","",""
"12957347","Buprenorphine versus methadone maintenance: a cost-effectiveness analysis","Doran CM, Shanahan M, Mattick RP, Ali R, White J, Bell J.","Drug Alcohol Depend. 2003 Sep 10;71(3):295-302. doi: 10.1016/s0376-8716(03)00169-8.","Doran CM","Drug Alcohol Depend","2003","2003/09/06","","","10.1016/s0376-8716(03)00169-8"
"12954802","Capsaicin-induced hyperalgesia and mu-opioid-induced antihyperalgesia in male and female Fischer 344 rats","Barrett AC, Smith ES, Picker MJ.","J Pharmacol Exp Ther. 2003 Oct;307(1):237-45. doi: 10.1124/jpet.103.054478. Epub 2003 Sep 3.","Barrett AC","J Pharmacol Exp Ther","2003","2003/09/05","","","10.1124/jpet.103.054478"
"12954743","Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D; Buprenorphine/Naloxone Collaborative Study Group.","N Engl J Med. 2003 Sep 4;349(10):949-58. doi: 10.1056/NEJMoa022164.","Fudala PJ","N Engl J Med","2003","2003/09/05","","","10.1056/NEJMoa022164"
"12954740","Office-based practice and opioid-use disorders","Clark HW.","N Engl J Med. 2003 Sep 4;349(10):928-30. doi: 10.1056/NEJMp038126.","Clark HW","N Engl J Med","2003","2003/09/05","","","10.1056/NEJMp038126"
"12925043","Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study","Ahmadi J, Ahmadi K, Ohaeri J.","Eur J Clin Invest. 2003 Sep;33(9):824-9. doi: 10.1046/j.1365-2362.2003.01218.x.","Ahmadi J","Eur J Clin Invest","2003","2003/08/20","","","10.1046/j.1365-2362.2003.01218.x"
"12924108","[Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain]","Likar R, Griessinger N, Sadjak A, Sittl R.","Wien Med Wochenschr. 2003;153(13-14):317-22. doi: 10.1046/j.1563-258x.2003.02120.x.","Likar R","Wien Med Wochenschr","2003","2003/08/20","","","10.1046/j.1563-258x.2003.02120.x"
"12920942","[Substitution therapy in drug addictions]","Auriacombe M, Fatseas M, Franques-Rénéric P, Daulouède JP, Tignol J.","Rev Prat. 2003 Jun 15;53(12):1327-34.","Auriacombe M","Rev Prat","2003","2003/08/19","","",""
"12915411","Office-based primary care physicians called on to treat the ""new"" addict","Mitka M.","JAMA. 2003 Aug 13;290(6):735-6. doi: 10.1001/jama.290.6.735.","Mitka M","JAMA","2003","2003/08/14","","","10.1001/jama.290.6.735"
"12915410","In-office opiate treatment ""not a panacea"": physicians slow to embrace therapeutic option","Vastag B.","JAMA. 2003 Aug 13;290(6):731-5. doi: 10.1001/jama.290.6.731.","Vastag B","JAMA","2003","2003/08/14","","","10.1001/jama.290.6.731"
"12910035","[Maintenance treatment for opiate dependence. Which should we deliver and how should we prescribe it?]","Jacquiez O.","Ann Med Interne (Paris). 2003 Jun;154 Spec No 1:S55-7.","Jacquiez O","Ann Med Interne (Paris)","2003","2003/08/12","","",""
"12910032","[High dosage buprenorphine and injection practices. A study of 303 patients]","Courty P.","Ann Med Interne (Paris). 2003 Jun;154 Spec No 1:S35-45.","Courty P","Ann Med Interne (Paris)","2003","2003/08/12","","",""
"12910030","[Analysis of drug consumption among ambulatory patients in a drug agency of Northern France (Lens)]","Brunelle E.","Ann Med Interne (Paris). 2003 Jun;154 Spec No 1:S15-23.","Brunelle E","Ann Med Interne (Paris)","2003","2003/08/12","","",""
"12910029","[High-dose buprenorphine prescription in southern France from 1999 to 2001]","Mancini J, Thirion X, Masut A, Ronflé E, Coudert C, Pradel V, Frauger E, Micallef J.","Ann Med Interne (Paris). 2003 Jun;154 Spec No 1:S7-14.","Mancini J","Ann Med Interne (Paris)","2003","2003/08/12","","",""
"12909198","Behavioral evidence for mu-opioid and 5-HT2A receptor interactions","Marek GJ.","Eur J Pharmacol. 2003 Aug 1;474(1):77-83. doi: 10.1016/s0014-2999(03)01971-x.","Marek GJ","Eur J Pharmacol","2003","2003/08/12","","","10.1016/s0014-2999(03)01971-x"
"12904197","Serious overdoses involving buprenorphine in Helsinki","Boyd J, Randell T, Luurila H, Kuisma M.","Acta Anaesthesiol Scand. 2003 Sep;47(8):1031-3. doi: 10.1034/j.1399-6576.2003.00201.x.","Boyd J","Acta Anaesthesiol Scand","2003","2003/08/09","","","10.1034/j.1399-6576.2003.00201.x"
"12902992","Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK.","Neuropsychopharmacology. 2003 Nov;28(11):2000-9. doi: 10.1038/sj.npp.1300251.","Greenwald MK","Neuropsychopharmacology","2003","2003/08/07","","","10.1038/sj.npp.1300251"
"12901482","Managing opioid dependence. Comparing buprenorphine with methadone","Cavacuiti C, Selby P.","Can Fam Physician. 2003 Jul;49:876-7.","Cavacuiti C","Can Fam Physician","2003","2003/08/07","PMC2214263","",""
"12899952","Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry","Ceccato A, Klinkenberg R, Hubert P, Streel B.","J Pharm Biomed Anal. 2003 Aug 8;32(4-5):619-31. doi: 10.1016/s0731-7085(03)00169-9.","Ceccato A","J Pharm Biomed Anal","2003","2003/08/06","","","10.1016/s0731-7085(03)00169-9"
"12884887","Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone","Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR.","Arch Gen Psychiatry. 1999 Sep;56(9):812-20. doi: 10.1001/archpsyc.56.9.812.","Oliveto AH","Arch Gen Psychiatry","1999","2003/07/30","","","10.1001/archpsyc.56.9.812"
"12875273","Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002","Colker AC.","Issue Brief Health Policy Track Serv. 2002 Dec 31:1-6.","Colker AC","Issue Brief Health Policy Track Serv","2002","2003/07/24","","",""
"12869624","Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons","Zollner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, Schafer M.","Mol Pharmacol. 2003 Aug;64(2):202-10. doi: 10.1124/mol.64.2.202.","Zollner C","Mol Pharmacol","2003","2003/07/19","","","10.1124/mol.64.2.202"
"12857659","Pharmacologic treatments for heroin and cocaine dependence","Kleber HD.","Am J Addict. 2003;12(s2):S5-S18.","Kleber HD","Am J Addict","2003","2003/07/15","","",""
"12838444","[Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine]","Haro G, Cervera G, Martínez-Raga J, Pérez-Gálvez B, Fernández-Garcés M, Sanjuan J.","Actas Esp Psiquiatr. 2003 Jul-Aug;31(4):205-19.","Haro G","Actas Esp Psiquiatr","2003","2003/07/03","","",""
"12831383","A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial","Gibson AE, Doran CM, Bell JR, Ryan A, Lintzeris N.","Med J Aust. 2003 Jul 7;179(1):38-42.","Gibson AE","Med J Aust","2003","2003/07/02","","",""
"12821205","Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions","Breen CL, Harris SJ, Lintzeris N, Mattick RP, Hawken L, Bell J, Ritter AJ, Lenné M, Mendoza E.","Drug Alcohol Depend. 2003 Jul 20;71(1):49-55. doi: 10.1016/s0376-8716(03)00071-1.","Breen CL","Drug Alcohol Depend","2003","2003/06/25","","","10.1016/s0376-8716(03)00071-1"
"12810142","Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients","Ahmadi J.","J Subst Abuse Treat. 2003 Apr;24(3):217-20. doi: 10.1016/s0740-5472(03)00024-2.","Ahmadi J","J Subst Abuse Treat","2003","2003/06/18","","","10.1016/s0740-5472(03)00024-2"
"12808001","Aromatase is the major enzyme metabolizing buprenorphine in human placenta","Deshmukh SV, Nanovskaya TN, Ahmed MS.","J Pharmacol Exp Ther. 2003 Sep;306(3):1099-105. doi: 10.1124/jpet.103.053199. Epub 2003 Jun 13.","Deshmukh SV","J Pharmacol Exp Ther","2003","2003/06/17","","","10.1124/jpet.103.053199"
"12806421","May 1999 NSW Drug Summit","Champion R, Gray J.","N S W Public Health Bull. 2003 Mar;14(3):59-61.","Champion R","N S W Public Health Bull","2003","2003/06/14","","",""
"12804429","Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","Mattick RP, Kimber J, Breen C, Davoli M.","Cochrane Database Syst Rev. 2003;(2):CD002207. doi: 10.1002/14651858.CD002207.","Mattick RP","Cochrane Database Syst Rev","2003","2003/06/14","","","10.1002/14651858.CD002207"
"12803393","Systemic uptake of buprenorphine by cats after oral mucosal administration","Robertson SA, Taylor PM, Sear JW.","Vet Rec. 2003 May 31;152(22):675-8. doi: 10.1136/vr.152.22.675.","Robertson SA","Vet Rec","2003","2003/06/14","","","10.1136/vr.152.22.675"
"12788596","Maintenance buprenorphine for opioid users","Newman R.","Lancet. 2003 May 31;361(9372):1907; author reply 1907-8. doi: 10.1016/S0140-6736(03)13513-1.","Newman R","Lancet","2003","2003/06/06","","","10.1016/S0140-6736(03)13513-1"
"12788595","Maintenance buprenorphine for opioid users","Farré M, Torrens M.","Lancet. 2003 May 31;361(9372):1906-7; author reply 1907-8. doi: 10.1016/S0140-6736(03)13512-X.","Farré M","Lancet","2003","2003/06/06","","","10.1016/S0140-6736(03)13512-X"
"12770518","Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey","Salvato C, Aretini G, Serraglia D, Terrazzani G, Debetto P, Giusti P, Chinellato A.","Pharmacol Res. 2003 Jul;48(1):75-82.","Salvato C","Pharmacol Res","2003","2003/05/29","","",""
"12766254","Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone","Sell SL, McMahon LR, France CP.","J Pharmacol Exp Ther. 2003 Sep;306(3):1167-73. doi: 10.1124/jpet.103.051425. Epub 2003 May 23.","Sell SL","J Pharmacol Exp Ther","2003","2003/05/27","","","10.1124/jpet.103.051425"
"12765884","Old dog--new (ma)trix","Budd K, Collett BJ.","Br J Anaesth. 2003 Jun;90(6):722-4. doi: 10.1093/bja/aeg133.","Budd K","Br J Anaesth","2003","2003/05/27","","","10.1093/bja/aeg133"
"12762334","Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule","Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services.","Fed Regist. 2003 May 22;68(99):27937-9.","Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services","Fed Regist","2003","2003/05/24","","",""
"12762216","New drug buprenorphine can treat patients addicted to heroin or prescription pain medications","Clark HW.","W V Med J. 2003 Jan-Feb;99(1):42.","Clark HW","W V Med J","2003","2003/05/24","","",""
"12757969","Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients","Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K.","Drug Alcohol Depend. 2003 Jun 5;70(3):315-25. doi: 10.1016/s0376-8716(03)00032-2.","Kosten T","Drug Alcohol Depend","2003","2003/05/22","","","10.1016/s0376-8716(03)00032-2"
"12757966","Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration study","Lintzeris N, Bammer G, Rushworth L, Jolley DJ, Whelan G.","Drug Alcohol Depend. 2003 Jun 5;70(3):287-94. doi: 10.1016/s0376-8716(03)00015-2.","Lintzeris N","Drug Alcohol Depend","2003","2003/05/22","","","10.1016/s0376-8716(03)00015-2"
"12756210","Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro","Zhang W, Ramamoorthy Y, Tyndale RF, Sellers EM.","Drug Metab Dispos. 2003 Jun;31(6):768-72. doi: 10.1124/dmd.31.6.768.","Zhang W","Drug Metab Dispos","2003","2003/05/21","","","10.1124/dmd.31.6.768"
"12754081","Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain","Selley DE, Herbert JT, Morgan D, Cook CD, Picker MJ, Sim-Selley LJ.","Brain Res Bull. 2003 May 15;60(3):201-8. doi: 10.1016/s0361-9230(03)00014-5.","Selley DE","Brain Res Bull","2003","2003/05/20","","","10.1016/s0361-9230(03)00014-5"
"12751987","Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment","Giacomuzzi SM, Riemer Y, Ertl M, Kemmler G, Rössler H, Hinterhuber H, Kurz M.","Addiction. 2003 May;98(5):693-702. doi: 10.1046/j.1360-0443.2003.00352.x.","Giacomuzzi SM","Addiction","2003","2003/05/20","","","10.1046/j.1360-0443.2003.00352.x"
"12751984","Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients","Kosten T, Poling J, Oliveto A.","Addiction. 2003 May;98(5):665-71. doi: 10.1046/j.1360-0443.2003.00380.x.","Kosten T","Addiction","2003","2003/05/20","","","10.1046/j.1360-0443.2003.00380.x"
"12747392","Homelessness and high-dosage buprenorphine misuse","Blanchon T, Boissonnas A, Vareseon I, Vidal-Trecan G.","Subst Use Misuse. 2003 Feb-May;38(3-6):429-42. doi: 10.1081/ja-120017380.","Blanchon T","Subst Use Misuse","2003","2003/05/16","","","10.1081/ja-120017380"
"12740181","Evaluation on drug dependence of buprenorphine","Liu ZM, Lü XX, Lian Z, Mu Y, Guo P, An X.","Acta Pharmacol Sin. 2003 May;24(5):448-52.","Liu ZM","Acta Pharmacol Sin","2003","2003/05/13","","",""
"12739602","Influence of detomidine and buprenorphine on motor-evoked potentials in horses","Nollet H, Van Ham L, Gasthuys F, Dewulf J, Vanderstraeten G, Deprez P.","Vet Rec. 2003 Apr 26;152(17):534-7. doi: 10.1136/vr.152.17.534.","Nollet H","Vet Rec","2003","2003/05/13","","","10.1136/vr.152.17.534"
"12739412","[Subutex is the first link in the care continuity of opiate dependence]","Arnsvik A.","Lakartidningen. 2003 Apr 10;100(15):1367.","Arnsvik A","Lakartidningen","2003","2003/05/13","","",""
"12738354","Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting","Leshner AI.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S103-4. doi: 10.1016/s0376-8716(03)00063-2.","Leshner AI","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00063-2"
"12738353","Use of buprenorphine in pregnancy: patient management and effects on the neonate","Johnson RE, Jones HE, Fischer G.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S87-101. doi: 10.1016/s0376-8716(03)00062-0.","Johnson RE","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00062-0"
"12738352","Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence","Bridge TP, Fudala PJ, Herbert S, Leiderman DB.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S79-85. doi: 10.1016/s0376-8716(03)00061-9.","Bridge TP","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00061-9"
"12738351","Buprenorphine: how to use it right","Johnson RE, Strain EC, Amass L.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S59-77. doi: 10.1016/s0376-8716(03)00060-7.","Johnson RE","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00060-7"
"12738350","Clinical efficacy of buprenorphine: comparisons to methadone and placebo","Ling W, Wesson DR.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S49-57. doi: 10.1016/s0376-8716(03)00059-0.","Ling W","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00059-0"
"12738349","Pharmacokinetics of the combination tablet of buprenorphine and naloxone","Chiang CN, Hawks RL.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S39-47. doi: 10.1016/s0376-8716(03)00058-9.","Chiang CN","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00058-9"
"12738348","Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?","Mendelson J, Jones RT.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S29-37. doi: 10.1016/s0376-8716(03)00057-7.","Mendelson J","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00057-7"
"12738347","The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic","Walsh SL, Eissenberg T.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S13-27. doi: 10.1016/s0376-8716(03)00056-5.","Walsh SL","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00056-5"
"12738346","From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States","Jaffe JH, O'Keeffe C.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S3-11. doi: 10.1016/s0376-8716(03)00055-3.","Jaffe JH","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00055-3"
"12738345","Foreword to: buprenorphine and buprenorphine/naloxone: a guide for clinicians","Fudala PJ, Bridge TP.","Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S1-2. doi: 10.1016/s0376-8716(03)00054-1.","Fudala PJ","Drug Alcohol Depend","2003","2003/05/10","","","10.1016/s0376-8716(03)00054-1"
"12721333","Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse","Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF.","J Pharmacol Exp Ther. 2003 Jul;306(1):394-400. doi: 10.1124/jpet.103.048835. Epub 2003 Apr 29.","Mizoguchi H","J Pharmacol Exp Ther","2003","2003/05/02","","","10.1124/jpet.103.048835"
"12715769","Prescription drug abuse: FDA and SAMHSA join forces","Meadows M.","FDA Consum. 2003 Mar-Apr;37(2):36.","Meadows M","FDA Consum","2003","2003/04/29","","",""
"12703865","What is your diagnosis? Polymyopathy and polyneuropathy","Mellanby RJ, Jeffery ND.","J Small Anim Pract. 2003 Apr;44(4):153, 189-90.","Mellanby RJ","J Small Anim Pract","2003","2003/04/22","","",""
"12703332","Clinical treatment of opioid addiction and dependence","Ling W, Rawson RA, Compton M.","Methods Mol Med. 2003;84:285-95. doi: 10.1385/1-59259-379-8:285.","Ling W","Methods Mol Med","2003","2003/04/22","","","10.1385/1-59259-379-8:285"
"12670004","Enzyme immunoassay validation for the detection of buprenorphine in urine","Cirimele V, Kintz P, Lohner S, Ludes B.","J Anal Toxicol. 2003 Mar;27(2):103-5. doi: 10.1093/jat/27.2.103.","Cirimele V","J Anal Toxicol","2003","2003/04/03","","","10.1093/jat/27.2.103"
"12665191","Improving opioid dependency treatment","Swoboda JT.","J Am Board Fam Pract. 2003 Mar-Apr;16(2):185-6.","Swoboda JT","J Am Board Fam Pract","2003","2003/04/01","","",""
"12665120","Buprenorphine TDS: use in daily practice, benefits for patients","Radbruch L.","Int J Clin Pract Suppl. 2003 Feb;(133):19-22; discussion 23-4.","Radbruch L","Int J Clin Pract Suppl","2003","2003/04/01","","",""
"12665119","Buprenorphine TDS: the clinical development rationale and results","Radbruch L, Vielvoye-Kerkmeer A.","Int J Clin Pract Suppl. 2003 Feb;(133):15-8; discussion 23-4.","Radbruch L","Int J Clin Pract Suppl","2003","2003/04/01","","",""
"12665118","Buprenorphine and the transdermal system: the ideal match in pain management","Budd K.","Int J Clin Pract Suppl. 2003 Feb;(133):9-14; discussion 23-4.","Budd K","Int J Clin Pract Suppl","2003","2003/04/01","","",""
"12665117","Buprenorphine: new pharmacological aspects","Cowan A.","Int J Clin Pract Suppl. 2003 Feb;(133):3-8; discussion 23-4.","Cowan A","Int J Clin Pract Suppl","2003","2003/04/01","","",""
"12664838","SAMHSA outlines how to treat addiction to prescription painkillers and heroin in physicians' offices","","Conn Med. 2003 Feb;67(2):103-4.","","Conn Med","2003","2003/04/01","","",""
"12659611","Meperidine misuse in a patient with sphincter of Oddi dysfunction","Hubbard GP, Wolfe KR.","Ann Pharmacother. 2003 Apr;37(4):534-7. doi: 10.1345/aph.1C108.","Hubbard GP","Ann Pharmacother","2003","2003/03/28","","","10.1345/aph.1C108"
"12653815","Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users","Gandhi DH, Jaffe JH, McNary S, Kavanagh GJ, Hayes M, Currens M.","Addiction. 2003 Apr;98(4):453-62. doi: 10.1046/j.1360-0443.2003.00334.x.","Gandhi DH","Addiction","2003","2003/03/26","","","10.1046/j.1360-0443.2003.00334.x"
"12653814","Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients","Mattick RP, Ali R, White JM, O'Brien S, Wolk S, Danz C.","Addiction. 2003 Apr;98(4):441-52. doi: 10.1046/j.1360-0443.2003.00335.x.","Mattick RP","Addiction","2003","2003/03/26","","","10.1046/j.1360-0443.2003.00335.x"
"12652094","Coordination of medical care and opioid dependence treatment in primary care: a case report","Fiellin DA, Rosenheck RA, Kosten TR.","Subst Abus. 2003 Mar;24(1):43-6. doi: 10.1080/08897070309511532.","Fiellin DA","Subst Abus","2003","2003/03/26","","","10.1080/08897070309511532"
"12637117","Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","Sittl R, Griessinger N, Likar R.","Clin Ther. 2003 Jan;25(1):150-68. doi: 10.1016/s0149-2918(03)90019-1.","Sittl R","Clin Ther","2003","2003/03/15","","","10.1016/s0149-2918(03)90019-1"
"12633918","Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine","Lopatko OV, White JM, Huber A, Ling W.","Drug Alcohol Depend. 2003 Apr 1;69(3):317-22. doi: 10.1016/s0376-8716(02)00322-8.","Lopatko OV","Drug Alcohol Depend","2003","2003/03/14","","","10.1016/s0376-8716(02)00322-8"
"12633914","Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results","Bochud Tornay C, Favrat B, Monnat M, Daeppen JB, Schnyder C, Bertschy G, Besson J.","Drug Alcohol Depend. 2003 Apr 1;69(3):283-8. doi: 10.1016/s0376-8716(02)00326-5.","Bochud Tornay C","Drug Alcohol Depend","2003","2003/03/14","","","10.1016/s0376-8716(02)00326-5"
"12633912","Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection","Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL.","Drug Alcohol Depend. 2003 Apr 1;69(3):263-72. doi: 10.1016/s0376-8716(02)00325-3.","Umbricht A","Drug Alcohol Depend","2003","2003/03/14","","","10.1016/s0376-8716(02)00325-3"
"12628307","Biosynthesis of drug glucuronides for use as authentic standards","Soars MG, Mattiuz EL, Jackson DA, Kulanthaivel P, Ehlhardt WJ, Wrighton SA.","J Pharmacol Toxicol Methods. 2002 May-Jun;47(3):161-8. doi: 10.1016/S1056-8719(02)00231-9.","Soars MG","J Pharmacol Toxicol Methods","2002","2003/03/12","","","10.1016/S1056-8719(02)00231-9"
"12625293","Drugs approved for opiate dependence","","FDA Consum. 2003 Jan-Feb;37(1):6.","","FDA Consum","2003","2003/03/11","","",""
"12622131","Treatment of opiate dependence in hands of primary care providers","","Public Health Rep. 2003 Jan-Feb;118(1):76.","","Public Health Rep","2003","2003/03/08","PMC1497508","",""
"12609698","Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France","Vidal-Trecan G, Varescon I, Nabet N, Boissonnas A.","Drug Alcohol Depend. 2003 Mar 1;69(2):175-81. doi: 10.1016/s0376-8716(02)00312-5.","Vidal-Trecan G","Drug Alcohol Depend","2003","2003/03/01","","","10.1016/s0376-8716(02)00312-5"
"12606938","Buprenorphine contains glucose","Katori K, Shigematsu K, Higa K.","Anesthesiology. 2003 Mar;98(3):799. doi: 10.1097/00000542-200303000-00047.","Katori K","Anesthesiology","2003","2003/02/28","","","10.1097/00000542-200303000-00047"
"12606177","1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial","Kakko J, Svanborg KD, Kreek MJ, Heilig M.","Lancet. 2003 Feb 22;361(9358):662-8. doi: 10.1016/S0140-6736(03)12600-1.","Kakko J","Lancet","2003","2003/02/28","","","10.1016/S0140-6736(03)12600-1"
"12606172","Maintenance buprenorphine for opioid users","Law FD, Nutt DJ.","Lancet. 2003 Feb 22;361(9358):634-5. doi: 10.1016/S0140-6736(03)12612-8.","Law FD","Lancet","2003","2003/02/28","","","10.1016/S0140-6736(03)12612-8"
"12602400","Pregnancy exposed to high-dose buprenorphine","","Prescrire Int. 2003 Feb;12(63):21.","","Prescrire Int","2003","2003/02/27","","",""
"12598270","Sequential use of midazolam and propofol for long-term sedation in postoperative mechanically ventilated patients","Saito M, Terao Y, Fukusaki M, Makita T, Shibata O, Sumikawa K.","Anesth Analg. 2003 Mar;96(3):834-8, table of contents. doi: 10.1213/01.ane.0000048714.01230.75.","Saito M","Anesth Analg","2003","2003/02/25","","","10.1213/01.ane.0000048714.01230.75"
"12592214","Buprenorphine: an alternative to methadone","","Med Lett Drugs Ther. 2003 Feb 17;45(1150):13-5.","","Med Lett Drugs Ther","2003","2003/02/20","","",""
"12585931","Agency offers guidance on office-based drug treatment for opioid addiction","Mitka M.","JAMA. 2003 Feb 12;289(6):690. doi: 10.1001/jama.289.6.690.","Mitka M","JAMA","2003","2003/02/15","","","10.1001/jama.289.6.690"
"12585846","Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction","Resnick RB.","Ann Intern Med. 2003 Feb 18;138(4):360. doi: 10.7326/0003-4819-138-4-200302180-00027.","Resnick RB","Ann Intern Med","2003","2003/02/15","","","10.7326/0003-4819-138-4-200302180-00027"
"12580571","Evaluation of postoperative analgesia in a rat model of incisional pain","St A Stewart L, Martin WJ.","Contemp Top Lab Anim Sci. 2003 Jan;42(1):28-34.","St A Stewart L","Contemp Top Lab Anim Sci","2003","2003/02/13","","",""
"12570846","Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse","Husbands SM, Lewis JW.","Mini Rev Med Chem. 2003 Mar;3(2):137-44. doi: 10.2174/1389557033405395.","Husbands SM","Mini Rev Med Chem","2003","2003/02/07","","","10.2174/1389557033405395"
"12569727","[Is Subutex a magic drug?]","Krook AL.","Tidsskr Nor Laegeforen. 2002 Dec 10;122(30):2925-6.","Krook AL","Tidsskr Nor Laegeforen","2002","2003/02/07","","",""
"12519569","Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","Mattick RP, Kimber J, Breen C, Davoli M.","Cochrane Database Syst Rev. 2002;(4):CD002207. doi: 10.1002/14651858.CD002207.","Mattick RP","Cochrane Database Syst Rev","2002","2003/01/10","","","10.1002/14651858.CD002207"
"12519138","Effect of route of buprenorphine on recovery and postoperative analgesic requirement in paediatric patients","Khan FA, Memon GA, Kamal RS.","Paediatr Anaesth. 2002 Nov;12(9):786-90. doi: 10.1046/j.1460-9592.2002.00941.x.","Khan FA","Paediatr Anaesth","2002","2003/01/10","","","10.1046/j.1460-9592.2002.00941.x"
"12519132","Use of caudal-epidural opioids in children: still state of the art or the beginning of the end?","Lönnqvist PA, Ivani G, Moriarty T.","Paediatr Anaesth. 2002 Nov;12(9):747-9. doi: 10.1046/j.1460-9592.2002.00953.x.","Lönnqvist PA","Paediatr Anaesth","2002","2003/01/10","","","10.1046/j.1460-9592.2002.00953.x"
"12518080","[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature]","Loustauneau A, Auriacombe M, Daulouede JP, Tignol J.","Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S31-6.","Loustauneau A","Ann Med Interne (Paris)","2002","2003/01/09","","",""
"12510051","Office-based treatment of opioid-dependent patients","Ferner RE, Daniels AM.","N Engl J Med. 2003 Jan 2;348(1):81-2; author reply 81-2. doi: 10.1056/NEJM200301023480118.","Ferner RE","N Engl J Med","2003","2003/01/03","","","10.1056/NEJM200301023480118"
"12507255","Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat","Borron SW, Monier C, Risède P, Baud FJ.","Hum Exp Toxicol. 2002 Nov;21(11):599-605. doi: 10.1191/0960327102ht303oa.","Borron SW","Hum Exp Toxicol","2002","2003/01/01","","","10.1191/0960327102ht303oa"
"12498093","[Comparative effect of partial opiate agonists buprenorphine and butorphanol on the phospholipid composition of hepatocytes plasma membranes during hemorrhagic shock in cats]","Leskova GF, Arkhipenko IuV.","Vopr Med Khim. 2002 Sep-Oct;48(5):497-502.","Leskova GF","Vopr Med Khim","2002","2002/12/25","","",""
"12495804","Buprenorphine treatment of opium-dependent outpatients seeking treatment in Iran","Ahmadi J, Bahrami N.","J Subst Abuse Treat. 2002 Dec;23(4):415-7. doi: 10.1016/s0740-5472(02)00272-6.","Ahmadi J","J Subst Abuse Treat","2002","2002/12/24","","","10.1016/s0740-5472(02)00272-6"
"12493578","A new series of 13 buprenorphine-related deaths","Kintz P.","Clin Biochem. 2002 Oct;35(7):513-6. doi: 10.1016/s0009-9120(02)00304-1.","Kintz P","Clin Biochem","2002","2002/12/21","","","10.1016/s0009-9120(02)00304-1"
"12492761","Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy","Schindler SD, Eder H, Ortner R, Rohrmeister K, Langer M, Fischer G.","Addiction. 2003 Jan;98(1):103-10. doi: 10.1046/j.1360-0443.2003.00245.x.","Schindler SD","Addiction","2003","2002/12/21","","","10.1046/j.1360-0443.2003.00245.x"
"12490605","Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay","Sterious SN, Walker EA.","J Pharmacol Exp Ther. 2003 Jan;304(1):301-9. doi: 10.1124/jpet.102.042093.","Sterious SN","J Pharmacol Exp Ther","2003","2002/12/20","","","10.1124/jpet.102.042093"
"12481193","Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction","Robinson SE.","CNS Drug Rev. 2002 Winter;8(4):377-90. doi: 10.1111/j.1527-3458.2002.tb00235.x.","Robinson SE","CNS Drug Rev","2002","2002/12/14","PMC6741692","","10.1111/j.1527-3458.2002.tb00235.x"
"12477234","Opioid rotation in the treatment of joint pain. A review of 67 cases","Grilo RM, Bertin P, Scotto di Fazano C, Coyral D, Bonnet C, Vergne P, Treves R.","Joint Bone Spine. 2002 Oct;69(5):491-4. doi: 10.1016/s1297-319x(02)00435-9.","Grilo RM","Joint Bone Spine","2002","2002/12/13","","","10.1016/s1297-319x(02)00435-9"
"12461829","Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine","Zuurmond WW, Meert TF, Noorduin H.","Acta Anaesthesiol Belg. 2002;53(3):193-201.","Zuurmond WW","Acta Anaesthesiol Belg","2002","2002/12/05","","",""
"12460076","From the Food and Drug Administration","","JAMA. 2002 Dec 4;288(21):2678.","","JAMA","2002","2002/12/04","","",""
"12456152","Pain evaluation and response to buprenorphine in rats subjected to sham middle cerebral artery occlusion","Kirsch JH, Klaus JA, Blizzard KK, Hurn PD, Murphy SJ.","Contemp Top Lab Anim Sci. 2002 Nov;41(6):9-14.","Kirsch JH","Contemp Top Lab Anim Sci","2002","2002/11/29","","",""
"12455298","Pharmacists may dispense new opioid addiction treatment","Traynor K.","Am J Health Syst Pharm. 2002 Nov 15;59(22):2150, 2152. doi: 10.1093/ajhp/59.22.2150.","Traynor K","Am J Health Syst Pharm","2002","2002/11/29","","","10.1093/ajhp/59.22.2150"
"12448114","[Buprenorphine as maintenance treatment in rehabilitation of heroin addicts]","Bramness JG, Bachs LC, Waal H.","Tidsskr Nor Laegeforen. 2002 Oct 20;122(25):2452-4.","Bramness JG","Tidsskr Nor Laegeforen","2002","2002/11/27","","",""
"12445973","Mechanisms involved in morphine-induced activation of synaptosomal Na+,K+-ATPase","Masocha W, González LG, Baeyens JM, Agil A.","Brain Res. 2002 Dec 13;957(2):311-9. doi: 10.1016/s0006-8993(02)03663-6.","Masocha W","Brain Res","2002","2002/11/26","","","10.1016/s0006-8993(02)03663-6"
"12438837","Training primary health care professionals to provide buprenorphine and LAAM treatment","Lintzeris N, Ritter A, Dunlop A, Muhleisen P.","Subst Abus. 2002 Dec;23(4):245-54. doi: 10.1080/08897070209511497.","Lintzeris N","Subst Abus","2002","2002/11/20","","","10.1080/08897070209511497"
"12435410","Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse","Mizoguchi H, Wu HE, Narita M, Hall FS, Sora I, Uhl GR, Nagase H, Tseng LF.","Neuroscience. 2002;115(3):715-21. doi: 10.1016/s0306-4522(02)00486-4.","Mizoguchi H","Neuroscience","2002","2002/11/19","","","10.1016/s0306-4522(02)00486-4"
"12433804","Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1","Rios GR, Tephly TR.","Drug Metab Dispos. 2002 Dec;30(12):1364-7. doi: 10.1124/dmd.30.12.1364.","Rios GR","Drug Metab Dispos","2002","2002/11/16","","","10.1124/dmd.30.12.1364"
"12428880","Comparison of the effects of buprenorphine, oxymorphone hydrochloride, and ketoprofen for postoperative analgesia after onychectomy or onychectomy and sterilization in cats","Dobbins S, Brown NO, Shofer FS.","J Am Anim Hosp Assoc. 2002 Nov-Dec;38(6):507-14. doi: 10.5326/0380507.","Dobbins S","J Am Anim Hosp Assoc","2002","2002/11/14","","","10.5326/0380507"
"12410780","A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal","Lintzeris N, Bell J, Bammer G, Jolley DJ, Rushworth L.","Addiction. 2002 Nov;97(11):1395-404. doi: 10.1046/j.1360-0443.2002.00215.x.","Lintzeris N","Addiction","2002","2002/11/02","","","10.1046/j.1360-0443.2002.00215.x"
"12409994","Delta opioid antagonist effects of buprenorphine in rhesus monkeys","Negus SS, Bidlack JM, Mello NK, Furness MS, Rice KC, Brandt MR.","Behav Pharmacol. 2002 Nov;13(7):557-70. doi: 10.1097/00008877-200211000-00005.","Negus SS","Behav Pharmacol","2002","2002/11/01","","","10.1097/00008877-200211000-00005"
"12404083","Effects of buprenorphine on candy and sweetened fluid self-administration by rhesus monkeys","Comer SD, Evans SM, Pudiak CM, Foltin RW.","Psychopharmacology (Berl). 2002 Nov;164(2):200-6. doi: 10.1007/s00213-002-1178-z. Epub 2002 Aug 27.","Comer SD","Psychopharmacology (Berl)","2002","2002/10/31","","","10.1007/s00213-002-1178-z"
"12396293","The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels","Fang JY, Sung KC, Wang JJ, Chu CC, Chen KT.","J Pharm Pharmacol. 2002 Oct;54(10):1329-37. doi: 10.1211/002235702760345392.","Fang JY","J Pharm Pharmacol","2002","2002/10/25","","","10.1211/002235702760345392"
"12393113","Late antinociception and lower untoward effects of concomitant intrathecal morphine and intravenous buprenorphine in humans","Beltrutti D, Niv D, Ben-Abraham R, Di Santo S, Weinbroum AA.","J Clin Anesth. 2002 Sep;14(6):441-6. doi: 10.1016/s0952-8180(02)00397-5.","Beltrutti D","J Clin Anesth","2002","2002/10/24","","","10.1016/s0952-8180(02)00397-5"
"12392802","Heroin detoxification with buprenorphine on an inpatient psychiatric unit","DiPaula BA, Schwartz R, Montoya ID, Barrett D, Tang C.","J Subst Abuse Treat. 2002 Oct;23(3):163-9. doi: 10.1016/s0740-5472(02)00244-1.","DiPaula BA","J Subst Abuse Treat","2002","2002/10/24","PMC2633653","NIHMS81311","10.1016/s0740-5472(02)00244-1"
"12388653","Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers","Comer SD, Collins ED.","J Pharmacol Exp Ther. 2002 Nov;303(2):695-703. doi: 10.1124/jpet.102.038141.","Comer SD","J Pharmacol Exp Ther","2002","2002/10/22","PMC4079473","NIHMS516229","10.1124/jpet.102.038141"
"12386540","[Buprenorphine abuse: high dose intravenous administration of buprenorphine]","Varescon I, Vidal-Trécan G, Nabet N, Boissonnas A.","Encephale. 2002 Sep-Oct;28(5 Pt 1):397-402.","Varescon I","Encephale","2002","2002/10/19","","",""
"12382389","[Recovery from total intravenous anesthesia with propofol and buprenorphine]","Tabuchi Y.","Masui. 2002 Sep;51(9):996-1000.","Tabuchi Y","Masui","2002","2002/10/18","","",""
"12377611","Experimental study of in vitro buprenorphine hydrochloride transdermal permeation through hairless mouse skin","Huang B, Gu MN, Li GF, Lin CS, Guo D.","Di Yi Jun Yi Da Xue Xue Bao. 2002 Oct;22(10):895-7.","Huang B","Di Yi Jun Yi Da Xue Xue Bao","2002","2002/10/16","","",""
"12373443","Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure","Dykstra LA, Granger AL, Allen RM, Zhang X, Rice KC.","Psychopharmacology (Berl). 2002 Oct;163(3-4):420-9. doi: 10.1007/s00213-002-1100-8. Epub 2002 May 25.","Dykstra LA","Psychopharmacology (Berl)","2002","2002/10/10","","","10.1007/s00213-002-1100-8"
"12369590","Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule","Drug Enforcement Administration (DEA), Department of Justice.","Fed Regist. 2002 Oct 7;67(194):62354-70.","Drug Enforcement Administration (DEA), Department of Justice","Fed Regist","2002","2002/10/09","","",""
"12359040","Abuse of buprenorphine by intravenous injection--the french connection","Tacke U.","Addiction. 2002 Oct;97(10):1355. doi: 10.1046/j.1360-0443.2002.00242.x.","Tacke U","Addiction","2002","2002/10/03","","","10.1046/j.1360-0443.2002.00242.x"
"12359034","Trends in opiate and opioid poisonings in addicts in north-east Paris and suburbs, 1995-99","Gueye PN, Megarbane B, Borron SW, Adnet F, Galliot-Guilley M, Ricordel I, Tourneau J, Goldgran-Toledano D, Baud FJ.","Addiction. 2002 Oct;97(10):1295-304. doi: 10.1046/j.1360-0443.2002.00189.x.","Gueye PN","Addiction","2002","2002/10/03","","","10.1046/j.1360-0443.2002.00189.x"
"12237786","Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone","Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U.","Pharmacopsychiatry. 2002 Sep;35(5):159-64. doi: 10.1055/s-2002-34115.","Seifert J","Pharmacopsychiatry","2002","2002/09/19","","","10.1055/s-2002-34115"
"12229998","A latent autoregressive model for longitudinal binary data subject to informative missingness","Albert PS, Follmann DA, Wang SA, Suh EB.","Biometrics. 2002 Sep;58(3):631-42. doi: 10.1111/j.0006-341x.2002.00631.x.","Albert PS","Biometrics","2002","2002/09/17","","","10.1111/j.0006-341x.2002.00631.x"
"12227226","Heroin detoxification with a single high dose of buprenorphine","Kutz I, Reznik V.","Isr J Psychiatry Relat Sci. 2002;39(2):113-9.","Kutz I","Isr J Psychiatry Relat Sci","2002","2002/09/14","","",""
"12220607","History and current status of opioid maintenance treatments: blending conference session","Kreek MJ, Vocci FJ.","J Subst Abuse Treat. 2002 Sep;23(2):93-105. doi: 10.1016/s0740-5472(02)00259-3.","Kreek MJ","J Subst Abuse Treat","2002","2002/09/11","","","10.1016/s0740-5472(02)00259-3"
"12220606","Buprenorphine: blending practice and research","Ling W, Smith D.","J Subst Abuse Treat. 2002 Sep;23(2):87-92. doi: 10.1016/s0740-5472(02)00257-x.","Ling W","J Subst Abuse Treat","2002","2002/09/11","","","10.1016/s0740-5472(02)00257-x"
"12218879","Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results","Lavignasse P, Lowenstein W, Batel P, Constant MV, Jourdain JJ, Kopp P, Reynaud-Maurupt C, Riff B, Videau B, Mucchielli A.","Ann Med Interne (Paris). 2002 May;153(3 Suppl):1S20-6.","Lavignasse P","Ann Med Interne (Paris)","2002","2002/09/10","","",""
"12218878","[Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis]","Levasseur L, Marzo JN, Ross N, Blatier C.","Ann Med Interne (Paris). 2002 May;153(3 Suppl):1S14-9.","Levasseur L","Ann Med Interne (Paris)","2002","2002/09/10","","",""
"12209151","Pharmacotherapy of addictions","Kreek MJ, LaForge KS, Butelman E.","Nat Rev Drug Discov. 2002 Sep;1(9):710-26. doi: 10.1038/nrd897.","Kreek MJ","Nat Rev Drug Discov","2002","2002/09/05","","","10.1038/nrd897"
"12203248","Effects of nebulizing and drying gas flow on capillary electrophoresis/mass spectrometry","Huikko K, Kotiaho T, Kostiainen R.","Rapid Commun Mass Spectrom. 2002;16(16):1562-8. doi: 10.1002/rcm.744.","Huikko K","Rapid Commun Mass Spectrom","2002","2002/08/31","","","10.1002/rcm.744"
"12189003","Buprenorphine dosing regime in the management of out-patient heroin withdrawal","Lintzeris N.","Drug Alcohol Rev. 2002 Mar;21(1):39-45. doi: 10.1080/09595230220119309.","Lintzeris N","Drug Alcohol Rev","2002","2002/08/22","","","10.1080/09595230220119309"
"12180559","Substitution therapy for heroin addiction","Bell J, Dru A, Fischer B, Levit S, Sarfraz MA.","Subst Use Misuse. 2002 Jun-Aug;37(8-10):1149-78. doi: 10.1081/ja-120004176.","Bell J","Subst Use Misuse","2002","2002/08/16","","","10.1081/ja-120004176"
"12176108","Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injury","Kouya PF, Hao JX, Xu XJ.","Eur J Pharmacol. 2002 Aug 16;450(1):49-53. doi: 10.1016/s0014-2999(02)02052-6.","Kouya PF","Eur J Pharmacol","2002","2002/08/15","","","10.1016/s0014-2999(02)02052-6"
"12171176","Effects of morphine, butorphanol, buprenorphine, and U50488H on the minimum alveolar concentration of isoflurane in cats","Ilkiw JE, Pascoe PJ, Tripp LD.","Am J Vet Res. 2002 Aug;63(8):1198-202. doi: 10.2460/ajvr.2002.63.1198.","Ilkiw JE","Am J Vet Res","2002","2002/08/13","","","10.2460/ajvr.2002.63.1198"
"12163109","The role of descending fibers from the rostral ventromedial medulla in opioid analgesia in rats","Gilbert AK, Franklin KB.","Eur J Pharmacol. 2002 Aug 2;449(1-2):75-84. doi: 10.1016/s0014-2999(02)01974-x.","Gilbert AK","Eur J Pharmacol","2002","2002/08/07","","","10.1016/s0014-2999(02)01974-x"
"12144743","Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals","Roughan JV, Flecknell PA.","Lab Anim. 2002 Jul;36(3):322-43. doi: 10.1258/002367702320162423.","Roughan JV","Lab Anim","2002","2002/07/30","","","10.1258/002367702320162423"
"12140228","Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex)","Cassoux N, Bodaghi B, Lehoang P, Edel Y.","Br J Ophthalmol. 2002 Aug;86(8):940-1. doi: 10.1136/bjo.86.8.940.","Cassoux N","Br J Ophthalmol","2002","2002/07/26","PMC1771222","","10.1136/bjo.86.8.940"
"12089847","[Regular prescription of narcotics and sedatives to drug-addicted patients in general practice]","Andersen HT.","Tidsskr Nor Laegeforen. 2002 May 10;122(12):1202-4.","Andersen HT","Tidsskr Nor Laegeforen","2002","2002/07/02","","",""
"12076434","Buprenorphine for the management of opioid withdrawal","Gowing L, Ali R, White J.","Cochrane Database Syst Rev. 2002;(2):CD002025. doi: 10.1002/14651858.CD002025.","Gowing L","Cochrane Database Syst Rev","2002","2002/06/22","","","10.1002/14651858.CD002025"
"12069411","A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies","Moody DE, Slawson MH, Strain EC, Laycock JD, Spanbauer AC, Foltz RL.","Anal Biochem. 2002 Jul 1;306(1):31-9. doi: 10.1006/abio.2002.5673.","Moody DE","Anal Biochem","2002","2002/06/19","","","10.1006/abio.2002.5673"
"12065706","Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine","Walker EA, Young AM.","J Pharmacol Exp Ther. 2002 Jul;302(1):101-10. doi: 10.1124/jpet.302.1.101.","Walker EA","J Pharmacol Exp Ther","2002","2002/06/18","","","10.1124/jpet.302.1.101"
"12065015","Which substitution pharmacotherapy is most effective in treating opioid dependence?","Gowing LR, Ali RL, White JM.","Med J Aust. 2002 May 20;176(10):493-4.","Gowing LR","Med J Aust","2002","2002/06/18","","",""
"12059897","Hepatic function during xenon anesthesia in pigs","Reinelt H, Marx T, Kotzerke J, Topalidis P, Luederwald S, Armbruster S, Schirmer U, Schmidt M.","Acta Anaesthesiol Scand. 2002 Jul;46(6):713-6. doi: 10.1034/j.1399-6576.2002.460614.x.","Reinelt H","Acta Anaesthesiol Scand","2002","2002/06/13","","","10.1034/j.1399-6576.2002.460614.x"
"12059888","Epidural buprenorphine in management of pain in multiple rib fractures","Govindarajan R, Bakalova T, Michael R, Abadir AR.","Acta Anaesthesiol Scand. 2002 Jul;46(6):660-5. doi: 10.1034/j.1399-6576.2002.460605.x.","Govindarajan R","Acta Anaesthesiol Scand","2002","2002/06/13","","","10.1034/j.1399-6576.2002.460605.x"
"12051505","Use of three infusion pumps for postoperative administration of buprenorphine or morphine in dogs","Gilberto DB, Motzel SL, Bone AN, Burns CL, Zeoli AH, Lodge KE, Goode TL.","J Am Vet Med Assoc. 2002 Jun 1;220(11):1655-60, 1650. doi: 10.2460/javma.2002.220.1655.","Gilberto DB","J Am Vet Med Assoc","2002","2002/06/08","","","10.2460/javma.2002.220.1655"
"12047733","Policy progress for physician treatment of opiate addiction","Merrill JO.","J Gen Intern Med. 2002 May;17(5):361-8. doi: 10.1046/j.1525-1497.2002.10628.x.","Merrill JO","J Gen Intern Med","2002","2002/06/06","PMC1495048","","10.1046/j.1525-1497.2002.10628.x"
"12044669","Gait analysis as an objective measure in a chronic pain model","Coulthard P, Pleuvry BJ, Brewster M, Wilson KL, Macfarlane TV.","J Neurosci Methods. 2002 May 15;116(2):197-213. doi: 10.1016/s0165-0270(02)00042-0.","Coulthard P","J Neurosci Methods","2002","2002/06/05","","","10.1016/s0165-0270(02)00042-0"
"12039619","Buprenorphine maintenance treatment of heroin dependence: the first experience from Iran","Ahmadi J.","J Subst Abuse Treat. 2002 Apr;22(3):157-9. doi: 10.1016/s0740-5472(02)00222-2.","Ahmadi J","J Subst Abuse Treat","2002","2002/06/01","","","10.1016/s0740-5472(02)00222-2"
"12033654","A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway","Krook AL, Brørs O, Dahlberg J, Grouff K, Magnus P, Røysamb E, Waal H.","Addiction. 2002 May;97(5):533-42. doi: 10.1046/j.1360-0443.2002.00090.x.","Krook AL","Addiction","2002","2002/05/30","","","10.1046/j.1360-0443.2002.00090.x"
"12033517","Inhibition of human drug metabolizing cytochrome P450 by buprenorphine","Umehara K, Shimokawa Y, Miyamoto G.","Biol Pharm Bull. 2002 May;25(5):682-5. doi: 10.1248/bpb.25.682.","Umehara K","Biol Pharm Bull","2002","2002/05/30","","","10.1248/bpb.25.682"
"12032023","The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat","Tejwani GA, Rattan AK.","Anesth Analg. 2002 Jun;94(6):1542-6, table of contents. doi: 10.1097/00000539-200206000-00031.","Tejwani GA","Anesth Analg","2002","2002/05/29","","","10.1097/00000539-200206000-00031"
"12030630","Buprenorphine and addiction: challenges for the pharmacist","Boatwright DE.","J Am Pharm Assoc (Wash). 2002 May-Jun;42(3):432-8. doi: 10.1331/108658002763316860.","Boatwright DE","J Am Pharm Assoc (Wash)","2002","2002/05/28","","","10.1331/108658002763316860"
"12028854","An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids","Mutschler NH, Stephen BJ, Teoh SK, Mendelson JH, Mello NK.","Nicotine Tob Res. 2002 May;4(2):223-8. doi: 10.1080/14622200210124012.","Mutschler NH","Nicotine Tob Res","2002","2002/05/25","","","10.1080/14622200210124012"
"12028743","The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients","Welsh CJ, Suman M, Cohen A, Broyles L, Bennett M, Weintraub E.","Am J Addict. 2002 Spring;11(2):135-40. doi: 10.1080/105500490290087901.","Welsh CJ","Am J Addict","2002","2002/05/25","","","10.1080/105500490290087901"
"12028741","Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers","Feingold A, Oliveto A, Schottenfeld R, Kosten TR.","Am J Addict. 2002 Spring;11(2):111-23. doi: 10.1080/10550490290087884.","Feingold A","Am J Addict","2002","2002/05/25","","","10.1080/10550490290087884"
"12016621","Opioid and local anesthetic combination for brachial plexus block to provide postoperative analgesia","Viel EJ, Cuvillon P, Eledjam JJ.","Reg Anesth Pain Med. 2002 May-Jun;27(3):336. doi: 10.1053/rapm.2002.30705.","Viel EJ","Reg Anesth Pain Med","2002","2002/05/23","","","10.1053/rapm.2002.30705"
"12016565","[Colitis ulcerosa and opioid addiction]","Häuser W, Lachiheb H, Grandt D.","Z Gastroenterol. 2002 May;40(5):299-303. doi: 10.1055/s-2002-30110.","Häuser W","Z Gastroenterol","2002","2002/05/23","","","10.1055/s-2002-30110"
"12014814","Treatment of heroin dependence with buprenorphine in primary care","Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS.","Am J Drug Alcohol Abuse. 2002;28(2):231-41. doi: 10.1081/ada-120002972.","Fiellin DA","Am J Drug Alcohol Abuse","2002","2002/05/17","","","10.1081/ada-120002972"
"12002809","Antinociceptive activity of a novel buprenorphine analogue","Lattanzi R, Negri L, Schmidhammer H, Giannini E.","Life Sci. 2002 Mar 22;70(18):2177-85. doi: 10.1016/s0024-3205(01)01553-3.","Lattanzi R","Life Sci","2002","2002/05/11","","","10.1016/s0024-3205(01)01553-3"
"11974198","The alternative therapy","Hicks M.","Nurs Stand. 2000 Jul 26-Aug 1;14(45):18.","Hicks M","Nurs Stand","2000","2002/04/27","","",""
"11967625","Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction","Tzschentke TM.","Psychopharmacology (Berl). 2002 Apr;161(1):1-16. doi: 10.1007/s00213-002-1003-8. Epub 2002 Mar 6.","Tzschentke TM","Psychopharmacology (Berl)","2002","2002/04/23","","","10.1007/s00213-002-1003-8"
"11965100","[Persistent injecting practices in subjects on methadone or buprenorphine maintenance therapy. A study of 600 cases]","Fontaa V, Bronner C.","Ann Med Interne (Paris). 2001 Nov;152 Suppl 7:59-69.","Fontaa V","Ann Med Interne (Paris)","2001","2002/04/20","","",""
"11965095","[Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases]","Lejeune C, Aubisson S, Simmat-Durand L, Cneude F, Piquet M, Gourarier L; Groupe d'Etudes Grossesse et addictions.","Ann Med Interne (Paris). 2001 Nov;152 Suppl 7:21-7.","Lejeune C","Ann Med Interne (Paris)","2001","2002/04/20","","",""
"11965094","[Changes in pharmacists practices (1996 - 2000) related to harm reduction policy (condoms, injecting equipment, methylmorphine) and maintenance therapy delivery (buprenorphine, methadone)]","Bonnet N, Beauverie P, Gaudoneix-Taïeb M, Poisson N, Imbert E, Fournier G.","Ann Med Interne (Paris). 2001 Nov;152 Suppl 7:15-20.","Bonnet N","Ann Med Interne (Paris)","2001","2002/04/20","","",""
"11965093","[Changes in high-dose buprenorphine maintenance therapy at the Fleury-Merogis (France) prison since 1996]","Durand E.","Ann Med Interne (Paris). 2001 Nov;152 Suppl 7:9-14.","Durand E","Ann Med Interne (Paris)","2001","2002/04/20","","",""
"11954898","Buprenorphine treatment of patients with non-malignant musculoskeletal diseases","Balint G.","Clin Rheumatol. 2002 Feb;21 Suppl 1:S17-8. doi: 10.1007/s100670200032.","Balint G","Clin Rheumatol","2002","2002/04/17","","","10.1007/s100670200032"
"11954897","Buprenorphine in a transdermal therapeutic system--a new option","Böhme K.","Clin Rheumatol. 2002 Feb;21 Suppl 1:S13-6. doi: 10.1007/s100670200031.","Böhme K","Clin Rheumatol","2002","2002/04/17","","","10.1007/s100670200031"
"11943501","Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny","Robinson SE.","Neurotoxicol Teratol. 2002 Mar-Apr;24(2):137-42. doi: 10.1016/s0892-0362(01)00185-4.","Robinson SE","Neurotoxicol Teratol","2002","2002/04/12","","","10.1016/s0892-0362(01)00185-4"
"11943078","Assessment of the postoperative discomfort of intra-auricularly hypophysectomized rats","Hansen AK, Christoffersen LB, Hejgaard KC, Thon R, Velschow S.","Lab Anim. 2002 Apr;36(2):144-52. doi: 10.1258/0023677021912424.","Hansen AK","Lab Anim","2002","2002/04/12","","","10.1258/0023677021912424"
"11943077","Oral buprenorphine and aspirin analgesia in rats undergoing liver transplantation","Jablonski P, Howden BO.","Lab Anim. 2002 Apr;36(2):134-43. doi: 10.1258/0023677021912415.","Jablonski P","Lab Anim","2002","2002/04/12","","","10.1258/0023677021912415"
"11926301","Analgesic efficacy of orally administered buprenorphine in rats","Martin LB, Thompson AC, Martin T, Kristal MB.","Comp Med. 2001 Feb;51(1):43-8.","Martin LB","Comp Med","2001","2002/04/03","","",""
"11924776","Effects of buprenorphine on immunogenicity and protective efficacy in the guinea pig keratoconjunctivitis model (Sereny test)","Hanson CE, Ruble GR, Essiet I, Hartman AB.","Comp Med. 2001 Jun;51(3):224-9.","Hanson CE","Comp Med","2001","2002/04/02","","",""
"11923061","Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine","Gopal S, Tzeng TB, Cowan A.","Eur J Pharm Sci. 2002 Apr;15(3):287-93. doi: 10.1016/s0928-0987(02)00009-x.","Gopal S","Eur J Pharm Sci","2002","2002/03/30","","","10.1016/s0928-0987(02)00009-x"
"11919661","Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans","Greenwald MK, Schuh KJ, Hopper JA, Schuster CR, Johanson CE.","Psychopharmacology (Berl). 2002 Apr;160(4):344-52. doi: 10.1007/s00213-001-0975-0. Epub 2002 Jan 31.","Greenwald MK","Psychopharmacology (Berl)","2002","2002/03/29","","","10.1007/s00213-001-0975-0"
"11915063","Buprenorphine added to the local anesthetic for axillary brachial plexus block prolongs postoperative analgesia","Candido KD, Winnie AP, Ghaleb AH, Fattouh MW, Franco CD.","Reg Anesth Pain Med. 2002 Mar-Apr;27(2):162-7. doi: 10.1053/rapm.2002.30671.","Candido KD","Reg Anesth Pain Med","2002","2002/03/27","","","10.1053/rapm.2002.30671"
"11913917","Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose","Clark NC, Lintzeris N, Muhleisen PJ.","Med J Aust. 2002 Feb 18;176(4):166-7.","Clark NC","Med J Aust","2002","2002/03/27","","",""
"11910210","Continuous intrathecal clonidine administration for the treatment of neuropathic pain","Uhle EI, Becker R, Gatscher S, Bertalanffy H.","Stereotact Funct Neurosurg. 2000;75(4):167-75. doi: 10.1159/000048402.","Uhle EI","Stereotact Funct Neurosurg","2000","2002/03/23","","","10.1159/000048402"
"11907183","Intravenous buprenorphine self-administration by detoxified heroin abusers","Comer SD, Collins ED, Fischman MW.","J Pharmacol Exp Ther. 2002 Apr;301(1):266-76. doi: 10.1124/jpet.301.1.266.","Comer SD","J Pharmacol Exp Ther","2002","2002/03/22","","","10.1124/jpet.301.1.266"
"11906798","A controlled trial of buprenorphine treatment for opium dependence: the first experience from Iran","Ahmadi J.","Drug Alcohol Depend. 2002 Apr 1;66(2):111-4. doi: 10.1016/s0376-8716(01)00202-2.","Ahmadi J","Drug Alcohol Depend","2002","2002/03/22","","","10.1016/s0376-8716(01)00202-2"
"11903869","Morphine, pethidine and buprenorphine disposition in the cat","Taylor PM, Robertson SA, Dixon MJ, Ruprah M, Sear JW, Lascelles BD, Waters C, Bloomfield M.","J Vet Pharmacol Ther. 2001 Dec;24(6):391-8. doi: 10.1046/j.1365-2885.2001.368goblin.x.","Taylor PM","J Vet Pharmacol Ther","2001","2002/03/21","","","10.1046/j.1365-2885.2001.368goblin.x"
"11897965","Toxicologic aspects of heroin substitution treatment","Cone EJ, Preston KL.","Ther Drug Monit. 2002 Apr;24(2):193-8. doi: 10.1097/00007691-200204000-00001.","Cone EJ","Ther Drug Monit","2002","2002/03/19","","","10.1097/00007691-200204000-00001"
"11889783","[The changes in hemodynamics and dose requirements in total intravenous anesthesia using propofol and buprenorphine]","Tabuchi Y.","Masui. 2002 Feb;51(2):157-61.","Tabuchi Y","Masui","2002","2002/03/14","","",""
"11889776","[Continuous epidural administration of droperidol to prevent postoperative nausea and vomiting]","Hayashi K, Higuchi J, Sakio H, Tanaka Y, Onoda N.","Masui. 2002 Feb;51(2):124-7.","Hayashi K","Masui","2002","2002/03/14","","",""
"11875630","Characterization of the discriminative stimulus effects of buprenorphine in pigeons","Galici R, Brandt MR, France CP.","Psychopharmacology (Berl). 2002 Mar;160(2):132-9. doi: 10.1007/s00213-001-0943-8. Epub 2002 Jan 22.","Galici R","Psychopharmacology (Berl)","2002","2002/03/05","","","10.1007/s00213-001-0943-8"
"11862344","Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine","Strain EC, Walsh SL, Bigelow GE.","Psychopharmacology (Berl). 2002 Jan;159(2):161-6. doi: 10.1007/s002130100920. Epub 2001 Oct 12.","Strain EC","Psychopharmacology (Berl)","2002","2002/02/28","","","10.1007/s002130100920"
"11855671","Effect of oral OPC-28326, a selective femoral arterial vasodilator, on hindlimb subcutaneous tissue temperature in conscious dogs under buprenorphine sedation","Orito K, Imaizumi T, Yoshida K, Kishi M, Fujiki H, Mori T.","Jpn J Pharmacol. 2002 Jan;88(1):119-22. doi: 10.1254/jjp.88.119.","Orito K","Jpn J Pharmacol","2002","2002/02/22","","","10.1254/jjp.88.119"
"11852662","[Blessing or problem child? Substitution therapy for opiate-addicted patients]","Pallenbach E.","Pharm Unserer Zeit. 2002;31(1):90-5. doi: 10.1002/1615-1003(200201)31:1<90::AID-PAUZ90>3.0.CO;2-F.","Pallenbach E","Pharm Unserer Zeit","2002","2002/02/21","","","10.1002/1615-1003(200201)31:1<90::AID-PAUZ90>3.0.CO;2-F"
"11851193","WHO Expert Committee on Drug Dependence. Thirty-second report","World Health Organization.","World Health Organ Tech Rep Ser. 2001;903:i-v, 1-26.","World Health Organization","World Health Organ Tech Rep Ser","2001","2002/02/20","","",""
"11847954","Opioid dependence treatment, including buprenorphine/naloxone","Raisch DW, Fye CL, Boardman KD, Sather MR.","Ann Pharmacother. 2002 Feb;36(2):312-21. doi: 10.1345/aph.10421.","Raisch DW","Ann Pharmacother","2002","2002/02/19","","","10.1345/aph.10421"
"11841899","Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis","Farré M, Mas A, Torrens M, Moreno V, Camí J.","Drug Alcohol Depend. 2002 Feb 1;65(3):283-90. doi: 10.1016/s0376-8716(01)00171-5.","Farré M","Drug Alcohol Depend","2002","2002/02/14","","","10.1016/s0376-8716(01)00171-5"
"11812504","Antidotal effects of buprenorphine on the behavioral alterations accompanying cocaine and combined cocaine-ethanol toxicity","Hayase T, Yamamoto Y, Yamamoto K.","Pharmacol Biochem Behav. 2002 Jan-Feb;71(1-2):19-27. doi: 10.1016/s0091-3057(01)00585-8.","Hayase T","Pharmacol Biochem Behav","2002","2002/01/29","","","10.1016/s0091-3057(01)00585-8"
"11803795","[Buprenorphine]","Uehlinger C.","Rev Med Suisse Romande. 2001 Dec;121(12):903-6.","Uehlinger C","Rev Med Suisse Romande","2001","2002/01/24","","",""
"11783744","Effect of opioid dependence pharmacotherapies on zidovudine disposition","McCance-Katz EF, Rainey PM, Friedland G, Kosten TR, Jatlow P.","Am J Addict. 2001 Fall;10(4):296-307.","McCance-Katz EF","Am J Addict","2001","2002/01/11","","",""
"11772481","Buprenorphine prescription by general practitioners in a French region","Thirion X, Lapierre V, Micallef J, Ronflé E, Masut A, Pradel V, Coudert C, Mabriez JC, Sanmarco JL.","Drug Alcohol Depend. 2002 Jan 1;65(2):197-204. doi: 10.1016/s0376-8716(01)00161-2.","Thirion X","Drug Alcohol Depend","2002","2002/01/05","","","10.1016/s0376-8716(01)00161-2"
"11765687","Noninvasive drug delivery","Zimmer R, Ashburn MA.","Compr Ther. 2001 Winter;27(4):293-301. doi: 10.1007/s12019-001-0027-z.","Zimmer R","Compr Ther","2001","2002/01/05","","","10.1007/s12019-001-0027-z"
"11765236","Cardiopulmonary effects of three different anaesthesia protocols in cats","Akkerdaas LC, Mioch P, Sap R, Hellebrekers LJ.","Vet Q. 2001 Nov;23(4):182-6. doi: 10.1080/01652176.2001.9695109.","Akkerdaas LC","Vet Q","2001","2002/01/05","","","10.1080/01652176.2001.9695109"
"11760922","Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon","Stimmel B.","J Addict Dis. 2001;20(4):1-5. doi: 10.1300/J069v20n04_01.","Stimmel B","J Addict Dis","2001","2002/01/05","","","10.1300/J069v20n04_01"
"11752690","Buprenorphine and midazolam act in combination to depress respiration in rats","Gueye PN, Borron SW, Risède P, Monier C, Buneaux F, Debray M, Baud FJ.","Toxicol Sci. 2002 Jan;65(1):107-14. doi: 10.1093/toxsci/65.1.107.","Gueye PN","Toxicol Sci","2002","2001/12/26","","","10.1093/toxsci/65.1.107"
"11752093","Transplacental transfer and metabolism of buprenorphine","Nanovskaya T, Deshmukh S, Brooks M, Ahmed MS.","J Pharmacol Exp Ther. 2002 Jan;300(1):26-33. doi: 10.1124/jpet.300.1.26.","Nanovskaya T","J Pharmacol Exp Ther","2002","2001/12/26","","","10.1124/jpet.300.1.26"
"11748323","Less driving impairment on buprenorphine than methadone in drug-dependent patients?","Soyka M, Horak M, Dittert S, Kagerer S.","J Neuropsychiatry Clin Neurosci. 2001 Fall;13(4):527-8. doi: 10.1176/jnp.13.4.527.","Soyka M","J Neuropsychiatry Clin Neurosci","2001","2001/12/19","","","10.1176/jnp.13.4.527"
"11745008","[Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept]","Rohrmeister K, Bernert G, Langer M, Fischer G, Weninger M, Pollak A.","Z Geburtshilfe Neonatol. 2001 Nov-Dec;205(6):224-30. doi: 10.1055/s-2001-19054.","Rohrmeister K","Z Geburtshilfe Neonatol","2001","2001/12/18","","","10.1055/s-2001-19054"
"11736770","Cerebral and regional organ perfusion in pigs during xenon anaesthesia","Schmidt M, Marx T, Kotzerke J, Lüderwald S, Armbruster S, Topalidis P, Schirmer U, Reinelt H.","Anaesthesia. 2001 Dec;56(12):1154-9. doi: 10.1046/j.1365-2044.2001.02322.x.","Schmidt M","Anaesthesia","2001","2001/12/12","","","10.1046/j.1365-2044.2001.02322.x"
"11732465","[Predictive factors of response to buprenorphine in the substitutive treatment of heroin addicts. Results of a multicenter study of 73 patients]","Laqueille X, Poirier MF, Jalfre V, Bourdel MC, Willard D, Olié JP.","Presse Med. 2001 Nov 3;30(32):1581-5.","Laqueille X","Presse Med","2001","2001/12/06","","",""
"11728787","Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-addicted patients?","Vignau J, Duhamel A, Catteau J, Legal G, Pho AH, Grailles I, Beauvillain J, Petit P, Beauvillain P, Parquet PJ.","J Subst Abuse Treat. 2001 Oct;21(3):135-44. doi: 10.1016/s0740-5472(01)00189-1.","Vignau J","J Subst Abuse Treat","2001","2001/12/01","","","10.1016/s0740-5472(01)00189-1"
"11714592","Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine","White R, Alcorn R, Feinmann C.","Drug Alcohol Depend. 2001 Dec 1;65(1):77-83. doi: 10.1016/s0376-8716(01)00149-1.","White R","Drug Alcohol Depend","2001","2001/11/21","","","10.1016/s0376-8716(01)00149-1"
"11700809","Buprenorphine: better late than never","Wodak AD, Hall WD.","Med J Aust. 2001 Oct 1;175(7):349-50.","Wodak AD","Med J Aust","2001","2001/11/10","","",""
"11699259","[Treatment of heroin addiction--clinical findings hand-in-hand with evidence]","Berglund M, Jonsson E, Thelander S.","Lakartidningen. 2001 Oct 10;98(41):4487.","Berglund M","Lakartidningen","2001","2001/11/09","","",""
"11687036","Opioid antagonists for smoking cessation","David S, Lancaster T, Stead LF.","Cochrane Database Syst Rev. 2001;(3):CD003086. doi: 10.1002/14651858.CD003086.","David S","Cochrane Database Syst Rev","2001","2001/11/01","","","10.1002/14651858.CD003086"
"11672491","The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States","Barnett PG, Zaric GS, Brandeau ML.","Addiction. 2001 Sep;96(9):1267-78. doi: 10.1046/j.1360-0443.2001.96912676.x.","Barnett PG","Addiction","2001","2001/10/24","","","10.1046/j.1360-0443.2001.96912676.x"
"11599605","Hydrolysis of conjugated metabolites of buprenorphine. I. The quantitative enzymatic hydrolysis of buprenorphine-3-beta-D-glucuronide in human urine","Feng S, ElSohly MA, Duckworth DT.","J Anal Toxicol. 2001 Oct;25(7):589-93. doi: 10.1093/jat/25.7.589.","Feng S","J Anal Toxicol","2001","2001/10/16","","","10.1093/jat/25.7.589"
"11599514","Opioid maintenance: the politics matter","Sindelar JL.","Addiction. 2001 Oct;96(10):1517-8.","Sindelar JL","Addiction","2001","2001/10/16","","",""
"11599513","Cost-effectiveness of buprenorphine maintenance versus methadone maintenance","French MT.","Addiction. 2001 Oct;96(10):1515-7.","French MT","Addiction","2001","2001/10/16","","",""
"11599512","Cost-effectiveness estimates for buprenorphine should factor in crime","Reuter P.","Addiction. 2001 Oct;96(10):1515.","Reuter P","Addiction","2001","2001/10/16","","",""
"11586837","[Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism]","Heilig M, Nilsson LH, Grönbladh L, Thulin SO, Sternebring B.","Lakartidningen. 2001 Sep 12;98(37):3956-8.","Heilig M","Lakartidningen","2001","2001/10/06","","",""
"11571885","[A national model for drug-supported rehabilitation of opiate addicts]","Waal H, Krook AL, Welle-Strand G, Espegren O, Hole R, Lazaridis KB, Sandvold M, Moen S, Høiseth T.","Tidsskr Nor Laegeforen. 2001 Aug 20;121(19):2301-5.","Waal H","Tidsskr Nor Laegeforen","2001","2001/09/27","","",""
"11571062","Comparison of methadone and high dosage buprenorphine users in French care centres","Barrau K, Thirion X, Micallef J, Chuniaud-Louche C, Bellemin B, San Marco JL.","Addiction. 2001 Oct;96(10):1433-41. doi: 10.1046/j.1360-0443.2001.961014337.x.","Barrau K","Addiction","2001","2001/09/26","","","10.1046/j.1360-0443.2001.961014337.x"
"11570387","Effects of medetomidine and buprenorphine administered for sedation in dogs","Robinson KJ, Jones RS, Cripps PJ.","J Small Anim Pract. 2001 Sep;42(9):444-7. doi: 10.1111/j.1748-5827.2001.tb02498.x.","Robinson KJ","J Small Anim Pract","2001","2001/09/26","","","10.1111/j.1748-5827.2001.tb02498.x"
"11564664","HS-599: a novel long acting opioid analgesic does not induce place-preference in rats","Lattanzi R, Negri L, Giannini E, Schmidhammer H, Schutz J, Improta G.","Br J Pharmacol. 2001 Sep;134(2):441-7. doi: 10.1038/sj.bjp.0704280.","Lattanzi R","Br J Pharmacol","2001","2001/09/21","PMC1572965","","10.1038/sj.bjp.0704280"
"11561267","Effect of epidural analgesia on postoperative paralytic ileus in chronic schizophrenia","Kudoh A, Katagai H, Takazawa T.","Reg Anesth Pain Med. 2001 Sep-Oct;26(5):456-60. doi: 10.1053/rapm.2001.25062.","Kudoh A","Reg Anesth Pain Med","2001","2001/09/19","","","10.1053/rapm.2001.25062"
"11554014","[The influence of age on hemodynamics and the dose requirements of propofol and buprenorphine in total intravenous anesthesia combined with continuous epidural anesthesia]","Tabuchi Y.","Masui. 2001 Aug;50(8):842-6.","Tabuchi Y","Masui","2001","2001/09/14","","",""
"11547472","[The benefit of combining spinal morphine and intravenous buprenorphine for perioperative pain]","Ben-Abraham R, Beltrutti D, Niv D, Weinbroum A.","Harefuah. 2001 Aug;140(8):709-12, 806.","Ben-Abraham R","Harefuah","2001","2001/09/08","","",""
"11533891","[Buprenorphine in pregnancy]","Eder H, Rupp I, Peternell A, Fischer G.","Psychiatr Prax. 2001 Sep;28(6):267-9. doi: 10.1055/s-2001-16875.","Eder H","Psychiatr Prax","2001","2001/09/05","","","10.1055/s-2001-16875"
"11531909","Opioid chronopharmacology","Fox AW.","Cephalalgia. 2001 Jul;21(6):708. doi: 10.1046/j.1468-2982.2001.00234.x.","Fox AW","Cephalalgia","2001","2001/09/05","","","10.1046/j.1468-2982.2001.00234.x"
"11516889","Deaths involving buprenorphine: a compendium of French cases","Kintz P.","Forensic Sci Int. 2001 Sep 15;121(1-2):65-9. doi: 10.1016/s0379-0738(01)00454-6.","Kintz P","Forensic Sci Int","2001","2001/08/23","","","10.1016/s0379-0738(01)00454-6"
"11516497","Electrically-assisted transdermal delivery of buprenorphine","Bose S, Ravis WR, Lin YJ, Zhang L, Hofmann GA, Banga AK.","J Control Release. 2001 Jun 15;73(2-3):197-203. doi: 10.1016/s0168-3659(01)00298-x.","Bose S","J Control Release","2001","2001/08/23","","","10.1016/s0168-3659(01)00298-x"
"11515335","[Review of scientific evidence on alternatives to methadone in the psychopharmacologic treatment of opiate dependence]","Iruín A, Aizpurua I, Ruiz de Apodaka J, Zapiraín E, Aizpuru A.","Rev Esp Salud Publica. 2001 May-Jun;75(3):207-19.","Iruín A","Rev Esp Salud Publica","2001","2001/08/23","","",""
"11510062","[The effect of intravenous patient controlled analgesia on activities of daily life and medical expense after thoracotomy]","Satoh M, Hirabayashi Y, Inoue S, Seo N.","Masui. 2001 Jul;50(7):736-41.","Satoh M","Masui","2001","2001/08/21","","",""
"11504153","An exploratory study of buprenorphine use in Bangladesh: a note","Ahmed SK, Ara N.","Subst Use Misuse. 2001 Jun;36(8):1071-83. doi: 10.1081/ja-100104490.","Ahmed SK","Subst Use Misuse","2001","2001/08/16","","","10.1081/ja-100104490"
"11503833","Buprenorphine replacement therapy: a confirmed benefit","","Prescrire Int. 1999 Aug;8(42):124-7.","","Prescrire Int","1999","2001/08/16","","",""
"11501175","Interaction of combined administration of intrathecal morphine with subcutaneous morphine or buprenorphine","Chen LH, Nemirovsky A, Gong QY.","Acta Pharmacol Sin. 2000 Aug;21(8):685-9.","Chen LH","Acta Pharmacol Sin","2000","2001/08/15","","",""
"11498722","Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats. Influence of nociceptive intensity and intrinsic efficacy at the mu receptor","Smith MA, Gray JD.","Psychopharmacology (Berl). 2001 Aug;156(4):445-53. doi: 10.1007/s002130100750.","Smith MA","Psychopharmacology (Berl)","2001","2001/08/11","","","10.1007/s002130100750"
"11487232","The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice","Gades NM, Danneman PJ, Wixson SK, Tolley EA.","Contemp Top Lab Anim Sci. 2000 Mar;39(2):8-13.","Gades NM","Contemp Top Lab Anim Sci","2000","2001/08/07","","",""
"11481150","Office-based treatment for opioid dependence: reaching new patient populations","Fiellin DA, Rosenheck RA, Kosten TR.","Am J Psychiatry. 2001 Aug;158(8):1200-4. doi: 10.1176/appi.ajp.158.8.1200.","Fiellin DA","Am J Psychiatry","2001","2001/08/02","","","10.1176/appi.ajp.158.8.1200"
"11476266","Rapid heroin detoxification using a single high dose of buprenorphine","Kutz I, Reznik V.","J Psychoactive Drugs. 2001 Apr-Jun;33(2):191-3. doi: 10.1080/02791072.2001.10400484.","Kutz I","J Psychoactive Drugs","2001","2001/07/31","","","10.1080/02791072.2001.10400484"
"11475905","Epidural analgesia with a combination of bupivacaine and buprenorphine in rats","Morimoto K, Nishimura R, Matsunaga S, Mochizuki M, Sasaki N.","J Vet Med A Physiol Pathol Clin Med. 2001 Jun;48(5):303-12. doi: 10.1046/j.1439-0442.2001.00360.x.","Morimoto K","J Vet Med A Physiol Pathol Clin Med","2001","2001/07/31","","","10.1046/j.1439-0442.2001.00360.x"
"11470347","Limits to buprenorphine dosing: a comparison between quintuple and sextuple the maintenance dose every 5 days","Gross A, Jacobs EA, Petry NM, Badger GJ, Bickel WK.","Drug Alcohol Depend. 2001 Sep 1;64(1):111-6. doi: 10.1016/s0376-8716(00)00227-1.","Gross A","Drug Alcohol Depend","2001","2001/07/27","","","10.1016/s0376-8716(00)00227-1"
"11464356","Buprenorphine added to the local anesthetic for brachial plexus block to provide postoperative analgesia in outpatients","Candido KD, Franco CD, Khan MA, Winnie AP, Raja DS.","Reg Anesth Pain Med. 2001 Jul-Aug;26(4):352-6. doi: 10.1053/rapm.2001.23931.","Candido KD","Reg Anesth Pain Med","2001","2001/07/21","","","10.1053/rapm.2001.23931"
"11459404","Influence of buprenorphine analgesia on post-operative recovery in two strains of rats","Jablonski P, Howden BO, Baxter K.","Lab Anim. 2001 Jul;35(3):213-22. doi: 10.1258/0023677011911651.","Jablonski P","Lab Anim","2001","2001/07/19","","","10.1258/0023677011911651"
"11454944","Effect of perinatal buprenorphine exposure on development in the rat","Robinson SE, Wallace MJ.","J Pharmacol Exp Ther. 2001 Aug;298(2):797-804.","Robinson SE","J Pharmacol Exp Ther","2001","2001/07/17","","",""
"11452842","A meta-analysis comparing the effectiveness of buprenorphine and methadone","West SL, O'Neal KK, Graham CW.","J Subst Abuse. 2000;12(4):405-14. doi: 10.1016/s0899-3289(01)00054-2.","West SL","J Subst Abuse","2000","2001/07/17","","","10.1016/s0899-3289(01)00054-2"
"11452775","[Ketoprofen (ketonal): a drug for preventing and treating postoperative pain]","Osipova NA, Beresnev VA, Vetsheva MS, Dolgopolova TV.","Anesteziol Reanimatol. 1999 Nov-Dec;(6):71-4.","Osipova NA","Anesteziol Reanimatol","1999","2001/07/17","","",""
"11450367","[Use of buprenorphine as a substitute treatment for opiate dependence in the Toxicology Clinics--introductory clinical report]","Radomska M, Pach J, Chrostek Maj J.","Przegl Lek. 2001;58(4):351-3.","Radomska M","Przegl Lek","2001","2001/07/14","","",""
"11444154","Gradual dose taper following chronic buprenorphine","Becker AB, Strain EC, Bigelow GE, Stitzer ML, Johnson RE.","Am J Addict. 2001 Spring;10(2):111-21. doi: 10.1080/105504901750227778.","Becker AB","Am J Addict","2001","2001/07/11","","","10.1080/105504901750227778"
"11436909","Narcotic analgesia in the acute abdomen--a review of prospective trials","McHale PM, LoVecchio F.","Eur J Emerg Med. 2001 Jun;8(2):131-6. doi: 10.1097/00063110-200106000-00009.","McHale PM","Eur J Emerg Med","2001","2001/07/05","","","10.1097/00063110-200106000-00009"
"11435992","[Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)]","Fhima A, Henrion R, Lowenstein W, Charpak Y.","Ann Med Interne (Paris). 2001 Apr;152 Suppl 3:IS26-36.","Fhima A","Ann Med Interne (Paris)","2001","2001/07/04","","",""
"11435989","[Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments]","Lepère B, Gourarier L, Sanchez M, Adda C, Peyret E, Nordmann F, Ben Soussen P, Gisselbrecht M, Lowenstein W.","Ann Med Interne (Paris). 2001 Apr;152 Suppl 3:IS5-12.","Lepère B","Ann Med Interne (Paris)","2001","2001/07/04","","",""
"11429365","The antinociceptive effect of the combination of spinal morphine with systemic morphine or buprenorphine","Nemirovsky A, Chen L, Zelman V, Jurna I.","Anesth Analg. 2001 Jul;93(1):197-203. doi: 10.1097/00000539-200107000-00039.","Nemirovsky A","Anesth Analg","2001","2001/06/29","","","10.1097/00000539-200107000-00039"
"11424343","A new era in opioid dependency treatment. Recent law allows qualified physicians to provide care in office setting","Clark HW.","Postgrad Med. 2001 Jun;109(6):15-6, 25. doi: 10.3810/pgm.2001.06.964.","Clark HW","Postgrad Med","2001","2001/06/27","","","10.3810/pgm.2001.06.964"
"11422100","SUNCT syndrome: a treatment option with local opioid blockade of the superior cervical ganglion? A case report","Sabatowski R, Huber M, Meuser T, Radbruch L.","Cephalalgia. 2001 Mar;21(2):154-6. doi: 10.1046/j.1468-2982.2001.00180.x.","Sabatowski R","Cephalalgia","2001","2001/06/26","","","10.1046/j.1468-2982.2001.00180.x"
"11420099","Perceptual and motor effects of morphine and buprenorphine in baboons","Hienz RD, Zarcone TJ, Brady JV.","Pharmacol Biochem Behav. 2001 May-Jun;69(1-2):305-13. doi: 10.1016/s0091-3057(01)00544-5.","Hienz RD","Pharmacol Biochem Behav","2001","2001/06/23","","","10.1016/s0091-3057(01)00544-5"
"11418229","Buprenorphine for opiate addiction: potential economic impact","Rosenheck R, Kosten T.","Drug Alcohol Depend. 2001 Aug 1;63(3):253-62. doi: 10.1016/s0376-8716(00)00214-3.","Rosenheck R","Drug Alcohol Depend","2001","2001/06/22","","","10.1016/s0376-8716(00)00214-3"
"11406341","Response expectancies in placebo analgesia and their clinical relevance","Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F.","Pain. 2001 Jul;93(1):77-84. doi: 10.1016/s0304-3959(01)00296-2.","Pollo A","Pain","2001","2001/06/19","","","10.1016/s0304-3959(01)00296-2"
"11399802","Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat","Gueye PN, Borron SW, Risède P, Monier C, Buneaux F, Debray M, Baud FJ.","Toxicol Sci. 2001 Jul;62(1):148-54. doi: 10.1093/toxsci/62.1.148.","Gueye PN","Toxicol Sci","2001","2001/06/16","","","10.1093/toxsci/62.1.148"
"11399214","Examining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimens","Petry NM, Bickel WK, Badger GJ.","Addiction. 2001 Jun;96(6):823-34. doi: 10.1046/j.1360-0443.2001.9668234.x.","Petry NM","Addiction","2001","2001/06/12","","","10.1046/j.1360-0443.2001.9668234.x"
"11395686","[Acute hepatitis following intravenous buprenorphine injection as a substitute drug in a drug-addict]","Wisniewski B, Perlemuter G, Buffet C.","Gastroenterol Clin Biol. 2001 Mar;25(3):328-9.","Wisniewski B","Gastroenterol Clin Biol","2001","2001/06/08","","",""
"11377924","Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys","Mello NK, Negus SS.","Neuropsychopharmacology. 2001 Jul;25(1):104-17. doi: 10.1016/S0893-133X(00)00247-5.","Mello NK","Neuropsychopharmacology","2001","2001/05/30","","","10.1016/S0893-133X(00)00247-5"
"11376918","Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent","Compton P, Charuvastra VC, Ling W.","Drug Alcohol Depend. 2001 Jul 1;63(2):139-46. doi: 10.1016/s0376-8716(00)00200-3.","Compton P","Drug Alcohol Depend","2001","2001/05/30","","","10.1016/s0376-8716(00)00200-3"
"11370644","Comment on Valenciano et al's ""Unsafe injecting practices among attendees of syringe exchange programmes in France""","Des Jarlais DC.","Addiction. 2001 May;96(5):777-8.","Des Jarlais DC","Addiction","2001","2001/05/24","","",""
"11353519","Antinociceptive activity of and clinical experience with buprenorphine in swine","Rodriguez NA, Cooper DM, Risdahl JM.","Contemp Top Lab Anim Sci. 2001 May;40(3):17-20.","Rodriguez NA","Contemp Top Lab Anim Sci","2001","2001/05/17","","",""
"11351930","Effects of buprenorphine/naloxone in opioid-dependent humans","Stoller KB, Bigelow GE, Walsh SL, Strain EC.","Psychopharmacology (Berl). 2001 Mar;154(3):230-42. doi: 10.1007/s002130000637.","Stoller KB","Psychopharmacology (Berl)","2001","2001/05/16","","","10.1007/s002130000637"
"11345072","Inefficacy of buprrenorphine in rats","Gades NM, Wixson SK, Danneman PJ, Tolley EA.","Contemp Top Lab Anim Sci. 2001 Mar;40(2):7.","Gades NM","Contemp Top Lab Anim Sci","2001","2001/05/10","","",""
"11339288","Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry","Polettini A, Huestis MA.","J Chromatogr B Biomed Sci Appl. 2001 Apr 25;754(2):447-59. doi: 10.1016/s0378-4347(01)00029-9.","Polettini A","J Chromatogr B Biomed Sci Appl","2001","2001/05/08","","","10.1016/s0378-4347(01)00029-9"
"11331027","A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence","Barnett PG, Rodgers JH, Bloch DA.","Addiction. 2001 May;96(5):683-90. doi: 10.1046/j.1360-0443.2001.9656834.x.","Barnett PG","Addiction","2001","2001/05/02","","","10.1046/j.1360-0443.2001.9656834.x"
"11318399","Buprenorphine treatment of heroin dependence (detoxification and maintenance) in a private practice setting","Resnick RB, Galanter M, Resnick E, Pycha C.","J Addict Dis. 2001;20(2):75-83. doi: 10.1300/j069v20n02_06.","Resnick RB","J Addict Dis","2001","2001/04/25","","","10.1300/j069v20n02_06"
"11318393","Treatment of opioid addiction in physicians' offices: it's about time","Schnoll SH.","J Addict Dis. 2001;20(2):1-3. doi: 10.1300/J069v20n02_01.","Schnoll SH","J Addict Dis","2001","2001/04/25","","","10.1300/J069v20n02_01"
"11316923","Observation of psychoactive substance consumption: methods and results of the French OPPIDUM programme","Thirion X, Micallef J, Barrau K, Djezzar S, Sanmarco JL, Lagier G.","Eur Addict Res. 2001 Mar;7(1):32-6. doi: 10.1159/000050711.","Thirion X","Eur Addict Res","2001","2001/04/24","","","10.1159/000050711"
"11314675","Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats","Walker EA, Young AM.","Psychopharmacology (Berl). 2001 Mar 1;154(2):131-42. doi: 10.1007/s002130000620.","Walker EA","Psychopharmacology (Berl)","2001","2001/04/21","","","10.1007/s002130000620"
"11303059","Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","Huang P, Kehner GB, Cowan A, Liu-Chen LY.","J Pharmacol Exp Ther. 2001 May;297(2):688-95.","Huang P","J Pharmacol Exp Ther","2001","2001/04/17","","",""
"11300671","A comparison of two opioid analgesics for relief of visceral pain induced by intestinal resection in rats","Gillingham MB, Clark MD, Dahly EM, Krugner-Higby LA, Ney DM.","Contemp Top Lab Anim Sci. 2001 Jan;40(1):21-6.","Gillingham MB","Contemp Top Lab Anim Sci","2001","2001/04/13","","",""
"11297835","Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes","Johnson RE, Jones HE, Jasinski DR, Svikis DS, Haug NA, Jansson LM, Kissin WB, Alpan G, Lantz ME, Cone EJ, Wilkins DG, Golden AS, Huggins GR, Lester BM.","Drug Alcohol Depend. 2001 Jun 1;63(1):97-103. doi: 10.1016/s0376-8716(00)00194-0.","Johnson RE","Drug Alcohol Depend","2001","2001/04/12","","","10.1016/s0376-8716(00)00194-0"
"11296435","[Dose-response study of preincisional buprenorphine on emergence time and postoperative analgesic requirement in patients anesthetized with sevoflurane]","Takahashi S, Tanaka M, Matsumiya N, Kondo T, Miyabe M, Toyooka H.","Masui. 2001 Mar;50(3):256-60.","Takahashi S","Masui","2001","2001/04/12","","",""
"11295322","The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys","Winger G, Woods JH.","Drug Alcohol Depend. 2001 May 1;62(3):181-9. doi: 10.1016/s0376-8716(00)00166-6.","Winger G","Drug Alcohol Depend","2001","2001/04/11","","","10.1016/s0376-8716(00)00166-6"
"11292548","Intranasal bioavailability of buprenorphine in rabbit correlated to sheep and man","Lindhardt K, Bagger M, Andreasen KH, Bechgaard E.","Int J Pharm. 2001 Apr 17;217(1-2):121-6. doi: 10.1016/s0378-5173(01)00591-9.","Lindhardt K","Int J Pharm","2001","2001/04/09","","","10.1016/s0378-5173(01)00591-9"
"11292003","Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans","Comer SD, Collins ED, Fischman MW.","Psychopharmacology (Berl). 2001 Feb;154(1):28-37. doi: 10.1007/s002130000623.","Comer SD","Psychopharmacology (Berl)","2001","2001/04/09","","","10.1007/s002130000623"
"11281569","Hepatitis after intravenous buprenorphine misuse in heroin addicts","Berson A, Gervais A, Cazals D, Boyer N, Durand F, Bernuau J, Marcellin P, Degott C, Valla D, Pessayre D.","J Hepatol. 2001 Feb;34(2):346-50. doi: 10.1016/s0168-8278(00)00049-0.","Berson A","J Hepatol","2001","2001/04/03","","","10.1016/s0168-8278(00)00049-0"
"11281555","Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation","Berson A, Fau D, Fornacciari R, Degove-Goddard P, Sutton A, Descatoire V, Haouzi D, Lettéron P, Moreau A, Feldmann G, Pessayre D.","J Hepatol. 2001 Feb;34(2):261-9. doi: 10.1016/s0168-8278(00)00050-7.","Berson A","J Hepatol","2001","2001/04/03","","","10.1016/s0168-8278(00)00050-7"
"11275413","Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia","Sánchez-Blázquez P, Gómez-Serranillos P, Garzón J.","Brain Res Bull. 2001 Jan 15;54(2):229-35. doi: 10.1016/s0361-9230(00)00448-2.","Sánchez-Blázquez P","Brain Res Bull","2001","2001/03/29","","","10.1016/s0361-9230(00)00448-2"
"11239921","Perinatal opioids reduce striatal nerve growth factor content in rat striatum","Wu VW, Mo Q, Yabe T, Schwartz JP, Robinson SE.","Eur J Pharmacol. 2001 Mar 2;414(2-3):211-4. doi: 10.1016/s0014-2999(01)00807-x.","Wu VW","Eur J Pharmacol","2001","2001/03/10","","","10.1016/s0014-2999(01)00807-x"
"11234466","[Accidental narcotic and buprenorphine poisoning in children notified at the Marseille Poison Center between 1993 and 1999]","Spadari M, Arditti J, Affaton MF, David JM, Valli M.","Therapie. 2000 Nov-Dec;55(6):705-8.","Spadari M","Therapie","2000","2001/03/10","","",""
"11226822","Development and validation of a sensitive analytical method for the simultaneous determination of buprenorphine and norbuprenorphine in human plasma","Gopal S, Tzeng TB, Cowan A.","Eur J Pharm Biopharm. 2001 Mar;51(2):147-51. doi: 10.1016/s0939-6411(00)00135-1.","Gopal S","Eur J Pharm Biopharm","2001","2001/02/28","","","10.1016/s0939-6411(00)00135-1"
"11221618","Treating opioid dependence","Stimmel B.","N Engl J Med. 2001 Feb 15;344(7):530; author reply 530-1. doi: 10.1056/NEJM200102153440715.","Stimmel B","N Engl J Med","2001","2001/02/28","","","10.1056/NEJM200102153440715"
"11215968","[Maintenance treatment of opiate addicts]","Kristensen O.","Tidsskr Nor Laegeforen. 2000 Dec 10;120(30):3816.","Kristensen O","Tidsskr Nor Laegeforen","2000","2001/02/24","","",""
"11215403","[Evolution and update of detoxification techniques for opiate addicts]","Yui K.","Nihon Shinkei Seishin Yakurigaku Zasshi. 2000 Oct;20(4):175-7.","Yui K","Nihon Shinkei Seishin Yakurigaku Zasshi","2000","2001/02/24","","",""
"11215228","[Intravenous patient controlled analgesia combined with continuous thoracic epidural analgesia for post-thoracotomy pain]","Satoh M, Hirabayashi Y, Seo N.","Masui. 2000 Nov;49(11):1222-5.","Satoh M","Masui","2000","2001/02/24","","",""
"11211745","[The influence of age on hemodynamics and the dose requirements of propofol and buprenorphine in total intravenous anesthesia]","Tabuchi Y.","Masui. 2001 Jan;50(1):29-33.","Tabuchi Y","Masui","2001","2001/02/24","","",""
"11207392","Response variability to analgesics: a role for non-specific activation of endogenous opioids","Amanzio M, Pollo A, Maggi G, Benedetti F.","Pain. 2001 Feb 15;90(3):205-15. doi: 10.1016/s0304-3959(00)00486-3.","Amanzio M","Pain","2001","2001/02/24","","","10.1016/s0304-3959(00)00486-3"
"11200569","Buprenorphine given after surgery does not alter renal ischemia/reperfusion injury","Deng J, St Clair M, Everett C, Reitman M, Star RA.","Comp Med. 2000 Dec;50(6):628-32.","Deng J","Comp Med","2000","2001/02/24","","",""
"11199877","Contemporary methods in pharmacotherapy in the opiate dependent treatment","Radomska M, Bisaga A, Popik P.","Przegl Lek. 2000;57(10):509-18.","Radomska M","Przegl Lek","2000","2001/02/24","","",""
"11199374","Buprenorphine or procaine for pain relief in acute pancreatitis. A prospective randomized study","Jakobs R, Adamek MU, von Bubnoff AC, Riemann JF.","Scand J Gastroenterol. 2000 Dec;35(12):1319-23. doi: 10.1080/003655200453692.","Jakobs R","Scand J Gastroenterol","2000","2001/02/24","","","10.1080/003655200453692"
"11197874","Stress-related behavioral alterations accompanying cocaine toxicity: the effects of mixed opioid drugs","Hayase T, Yamamoto Y, Yamamoto K.","Nihon Arukoru Yakubutsu Igakkai Zasshi. 2000 Dec;35(6):402-14.","Hayase T","Nihon Arukoru Yakubutsu Igakkai Zasshi","2000","2001/02/24","","",""
"11187226","[New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ]","Petersen H, Skauge L, Svejsø J, Ege PP.","Ugeskr Laeger. 2000 Nov 27;162(48):6553-6.","Petersen H","Ugeskr Laeger","2000","2001/02/24","","",""
"11182872","Injecting misuse of buprenorphine among French drug users","Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti JP.","Addiction. 2001 Feb;96(2):267-72. doi: 10.1046/j.1360-0443.2001.96226710.x.","Obadia Y","Addiction","2001","2001/02/22","","","10.1046/j.1360-0443.2001.96226710.x"
"11175458","Buprenorphine: a new treatment for opioid addiction","","Harv Ment Health Lett. 2001 Feb;17(8):6-7.","","Harv Ment Health Lett","2001","2001/02/15","","",""
"11173173","Double-blind randomized trial of buprenorphine and methadone in opiate dependence","Petitjean S, Stohler R, Déglon JJ, Livoti S, Waldvogel D, Uehlinger C, Ladewig D.","Drug Alcohol Depend. 2001 Mar 1;62(1):97-104. doi: 10.1016/s0376-8716(00)00163-0.","Petitjean S","Drug Alcohol Depend","2001","2001/02/15","","","10.1016/s0376-8716(00)00163-0"
"11164693","Novelty seeking as a predictor of treatment retention for heroin dependent cocaine users","Helmus TC, Downey KK, Arfken CL, Henderson MJ, Schuster CR.","Drug Alcohol Depend. 2001 Feb 1;61(3):287-95. doi: 10.1016/s0376-8716(00)00153-8.","Helmus TC","Drug Alcohol Depend","2001","2001/02/13","","","10.1016/s0376-8716(00)00153-8"
"11164692","Recent evolution in opiate dependence in France during generalisation of maintenance treatments","Thirion X, Micallef J, Barrau K, Djezzar S, Lambert H, Sanmarco JL, Lagier G.","Drug Alcohol Depend. 2001 Feb 1;61(3):281-5. doi: 10.1016/s0376-8716(00)00147-2.","Thirion X","Drug Alcohol Depend","2001","2001/02/13","","","10.1016/s0376-8716(00)00147-2"
"11155787","Response to ""detoxification with buprenorphine of a pregnant heroin addict""","Welsh CJ, Cargiulo TP.","Am J Addict. 2000 Fall;9(4):340-1. doi: 10.1080/105504900750047391.","Welsh CJ","Am J Addict","2000","2001/01/13","","","10.1080/105504900750047391"
"11153633","Moderate hypothermia improves imbalances of thromboxane A2 and prostaglandin I2 production after traumatic brain injury in humans","Aibiki M, Maekawa S, Yokono S.","Crit Care Med. 2000 Dec;28(12):3902-6. doi: 10.1097/00003246-200012000-00029.","Aibiki M","Crit Care Med","2000","2001/01/12","","","10.1097/00003246-200012000-00029"
"11150107","Deaths attributable to methadone vs buprenorphine in France","Auriacombe M, Franques P, Tignol J.","JAMA. 2001 Jan 3;285(1):45. doi: 10.1001/jama.285.1.45.","Auriacombe M","JAMA","2001","2001/01/10","","","10.1001/jama.285.1.45"
"11147165","Buprenorphine: ""field trials"" of a new drug","Agar M, Bourgois P, French J, Murdoch O.","Qual Health Res. 2001 Jan;11(1):69-84. doi: 10.1177/104973201129118948.","Agar M","Qual Health Res","2001","2001/01/09","","","10.1177/104973201129118948"
"11137282","Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans","Amass L, Kamien JB, Mikulich SK.","Drug Alcohol Depend. 2001 Jan 1;61(2):173-81. doi: 10.1016/s0376-8716(00)00141-1.","Amass L","Drug Alcohol Depend","2001","2001/01/04","","","10.1016/s0376-8716(00)00141-1"
"11134491","Buprenorphine substitution ameliorates spontaneous withdrawal in fentanyl-dependent rat pups","Lohmann AB, Smith FL.","Pediatr Res. 2001 Jan;49(1):50-5. doi: 10.1203/00006450-200101000-00013.","Lohmann AB","Pediatr Res","2001","2001/01/03","","","10.1203/00006450-200101000-00013"
"11124101","Effects of surgery and analgesic administration on spontaneous behaviour in singly housed rats","Roughan JV, Flecknell PA.","Res Vet Sci. 2000 Dec;69(3):283-8. doi: 10.1053/rvsc.2000.0430.","Roughan JV","Res Vet Sci","2000","2000/12/22","","","10.1053/rvsc.2000.0430"
"11123005","Buprenorphine and naloxone for heroin dependence","Johnson RE, McCagh JC.","Curr Psychiatry Rep. 2000 Dec;2(6):519-26. doi: 10.1007/s11920-000-0012-8.","Johnson RE","Curr Psychiatry Rep","2000","2000/12/21","","","10.1007/s11920-000-0012-8"
"11115734","Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice","Kuzmin AV, Gerrits MA, Zvartau EE, van Ree JM.","Eur Neuropsychopharmacol. 2000 Dec;10(6):447-54. doi: 10.1016/s0924-977x(00)00117-6.","Kuzmin AV","Eur Neuropsychopharmacol","2000","2000/12/15","","","10.1016/s0924-977x(00)00117-6"
"11104938","Comparison of high dose buprenorphine treatments of opiate dependent outpatients in four healthcare networks","De Ducla M, Gagnon A, Mucchielli A, Robinet S, Vellay A.","Ann Med Interne (Paris). 2000 Oct;151 Suppl B:B9-15.","De Ducla M","Ann Med Interne (Paris)","2000","2000/12/06","","",""
"11104936","[A clear look]","Vasseur V.","Ann Med Interne (Paris). 2000 Oct;151 Suppl B:B4.","Vasseur V","Ann Med Interne (Paris)","2000","2000/12/06","","",""
"11099141","Serial laparoscopic biopsies of liver and spleen from Schistosoma-infected baboons (Papio spp.)","Rawlings CA, Van Lue S, King C, Freeman L, Damian RT, Greenacre C, Chernosky A, Mohamed FM, Chou TM.","Comp Med. 2000 Oct;50(5):551-5.","Rawlings CA","Comp Med","2000","2000/12/01","","",""
"11099129","Modified procedure for implantation of subcutaneous central venous access devices in macaques (Macaca mulatta)","Nuchtern J, McGuffey L, Durfee J, Dauser R, Blaney SM.","Comp Med. 2000 Oct;50(5):486-9.","Nuchtern J","Comp Med","2000","2000/12/01","","",""
"11091779","Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs. The MANIF 2000 Study Group","Reynaud-Maurupt C, Carrieri MP, Gastaud JA, Pradier C, Obadia Y, Moatti JP.","AIDS Care. 2000 Aug;12(4):461-70. doi: 10.1080/09540120050123864.","Reynaud-Maurupt C","AIDS Care","2000","2000/11/25","","","10.1080/09540120050123864"
"11072864","Oral buprenorphine is anti-inflammatory and modulates the pathogenesis of streptococcal cell wall polymer-induced arthritis in the Lew/SSN rat","Volker D, Bate M, Gentle R, Garg M.","Lab Anim. 2000 Oct;34(4):423-9. doi: 10.1258/002367700780387732.","Volker D","Lab Anim","2000","2000/11/10","","","10.1258/002367700780387732"
"11072859","Transdermal fentanyl compared with parenteral buprenorphine in post-surgical pain in swine: a case study","Harvey-Clark CJ, Gilespie K, Riggs KW.","Lab Anim. 2000 Oct;34(4):386-98. doi: 10.1258/002367700780387750.","Harvey-Clark CJ","Lab Anim","2000","2000/11/10","","","10.1258/002367700780387750"
"11064186","Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine","Harris DS, Jones RT, Welm S, Upton RA, Lin E, Mendelson J.","Drug Alcohol Depend. 2000 Dec 22;61(1):85-94. doi: 10.1016/s0376-8716(00)00126-5.","Harris DS","Drug Alcohol Depend","2000","2000/11/07","","","10.1016/s0376-8716(00)00126-5"
"11061678","A comparative clinical study of the effect of WeiniCom, a Chinese herbal compound, on alleviation of withdrawal symptoms and craving for heroin in detoxification treatment","Hao W, Zhao M.","J Psychoactive Drugs. 2000 Jul-Sep;32(3):277-84. doi: 10.1080/02791072.2000.10400450.","Hao W","J Psychoactive Drugs","2000","2000/11/04","","","10.1080/02791072.2000.10400450"
"11058680","Treating opioid dependence--new data and new opportunities","O'Connor PG.","N Engl J Med. 2000 Nov 2;343(18):1332-4. doi: 10.1056/NEJM200011023431809.","O'Connor PG","N Engl J Med","2000","2000/11/04","","","10.1056/NEJM200011023431809"
"11058673","A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE.","N Engl J Med. 2000 Nov 2;343(18):1290-7. doi: 10.1056/NEJM200011023431802.","Johnson RE","N Engl J Med","2000","2000/11/04","","","10.1056/NEJM200011023431802"
"11056574","From the Food and Drug Administration","Henney JE.","JAMA. 2000 Nov 1;284(17):2178. doi: 10.1001/jama.284.17.2178-jfd00009-2-1.","Henney JE","JAMA","2000","2000/11/01","","","10.1001/jama.284.17.2178-jfd00009-2-1"
"11048355","A longitudinal study of male buprenorphine addicts attending an addiction clinic in India","Basu D, Mattoo SK, Malhotra A, Gupta N, Malhotra R.","Addiction. 2000 Sep;95(9):1363-72. doi: 10.1046/j.1360-0443.2000.95913637.x.","Basu D","Addiction","2000","2000/10/26","","","10.1046/j.1360-0443.2000.95913637.x"
"11046087","Analgesic synergy between topical lidocaine and topical opioids","Kolesnikov YA, Chereshnev I, Pasternak GW.","J Pharmacol Exp Ther. 2000 Nov;295(2):546-51.","Kolesnikov YA","J Pharmacol Exp Ther","2000","2000/10/25","","",""
"11042867","[Detoxification of poly-substance abusers with buprenorphine. Effects on affect, anxiety, and withdrawal symptoms]","Paetzold W, Eronat V, Seifert J, Holze I, Emrich HM, Schneider U.","Nervenarzt. 2000 Sep;71(9):722-9. doi: 10.1007/s001150050656.","Paetzold W","Nervenarzt","2000","2000/10/24","","","10.1007/s001150050656"
"11037118","Reduction of isoflurane MAC with buprenorphine and morphine in rats","Criado AB, Gómez de Segura IA, Tendillo FJ, Marsico F.","Lab Anim. 2000 Jul;34(3):252-9. doi: 10.1258/002367700780384717.","Criado AB","Lab Anim","2000","2000/10/19","","","10.1258/002367700780384717"
"11025950","[Clinical evaluation of combined spinal-epidural anesthesia by needle-through-needle approach in 485 surgical cases]","Tsutsui T, Muranaka K, Setoyama K.","Masui. 2000 Sep;49(9):970-5.","Tsutsui T","Masui","2000","2000/10/12","","",""
"11011303","[Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)]","Duburcq A, Charpak Y, Blin P, Madec L.","Rev Epidemiol Sante Publique. 2000 Aug;48(4):363-73.","Duburcq A","Rev Epidemiol Sante Publique","2000","2000/09/30","","",""
"11000922","Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine","Petry NM, Bickel WK, Piasecki D, Marsch LA, Badger GJ.","Am J Addict. 2000 Summer;9(3):265-9. doi: 10.1080/10550490050148099.","Petry NM","Am J Addict","2000","2000/09/23","","","10.1080/10550490050148099"
"11000552","Intranasal absorption of buprenorphine--in vivo bioavailability study in sheep","Lindhardt K, Ravn C, Gizurarson S, Bechgaard E.","Int J Pharm. 2000 Sep 15;205(1-2):159-63. doi: 10.1016/s0378-5173(00)00499-3.","Lindhardt K","Int J Pharm","2000","2000/09/23","","","10.1016/s0378-5173(00)00499-3"
"10999352","Buprenorphine to norbuprenorphine ratio in human hair","Cirimele V, Kintz P, Lohner S, Ludes B.","J Anal Toxicol. 2000 Sep;24(6):448-9. doi: 10.1093/jat/24.6.448.","Cirimele V","J Anal Toxicol","2000","2000/09/22","","","10.1093/jat/24.6.448"
"10998995","[Bupranal: a new highly efficacious Russian analgesic]","Zvartau EE, Kalinin VN.","Voen Med Zh. 2000 Aug;321(8):46-9.","Zvartau EE","Voen Med Zh","2000","2000/09/22","","",""
"10998549","Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor","Bloms-Funke P, Gillen C, Schuettler AJ, Wnendt S.","Peptides. 2000 Jul;21(7):1141-6. doi: 10.1016/s0196-9781(00)00252-7.","Bloms-Funke P","Peptides","2000","2000/09/22","","","10.1016/s0196-9781(00)00252-7"
"10993435","Dilated bile duct in patients receiving narcotic substitution: an early report","Zylberberg H, Fontaine H, Corréas JM, Carnot F, Bréchot C, Pol S.","J Clin Gastroenterol. 2000 Sep;31(2):159-61. doi: 10.1097/00004836-200009000-00015.","Zylberberg H","J Clin Gastroenterol","2000","2000/09/19","","","10.1097/00004836-200009000-00015"
"10963298","Apoptosis of NG108-15 cells induced by buprenorphine hydrochloride occurs via the caspase-3 pathway","Kugawa F, Ueno A, Aoki M.","Biol Pharm Bull. 2000 Aug;23(8):930-5. doi: 10.1248/bpb.23.930.","Kugawa F","Biol Pharm Bull","2000","2000/08/30","","","10.1248/bpb.23.930"
"10962771","A comparison of four buprenorphine dosing regimens using open-dosing procedures: is twice-weekly dosing possible?","Petry NM, Bickel WK, Badger GJ.","Addiction. 2000 Jul;95(7):1069-77. doi: 10.1046/j.1360-0443.2000.95710698.x.","Petry NM","Addiction","2000","2000/08/30","","","10.1046/j.1360-0443.2000.95710698.x"
"10958085","Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor","Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ.","Psychopharmacology (Berl). 2000 Jul;150(4):430-42. doi: 10.1007/s002130000453.","Cook CD","Psychopharmacology (Berl)","2000","2000/08/25","","","10.1007/s002130000453"
"10951654","Drugs for pain","","Med Lett Drugs Ther. 2000 Aug 21;42(1085):73-8.","","Med Lett Drugs Ther","2000","2000/08/22","","",""
"10945934","Sensitization to the morphine-like discriminative stimulus effects of buprenorphine in rats","Bartoletti M, Gubellini C, Gaiardi M.","Pharmacol Res. 2000 Sep;42(3):269-73. doi: 10.1006/phrs.2000.0688.","Bartoletti M","Pharmacol Res","2000","2000/08/18","","","10.1006/phrs.2000.0688"
"10945877","BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice","Broom DC, Guo L, Coop A, Husbands SM, Lewis JW, Woods JH, Traynor JR.","J Pharmacol Exp Ther. 2000 Sep;294(3):1195-200.","Broom DC","J Pharmacol Exp Ther","2000","2000/08/17","","",""
"10942856","Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study","Zubieta J, Greenwald MK, Lombardi U, Woods JH, Kilbourn MR, Jewett DM, Koeppe RA, Schuster CR, Johanson CE.","Neuropsychopharmacology. 2000 Sep;23(3):326-34. doi: 10.1016/S0893-133X(00)00110-X.","Zubieta J","Neuropsychopharmacology","2000","2000/08/16","","","10.1016/S0893-133X(00)00110-X"
"10936512","Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","Gomez-Flores R, Weber RJ.","Immunopharmacology. 2000 Jul 20;48(2):145-56. doi: 10.1016/s0162-3109(00)00198-3.","Gomez-Flores R","Immunopharmacology","2000","2000/08/11","","","10.1016/s0162-3109(00)00198-3"
"10934299","Opioid analgesic-induced apoptosis and caspase-independent cell death in human lung carcinoma A549 cells","Yoshida A, Tokuyama S, Iwamura T, Ueda H.","Int J Mol Med. 2000 Sep;6(3):329-35. doi: 10.3892/ijmm.6.3.329.","Yoshida A","Int J Mol Med","2000","2000/08/10","","","10.3892/ijmm.6.3.329"
"10933025","[A comparison of fentanyl and buprenorphine in total intravenous anesthesia using propofol during spinal surgery]","Tabuchi Y, Takahashi S.","Masui. 2000 Jul;49(7):745-9.","Tabuchi Y","Masui","2000","2000/08/10","","",""
"10932843","Disulfiram and buprenorphine for treating cocaine addiction","","AIDS Read. 2000 Jul;10(7):409.","","AIDS Read","2000","2000/08/10","","",""
"10928310","Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers","Strain EC, Stoller K, Walsh SL, Bigelow GE.","Psychopharmacology (Berl). 2000 Mar;148(4):374-83. doi: 10.1007/s002130050066.","Strain EC","Psychopharmacology (Berl)","2000","2000/08/06","","","10.1007/s002130050066"
"10927866","Differential modulation of nociceptive responses to mu and kappa opioid receptor directed drugs by blood glucose in experimentally induced diabetes rats","Tandon M, Srivastava RK, Nagpal RK, Khosla P, Singh J.","Indian J Exp Biol. 2000 Mar;38(3):242-8.","Tandon M","Indian J Exp Biol","2000","2000/08/06","","",""
"10914298","Detoxification with buprenorphine of a pregnant heroin addict","Annitto WJ.","Am J Addict. 2000 Winter;9(1):92-3. doi: 10.1080/10550490050172272.","Annitto WJ","Am J Addict","2000","2000/07/29","","","10.1080/10550490050172272"
"10909149","[Drug-addicted prisoners: seroprevalence of human immunodeficiency virus and hepatitis B and C virus soon after the marketing of buprenorphine]","Claudon-Charpentier A, Hoibian M, Glasser P, Lalanne H, Pasquali JL.","Rev Med Interne. 2000 Jun;21(6):505-9. doi: 10.1016/s0248-8663(00)89225-5.","Claudon-Charpentier A","Rev Med Interne","2000","2000/07/26","","","10.1016/s0248-8663(00)89225-5"
"10908521","Buprenorphine for the management of opioid withdrawal","Gowing L, Ali R, White J.","Cochrane Database Syst Rev. 2000;(3):CD002025. doi: 10.1002/14651858.CD002025.","Gowing L","Cochrane Database Syst Rev","2000","2000/07/25","","","10.1002/14651858.CD002025"
"10896028","Relationship between cocaine-induced hepatotoxic neurobehavioral & biochemical changes in mice: the antidotal effects of buprenorphine","Hayase T, Yamamoto Y, Yamamoto K, Abiru H, Nishitani Y, Fukui Y.","Life Sci. 2000 May 26;67(1):45-52. doi: 10.1016/s0024-3205(00)00599-3.","Hayase T","Life Sci","2000","2000/07/15","","","10.1016/s0024-3205(00)00599-3"
"10891786","[The financial impact of maintenance treatment in heroin addictive behavior: the case of Subutex]","Kopp P, Rumeau-Pichon C, Le Pen C.","Rev Epidemiol Sante Publique. 2000 Jun;48(3):256-70.","Kopp P","Rev Epidemiol Sante Publique","2000","2000/07/13","","",""
"10879015","[Drug dependence in pregnancy. Better to substitute than complete withdrawal]","Ottenjann H.","MMW Fortschr Med. 2000 Apr 27;142(17):16.","Ottenjann H","MMW Fortschr Med","2000","2000/07/06","","",""
"10877739","Pharmacologic treatment of heroin-dependent patients","O'Connor PG, Fiellin DA.","Ann Intern Med. 2000 Jul 4;133(1):40-54. doi: 10.7326/0003-4819-133-1-200007040-00008.","O'Connor PG","Ann Intern Med","2000","2000/07/06","","","10.7326/0003-4819-133-1-200007040-00008"
"10873929","Lack of interaction of buprenorphine with flunitrazepam metabolism","Kilicarslan T, Sellers EM.","Am J Psychiatry. 2000 Jul;157(7):1164-6. doi: 10.1176/appi.ajp.157.7.1164.","Kilicarslan T","Am J Psychiatry","2000","2000/06/30","","","10.1176/appi.ajp.157.7.1164"
"10862808","Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial","George TP, Chawarski MC, Pakes J, Carroll KM, Kosten TR, Schottenfeld RS.","Biol Psychiatry. 2000 Jun 15;47(12):1080-6. doi: 10.1016/s0006-3223(99)00310-8.","George TP","Biol Psychiatry","2000","2000/06/23","","","10.1016/s0006-3223(99)00310-8"
"10862807","Thrice-weekly versus daily buprenorphine maintenance","Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR.","Biol Psychiatry. 2000 Jun 15;47(12):1072-9. doi: 10.1016/s0006-3223(99)00270-x.","Schottenfeld RS","Biol Psychiatry","2000","2000/06/23","","","10.1016/s0006-3223(99)00270-x"
"10859082","Hemorrhoidectomy with posterior perineal block: experience with 400 cases","Gabrielli F, Cioffi U, Chiarelli M, Guttadauro A, De Simone M.","Dis Colon Rectum. 2000 Jun;43(6):809-12. doi: 10.1007/BF02238019.","Gabrielli F","Dis Colon Rectum","2000","2000/06/20","","","10.1007/BF02238019"
"10855374","[Follow-up of opioid addicts treated with high-dose buprenorphine in a health care network. National retrospective study. Experience of French general physicians]","De Ducla M, Gagnon A, Mucchielli A, Robinet S, Vellay A.","Ann Med Interne (Paris). 2000 Apr;151 Suppl A:A27-32.","De Ducla M","Ann Med Interne (Paris)","2000","2000/06/16","","",""
"10855372","[Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction]","Thirion X, Barrau K, Micallef J, Haramburu F, Lowenstein W, Sanmarco JL.","Ann Med Interne (Paris). 2000 Apr;151 Suppl A:A10-7.","Thirion X","Ann Med Interne (Paris)","2000","2000/06/16","","",""
"10843300","Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance","Downey KK, Helmus TC, Schuster CR.","Exp Clin Psychopharmacol. 2000 May;8(2):176-84. doi: 10.1037//1064-1297.8.2.176.","Downey KK","Exp Clin Psychopharmacol","2000","2000/06/08","","","10.1037//1064-1297.8.2.176"
"10821989","Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group","Carrieri MP, Vlahov D, Dellamonica P, Gallais H, Lepeu G, Spire B, Obadia Y.","Drug Alcohol Depend. 2000 Jul 1;60(1):51-4. doi: 10.1016/s0376-8716(99)00136-2.","Carrieri MP","Drug Alcohol Depend","2000","2000/05/24","","","10.1016/s0376-8716(99)00136-2"
"10821988","Buprenorphine: a controlled clinical trial in the treatment of opioid dependence","Pani PP, Maremmani I, Pirastu R, Tagliamonte A, Gessa GL.","Drug Alcohol Depend. 2000 Jul 1;60(1):39-50. doi: 10.1016/s0376-8716(99)00140-4.","Pani PP","Drug Alcohol Depend","2000","2000/05/24","","","10.1016/s0376-8716(99)00140-4"
"10821412","Quantitative determination of dihydroetorphine in rat plasma and brain by liquid chromatography-tandem mass spectrometry","Ohmori S, Hayashi T, Kawase M, Saito S, Morimoto Y.","J Chromatogr B Biomed Sci Appl. 2000 Apr 14;740(2):253-63. doi: 10.1016/s0378-4347(00)00129-8.","Ohmori S","J Chromatogr B Biomed Sci Appl","2000","2000/05/23","","","10.1016/s0378-4347(00)00129-8"
"10821205","The discriminative stimulus effects of morphine in pigeons responding under a progressive ratio schedule of food presentation","Brandt MR, Galici R, France CP.","Behav Pharmacol. 2000 Feb;11(1):15-28. doi: 10.1097/00008877-200002000-00002.","Brandt MR","Behav Pharmacol","2000","2000/05/23","","","10.1097/00008877-200002000-00002"
"10817461","Effects of repeated anaesthesia with ketamine/medetomidine and of pre-anaesthetic administration of buprenorphine in rats","Hedenqvist P, Roughan JV, Flecknell PA.","Lab Anim. 2000 Apr;34(2):207-11. doi: 10.1258/002367700780457536.","Hedenqvist P","Lab Anim","2000","2000/05/19","","","10.1258/002367700780457536"
"10817460","Adverse effects on growth rates in rats caused by buprenorphine administration","Jacobson C.","Lab Anim. 2000 Apr;34(2):202-6. doi: 10.1258/002367700780457509.","Jacobson C","Lab Anim","2000","2000/05/19","","","10.1258/002367700780457509"
"10815411","[Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly]","Blennow G, Fergusson A, Medvedeo A.","Lakartidningen. 2000 Apr 12;97(15):1830-3.","Blennow G","Lakartidningen","2000","2000/05/18","","",""
"10812283","A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence","Pérez de los Cobos J, Martin S, Etcheberrigaray A, Trujols J, Batlle F, Tejero A, Queraltó JM, Casas M.","Drug Alcohol Depend. 2000 Jun 1;59(3):223-33. doi: 10.1016/s0376-8716(99)00122-2.","Pérez de los Cobos J","Drug Alcohol Depend","2000","2000/05/17","","","10.1016/s0376-8716(99)00122-2"
"10791933","Analgesic effects of butorphanol and buprenorphine in conscious African grey parrots (Psittacus erithacus erithacus and Psittacus erithacus timneh)","Paul-Murphy JR, Brunson DB, Miletic V.","Am J Vet Res. 1999 Oct;60(10):1218-21.","Paul-Murphy JR","Am J Vet Res","1999","2000/05/03","","",""
"10791932","A technique for evaluating analgesia in conscious perching birds","Paul-Murphy JR, Brunson DB, Miletic V.","Am J Vet Res. 1999 Oct;60(10):1213-7.","Paul-Murphy JR","Am J Vet Res","1999","2000/05/03","","",""
"10789517","Gauged attenuation of congenital portosystemic shunts: results in 160 dogs and 15 cats","Wolschrijn CF, Mahapokai W, Rothuizen J, Meyer HP, van Sluijs FJ.","Vet Q. 2000 Apr;22(2):94-8. doi: 10.1080/01652176.2000.9695032.","Wolschrijn CF","Vet Q","2000","2000/05/02","","","10.1080/01652176.2000.9695032"
"10781115","Postoperative pain control following remifentanil-based anaesthesia for major abdominal surgery","Albrecht S, Fechner J, Geisslinger G, Maass AB, Upadhyaya B, Moecke H, Haigh C, Schüttler J.","Anaesthesia. 2000 Apr;55(4):315-22. doi: 10.1046/j.1365-2044.2000.01122.x.","Albrecht S","Anaesthesia","2000","2000/04/26","","","10.1046/j.1365-2044.2000.01122.x"
"10780844","The effect of buprenorphine on the course of disease in laboratory rabbits infected with myxoma virus","Robinson AJ, Müller WJ, Braid AL, Kerr PJ.","Lab Anim. 1999 Jul;33(3):252-7. doi: 10.1258/002367799780578129.","Robinson AJ","Lab Anim","1999","2000/04/26","","","10.1258/002367799780578129"
"10780842","The influence of pre-anaesthetic administration of buprenorphine on the anaesthetic effects of ketamine/medetomidine and pentobarbitone in rats and the consequences of repeated anaesthesia","Roughan JV, Ojeda OB, Flecknell PA.","Lab Anim. 1999 Jul;33(3):234-42. doi: 10.1258/002367799780578183.","Roughan JV","Lab Anim","1999","2000/04/26","","","10.1258/002367799780578183"
"10780821","Use of oral buprenorphine ('buprenorphine jello') for postoperative analgesia in rats--a clinical trial","Flecknell PA, Roughan JV, Stewart R.","Lab Anim. 1999 Apr;33(2):169-74. doi: 10.1258/002367799780578381.","Flecknell PA","Lab Anim","1999","2000/04/26","","","10.1258/002367799780578381"
"10778781","Interference of pain control employing opioids in in vivo immunological experiments","Piersma FE, Daemen MA, Bogaard AE, Buurman WA.","Lab Anim. 1999 Oct;33(4):328-33. doi: 10.1258/002367799780487887.","Piersma FE","Lab Anim","1999","2000/04/25","","","10.1258/002367799780487887"
"10759392","EEG evaluation of reflex testing as assessment of depth of pentobarbital anaesthesia in the rat","Haberham ZL, van den Brom WE, Venker-van Haagen AJ, Baumans V, de Groot HN, Hellebrekers LJ.","Lab Anim. 1999 Jan;33(1):47-57. doi: 10.1258/002367799780578570.","Haberham ZL","Lab Anim","1999","2000/04/12","","","10.1258/002367799780578570"
"10759387","A comparison of pre- and post-surgical administration of bupivacaine or buprenorphine following laparotomy in the rat","Hayes JH, Flecknell PA.","Lab Anim. 1999 Jan;33(1):16-23. doi: 10.1258/002367799780578534.","Hayes JH","Lab Anim","1999","2000/04/12","","","10.1258/002367799780578534"
"10755464","Effect of buprenorphine on CYP3A activity in rat and human liver microsomes","Ibrahim RB, Wilson JG, Thorsby ME, Edwards DJ.","Life Sci. 2000 Feb 25;66(14):1293-8. doi: 10.1016/s0024-3205(00)00436-7.","Ibrahim RB","Life Sci","2000","2001/02/07","","","10.1016/s0024-3205(00)00436-7"
"10753497","Increased burn-induced immunosuppression in lipopolysaccharide-resistant mice","Jobin N, Garrel DR, Bernier J.","Cell Immunol. 2000 Mar 15;200(2):65-75. doi: 10.1006/cimm.2000.1619.","Jobin N","Cell Immunol","2000","2000/04/08","","","10.1006/cimm.2000.1619"
"10746542","Bupivacaine versus buprenorphine","Folk JW, Duc TA.","Reg Anesth Pain Med. 2000 Mar-Apr;25(2):212.","Folk JW","Reg Anesth Pain Med","2000","2000/04/04","","",""
"10742642","An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence","Rothman RB, Gorelick DA, Heishman SJ, Eichmiller PR, Hill BH, Norbeck J, Liberto JG.","J Subst Abuse Treat. 2000 Apr;18(3):277-81. doi: 10.1016/s0740-5472(99)00074-4.","Rothman RB","J Subst Abuse Treat","2000","2000/04/01","","","10.1016/s0740-5472(99)00074-4"
"10742639","Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities","Schottenfeld RS, Pantalon MV, Chawarski MC, Pakes J.","J Subst Abuse Treat. 2000 Apr;18(3):255-61. doi: 10.1016/s0740-5472(99)00062-8.","Schottenfeld RS","J Subst Abuse Treat","2000","2000/04/01","","","10.1016/s0740-5472(99)00062-8"
"10729371","Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys","Kishioka S, Paronis CA, Lewis JW, Woods JH.","Eur J Pharmacol. 2000 Mar 17;391(3):289-97. doi: 10.1016/s0014-2999(00)00039-x.","Kishioka S","Eur J Pharmacol","2000","2000/03/24","","","10.1016/s0014-2999(00)00039-x"
"10723852","Treatment of opioid-dependent pregnant women with buprenorphine","Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, Langer M, Aschauer HN.","Addiction. 2000 Feb;95(2):239-44. doi: 10.1046/j.1360-0443.2000.95223910.x.","Fischer G","Addiction","2000","2000/03/21","","","10.1046/j.1360-0443.2000.95223910.x"
"10708285","Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group","Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J.","AIDS. 2000 Jan 28;14(2):151-5. doi: 10.1097/00002030-200001280-00010.","Moatti JP","AIDS","2000","2000/03/09","","","10.1097/00002030-200001280-00010"
"10701946","Voltammetric study and determination of buprenorphine in pharmaceuticals","García-Fernández MA, Fernández-Abedul MT, Costa-García A.","J Pharm Biomed Anal. 1999 Dec;21(4):809-15. doi: 10.1016/s0731-7085(99)00193-4.","García-Fernández MA","J Pharm Biomed Anal","1999","2000/03/04","","","10.1016/s0731-7085(99)00193-4"
"10689843","[Anesthetic management in a patient with severe acute pancreatitis during pregnancy]","Hino H, Nagano K, Yamanaka I, Suzuki R, Okada T.","Masui. 2000 Jan;49(1):45-8.","Hino H","Masui","2000","2000/02/26","","",""
"10688632","Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?","Zaki PA, Keith DE Jr, Brine GA, Carroll FI, Evans CJ.","J Pharmacol Exp Ther. 2000 Mar;292(3):1127-34.","Zaki PA","J Pharmacol Exp Ther","2000","2000/02/25","","",""
"10678328","Comparing buprenorphine and methadone maintenance","Newman RG.","J Nerv Ment Dis. 1994 Apr;182(4):245-6. doi: 10.1097/00005053-199404000-00014.","Newman RG","J Nerv Ment Dis","1994","1994/04/01","","","10.1097/00005053-199404000-00014"
"10678140","Effects of low-pH treatment on cAMP second messenger system regulated by different opioid agonists","Liu JG, Gong ZH, Qin BY.","Zhongguo Yao Li Xue Bao. 1999 Jun;20(6):500-4.","Liu JG","Zhongguo Yao Li Xue Bao","1999","2000/05/08","","",""
"10678096","Effects of opioid receptor agonists on cAMP second messenger system","Liu JG, Gong ZH, Qin BY.","Zhongguo Yao Li Xue Bao. 1999 May;20(5):452-6.","Liu JG","Zhongguo Yao Li Xue Bao","1999","2000/05/20","","",""
"10669065","Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet","Amass L, Kamien JB, Mikulich SK.","Drug Alcohol Depend. 2000 Feb 1;58(1-2):143-52. doi: 10.1016/s0376-8716(99)00074-5.","Amass L","Drug Alcohol Depend","2000","2000/02/11","","","10.1016/s0376-8716(99)00074-5"
"10669052","Gender differences in hostility of opioid-dependent outpatients: role in early treatment termination","Petry NM, Bickel WK.","Drug Alcohol Depend. 2000 Feb 1;58(1-2):27-33. doi: 10.1016/s0376-8716(99)00058-7.","Petry NM","Drug Alcohol Depend","2000","2000/02/11","","","10.1016/s0376-8716(99)00058-7"
"10668610","[Predictive factors for patient maintenance on buprenorphine high dosage treatment: a naturalistic study in primary care]","Gasquet I, Lançon C, Parquet P.","Encephale. 1999 Nov-Dec;25(6):645-51.","Gasquet I","Encephale","1999","2000/02/11","","",""
"10665107","Precipitated withdrawal in an opioid-dependent outpatient receiving alternate-day buprenorphine dosing","Jacobs EA, Bickel WK.","Addiction. 1999 Jan;94(1):140-1.","Jacobs EA","Addiction","1999","2000/02/09","","",""
"10658237","Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution","Jäppinen A, Kokki H, Naaranlahti TJ, Rasi AS.","Pharm World Sci. 1999 Dec;21(6):272-4. doi: 10.1023/a:1008771621812.","Jäppinen A","Pharm World Sci","1999","2000/02/05","","","10.1023/a:1008771621812"
"10649968","Structural determinants of efficacy for kappa opioid receptors in the orvinol series: 7,7-spiro analogues of buprenorphine","Husbands SM, Lewis JW.","J Med Chem. 2000 Jan 27;43(2):139-41. doi: 10.1021/jm991165p.","Husbands SM","J Med Chem","2000","2000/01/29","","","10.1021/jm991165p"
"10643813","Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor","Hashimoto Y, Caló G, Guerrini R, Smith G, Lambert DG.","Neurosci Lett. 2000 Jan 7;278(1-2):109-12. doi: 10.1016/s0304-3940(99)00915-5.","Hashimoto Y","Neurosci Lett","2000","2000/01/22","","","10.1016/s0304-3940(99)00915-5"
"10641946","Fatal intoxication following self-administration of a massive dose of buprenorphine","Gaulier JM, Marquet P, Lacassie E, Dupuy JL, Lachatre G.","J Forensic Sci. 2000 Jan;45(1):226-8.","Gaulier JM","J Forensic Sci","2000","2000/01/21","","",""
"10630350","Should cocaine-abusing, buprenorphine-maintained patients receive auricular acupuncture? Findings from an acute effects study","Margolin A, Avants SK.","J Altern Complement Med. 1999 Dec;5(6):567-74. doi: 10.1089/acm.1999.5.567.","Margolin A","J Altern Complement Med","1999","2000/01/12","","","10.1089/acm.1999.5.567"
"10615719","Buprenorphine versus methadone maintenance for the treatment of opioid dependence","Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stühlinger G, Pezawas L, Aschauer HN, Kasper S.","Addiction. 1999 Sep;94(9):1337-47. doi: 10.1046/j.1360-0443.1999.94913376.x.","Fischer G","Addiction","1999","2000/01/01","","","10.1046/j.1360-0443.1999.94913376.x"
"10587741","[Buprenorphine and pregnancy. Analysis of 24 cases]","Jernite M, Viville B, Escande B, Brettes JP, Messer J.","Arch Pediatr. 1999 Nov;6(11):1179-85. doi: 10.1016/S0929-693X(00)86300-9.","Jernite M","Arch Pediatr","1999","1999/12/10","","","10.1016/S0929-693X(00)86300-9"
"10567329","Opiate drugs and delta-receptor-mediated myocardial protection","Benedict PE, Benedict MB, Su TP, Bolling SF.","Circulation. 1999 Nov 9;100(19 Suppl):II357-60. doi: 10.1161/01.cir.100.suppl_2.ii-357.","Benedict PE","Circulation","1999","1999/11/24","","","10.1161/01.cir.100.suppl_2.ii-357"
"10565829","Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group","Traynor JR, Guo L, Coop A, Lewis JW, Woods JH.","J Pharmacol Exp Ther. 1999 Dec;291(3):1093-9.","Traynor JR","J Pharmacol Exp Ther","1999","1999/11/24","","",""
"10530511","Buprenorphine potentiates L-DOPA-induced contralateral rotation in 6-hydroxydopamine-treated rats","Adams AC, Keefe KA.","Neurosci Lett. 1999 Oct 15;274(1):25-8. doi: 10.1016/s0304-3940(99)00668-0.","Adams AC","Neurosci Lett","1999","1999/10/26","","","10.1016/s0304-3940(99)00668-0"
"10529021","Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance","Greenwald MK, Johanson CE, Schuster CR.","Drug Alcohol Depend. 1999 Oct 1;56(3):191-203. doi: 10.1016/s0376-8716(99)00032-0.","Greenwald MK","Drug Alcohol Depend","1999","1999/10/21","","","10.1016/s0376-8716(99)00032-0"
"10529020","Naltrexone shortened opioid detoxification with buprenorphine","Umbricht A, Montoya ID, Hoover DR, Demuth KL, Chiang CT, Preston KL.","Drug Alcohol Depend. 1999 Oct 1;56(3):181-90. doi: 10.1016/s0376-8716(99)00033-2.","Umbricht A","Drug Alcohol Depend","1999","1999/10/21","","","10.1016/s0376-8716(99)00033-2"
"10527644","Effects of buprenorphine on motility in morphine post-dependent rats","Bartoletti M, Gaiardi M, Gubellini C.","Pharmacol Res. 1999 Oct;40(4):327-32. doi: 10.1006/phrs.1999.0517.","Bartoletti M","Pharmacol Res","1999","1999/10/21","","","10.1006/phrs.1999.0517"
"10525745","Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients","Bickel WK, Amass L, Crean JP, Badger GJ.","Psychopharmacology (Berl). 1999 Sep;146(2):111-8. doi: 10.1007/s002130051096.","Bickel WK","Psychopharmacology (Berl)","1999","1999/10/20","","","10.1007/s002130051096"
"10522247","[Buprenorphine vs. methadone as maintenance treatment for opioid dependence]","Fischer G, Gombas W, Eder H, Jagsch R, Stühlinger G, Aschauer HN, Kasper S.","Nervenarzt. 1999 Sep;70(9):795-802. doi: 10.1007/s001150050514.","Fischer G","Nervenarzt","1999","1999/10/16","","","10.1007/s001150050514"
"10517544","A retrospective study of buprenorphine and norbuprenorphine in human hair after multiple doses","Wilkins DG, Rollins DE, Valdez AS, Mizuno A, Krueger GG, Cone EJ.","J Anal Toxicol. 1999 Oct;23(6):409-15. doi: 10.1093/jat/23.6.409.","Wilkins DG","J Anal Toxicol","1999","1999/10/12","","","10.1093/jat/23.6.409"
"10511067","A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence","Petry NM, Bickel WK, Badger GJ.","Clin Pharmacol Ther. 1999 Sep;66(3):306-14. doi: 10.1016/S0009-9236(99)70039-1.","Petry NM","Clin Pharmacol Ther","1999","1999/10/08","","","10.1016/S0009-9236(99)70039-1"
"10502307","Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [35S]-GTP-gamma-S functional binding assay","Romero DV, Partilla JS, Zheng QX, Heyliger SO, Ni Q, Rice KC, Lai J, Rothman RB.","Synapse. 1999 Nov;34(2):83-94. doi: 10.1002/(SICI)1098-2396(199911)34:2<83::AID-SYN1>3.0.CO;2-S.","Romero DV","Synapse","1999","1999/09/29","","","10.1002/(SICI)1098-2396(199911)34:2<83::AID-SYN1>3.0.CO;2-S"
"10493109","Differential binding properties of oripavines at cloned mu- and delta-opioid receptors","Lee KO, Akil H, Woods JH, Traynor JR.","Eur J Pharmacol. 1999 Aug 13;378(3):323-30. doi: 10.1016/s0014-2999(99)00460-4.","Lee KO","Eur J Pharmacol","1999","1999/09/24","","","10.1016/s0014-2999(99)00460-4"
"10481428","[Continuous total intravenous anesthesia is recommended for wake-up test]","Onaka M, Yamamoto H, Akatsuka M, Mori H.","Masui. 1999 Aug;48(8):897-9.","Onaka M","Masui","1999","1999/09/11","","",""
"10472517","Discounting of delayed rewards in opioid-dependent outpatients: exponential or hyperbolic discounting functions?","Madden GJ, Bickel WK, Jacobs EA.","Exp Clin Psychopharmacol. 1999 Aug;7(3):284-93. doi: 10.1037//1064-1297.7.3.284.","Madden GJ","Exp Clin Psychopharmacol","1999","1999/09/03","","","10.1037//1064-1297.7.3.284"
"10463317","Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans","Schuh KJ, Walsh SL, Stitzer ML.","Psychopharmacology (Berl). 1999 Jul;145(2):162-74. doi: 10.1007/s002130051045.","Schuh KJ","Psychopharmacology (Berl)","1999","1999/08/27","","","10.1007/s002130051045"
"10462093","Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet","Schuh KJ, Johanson CE.","Drug Alcohol Depend. 1999 Aug 2;56(1):55-60. doi: 10.1016/s0376-8716(99)00012-5.","Schuh KJ","Drug Alcohol Depend","1999","1999/08/26","","","10.1016/s0376-8716(99)00012-5"
"10445776","Intrathecal infusion of bupivacaine with or without buprenorphine relieved intractable pain in three patients with vertebral compression fractures caused by osteoporosis","Dahm PO, Nitescu PV, Appelgren LK, Curelaru ID.","Reg Anesth Pain Med. 1999 Jul-Aug;24(4):352-7. doi: 10.1016/s1098-7339(99)90111-6.","Dahm PO","Reg Anesth Pain Med","1999","1999/08/13","","","10.1016/s1098-7339(99)90111-6"
"10445490","Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry","Vincent F, Bessard J, Vacheron J, Mallaret M, Bessard G.","J Anal Toxicol. 1999 Jul-Aug;23(4):270-9. doi: 10.1093/jat/23.4.270.","Vincent F","J Anal Toxicol","1999","1999/08/13","","","10.1093/jat/23.4.270"
"10432001","Acute hand ischemia secondary to intraarterial buprenorphine injection: treatment with iloprost and dextran-40--a case report","Gouny P, Gaitz JP, Vayssairat M.","Angiology. 1999 Jul;50(7):605-6. doi: 10.1177/000331979905000711.","Gouny P","Angiology","1999","1999/08/04","","","10.1177/000331979905000711"
"10429417","[Chronic pain during dialysis. Pharmacologic therapy and its costs]","Fortina F, Agllata S, Ragazzoni E, Sacco A, Cardillo V, Travaglini S, Brini P, Cavagnino A.","Minerva Urol Nefrol. 1999 Jun;51(2):85-7.","Fortina F","Minerva Urol Nefrol","1999","1999/08/03","","",""
"10420316","[Drug withdrawal therapies]","Ladewig D, Petitjean S.","Internist (Berl). 1999 Jun;40(6):624-7. doi: 10.1007/s001080050380.","Ladewig D","Internist (Berl)","1999","1999/07/27","","","10.1007/s001080050380"
"10419552","Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay","Wnendt S, Krüger T, Janocha E, Hildebrandt D, Englberger W.","Mol Pharmacol. 1999 Aug;56(2):334-8. doi: 10.1124/mol.56.2.334.","Wnendt S","Mol Pharmacol","1999","1999/07/27","","","10.1124/mol.56.2.334"
"10416067","Intubation not for guinea pigs","Bauck L.","Can Vet J. 1999 Jul;40(7):455.","Bauck L","Can Vet J","1999","1999/07/23","PMC1539741","",""
"10402160","Plasma concentrations of buprenorphine 24 to 72 hours after dosing","Chawarski MC, Schottenfeld RS, O'Connor PG, Pakes J.","Drug Alcohol Depend. 1999 Jun 1;55(1-2):157-63. doi: 10.1016/s0376-8716(98)00192-6.","Chawarski MC","Drug Alcohol Depend","1999","1999/07/13","","","10.1016/s0376-8716(98)00192-6"
"10394262","[Substitution treatment for opiate dependence: survey of community pharmacies in Aquitaine]","Jeantaud I, Haramburu F, Bégaud B.","Therapie. 1999 Mar-Apr;54(2):251-5.","Jeantaud I","Therapie","1999","1999/07/08","","",""
"10394261","[Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997]","Thirion X, Micallef J, Guet F, Delarozière JC, Arditti J, Huntsman A, Sanmarco JL, Lagier G.","Therapie. 1999 Mar-Apr;54(2):243-9.","Thirion X","Therapie","1999","1999/07/08","","",""
"10380514","[Economical benefit of continuous total intravenous anesthesia]","Onaka M, Yamamoto H, Akatsuka M, Mori H.","Masui. 1999 May;48(5):548-55.","Onaka M","Masui","1999","1999/06/25","","",""
"10371665","Evaluation of intraarticular opioid analgesia for the relief of articular pain in the domestic fowl","Gentle MJ, Hocking PM, Bernard R, Dunn LN.","Pharmacol Biochem Behav. 1999 Jun;63(2):339-43. doi: 10.1016/s0091-3057(99)00029-5.","Gentle MJ","Pharmacol Biochem Behav","1999","1999/06/17","","","10.1016/s0091-3057(99)00029-5"
"10354966","Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations","Nath RP, Upton RA, Everhart ET, Cheung P, Shwonek P, Jones RT, Mendelson JE.","J Clin Pharmacol. 1999 Jun;39(6):619-23. doi: 10.1177/00912709922008236.","Nath RP","J Clin Pharmacol","1999","1999/06/04","","","10.1177/00912709922008236"
"10349563","Development of biodegradable drug delivery system to treat addiction","Mandal TK.","Drug Dev Ind Pharm. 1999 Jun;25(6):773-9. doi: 10.1081/ddc-100102237.","Mandal TK","Drug Dev Ind Pharm","1999","1999/06/01","","","10.1081/ddc-100102237"
"10336526","Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure","Jones HE, Bigelow GE, Preston KL.","J Pharmacol Exp Ther. 1999 Jun;289(3):1350-61.","Jones HE","J Pharmacol Exp Ther","1999","1999/05/21","","",""
"10312332","Buprenorphine: a cost-effective alternative to Schedule II analgesics for moderate to severe pain relief","Rosenthal MH, Bayait F.","Hosp Formul. 1988 Jan;23(1):57-60, 62, 71.","Rosenthal MH","Hosp Formul","1988","1987/12/11","","",""
"10235658","Buprenorphine pharmacokinetic parameters during coronary artery bypass graft surgery","Amani A, Joseph T, Balasaraswathi K.","Indian J Physiol Pharmacol. 1997 Oct;41(4):361-8.","Amani A","Indian J Physiol Pharmacol","1997","1999/05/11","","",""
"10225070","Lumbar versus thoracic epidural buprenorphine for postoperative analgesia following coronary artery bypass graft surgery","Mehta Y, Juneja R, Madhok H, Trehan N.","Acta Anaesthesiol Scand. 1999 Apr;43(4):388-93. doi: 10.1034/j.1399-6576.1999.430404.x.","Mehta Y","Acta Anaesthesiol Scand","1999","1999/05/04","","","10.1034/j.1399-6576.1999.430404.x"
"10223149","[Buprenorphine (Subutex) and neonatal withdrawal syndrome]","Hervé F, Quenum S.","Arch Pediatr. 1998 Feb;5(2):206-7. doi: 10.1016/s0929-693x(97)86842-x.","Hervé F","Arch Pediatr","1998","1999/05/01","","","10.1016/s0929-693x(97)86842-x"
"10216978","[Hepatonephritis and massive ingestion of buprenorphine]","Houdret N, Asnar V, Szostak-Talbodec N, Leteurtre E, Humbert L, Lecomte-Houcke M, Lhermitte M, Paris JC.","Acta Clin Belg. 1999;53 Suppl 1:29-31.","Houdret N","Acta Clin Belg","1999","1999/04/27","","",""
"10215864","Nonselective coupling of the human mu-opioid receptor to multiple inhibitory G-protein isoforms","Gaibelet G, Meilhoc E, Riond J, Saves I, Exner T, Liaubet L, Nürnberg B, Masson JM, Emorine LJ.","Eur J Biochem. 1999 Apr;261(2):517-23. doi: 10.1046/j.1432-1327.1999.00301.x.","Gaibelet G","Eur J Biochem","1999","1999/04/24","","","10.1046/j.1432-1327.1999.00301.x"
"10206545","Ring constrained analogues of the orvinols: the furanomorphides","Husbands SM, Breeden SW, Grivas K, Lewis JW.","Bioorg Med Chem Lett. 1999 Mar 22;9(6):831-4. doi: 10.1016/s0960-894x(99)00085-2.","Husbands SM","Bioorg Med Chem Lett","1999","1999/04/17","","","10.1016/s0960-894x(99)00085-2"
"10193138","Treatment considerations in the opioid dependent patient","Wartenberg AA.","Med Health R I. 1999 Mar;82(3):91-4.","Wartenberg AA","Med Health R I","1999","1999/04/08","","",""
"10080036","Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats","Craft RM, Heideman LM, Bartok RE.","Drug Alcohol Depend. 1999 Jan 7;53(2):95-109. doi: 10.1016/s0376-8716(98)00112-4.","Craft RM","Drug Alcohol Depend","1999","1999/03/18","","","10.1016/s0376-8716(98)00112-4"
"10079471","Alternatives to oral opioids for cancer pain","Mercadante S, Fulfaro F.","Oncology (Williston Park). 1999 Feb;13(2):215-20, 225; discussion 226-9.","Mercadante S","Oncology (Williston Park)","1999","1999/03/18","","",""
"10075626","Myocardial infarction associated with buprenorphine","Cracowski JL, Mallaret M, Vanzetto G.","Ann Intern Med. 1999 Mar 16;130(6):536; author reply 536-7. doi: 10.7326/0003-4819-130-6-199903160-00011.","Cracowski JL","Ann Intern Med","1999","1999/03/13","","","10.7326/0003-4819-130-6-199903160-00011"
"10072959","Rapid detoxification of heroin dependence by buprenorphine","Liu ZM, Cai ZJ, Wang XP, Ge Y, Li CM.","Zhongguo Yao Li Xue Bao. 1997 Mar;18(2):112-4.","Liu ZM","Zhongguo Yao Li Xue Bao","1997","1997/03/01","","",""
"10071631","[Pregnancy, abortion and delivery in a cohort of heroin dependent patients treated with drug substitution (methadone and buprenorphine) in Aquitaine]","Auriacombe M, Afflelou S, Lavignasse P, Lafitte C, Roux D, Daulouède JP, Tignol J.","Presse Med. 1999 Jan 30;28(4):177.","Auriacombe M","Presse Med","1999","1999/03/11","","",""
"10051763","Inducing placebo respiratory depressant responses in humans via opioid receptors","Benedetti F, Amanzio M, Baldi S, Casadio C, Maggi G.","Eur J Neurosci. 1999 Feb;11(2):625-31. doi: 10.1046/j.1460-9568.1999.00465.x.","Benedetti F","Eur J Neurosci","1999","1999/03/03","","","10.1046/j.1460-9568.1999.00465.x"
"10036608","Buprenorphine dose self-selection: effects of an alternative reinforcer, behavioral economic analysis of demand, and examination of subjective drug effects","Petry NM, Bickel WK.","Exp Clin Psychopharmacol. 1999 Feb;7(1):38-48. doi: 10.1037//1064-1297.7.1.38.","Petry NM","Exp Clin Psychopharmacol","1999","1999/02/26","","","10.1037//1064-1297.7.1.38"
"10030480","Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence","Petry NM, Bickel WK.","Psychiatr Serv. 1999 Feb;50(2):219-27. doi: 10.1176/ps.50.2.219.","Petry NM","Psychiatr Serv","1999","1999/02/25","","","10.1176/ps.50.2.219"
"10025042","[Acupuncture and ganglionic local opioid analgesia in trigeminal neuralgia]","Spacek A, Hanl G, Groiss O, Koinig H, Kress HG.","Wien Med Wochenschr. 1998;148(19):447-9.","Spacek A","Wien Med Wochenschr","1998","1999/02/20","","",""
"10023607","Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings","Litten RZ, Allen JP.","J Subst Abuse Treat. 1999 Mar;16(2):105-12. doi: 10.1016/s0740-5472(98)00028-2.","Litten RZ","J Subst Abuse Treat","1999","1999/02/19","","","10.1016/s0740-5472(98)00028-2"
"9990217","[The effects of low-doses of fentanyl, buprenorphine and pentazocine on circulatory responses to endotracheal intubation]","Adachi Y, Takamatsu I, Harada M, Uchihashi Y, Karasawa F, Sato T, Sugahara S.","Masui. 1998 Dec;47(12):1478-81.","Adachi Y","Masui","1998","1999/02/17","","",""
"9972766","An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity","Morgan D, Cook CD, Smith MA, Picker MJ.","Anesth Analg. 1999 Feb;88(2):407-13. doi: 10.1097/00000539-199902000-00035.","Morgan D","Anesth Analg","1999","1999/02/11","","","10.1097/00000539-199902000-00035"
"9952101","Progressive systemic sclerosis: intrathecal pain management","Lundborg CN, Nitescu PV, Appelgren LK, Curelaru ID.","Reg Anesth Pain Med. 1999 Jan-Feb;24(1):89-93. doi: 10.1016/s1098-7339(99)90171-2.","Lundborg CN","Reg Anesth Pain Med","1999","1999/02/10","","","10.1016/s1098-7339(99)90171-2"
"9952063","Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers","Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP.","Psychopharmacology (Berl). 1999 Jan;141(1):37-46. doi: 10.1007/s002130050804.","Mendelson J","Psychopharmacology (Berl)","1999","1999/02/10","","","10.1007/s002130050804"
"9926562","French general practitioners' attitudes toward maintenance drug abuse treatment with buprenorphine","Moatti JP, Souville M, Escaffre N, Obadia Y.","Addiction. 1998 Oct;93(10):1567-75. doi: 10.1046/j.1360-0443.1998.9310156714.x.","Moatti JP","Addiction","1998","1999/02/02","","","10.1046/j.1360-0443.1998.9310156714.x"
"9926544","Six deaths linked to concomitant use of buprenorphine and benzodiazepines","Reynaud M, Petit G, Potard D, Courty P.","Addiction. 1998 Sep;93(9):1385-92. doi: 10.1046/j.1360-0443.1998.93913859.x.","Reynaud M","Addiction","1998","1999/02/02","","","10.1046/j.1360-0443.1998.93913859.x"
"9926189","Intra-articular buprenorphine after knee arthroscopy. A randomised, prospective, double-blind study","Varrassi G, Marinangeli F, Ciccozzi A, Iovinelli G, Facchetti G, Ciccone A.","Acta Anaesthesiol Scand. 1999 Jan;43(1):51-5. doi: 10.1034/j.1399-6576.1999.430112.x.","Varrassi G","Acta Anaesthesiol Scand","1999","1999/02/02","","","10.1034/j.1399-6576.1999.430112.x"
"9893702","[Substitution therapy of drug addicts]","Weber JC, Kopferschmitt J.","Presse Med. 1998 Dec 12;27(39):2088-99.","Weber JC","Presse Med","1998","1999/01/20","","",""
"9866242","[Comparative evaluation of the use of nalbuphine and buprenorphine in prehospital care]","Nikoda VV, Lebedeva RN, Artamoshina MP, Storozhenko IN.","Anesteziol Reanimatol. 1998 Sep-Oct;(5):23-8.","Nikoda VV","Anesteziol Reanimatol","1998","1998/12/29","","",""
"9862403","Tolerance and cross-tolerance to the rate-suppressing effects of opioids in butorphanol-treated rats: influence of maintenance dose and relative efficacy at the mu receptor","Smith MA, Picker MJ.","Psychopharmacology (Berl). 1998 Nov;140(1):57-68. doi: 10.1007/s002130050739.","Smith MA","Psychopharmacology (Berl)","1998","1998/12/23","","","10.1007/s002130050739"
"9862399","Buprenorphine alters ethanol self-administration in rats: dose-response and time-dependent effects","June HL, Cason CR, Chen SH, Lewis MJ.","Psychopharmacology (Berl). 1998 Nov;140(1):29-37. doi: 10.1007/s002130050735.","June HL","Psychopharmacology (Berl)","1998","1998/12/23","","","10.1007/s002130050735"
"9862398","The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor","Morgan D, Picker MJ.","Psychopharmacology (Berl). 1998 Nov;140(1):20-8. doi: 10.1007/s002130050734.","Morgan D","Psychopharmacology (Berl)","1998","1998/12/23","","","10.1007/s002130050734"
"9852372","Outpatient opiate detoxification treatment with buprenorphine. Preliminary investigation","Diamant K, Fischer G, Schneider C, Lenzinger E, Pezawas L, Schindler S, Eder H.","Eur Addict Res. 1998 Dec;4(4):198-202. doi: 10.1159/000018953.","Diamant K","Eur Addict Res","1998","1998/12/16","","","10.1159/000018953"
"9844540","[Analgesia in thoracic injuries: a comparative study of 2 techniques of loco-regional analgesia]","Daghfous M, Nafaa N, Abderrahim N, Ghazouani S, Cherif A, Atyaoui F, Daoud A, Najah N.","Tunis Med. 1998 Feb;76(2):1047-51.","Daghfous M","Tunis Med","1998","1998/12/09","","",""
"9834591","[Anesthetic management by continuous total intravenous anesthesia]","Onaka M, Yamamoto H, Akatsuka M, Mori H.","Masui. 1998 Oct;47(10):1200-6.","Onaka M","Masui","1998","1998/12/03","","",""
"9810184","[Ambulatory opiate withdrawal]","Broers B, Voegeli JP.","Rev Med Suisse Romande. 1998 Sep;118(9):743-6.","Broers B","Rev Med Suisse Romande","1998","1998/11/12","","",""
"9807754","Anaesthesia for lambs undergoing spinal surgery: a case series","Clutton RE, Murison PJ, Funnell OD.","Lab Anim. 1998 Oct;32(4):414-21. doi: 10.1258/002367798780599767.","Clutton RE","Lab Anim","1998","1998/11/10","","","10.1258/002367798780599767"
"9806004","[Maintenance treatment with high-dose buprenorphine: are the recommendations being followed?]","Seyer D, Dif C, Balthazard G, Sciortino V.","Therapie. 1998 Jul-Aug;53(4):349-54.","Seyer D","Therapie","1998","1998/11/07","","",""
"9804882","Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine","Belcheva MM, Bohn LM, Ho MT, Johnson FE, Yanai J, Barron S, Coscia CJ.","Brain Res Dev Brain Res. 1998 Nov 1;111(1):35-42. doi: 10.1016/s0165-3806(98)00117-5.","Belcheva MM","Brain Res Dev Brain Res","1998","1998/11/07","","","10.1016/s0165-3806(98)00117-5"
"9788517","Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities","Tracqui A, Kintz P, Ludes B.","J Anal Toxicol. 1998 Oct;22(6):430-4. doi: 10.1093/jat/22.6.430.","Tracqui A","J Anal Toxicol","1998","1998/10/27","","","10.1093/jat/22.6.430"
"9781463","Effects of buprenorphine on cardiovascular and pulmonary function in clinically normal horses and horses with chronic obstructive pulmonary disease","Szöke MO, Blais D, Cuvelliez SG, Lavoie JP.","Am J Vet Res. 1998 Oct;59(10):1287-91.","Szöke MO","Am J Vet Res","1998","1998/10/22","","",""
"9777603","Determination of buprenorphine in plasma by liquid chromatography: application to heroin-dependent subjects","Lagrange F, Pehourcq F, Baumevieille M, Begaud B.","J Pharm Biomed Anal. 1998 Apr;16(8):1295-300. doi: 10.1016/s0731-7085(97)00139-8.","Lagrange F","J Pharm Biomed Anal","1998","1998/10/20","","","10.1016/s0731-7085(97)00139-8"
"9773109","[Study of narcotics and buprenorphine prescriptions in the Provence-Alps-Côte d'Azur region]","Millet P, Monnier B, Affaton MF, Campocasso J, Arditti J, Jouglard J.","Therapie. 1998 Mar-Apr;53(2):107-12.","Millet P","Therapie","1998","1998/10/17","","",""
"9767947","[Acute poisoning during substitution therapy based on high-dosage buprenorphine. 29 clinical cases--20 fatal cases]","Tracqui A, Tournoud C, Flesch F, Kopferschmitt J, Kintz P, Deveaux M, Ghysel MH, Marquet P, Pépin G, Petit G, Jaeger A, Ludes B.","Presse Med. 1998 Mar 28;27(12):557-61.","Tracqui A","Presse Med","1998","1998/10/13","","",""
"9767205","Buprenorphine maintenance in pregnant opiate addicts","Fischer G, Etzersdorfer P, Eder H, Jagsch R, Langer M, Weninger M.","Eur Addict Res. 1998;4 Suppl 1:32-6. doi: 10.1159/000052040.","Fischer G","Eur Addict Res","1998","1998/10/10","","","10.1159/000052040"
"9767204","Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine","Vignau J.","Eur Addict Res. 1998;4 Suppl 1:29-31. doi: 10.1159/000052039.","Vignau J","Eur Addict Res","1998","1998/10/10","","","10.1159/000052039"
"9767203","Differences between general practitioner- and addiction centre-prescribed buprenorphine substitution therapy in France. Preliminary results","Vignau J, Brunelle E.","Eur Addict Res. 1998;4 Suppl 1:24-8. doi: 10.1159/000052038.","Vignau J","Eur Addict Res","1998","1998/10/10","","","10.1159/000052038"
"9767202","The French experience--the pharmacist, general practitioner and patient perspective","Bouchez J, Vignau J.","Eur Addict Res. 1998;4 Suppl 1:19-23. doi: 10.1159/000052037.","Bouchez J","Eur Addict Res","1998","1998/10/10","","","10.1159/000052037"
"9767201","Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study","Uehlinger C, Déglon J, Livoti S, Petitjean S, Waldvogel D, Ladewig D.","Eur Addict Res. 1998;4 Suppl 1:13-8. doi: 10.1159/000052036.","Uehlinger C","Eur Addict Res","1998","1998/10/10","","","10.1159/000052036"
"9767200","Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients. Preliminary results","Bouchez J, Beauverie P, Touzeau D.","Eur Addict Res. 1998;4 Suppl 1:8-12. doi: 10.1159/000052035.","Bouchez J","Eur Addict Res","1998","1998/10/10","","","10.1159/000052035"
"9767199","Comparison of buprenorphine and methadone maintenance in opiate addicts","Eder H, Fischer G, Gombas W, Jagsch R, Stühlinger G, Kasper S.","Eur Addict Res. 1998;4 Suppl 1:3-7. doi: 10.1159/000052034.","Eder H","Eur Addict Res","1998","1998/10/10","","","10.1159/000052034"
"9762758","Comparison of pethidine, buprenorphine and ketoprofen for postoperative analgesia after ovariohysterectomy in the cat","Slingsby LS, Waterman-Pearson AE.","Vet Rec. 1998 Aug 15;143(7):185-9. doi: 10.1136/vr.143.7.185.","Slingsby LS","Vet Rec","1998","1998/10/08","","","10.1136/vr.143.7.185"
"9741185","[Pain therapy in dogs and cats--clinical experiences with buprenorphine (Temgesic)]","Kramer S, Nolte I, Albrecht J, Klein A, Busse L, Farlopoulos S.","Berl Munch Tierarztl Wochenschr. 1998 Jul-Aug;111(7-8):285-90.","Kramer S","Berl Munch Tierarztl Wochenschr","1998","1998/09/19","","",""
"9728833","Antinociceptive effect induced by the combined administration of spinal morphine and systemic buprenorphine","Niv D, Nemirovsky A, Metzner J, Rudick V, Jurna I, Urca G.","Anesth Analg. 1998 Sep;87(3):583-6. doi: 10.1097/00000539-199809000-00016.","Niv D","Anesth Analg","1998","1998/09/05","","","10.1097/00000539-199809000-00016"
"9727815","A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic","O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, Rounsaville BJ, Pakes JA, Schottenfeld RS.","Am J Med. 1998 Aug;105(2):100-5. doi: 10.1016/s0002-9343(98)00194-6.","O'Connor PG","Am J Med","1998","1998/09/04","","","10.1016/s0002-9343(98)00194-6"
"9706950","The urodynamic effects of intravenous opioids and ketoprofen in humans","Malinovsky JM, Le Normand L, Lepage JY, Malinge M, Cozian A, Pinaud M, Buzelin JM.","Anesth Analg. 1998 Aug;87(2):456-61. doi: 10.1097/00000539-199808000-00042.","Malinovsky JM","Anesth Analg","1998","1998/08/26","","","10.1097/00000539-199808000-00042"
"9703213","Interactions of buprenorphine and selective dopamine receptor antagonists in the rat nucleus accumbens","Nantwi KD, Hicks S, Bradley D Jr, Schoener EP.","Gen Pharmacol. 1998 Sep;31(3):425-9. doi: 10.1016/s0306-3623(98)00020-2.","Nantwi KD","Gen Pharmacol","1998","1998/08/14","","","10.1016/s0306-3623(98)00020-2"
"9700759","Opioid peptide receptor studies. 9. Identification of a novel non-mu- non-delta-like opioid peptide binding site in rat brain","Ni Q, Xu H, Partilla JS, Rice KC, Matecka D, Calderon SN, Porreca F, Lai J, Schmidhammer H, Krassnig R, Rothman RB.","Peptides. 1998;19(6):1079-90. doi: 10.1016/s0196-9781(98)00046-1.","Ni Q","Peptides","1998","1998/08/13","","","10.1016/s0196-9781(98)00046-1"
"9698952","Postoperative analgesia with epidural bupivacaine and low-dose fentanyl--a comparison of two concentrations","Sjöström S, Bläss J.","Acta Anaesthesiol Scand. 1998 Aug;42(7):776-82. doi: 10.1111/j.1399-6576.1998.tb05321.x.","Sjöström S","Acta Anaesthesiol Scand","1998","1998/08/12","","","10.1111/j.1399-6576.1998.tb05321.x"
"9698298","Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4","Kobayashi K, Yamamoto T, Chiba K, Tani M, Shimada N, Ishizaki T, Kuroiwa Y.","Drug Metab Dispos. 1998 Aug;26(8):818-21.","Kobayashi K","Drug Metab Dispos","1998","1998/08/11","","",""
"9684393","Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine","Kuhlman JJ Jr, Levine B, Johnson RE, Fudala PJ, Cone EJ.","Addiction. 1998 Apr;93(4):549-59. doi: 10.1046/j.1360-0443.1998.93454910.x.","Kuhlman JJ Jr","Addiction","1998","1998/07/31","","","10.1046/j.1360-0443.1998.93454910.x"
"9684388","Marijuana use and treatment outcome among opioid-dependent patients","Budney AJ, Bickel WK, Amass L.","Addiction. 1998 Apr;93(4):493-503. doi: 10.1046/j.1360-0443.1998.9344935.x.","Budney AJ","Addiction","1998","1998/07/31","","","10.1046/j.1360-0443.1998.9344935.x"
"9684386","Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","Ling W, Charuvastra C, Collins JF, Batki S, Brown LS Jr, Kintaudi P, Wesson DR, McNicholas L, Tusel DJ, Malkerneker U, Renner JA Jr, Santos E, Casadonte P, Fye C, Stine S, Wang RI, Segal D.","Addiction. 1998 Apr;93(4):475-86. doi: 10.1046/j.1360-0443.1998.9344753.x.","Ling W","Addiction","1998","1998/07/31","","","10.1046/j.1360-0443.1998.9344753.x"
"9676185","[Painful muscle spasms of the trunk and upper limbs: tetanus or latrodectism? A case report]","Ciccone A, Antonucci A, Mariotti D, Critaro M, Fioritto G.","Minerva Med. 1998 May;89(5):181-3.","Ciccone A","Minerva Med","1998","1998/07/24","","",""
"9658424","[Neonatal buprenorphine withdrawal syndrome, what is the right therapy?]","Regini P, Cutrone M, Donzelli F, Flora PG, Montesanto G.","Pediatr Med Chir. 1998 Jan-Feb;20(1):67-9.","Regini P","Pediatr Med Chir","1998","1998/07/11","","",""
"9652105","A behavioral intervention for improving verbal behaviors of heroin addicts in a treatment clinic","Petry NM, Bickel WK, Tzanis E, Taylor R, Kubik E, Foster M, Hughes ME.","J Appl Behav Anal. 1998 Summer;31(2):291-7. doi: 10.1901/jaba.1998.31-291.","Petry NM","J Appl Behav Anal","1998","1998/07/04","PMC1284117","","10.1901/jaba.1998.31-291"
"9652044","An alternative premedication and induction regime for cats with a decreased cardio-vascular reserve","Akkerdaas LC, Sap R, Hellebreker LJ.","Vet Q. 1998;20 Suppl 1:S108. doi: 10.1080/01652176.1998.10807452.","Akkerdaas LC","Vet Q","1998","1998/07/04","","","10.1080/01652176.1998.10807452"
"9650855","Buprenorphine hydrochloride induces apoptosis in NG108-15 nerve cells","Kugawa F, Arae K, Ueno A, Aoki M.","Eur J Pharmacol. 1998 Apr 17;347(1):105-12. doi: 10.1016/s0014-2999(98)00080-6.","Kugawa F","Eur J Pharmacol","1998","1998/07/03","","","10.1016/s0014-2999(98)00080-6"
"9643170","Haematological changes in buprenorphine-treated mice","Banerjee D, Sarkar NK.","Folia Biol (Krakow). 1997;45(3-4):157-62.","Banerjee D","Folia Biol (Krakow)","1997","1997/01/01","","",""
"9634647","Taste conditioning effects of buprenorphine in morphine-naive and morphine-experienced rats","Gaiardi M, Gubellini C, Bartoletti M.","Pharmacol Res. 1998 Apr;37(4):303-7. doi: 10.1006/phrs.1998.0303.","Gaiardi M","Pharmacol Res","1998","1998/06/23","","","10.1006/phrs.1998.0303"
"9633038","A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine- and opioid-dependent patients. Preliminary findings","Avants SK, Margolin A, DePhilippis D, Kosten TR.","J Subst Abuse Treat. 1998 May-Jun;15(3):261-5. doi: 10.1016/s0740-5472(97)00226-2.","Avants SK","J Subst Abuse Treat","1998","1998/06/20","","","10.1016/s0740-5472(97)00226-2"
"9618423","Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys","Pitts RC, Allen RM, Walker EA, Dykstra LA.","J Pharmacol Exp Ther. 1998 Jun;285(3):1197-206.","Pitts RC","J Pharmacol Exp Ther","1998","1998/06/17","","",""
"9613100","Effects of buprenorphine and Ro 15-4513 on delayed death and brain beta-endorphin levels in rats treated with cocaine or cocaine-ethanol","Hayase T, Yamamoto Y, Yamamoto K, Abiru H, Fukui Y.","Nihon Arukoru Yakubutsu Igakkai Zasshi. 1998 Apr;33(2):112-34.","Hayase T","Nihon Arukoru Yakubutsu Igakkai Zasshi","1998","1998/06/05","","",""
"9602605","Extradural buprenorphine and breast feeding after caesarean section","Celebioglu B.","Br J Anaesth. 1998 Feb;80(2):271. doi: 10.1093/bja/80.2.271.","Celebioglu B","Br J Anaesth","1998","1998/05/29","","","10.1093/bja/80.2.271"
"9594519","[Effect of the continuous epidural buprenorphine injection in patients after lower extremity arthroplasty]","Asajima R, Nishikawa N, Kida H, Matsunami K.","Masui. 1998 Apr;47(4):466-9.","Asajima R","Masui","1998","1998/05/22","","",""
"9589267","Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts","Fudala PJ, Yu E, Macfadden W, Boardman C, Chiang CN.","Drug Alcohol Depend. 1998 Mar 1;50(1):1-8. doi: 10.1016/s0376-8716(98)00008-8.","Fudala PJ","Drug Alcohol Depend","1998","1998/05/20","","","10.1016/s0376-8716(98)00008-8"
"9587897","Influence of oral buprenorphine, oral naltrexone or morphine on the effects of laparotomy in the rat","Liles JH, Flecknell PA, Roughan J, Cruz-Madorran I.","Lab Anim. 1998 Apr;32(2):149-61. doi: 10.1258/002367798780600025.","Liles JH","Lab Anim","1998","1998/05/20","","","10.1258/002367798780600025"
"9587803","Stability of morphine and buprenorphine in whole blood","Hadidi KA, Oliver JS.","Int J Legal Med. 1998;111(3):165-7. doi: 10.1007/s004140050141.","Hadidi KA","Int J Legal Med","1998","1998/05/20","","","10.1007/s004140050141"
"9587719","Effect of balanced analgesia with buprenorphine on pain response and general anaesthesia requirement during lithotripsy procedures","Tauzin-Fin P, Delort-Laval S, Krol-Houdek MC, Maurette P, Bannwarth B.","Eur J Anaesthesiol. 1998 Mar;15(2):147-52.","Tauzin-Fin P","Eur J Anaesthesiol","1998","1998/05/20","","",""
"9583767","The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression","Benedetti F, Amanzio M, Baldi S, Casadio C, Cavallo A, Mancuso M, Ruffini E, Oliaro A, Maggi G.","Pain. 1998 Apr;75(2-3):313-9. doi: 10.1016/s0304-3959(98)00010-4.","Benedetti F","Pain","1998","1998/05/16","","","10.1016/s0304-3959(98)00010-4"
"9580582","The effects of buprenorphine on self-administration of cocaine and heroin ""speedball"" combinations and heroin alone by rhesus monkeys","Mello NK, Negus SS.","J Pharmacol Exp Ther. 1998 May;285(2):444-56.","Mello NK","J Pharmacol Exp Ther","1998","1998/05/15","","",""
"9580040","[Perfusion of donor tissue improves the preservation of graft in heterotopic tracheal transplantation]","Jiménez MF, Gómez-Alonso A, Varela G, Ludeña MD, García-Criado J.","Arch Bronconeumol. 1997 Dec;33(11):572-6. doi: 10.1016/s0300-2896(15)30515-9.","Jiménez MF","Arch Bronconeumol","1997","1998/05/15","","","10.1016/s0300-2896(15)30515-9"
"9566806","Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans","Amass L, Bickel WK, Crean JP, Blake J, Higgins ST.","Psychopharmacology (Berl). 1998 Apr;136(3):217-25. doi: 10.1007/s002130050559.","Amass L","Psychopharmacology (Berl)","1998","1998/05/05","","","10.1007/s002130050559"
"9565774","In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine","Iribarne C, Picart D, Dréano Y, Berthou F.","Fundam Clin Pharmacol. 1998;12(2):194-9. doi: 10.1111/j.1472-8206.1998.tb00941.x.","Iribarne C","Fundam Clin Pharmacol","1998","1998/05/05","","","10.1111/j.1472-8206.1998.tb00941.x"
"9553234","The analgesic effect of PCA buprenorphine in Taiwan's gynecologic patients","Ho ST, Wang JJ, Liu HS, Tzeng JI, Liaw WJ.","Acta Anaesthesiol Sin. 1997 Dec;35(4):195-9.","Ho ST","Acta Anaesthesiol Sin","1997","1998/04/29","","",""
"9548895","Incorporation of drugs for the treatment of substance abuse into pigmented and nonpigmented hair","Wilkins DG, Valdez AS, Nagasawa PR, Gygi SP, Rollins DE.","J Pharm Sci. 1998 Apr;87(4):435-40. doi: 10.1021/js970360t.","Wilkins DG","J Pharm Sci","1998","1998/04/21","","","10.1021/js970360t"
"9547204","[Treatment of erythromelalgia with buprenorphine]","Trapiella Martínez L, Quirós JF, Caminal Montero L, Fernández Fernández C.","Rev Clin Esp. 1997 Nov;197(11):792.","Trapiella Martínez L","Rev Clin Esp","1997","1998/04/18","","",""
"9520235","Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain","Benedetti F, Vighetti S, Amanzio M, Casadio C, Oliaro A, Bergamasco B, Maggi G.","Pain. 1998 Feb;74(2-3):205-11. doi: 10.1016/s0304-3959(97)00172-3.","Benedetti F","Pain","1998","1998/03/31","","","10.1016/s0304-3959(97)00172-3"
"9517881","Pica behavior associated with buprenorphine administration in the rat","Bender HM.","Lab Anim Sci. 1998 Feb;48(1):5.","Bender HM","Lab Anim Sci","1998","1998/03/28","","",""
"9513799","Abuse liability of buprenorphine--a study among experienced drug users","Bedi NS, Ray R, Jain R, Dhar NK.","Indian J Physiol Pharmacol. 1998 Jan;42(1):95-100.","Bedi NS","Indian J Physiol Pharmacol","1998","1998/03/26","","",""
"9513631","A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients","Margolin A, Avants SK, DePhilippis D, Kosten TR.","Am J Drug Alcohol Abuse. 1998 Feb;24(1):85-101. doi: 10.3109/00952999809001700.","Margolin A","Am J Drug Alcohol Abuse","1998","1998/03/26","","","10.3109/00952999809001700"
"9501765","Six deaths linked to misuse of buprenorphine-benzodiazepine combinations","Reynaud M, Tracqui A, Petit G, Potard D, Courty P.","Am J Psychiatry. 1998 Mar;155(3):448-9.","Reynaud M","Am J Psychiatry","1998","1998/03/21","","",""
"9492501","[Effect of epidural pressure gradient on buprenorphine flux through the dural hole after combined spinal-epidural anesthesia--comparison between bolus injection and continuous infusion]","Okada K, Okada S, Nishitani K.","Masui. 1998 Jan;47(1):64-8.","Okada K","Masui","1998","1998/03/11","","",""
"9492389","Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors","Iribarne C, Berthou F, Carlhant D, Dreano Y, Picart D, Lohezic F, Riche C.","Drug Metab Dispos. 1998 Mar;26(3):257-60.","Iribarne C","Drug Metab Dispos","1998","1998/04/04","","",""
"9480189","[Intravenous patient-controlled analgesia (PCA) in the treatment of postoperative pain: rationale and clinical application]","Finco G, Polati E, Gottin L, Bartoloni A, Milan B, Zanoni L, Valle L.","Chir Ital. 1995;47(6):20-5.","Finco G","Chir Ital","1995","1995/01/01","","",""
"9466023","Analgesia after upper abdominal surgery with extradural buprenorphine with lidocaine","Wajima Z, Shitara T, Ishikawa G, Inoue T, Ogawa R.","Can J Anaesth. 1998 Jan;45(1):28-33. doi: 10.1007/BF03011988.","Wajima Z","Can J Anaesth","1998","1998/02/18","","","10.1007/BF03011988"
"9457145","Prognostic factors in Buprenorphine- versus methadone-maintained patients","Schottenfeld RS, Pakes JR, Kosten TR.","J Nerv Ment Dis. 1998 Jan;186(1):35-43. doi: 10.1097/00005053-199801000-00006.","Schottenfeld RS","J Nerv Ment Dis","1998","1998/02/11","","","10.1097/00005053-199801000-00006"
"9439446","Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine","Everhart ET, Cheung P, Shwonek P, Zabel K, Tisdale EC, Jacob P 3rd, Mendelson J, Jones RT.","Clin Chem. 1997 Dec;43(12):2292-302.","Everhart ET","Clin Chem","1997","1998/01/24","","",""
"9435189","Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist","Bot G, Blake AD, Li S, Reisine T.","J Pharmacol Exp Ther. 1998 Jan;284(1):283-90.","Bot G","J Pharmacol Exp Ther","1998","1998/01/22","","",""
"9422382","Mutagenesis of a single amino acid in the rat mu-opioid receptor discriminates ligand binding","Bot G, Blake AD, Li S, Reisine T.","J Neurochem. 1998 Jan;70(1):358-65. doi: 10.1046/j.1471-4159.1998.70010358.x.","Bot G","J Neurochem","1998","1998/01/09","","","10.1046/j.1471-4159.1998.70010358.x"
"9404358","[Local complications after intravenous injection of dissolved tablets of buprenorphine]","Decocq G, Fremaux D, Smail A, Compagnon M, Andréjak M.","Presse Med. 1997 Oct 11;26(30):1433.","Decocq G","Presse Med","1997","1997/12/24","","",""
"9404175","Comparison of nalbuphine and buprenorphine in total intravenous anaesthesia","Khan FA, Zaidi A, Kamal RS.","Anaesthesia. 1997 Nov;52(11):1095-101. doi: 10.1111/j.1365-2044.1997.211-az0347.x.","Khan FA","Anaesthesia","1997","1997/12/24","","","10.1111/j.1365-2044.1997.211-az0347.x"
"9390114","Buprenorphine withdrawal syndrome in a newborn","Marquet P, Chevrel J, Lavignasse P, Merle L, Lachâtre G.","Clin Pharmacol Ther. 1997 Nov;62(5):569-71. doi: 10.1016/S0009-9236(97)90053-9.","Marquet P","Clin Pharmacol Ther","1997","1997/12/09","","","10.1016/S0009-9236(97)90053-9"
"9384844","Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies","Mello NK, Mendelson JH, Lukas SE, Gastfriend DR, Teoh SK, Holman BL.","Harv Rev Psychiatry. 1993 Sep-Oct;1(3):168-83. doi: 10.3109/10673229309017075.","Mello NK","Harv Rev Psychiatry","1993","1993/09/01","","","10.3109/10673229309017075"
"9379748","[Changes in the pattern of opioid analgesic consumption in Spain]","Carvajal A, García del Pozo J, Martín Arias LH, Martín de Diego I, Rueda AM, Caro-Patón T, Alvarez Requejo A.","Med Clin (Barc). 1997 Sep 13;109(8):281-3.","Carvajal A","Med Clin (Barc)","1997","1998/02/12","","",""
"9377992","[Postoperative analgesia after endoscopic abdominal operations. A randomized double-blind study of perioperative effectiveness of metamizole]","Steffen P, Seeling W, Kunz R, Schuhmacher I, Georgieff M.","Chirurg. 1997 Aug;68(8):806-10. doi: 10.1007/s001040050275.","Steffen P","Chirurg","1997","1997/08/01","","","10.1007/s001040050275"
"9372538","Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine","Tallarida RJ, Kimmel HL, Holtzman SG.","Psychopharmacology (Berl). 1997 Oct;133(4):378-82. doi: 10.1007/s002130050417.","Tallarida RJ","Psychopharmacology (Berl)","1997","1998/01/24","","","10.1007/s002130050417"
"9372537","Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat","Kimmel HL, Tallarida RJ, Holtzman SG.","Psychopharmacology (Berl). 1997 Oct;133(4):372-7. doi: 10.1007/s002130050416.","Kimmel HL","Psychopharmacology (Berl)","1997","1998/01/24","","","10.1007/s002130050416"
"9365490","[Misuse of buprenorphine-benzodiazepines combination: 6 deaths]","Reynaud M, Petit G, Potard D, Courty P.","Presse Med. 1997 Sep 27;26(28):1337-8.","Reynaud M","Presse Med","1997","1997/11/20","","",""
"9361893","Cardiovascular effects of buprenorphine in anesthetized dogs","Martinez EA, Hartsfield SM, Melendez LD, Matthews NS, Slater MR.","Am J Vet Res. 1997 Nov;58(11):1280-4.","Martinez EA","Am J Vet Res","1997","1997/11/15","","",""
"9353374","Effects of proposed treatments for cocaine addiction on hemodynamic responsiveness to cocaine in conscious rats","Knuepfer MM, Gan Q.","J Pharmacol Exp Ther. 1997 Nov;283(2):592-603.","Knuepfer MM","J Pharmacol Exp Ther","1997","1997/11/14","","",""
"9350703","Analgesics in mice used in cancer research: reduction of discomfort?","van Loo PL, Everse LA, Bernsen MR, Baumans V, Hellebrekers LJ, Kruitwagen CL, den Otter W.","Lab Anim. 1997 Oct;31(4):318-25. doi: 10.1258/002367797780596211.","van Loo PL","Lab Anim","1997","1997/11/14","","","10.1258/002367797780596211"
"9349066","The addition of opioids to local anaesthetics in brachial plexus block: the comparative effects of morphine, buprenorphine and sufentanil","Bazin JE, Massoni C, Bruelle P, Fenies V, Groslier D, Schoeffler P.","Anaesthesia. 1997 Sep;52(9):858-62. doi: 10.1111/j.1365-2044.1997.174-az0311.x.","Bazin JE","Anaesthesia","1997","1998/02/12","","","10.1111/j.1365-2044.1997.174-az0311.x"
"9337499","Effects of adding behavioral treatment to opioid detoxification with buprenorphine","Bickel WK, Amass L, Higgins ST, Badger GJ, Esch RA.","J Consult Clin Psychol. 1997 Oct;65(5):803-10. doi: 10.1037//0022-006x.65.5.803.","Bickel WK","J Consult Clin Psychol","1997","1997/10/24","","","10.1037//0022-006x.65.5.803"
"9331984","Differential effects of buprenorphine and pentazocine on the regional cerebral metabolic rate for glucose in the conscious rat","Suzuki T, Oshimi M, Hanano M.","Biol Pharm Bull. 1997 Sep;20(9):997-1001. doi: 10.1248/bpb.20.997.","Suzuki T","Biol Pharm Bull","1997","1997/10/23","","","10.1248/bpb.20.997"
"9323518","Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry","Moody DE, Laycock JD, Spanbauer AC, Crouch DJ, Foltz RL, Josephs JL, Amass L, Bickel WK.","J Anal Toxicol. 1997 Oct;21(6):406-14. doi: 10.1093/jat/21.6.406.","Moody DE","J Anal Toxicol","1997","1997/11/05","","","10.1093/jat/21.6.406"
"9316825","Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers","Zacny JP, Conley K, Galinkin J.","J Pharmacol Exp Ther. 1997 Sep;282(3):1187-97.","Zacny JP","J Pharmacol Exp Ther","1997","1997/10/08","","",""
"9313020","Three methods of opioid detoxification in a primary care setting. A randomized trial","O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ.","Ann Intern Med. 1997 Oct 1;127(7):526-30. doi: 10.7326/0003-4819-127-7-199710010-00004.","O'Connor PG","Ann Intern Med","1997","1997/10/06","","","10.7326/0003-4819-127-7-199710010-00004"
"9311407","Analgesia after upper abdominal surgery using extradural administration of a fixed dose of buprenorphine in combination with lignocaine given at two infusion rates: a comparative study","Wajima Z, Shitara T, Ishikawa G, Kaneko K, Inoue T, Ogawa R.","Acta Anaesthesiol Scand. 1997 Sep;41(8):1061-5. doi: 10.1111/j.1399-6576.1997.tb04836.x.","Wajima Z","Acta Anaesthesiol Scand","1997","1997/10/06","","","10.1111/j.1399-6576.1997.tb04836.x"
"9301399","Extradural buprenorphine suppresses breast feeding after caesarean section","Hirose M, Hosokawa T, Tanaka Y.","Br J Anaesth. 1997 Jul;79(1):120-1. doi: 10.1093/bja/79.1.120.","Hirose M","Br J Anaesth","1997","1997/07/01","","","10.1093/bja/79.1.120"
"9300589","Prenatal buprenorphine exposure and sexually dimorphic nonreproductive behaviors in rats","Barron S, Chung VM.","Pharmacol Biochem Behav. 1997 Oct;58(2):337-43. doi: 10.1016/s0091-3057(97)00260-8.","Barron S","Pharmacol Biochem Behav","1997","1997/09/23","","","10.1016/s0091-3057(97)00260-8"
"9293303","Screening for drugs of abuse (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs","Simpson D, Braithwaite RA, Jarvie DR, Stewart MJ, Walker S, Watson IW, Widdop B.","Ann Clin Biochem. 1997 Sep;34 ( Pt 5):460-510. doi: 10.1177/000456329703400502.","Simpson D","Ann Clin Biochem","1997","1997/09/18","","","10.1177/000456329703400502"
"9283506","Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse","Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR.","Arch Gen Psychiatry. 1997 Aug;54(8):713-20. doi: 10.1001/archpsyc.1997.01830200041006.","Schottenfeld RS","Arch Gen Psychiatry","1997","1997/08/01","","","10.1001/archpsyc.1997.01830200041006"
"9280368","A comparison of preoperative morphine and buprenorphine for postoperative analgesia for arthrotomy in dogs","Brodbelt DC, Taylor PM, Stanway GW.","J Vet Pharmacol Ther. 1997 Aug;20(4):284-9. doi: 10.1046/j.1365-2885.1997.00060.x.","Brodbelt DC","J Vet Pharmacol Ther","1997","1997/08/01","","","10.1046/j.1365-2885.1997.00060.x"
"9262317","Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys","Brandt MR, Cabansag SR, France CP.","J Pharmacol Exp Ther. 1997 Aug;282(2):574-84.","Brandt MR","J Pharmacol Exp Ther","1997","1997/08/01","","",""
"9259005","Antagonism of morphine-like discriminative effects by beta-funaltrexamine","Holtzman SG.","Pharmacol Biochem Behav. 1997 Aug;57(4):771-7. doi: 10.1016/s0091-3057(96)00395-4.","Holtzman SG","Pharmacol Biochem Behav","1997","1997/08/01","","","10.1016/s0091-3057(96)00395-4"
"9246550","Tolerance and cross tolerance to the accuracy- and rate-decreasing effects of mu opioids in rats responding under a fixed-consecutive-number schedule","Smith MA, Pitts RC, Picker MJ.","Drug Alcohol Depend. 1997 Jun 6;46(1-2):19-30. doi: 10.1016/s0376-8716(97)00039-2.","Smith MA","Drug Alcohol Depend","1997","1997/06/06","","","10.1016/s0376-8716(97)00039-2"
"9241634","Pica behavior associated with buprenorphine administration in the rat","Clark JA Jr, Myers PH, Goelz MF, Thigpen JE, Forsythe DB.","Lab Anim Sci. 1997 Jun;47(3):300-3.","Clark JA Jr","Lab Anim Sci","1997","1997/06/01","","",""
"9223884","[Epidural buprenorphine and epidural droperidol for post-operative nausea or vomiting]","Yokoyama K, Takahashi H, Toyoshima M, Tanaka K.","Masui. 1997 Jun;46(6):798-802.","Yokoyama K","Masui","1997","1997/06/01","","",""
"9190324","[Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine]","Bono AV, Cuffari S.","Drugs. 1997;53 Suppl 2:40-9. doi: 10.2165/00003495-199700532-00009.","Bono AV","Drugs","1997","1997/01/01","","","10.2165/00003495-199700532-00009"
"9187385","Gas chromatographic-mass spectrometric quantitation of urinary buprenorphine and norbuprenorphine after derivatization by direct extractive alkylation","Lisi AM, Kazlauskas R, Trout GJ.","J Chromatogr B Biomed Sci Appl. 1997 Apr 25;692(1):67-77. doi: 10.1016/s0378-4347(96)00496-3.","Lisi AM","J Chromatogr B Biomed Sci Appl","1997","1997/04/25","","","10.1016/s0378-4347(96)00496-3"
"9185312","Options for management of acute pain in the rat","Abbott FV, Bonder M.","Vet Rec. 1997 May 24;140(21):553-7. doi: 10.1136/vr.140.21.553.","Abbott FV","Vet Rec","1997","1997/05/24","","","10.1136/vr.140.21.553"
"9180349","Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes","Iribarne C, Picart D, Dréano Y, Bail JP, Berthou F.","Life Sci. 1997;60(22):1953-64. doi: 10.1016/s0024-3205(97)00160-4.","Iribarne C","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00160-4"
"9180346","Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice","Kamei J, Sodeyama M, Tsuda M, Suzuki T, Nagase H.","Life Sci. 1997;60(22):PL 333-7. doi: 10.1016/s0024-3205(97)00170-7.","Kamei J","Life Sci","1997","1997/01/01","","","10.1016/s0024-3205(97)00170-7"
"9179510","Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients","Eissenberg T, Johnson RE, Bigelow GE, Walsh SL, Liebson IA, Strain EC, Stitzer ML.","Drug Alcohol Depend. 1997 Apr 14;45(1-2):81-91. doi: 10.1016/s0376-8716(97)01347-1.","Eissenberg T","Drug Alcohol Depend","1997","1997/04/14","","","10.1016/s0376-8716(97)01347-1"
"9179503","Effects of buprenorphine and an alternative nondrug reinforcer, alone and in combination on smoked cocaine self-administration in monkeys","Rodefer JS, Mattox AJ, Thompson SS, Carroll ME.","Drug Alcohol Depend. 1997 Apr 14;45(1-2):21-9. doi: 10.1016/s0376-8716(97)01341-0.","Rodefer JS","Drug Alcohol Depend","1997","1997/04/14","","","10.1016/s0376-8716(97)01341-0"
"9175012","A method for long duration anaesthesia for a new hindlimb ischaemia-reperfusion model in mice","Wiersema AM, Dirksen R, Oyen WJ, Van der Vliet JA.","Lab Anim. 1997 Apr;31(2):151-6. doi: 10.1258/002367797780600125.","Wiersema AM","Lab Anim","1997","1997/04/01","","","10.1258/002367797780600125"
"9174982","Analysis of buprenorphine in rat plasma using a solid-phase extraction technique and high-performance liquid chromatography with electrochemical detection","Salem A, Pierce TL, Hope W.","J Pharmacol Toxicol Methods. 1997 Mar;37(2):75-81. doi: 10.1016/s1056-8719(97)00001-4.","Salem A","J Pharmacol Toxicol Methods","1997","1997/03/01","","","10.1016/s1056-8719(97)00001-4"
"9172024","Postthyroidectomy analgesia: morphine, buprenorphine, or bupivacaine?","Lacoste L, Thomas D, Kraimps JL, Chabin M, Ingrand P, Barbier J, Fusciardi J.","J Clin Anesth. 1997 May;9(3):189-93. doi: 10.1016/s0952-8180(97)00038-x.","Lacoste L","J Clin Anesth","1997","1997/05/01","","","10.1016/s0952-8180(97)00038-x"
"9172009","Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial","Brema F, Pastorino G, Martini MC, Gottlieb A, Luzzani M, Libretti A, Saccà L, Cigolari S.","Int J Clin Pharmacol Res. 1996;16(4-5):109-16.","Brema F","Int J Clin Pharmacol Res","1996","1996/01/01","","",""
"9167469","Ganglionic local opioid analgesia for refractory trigeminal neuralgia","Spacek A, Böhm D, Kress HG.","Lancet. 1997 May 24;349(9064):1521. doi: 10.1016/S0140-6736(05)62101-0.","Spacek A","Lancet","1997","1997/05/24","","","10.1016/S0140-6736(05)62101-0"
"9167373","Dilatation of radiation-induced esophageal strictures under sublingual buprenorphine analgesia: a pilot study","Desai DC, Wagle SD, Mohandas KM, Swaroop VS.","Indian J Gastroenterol. 1997 Jan;16(1):14-5.","Desai DC","Indian J Gastroenterol","1997","1997/01/01","","",""
"9167372","Pain relief in chronic pancreatitis with epidural buprenorphine injection","Desai PM.","Indian J Gastroenterol. 1997 Jan;16(1):12-3.","Desai PM","Indian J Gastroenterol","1997","1997/01/01","","",""
"9151365","Discriminative stimulus effects of buprenorphine in the rat","Holtzman SG.","Psychopharmacology (Berl). 1997 Apr;130(3):292-9. doi: 10.1007/s002130050242.","Holtzman SG","Psychopharmacology (Berl)","1997","1997/04/01","","","10.1007/s002130050242"
"9151189","Pre-incisional caudal epidural blockade and the relief of pain after lumbar spine operations","Kakiuchi M, Abe K.","Int Orthop. 1997;21(1):62-6. doi: 10.1007/s002640050121.","Kakiuchi M","Int Orthop","1997","1997/01/01","PMC3615687","","10.1007/s002640050121"
"9146820","Buprenorphine and naloxone interactions in methadone maintenance patients","Mendelson J, Jones RT, Welm S, Brown J, Batki SL.","Biol Psychiatry. 1997 Jun 1;41(11):1095-101. doi: 10.1016/S0006-3223(96)00266-1.","Mendelson J","Biol Psychiatry","1997","1997/06/01","","","10.1016/S0006-3223(96)00266-1"
"9134072","A protocol to switch high-dose, methadone-maintained subjects to buprenorphine","Levin FR, Fischman MW, Connerney I, Foltin RW.","Am J Addict. 1997 Spring;6(2):105-16. doi: 10.3109/10550499709137021.","Levin FR","Am J Addict","1997","1997/04/01","","","10.3109/10550499709137021"
"9114907","The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates","Barrett DA, Simpson J, Rutter N, Kurihara-Bergstrom T, Shaw PN, Davis SS.","Br J Clin Pharmacol. 1993 Sep;36(3):215-9. doi: 10.1111/j.1365-2125.1993.tb04220.x.","Barrett DA","Br J Clin Pharmacol","1993","1993/09/01","PMC1364641","","10.1111/j.1365-2125.1993.tb04220.x"
"9110879","[Substitution treatments. Pharmacological and legislative aspects]","Bouchez J, Khan-Shaghaghi E, Beauverie P, Poisson N.","Soins. 1997 Jan-Feb;(612):7-10.","Bouchez J","Soins","1997","1997/01/01","","",""
"9106906","Motivational properties of buprenorphine as assessed by place and taste conditioning in rats","Gaiardi M, Bartoletti M, Bacchi A, Gubellini C, Babbini M.","Psychopharmacology (Berl). 1997 Mar;130(2):104-8. doi: 10.1007/s002130050216.","Gaiardi M","Psychopharmacology (Berl)","1997","1997/03/01","","","10.1007/s002130050216"
"9103526","Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine","Ohtani M, Kotaki H, Nishitateno K, Sawada Y, Iga T.","J Pharmacol Exp Ther. 1997 Apr;281(1):428-33.","Ohtani M","J Pharmacol Exp Ther","1997","1997/04/01","","",""
"9085402","The effects of buprenorphine in buprenorphine-maintained volunteers","Strain EC, Walsh SL, Preston KL, Liebson IA, Bigelow GE.","Psychopharmacology (Berl). 1997 Feb;129(4):329-38. doi: 10.1007/s002130050199.","Strain EC","Psychopharmacology (Berl)","1997","1997/02/01","","","10.1007/s002130050199"
"9083835","Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography-mass spectrometry","Hoja H, Marquet P, Verneuil B, Lotfi H, Dupuy JL, Lachâtre G.","J Anal Toxicol. 1997 Mar-Apr;21(2):160-5. doi: 10.1093/jat/21.2.160.","Hoja H","J Anal Toxicol","1997","1997/03/01","","","10.1093/jat/21.2.160"
"9062866","Analgesic effects on endogenous melatonin secretion","Lapwood KR, Bhagat L, Simpson MP.","J Pineal Res. 1997 Jan;22(1):20-5. doi: 10.1111/j.1600-079x.1997.tb00298.x.","Lapwood KR","J Pineal Res","1997","1997/01/01","","","10.1111/j.1600-079x.1997.tb00298.x"
"9055963","Spectro-temporal mapping of the surface electrocardiogram in clinically normal dogs","Calvert CA, Kushner LI, Jacobs GJ, Brown J.","Am J Vet Res. 1997 Mar;58(3):211-7.","Calvert CA","Am J Vet Res","1997","1997/03/01","","",""
"9048270","Bioavailability of sublingual buprenorphine","Mendelson J, Upton RA, Everhart ET, Jacob P 3rd, Jones RT.","J Clin Pharmacol. 1997 Jan;37(1):31-7. doi: 10.1177/009127009703700106.","Mendelson J","J Clin Pharmacol","1997","1997/01/01","","","10.1177/009127009703700106"
"9033830","[Abdominal syndromes and analgesia]","Camus-Kerebel C, Malledant Y, Joly A.","Cah Anesthesiol. 1996;44(4):335-9.","Camus-Kerebel C","Cah Anesthesiol","1996","1996/01/01","","",""
"9030411","Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia","Pick CG, Peter Y, Schreiber S, Weizman R.","Brain Res. 1997 Jan 2;744(1):41-6. doi: 10.1016/s0006-8993(96)01069-4.","Pick CG","Brain Res","1997","1997/01/02","","","10.1016/s0006-8993(96)01069-4"
"9029056","Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds","King CD, Rios GR, Green MD, MacKenzie PI, Tephly TR.","Drug Metab Dispos. 1997 Feb;25(2):251-5.","King CD","Drug Metab Dispos","1997","1997/02/01","","",""
"9023451","Comparative study of epidurally administered clonidine and buprenorphine on anesthetic requirement and electroencephalographic activity","Nishimi Y.","Keio J Med. 1996 Dec;45(4):324-31. doi: 10.2302/kjm.45.324.","Nishimi Y","Keio J Med","1996","1996/12/01","","","10.2302/kjm.45.324"
"8995364","Differential opioid agonist regulation of the mouse mu opioid receptor","Blake AD, Bot G, Freeman JC, Reisine T.","J Biol Chem. 1997 Jan 10;272(2):782-90. doi: 10.1074/jbc.272.2.782.","Blake AD","J Biol Chem","1997","1997/01/10","","","10.1074/jbc.272.2.782"
"8989008","Effects of epidural and intravenous buprenorphine on halothane minimum alveolar anesthetic concentration and hemodynamic responses","Inagaki Y, Kuzukawa A.","Anesth Analg. 1997 Jan;84(1):100-5. doi: 10.1097/00000539-199701000-00019.","Inagaki Y","Anesth Analg","1997","1997/01/01","","","10.1097/00000539-199701000-00019"
"8988582","HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples","Tracqui A, Kintz P, Mangin P.","J Forensic Sci. 1997 Jan;42(1):111-4.","Tracqui A","J Forensic Sci","1997","1997/01/01","","",""
"8984864","Lack of efficacy of intra-articular opioids for analgesia after day-case arthroscopy","Wrench IJ, Taylor P, Hobbs GJ.","Anaesthesia. 1996 Oct;51(10):920-2. doi: 10.1111/j.1365-2044.1996.tb14957.x.","Wrench IJ","Anaesthesia","1996","1996/10/01","","","10.1111/j.1365-2044.1996.tb14957.x"
"8982695","Gastrointestinal actions of buprenorphine: are different receptors involved?","Bhounsule SA, D'Sa S, Fernandes N, D'Souza RD, Dhume VG.","Eur J Pharmacol. 1996 Dec 5;316(2-3):253-6. doi: 10.1016/s0014-2999(96)00668-1.","Bhounsule SA","Eur J Pharmacol","1996","1996/12/05","","","10.1016/s0014-2999(96)00668-1"
"8981591","Prenatal administration of buprenorphine in the rat: effects on the rest-activity cycle at 22 and 30 days of age","Hutchings DE, Hamowy AS, Williams EM, Zmitrovich AC.","Pharmacol Biochem Behav. 1996 Dec;55(4):607-13. doi: 10.1016/s0091-3057(96)00287-0.","Hutchings DE","Pharmacol Biochem Behav","1996","1996/12/01","","","10.1016/s0091-3057(96)00287-0"
"8975564","[Clinical use of sublingual buprenorphine hydrochloride for analgesia in the early postoperative period]","Lebedeva RN, Nikoda VV, Petrov RO, Kuleshova LA.","Anesteziol Reanimatol. 1996 Jul-Aug;(4):22-5.","Lebedeva RN","Anesteziol Reanimatol","1996","1996/07/01","","",""
"8975563","[Case of prolonged use of high doses of opiates and opioids by oncologic surgical patient]","Petrova VV, Edeleva NV.","Anesteziol Reanimatol. 1996 Jul-Aug;(4):21-2.","Petrova VV","Anesteziol Reanimatol","1996","1996/07/01","","",""
"8974441","[Transient myocardial ischemia secondary to the use of cocaine-like anesthetic drug]","Elia LR, Gaeta G, Licciardi L, Boccalatte A.","Ann Ital Med Int. 1996 Apr-Jun;11(2):140-3.","Elia LR","Ann Ital Med Int","1996","1996/04/01","","",""
"8970542","Pathophysiology of drug dependence","Galynker II, Goldfarb CR, Ongseng F, Finestone H.","J Nucl Med. 1996 Dec;37(12):2098.","Galynker II","J Nucl Med","1996","1996/12/01","","",""
"8961492","Sublingual buprenorphine compared to morphine delivered by a patient-controlled analgesia system as postoperative analgesia after prostatectomy","Gaitini L, Moskovitz B, Katz E, Vaisberg A, Vaida S, Nativ O.","Urol Int. 1996;57(4):227-9. doi: 10.1159/000282920.","Gaitini L","Urol Int","1996","1996/01/01","","","10.1159/000282920"
"8953876","[Epidural administration of buprenorphine after combined spinal epidural anesthesia]","Endoh M, Matsuda A.","Masui. 1996 Nov;45(11):1396-9.","Endoh M","Masui","1996","1996/11/01","","",""
"8951507","Effect of mu-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats","Walker JS, Chandler AK, Wilson JL, Binder W, Day RO.","Inflamm Res. 1996 Nov;45(11):557-63. doi: 10.1007/BF02342227.","Walker JS","Inflamm Res","1996","1996/11/01","","","10.1007/BF02342227"
"8949735","[Withdrawal syndrome in 2 drug addicts after intravenous injection of buprenorphine?]","Gourarier L, Lowenstein W, Gisselbrecht M, Chauveau JM, Haas C, Durand H.","Presse Med. 1996 Sep 21;25(27):1239-40.","Gourarier L","Presse Med","1996","1996/09/21","","",""
"8930154","Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans","Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE.","J Pharmacol Exp Ther. 1996 Nov;279(2):524-38.","Walsh SL","J Pharmacol Exp Ther","1996","1996/11/01","","",""
"8911590","A pilot study of primary-care-based buprenorphine maintenance for heroin dependence","O'Connor PG, Oliveto AH, Shi JM, Triffleman E, Carroll KM, Kosten TR, Rounsaville BJ.","Am J Drug Alcohol Abuse. 1996 Nov;22(4):523-31. doi: 10.3109/00952999609001678.","O'Connor PG","Am J Drug Alcohol Abuse","1996","1996/11/01","","","10.3109/00952999609001678"
"8899844","Permeation of buprenorphine and its 3-alkyl-ester prodrugs through human skin","Stinchcomb AL, Paliwal A, Dua R, Imoto H, Woodard RW, Flynn GL.","Pharm Res. 1996 Oct;13(10):1519-23. doi: 10.1023/a:1016079513007.","Stinchcomb AL","Pharm Res","1996","1996/10/01","","","10.1023/a:1016079513007"
"8896694","Effects of acepromazine and buprenorphine on measured indices of the signal-averaged electrocardiogram in healthy dogs","Kushner LI, Calvert CA, Boyle CR.","Am J Vet Res. 1996 Oct;57(10):1511-4.","Kushner LI","Am J Vet Res","1996","1996/10/01","","",""
"8889674","Sweat testing in opioid users with a sweat patch","Kintz P, Tracqui A, Mangin P, Edel Y.","J Anal Toxicol. 1996 Oct;20(6):393-7. doi: 10.1093/jat/20.6.393.","Kintz P","J Anal Toxicol","1996","1996/10/01","","","10.1093/jat/20.6.393"
"8889672","Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine","Kuhlman JJ Jr, Lalani S, Magluilo J Jr, Levine B, Darwin WD.","J Anal Toxicol. 1996 Oct;20(6):369-78. doi: 10.1093/jat/20.6.369.","Kuhlman JJ Jr","J Anal Toxicol","1996","1996/10/01","","","10.1093/jat/20.6.369"
"8888002","Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice","Kamei J, Suzuki T, Nagase H.","Neurosci Lett. 1996 Sep 6;215(2):87-90.","Kamei J","Neurosci Lett","1996","1996/09/06","","",""
"8886295","P300 assessment of opiate and cocaine users: effects of detoxification and buprenorphine treatment","Kouri EM, Lukas SE, Mendelson JH.","Biol Psychiatry. 1996 Oct 1;40(7):617-28. doi: 10.1016/0006-3223(95)00468-8.","Kouri EM","Biol Psychiatry","1996","1996/10/01","","","10.1016/0006-3223(95)00468-8"
"8880825","Respiratory depression following administration of low dose buprenorphine as postoperative analgesic after fentanyl balanced anaesthesia","Zanette G, Manani G, Giusti F, Pittoni G, Ori C.","Paediatr Anaesth. 1996;6(5):419-22. doi: 10.1046/j.1460-9592.1996.d01-1.x.","Zanette G","Paediatr Anaesth","1996","1996/01/01","","","10.1046/j.1460-9592.1996.d01-1.x"
"8874907","Epidural administered buprenorphine in the perioperative period","Miwa Y, Yonemura E, Fukushima K.","Can J Anaesth. 1996 Sep;43(9):907-13. doi: 10.1007/BF03011803.","Miwa Y","Can J Anaesth","1996","1996/09/01","","","10.1007/BF03011803"
"8865712","[Effective treatment of a man with head injury and multiple rib fractures with epidural analgesia]","Kariya N, Oda Y, Yukioka H, Fujimori M.","Masui. 1996 Feb;45(2):223-6.","Kariya N","Masui","1996","1996/02/01","","",""
"8850319","Transdermal prodrug concepts: permeation of buprenorphine and its alkyl esters through hairless mouse skin and influence of vehicles","Imoto H, Zhou Z, Stinchcomb AL, Flynn GL.","Biol Pharm Bull. 1996 Feb;19(2):263-7. doi: 10.1248/bpb.19.263.","Imoto H","Biol Pharm Bull","1996","1996/02/01","","","10.1248/bpb.19.263"
"8835660","Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry","Kuhlman JJ Jr, Magluilo J Jr, Cone E, Levine B.","J Anal Toxicol. 1996 Jul-Aug;20(4):229-35. doi: 10.1093/jat/20.4.229.","Kuhlman JJ Jr","J Anal Toxicol","1996","1996/07/01","","","10.1093/jat/20.4.229"
"8834420","Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index","Strain EC, Stitzer ML, Liebson IA, Bigelow GE.","J Clin Psychopharmacol. 1996 Feb;16(1):58-67. doi: 10.1097/00004714-199602000-00010.","Strain EC","J Clin Psychopharmacol","1996","1996/02/01","","","10.1097/00004714-199602000-00010"
"8832308","Effect of epidural buprenorphine and clonidine on vesical functions in women","Batra YK, Gill PK, Vaidyanathan S, Aggarwal A.","Int J Clin Pharmacol Ther. 1996 Jul;34(7):309-11.","Batra YK","Int J Clin Pharmacol Ther","1996","1996/07/01","","",""
"8831319","Transcutaneous cranial electrical stimulation (Limoge's currents) decreases early buprenorphine analgesic requirements after abdominal surgery","Mignon A, Laudenbach V, Guischard F, Limoge A, Desmonts JM, Mantz J.","Anesth Analg. 1996 Oct;83(4):771-5. doi: 10.1097/00000539-199610000-00020.","Mignon A","Anesth Analg","1996","1996/10/01","","","10.1097/00000539-199610000-00020"
"8829938","Post-operative intravenous continuous analgesia: comparison of buprenorphine, fentanyl and nalbuphine","Lejus C, Blanloeil Y, François T, Testa S, Michel P, Dixneuf B.","Eur J Anaesthesiol. 1996 Jan;13(1):57-65. doi: 10.1097/00003643-199601000-00011.","Lejus C","Eur J Anaesthesiol","1996","1996/01/01","","","10.1097/00003643-199601000-00011"
"8826540","Combined effects of buprenorphine and a nondrug alternative reinforcer on i.v. cocaine self-administration in rats maintained under FR schedules","Comer SD, Lac ST, Wyvell CL, Carroll ME.","Psychopharmacology (Berl). 1996 Jun;125(4):355-60. doi: 10.1007/BF02246018.","Comer SD","Psychopharmacology (Berl)","1996","1996/06/01","","","10.1007/BF02246018"
"8819498","Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans","Foltin RW, Fischman MW.","J Pharmacol Exp Ther. 1996 Sep;278(3):1153-64.","Foltin RW","J Pharmacol Exp Ther","1996","1996/09/01","","",""
"8814462","The analgesic drug buprenorphine inhibits osteoclastic bone resorption in vitro, but is proinflammatory in rat adjuvant arthritis","Hall TJ, Jagher B, Schaeublin M, Wiesenberg I.","Inflamm Res. 1996 Jun;45(6):299-302. doi: 10.1007/BF02280995.","Hall TJ","Inflamm Res","1996","1996/06/01","","","10.1007/BF02280995"
"8806713","The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1","King CD, Green MD, Rios GR, Coffman BL, Owens IS, Bishop WP, Tephly TR.","Arch Biochem Biophys. 1996 Aug 1;332(1):92-100. doi: 10.1006/abbi.1996.0320.","King CD","Arch Biochem Biophys","1996","1996/08/01","","","10.1006/abbi.1996.0320"
"8792868","A simple thin-layer chromatographic method for the analysis of buprenorphine in urine","Alemany G, Gamundí A, Rosselló C, Nicolau MC.","Biomed Chromatogr. 1996 May-Jun;10(3):146-7. doi: 10.1002/(SICI)1099-0801(199605)10:3<146::AID-BMC574>3.0.CO;2-A.","Alemany G","Biomed Chromatogr","1996","1996/05/01","","","10.1002/(SICI)1099-0801(199605)10:3<146::AID-BMC574>3.0.CO;2-A"
"8782244","Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brain","Galynker I, Schlyer DJ, Dewey SL, Fowler JS, Logan J, Gatley SJ, MacGregor RR, Ferrieri RA, Holland MJ, Brodie J, Simon E, Wolf AP.","Nucl Med Biol. 1996 Apr;23(3):325-31. doi: 10.1016/0969-8051(95)02087-x.","Galynker I","Nucl Med Biol","1996","1996/04/01","","","10.1016/0969-8051(95)02087-x"
"8780998","Protective effects of buprenorphine against amplified cocaine and ethanol lethality in mice: role of cocaethylene","Hayase T, Yamamoto Y, Yamamoto K.","J Toxicol Sci. 1996 May;21(2):143-56. doi: 10.2131/jts.21.2_143.","Hayase T","J Toxicol Sci","1996","1996/05/01","","","10.2131/jts.21.2_143"
"8780832","Buprenorphine for depression: the un-adoptable orphan","Callaway E.","Biol Psychiatry. 1996 Jun 15;39(12):989-90. doi: 10.1016/0006-3223(96)00158-8.","Callaway E","Biol Psychiatry","1996","1996/06/15","","","10.1016/0006-3223(96)00158-8"
"8780276","Mode and site of analgesic action of epidural buprenorphine in humans","Inagaki Y, Mashimo T, Yoshiya I.","Anesth Analg. 1996 Sep;83(3):530-6. doi: 10.1097/00000539-199609000-00016.","Inagaki Y","Anesth Analg","1996","1996/09/01","","","10.1097/00000539-199609000-00016"
"8775841","Clinical trials of pharmacologic treatments in pregnant women--methodologic considerations","Schottenfeld RS.","NIDA Res Monogr. 1995;149:201-23.","Schottenfeld RS","NIDA Res Monogr","1995","1995/01/01","","",""
"8768738","Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans","Schuh KJ, Walsh SL, Bigelow GE, Preston KL, Stitzer ML.","J Pharmacol Exp Ther. 1996 Aug;278(2):836-46.","Schuh KJ","J Pharmacol Exp Ther","1996","1996/08/01","","",""
"8752776","[The effect of continuous epidural infusion of combination of buprenorphine and bupivacaine for postoperative pain relief using a portable 0.5 ml.h-1 type infuser with patient control module]","Komatsu H, Matsumoto S, Nagasaki G, Hori M.","Masui. 1996 Jun;45(6):735-40.","Komatsu H","Masui","1996","1996/06/01","","",""
"8750730","Buprenorphine blocks diffuse noxious inhibitory controls in the rat","Guirimand F, Chauvin M, Willer JC, Le Bars D.","Eur J Pharmacol. 1995 Dec 29;294(2-3):651-9. doi: 10.1016/0014-2999(95)00600-1.","Guirimand F","Eur J Pharmacol","1995","1995/12/29","","","10.1016/0014-2999(95)00600-1"
"8749726","Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users","Oliveto A, Kosten TR, Schottenfeld R, Falcioni J, Ziedonis D.","J Subst Abuse Treat. 1995 Nov-Dec;12(6):423-8. doi: 10.1016/0740-5472(95)02015-2.","Oliveto A","J Subst Abuse Treat","1995","1995/11/01","","","10.1016/0740-5472(95)02015-2"
"8746929","Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: a dose-response analysis","Lukas SE, Mello NK, Drieze JM, Mendelson JH.","Drug Alcohol Depend. 1995 Nov;40(1):87-98. doi: 10.1016/0376-8716(95)01195-1.","Lukas SE","Drug Alcohol Depend","1995","1995/11/01","","","10.1016/0376-8716(95)01195-1"
"8746921","Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing","Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE.","Drug Alcohol Depend. 1995 Nov;40(1):27-35. doi: 10.1016/0376-8716(95)01189-7.","Johnson RE","Drug Alcohol Depend","1995","1995/11/01","","","10.1016/0376-8716(95)01189-7"
"8746920","A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence","Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE.","Drug Alcohol Depend. 1995 Nov;40(1):17-25. doi: 10.1016/0376-8716(95)01186-2.","Johnson RE","Drug Alcohol Depend","1995","1995/11/01","","","10.1016/0376-8716(95)01186-2"
"8737562","Dual isolation technique for paediatric lung surgery","Pantvaidya SH, Golam KK, Pai RV, Saksena SG, Kaul SA.","J Postgrad Med. 1994 Apr-Jun;40(2):89-91.","Pantvaidya SH","J Postgrad Med","1994","1994/04/01","","",""
"8737553","Post-operative pain relief in children following caudal bupivacaine and buprenorphine--a comparative study","Anilkumar TK, Karpurkar SA, Shinde VS.","J Postgrad Med. 1994 Apr-Jun;40(2):61-4.","Anilkumar TK","J Postgrad Med","1994","1994/04/01","","",""
"8735515","Assessment of orocaecal transit time in cats by the breath hydrogen method: the effects of sedation and a comparison of definitions","Sparkes AH, Papasouliotis K, Viner J, Cripps PJ, Gruffydd-Jones TJ.","Res Vet Sci. 1996 May;60(3):243-6. doi: 10.1016/s0034-5288(96)90047-8.","Sparkes AH","Res Vet Sci","1996","1996/05/01","","","10.1016/s0034-5288(96)90047-8"
"8732618","Total spinal anaesthesia following caudal block with bupivacaine and buprenorphine","Afshan G, Khan FA.","Paediatr Anaesth. 1996;6(3):239-42. doi: 10.1111/j.1460-9592.1996.tb00437.x.","Afshan G","Paediatr Anaesth","1996","1996/01/01","","","10.1111/j.1460-9592.1996.tb00437.x"
"8729309","[Comparative study of buprenorphine and its combination to ketoprofen or propacetamol for postoperative analgesia in urologic surgery]","Tauzin-Fin P, Delort-Laval S, Guenard Y, Krol-Houdek MC, Muscagorry JM, Maurette P.","Ann Fr Anesth Reanim. 1996;15(1):41-6. doi: 10.1016/0750-7658(96)89401-9.","Tauzin-Fin P","Ann Fr Anesth Reanim","1996","1996/01/01","","","10.1016/0750-7658(96)89401-9"
"8725596","[Epidural buprenorphine does not improve diaphragmatic function after upper abdominal surgery]","Fujimura N, Namba H, Tsunoda K, Kawamata T, Taki K, Igarashi M, Namiki A.","Masui. 1996 Apr;45(4):428-32.","Fujimura N","Masui","1996","1996/04/01","","",""
"8723890","Hemodynamic effects of medetomidine-midazolam-butorphanol and medetomidine-midazolam-buprenorphine combinations and reversibility by atipamezole in dogs","Pypendop B, Serteyn D, Verstegen J.","Am J Vet Res. 1996 May;57(5):724-30.","Pypendop B","Am J Vet Res","1996","1996/05/01","","",""
"8721470","Menstrual stage influences postoperative nausea and vomiting following epidural buprenorphine","Kitamura A, Kon T, Kamiyama M, Ogawa R.","Acta Anaesthesiol Scand. 1996 Mar;40(3):368-71. doi: 10.1111/j.1399-6576.1996.tb04447.x.","Kitamura A","Acta Anaesthesiol Scand","1996","1996/03/01","","","10.1111/j.1399-6576.1996.tb04447.x"
"8721127","[The relief of postoperative pain by suppositories of buprenorphine or NSAID]","Akatsuka M, Tanaka M, Otsuka M, Nakano H, Tanaka Y, Uda R, Rou N, Inamori K.","Masui. 1996 Mar;45(3):298-303.","Akatsuka M","Masui","1996","1996/03/01","","",""
"8712329","The effect of increasing the dose of buprenorphine on the haemodynamic response associated with tracheal intubation","Khan FA, Kamal RS.","Anaesthesia. 1996 Mar;51(3):274-9. doi: 10.1111/j.1365-2044.1996.tb13646.x.","Khan FA","Anaesthesia","1996","1996/03/01","","","10.1111/j.1365-2044.1996.tb13646.x"
"8708492","Identification of patients treated with strong analgesics: an assessment of two Danish information systems with respect to epidemiological research","Sørensen HT, Hansen I, Ejlersen E, Sabroe S, Hamburger H.","J Med Syst. 1996 Feb;20(1):57-65. doi: 10.1007/BF02260874.","Sørensen HT","J Med Syst","1996","1996/02/01","","","10.1007/BF02260874"
"8704003","Urine toxicology as an outcome measure in drug abuse clinical trials: must every sample be analyzed?","Compton PA, Ling W, Wesson DR, Charuvastra VC, Wilkins J.","J Addict Dis. 1996;15(2):85-92. doi: 10.1300/J069v15n02_07.","Compton PA","J Addict Dis","1996","1996/01/01","","","10.1300/J069v15n02_07"
"8699542","Preferences for clinic privileges, retail items and social activities in an outpatient buprenorphine treatment program","Amass L, Bickel WK, Crean JP, Higgins ST, Badger GJ.","J Subst Abuse Treat. 1996 Jan-Feb;13(1):43-9. doi: 10.1016/0740-5472(95)02060-8.","Amass L","J Subst Abuse Treat","1996","1996/01/01","","","10.1016/0740-5472(95)02060-8"
"8694322","Preoperative wound infiltration with bupivacaine reduces early and late opioid requirement after hysterectomy","Hannibal K, Galatius H, Hansen A, Obel E, Ejlersen E.","Anesth Analg. 1996 Aug;83(2):376-81. doi: 10.1097/00000539-199608000-00030.","Hannibal K","Anesth Analg","1996","1996/08/01","","","10.1097/00000539-199608000-00030"
"8689806","Buprenorphine and naloxone interactions in opiate-dependent volunteers","Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ.","Clin Pharmacol Ther. 1996 Jul;60(1):105-14. doi: 10.1016/S0009-9236(96)90173-3.","Mendelson J","Clin Pharmacol Ther","1996","1996/07/01","","","10.1016/S0009-9236(96)90173-3"
"8667193","Buprenorphine differentially alters opioid receptor adaptation in rat brain regions","Belcheva MM, Ho MT, Ignatova EG, Jefcoat LB, Barg J, Vogel Z, McHale RJ, Johnson FE, Coscia CJ.","J Pharmacol Exp Ther. 1996 Jun;277(3):1322-7.","Belcheva MM","J Pharmacol Exp Ther","1996","1996/06/01","PMC1805810","NIHMS17971",""
"8646980","[Therapy of chronic pancreatitis]","Olligs J.","Dtsch Med Wochenschr. 1996 May 24;121(21):711.","Olligs J","Dtsch Med Wochenschr","1996","1996/05/24","","",""
"8641317","Legal opioid consumption in Denmark 1981-1993","Groth Clausen T, Eriksen J, Borgbjerg FM.","Eur J Clin Pharmacol. 1995;48(5):321-5. doi: 10.1007/BF00194945.","Groth Clausen T","Eur J Clin Pharmacol","1995","1995/01/01","","","10.1007/BF00194945"
"8632309","Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans","Eissenberg T, Greenwald MK, Johnson RE, Liebson IA, Bigelow GE, Stitzer ML.","J Pharmacol Exp Ther. 1996 Feb;276(2):449-59.","Eissenberg T","J Pharmacol Exp Ther","1996","1996/02/01","","",""
"8624183","A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence","Ling W, Wesson DR, Charuvastra C, Klett CJ.","Arch Gen Psychiatry. 1996 May;53(5):401-7. doi: 10.1001/archpsyc.1996.01830050035005.","Ling W","Arch Gen Psychiatry","1996","1996/05/01","","","10.1001/archpsyc.1996.01830050035005"
"8614238","Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors","Kamei J, Saitoh A, Suzuki T, Misawa M, Nagase H, Kasuya Y.","Life Sci. 1995 Mar 3;56(15):PL285-90. doi: 10.1016/0024-3205(95)00078-x.","Kamei J","Life Sci","1995","1995/03/03","","","10.1016/0024-3205(95)00078-x"
"8613955","Respiratory effects of opioid full and partial agonists in rhesus monkeys","Liguori A, Morse WH, Bergman J.","J Pharmacol Exp Ther. 1996 Apr;277(1):462-72.","Liguori A","J Pharmacol Exp Ther","1996","1996/04/01","","",""
"8598706","What is important in drug misuse treatment?","Seivewright NA, Greenwood J.","Lancet. 1996 Feb 10;347(8998):373-6. doi: 10.1016/s0140-6736(96)90542-5.","Seivewright NA","Lancet","1996","1996/02/10","","","10.1016/s0140-6736(96)90542-5"
"8590491","Anaesthetic management for caesarean section in a patient with Kawasaki disease","Alam S, Sakura S, Kosaka Y.","Can J Anaesth. 1995 Nov;42(11):1024-6. doi: 10.1007/BF03011076.","Alam S","Can J Anaesth","1995","1995/11/01","","","10.1007/BF03011076"
"8587920","The effects of chronic morphine on the generalization of buprenorphine stimulus control: an assessment of kappa antagonist activity","Riley AL, Pournaghash S.","Pharmacol Biochem Behav. 1995 Dec;52(4):779-87. doi: 10.1016/0091-3057(95)00180-5.","Riley AL","Pharmacol Biochem Behav","1995","1995/12/01","","","10.1016/0091-3057(95)00180-5"
"8584493","A solubility and related physicochemical property comparison of buprenorphine and its 3-alkyl esters","Stinchcomb AL, Dua R, Paliwal A, Woodard RW, Flynn GL.","Pharm Res. 1995 Oct;12(10):1526-9. doi: 10.1023/a:1016299824162.","Stinchcomb AL","Pharm Res","1995","1995/10/01","","","10.1023/a:1016299824162"
"8565000","The cognitive and psychomotor effects of opioid drugs in cancer pain management","O'Neill WM.","Cancer Surv. 1994;21:67-84.","O'Neill WM","Cancer Surv","1994","1994/01/01","","",""
"8562715","[Pharmacokinetics of buprenorphine in subcutaneous administration]","Gralow I, von Hornstein WF, Schleyer E, Hiddemann W.","Anasthesiol Intensivmed Notfallmed Schmerzther. 1995 Nov;30(7):412-6. doi: 10.1055/s-2007-996518.","Gralow I","Anasthesiol Intensivmed Notfallmed Schmerzther","1995","1995/11/01","","","10.1055/s-2007-996518"
"8556409","[Withdrawal in opiate addicts in an internal medicine hospital unit]","Crémer GA, Boissonnas A.","Bull Acad Natl Med. 1995 Oct;179(7):1335-51; discussion 1351-4.","Crémer GA","Bull Acad Natl Med","1995","1995/10/01","","",""
"8555282","Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence","Compton PA, Ling W, Charuvastra VC, Wesson DR.","J Addict Dis. 1995;14(3):97-114. doi: 10.1300/J069v14n03_07.","Compton PA","J Addict Dis","1995","1995/01/01","","","10.1300/J069v14n03_07"
"8542854","Comparison of bupivacaine plus buprenorphine with bupivacaine alone by caudal blockade for post-operative pain relief after hip and knee arthroplasty","Gao F, Waters B, Seager J, Dowling C, Vickers MD.","Eur J Anaesthesiol. 1995 Sep;12(5):471-6.","Gao F","Eur J Anaesthesiol","1995","1995/09/01","","",""
"8541358","Community based heroin addicts who turn to experimental treatment rather than conventional care","Michaels J, Galanter M, Resnick R, Marmor M, Lifshutz H, Perrone R.","J Addict Dis. 1995;14(2):33-42. doi: 10.1300/J069v14n02_04.","Michaels J","J Addict Dis","1995","1995/01/01","","","10.1300/J069v14n02_04"
"8523655","[The mu, delta and kappa properties of various opioids]","Ohta S, Niwa M, Nozaki M, Hattori M, Shimonaka H, Dohi S.","Masui. 1995 Sep;44(9):1228-32.","Ohta S","Masui","1995","1995/09/01","","",""
"8515850","[Comparison of ketorolac/buprenorphine in the treatment of post-cholecystectomy pain]","Crimi G, Fusto A, Asaro L, Bentivegna S, Castiglione G, Pappalardo G.","Minerva Anestesiol. 1993 Mar;59(3):115-9.","Crimi G","Minerva Anestesiol","1993","1993/03/01","","",""
"8515541","[Epidural opioids for post-operative pain control in pediatric patients with cerebral palsy]","Ohta K, Katsuno M, Kawana S, Namiki A.","Masui. 1993 May;42(5):664-8.","Ohta K","Masui","1993","1993/05/01","","",""
"8507257","Epidural opioid selection","Chrubasik J, Martin E, Chrubasik S, Friedrich G.","Anesth Analg. 1993 Mar;76(3):674-5. doi: 10.1213/00000539-199303000-00062.","Chrubasik J","Anesth Analg","1993","1993/03/01","","","10.1213/00000539-199303000-00062"
"8501457","Buprenorphine versus methadone maintenance for opioid dependence","Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J.","J Nerv Ment Dis. 1993 Jun;181(6):358-64. doi: 10.1097/00005053-199306000-00004.","Kosten TR","J Nerv Ment Dis","1993","1993/06/01","","","10.1097/00005053-199306000-00004"
"8491067","Subjective and physiologic effects of intravenous buprenorphine in humans","Pickworth WB, Johnson RE, Holicky BA, Cone EJ.","Clin Pharmacol Ther. 1993 May;53(5):570-6. doi: 10.1038/clpt.1993.72.","Pickworth WB","Clin Pharmacol Ther","1993","1993/05/01","","","10.1038/clpt.1993.72"
"8480833","Buprenorphine versus heroin dependence: comparison of toxicologic and psychopathologic characteristics","Torrens M, San L, Camí J.","Am J Psychiatry. 1993 May;150(5):822-4. doi: 10.1176/ajp.150.5.822.","Torrens M","Am J Psychiatry","1993","1993/05/01","","","10.1176/ajp.150.5.822"
"8478703","Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users","Holman BL, Mendelson J, Garada B, Teoh SK, Hallgring E, Johnson KA, Mello NK.","J Nucl Med. 1993 May;34(5):723-7.","Holman BL","J Nucl Med","1993","1993/05/01","","",""
"8474672","[Buprenorphine as preanesthetic medication in peridural anesthesia]","Forastiere EM, Belcastro F, Iacovacci V, Greco R.","Minerva Anestesiol. 1993 Jan-Feb;59(1-2):41-8.","Forastiere EM","Minerva Anestesiol","1993","1993/01/01","","",""
"8468778","[The plasma concentration of buprenorphine during its continuous epidural infusion after catheterization at different vertebral levels]","Shiraishi Y, Sakai S, Yokoyama J, Hayatsu K, Mochizuki T, Moriwaki G, Mizutani A.","Masui. 1993 Mar;42(3):371-5.","Shiraishi Y","Masui","1993","1993/03/01","","",""
"8463453","Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation","Teoh SK, Mendelson JH, Mello NK, Kuehnle J, Sintavanarong P, Rhoades EM.","J Clin Psychopharmacol. 1993 Apr;13(2):87-99.","Teoh SK","J Clin Psychopharmacol","1993","1993/04/01","","",""
"8462413","Buprenorphine and cocaine effects on social behavior of monkeys","Crowley TJ, Williams EA, Mikulich SK, Ingersoll NC.","Drug Alcohol Depend. 1993 Feb;31(3):235-45. doi: 10.1016/0376-8716(93)90006-c.","Crowley TJ","Drug Alcohol Depend","1993","1993/02/01","","","10.1016/0376-8716(93)90006-c"
"8456048","Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine","Gold MS.","Psychiatr Clin North Am. 1993 Mar;16(1):61-73.","Gold MS","Psychiatr Clin North Am","1993","1993/03/01","","",""
"8453740","Plasma catecholamine levels in porcine Escherichia coli septicaemia and following treatment with buprenorphine or naloxone","Donaldson MD, Vesey CJ, Bouloux PM, Watson JD, Besser GM, Hinds CJ.","Circ Shock. 1993 Mar;39(3):169-77.","Donaldson MD","Circ Shock","1993","1993/03/01","","",""
"8442513","Development of a radioimmunoassay for the determination of buprenorphine in biological samples","Debrabandere L, Van Boven M, Daenens P.","Analyst. 1993 Feb;118(2):137-43. doi: 10.1039/an9931800137.","Debrabandere L","Analyst","1993","1993/02/01","","","10.1039/an9931800137"
"8437105","Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys","Mello NK, Kamien JB, Lukas SE, Mendelson JH, Drieze JM, Sholar JW.","J Pharmacol Exp Ther. 1993 Feb;264(2):530-41.","Mello NK","J Pharmacol Exp Ther","1993","1993/02/01","","",""
"8431046","Continuous intercostal analgesia with 0.5% bupivacaine after thoracotomy: a randomized study","Deneuville M, Bisserier A, Regnard JF, Chevalier M, Levasseur P, Hervé P.","Ann Thorac Surg. 1993 Feb;55(2):381-5. doi: 10.1016/0003-4975(93)91004-7.","Deneuville M","Ann Thorac Surg","1993","1993/02/01","","","10.1016/0003-4975(93)91004-7"
"8411615","Desirability of using buprenorphine and diazepam as an adjunct to atropine in patients undergoing fibreoptic bronchoscopy","Aslam M, Beg M.","J Pak Med Assoc. 1993 Jun;43(6):120-2.","Aslam M","J Pak Med Assoc","1993","1993/06/01","","",""
"8393519","Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine","Belcheva MM, Barg J, McHale RJ, Dawn S, Ho MT, Ignatova E, Coscia CJ.","Mol Pharmacol. 1993 Jul;44(1):173-9.","Belcheva MM","Mol Pharmacol","1993","1993/07/01","PMC2516495","NIHMS57740",""
"8381654","Intercostal nerve block, interpleural analgesia, thoracic epidural block or systemic opioid application for pain relief after thoracotomy?","Bachmann-Mennenga B, Biscoping J, Kuhn DF, Schürg R, Ryan B, Erkens U, Hempelmann G.","Eur J Cardiothorac Surg. 1993;7(1):12-8. doi: 10.1016/1010-7940(93)90141-w.","Bachmann-Mennenga B","Eur J Cardiothorac Surg","1993","1993/01/01","","","10.1016/1010-7940(93)90141-w"
"8380866","Buprenorphine prevents and reverses the expression of chronic etorphine-induced sensitization of adenylyl cyclase in SK-N-SH human neuroblastoma cells","Thomas JM, Hoffman BB.","J Pharmacol Exp Ther. 1993 Jan;264(1):368-74.","Thomas JM","J Pharmacol Exp Ther","1993","1993/01/01","","",""
"8373940","Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans","Schottenfeld RS, Pakes J, Ziedonis D, Kosten TR.","Biol Psychiatry. 1993 Jul 1-15;34(1-2):66-74. doi: 10.1016/0006-3223(93)90258-f.","Schottenfeld RS","Biol Psychiatry","1993","1993/07/01","","","10.1016/0006-3223(93)90258-f"
"8372257","[Treatment of postoperative pain with intravenous PCA system. Comparison with morphine, metamizole, and buprenorphine]","Torres LM, Collado F, Almarcha JM, Huertas VG, de Antonio P, Rodríguez M.","Rev Esp Anestesiol Reanim. 1993 Jul-Aug;40(4):181-4.","Torres LM","Rev Esp Anestesiol Reanim","1993","1993/07/01","","",""
"8370341","The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand","Robinson GM, Dukes PD, Robinson BJ, Cooke RR, Mahoney GN.","Drug Alcohol Depend. 1993 Jun;33(1):81-6. doi: 10.1016/0376-8716(93)90036-p.","Robinson GM","Drug Alcohol Depend","1993","1993/06/01","","","10.1016/0376-8716(93)90036-p"
"8366559","[Postoperative pain relief by preanesthetic administration of buprenorphine suppository in elective mastectomy]","Kakehata J, Ogino H, Sasaki K, Mashio H, Gohda Y, Komura Y, Imai M, Kemmotsu O.","Masui. 1993 Aug;42(8):1184-9.","Kakehata J","Masui","1993","1993/08/01","","",""
"8356856","Comparison of the ventilatory effects of morphine and buprenorphine in children","Hamunen K, Olkkola KT, Maunuksela EL.","Acta Anaesthesiol Scand. 1993 Jul;37(5):449-53. doi: 10.1111/j.1399-6576.1993.tb03744.x.","Hamunen K","Acta Anaesthesiol Scand","1993","1993/07/01","","","10.1111/j.1399-6576.1993.tb03744.x"
"8351337","CT-guided injection of the stellate ganglion: description of technique and efficacy of sympathetic blockade","Erickson SJ, Hogan QH.","Radiology. 1993 Sep;188(3):707-9. doi: 10.1148/radiology.188.3.8351337.","Erickson SJ","Radiology","1993","1993/09/01","","","10.1148/radiology.188.3.8351337"
"8350797","Epidural buprenorphine and bupivacaine in major gynaecological operations","Loh SP.","Med J Malaysia. 1993 Jun;48(2):207-10.","Loh SP","Med J Malaysia","1993","1993/06/01","","",""
"8348877","The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland)","Forsyth AJ, Farquhar D, Gemmell M, Shewan D, Davies JB.","Drug Alcohol Depend. 1993 May;32(3):277-80. doi: 10.1016/0376-8716(93)90092-5.","Forsyth AJ","Drug Alcohol Depend","1993","1993/05/01","","","10.1016/0376-8716(93)90092-5"
"8330602","Comparison of caudal morphine and buprenorphine for post-operative analgesia in children","Girotra S, Kumar S, Rajendran KM.","Eur J Anaesthesiol. 1993 Jul;10(4):309-12.","Girotra S","Eur J Anaesthesiol","1993","1993/07/01","","",""
"8330600","Optimal regional anaesthesia for abdominal hysterectomy: combined subarachnoid and epidural block compared with other regional techniques","Mihic DN, Abram SE.","Eur J Anaesthesiol. 1993 Jul;10(4):297-301.","Mihic DN","Eur J Anaesthesiol","1993","1993/07/01","","",""
"8330599","Intramuscular buprenorphine for pain relief after abdominal surgery: a comparison between on-demand and prophylactic administration","Dejonckheere M, Levarlet M, D'Hollander A.","Eur J Anaesthesiol. 1993 Jul;10(4):291-5.","Dejonckheere M","Eur J Anaesthesiol","1993","1993/07/01","","",""
"8329254","Efficacy of postoperative pain treatment regimens using both buprenorphine and papaveretum sequentially after abdominal hysterectomy","Green DW, O'Connor L, Hanna M.","Br J Anaesth. 1993 Jun;70(6):626-30. doi: 10.1093/bja/70.6.626.","Green DW","Br J Anaesth","1993","1993/06/01","","","10.1093/bja/70.6.626"
"8322565","Complications related to thoracic epidural analgesia: a prospective study in 1071 surgical patients","Scherer R, Schmutzler M, Giebler R, Erhard J, Stöcker L, Kox WJ.","Acta Anaesthesiol Scand. 1993 May;37(4):370-4. doi: 10.1111/j.1399-6576.1993.tb03731.x.","Scherer R","Acta Anaesthesiol Scand","1993","1993/05/01","","","10.1111/j.1399-6576.1993.tb03731.x"
"8322564","Caudal buprenorphine for postoperative analgesia in children: a comparison with intramuscular buprenorphine","Girotra S, Kumar S, Rajendran KM.","Acta Anaesthesiol Scand. 1993 May;37(4):361-4. doi: 10.1111/j.1399-6576.1993.tb03729.x.","Girotra S","Acta Anaesthesiol Scand","1993","1993/05/01","","","10.1111/j.1399-6576.1993.tb03729.x"
"8322143","Buprenorphine versus morphine for patient-controlled analgesia after cholecystectomy","Dingus DJ, Sherman JC, Rogers DA, DiPiro JT, May R, Bowden TA Jr.","Surg Gynecol Obstet. 1993 Jul;177(1):1-6.","Dingus DJ","Surg Gynecol Obstet","1993","1993/07/01","","",""
"8319750","Naloxone causes apparent antinociception and pronociception simultaneously in the rat paw formalin test","Wheeler-Aceto H, Cowan A.","Eur J Pharmacol. 1993 May 19;236(2):193-9. doi: 10.1016/0014-2999(93)90589-a.","Wheeler-Aceto H","Eur J Pharmacol","1993","1993/05/19","","","10.1016/0014-2999(93)90589-a"
"8317029","[Buprenorphine for postoperative analgesia after total hip alloplasty]","Sjøgren P, Laub MS, Grønnebech H, Sørensen C, Thomsen AB, Valentin N.","Ugeskr Laeger. 1993 Jun 7;155(23):1791-3.","Sjøgren P","Ugeskr Laeger","1993","1993/06/07","","",""
"8315799","[Epidural buprenorphine under nitrous oxide-oxygen-enflurane anesthesia in elderly patients]","Tachibana C, Satoh K, Ohe Y, Hashimoto N, Furuya Y.","Masui. 1993 Apr;42(4):574-8.","Tachibana C","Masui","1993","1993/04/01","","",""
"8314940","Column-switching solid-phase trace-enrichment high-performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detection","Schleyer E, Lohmann R, Rolf C, Gralow A, Kaufmann CC, Unterhalt M, Hiddemann W.","J Chromatogr. 1993 May 5;614(2):275-83. doi: 10.1016/0378-4347(93)80319-y.","Schleyer E","J Chromatogr","1993","1993/05/05","","","10.1016/0378-4347(93)80319-y"
"8309223","Determination of buprenorphine and its dealkylated metabolite in human hair","Kintz P.","J Anal Toxicol. 1993 Nov-Dec;17(7):443-4. doi: 10.1093/jat/17.7.443.","Kintz P","J Anal Toxicol","1993","1993/11/01","","","10.1093/jat/17.7.443"
"8309062","[The effect of wound perfusion on the relief of postoperative pain]","Suzuki A, Yoshikawa M, Matsuzawa N.","Masui. 1994 Jan;43(1):96-101.","Suzuki A","Masui","1994","1994/01/01","","",""
"8301837","[Anesthetic management of a patient with acute intermittent porphyria]","Ii C, Tanaka N, Okamura H, Okagawa Y, Morioka T.","Masui. 1993 Dec;42(12):1849-52.","Ii C","Masui","1993","1993/12/01","","",""
"8301823","[Postoperative pain therapy: a survey of patient attitudes to postoperative pain relief]","Mitsuhata H, Hirabayashi Y, Saitoh K, Inoue S, Kawakami T, Shimizu R.","Masui. 1993 Dec;42(12):1769-75.","Mitsuhata H","Masui","1993","1993/12/01","","",""
"8301822","[Comparison of buprenorphine and fentanyl for postoperative pain relief by continuous epidural infusion]","Hayashi H, Nishiuchi T, Tamura H, Takeda K.","Masui. 1993 Dec;42(12):1763-8.","Hayashi H","Masui","1993","1993/12/01","","",""
"8289903","Clinical and research perspectives on cocaine abuse: the pharmacotherapy of cocaine abuse","Kosten TR.","NIDA Res Monogr. 1993;135:48-56.","Kosten TR","NIDA Res Monogr","1993","1993/01/01","","",""
"8280545","Oral bromfenac 10 and 25 mg compared with sublingual buprenorphine 0.2 and 0.4 mg for postoperative pain relief","Carroll D, Frankland T, Nagle C, McQuay H.","Br J Anaesth. 1993 Dec;71(6):814-7. doi: 10.1093/bja/71.6.814.","Carroll D","Br J Anaesth","1993","1993/12/01","","","10.1093/bja/71.6.814"
"8280345","Naltrexone-buprenorphine interactions: effects on cocaine self-administration","Mello NK, Lukas SE, Mendelson JH, Drieze J.","Neuropsychopharmacology. 1993 Nov;9(3):211-24. doi: 10.1038/npp.1993.57.","Mello NK","Neuropsychopharmacology","1993","1993/11/01","","","10.1038/npp.1993.57"
"8278436","Buprenorphine as a stimulus in drug discrimination learning: an assessment of mu and kappa receptor activity","Pournaghash S, Riley AL.","Pharmacol Biochem Behav. 1993 Nov;46(3):593-604. doi: 10.1016/0091-3057(93)90549-9.","Pournaghash S","Pharmacol Biochem Behav","1993","1993/11/01","","","10.1016/0091-3057(93)90549-9"
"8277729","Evaluation of butorphanol tartrate and buprenorphine hydrochloride on the inflammatory reaction of the Sereny Test","Swearengen JR, Cockman-Thomas RA, Davis JA, Weina PJ.","Lab Anim Sci. 1993 Oct;43(5):471-5.","Swearengen JR","Lab Anim Sci","1993","1993/10/01","","",""
"8277712","The influence of buprenorphine or bupivacaine on the post-operative effects of laparotomy and bile-duct ligation in rats","Liles JH, Flecknell PA.","Lab Anim. 1993 Oct;27(4):374-80. doi: 10.1258/002367793780745552.","Liles JH","Lab Anim","1993","1993/10/01","","","10.1258/002367793780745552"
"8273766","Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study","Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR.","Am J Drug Alcohol Abuse. 1993;19(4):451-64. doi: 10.3109/00952999309001634.","Rosen MI","Am J Drug Alcohol Abuse","1993","1993/01/01","","","10.3109/00952999309001634"
"8271108","A clinical note on sublingual buprenorphine","De Conno F, Ripamonti C, Sbanotto A, Barletta L.","J Palliat Care. 1993 Autumn;9(3):44-6.","De Conno F","J Palliat Care","1993","1993/01/01","","",""
"8267120","Buprenorphine for benzodiazepine-abusing heroin addicts","KOSTEN TR.","Am J Psychiatry. 1994 Jan;151(1):151. doi: 10.1176/ajp.151.1.151a.","KOSTEN TR","Am J Psychiatry","1994","1994/01/01","","","10.1176/ajp.151.1.151a"
"8260302","Lack of a ceiling effect for intrathecal buprenorphine on C fibre mediated somatosympathetic reflexes","Wang C, Chakrabarti MK, Whitwam JG.","Br J Anaesth. 1993 Oct;71(4):528-33. doi: 10.1093/bja/71.4.528.","Wang C","Br J Anaesth","1993","1993/10/01","","","10.1093/bja/71.4.528"
"8257551","Buprenorphine in opiate withdrawal: a comparison with clonidine","Nigam AK, Ray R, Tripathi BM.","J Subst Abuse Treat. 1993 Jul-Aug;10(4):391-4. doi: 10.1016/0740-5472(93)90024-v.","Nigam AK","J Subst Abuse Treat","1993","1993/07/01","","","10.1016/0740-5472(93)90024-v"
"8254871","[Patient-controlled analgesia with epidural pethidine or buprenorphine plus bupivacaine for postoperative analgesia]","Mitsuhata H, Hirabayashi Y, Saitoh K, Horiguchi Y, Togashi H, Shimizu R, Hasegawa J, Matsumoto S.","Masui. 1993 Nov;42(11):1623-7.","Mitsuhata H","Masui","1993","1993/11/01","","",""
"8254870","[Continuous epidural buprenorphine for postoperative pain relief in patients after lower abdominal surgery]","Hirabayashi Y, Mitsuhata H, Shimizu R, Saitoh J, Saitoh K, Fukuda H.","Masui. 1993 Nov;42(11):1618-22.","Hirabayashi Y","Masui","1993","1993/11/01","","",""
"8251871","Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990","San L, Torrens M, Castillo C, Porta M, de la Torre R.","Addiction. 1993 Oct;88(10):1341-9. doi: 10.1111/j.1360-0443.1993.tb02020.x.","San L","Addiction","1993","1993/10/01","","","10.1111/j.1360-0443.1993.tb02020.x"
"8250364","[Analgesia after thoracotomy by extrapleural administration of continuous bupivacaine]","Theissen O, Boileau S, Cornet C, Mazoit JX, Borrelly J, Feldman L, Laxenaire MC.","Ann Fr Anesth Reanim. 1993;12(3):265-72. doi: 10.1016/s0750-7658(05)80652-5.","Theissen O","Ann Fr Anesth Reanim","1993","1993/01/01","","","10.1016/s0750-7658(05)80652-5"
"8250363","[Analgesia by sublingual buprenorphine in extracorporeal kidney lithotripsy]","Tauzin-Fin P, Saumtally S, Houdek MC, Muscagorry JM.","Ann Fr Anesth Reanim. 1993;12(3):260-4. doi: 10.1016/s0750-7658(05)80651-3.","Tauzin-Fin P","Ann Fr Anesth Reanim","1993","1993/01/01","","","10.1016/s0750-7658(05)80651-3"
"8238835","Respiratory depression following combination of epidural buprenorphine and intramuscular ketorolac","Jain PN, Shah SC.","Anaesthesia. 1993 Oct;48(10):898-9. doi: 10.1111/j.1365-2044.1993.tb07425.x.","Jain PN","Anaesthesia","1993","1993/10/01","","","10.1111/j.1365-2044.1993.tb07425.x"
"8232789","Effects of buprenorphine on motility in chronically morphine treated rats","Bartoletti M, Gaiardi M, Gubellini C, Bacchi A, Babbini M.","Neuropharmacology. 1993 Sep;32(9):865-8. doi: 10.1016/0028-3908(93)90141-o.","Bartoletti M","Neuropharmacology","1993","1993/09/01","","","10.1016/0028-3908(93)90141-o"
"8230722","[Cervical epidural morphine and buprenorphine for postoperative pain relief after thoracic surgery--a comparative study in the same patients]","Inoue Y, Nakazawa K, Hikawa Y, Saitoh Y, Yasuda K.","Masui. 1993 Sep;42(9):1338-42.","Inoue Y","Masui","1993","1993/09/01","","",""
"8230700","[Postoperative pain relief by continuous epidural infusion: a comparison of three solutions]","Hayashi H, Kanoh T, Inoue T, Nishiuchi T, Tamura H, Takeda K.","Masui. 1993 Oct;42(10):1477-83.","Hayashi H","Masui","1993","1993/10/01","","",""
"8217067","Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine","Mannelli P, Janiri L, Tempesta E, Jones RT.","Br J Psychiatry Suppl. 1993 Sep;(21):39-45.","Mannelli P","Br J Psychiatry Suppl","1993","1993/09/01","","",""
"8214197","Cocaine abuse among methadone-maintained patients","Oliveto A, Kosten T, Schottenfeld R, Ziedonis D.","Am J Psychiatry. 1993 Nov;150(11):1755. doi: 10.1176/ajp.150.11.1755a.","Oliveto A","Am J Psychiatry","1993","1993/11/01","","","10.1176/ajp.150.11.1755a"
"8211445","Clinical experience with epidural buprenorphine for analgesia","Blaine EM, Lund CR, Mantel LH, Stidworthy AJ, Drummond RA, Findlay ID, Keet KD.","S Afr Med J. 1993 May;83(5):371-2.","Blaine EM","S Afr Med J","1993","1993/05/01","","",""
"8205770","Common errors in the pharmacologic treatment of drug dependence and withdrawal","Hughes JR, Higgins ST, Bickel WK.","Compr Ther. 1994;20(2):89-94.","Hughes JR","Compr Ther","1994","1994/01/01","","",""
"8197580","Buprenorphine and morphine produce equivalent increases in extracellular single unit activity of dopamine neurons in the ventral tegmental area in vivo","Grant SJ, Sonti G.","Synapse. 1994 Mar;16(3):181-7. doi: 10.1002/syn.890160303.","Grant SJ","Synapse","1994","1994/03/01","","","10.1002/syn.890160303"
"8185068","[Current aspects of pharmacotherapy of chronic pain in incurable cancer patients]","Osipova NA, Novikov GA, Prokhorov BM, Loseva NA, Beresnev VA, Sokolenov AS.","Anesteziol Reanimatol. 1993 Nov-Dec;(6):22-9.","Osipova NA","Anesteziol Reanimatol","1993","1993/11/01","","",""
"8185067","[Clinical application of buprenorphine hydrochloride for analgesia of patients in the early postoperative period]","Lebedeva RN, Nikoda VV, Petrov RO.","Anesteziol Reanimatol. 1993 Nov-Dec;(6):20-2.","Lebedeva RN","Anesteziol Reanimatol","1993","1993/11/01","","",""
"8181201","Clinical pharmacology of buprenorphine: ceiling effects at high doses","Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE.","Clin Pharmacol Ther. 1994 May;55(5):569-80. doi: 10.1038/clpt.1994.71.","Walsh SL","Clin Pharmacol Ther","1994","1994/05/01","","","10.1038/clpt.1994.71"
"8173501","Naloxone-induced withdrawal in patients with buprenorphine dependence","Nigam AK, Srivastava RP, Saxena S, Chavan BS, Sundaram KR.","Addiction. 1994 Mar;89(3):317-20. doi: 10.1111/j.1360-0443.1994.tb00898.x.","Nigam AK","Addiction","1994","1994/03/01","","","10.1111/j.1360-0443.1994.tb00898.x"
"8169777","Transdermal delivery of buprenorphine through cadaver skin","Roy SD, Roos E, Sharma K.","J Pharm Sci. 1994 Feb;83(2):126-30. doi: 10.1002/jps.2600830204.","Roy SD","J Pharm Sci","1994","1994/02/01","","","10.1002/jps.2600830204"
"8166343","Position statement on methadone maintenance treatment","","Am J Psychiatry. 1994 May;151(5):792-4. doi: 10.1176/ajp.151.5.792.","","Am J Psychiatry","1994","1994/05/01","","","10.1176/ajp.151.5.792"
"8164503","Alternate-day dosing during buprenorphine treatment of opioid dependence","Amass L, Bickel WK, Higgins ST, Badger GJ.","Life Sci. 1994;54(17):1215-28. doi: 10.1016/0024-3205(94)00848-5.","Amass L","Life Sci","1994","1994/01/01","","","10.1016/0024-3205(94)00848-5"
"8151000","Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men","Teoh SK, Mello NK, Mendelson JH, Kuehnle J, Gastfriend DR, Rhoades E, Sholar W.","J Clin Psychopharmacol. 1994 Feb;14(1):15-27.","Teoh SK","J Clin Psychopharmacol","1994","1994/02/01","","",""
"8149883","Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats","Ohtani M, Kotaki H, Uchino K, Sawada Y, Iga T.","Drug Metab Dispos. 1994 Jan-Feb;22(1):2-7.","Ohtani M","Drug Metab Dispos","1994","1994/01/01","","",""
"8146232","Changes in food-maintained progressive-ratio responding of rats following chronic buprenorphine or methadone administration","Macenski MJ, Schaal DW, Cleary J, Thompson T.","Pharmacol Biochem Behav. 1994 Feb;47(2):379-83. doi: 10.1016/0091-3057(94)90027-2.","Macenski MJ","Pharmacol Biochem Behav","1994","1994/02/01","","","10.1016/0091-3057(94)90027-2"
"8138651","Comparative evaluation of intramuscular buprenorphine, pentazocine and nefopam in post-operative pain relief","Sidhu BS, Khichy S, Singh KH.","J Indian Med Assoc. 1993 Nov;91(11):288-9.","Sidhu BS","J Indian Med Assoc","1993","1993/11/01","","",""
"8115870","[Substitution treatments]","Jutel J.","Soins Psychiatr. 1993 Oct;(156):34-7.","Jutel J","Soins Psychiatr","1993","1993/10/01","","",""
"8111612","The effects of surgical stimulus on the rat and the influence of analgesic treatment","Liles JH, Flecknell PA.","Br Vet J. 1993 Nov-Dec;149(6):515-25. doi: 10.1016/S0007-1935(05)80036-3.","Liles JH","Br Vet J","1993","1993/11/01","","","10.1016/S0007-1935(05)80036-3"
"8111608","The importance of post-operative analgesia","Johnson CB, Taylor PM.","Br Vet J. 1993 Nov-Dec;149(6):505-6. doi: 10.1016/S0007-1935(05)80032-6.","Johnson CB","Br Vet J","1993","1993/11/01","","","10.1016/S0007-1935(05)80032-6"
"8105060","Buprenorphine-cocaine interactions in mice: effect on locomotor activity and hole-dipping behaviour","Jackson HC, Griffin IJ, Nutt DJ.","J Pharm Pharmacol. 1993 Jul;45(7):636-40. doi: 10.1111/j.2042-7158.1993.tb05668.x.","Jackson HC","J Pharm Pharmacol","1993","1993/07/01","","","10.1111/j.2042-7158.1993.tb05668.x"
"8099508","[Effects of buprenorphine on gastrointestinal interdigestive myo-electric complex in dogs]","Murakuni H, Seimiya S, Shimada N, Ozawa T, Tsugu Y.","J Smooth Muscle Res. 1993 Feb;29(1):19-27. doi: 10.1540/jsmr.29.19.","Murakuni H","J Smooth Muscle Res","1993","1993/02/01","","","10.1540/jsmr.29.19"
"8091634","Cardiorespiratory effects of four opioid-tranquilizer combinations in dogs","Jacobson JD, McGrath CJ, Smith EP.","Vet Surg. 1994 Jul-Aug;23(4):299-306. doi: 10.1111/j.1532-950x.1994.tb00488.x.","Jacobson JD","Vet Surg","1994","1994/07/01","","","10.1111/j.1532-950x.1994.tb00488.x"
"8091633","Analgesia in dogs after intercostal thoracotomy: a clinical trial comparing intravenous buprenorphine and interpleural bupivacaine","Conzemius MG, Brockman DJ, King LG, Perkowski SZ.","Vet Surg. 1994 Jul-Aug;23(4):291-8. doi: 10.1111/j.1532-950x.1994.tb00487.x.","Conzemius MG","Vet Surg","1994","1994/07/01","","","10.1111/j.1532-950x.1994.tb00487.x"
"8087638","[Are there indications for oral or sublingual administration of morphines?]","Spielvogel C.","Cah Anesthesiol. 1994;42(2):219-21.","Spielvogel C","Cah Anesthesiol","1994","1994/01/01","","",""
"8081187","Misuse of legal opioids","","Addiction. 1994 Jul;89(7):885-6.","","Addiction","1994","1994/07/01","","",""
"8023029","Modelling transitional and joint marginal distributions in repeated categorical data","Follmann D.","Stat Med. 1994 Mar 15-Apr 15;13(5-7):467-77. doi: 10.1002/sim.4780130510.","Follmann D","Stat Med","1994","1994/03/15","","","10.1002/sim.4780130510"
"8021804","Interactions of opioids with caffeine: evaluation by ambulatory activity in mice","Kuribara H, Uchihashi Y.","J Pharm Pharmacol. 1994 Feb;46(2):141-4. doi: 10.1111/j.2042-7158.1994.tb03758.x.","Kuribara H","J Pharm Pharmacol","1994","1994/02/01","","","10.1111/j.2042-7158.1994.tb03758.x"
"8020299","Noncardiogenic pulmonary edema induced by sublingual buprenorphine","Thammakumpee G, Sumpatanukule P.","Chest. 1994 Jul;106(1):306-8. doi: 10.1378/chest.106.1.306.","Thammakumpee G","Chest","1994","1994/07/01","","","10.1378/chest.106.1.306"
"8010459","Intraoperative combined administration of indomethacin and buprenorphine suppositories as prophylactic therapy for post-open-cholecystectomy pain","Watanabe S, Kondo T, Asakura N, Inomata S.","Anesth Analg. 1994 Jul;79(1):85-8. doi: 10.1213/00000539-199407000-00016.","Watanabe S","Anesth Analg","1994","1994/07/01","","","10.1213/00000539-199407000-00016"
"8010359","Comparison of buprenorphine and methadone in the treatment of opioid dependence","Strain EC, Stitzer ML, Liebson IA, Bigelow GE.","Am J Psychiatry. 1994 Jul;151(7):1025-30. doi: 10.1176/ajp.151.7.1025.","Strain EC","Am J Psychiatry","1994","1994/07/01","","","10.1176/ajp.151.7.1025"
"7995313","Use of codeine analgesics in a general population. A Norwegian study of moderately strong analgesics","Eggen AE, Andrew M.","Eur J Clin Pharmacol. 1994;46(6):491-6. doi: 10.1007/BF00196103.","Eggen AE","Eur J Clin Pharmacol","1994","1994/01/01","","","10.1007/BF00196103"
"7992934","[Risk evaluation of oxygen desaturation after buprenorphine or morphine administration during the early postoperative period]","Basdevant C, Spérandio M, Gauthé-Feissel M, Raffin L, Fischler M.","Ann Fr Anesth Reanim. 1994;13(3):285-8. doi: 10.1016/s0750-7658(94)80035-9.","Basdevant C","Ann Fr Anesth Reanim","1994","1994/01/01","","","10.1016/s0750-7658(94)80035-9"
"7968322","Effects of opioid agonists and opioid antagonists in endotoxic shock in rats","Tseng CS, Tso HS.","Ma Zui Xue Za Zhi. 1993 Mar;31(1):1-8.","Tseng CS","Ma Zui Xue Za Zhi","1993","1993/03/01","","",""
"7967042","[Anesthetic management with continuous epidural buprenorphine of a patient with dystrophia myotonica]","Kawamura A, Kashimoto S, Yamaguchi T, Kume M, Kumazawa T.","Masui. 1994 Sep;43(9):1392-4.","Kawamura A","Masui","1994","1994/09/01","","",""
"7966548","A comparison of the effects of buprenorphine, carprofen and flunixin following laparotomy in rats","Liles JH, Flecknell PA.","J Vet Pharmacol Ther. 1994 Aug;17(4):284-90. doi: 10.1111/j.1365-2885.1994.tb00247.x.","Liles JH","J Vet Pharmacol Ther","1994","1994/08/01","","","10.1111/j.1365-2885.1994.tb00247.x"
"7965818","In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats","Walker EA, Makhay MM, House JD, Young AM.","J Pharmacol Exp Ther. 1994 Nov;271(2):959-68.","Walker EA","J Pharmacol Exp Ther","1994","1994/11/01","","",""
"7955341","Transient down-regulation of neonatal rat brain mu-opioid receptors upon in utero exposure to buprenorphine","Belcheva MM, Dawn S, Barg J, McHale RJ, Ho MT, Ignatova E, Coscia CJ.","Brain Res Dev Brain Res. 1994 Jul 15;80(1-2):158-62. doi: 10.1016/0165-3806(94)90100-7.","Belcheva MM","Brain Res Dev Brain Res","1994","1994/07/15","","","10.1016/0165-3806(94)90100-7"
"7949039","[Dose-dependent effect of buprenorphine on the phospholipid composition of the liver cell membrane in cats during hemorrhagic shock]","Leskova GF, Udovichenko VI.","Biull Eksp Biol Med. 1994 Aug;118(8):164-5.","Leskova GF","Biull Eksp Biol Med","1994","1994/08/01","","",""
"7941951","Epidural buprenorphine. How safe is ""safe""","Chrubasik J, Martin E, Chrubasik S, Friedrich G, Black A.","Acta Anaesthesiol Scand. 1994 Jul;38(5):525-6. doi: 10.1111/j.1399-6576.1994.tb03942.x.","Chrubasik J","Acta Anaesthesiol Scand","1994","1994/07/01","","","10.1111/j.1399-6576.1994.tb03942.x"
"7938128","Phencyclidine (PCP) self-administration and withdrawal in rhesus monkeys: effects of buprenorphine and dizocilpine (MK-801) pretreatment","Carroll ME, Carmona GN, Rodefer JS.","Pharmacol Biochem Behav. 1994 Jul;48(3):723-32. doi: 10.1016/0091-3057(94)90339-5.","Carroll ME","Pharmacol Biochem Behav","1994","1994/07/01","","","10.1016/0091-3057(94)90339-5"
"7933504","[Study of administration of buprenorphine suppository for postoperative pain relief following transvaginal hysterectomy]","Satoh O, Kawamata M, Miyabe M, Nakae Y, Tsukamoto T, Namiki A.","Masui. 1994 Aug;43(8):1212-5.","Satoh O","Masui","1994","1994/08/01","","",""
"7933486","[Continuous epidural buprenorphine for postoperative pain relief in upper abdominal surgery]","Hirabayashi Y, Mitsuhata H, Shimizu R, Togashi H, Kawakami H, Inoue S, Saitoh K, Fukuda H.","Masui. 1994 Jul;43(7):988-92.","Hirabayashi Y","Masui","1994","1994/07/01","","",""
"7933485","[Effect of intrathecal administration of opioid on minimum alveolar concentration and postoperative pain relief--a comparison of morphine and buprenorphine]","Nishimi Y, Yonemura E, Miwa Y, Fukushima K.","Masui. 1994 Jul;43(7):980-7.","Nishimi Y","Masui","1994","1994/07/01","","",""
"7931856","Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine","Ling W, Rawson RA, Compton MA.","J Psychoactive Drugs. 1994 Apr-Jun;26(2):119-28. doi: 10.1080/02791072.1994.10472259.","Ling W","J Psychoactive Drugs","1994","1994/04/01","","","10.1080/02791072.1994.10472259"
"7916913","Buprenorphine reduces cerebral glucose metabolism in polydrug abusers","Walsh SL, Gilson SF, Jasinski DR, Stapleton JM, Phillips RL, Dannals RF, Schmidt J, Preston KL, Grayson R, Bigelow GE, et al.","Neuropsychopharmacology. 1994 May;10(3):157-70. doi: 10.1038/npp.1994.18.","Walsh SL","Neuropsychopharmacology","1994","1994/05/01","","","10.1038/npp.1994.18"
"7903391","Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats","Comer SD, Lac ST, Curtis LK, Carroll ME.","J Pharmacol Exp Ther. 1993 Dec;267(3):1470-7.","Comer SD","J Pharmacol Exp Ther","1993","1993/12/01","","",""
"7893194","Gastric cytoprotective effect of morphine is probably not mediated by mu-receptors","Bhounsule SA, D'Souza RS, Dhume VG.","Arch Int Pharmacodyn Ther. 1994 Jul-Aug;328(1):99-105.","Bhounsule SA","Arch Int Pharmacodyn Ther","1994","1994/07/01","","",""
"7884840","A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: effect on biopsychosocial status","Auriacombe M, Grabot D, Daulouède JP, Vergnolle JP, O'Brien C, Tignol J.","J Subst Abuse Treat. 1994 Nov-Dec;11(6):565-8. doi: 10.1016/0740-5472(94)90008-6.","Auriacombe M","J Subst Abuse Treat","1994","1994/11/01","","","10.1016/0740-5472(94)90008-6"
"7880042","[Can substitution practices be indicated in withdrawal programs for heroin addicts?]","Boissonnas A.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:96-7.","Boissonnas A","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880040","[Are maintenance substitution practices indicated in the framework of health care of drug addicts?]","Déglon JJ.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:92-3.","Déglon JJ","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880034","[Incidence of the development of substitution treatments and specialized care centers]","Morel A.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:82-3.","Morel A","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880032","[Do substitution treatments reduce the incidence of human immunodeficiency virus infections in intravenous heroin addicts? Review of pertinent literature]","Lowenstein W, Haas C, Durand H.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:75-8.","Lowenstein W","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880028","[Criteria of evaluation of results of drug dependence substitution programs as a function of objectives and means: high threshold, low threshold, withdrawal...]","Charpak Y.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:69-70.","Charpak Y","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880027","[Role of pharmacy professionals in the network of drug addict care. Follow-up: buprenorphine, methadone, general practitioner network]","Gelbhart P.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:67-8.","Gelbhart P","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880026","[Proposal of dispensary pharmacists to improve current practices of substitution. Self-substitution and prescribed substitution]","Lamarche J.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:65-6.","Lamarche J","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880021","[How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections?]","Boissonnas A.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:54-5.","Boissonnas A","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880019","[Value and limitations of substitution treatments in the care of drug addicts]","Carpentier J, Bloch-Lainé JF, Hefez S.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:50-1.","Carpentier J","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880017","[Report on the buprenorphine substitution experience in urban medicine in Belgium]","Reisinger M.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:46-7.","Reisinger M","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880009","[Buprenorphine in the treatment of opiate dependence]","Auriacombe M, O'Brien CP, Tignol J.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:27.","Auriacombe M","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880007","[Comparative value of buprenorphine and methadone]","Reisinger M.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:23-5.","Reisinger M","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880005","[Comparative pharmacodynamics of methadone, buprenorphine and codeine]","Beauverie P, Khan E, Ghaleh B, van de Vyver M, Poisson N, Jacquot C.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:15-8.","Beauverie P","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7862888","Effects of concurrent saccharin availability and buprenorphine pretreatment on demand for smoked cocaine base in rhesus monkeys","Comer SD, Hunt VR, Carroll ME.","Psychopharmacology (Berl). 1994 Jun;115(1-2):15-23. doi: 10.1007/BF02244746.","Comer SD","Psychopharmacology (Berl)","1994","1994/06/01","","","10.1007/BF02244746"
"7861609","[Repeated use of Drug Infusion Balloon Catheter for postoperative pain management]","Koyama K, Mori K, Kaneko I.","Masui. 1994 Nov;43(11):1744-7.","Koyama K","Masui","1994","1994/11/01","","",""
"7861603","[The effect of subcutaneous administration of buprenorphine with patient controlled analgesia system for post-operative pain relief]","Matsumoto S, Mitsuhata H, Akiyama H, Terada H, Matsumoto H.","Masui. 1994 Nov;43(11):1709-13.","Matsumoto S","Masui","1994","1994/11/01","","",""
"7861593","[Evaluation of analgesic effects of morphine, buprenorphine and pentazocine in rats receiving somatic and visceral stimulation]","Iwasaki H, Ohmori H, Kobayashi I, Omote K, Kawamata M, Namiki A.","Masui. 1994 Nov;43(11):1648-52.","Iwasaki H","Masui","1994","1994/11/01","","",""
"7860555","Generalised seizure following sublingual buprenorphine","Pathre AV, Johari V, Ray A, Chikhalikar AA, Dalvi SG.","J Assoc Physicians India. 1994 Apr;42(4):327-8.","Pathre AV","J Assoc Physicians India","1994","1994/04/01","","",""
"7853176","Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone","Strain EC, Preston KL, Liebson IA, Bigelow GE.","J Pharmacol Exp Ther. 1995 Feb;272(2):628-38.","Strain EC","J Pharmacol Exp Ther","1995","1995/02/01","","",""
"7853163","Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling","Ohtani M, Kotaki H, Sawada Y, Iga T.","J Pharmacol Exp Ther. 1995 Feb;272(2):505-10.","Ohtani M","J Pharmacol Exp Ther","1995","1995/02/01","","",""
"7851281","Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine","Janiri L, Mannelli P, Persico AM, Serretti A, Tempesta E.","Drug Alcohol Depend. 1994 Oct;36(2):139-45. doi: 10.1016/0376-8716(94)90096-5.","Janiri L","Drug Alcohol Depend","1994","1994/10/01","","","10.1016/0376-8716(94)90096-5"
"7851278","A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids","Cheskin LJ, Fudala PJ, Johnson RE.","Drug Alcohol Depend. 1994 Oct;36(2):115-21. doi: 10.1016/0376-8716(94)90093-0.","Cheskin LJ","Drug Alcohol Depend","1994","1994/10/01","","","10.1016/0376-8716(94)90093-0"
"7848799","Buprenorphine and hepatic pruritus","Juby LD, Wong VS, Losowsky MS.","Br J Clin Pract. 1994 Nov-Dec;48(6):331.","Juby LD","Br J Clin Pract","1994","1994/11/01","","",""
"7832179","Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance","Stine SM, Kosten TR.","Am J Drug Alcohol Abuse. 1994 Nov;20(4):445-58. doi: 10.3109/00952999409109183.","Stine SM","Am J Drug Alcohol Abuse","1994","1994/11/01","","","10.3109/00952999409109183"
"7830376","Assessment of immunotoxicity of buprenorphine","Van Loveren H, Gianotten N, Hendriksen CF, Schuurman HJ, Van der Laan JW.","Lab Anim. 1994 Oct;28(4):355-63. doi: 10.1258/002367794780745119.","Van Loveren H","Lab Anim","1994","1994/10/01","","","10.1258/002367794780745119"
"7816882","Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference in rats","Rowlett JK, Gibson TR, Bardo MT.","Pharmacol Biochem Behav. 1994 Sep;49(1):241-5. doi: 10.1016/0091-3057(94)90484-7.","Rowlett JK","Pharmacol Biochem Behav","1994","1994/09/01","","","10.1016/0091-3057(94)90484-7"
"7815715","[Effect of indomethacin as an adjunct to postoperative pain relief by continuous epidural infusion of bupivacaine and buprenorphine]","Hirabayashi Y, Mitsuhata H, Shimizu R, Hotta K, Horiguchi Y, Saitoh J, Saitoh K, Fukuda H.","Masui. 1994 Oct;43(10):1598-601.","Hirabayashi Y","Masui","1994","1994/10/01","","",""
"7815029","Hair analysis for buprenorphine and its dealkylated metabolite by RIA and confirmation by LC/ECD","Kintz P, Cirimele V, Edel Y, Jamey C, Mangin P.","J Forensic Sci. 1994 Nov;39(6):1497-503.","Kintz P","J Forensic Sci","1994","1994/11/01","","",""
"7802321","[Clinical use of tramadol in lithotripsy compared with buprenorphine]","Levit AL, Grinberg BI.","Anesteziol Reanimatol. 1994 Jul-Aug;(4):51-3.","Levit AL","Anesteziol Reanimatol","1994","1994/07/01","","",""
"7802320","[Prolonged sacral anesthesia with buprenorphine in combination with a local anesthetic in the treatment of chronic pain of oncologic patients with lesions of organs of the small pelvis]","Gantsev ShKh, Vaĭsman MA, Gazizov AA.","Anesteziol Reanimatol. 1994 Jul-Aug;(4):50-1.","Gantsev ShKh","Anesteziol Reanimatol","1994","1994/07/01","","",""
"7802314","[Suggestions concerning modification of traditional 3-stage schedule of drug therapy of chronic pain in incurable oncologic patients]","Osipova NA, Chissov VI.","Anesteziol Reanimatol. 1994 Jul-Aug;(4):30-2.","Osipova NA","Anesteziol Reanimatol","1994","1994/07/01","","",""
"7802313","[Effects of opioid analgesics on pulmonary ventilation and metabolism in patients with acute postoperative pain]","Nikoda VV, Petrov RO, Sandrikov VA, Chizhov AI.","Anesteziol Reanimatol. 1994 Jul-Aug;(4):28-9.","Nikoda VV","Anesteziol Reanimatol","1994","1994/07/01","","",""
"7802310","[A clinical-experimental study of narcotic properties of opiate receptor agonists-antagonists and experience in their use in drug addiction practice]","Sofronov AG, Kuz'min AV, Pchelintsev MV, Belogurov SB.","Anesteziol Reanimatol. 1994 Jul-Aug;(4):13-5.","Sofronov AG","Anesteziol Reanimatol","1994","1994/07/01","","",""
"7791107","Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure","Walker EA, Zernig G, Woods JH.","J Pharmacol Exp Ther. 1995 Jun;273(3):1345-52.","Walker EA","J Pharmacol Exp Ther","1995","1995/06/01","","",""
"7790946","Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine","Levin JM, Mendelson JH, Holman BL, Teoh SK, Garada B, Schwartz RB, Mello NK.","J Nucl Med. 1995 Jul;36(7):1211-5.","Levin JM","J Nucl Med","1995","1995/07/01","","",""
"7780813","[Current status and prospectives of combating addiction of heroin]","Yang G.","Zhonghua Yi Xue Za Zhi. 1995 Mar;75(3):132.","Yang G","Zhonghua Yi Xue Za Zhi","1995","1995/03/01","","",""
"7776511","[Postoperative analgesia service by continuous epidural infusion with buprenorphine]","Hirabayashi Y, Mitsuhata H, Shimizu R, Saitoh K, Fukuda H, Saitoh J, Horiguchi Y, Togashi H, Inoue S, Hotta K, et al.","Masui. 1995 Apr;44(4):493-8.","Hirabayashi Y","Masui","1995","1995/04/01","","",""
"7776510","[Continuous epidural buprenorphine for postoperative pain relief after thoracotomy]","Hirabayashi Y, Mitsuhata H, Shimizu R, Ikeno S, Togashi H, Saitoh J, Saitoh K, Fukuda H.","Masui. 1995 Apr;44(4):489-92.","Hirabayashi Y","Masui","1995","1995/04/01","","",""
"7766771","An approximate generalized linear model with random effects for informative missing data","Follmann D, Wu M.","Biometrics. 1995 Mar;51(1):151-68.","Follmann D","Biometrics","1995","1995/03/01","","",""
"7761011","[Postoperative analgesia: peridural morphine versus sublingual buprenorphine. Comparative clinical study]","Forastiere EM, Iacovacci V, Proietti S, Belcastro F, Piastra L, Greco R.","Minerva Anestesiol. 1994 Oct;60(10 Suppl 2):9-14.","Forastiere EM","Minerva Anestesiol","1994","1994/10/01","","",""
"7761010","[Continuous venous infusion of buprenorphine with autonomous elastomeric system in the control of postoperative pain]","Greco R, Piastra M, Iacovacci V, Belcastro F, Forastiere EM, Proietti S, Piastra L.","Minerva Anestesiol. 1994 Oct;60(10 Suppl 2):1-8.","Greco R","Minerva Anestesiol","1994","1994/10/01","","",""
"7752087","Effects of intravenous morphine and buprenorphine on a C-fiber reflex in the rat","Guirimand F, Chauvin M, Willer JC, Le Bars D.","J Pharmacol Exp Ther. 1995 May;273(2):830-41.","Guirimand F","J Pharmacol Exp Ther","1995","1995/05/01","","",""
"7750360","Buprenorphine causes pulmonary edema just like all other mu-opioid narcotics. Upper airway obstruction, negative alveolar pressure","Gould DB.","Chest. 1995 May;107(5):1478-9. doi: 10.1378/chest.107.5.1478-a.","Gould DB","Chest","1995","1995/05/01","","","10.1378/chest.107.5.1478-a"
"7746511","The partial mu opiate agonist buprenorphine protects a sub-population of thalamic reticular neurons following cardiac arrest in rats","Jones MK, Ross DT.","Neurosci Lett. 1995 Feb 9;185(2):91-4. doi: 10.1016/0304-3940(94)11232-8.","Jones MK","Neurosci Lett","1995","1995/02/09","","","10.1016/0304-3940(94)11232-8"
"7740067","Buprenorphine increases intake of freely available and operant-contingent food in satiated rats","Rudski JM, Thomas D, Billington CJ, Levine AS.","Pharmacol Biochem Behav. 1995 Feb;50(2):271-6. doi: 10.1016/0091-3057(94)00313-8.","Rudski JM","Pharmacol Biochem Behav","1995","1995/02/01","","","10.1016/0091-3057(94)00313-8"
"7739107","[Anesthetic management of a patient with Cowden syndrome]","Shiraishi N, Nakamura T, Saito H, Ogawa S, Suzuki H.","Masui. 1995 Feb;44(2):282-5.","Shiraishi N","Masui","1995","1995/02/01","","",""
"7734458","A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification","Amass L, Bickel WK, Higgins ST, Hughes JR.","J Addict Dis. 1994;13(3):33-45. doi: 10.1300/j069v13n03_04.","Amass L","J Addict Dis","1994","1994/01/01","","","10.1300/j069v13n03_04"
"7726400","Intrathecal buprenorphine in the treatment of phantom limb pain","Omote K, Ohmori H, Kawamata M, Matsumoto M, Namiki A.","Anesth Analg. 1995 May;80(5):1030-2. doi: 10.1097/00000539-199505000-00030.","Omote K","Anesth Analg","1995","1995/05/01","","","10.1097/00000539-199505000-00030"
"7721245","The effect of epidural morphine on human intestinal motility in the early postoperative period","Shibata Y, Nimura Y, Yasui A, Miyachi M, Shimada Y.","Hepatogastroenterology. 1994 Dec;41(6):559-63.","Shibata Y","Hepatogastroenterology","1994","1994/12/01","","",""
"7714228","Buprenorphine treatment of refractory depression","Bodkin JA, Zornberg GL, Lukas SE, Cole JO.","J Clin Psychopharmacol. 1995 Feb;15(1):49-57. doi: 10.1097/00004714-199502000-00008.","Bodkin JA","J Clin Psychopharmacol","1995","1995/02/01","","","10.1097/00004714-199502000-00008"
"7701040","Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users","Strain EC, Stitzer ML, Liebson IA, Bigelow GE.","Psychopharmacology (Berl). 1994 Dec;116(4):401-6. doi: 10.1007/BF02247469.","Strain EC","Psychopharmacology (Berl)","1994","1994/12/01","","","10.1007/BF02247469"
"7701039","Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys","Fukase H, Fukuzaki K, Koja T, Nagata R, Lukas SE.","Psychopharmacology (Berl). 1994 Dec;116(4):396-400. doi: 10.1007/BF02247468.","Fukase H","Psychopharmacology (Berl)","1994","1994/12/01","","","10.1007/BF02247468"
"7701033","SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine","van Dyck CH, Rosen MI, Thomas HM, McMahon TJ, Wallace EA, O'Connor PG, Sullivan M, Krystal JH, Hoffer PB, Woods SW, et al.","Psychiatry Res. 1994 Dec;55(4):181-91. doi: 10.1016/0925-4927(94)90013-2.","van Dyck CH","Psychiatry Res","1994","1994/12/01","","","10.1016/0925-4927(94)90013-2"
"7699809","[Severe bradycardia and hypotension during epidural anesthesia in a patient undergoing hemorrhoidectomy]","Fukuda H, Miyashita K, Ishii R, Motegi R, Saitou K, Hirabayashi Y, Shimizu R.","Masui. 1995 Jan;44(1):100-2.","Fukuda H","Masui","1995","1995/01/01","","",""
"7695154","Cardiorespiratory effects of acepromazine maleate and buprenorphine hydrochloride in clinically normal dogs","Stepien RL, Bonagura JD, Bednarski RM, Muir WW 3rd.","Am J Vet Res. 1995 Jan;56(1):78-84.","Stepien RL","Am J Vet Res","1995","1995/01/01","","",""
"7686230","[Effects of morphine, buprenorphine and butorphanol on airway dynamics of the rabbit]","Ohya M, Taguchi H, Mima M, Koumoto K, Fukae T, Uchida M.","Masui. 1993 Apr;42(4):498-503.","Ohya M","Masui","1993","1993/04/01","","",""
"7677393","[Buprenorphine: its ambiguity]","Huguet-Levet E.","Ann Pharm Fr. 1995;53(3):124-30.","Huguet-Levet E","Ann Pharm Fr","1995","1995/01/01","","",""
"7675960","Effects of buprenorphine and methadone in methadone-maintained subjects","Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow GE, Stitzer ML.","Psychopharmacology (Berl). 1995 Jun;119(3):268-76. doi: 10.1007/BF02246290.","Walsh SL","Psychopharmacology (Berl)","1995","1995/06/01","","","10.1007/BF02246290"
"7637176","[Continuous epidural droperidol for postoperative pain]","Isosu T, Katoh M, Okuaki A.","Masui. 1995 Jul;44(7):1014-7.","Isosu T","Masui","1995","1995/07/01","","",""
"7623388","Effects of ethnicity on low-dose opiate stabilization","Kosten TR, Rayford BS.","J Subst Abuse Treat. 1995 Mar-Apr;12(2):111-6. doi: 10.1016/0740-5472(94)00069-4.","Kosten TR","J Subst Abuse Treat","1995","1995/03/01","","","10.1016/0740-5472(94)00069-4"
"7609291","[Rectal diclofenac coupled with continuous epidural infusion with buprenorphine and bupivacaine for pain relief after upper and lower abdominal surgery]","Hirabayashi Y, Mitsuhata H, Shimizu R, Saitoh J, Saitoh K, Fukuda H.","Masui. 1995 May;44(5):650-5.","Hirabayashi Y","Masui","1995","1995/05/01","","",""
"7605040","[Use of an opiate analgetic buprenorphine in the craniofacial surgery and dentistry]","Gripuk SF, Svirina MA, Borisova AIu.","Anesteziol Reanimatol. 1995 Jan-Feb;(1):49-51.","Gripuk SF","Anesteziol Reanimatol","1995","1995/01/01","","",""
"7602287","Development of a fluoroimmunoassay for the detection of buprenorphine in urine","Debrabandere L, Van Boven M, Daenens P.","J Forensic Sci. 1995 Mar;40(2):250-3.","Debrabandere L","J Forensic Sci","1995","1995/03/01","","",""
"7583900","[Analgesia with intra-articular injection of buprenorphine after surgery of the shoulder]","Fellahi JL, Magues JP, Marquer B, Guérot A, Mansat M, Cathala B.","Cah Anesthesiol. 1995;43(3):313-8.","Fellahi JL","Cah Anesthesiol","1995","1995/01/01","","",""
"7578651","Buprenorphine for human immunovirus-positive opiate-dependent patients","Montoya ID, Umbricht A, Preston KL.","Biol Psychiatry. 1995 Jul 15;38(2):135-6. doi: 10.1016/0006-3223(95)00071-N.","Montoya ID","Biol Psychiatry","1995","1995/07/15","PMC2633647","NIHMS85062","10.1016/0006-3223(95)00071-N"
"7572013","Premedication with sublingual buprenorphine for out-patient arthroscopy: reduced need for postoperative pethidine but higher incidence of nausea","Juhlin-Dannfelt M, Adamsen S, Olvon E, Beskow A, Brodin B.","Acta Anaesthesiol Scand. 1995 Jul;39(5):633-6. doi: 10.1111/j.1399-6576.1995.tb04140.x.","Juhlin-Dannfelt M","Acta Anaesthesiol Scand","1995","1995/07/01","","","10.1111/j.1399-6576.1995.tb04140.x"
"7565488","Prenatal administration of buprenorphine using the osmotic minipump: a preliminary study of maternal and offspring toxicity and growth in the rat","Hutchings DE, Zmitrovich AC, Hamowy AS, Liu PY.","Neurotoxicol Teratol. 1995 Jul-Aug;17(4):419-23. doi: 10.1016/0892-0362(94)00079-s.","Hutchings DE","Neurotoxicol Teratol","1995","1995/07/01","","","10.1016/0892-0362(94)00079-s"
"7564887","Antagonistic effect of buprenorphine on the antitussive effect of morphine is mediated via the activation of mu 1-opioid receptors","Kamei J, Saitoh A, Morita K, Nagase H.","Life Sci. 1995;57(16):PL231-5. doi: 10.1016/0024-3205(95)02115-y.","Kamei J","Life Sci","1995","1995/01/01","","","10.1016/0024-3205(95)02115-y"
"7564037","[Epidural injection for postoperative pain relief after thoracoscopic surgery]","Nogimura H, Suzuki K, Kobayashi R, Toyoda F, Kageyama Y, Harada Y.","Kyobu Geka. 1995 Aug;48(9):756-8.","Nogimura H","Kyobu Geka","1995","1995/08/01","","",""
"7562845","Modern opioids: uses defined by chrono-pharmacology, not receptor selectivity","Fox AW.","J R Soc Med. 1995 Sep;88(9):502-4.","Fox AW","J R Soc Med","1995","1995/09/01","PMC1295326","",""
"7542336","Acute administration of buprenorphine in humans: partial agonist and blockade effects","Walsh SL, Preston KL, Bigelow GE, Stitzer ML.","J Pharmacol Exp Ther. 1995 Jul;274(1):361-72.","Walsh SL","J Pharmacol Exp Ther","1995","1995/07/01","","",""
"7525929","Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure","Preston KL, Bigelow GE.","J Pharmacol Exp Ther. 1994 Oct;271(1):48-60.","Preston KL","J Pharmacol Exp Ther","1994","1994/10/01","","",""
"7525167","Effect of buprenorphine on pancreatic enzyme synthesis and secretion in normal rats and rats with acute edematous pancreatitis","Ogden JM, Modlin IM, Gorelick FS, Marks IN.","Dig Dis Sci. 1994 Nov;39(11):2407-15. doi: 10.1007/BF02087658.","Ogden JM","Dig Dis Sci","1994","1994/11/01","","","10.1007/BF02087658"
"7519977","Buprenorphine: duration of blockade of effects of intramuscular hydromorphone","Rosen MI, Wallace EA, McMahon TJ, Pearsall HR, Woods SW, Price LH, Kosten TR.","Drug Alcohol Depend. 1994 Apr;35(2):141-9. doi: 10.1016/0376-8716(94)90121-x.","Rosen MI","Drug Alcohol Depend","1994","1994/04/01","","","10.1016/0376-8716(94)90121-x"
"7514974","Managing illicit drug use. A practical guide","Wodak A.","Drugs. 1994 Mar;47(3):446-57. doi: 10.2165/00003495-199447030-00005.","Wodak A","Drugs","1994","1994/03/01","","","10.2165/00003495-199447030-00005"
"7489472","Paediatric ventilatory effects of morphine and buprenorphine revisited","Olkkola KT, Leijala MA, Maunuksela EL.","Paediatr Anaesth. 1995;5(5):303-5. doi: 10.1111/j.1460-9592.1995.tb00311.x.","Olkkola KT","Paediatr Anaesth","1995","1995/01/01","","","10.1111/j.1460-9592.1995.tb00311.x"
"7489418","Caudal analgesia with buprenorphine for postoperative pain relief in children","Kamal RS, Khan FA.","Paediatr Anaesth. 1995;5(2):101-6. doi: 10.1111/j.1460-9592.1995.tb00253.x.","Kamal RS","Paediatr Anaesth","1995","1995/01/01","","","10.1111/j.1460-9592.1995.tb00253.x"
"7473148","Effects of intrathecal and intracerebroventricular buprenorphine on a C-fiber reflex in the rat","Guirimand F, Chauvin M, Willer JC, Le Bars D.","J Pharmacol Exp Ther. 1995 Nov;275(2):629-37.","Guirimand F","J Pharmacol Exp Ther","1995","1995/11/01","","",""
"7457948","[Comparison between the side-effects of buprenorphine and morphine in conscious man (author's transl)]","Cathelin M, Vignes R, Viars P.","Anesth Analg (Paris). 1980;37(5-6):283-93.","Cathelin M","Anesth Analg (Paris)","1980","1980/01/01","","",""
"7457947","[Comparison between the analgesic effects of buprenorphine and morphine in conscious man (author's transl)]","Cathelin M, Vignes R, Viars P.","Anesth Analg (Paris). 1980;37(5-6):275-82.","Cathelin M","Anesth Analg (Paris)","1980","1980/01/01","","",""
"7445209","[Buprenorphine (Temgesic)]","Christensen CB.","Ugeskr Laeger. 1980 Oct;142(44):2918-9.","Christensen CB","Ugeskr Laeger","1980","1980/10/01","","",""
"7439255","The radioimmunoassay of buprenorphine","Bartlett AJ, Lloyd-Jones JG, Rance MJ, Flockhart IR, Dockray GJ, Bennett MR, Moore RA.","Eur J Clin Pharmacol. 1980 Oct;18(4):339-45. doi: 10.1007/BF00561392.","Bartlett AJ","Eur J Clin Pharmacol","1980","1980/10/01","","","10.1007/BF00561392"
"7438685","Buprenorphine kinetics","Bullingham RE, McQuay HJ, Moore A, Bennett MR.","Clin Pharmacol Ther. 1980 Nov;28(5):667-72. doi: 10.1038/clpt.1980.219.","Bullingham RE","Clin Pharmacol Ther","1980","1980/11/01","","","10.1038/clpt.1980.219"
"7437209","Clinical effects of buprenorphine during and after operation","McQuay HJ, Bullingham RE, Paterson GM, Moore RA.","Br J Anaesth. 1980 Oct;52(10):1013-9. doi: 10.1093/bja/52.10.1013.","McQuay HJ","Br J Anaesth","1980","1980/10/01","","","10.1093/bja/52.10.1013"
"7435902","Buprenorphine in postoperative pain: results in 7500 patients","Harcus AH, Ward AE, Smith DW.","Anaesthesia. 1980 Apr;35(4):382-6. doi: 10.1111/j.1365-2044.1980.tb05125.x.","Harcus AH","Anaesthesia","1980","1980/04/01","","","10.1111/j.1365-2044.1980.tb05125.x"
"7407029","Buprenorphine: experience in an elderly population of 975 patients during a year's monitored release","Harcus AW, Ward AE, Smith DW.","Br J Clin Pract. 1980 May;34(5):144-6.","Harcus AW","Br J Clin Pract","1980","1980/05/01","","",""
"7396100","[Modification of the analgetic effects (buprenorphine, pentazocine, pethidine) on respiration and haemodynamics by epidural, halothane- or neuroleptanaesthesia (author's transl)]","Wüst HJ, Moritz KG, Sandmann W, Richter O.","Anasth Intensivther Notfallmed. 1980 Apr;15(2):119-34.","Wüst HJ","Anasth Intensivther Notfallmed","1980","1980/04/01","","",""
"7377558","[Buprenorphine. Haemodynamic study (author's transl)]","Melon E, Lienhart A, Viars P.","Anesth Analg (Paris). 1980;37(3-4):121-5.","Melon E","Anesth Analg (Paris)","1980","1980/01/01","","",""
"7371972","The monitored release of buprenorphine: results in the young","Harcus AW, Ward AE, Smith DW.","J Int Med Res. 1980;8(2):153-5. doi: 10.1177/030006058000800210.","Harcus AW","J Int Med Res","1980","1980/01/01","","","10.1177/030006058000800210"
"7360334","Effects of buprenorphine, a new narcotic agonist-antagonist analgesic on the EEG, power spectrum and behavior of the rat","Kareti S, Moreton JE, Khazan N.","Neuropharmacology. 1980 Feb;19(2):195-201. doi: 10.1016/0028-3908(80)90138-0.","Kareti S","Neuropharmacology","1980","1980/02/01","","","10.1016/0028-3908(80)90138-0"
"7352279","Buprenorphine suppresses heroin use by heroin addicts","Mello NK, Mendelson JH.","Science. 1980 Feb 8;207(4431):657-9. doi: 10.1126/science.7352279.","Mello NK","Science","1980","1980/02/08","","","10.1126/science.7352279"
"7339167","[Analgesics]","Fitzal S.","Klin Anasthesiol Intensivther. 1981;23:161-74.","Fitzal S","Klin Anasthesiol Intensivther","1981","1981/01/01","","",""
"7336517","[Neuroleptic anesthesia with buprenorphine (Temgesic) as an analgesic. A comparison with fentanyl (Haldid)]","Hansen LK, Obel D, Hüttel MS, Andersen PK.","Ugeskr Laeger. 1981 Dec 21;143(52):3547-50.","Hansen LK","Ugeskr Laeger","1981","1981/12/21","","",""
"7332090","[A doubleblind comparison of tramadol and buprenorphine in the control of postoperative pain (author's transl)]","Alon E, Schulthess G, Axhausen C, Hossli G.","Anaesthesist. 1981 Dec;30(12):623-6.","Alon E","Anaesthesist","1981","1981/12/01","","",""
"7328731","[A comparison between pentazocine and buprenorphine in analgesic -supplemented anesthesia (author's transl)]","Momose T, Ito K, Enomoto N, Yogozawa T, Yamda M, Kuge T.","Masui. 1981 Oct;30(10):1053-61.","Momose T","Masui","1981","1981/10/01","","",""
"7328730","[Buprenorphine as a supplement of N2O-relaxant anesthesia in abdominal surgery (author's transl)]","Aoki Y, Tashiro C, Sai Y, Negishi T, Takezawa J, Amano M, Takeda K, Sha M, Yoshiya I.","Masui. 1981 Oct;30(10):1047-52.","Aoki Y","Masui","1981","1981/10/01","","",""
"7328729","[Application of buprenorphine to general anesthesia : evaluation of respiration, hemodynamics, analgesic effect and side effects (author's transl)]","Lee KH, Nioka S, Yoda K, Miyazaka M.","Masui. 1981 Oct;30(10):1041-6.","Lee KH","Masui","1981","1981/10/01","","",""
"7328728","[The application of buprenorphine in balanced anesthesia (author's transl)]","Hanaoka K, Kugimiya T, Ogawa K, Fuke N, Tagami M, Fujisawa M, Yoshikawa H, Tachibana N, Inada Y, Yamamura H.","Masui. 1981 Oct;30(10):1034-40.","Hanaoka K","Masui","1981","1981/10/01","","",""
"7328727","[Buprenorphine (author's transl)]","Yamamura H.","Masui. 1981 Oct;30(10):1029-33.","Yamamura H","Masui","1981","1981/10/01","","",""
"7325347","[Buprenorphine and nicomorphine in a double-blind trial for the control of postoperative pain (author's transl)]","Ravjower I, Alon E, Hossli G.","Anasth Intensivther Notfallmed. 1981 Dec;16(6):340-2.","Ravjower I","Anasth Intensivther Notfallmed","1981","1981/12/01","","",""
"7324833","The effect of buprenorphine and oxycodone on the intracholedochal passage pressure","Tigerstedt I, Turunen M, Tammisto T, Hästbacka J.","Acta Anaesthesiol Scand. 1981 Apr;25(2):99-102. doi: 10.1111/j.1399-6576.1981.tb01617.x.","Tigerstedt I","Acta Anaesthesiol Scand","1981","1981/04/01","","","10.1111/j.1399-6576.1981.tb01617.x"
"7322008","[Buprenorphine for pain replaces morphine]","von Bock und Polach U.","Med Klin. 1981 Dec 18;76(26):755-6.","von Bock und Polach U","Med Klin","1981","1981/12/18","","",""
"7319134","Sublingual buprenorphine versus oral dihydrocodeine in post-operative pain","Masson AH.","J Int Med Res. 1981;9(6):506-10. doi: 10.1177/030006058100900614.","Masson AH","J Int Med Res","1981","1981/01/01","","","10.1177/030006058100900614"
"7312818","[Buprenorphine for the relief of pain after operation (author's transl)]","Fassolt A.","Schweiz Rundsch Med Prax. 1981 Nov 17;70(47):2136-41.","Fassolt A","Schweiz Rundsch Med Prax","1981","1981/11/17","","",""
"7306425","Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis","Bullingham RE, McQuay HJ, Dwyer D, Allen MC, Moore RA.","Br J Clin Pharmacol. 1981 Aug;12(2):117-22. doi: 10.1111/j.1365-2125.1981.tb01189.x.","Bullingham RE","Br J Clin Pharmacol","1981","1981/08/01","PMC1401880","","10.1111/j.1365-2125.1981.tb01189.x"
"7304894","High dose buprenorphine for postoperative analgesia","Budd K.","Anaesthesia. 1981 Sep;36(9):900-3. doi: 10.1111/j.1365-2044.1981.tb08867.x.","Budd K","Anaesthesia","1981","1981/09/01","","","10.1111/j.1365-2044.1981.tb08867.x"
"7293215","Biliary excretion, metabolism and enterohepatic circulation of buprenorphine","Brewster D, Humphrey MJ, McLeavy MA.","Xenobiotica. 1981 Mar;11(3):189-96. doi: 10.3109/00498258109045291.","Brewster D","Xenobiotica","1981","1981/03/01","","","10.3109/00498258109045291"
"7277680","[Long-acting analgesic, buprenorphine, in the management of immediate postoperative pain (author's transl)]","Yamashita M, Wakayama S, Koishi K, Shintaku Y, Ogino R, Oyama T.","Masui. 1981 Feb;30(2):174-8.","Yamashita M","Masui","1981","1981/02/01","","",""
"7263931","Multidose/observational, comparative clinical analgetic evaluation of buprenorphine","Mok MS, Lippmann M, Steen SN.","J Clin Pharmacol. 1981 Jul;21(7):323-9. doi: 10.1002/j.1552-4604.1981.tb01774.x.","Mok MS","J Clin Pharmacol","1981","1981/07/01","","","10.1002/j.1552-4604.1981.tb01774.x"
"7258587","Syringe pump malfunction","Chow AE.","Anaesthesia. 1981 May;36(5):523-5. doi: 10.1111/j.1365-2044.1981.tb10289.x.","Chow AE","Anaesthesia","1981","1981/05/01","","","10.1111/j.1365-2044.1981.tb10289.x"
"7250147","Plasma concentration and disposition of buprenorphine after intravenous and intramuscular doses to baboons","Lloyd-Jones JG, Robinson P, Henson R, Biggs SR, Taylor T.","Eur J Drug Metab Pharmacokinet. 1980;5(4):233-9. doi: 10.1007/BF03189469.","Lloyd-Jones JG","Eur J Drug Metab Pharmacokinet","1980","1980/01/01","","","10.1007/BF03189469"
"7232665","Clinical pharmacology of mixed agonist-antagonist drugs [proceedings]","Jasinski DR.","Psychopharmacol Bull. 1981 Jan;17(1):85-6.","Jasinski DR","Psychopharmacol Bull","1981","1981/01/01","","",""
"7229117","The study of analgesics following single and repeated doses","Wang RI, Johnson RP, Robinson N, Waite E.","J Clin Pharmacol. 1981 Feb-Mar;21(2):121-5. doi: 10.1002/j.1552-4604.1981.tb01761.x.","Wang RI","J Clin Pharmacol","1981","1981/02/01","","","10.1002/j.1552-4604.1981.tb01761.x"
"7224117","Sex and surgical stress","Moore RA, Smith RF, McQuay HJ, Bullingham RE.","Anaesthesia. 1981 Mar;36(3):263-7. doi: 10.1111/j.1365-2044.1981.tb10198.x.","Moore RA","Anaesthesia","1981","1981/03/01","","","10.1111/j.1365-2044.1981.tb10198.x"
"7220432","Recent advances in anaesthesia","Barnes PK.","Practitioner. 1980 Oct;224(1348):1045-9.","Barnes PK","Practitioner","1980","1980/10/01","","",""
"7218511","[Evaluation of analgesic and sedative effects of a new analgesic, buprenorphine: comparison of intravenous buprenorphine and pentazocine during the immediate post-operative period (author's transl)]","Nishioka K, Imamura T, Amaha K.","Masui. 1981 Jan;30(1):64-9.","Nishioka K","Masui","1981","1981/01/01","","",""
"7202515","A comparison of the neurochemical effects of buprenorphine with those of morphine and haloperidol in rats","Dettmar PW, Cowan A, Walter DS.","Eur J Pharmacol. 1981 Jan 16;69(2):147-53. doi: 10.1016/0014-2999(81)90409-x.","Dettmar PW","Eur J Pharmacol","1981","1981/01/16","","","10.1016/0014-2999(81)90409-x"
"7198266","Buprenorphine self-administration by rhesus monkey","Mello NK, Bree MP, Mendelson JH.","Pharmacol Biochem Behav. 1981 Aug;15(2):215-25. doi: 10.1016/0091-3057(81)90180-5.","Mello NK","Pharmacol Biochem Behav","1981","1981/08/01","","","10.1016/0091-3057(81)90180-5"
"7194242","[Analgesia with buprenorphin (Temgesic) in abortions with sulproston (PGE2 derivative)]","Heinzl S, Vuletic N, Stirmer V, Radakovic D.","Gynakol Rundsch. 1980 Jun;20 Suppl 1:69-71.","Heinzl S","Gynakol Rundsch","1980","1980/06/01","","",""
"7184401","[Effect of a long-acting analgesic, buprenorphine on cancer pain--a single-blind crossover comparison with pentazocine]","Taguchi T.","Gan To Kagaku Ryoho. 1982 Feb;9(2):250-7.","Taguchi T","Gan To Kagaku Ryoho","1982","1982/02/01","","",""
"7162654","[Buprenorphine in the treatment of postoperative pain]","Alon E, Rajower I, Schulthess G, Hossli G.","Minerva Anestesiol. 1982 Nov;48(11):791-4.","Alon E","Minerva Anestesiol","1982","1982/11/01","","",""
"7158741","[Buprenorphine in peridural conduction anesthesia. A comparative study with and without bupivacaine]","Louis C, Freye E, Hartung E, Haag W.","Anasth Intensivther Notfallmed. 1982 Dec;17(6):341-4.","Louis C","Anasth Intensivther Notfallmed","1982","1982/12/01","","",""
"7155049","Buprenorphine-supplemented anesthesia in abdominal surgery","Tashiro C, Aoki Y, Yoshiya I.","Med J Osaka Univ. 1982 Sep;33(1-2):35-40.","Tashiro C","Med J Osaka Univ","1982","1982/09/01","","",""
"7150869","Involvement of the median raphe nucleus in antinociception induced by morphine, buprenorphine and tilidine in the rat","Bryant RM, Olley JE, Tyers MB.","Br J Pharmacol. 1982 Dec;77(4):615-24. doi: 10.1111/j.1476-5381.1982.tb09339.x.","Bryant RM","Br J Pharmacol","1982","1982/12/01","PMC2044677","","10.1111/j.1476-5381.1982.tb09339.x"
"7140531","Sublingual buprenorphine","","Drug Ther Bull. 1982 Sep 17;20(19):74-6.","","Drug Ther Bull","1982","1982/09/17","","",""
"7131749","[Anesthesia with buprenorphine for cardiac surgery]","Kawate R, Yoshikawa H, Kawashima Y, Uchida N, Nampo T, Meguro K.","Masui. 1982 Jul;31(7):748-54.","Kawate R","Masui","1982","1982/07/01","","",""
"7127370","Activity and tolerability of buprenorphine after parenteral and sublingual administration","Rossano C, De Luca LF, Firetto V, Fossi F.","Clin Ther. 1982;5(1):61-8.","Rossano C","Clin Ther","1982","1982/01/01","","",""
"7126409","Extradural buprenorphine","Zenz M, Piepenbrock S.","Br J Anaesth. 1982 Oct;54(10):1146-7. doi: 10.1093/bja/54.10.1146-a.","Zenz M","Br J Anaesth","1982","1982/10/01","","","10.1093/bja/54.10.1146-a"
"7124308","Analgesia for circumcision in children. A comparison of caudal bupivacaine and intramuscular buprenorphine","May AE, Wandless J, James RH.","Acta Anaesthesiol Scand. 1982 Aug;26(4):331-3. doi: 10.1111/j.1399-6576.1982.tb01776.x.","May AE","Acta Anaesthesiol Scand","1982","1982/08/01","","","10.1111/j.1399-6576.1982.tb01776.x"
"7120124","Buprenorphine effects on human heroin self-administration: an operant analysis","Mello NK, Mendelson JH, Kuehnle JC.","J Pharmacol Exp Ther. 1982 Oct;223(1):30-9.","Mello NK","J Pharmacol Exp Ther","1982","1982/10/01","","",""
"7087167","[Cardiovascular effects of buprenorphine (author's transl)]","Tsunoda Y, Sakanishi N, Nakagawa M, Takano Y, Takekawa K, Sakahira K, Manade M, Watanade Y, Ikezono E.","Masui. 1982 Feb;31(2):133-8.","Tsunoda Y","Masui","1982","1982/02/01","","",""
"7087166","[Pharmacokinetics of intravenous buprenorphine in patients anesthetized with N2O-buprenorphine (author's transl)]","Aoki Y, Tashiro C.","Masui. 1982 Feb;31(2):129-32.","Aoki Y","Masui","1982","1982/02/01","","",""
"7084817","[Analgesic and narcotic antagonist effects of buprenorphine (author's transl)]","Hiyama T, Shintani S, Tsutsui M, Yasuda Y.","Nihon Yakurigaku Zasshi. 1982 Mar;79(3):147-62.","Hiyama T","Nihon Yakurigaku Zasshi","1982","1982/03/01","","",""
"7084303","Effect of peptides on the development of tolerance to buprenorphine, a mixed opiate agonist-antagonist analgesic","Bhargava HN.","Eur J Pharmacol. 1982 Apr 8;79(1-2):117-23. doi: 10.1016/0014-2999(82)90582-9.","Bhargava HN","Eur J Pharmacol","1982","1982/04/08","","","10.1016/0014-2999(82)90582-9"
"7082534","Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis","Bullingham RE, McQuay HJ, Porter EJ, Allen MC, Moore RA.","Br J Clin Pharmacol. 1982 May;13(5):665-73. doi: 10.1111/j.1365-2125.1982.tb01434.x.","Bullingham RE","Br J Clin Pharmacol","1982","1982/05/01","PMC1402077","","10.1111/j.1365-2125.1982.tb01434.x"
"7066163","A comparative study of intramuscular buprenorphine and morphine in the treatment of chronic pain of malignant origin","Kjaer M, Henriksen H, Knudsen J.","Br J Clin Pharmacol. 1982 Apr;13(4):487-92. doi: 10.1111/j.1365-2125.1982.tb01409.x.","Kjaer M","Br J Clin Pharmacol","1982","1982/04/01","PMC1402045","","10.1111/j.1365-2125.1982.tb01409.x"
"7066147","Adverse reaction to extradural buprenorphine","Christensen FR, Andersen LW.","Br J Anaesth. 1982 Apr;54(4):476. doi: 10.1093/bja/54.4.476.","Christensen FR","Br J Anaesth","1982","1982/04/01","","","10.1093/bja/54.4.476"
"7066145","Preoperative buprenorphine does not prevent myoclonia seen after etomidate","Klausen N, Johansen SH, Janstrup F, Hansen JG.","Br J Anaesth. 1982 Apr;54(4):475. doi: 10.1093/bja/54.4.475.","Klausen N","Br J Anaesth","1982","1982/04/01","","","10.1093/bja/54.4.475"
"7066139","Pain relief after abdominal surgery--a comparison of i.m. morphine, sublingual buprenorphine and self-administered i.v. pethidine","Ellis R, Haines D, Shah R, Cotton BR, Smith G.","Br J Anaesth. 1982 Apr;54(4):421-8. doi: 10.1093/bja/54.4.421.","Ellis R","Br J Anaesth","1982","1982/04/01","","","10.1093/bja/54.4.421"
"7066127","Patient administration of I.V. buprenorphine for postoperative pain relief using the ""Cardiff"" demand analgesia apparatus","Gibbs JM, Johnson HD, Davis FM.","Br J Anaesth. 1982 Mar;54(3):279-84. doi: 10.1093/bja/54.3.279.","Gibbs JM","Br J Anaesth","1982","1982/03/01","","","10.1093/bja/54.3.279"
"7057390","Buprenorphine effects on plasma luteinizing hormone and prolactin in male heroin addicts","Mendelson JH, Ellingboe J, Mello NK, Kuehnle J.","J Pharmacol Exp Ther. 1982 Feb;220(2):252-5.","Mendelson JH","J Pharmacol Exp Ther","1982","1982/02/01","","",""
"7055528","Single-dose comparison of buprenorphine 0.3 and 0.6 mg i.v. given after operation: clinical effects and plasma concentration","Watson PJ, McQuay HJ, Bullingham RE, Allen MC, Moore RA.","Br J Anaesth. 1982 Jan;54(1):37-43. doi: 10.1093/bja/54.1.37.","Watson PJ","Br J Anaesth","1982","1982/01/01","","","10.1093/bja/54.1.37"
"7047580","Buprenorphine and morphine efficacy in postoperative pain: a double-blind multiple-dose study","Ouellette RD.","J Clin Pharmacol. 1982 Apr;22(4):165-72. doi: 10.1002/j.1552-4604.1982.tb02158.x.","Ouellette RD","J Clin Pharmacol","1982","1982/04/01","","","10.1002/j.1552-4604.1982.tb02158.x"
"7041936","An oral buprenorphine and paracetamol combination compared with paracetamol alone: a single dose double-blind postoperative study","Bullingham RE, McQuay HJ, Moore RA, Weir L.","Br J Clin Pharmacol. 1981 Dec;12(6):863-7. doi: 10.1111/j.1365-2125.1981.tb01322.x.","Bullingham RE","Br J Clin Pharmacol","1981","1981/12/01","PMC1401930","","10.1111/j.1365-2125.1981.tb01322.x"
"7039643","Controlled comparison of I.M. morphine and buprenorphine for analgesia after abdominal surgery","Cook PJ, James IM, Hobbs KE, Browne DR.","Br J Anaesth. 1982 Mar;54(3):285-90. doi: 10.1093/bja/54.3.285.","Cook PJ","Br J Anaesth","1982","1982/03/01","","","10.1093/bja/54.3.285"
"7034583","[A double-blind comparison of epidural buprenorphine and epidural morphine in postoperative pain (author's transl)]","Zenz M, Piepenbrock S, Hübner B, Glocke M.","Anasth Intensivther Notfallmed. 1981 Dec;16(6):333-9.","Zenz M","Anasth Intensivther Notfallmed","1981","1981/12/01","","",""
"7018155","Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain","Tigerstedt I, Tammisto T.","Acta Anaesthesiol Scand. 1980 Dec;24(6):462-8. doi: 10.1111/j.1399-6576.1980.tb01584.x.","Tigerstedt I","Acta Anaesthesiol Scand","1980","1980/12/01","","","10.1111/j.1399-6576.1980.tb01584.x"
"7004250","Haemodynamic changes following buprenorphine and morphine","Scott DH, Arthur GR, Scott DB.","Anaesthesia. 1980 Oct;35(10):957-61. doi: 10.1111/j.1365-2044.1980.tb04993.x.","Scott DH","Anaesthesia","1980","1980/10/01","","","10.1111/j.1365-2044.1980.tb04993.x"
"6990950","A double-blind comparison between fentanyl and buprenorphrine in analgesic-supplemented anaesthesia","Kay B.","Br J Anaesth. 1980 Apr;52(4):453-7. doi: 10.1093/bja/52.4.453.","Kay B","Br J Anaesth","1980","1980/04/01","","","10.1093/bja/52.4.453"
"6981044","[Effect of buprenorphine on circulation and breathing]","Kramer M, Stoyanov M, Komeriner D, Kling D, Walter P, Hempelman G.","Med Welt. 1982 Jun 4;33(22):830-3.","Kramer M","Med Welt","1982","1982/06/04","","",""
"6952112","Pain relief","McQueen EG.","N Z Med J. 1982 Feb 10;95(701):88-9.","McQueen EG","N Z Med J","1982","1982/02/10","","",""
"6950300","Pain relief","Adams T.","N Z Med J. 1981 Dec 23;94(698):470.","Adams T","N Z Med J","1981","1981/12/23","","",""
"6896119","[Physostigmine reversal of central anticholinergic syndrome induced by midazolam/fentanyl, benzoctamine/buprenorphine and etomidate/carticaine or by atropine/promethazine/pethidine for premedication? (author's transl)]","Jost U, Schmid A, Ruppert M.","Anaesthesist. 1982 Jan;31(1):21-4.","Jost U","Anaesthesist","1982","1982/01/01","","",""
"6875844","Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys","Dykstra LA.","J Pharmacol Exp Ther. 1983 Aug;226(2):317-23.","Dykstra LA","J Pharmacol Exp Ther","1983","1983/08/01","","",""
"6869711","Day-case dental anaesthesia. Evaluation of pre-operative sublingual buprenorphine","Ogg TW, MacDonald IA, Beechey AP, Morrison CG.","Anaesthesia. 1983 Jun;38(6):534-9.","Ogg TW","Anaesthesia","1983","1983/06/01","","",""
"6866541","Pain treatment on outpatient basis utilizing extradural opiates. A Danish multicentre study comprising 105 patients","Crawford ME, Andersen HB, Augustenborg G, Bay J, Beck O, Benveniste D, Larsen LB, Carl P, Djernes M, Eriksen J, Grell AM, Henriksen H, Johansen SH, Jørgensen HO, Møller IW, Pedersen JE, Ravlo O.","Pain. 1983 May;16(1):41-7. doi: 10.1016/0304-3959(83)90084-2.","Crawford ME","Pain","1983","1983/05/01","","","10.1016/0304-3959(83)90084-2"
"6866170","[A case of secondary buprenorphine (Temgesic) dependence]","Benos J.","Nervenarzt. 1983 May;54(5):259-61.","Benos J","Nervenarzt","1983","1983/05/01","","",""
"6850163","Opioid agonist and antagonist behavioural effects of buprenorphine","Leander JD.","Br J Pharmacol. 1983 Apr;78(4):607-15. doi: 10.1111/j.1476-5381.1983.tb09410.x.","Leander JD","Br J Pharmacol","1983","1983/04/01","PMC2044742","","10.1111/j.1476-5381.1983.tb09410.x"
"6846782","[Buprenorphine as a postoperative analgesic following halothane anesthesia. Hemodynamic and respiratory effects]","Piepenbrock S, Zenz M, Reichelt W, Wölfel D, Reinhart K.","Anaesthesist. 1983 Feb;32(2):67-74.","Piepenbrock S","Anaesthesist","1983","1983/02/01","","",""
"6842402","Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration","Geller EB, Hawk C, Keinath SH, Tallarida RJ, Adler MW.","J Pharmacol Exp Ther. 1983 May;225(2):391-8.","Geller EB","J Pharmacol Exp Ther","1983","1983/05/01","","",""
"6836002","A long-acting buprenorphine delivery system","Pontani RB, Misra AL.","Pharmacol Biochem Behav. 1983 Mar;18(3):471-4. doi: 10.1016/0091-3057(83)90472-0.","Pontani RB","Pharmacol Biochem Behav","1983","1983/03/01","","","10.1016/0091-3057(83)90472-0"
"6829887","High dose buprenorphine for postoperative analgesia","Papworth DP.","Anaesthesia. 1983 Feb;38(2):163. doi: 10.1111/j.1365-2044.1983.tb13941.x.","Papworth DP","Anaesthesia","1983","1983/02/01","","","10.1111/j.1365-2044.1983.tb13941.x"
"6818866","[Respiratory depression after epidural opiate analgesia with buprenorphine hydrochloride? A clinical case report]","Zinck B, Fritz KW.","Anasth Intensivther Notfallmed. 1982 Dec;17(6):345-7.","Zinck B","Anasth Intensivther Notfallmed","1982","1982/12/01","","",""
"6818864","[Modified neuroleptanalgesia with buprenorphine]","Weidler B, von Bormann B, Seim M, Sturm G, Schwanen N, Hempelmann G.","Anasth Intensivther Notfallmed. 1982 Dec;17(6):319-24.","Weidler B","Anasth Intensivther Notfallmed","1982","1982/12/01","","",""
"6811932","Progress report of the NIDA Addiction Research Center","Jasinski DR, Haertzen CA, Henningfield JE, Johnson RE, Makhzoumi HM, Miyasato K.","NIDA Res Monogr. 1982 Apr;41:45-52.","Jasinski DR","NIDA Res Monogr","1982","1982/04/01","","",""
"6811921","Clinical analgesic assay of sublingual buprenorphine and intramuscular morphine","Wallenstein SL, Kaiko RF, Rogers AG, Houde RW.","NIDA Res Monogr. 1982 Apr;41:288-93.","Wallenstein SL","NIDA Res Monogr","1982","1982/04/01","","",""
"6811910","Dependence potential of buprenorphine studied in rhesus monkeys","Yanagita T, Katoh S, Wakasa Y, Oinuma N.","NIDA Res Monogr. 1982 Apr;41:208-14.","Yanagita T","NIDA Res Monogr","1982","1982/04/01","","",""
"6805715","Prospective double-blind comparison of buprenorphine and pethidine in ureteric colic","Finlay IG, Scott R, McArdle CS.","Br Med J (Clin Res Ed). 1982 Jun 19;284(6332):1830-1. doi: 10.1136/bmj.284.6332.1830.","Finlay IG","Br Med J (Clin Res Ed)","1982","1982/06/19","PMC1498725","","10.1136/bmj.284.6332.1830"
"6802995","An assessment of buprenorphine as an analgesic","Gardezi SA, Ahmed HS, Chaudhary AM, Ahmed I.","J Pak Med Assoc. 1981 Nov;31(11):250-3.","Gardezi SA","J Pak Med Assoc","1981","1981/11/01","","",""
"6802019","[The influence of buprenorphine and tramadol on the postoperative CO2 response after general anaesthesia (author's transl)]","Klose R, Ehrhart A, Jung R.","Anasth Intensivther Notfallmed. 1982 Feb;17(1):29-34.","Klose R","Anasth Intensivther Notfallmed","1982","1982/02/01","","",""
"6794327","Comparative study on the circulatory and respiratory effects of buprenorphine and methadone","de Klerk G, Mattie H, Spierdijk J.","Acta Anaesthesiol Belg. 1981;32(2):131-9.","de Klerk G","Acta Anaesthesiol Belg","1981","1981/01/01","","",""
"6785803","Differential effects of opiate agonists-antagonists on morphine-induced hyperexcitability and analgesia in mice","Filibeck U, Castellano C, Oliverio A.","Psychopharmacology (Berl). 1981;73(2):134-6. doi: 10.1007/BF00429203.","Filibeck U","Psychopharmacology (Berl)","1981","1981/01/01","","","10.1007/BF00429203"
"6783946","Reinforcing properties of buprenorphine: a behavioral analysis","Mello NK, Bree MP, Mendelson JH.","NIDA Res Monogr. 1981 Feb;34:36-42.","Mello NK","NIDA Res Monogr","1981","1981/02/01","","",""
"6768078","Effects of heroin self-administration on cigarette smoking","Mello NK, Mendelson JH, Sellers ML, Kuehnle JC.","Psychopharmacology (Berl). 1980 Jan;67(1):45-52. doi: 10.1007/BF00427594.","Mello NK","Psychopharmacology (Berl)","1980","1980/01/01","","","10.1007/BF00427594"
"6762690","[Prevention of postoperative pain with buprenorphine, morphine or pethidine]","Isaksen B, Mikkelsen H, Bryne H.","Tidsskr Nor Laegeforen. 1982 Nov 10;102(31):1647-8.","Isaksen B","Tidsskr Nor Laegeforen","1982","1982/11/10","","",""
"6760767","Possible antidepressive effects of opioids: action of buprenorphine","Emrich HM, Vogt P, Herz A.","Ann N Y Acad Sci. 1982;398:108-12. doi: 10.1111/j.1749-6632.1982.tb39483.x.","Emrich HM","Ann N Y Acad Sci","1982","1982/01/01","","","10.1111/j.1749-6632.1982.tb39483.x"
"6758261","[Long-term treatment with epidural opiates. A multicenter account of 125 patients]","Andersen HB, Benveniste D, Bitsch-Larsen L, Carl P, Crawford M, Djernes M, Eriksen J, Grell AM, Henriksen H, Jansen E, Kaalund-Jørgensen HO, Laugesen L, Lønholdt C, Neumann P, Pedersen JE, Wolff J.","Ugeskr Laeger. 1982 Sep 6;144(36):2633-7.","Andersen HB","Ugeskr Laeger","1982","1982/09/06","","",""
"6734042","Electroencephalographic and behavioral correlates of buprenorphine administration","Lukas SE, Jasinski DR, Johnson RE.","Clin Pharmacol Ther. 1984 Jul;36(1):127-32. doi: 10.1038/clpt.1984.150.","Lukas SE","Clin Pharmacol Ther","1984","1984/07/01","","","10.1038/clpt.1984.150"
"6730874","Pain relief with epidural buprenorphine after spinal fusion: a comparison with intramuscular morphine","Murphy DF, MacEvilly M.","Acta Anaesthesiol Scand. 1984 Apr;28(2):144-6. doi: 10.1111/j.1399-6576.1984.tb02030.x.","Murphy DF","Acta Anaesthesiol Scand","1984","1984/04/01","","","10.1111/j.1399-6576.1984.tb02030.x"
"6730739","[Buprenorphine-nitrous oxide-oxygen anesthesia in swine as an animal model]","Pfenninger E, Grünert A, Müller W, Siegler W.","Z Versuchstierkd. 1984;26(2):67-76.","Pfenninger E","Z Versuchstierkd","1984","1984/01/01","","",""
"6729155","[Peridural use of buprenorphine. Case report]","Dahl HD.","Reg Anaesth. 1984 Apr;7(2):56-8.","Dahl HD","Reg Anaesth","1984","1984/04/01","","",""
"6727551","A novel form of dependency of hepatic extraction ratio of opioids in vivo upon the portal vein concentration of drug: comparison of morphine, diamorphine, fentanyl, methadone and buprenorphine in the chronically cannulated cow","Bullingham RE, Moore RA, Symonds HW, Allen MC, Baldwin D, McQuay HJ.","Life Sci. 1984 May 21;34(21):2047-56. doi: 10.1016/0024-3205(84)90369-2.","Bullingham RE","Life Sci","1984","1984/05/21","","","10.1016/0024-3205(84)90369-2"
"6711799","[Animal experiment study on intracranial pressure, after ketamine administration]","Pfenninger E, Dick W, Grünert A, Lotz P.","Anaesthesist. 1984 Feb;33(2):82-8.","Pfenninger E","Anaesthesist","1984","1984/02/01","","",""
"6711782","Mandatory sublingual buprenorphine for postoperative pain","Bullingham RE, O'Sullivan G, McQuay HJ, Poppleton P, Rolfe M, Weir L, Moore RA.","Anaesthesia. 1984 Apr;39(4):329-34. doi: 10.1111/j.1365-2044.1984.tb07272.x.","Bullingham RE","Anaesthesia","1984","1984/04/01","","","10.1111/j.1365-2044.1984.tb07272.x"
"6711781","Non-parenteral postoperative analgesia. A comparison of sublingual buprenorphine and morphine sulphate (slow release) tablets","Derbyshire DR, Vater M, Maile CI, Larsson IM, Aitkenhead AR, Smith G.","Anaesthesia. 1984 Apr;39(4):324-8. doi: 10.1111/j.1365-2044.1984.tb07271.x.","Derbyshire DR","Anaesthesia","1984","1984/04/01","","","10.1111/j.1365-2044.1984.tb07271.x"
"6710826","Combined use of sedatives and opiates in horses","Nolan AM, Hall LW.","Vet Rec. 1984 Jan 21;114(3):63-7. doi: 10.1136/vr.114.3.63.","Nolan AM","Vet Rec","1984","1984/01/21","","","10.1136/vr.114.3.63"
"6707916","Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey","DeRossett SE, Holtzman SG.","J Pharmacol Exp Ther. 1984 Mar;228(3):669-75.","DeRossett SE","J Pharmacol Exp Ther","1984","1984/03/01","","",""
"6707893","Stability of the 6,14-endo-ethanotetrahydrooripavine analgesics: acid-catalyzed rearrangement of buprenorphine","Cone EJ, Gorodetzky CW, Darwin WD, Buchwald WF.","J Pharm Sci. 1984 Feb;73(2):243-6. doi: 10.1002/jps.2600730225.","Cone EJ","J Pharm Sci","1984","1984/02/01","","","10.1002/jps.2600730225"
"6703303","Buprenorphine, benzodiazepines and respiratory depression","Green DW.","Anaesthesia. 1984 Mar;39(3):287-8. doi: 10.1111/j.1365-2044.1984.tb07248.x.","Green DW","Anaesthesia","1984","1984/03/01","","","10.1111/j.1365-2044.1984.tb07248.x"
"6700515","A case of buprenorphine abuse","Quigley AJ, Bredemeyer DE, Seow SS.","Med J Aust. 1984 Mar 31;140(7):425-6.","Quigley AJ","Med J Aust","1984","1984/03/31","","",""
"6700503","Buprenorphine. New wonder drug or new hazard?","Wodak AD.","Med J Aust. 1984 Mar 31;140(7):389-90.","Wodak AD","Med J Aust","1984","1984/03/31","","",""
"6694639","Temgesic restricted to hospitals","Curran AC.","Med J Aust. 1984 Feb 18;140(4):246.","Curran AC","Med J Aust","1984","1984/02/18","","",""
"6689268","[Mechanism of morphine-induced suppression of central nervous system blood flow]","Dohi S, Matsumiya N, Abe T.","No To Shinkei. 1983 Nov;35(11):1083-8.","Dohi S","No To Shinkei","1983","1983/11/01","","",""
"6687818","Antinociceptive actions of morphine and buprenorphine given intrathecally in the conscious rat","Bryant RM, Olley JE, Tyers MB.","Br J Pharmacol. 1983 Apr;78(4):659-63. doi: 10.1111/j.1476-5381.1983.tb09417.x.","Bryant RM","Br J Pharmacol","1983","1983/04/01","PMC2044748","","10.1111/j.1476-5381.1983.tb09417.x"
"6683540","Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocine","Ventafridda V, De Conno F, Guarise G, Tamburini M, Savio G.","Arzneimittelforschung. 1983;33(4):587-90.","Ventafridda V","Arzneimittelforschung","1983","1983/01/01","","",""
"6657731","The suppression of ethanol self injection by buprenorphine","Martin A, Pilotto R, Singer G, Oei TP.","Pharmacol Biochem Behav. 1983 Dec;19(6):985-6. doi: 10.1016/0091-3057(83)90403-3.","Martin A","Pharmacol Biochem Behav","1983","1983/12/01","","","10.1016/0091-3057(83)90403-3"
"6651208","Use of midazolam and buprenorphine in combination anaesthesia","Sjövall S.","Ann Clin Res. 1983 Aug;15(4):151-5.","Sjövall S","Ann Clin Res","1983","1983/08/01","","",""
"6645791","Development of enhanced sensitivity to naloxone","Dykstra LA.","Life Sci. 1983 Nov 21;33(21):2079-89. doi: 10.1016/0024-3205(83)90331-4.","Dykstra LA","Life Sci","1983","1983/11/21","","","10.1016/0024-3205(83)90331-4"
"6620548","[Hormonal effects of buprenorphine anesthesia in man]","Yokono A, Yoda K, Miyazaki M.","Masui. 1983 Jun;32(6):723-8.","Yokono A","Masui","1983","1983/06/01","","",""
"6614422","[Epidural buprenorphine for postoperative analgesia after hip operations]","Gerig HJ, Kern F.","Anaesthesist. 1983 Jul;32(7):345-8.","Gerig HJ","Anaesthesist","1983","1983/07/01","","",""
"6614418","[Peridural opiate analgesia. Clinical results of a 2-year study]","Zenz M, Piepenbrock S, Tryba M, Brämswig H.","Anaesthesist. 1983 Jun;32(6):289-94.","Zenz M","Anaesthesist","1983","1983/06/01","","",""
"6584767","Buprenorphine side effects","Holmes AD.","N Z Med J. 1984 Mar 14;97(751):166.","Holmes AD","N Z Med J","1984","1984/03/14","","",""
"6578447","Temgesic abuse","Harper I.","N Z Med J. 1983 Oct 12;96(741):777.","Harper I","N Z Med J","1983","1983/10/12","","",""
"6547177","Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone","Shannon HE, Cone EJ, Gorodetzky CW.","J Pharmacol Exp Ther. 1984 Jun;229(3):768-74.","Shannon HE","J Pharmacol Exp Ther","1984","1984/06/01","","",""
"6536878","[Tolerance to peridural buprenorphine in cancer pain. Case report]","Nicosia F, Albani A, Lombardi M, Tagliagambe A.","Minerva Anestesiol. 1984 Dec;50(12):669-72.","Nicosia F","Minerva Anestesiol","1984","1984/12/01","","",""
"6536870","[Comparative study of buprenorphine and morphine for pain control in the immediate postoperative period by peridural administration]","Sciandra G, Bono D, Coaloa M, Garelli G, Piazza L, Viglietti AM.","Minerva Anestesiol. 1984 Dec;50(12):607-14.","Sciandra G","Minerva Anestesiol","1984","1984/12/01","","",""
"6535075","[Buprenorphine vs pentazocine in treating postoperative pain in gynecological surgery]","Romano E, Mocavero G, Vacri A, Fasiolo S, Caristi D, Cassio S.","Minerva Anestesiol. 1984 Nov;50(11):577-80.","Romano E","Minerva Anestesiol","1984","1984/11/01","","",""
"6532961","Antiarrhythmic activity of buprenorphine against cardiac arrhythmia following coronary artery ligation","Pant KK, Gurtu S, Saxena RC, Bhargava KP.","Indian J Med Res. 1984 Oct;80:487-90.","Pant KK","Indian J Med Res","1984","1984/10/01","","",""
"6529632","[Per- and postoperative buprenorphine analgesia: cardiocirculatory and respiratory effects]","Rifat K, Magnin C, Morel D.","Cah Anesthesiol. 1984 Jan-Feb;32(1):33-6.","Rifat K","Cah Anesthesiol","1984","1984/01/01","","",""
"6521876","[Buprenorphine in postoperative pain. Comparison of intravenous and sublingual administration]","Piva L, Bedoni M, Pagnoni B, Della Rosa A.","Minerva Anestesiol. 1984 Jul-Aug;50(7-8):367-71.","Piva L","Minerva Anestesiol","1984","1984/07/01","","",""
"6514833","Effects of naloxone and buprenorphine on intravenous acetaldehyde self-injection in rats","Myers WD, Ng KT, Singer G.","Physiol Behav. 1984 Sep;33(3):449-55. doi: 10.1016/0031-9384(84)90168-9.","Myers WD","Physiol Behav","1984","1984/09/01","","","10.1016/0031-9384(84)90168-9"
"6507832","Postoperative analgesia: a technique using continuous intravenous infusion of buprenorphine","Fry EN.","Anaesthesia. 1984 Nov;39(11):1134-5. doi: 10.1111/j.1365-2044.1984.tb08940.x.","Fry EN","Anaesthesia","1984","1984/11/01","","","10.1111/j.1365-2044.1984.tb08940.x"
"6502551","First and second line treatment in the Falklands Campaign. A retrospective view","Jackson DS, Jowitt MD, Knight RJ.","J R Army Med Corps. 1984 Jun;130(2):79-83. doi: 10.1136/jramc-130-02-03.","Jackson DS","J R Army Med Corps","1984","1984/06/01","","","10.1136/jramc-130-02-03"
"6491561","The effect of buprenorphine and morphine on intraluminal pressure of the common bile duct","Pausawasdi S, Kanjanapitak A, Kanjanapanjapol S.","J Med Assoc Thai. 1984 Jun;67(6):329-33.","Pausawasdi S","J Med Assoc Thai","1984","1984/06/01","","",""
"6481272","A comparison of buprenorphine and morphine for immediate postoperative pain relief in Thai patients","Pausawasdi S, Tontisirin O, Bunyaratavej S.","J Med Assoc Thai. 1984 May;67(5):284-9.","Pausawasdi S","J Med Assoc Thai","1984","1984/05/01","","",""
"6476361","Epidural buprenorphine","Murchison DJ, Davis FM, Gibbs JM, Maycock EJ.","Anaesth Intensive Care. 1984 May;12(2):179.","Murchison DJ","Anaesth Intensive Care","1984","1984/05/01","","",""
"6476299","[Sublingual buprenorphine in the therapy of postoperative pain]","Tolksdorf W, Bangert J, Glocke M, Müller W.","Anasth Intensivther Notfallmed. 1984 Jun;19(3):117-23.","Tolksdorf W","Anasth Intensivther Notfallmed","1984","1984/06/01","","",""
"6474320","Comparison of analgesic activity of buprenorphine hydrochloride and morphine in patients with moderate to severe pain postoperatively","Ouellette RD.","Surg Gynecol Obstet. 1984 Sep;159(3):201-6.","Ouellette RD","Surg Gynecol Obstet","1984","1984/09/01","","",""
"6472645","[Our experience with a long-acting analgesic: buprenorphine]","Lo Mele FP, De Meo M, Caroprese VL, Di Biase R, Memoli G.","Minerva Anestesiol. 1984 Apr;50(4):133-6.","Lo Mele FP","Minerva Anestesiol","1984","1984/04/01","","",""
"6434956","Buprenorphine, heroin, and methadone: comparison of relative reinforcing properties","Mello NK, Bree MP, Mendelson JH.","NIDA Res Monogr. 1984 Mar;49:172-8.","Mello NK","NIDA Res Monogr","1984","1984/03/01","","",""
"6430310","Comparison of morphine and sublingual buprenorphine following abdominal surgery","Cuschieri RJ, Morran CG, McArdle CS.","Br J Anaesth. 1984 Aug;56(8):855-9. doi: 10.1093/bja/56.8.855.","Cuschieri RJ","Br J Anaesth","1984","1984/08/01","","","10.1093/bja/56.8.855"
"6428606","Analgesia in acute pancreatitis","Brown NM, Strachan JW.","Br Med J (Clin Res Ed). 1984 Jun 23;288(6434):1917. doi: 10.1136/bmj.288.6434.1917-c.","Brown NM","Br Med J (Clin Res Ed)","1984","1984/06/23","PMC1441814","","10.1136/bmj.288.6434.1917-c"
"6426616","Analgesia in acute pancreatitis: comparison of buprenorphine and pethidine","Blamey SL, Finlay IG, Carter DC, Imrie CW.","Br Med J (Clin Res Ed). 1984 May 19;288(6429):1494-5. doi: 10.1136/bmj.288.6429.1494-a.","Blamey SL","Br Med J (Clin Res Ed)","1984","1984/05/19","PMC1441137","","10.1136/bmj.288.6429.1494-a"
"6422790","[Buprenorphine and pentazocine for postoperative analgesia. A double blind study following abdominal surgery]","Piepenbrock S, Zenz M, Gorus R, Link J, Reinhart K.","Anaesthesist. 1983 Dec;32(12):601-9.","Piepenbrock S","Anaesthesist","1983","1983/12/01","","",""
"6420684","[Drug dependence of buprenorphine]","Richert S, Strauss A, von Arnim T, Vogel P, Zech A.","MMW Munch Med Wochenschr. 1983 Dec 23;125(51):1195-8.","Richert S","MMW Munch Med Wochenschr","1983","1983/12/23","","",""
"6415992","Changes in pituitary secretion induced by an agonist-antagonist opioid drug, buprenorphine","Rolandi E, Marabini A, Franceschini R, Messina V, Bongera P, Barreca T.","Acta Endocrinol (Copenh). 1983 Nov;104(3):257-60. doi: 10.1530/acta.0.1040257.","Rolandi E","Acta Endocrinol (Copenh)","1983","1983/11/01","","","10.1530/acta.0.1040257"
"6415458","[Abuse potential of buprenorphine]","Keup W, Wörz R, Eckstein G, Franz H.","MMW Munch Med Wochenschr. 1983 Sep 30;125(39):835-7.","Keup W","MMW Munch Med Wochenschr","1983","1983/09/30","","",""
"6415457","[Again an analgesic uncovered as an addictive drug: the endless screw]","Forth W.","MMW Munch Med Wochenschr. 1983 Sep 30;125(39):834.","Forth W","MMW Munch Med Wochenschr","1983","1983/09/30","","",""
"6410281","Opioid antagonists: do they have a role in treatment programs?","O'Brien CP, Greenstein RA, Evans B, Woody GE, Arndt R.","NIDA Res Monogr. 1983 Apr;43:71-8.","O'Brien CP","NIDA Res Monogr","1983","1983/04/01","","",""
"6410250","Buprenorphine self-administration by the baboon: comparison with other opioids","Lukas SE, Griffiths RR, Brady JV.","NIDA Res Monogr. 1983 Apr;43:178-83.","Lukas SE","NIDA Res Monogr","1983","1983/04/01","","",""
"6408664","Stimulation of avoidance behavior by buprenorphine in rats","Shannon HE.","Psychopharmacology (Berl). 1983;80(1):19-23. doi: 10.1007/BF00427487.","Shannon HE","Psychopharmacology (Berl)","1983","1983/01/01","","","10.1007/BF00427487"
"6403440","[Sublingual buprenorphine tablets: initial clinical experiences in long-term therapy of cancer pain]","Zenz M, Piepenbrock S, Tryba M, Klauke W, Everlien M.","Fortschr Med. 1983 Feb 3;101(5):191-4.","Zenz M","Fortschr Med","1983","1983/02/03","","",""
"6402239","Acute urinary retention associated with sublingual buprenorphine","Murray K.","Br Med J (Clin Res Ed). 1983 Mar 5;286(6367):763-4. doi: 10.1136/bmj.286.6367.763-a.","Murray K","Br Med J (Clin Res Ed)","1983","1983/03/05","PMC1547042","","10.1136/bmj.286.6367.763-a"
"6402201","Intramuscular on demand analgesia: double blind controlled trial of pethidine, buprenorphine, morphine, and meptazinol","Harmer M, Slattery PJ, Rosen M, Vickers MD.","Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):680-2. doi: 10.1136/bmj.286.6366.680.","Harmer M","Br Med J (Clin Res Ed)","1983","1983/02/26","PMC1547096","","10.1136/bmj.286.6366.680"
"6393818","A comparison of morphine and buprenorphine for analgesia after abdominal surgery","Bradley JP.","Anaesth Intensive Care. 1984 Nov;12(4):303-10. doi: 10.1177/0310057X8401200403.","Bradley JP","Anaesth Intensive Care","1984","1984/11/01","","","10.1177/0310057X8401200403"
"6392598","[Epidural or intravenous buprenorphine for postoperative pain relief]","Matsunaga M, Dan K, Higa K, Yoshida K, Fukushima K.","Masui. 1984 Sep;33(9):995-1002.","Matsunaga M","Masui","1984","1984/09/01","","",""
"6385337","[Early postoperative treatment of pain with buprenorphine]","Gundersen Y, Andersen R, Alver T.","Tidsskr Nor Laegeforen. 1984 Sep 10;104(25):1717-20.","Gundersen Y","Tidsskr Nor Laegeforen","1984","1984/09/10","","",""
"6381783","[A study on the effects of preanesthetic medication. Comparison of buprenorphine, pentazocine and placebo with hydroxyzine and atropine]","Hazano S, Fukui S, Kamei M, Sakai T, Mima T.","Masui. 1984 Apr;33(4):390-6.","Hazano S","Masui","1984","1984/04/01","","",""
"6381692","Effects of opioids on accuracy of a fixed-ratio discrimination in monkeys and rats","Moerschbaecher JM, Mastropaolo J, Winsauer PJ, Thompson DM.","J Pharmacol Exp Ther. 1984 Sep;230(3):541-9.","Moerschbaecher JM","J Pharmacol Exp Ther","1984","1984/09/01","","",""
"6375465","Epidural buprenorphine--a double-blind study of postoperative analgesia and side effects","Lanz E, Simko G, Theiss D, Glocke MH.","Anesth Analg. 1984 Jun;63(6):593-8.","Lanz E","Anesth Analg","1984","1984/06/01","","",""
"6371287","[The comparative study of buprenorphine and pentazocine for preanesthetic medication]","Maki H, Sekiguchi H, Nagano M.","Masui. 1984 Jan;33(1):82-7.","Maki H","Masui","1984","1984/01/01","","",""
"6370028","[Stress reduction by i.m. premedication with 6 different single substances]","Tolksdorf W, Berlin J, Petrakis N, Rey ER, Schmidt R.","Anasth Intensivther Notfallmed. 1984 Feb;19(1):1-7.","Tolksdorf W","Anasth Intensivther Notfallmed","1984","1984/02/01","","",""
"6364520","[Treatment of postoperative pain with epidural buprenorphine and morphine after high laparotomies]","Husegaard HC, Petersen TK, Rybro L, Schurizek BA, Wernberg M.","Ugeskr Laeger. 1984 Jan 2;146(1):14-7.","Husegaard HC","Ugeskr Laeger","1984","1984/01/02","","",""
"6358046","[Premedication with buprenorphine hydrochloride. A clinical study]","Fritz KW, Zinck B, Lauchart W, Kirchner E.","Intensivmed Prax. 1983 Oct;6:47-51.","Fritz KW","Intensivmed Prax","1983","1983/10/01","","",""
"6356971","A comparison of intramuscular and sublingual buprenorphine, intramuscular morphine and placebo as premedication","O'Sullivan G, Bullingham RE, McQuay HJ, Poppleton P, Rolfe M, Weir L, Moore RA.","Anaesthesia. 1983 Oct;38(10):977-84. doi: 10.1111/j.1365-2044.1983.tb12029.x.","O'Sullivan G","Anaesthesia","1983","1983/10/01","","","10.1111/j.1365-2044.1983.tb12029.x"
"6352139","Clinical pharmacokinetics of narcotic agonist-antagonist drugs","Bullingham RE, McQuay HJ, Moore RA.","Clin Pharmacokinet. 1983 Jul-Aug;8(4):332-43. doi: 10.2165/00003088-198308040-00004.","Bullingham RE","Clin Pharmacokinet","1983","1983/07/01","","","10.2165/00003088-198308040-00004"
"6349411","Epidural buprenorphine for pain relief after major abdominal surgery. A controlled comparison with epidural morphine","Cahill J, Murphy D, O'Brien D, Mulhall J, Fitzpatrick G.","Anaesthesia. 1983 Aug;38(8):760-4. doi: 10.1111/j.1365-2044.1983.tb12199.x.","Cahill J","Anaesthesia","1983","1983/08/01","","","10.1111/j.1365-2044.1983.tb12199.x"
"6342461","[Buprenorphine (Temgesic) as a peroperative analgesic. A multicenter study]","Abrahamsson J, Niemand D, Olsson AK, Törnebrandt K.","Anaesthesist. 1983 Feb;32(2):75-9.","Abrahamsson J","Anaesthesist","1983","1983/02/01","","",""
"6336941","Comparison between buprenorphine and pentazocine given i.v. on demand in the control of postoperative pain","Harmer M, Slattery PJ, Rosen M, Vickers MD.","Br J Anaesth. 1983 Jan;55(1):21-5. doi: 10.1093/bja/55.1.21.","Harmer M","Br J Anaesth","1983","1983/01/01","","","10.1093/bja/55.1.21"
"6328350","Binding of buprenorphine to opiate receptors. Regulation by guanyl nucleotides and metal ions","Villiger JW.","Neuropharmacology. 1984 Mar;23(3):373-5. doi: 10.1016/0028-3908(84)90201-6.","Villiger JW","Neuropharmacology","1984","1984/03/01","","","10.1016/0028-3908(84)90201-6"
"6319861","Chromatography and partial purification of solubilized opiate receptors","Pfeiffer A.","Life Sci. 1983;33 Suppl 1:203-6. doi: 10.1016/0024-3205(83)90478-2.","Pfeiffer A","Life Sci","1983","1983/01/01","","","10.1016/0024-3205(83)90478-2"
"6308456","Progress report of the NIDA Addiction Research Center, Baltimore, Maryland, 1982","Jasinski DR, Henningfield JE, Hickey JE, Johnson RE.","NIDA Res Monogr. 1983 Apr;43:92-8.","Jasinski DR","NIDA Res Monogr","1983","1983/04/01","","",""
"6308210","Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment","Wood PL, Sanschagrin D, Richard JW, Thakur M.","J Pharmacol Exp Ther. 1983 Aug;226(2):545-50.","Wood PL","J Pharmacol Exp Ther","1983","1983/08/01","","",""
"6298835","Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey","Locke KW, Brown DR, Holtzman SG.","Pharmacol Biochem Behav. 1982 Dec;17(6):1275-9. doi: 10.1016/0091-3057(82)90133-2.","Locke KW","Pharmacol Biochem Behav","1982","1982/12/01","","","10.1016/0091-3057(82)90133-2"
"6298527","Estimation in vivo of the receptor constants of morphine in naive and morphine-tolerant rats","Porreca F, Cowan A, Raffa RB, Tallarida RJ.","Life Sci. 1982 Nov 15-22;31(20-21):2355-8. doi: 10.1016/0024-3205(82)90155-2.","Porreca F","Life Sci","1982","1982/11/15","","","10.1016/0024-3205(82)90155-2"
"6294424","A comparison of the receptor constants of morphine and ethylketocyclazocine for analgesia and inhibition of gastrointestinal transit in the rat","Porreca F, Raffa RB, Cowan A, Tallarida RJ.","Life Sci. 1982 Nov 1;31(18):1955-61. doi: 10.1016/0024-3205(82)90034-0.","Porreca F","Life Sci","1982","1982/11/01","","","10.1016/0024-3205(82)90034-0"
"6288917","Buprenorphine: differential interaction with opiate receptor subtypes in vivo","Sadée W, Rosenbaum JS, Herz A.","J Pharmacol Exp Ther. 1982 Oct;223(1):157-62.","Sadée W","J Pharmacol Exp Ther","1982","1982/10/01","","",""
"6283067","The affinity of morphine for its pharmacologic receptor in vivo","Tallarida RJ, Cowan A.","J Pharmacol Exp Ther. 1982 Jul;222(1):198-201.","Tallarida RJ","J Pharmacol Exp Ther","1982","1982/07/01","","",""
"6282596","Morphine-receptor dissociation constant and the stimulus-effect relation for inhibition of gastrointestinal transit in the rat","Raffa RB, Porreca F, Cowan A, Tallarida RJ.","Eur J Pharmacol. 1982 Apr 8;79(1-2):11-6. doi: 10.1016/0014-2999(82)90569-6.","Raffa RB","Eur J Pharmacol","1982","1982/04/08","","","10.1016/0014-2999(82)90569-6"
"6281389","Buprenorphine: high-affinity binding to dorsal spinal cord","Villiger JW, Taylor KM.","J Neurochem. 1982 Jun;38(6):1771-3. doi: 10.1111/j.1471-4159.1982.tb06662.x.","Villiger JW","J Neurochem","1982","1982/06/01","","","10.1111/j.1471-4159.1982.tb06662.x"
"6276633","Buprenorphine : characteristics of binding sites in the rat central nervous system","Villiger JW, Taylor KM.","Life Sci. 1981 Dec 28;29(26):2699-708. doi: 10.1016/0024-3205(81)90529-4.","Villiger JW","Life Sci","1981","1981/12/28","","","10.1016/0024-3205(81)90529-4"
"6271322","In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions","Dum JE, Herz A.","Br J Pharmacol. 1981 Nov;74(3):627-33. doi: 10.1111/j.1476-5381.1981.tb10473.x.","Dum JE","Br J Pharmacol","1981","1981/11/01","PMC2071750","","10.1111/j.1476-5381.1981.tb10473.x"
"6270490","A radioreceptor assay for opiate drugs in human cerebrospinal fluid and plasma","Villiger JW, Boas RA, Taylor KM.","Life Sci. 1981 Jul 20;29(3):229-33. doi: 10.1016/0024-3205(81)90238-1.","Villiger JW","Life Sci","1981","1981/07/20","","","10.1016/0024-3205(81)90238-1"
"6262856","Structure activity and receptor binding of antagonist analgesics [[proceedings]","Lewis JW, Rance MJ.","Psychopharmacol Bull. 1981 Jan;17(1):83-5.","Lewis JW","Psychopharmacol Bull","1981","1981/01/01","","",""
"6262686","Actions of kappa, sigma and partial mu narcotic receptor agonists on rat brain acetylcholine turnover","Wood PL, Rackham A.","Neurosci Lett. 1981 Apr 9;23(1):75-80. doi: 10.1016/0304-3940(81)90190-7.","Wood PL","Neurosci Lett","1981","1981/04/09","","","10.1016/0304-3940(81)90190-7"
"6262095","Buprenorphrine: demonstration of physical dependence liability","Dum J, Bläsig J, Herz A.","Eur J Pharmacol. 1981 Mar 26;70(3):293-300. doi: 10.1016/0014-2999(81)90163-1.","Dum J","Eur J Pharmacol","1981","1981/03/26","","","10.1016/0014-2999(81)90163-1"
"6236024","[Notes on buprenorphine]","Cugurra F.","Clin Ter. 1984 May 31;109(4):311-3.","Cugurra F","Clin Ter","1984","1984/05/31","","",""
"6232405","[New anesthetics and development of methods of anesthesia (Part 1)]","Miyazaki M, Yoda K, Okuda C, Tsukawaki Y, Ogli K, Yokono A.","Masui. 1984 Jan;33(1):66-75.","Miyazaki M","Masui","1984","1984/01/01","","",""
"6220729","Comparison of buprenorphine-hyoscine and papaveretum-hyoscine as premedicants for gynaecological surgery","Sear JW, Alexander JI.","Br J Anaesth. 1983 Apr;55(4):319-24. doi: 10.1093/bja/55.4.319.","Sear JW","Br J Anaesth","1983","1983/04/01","","","10.1093/bja/55.4.319"
"6207431","Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine","France CP, Jacobson AE, Woods JH.","NIDA Res Monogr. 1984 Mar;49:136-42.","France CP","NIDA Res Monogr","1984","1984/03/01","","",""
"6206224","Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine","France CP, Jacobson AE, Woods JH.","J Pharmacol Exp Ther. 1984 Sep;230(3):652-7.","France CP","J Pharmacol Exp Ther","1984","1984/09/01","","",""
"6197797","[Sublingual buprenorphine in the treatment of pain caused by cancer. Transition to buprenorphine from other opiates]","Enig B.","Ugeskr Laeger. 1983 Oct 17;145(42):3236-40.","Enig B","Ugeskr Laeger","1983","1983/10/17","","",""
"6192515","[Ambulatory treatment of an acute attack in urinary calculi. A randomized study of the effects of Petidin, Fortralin, Temgesic and Confortid]","Daljord OA, Barstad S, Norenberg P.","Tidsskr Nor Laegeforen. 1983 Apr 30;103(12):1006-8.","Daljord OA","Tidsskr Nor Laegeforen","1983","1983/04/30","","",""
"6188822","Comparison of buprenorphine and methadone effects on opiate self-administration in primates","Mello NK, Bree MP, Mendelson JH.","J Pharmacol Exp Ther. 1983 May;225(2):378-86.","Mello NK","J Pharmacol Exp Ther","1983","1983/05/01","","",""
"6182077","[Temgesic--analgesic with a central action]","","Fortschr Med. 1982 Aug 12;100(30):1414-5.","","Fortschr Med","1982","1982/08/12","","",""
"6181598","[Intramuscular buprenorphine and morphine in the treatment of cancer pain. A controlled study]","Kjaer M, Henriksen H, Knudsen EJ.","Ugeskr Laeger. 1982 May 3;144(18):1306-9.","Kjaer M","Ugeskr Laeger","1982","1982/05/03","","",""
"6181414","Comparison of the effects of buprenorphine and methadone on opiate self-administration in primates","Mello NK, Bree MP, Mendelson JH.","NIDA Res Monogr. 1982 Apr;41:67-73.","Mello NK","NIDA Res Monogr","1982","1982/04/01","","",""
"6174908","Pain relief","Gibbs JM.","N Z Med J. 1982 Jan 27;95(700):56.","Gibbs JM","N Z Med J","1982","1982/01/27","","",""
"6152317","Physical dependence induced by opiate partial agonists in the rat","McCarthy PS, Howlett GJ.","Neuropeptides. 1984 Dec;5(1-3):11-4. doi: 10.1016/0143-4179(84)90014-3.","McCarthy PS","Neuropeptides","1984","1984/12/01","","","10.1016/0143-4179(84)90014-3"
"6152192","[Local and morphinic anesthetics administered by the peridural route]","Motsch J.","Cah Anesthesiol. 1984 Jan-Feb;32(1):43-5.","Motsch J","Cah Anesthesiol","1984","1984/01/01","","",""
"6151332","Studies on the peripheral action of opioids in postoperative pain in man","Bullingham RE, McQuay HJ, Moore RA.","Acta Anaesthesiol Belg. 1984;35 Suppl:285-90.","Bullingham RE","Acta Anaesthesiol Belg","1984","1984/01/01","","",""
"6149907","The metabolism and excretion of buprenorphine in humans","Cone EJ, Gorodetzky CW, Yousefnejad D, Buchwald WF, Johnson RE.","Drug Metab Dispos. 1984 Sep-Oct;12(5):577-81.","Cone EJ","Drug Metab Dispos","1984","1984/09/01","","",""
"6148697","Progress report from the NIDA Addiction Research Center, Baltimore, Maryland","Jasinski DR, Boren JJ, Henningfield JE, Johnson RE, Lange WR, Lukas SE.","NIDA Res Monogr. 1984 Mar;49:69-76.","Jasinski DR","NIDA Res Monogr","1984","1984/03/01","","",""
"6146703","In vivo evidence for benzomorphan-selective receptors in rats","Gmerek DE, Cowan A.","J Pharmacol Exp Ther. 1984 Jul;230(1):110-5.","Gmerek DE","J Pharmacol Exp Ther","1984","1984/07/01","","",""
"6145770","The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine","Bianchi G, Fiocchi R, Peracchia F, Petrillo P, Tavani A, Manara L.","J Pharm Pharmacol. 1984 May;36(5):326-30. doi: 10.1111/j.2042-7158.1984.tb04384.x.","Bianchi G","J Pharm Pharmacol","1984","1984/05/01","","","10.1111/j.2042-7158.1984.tb04384.x"
"6142942","Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids","Young AM, Stephens KR, Hein DW, Woods JH.","J Pharmacol Exp Ther. 1984 Apr;229(1):118-26.","Young AM","J Pharmacol Exp Ther","1984","1984/04/01","","",""
"6141626","Control of cancer pain with analgesics acting in the central nervous system","Wörz R.","Recent Results Cancer Res. 1984;89:100-6. doi: 10.1007/978-3-642-82028-1_11.","Wörz R","Recent Results Cancer Res","1984","1984/01/01","","","10.1007/978-3-642-82028-1_11"
"6141486","In vivo characterization of four types of opioid binding sites in rat brain","Sadée W, Richards ML, Grevel J, Rosenbaum JS.","Life Sci. 1983;33 Suppl 1:187-9. doi: 10.1016/0024-3205(83)90474-5.","Sadée W","Life Sci","1983","1983/01/01","","","10.1016/0024-3205(83)90474-5"
"6139041","Buprenorphine, benzodiazepines and respiratory depression","Faroqui MH, Cole M, Curran J.","Anaesthesia. 1983 Oct;38(10):1002-3. doi: 10.1111/j.1365-2044.1983.tb12045.x.","Faroqui MH","Anaesthesia","1983","1983/10/01","","","10.1111/j.1365-2044.1983.tb12045.x"
"6136392","Opiate receptor pharmacology: mixed agonist/antagonist narcotics","Hameroff SR.","Contemp Anesth Pract. 1983;7:27-43.","Hameroff SR","Contemp Anesth Pract","1983","1983/01/01","","",""
"6135366","Buprenorphine and lorazepam","Forrest AL.","Anaesthesia. 1983 Jun;38(6):598. doi: 10.1111/j.1365-2044.1983.tb14083.x.","Forrest AL","Anaesthesia","1983","1983/06/01","","","10.1111/j.1365-2044.1983.tb14083.x"
"6126811","The effects of centrally acting peptides on the chronic actions of buprenorphine in the rat","Bhargava HN.","NIDA Res Monogr. 1982 Apr;41:134-40.","Bhargava HN","NIDA Res Monogr","1982","1982/04/01","","",""
"6126640","Antidepressant effects of buprenorphine","Emrich HM, Vogt P, Herz A, Kissling W.","Lancet. 1982 Sep 25;2(8300):709. doi: 10.1016/s0140-6736(82)90727-9.","Emrich HM","Lancet","1982","1982/09/25","","","10.1016/s0140-6736(82)90727-9"
"6123475","[Pharmacological properties of buprenorphine, a new analgesic agent. Part II. (author's transl)]","Shintani S, Umezato M, Toba Y, Yamaji Y, Kitaura K, Tani T, Ishiyama H, Kikuchi T, Mori T, Nakai S, Watanabe K, Hiyama T.","Nihon Yakurigaku Zasshi. 1982 Mar;79(3):173-91. doi: 10.1254/fpj.79.173.","Shintani S","Nihon Yakurigaku Zasshi","1982","1982/03/01","","","10.1254/fpj.79.173"
"6123474","[Interactions between buprenorphine, narcotic analgesic, and centrally acting drugs in prolongation of halothane-induced sleeping and analgesia (author's transl)]","Yasuda Y, Shioya Y, Nakai S, Shintani S, Hiyama T.","Nihon Yakurigaku Zasshi. 1982 Mar;79(3):163-72.","Yasuda Y","Nihon Yakurigaku Zasshi","1982","1982/03/01","","",""
"6115924","The systemic bioavailability of buprenorphine by various routes of administration","Brewster D, Humphrey MJ, Mcleavy MA.","J Pharm Pharmacol. 1981 Aug;33(8):500-6. doi: 10.1111/j.2042-7158.1981.tb13848.x.","Brewster D","J Pharm Pharmacol","1981","1981/08/01","","","10.1111/j.2042-7158.1981.tb13848.x"
"6107711","Buprenorphine and stress","Moore RA, McQuay HJ, Bullingham RE.","Lancet. 1980 Nov 15;2(8203):1084. doi: 10.1016/s0140-6736(80)92308-9.","Moore RA","Lancet","1980","1980/11/15","","","10.1016/s0140-6736(80)92308-9"
"6107472","Buprenorphine","Fry EN.","Lancet. 1980 Oct 11;2(8198):798. doi: 10.1016/s0140-6736(80)90407-9.","Fry EN","Lancet","1980","1980/10/11","","","10.1016/s0140-6736(80)90407-9"
"6106780","Reversal of postoperative hyperglycaemia by buprenorphine","Moore RA, McQuay HJ, Bullingham RE.","Lancet. 1980 Sep 13;2(8194):597-8. doi: 10.1016/s0140-6736(80)92038-3.","Moore RA","Lancet","1980","1980/09/13","","","10.1016/s0140-6736(80)92038-3"
"6099494","The suppression of deprivation and antagonist-induced withdrawal in morphine-dependent rhesus monkeys","Gmerek DE.","Neuropeptides. 1984 Dec;5(1-3):19-22. doi: 10.1016/0143-4179(84)90016-7.","Gmerek DE","Neuropeptides","1984","1984/12/01","","","10.1016/0143-4179(84)90016-7"
"6099486","Characterization of prototypical opioid antagonists, agonist-antagonists, and agonists in the morphine-dependent rhesus monkey","Aceto MD.","Neuropeptides. 1984 Dec;5(1-3):15-8. doi: 10.1016/0143-4179(84)90015-5.","Aceto MD","Neuropeptides","1984","1984/12/01","","","10.1016/0143-4179(84)90015-5"
"6096836","[New drugs in the group of opiate-antagonistic analgesics]","Rewerski W, Janicki PK.","Pol Tyg Lek. 1984 Oct 22;39(43):1405-8.","Rewerski W","Pol Tyg Lek","1984","1984/10/22","","",""
"4095879","Use of buprenorphine hydrochloride","Piercy AD.","Vet Rec. 1985 Sep 7;117(10):256. doi: 10.1136/vr.117.10.256.","Piercy AD","Vet Rec","1985","1985/09/07","","","10.1136/vr.117.10.256"
"4092611","Buprenorphine as new treatment for heroin dependence","Reisinger M.","Drug Alcohol Depend. 1985 Dec;16(3):257-62. doi: 10.1016/0376-8716(85)90050-x.","Reisinger M","Drug Alcohol Depend","1985","1985/12/01","","","10.1016/0376-8716(85)90050-x"
"4090237","Use of buprenorphine hydrochloride","Stock JE.","Vet Rec. 1985 Aug 24;117(8):190-1. doi: 10.1136/vr.117.8.190.","Stock JE","Vet Rec","1985","1985/08/24","","","10.1136/vr.117.8.190"
"4087342","[Cerebral circulation and metabolism during high-dose buprenorphine and fentanyl anesthesia]","Tada T, Ishidera T, Sakai M, Ichiyanagi K.","Masui. 1985 Nov;34(11):1450-5.","Tada T","Masui","1985","1985/11/01","","",""
"4080772","Buprenorphine effects on food-maintained responding in Macaque monkeys","Mello NK, Bree MP, Lukas SE, Mendelson JH.","Pharmacol Biochem Behav. 1985 Dec;23(6):1037-44. doi: 10.1016/0091-3057(85)90111-x.","Mello NK","Pharmacol Biochem Behav","1985","1985/12/01","","","10.1016/0091-3057(85)90111-x"
"4079880","[Pain in children with neoplastic disease]","Massimo L, Haupt R, Zamorani ME.","Minerva Pediatr. 1985 Sep 15;37(17):621-4.","Massimo L","Minerva Pediatr","1985","1985/09/15","","",""
"4079443","Assessment of an in situ rat intestine preparation with perfused vascular bed for studying the absorption and first-pass metabolism of drugs","Castle SJ, Tucker GT, Woods HF, Underwood JC, Nicholson CM, Havler ME, Lewis CJ, Flockhart IR, Lloyd-Jones G.","J Pharmacol Methods. 1985 Dec;14(4):255-74. doi: 10.1016/0160-5402(85)90002-6.","Castle SJ","J Pharmacol Methods","1985","1985/12/01","","","10.1016/0160-5402(85)90002-6"
"4077942","Analysis of buprenorphine by high-performance liquid chromatography","Tebbett IR.","J Chromatogr. 1985 Nov 22;347(3):411-3. doi: 10.1016/s0021-9673(01)95515-3.","Tebbett IR","J Chromatogr","1985","1985/11/22","","","10.1016/s0021-9673(01)95515-3"
"4066392","Quantitative determination of buprenorphine in human plasma by high-performance liquid chromatography","Noda J, Kojima T.","Hiroshima J Med Sci. 1985 Sep;34(3):261-5.","Noda J","Hiroshima J Med Sci","1985","1985/09/01","","",""
"4061002","Buprenorphine delays drug absorption and gastric emptying in man","Adelhøj B, Petring OU, Ibsen M, Brynnum J, Poulsen HE.","Acta Anaesthesiol Scand. 1985 Aug;29(6):599-601. doi: 10.1111/j.1399-6576.1985.tb02262.x.","Adelhøj B","Acta Anaesthesiol Scand","1985","1985/08/01","","","10.1111/j.1399-6576.1985.tb02262.x"
"4057080","Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon","France CP, Woods JH.","J Pharmacol Exp Ther. 1985 Nov;235(2):442-7.","France CP","J Pharmacol Exp Ther","1985","1985/11/01","","",""
"4051160","Buprenorphine in end stage renal failure","Summerfield RJ, Allen MC, Moore RA, Sear JW, McQuay HJ.","Anaesthesia. 1985 Sep;40(9):914. doi: 10.1111/j.1365-2044.1985.tb11063.x.","Summerfield RJ","Anaesthesia","1985","1985/09/01","","","10.1111/j.1365-2044.1985.tb11063.x"
"4045722","Effects of buprenorphine on shock titration in squirrel monkeys","Dykstra LA.","J Pharmacol Exp Ther. 1985 Oct;235(1):20-5.","Dykstra LA","J Pharmacol Exp Ther","1985","1985/10/01","","",""
"4041319","Naloxone--a strong analgesic in combination with high-dose buprenorphine","Pedersen JE, Chraemmer-Jørgensen B, Schnidt JF, Risbo A.","Br J Anaesth. 1985 Oct;57(10):1045-6. doi: 10.1093/bja/57.10.1045-a.","Pedersen JE","Br J Anaesth","1985","1985/10/01","","","10.1093/bja/57.10.1045-a"
"4039649","Substitution and primary dependence studies in animals","Woods JH, Gmerek DE.","Drug Alcohol Depend. 1985 Feb;14(3-4):233-47. doi: 10.1016/0376-8716(85)90059-6.","Woods JH","Drug Alcohol Depend","1985","1985/02/01","","","10.1016/0376-8716(85)90059-6"
"4025755","Postoperative pain relief with naloxone. Severe respiratory depression and pain after high dose buprenorphine","Schmidt JF, Chraemmer-Jørgensen B, Pedersen JE, Risbo A.","Anaesthesia. 1985 Jun;40(6):583-6. doi: 10.1111/j.1365-2044.1985.tb10903.x.","Schmidt JF","Anaesthesia","1985","1985/06/01","","","10.1111/j.1365-2044.1985.tb10903.x"
"4024663","Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant","Pontani RB, Vadlamani NL, Misra AL.","Xenobiotica. 1985 Apr;15(4):287-97. doi: 10.3109/00498258509045363.","Pontani RB","Xenobiotica","1985","1985/04/01","","","10.3109/00498258509045363"
"4022409","[Buprenorphine in general anesthesia. I. Preliminary study]","Romano E, Mocavero G, Erice F, Romani T.","Minerva Anestesiol. 1985 Jan-Feb;51(1-2):9-14.","Romano E","Minerva Anestesiol","1985","1985/01/01","","",""
"4021074","[The cardiovascular effect of buprenorphine in dogs and open heart surgery patients]","Arima T, Yoshida N, Nakamura S, Ikei Y, Oohata M, Hori T.","Masui. 1985 Mar;34(3):312-8.","Arima T","Masui","1985","1985/03/01","","",""
"4020627","Pharmacokinetics of morphine and its surrogates VI: Bioanalysis, solvolysis kinetics, solubility, pK'a values, and protein binding of buprenorphine","Garrett ER, Chandran VR.","J Pharm Sci. 1985 May;74(5):515-24. doi: 10.1002/jps.2600740505.","Garrett ER","J Pharm Sci","1985","1985/05/01","","","10.1002/jps.2600740505"
"4019659","Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring","Blom Y, Bondesson U, Anggård E.","J Chromatogr. 1985 Feb 27;338(1):89-98. doi: 10.1016/0378-4347(85)80073-6.","Blom Y","J Chromatogr","1985","1985/02/27","","","10.1016/0378-4347(85)80073-6"
"4013631","A long-term open, clinical and pharmacokinetic assessment of sublingual buprenorphine in patients suffering from chronic pain","Adriaensen H, Mattelaer B, Vanmeenen H.","Acta Anaesthesiol Belg. 1985 Mar;36(1):33-40.","Adriaensen H","Acta Anaesthesiol Belg","1985","1985/03/01","","",""
"4011002","[Role of the pain specialist in the treatment of pancreatic pain]","Mocavero G.","Minerva Chir. 1985 Apr 15;40(7):513-6.","Mocavero G","Minerva Chir","1985","1985/04/15","","",""
"4006747","Stronger analgesics with low risk of dependence--buprenorphine, meptazinol and nalbuphine","","Drug Ther Bull. 1985 Jun 17;23(12):45-6.","","Drug Ther Bull","1985","1985/06/17","","",""
"3990166","Epidural opiates: long-term experiences in cancer pain","Zenz M, Piepenbrock S, Tryba M.","Klin Wochenschr. 1985 Mar 1;63(5):225-9. doi: 10.1007/BF01731174.","Zenz M","Klin Wochenschr","1985","1985/03/01","","","10.1007/BF01731174"
"3985394","Epidural buprenorphine for postoperative pain relief","Murphy DF, Cahill J, Fitzpatrick G, MacEvilly M.","Anesth Analg. 1985 Apr;64(4):456-7.","Murphy DF","Anesth Analg","1985","1985/04/01","","",""
"3978009","Buprenorphine-supplemented anaesthesia. Influence of dose on duration of analgesia after cholecystectomy","Obel D, Hansen LK, Hüttel MS, Andersen PK.","Br J Anaesth. 1985 Mar;57(3):271-4. doi: 10.1093/bja/57.3.271.","Obel D","Br J Anaesth","1985","1985/03/01","","","10.1093/bja/57.3.271"
"3976330","Sublingual buprenorphine for premedication and postoperative pain relief in orthopaedic surgery","Risbo A, Chraemmer Jørgensen B, Kolby P, Pedersen J, Schmidt JF.","Acta Anaesthesiol Scand. 1985 Feb;29(2):180-2. doi: 10.1111/j.1399-6576.1985.tb02181.x.","Risbo A","Acta Anaesthesiol Scand","1985","1985/02/01","","","10.1111/j.1399-6576.1985.tb02181.x"
"3964516","""Patient demand"" postoperative analgesia with buprenorphine. Comparison between sublingual and i.m. administration","Shah MV, Jones DI, Rosen M.","Br J Anaesth. 1986 May;58(5):508-11. doi: 10.1093/bja/58.5.508.","Shah MV","Br J Anaesth","1986","1986/05/01","","","10.1093/bja/58.5.508"
"3959968","Buprenorphine: a new maintenance opiate?","Seow SS, Quigley AJ, Ilett KF, Dusci LJ, Swensen G, Harrison-Stewart A, Rappeport L.","Med J Aust. 1986 Apr 14;144(8):407-11.","Seow SS","Med J Aust","1986","1986/04/14","","",""
"3958098","Sensitive screening method for buprenorphine in urine","Hackett LP, Dusci LJ, Ilett KF, Seow SS, Quigley AJ.","J Chromatogr. 1986 Jan 24;374(2):400-4. doi: 10.1016/s0378-4347(00)83299-5.","Hackett LP","J Chromatogr","1986","1986/01/24","","","10.1016/s0378-4347(00)83299-5"
"3954137","Early respiratory depression resistant to naloxone following epidural buprenorphine","Knape JT.","Anesthesiology. 1986 Mar;64(3):382-4. doi: 10.1097/00000542-198603000-00018.","Knape JT","Anesthesiology","1986","1986/03/01","","","10.1097/00000542-198603000-00018"
"3946773","Longterm treatment with epidural opioids. A retrospective study comprising 150 patients treated with morphine chloride and buprenorphine","Carl P, Crawford ME, Ravlo O, Bach V.","Anaesthesia. 1986 Jan;41(1):32-8. doi: 10.1111/j.1365-2044.1986.tb12700.x.","Carl P","Anaesthesia","1986","1986/01/01","","","10.1111/j.1365-2044.1986.tb12700.x"
"3938971","[The use of buprenorphine in combination with loco-regional anesthesia during oro-dental surgical procedures]","Patrignani F, Tempesta F, Favaro R, Ales G, Patrignani L.","G Anest Stomatol. 1985 Oct-Dec;14(4):9-15.","Patrignani F","G Anest Stomatol","1985","1985/10/01","","",""
"3929312","Buprenorphine effects on cigarette smoking","Mello NK, Lukas SE, Mendelson JH.","Psychopharmacology (Berl). 1985;86(4):417-25. doi: 10.1007/BF00427902.","Mello NK","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00427902"
"3925805","[Modification of circulatory behavior by the administration of buprenorphine in the postoperative phase]","Albrecht M, van Ackern K.","Anasth Intensivther Notfallmed. 1985 Apr;20(2):65-8.","Albrecht M","Anasth Intensivther Notfallmed","1985","1985/04/01","","",""
"3908076","Newer methods of delivery of opiates for relief of pain","Slattery PJ, Boas RA.","Drugs. 1985 Dec;30(6):539-51. doi: 10.2165/00003495-198530060-00005.","Slattery PJ","Drugs","1985","1985/12/01","","","10.2165/00003495-198530060-00005"
"3907065","[Buprenorphine (Temgesic), fentanyl (Haldid) and pentazocine (Fortral) in flunitrazepam (Rohypnol)-based anesthesia]","Carl P, Crawford M.","Ugeskr Laeger. 1985 Aug 12;147(33):2596-9.","Carl P","Ugeskr Laeger","1985","1985/08/12","","",""
"3895692","[Sublingual buprenorphine (Temgesic) for the management of postoperative pain. A comparative study of intramuscular pethidine and buprenorphine]","Crawford ME, Carl P, Bøggild-Madsen NB, Ravlo O, Bach V, Larsen AI, Kruse L.","Ugeskr Laeger. 1985 Jun 3;147(23):1842-5.","Crawford ME","Ugeskr Laeger","1985","1985/06/03","","",""
"3890604","Buprenorphine versus morphine. A comparison of intra-operative and postoperative analgesia","Green DW, Sinclair JR, Mikhael MS.","Anaesthesia. 1985 Apr;40(4):371-5. doi: 10.1111/j.1365-2044.1985.tb10793.x.","Green DW","Anaesthesia","1985","1985/04/01","","","10.1111/j.1365-2044.1985.tb10793.x"
"3890312","[Tardive respiratory depression in a young healthy man after intravenous buprenorphine]","Adelhøj B, Petring OU, Ibsen M, Brynnum J, Poulsen HE.","Ugeskr Laeger. 1985 Apr 15;147(16):1343.","Adelhøj B","Ugeskr Laeger","1985","1985/04/15","","",""
"3888577","Behavioral pharmacology of buprenorphine","Mello NK, Mendelson JH.","Drug Alcohol Depend. 1985 Feb;14(3-4):283-303. doi: 10.1016/0376-8716(85)90062-6.","Mello NK","Drug Alcohol Depend","1985","1985/02/01","","","10.1016/0376-8716(85)90062-6"
"3888576","Review of self-administration","Balster RL, Lukas SE.","Drug Alcohol Depend. 1985 Feb;14(3-4):249-61. doi: 10.1016/0376-8716(85)90060-2.","Balster RL","Drug Alcohol Depend","1985","1985/02/01","","","10.1016/0376-8716(85)90060-2"
"3877884","[Somatosensory evoked potentials in pain studies]","Amantea B, Savoia G, Belfiore F, Esposito C, Cuocolo R.","Minerva Anestesiol. 1985 May;51(5):203-12.","Amantea B","Minerva Anestesiol","1985","1985/05/01","","",""
"3864560","Comparison of hemodynamic effects of morphine, butorphanol, buprenorphine and pentazocine on ICU patients","Mitaka C, Sakanishi N, Tsunoda Y, Mishima Y.","Bull Tokyo Med Dent Univ. 1985 Jun;32(2):31-9.","Mitaka C","Bull Tokyo Med Dent Univ","1985","1985/06/01","","",""
"3855518","Temgesic sublingual","Johnson LF.","N Z Med J. 1985 Jan 23;98(771):27.","Johnson LF","N Z Med J","1985","1985/01/23","","",""
"3841800","Therapeutic approach to the Pancoast pain syndrome","Esposito S, Bruni P, Delitala A, Canova A, Hernandez R, Callovini GM.","Appl Neurophysiol. 1985;48(1-6):262-6. doi: 10.1159/000101138.","Esposito S","Appl Neurophysiol","1985","1985/01/01","","","10.1159/000101138"
"3838755","63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces","Cone EJ, Gorodetzky CW, Yousefnejad D, Darwin WD.","J Chromatogr. 1985 Feb 8;337(2):291-300. doi: 10.1016/0378-4347(85)80042-6.","Cone EJ","J Chromatogr","1985","1985/02/08","","","10.1016/0378-4347(85)80042-6"
"3836380","[Epidural buprenorphine versus morphine in bone cancer pain]","Lari S, Fabbri G, Mattioli R, Elmar K.","Minerva Anestesiol. 1985 Nov-Dec;51(11-12):609-14.","Lari S","Minerva Anestesiol","1985","1985/11/01","","",""
"3834116","[Plasma ADH levels during open heart surgery--comparison with buprenorphine diazepam-N2O-O2 anesthesia and fentanyl infusion anesthesia]","Okutani R, Kono K, Kinoshita O, Nakamura H, Kaetsu H, Kiyonari N, Ishida H.","Masui. 1985 Dec;34(12):1630-7.","Okutani R","Masui","1985","1985/12/01","","",""
"3829309","Postoperative paraplegia associated with epidural narcotic administration","Tashiro C, Iwasaki M, Nakahara K, Yoshiya I.","Can J Anaesth. 1987 Mar;34(2):190-2. doi: 10.1007/BF03015345.","Tashiro C","Can J Anaesth","1987","1987/03/01","","","10.1007/BF03015345"
"3823544","[Intraspinal buprenorphine in surgical anesthesia]","Carrasco MS, Torres LM, Gomar C, Fernández C.","Rev Esp Anestesiol Reanim. 1986 Nov-Dec;33(6):457.","Carrasco MS","Rev Esp Anestesiol Reanim","1986","1986/11/01","","",""
"3806399","Effects of mixed agonist-antagonist opioids on the acquisition of conditional discriminations in monkeys","Moerschbaecher JM, Devia C, Brocklehurst C.","J Pharmacol Exp Ther. 1987 Jan;240(1):74-81.","Moerschbaecher JM","J Pharmacol Exp Ther","1987","1987/01/01","","",""
"3796851","[Modified diazoanalgesia with buprenorphine: use in specialized surgery]","Patrizi A, Montanaro F, Principi F, Manni MP, Pattumelli MC, Borgia ML, Abukharma O, el Mouahllem O, Altissimi C.","Minerva Anestesiol. 1986 Jun-Jul;52(6-7):209-16.","Patrizi A","Minerva Anestesiol","1986","1986/06/01","","",""
"3783912","[Effects of morphine, buprenorphine with and without diazepam on hemodynamic changes in dogs with acute coronary arterial occlusion]","Sone T, Kato T, Yamamoto M, Sakamoto K, Tanaka S, Iida H, Harada T, Tanahashi T.","Masui. 1986 Aug;35(8):1199-206.","Sone T","Masui","1986","1986/08/01","","",""
"3780289","An open study of sub-lingual buprenorphine in the treatment of chronic pain in the elderly","Nasar MA, McLeavy MA, Knox J.","Curr Med Res Opin. 1986;10(4):251-5. doi: 10.1185/03007998609110446.","Nasar MA","Curr Med Res Opin","1986","1986/01/01","","","10.1185/03007998609110446"
"3774170","[Buprenorphine as the analgesic of first choice in post-operative pain]","Salvi E, Bianco R, Bosoni P, Chiossi A, Gambino A, Parmeggiani G.","Minerva Anestesiol. 1986 May;52(5):161-6.","Salvi E","Minerva Anestesiol","1986","1986/05/01","","",""
"3767253","Radioimmunoassay of buprenorphine with iodine label: analysis of buprenorphine and metabolites in human plasma","Hand CW, Baldwin D, Moore RA, Allen MC, McQuay HJ.","Ann Clin Biochem. 1986 Jan;23 ( Pt 1):47-53. doi: 10.1177/000456328602300105.","Hand CW","Ann Clin Biochem","1986","1986/01/01","","","10.1177/000456328602300105"
"3766147","The analgesic effect of buprenorphine, etorphine and pethidine in the pig: a randomized double blind cross-over study","Hermansen K, Pedersen LE, Olesen HO.","Acta Pharmacol Toxicol (Copenh). 1986 Jul;59(1):27-35. doi: 10.1111/j.1600-0773.1986.tb00130.x.","Hermansen K","Acta Pharmacol Toxicol (Copenh)","1986","1986/07/01","","","10.1111/j.1600-0773.1986.tb00130.x"
"3753938","Intrathecal injection of codeine, buprenorphine, tilidine, tramadol and nefopam depresses the tail-flick response in rats","Bernatzky G, Jurna I.","Eur J Pharmacol. 1986 Jan 14;120(1):75-80. doi: 10.1016/0014-2999(86)90642-4.","Bernatzky G","Eur J Pharmacol","1986","1986/01/14","","","10.1016/0014-2999(86)90642-4"
"3748427","[Use of buprenorphine in general anesthesia. Methods of administration]","Oddi N, Atzeri MG, Olivero M, Savarese F.","Minerva Anestesiol. 1986 Mar-Apr;52(3-4):79-82.","Oddi N","Minerva Anestesiol","1986","1986/03/01","","",""
"3748422","[Postoperative analgesia in cesarean section. Double-blind comparison between buprenorphine and pentazocine]","Lodoli L, Ponzi S, Gullì G, Fazio O.","Minerva Anestesiol. 1986 Mar-Apr;52(3-4):107-12.","Lodoli L","Minerva Anestesiol","1986","1986/03/01","","",""
"3747263","Effects of desipramine and chlorimipramine on buprenorphine analgesia in mice","Ageel AM.","Jpn J Pharmacol. 1986 Jun;41(2):139-45. doi: 10.1254/jjp.41.139.","Ageel AM","Jpn J Pharmacol","1986","1986/06/01","","","10.1254/jjp.41.139"
"3747120","[The effect of buprenorphine on cerebral metabolism in mongrel dogs]","Tada T, Ishidera T, Sakai M, Ichiyanagi K.","Masui. 1986 May;35(5):724-8.","Tada T","Masui","1986","1986/05/01","","",""
"3747119","[Plasma and urine ADH levels during open heart surgery with buprenorphine-N2O-O2 anesthesia]","Okutani R, Kono K, Kinoshita O, Nakamura H, Kaetsu H, Kiyonari N, Ishida H, Ogawa K.","Masui. 1986 May;35(5):717-23.","Okutani R","Masui","1986","1986/05/01","","",""
"3746670","Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon","Lukas SE, Brady JV, Griffiths RR.","J Pharmacol Exp Ther. 1986 Sep;238(3):924-31.","Lukas SE","J Pharmacol Exp Ther","1986","1986/09/01","","",""
"3739870","[Clinical effect of buprenorphine in ureteral colic]","Ikeda A, Hirata A, Miyazaki K, Fujita Y.","Hinyokika Kiyo. 1986 Apr;32(4):619-23.","Ikeda A","Hinyokika Kiyo","1986","1986/04/01","","",""
"3731735","[Could buprenorphine constitute an analgesic alternative in orthopedic traumatology?]","Accorinti L, Congestrì F, Melissari M, Ciampa C, Riccardo Spinelli PM, De Angelis F.","Clin Ter. 1986 May 15;117(3):219-21.","Accorinti L","Clin Ter","1986","1986/05/15","","",""
"3723808","[Treatment of cancer pain by continuous subcutaneous infusion of buprenorphine]","Umeda S, Noda J, Arai T, Omatsu Y, Moriyama S, Harima A.","Gan No Rinsho. 1986 May;32(5):497-500.","Umeda S","Gan No Rinsho","1986","1986/05/01","","",""
"3721055","A combination of buprenorphine and naloxone compared with buprenorphine administered intramuscularly in postoperative patients","Rolly G, Poelaert J, Mungroop H, Paelinck H.","J Int Med Res. 1986;14(3):148-52. doi: 10.1177/030006058601400306.","Rolly G","J Int Med Res","1986","1986/01/01","","","10.1177/030006058601400306"
"3709213","Comparison of intramuscular buprenorphine and a buprenorphine/naloxone combination in the treatment of post-operative pain","Vanacker B, Vandermeersch E, Tomassen J.","Curr Med Res Opin. 1986;10(2):139-44. doi: 10.1185/03007998609110432.","Vanacker B","Curr Med Res Opin","1986","1986/01/01","","","10.1185/03007998609110432"
"3699566","Effect of modern analgesic drugs (tramadol, pentazocine, and buprenorphine) on the bile duct sphincter in man","Staritz M, Poralla T, Manns M, Meyer Zum Büschenfelde KH.","Gut. 1986 May;27(5):567-9. doi: 10.1136/gut.27.5.567.","Staritz M","Gut","1986","1986/05/01","PMC1433495","","10.1136/gut.27.5.567"
"3696750","Epidural administration of opiates by a new device","Ahlgren FI, Ahlgren MB.","Pain. 1987 Dec;31(3):353-7. doi: 10.1016/0304-3959(87)90164-3.","Ahlgren FI","Pain","1987","1987/12/01","","","10.1016/0304-3959(87)90164-3"
"3691607","Psychomotor, respiratory and neuroendocrinological effects of buprenorphine and amitriptyline in healthy volunteers","Saarialho-Kere U, Mattila MJ, Paloheimo M, Seppälä T.","Eur J Clin Pharmacol. 1987;33(2):139-46. doi: 10.1007/BF00544557.","Saarialho-Kere U","Eur J Clin Pharmacol","1987","1987/01/01","","","10.1007/BF00544557"
"3685559","[Addiction to buprenorphine]","San Molina L, Porta Serra M.","Rev Clin Esp. 1987 Oct;181(5):288-9.","San Molina L","Rev Clin Esp","1987","1987/10/01","","",""
"3683616","[Failed pain control with sublingual application of buprenorphine]","Overweg-van Kints J, Stricker BH.","Ned Tijdschr Geneeskd. 1987 Oct 31;131(44):1973-4.","Overweg-van Kints J","Ned Tijdschr Geneeskd","1987","1987/10/31","","",""
"3682172","[Optimum dose of epidural buprenorphine for post-operative analgesia]","Ochi G, Kurashiki T.","Masui. 1987 Jul;36(7):1093-9.","Ochi G","Masui","1987","1987/07/01","","",""
"3682167","[Effect of modified NLA with flunitrazepam and buprenorphine and surgery on adrenocortical function in man]","Hashimoto H, Murakawa T, Oshima S, Matsuki A, Oyama T.","Masui. 1987 Jul;36(7):1069-73.","Hashimoto H","Masui","1987","1987/07/01","","",""
"3682166","[Effect of modified NLA on thyroid functions in man]","Matsuki A, Nagao H, Nagao N, Kotani N, Kudo M, Oyama T.","Masui. 1987 Jul;36(7):1064-8.","Matsuki A","Masui","1987","1987/07/01","","",""
"3678038","Effects of buprenorphine in heroin addicts","Blom Y, Bondesson U, Gunne LM.","Drug Alcohol Depend. 1987 Sep;20(1):1-7. doi: 10.1016/0376-8716(87)90069-x.","Blom Y","Drug Alcohol Depend","1987","1987/09/01","","","10.1016/0376-8716(87)90069-x"
"3659500","[New analgesics (II). Buprenorphine as a postoperative analgesic: our experience]","Martí Viaño JL, López Sáez-Benito J, Ramón Pérez JM, Negueruela Cardo A, Navarro Pastor M.","Rev Esp Anestesiol Reanim. 1987 Jul-Aug;34(4):251-4.","Martí Viaño JL","Rev Esp Anestesiol Reanim","1987","1987/07/01","","",""
"3658208","[Comparative study of intramuscular and sublingual administration in buprenorphine therapy of acute postoperative pain]","Veneziani A, Morelli M, Novelli GP.","Minerva Anestesiol. 1987 Mar;53(3):95-102.","Veneziani A","Minerva Anestesiol","1987","1987/03/01","","",""
"3658206","[The buprenorphine-droperidol combination in general anesthesia]","Latis G, Negri C, Corsini M, Bordini O, Ferretto M, Vacca F, Cinti M.","Minerva Anestesiol. 1987 Mar;53(3):79-84.","Latis G","Minerva Anestesiol","1987","1987/03/01","","",""
"3651280","Use of simple tests to determine the residual effects of the analgesic component of balanced anaesthesia","Manner T, Kanto J, Salonen M.","Br J Anaesth. 1987 Aug;59(8):978-82. doi: 10.1093/bja/59.8.978.","Manner T","Br J Anaesth","1987","1987/08/01","","","10.1093/bja/59.8.978"
"3642887","[Drug information. Sublingual synthetic morphine preparations]","Dahlerup J.","Sygeplejersken. 1986 Feb 19;86(8):26, 39.","Dahlerup J","Sygeplejersken","1986","1986/02/19","","",""
"3627486","[Report of a case of respiratory depression attributed to the use of peridural buprenorphine]","Martegani G, Varesio V, Agosta I.","Minerva Anestesiol. 1987 Apr;53(4):141-3.","Martegani G","Minerva Anestesiol","1987","1987/04/01","","",""
"3616138","Influence of buprenorphine on acute experimental pancreatitis","Wereszczyńska-Siemiatkowska U, Nebendahl K, Pohl U, Otto J, Groene HJ, Wilms H, Lankisch PG.","Res Exp Med (Berl). 1987;187(3):211-6. doi: 10.1007/BF01852085.","Wereszczyńska-Siemiatkowska U","Res Exp Med (Berl)","1987","1987/01/01","","","10.1007/BF01852085"
"3614964","Buprenorphine vs. morphine via the epidural route: a controlled comparative clinical study of respiratory effects and analgesic activity","Pasqualucci V, Tantucci C, Paoletti F, Dottorini ML, Bifarini G, Belfiori R, Berioli MB, Grassi V, Sorbini CA.","Pain. 1987 Jun;29(3):273-86. doi: 10.1016/0304-3959(87)90042-x.","Pasqualucci V","Pain","1987","1987/06/01","","","10.1016/0304-3959(87)90042-x"
"3614694","[Clinical experience with a combination of bupivacaine and buprenorphine for subarachnoid anesthesia in orthopedic-traumatologic surgery in the elderly patient]","Dezzani V, Francone L, Mulatero S, Remondino M.","Minerva Anestesiol. 1987 Jan-Feb;53(1-2):9-18.","Dezzani V","Minerva Anestesiol","1987","1987/01/01","","",""
"3614690","[Use of intravenous buprenorphine (Temgesic) in the prevention of postoperative pain]","Seveso M, Vimercati C, Sommaruga G, Dal Prà ML.","Minerva Anestesiol. 1987 Jan-Feb;53(1-2):33-40.","Seveso M","Minerva Anestesiol","1987","1987/01/01","","",""
"3614688","[Combination of buprenorphine and trazodone in preanesthetic medication]","Santamaria LB, Sinardi AU, Sutera T, Latella S, De Pasquale M, De Leo S, Mandolfino T.","Minerva Anestesiol. 1987 Jan-Feb;53(1-2):1-8.","Santamaria LB","Minerva Anestesiol","1987","1987/01/01","","",""
"3613060","[Effect of agonistic morphine antagonists (cyclazocine, butorphanol, buprenorphine) on EEG activity and the depth of anesthesia in rats]","Ogawa T, Sano Y, Hirabayshi Y, Yoshikawa H, Wauquier A, Cuesta P, Clinken B, William M, Van den Broeck.","Masui. 1987 Apr;36(4):490-7.","Ogawa T","Masui","1987","1987/04/01","","",""
"3599403","Analgesic and hemodynamic effects of buprenorphine in acute infarction of the heart","Sganzerla P, Cipolla C, Della Bella P, Fabbiocchi F, Grazi S, Rimondini A, Guazzi MD.","Jpn Heart J. 1987 Jan;28(1):63-71. doi: 10.1536/ihj.28.63.","Sganzerla P","Jpn Heart J","1987","1987/01/01","","","10.1536/ihj.28.63"
"3594070","Developmental responses to opioids reveals a lack of effect on stress-induced corticosterone levels in neonatal rats","Bailey CC, Kitchen I.","Br J Pharmacol. 1987 May;91(1):119-25. doi: 10.1111/j.1476-5381.1987.tb08990.x.","Bailey CC","Br J Pharmacol","1987","1987/05/01","PMC1853487","","10.1111/j.1476-5381.1987.tb08990.x"
"3592200","Buprenorphine, benzodiazepines and prolonged respiratory depression","Sekar M, Mimpriss TJ.","Anaesthesia. 1987 May;42(5):567-8. doi: 10.1111/j.1365-2044.1987.tb04085.x.","Sekar M","Anaesthesia","1987","1987/05/01","","","10.1111/j.1365-2044.1987.tb04085.x"
"3592172","Prolonged and biphasic respiratory depression following epidural buprenorphine","Molke Jensen F, Jensen NH, Holk IK, Ravnborg M.","Anaesthesia. 1987 May;42(5):470-5. doi: 10.1111/j.1365-2044.1987.tb04036.x.","Molke Jensen F","Anaesthesia","1987","1987/05/01","","","10.1111/j.1365-2044.1987.tb04036.x"
"3587575","Radioelectroencephalography (Tele-Stereo-EEG) in the rat as a pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital","Dimpfel W, Spüler M, Nickel B.","Neuropsychobiology. 1986;16(2-3):163-8. doi: 10.1159/000118319.","Dimpfel W","Neuropsychobiology","1986","1986/01/01","","","10.1159/000118319"
"3566119","Analgesia in the acute abdomen","Meiklejohn B.","Ann R Coll Surg Engl. 1987 Jan;69(1):42-3.","Meiklejohn B","Ann R Coll Surg Engl","1987","1987/01/01","PMC2498416","",""
"3563770","Intramuscular buprenorphine compared with morphine for postoperative analgesia","Payne KA, Murray WB, Barrett H.","S Afr Med J. 1987 Mar 21;71(6):359-61.","Payne KA","S Afr Med J","1987","1987/03/21","","",""
"3560424","[Changes in complement and catecholamine during anesthesia in open-heart surgery]","Isshiki A, Hamada K, Niki H, Nonaka J, Kubota K, Omi A, Ikeda K, Ikeda T, Makino Y.","Masui. 1987 Jan;36(1):32-8.","Isshiki A","Masui","1987","1987/01/01","","",""
"3556374","Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers","Manner T, Kanto J, Salonen M.","Eur J Clin Pharmacol. 1987;31(6):673-6. doi: 10.1007/BF00541294.","Manner T","Eur J Clin Pharmacol","1987","1987/01/01","","","10.1007/BF00541294"
"3544957","Pain relief after major abdominal surgery: a double-blind controlled comparison of sublingual buprenorphine, intramuscular buprenorphine, and intramuscular meperidine","Carl P, Crawford ME, Madsen NB, Ravlo O, Bach V, Larsen AI.","Anesth Analg. 1987 Feb;66(2):142-6.","Carl P","Anesth Analg","1987","1987/02/01","","",""
"3544649","Postoperative pain relief with high-dose epidural buprenorphine: a double-blind study","Gundersen RY, Andersen R, Narverud G.","Acta Anaesthesiol Scand. 1986 Nov;30(8):664-7. doi: 10.1111/j.1399-6576.1986.tb02497.x.","Gundersen RY","Acta Anaesthesiol Scand","1986","1986/11/01","","","10.1111/j.1399-6576.1986.tb02497.x"
"3540873","Crossover trials in clinical analgesic assays: studies of buprenorphine and morphine","Wallenstein SL, Kaiko RF, Rogers AG, Houde RW.","Pharmacotherapy. 1986 Sep-Oct;6(5):228-35. doi: 10.1002/j.1875-9114.1986.tb03481.x.","Wallenstein SL","Pharmacotherapy","1986","1986/09/01","","","10.1002/j.1875-9114.1986.tb03481.x"
"3538987","Analgesia in the acute abdomen","Zoltie N, Cust MP.","Ann R Coll Surg Engl. 1986 Jul;68(4):209-10.","Zoltie N","Ann R Coll Surg Engl","1986","1986/07/01","PMC2498389","",""
"3526421","Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study","Dullemond-Westland AC, Neijt JP, Nortier JW, Sitsen JM.","Radiother Oncol. 1986 Jun;6(2):127-33. doi: 10.1016/s0167-8140(86)80019-6.","Dullemond-Westland AC","Radiother Oncol","1986","1986/06/01","","","10.1016/s0167-8140(86)80019-6"
"3523826","[Treatment of acute biliary and kidney/urether pain. A comparative study of the effects of intravenous injections of buprenorphine, indomethacin and pethidine]","Viksmoen L, Grüner OP, Hertzenberg S, Laerum E, Waaler G.","Tidsskr Nor Laegeforen. 1986 May 20;106(13):1104-8.","Viksmoen L","Tidsskr Nor Laegeforen","1986","1986/05/20","","",""
"3517611","Buprenorphine","","Med Lett Drugs Ther. 1986 May 23;28(714):56.","","Med Lett Drugs Ther","1986","1986/05/23","","",""
"3511767","Epidural buprenorphine for postoperative analgesia. A controlled comparison with epidural morphine","Wolff J, Carl P, Crawford ME.","Anaesthesia. 1986 Jan;41(1):76-9. doi: 10.1111/j.1365-2044.1986.tb12710.x.","Wolff J","Anaesthesia","1986","1986/01/01","","","10.1111/j.1365-2044.1986.tb12710.x"
"3511410","[Controlled study of the analgesic effect and tolerability of buprenorphine in cancer patients]","Dini D, Fassio T, Gottlieb A, Gini M.","Minerva Med. 1986 Jan 28;77(3-4):93-104.","Dini D","Minerva Med","1986","1986/01/28","","",""
"3510458","A comparison of buprenorphine and pentazocine for the relief of postoperative pain","Freedman M.","S Afr Med J. 1986 Jan 4;69(1):27-8.","Freedman M","S Afr Med J","1986","1986/01/04","","",""
"3488520","[Transcutaneous electric stimulation and sublingual buprenorphine. Comparative study]","Viviani C, Mori M, Gabini R, Magi E, Tulli G, Capria V.","Minerva Anestesiol. 1986 Jan-Feb;52(1-2):9-14.","Viviani C","Minerva Anestesiol","1986","1986/01/01","","",""
"3469768","Buprenorphine in oral surgery. A comparison with fentanyl","Litchfield NB.","SAAD Dig. 1986 Oct;6(8):182-6.","Litchfield NB","SAAD Dig","1986","1986/10/01","","",""
"3456123","Abuse of buprenorphine","Rainey HB.","N Z Med J. 1986 Feb 12;99(795):72.","Rainey HB","N Z Med J","1986","1986/02/12","","",""
"3452786","[Analgesia with sublingual buprenorphine in postoperative abdominal pain]","Casali R, Nesi MG, Novelli GP.","Minerva Anestesiol. 1987 Oct;53(10):601-7.","Casali R","Minerva Anestesiol","1987","1987/10/01","","",""
"3452785","[Postoperative analgesia: peridural or intramuscular buprenorphine ?]","Minoni C, Falchi S, Novelli GP.","Minerva Anestesiol. 1987 Oct;53(10):595-600.","Minoni C","Minerva Anestesiol","1987","1987/10/01","","",""
"3448533","[Parenteral opiates and late somatosensory evoked potentials in chronic pain]","Paladini VA, Gioseffi M, Benvegnù M, Signoretto F, Gobbato E, Mocavero G.","Minerva Anestesiol. 1987 Sep;53(9):535-42.","Paladini VA","Minerva Anestesiol","1987","1987/09/01","","",""
"3448515","[Peridural fibrosis: possible mechanism of tolerance]","Mariot G, Micheletto G, Gallo F, Vendramin T.","Minerva Anestesiol. 1987 Jul-Aug;53(7-8):423-30.","Mariot G","Minerva Anestesiol","1987","1987/07/01","","",""
"3440438","Analysis of epidemiological data on agonist-antagonist analgesics","Ghodse AH.","Drug Alcohol Depend. 1987 Dec;20(4):375-83. doi: 10.1016/0376-8716(87)90010-x.","Ghodse AH","Drug Alcohol Depend","1987","1987/12/01","","","10.1016/0376-8716(87)90010-x"
"3430702","[A highly sensitive method for the determination of buprenorphine in the human serum by high performance liquid chromatography]","Naito H.","Masui. 1987 Aug;36(8):1245-56.","Naito H","Masui","1987","1987/08/01","","",""
"3427266","Investigation of the antinociceptive activity of buprenorphine in sheep","Nolan A, Livingston A, Waterman AE.","Br J Pharmacol. 1987 Nov;92(3):527-33. doi: 10.1111/j.1476-5381.1987.tb11353.x.","Nolan A","Br J Pharmacol","1987","1987/11/01","PMC1853699","","10.1111/j.1476-5381.1987.tb11353.x"
"3423807","Sublingual buprenorphine for post-operative pain","Tan WT, Tan J.","Singapore Med J. 1987 Aug;28(4):355-7.","Tan WT","Singapore Med J","1987","1987/08/01","","",""
"3417462","Patient-controlled analgesia versus intermittent analgesia dosing","Lange MP, Dahn MS, Jacobs LA.","Heart Lung. 1988 Sep;17(5):495-8.","Lange MP","Heart Lung","1988","1988/09/01","","",""
"3416736","Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys","Mello NK, Lukas SE, Bree MP, Mendelson JH.","Drug Alcohol Depend. 1988 May;21(2):81-97. doi: 10.1016/0376-8716(88)90053-1.","Mello NK","Drug Alcohol Depend","1988","1988/05/01","","","10.1016/0376-8716(88)90053-1"
"3402520","Influence of naloxone on the postoperative analgesic and respiratory effects of buprenorphine","Lehmann KA, Reichling U, Wirtz R.","Eur J Clin Pharmacol. 1988;34(4):343-52. doi: 10.1007/BF00542434.","Lehmann KA","Eur J Clin Pharmacol","1988","1988/01/01","","","10.1007/BF00542434"
"3398224","[Analgesic effect of epidural buprenorphine in volunteers]","Tsubaki T, Himuro H, Murata T, Tanaka H, Nakamura I, Minote N, Aono K.","Masui. 1988 Apr;37(4):439-45.","Tsubaki T","Masui","1988","1988/04/01","","",""
"3398223","[Comparison of sublingual and intramuscular buprenorphine for pain relief after upper abdominal surgery]","Hayakawa J, Ohtani M, Usuda Y, Numata K.","Masui. 1988 Apr;37(4):434-8.","Hayakawa J","Masui","1988","1988/04/01","","",""
"3386393","Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effects","Sbacchi M, Colombo M, La Regina A, Petrillo P, Tavani A.","Life Sci. 1988;42(21):2079-89. doi: 10.1016/0024-3205(88)90121-x.","Sbacchi M","Life Sci","1988","1988/01/01","","","10.1016/0024-3205(88)90121-x"
"3377946","Comparison of extradural buprenorphine and extradural morphine after caesarean section","Simpson KH, Madej TH, McDowell JM, MacDonald R, Lyons G.","Br J Anaesth. 1988 May;60(6):627-31. doi: 10.1093/bja/60.6.627.","Simpson KH","Br J Anaesth","1988","1988/05/01","","","10.1093/bja/60.6.627"
"3367501","[Evaluation of the analgesic effect of buprenorphine administered in the epidural space for postoperative pain relief by a pressure algesimeter]","Inagaki Y, Takeyama E.","Masui. 1988 Jan;37(1):53-7.","Inagaki Y","Masui","1988","1988/01/01","","",""
"3365064","Low dose naloxone enhances buprenorphine in a tooth pulp antinociceptive assay","Bergman SA, Wynn RL, Myers DE, Rudo FG.","Arch Int Pharmacodyn Ther. 1988 Jan-Feb;291:229-37.","Bergman SA","Arch Int Pharmacodyn Ther","1988","1988/01/01","","",""
"3364665","[Postoperative on-demand analgesia with buprenorphine]","Lehmann KA, Gördes B.","Anaesthesist. 1988 Feb;37(2):65-70.","Lehmann KA","Anaesthesist","1988","1988/02/01","","",""
"3362932","Tolerance to the effects of buprenorphine on schedule-controlled behavior and analgesia in rats","Berthold CW 3rd, Moerschbaecher JM.","Pharmacol Biochem Behav. 1988 Feb;29(2):393-6. doi: 10.1016/0091-3057(88)90174-8.","Berthold CW 3rd","Pharmacol Biochem Behav","1988","1988/02/01","","","10.1016/0091-3057(88)90174-8"
"3359074","Usefulness of buprenorphine in dispute","Green DW.","Br J Hosp Med. 1988 Jan;39(1):84-5.","Green DW","Br J Hosp Med","1988","1988/01/01","","",""
"3354808","Intrathecal buprenorphine for postoperative analgesia in the elderly patient","Capogna G, Celleno D, Tagariello V, Loffreda-Mancinelli C.","Anaesthesia. 1988 Feb;43(2):128-30. doi: 10.1111/j.1365-2044.1988.tb05482.x.","Capogna G","Anaesthesia","1988","1988/02/01","","","10.1111/j.1365-2044.1988.tb05482.x"
"3345281","Influence of pretreatment with a monoamine oxidase inhibitor (phenelzine) on the effects of buprenorphine and pethidine in the conscious rabbit","Mackenzie JE, Frank LW.","Br J Anaesth. 1988 Feb;60(2):216-21. doi: 10.1093/bja/60.2.216.","Mackenzie JE","Br J Anaesth","1988","1988/02/01","","","10.1093/bja/60.2.216"
"3344976","Comparison of buprenorphine with morphine in the treatment of postoperative pain in children","Maunuksela EL, Korpela R, Olkkola KT.","Anesth Analg. 1988 Mar;67(3):233-9.","Maunuksela EL","Anesth Analg","1988","1988/03/01","","",""
"3337794","Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain of children","Maunuksela EL, Korpela R, Olkkola KT.","Br J Anaesth. 1988 Jan;60(1):48-55. doi: 10.1093/bja/60.1.48.","Maunuksela EL","Br J Anaesth","1988","1988/01/01","","","10.1093/bja/60.1.48"
"3324612","Buprenorphine as premedication and as analgesic during and after light isoflurane-N2O-O2 anaesthesia. A comparison with oxycodone plus fentanyl","Korttila K, Hovorka J.","Acta Anaesthesiol Scand. 1987 Nov;31(8):673-9. doi: 10.1111/j.1399-6576.1987.tb02644.x.","Korttila K","Acta Anaesthesiol Scand","1987","1987/11/01","","","10.1111/j.1399-6576.1987.tb02644.x"
"3318896","Constant i.v. infusions of nalbuphine or buprenorphine for pain after abdominal surgery","Pugh GC, Drummond GB, Elton RA, Macintyre CC.","Br J Anaesth. 1987 Nov;59(11):1364-74. doi: 10.1093/bja/59.11.1364.","Pugh GC","Br J Anaesth","1987","1987/11/01","","","10.1093/bja/59.11.1364"
"3310672","Antipsychotic effect of buprenorphine in schizophrenia","Schmauss C, Yassouridis A, Emrich HM.","Am J Psychiatry. 1987 Oct;144(10):1340-2. doi: 10.1176/ajp.144.10.1340.","Schmauss C","Am J Psychiatry","1987","1987/10/01","","","10.1176/ajp.144.10.1340"
"3307727","A double-blind comparison of the relative efficacy, side effects and cost of buprenorphine and morphine in patients after cardiac surgery","Rabinov M, Rosenfeldt FL, McLean AJ.","Aust N Z J Surg. 1987 Apr;57(4):227-31. doi: 10.1111/j.1445-2197.1987.tb01345.x.","Rabinov M","Aust N Z J Surg","1987","1987/04/01","","","10.1111/j.1445-2197.1987.tb01345.x"
"3302764","[Buprenorphine in cancer pain: cross comparison with pentazocine]","De Conno F, Ripamonti C, Tamburini M, Ventafridda V.","Minerva Med. 1987 Aug 15;78(15):1177-81.","De Conno F","Minerva Med","1987","1987/08/15","","",""
"3302336","[Balanced anesthesia with etomidate, cyclazocine, butorphanol, buprenorphine and N2O and the regulatory function of the renin, angiotensin and catecholamine]","Ogawa T, Hirabayashi Y, Inoue S, Wauquier A, Hörig C, Cuesta P.","Masui. 1987 Mar;36(3):304-12.","Ogawa T","Masui","1987","1987/03/01","","",""
"3302226","Buprenorphine and pethidine in the treatment of post-operative pain","Khandeparkar JM, Mittal FK, Tendolkar AG, Dewoolkar LV, Bhatt MM, Parulkar GB, Pandit PR.","J Postgrad Med. 1987 Jan;33(1):18-23.","Khandeparkar JM","J Postgrad Med","1987","1987/01/01","","",""
"3297075","Continuous-plus-on-demand epidural infusion of buprenorphine versus morphine in postoperative treatment of pain. Postoperative epidural infusion of buprenorphine","Chrubasik J, Vogel W, Trötschler H, Farthmann EH.","Arzneimittelforschung. 1987 Mar;37(3):361-3.","Chrubasik J","Arzneimittelforschung","1987","1987/03/01","","",""
"3286657","Epidural buprenorphine for pain relief after spinal decompression","Wilde GP, Whitaker AJ, Moulton A.","J Bone Joint Surg Br. 1988 May;70(3):448-50.","Wilde GP","J Bone Joint Surg Br","1988","1988/05/01","","",""
"3284406","[Quality of buprenorphine and morphine as components of combined anesthesia]","Knoche E, Dick W, Rummel C, Konietzke D.","Anaesthesist. 1988 Feb;37(2):57-64.","Knoche E","Anaesthesist","1988","1988/02/01","","",""
"3276999","Buprenorphine detoxification from opioid dependence: a pilot study","Kosten TR, Kleber HD.","Life Sci. 1988;42(6):635-41. doi: 10.1016/0024-3205(88)90454-7.","Kosten TR","Life Sci","1988","1988/01/01","","","10.1016/0024-3205(88)90454-7"
"3275523","A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts","Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE.","Clin Pharmacol Ther. 1988 Jan;43(1):72-8. doi: 10.1038/clpt.1988.13.","Bickel WK","Clin Pharmacol Ther","1988","1988/01/01","","","10.1038/clpt.1988.13"
"3265643","Buprenorphine abuse among opiate addicts","O'Connor JJ, Moloney E, Travers R, Campbell A.","Br J Addict. 1988 Sep;83(9):1085-7. doi: 10.1111/j.1360-0443.1988.tb00536.x.","O'Connor JJ","Br J Addict","1988","1988/09/01","","","10.1111/j.1360-0443.1988.tb00536.x"
"3254985","Post-operative analgesia after subarachnoid administration of mixture of buprenorphine and lignocaine","Dasgupta D, Dixit R.","J Postgrad Med. 1988 Oct;34(4):205-10.","Dasgupta D","J Postgrad Med","1988","1988/10/01","","",""
"3254984","Post-operative analgesia after epidural administration of mixture of buprenorphine and lignocaine","Dasgupta D, Dixit R.","J Postgrad Med. 1988 Oct;34(4):201-4.","Dasgupta D","J Postgrad Med","1988","1988/10/01","","",""
"3253717","Antihistaminic-opioid combination: effect on locomotor activity in mice","Sansone M.","Pol J Pharmacol Pharm. 1988 Sep-Oct;40(5):515-23.","Sansone M","Pol J Pharmacol Pharm","1988","1988/09/01","","",""
"3244434","[Use of 3 different anesthetic mixtures in peridural anesthesia for extracorporeal shockwave lithotripsy (ESWL)]","Tempia A, Fiore G, Berardino M, Aimone-Secat M, Ballaris MA, Pattono R.","Minerva Anestesiol. 1988 Jul-Aug;54(7-8):315-20.","Tempia A","Minerva Anestesiol","1988","1988/07/01","","",""
"3238136","[Anesthesia in a quintuple pregnancy]","Branda JC, Tumbarella M, Cerdá MA.","Rev Esp Anestesiol Reanim. 1988 Nov-Dec;35(6):346-7.","Branda JC","Rev Esp Anestesiol Reanim","1988","1988/11/01","","",""
"3232162","Intraoperative EEG monitoring: (I). Parametric representation of processed EEG during anesthesia","Kinefuchi Y, Katoh H, Ohtani I, Iga T, Shirakura K, Yamasaki Y.","Tokai J Exp Clin Med. 1988 Feb;13(1):53-61.","Kinefuchi Y","Tokai J Exp Clin Med","1988","1988/02/01","","",""
"3230625","[The usefulness of buprenorphine 0.05 mg as a supplemental drug for enflurane anesthesia in patients from forties to seventies]","Kawate M, Hanaoka K.","Masui. 1988 Jul;37(7):794-7.","Kawate M","Masui","1988","1988/07/01","","",""
"3227140","[Buprenorphine in heart surgery. Hemodynamic study in patients with mitral valve disease]","Fraile JR, Gómez-Arnau J, Cervera JS, Escarpa A, Díez-Lobo AI, Peral P.","Rev Esp Anestesiol Reanim. 1988 Sep-Oct;35(5):245-8.","Fraile JR","Rev Esp Anestesiol Reanim","1988","1988/09/01","","",""
"3227044","Differential tolerance development to buprenorphine-, diprenorphine-, and heroin-induced disruption of food-maintained responding in macaque monkeys","Lukas SE, Mello NK, Bree MP, Mendelson JH.","Pharmacol Biochem Behav. 1988 Aug;30(4):977-82. doi: 10.1016/0091-3057(88)90129-3.","Lukas SE","Pharmacol Biochem Behav","1988","1988/08/01","","","10.1016/0091-3057(88)90129-3"
"3226762","Can opiates relieve neuropathic pain?","Fields HL.","Pain. 1988 Dec;35(3):365-7. doi: 10.1016/0304-3959(88)90148-0.","Fields HL","Pain","1988","1988/12/01","","","10.1016/0304-3959(88)90148-0"
"3225903","[Effect of butorphanol and buprenorphine on cerebrospinal fluid pressure]","Matsumiya N, Shimizu H, Fujita S, Mayumi T.","Masui. 1988 Nov;37(11):1346-50.","Matsumiya N","Masui","1988","1988/11/01","","",""
"3223639","[Epidural analgesia after thoracic surgery: morphine versus buprenorphine]","Petit J, Comar D, Pigot B, Eustache ML, Oksenhendler G, Winckler C.","Ann Fr Anesth Reanim. 1988;7(6):464-70. doi: 10.1016/s0750-7658(88)80084-4.","Petit J","Ann Fr Anesth Reanim","1988","1988/01/01","","","10.1016/s0750-7658(88)80084-4"
"3220837","A physicochemical study of the interaction of phosphatidylinositol with buprenorphine and naloxone","Reig F, Espígol C, García Antón JM, Valencia G, Alsina MA.","J Bioenerg Biomembr. 1988 Aug;20(4):533-49. doi: 10.1007/BF00762208.","Reig F","J Bioenerg Biomembr","1988","1988/08/01","","","10.1007/BF00762208"
"3219638","[A vertiginous syndrome: a side effect of buprenorphine?]","Richard JP, Benelli M, Bareille P.","Cah Anesthesiol. 1988 Dec;36(8):641-2.","Richard JP","Cah Anesthesiol","1988","1988/12/01","","",""
"3211364","Effects of exposure in utero to methadone and buprenorphine on enkephalin levels in the developing rat brain","Tiong GK, Olley JE.","Neurosci Lett. 1988 Oct 31;93(1):101-6. doi: 10.1016/0304-3940(88)90020-1.","Tiong GK","Neurosci Lett","1988","1988/10/31","","","10.1016/0304-3940(88)90020-1"
"3199502","[Pharmacokinetics of intravenous and epidural buprenorphine analgesia]","Naito H.","Masui. 1988 Oct;37(10):1180-91.","Naito H","Masui","1988","1988/10/01","","",""
"3186272","The effect of buprenorphine on the analgesic and respiratory depressant effects of pethidine: a preliminary study","Vedig AE, Gibbs JM, Rutten AJ, Ilsley AH.","Pain. 1988 Sep;34(3):253-9. doi: 10.1016/0304-3959(88)90120-0.","Vedig AE","Pain","1988","1988/09/01","","","10.1016/0304-3959(88)90120-0"
"3183952","Effects of buprenorphine, methadone and naloxone on acquisition of behavioral chains","Cleary J, Ho B, Nader M, Thompson T.","J Pharmacol Exp Ther. 1988 Nov;247(2):569-75.","Cleary J","J Pharmacol Exp Ther","1988","1988/11/01","","",""
"3176837","Buprenorphine antagonism of ventilatory depression following fentanyl anaesthesia","Boysen K, Hertel S, Chraemmer-Jørgensen B, Risbo A, Poulsen NJ.","Acta Anaesthesiol Scand. 1988 Aug;32(6):490-2. doi: 10.1111/j.1399-6576.1988.tb02772.x.","Boysen K","Acta Anaesthesiol Scand","1988","1988/08/01","","","10.1111/j.1399-6576.1988.tb02772.x"
"3175177","[Paroxysmal auricular fibrillation after the ingestion of buprenorphine]","Górgolas Hernández-Mora P, Marcos Sánchez F, Aparicio Martínez J, de Juana Velasco P.","Rev Clin Esp. 1988 Jun;183(2):99-100.","Górgolas Hernández-Mora P","Rev Clin Esp","1988","1988/06/01","","",""
"3174743","The reinforcing properties of the mixed agonist-antagonist buprenorphine as assessed by brain-stimulation reward","Hubner CB, Kornetsky C.","Pharmacol Biochem Behav. 1988 May;30(1):195-7. doi: 10.1016/0091-3057(88)90443-1.","Hubner CB","Pharmacol Biochem Behav","1988","1988/05/01","","","10.1016/0091-3057(88)90443-1"
"3172701","An analgesiometry system for use in rabbits with some preliminary data on the effects of buprenorphine and lofentanil","Wootton R, Cross G, Wood S, West CD.","Lab Anim. 1988 Jul;22(3):217-22. doi: 10.1258/002367788780746395.","Wootton R","Lab Anim","1988","1988/07/01","","","10.1258/002367788780746395"
"3149157","[Effect of opioids on granulocyte adherence]","Krumholz W, Weber C, Käbisch S, Hempelmann G.","Anasth Intensivther Notfallmed. 1988 Dec;23(6):313-5.","Krumholz W","Anasth Intensivther Notfallmed","1988","1988/12/01","","",""
"3145473","[Potentiating drugs in postoperative pain control with opiates for patient controlled analgesia]","Cuocolo R, Savoia G, Amantea B, Brando G, Santangelo E, Abate C, Celano S, Celentano L, Orlando C, Belfiore F, et al.","Minerva Anestesiol. 1988 Apr;54(4):105-14.","Cuocolo R","Minerva Anestesiol","1988","1988/04/01","","",""
"3141817","Enzyme immunoassay of buprenorphine","Tiong GK, Olley JE.","Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):202-6. doi: 10.1007/BF00174871.","Tiong GK","Naunyn Schmiedebergs Arch Pharmacol","1988","1988/08/01","","","10.1007/BF00174871"
"3137594","Tripelennamine enhances buprenorphine-, but not pentazocine-induced hyperactivity in mice","Sansone M, Castellano C, Libri V.","Psychopharmacology (Berl). 1988;95(2):176-9. doi: 10.1007/BF00174505.","Sansone M","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF00174505"
"3128807","A comparison of the stimulus effects of codeine in rhesus monkeys under the contingencies of a two lever discrimination task and a cross self-administration paradigm: tests of generalization to pentazocine, buprenorphine, tilidine, and different doses of codeine","Hoffmeister F.","Psychopharmacology (Berl). 1988;94(3):315-20. doi: 10.1007/BF00174682.","Hoffmeister F","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF00174682"
"3125937","Pain in the jungle","Hanks GW.","Br Med J (Clin Res Ed). 1988 Feb 6;296(6619):431. doi: 10.1136/bmj.296.6619.431-b.","Hanks GW","Br Med J (Clin Res Ed)","1988","1988/02/06","PMC2545012","","10.1136/bmj.296.6619.431-b"
"3123005","Near fatal auditory hallucinations after buprenorphine","Paraskevaides EC.","Br Med J (Clin Res Ed). 1988 Jan 16;296(6616):214. doi: 10.1136/bmj.296.6616.214-b.","Paraskevaides EC","Br Med J (Clin Res Ed)","1988","1988/01/16","PMC2544951","","10.1136/bmj.296.6616.214-b"
"3115138","[O.15 mg Intrathecal buprenorphine applied for postoperative analgesia. A clinical double-blind study]","Lipp M, Daubländer M, Lanz E.","Anaesthesist. 1987 May;36(5):233-8.","Lipp M","Anaesthesist","1987","1987/05/01","","",""
"3113290","Pupillary diameter and ventilatory CO2 sensitivity after epidural morphine and buprenorphine in volunteers","Ravnborg M, Jensen FM, Jensen NH, Holk IK.","Anesth Analg. 1987 Sep;66(9):847-51.","Ravnborg M","Anesth Analg","1987","1987/09/01","","",""
"3108556","[Anesthetic management of a patient with platelet cyclo-oxygenase deficiency]","Kitahara T, Fukuda M, Matsuki M, Shimoji K, Takeshige S.","Masui. 1987 Feb;36(2):261-5.","Kitahara T","Masui","1987","1987/02/01","","",""
"3101386","Peroperative buprenorphine: do high dosages shorten analgesia postoperatively?","Pedersen JE, Chraemmer-Jørgensen B, Schmidt JF, Risbo A.","Acta Anaesthesiol Scand. 1986 Nov;30(8):660-3. doi: 10.1111/j.1399-6576.1986.tb02496.x.","Pedersen JE","Acta Anaesthesiol Scand","1986","1986/11/01","","","10.1111/j.1399-6576.1986.tb02496.x"
"3101099","Negative reinforcing properties of naloxone in the non-dependent rhesus monkey: influence on reinforcing properties of codeine, tilidine, buprenorphine, and pentazocine","Hoffmeister F.","Psychopharmacology (Berl). 1986;90(4):441-50. doi: 10.1007/BF00174058.","Hoffmeister F","Psychopharmacology (Berl)","1986","1986/01/01","","","10.1007/BF00174058"
"3090442","Clinical investigations of drug effects in women","Mendelson JH, Mello NK.","NIDA Res Monogr. 1986;65:21-30.","Mendelson JH","NIDA Res Monogr","1986","1986/01/01","","",""
"3071176","[Analgesic effect and side-effects of buprenorphine in acute coronary heart disease. A randomized double-blind comparison with morphine]","Weiss P, Ritz R.","Anasth Intensivther Notfallmed. 1988 Dec;23(6):309-12.","Weiss P","Anasth Intensivther Notfallmed","1988","1988/12/01","","",""
"3069539","[Buprenorphine and pentazocine in acute myocardial infarct. Study for a differential use]","Cecchi CA, Bacci G, Battelli PL, Multinu D, Signorini AC, Scheggi M, Marchi F.","G Ital Cardiol. 1988 Sep;18(9):745-7.","Cecchi CA","G Ital Cardiol","1988","1988/09/01","","",""
"3054197","[Change of analgesic effect of intrathecal buprenorphine combined with local anesthetic used for postoperative pain relief]","Inagaki Y, Takeyama E.","Masui. 1988 Aug;37(8):955-60.","Inagaki Y","Masui","1988","1988/08/01","","",""
"3048768","Beneficial effects of buprenorphine (a partial opiate agonist) in porcine Escherichia coli septicaemia: a comparison with naloxone","Donaldson MD, Vesey CJ, Wilks M, Hinds CJ.","Circ Shock. 1988 Jul;25(3):209-21.","Donaldson MD","Circ Shock","1988","1988/07/01","","",""
"3042551","[Pain therapy in gynecologic malignancies]","von Matthiessen H.","Gynakologe. 1988 Jun;21(2):81-7.","von Matthiessen H","Gynakologe","1988","1988/06/01","","",""
"3042275","Buprenorphine","Lober C.","Conn Med. 1988 May;52(5):285-7.","Lober C","Conn Med","1988","1988/05/01","","",""
"3033213","Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands","Zimmerman DM, Leander JD, Reel JK, Hynes MD.","J Pharmacol Exp Ther. 1987 May;241(2):374-8.","Zimmerman DM","J Pharmacol Exp Ther","1987","1987/05/01","","",""
"3030969","Preparation of [11C]buprenorphine--a potential radioligand for the study of the opiate receptor system in vivo","Luthra SK, Pike VW, Brady F, Horlock PL, Prenant C, Crouzel C.","Int J Rad Appl Instrum A. 1987;38(1):65-6. doi: 10.1016/0883-2889(87)90239-5.","Luthra SK","Int J Rad Appl Instrum A","1987","1987/01/01","","","10.1016/0883-2889(87)90239-5"
"3017495","Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat","Hayes AG, Skingle M, Tyers MB.","Br J Pharmacol. 1986 Aug;88(4):867-72. doi: 10.1111/j.1476-5381.1986.tb16260.x.","Hayes AG","Br J Pharmacol","1986","1986/08/01","PMC1917077","","10.1111/j.1476-5381.1986.tb16260.x"
"3013652","The mu, kappa and delta properties of various opioid agonists","Takemori AE, Ikeda M, Portoghese PS.","Eur J Pharmacol. 1986 Apr 29;123(3):357-61. doi: 10.1016/0014-2999(86)90709-0.","Takemori AE","Eur J Pharmacol","1986","1986/04/29","","","10.1016/0014-2999(86)90709-0"
"3013044","[Intra- and postoperative interactions between the 2 opioids fentanyl and buprenorphine]","Müller H, Gerlach H, Gips H, Richter M, Börner U, Hempelmann G.","Anaesthesist. 1986 Apr;35(4):219-25.","Müller H","Anaesthesist","1986","1986/04/01","","",""
"3012081","Is there a common, high-affinity opioid binding site in rat brain?","Blurton PA, Broadhurst AM, Wood MD, Wyllie MG.","J Recept Res. 1986;6(1):85-93. doi: 10.3109/10799898609073926.","Blurton PA","J Recept Res","1986","1986/01/01","","","10.3109/10799898609073926"
"3007830","Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations","Kajiwara M, Aoki K, Ishii K, Numata H, Matsumiya T, Oka T.","Jpn J Pharmacol. 1986 Jan;40(1):95-101. doi: 10.1254/jjp.40.95.","Kajiwara M","Jpn J Pharmacol","1986","1986/01/01","","","10.1254/jjp.40.95"
"2998812","In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method","Richards ML, Sadée W.","Eur J Pharmacol. 1985 Aug 27;114(3):343-53. doi: 10.1016/0014-2999(85)90379-6.","Richards ML","Eur J Pharmacol","1985","1985/08/27","","","10.1016/0014-2999(85)90379-6"
"2997571","The effects of the acute administration of buprenorphine hydrochloride on the release of anterior pituitary hormones in the rat: evidence for the involvement of multiple opiate receptors","Pechnick RN, George R, Poland RE.","Life Sci. 1985 Nov 18;37(20):1861-8. doi: 10.1016/0024-3205(85)90002-5.","Pechnick RN","Life Sci","1985","1985/11/18","","","10.1016/0024-3205(85)90002-5"
"2986930","Buprenorphine","Lewis JW.","Drug Alcohol Depend. 1985 Feb;14(3-4):363-72. doi: 10.1016/0376-8716(85)90067-5.","Lewis JW","Drug Alcohol Depend","1985","1985/02/01","","","10.1016/0376-8716(85)90067-5"
"2982388","Clinical actions of fentanyl and buprenorphine. The significance of receptor binding","Boas RA, Villiger JW.","Br J Anaesth. 1985 Feb;57(2):192-6. doi: 10.1093/bja/57.2.192.","Boas RA","Br J Anaesth","1985","1985/02/01","","","10.1093/bja/57.2.192"
"2972228","Pruritus with sublingual buprenorphine","Woodham M.","Anaesthesia. 1988 Sep;43(9):806-7. doi: 10.1111/j.1365-2044.1988.tb05784.x.","Woodham M","Anaesthesia","1988","1988/09/01","","","10.1111/j.1365-2044.1988.tb05784.x"
"2971143","Partial agonists of the morphine type: facilitative effects on electrophysiologically recorded C-fiber reflexes in the cat","Bell JA, Shannon HE.","Neuropharmacology. 1988 Jun;27(6):649-52. doi: 10.1016/0028-3908(88)90188-8.","Bell JA","Neuropharmacology","1988","1988/06/01","","","10.1016/0028-3908(88)90188-8"
"2954811","Which potent opioid? Important criteria for selection","Bovill JG.","Drugs. 1987 May;33(5):520-30. doi: 10.2165/00003495-198733050-00006.","Bovill JG","Drugs","1987","1987/05/01","","","10.2165/00003495-198733050-00006"
"2935653","[The effect of buprenorphine on oxidative phosphorylation in isolated rat liver mitochondria]","Tanaka S, Shimonaka H, Tanahashi T, Uematsu H, Yamamoto M, Kawai K, Nozawa Y.","Masui. 1985 Nov;34(11):1456-62.","Tanaka S","Masui","1985","1985/11/01","","",""
"2928760","Lukewarm turkey","Horgan J.","Sci Am. 1989 Mar;260(3):32. doi: 10.1038/scientificamerican0389-32.","Horgan J","Sci Am","1989","1989/03/01","","","10.1038/scientificamerican0389-32"
"2927249","Role of opioid antagonists in treating intravenous cocaine abuse","Kosten TR, Kleber HD, Morgan C.","Life Sci. 1989;44(13):887-92. doi: 10.1016/0024-3205(89)90589-4.","Kosten TR","Life Sci","1989","1989/01/01","","","10.1016/0024-3205(89)90589-4"
"2908210","[Stress and postoperative analgesia]","Stacca R, Porro CA, Piccinini P, Petraglia F, Facchinetti F.","Minerva Anestesiol. 1988 Oct;54(10):445-50.","Stacca R","Minerva Anestesiol","1988","1988/10/01","","",""
"2907529","[Reactions and interactions of drugs]","D'arcy PF.","J Pharm Belg. 1988 Sep-Oct;43(5):401-4.","D'arcy PF","J Pharm Belg","1988","1988/09/01","","",""
"2907043","Plasma levels of opioid material in man following sublingual and intravenous administration of buprenorphine: exogenous/endogenous opioid interaction?","Olley JE, Tiong GK.","J Pharm Pharmacol. 1988 Sep;40(9):666-7. doi: 10.1111/j.2042-7158.1988.tb05336.x.","Olley JE","J Pharm Pharmacol","1988","1988/09/01","","","10.1111/j.2042-7158.1988.tb05336.x"
"2901137","[Buprenorphine: pharmacologic and clinical aspects]","Lorenzo P, Leza JC.","Rev Clin Esp. 1988 Mar;182(4):230-3.","Lorenzo P","Rev Clin Esp","1988","1988/03/01","","",""
"2896478","[Almitrine temporarily suppresses respiratory depression caused by buprenorphine]","Kay B, Pollard BJ.","Ann Fr Anesth Reanim. 1988;7(2):176-7. doi: 10.1016/s0750-7658(88)80153-9.","Kay B","Ann Fr Anesth Reanim","1988","1988/01/01","","","10.1016/s0750-7658(88)80153-9"
"2894288","The clinical usefulness of agonist-antagonistic opioid analgesics in chronic pain","Hanks GW.","Drug Alcohol Depend. 1987 Dec;20(4):339-46. doi: 10.1016/0376-8716(87)90007-x.","Hanks GW","Drug Alcohol Depend","1987","1987/12/01","","","10.1016/0376-8716(87)90007-x"
"2893560","Epidural sufentanil versus intramuscular buprenorphine for postoperative analgesia. A double-blind comparative trial","Donadoni R, Rolly G.","Anaesthesia. 1987 Nov;42(11):1171-5. doi: 10.1111/j.1365-2044.1987.tb05222.x.","Donadoni R","Anaesthesia","1987","1987/11/01","","","10.1111/j.1365-2044.1987.tb05222.x"
"2893012","Prolonged respiratory depression caused by sublingual buprenorphine","Thörn SE, Rawal N, Wennhager M.","Lancet. 1988 Jan 23;1(8578):179-80. doi: 10.1016/s0140-6736(88)92749-3.","Thörn SE","Lancet","1988","1988/01/23","","","10.1016/s0140-6736(88)92749-3"
"2891490","Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine","Mistry M, Houston JB.","Drug Metab Dispos. 1987 Sep-Oct;15(5):710-7.","Mistry M","Drug Metab Dispos","1987","1987/09/01","","",""
"2888499","Opioid agonist/antagonists in general anaesthesia","Wilkinson DJ.","Br J Hosp Med. 1987 Aug;38(2):130-3.","Wilkinson DJ","Br J Hosp Med","1987","1987/08/01","","",""
"2871181","Buprenorphine","Vance DA.","J Post Anesth Nurs. 1986 Feb;1(1):41.","Vance DA","J Post Anesth Nurs","1986","1986/02/01","","",""
"2870660","[Opiate receptors]","Latasch L, Christ R.","Anaesthesist. 1986 Feb;35(2):55-65.","Latasch L","Anaesthesist","1986","1986/02/01","","",""
"2867881","Quantitation of extrahepatic metabolism. Pulmonary and intestinal conjugation of naphthol","Mistry M, Houston JB.","Drug Metab Dispos. 1985 Nov-Dec;13(6):740-5.","Mistry M","Drug Metab Dispos","1985","1985/11/01","","",""
"2867050","Pharmacological advances in addiction treatment","Preston KL, Bigelow GE.","Int J Addict. 1985 Jun-Jul;20(6-7):845-67. doi: 10.3109/10826088509047756.","Preston KL","Int J Addict","1985","1985/06/01","","","10.3109/10826088509047756"
"2866738","[Use of morphine derivatives by the systemic route in the treatment of acute pain]","Korinek AM.","Ann Fr Anesth Reanim. 1985;4(5):451-4. doi: 10.1016/s0750-7658(85)80283-5.","Korinek AM","Ann Fr Anesth Reanim","1985","1985/01/01","","","10.1016/s0750-7658(85)80283-5"
"2864048","Efficacy of the extradural administration of lofentanil, buprenorphine or saline in the management of postoperative pain. A double-blind study","Bilsback P, Rolly G, Tampubolon O.","Br J Anaesth. 1985 Oct;57(10):943-8. doi: 10.1093/bja/57.10.943.","Bilsback P","Br J Anaesth","1985","1985/10/01","","","10.1093/bja/57.10.943"
"2863704","Abuse of buprenorphine","Strang J.","Lancet. 1985 Sep 28;2(8457):725. doi: 10.1016/s0140-6736(85)92961-7.","Strang J","Lancet","1985","1985/09/28","","","10.1016/s0140-6736(85)92961-7"
"2861882","[New morphine-type analgesics in anesthesia]","Lehot JJ, Bastien O, Girard C, Ruynat L, Tartulier M.","Cah Anesthesiol. 1985 Apr-May;33(3):239-47.","Lehot JJ","Cah Anesthesiol","1985","1985/04/01","","",""
"2858839","Regular interval preventive pain relief compared with on demand treatment after hysterectomy","Jørgensen BC, Schmidt JF, Risbo A, Pedersen J, Kolby P.","Pain. 1985 Feb;21(2):137-42. doi: 10.1016/0304-3959(85)90283-0.","Jørgensen BC","Pain","1985","1985/02/01","","","10.1016/0304-3959(85)90283-0"
"2857568","Receptor binding and its significance","Hull CJ.","Br J Anaesth. 1985 Feb;57(2):131-3. doi: 10.1093/bja/57.2.131.","Hull CJ","Br J Anaesth","1985","1985/02/01","","","10.1093/bja/57.2.131"
"2850923","Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice","Leander JD.","Eur J Pharmacol. 1988 Jul 14;151(3):457-61. doi: 10.1016/0014-2999(88)90543-2.","Leander JD","Eur J Pharmacol","1988","1988/07/14","","","10.1016/0014-2999(88)90543-2"
"2850212","Kappa antagonist properties of buprenorphine in the shock titration procedure","Negus SS, Dykstra LA.","Eur J Pharmacol. 1988 Oct 26;156(1):77-86. doi: 10.1016/0014-2999(88)90149-5.","Negus SS","Eur J Pharmacol","1988","1988/10/26","","","10.1016/0014-2999(88)90149-5"
"2845300","[Evaluation of analgesic protection using RIA determination of prolactin, ACTH, cortisol and aldosterone during general anesthesia with enflurane-isoflurane and buprenorphine]","Alteri S, Beruschi M, Bolli L, Fazio R, Maddaloni G, Mammarella M, Mammini R, Paesani G, Poli P, Riccardi R, et al.","Minerva Anestesiol. 1987 Nov;53(11):633-7.","Alteri S","Minerva Anestesiol","1987","1987/11/01","","",""
"2841613","Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of mu opioid receptors in mice","Baba M, Oishi R, Saeki K.","Naunyn Schmiedebergs Arch Pharmacol. 1988 Apr;337(4):423-8. doi: 10.1007/BF00169534.","Baba M","Naunyn Schmiedebergs Arch Pharmacol","1988","1988/04/01","","","10.1007/BF00169534"
"2841602","Neuroadaptation of rats to kappa agonists U-50,488 and tifluadom","Murray C, Cowan A.","NIDA Res Monogr. 1988;81:136-42.","Murray C","NIDA Res Monogr","1988","1988/01/01","","",""
"2840178","[Morphine antagonists (pentazocine, nalorphine, naloxone and buprenophine)]","Fournier T, Besserve P, Lefèvre P, Lephay A, Ossart M.","Cah Anesthesiol. 1988 May;36(3):223-34.","Fournier T","Cah Anesthesiol","1988","1988/05/01","","",""
"2833735","Comparative physical dependence studies in rats with flupirtine and opiate receptor stimulating analgesics","Nickel B, Aledter A.","Postgrad Med J. 1987;63 Suppl 3:41-3.","Nickel B","Postgrad Med J","1987","1987/01/01","","",""
"2832191","Evidence for a differential interaction of buprenorphine with opiate receptor subtypes controlling prolactin secretion","Amoroso S, Di Renzo G, Cuocolo R, Amantea B, Leo A, Taglialatela M, Annunziato L.","Eur J Pharmacol. 1988 Jan 19;145(3):257-60. doi: 10.1016/0014-2999(88)90427-x.","Amoroso S","Eur J Pharmacol","1988","1988/01/19","","","10.1016/0014-2999(88)90427-x"
"2823167","Buprenorphine has potent kappa opioid receptor antagonist activity","Leander JD.","Neuropharmacology. 1987 Sep;26(9):1445-7. doi: 10.1016/0028-3908(87)90112-2.","Leander JD","Neuropharmacology","1987","1987/09/01","","","10.1016/0028-3908(87)90112-2"
"2821559","Effects of mu, kappa and sigma opioids on fixed consecutive number responding in rats","Bronson ME, Moerschbaecher JM.","Pharmacol Biochem Behav. 1987 Aug;27(4):733-43. doi: 10.1016/0091-3057(87)90201-2.","Bronson ME","Pharmacol Biochem Behav","1987","1987/08/01","","","10.1016/0091-3057(87)90201-2"
"2799329","[The course of pain following hospital admission of patients with chronic tumor pain]","Heimgartner D, Senn HJ.","Schweiz Med Wochenschr. 1989 Jul 29;119(30):1040-5.","Heimgartner D","Schweiz Med Wochenschr","1989","1989/07/29","","",""
"2790552","[Peridural anesthesia for thoracic surgery]","Charlet P, Robert D, Kaladji C, Pegoix M, Lochu T, Quesnel J.","Cah Anesthesiol. 1989 Jun-Jul;37(4):279-81.","Charlet P","Cah Anesthesiol","1989","1989/06/01","","",""
"2790101","Treatment of cocaine abuse with buprenorphine","Kosten TR, Kleber HD, Morgan C.","Biol Psychiatry. 1989 Oct;26(6):637-9. doi: 10.1016/0006-3223(89)90090-5.","Kosten TR","Biol Psychiatry","1989","1989/10/01","","","10.1016/0006-3223(89)90090-5"
"2785813","Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac","MacDonald FC, Gough KJ, Nicoll RA, Dow RJ.","Br J Clin Pharmacol. 1989 Apr;27(4):453-9. doi: 10.1111/j.1365-2125.1989.tb05393.x.","MacDonald FC","Br J Clin Pharmacol","1989","1989/04/01","PMC1379724","","10.1111/j.1365-2125.1989.tb05393.x"
"2782578","Treatment of epidural morphine-induced pruritus with buprenorphine","Keaveny JP, Harper NJ.","Anaesthesia. 1989 Aug;44(8):691. doi: 10.1111/j.1365-2044.1989.tb13600.x.","Keaveny JP","Anaesthesia","1989","1989/08/01","","","10.1111/j.1365-2044.1989.tb13600.x"
"2779810","[Continuous intravenous infusion with patient-controlled anesthesia for postoperative analgesia in cesarean section: morphine versus buprenorphine]","Capogna G, Celleno D, Sebastiani M, Costantino P, Reggio S.","Minerva Anestesiol. 1989 Jan-Feb;55(1-2):33-8.","Capogna G","Minerva Anestesiol","1989","1989/01/01","","",""
"2779808","[A combination of buprenorphine and bupivacaine for peridural anesthesia. Our experience]","Gungui P, Sollai T, Solla E, Mannu B, Montisci R.","Minerva Anestesiol. 1989 Jan-Feb;55(1-2):25-8.","Gungui P","Minerva Anestesiol","1989","1989/01/01","","",""
"2778671","Pharmacokinetics of morphine and its surrogates. IX: Discrepancies among infused buprenorphine plasma concentrations sampled from different veins","Garrett ER, Chandran VR.","J Pharm Sci. 1989 Aug;78(8):644-7. doi: 10.1002/jps.2600780809.","Garrett ER","J Pharm Sci","1989","1989/08/01","","","10.1002/jps.2600780809"
"2776393","Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction","Johnson RE, Cone EJ, Henningfield JE, Fudala PJ.","Clin Pharmacol Ther. 1989 Sep;46(3):335-43. doi: 10.1038/clpt.1989.147.","Johnson RE","Clin Pharmacol Ther","1989","1989/09/01","","","10.1038/clpt.1989.147"
"2775626","Pharmacokinetics of intravenous buprenorphine in children","Olkkola KT, Maunuksela EL, Korpela R.","Br J Clin Pharmacol. 1989 Aug;28(2):202-4. doi: 10.1111/j.1365-2125.1989.tb05418.x.","Olkkola KT","Br J Clin Pharmacol","1989","1989/08/01","PMC1379907","","10.1111/j.1365-2125.1989.tb05418.x"
"2774230","Urodynamic studies after intrathecal fentanyl and buprenorphine in the dog","Drenger B, Magora F.","Anesth Analg. 1989 Sep;69(3):348-53.","Drenger B","Anesth Analg","1989","1989/09/01","","",""
"2772637","Buprenorphine suppresses cocaine self-administration by rhesus monkeys","Mello NK, Mendelson JH, Bree MP, Lukas SE.","Science. 1989 Aug 25;245(4920):859-62. doi: 10.1126/science.2772637.","Mello NK","Science","1989","1989/08/25","","","10.1126/science.2772637"
"2771123","[Use of buprenorphine as a cornerstone in narcosis and as analgesic in the postoperative period in gynecologic surgery]","Lodoli L, Ponzi S, Scaricabarozzi I.","Minerva Chir. 1989 Jun 30;44(12):1685-8.","Lodoli L","Minerva Chir","1989","1989/06/30","","",""
"2758241","The antiarrhythmic and cardiac electrophysiological effects of buprenorphine","Boachie-Ansah G, Sitsapesan R, Kane KA, Parratt JR.","Br J Pharmacol. 1989 Jul;97(3):801-8. doi: 10.1111/j.1476-5381.1989.tb12019.x.","Boachie-Ansah G","Br J Pharmacol","1989","1989/07/01","PMC1854585","","10.1111/j.1476-5381.1989.tb12019.x"
"2753313","[Is buprenorphine hepatotoxic?]","Hirschauer C, Guillemot F, Héraud M, Mathieu-Chandelier C, Cortot A, Paris JC.","Gastroenterol Clin Biol. 1989 Jun;13(6-7):636.","Hirschauer C","Gastroenterol Clin Biol","1989","1989/06/01","","",""
"2742099","Effect of buprenorphine on the cardiovascular response to tracheal intubation","Khan FA, Kamal RS.","Anaesthesia. 1989 May;44(5):394-7. doi: 10.1111/j.1365-2044.1989.tb11336.x.","Khan FA","Anaesthesia","1989","1989/05/01","","","10.1111/j.1365-2044.1989.tb11336.x"
"2738496","Sublingual buprenorphine and pethidine for immediate postoperative pain relief in major gynecologic surgery: a comparative study","Tungphaisal S, Chandeying V, Sutthijumroon S, Aeuwpadung S.","J Med Assoc Thai. 1989 Mar;72(3):150-3.","Tungphaisal S","J Med Assoc Thai","1989","1989/03/01","","",""
"2734763","[Buprenorphine (Temgesic)--a new agent for abuse]","Waal H.","Tidsskr Nor Laegeforen. 1989 Apr 30;109(12):1326-7.","Waal H","Tidsskr Nor Laegeforen","1989","1989/04/30","","",""
"2733386","Radioimmunoassay of buprenorphine in urine: studies in patients and in a drug clinic","Hand CW, Ryan KE, Dutt SK, Moore RA, O'Connor J, Talbot D, McQuay HJ.","J Anal Toxicol. 1989 Mar-Apr;13(2):100-4. doi: 10.1093/jat/13.2.100.","Hand CW","J Anal Toxicol","1989","1989/03/01","","","10.1093/jat/13.2.100"
"2733136","[Clinical evaluation of buprenorphine suppositories in postoperative patients--plasma concentrations and effects on the respiratory and circulatory system]","Tashiro C, Takenoshita M, Mori T, Yoshiya I, Terakawa N, Tanizawa O, Yonenobu S, Ono K, Yoshikawa K.","Masui. 1989 Feb;38(2):182-9.","Tashiro C","Masui","1989","1989/02/01","","",""
"2731059","[The use of buprenorphine in the postoperative period in heart surgery. Evaluation of its efficacy and tolerance]","Grill S, Lasalle C, Cousin MT.","Cah Anesthesiol. 1989 Mar-Apr;37(2):89-93.","Grill S","Cah Anesthesiol","1989","1989/03/01","","",""
"2728828","Spinal buprenorphine for postoperative analgesia after caesarean section","Celleno D, Capogna G.","Acta Anaesthesiol Scand. 1989 Apr;33(3):236-8. doi: 10.1111/j.1399-6576.1989.tb02897.x.","Celleno D","Acta Anaesthesiol Scand","1989","1989/04/01","","","10.1111/j.1399-6576.1989.tb02897.x"
"2724512","[Periodic sublingual buprenorphine for pain relief after upper abdominal surgery]","Hayakawa J, Usuda Y, Okutsu Y, Numata K.","Masui. 1989 Apr;38(4):493-7.","Hayakawa J","Masui","1989","1989/04/01","","",""
"2723127","Naloxone suppresses buprenorphine stimulation of plasma prolactin","Mendelson JH, Mello NK, Teoh SK, Lloyd-Jones JG, Clifford JM.","J Clin Psychopharmacol. 1989 Apr;9(2):105-9. doi: 10.1097/00004714-198904000-00006.","Mendelson JH","J Clin Psychopharmacol","1989","1989/04/01","","","10.1097/00004714-198904000-00006"
"2723013","Quantitative determination of buprenorphine and its active metabolite, norbuprenorphine, in human plasma by gas chromatography--chemical ionization mass spectrometry","Ohtani M, Shibuya F, Kotaki H, Uchino K, Saitoh Y, Nakagawa F.","J Chromatogr. 1989 Feb 24;487(2):469-75. doi: 10.1016/s0378-4347(00)83057-1.","Ohtani M","J Chromatogr","1989","1989/02/24","","","10.1016/s0378-4347(00)83057-1"
"2721544","Effects of buprenorphine on motor activity of the sphincter of Oddi in man","Cuer JC, Dapoigny M, Ajmi S, Larpent JL, Lunaud B, Ferrier C, Bommelaer G.","Eur J Clin Pharmacol. 1989;36(2):203-4. doi: 10.1007/BF00609196.","Cuer JC","Eur J Clin Pharmacol","1989","1989/01/01","","","10.1007/BF00609196"
"2721107","Sublingual versus subcutaneous buprenorphine in opiate abusers","Jasinski DR, Fudala PJ, Johnson RE.","Clin Pharmacol Ther. 1989 May;45(5):513-9. doi: 10.1038/clpt.1989.66.","Jasinski DR","Clin Pharmacol Ther","1989","1989/05/01","","","10.1038/clpt.1989.66"
"2719445","[Deafness surgery in adults. The growing role of improved local anesthesia]","Martin C, Navez M, Baylot D, Prades JM.","Ann Otolaryngol Chir Cervicofac. 1989;106(1):65-7.","Martin C","Ann Otolaryngol Chir Cervicofac","1989","1989/01/01","","",""
"2717796","[Addiction to buprenorphine]","Cervera G, Artero A, Redondo A, Guiz J.","Rev Clin Esp. 1989 Feb;184(3):159.","Cervera G","Rev Clin Esp","1989","1989/02/01","","",""
"2708841","Disseminated candidiasis in a drug addict not using heroin","Scheidegger C, Frei R.","J Infect Dis. 1989 May;159(5):1007-8. doi: 10.1093/infdis/159.5.1007-a.","Scheidegger C","J Infect Dis","1989","1989/05/01","","","10.1093/infdis/159.5.1007-a"
"2699011","[Comparison of the use of classic diazoanalgesia in surgery and an applicative variant with buprenorphine]","Manni MP, Aragona P, Borgia ML, Pattumelli MC, Patrizi A, Pelagalli L, Principi F, Altissimi C.","Minerva Anestesiol. 1989 Oct;55(10):397-402.","Manni MP","Minerva Anestesiol","1989","1989/10/01","","",""
"2675644","Rapid detoxification from opioid dependence","Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD.","Am J Psychiatry. 1989 Oct;146(10):1349. doi: 10.1176/ajp.146.10.1349a.","Kosten TR","Am J Psychiatry","1989","1989/10/01","","","10.1176/ajp.146.10.1349a"
"2641039","Combination of naloxone with buprenorphine in humans","Weinhold LL, Bigelow GE, Preston KL.","NIDA Res Monogr. 1989;95:485.","Weinhold LL","NIDA Res Monogr","1989","1989/01/01","","",""
"2641031","Buprenorphine treatment of cocaine abuse","Kosten TR, Morgan CJ, Kleber HD.","NIDA Res Monogr. 1989;95:461.","Kosten TR","NIDA Res Monogr","1989","1989/01/01","","",""
"2641003","Outpatient maintenance/detoxification comparison of methadone and buprenorphine","Johnson RE, Fudala PJ, Collins CC, Jaffe JH.","NIDA Res Monogr. 1989;95:384.","Johnson RE","NIDA Res Monogr","1989","1989/01/01","","",""
"2640985","Buprenorphine suppresses cocaine self-administration in rhesus monkeys","Mello NK, Mendelson JH, Bree MP, Lukas SE.","NIDA Res Monogr. 1989;95:333-4.","Mello NK","NIDA Res Monogr","1989","1989/01/01","","",""
"2633073","[Buprenorphine in balanced anesthesia]","Di Noto M, Morgana G, Piccolo G, Proietti L.","Minerva Anestesiol. 1989 Oct;55(10):409-11.","Di Noto M","Minerva Anestesiol","1989","1989/10/01","","",""
"2627049","[Buprenorphine (Temgesic) can be used in hepatic porphyria]","Deybach JC, Blanloeil Y.","Ann Fr Anesth Reanim. 1989;8(5):525. doi: 10.1016/s0750-7658(89)80022-x.","Deybach JC","Ann Fr Anesth Reanim","1989","1989/01/01","","","10.1016/s0750-7658(89)80022-x"
"2619004","Buprenorphine as a premedicant in phaeochromocytoma","Girotra S, Atray R, Mittal M.","Anaesthesia. 1989 Dec;44(12):1009-10. doi: 10.1111/j.1365-2044.1989.tb09232.x.","Girotra S","Anaesthesia","1989","1989/12/01","","","10.1111/j.1365-2044.1989.tb09232.x"
"2617376","[Buprenorphine in the analgesic treatment of patients subjected to bladder mapping]","Altomare M, Dell'Olio P.","Minerva Urol Nefrol. 1989 Jul-Sep;41(3):199-200.","Altomare M","Minerva Urol Nefrol","1989","1989/07/01","","",""
"2615545","[Prevalence of buprenorphine use by heroin addicts undergoing treatment]","San L, Tremoleda J, Ollé JM, Porta Serra M, de la Torre R.","Med Clin (Barc). 1989 Nov 25;93(17):645-8.","San L","Med Clin (Barc)","1989","1989/11/25","","",""
"2614900","[Influence of four opioids on pulmonary oxygenation and naloxone's effects in mechanically ventilated dogs]","Takahashi H, Dohi S, Matsumiya N, Takeshima R, Naito H.","Masui. 1989 Jul;38(7):880-7.","Takahashi H","Masui","1989","1989/07/01","","",""
"2608988","[Data on buprenorphine consumption in drug addicted individuals]","Segui J, Cascio A, Soler Insa JM.","Rev Clin Esp. 1989 Oct;185(5):271-2.","Segui J","Rev Clin Esp","1989","1989/10/01","","",""
"2597815","Emergence of buprenorphine dependence","Gray RF, Ferry A, Jauhar P.","Br J Addict. 1989 Nov;84(11):1373-4. doi: 10.1111/j.1360-0443.1989.tb00745.x.","Gray RF","Br J Addict","1989","1989/11/01","","","10.1111/j.1360-0443.1989.tb00745.x"
"2579784","[Long-term therapy of cancer pain. A controlled study on buprenorphine]","Zenz M, Piepenbrock S, Tryba M, Glocke M, Everlien M, Klauke W.","Dtsch Med Wochenschr. 1985 Mar 22;110(12):448-53. doi: 10.1055/s-2008-1068844.","Zenz M","Dtsch Med Wochenschr","1985","1985/03/22","","","10.1055/s-2008-1068844"
"2577247","Antinociceptive effects of localized administration of opioids compared with lidocaine","Hassan HG, Pilcher CW, Akerman B, Renck H.","Reg Anesth. 1989 May-Jun;14(3):138-44.","Hassan HG","Reg Anesth","1989","1989/05/01","","",""
"2577032","Use of the formalin test in evaluating analgesics","Cowan A, Porreca F, Wheeler H.","NIDA Res Monogr. 1989;95:116-22.","Cowan A","NIDA Res Monogr","1989","1989/01/01","","",""
"2576057","The systemic availability of buprenorphine administered by nasal spray","Eriksen J, Jensen NH, Kamp-Jensen M, Bjarnø H, Friis P, Brewster D.","J Pharm Pharmacol. 1989 Nov;41(11):803-5. doi: 10.1111/j.2042-7158.1989.tb06374.x.","Eriksen J","J Pharm Pharmacol","1989","1989/11/01","","","10.1111/j.2042-7158.1989.tb06374.x"
"2572707","From the Alcohol, Drug Abuse, and Mental Health Administration","Goodwin FK.","JAMA. 1989 Nov 17;262(19):2654.","Goodwin FK","JAMA","1989","1989/11/17","","",""
"2569364","A comparison of the incidence of pruritus following epidural opioid administration in the parturient","Ackerman WE, Juneja MM, Kaczorowski DM, Colclough GW.","Can J Anaesth. 1989 Jul;36(4):388-91. doi: 10.1007/BF03005335.","Ackerman WE","Can J Anaesth","1989","1989/07/01","","","10.1007/BF03005335"
"2566343","Buprenorphine and temazepam abuse by drug takers in Glasgow--an increase","Sakol MS, Stark C, Sykes R.","Br J Addict. 1989 Apr;84(4):439-41. doi: 10.1111/j.1360-0443.1989.tb00589.x.","Sakol MS","Br J Addict","1989","1989/04/01","","","10.1111/j.1360-0443.1989.tb00589.x"
"2561845","Kappa antagonist effects of buprenorphine in the rat drug-discrimination procedure","Negus SS, Picker MJ, Dykstra LA.","NIDA Res Monogr. 1989;95:518-9.","Negus SS","NIDA Res Monogr","1989","1989/01/01","","",""
"2559806","Comparative effects of the opioids fentanyl and buprenorphine on ventricular vulnerability during acute coronary artery occlusion","Saini V, Carr DB, Verrier RL.","Cardiovasc Res. 1989 Dec;23(12):1001-6. doi: 10.1093/cvr/23.12.1001.","Saini V","Cardiovasc Res","1989","1989/12/01","","","10.1093/cvr/23.12.1001"
"2546225","Pharmacokinetics of [3H]-buprenorphine in the rat","Holland MJ, Carr KD, Simon EJ.","Res Commun Chem Pathol Pharmacol. 1989 Apr;64(1):3-16.","Holland MJ","Res Commun Chem Pathol Pharmacol","1989","1989/04/01","","",""
"2545795","Opioid receptors in human neoplasms: growth hormone and prolactin response to morphine, met-enkephalin and buprenorphine in cancer patients","Lissoni P, Barni S, Garuti F, Astuti R, Tancini G.","Int J Biol Markers. 1989 Jan-Mar;4(1):55-6.","Lissoni P","Int J Biol Markers","1989","1989/01/01","","",""
"2543017","Kappa antagonist properties of buprenorphine in non-tolerant and morphine-tolerant rats","Negus SS, Picker MJ, Dykstra LA.","Psychopharmacology (Berl). 1989;98(1):141-3. doi: 10.1007/BF00442021.","Negus SS","Psychopharmacology (Berl)","1989","1989/01/01","","","10.1007/BF00442021"
"2520961","The use of intrathecal morphine in thoracic anesthesia","Hentz JG, Valle-Robillart A, Franckhauser J, Froehly S, Dupeyron JP.","J Cardiothorac Anesth. 1989 Oct;3(5 Suppl 1):24. doi: 10.1016/0888-6296(89)90767-9.","Hentz JG","J Cardiothorac Anesth","1989","1989/10/01","","","10.1016/0888-6296(89)90767-9"
"2520912","Variations in hemodynamic and stress hormonal responses in open heart surgery with buprenorphine/diazepam anesthesia","Okutani R, Kono K, Kinoshita O, Nakamura H, Ishida H, Philbin DM.","J Cardiothorac Anesth. 1989 Aug;3(4):401-6. doi: 10.1016/s0888-6296(89)97267-0.","Okutani R","J Cardiothorac Anesth","1989","1989/08/01","","","10.1016/s0888-6296(89)97267-0"
"2520396","Continuous subcutaneous infusion of buprenorphine for cancer pain control","Noda J, Umeda S, Arai T, Harima A, Mori K.","Clin J Pain. 1989 Jun;5(2):147-52. doi: 10.1097/00002508-198906000-00004.","Noda J","Clin J Pain","1989","1989/06/01","","","10.1097/00002508-198906000-00004"
"2519136","Buprenorphine is now a controlled drug","","Drug Ther Bull. 1989 Oct 16;27(21):84.","","Drug Ther Bull","1989","1989/10/16","","",""
"2497861","Hallucinations after epidural buprenorphine","MacEvilly M, O'Carroll C.","BMJ. 1989 Apr 8;298(6678):928-9. doi: 10.1136/bmj.298.6678.928-a.","MacEvilly M","BMJ","1989","1989/04/08","PMC1836218","","10.1136/bmj.298.6678.928-a"
"2491980","Naloxone reversal of buprenorphine-induced respiratory depression","Gal TJ.","Clin Pharmacol Ther. 1989 Jan;45(1):66-71. doi: 10.1038/clpt.1989.10.","Gal TJ","Clin Pharmacol Ther","1989","1989/01/01","","","10.1038/clpt.1989.10"
"2488032","Esthesiometric evaluations of corneal anesthesia and prolonged analgesia in rabbits","Trevithick JR, Dzialoszynski T, Hirst M, Cullen AP.","Lens Eye Toxic Res. 1989;6(1-2):387-93.","Trevithick JR","Lens Eye Toxic Res","1989","1989/01/01","","",""
"2486654","Brachial plexus block with opioids for postoperative pain relief: comparison between buprenorphine and morphine","Viel EJ, Eledjam JJ, De La Coussaye JE, D'Athis F.","Reg Anesth. 1989 Nov-Dec;14(6):274-8.","Viel EJ","Reg Anesth","1989","1989/11/01","","",""
"2486625","[Evaluation of treatment of acute myocardial infarction before admission to a coronary care unit]","Mizobe Y, Ohishi T, Yasukawa T.","J Cardiol. 1989 Dec;19(4):1045-52.","Mizobe Y","J Cardiol","1989","1989/12/01","","",""
"2473187","Drug discrimination in human postaddicts: agonist-antagonist opioids","Preston KL, Bigelow GE, Bickel WK, Liebson IA.","J Pharmacol Exp Ther. 1989 Jul;250(1):184-96.","Preston KL","J Pharmacol Exp Ther","1989","1989/07/01","","",""
"2465994","[Treatment of cancer pain with buprenorphine. Personal experience]","Trombatore G, Pontillo T, Tropea C, Li Destri G, Scilletta B, Racalbuto A, Di Cataldo A, Russello D, Puleo S.","G Ital Oncol. 1988 Jul-Dec;8(3-4):113-5.","Trombatore G","G Ital Oncol","1988","1988/07/01","","",""
"2459370","Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans","Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE.","J Pharmacol Exp Ther. 1988 Oct;247(1):47-53.","Bickel WK","J Pharmacol Exp Ther","1988","1988/10/01","","",""
"2458208","Sublingual absorption of selected opioid analgesics","Weinberg DS, Inturrisi CE, Reidenberg B, Moulin DE, Nip TJ, Wallenstein S, Houde RW, Foley KM.","Clin Pharmacol Ther. 1988 Sep;44(3):335-42. doi: 10.1038/clpt.1988.159.","Weinberg DS","Clin Pharmacol Ther","1988","1988/09/01","","","10.1038/clpt.1988.159"
"2457160","Drug discrimination in human post-addicts: agonist/antagonist opioids","Preston K, Bigelow G, Bickel W, Liebson I.","NIDA Res Monogr. 1988;81:209-15.","Preston K","NIDA Res Monogr","1988","1988/01/01","","",""
"2454440","Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","Arnér S, Meyerson BA.","Pain. 1988 Apr;33(1):11-23. doi: 10.1016/0304-3959(88)90198-4.","Arnér S","Pain","1988","1988/04/01","","","10.1016/0304-3959(88)90198-4"
"2453895","Buprenorphine and naloxone alone and in combination in opioid-dependent humans","Preston KL, Bigelow GE, Liebson IA.","Psychopharmacology (Berl). 1988;94(4):484-90. doi: 10.1007/BF00212842.","Preston KL","Psychopharmacology (Berl)","1988","1988/01/01","","","10.1007/BF00212842"
"2449618","A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties","Bickel WK, Johnson RE, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR.","NIDA Res Monogr. 1987;76:182-8.","Bickel WK","NIDA Res Monogr","1987","1987/01/01","","",""
"2449616","Abuse liability assessment of buprenorphine-naloxone combinations","Bigelow GE, Preston KL, Liebson IA.","NIDA Res Monogr. 1987;76:145-9.","Bigelow GE","NIDA Res Monogr","1987","1987/01/01","","",""
"2442668","[Acute study of parenteral buprenorphine versus parenteral morphine]","Ripamonti C, De Conno F, Tamburini M, Ventafridda V.","Minerva Anestesiol. 1987 Apr;53(4):135-9.","Ripamonti C","Minerva Anestesiol","1987","1987/04/01","","",""
"2430191","Withdrawal responses of guinea-pig isolated ileum following brief exposure to opiates and opioid peptides","Chahl LA.","Naunyn Schmiedebergs Arch Pharmacol. 1986 Aug;333(4):387-92. doi: 10.1007/BF00500014.","Chahl LA","Naunyn Schmiedebergs Arch Pharmacol","1986","1986/08/01","","","10.1007/BF00500014"
"2429532","[A study on hemorrhage during and after operation of TURP (transurethral prostatic resection)--effect of morphine or buprenorphine for suppression of postoperative hemorrhage by epidural infusion]","Kato H, Saito M, Kaneto H, Irisawa C.","Hinyokika Kiyo. 1986 Jun;32(6):827-33.","Kato H","Hinyokika Kiyo","1986","1986/06/01","","",""
"2395965","[Systemic application of opiates in dentistry (2)]","Otto S.","Quintessenz. 1990 Mar;41(3):493-9.","Otto S","Quintessenz","1990","1990/03/01","","",""
"2395958","[Systematic application of opiates in dentistry (1)]","Otto S.","Quintessenz. 1990 Feb;41(2):303-10.","Otto S","Quintessenz","1990","1990/02/01","","",""
"2395121","Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys","Mello NK, Mendelson JH, Bree MP, Lukas SE.","J Pharmacol Exp Ther. 1990 Sep;254(3):926-39.","Mello NK","J Pharmacol Exp Ther","1990","1990/09/01","","",""
"2394102","Buprenorphine sedation of intensive care patients and ileus reversal","Gawrisch E, Cheng EY.","Crit Care Med. 1990 Sep;18(9):1034-6. doi: 10.1097/00003246-199009000-00022.","Gawrisch E","Crit Care Med","1990","1990/09/01","","","10.1097/00003246-199009000-00022"
"2393441","Rapid opioid detoxification with electrosleep and naloxone","Westermeyer J.","Am J Psychiatry. 1990 Jul;147(7):952-3. doi: 10.1176/ajp.147.7.952b.","Westermeyer J","Am J Psychiatry","1990","1990/07/01","","","10.1176/ajp.147.7.952b"
"2393107","1,4-Benzodiazepines antagonize opiate-induced antinociception in mice","Rosland JH, Hole K.","Anesth Analg. 1990 Sep;71(3):242-8. doi: 10.1213/00000539-199009000-00005.","Rosland JH","Anesth Analg","1990","1990/09/01","","","10.1213/00000539-199009000-00005"
"2384956","[Effects of narcotic analgesics on somatosympathetic reflex discharges in anesthetized cats: buprenorphine and naloxone]","Kato J, Saeki S, Ogawa S.","Masui. 1990 May;39(5):605-12.","Kato J","Masui","1990","1990/05/01","","",""
"2384948","[Is epidural buprenorphine with nitrous oxide-oxygen-enflurane anesthesia indicated for surgery of short-duration?]","Satoh K, Ohe Y.","Masui. 1990 May;39(5):554-8.","Satoh K","Masui","1990","1990/05/01","","",""
"2384583","Analysis of buprenorphine in plasma and urine by gas chromatography","Martínez D, Jurado MC, Repetto M.","J Chromatogr. 1990 Jun 29;528(2):459-63. doi: 10.1016/s0378-4347(00)82404-4.","Martínez D","J Chromatogr","1990","1990/06/29","","","10.1016/s0378-4347(00)82404-4"
"2372154","[Postoperative analgesia after cesarean section: sublingual buprenorphine versus subcutaneous morphine]","Abid A, Benhamou D, Labaille T.","Ann Fr Anesth Reanim. 1990;9(3):275-9. doi: 10.1016/s0750-7658(05)80186-8.","Abid A","Ann Fr Anesth Reanim","1990","1990/01/01","","","10.1016/s0750-7658(05)80186-8"
"2362343","[Comparison of intravenous buprenorphine or fentanyl and epidural buprenorphine for pain relief after upper abdominal surgery]","Yasuda S, Hiyama A, Shigematsu T, Kaneko S, Miyazawa N, Tabuchi H, Toyoda Y, Tatara T.","Masui. 1990 Apr;39(4):487-90.","Yasuda S","Masui","1990","1990/04/01","","",""
"2356939","Postoperative analgesia in children who have genito-urinary surgery. A comparison between caudal buprenorphine and bupivacaine","Girotra S, Kumar S, Rajendran KM.","Anaesthesia. 1990 May;45(5):406-8. doi: 10.1111/j.1365-2044.1990.tb14788.x.","Girotra S","Anaesthesia","1990","1990/05/01","","","10.1111/j.1365-2044.1990.tb14788.x"
"2349809","[The effect of lung diminishing interventions on immediate postoperative lung function and their modification by various forms of analgesia]","Horch R, Krönung G, Westhofen P, Giebel GD.","Z Erkr Atmungsorgane. 1990;174(2):113-20.","Horch R","Z Erkr Atmungsorgane","1990","1990/01/01","","",""
"2340348","Pharmacokinetics of morphine and its surrogates. X: Analyses and pharmacokinetics of buprenorphine in dogs","Garrett ER, Chandran VR.","Biopharm Drug Dispos. 1990 May-Jun;11(4):311-50. doi: 10.1002/bdd.2510110403.","Garrett ER","Biopharm Drug Dispos","1990","1990/05/01","","","10.1002/bdd.2510110403"
"2328561","Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal","Fudala PJ, Jaffe JH, Dax EM, Johnson RE.","Clin Pharmacol Ther. 1990 Apr;47(4):525-34. doi: 10.1038/clpt.1990.67.","Fudala PJ","Clin Pharmacol Ther","1990","1990/04/01","","","10.1038/clpt.1990.67"
"2328175","Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites","Hand CW, Sear JW, Uppington J, Ball MJ, McQuay HJ, Moore RA.","Br J Anaesth. 1990 Mar;64(3):276-82. doi: 10.1093/bja/64.3.276.","Hand CW","Br J Anaesth","1990","1990/03/01","","","10.1093/bja/64.3.276"
"2323312","Opioid antagonist challenges in buprenorphine maintained patients","Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD.","Drug Alcohol Depend. 1990 Feb;25(1):73-8. doi: 10.1016/0376-8716(90)90144-4.","Kosten TR","Drug Alcohol Depend","1990","1990/02/01","","","10.1016/0376-8716(90)90144-4"
"2313769","Depressive symptoms during buprenorphine treatment of opioid abusers","Kosten TR, Morgan C, Kosten TA.","J Subst Abuse Treat. 1990;7(1):51-4. doi: 10.1016/0740-5472(90)90035-o.","Kosten TR","J Subst Abuse Treat","1990","1990/01/01","","","10.1016/0740-5472(90)90035-o"
"2311163","Epidural buprenorphine","Fox AW.","Can J Anaesth. 1990 Mar;37(2):273-4. doi: 10.1007/BF03005496.","Fox AW","Can J Anaesth","1990","1990/03/01","","","10.1007/BF03005496"
"2309545","Sublingual buprenorphine as postoperative analgesic: a double-blind comparison with pethidine","Moa G, Zetterström H.","Acta Anaesthesiol Scand. 1990 Jan;34(1):68-71. doi: 10.1111/j.1399-6576.1990.tb03044.x.","Moa G","Acta Anaesthesiol Scand","1990","1990/01/01","","","10.1111/j.1399-6576.1990.tb03044.x"
"2305652","Subarachnoid buprenorphine administered by implantable micropumps","Francaviglia N, Silvestro C, Carta F, Davini V, Perria C, Scaricabarozzi I, Cipolla PV.","Acta Neurochir (Wien). 1990;102(1-2):62-8. doi: 10.1007/BF01402188.","Francaviglia N","Acta Neurochir (Wien)","1990","1990/01/01","","","10.1007/BF01402188"
"2304681","The safety of buprenorphine (Temgesic)","Varey NC.","N Z Med J. 1990 Jan 24;103(882):24.","Varey NC","N Z Med J","1990","1990/01/24","","",""
"2304255","[Epidural buprenorphine with nitrous oxide-oxygen-enflurane anesthesia]","Satoh K, Ohe Y.","Masui. 1990 Jan;39(1):8-12.","Satoh K","Masui","1990","1990/01/01","","",""
"2304247","[Epidural morphine and buprenorphine for postoperative pain relief after hepatectomy]","Takata T, Yukioka H, Fujimori M.","Masui. 1990 Jan;39(1):13-8.","Takata T","Masui","1990","1990/01/01","","",""
"2290501","[Continuous peridural administration of bupivacaine and buprenorphine: effect on labor]","Bifarini G, Ciammitti B, Falconi S, Spaccatini A.","Minerva Anestesiol. 1990 Oct;56(10):1047-9.","Bifarini G","Minerva Anestesiol","1990","1990/10/01","","",""
"2290047","[Epidural anesthesia with buprenorphine for chest surgery and its prophylactic effects of postoperative pulmonary complications]","Kuda T, Hara N, Kubota I, Chikama H, Motohiro A, Ichinose Y, Ohta M.","Nihon Kyobu Geka Gakkai Zasshi. 1990 Dec;38(12):2376-9.","Kuda T","Nihon Kyobu Geka Gakkai Zasshi","1990","1990/12/01","","",""
"2289007","Buprenorphine responders","Mongan L, Callaway E.","Biol Psychiatry. 1990 Dec 15;28(12):1078-80. doi: 10.1016/0006-3223(90)90619-d.","Mongan L","Biol Psychiatry","1990","1990/12/15","","","10.1016/0006-3223(90)90619-d"
"2286420","Effects of morphine, buprenorphine, pentazocine and nalorphine on acquisition and extinction of active avoidance responses in rats","Saha N, Datta H, Sharma PL.","Indian J Physiol Pharmacol. 1990 Jul;34(3):179-82.","Saha N","Indian J Physiol Pharmacol","1990","1990/07/01","","",""
"2265296","Buprenorphine abuse: report from India","Chowdhury AN, Chowdhury S.","Br J Addict. 1990 Oct;85(10):1349-50. doi: 10.1111/j.1360-0443.1990.tb01612.x.","Chowdhury AN","Br J Addict","1990","1990/10/01","","","10.1111/j.1360-0443.1990.tb01612.x"
"2255932","A comparison of buprenorphine and pethidine in analgesic supplemented anaesthesia","Khan FA, Kamal RS.","Singapore Med J. 1990 Aug;31(4):345-9.","Khan FA","Singapore Med J","1990","1990/08/01","","",""
"2255039","[Cardiovascular changes after intubation and at the time of incision during nitrous oxide-oxygen anesthesia with epidural buprenorphine]","Iwade M, Satoh K, Ohe Y.","Masui. 1990 Oct;39(10):1339-42.","Iwade M","Masui","1990","1990/10/01","","",""
"2247319","Intrathecal etorphine, fentanyl and buprenorphine on spinal nociceptive neurones in the rat","Dickenson AH, Sullivan AF, McQuay HJ.","Pain. 1990 Aug;42(2):227-34. doi: 10.1016/0304-3959(90)91166-g.","Dickenson AH","Pain","1990","1990/08/01","","","10.1016/0304-3959(90)91166-g"
"2243541","Buprenorphine-induced pupillary effects in human volunteers","Pickworth WB, Lee H, Fudala PJ.","Life Sci. 1990;47(14):1269-77. doi: 10.1016/0024-3205(90)90220-l.","Pickworth WB","Life Sci","1990","1990/01/01","","","10.1016/0024-3205(90)90220-l"
"2240504","Total intravenous anaesthesia with propofol and buprenorphine","Kamal RS, Khan FA, Khan FH.","Anaesthesia. 1990 Oct;45(10):865-70. doi: 10.1111/j.1365-2044.1990.tb14574.x.","Kamal RS","Anaesthesia","1990","1990/10/01","","","10.1111/j.1365-2044.1990.tb14574.x"
"2236778","[Intramuscular buprenorphine in the symptomatic treatment of renal colic]","González Ramallo VJ, Muiño Míguez A, Rodríguez de Castro E, Lázaro Bermejo C.","Rev Clin Esp. 1990 May;186(8):414.","González Ramallo VJ","Rev Clin Esp","1990","1990/05/01","","",""
"2209411","Safety and side-effects of buprenorphine in the clinical management of heroin addiction","Lange WR, Fudala PJ, Dax EM, Johnson RE.","Drug Alcohol Depend. 1990 Aug;26(1):19-28. doi: 10.1016/0376-8716(90)90078-s.","Lange WR","Drug Alcohol Depend","1990","1990/08/01","","","10.1016/0376-8716(90)90078-s"
"2197054","Clinical toxicology of drugs used in the treatment of opiate dependency","Fraser AD.","Clin Lab Med. 1990 Jun;10(2):375-86.","Fraser AD","Clin Lab Med","1990","1990/06/01","","",""
"2194053","[Influence of intrathecal morphine and buprenorphine on EEG and their analgesic effect]","Yonemura E, Shimada M, Nakamura M, Fukushima K.","Masui. 1990 Apr;39(4):478-86.","Yonemura E","Masui","1990","1990/04/01","","",""
"2192406","[Postoperative peridural analgesia via catheter following abdominal surgery. Peridural bupivacaine versus buprenorphine]","Seeling W, Kustermann J, Schneider E.","Reg Anaesth. 1990 May;13(3):78-87.","Seeling W","Reg Anaesth","1990","1990/05/01","","",""
"2179136","Haematogenous Serratia marcescens endophthalmitis in an HIV-infected intravenous drug addict","Alvarez R, Adan A, Martinez JA, Casale A, Miro JM.","Infection. 1990 Jan-Feb;18(1):29-30. doi: 10.1007/BF01644178.","Alvarez R","Infection","1990","1990/01/01","","","10.1007/BF01644178"
"2172186","Facile synthesis of [11C]buprenorphine for positron emission tomographic studies of opioid receptors","Lever JR, Mazza SM, Dannals RF, Ravert HT, Wilson AA, Wagner HN Jr.","Int J Rad Appl Instrum A. 1990;41(8):745-52. doi: 10.1016/0883-2889(90)90022-9.","Lever JR","Int J Rad Appl Instrum A","1990","1990/01/01","","","10.1016/0883-2889(90)90022-9"
"2160444","No-carrier-added (NCA) N-(3-[18F]fluoropropyl)-N-norbuprenorphine and N-(3-[18F]fluoropropyl)-N-nordiprenorphine--synthesis, anatomical distribution in mice and rats, and tomographic studies in a baboon","Bai LQ, Teng RR, Shiue CY, Wolf AP, Dewey SL, Holland MJ, Simon EJ.","Int J Rad Appl Instrum B. 1990;17(2):217-27. doi: 10.1016/0883-2897(90)90150-y.","Bai LQ","Int J Rad Appl Instrum B","1990","1990/01/01","","","10.1016/0883-2897(90)90150-y"
"2159077","From the Alcohol, Drug Abuse, and Mental Health Administration","Goodwin FK.","JAMA. 1990 May 23-30;263(20):2725.","Goodwin FK","JAMA","1990","1990/05/23","","",""
"2127853","Effects on opioid-induced rate reductions by doxepin and bupropion","Macenski MJ, Cleary J, Thompson T.","Pharmacol Biochem Behav. 1990 Oct;37(2):247-52. doi: 10.1016/0091-3057(90)90329-g.","Macenski MJ","Pharmacol Biochem Behav","1990","1990/10/01","","","10.1016/0091-3057(90)90329-g"
"2090691","Emergence of buprenorphine addiction","Chowdhury S, Chowdhury AN.","J Indian Med Assoc. 1990 Oct;88(10):294.","Chowdhury S","J Indian Med Assoc","1990","1990/10/01","","",""
"2088160","[Effect of buprenorphine on external pancreatic secretion in rats]","Nagain C, Chariot J, Roze C, Vaille C.","Ann Pharm Fr. 1990;48(5):248-54.","Nagain C","Ann Pharm Fr","1990","1990/01/01","","",""
"2071440","A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PET","Shiue CY, Bai LQ, Teng RR, Arnett CD, Dewey SL, Wolf AP, McPherson DW, Fowler JS, Logan J, Holland MJ, et al.","Int J Rad Appl Instrum B. 1991;18(3):281-8. doi: 10.1016/0883-2897(91)90123-3.","Shiue CY","Int J Rad Appl Instrum B","1991","1991/01/01","","","10.1016/0883-2897(91)90123-3"
"2069536","The ambulation-increasing effect of buprenorphine in mice: comparison with the effect of morphine","Kuribara H, Tadokoro S.","Arukoru Kenkyuto Yakubutsu Ison. 1991 Feb;26(1):37-48.","Kuribara H","Arukoru Kenkyuto Yakubutsu Ison","1991","1991/02/01","","",""
"2065712","Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross-tolerance to morphine","Kayser V, Besson JM, Guilbaud G.","Eur J Pharmacol. 1991 Mar 19;195(1):37-45. doi: 10.1016/0014-2999(91)90379-5.","Kayser V","Eur J Pharmacol","1991","1991/03/19","","","10.1016/0014-2999(91)90379-5"
"2062170","Intravenous buprenorphine reduces pupil size and the light reflex in humans","Pickworth WB, Bunker E, Welch P, Cone E.","Life Sci. 1991;49(2):129-38. doi: 10.1016/0024-3205(91)90026-8.","Pickworth WB","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90026-8"
"2057087","[Use of propofol and buprenorphine for total intravenous anesthesia]","Pulito G, Marasi G, Paolucci R, Borghesi L, Monti P.","Minerva Anestesiol. 1991 Jan-Feb;57(1-2):29-34.","Pulito G","Minerva Anestesiol","1991","1991/01/01","","",""
"2055424","Buprenorphine: bell-shaped dose-response curve for its antagonist effects","Lizasoain I, Leza JC, Lorenzo P.","Gen Pharmacol. 1991;22(2):297-300. doi: 10.1016/0306-3623(91)90452-c.","Lizasoain I","Gen Pharmacol","1991","1991/01/01","","","10.1016/0306-3623(91)90452-c"
"2050347","Buprenorphine: beyond methadone?","Rosen MI, Kosten TR.","Hosp Community Psychiatry. 1991 Apr;42(4):347-9. doi: 10.1176/ps.42.4.347.","Rosen MI","Hosp Community Psychiatry","1991","1991/04/01","","","10.1176/ps.42.4.347"
"2046436","[Veterinary drugs: a new source of drug abuse?]","López Briz E, Barreda Aznar A, Guevara Serrano J, Blasco Mascaró.","Med Clin (Barc). 1991 Mar 23;96(11):437.","López Briz E","Med Clin (Barc)","1991","1991/03/23","","",""
"2044393","Ketorolac, a new non-opioid analgesic: a single-blind trial versus buprenorphine in pain after orthopaedic surgery","Cañadell-Carafi J, Moreno-Londoño A, González-Caudevilla B.","Curr Med Res Opin. 1991;12(6):343-9. doi: 10.1185/03007999109111503.","Cañadell-Carafi J","Curr Med Res Opin","1991","1991/01/01","","","10.1185/03007999109111503"
"2033521","Tolerance to morphine-like stimulus effects of mu opioid agonists","Young AM, Kapitsopoulos G, Makhay MM.","J Pharmacol Exp Ther. 1991 May;257(2):795-805.","Young AM","J Pharmacol Exp Ther","1991","1991/05/01","","",""
"2032058","Effect of scheduling of buprenorphine (Temgesic) on drug abuse patterns in Glasgow","Stewart MJ.","BMJ. 1991 Apr 20;302(6782):969. doi: 10.1136/bmj.302.6782.969-a.","Stewart MJ","BMJ","1991","1991/04/20","PMC1669491","","10.1136/bmj.302.6782.969-a"
"2032057","Abuse of buprenorphine (Temgesic) by snorting","Strang J.","BMJ. 1991 Apr 20;302(6782):969. doi: 10.1136/bmj.302.6782.969-b.","Strang J","BMJ","1991","1991/04/20","PMC1669456","","10.1136/bmj.302.6782.969-b"
"2020470","MST continus: morphine 200 mg: big dose--big money","Miller AJ.","N Z Med J. 1991 Apr 24;104(910):171.","Miller AJ","N Z Med J","1991","1991/04/24","","",""
"1988653","Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse","Brown EE, Finlay JM, Wong JT, Damsma G, Fibiger HC.","J Pharmacol Exp Ther. 1991 Jan;256(1):119-26.","Brown EE","J Pharmacol Exp Ther","1991","1991/01/01","","",""
"1979183","[Pharmacologic correction of postradiation changes of pain sensitivity in rats]","Abdrakhmanov AA, Aĭtkhozhina GK.","Radiobiologiia. 1990 Sep-Oct;30(5):647-50.","Abdrakhmanov AA","Radiobiologiia","1990","1990/09/01","","",""
"1972904","Haemodynamic effects of i.m. opioids for analgesia during ventilator treatment after oesophagectomy","Yukioka H, Fujimori M.","Can J Anaesth. 1990 May;37(4 Pt 2):S115.","Yukioka H","Can J Anaesth","1990","1990/05/01","","",""
"1969472","Analgesia produced by E-2078, a systemically active dynorphin analog, in mice","Nakazawa T, Furuya Y, Kaneko T, Yamatsu K, Yoshino H, Tachibana S.","J Pharmacol Exp Ther. 1990 Mar;252(3):1247-54.","Nakazawa T","J Pharmacol Exp Ther","1990","1990/03/01","","",""
"1969295","Buprenorphine and temazepam--abuse","Hammersley R, Lavelle T, Forsyth A.","Br J Addict. 1990 Feb;85(2):301-3. doi: 10.1111/j.1360-0443.1990.tb03088.x.","Hammersley R","Br J Addict","1990","1990/02/01","","","10.1111/j.1360-0443.1990.tb03088.x"
"1965748","Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure","Negus SS, Picker MJ, Dykstra LA.","Psychopharmacology (Berl). 1990;102(4):465-73. doi: 10.1007/BF02247126.","Negus SS","Psychopharmacology (Berl)","1990","1990/01/01","","","10.1007/BF02247126"
"1961493","[Postoperative analgesia with buprenorphine: comparison of administration routes]","Costantino P, Celleno D, Sebastiani M, Capogna G, Varrassi G.","Minerva Anestesiol. 1991 Oct;57(10):1100-1.","Costantino P","Minerva Anestesiol","1991","1991/10/01","","",""
"1961484","[Safety of patient controlled analgesia in the geriatric patient]","Santangelo E, Savoia G, Scopa C, Barone P, Massa MG, De Martino G.","Minerva Anestesiol. 1991 Oct;57(10):1080-1.","Santangelo E","Minerva Anestesiol","1991","1991/10/01","","",""
"1952031","Caudal buprenorphine in children: where should they be nursed","Striebel HW, Gottschalk B.","Anaesthesia. 1991 Oct;46(10):899-900. doi: 10.1111/j.1365-2044.1991.tb09641.x.","Striebel HW","Anaesthesia","1991","1991/10/01","","","10.1111/j.1365-2044.1991.tb09641.x"
"1950193","[Premedication and analgesic dose procedures in dental medicine]","Lipp M, Daubländer M.","Zahnarztl Prax. 1991 Jul 12;42(7):250, 253-4.","Lipp M","Zahnarztl Prax","1991","1991/07/12","","",""
"1943479","Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment","Kosten TA, Marby DW, Nestler EJ.","Life Sci. 1991;49(24):PL201-6. doi: 10.1016/0024-3205(91)90490-3.","Kosten TA","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90490-3"
"1932153","The use of buprenorphine and temazepam by drug injectors","Lavelle TL, Hammersley R, Forsyth A.","J Addict Dis. 1991;10(3):5-14. doi: 10.1300/J069v10n03_02.","Lavelle TL","J Addict Dis","1991","1991/01/01","","","10.1300/J069v10n03_02"
"1932148","Buprenorphine and cocaine addiction: the need for caution","Stimmel B.","J Addict Dis. 1991;10(3):1-4. doi: 10.1300/J069v10n03_01.","Stimmel B","J Addict Dis","1991","1991/01/01","","","10.1300/J069v10n03_01"
"1927058","Effects of repeated administration of buprenorphine on ambulatory activity in mice","Kuribara H, Katsuya T, Asahi T, Tadokoro S.","Yakubutsu Seishin Kodo. 1991 Apr;11(2):123-7.","Kuribara H","Yakubutsu Seishin Kodo","1991","1991/04/01","","",""
"1924919","[The prevalence of buprenorphine consumption in a sample of outpatient drug abusers]","Seguí J, Cascio A, Aragón C, Llovet JM, Soler JM, Salvador L.","Rev Clin Esp. 1991 Jun;189(1):14-7.","Seguí J","Rev Clin Esp","1991","1991/06/01","","",""
"1922859","[The use of propofol in combination with fentanyl or buprenorphine in long-duration anesthesia]","Tempia A, Cerutti F, Fiore G, Balagna R, Lusso C, Pattono R.","Minerva Anestesiol. 1991 Apr;57(4):123-30.","Tempia A","Minerva Anestesiol","1991","1991/04/01","","",""
"1920787","[Continuous intravenous infusion of pethidine or buprenorphine for postoperative analgesia]","Mitsuhata H, Matsumoto S, Hasegawa J, Ohtaka K.","Masui. 1991 Jul;40(7):1123-7.","Mitsuhata H","Masui","1991","1991/07/01","","",""
"1912151","[Subgroups of drug abuse patients who consume buprenorphine]","Seguí J, Cascio A, Aragón C, Llovet JM, Soler JM, Salvador L.","An Med Interna. 1991 Jan;8(1):18-22.","Seguí J","An Med Interna","1991","1991/01/01","","",""
"1907922","Buprenorphine and morphine cause antinociception by different transduction mechanisms","Wheeler-Aceto H, Cowan A.","Eur J Pharmacol. 1991 Apr 3;195(3):411-3. doi: 10.1016/0014-2999(91)90485-9.","Wheeler-Aceto H","Eur J Pharmacol","1991","1991/04/03","","","10.1016/0014-2999(91)90485-9"
"1878232","Postoperative pain management and respiratory depression after thoracotomy: a comparison of intramuscular piritramide and intravenous patient-controlled analgesia using fentanyl or buprenorphine","Lehmann KA, Grond S, Freier J, Zech D.","J Clin Anesth. 1991 May-Jun;3(3):194-201. doi: 10.1016/0952-8180(91)90158-j.","Lehmann KA","J Clin Anesth","1991","1991/05/01","","","10.1016/0952-8180(91)90158-j"
"1876147","Buprenorphine suppresses cocaine self-administration by rhesus monkeys over 1 to 4 months of daily treatment","Kamien JB, Mello NK, Mendelson JH, Lukas SE.","NIDA Res Monogr. 1990;105:619-20.","Kamien JB","NIDA Res Monogr","1990","1991/01/01","","",""
"1876146","Effects of naltrexone on cocaine self-administration by rhesus monkey","Mello NK, Kamien JB, Mendelson JH, Lukas SE.","NIDA Res Monogr. 1990;105:617-8.","Mello NK","NIDA Res Monogr","1990","1991/01/01","","",""
"1876131","Outpatient comparison of buprenorphine and methadone maintenance. II. Effects on cocaine usage, retention time in study and missed clinic visits","Fudala PJ, Johnson RE, Jaffe JH.","NIDA Res Monogr. 1990;105:587-8.","Fudala PJ","NIDA Res Monogr","1990","1991/01/01","","",""
"1876130","Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology","Johnson RE, Fudala PJ, Jaffe JH.","NIDA Res Monogr. 1990;105:585-6.","Johnson RE","NIDA Res Monogr","1990","1991/01/01","","",""
"1876122","Elevated drug saliva levels suggest a ""depot-like"" effect in subjects treated with sublingual buprenorphine","Cone EJ, Dickerson SL, Darwin WD, Fudala P, Johnson RE.","NIDA Res Monogr. 1990;105:569.","Cone EJ","NIDA Res Monogr","1990","1991/01/01","","",""
"1876075","Double blind assessment of buprenorphine withdrawal in opiate-addicts","Sam L, Camí J, Fernandez T, Ollé JM, Peri JM, Torrens M.","NIDA Res Monogr. 1990;105:455.","Sam L","NIDA Res Monogr","1990","1991/01/01","","",""
"1876053","Nonpeptide opioids: in vivo effects on the immune system","Williams W, Rice KC, Weber RJ.","NIDA Res Monogr. 1990;105:404-7.","Williams W","NIDA Res Monogr","1990","1991/01/01","","",""
"1875999","Buprenorphine treatment for concurrent heroin and cocaine dependence: phase I study","Mendelson JH, Mello NK, Teoh SK, Kuehnle J, Sintavanarong P, Dooley-Coufos K.","NIDA Res Monogr. 1990;105:196-202.","Mendelson JH","NIDA Res Monogr","1990","1991/01/01","","",""
"1875998","Preclinical evaluation of the effects of buprenorphine, naltrexone and desipramine on cocaine self-administration","Mello NK.","NIDA Res Monogr. 1990;105:189-95.","Mello NK","NIDA Res Monogr","1990","1991/01/01","","",""
"1875542","[The effect of continuous epidural infusion of a combination of 1% mepivacaine and buprenorphine for post-operative pain relief]","Ohtaka K, Matsumoto S, Mitsuhata H, Yabe M.","Masui. 1991 Jun;40(6):942-8.","Ohtaka K","Masui","1991","1991/06/01","","",""
"1874857","High-performance liquid chromatography with electrochemical detection of buprenorphine and its major metabolite in urine","Debrabandere L, Van Boven M, Daenens P.","J Chromatogr. 1991 Apr 5;564(2):557-66. doi: 10.1016/0378-4347(91)80524-g.","Debrabandere L","J Chromatogr","1991","1991/04/05","","","10.1016/0378-4347(91)80524-g"
"1862999","[Synthetic analgesics of a new generation in present-day anesthesiology]","Petrova VV.","Anesteziol Reanimatol. 1991 Mar-Apr;(2):69-73.","Petrova VV","Anesteziol Reanimatol","1991","1991/03/01","","",""
"1862786","Treatment of heroin addicts using buprenorphine","Kosten TR, Morgan C, Kleber HD.","Am J Drug Alcohol Abuse. 1991 Jun;17(2):119-28. doi: 10.3109/00952999108992815.","Kosten TR","Am J Drug Alcohol Abuse","1991","1991/06/01","","","10.3109/00952999108992815"
"1850210","Buprenorphine: a kappa-receptor agonist?","Ginsburg RS, Lippmann M.","Anesth Analg. 1991 May;72(5):718. doi: 10.1213/00000539-199105000-00034.","Ginsburg RS","Anesth Analg","1991","1991/05/01","","","10.1213/00000539-199105000-00034"
"1846412","Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey","Negus SS, Picker MJ, Dykstra LA.","J Pharmacol Exp Ther. 1991 Jan;256(1):149-58.","Negus SS","J Pharmacol Exp Ther","1991","1991/01/01","","",""
"1811431","Epidural buprenorphine or morphine for the relief of head and neck cancer pain","Hashimoto Y, Utsumi T, Tanioka H, Rigor BM.","Anesth Prog. 1991 Mar-Apr;38(2):69-71.","Hashimoto Y","Anesth Prog","1991","1991/03/01","PMC2148689","",""
"1807006","Efficacy of patient-controlled analgesia for management of pain after abdominal operations","Ouchi K, Takeda K, Matsuno S.","Tohoku J Exp Med. 1991 Nov;165(3):193-9. doi: 10.1620/tjem.165.193.","Ouchi K","Tohoku J Exp Med","1991","1991/11/01","","","10.1620/tjem.165.193"
"1806198","[Postoperative analgesia for nephrectomy]","Baude C, Long D, Chabrol B, Moskovtchenko JF.","Cah Anesthesiol. 1991;39(8):533-6.","Baude C","Cah Anesthesiol","1991","1991/01/01","","",""
"1798504","[Totally venous anesthesia with propofol and buprenorphine in major orthopedic surgery]","Pagani I, Ramaioli F, Carnevale L, Mussi P, Raimondi M.","Minerva Anestesiol. 1991 Sep;57(9):608-9.","Pagani I","Minerva Anestesiol","1991","1991/09/01","","",""
"1798460","[Buprenorphine as preanesthetic drug in peridural anesthesia]","Forastiere EM, Iacovacci V, Belcastro F, Paoietti S, Greco A.","Minerva Anestesiol. 1991 Sep;57(9):508-9.","Forastiere EM","Minerva Anestesiol","1991","1991/09/01","","",""
"1798449","[Retrograde venous anesthesia with a combination of dimepivacaine++ and buprenorphine: theoretical suppositions and first experience]","Greco M, Raffa M, De Cillis P, Sacco B, Sorrentini E.","Minerva Anestesiol. 1991 Sep;57(9):481-2.","Greco M","Minerva Anestesiol","1991","1991/09/01","","",""
"1797849","Determination of buprenorphine by high-performance liquid chromatography with fluorescence detection: application to human and rabbit pharmacokinetic studies","Ho ST, Wang JJ, Ho W, Hu OY.","J Chromatogr. 1991 Oct 4;570(2):339-50. doi: 10.1016/0378-4347(91)80537-m.","Ho ST","J Chromatogr","1991","1991/10/04","","","10.1016/0378-4347(91)80537-m"
"1785960","Modifications of ambulation-increasing effect of morphine and buprenorphine following repeated administration in mice","Asahi T, Kuribara H, Tadokoro S.","Arukoru Kenkyuto Yakubutsu Ison. 1991 Dec;26(6):522-30.","Asahi T","Arukoru Kenkyuto Yakubutsu Ison","1991","1991/12/01","","",""
"1784506","The effects of oral morphine and buprenorphine on autotomy following brachial nerve sections in rat","Yamamoto T, Mizuguchi T.","Pain. 1991 Dec;47(3):353-8. doi: 10.1016/0304-3959(91)90228-p.","Yamamoto T","Pain","1991","1991/12/01","","","10.1016/0304-3959(91)90228-p"
"1768545","Effect of sublingual buprenorphine on gastric emptying of a liquid meal","Trotter TN, Rowbotham DJ, Windram I, Mushambi MC.","Br J Anaesth. 1991 Dec;67(6):748-50. doi: 10.1093/bja/67.6.748.","Trotter TN","Br J Anaesth","1991","1991/12/01","","","10.1093/bja/67.6.748"
"1763589","Failure of transcutaneous electrical nerve stimulation and indomethacin to reduce opiate requirement following cholecystectomy","Laitinen J, Nuutinen L.","Acta Anaesthesiol Scand. 1991 Nov;35(8):700-5. doi: 10.1111/j.1399-6576.1991.tb03375.x.","Laitinen J","Acta Anaesthesiol Scand","1991","1991/11/01","","","10.1111/j.1399-6576.1991.tb03375.x"
"1754079","[Use of buprenorphine after right hepatectomy]","Manzi R, Rizzi M, D'Elia F, Perego G, Scaricabarozzi I, Prada A, Terno G.","Minerva Anestesiol. 1991 Jun;57(6):379-82.","Manzi R","Minerva Anestesiol","1991","1991/06/01","","",""
"1749829","Buprenorphine responders: a diagnostic subgroup of heroin addicts?","Resnick RB, Resnick E, Galanter M.","Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(4):531-8. doi: 10.1016/0278-5846(91)90028-y.","Resnick RB","Prog Neuropsychopharmacol Biol Psychiatry","1991","1991/01/01","","","10.1016/0278-5846(91)90028-y"
"1748776","Postoperative analgesia with extradural buprenorphine and pentazocine","Rudra A, Roy S, Roy S, Gupta K, Kundu JP.","J Indian Med Assoc. 1991 May;89(5):123-4.","Rudra A","J Indian Med Assoc","1991","1991/05/01","","",""
"1746507","Buprenorphine for pain relief in a patient with drug abuse","Hughes JR, Bickel WK, Higgins ST.","Am J Drug Alcohol Abuse. 1991;17(4):451-5. doi: 10.3109/00952999109001604.","Hughes JR","Am J Drug Alcohol Abuse","1991","1991/01/01","","","10.3109/00952999109001604"
"1745104","Antagonism of acute cocaine toxicity by buprenorphine","Shukla VK, Goldfrank LR, Turndorf H, Bansinath M.","Life Sci. 1991;49(25):1887-93. doi: 10.1016/0024-3205(91)90289-n.","Shukla VK","Life Sci","1991","1991/01/01","","","10.1016/0024-3205(91)90289-n"
"1744987","Enhancement of the ambulation-increasing effect of opioid analgesics by ethanol in mice","Kuribara H, Asashi T, Tadokoro S.","Jpn J Pharmacol. 1991 Aug;56(4):457-63. doi: 10.1254/jjp.56.457.","Kuribara H","Jpn J Pharmacol","1991","1991/08/01","","","10.1254/jjp.56.457"
"1744931","Further studies on the antinociceptive activity and respiratory effects of buprenorphine in sheep","Waterman AE, Livingston A, Amin A.","J Vet Pharmacol Ther. 1991 Sep;14(3):230-4. doi: 10.1111/j.1365-2885.1991.tb00831.x.","Waterman AE","J Vet Pharmacol Ther","1991","1991/09/01","","","10.1111/j.1365-2885.1991.tb00831.x"
"1731541","Epidural patient-controlled analgesia after cesarean section: buprenorphine-0.015% bupivacaine with epinephrine versus fentanyl-0.015% bupivacaine with and without epinephrine","Cohen S, Amar D, Pantuck CB, Pantuck EJ, Weissman AM, Landa S, Singer N.","Anesth Analg. 1992 Feb;74(2):226-30. doi: 10.1213/00000539-199202000-00009.","Cohen S","Anesth Analg","1992","1992/02/01","","","10.1213/00000539-199202000-00009"
"1717858","Transoval administration of opiates into trigeminal cistern for cancer pain. Preliminary report","Esposito S, Delitala A.","Neurochirurgia (Stuttg). 1991 Jul;34(4):116-8. doi: 10.1055/s-2008-1052068.","Esposito S","Neurochirurgia (Stuttg)","1991","1991/07/01","","","10.1055/s-2008-1052068"
"1715035","The effects of buprenorphine in methadone-dependent volunteers","Strain EC, Bigelow GE, Preston KL, Liebson I.","NIDA Res Monogr. 1990;105:584.","Strain EC","NIDA Res Monogr","1990","1991/01/01","","",""
"1708499","Prolonged nausea and vomiting associated with buprenorphine","Fullerton T, Timm EG, Kolski GB, Bertino JS Jr.","Pharmacotherapy. 1991;11(1):90-3.","Fullerton T","Pharmacotherapy","1991","1991/01/11","","",""
"1703389","[45Ca-uptake, mitochondrial protein bound Ca2+ and ultrastructural distribution of Ca2+ in some brain regions of mice during drug-induced analgesia]","Zhao XN, Zhang ZX, Shi SL, Wang XG, Yang AZ, Wang TL, Zhao WF, Huang MJ, Chen RS.","Zhongguo Yao Li Xue Bao. 1990 Mar;11(2):112-6.","Zhao XN","Zhongguo Yao Li Xue Bao","1990","1990/03/01","","",""
"1693031","No cutaneous histamine release with buprenorphine?","Girotra S, Atray R, Mittal M.","Acta Anaesthesiol Scand. 1990 May;34(4):301-3. doi: 10.1111/j.1399-6576.1990.tb03090.x.","Girotra S","Acta Anaesthesiol Scand","1990","1990/05/01","","","10.1111/j.1399-6576.1990.tb03090.x"
"1691559","[Delayed-action opioids--limitations and advantages]","Bonde J, Christrup LL, Jonsson T.","Ugeskr Laeger. 1990 Apr 2;152(14):1022-4.","Bonde J","Ugeskr Laeger","1990","1990/04/02","","",""
"1687424","[Emergency drugs]","Pelissier A, Roche Y.","Rev Odontostomatol (Paris). 1991 Sep-Oct;20(5):407-19.","Pelissier A","Rev Odontostomatol (Paris)","1991","1991/09/01","","",""
"1676005","Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity","Leza JC, Lizasoain I, Lorenzo P.","Gen Pharmacol. 1991;22(2):293-6. doi: 10.1016/0306-3623(91)90451-b.","Leza JC","Gen Pharmacol","1991","1991/01/01","","","10.1016/0306-3623(91)90451-b"
"1675119","Epidural analgesia during and after cesarean delivery. Comparison of five opioids","Celleno D, Capogna G, Sebastiani M, Costantino P, Muratori F, Cipriani G, Emanuelli M.","Reg Anesth. 1991 Mar-Apr;16(2):79-83.","Celleno D","Reg Anesth","1991","1991/03/01","","",""
"1664666","[Pharmacology of buprenorphine]","Arnould JF, Pinaud M.","Ann Fr Anesth Reanim. 1991;10(6):559-64. doi: 10.1016/S0750-7658(05)80295-3.","Arnould JF","Ann Fr Anesth Reanim","1991","1991/01/01","","","10.1016/S0750-7658(05)80295-3"
"1662176","Interactions of N-cyclopropylmethyl(-)-6 beta-acetylthionormorphine with mu-, kappa-, delta- and sigma-opioid receptors","Takayanagi I, Koike K, Satoh M.","Gen Pharmacol. 1991;22(5):965-7. doi: 10.1016/0306-3623(91)90239-3.","Takayanagi I","Gen Pharmacol","1991","1991/01/01","","","10.1016/0306-3623(91)90239-3"
"1658819","Onset of tolerance to discriminative stimulus effects of morphine","Young AM, Steigerwald ES, Makhay MM, Kapitsopoulos G.","Pharmacol Biochem Behav. 1991 Jun;39(2):487-93. doi: 10.1016/0091-3057(91)90213-l.","Young AM","Pharmacol Biochem Behav","1991","1991/06/01","","","10.1016/0091-3057(91)90213-l"
"1652079","Pharmacological properties of (+)-buprenorphine and (+)-diprenorphine","Grayson NA, Rothman RB, Xu H, Rice KC.","NIDA Res Monogr. 1990;105:380-1.","Grayson NA","NIDA Res Monogr","1990","1991/01/01","","",""
"1647294","The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine","Witkin JM, Johnson RE, Jaffe JH, Goldberg SR, Grayson NA, Rice KC, Katz JL.","Drug Alcohol Depend. 1991 Mar;27(2):177-84. doi: 10.1016/0376-8716(91)90037-y.","Witkin JM","Drug Alcohol Depend","1991","1991/03/01","","","10.1016/0376-8716(91)90037-y"
"1623635","Buprenorphine and gastrointestinal transit in rats: effect of naloxone on the biphasic dose-response curve","Cowan A.","Clin Exp Pharmacol Physiol. 1992 Jan;19(1):47-9. doi: 10.1111/j.1440-1681.1992.tb00396.x.","Cowan A","Clin Exp Pharmacol Physiol","1992","1992/01/01","","","10.1111/j.1440-1681.1992.tb00396.x"
"1612814","Acute respiratory effects of sublingual buprenorphine: comparison with intramuscular morphine","Tantucci C, Paoletti F, Bruni B, Dottorini ML, Peccini F, Boanelli A, Belfiori R, Pasqualucci V.","Int J Clin Pharmacol Ther Toxicol. 1992 Jun;30(6):202-7.","Tantucci C","Int J Clin Pharmacol Ther Toxicol","1992","1992/06/01","","",""
"1609037","Buprenorphine for cocaine and opiate dependence","Kosten TR, Rosen MI, Schottenfeld R, Ziedonis D.","Psychopharmacol Bull. 1992;28(1):15-9.","Kosten TR","Psychopharmacol Bull","1992","1992/01/01","","",""
"1609035","Buprenorphine: an alternative to methadone for heroin dependence treatment","Resnick RB, Galanter M, Pycha C, Cohen A, Grandison P, Flood N.","Psychopharmacol Bull. 1992;28(1):109-13.","Resnick RB","Psychopharmacol Bull","1992","1992/01/01","","",""
"1595337","Application of sublingual buprenorphine in combination with naproxen or paracetamol for post-operative pain relief in cholecystectomy patients in a double-blind study","Witjes WP, Crul BJ, Vollaard EJ, Joosten HJ, von Egmond J.","Acta Anaesthesiol Scand. 1992 May;36(4):323-7. doi: 10.1111/j.1399-6576.1992.tb03475.x.","Witjes WP","Acta Anaesthesiol Scand","1992","1992/05/01","","","10.1111/j.1399-6576.1992.tb03475.x"
"1593145","Intrathecal buprenorphine for postoperative analgesia in orthopaedic surgery","Sen M.","J Indian Med Assoc. 1992 Jan;90(1):5-6.","Sen M","J Indian Med Assoc","1992","1992/01/01","","",""
"1591635","[The use of buprenorphine for peroperative analgesia]","Germain JL, Hermant JL, Hasnaoui AB, Casteran R, Lamotte N, Pourriat JL.","Cah Anesthesiol. 1992;40(1):9-13.","Germain JL","Cah Anesthesiol","1992","1992/01/01","","",""
"1579619","Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats","Carroll ME, Lac ST.","Psychopharmacology (Berl). 1992;106(4):439-46. doi: 10.1007/BF02244812.","Carroll ME","Psychopharmacology (Berl)","1992","1992/01/01","","","10.1007/BF02244812"
"1578593","A controlled trial of buprenorphine treatment for opioid dependence","Johnson RE, Jaffe JH, Fudala PJ.","JAMA. 1992 May 27;267(20):2750-5.","Johnson RE","JAMA","1992","1992/05/27","","",""
"1560376","Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys","Winger G, Skjoldager P, Woods JH.","J Pharmacol Exp Ther. 1992 Apr;261(1):311-7.","Winger G","J Pharmacol Exp Ther","1992","1992/04/01","","",""
"1560373","Buprenorphine's effects on self-administration of smoked cocaine base and orally delivered phencyclidine, ethanol and saccharin in rhesus monkeys","Carroll ME, Carmona GN, May SA, Buzalsky S, Larson C.","J Pharmacol Exp Ther. 1992 Apr;261(1):26-37.","Carroll ME","J Pharmacol Exp Ther","1992","1992/04/01","","",""
"1547574","Analysis of commonly abused drugs in urine at selected threshold (cutoff) concentrations","Watson ID.","Clin Chem. 1992 Mar;38(3):441.","Watson ID","Clin Chem","1992","1992/03/01","","",""
"1545487","[Evaluation of buprenorphine hydrochloride suppositories for postoperative pain relief]","Saruki N, Johnokoshi H, Tozawa R, Fujita T.","Masui. 1992 Jan;41(1):100-5.","Saruki N","Masui","1992","1992/01/01","","",""
"1545386","The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys","Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J, Cone EJ.","J Pharmacol Exp Ther. 1992 Mar;260(3):1185-93.","Mello NK","J Pharmacol Exp Ther","1992","1992/03/01","","",""
"1545216","Analysis of buprenorphine in urine specimens","Debrabandere L, Van Boven M, Daenens P.","J Forensic Sci. 1992 Jan;37(1):82-9.","Debrabandere L","J Forensic Sci","1992","1992/01/01","","",""
"1536441","[Intrapleural bupivacaine and parenteral opioid for postoperative analgesia. A comparative study]","Rose U, Attar Z.","Anaesthesist. 1992 Jan;41(1):53-7.","Rose U","Anaesthesist","1992","1992/01/01","","",""
"1528580","Epidural opioids for postoperative pain relief following hepatectomy","Yukioka H, Fujimori M.","Osaka City Med J. 1992 Jun;38(1):67-77.","Yukioka H","Osaka City Med J","1992","1992/06/01","","",""
"1522316","Gemella morbillorum endocarditis in an intravenous drug abuser","Bell E, McCartney AC.","J Infect. 1992 Jul;25(1):110-2. doi: 10.1016/0163-4453(92)93753-d.","Bell E","J Infect","1992","1992/07/01","","","10.1016/0163-4453(92)93753-d"
"1522305","Role of sublingual administration of tablet buprenorphine hydrochloride on relief of labour pain","Roy S, Basu RK.","J Indian Med Assoc. 1992 Jun;90(6):151-3.","Roy S","J Indian Med Assoc","1992","1992/06/01","","",""
"1517643","Phenytoin as a coanalgesic in cancer pain","Yajnik S, Singh GP, Singh G, Kumar M.","J Pain Symptom Manage. 1992 May;7(4):209-13. doi: 10.1016/0885-3924(92)90077-u.","Yajnik S","J Pain Symptom Manage","1992","1992/05/01","","","10.1016/0885-3924(92)90077-u"
"1503304","[Late acute respiratory insufficiency after buprenorphine injection]","Tixier-Wulff S, Jourdan C.","Ann Fr Anesth Reanim. 1992;11(2):240-1. doi: 10.1016/s0750-7658(05)80025-5.","Tixier-Wulff S","Ann Fr Anesth Reanim","1992","1992/01/01","","","10.1016/s0750-7658(05)80025-5"
"1502961","[Buprenorphine use, a bad prognostic indicator in drug dependence]","Seguí J, Cascio A, Aragón C, Llovet JM, Soler JM, Salvador L.","Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1992 Jan-Feb;20(1):17-22.","Seguí J","Actas Luso Esp Neurol Psiquiatr Cienc Afines","1992","1992/01/01","","",""
"1501431","The effects of buprenorphine, nalbuphine and butorphanol alone or following halothane anaesthesia on food and water consumption and locomotor movement in rats","Liles JH, Flecknell PA.","Lab Anim. 1992 Jul;26(3):180-9. doi: 10.1258/002367792780740558.","Liles JH","Lab Anim","1992","1992/07/01","","","10.1258/002367792780740558"
"1497132","[Obstetrical peridural anesthesia with bupivacaine and buprenorphine. A randomized double-blind study in comparison with untreated controls]","Lehmann KA, Stern S, Breuker KH.","Anaesthesist. 1992 Jul;41(7):414-22.","Lehmann KA","Anaesthesist","1992","1992/07/01","","",""
"1485670","[Norfin in oncological practice]","Osipova NA, Petrova VV, Novikov GA, Beresnev VA, Sergeeva IE, Dolgopolova TV.","Anesteziol Reanimatol. 1992 Jul-Aug;(4):3-7.","Osipova NA","Anesteziol Reanimatol","1992","1992/07/01","","",""
"1479654","[Continuous epidural infusion of bupivacaine and buprenorphine for postoperative pain relief]","Hirabayashi Y, Saitoh K, Fukuda H, Mitsuhata H, Shimizu R.","Masui. 1992 Dec;41(12):1875-80.","Hirabayashi Y","Masui","1992","1992/12/01","","",""
"1479653","[Analgesic effects of epidurally administered fentanyl for postoperative pain relief--comparison with buprenorphine]","Kaetsu H, Takeshi M, Chigusa S, Sakaue M, Hasegawa M, Obara H.","Masui. 1992 Dec;41(12):1870-4.","Kaetsu H","Masui","1992","1992/12/01","","",""
"1476293","[Combination of buprenorphine and propofol for the anesthesia of a burnt child]","Germain JL, Bernasconi C.","Ann Fr Anesth Reanim. 1992;11(5):604-5. doi: 10.1016/s0750-7658(05)80770-1.","Germain JL","Ann Fr Anesth Reanim","1992","1992/01/01","","","10.1016/s0750-7658(05)80770-1"
"1471517","Piroxicam spares buprenorphine after total joint replacement. Controlled study of pain treatment in 81 patients","Boeckstyns ME, Backer M, Petersen EM, Høj I, Albrechtsen H, Andersen HB.","Acta Orthop Scand. 1992 Dec;63(6):658-60. doi: 10.1080/17453679209169730.","Boeckstyns ME","Acta Orthop Scand","1992","1992/12/01","","","10.1080/17453679209169730"
"1445968","Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: preliminary findings","Kosten TR, Morgan C, Kreek MJ.","Biol Psychiatry. 1992 Sep 15;32(6):523-8. doi: 10.1016/0006-3223(92)90220-t.","Kosten TR","Biol Psychiatry","1992","1992/09/15","","","10.1016/0006-3223(92)90220-t"
"1436019","Issues in the analysis of clinical trials for opiate dependence","Follmann D, Wu M, Geller N.","NIDA Res Monogr. 1992;128:97-113; discussion 114-5.","Follmann D","NIDA Res Monogr","1992","1992/01/01","","",""
"1436018","Three estimators of the probability of opiate use from incomplete data","Gross AJ.","NIDA Res Monogr. 1992;128:82-94; discussion 95-6.","Gross AJ","NIDA Res Monogr","1992","1992/01/01","","",""
"1436017","A Bayesian nonparametric approach to analysis of treatment for drug-dependence data","Tiwari RC.","NIDA Res Monogr. 1992;128:70-81.","Tiwari RC","NIDA Res Monogr","1992","1992/01/01","","",""
"1436013","A Markov model for NIDA data on treatment of opiate dependence","Lee ML.","NIDA Res Monogr. 1992;128:160-7; discussion 168-9.","Lee ML","NIDA Res Monogr","1992","1992/01/01","","",""
"1436012","Background and design of a controlled clinical trial (ARC 090) for the treatment of opioid dependence","Johnson RE, Fudala PJ.","NIDA Res Monogr. 1992;128:14-24.","Johnson RE","NIDA Res Monogr","1992","1992/01/01","","",""
"1436011","Toward a dynamic analysis of disease-state transition monitored by serial clinical laboratory tests","Weng TS.","NIDA Res Monogr. 1992;128:137-57; discussion 158-9.","Weng TS","NIDA Res Monogr","1992","1992/01/01","","",""
"1436010","Analysis of clinical trials for treatment of opiate dependence: what are the possibilities?","Jain RB.","NIDA Res Monogr. 1992;128:116-34; discussion 135-6.","Jain RB","NIDA Res Monogr","1992","1992/01/01","","",""
"1435974","Clinical parallels of chronic drug self-administration models for treatment evaluation","Mendelson JH, Mello NK.","NIDA Res Monogr. 1992;119:170-4.","Mendelson JH","NIDA Res Monogr","1992","1992/01/01","","",""
"1433832","[Postoperative pain relief by continuous epidural infusion of bupivacaine and buprenorphine]","Hirabayashi Y, Fukuda H, Saitou K, Tamagawa K, Ikeno S, Furuya K, Mitsuhata H, Akazawa S, Kasuda H, Shimizu R.","Masui. 1992 Oct;41(10):1580-4.","Hirabayashi Y","Masui","1992","1992/10/01","","",""
"1433831","[Effect of epidural buprenorphine on postoperative respiratory function]","Ichiishi N, Hiraishi T, Hara O, Konishi R, Osamura Y, Ashizawa N, Hanaoka K.","Masui. 1992 Oct;41(10):1574-9.","Ichiishi N","Masui","1992","1992/10/01","","",""
"1414399","Cases of buprenorphine abuse in India","Singh RA, Mattoo SK, Malhotra A, Varma VK.","Acta Psychiatr Scand. 1992 Jul;86(1):46-8. doi: 10.1111/j.1600-0447.1992.tb03224.x.","Singh RA","Acta Psychiatr Scand","1992","1992/07/01","","","10.1111/j.1600-0447.1992.tb03224.x"
"1406911","Primate studies of the behavioral pharmacology of buprenorphine","Mello NK, Mendelson JH.","NIDA Res Monogr. 1992;121:61-100.","Mello NK","NIDA Res Monogr","1992","1992/01/01","","",""
"1406910","Buprenorphine--background to its development as a treatment for opiate dependence","Lewis JW, Walter D.","NIDA Res Monogr. 1992;121:5-11.","Lewis JW","NIDA Res Monogr","1992","1992/01/01","","",""
"1406909","Human laboratory studies of buprenorphine","Mendelson JH, Mello NK.","NIDA Res Monogr. 1992;121:38-60.","Mendelson JH","NIDA Res Monogr","1992","1992/01/01","","",""
"1406908","Assessment of buprenorphine in a drug discrimination procedure in humans","Bigelow GE, Preston KL.","NIDA Res Monogr. 1992;121:28-37.","Bigelow GE","NIDA Res Monogr","1992","1992/01/01","","",""
"1406907","Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse","Woods JH, France CP, Winger GD.","NIDA Res Monogr. 1992;121:12-27.","Woods JH","NIDA Res Monogr","1992","1992/01/01","","",""
"1406906","Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone","Kosten TR, Morgan C, Kleber HD.","NIDA Res Monogr. 1992;121:101-19.","Kosten TR","NIDA Res Monogr","1992","1992/01/01","","",""
"1396108","Buprenorphine alone and in combination with naloxone in non-dependent humans","Weinhold LL, Preston KL, Farre M, Liebson IA, Bigelow GE.","Drug Alcohol Depend. 1992 Aug;30(3):263-74. doi: 10.1016/0376-8716(92)90061-g.","Weinhold LL","Drug Alcohol Depend","1992","1992/08/01","","","10.1016/0376-8716(92)90061-g"
"1396104","Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone","Dykstra LA, Doty P, Johnson AB, Picker MJ.","Drug Alcohol Depend. 1992 Aug;30(3):227-34. doi: 10.1016/0376-8716(92)90056-i.","Dykstra LA","Drug Alcohol Depend","1992","1992/08/01","","","10.1016/0376-8716(92)90056-i"
"1392552","Predicting initiation to and cessation of buprenorphine and temazepam use amongst adolescents","Hammersley R, Lavelle T, Forsyth A.","Br J Addict. 1992 Sep;87(9):1303-11. doi: 10.1111/j.1360-0443.1992.tb02739.x.","Hammersley R","Br J Addict","1992","1992/09/01","","","10.1111/j.1360-0443.1992.tb02739.x"
"1384891","[Last-generation synthetic opioid analgesics as alternative to opiates in oncologic surgery]","Osipova NA, Petrova VV, Novikov GA, Solov'ev AA, Sergeeva IE, Mel'nikova ZL.","Vestn Ross Akad Med Nauk. 1992;(6):44-50.","Osipova NA","Vestn Ross Akad Med Nauk","1992","1992/01/01","","",""
"1383825","Development of buprenorphine for the treatment of opioid dependence","Johnson RE, Fudala PJ.","NIDA Res Monogr. 1992;121:120-41.","Johnson RE","NIDA Res Monogr","1992","1992/01/01","","",""
"1376362","Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers","Strain EC, Preston KL, Liebson IA, Bigelow GE.","J Pharmacol Exp Ther. 1992 Jun;261(3):985-93.","Strain EC","J Pharmacol Exp Ther","1992","1992/06/01","","",""
"1350432","[Development of continuous monitoring of spontaneous respiration in the postoperative phase. 2. Cutaneous oxygen and carbon dioxide partial pressures following i.v. bolus application of fentanyl, buprenorphine, naloxone and amiphenazole in healthy adult subjects]","Lehmann KA, Huttarsch H, Schroeder B, Zech D.","Anaesthesist. 1992 Apr;41(4):192-8.","Lehmann KA","Anaesthesist","1992","1992/04/01","","",""
"1330471","Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA","Brooke D, Fudala PJ, Johnson RE.","Drug Alcohol Depend. 1992 Oct;31(1):37-43. doi: 10.1016/0376-8716(92)90006-x.","Brooke D","Drug Alcohol Depend","1992","1992/10/01","","","10.1016/0376-8716(92)90006-x"
"1329800","Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man","Mendelson JH, Teoh SK, Mello NK, Ellingboe J.","Neuropsychopharmacology. 1992 Sep;7(2):157-62.","Mendelson JH","Neuropsychopharmacology","1992","1992/09/01","","",""
"1328733","The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference","Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H.","Jpn J Pharmacol. 1992 Apr;58(4):435-42. doi: 10.1254/jjp.58.435.","Suzuki T","Jpn J Pharmacol","1992","1992/04/01","","","10.1254/jjp.58.435"
"1311974","Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects","San L, Camí J, Fernández T, Ollé JM, Peri JM, Torrens M.","Br J Addict. 1992 Jan;87(1):55-62. doi: 10.1111/j.1360-0443.1992.tb01900.x.","San L","Br J Addict","1992","1992/01/01","","","10.1111/j.1360-0443.1992.tb01900.x"
"1301649","[Buprenorphine abuse in a series of 50 drug addicts hospitalized at a Drug Dependence Evaluation hospital in Marseille]","Arditti J, Bourdon JH, Jean P, Landi H, Nasset D, Jouglard J, Thirion X.","Therapie. 1992 Nov;47(6):561-2.","Arditti J","Therapie","1992","1992/11/01","","",""
"1294917","[Blood levels of cortisol and prolactin. Are they indices of the degree of protection against surgical stress?]","Riverso P, Launo C, Bonilauri M, Faraldi C, Federici E, Napoleone M, Palermo S, Alpa E.","Minerva Anestesiol. 1992 Dec;58(12):1315-7.","Riverso P","Minerva Anestesiol","1992","1992/12/01","","",""
"1285673","Effects of buprenorphine on respiratory and cardiovascular functions during hypoxia in anaesthetized rabbits","Delpierre S, Vanuxem P.","Arch Int Pharmacodyn Ther. 1992 Sep-Oct;319:49-57.","Delpierre S","Arch Int Pharmacodyn Ther","1992","1992/09/01","","",""
"1280014","Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release","Stellato C, Cirillo R, de Paulis A, Casolaro V, Patella V, Mastronardi P, Mazzarella B, Marone G.","Anesthesiology. 1992 Nov;77(5):932-40.","Stellato C","Anesthesiology","1992","1992/11/01","","",""
"747691","Lack of effect of morphine and buprenorphine on hypoxic pulmonary vasoconstriction in the isolated perfused cat lung and the perfused lobe of the dog lung","Gibbs JM, Johnson H.","Br J Anaesth. 1978 Dec;50(12):1197-201. doi: 10.1093/bja/50.12.1197.","Gibbs JM","Br J Anaesth","1978","1978/12/01","","","10.1093/bja/50.12.1197"
"744302","The antagonism by naloxone of agents that interact with dopaminergic neurones","Dettmar PW, Cowan A, Walter DS.","Biochem Soc Trans. 1978;6(5):1004-6. doi: 10.1042/bst0061004.","Dettmar PW","Biochem Soc Trans","1978","1978/01/01","","","10.1042/bst0061004"
"740629","[The effect of buprenorphin on circulation, respiration and the electroencephalogram (a postoperative study of 12 neurosurgical cases) (author's transl)]","Huse K, Stahl HJ, Krämer M.","Prakt Anaesth. 1978 Dec;13(6):489-94.","Huse K","Prakt Anaesth","1978","1978/12/01","","",""
"728741","Haemodynamic effects of buprenorphine after heart surgery","Rosenfeldt FL, Houston B, Thompson D, Naqui N, Malcolm AD, Williams BT, Coltart DJ.","Br Med J. 1978 Dec 9;2(6152):1602-3. doi: 10.1136/bmj.2.6152.1602.","Rosenfeldt FL","Br Med J","1978","1978/12/09","PMC1608864","","10.1136/bmj.2.6152.1602"
"698486","Enhancement of a nociceptive reaction by opioid antagonists in mice","Jacob JJ, Ramabadran K.","Br J Pharmacol. 1978 Sep;64(1):91-8. doi: 10.1111/j.1476-5381.1978.tb08645.x.","Jacob JJ","Br J Pharmacol","1978","1978/09/01","PMC1668273","","10.1111/j.1476-5381.1978.tb08645.x"
"694147","[Sequential anesthesia-analgesia: sulfentanyl-buprenorphine combination]","Arroyo Carreras JL, Medina Enríquez J, Carrascosa Moreno F, Pérez Reiner R, Pezonaga Pĕrez L, González Esparza L, El Busto Osacar JJ.","Rev Esp Anestesiol Reanim. 1978 Mar;25(2):149-57.","Arroyo Carreras JL","Rev Esp Anestesiol Reanim","1978","1978/03/01","","",""
"583326","Antinociceptive actions of morphine and buprenorphine given intrathecally in conscious rats [proceedings]","Bryant RM, Tyers MB.","Br J Pharmacol. 1979 Jul;66(3):472P-473P.","Bryant RM","Br J Pharmacol","1979","1979/07/01","PMC2043708","",""
"552286","Buprenorphine for postoperative analgesia","Sear JW, Cartwright DP, Alexander JI.","Br J Anaesth. 1979 Jan;51(1):71. doi: 10.1093/bja/51.1.71.","Sear JW","Br J Anaesth","1979","1979/01/01","","","10.1093/bja/51.1.71"
"547663","Delayed respiratory depression. A case report and a new hypothesis","McQuay HJ, Bullingham RE, Bennett MR, Moore RA.","Acta Anaesthesiol Belg. 1979;30 Suppl:245-7.","McQuay HJ","Acta Anaesthesiol Belg","1979","1979/01/01","","",""
"547656","Electroencephalographic study of pentazocine and buprenorphine","Kubicki S, Azcona A.","Acta Anaesthesiol Belg. 1979;30 Suppl:123-33.","Kubicki S","Acta Anaesthesiol Belg","1979","1979/01/01","","",""
"526414","Intra-muscular buprenorphine--clinical experience in its use for relieving pain due to malignant disease","Ostrowski MJ, Jackson AW.","Br J Clin Pract. 1979 Oct;33(10):286, 293.","Ostrowski MJ","Br J Clin Pract","1979","1979/10/01","","",""
"525837","[Comparative study about the analgesic effect of buprenorphine (author's transl)]","Rigolot JC, Vergnes Y, Bouket JL, Gauthier-Lafaye P.","Anesth Analg (Paris). 1979;36(7-8):317-21.","Rigolot JC","Anesth Analg (Paris)","1979","1979/01/01","","",""
"510395","Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats","Tavani A, Bianchi G, Manara L.","Eur J Pharmacol. 1979 Oct 26;59(1-2):151-4. doi: 10.1016/0014-2999(79)90039-6.","Tavani A","Eur J Pharmacol","1979","1979/10/26","","","10.1016/0014-2999(79)90039-6"
"509142","Post-marketing surveillance of drugs","Harcus AW, Ward AE, Smith DW.","Br Med J. 1979 Oct 6;2(6194):867. doi: 10.1136/bmj.2.6194.867-c.","Harcus AW","Br Med J","1979","1979/10/06","PMC1596695","","10.1136/bmj.2.6194.867-c"
"497691","Comparison of buprenorphine and diamorphine in suspected myocardial infarction","Simpson HC.","Br Med J. 1979 Sep 1;2(6189):551. doi: 10.1136/bmj.2.6189.551-a.","Simpson HC","Br Med J","1979","1979/09/01","PMC1596198","","10.1136/bmj.2.6189.551-a"
"484814","Relief of pain after surgery. A comparison of sublingual buprenorphine and intramuscular papaveretum","Fry EN.","Anaesthesia. 1979 Jun;34(6):549-51. doi: 10.1111/j.1365-2044.1979.tb06339.x.","Fry EN","Anaesthesia","1979","1979/06/01","","","10.1111/j.1365-2044.1979.tb06339.x"
"483080","The respiratory depressive effects of intravenous buprenorphine in patients in an intensive care unit","Downing JW, Goodwin NM, Hicks J.","S Afr Med J. 1979 Jun 16;55(25):1023-7.","Downing JW","S Afr Med J","1979","1979/06/16","","",""
"474948","Analgesic effects of sublingual buprenorphine","Edge WG, Cooper GM, Morgan M.","Anaesthesia. 1979 May;34(5):463-7. doi: 10.1111/j.1365-2044.1979.tb06325.x.","Edge WG","Anaesthesia","1979","1979/05/01","","","10.1111/j.1365-2044.1979.tb06325.x"
"466334","Methodology of monitored release of a new preparation: buprenorphine","Harcus AW, Ward AE, Smith DW.","Br Med J. 1979 Jul 21;2(6183):163-5. doi: 10.1136/bmj.2.6183.163.","Harcus AW","Br Med J","1979","1979/07/21","PMC1595870","","10.1136/bmj.2.6183.163"
"465292","Pharmacological and clinical importance of narcotic antagonists and mixed antagonists--use in cardiology","Coltart DJ, Malcolm AD.","Br J Clin Pharmacol. 1979;7 Suppl 3(Suppl 3):309S-311S. doi: 10.1111/j.1365-2125.1979.tb04705.x.","Coltart DJ","Br J Clin Pharmacol","1979","1979/01/01","PMC1429307","","10.1111/j.1365-2125.1979.tb04705.x"
"453488","Metoclipramide and opiate emesis","Cundy JM.","Anaesthesia. 1979 Apr;34(4):374. doi: 10.1111/j.1365-2044.1979.tb04954.x.","Cundy JM","Anaesthesia","1979","1979/04/01","","","10.1111/j.1365-2044.1979.tb04954.x"
"444978","Continuous narcotic infusions for relief of postoperative pain","Fry EN.","Br Med J. 1979 Apr 28;1(6171):1149. doi: 10.1136/bmj.1.6171.1149-a.","Fry EN","Br Med J","1979","1979/04/28","PMC1598765","","10.1136/bmj.1.6171.1149-a"
"421663","Buprenorphine injection (Temgesic)","","Drug Ther Bull. 1979 Mar 2;17(5):17-9.","","Drug Ther Bull","1979","1979/03/02","","",""
"421114","Haemodynamic effects of buprenorphine after heart surgery","Bethune DW.","Br Med J. 1979 Feb 3;1(6159):345. doi: 10.1136/bmj.1.6159.345-b.","Bethune DW","Br Med J","1979","1979/02/03","PMC1597646","","10.1136/bmj.1.6159.345-b"
"391321","Comparison of buprenorphine and pethidine given intravenously on demand to relieve postoperative pain","Chakravarty K, Tucker W, Rosen M, Vickers MD.","Br Med J. 1979 Oct 13;2(6195):895-7. doi: 10.1136/bmj.2.6195.895.","Chakravarty K","Br Med J","1979","1979/10/13","PMC1596754","","10.1136/bmj.2.6195.895"
"383195","Randomised trial comparing buprenorphine and diamorphine for chest pain in suspected myocardial infarction","Hayes MJ, Fraser AR, Hampton JR.","Br Med J. 1979 Aug 4;2(6185):300-2. doi: 10.1136/bmj.2.6185.300.","Hayes MJ","Br Med J","1979","1979/08/04","PMC1595690","","10.1136/bmj.2.6185.300"
"380617","A trial of sublingual buprenorphine in cancer pain","Robbie DS.","Br J Clin Pharmacol. 1979;7 Suppl 3(Suppl 3):315S-317S. doi: 10.1111/j.1365-2125.1979.tb04706.x.","Robbie DS","Br J Clin Pharmacol","1979","1979/01/01","PMC1429302","","10.1111/j.1365-2125.1979.tb04706.x"
"378645","Buprenorphine: a review of its pharmacological properties and therapeutic efficacy","Heel RC, Brogden RN, Speight TM, Avery GS.","Drugs. 1979 Feb;17(2):81-110. doi: 10.2165/00003495-197917020-00001.","Heel RC","Drugs","1979","1979/02/01","","","10.2165/00003495-197917020-00001"
"286917","Overdosage of buprenorphine: case report","Banks CD.","N Z Med J. 1979 Apr 11;89(633):255-7.","Banks CD","N Z Med J","1979","1979/04/11","","",""
"223616","Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs","Rance MJ.","Br J Clin Pharmacol. 1979;7 Suppl 3(Suppl 3):281S-286S. doi: 10.1111/j.1365-2125.1979.tb04701.x.","Rance MJ","Br J Clin Pharmacol","1979","1979/01/01","PMC1429313","","10.1111/j.1365-2125.1979.tb04701.x"
"215096","Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction","Jasinski DR, Pevnick JS, Griffith JD.","Arch Gen Psychiatry. 1978 Apr;35(4):501-16. doi: 10.1001/archpsyc.1978.01770280111012.","Jasinski DR","Arch Gen Psychiatry","1978","1978/04/01","","","10.1001/archpsyc.1978.01770280111012"
"115537","Drug information and cost effectiveness","Maynard A.","Br Med J. 1979 Sep 1;2(6189):546-7. doi: 10.1136/bmj.2.6189.546-a.","Maynard A","Br Med J","1979","1979/09/01","PMC1596200","","10.1136/bmj.2.6189.546-a"
"34176","Discriminative stimulus properties of narcotic analgesic drugs","Colpaert FC.","Pharmacol Biochem Behav. 1978 Dec;9(6):863-87. doi: 10.1016/0091-3057(78)90370-2.","Colpaert FC","Pharmacol Biochem Behav","1978","1978/12/01","","","10.1016/0091-3057(78)90370-2"
"31641","Pharmacotherapy of narcotic dependence","Maykut MO.","Prog Neuropsychopharmacol. 1977;1(1-2):31-49. doi: 10.1016/0364-7722(77)90026-1.","Maykut MO","Prog Neuropsychopharmacol","1977","1977/01/01","","","10.1016/0364-7722(77)90026-1"
"30820","Opiate analgesics: the effect of agonist-antagonist character on prolactin secretion","Brown B, Dettmar PW, Dobson PR, Lynn AG, Metcalf G, Morgan BA.","J Pharm Pharmacol. 1978 Oct;30(10):644-5. doi: 10.1111/j.2042-7158.1978.tb13348.x.","Brown B","J Pharm Pharmacol","1978","1978/10/01","","","10.1111/j.2042-7158.1978.tb13348.x"
